<!DOCTYPE html>

<html xmlns="http://www.w3.org/1999/xhtml">

<head>

<meta charset="utf-8" />
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="generator" content="pandoc" />


<meta name="author" content="ALSF CCDL - Candace Savonen" />


<title>Batch Correction</title>

<script>/*! jQuery v1.11.3 | (c) 2005, 2015 jQuery Foundation, Inc. | jquery.org/license */
!function(a,b){"object"==typeof module&&"object"==typeof module.exports?module.exports=a.document?b(a,!0):function(a){if(!a.document)throw new Error("jQuery requires a window with a document");return b(a)}:b(a)}("undefined"!=typeof window?window:this,function(a,b){var c=[],d=c.slice,e=c.concat,f=c.push,g=c.indexOf,h={},i=h.toString,j=h.hasOwnProperty,k={},l="1.11.3",m=function(a,b){return new m.fn.init(a,b)},n=/^[\s\uFEFF\xA0]+|[\s\uFEFF\xA0]+$/g,o=/^-ms-/,p=/-([\da-z])/gi,q=function(a,b){return b.toUpperCase()};m.fn=m.prototype={jquery:l,constructor:m,selector:"",length:0,toArray:function(){return d.call(this)},get:function(a){return null!=a?0>a?this[a+this.length]:this[a]:d.call(this)},pushStack:function(a){var b=m.merge(this.constructor(),a);return b.prevObject=this,b.context=this.context,b},each:function(a,b){return m.each(this,a,b)},map:function(a){return this.pushStack(m.map(this,function(b,c){return a.call(b,c,b)}))},slice:function(){return this.pushStack(d.apply(this,arguments))},first:function(){return this.eq(0)},last:function(){return this.eq(-1)},eq:function(a){var b=this.length,c=+a+(0>a?b:0);return this.pushStack(c>=0&&b>c?[this[c]]:[])},end:function(){return this.prevObject||this.constructor(null)},push:f,sort:c.sort,splice:c.splice},m.extend=m.fn.extend=function(){var a,b,c,d,e,f,g=arguments[0]||{},h=1,i=arguments.length,j=!1;for("boolean"==typeof g&&(j=g,g=arguments[h]||{},h++),"object"==typeof g||m.isFunction(g)||(g={}),h===i&&(g=this,h--);i>h;h++)if(null!=(e=arguments[h]))for(d in e)a=g[d],c=e[d],g!==c&&(j&&c&&(m.isPlainObject(c)||(b=m.isArray(c)))?(b?(b=!1,f=a&&m.isArray(a)?a:[]):f=a&&m.isPlainObject(a)?a:{},g[d]=m.extend(j,f,c)):void 0!==c&&(g[d]=c));return g},m.extend({expando:"jQuery"+(l+Math.random()).replace(/\D/g,""),isReady:!0,error:function(a){throw new Error(a)},noop:function(){},isFunction:function(a){return"function"===m.type(a)},isArray:Array.isArray||function(a){return"array"===m.type(a)},isWindow:function(a){return null!=a&&a==a.window},isNumeric:function(a){return!m.isArray(a)&&a-parseFloat(a)+1>=0},isEmptyObject:function(a){var b;for(b in a)return!1;return!0},isPlainObject:function(a){var b;if(!a||"object"!==m.type(a)||a.nodeType||m.isWindow(a))return!1;try{if(a.constructor&&!j.call(a,"constructor")&&!j.call(a.constructor.prototype,"isPrototypeOf"))return!1}catch(c){return!1}if(k.ownLast)for(b in a)return j.call(a,b);for(b in a);return void 0===b||j.call(a,b)},type:function(a){return null==a?a+"":"object"==typeof a||"function"==typeof a?h[i.call(a)]||"object":typeof a},globalEval:function(b){b&&m.trim(b)&&(a.execScript||function(b){a.eval.call(a,b)})(b)},camelCase:function(a){return a.replace(o,"ms-").replace(p,q)},nodeName:function(a,b){return a.nodeName&&a.nodeName.toLowerCase()===b.toLowerCase()},each:function(a,b,c){var d,e=0,f=a.length,g=r(a);if(c){if(g){for(;f>e;e++)if(d=b.apply(a[e],c),d===!1)break}else for(e in a)if(d=b.apply(a[e],c),d===!1)break}else if(g){for(;f>e;e++)if(d=b.call(a[e],e,a[e]),d===!1)break}else for(e in a)if(d=b.call(a[e],e,a[e]),d===!1)break;return a},trim:function(a){return null==a?"":(a+"").replace(n,"")},makeArray:function(a,b){var c=b||[];return null!=a&&(r(Object(a))?m.merge(c,"string"==typeof a?[a]:a):f.call(c,a)),c},inArray:function(a,b,c){var d;if(b){if(g)return g.call(b,a,c);for(d=b.length,c=c?0>c?Math.max(0,d+c):c:0;d>c;c++)if(c in b&&b[c]===a)return c}return-1},merge:function(a,b){var c=+b.length,d=0,e=a.length;while(c>d)a[e++]=b[d++];if(c!==c)while(void 0!==b[d])a[e++]=b[d++];return a.length=e,a},grep:function(a,b,c){for(var d,e=[],f=0,g=a.length,h=!c;g>f;f++)d=!b(a[f],f),d!==h&&e.push(a[f]);return e},map:function(a,b,c){var d,f=0,g=a.length,h=r(a),i=[];if(h)for(;g>f;f++)d=b(a[f],f,c),null!=d&&i.push(d);else for(f in a)d=b(a[f],f,c),null!=d&&i.push(d);return e.apply([],i)},guid:1,proxy:function(a,b){var c,e,f;return"string"==typeof b&&(f=a[b],b=a,a=f),m.isFunction(a)?(c=d.call(arguments,2),e=function(){return a.apply(b||this,c.concat(d.call(arguments)))},e.guid=a.guid=a.guid||m.guid++,e):void 0},now:function(){return+new Date},support:k}),m.each("Boolean Number String Function Array Date RegExp Object Error".split(" "),function(a,b){h["[object "+b+"]"]=b.toLowerCase()});function r(a){var b="length"in a&&a.length,c=m.type(a);return"function"===c||m.isWindow(a)?!1:1===a.nodeType&&b?!0:"array"===c||0===b||"number"==typeof b&&b>0&&b-1 in a}var s=function(a){var b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u="sizzle"+1*new Date,v=a.document,w=0,x=0,y=ha(),z=ha(),A=ha(),B=function(a,b){return a===b&&(l=!0),0},C=1<<31,D={}.hasOwnProperty,E=[],F=E.pop,G=E.push,H=E.push,I=E.slice,J=function(a,b){for(var c=0,d=a.length;d>c;c++)if(a[c]===b)return c;return-1},K="checked|selected|async|autofocus|autoplay|controls|defer|disabled|hidden|ismap|loop|multiple|open|readonly|required|scoped",L="[\\x20\\t\\r\\n\\f]",M="(?:\\\\.|[\\w-]|[^\\x00-\\xa0])+",N=M.replace("w","w#"),O="\\["+L+"*("+M+")(?:"+L+"*([*^$|!~]?=)"+L+"*(?:'((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\"|("+N+"))|)"+L+"*\\]",P=":("+M+")(?:\\((('((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\")|((?:\\\\.|[^\\\\()[\\]]|"+O+")*)|.*)\\)|)",Q=new RegExp(L+"+","g"),R=new RegExp("^"+L+"+|((?:^|[^\\\\])(?:\\\\.)*)"+L+"+$","g"),S=new RegExp("^"+L+"*,"+L+"*"),T=new RegExp("^"+L+"*([>+~]|"+L+")"+L+"*"),U=new RegExp("="+L+"*([^\\]'\"]*?)"+L+"*\\]","g"),V=new RegExp(P),W=new RegExp("^"+N+"$"),X={ID:new RegExp("^#("+M+")"),CLASS:new RegExp("^\\.("+M+")"),TAG:new RegExp("^("+M.replace("w","w*")+")"),ATTR:new RegExp("^"+O),PSEUDO:new RegExp("^"+P),CHILD:new RegExp("^:(only|first|last|nth|nth-last)-(child|of-type)(?:\\("+L+"*(even|odd|(([+-]|)(\\d*)n|)"+L+"*(?:([+-]|)"+L+"*(\\d+)|))"+L+"*\\)|)","i"),bool:new RegExp("^(?:"+K+")$","i"),needsContext:new RegExp("^"+L+"*[>+~]|:(even|odd|eq|gt|lt|nth|first|last)(?:\\("+L+"*((?:-\\d)?\\d*)"+L+"*\\)|)(?=[^-]|$)","i")},Y=/^(?:input|select|textarea|button)$/i,Z=/^h\d$/i,$=/^[^{]+\{\s*\[native \w/,_=/^(?:#([\w-]+)|(\w+)|\.([\w-]+))$/,aa=/[+~]/,ba=/'|\\/g,ca=new RegExp("\\\\([\\da-f]{1,6}"+L+"?|("+L+")|.)","ig"),da=function(a,b,c){var d="0x"+b-65536;return d!==d||c?b:0>d?String.fromCharCode(d+65536):String.fromCharCode(d>>10|55296,1023&d|56320)},ea=function(){m()};try{H.apply(E=I.call(v.childNodes),v.childNodes),E[v.childNodes.length].nodeType}catch(fa){H={apply:E.length?function(a,b){G.apply(a,I.call(b))}:function(a,b){var c=a.length,d=0;while(a[c++]=b[d++]);a.length=c-1}}}function ga(a,b,d,e){var f,h,j,k,l,o,r,s,w,x;if((b?b.ownerDocument||b:v)!==n&&m(b),b=b||n,d=d||[],k=b.nodeType,"string"!=typeof a||!a||1!==k&&9!==k&&11!==k)return d;if(!e&&p){if(11!==k&&(f=_.exec(a)))if(j=f[1]){if(9===k){if(h=b.getElementById(j),!h||!h.parentNode)return d;if(h.id===j)return d.push(h),d}else if(b.ownerDocument&&(h=b.ownerDocument.getElementById(j))&&t(b,h)&&h.id===j)return d.push(h),d}else{if(f[2])return H.apply(d,b.getElementsByTagName(a)),d;if((j=f[3])&&c.getElementsByClassName)return H.apply(d,b.getElementsByClassName(j)),d}if(c.qsa&&(!q||!q.test(a))){if(s=r=u,w=b,x=1!==k&&a,1===k&&"object"!==b.nodeName.toLowerCase()){o=g(a),(r=b.getAttribute("id"))?s=r.replace(ba,"\\$&"):b.setAttribute("id",s),s="[id='"+s+"'] ",l=o.length;while(l--)o[l]=s+ra(o[l]);w=aa.test(a)&&pa(b.parentNode)||b,x=o.join(",")}if(x)try{return H.apply(d,w.querySelectorAll(x)),d}catch(y){}finally{r||b.removeAttribute("id")}}}return i(a.replace(R,"$1"),b,d,e)}function ha(){var a=[];function b(c,e){return a.push(c+" ")>d.cacheLength&&delete b[a.shift()],b[c+" "]=e}return b}function ia(a){return a[u]=!0,a}function ja(a){var b=n.createElement("div");try{return!!a(b)}catch(c){return!1}finally{b.parentNode&&b.parentNode.removeChild(b),b=null}}function ka(a,b){var c=a.split("|"),e=a.length;while(e--)d.attrHandle[c[e]]=b}function la(a,b){var c=b&&a,d=c&&1===a.nodeType&&1===b.nodeType&&(~b.sourceIndex||C)-(~a.sourceIndex||C);if(d)return d;if(c)while(c=c.nextSibling)if(c===b)return-1;return a?1:-1}function ma(a){return function(b){var c=b.nodeName.toLowerCase();return"input"===c&&b.type===a}}function na(a){return function(b){var c=b.nodeName.toLowerCase();return("input"===c||"button"===c)&&b.type===a}}function oa(a){return ia(function(b){return b=+b,ia(function(c,d){var e,f=a([],c.length,b),g=f.length;while(g--)c[e=f[g]]&&(c[e]=!(d[e]=c[e]))})})}function pa(a){return a&&"undefined"!=typeof a.getElementsByTagName&&a}c=ga.support={},f=ga.isXML=function(a){var b=a&&(a.ownerDocument||a).documentElement;return b?"HTML"!==b.nodeName:!1},m=ga.setDocument=function(a){var b,e,g=a?a.ownerDocument||a:v;return g!==n&&9===g.nodeType&&g.documentElement?(n=g,o=g.documentElement,e=g.defaultView,e&&e!==e.top&&(e.addEventListener?e.addEventListener("unload",ea,!1):e.attachEvent&&e.attachEvent("onunload",ea)),p=!f(g),c.attributes=ja(function(a){return a.className="i",!a.getAttribute("className")}),c.getElementsByTagName=ja(function(a){return a.appendChild(g.createComment("")),!a.getElementsByTagName("*").length}),c.getElementsByClassName=$.test(g.getElementsByClassName),c.getById=ja(function(a){return o.appendChild(a).id=u,!g.getElementsByName||!g.getElementsByName(u).length}),c.getById?(d.find.ID=function(a,b){if("undefined"!=typeof b.getElementById&&p){var c=b.getElementById(a);return c&&c.parentNode?[c]:[]}},d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){return a.getAttribute("id")===b}}):(delete d.find.ID,d.filter.ID=function(a){var b=a.replace(ca,da);return function(a){var c="undefined"!=typeof a.getAttributeNode&&a.getAttributeNode("id");return c&&c.value===b}}),d.find.TAG=c.getElementsByTagName?function(a,b){return"undefined"!=typeof b.getElementsByTagName?b.getElementsByTagName(a):c.qsa?b.querySelectorAll(a):void 0}:function(a,b){var c,d=[],e=0,f=b.getElementsByTagName(a);if("*"===a){while(c=f[e++])1===c.nodeType&&d.push(c);return d}return f},d.find.CLASS=c.getElementsByClassName&&function(a,b){return p?b.getElementsByClassName(a):void 0},r=[],q=[],(c.qsa=$.test(g.querySelectorAll))&&(ja(function(a){o.appendChild(a).innerHTML="<a id='"+u+"'></a><select id='"+u+"-\f]' msallowcapture=''><option selected=''></option></select>",a.querySelectorAll("[msallowcapture^='']").length&&q.push("[*^$]="+L+"*(?:''|\"\")"),a.querySelectorAll("[selected]").length||q.push("\\["+L+"*(?:value|"+K+")"),a.querySelectorAll("[id~="+u+"-]").length||q.push("~="),a.querySelectorAll(":checked").length||q.push(":checked"),a.querySelectorAll("a#"+u+"+*").length||q.push(".#.+[+~]")}),ja(function(a){var b=g.createElement("input");b.setAttribute("type","hidden"),a.appendChild(b).setAttribute("name","D"),a.querySelectorAll("[name=d]").length&&q.push("name"+L+"*[*^$|!~]?="),a.querySelectorAll(":enabled").length||q.push(":enabled",":disabled"),a.querySelectorAll("*,:x"),q.push(",.*:")})),(c.matchesSelector=$.test(s=o.matches||o.webkitMatchesSelector||o.mozMatchesSelector||o.oMatchesSelector||o.msMatchesSelector))&&ja(function(a){c.disconnectedMatch=s.call(a,"div"),s.call(a,"[s!='']:x"),r.push("!=",P)}),q=q.length&&new RegExp(q.join("|")),r=r.length&&new RegExp(r.join("|")),b=$.test(o.compareDocumentPosition),t=b||$.test(o.contains)?function(a,b){var c=9===a.nodeType?a.documentElement:a,d=b&&b.parentNode;return a===d||!(!d||1!==d.nodeType||!(c.contains?c.contains(d):a.compareDocumentPosition&&16&a.compareDocumentPosition(d)))}:function(a,b){if(b)while(b=b.parentNode)if(b===a)return!0;return!1},B=b?function(a,b){if(a===b)return l=!0,0;var d=!a.compareDocumentPosition-!b.compareDocumentPosition;return d?d:(d=(a.ownerDocument||a)===(b.ownerDocument||b)?a.compareDocumentPosition(b):1,1&d||!c.sortDetached&&b.compareDocumentPosition(a)===d?a===g||a.ownerDocument===v&&t(v,a)?-1:b===g||b.ownerDocument===v&&t(v,b)?1:k?J(k,a)-J(k,b):0:4&d?-1:1)}:function(a,b){if(a===b)return l=!0,0;var c,d=0,e=a.parentNode,f=b.parentNode,h=[a],i=[b];if(!e||!f)return a===g?-1:b===g?1:e?-1:f?1:k?J(k,a)-J(k,b):0;if(e===f)return la(a,b);c=a;while(c=c.parentNode)h.unshift(c);c=b;while(c=c.parentNode)i.unshift(c);while(h[d]===i[d])d++;return d?la(h[d],i[d]):h[d]===v?-1:i[d]===v?1:0},g):n},ga.matches=function(a,b){return ga(a,null,null,b)},ga.matchesSelector=function(a,b){if((a.ownerDocument||a)!==n&&m(a),b=b.replace(U,"='$1']"),!(!c.matchesSelector||!p||r&&r.test(b)||q&&q.test(b)))try{var d=s.call(a,b);if(d||c.disconnectedMatch||a.document&&11!==a.document.nodeType)return d}catch(e){}return ga(b,n,null,[a]).length>0},ga.contains=function(a,b){return(a.ownerDocument||a)!==n&&m(a),t(a,b)},ga.attr=function(a,b){(a.ownerDocument||a)!==n&&m(a);var e=d.attrHandle[b.toLowerCase()],f=e&&D.call(d.attrHandle,b.toLowerCase())?e(a,b,!p):void 0;return void 0!==f?f:c.attributes||!p?a.getAttribute(b):(f=a.getAttributeNode(b))&&f.specified?f.value:null},ga.error=function(a){throw new Error("Syntax error, unrecognized expression: "+a)},ga.uniqueSort=function(a){var b,d=[],e=0,f=0;if(l=!c.detectDuplicates,k=!c.sortStable&&a.slice(0),a.sort(B),l){while(b=a[f++])b===a[f]&&(e=d.push(f));while(e--)a.splice(d[e],1)}return k=null,a},e=ga.getText=function(a){var b,c="",d=0,f=a.nodeType;if(f){if(1===f||9===f||11===f){if("string"==typeof a.textContent)return a.textContent;for(a=a.firstChild;a;a=a.nextSibling)c+=e(a)}else if(3===f||4===f)return a.nodeValue}else while(b=a[d++])c+=e(b);return c},d=ga.selectors={cacheLength:50,createPseudo:ia,match:X,attrHandle:{},find:{},relative:{">":{dir:"parentNode",first:!0}," ":{dir:"parentNode"},"+":{dir:"previousSibling",first:!0},"~":{dir:"previousSibling"}},preFilter:{ATTR:function(a){return a[1]=a[1].replace(ca,da),a[3]=(a[3]||a[4]||a[5]||"").replace(ca,da),"~="===a[2]&&(a[3]=" "+a[3]+" "),a.slice(0,4)},CHILD:function(a){return a[1]=a[1].toLowerCase(),"nth"===a[1].slice(0,3)?(a[3]||ga.error(a[0]),a[4]=+(a[4]?a[5]+(a[6]||1):2*("even"===a[3]||"odd"===a[3])),a[5]=+(a[7]+a[8]||"odd"===a[3])):a[3]&&ga.error(a[0]),a},PSEUDO:function(a){var b,c=!a[6]&&a[2];return X.CHILD.test(a[0])?null:(a[3]?a[2]=a[4]||a[5]||"":c&&V.test(c)&&(b=g(c,!0))&&(b=c.indexOf(")",c.length-b)-c.length)&&(a[0]=a[0].slice(0,b),a[2]=c.slice(0,b)),a.slice(0,3))}},filter:{TAG:function(a){var b=a.replace(ca,da).toLowerCase();return"*"===a?function(){return!0}:function(a){return a.nodeName&&a.nodeName.toLowerCase()===b}},CLASS:function(a){var b=y[a+" "];return b||(b=new RegExp("(^|"+L+")"+a+"("+L+"|$)"))&&y(a,function(a){return b.test("string"==typeof a.className&&a.className||"undefined"!=typeof a.getAttribute&&a.getAttribute("class")||"")})},ATTR:function(a,b,c){return function(d){var e=ga.attr(d,a);return null==e?"!="===b:b?(e+="","="===b?e===c:"!="===b?e!==c:"^="===b?c&&0===e.indexOf(c):"*="===b?c&&e.indexOf(c)>-1:"$="===b?c&&e.slice(-c.length)===c:"~="===b?(" "+e.replace(Q," ")+" ").indexOf(c)>-1:"|="===b?e===c||e.slice(0,c.length+1)===c+"-":!1):!0}},CHILD:function(a,b,c,d,e){var f="nth"!==a.slice(0,3),g="last"!==a.slice(-4),h="of-type"===b;return 1===d&&0===e?function(a){return!!a.parentNode}:function(b,c,i){var j,k,l,m,n,o,p=f!==g?"nextSibling":"previousSibling",q=b.parentNode,r=h&&b.nodeName.toLowerCase(),s=!i&&!h;if(q){if(f){while(p){l=b;while(l=l[p])if(h?l.nodeName.toLowerCase()===r:1===l.nodeType)return!1;o=p="only"===a&&!o&&"nextSibling"}return!0}if(o=[g?q.firstChild:q.lastChild],g&&s){k=q[u]||(q[u]={}),j=k[a]||[],n=j[0]===w&&j[1],m=j[0]===w&&j[2],l=n&&q.childNodes[n];while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if(1===l.nodeType&&++m&&l===b){k[a]=[w,n,m];break}}else if(s&&(j=(b[u]||(b[u]={}))[a])&&j[0]===w)m=j[1];else while(l=++n&&l&&l[p]||(m=n=0)||o.pop())if((h?l.nodeName.toLowerCase()===r:1===l.nodeType)&&++m&&(s&&((l[u]||(l[u]={}))[a]=[w,m]),l===b))break;return m-=e,m===d||m%d===0&&m/d>=0}}},PSEUDO:function(a,b){var c,e=d.pseudos[a]||d.setFilters[a.toLowerCase()]||ga.error("unsupported pseudo: "+a);return e[u]?e(b):e.length>1?(c=[a,a,"",b],d.setFilters.hasOwnProperty(a.toLowerCase())?ia(function(a,c){var d,f=e(a,b),g=f.length;while(g--)d=J(a,f[g]),a[d]=!(c[d]=f[g])}):function(a){return e(a,0,c)}):e}},pseudos:{not:ia(function(a){var b=[],c=[],d=h(a.replace(R,"$1"));return d[u]?ia(function(a,b,c,e){var f,g=d(a,null,e,[]),h=a.length;while(h--)(f=g[h])&&(a[h]=!(b[h]=f))}):function(a,e,f){return b[0]=a,d(b,null,f,c),b[0]=null,!c.pop()}}),has:ia(function(a){return function(b){return ga(a,b).length>0}}),contains:ia(function(a){return a=a.replace(ca,da),function(b){return(b.textContent||b.innerText||e(b)).indexOf(a)>-1}}),lang:ia(function(a){return W.test(a||"")||ga.error("unsupported lang: "+a),a=a.replace(ca,da).toLowerCase(),function(b){var c;do if(c=p?b.lang:b.getAttribute("xml:lang")||b.getAttribute("lang"))return c=c.toLowerCase(),c===a||0===c.indexOf(a+"-");while((b=b.parentNode)&&1===b.nodeType);return!1}}),target:function(b){var c=a.location&&a.location.hash;return c&&c.slice(1)===b.id},root:function(a){return a===o},focus:function(a){return a===n.activeElement&&(!n.hasFocus||n.hasFocus())&&!!(a.type||a.href||~a.tabIndex)},enabled:function(a){return a.disabled===!1},disabled:function(a){return a.disabled===!0},checked:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&!!a.checked||"option"===b&&!!a.selected},selected:function(a){return a.parentNode&&a.parentNode.selectedIndex,a.selected===!0},empty:function(a){for(a=a.firstChild;a;a=a.nextSibling)if(a.nodeType<6)return!1;return!0},parent:function(a){return!d.pseudos.empty(a)},header:function(a){return Z.test(a.nodeName)},input:function(a){return Y.test(a.nodeName)},button:function(a){var b=a.nodeName.toLowerCase();return"input"===b&&"button"===a.type||"button"===b},text:function(a){var b;return"input"===a.nodeName.toLowerCase()&&"text"===a.type&&(null==(b=a.getAttribute("type"))||"text"===b.toLowerCase())},first:oa(function(){return[0]}),last:oa(function(a,b){return[b-1]}),eq:oa(function(a,b,c){return[0>c?c+b:c]}),even:oa(function(a,b){for(var c=0;b>c;c+=2)a.push(c);return a}),odd:oa(function(a,b){for(var c=1;b>c;c+=2)a.push(c);return a}),lt:oa(function(a,b,c){for(var d=0>c?c+b:c;--d>=0;)a.push(d);return a}),gt:oa(function(a,b,c){for(var d=0>c?c+b:c;++d<b;)a.push(d);return a})}},d.pseudos.nth=d.pseudos.eq;for(b in{radio:!0,checkbox:!0,file:!0,password:!0,image:!0})d.pseudos[b]=ma(b);for(b in{submit:!0,reset:!0})d.pseudos[b]=na(b);function qa(){}qa.prototype=d.filters=d.pseudos,d.setFilters=new qa,g=ga.tokenize=function(a,b){var c,e,f,g,h,i,j,k=z[a+" "];if(k)return b?0:k.slice(0);h=a,i=[],j=d.preFilter;while(h){(!c||(e=S.exec(h)))&&(e&&(h=h.slice(e[0].length)||h),i.push(f=[])),c=!1,(e=T.exec(h))&&(c=e.shift(),f.push({value:c,type:e[0].replace(R," ")}),h=h.slice(c.length));for(g in d.filter)!(e=X[g].exec(h))||j[g]&&!(e=j[g](e))||(c=e.shift(),f.push({value:c,type:g,matches:e}),h=h.slice(c.length));if(!c)break}return b?h.length:h?ga.error(a):z(a,i).slice(0)};function ra(a){for(var b=0,c=a.length,d="";c>b;b++)d+=a[b].value;return d}function sa(a,b,c){var d=b.dir,e=c&&"parentNode"===d,f=x++;return b.first?function(b,c,f){while(b=b[d])if(1===b.nodeType||e)return a(b,c,f)}:function(b,c,g){var h,i,j=[w,f];if(g){while(b=b[d])if((1===b.nodeType||e)&&a(b,c,g))return!0}else while(b=b[d])if(1===b.nodeType||e){if(i=b[u]||(b[u]={}),(h=i[d])&&h[0]===w&&h[1]===f)return j[2]=h[2];if(i[d]=j,j[2]=a(b,c,g))return!0}}}function ta(a){return a.length>1?function(b,c,d){var e=a.length;while(e--)if(!a[e](b,c,d))return!1;return!0}:a[0]}function ua(a,b,c){for(var d=0,e=b.length;e>d;d++)ga(a,b[d],c);return c}function va(a,b,c,d,e){for(var f,g=[],h=0,i=a.length,j=null!=b;i>h;h++)(f=a[h])&&(!c||c(f,d,e))&&(g.push(f),j&&b.push(h));return g}function wa(a,b,c,d,e,f){return d&&!d[u]&&(d=wa(d)),e&&!e[u]&&(e=wa(e,f)),ia(function(f,g,h,i){var j,k,l,m=[],n=[],o=g.length,p=f||ua(b||"*",h.nodeType?[h]:h,[]),q=!a||!f&&b?p:va(p,m,a,h,i),r=c?e||(f?a:o||d)?[]:g:q;if(c&&c(q,r,h,i),d){j=va(r,n),d(j,[],h,i),k=j.length;while(k--)(l=j[k])&&(r[n[k]]=!(q[n[k]]=l))}if(f){if(e||a){if(e){j=[],k=r.length;while(k--)(l=r[k])&&j.push(q[k]=l);e(null,r=[],j,i)}k=r.length;while(k--)(l=r[k])&&(j=e?J(f,l):m[k])>-1&&(f[j]=!(g[j]=l))}}else r=va(r===g?r.splice(o,r.length):r),e?e(null,g,r,i):H.apply(g,r)})}function xa(a){for(var b,c,e,f=a.length,g=d.relative[a[0].type],h=g||d.relative[" "],i=g?1:0,k=sa(function(a){return a===b},h,!0),l=sa(function(a){return J(b,a)>-1},h,!0),m=[function(a,c,d){var e=!g&&(d||c!==j)||((b=c).nodeType?k(a,c,d):l(a,c,d));return b=null,e}];f>i;i++)if(c=d.relative[a[i].type])m=[sa(ta(m),c)];else{if(c=d.filter[a[i].type].apply(null,a[i].matches),c[u]){for(e=++i;f>e;e++)if(d.relative[a[e].type])break;return wa(i>1&&ta(m),i>1&&ra(a.slice(0,i-1).concat({value:" "===a[i-2].type?"*":""})).replace(R,"$1"),c,e>i&&xa(a.slice(i,e)),f>e&&xa(a=a.slice(e)),f>e&&ra(a))}m.push(c)}return ta(m)}function ya(a,b){var c=b.length>0,e=a.length>0,f=function(f,g,h,i,k){var l,m,o,p=0,q="0",r=f&&[],s=[],t=j,u=f||e&&d.find.TAG("*",k),v=w+=null==t?1:Math.random()||.1,x=u.length;for(k&&(j=g!==n&&g);q!==x&&null!=(l=u[q]);q++){if(e&&l){m=0;while(o=a[m++])if(o(l,g,h)){i.push(l);break}k&&(w=v)}c&&((l=!o&&l)&&p--,f&&r.push(l))}if(p+=q,c&&q!==p){m=0;while(o=b[m++])o(r,s,g,h);if(f){if(p>0)while(q--)r[q]||s[q]||(s[q]=F.call(i));s=va(s)}H.apply(i,s),k&&!f&&s.length>0&&p+b.length>1&&ga.uniqueSort(i)}return k&&(w=v,j=t),r};return c?ia(f):f}return h=ga.compile=function(a,b){var c,d=[],e=[],f=A[a+" "];if(!f){b||(b=g(a)),c=b.length;while(c--)f=xa(b[c]),f[u]?d.push(f):e.push(f);f=A(a,ya(e,d)),f.selector=a}return f},i=ga.select=function(a,b,e,f){var i,j,k,l,m,n="function"==typeof a&&a,o=!f&&g(a=n.selector||a);if(e=e||[],1===o.length){if(j=o[0]=o[0].slice(0),j.length>2&&"ID"===(k=j[0]).type&&c.getById&&9===b.nodeType&&p&&d.relative[j[1].type]){if(b=(d.find.ID(k.matches[0].replace(ca,da),b)||[])[0],!b)return e;n&&(b=b.parentNode),a=a.slice(j.shift().value.length)}i=X.needsContext.test(a)?0:j.length;while(i--){if(k=j[i],d.relative[l=k.type])break;if((m=d.find[l])&&(f=m(k.matches[0].replace(ca,da),aa.test(j[0].type)&&pa(b.parentNode)||b))){if(j.splice(i,1),a=f.length&&ra(j),!a)return H.apply(e,f),e;break}}}return(n||h(a,o))(f,b,!p,e,aa.test(a)&&pa(b.parentNode)||b),e},c.sortStable=u.split("").sort(B).join("")===u,c.detectDuplicates=!!l,m(),c.sortDetached=ja(function(a){return 1&a.compareDocumentPosition(n.createElement("div"))}),ja(function(a){return a.innerHTML="<a href='#'></a>","#"===a.firstChild.getAttribute("href")})||ka("type|href|height|width",function(a,b,c){return c?void 0:a.getAttribute(b,"type"===b.toLowerCase()?1:2)}),c.attributes&&ja(function(a){return a.innerHTML="<input/>",a.firstChild.setAttribute("value",""),""===a.firstChild.getAttribute("value")})||ka("value",function(a,b,c){return c||"input"!==a.nodeName.toLowerCase()?void 0:a.defaultValue}),ja(function(a){return null==a.getAttribute("disabled")})||ka(K,function(a,b,c){var d;return c?void 0:a[b]===!0?b.toLowerCase():(d=a.getAttributeNode(b))&&d.specified?d.value:null}),ga}(a);m.find=s,m.expr=s.selectors,m.expr[":"]=m.expr.pseudos,m.unique=s.uniqueSort,m.text=s.getText,m.isXMLDoc=s.isXML,m.contains=s.contains;var t=m.expr.match.needsContext,u=/^<(\w+)\s*\/?>(?:<\/\1>|)$/,v=/^.[^:#\[\.,]*$/;function w(a,b,c){if(m.isFunction(b))return m.grep(a,function(a,d){return!!b.call(a,d,a)!==c});if(b.nodeType)return m.grep(a,function(a){return a===b!==c});if("string"==typeof b){if(v.test(b))return m.filter(b,a,c);b=m.filter(b,a)}return m.grep(a,function(a){return m.inArray(a,b)>=0!==c})}m.filter=function(a,b,c){var d=b[0];return c&&(a=":not("+a+")"),1===b.length&&1===d.nodeType?m.find.matchesSelector(d,a)?[d]:[]:m.find.matches(a,m.grep(b,function(a){return 1===a.nodeType}))},m.fn.extend({find:function(a){var b,c=[],d=this,e=d.length;if("string"!=typeof a)return this.pushStack(m(a).filter(function(){for(b=0;e>b;b++)if(m.contains(d[b],this))return!0}));for(b=0;e>b;b++)m.find(a,d[b],c);return c=this.pushStack(e>1?m.unique(c):c),c.selector=this.selector?this.selector+" "+a:a,c},filter:function(a){return this.pushStack(w(this,a||[],!1))},not:function(a){return this.pushStack(w(this,a||[],!0))},is:function(a){return!!w(this,"string"==typeof a&&t.test(a)?m(a):a||[],!1).length}});var x,y=a.document,z=/^(?:\s*(<[\w\W]+>)[^>]*|#([\w-]*))$/,A=m.fn.init=function(a,b){var c,d;if(!a)return this;if("string"==typeof a){if(c="<"===a.charAt(0)&&">"===a.charAt(a.length-1)&&a.length>=3?[null,a,null]:z.exec(a),!c||!c[1]&&b)return!b||b.jquery?(b||x).find(a):this.constructor(b).find(a);if(c[1]){if(b=b instanceof m?b[0]:b,m.merge(this,m.parseHTML(c[1],b&&b.nodeType?b.ownerDocument||b:y,!0)),u.test(c[1])&&m.isPlainObject(b))for(c in b)m.isFunction(this[c])?this[c](b[c]):this.attr(c,b[c]);return this}if(d=y.getElementById(c[2]),d&&d.parentNode){if(d.id!==c[2])return x.find(a);this.length=1,this[0]=d}return this.context=y,this.selector=a,this}return a.nodeType?(this.context=this[0]=a,this.length=1,this):m.isFunction(a)?"undefined"!=typeof x.ready?x.ready(a):a(m):(void 0!==a.selector&&(this.selector=a.selector,this.context=a.context),m.makeArray(a,this))};A.prototype=m.fn,x=m(y);var B=/^(?:parents|prev(?:Until|All))/,C={children:!0,contents:!0,next:!0,prev:!0};m.extend({dir:function(a,b,c){var d=[],e=a[b];while(e&&9!==e.nodeType&&(void 0===c||1!==e.nodeType||!m(e).is(c)))1===e.nodeType&&d.push(e),e=e[b];return d},sibling:function(a,b){for(var c=[];a;a=a.nextSibling)1===a.nodeType&&a!==b&&c.push(a);return c}}),m.fn.extend({has:function(a){var b,c=m(a,this),d=c.length;return this.filter(function(){for(b=0;d>b;b++)if(m.contains(this,c[b]))return!0})},closest:function(a,b){for(var c,d=0,e=this.length,f=[],g=t.test(a)||"string"!=typeof a?m(a,b||this.context):0;e>d;d++)for(c=this[d];c&&c!==b;c=c.parentNode)if(c.nodeType<11&&(g?g.index(c)>-1:1===c.nodeType&&m.find.matchesSelector(c,a))){f.push(c);break}return this.pushStack(f.length>1?m.unique(f):f)},index:function(a){return a?"string"==typeof a?m.inArray(this[0],m(a)):m.inArray(a.jquery?a[0]:a,this):this[0]&&this[0].parentNode?this.first().prevAll().length:-1},add:function(a,b){return this.pushStack(m.unique(m.merge(this.get(),m(a,b))))},addBack:function(a){return this.add(null==a?this.prevObject:this.prevObject.filter(a))}});function D(a,b){do a=a[b];while(a&&1!==a.nodeType);return a}m.each({parent:function(a){var b=a.parentNode;return b&&11!==b.nodeType?b:null},parents:function(a){return m.dir(a,"parentNode")},parentsUntil:function(a,b,c){return m.dir(a,"parentNode",c)},next:function(a){return D(a,"nextSibling")},prev:function(a){return D(a,"previousSibling")},nextAll:function(a){return m.dir(a,"nextSibling")},prevAll:function(a){return m.dir(a,"previousSibling")},nextUntil:function(a,b,c){return m.dir(a,"nextSibling",c)},prevUntil:function(a,b,c){return m.dir(a,"previousSibling",c)},siblings:function(a){return m.sibling((a.parentNode||{}).firstChild,a)},children:function(a){return m.sibling(a.firstChild)},contents:function(a){return m.nodeName(a,"iframe")?a.contentDocument||a.contentWindow.document:m.merge([],a.childNodes)}},function(a,b){m.fn[a]=function(c,d){var e=m.map(this,b,c);return"Until"!==a.slice(-5)&&(d=c),d&&"string"==typeof d&&(e=m.filter(d,e)),this.length>1&&(C[a]||(e=m.unique(e)),B.test(a)&&(e=e.reverse())),this.pushStack(e)}});var E=/\S+/g,F={};function G(a){var b=F[a]={};return m.each(a.match(E)||[],function(a,c){b[c]=!0}),b}m.Callbacks=function(a){a="string"==typeof a?F[a]||G(a):m.extend({},a);var b,c,d,e,f,g,h=[],i=!a.once&&[],j=function(l){for(c=a.memory&&l,d=!0,f=g||0,g=0,e=h.length,b=!0;h&&e>f;f++)if(h[f].apply(l[0],l[1])===!1&&a.stopOnFalse){c=!1;break}b=!1,h&&(i?i.length&&j(i.shift()):c?h=[]:k.disable())},k={add:function(){if(h){var d=h.length;!function f(b){m.each(b,function(b,c){var d=m.type(c);"function"===d?a.unique&&k.has(c)||h.push(c):c&&c.length&&"string"!==d&&f(c)})}(arguments),b?e=h.length:c&&(g=d,j(c))}return this},remove:function(){return h&&m.each(arguments,function(a,c){var d;while((d=m.inArray(c,h,d))>-1)h.splice(d,1),b&&(e>=d&&e--,f>=d&&f--)}),this},has:function(a){return a?m.inArray(a,h)>-1:!(!h||!h.length)},empty:function(){return h=[],e=0,this},disable:function(){return h=i=c=void 0,this},disabled:function(){return!h},lock:function(){return i=void 0,c||k.disable(),this},locked:function(){return!i},fireWith:function(a,c){return!h||d&&!i||(c=c||[],c=[a,c.slice?c.slice():c],b?i.push(c):j(c)),this},fire:function(){return k.fireWith(this,arguments),this},fired:function(){return!!d}};return k},m.extend({Deferred:function(a){var b=[["resolve","done",m.Callbacks("once memory"),"resolved"],["reject","fail",m.Callbacks("once memory"),"rejected"],["notify","progress",m.Callbacks("memory")]],c="pending",d={state:function(){return c},always:function(){return e.done(arguments).fail(arguments),this},then:function(){var a=arguments;return m.Deferred(function(c){m.each(b,function(b,f){var g=m.isFunction(a[b])&&a[b];e[f[1]](function(){var a=g&&g.apply(this,arguments);a&&m.isFunction(a.promise)?a.promise().done(c.resolve).fail(c.reject).progress(c.notify):c[f[0]+"With"](this===d?c.promise():this,g?[a]:arguments)})}),a=null}).promise()},promise:function(a){return null!=a?m.extend(a,d):d}},e={};return d.pipe=d.then,m.each(b,function(a,f){var g=f[2],h=f[3];d[f[1]]=g.add,h&&g.add(function(){c=h},b[1^a][2].disable,b[2][2].lock),e[f[0]]=function(){return e[f[0]+"With"](this===e?d:this,arguments),this},e[f[0]+"With"]=g.fireWith}),d.promise(e),a&&a.call(e,e),e},when:function(a){var b=0,c=d.call(arguments),e=c.length,f=1!==e||a&&m.isFunction(a.promise)?e:0,g=1===f?a:m.Deferred(),h=function(a,b,c){return function(e){b[a]=this,c[a]=arguments.length>1?d.call(arguments):e,c===i?g.notifyWith(b,c):--f||g.resolveWith(b,c)}},i,j,k;if(e>1)for(i=new Array(e),j=new Array(e),k=new Array(e);e>b;b++)c[b]&&m.isFunction(c[b].promise)?c[b].promise().done(h(b,k,c)).fail(g.reject).progress(h(b,j,i)):--f;return f||g.resolveWith(k,c),g.promise()}});var H;m.fn.ready=function(a){return m.ready.promise().done(a),this},m.extend({isReady:!1,readyWait:1,holdReady:function(a){a?m.readyWait++:m.ready(!0)},ready:function(a){if(a===!0?!--m.readyWait:!m.isReady){if(!y.body)return setTimeout(m.ready);m.isReady=!0,a!==!0&&--m.readyWait>0||(H.resolveWith(y,[m]),m.fn.triggerHandler&&(m(y).triggerHandler("ready"),m(y).off("ready")))}}});function I(){y.addEventListener?(y.removeEventListener("DOMContentLoaded",J,!1),a.removeEventListener("load",J,!1)):(y.detachEvent("onreadystatechange",J),a.detachEvent("onload",J))}function J(){(y.addEventListener||"load"===event.type||"complete"===y.readyState)&&(I(),m.ready())}m.ready.promise=function(b){if(!H)if(H=m.Deferred(),"complete"===y.readyState)setTimeout(m.ready);else if(y.addEventListener)y.addEventListener("DOMContentLoaded",J,!1),a.addEventListener("load",J,!1);else{y.attachEvent("onreadystatechange",J),a.attachEvent("onload",J);var c=!1;try{c=null==a.frameElement&&y.documentElement}catch(d){}c&&c.doScroll&&!function e(){if(!m.isReady){try{c.doScroll("left")}catch(a){return setTimeout(e,50)}I(),m.ready()}}()}return H.promise(b)};var K="undefined",L;for(L in m(k))break;k.ownLast="0"!==L,k.inlineBlockNeedsLayout=!1,m(function(){var a,b,c,d;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="display:inline;margin:0;border:0;padding:1px;width:1px;zoom:1",k.inlineBlockNeedsLayout=a=3===b.offsetWidth,a&&(c.style.zoom=1)),c.removeChild(d))}),function(){var a=y.createElement("div");if(null==k.deleteExpando){k.deleteExpando=!0;try{delete a.test}catch(b){k.deleteExpando=!1}}a=null}(),m.acceptData=function(a){var b=m.noData[(a.nodeName+" ").toLowerCase()],c=+a.nodeType||1;return 1!==c&&9!==c?!1:!b||b!==!0&&a.getAttribute("classid")===b};var M=/^(?:\{[\w\W]*\}|\[[\w\W]*\])$/,N=/([A-Z])/g;function O(a,b,c){if(void 0===c&&1===a.nodeType){var d="data-"+b.replace(N,"-$1").toLowerCase();if(c=a.getAttribute(d),"string"==typeof c){try{c="true"===c?!0:"false"===c?!1:"null"===c?null:+c+""===c?+c:M.test(c)?m.parseJSON(c):c}catch(e){}m.data(a,b,c)}else c=void 0}return c}function P(a){var b;for(b in a)if(("data"!==b||!m.isEmptyObject(a[b]))&&"toJSON"!==b)return!1;

return!0}function Q(a,b,d,e){if(m.acceptData(a)){var f,g,h=m.expando,i=a.nodeType,j=i?m.cache:a,k=i?a[h]:a[h]&&h;if(k&&j[k]&&(e||j[k].data)||void 0!==d||"string"!=typeof b)return k||(k=i?a[h]=c.pop()||m.guid++:h),j[k]||(j[k]=i?{}:{toJSON:m.noop}),("object"==typeof b||"function"==typeof b)&&(e?j[k]=m.extend(j[k],b):j[k].data=m.extend(j[k].data,b)),g=j[k],e||(g.data||(g.data={}),g=g.data),void 0!==d&&(g[m.camelCase(b)]=d),"string"==typeof b?(f=g[b],null==f&&(f=g[m.camelCase(b)])):f=g,f}}function R(a,b,c){if(m.acceptData(a)){var d,e,f=a.nodeType,g=f?m.cache:a,h=f?a[m.expando]:m.expando;if(g[h]){if(b&&(d=c?g[h]:g[h].data)){m.isArray(b)?b=b.concat(m.map(b,m.camelCase)):b in d?b=[b]:(b=m.camelCase(b),b=b in d?[b]:b.split(" ")),e=b.length;while(e--)delete d[b[e]];if(c?!P(d):!m.isEmptyObject(d))return}(c||(delete g[h].data,P(g[h])))&&(f?m.cleanData([a],!0):k.deleteExpando||g!=g.window?delete g[h]:g[h]=null)}}}m.extend({cache:{},noData:{"applet ":!0,"embed ":!0,"object ":"clsid:D27CDB6E-AE6D-11cf-96B8-444553540000"},hasData:function(a){return a=a.nodeType?m.cache[a[m.expando]]:a[m.expando],!!a&&!P(a)},data:function(a,b,c){return Q(a,b,c)},removeData:function(a,b){return R(a,b)},_data:function(a,b,c){return Q(a,b,c,!0)},_removeData:function(a,b){return R(a,b,!0)}}),m.fn.extend({data:function(a,b){var c,d,e,f=this[0],g=f&&f.attributes;if(void 0===a){if(this.length&&(e=m.data(f),1===f.nodeType&&!m._data(f,"parsedAttrs"))){c=g.length;while(c--)g[c]&&(d=g[c].name,0===d.indexOf("data-")&&(d=m.camelCase(d.slice(5)),O(f,d,e[d])));m._data(f,"parsedAttrs",!0)}return e}return"object"==typeof a?this.each(function(){m.data(this,a)}):arguments.length>1?this.each(function(){m.data(this,a,b)}):f?O(f,a,m.data(f,a)):void 0},removeData:function(a){return this.each(function(){m.removeData(this,a)})}}),m.extend({queue:function(a,b,c){var d;return a?(b=(b||"fx")+"queue",d=m._data(a,b),c&&(!d||m.isArray(c)?d=m._data(a,b,m.makeArray(c)):d.push(c)),d||[]):void 0},dequeue:function(a,b){b=b||"fx";var c=m.queue(a,b),d=c.length,e=c.shift(),f=m._queueHooks(a,b),g=function(){m.dequeue(a,b)};"inprogress"===e&&(e=c.shift(),d--),e&&("fx"===b&&c.unshift("inprogress"),delete f.stop,e.call(a,g,f)),!d&&f&&f.empty.fire()},_queueHooks:function(a,b){var c=b+"queueHooks";return m._data(a,c)||m._data(a,c,{empty:m.Callbacks("once memory").add(function(){m._removeData(a,b+"queue"),m._removeData(a,c)})})}}),m.fn.extend({queue:function(a,b){var c=2;return"string"!=typeof a&&(b=a,a="fx",c--),arguments.length<c?m.queue(this[0],a):void 0===b?this:this.each(function(){var c=m.queue(this,a,b);m._queueHooks(this,a),"fx"===a&&"inprogress"!==c[0]&&m.dequeue(this,a)})},dequeue:function(a){return this.each(function(){m.dequeue(this,a)})},clearQueue:function(a){return this.queue(a||"fx",[])},promise:function(a,b){var c,d=1,e=m.Deferred(),f=this,g=this.length,h=function(){--d||e.resolveWith(f,[f])};"string"!=typeof a&&(b=a,a=void 0),a=a||"fx";while(g--)c=m._data(f[g],a+"queueHooks"),c&&c.empty&&(d++,c.empty.add(h));return h(),e.promise(b)}});var S=/[+-]?(?:\d*\.|)\d+(?:[eE][+-]?\d+|)/.source,T=["Top","Right","Bottom","Left"],U=function(a,b){return a=b||a,"none"===m.css(a,"display")||!m.contains(a.ownerDocument,a)},V=m.access=function(a,b,c,d,e,f,g){var h=0,i=a.length,j=null==c;if("object"===m.type(c)){e=!0;for(h in c)m.access(a,b,h,c[h],!0,f,g)}else if(void 0!==d&&(e=!0,m.isFunction(d)||(g=!0),j&&(g?(b.call(a,d),b=null):(j=b,b=function(a,b,c){return j.call(m(a),c)})),b))for(;i>h;h++)b(a[h],c,g?d:d.call(a[h],h,b(a[h],c)));return e?a:j?b.call(a):i?b(a[0],c):f},W=/^(?:checkbox|radio)$/i;!function(){var a=y.createElement("input"),b=y.createElement("div"),c=y.createDocumentFragment();if(b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",k.leadingWhitespace=3===b.firstChild.nodeType,k.tbody=!b.getElementsByTagName("tbody").length,k.htmlSerialize=!!b.getElementsByTagName("link").length,k.html5Clone="<:nav></:nav>"!==y.createElement("nav").cloneNode(!0).outerHTML,a.type="checkbox",a.checked=!0,c.appendChild(a),k.appendChecked=a.checked,b.innerHTML="<textarea>x</textarea>",k.noCloneChecked=!!b.cloneNode(!0).lastChild.defaultValue,c.appendChild(b),b.innerHTML="<input type='radio' checked='checked' name='t'/>",k.checkClone=b.cloneNode(!0).cloneNode(!0).lastChild.checked,k.noCloneEvent=!0,b.attachEvent&&(b.attachEvent("onclick",function(){k.noCloneEvent=!1}),b.cloneNode(!0).click()),null==k.deleteExpando){k.deleteExpando=!0;try{delete b.test}catch(d){k.deleteExpando=!1}}}(),function(){var b,c,d=y.createElement("div");for(b in{submit:!0,change:!0,focusin:!0})c="on"+b,(k[b+"Bubbles"]=c in a)||(d.setAttribute(c,"t"),k[b+"Bubbles"]=d.attributes[c].expando===!1);d=null}();var X=/^(?:input|select|textarea)$/i,Y=/^key/,Z=/^(?:mouse|pointer|contextmenu)|click/,$=/^(?:focusinfocus|focusoutblur)$/,_=/^([^.]*)(?:\.(.+)|)$/;function aa(){return!0}function ba(){return!1}function ca(){try{return y.activeElement}catch(a){}}m.event={global:{},add:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m._data(a);if(r){c.handler&&(i=c,c=i.handler,e=i.selector),c.guid||(c.guid=m.guid++),(g=r.events)||(g=r.events={}),(k=r.handle)||(k=r.handle=function(a){return typeof m===K||a&&m.event.triggered===a.type?void 0:m.event.dispatch.apply(k.elem,arguments)},k.elem=a),b=(b||"").match(E)||[""],h=b.length;while(h--)f=_.exec(b[h])||[],o=q=f[1],p=(f[2]||"").split(".").sort(),o&&(j=m.event.special[o]||{},o=(e?j.delegateType:j.bindType)||o,j=m.event.special[o]||{},l=m.extend({type:o,origType:q,data:d,handler:c,guid:c.guid,selector:e,needsContext:e&&m.expr.match.needsContext.test(e),namespace:p.join(".")},i),(n=g[o])||(n=g[o]=[],n.delegateCount=0,j.setup&&j.setup.call(a,d,p,k)!==!1||(a.addEventListener?a.addEventListener(o,k,!1):a.attachEvent&&a.attachEvent("on"+o,k))),j.add&&(j.add.call(a,l),l.handler.guid||(l.handler.guid=c.guid)),e?n.splice(n.delegateCount++,0,l):n.push(l),m.event.global[o]=!0);a=null}},remove:function(a,b,c,d,e){var f,g,h,i,j,k,l,n,o,p,q,r=m.hasData(a)&&m._data(a);if(r&&(k=r.events)){b=(b||"").match(E)||[""],j=b.length;while(j--)if(h=_.exec(b[j])||[],o=q=h[1],p=(h[2]||"").split(".").sort(),o){l=m.event.special[o]||{},o=(d?l.delegateType:l.bindType)||o,n=k[o]||[],h=h[2]&&new RegExp("(^|\\.)"+p.join("\\.(?:.*\\.|)")+"(\\.|$)"),i=f=n.length;while(f--)g=n[f],!e&&q!==g.origType||c&&c.guid!==g.guid||h&&!h.test(g.namespace)||d&&d!==g.selector&&("**"!==d||!g.selector)||(n.splice(f,1),g.selector&&n.delegateCount--,l.remove&&l.remove.call(a,g));i&&!n.length&&(l.teardown&&l.teardown.call(a,p,r.handle)!==!1||m.removeEvent(a,o,r.handle),delete k[o])}else for(o in k)m.event.remove(a,o+b[j],c,d,!0);m.isEmptyObject(k)&&(delete r.handle,m._removeData(a,"events"))}},trigger:function(b,c,d,e){var f,g,h,i,k,l,n,o=[d||y],p=j.call(b,"type")?b.type:b,q=j.call(b,"namespace")?b.namespace.split("."):[];if(h=l=d=d||y,3!==d.nodeType&&8!==d.nodeType&&!$.test(p+m.event.triggered)&&(p.indexOf(".")>=0&&(q=p.split("."),p=q.shift(),q.sort()),g=p.indexOf(":")<0&&"on"+p,b=b[m.expando]?b:new m.Event(p,"object"==typeof b&&b),b.isTrigger=e?2:3,b.namespace=q.join("."),b.namespace_re=b.namespace?new RegExp("(^|\\.)"+q.join("\\.(?:.*\\.|)")+"(\\.|$)"):null,b.result=void 0,b.target||(b.target=d),c=null==c?[b]:m.makeArray(c,[b]),k=m.event.special[p]||{},e||!k.trigger||k.trigger.apply(d,c)!==!1)){if(!e&&!k.noBubble&&!m.isWindow(d)){for(i=k.delegateType||p,$.test(i+p)||(h=h.parentNode);h;h=h.parentNode)o.push(h),l=h;l===(d.ownerDocument||y)&&o.push(l.defaultView||l.parentWindow||a)}n=0;while((h=o[n++])&&!b.isPropagationStopped())b.type=n>1?i:k.bindType||p,f=(m._data(h,"events")||{})[b.type]&&m._data(h,"handle"),f&&f.apply(h,c),f=g&&h[g],f&&f.apply&&m.acceptData(h)&&(b.result=f.apply(h,c),b.result===!1&&b.preventDefault());if(b.type=p,!e&&!b.isDefaultPrevented()&&(!k._default||k._default.apply(o.pop(),c)===!1)&&m.acceptData(d)&&g&&d[p]&&!m.isWindow(d)){l=d[g],l&&(d[g]=null),m.event.triggered=p;try{d[p]()}catch(r){}m.event.triggered=void 0,l&&(d[g]=l)}return b.result}},dispatch:function(a){a=m.event.fix(a);var b,c,e,f,g,h=[],i=d.call(arguments),j=(m._data(this,"events")||{})[a.type]||[],k=m.event.special[a.type]||{};if(i[0]=a,a.delegateTarget=this,!k.preDispatch||k.preDispatch.call(this,a)!==!1){h=m.event.handlers.call(this,a,j),b=0;while((f=h[b++])&&!a.isPropagationStopped()){a.currentTarget=f.elem,g=0;while((e=f.handlers[g++])&&!a.isImmediatePropagationStopped())(!a.namespace_re||a.namespace_re.test(e.namespace))&&(a.handleObj=e,a.data=e.data,c=((m.event.special[e.origType]||{}).handle||e.handler).apply(f.elem,i),void 0!==c&&(a.result=c)===!1&&(a.preventDefault(),a.stopPropagation()))}return k.postDispatch&&k.postDispatch.call(this,a),a.result}},handlers:function(a,b){var c,d,e,f,g=[],h=b.delegateCount,i=a.target;if(h&&i.nodeType&&(!a.button||"click"!==a.type))for(;i!=this;i=i.parentNode||this)if(1===i.nodeType&&(i.disabled!==!0||"click"!==a.type)){for(e=[],f=0;h>f;f++)d=b[f],c=d.selector+" ",void 0===e[c]&&(e[c]=d.needsContext?m(c,this).index(i)>=0:m.find(c,this,null,[i]).length),e[c]&&e.push(d);e.length&&g.push({elem:i,handlers:e})}return h<b.length&&g.push({elem:this,handlers:b.slice(h)}),g},fix:function(a){if(a[m.expando])return a;var b,c,d,e=a.type,f=a,g=this.fixHooks[e];g||(this.fixHooks[e]=g=Z.test(e)?this.mouseHooks:Y.test(e)?this.keyHooks:{}),d=g.props?this.props.concat(g.props):this.props,a=new m.Event(f),b=d.length;while(b--)c=d[b],a[c]=f[c];return a.target||(a.target=f.srcElement||y),3===a.target.nodeType&&(a.target=a.target.parentNode),a.metaKey=!!a.metaKey,g.filter?g.filter(a,f):a},props:"altKey bubbles cancelable ctrlKey currentTarget eventPhase metaKey relatedTarget shiftKey target timeStamp view which".split(" "),fixHooks:{},keyHooks:{props:"char charCode key keyCode".split(" "),filter:function(a,b){return null==a.which&&(a.which=null!=b.charCode?b.charCode:b.keyCode),a}},mouseHooks:{props:"button buttons clientX clientY fromElement offsetX offsetY pageX pageY screenX screenY toElement".split(" "),filter:function(a,b){var c,d,e,f=b.button,g=b.fromElement;return null==a.pageX&&null!=b.clientX&&(d=a.target.ownerDocument||y,e=d.documentElement,c=d.body,a.pageX=b.clientX+(e&&e.scrollLeft||c&&c.scrollLeft||0)-(e&&e.clientLeft||c&&c.clientLeft||0),a.pageY=b.clientY+(e&&e.scrollTop||c&&c.scrollTop||0)-(e&&e.clientTop||c&&c.clientTop||0)),!a.relatedTarget&&g&&(a.relatedTarget=g===a.target?b.toElement:g),a.which||void 0===f||(a.which=1&f?1:2&f?3:4&f?2:0),a}},special:{load:{noBubble:!0},focus:{trigger:function(){if(this!==ca()&&this.focus)try{return this.focus(),!1}catch(a){}},delegateType:"focusin"},blur:{trigger:function(){return this===ca()&&this.blur?(this.blur(),!1):void 0},delegateType:"focusout"},click:{trigger:function(){return m.nodeName(this,"input")&&"checkbox"===this.type&&this.click?(this.click(),!1):void 0},_default:function(a){return m.nodeName(a.target,"a")}},beforeunload:{postDispatch:function(a){void 0!==a.result&&a.originalEvent&&(a.originalEvent.returnValue=a.result)}}},simulate:function(a,b,c,d){var e=m.extend(new m.Event,c,{type:a,isSimulated:!0,originalEvent:{}});d?m.event.trigger(e,null,b):m.event.dispatch.call(b,e),e.isDefaultPrevented()&&c.preventDefault()}},m.removeEvent=y.removeEventListener?function(a,b,c){a.removeEventListener&&a.removeEventListener(b,c,!1)}:function(a,b,c){var d="on"+b;a.detachEvent&&(typeof a[d]===K&&(a[d]=null),a.detachEvent(d,c))},m.Event=function(a,b){return this instanceof m.Event?(a&&a.type?(this.originalEvent=a,this.type=a.type,this.isDefaultPrevented=a.defaultPrevented||void 0===a.defaultPrevented&&a.returnValue===!1?aa:ba):this.type=a,b&&m.extend(this,b),this.timeStamp=a&&a.timeStamp||m.now(),void(this[m.expando]=!0)):new m.Event(a,b)},m.Event.prototype={isDefaultPrevented:ba,isPropagationStopped:ba,isImmediatePropagationStopped:ba,preventDefault:function(){var a=this.originalEvent;this.isDefaultPrevented=aa,a&&(a.preventDefault?a.preventDefault():a.returnValue=!1)},stopPropagation:function(){var a=this.originalEvent;this.isPropagationStopped=aa,a&&(a.stopPropagation&&a.stopPropagation(),a.cancelBubble=!0)},stopImmediatePropagation:function(){var a=this.originalEvent;this.isImmediatePropagationStopped=aa,a&&a.stopImmediatePropagation&&a.stopImmediatePropagation(),this.stopPropagation()}},m.each({mouseenter:"mouseover",mouseleave:"mouseout",pointerenter:"pointerover",pointerleave:"pointerout"},function(a,b){m.event.special[a]={delegateType:b,bindType:b,handle:function(a){var c,d=this,e=a.relatedTarget,f=a.handleObj;return(!e||e!==d&&!m.contains(d,e))&&(a.type=f.origType,c=f.handler.apply(this,arguments),a.type=b),c}}}),k.submitBubbles||(m.event.special.submit={setup:function(){return m.nodeName(this,"form")?!1:void m.event.add(this,"click._submit keypress._submit",function(a){var b=a.target,c=m.nodeName(b,"input")||m.nodeName(b,"button")?b.form:void 0;c&&!m._data(c,"submitBubbles")&&(m.event.add(c,"submit._submit",function(a){a._submit_bubble=!0}),m._data(c,"submitBubbles",!0))})},postDispatch:function(a){a._submit_bubble&&(delete a._submit_bubble,this.parentNode&&!a.isTrigger&&m.event.simulate("submit",this.parentNode,a,!0))},teardown:function(){return m.nodeName(this,"form")?!1:void m.event.remove(this,"._submit")}}),k.changeBubbles||(m.event.special.change={setup:function(){return X.test(this.nodeName)?(("checkbox"===this.type||"radio"===this.type)&&(m.event.add(this,"propertychange._change",function(a){"checked"===a.originalEvent.propertyName&&(this._just_changed=!0)}),m.event.add(this,"click._change",function(a){this._just_changed&&!a.isTrigger&&(this._just_changed=!1),m.event.simulate("change",this,a,!0)})),!1):void m.event.add(this,"beforeactivate._change",function(a){var b=a.target;X.test(b.nodeName)&&!m._data(b,"changeBubbles")&&(m.event.add(b,"change._change",function(a){!this.parentNode||a.isSimulated||a.isTrigger||m.event.simulate("change",this.parentNode,a,!0)}),m._data(b,"changeBubbles",!0))})},handle:function(a){var b=a.target;return this!==b||a.isSimulated||a.isTrigger||"radio"!==b.type&&"checkbox"!==b.type?a.handleObj.handler.apply(this,arguments):void 0},teardown:function(){return m.event.remove(this,"._change"),!X.test(this.nodeName)}}),k.focusinBubbles||m.each({focus:"focusin",blur:"focusout"},function(a,b){var c=function(a){m.event.simulate(b,a.target,m.event.fix(a),!0)};m.event.special[b]={setup:function(){var d=this.ownerDocument||this,e=m._data(d,b);e||d.addEventListener(a,c,!0),m._data(d,b,(e||0)+1)},teardown:function(){var d=this.ownerDocument||this,e=m._data(d,b)-1;e?m._data(d,b,e):(d.removeEventListener(a,c,!0),m._removeData(d,b))}}}),m.fn.extend({on:function(a,b,c,d,e){var f,g;if("object"==typeof a){"string"!=typeof b&&(c=c||b,b=void 0);for(f in a)this.on(f,b,c,a[f],e);return this}if(null==c&&null==d?(d=b,c=b=void 0):null==d&&("string"==typeof b?(d=c,c=void 0):(d=c,c=b,b=void 0)),d===!1)d=ba;else if(!d)return this;return 1===e&&(g=d,d=function(a){return m().off(a),g.apply(this,arguments)},d.guid=g.guid||(g.guid=m.guid++)),this.each(function(){m.event.add(this,a,d,c,b)})},one:function(a,b,c,d){return this.on(a,b,c,d,1)},off:function(a,b,c){var d,e;if(a&&a.preventDefault&&a.handleObj)return d=a.handleObj,m(a.delegateTarget).off(d.namespace?d.origType+"."+d.namespace:d.origType,d.selector,d.handler),this;if("object"==typeof a){for(e in a)this.off(e,b,a[e]);return this}return(b===!1||"function"==typeof b)&&(c=b,b=void 0),c===!1&&(c=ba),this.each(function(){m.event.remove(this,a,c,b)})},trigger:function(a,b){return this.each(function(){m.event.trigger(a,b,this)})},triggerHandler:function(a,b){var c=this[0];return c?m.event.trigger(a,b,c,!0):void 0}});function da(a){var b=ea.split("|"),c=a.createDocumentFragment();if(c.createElement)while(b.length)c.createElement(b.pop());return c}var ea="abbr|article|aside|audio|bdi|canvas|data|datalist|details|figcaption|figure|footer|header|hgroup|mark|meter|nav|output|progress|section|summary|time|video",fa=/ jQuery\d+="(?:null|\d+)"/g,ga=new RegExp("<(?:"+ea+")[\\s/>]","i"),ha=/^\s+/,ia=/<(?!area|br|col|embed|hr|img|input|link|meta|param)(([\w:]+)[^>]*)\/>/gi,ja=/<([\w:]+)/,ka=/<tbody/i,la=/<|&#?\w+;/,ma=/<(?:script|style|link)/i,na=/checked\s*(?:[^=]|=\s*.checked.)/i,oa=/^$|\/(?:java|ecma)script/i,pa=/^true\/(.*)/,qa=/^\s*<!(?:\[CDATA\[|--)|(?:\]\]|--)>\s*$/g,ra={option:[1,"<select multiple='multiple'>","</select>"],legend:[1,"<fieldset>","</fieldset>"],area:[1,"<map>","</map>"],param:[1,"<object>","</object>"],thead:[1,"<table>","</table>"],tr:[2,"<table><tbody>","</tbody></table>"],col:[2,"<table><tbody></tbody><colgroup>","</colgroup></table>"],td:[3,"<table><tbody><tr>","</tr></tbody></table>"],_default:k.htmlSerialize?[0,"",""]:[1,"X<div>","</div>"]},sa=da(y),ta=sa.appendChild(y.createElement("div"));ra.optgroup=ra.option,ra.tbody=ra.tfoot=ra.colgroup=ra.caption=ra.thead,ra.th=ra.td;function ua(a,b){var c,d,e=0,f=typeof a.getElementsByTagName!==K?a.getElementsByTagName(b||"*"):typeof a.querySelectorAll!==K?a.querySelectorAll(b||"*"):void 0;if(!f)for(f=[],c=a.childNodes||a;null!=(d=c[e]);e++)!b||m.nodeName(d,b)?f.push(d):m.merge(f,ua(d,b));return void 0===b||b&&m.nodeName(a,b)?m.merge([a],f):f}function va(a){W.test(a.type)&&(a.defaultChecked=a.checked)}function wa(a,b){return m.nodeName(a,"table")&&m.nodeName(11!==b.nodeType?b:b.firstChild,"tr")?a.getElementsByTagName("tbody")[0]||a.appendChild(a.ownerDocument.createElement("tbody")):a}function xa(a){return a.type=(null!==m.find.attr(a,"type"))+"/"+a.type,a}function ya(a){var b=pa.exec(a.type);return b?a.type=b[1]:a.removeAttribute("type"),a}function za(a,b){for(var c,d=0;null!=(c=a[d]);d++)m._data(c,"globalEval",!b||m._data(b[d],"globalEval"))}function Aa(a,b){if(1===b.nodeType&&m.hasData(a)){var c,d,e,f=m._data(a),g=m._data(b,f),h=f.events;if(h){delete g.handle,g.events={};for(c in h)for(d=0,e=h[c].length;e>d;d++)m.event.add(b,c,h[c][d])}g.data&&(g.data=m.extend({},g.data))}}function Ba(a,b){var c,d,e;if(1===b.nodeType){if(c=b.nodeName.toLowerCase(),!k.noCloneEvent&&b[m.expando]){e=m._data(b);for(d in e.events)m.removeEvent(b,d,e.handle);b.removeAttribute(m.expando)}"script"===c&&b.text!==a.text?(xa(b).text=a.text,ya(b)):"object"===c?(b.parentNode&&(b.outerHTML=a.outerHTML),k.html5Clone&&a.innerHTML&&!m.trim(b.innerHTML)&&(b.innerHTML=a.innerHTML)):"input"===c&&W.test(a.type)?(b.defaultChecked=b.checked=a.checked,b.value!==a.value&&(b.value=a.value)):"option"===c?b.defaultSelected=b.selected=a.defaultSelected:("input"===c||"textarea"===c)&&(b.defaultValue=a.defaultValue)}}m.extend({clone:function(a,b,c){var d,e,f,g,h,i=m.contains(a.ownerDocument,a);if(k.html5Clone||m.isXMLDoc(a)||!ga.test("<"+a.nodeName+">")?f=a.cloneNode(!0):(ta.innerHTML=a.outerHTML,ta.removeChild(f=ta.firstChild)),!(k.noCloneEvent&&k.noCloneChecked||1!==a.nodeType&&11!==a.nodeType||m.isXMLDoc(a)))for(d=ua(f),h=ua(a),g=0;null!=(e=h[g]);++g)d[g]&&Ba(e,d[g]);if(b)if(c)for(h=h||ua(a),d=d||ua(f),g=0;null!=(e=h[g]);g++)Aa(e,d[g]);else Aa(a,f);return d=ua(f,"script"),d.length>0&&za(d,!i&&ua(a,"script")),d=h=e=null,f},buildFragment:function(a,b,c,d){for(var e,f,g,h,i,j,l,n=a.length,o=da(b),p=[],q=0;n>q;q++)if(f=a[q],f||0===f)if("object"===m.type(f))m.merge(p,f.nodeType?[f]:f);else if(la.test(f)){h=h||o.appendChild(b.createElement("div")),i=(ja.exec(f)||["",""])[1].toLowerCase(),l=ra[i]||ra._default,h.innerHTML=l[1]+f.replace(ia,"<$1></$2>")+l[2],e=l[0];while(e--)h=h.lastChild;if(!k.leadingWhitespace&&ha.test(f)&&p.push(b.createTextNode(ha.exec(f)[0])),!k.tbody){f="table"!==i||ka.test(f)?"<table>"!==l[1]||ka.test(f)?0:h:h.firstChild,e=f&&f.childNodes.length;while(e--)m.nodeName(j=f.childNodes[e],"tbody")&&!j.childNodes.length&&f.removeChild(j)}m.merge(p,h.childNodes),h.textContent="";while(h.firstChild)h.removeChild(h.firstChild);h=o.lastChild}else p.push(b.createTextNode(f));h&&o.removeChild(h),k.appendChecked||m.grep(ua(p,"input"),va),q=0;while(f=p[q++])if((!d||-1===m.inArray(f,d))&&(g=m.contains(f.ownerDocument,f),h=ua(o.appendChild(f),"script"),g&&za(h),c)){e=0;while(f=h[e++])oa.test(f.type||"")&&c.push(f)}return h=null,o},cleanData:function(a,b){for(var d,e,f,g,h=0,i=m.expando,j=m.cache,l=k.deleteExpando,n=m.event.special;null!=(d=a[h]);h++)if((b||m.acceptData(d))&&(f=d[i],g=f&&j[f])){if(g.events)for(e in g.events)n[e]?m.event.remove(d,e):m.removeEvent(d,e,g.handle);j[f]&&(delete j[f],l?delete d[i]:typeof d.removeAttribute!==K?d.removeAttribute(i):d[i]=null,c.push(f))}}}),m.fn.extend({text:function(a){return V(this,function(a){return void 0===a?m.text(this):this.empty().append((this[0]&&this[0].ownerDocument||y).createTextNode(a))},null,a,arguments.length)},append:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.appendChild(a)}})},prepend:function(){return this.domManip(arguments,function(a){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var b=wa(this,a);b.insertBefore(a,b.firstChild)}})},before:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this)})},after:function(){return this.domManip(arguments,function(a){this.parentNode&&this.parentNode.insertBefore(a,this.nextSibling)})},remove:function(a,b){for(var c,d=a?m.filter(a,this):this,e=0;null!=(c=d[e]);e++)b||1!==c.nodeType||m.cleanData(ua(c)),c.parentNode&&(b&&m.contains(c.ownerDocument,c)&&za(ua(c,"script")),c.parentNode.removeChild(c));return this},empty:function(){for(var a,b=0;null!=(a=this[b]);b++){1===a.nodeType&&m.cleanData(ua(a,!1));while(a.firstChild)a.removeChild(a.firstChild);a.options&&m.nodeName(a,"select")&&(a.options.length=0)}return this},clone:function(a,b){return a=null==a?!1:a,b=null==b?a:b,this.map(function(){return m.clone(this,a,b)})},html:function(a){return V(this,function(a){var b=this[0]||{},c=0,d=this.length;if(void 0===a)return 1===b.nodeType?b.innerHTML.replace(fa,""):void 0;if(!("string"!=typeof a||ma.test(a)||!k.htmlSerialize&&ga.test(a)||!k.leadingWhitespace&&ha.test(a)||ra[(ja.exec(a)||["",""])[1].toLowerCase()])){a=a.replace(ia,"<$1></$2>");try{for(;d>c;c++)b=this[c]||{},1===b.nodeType&&(m.cleanData(ua(b,!1)),b.innerHTML=a);b=0}catch(e){}}b&&this.empty().append(a)},null,a,arguments.length)},replaceWith:function(){var a=arguments[0];return this.domManip(arguments,function(b){a=this.parentNode,m.cleanData(ua(this)),a&&a.replaceChild(b,this)}),a&&(a.length||a.nodeType)?this:this.remove()},detach:function(a){return this.remove(a,!0)},domManip:function(a,b){a=e.apply([],a);var c,d,f,g,h,i,j=0,l=this.length,n=this,o=l-1,p=a[0],q=m.isFunction(p);if(q||l>1&&"string"==typeof p&&!k.checkClone&&na.test(p))return this.each(function(c){var d=n.eq(c);q&&(a[0]=p.call(this,c,d.html())),d.domManip(a,b)});if(l&&(i=m.buildFragment(a,this[0].ownerDocument,!1,this),c=i.firstChild,1===i.childNodes.length&&(i=c),c)){for(g=m.map(ua(i,"script"),xa),f=g.length;l>j;j++)d=i,j!==o&&(d=m.clone(d,!0,!0),f&&m.merge(g,ua(d,"script"))),b.call(this[j],d,j);if(f)for(h=g[g.length-1].ownerDocument,m.map(g,ya),j=0;f>j;j++)d=g[j],oa.test(d.type||"")&&!m._data(d,"globalEval")&&m.contains(h,d)&&(d.src?m._evalUrl&&m._evalUrl(d.src):m.globalEval((d.text||d.textContent||d.innerHTML||"").replace(qa,"")));i=c=null}return this}}),m.each({appendTo:"append",prependTo:"prepend",insertBefore:"before",insertAfter:"after",replaceAll:"replaceWith"},function(a,b){m.fn[a]=function(a){for(var c,d=0,e=[],g=m(a),h=g.length-1;h>=d;d++)c=d===h?this:this.clone(!0),m(g[d])[b](c),f.apply(e,c.get());return this.pushStack(e)}});var Ca,Da={};function Ea(b,c){var d,e=m(c.createElement(b)).appendTo(c.body),f=a.getDefaultComputedStyle&&(d=a.getDefaultComputedStyle(e[0]))?d.display:m.css(e[0],"display");return e.detach(),f}function Fa(a){var b=y,c=Da[a];return c||(c=Ea(a,b),"none"!==c&&c||(Ca=(Ca||m("<iframe frameborder='0' width='0' height='0'/>")).appendTo(b.documentElement),b=(Ca[0].contentWindow||Ca[0].contentDocument).document,b.write(),b.close(),c=Ea(a,b),Ca.detach()),Da[a]=c),c}!function(){var a;k.shrinkWrapBlocks=function(){if(null!=a)return a;a=!1;var b,c,d;return c=y.getElementsByTagName("body")[0],c&&c.style?(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),typeof b.style.zoom!==K&&(b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:1px;width:1px;zoom:1",b.appendChild(y.createElement("div")).style.width="5px",a=3!==b.offsetWidth),c.removeChild(d),a):void 0}}();var Ga=/^margin/,Ha=new RegExp("^("+S+")(?!px)[a-z%]+$","i"),Ia,Ja,Ka=/^(top|right|bottom|left)$/;a.getComputedStyle?(Ia=function(b){return b.ownerDocument.defaultView.opener?b.ownerDocument.defaultView.getComputedStyle(b,null):a.getComputedStyle(b,null)},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c.getPropertyValue(b)||c[b]:void 0,c&&(""!==g||m.contains(a.ownerDocument,a)||(g=m.style(a,b)),Ha.test(g)&&Ga.test(b)&&(d=h.width,e=h.minWidth,f=h.maxWidth,h.minWidth=h.maxWidth=h.width=g,g=c.width,h.width=d,h.minWidth=e,h.maxWidth=f)),void 0===g?g:g+""}):y.documentElement.currentStyle&&(Ia=function(a){return a.currentStyle},Ja=function(a,b,c){var d,e,f,g,h=a.style;return c=c||Ia(a),g=c?c[b]:void 0,null==g&&h&&h[b]&&(g=h[b]),Ha.test(g)&&!Ka.test(b)&&(d=h.left,e=a.runtimeStyle,f=e&&e.left,f&&(e.left=a.currentStyle.left),h.left="fontSize"===b?"1em":g,g=h.pixelLeft+"px",h.left=d,f&&(e.left=f)),void 0===g?g:g+""||"auto"});function La(a,b){return{get:function(){var c=a();if(null!=c)return c?void delete this.get:(this.get=b).apply(this,arguments)}}}!function(){var b,c,d,e,f,g,h;if(b=y.createElement("div"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=d&&d.style){c.cssText="float:left;opacity:.5",k.opacity="0.5"===c.opacity,k.cssFloat=!!c.cssFloat,b.style.backgroundClip="content-box",b.cloneNode(!0).style.backgroundClip="",k.clearCloneStyle="content-box"===b.style.backgroundClip,k.boxSizing=""===c.boxSizing||""===c.MozBoxSizing||""===c.WebkitBoxSizing,m.extend(k,{reliableHiddenOffsets:function(){return null==g&&i(),g},boxSizingReliable:function(){return null==f&&i(),f},pixelPosition:function(){return null==e&&i(),e},reliableMarginRight:function(){return null==h&&i(),h}});function i(){var b,c,d,i;c=y.getElementsByTagName("body")[0],c&&c.style&&(b=y.createElement("div"),d=y.createElement("div"),d.style.cssText="position:absolute;border:0;width:0;height:0;top:0;left:-9999px",c.appendChild(d).appendChild(b),b.style.cssText="-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;display:block;margin-top:1%;top:1%;border:1px;padding:1px;width:4px;position:absolute",e=f=!1,h=!0,a.getComputedStyle&&(e="1%"!==(a.getComputedStyle(b,null)||{}).top,f="4px"===(a.getComputedStyle(b,null)||{width:"4px"}).width,i=b.appendChild(y.createElement("div")),i.style.cssText=b.style.cssText="-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;display:block;margin:0;border:0;padding:0",i.style.marginRight=i.style.width="0",b.style.width="1px",h=!parseFloat((a.getComputedStyle(i,null)||{}).marginRight),b.removeChild(i)),b.innerHTML="<table><tr><td></td><td>t</td></tr></table>",i=b.getElementsByTagName("td"),i[0].style.cssText="margin:0;border:0;padding:0;display:none",g=0===i[0].offsetHeight,g&&(i[0].style.display="",i[1].style.display="none",g=0===i[0].offsetHeight),c.removeChild(d))}}}(),m.swap=function(a,b,c,d){var e,f,g={};for(f in b)g[f]=a.style[f],a.style[f]=b[f];e=c.apply(a,d||[]);for(f in b)a.style[f]=g[f];return e};var Ma=/alpha\([^)]*\)/i,Na=/opacity\s*=\s*([^)]*)/,Oa=/^(none|table(?!-c[ea]).+)/,Pa=new RegExp("^("+S+")(.*)$","i"),Qa=new RegExp("^([+-])=("+S+")","i"),Ra={position:"absolute",visibility:"hidden",display:"block"},Sa={letterSpacing:"0",fontWeight:"400"},Ta=["Webkit","O","Moz","ms"];function Ua(a,b){if(b in a)return b;var c=b.charAt(0).toUpperCase()+b.slice(1),d=b,e=Ta.length;while(e--)if(b=Ta[e]+c,b in a)return b;return d}function Va(a,b){for(var c,d,e,f=[],g=0,h=a.length;h>g;g++)d=a[g],d.style&&(f[g]=m._data(d,"olddisplay"),c=d.style.display,b?(f[g]||"none"!==c||(d.style.display=""),""===d.style.display&&U(d)&&(f[g]=m._data(d,"olddisplay",Fa(d.nodeName)))):(e=U(d),(c&&"none"!==c||!e)&&m._data(d,"olddisplay",e?c:m.css(d,"display"))));for(g=0;h>g;g++)d=a[g],d.style&&(b&&"none"!==d.style.display&&""!==d.style.display||(d.style.display=b?f[g]||"":"none"));return a}function Wa(a,b,c){var d=Pa.exec(b);return d?Math.max(0,d[1]-(c||0))+(d[2]||"px"):b}function Xa(a,b,c,d,e){for(var f=c===(d?"border":"content")?4:"width"===b?1:0,g=0;4>f;f+=2)"margin"===c&&(g+=m.css(a,c+T[f],!0,e)),d?("content"===c&&(g-=m.css(a,"padding"+T[f],!0,e)),"margin"!==c&&(g-=m.css(a,"border"+T[f]+"Width",!0,e))):(g+=m.css(a,"padding"+T[f],!0,e),"padding"!==c&&(g+=m.css(a,"border"+T[f]+"Width",!0,e)));return g}function Ya(a,b,c){var d=!0,e="width"===b?a.offsetWidth:a.offsetHeight,f=Ia(a),g=k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,f);if(0>=e||null==e){if(e=Ja(a,b,f),(0>e||null==e)&&(e=a.style[b]),Ha.test(e))return e;d=g&&(k.boxSizingReliable()||e===a.style[b]),e=parseFloat(e)||0}return e+Xa(a,b,c||(g?"border":"content"),d,f)+"px"}m.extend({cssHooks:{opacity:{get:function(a,b){if(b){var c=Ja(a,"opacity");return""===c?"1":c}}}},cssNumber:{columnCount:!0,fillOpacity:!0,flexGrow:!0,flexShrink:!0,fontWeight:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,widows:!0,zIndex:!0,zoom:!0},cssProps:{"float":k.cssFloat?"cssFloat":"styleFloat"},style:function(a,b,c,d){if(a&&3!==a.nodeType&&8!==a.nodeType&&a.style){var e,f,g,h=m.camelCase(b),i=a.style;if(b=m.cssProps[h]||(m.cssProps[h]=Ua(i,h)),g=m.cssHooks[b]||m.cssHooks[h],void 0===c)return g&&"get"in g&&void 0!==(e=g.get(a,!1,d))?e:i[b];if(f=typeof c,"string"===f&&(e=Qa.exec(c))&&(c=(e[1]+1)*e[2]+parseFloat(m.css(a,b)),f="number"),null!=c&&c===c&&("number"!==f||m.cssNumber[h]||(c+="px"),k.clearCloneStyle||""!==c||0!==b.indexOf("background")||(i[b]="inherit"),!(g&&"set"in g&&void 0===(c=g.set(a,c,d)))))try{i[b]=c}catch(j){}}},css:function(a,b,c,d){var e,f,g,h=m.camelCase(b);return b=m.cssProps[h]||(m.cssProps[h]=Ua(a.style,h)),g=m.cssHooks[b]||m.cssHooks[h],g&&"get"in g&&(f=g.get(a,!0,c)),void 0===f&&(f=Ja(a,b,d)),"normal"===f&&b in Sa&&(f=Sa[b]),""===c||c?(e=parseFloat(f),c===!0||m.isNumeric(e)?e||0:f):f}}),m.each(["height","width"],function(a,b){m.cssHooks[b]={get:function(a,c,d){return c?Oa.test(m.css(a,"display"))&&0===a.offsetWidth?m.swap(a,Ra,function(){return Ya(a,b,d)}):Ya(a,b,d):void 0},set:function(a,c,d){var e=d&&Ia(a);return Wa(a,c,d?Xa(a,b,d,k.boxSizing&&"border-box"===m.css(a,"boxSizing",!1,e),e):0)}}}),k.opacity||(m.cssHooks.opacity={get:function(a,b){return Na.test((b&&a.currentStyle?a.currentStyle.filter:a.style.filter)||"")?.01*parseFloat(RegExp.$1)+"":b?"1":""},set:function(a,b){var c=a.style,d=a.currentStyle,e=m.isNumeric(b)?"alpha(opacity="+100*b+")":"",f=d&&d.filter||c.filter||"";c.zoom=1,(b>=1||""===b)&&""===m.trim(f.replace(Ma,""))&&c.removeAttribute&&(c.removeAttribute("filter"),""===b||d&&!d.filter)||(c.filter=Ma.test(f)?f.replace(Ma,e):f+" "+e)}}),m.cssHooks.marginRight=La(k.reliableMarginRight,function(a,b){return b?m.swap(a,{display:"inline-block"},Ja,[a,"marginRight"]):void 0}),m.each({margin:"",padding:"",border:"Width"},function(a,b){m.cssHooks[a+b]={expand:function(c){for(var d=0,e={},f="string"==typeof c?c.split(" "):[c];4>d;d++)e[a+T[d]+b]=f[d]||f[d-2]||f[0];return e}},Ga.test(a)||(m.cssHooks[a+b].set=Wa)}),m.fn.extend({css:function(a,b){return V(this,function(a,b,c){var d,e,f={},g=0;if(m.isArray(b)){for(d=Ia(a),e=b.length;e>g;g++)f[b[g]]=m.css(a,b[g],!1,d);return f}return void 0!==c?m.style(a,b,c):m.css(a,b)},a,b,arguments.length>1)},show:function(){return Va(this,!0)},hide:function(){return Va(this)},toggle:function(a){return"boolean"==typeof a?a?this.show():this.hide():this.each(function(){U(this)?m(this).show():m(this).hide()})}});function Za(a,b,c,d,e){
return new Za.prototype.init(a,b,c,d,e)}m.Tween=Za,Za.prototype={constructor:Za,init:function(a,b,c,d,e,f){this.elem=a,this.prop=c,this.easing=e||"swing",this.options=b,this.start=this.now=this.cur(),this.end=d,this.unit=f||(m.cssNumber[c]?"":"px")},cur:function(){var a=Za.propHooks[this.prop];return a&&a.get?a.get(this):Za.propHooks._default.get(this)},run:function(a){var b,c=Za.propHooks[this.prop];return this.options.duration?this.pos=b=m.easing[this.easing](a,this.options.duration*a,0,1,this.options.duration):this.pos=b=a,this.now=(this.end-this.start)*b+this.start,this.options.step&&this.options.step.call(this.elem,this.now,this),c&&c.set?c.set(this):Za.propHooks._default.set(this),this}},Za.prototype.init.prototype=Za.prototype,Za.propHooks={_default:{get:function(a){var b;return null==a.elem[a.prop]||a.elem.style&&null!=a.elem.style[a.prop]?(b=m.css(a.elem,a.prop,""),b&&"auto"!==b?b:0):a.elem[a.prop]},set:function(a){m.fx.step[a.prop]?m.fx.step[a.prop](a):a.elem.style&&(null!=a.elem.style[m.cssProps[a.prop]]||m.cssHooks[a.prop])?m.style(a.elem,a.prop,a.now+a.unit):a.elem[a.prop]=a.now}}},Za.propHooks.scrollTop=Za.propHooks.scrollLeft={set:function(a){a.elem.nodeType&&a.elem.parentNode&&(a.elem[a.prop]=a.now)}},m.easing={linear:function(a){return a},swing:function(a){return.5-Math.cos(a*Math.PI)/2}},m.fx=Za.prototype.init,m.fx.step={};var $a,_a,ab=/^(?:toggle|show|hide)$/,bb=new RegExp("^(?:([+-])=|)("+S+")([a-z%]*)$","i"),cb=/queueHooks$/,db=[ib],eb={"*":[function(a,b){var c=this.createTween(a,b),d=c.cur(),e=bb.exec(b),f=e&&e[3]||(m.cssNumber[a]?"":"px"),g=(m.cssNumber[a]||"px"!==f&&+d)&&bb.exec(m.css(c.elem,a)),h=1,i=20;if(g&&g[3]!==f){f=f||g[3],e=e||[],g=+d||1;do h=h||".5",g/=h,m.style(c.elem,a,g+f);while(h!==(h=c.cur()/d)&&1!==h&&--i)}return e&&(g=c.start=+g||+d||0,c.unit=f,c.end=e[1]?g+(e[1]+1)*e[2]:+e[2]),c}]};function fb(){return setTimeout(function(){$a=void 0}),$a=m.now()}function gb(a,b){var c,d={height:a},e=0;for(b=b?1:0;4>e;e+=2-b)c=T[e],d["margin"+c]=d["padding"+c]=a;return b&&(d.opacity=d.width=a),d}function hb(a,b,c){for(var d,e=(eb[b]||[]).concat(eb["*"]),f=0,g=e.length;g>f;f++)if(d=e[f].call(c,b,a))return d}function ib(a,b,c){var d,e,f,g,h,i,j,l,n=this,o={},p=a.style,q=a.nodeType&&U(a),r=m._data(a,"fxshow");c.queue||(h=m._queueHooks(a,"fx"),null==h.unqueued&&(h.unqueued=0,i=h.empty.fire,h.empty.fire=function(){h.unqueued||i()}),h.unqueued++,n.always(function(){n.always(function(){h.unqueued--,m.queue(a,"fx").length||h.empty.fire()})})),1===a.nodeType&&("height"in b||"width"in b)&&(c.overflow=[p.overflow,p.overflowX,p.overflowY],j=m.css(a,"display"),l="none"===j?m._data(a,"olddisplay")||Fa(a.nodeName):j,"inline"===l&&"none"===m.css(a,"float")&&(k.inlineBlockNeedsLayout&&"inline"!==Fa(a.nodeName)?p.zoom=1:p.display="inline-block")),c.overflow&&(p.overflow="hidden",k.shrinkWrapBlocks()||n.always(function(){p.overflow=c.overflow[0],p.overflowX=c.overflow[1],p.overflowY=c.overflow[2]}));for(d in b)if(e=b[d],ab.exec(e)){if(delete b[d],f=f||"toggle"===e,e===(q?"hide":"show")){if("show"!==e||!r||void 0===r[d])continue;q=!0}o[d]=r&&r[d]||m.style(a,d)}else j=void 0;if(m.isEmptyObject(o))"inline"===("none"===j?Fa(a.nodeName):j)&&(p.display=j);else{r?"hidden"in r&&(q=r.hidden):r=m._data(a,"fxshow",{}),f&&(r.hidden=!q),q?m(a).show():n.done(function(){m(a).hide()}),n.done(function(){var b;m._removeData(a,"fxshow");for(b in o)m.style(a,b,o[b])});for(d in o)g=hb(q?r[d]:0,d,n),d in r||(r[d]=g.start,q&&(g.end=g.start,g.start="width"===d||"height"===d?1:0))}}function jb(a,b){var c,d,e,f,g;for(c in a)if(d=m.camelCase(c),e=b[d],f=a[c],m.isArray(f)&&(e=f[1],f=a[c]=f[0]),c!==d&&(a[d]=f,delete a[c]),g=m.cssHooks[d],g&&"expand"in g){f=g.expand(f),delete a[d];for(c in f)c in a||(a[c]=f[c],b[c]=e)}else b[d]=e}function kb(a,b,c){var d,e,f=0,g=db.length,h=m.Deferred().always(function(){delete i.elem}),i=function(){if(e)return!1;for(var b=$a||fb(),c=Math.max(0,j.startTime+j.duration-b),d=c/j.duration||0,f=1-d,g=0,i=j.tweens.length;i>g;g++)j.tweens[g].run(f);return h.notifyWith(a,[j,f,c]),1>f&&i?c:(h.resolveWith(a,[j]),!1)},j=h.promise({elem:a,props:m.extend({},b),opts:m.extend(!0,{specialEasing:{}},c),originalProperties:b,originalOptions:c,startTime:$a||fb(),duration:c.duration,tweens:[],createTween:function(b,c){var d=m.Tween(a,j.opts,b,c,j.opts.specialEasing[b]||j.opts.easing);return j.tweens.push(d),d},stop:function(b){var c=0,d=b?j.tweens.length:0;if(e)return this;for(e=!0;d>c;c++)j.tweens[c].run(1);return b?h.resolveWith(a,[j,b]):h.rejectWith(a,[j,b]),this}}),k=j.props;for(jb(k,j.opts.specialEasing);g>f;f++)if(d=db[f].call(j,a,k,j.opts))return d;return m.map(k,hb,j),m.isFunction(j.opts.start)&&j.opts.start.call(a,j),m.fx.timer(m.extend(i,{elem:a,anim:j,queue:j.opts.queue})),j.progress(j.opts.progress).done(j.opts.done,j.opts.complete).fail(j.opts.fail).always(j.opts.always)}m.Animation=m.extend(kb,{tweener:function(a,b){m.isFunction(a)?(b=a,a=["*"]):a=a.split(" ");for(var c,d=0,e=a.length;e>d;d++)c=a[d],eb[c]=eb[c]||[],eb[c].unshift(b)},prefilter:function(a,b){b?db.unshift(a):db.push(a)}}),m.speed=function(a,b,c){var d=a&&"object"==typeof a?m.extend({},a):{complete:c||!c&&b||m.isFunction(a)&&a,duration:a,easing:c&&b||b&&!m.isFunction(b)&&b};return d.duration=m.fx.off?0:"number"==typeof d.duration?d.duration:d.duration in m.fx.speeds?m.fx.speeds[d.duration]:m.fx.speeds._default,(null==d.queue||d.queue===!0)&&(d.queue="fx"),d.old=d.complete,d.complete=function(){m.isFunction(d.old)&&d.old.call(this),d.queue&&m.dequeue(this,d.queue)},d},m.fn.extend({fadeTo:function(a,b,c,d){return this.filter(U).css("opacity",0).show().end().animate({opacity:b},a,c,d)},animate:function(a,b,c,d){var e=m.isEmptyObject(a),f=m.speed(b,c,d),g=function(){var b=kb(this,m.extend({},a),f);(e||m._data(this,"finish"))&&b.stop(!0)};return g.finish=g,e||f.queue===!1?this.each(g):this.queue(f.queue,g)},stop:function(a,b,c){var d=function(a){var b=a.stop;delete a.stop,b(c)};return"string"!=typeof a&&(c=b,b=a,a=void 0),b&&a!==!1&&this.queue(a||"fx",[]),this.each(function(){var b=!0,e=null!=a&&a+"queueHooks",f=m.timers,g=m._data(this);if(e)g[e]&&g[e].stop&&d(g[e]);else for(e in g)g[e]&&g[e].stop&&cb.test(e)&&d(g[e]);for(e=f.length;e--;)f[e].elem!==this||null!=a&&f[e].queue!==a||(f[e].anim.stop(c),b=!1,f.splice(e,1));(b||!c)&&m.dequeue(this,a)})},finish:function(a){return a!==!1&&(a=a||"fx"),this.each(function(){var b,c=m._data(this),d=c[a+"queue"],e=c[a+"queueHooks"],f=m.timers,g=d?d.length:0;for(c.finish=!0,m.queue(this,a,[]),e&&e.stop&&e.stop.call(this,!0),b=f.length;b--;)f[b].elem===this&&f[b].queue===a&&(f[b].anim.stop(!0),f.splice(b,1));for(b=0;g>b;b++)d[b]&&d[b].finish&&d[b].finish.call(this);delete c.finish})}}),m.each(["toggle","show","hide"],function(a,b){var c=m.fn[b];m.fn[b]=function(a,d,e){return null==a||"boolean"==typeof a?c.apply(this,arguments):this.animate(gb(b,!0),a,d,e)}}),m.each({slideDown:gb("show"),slideUp:gb("hide"),slideToggle:gb("toggle"),fadeIn:{opacity:"show"},fadeOut:{opacity:"hide"},fadeToggle:{opacity:"toggle"}},function(a,b){m.fn[a]=function(a,c,d){return this.animate(b,a,c,d)}}),m.timers=[],m.fx.tick=function(){var a,b=m.timers,c=0;for($a=m.now();c<b.length;c++)a=b[c],a()||b[c]!==a||b.splice(c--,1);b.length||m.fx.stop(),$a=void 0},m.fx.timer=function(a){m.timers.push(a),a()?m.fx.start():m.timers.pop()},m.fx.interval=13,m.fx.start=function(){_a||(_a=setInterval(m.fx.tick,m.fx.interval))},m.fx.stop=function(){clearInterval(_a),_a=null},m.fx.speeds={slow:600,fast:200,_default:400},m.fn.delay=function(a,b){return a=m.fx?m.fx.speeds[a]||a:a,b=b||"fx",this.queue(b,function(b,c){var d=setTimeout(b,a);c.stop=function(){clearTimeout(d)}})},function(){var a,b,c,d,e;b=y.createElement("div"),b.setAttribute("className","t"),b.innerHTML="  <link/><table></table><a href='/a'>a</a><input type='checkbox'/>",d=b.getElementsByTagName("a")[0],c=y.createElement("select"),e=c.appendChild(y.createElement("option")),a=b.getElementsByTagName("input")[0],d.style.cssText="top:1px",k.getSetAttribute="t"!==b.className,k.style=/top/.test(d.getAttribute("style")),k.hrefNormalized="/a"===d.getAttribute("href"),k.checkOn=!!a.value,k.optSelected=e.selected,k.enctype=!!y.createElement("form").enctype,c.disabled=!0,k.optDisabled=!e.disabled,a=y.createElement("input"),a.setAttribute("value",""),k.input=""===a.getAttribute("value"),a.value="t",a.setAttribute("type","radio"),k.radioValue="t"===a.value}();var lb=/\r/g;m.fn.extend({val:function(a){var b,c,d,e=this[0];{if(arguments.length)return d=m.isFunction(a),this.each(function(c){var e;1===this.nodeType&&(e=d?a.call(this,c,m(this).val()):a,null==e?e="":"number"==typeof e?e+="":m.isArray(e)&&(e=m.map(e,function(a){return null==a?"":a+""})),b=m.valHooks[this.type]||m.valHooks[this.nodeName.toLowerCase()],b&&"set"in b&&void 0!==b.set(this,e,"value")||(this.value=e))});if(e)return b=m.valHooks[e.type]||m.valHooks[e.nodeName.toLowerCase()],b&&"get"in b&&void 0!==(c=b.get(e,"value"))?c:(c=e.value,"string"==typeof c?c.replace(lb,""):null==c?"":c)}}}),m.extend({valHooks:{option:{get:function(a){var b=m.find.attr(a,"value");return null!=b?b:m.trim(m.text(a))}},select:{get:function(a){for(var b,c,d=a.options,e=a.selectedIndex,f="select-one"===a.type||0>e,g=f?null:[],h=f?e+1:d.length,i=0>e?h:f?e:0;h>i;i++)if(c=d[i],!(!c.selected&&i!==e||(k.optDisabled?c.disabled:null!==c.getAttribute("disabled"))||c.parentNode.disabled&&m.nodeName(c.parentNode,"optgroup"))){if(b=m(c).val(),f)return b;g.push(b)}return g},set:function(a,b){var c,d,e=a.options,f=m.makeArray(b),g=e.length;while(g--)if(d=e[g],m.inArray(m.valHooks.option.get(d),f)>=0)try{d.selected=c=!0}catch(h){d.scrollHeight}else d.selected=!1;return c||(a.selectedIndex=-1),e}}}}),m.each(["radio","checkbox"],function(){m.valHooks[this]={set:function(a,b){return m.isArray(b)?a.checked=m.inArray(m(a).val(),b)>=0:void 0}},k.checkOn||(m.valHooks[this].get=function(a){return null===a.getAttribute("value")?"on":a.value})});var mb,nb,ob=m.expr.attrHandle,pb=/^(?:checked|selected)$/i,qb=k.getSetAttribute,rb=k.input;m.fn.extend({attr:function(a,b){return V(this,m.attr,a,b,arguments.length>1)},removeAttr:function(a){return this.each(function(){m.removeAttr(this,a)})}}),m.extend({attr:function(a,b,c){var d,e,f=a.nodeType;if(a&&3!==f&&8!==f&&2!==f)return typeof a.getAttribute===K?m.prop(a,b,c):(1===f&&m.isXMLDoc(a)||(b=b.toLowerCase(),d=m.attrHooks[b]||(m.expr.match.bool.test(b)?nb:mb)),void 0===c?d&&"get"in d&&null!==(e=d.get(a,b))?e:(e=m.find.attr(a,b),null==e?void 0:e):null!==c?d&&"set"in d&&void 0!==(e=d.set(a,c,b))?e:(a.setAttribute(b,c+""),c):void m.removeAttr(a,b))},removeAttr:function(a,b){var c,d,e=0,f=b&&b.match(E);if(f&&1===a.nodeType)while(c=f[e++])d=m.propFix[c]||c,m.expr.match.bool.test(c)?rb&&qb||!pb.test(c)?a[d]=!1:a[m.camelCase("default-"+c)]=a[d]=!1:m.attr(a,c,""),a.removeAttribute(qb?c:d)},attrHooks:{type:{set:function(a,b){if(!k.radioValue&&"radio"===b&&m.nodeName(a,"input")){var c=a.value;return a.setAttribute("type",b),c&&(a.value=c),b}}}}}),nb={set:function(a,b,c){return b===!1?m.removeAttr(a,c):rb&&qb||!pb.test(c)?a.setAttribute(!qb&&m.propFix[c]||c,c):a[m.camelCase("default-"+c)]=a[c]=!0,c}},m.each(m.expr.match.bool.source.match(/\w+/g),function(a,b){var c=ob[b]||m.find.attr;ob[b]=rb&&qb||!pb.test(b)?function(a,b,d){var e,f;return d||(f=ob[b],ob[b]=e,e=null!=c(a,b,d)?b.toLowerCase():null,ob[b]=f),e}:function(a,b,c){return c?void 0:a[m.camelCase("default-"+b)]?b.toLowerCase():null}}),rb&&qb||(m.attrHooks.value={set:function(a,b,c){return m.nodeName(a,"input")?void(a.defaultValue=b):mb&&mb.set(a,b,c)}}),qb||(mb={set:function(a,b,c){var d=a.getAttributeNode(c);return d||a.setAttributeNode(d=a.ownerDocument.createAttribute(c)),d.value=b+="","value"===c||b===a.getAttribute(c)?b:void 0}},ob.id=ob.name=ob.coords=function(a,b,c){var d;return c?void 0:(d=a.getAttributeNode(b))&&""!==d.value?d.value:null},m.valHooks.button={get:function(a,b){var c=a.getAttributeNode(b);return c&&c.specified?c.value:void 0},set:mb.set},m.attrHooks.contenteditable={set:function(a,b,c){mb.set(a,""===b?!1:b,c)}},m.each(["width","height"],function(a,b){m.attrHooks[b]={set:function(a,c){return""===c?(a.setAttribute(b,"auto"),c):void 0}}})),k.style||(m.attrHooks.style={get:function(a){return a.style.cssText||void 0},set:function(a,b){return a.style.cssText=b+""}});var sb=/^(?:input|select|textarea|button|object)$/i,tb=/^(?:a|area)$/i;m.fn.extend({prop:function(a,b){return V(this,m.prop,a,b,arguments.length>1)},removeProp:function(a){return a=m.propFix[a]||a,this.each(function(){try{this[a]=void 0,delete this[a]}catch(b){}})}}),m.extend({propFix:{"for":"htmlFor","class":"className"},prop:function(a,b,c){var d,e,f,g=a.nodeType;if(a&&3!==g&&8!==g&&2!==g)return f=1!==g||!m.isXMLDoc(a),f&&(b=m.propFix[b]||b,e=m.propHooks[b]),void 0!==c?e&&"set"in e&&void 0!==(d=e.set(a,c,b))?d:a[b]=c:e&&"get"in e&&null!==(d=e.get(a,b))?d:a[b]},propHooks:{tabIndex:{get:function(a){var b=m.find.attr(a,"tabindex");return b?parseInt(b,10):sb.test(a.nodeName)||tb.test(a.nodeName)&&a.href?0:-1}}}}),k.hrefNormalized||m.each(["href","src"],function(a,b){m.propHooks[b]={get:function(a){return a.getAttribute(b,4)}}}),k.optSelected||(m.propHooks.selected={get:function(a){var b=a.parentNode;return b&&(b.selectedIndex,b.parentNode&&b.parentNode.selectedIndex),null}}),m.each(["tabIndex","readOnly","maxLength","cellSpacing","cellPadding","rowSpan","colSpan","useMap","frameBorder","contentEditable"],function(){m.propFix[this.toLowerCase()]=this}),k.enctype||(m.propFix.enctype="encoding");var ub=/[\t\r\n\f]/g;m.fn.extend({addClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j="string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).addClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):" ")){f=0;while(e=b[f++])d.indexOf(" "+e+" ")<0&&(d+=e+" ");g=m.trim(d),c.className!==g&&(c.className=g)}return this},removeClass:function(a){var b,c,d,e,f,g,h=0,i=this.length,j=0===arguments.length||"string"==typeof a&&a;if(m.isFunction(a))return this.each(function(b){m(this).removeClass(a.call(this,b,this.className))});if(j)for(b=(a||"").match(E)||[];i>h;h++)if(c=this[h],d=1===c.nodeType&&(c.className?(" "+c.className+" ").replace(ub," "):"")){f=0;while(e=b[f++])while(d.indexOf(" "+e+" ")>=0)d=d.replace(" "+e+" "," ");g=a?m.trim(d):"",c.className!==g&&(c.className=g)}return this},toggleClass:function(a,b){var c=typeof a;return"boolean"==typeof b&&"string"===c?b?this.addClass(a):this.removeClass(a):this.each(m.isFunction(a)?function(c){m(this).toggleClass(a.call(this,c,this.className,b),b)}:function(){if("string"===c){var b,d=0,e=m(this),f=a.match(E)||[];while(b=f[d++])e.hasClass(b)?e.removeClass(b):e.addClass(b)}else(c===K||"boolean"===c)&&(this.className&&m._data(this,"__className__",this.className),this.className=this.className||a===!1?"":m._data(this,"__className__")||"")})},hasClass:function(a){for(var b=" "+a+" ",c=0,d=this.length;d>c;c++)if(1===this[c].nodeType&&(" "+this[c].className+" ").replace(ub," ").indexOf(b)>=0)return!0;return!1}}),m.each("blur focus focusin focusout load resize scroll unload click dblclick mousedown mouseup mousemove mouseover mouseout mouseenter mouseleave change select submit keydown keypress keyup error contextmenu".split(" "),function(a,b){m.fn[b]=function(a,c){return arguments.length>0?this.on(b,null,a,c):this.trigger(b)}}),m.fn.extend({hover:function(a,b){return this.mouseenter(a).mouseleave(b||a)},bind:function(a,b,c){return this.on(a,null,b,c)},unbind:function(a,b){return this.off(a,null,b)},delegate:function(a,b,c,d){return this.on(b,a,c,d)},undelegate:function(a,b,c){return 1===arguments.length?this.off(a,"**"):this.off(b,a||"**",c)}});var vb=m.now(),wb=/\?/,xb=/(,)|(\[|{)|(}|])|"(?:[^"\\\r\n]|\\["\\\/bfnrt]|\\u[\da-fA-F]{4})*"\s*:?|true|false|null|-?(?!0\d)\d+(?:\.\d+|)(?:[eE][+-]?\d+|)/g;m.parseJSON=function(b){if(a.JSON&&a.JSON.parse)return a.JSON.parse(b+"");var c,d=null,e=m.trim(b+"");return e&&!m.trim(e.replace(xb,function(a,b,e,f){return c&&b&&(d=0),0===d?a:(c=e||b,d+=!f-!e,"")}))?Function("return "+e)():m.error("Invalid JSON: "+b)},m.parseXML=function(b){var c,d;if(!b||"string"!=typeof b)return null;try{a.DOMParser?(d=new DOMParser,c=d.parseFromString(b,"text/xml")):(c=new ActiveXObject("Microsoft.XMLDOM"),c.async="false",c.loadXML(b))}catch(e){c=void 0}return c&&c.documentElement&&!c.getElementsByTagName("parsererror").length||m.error("Invalid XML: "+b),c};var yb,zb,Ab=/#.*$/,Bb=/([?&])_=[^&]*/,Cb=/^(.*?):[ \t]*([^\r\n]*)\r?$/gm,Db=/^(?:about|app|app-storage|.+-extension|file|res|widget):$/,Eb=/^(?:GET|HEAD)$/,Fb=/^\/\//,Gb=/^([\w.+-]+:)(?:\/\/(?:[^\/?#]*@|)([^\/?#:]*)(?::(\d+)|)|)/,Hb={},Ib={},Jb="*/".concat("*");try{zb=location.href}catch(Kb){zb=y.createElement("a"),zb.href="",zb=zb.href}yb=Gb.exec(zb.toLowerCase())||[];function Lb(a){return function(b,c){"string"!=typeof b&&(c=b,b="*");var d,e=0,f=b.toLowerCase().match(E)||[];if(m.isFunction(c))while(d=f[e++])"+"===d.charAt(0)?(d=d.slice(1)||"*",(a[d]=a[d]||[]).unshift(c)):(a[d]=a[d]||[]).push(c)}}function Mb(a,b,c,d){var e={},f=a===Ib;function g(h){var i;return e[h]=!0,m.each(a[h]||[],function(a,h){var j=h(b,c,d);return"string"!=typeof j||f||e[j]?f?!(i=j):void 0:(b.dataTypes.unshift(j),g(j),!1)}),i}return g(b.dataTypes[0])||!e["*"]&&g("*")}function Nb(a,b){var c,d,e=m.ajaxSettings.flatOptions||{};for(d in b)void 0!==b[d]&&((e[d]?a:c||(c={}))[d]=b[d]);return c&&m.extend(!0,a,c),a}function Ob(a,b,c){var d,e,f,g,h=a.contents,i=a.dataTypes;while("*"===i[0])i.shift(),void 0===e&&(e=a.mimeType||b.getResponseHeader("Content-Type"));if(e)for(g in h)if(h[g]&&h[g].test(e)){i.unshift(g);break}if(i[0]in c)f=i[0];else{for(g in c){if(!i[0]||a.converters[g+" "+i[0]]){f=g;break}d||(d=g)}f=f||d}return f?(f!==i[0]&&i.unshift(f),c[f]):void 0}function Pb(a,b,c,d){var e,f,g,h,i,j={},k=a.dataTypes.slice();if(k[1])for(g in a.converters)j[g.toLowerCase()]=a.converters[g];f=k.shift();while(f)if(a.responseFields[f]&&(c[a.responseFields[f]]=b),!i&&d&&a.dataFilter&&(b=a.dataFilter(b,a.dataType)),i=f,f=k.shift())if("*"===f)f=i;else if("*"!==i&&i!==f){if(g=j[i+" "+f]||j["* "+f],!g)for(e in j)if(h=e.split(" "),h[1]===f&&(g=j[i+" "+h[0]]||j["* "+h[0]])){g===!0?g=j[e]:j[e]!==!0&&(f=h[0],k.unshift(h[1]));break}if(g!==!0)if(g&&a["throws"])b=g(b);else try{b=g(b)}catch(l){return{state:"parsererror",error:g?l:"No conversion from "+i+" to "+f}}}return{state:"success",data:b}}m.extend({active:0,lastModified:{},etag:{},ajaxSettings:{url:zb,type:"GET",isLocal:Db.test(yb[1]),global:!0,processData:!0,async:!0,contentType:"application/x-www-form-urlencoded; charset=UTF-8",accepts:{"*":Jb,text:"text/plain",html:"text/html",xml:"application/xml, text/xml",json:"application/json, text/javascript"},contents:{xml:/xml/,html:/html/,json:/json/},responseFields:{xml:"responseXML",text:"responseText",json:"responseJSON"},converters:{"* text":String,"text html":!0,"text json":m.parseJSON,"text xml":m.parseXML},flatOptions:{url:!0,context:!0}},ajaxSetup:function(a,b){return b?Nb(Nb(a,m.ajaxSettings),b):Nb(m.ajaxSettings,a)},ajaxPrefilter:Lb(Hb),ajaxTransport:Lb(Ib),ajax:function(a,b){"object"==typeof a&&(b=a,a=void 0),b=b||{};var c,d,e,f,g,h,i,j,k=m.ajaxSetup({},b),l=k.context||k,n=k.context&&(l.nodeType||l.jquery)?m(l):m.event,o=m.Deferred(),p=m.Callbacks("once memory"),q=k.statusCode||{},r={},s={},t=0,u="canceled",v={readyState:0,getResponseHeader:function(a){var b;if(2===t){if(!j){j={};while(b=Cb.exec(f))j[b[1].toLowerCase()]=b[2]}b=j[a.toLowerCase()]}return null==b?null:b},getAllResponseHeaders:function(){return 2===t?f:null},setRequestHeader:function(a,b){var c=a.toLowerCase();return t||(a=s[c]=s[c]||a,r[a]=b),this},overrideMimeType:function(a){return t||(k.mimeType=a),this},statusCode:function(a){var b;if(a)if(2>t)for(b in a)q[b]=[q[b],a[b]];else v.always(a[v.status]);return this},abort:function(a){var b=a||u;return i&&i.abort(b),x(0,b),this}};if(o.promise(v).complete=p.add,v.success=v.done,v.error=v.fail,k.url=((a||k.url||zb)+"").replace(Ab,"").replace(Fb,yb[1]+"//"),k.type=b.method||b.type||k.method||k.type,k.dataTypes=m.trim(k.dataType||"*").toLowerCase().match(E)||[""],null==k.crossDomain&&(c=Gb.exec(k.url.toLowerCase()),k.crossDomain=!(!c||c[1]===yb[1]&&c[2]===yb[2]&&(c[3]||("http:"===c[1]?"80":"443"))===(yb[3]||("http:"===yb[1]?"80":"443")))),k.data&&k.processData&&"string"!=typeof k.data&&(k.data=m.param(k.data,k.traditional)),Mb(Hb,k,b,v),2===t)return v;h=m.event&&k.global,h&&0===m.active++&&m.event.trigger("ajaxStart"),k.type=k.type.toUpperCase(),k.hasContent=!Eb.test(k.type),e=k.url,k.hasContent||(k.data&&(e=k.url+=(wb.test(e)?"&":"?")+k.data,delete k.data),k.cache===!1&&(k.url=Bb.test(e)?e.replace(Bb,"$1_="+vb++):e+(wb.test(e)?"&":"?")+"_="+vb++)),k.ifModified&&(m.lastModified[e]&&v.setRequestHeader("If-Modified-Since",m.lastModified[e]),m.etag[e]&&v.setRequestHeader("If-None-Match",m.etag[e])),(k.data&&k.hasContent&&k.contentType!==!1||b.contentType)&&v.setRequestHeader("Content-Type",k.contentType),v.setRequestHeader("Accept",k.dataTypes[0]&&k.accepts[k.dataTypes[0]]?k.accepts[k.dataTypes[0]]+("*"!==k.dataTypes[0]?", "+Jb+"; q=0.01":""):k.accepts["*"]);for(d in k.headers)v.setRequestHeader(d,k.headers[d]);if(k.beforeSend&&(k.beforeSend.call(l,v,k)===!1||2===t))return v.abort();u="abort";for(d in{success:1,error:1,complete:1})v[d](k[d]);if(i=Mb(Ib,k,b,v)){v.readyState=1,h&&n.trigger("ajaxSend",[v,k]),k.async&&k.timeout>0&&(g=setTimeout(function(){v.abort("timeout")},k.timeout));try{t=1,i.send(r,x)}catch(w){if(!(2>t))throw w;x(-1,w)}}else x(-1,"No Transport");function x(a,b,c,d){var j,r,s,u,w,x=b;2!==t&&(t=2,g&&clearTimeout(g),i=void 0,f=d||"",v.readyState=a>0?4:0,j=a>=200&&300>a||304===a,c&&(u=Ob(k,v,c)),u=Pb(k,u,v,j),j?(k.ifModified&&(w=v.getResponseHeader("Last-Modified"),w&&(m.lastModified[e]=w),w=v.getResponseHeader("etag"),w&&(m.etag[e]=w)),204===a||"HEAD"===k.type?x="nocontent":304===a?x="notmodified":(x=u.state,r=u.data,s=u.error,j=!s)):(s=x,(a||!x)&&(x="error",0>a&&(a=0))),v.status=a,v.statusText=(b||x)+"",j?o.resolveWith(l,[r,x,v]):o.rejectWith(l,[v,x,s]),v.statusCode(q),q=void 0,h&&n.trigger(j?"ajaxSuccess":"ajaxError",[v,k,j?r:s]),p.fireWith(l,[v,x]),h&&(n.trigger("ajaxComplete",[v,k]),--m.active||m.event.trigger("ajaxStop")))}return v},getJSON:function(a,b,c){return m.get(a,b,c,"json")},getScript:function(a,b){return m.get(a,void 0,b,"script")}}),m.each(["get","post"],function(a,b){m[b]=function(a,c,d,e){return m.isFunction(c)&&(e=e||d,d=c,c=void 0),m.ajax({url:a,type:b,dataType:e,data:c,success:d})}}),m._evalUrl=function(a){return m.ajax({url:a,type:"GET",dataType:"script",async:!1,global:!1,"throws":!0})},m.fn.extend({wrapAll:function(a){if(m.isFunction(a))return this.each(function(b){m(this).wrapAll(a.call(this,b))});if(this[0]){var b=m(a,this[0].ownerDocument).eq(0).clone(!0);this[0].parentNode&&b.insertBefore(this[0]),b.map(function(){var a=this;while(a.firstChild&&1===a.firstChild.nodeType)a=a.firstChild;return a}).append(this)}return this},wrapInner:function(a){return this.each(m.isFunction(a)?function(b){m(this).wrapInner(a.call(this,b))}:function(){var b=m(this),c=b.contents();c.length?c.wrapAll(a):b.append(a)})},wrap:function(a){var b=m.isFunction(a);return this.each(function(c){m(this).wrapAll(b?a.call(this,c):a)})},unwrap:function(){return this.parent().each(function(){m.nodeName(this,"body")||m(this).replaceWith(this.childNodes)}).end()}}),m.expr.filters.hidden=function(a){return a.offsetWidth<=0&&a.offsetHeight<=0||!k.reliableHiddenOffsets()&&"none"===(a.style&&a.style.display||m.css(a,"display"))},m.expr.filters.visible=function(a){return!m.expr.filters.hidden(a)};var Qb=/%20/g,Rb=/\[\]$/,Sb=/\r?\n/g,Tb=/^(?:submit|button|image|reset|file)$/i,Ub=/^(?:input|select|textarea|keygen)/i;function Vb(a,b,c,d){var e;if(m.isArray(b))m.each(b,function(b,e){c||Rb.test(a)?d(a,e):Vb(a+"["+("object"==typeof e?b:"")+"]",e,c,d)});else if(c||"object"!==m.type(b))d(a,b);else for(e in b)Vb(a+"["+e+"]",b[e],c,d)}m.param=function(a,b){var c,d=[],e=function(a,b){b=m.isFunction(b)?b():null==b?"":b,d[d.length]=encodeURIComponent(a)+"="+encodeURIComponent(b)};if(void 0===b&&(b=m.ajaxSettings&&m.ajaxSettings.traditional),m.isArray(a)||a.jquery&&!m.isPlainObject(a))m.each(a,function(){e(this.name,this.value)});else for(c in a)Vb(c,a[c],b,e);return d.join("&").replace(Qb,"+")},m.fn.extend({serialize:function(){return m.param(this.serializeArray())},serializeArray:function(){return this.map(function(){var a=m.prop(this,"elements");return a?m.makeArray(a):this}).filter(function(){var a=this.type;return this.name&&!m(this).is(":disabled")&&Ub.test(this.nodeName)&&!Tb.test(a)&&(this.checked||!W.test(a))}).map(function(a,b){var c=m(this).val();return null==c?null:m.isArray(c)?m.map(c,function(a){return{name:b.name,value:a.replace(Sb,"\r\n")}}):{name:b.name,value:c.replace(Sb,"\r\n")}}).get()}}),m.ajaxSettings.xhr=void 0!==a.ActiveXObject?function(){return!this.isLocal&&/^(get|post|head|put|delete|options)$/i.test(this.type)&&Zb()||$b()}:Zb;var Wb=0,Xb={},Yb=m.ajaxSettings.xhr();a.attachEvent&&a.attachEvent("onunload",function(){for(var a in Xb)Xb[a](void 0,!0)}),k.cors=!!Yb&&"withCredentials"in Yb,Yb=k.ajax=!!Yb,Yb&&m.ajaxTransport(function(a){if(!a.crossDomain||k.cors){var b;return{send:function(c,d){var e,f=a.xhr(),g=++Wb;if(f.open(a.type,a.url,a.async,a.username,a.password),a.xhrFields)for(e in a.xhrFields)f[e]=a.xhrFields[e];a.mimeType&&f.overrideMimeType&&f.overrideMimeType(a.mimeType),a.crossDomain||c["X-Requested-With"]||(c["X-Requested-With"]="XMLHttpRequest");for(e in c)void 0!==c[e]&&f.setRequestHeader(e,c[e]+"");f.send(a.hasContent&&a.data||null),b=function(c,e){var h,i,j;if(b&&(e||4===f.readyState))if(delete Xb[g],b=void 0,f.onreadystatechange=m.noop,e)4!==f.readyState&&f.abort();else{j={},h=f.status,"string"==typeof f.responseText&&(j.text=f.responseText);try{i=f.statusText}catch(k){i=""}h||!a.isLocal||a.crossDomain?1223===h&&(h=204):h=j.text?200:404}j&&d(h,i,j,f.getAllResponseHeaders())},a.async?4===f.readyState?setTimeout(b):f.onreadystatechange=Xb[g]=b:b()},abort:function(){b&&b(void 0,!0)}}}});function Zb(){try{return new a.XMLHttpRequest}catch(b){}}function $b(){try{return new a.ActiveXObject("Microsoft.XMLHTTP")}catch(b){}}m.ajaxSetup({accepts:{script:"text/javascript, application/javascript, application/ecmascript, application/x-ecmascript"},contents:{script:/(?:java|ecma)script/},converters:{"text script":function(a){return m.globalEval(a),a}}}),m.ajaxPrefilter("script",function(a){void 0===a.cache&&(a.cache=!1),a.crossDomain&&(a.type="GET",a.global=!1)}),m.ajaxTransport("script",function(a){if(a.crossDomain){var b,c=y.head||m("head")[0]||y.documentElement;return{send:function(d,e){b=y.createElement("script"),b.async=!0,a.scriptCharset&&(b.charset=a.scriptCharset),b.src=a.url,b.onload=b.onreadystatechange=function(a,c){(c||!b.readyState||/loaded|complete/.test(b.readyState))&&(b.onload=b.onreadystatechange=null,b.parentNode&&b.parentNode.removeChild(b),b=null,c||e(200,"success"))},c.insertBefore(b,c.firstChild)},abort:function(){b&&b.onload(void 0,!0)}}}});var _b=[],ac=/(=)\?(?=&|$)|\?\?/;m.ajaxSetup({jsonp:"callback",jsonpCallback:function(){var a=_b.pop()||m.expando+"_"+vb++;return this[a]=!0,a}}),m.ajaxPrefilter("json jsonp",function(b,c,d){var e,f,g,h=b.jsonp!==!1&&(ac.test(b.url)?"url":"string"==typeof b.data&&!(b.contentType||"").indexOf("application/x-www-form-urlencoded")&&ac.test(b.data)&&"data");return h||"jsonp"===b.dataTypes[0]?(e=b.jsonpCallback=m.isFunction(b.jsonpCallback)?b.jsonpCallback():b.jsonpCallback,h?b[h]=b[h].replace(ac,"$1"+e):b.jsonp!==!1&&(b.url+=(wb.test(b.url)?"&":"?")+b.jsonp+"="+e),b.converters["script json"]=function(){return g||m.error(e+" was not called"),g[0]},b.dataTypes[0]="json",f=a[e],a[e]=function(){g=arguments},d.always(function(){a[e]=f,b[e]&&(b.jsonpCallback=c.jsonpCallback,_b.push(e)),g&&m.isFunction(f)&&f(g[0]),g=f=void 0}),"script"):void 0}),m.parseHTML=function(a,b,c){if(!a||"string"!=typeof a)return null;"boolean"==typeof b&&(c=b,b=!1),b=b||y;var d=u.exec(a),e=!c&&[];return d?[b.createElement(d[1])]:(d=m.buildFragment([a],b,e),e&&e.length&&m(e).remove(),m.merge([],d.childNodes))};var bc=m.fn.load;m.fn.load=function(a,b,c){if("string"!=typeof a&&bc)return bc.apply(this,arguments);var d,e,f,g=this,h=a.indexOf(" ");return h>=0&&(d=m.trim(a.slice(h,a.length)),a=a.slice(0,h)),m.isFunction(b)?(c=b,b=void 0):b&&"object"==typeof b&&(f="POST"),g.length>0&&m.ajax({url:a,type:f,dataType:"html",data:b}).done(function(a){e=arguments,g.html(d?m("<div>").append(m.parseHTML(a)).find(d):a)}).complete(c&&function(a,b){g.each(c,e||[a.responseText,b,a])}),this},m.each(["ajaxStart","ajaxStop","ajaxComplete","ajaxError","ajaxSuccess","ajaxSend"],function(a,b){m.fn[b]=function(a){return this.on(b,a)}}),m.expr.filters.animated=function(a){return m.grep(m.timers,function(b){return a===b.elem}).length};var cc=a.document.documentElement;function dc(a){return m.isWindow(a)?a:9===a.nodeType?a.defaultView||a.parentWindow:!1}m.offset={setOffset:function(a,b,c){var d,e,f,g,h,i,j,k=m.css(a,"position"),l=m(a),n={};"static"===k&&(a.style.position="relative"),h=l.offset(),f=m.css(a,"top"),i=m.css(a,"left"),j=("absolute"===k||"fixed"===k)&&m.inArray("auto",[f,i])>-1,j?(d=l.position(),g=d.top,e=d.left):(g=parseFloat(f)||0,e=parseFloat(i)||0),m.isFunction(b)&&(b=b.call(a,c,h)),null!=b.top&&(n.top=b.top-h.top+g),null!=b.left&&(n.left=b.left-h.left+e),"using"in b?b.using.call(a,n):l.css(n)}},m.fn.extend({offset:function(a){if(arguments.length)return void 0===a?this:this.each(function(b){m.offset.setOffset(this,a,b)});var b,c,d={top:0,left:0},e=this[0],f=e&&e.ownerDocument;if(f)return b=f.documentElement,m.contains(b,e)?(typeof e.getBoundingClientRect!==K&&(d=e.getBoundingClientRect()),c=dc(f),{top:d.top+(c.pageYOffset||b.scrollTop)-(b.clientTop||0),left:d.left+(c.pageXOffset||b.scrollLeft)-(b.clientLeft||0)}):d},position:function(){if(this[0]){var a,b,c={top:0,left:0},d=this[0];return"fixed"===m.css(d,"position")?b=d.getBoundingClientRect():(a=this.offsetParent(),b=this.offset(),m.nodeName(a[0],"html")||(c=a.offset()),c.top+=m.css(a[0],"borderTopWidth",!0),c.left+=m.css(a[0],"borderLeftWidth",!0)),{top:b.top-c.top-m.css(d,"marginTop",!0),left:b.left-c.left-m.css(d,"marginLeft",!0)}}},offsetParent:function(){return this.map(function(){var a=this.offsetParent||cc;while(a&&!m.nodeName(a,"html")&&"static"===m.css(a,"position"))a=a.offsetParent;return a||cc})}}),m.each({scrollLeft:"pageXOffset",scrollTop:"pageYOffset"},function(a,b){var c=/Y/.test(b);m.fn[a]=function(d){return V(this,function(a,d,e){var f=dc(a);return void 0===e?f?b in f?f[b]:f.document.documentElement[d]:a[d]:void(f?f.scrollTo(c?m(f).scrollLeft():e,c?e:m(f).scrollTop()):a[d]=e)},a,d,arguments.length,null)}}),m.each(["top","left"],function(a,b){m.cssHooks[b]=La(k.pixelPosition,function(a,c){return c?(c=Ja(a,b),Ha.test(c)?m(a).position()[b]+"px":c):void 0})}),m.each({Height:"height",Width:"width"},function(a,b){m.each({padding:"inner"+a,content:b,"":"outer"+a},function(c,d){m.fn[d]=function(d,e){var f=arguments.length&&(c||"boolean"!=typeof d),g=c||(d===!0||e===!0?"margin":"border");return V(this,function(b,c,d){var e;return m.isWindow(b)?b.document.documentElement["client"+a]:9===b.nodeType?(e=b.documentElement,Math.max(b.body["scroll"+a],e["scroll"+a],b.body["offset"+a],e["offset"+a],e["client"+a])):void 0===d?m.css(b,c,g):m.style(b,c,d,g)},b,f?d:void 0,f,null)}})}),m.fn.size=function(){return this.length},m.fn.andSelf=m.fn.addBack,"function"==typeof define&&define.amd&&define("jquery",[],function(){return m});var ec=a.jQuery,fc=a.$;return m.noConflict=function(b){return a.$===m&&(a.$=fc),b&&a.jQuery===m&&(a.jQuery=ec),m},typeof b===K&&(a.jQuery=a.$=m),m});
</script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<style type="text/css">html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}article,aside,details,figcaption,figure,footer,header,hgroup,main,menu,nav,section,summary{display:block}audio,canvas,progress,video{display:inline-block;vertical-align:baseline}audio:not([controls]){display:none;height:0}[hidden],template{display:none}a{background-color:transparent}a:active,a:hover{outline:0}abbr[title]{border-bottom:1px dotted}b,strong{font-weight:700}dfn{font-style:italic}h1{margin:.67em 0;font-size:2em}mark{color:#000;background:#ff0}small{font-size:80%}sub,sup{position:relative;font-size:75%;line-height:0;vertical-align:baseline}sup{top:-.5em}sub{bottom:-.25em}img{border:0}svg:not(:root){overflow:hidden}figure{margin:1em 40px}hr{height:0;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}pre{overflow:auto}code,kbd,pre,samp{font-family:monospace,monospace;font-size:1em}button,input,optgroup,select,textarea{margin:0;font:inherit;color:inherit}button{overflow:visible}button,select{text-transform:none}button,html input[type=button],input[type=reset],input[type=submit]{-webkit-appearance:button;cursor:pointer}button[disabled],html input[disabled]{cursor:default}button::-moz-focus-inner,input::-moz-focus-inner{padding:0;border:0}input{line-height:normal}input[type=checkbox],input[type=radio]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;padding:0}input[type=number]::-webkit-inner-spin-button,input[type=number]::-webkit-outer-spin-button{height:auto}input[type=search]{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;-webkit-appearance:textfield}input[type=search]::-webkit-search-cancel-button,input[type=search]::-webkit-search-decoration{-webkit-appearance:none}fieldset{padding:.35em .625em .75em;margin:0 2px;border:1px solid silver}legend{padding:0;border:0}textarea{overflow:auto}optgroup{font-weight:700}table{border-spacing:0;border-collapse:collapse}td,th{padding:0}@media print{*,:after,:before{color:#000!important;text-shadow:none!important;background:0 0!important;-webkit-box-shadow:none!important;box-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}abbr[title]:after{content:" (" attr(title) ")"}a[href^="javascript:"]:after,a[href^="#"]:after{content:""}blockquote,pre{border:1px solid #999;page-break-inside:avoid}thead{display:table-header-group}img,tr{page-break-inside:avoid}img{max-width:100%!important}h2,h3,p{orphans:3;widows:3}h2,h3{page-break-after:avoid}.navbar{display:none}.btn>.caret,.dropup>.btn>.caret{border-top-color:#000!important}.label{border:1px solid #000}.table{border-collapse:collapse!important}.table td,.table th{background-color:#fff!important}.table-bordered td,.table-bordered th{border:1px solid #ddd!important}}@font-face{font-family:'Glyphicons Halflings';src:url(data:application/vnd.ms-fontobject;base64,n04AAEFNAAACAAIABAAAAAAABQAAAAAAAAABAJABAAAEAExQAAAAAAAAAAIAAAAAAAAAAAEAAAAAAAAAJxJ/LAAAAAAAAAAAAAAAAAAAAAAAACgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzAAAADgBSAGUAZwB1AGwAYQByAAAAeABWAGUAcgBzAGkAbwBuACAAMQAuADAAMAA5ADsAUABTACAAMAAwADEALgAwADAAOQA7AGgAbwB0AGMAbwBuAHYAIAAxAC4AMAAuADcAMAA7AG0AYQBrAGUAbwB0AGYALgBsAGkAYgAyAC4ANQAuADUAOAAzADIAOQAAADgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzACAAUgBlAGcAdQBsAGEAcgAAAAAAQlNHUAAAAAAAAAAAAAAAAAAAAAADAKncAE0TAE0ZAEbuFM3pjM/SEdmjKHUbyow8ATBE40IvWA3vTu8LiABDQ+pexwUMcm1SMnNryctQSiI1K5ZnbOlXKmnVV5YvRe6RnNMFNCOs1KNVpn6yZhCJkRtVRNzEufeIq7HgSrcx4S8h/v4vnrrKc6oCNxmSk2uKlZQHBii6iKFoH0746ThvkO1kJHlxjrkxs+LWORaDQBEtiYJIR5IB9Bi1UyL4Rmr0BNigNkMzlKQmnofBHviqVzUxwdMb3NdCn69hy+pRYVKGVS/1tnsqv4LL7wCCPZZAZPT4aCShHjHJVNuXbmMrY5LeQaGnvAkXlVrJgKRAUdFjrWEah9XebPeQMj7KS7DIBAFt8ycgC5PLGUOHSE3ErGZCiViNLL5ZARfywnCoZaKQCu6NuFX42AEeKtKUGnr/Cm2Cy8tpFhBPMW5Fxi4Qm4TkDWh4IWFDClhU2hRWosUWqcKLlgyXB+lSHaWaHiWlBAR8SeSgSPCQxdVQgzUixWKSTrIQEbU94viDctkvX+VSjJuUmV8L4CXShI11esnp0pjWNZIyxKHS4wVQ2ime1P4RnhvGw0aDN1OLAXGERsB7buFpFGGBAre4QEQR0HOIO5oYH305G+KspT/FupEGGafCCwxSe6ZUa+073rXHnNdVXE6eWvibUS27XtRzkH838mYLMBmYysZTM0EM3A1fbpCBYFccN1B/EnCYu/TgCGmr7bMh8GfYL+BfcLvB0gRagC09w9elfldaIy/hNCBLRgBgtCC7jAF63wLSMAfbfAlEggYU0bUA7ACCJmTDpEmJtI78w4/BO7dN7JR7J7ZvbYaUbaILSQsRBiF3HGk5fEg6p9unwLvn98r+vnsV+372uf1xBLq4qU/45fTuqaAP+pssmCCCTF0mhEow8ZXZOS8D7Q85JsxZ+Azok7B7O/f6J8AzYBySZQB/QHYUSA+EeQhEWiS6AIQzgcsDiER4MjgMBAWDV4AgQ3g1eBgIdweCQmCjJEMkJ+PKRWyFHHmg1Wi/6xzUgA0LREoKJChwnQa9B+5RQZRB3IlBlkAnxyQNaANwHMowzlYSMCBgnbpzvqpl0iTJNCQidDI9ZrSYNIRBhHtUa5YHMHxyGEik9hDE0AKj72AbTCaxtHPUaKZdAZSnQTyjGqGLsmBStCejApUhg4uBMU6mATujEl+KdDPbI6Ag4vLr+hjY6lbjBeoLKnZl0UZgRX8gTySOeynZVz1wOq7e1hFGYIq+MhrGxDLak0PrwYzSXtcuyhXEhwOYofiW+EcI/jw8P6IY6ed+etAbuqKp5QIapT77LnAe505lMuqL79a0ut4rWexzFttsOsLDy7zvtQzcq3U1qabe7tB0wHWVXji+zDbo8x8HyIRUbXnwUcklFv51fvTymiV+MXLSmGH9d9+aXpD5X6lao41anWGig7IwIdnoBY2ht/pO9mClLo4NdXHAsefqWUKlXJkbqPOFhMoR4aiA1BXqhRNbB2Xwi+7u/jpAoOpKJ0UX24EsrzMfHXViakCNcKjBxuQX8BO0ZqjJ3xXzf+61t2VXOSgJ8xu65QKgtN6FibPmPYsXbJRHHqbgATcSZxBqGiDiU4NNNsYBsKD0MIP/OfKnlk/Lkaid/O2NbKeuQrwOB2Gq3YHyr6ALgzym5wIBnsdC1ZkoBFZSQXChZvlesPqvK2c5oHHT3Q65jYpNxnQcGF0EHbvYqoFw60WNlXIHQF2HQB7zD6lWjZ9rVqUKBXUT6hrkZOle0RFYII0V5ZYGl1JAP0Ud1fZZMvSomBzJ710j4Me8mjQDwEre5Uv2wQfk1ifDwb5ksuJQQ3xt423lbuQjvoIQByQrNDh1JxGFkOdlJvu/gFtuW0wR4cgd+ZKesSV7QkNE2kw6AV4hoIuC02LGmTomyf8PiO6CZzOTLTPQ+HW06H+tx+bQ8LmDYg1pTFrp2oJXgkZTyeRJZM0C8aE2LpFrNVDuhARsN543/FV6klQ6Tv1OoZGXLv0igKrl/CmJxRmX7JJbJ998VSIPQRyDBICzl4JJlYHbdql30NvYcOuZ7a10uWRrgoieOdgIm4rlq6vNOQBuqESLbXG5lzdJGHw2m0sDYmODXbYGTfSTGRKpssTO95fothJCjUGQgEL4yKoGAF/0SrpUDNn8CBgBcSDQByAeNkCXp4S4Ro2Xh4OeaGRgR66PVOsU8bc6TR5/xTcn4IVMLOkXSWiXxkZQCbvKfmoAvQaKjO3EDKwkwqHChCDEM5loQRPd5ACBki1TjF772oaQhQbQ5C0lcWXPFOzrfsDGUXGrpxasbG4iab6eByaQkQfm0VFlP0ZsDkvvqCL6QXMUwCjdMx1ZOyKhTJ7a1GWAdOUcJ8RSejxNVyGs31OKMyRyBVoZFjqIkmKlLQ5eHMeEL4MkUf23cQ/1SgRCJ1dk4UdBT7OoyuNgLs0oCd8RnrEIb6QdMxT2QjD4zMrJkfgx5aDMcA4orsTtKCqWb/Veyceqa5OGSmB28YwH4rFbkQaLoUN8OQQYnD3w2eXpI4ScQfbCUZiJ4yMOIKLyyTc7BQ4uXUw6Ee6/xM+4Y67ngNBknxIPwuppgIhFcwJyr6EIj+LzNj/mfR2vhhRlx0BILZoAYruF0caWQ7YxO66UmeguDREAFHYuC7HJviRgVO6ruJH59h/C/PkgSle8xNzZJULLWq9JMDTE2fjGE146a1Us6PZDGYle6ldWRqn/pdpgHKNGrGIdkRK+KPETT9nKT6kLyDI8xd9A1FgWmXWRAIHwZ37WyZHOVyCadJEmMVz0MadMjDrPho+EIochkVC2xgGiwwsQ6DMv2P7UXqT4x7CdcYGId2BJQQa85EQKmCmwcRejQ9Bm4oATENFPkxPXILHpMPUyWTI5rjNOsIlmEeMbcOCEqInpXACYQ9DDxmFo9vcmsDblcMtg4tqBerNngkIKaFJmrQAPnq1dEzsMXcwjcHdfdCibcAxxA+q/j9m3LM/O7WJka4tSidVCjsvo2lQ/2ewyoYyXwAYyr2PlRoR5MpgVmSUIrM3PQxXPbgjBOaDQFIyFMJvx3Pc5RSYj12ySVF9fwFPQu2e2KWVoL9q3Ayv3IzpGHUdvdPdrNUdicjsTQ2ISy7QU3DrEytIjvbzJnAkmANXjAFERA0MUoPF3/5KFmW14bBNOhwircYgMqoDpUMcDtCmBE82QM2YtdjVLB4kBuKho/bcwQdeboqfQartuU3CsCf+cXkgYAqp/0Ee3RorAZt0AvvOCSI4JICIlGlsV0bsSid/NIEALAAzb6HAgyWHBps6xAOwkJIGcB82CxRQq4sJf3FzA70A+TRqcqjEMETCoez3mkPcpnoALs0ugJY8kQwrC+JE5ik3w9rzrvDRjAQnqgEVvdGrNwlanR0SOKWzxOJOvLJhcd8Cl4AshACUkv9czdMkJCVQSQhp6kp7StAlpVRpK0t0SW6LHeBJnE2QchB5Ccu8kxRghZXGIgZIiSj7gEKMJDClcnX6hgoqJMwiQDigIXg3ioFLCgDgjPtYHYpsF5EiA4kcnN18MZtOrY866dEQAb0FB34OGKHGZQjwW/WDHA60cYFaI/PjpzquUqdaYGcIq+mLez3WLFFCtNBN2QJcrlcoELgiPku5R5dSlJFaCEqEZle1AQzAKC+1SotMcBNyQUFuRHRF6OlimSBgjZeTBCwLyc6A+P/oFRchXTz5ADknYJHxzrJ5pGuIKRQISU6WyKTBBjD8WozmVYWIsto1AS5rxzKlvJu4E/vwOiKxRtCWsDM+eTHUrmwrCK5BIfMzGkD+0Fk5LzBs0jMYXktNDblB06LMNJ09U8pzSLmo14MS0OMjcdrZ31pyQqxJJpRImlSvfYAK8inkYU52QY2FPEVsjoWewpwhRp5yAuNpkqhdb7ku9Seefl2D0B8SMTFD90xi4CSOwwZy9IKkpMtI3FmFUg3/kFutpQGNc3pCR7gvC4sgwbupDu3DyEN+W6YGLNM21jpB49irxy9BSlHrVDlnihGKHwPrbVFtc+h1rVQKZduxIyojccZIIcOCmhEnC7UkY68WXKQgLi2JCDQkQWJRQuk60hZp0D3rtCTINSeY9Ej2kIKYfGxwOs4j9qMM7fYZiipzgcf7TamnehqdhsiMiCawXnz4xAbyCkLAx5EGbo3Ax1u3dUIKnTxIaxwQTHehPl3V491H0+bC5zgpGz7Io+mjdhKlPJ01EeMpM7UsRJMi1nGjmJg35i6bQBAAxjO/ENJubU2mg3ONySEoWklCwdABETcs7ck3jgiuU9pcKKpbgn+3YlzV1FzIkB6pmEDOSSyDfPPlQskznctFji0kpgZjW5RZe6x9kYT4KJcXg0bNiCyif+pZACCyRMmYsfiKmN9tSO65F0R2OO6ytlEhY5Sj6uRKfFxw0ijJaAx/k3QgnAFSq27/2i4GEBA+UvTJKK/9eISNvG46Em5RZfjTYLdeD8kdXHyrwId/DQZUaMCY4gGbke2C8vfjgV/Y9kkRQOJIn/xM9INZSpiBnqX0Q9GlQPpPKAyO5y+W5NMPSRdBCUlmuxl40ZfMCnf2Cp044uI9WLFtCi4YVxKjuRCOBWIb4XbIsGdbo4qtMQnNOQz4XDSui7W/N6l54qOynCqD3DpWQ+mpD7C40D8BZEWGJX3tlAaZBMj1yjvDYKwCJBa201u6nBKE5UE+7QSEhCwrXfbRZylAaAkplhBWX50dumrElePyNMRYUrC99UmcSSNgImhFhDI4BXjMtiqkgizUGCrZ8iwFxU6fQ8GEHCFdLewwxYWxgScAYMdMLmcZR6b7rZl95eQVDGVoUKcRMM1ixXQtXNkBETZkVVPg8LoSrdetHzkuM7DjZRHP02tCxA1fmkXKF3VzfN1pc1cv/8lbTIkkYpqKM9VOhp65ktYk+Q46myFWBapDfyWUCnsnI00QTBQmuFjMZTcd0V2NQ768Fhpby04k2IzNR1wKabuGJqYWwSly6ocMFGTeeI+ejsWDYgEvr66QgqdcIbFYDNgsm0x9UHY6SCd5+7tpsLpKdvhahIDyYmEJQCqMqtCF6UlrE5GXRmbu+vtm3BFSxI6ND6UxIE7GsGMgWqghXxSnaRJuGFveTcK5ZVSPJyjUxe1dKgI6kNF7EZhIZs8y8FVqwEfbM0Xk2ltORVDKZZM40SD3qQoQe0orJEKwPfZwm3YPqwixhUMOndis6MhbmfvLBKjC8sKKIZKbJk8L11oNkCQzCgvjhyyEiQSuJcgCQSG4Mocfgc0Hkwcjal1UNgP0CBPikYqBIk9tONv4kLtBswH07vUCjEaHiFGlLf8MgXKzSgjp2HolRRccAOh0ILHz9qlGgIFkwAnzHJRjWFhlA7ROwINyB5HFj59PRZHFor6voq7l23EPNRwdWhgawqbivLSjRA4htEYUFkjESu67icTg5S0aW1sOkCiIysfJ9UnIWevOOLGpepcBxy1wEhd2WI3AZg7sr9WBmHWyasxMcvY/iOmsLtHSWNUWEGk9hScMPShasUA1AcHOtRZlqMeQ0OzYS9vQvYUjOLrzP07BUAFikcJNMi7gIxEw4pL1G54TcmmmoAQ5s7TGWErJZ2Io4yQ0ljRYhL8H5e62oDtLF8aDpnIvZ5R3GWJyAugdiiJW9hQAVTsnCBHhwu7rkBlBX6r3b7ejEY0k5GGeyKv66v+6dg7mcJTrWHbtMywbedYqCQ0FPwoytmSWsL8WTtChZCKKzEF7vP6De4x2BJkkniMgSdWhbeBSLtJZR9CTHetK1xb34AYIJ37OegYIoPVbXgJ/qDQK+bfCtxQRVKQu77WzOoM6SGL7MaZwCGJVk46aImai9fmam+WpHG+0BtQPWUgZ7RIAlPq6lkECUhZQ2gqWkMYKcYMYaIc4gYCDFHYa2d1nzp3+J1eCBay8IYZ0wQRKGAqvCuZ/UgbQPyllosq+XtfKIZOzmeJqRazpmmoP/76YfkjzV2NlXTDSBYB04SVlNQsFTbGPk1t/I4Jktu0XSgifO2ozFOiwd/0SssJDn0dn4xqk4GDTTKX73/wQyBLdqgJ+Wx6AQaba3BA9CKEzjtQYIfAsiYamapq80LAamYjinlKXUkxdpIDk0puXUEYzSalfRibAeDAKpNiqQ0FTwoxuGYzRnisyTotdVTclis1LHRQCy/qqL8oUaQzWRxilq5Mi0IJGtMY02cGLD69vGjkj3p6pGePKI8bkBv5evq8SjjyU04vJR2cQXQwSJyoinDsUJHCQ50jrFTT7yRdbdYQMB3MYCb6uBzJ9ewhXYPAIZSXfeEQBZZ3GPN3Nbhh/wkvAJLXnQMdi5NYYZ5GHE400GS5rXkOZSQsdZgIbzRnF9ueLnsfQ47wHAsirITnTlkCcuWWIUhJSbpM3wWhXNHvt2xUsKKMpdBSbJnBMcihkoDqAd1Zml/R4yrzow1Q2A5G+kzo/RhRxQS2lCSDRV8LlYLBOOoo1bF4jwJAwKMK1tWLHlu9i0j4Ig8qVm6wE1DxXwAwQwsaBWUg2pOOol2dHxyt6npwJEdLDDVYyRc2D0HbcbLUJQj8gPevQBUBOUHXPrsAPBERICpnYESeu2OHotpXQxRGlCCtLdIsu23MhZVEoJg8Qumj/UMMc34IBqTKLDTp76WzL/dMjCxK7MjhiGjeYAC/kj/jY/Rde7hpSM1xChrog6yZ7OWTuD56xBJnGFE+pT2ElSyCnJcwVzCjkqeNLfMEJqKW0G7OFIp0G+9mh50I9o8k1tpCY0xYqFNIALgIfc2me4n1bmJnRZ89oepgLPT0NTMLNZsvSCZAc3TXaNB07vail36/dBySis4m9/DR8izaLJW6bWCkVgm5T+ius3ZXq4xI+GnbveLbdRwF2mNtsrE0JjYc1AXknCOrLSu7Te/r4dPYMCl5qtiHNTn+TPbh1jCBHH+dMJNhwNgs3nT+OhQoQ0vYif56BMG6WowAcHR3DjQolxLzyVekHj00PBAaW7IIAF1EF+uRIWyXjQMAs2chdpaKPNaB+kSezYt0+CA04sOg5vx8Fr7Ofa9sUv87h7SLAUFSzbetCCZ9pmyLt6l6/TzoA1/ZBG9bIUVHLAbi/kdBFgYGyGwRQGBpkqCEg2ah9UD6EedEcEL3j4y0BQQCiExEnocA3SZboh+epgd3YsOkHskZwPuQ5OoyA0fTA5AXrHcUOQF+zkJHIA7PwCDk1gGVmGUZSSoPhNf+Tklauz98QofOlCIQ/tCD4dosHYPqtPCXB3agggQQIqQJsSkB+qn0rkQ1toJjON/OtCIB9RYv3PqRA4C4U68ZMlZn6BdgEvi2ziU+TQ6NIw3ej+AtDwMGEZk7e2IjxUWKdAxyaw9OCwSmeADTPPleyk6UhGDNXQb++W6Uk4q6F7/rg6WVTo82IoCxSIsFDrav4EPHphD3u4hR53WKVvYZUwNCCeM4PMBWzK+EfIthZOkuAwPo5C5jgoZgn6dUdvx5rIDmd58cXXdKNfw3l+wM2UjgrDJeQHhbD7HW2QDoZMCujgIUkk5Fg8VCsdyjOtnGRx8wgKRPZN5dR0zPUyfGZFVihbFRniXZFOZGKPnEQzU3AnD1KfR6weHW2XS6KbPJxUkOTZsAB9vTVp3Le1F8q5l+DMcLiIq78jxAImD2pGFw0VHfRatScGlK6SMu8leTmhUSMy8Uhdd6xBiH3Gdman4tjQGLboJfqz6fL2WKHTmrfsKZRYX6BTDjDldKMosaSTLdQS7oDisJNqAUhw1PfTlnacCO8vl8706Km1FROgLDmudzxg+EWTiArtHgLsRrAXYWdB0NmToNCJdKm0KWycZQqb+Mw76Qy29iQ5up/X7oyw8QZ75kP5F6iJAJz6KCmqxz8fEa/xnsMYcIO/vEkGRuMckhr4rIeLrKaXnmIzlNLxbFspOphkcnJdnz/Chp/Vlpj2P7jJQmQRwGnltkTV5dbF9fE3/fxoSqTROgq9wFUlbuYzYcasE0ouzBo+dDCDzxKAfhbAZYxQiHrLzV2iVexnDX/QnT1fsT/xuhu1ui5qIytgbGmRoQkeQooO8eJNNZsf0iALur8QxZFH0nCMnjerYQqG1pIfjyVZWxhVRznmmfLG00BcBWJE6hzQWRyFknuJnXuk8A5FRDCulwrWASSNoBtR+CtGdkPwYN2o7DOw/VGlCZPusRBFXODQdUM5zeHDIVuAJBLqbO/f9Qua+pDqEPk230Sob9lEZ8BHiCorjVghuI0lI4JDgHGRDD/prQ84B1pVGkIpVUAHCG+iz3Bn3qm2AVrYcYWhock4jso5+J7HfHVj4WMIQdGctq3psBCVVzupQOEioBGA2Bk+UILT7+VoX5mdxxA5fS42gISQVi/HTzrgMxu0fY6hE1ocUwwbsbWcezrY2n6S8/6cxXkOH4prpmPuFoikTzY7T85C4T2XYlbxLglSv2uLCgFv8Quk/wdesUdWPeHYIH0R729JIisN9Apdd4eB10aqwXrPt+Su9mA8k8n1sjMwnfsfF2j3jMUzXepSHmZ/BfqXvzgUNQQWOXO8YEuFBh4QTYCkOAPxywpYu1VxiDyJmKVcmJPGWk/gc3Pov02StyYDahwmzw3E1gYC9wkupyWfDqDSUMpCTH5e5N8B//lHiMuIkTNw4USHrJU67bjXGqNav6PBuQSoqTxc8avHoGmvqNtXzIaoyMIQIiiUHIM64cXieouplhNYln7qgc4wBVAYR104kO+CvKqsg4yIUlFNThVUAKZxZt1XA34h3TCUUiXVkZ0w8Hh2R0Z5L0b4LZvPd/p1gi/07h8qfwHrByuSxglc9cI4QIg2oqvC/qm0i7tjPLTgDhoWTAKDO2ONW5oe+/eKB9vZB8K6C25yCZ9RFVMnb6NRdRjyVK57CHHSkJBfnM2/j4ODUwRkqrtBBCrDsDpt8jhZdXoy/1BCqw3sSGhgGGy0a5Jw6BP/TExoCmNFYjZl248A0osgPyGEmRA+fAsqPVaNAfytu0vuQJ7rk3J4kTDTR2AlCHJ5cls26opZM4w3jMULh2YXKpcqGBtuleAlOZnaZGbD6DHzMd6i2oFeJ8z9XYmalg1Szd/ocZDc1C7Y6vcALJz2lYnTXiWEr2wawtoR4g3jvWUU2Ngjd1cewtFzEvM1NiHZPeLlIXFbBPawxNgMwwAlyNSuGF3zizVeOoC9bag1qRAQKQE/EZBWC2J8mnXAN2aTBboZ7HewnObE8CwROudZHmUM5oZ/Ugd/JZQK8lvAm43uDRAbyW8gZ+ZGq0EVerVGUKUSm/Idn8AQHdR4m7bue88WBwft9mSCeMOt1ncBwziOmJYI2ZR7ewNMPiCugmSsE4EyQ+QATJG6qORMGd4snEzc6B4shPIo4G1T7PgSm8PY5eUkPdF8JZ0VBtadbHXoJgnEhZQaODPj2gpODKJY5Yp4DOsLBFxWbvXN755KWylJm+oOd4zEL9Hpubuy2gyyfxh8oEfFutnYWdfB8PdESLWYvSqbElP9qo3u6KTmkhoacDauMNNjj0oy40DFV7Ql0aZj77xfGl7TJNHnIwgqOkenruYYNo6h724+zUQ7+vkCpZB+pGA562hYQiDxHVWOq0oDQl/QsoiY+cuI7iWq/ZIBtHcXJ7kks+h2fCNUPA82BzjnqktNts+RLdk1VSu+tqEn7QZCCsvEqk6FkfiOYkrsw092J8jsfIuEKypNjLxrKA9kiA19mxBD2suxQKCzwXGws7kEJvlhUiV9tArLIdZW0IORcxEzdzKmjtFhsjKy/44XYXdI5noQoRcvjZ1RMPACRqYg2V1+OwOepcOknRLLFdYgTkT5UApt/JhLM3jeFYprZV+Zow2g8fP+U68hkKFWJj2yBbKqsrp25xkZX1DAjUw52IMYWaOhab8Kp05VrdNftqwRrymWF4OQSjbdfzmRZirK8FMJELEgER2PHjEAN9pGfLhCUiTJFbd5LBkOBMaxLr/A1SY9dXFz4RjzoU9ExfJCmx/I9FKEGT3n2cmzl2X42L3Jh+AbQq6sA+Ss1kitoa4TAYgKHaoybHUDJ51oETdeI/9ThSmjWGkyLi5QAGWhL0BG1UsTyRGRJOldKBrYJeB8ljLJHfATWTEQBXBDnQexOHTB+Un44zExFE4vLytcu5NwpWrUxO/0ZICUGM7hGABXym0V6ZvDST0E370St9MIWQOTWngeoQHUTdCJUP04spMBMS8LSker9cReVQkULFDIZDFPrhTzBl6sed9wcZQTbL+BDqMyaN3RJPh/anbx+Iv+qgQdAa3M9Z5JmvYlh4qop+Ho1F1W5gbOE9YKLgAnWytXElU4G8GtW47lhgFE6gaSs+gs37sFvi0PPVvA5dnCBgILTwoKd/+DoL9F6inlM7H4rOTzD79KJgKlZO/Zgt22UsKhrAaXU5ZcLrAglTVKJEmNJvORGN1vqrcfSMizfpsgbIe9zno+gBoKVXgIL/VI8dB1O5o/R3Suez/gD7M781ShjKpIIORM/nxG+jjhhgPwsn2IoXsPGPqYHXA63zJ07M2GPEykQwJBYLK808qYxuIew4frk52nhCsnCYmXiR6CuapvE1IwRB4/QftDbEn+AucIr1oxrLabRj9q4ae0+fXkHnteAJwXRbVkR0mctVSwEbqhJiMSZUp9DNbEDMmjX22m3ABpkrPQQTP3S1sib5pD2VRKRd+eNAjLYyT0hGrdjWJZy24OYXRoWQAIhGBZRxuBFMjjZQhpgrWo8SiFYbojcHO8V5DyscJpLTHyx9Fimassyo5U6WNtquUMYgccaHY5amgR3PQzq3ToNM5ABnoB9kuxsebqmYZm0R9qxJbFXCQ1UPyFIbxoUraTJFDpCk0Wk9GaYJKz/6oHwEP0Q14lMtlddQsOAU9zlYdMVHiT7RQP3XCmWYDcHCGbVRHGnHuwzScA0BaSBOGkz3lM8CArjrBsyEoV6Ys4qgDK3ykQQPZ3hCRGNXQTNNXbEb6tDiTDLKOyMzRhCFT+mAUmiYbV3YQVqFVp9dorv+TsLeCykS2b5yyu8AV7IS9cxcL8z4Kfwp+xJyYLv1OsxQCZwTB4a8BZ/5EdxTBJthApqyfd9u3ifr/WILTqq5VqgwMT9SOxbSGWLQJUUWCVi4k9tho9nEsbUh7U6NUsLmkYFXOhZ0kmamaJLRNJzSj/qn4Mso6zb6iLLBXoaZ6AqeWCjHQm2lztnejYYM2eubnpBdKVLORZhudH3JF1waBJKA9+W8EhMj3Kzf0L4vi4k6RoHh3Z5YgmSZmk6ns4fjScjAoL8GoOECgqgYEBYUGFVO4FUv4/YtowhEmTs0vrvlD/CrisnoBNDAcUi/teY7OctFlmARQzjOItrrlKuPO6E2Ox93L4O/4DcgV/dZ7qR3VBwVQxP1GCieA4RIpweYJ5FoYrHxqRBdJjnqbsikA2Ictbb8vE1GYIo9dacK0REgDX4smy6GAkxlH1yCGGsk+tgiDhNKuKu3yNrMdxafmKTF632F8Vx4BNK57GvlFisrkjN9WDAtjsWA0ENT2e2nETUb/n7qwhvGnrHuf5bX6Vh/n3xffU3PeHdR+FA92i6ufT3AlyAREoNDh6chiMWTvjKjHDeRhOa9YkOQRq1vQXEMppAQVwHCuIcV2g5rBn6GmZZpTR7vnSD6ZmhdSl176gqKTXu5E+YbfL0adwNtHP7dT7t7b46DVZIkzaRJOM+S6KcrzYVg+T3wSRFRQashjfU18NutrKa/7PXbtuJvpIjbgPeqd+pjmRw6YKpnANFSQcpzTZgpSNJ6J7uiagAbir/8tNXJ/OsOnRh6iuIexxrmkIneAgz8QoLmiaJ8sLQrELVK2yn3wOHp57BAZJhDZjTBzyoRAuuZ4eoxHruY1pSb7qq79cIeAdOwin4GdgMeIMHeG+FZWYaiUQQyC5b50zKjYw97dFjAeY2I4Bnl105Iku1y0lMA1ZHolLx19uZnRdILcXKlZGQx/GdEqSsMRU1BIrFqRcV1qQOOHyxOLXEGcbRtAEsuAC2V4K3p5mFJ22IDWaEkk9ttf5Izb2LkD1MnrSwztXmmD/Qi/EmVEFBfiKGmftsPwVaIoZanlKndMZsIBOskFYpDOq3QUs9aSbAAtL5Dbokus2G4/asthNMK5UQKCOhU97oaOYNGsTah+jfCKsZnTRn5TbhFX8ghg8CBYt/BjeYYYUrtUZ5jVij/op7V5SsbA4mYTOwZ46hqdpbB6Qvq3AS2HHNkC15pTDIcDNGsMPXaBidXYPHc6PJAkRh29Vx8KcgX46LoUQBhRM+3SW6Opll/wgxxsPgKJKzr5QCmwkUxNbeg6Wj34SUnEzOemSuvS2OetRCO8Tyy+QbSKVJcqkia+GvDefFwMOmgnD7h81TUtMn+mRpyJJ349HhAnoWFTejhpYTL9G8N2nVg1qkXBeoS9Nw2fB27t7trm7d/QK7Cr4uoCeOQ7/8JfKT77KiDzLImESHw/0wf73QeHu74hxv7uihi4fTX+XEwAyQG3264dwv17aJ5N335Vt9sdrAXhPOAv8JFvzqyYXwfx8WYJaef1gMl98JRFyl5Mv5Uo/oVH5ww5OzLFsiTPDns7fS6EURSSWd/92BxMYQ8sBaH+j+wthQPdVgDGpTfi+JQIWMD8xKqULliRH01rTeyF8x8q/GBEEEBrAJMPf25UQwi0b8tmqRXY7kIvNkzrkvRWLnxoGYEJsz8u4oOyMp8cHyaybb1HdMCaLApUE+/7xLIZGP6H9xuSEXp1zLIdjk5nBaMuV/yTDRRP8Y2ww5RO6d2D94o+6ucWIqUAvgHIHXhZsmDhjVLczmZ3ca0Cb3PpKwt2UtHVQ0BgFJsqqTsnzZPlKahRUkEu4qmkJt+kqdae76ViWe3STan69yaF9+fESD2lcQshLHWVu4ovItXxO69bqC5p1nZLvI8NdQB9s9UNaJGlQ5mG947ipdDA0eTIw/A1zEdjWquIsQXXGIVEH0thC5M+W9pZe7IhAVnPJkYCCXN5a32HjN6nsvokEqRS44tGIs7s2LVTvcrHAF+RVmI8L4HUYk4x+67AxSMJKqCg8zrGOgvK9kNMdDrNiUtSWuHFpC8/p5qIQrEo/H+1l/0cAwQ2nKmpWxKcMIuHY44Y6DlkpO48tRuUGBWT0FyHwSKO72Ud+tJUfdaZ4CWNijzZtlRa8+CkmO/EwHYfPZFU/hzjFWH7vnzHRMo+aF9u8qHSAiEkA2HjoNQPEwHsDKOt6hOoK3Ce/+/9boMWDa44I6FrQhdgS7OnNaSzwxWKZMcyHi6LN4WC6sSj0qm2PSOGBTvDs/GWJS6SwEN/ULwpb4LQo9fYjUfSXRwZkynUazlSpvX9e+G2zor8l+YaMxSEomDdLHGcD6YVQPegTaA74H8+V4WvJkFUrjMLGLlvSZQWvi8/QA7yzQ8GPno//5SJHRP/OqKObPCo81s/+6WgLqykYpGAgQZhVDEBPXWgU/WzFZjKUhSFInufPRiMAUULC6T11yL45ZrRoB4DzOyJShKXaAJIBS9wzLYIoCEcJKQW8GVCx4fihqJ6mshBUXSw3wWVj3grrHQlGNGhIDNNzsxQ3M+GWn6ASobIWC+LbYOC6UpahVO13Zs2zOzZC8z7FmA05JhUGyBsF4tsG0drcggIFzgg/kpf3+CnAXKiMgIE8Jk/Mhpkc8DUJEUzDSnWlQFme3d0sHZDrg7LavtsEX3cHwjCYA17pMTfx8Ajw9hHscN67hyo+RJQ4458RmPywXykkVcW688oVUrQhahpPRvTWPnuI0B+SkQu7dCyvLRyFYlC1LG1gRCIvn3rwQeINzZQC2KXq31FaR9UmVV2QeGVqBHjmE+VMd3b1fhCynD0pQNhCG6/WCDbKPyE7NRQzL3BzQAJ0g09aUzcQA6mUp9iZFK6Sbp/YbHjo++7/Wj8S4YNa+ZdqAw1hDrKWFXv9+zaXpf8ZTDSbiqsxnwN/CzK5tPkOr4tRh2kY3Bn9JtalbIOI4b3F7F1vPQMfoDcdxMS8CW9m/NCW/HILTUVWQIPiD0j1A6bo8vsv6P1hCESl2abrSJWDrq5sSzUpwoxaCU9FtJyYH4QFMxDBpkkBR6kn0LMPO+5EJ7Z6bCiRoPedRZ/P0SSdii7ZnPAtVwwHUidcdyspwncz5uq6vvm4IEDbJVLUFCn/LvIHfooUBTkFO130FC7CmmcrKdgDJcid9mvVzsDSibOoXtIf9k6ABle3PmIxejodc4aob0QKS432srrCMndbfD454q52V01G4q913mC5HOsTzWF4h2No1av1VbcUgWAqyoZl+11PoFYnNv2HwAODeNRkHj+8SF1fcvVBu6MrehHAZK1Gm69ICcTKizykHgGFx7QdowTVAsYEF2tVc0Z6wLryz2FI1sc5By2znJAAmINndoJiB4sfPdPrTC8RnkW7KRCwxC6YvXg5ahMlQuMpoCSXjOlBy0Kij+bsCYPbGp8BdCBiLmLSAkEQRaieWo1SYvZIKJGj9Ur/eWHjiB7SOVdqMAVmpBvfRiebsFjger7DC+8kRFGtNrTrnnGD2GAJb8rQCWkUPYHhwXsjNBSkE6lGWUj5QNhK0DMNM2l+kXRZ0KLZaGsFSIdQz/HXDxf3/TE30+DgBKWGWdxElyLccJfEpjsnszECNoDGZpdwdRgCixeg9L4EPhH+RptvRMVRaahu4cySjS3P5wxAUCPkmn+rhyASpmiTaiDeggaIxYBmtLZDDhiWIJaBgzfCsAGUF1Q1SFZYyXDt9skCaxJsxK2Ms65dmdp5WAZyxik/zbrTQk5KmgxCg/f45L0jywebOWUYFJQAJia7XzCV0x89rpp/f3AVWhSPyTanqmik2SkD8A3Ml4NhIGLAjBXtPShwKYfi2eXtrDuKLk4QlSyTw1ftXgwqA2jUuopDl+5tfUWZNwBpEPXghzbBggYCw/dhy0ntds2yeHCDKkF/YxQjNIL/F/37jLPHCKBO9ibwYCmuxImIo0ijV2Wbg3kSN2psoe8IsABv3RNFaF9uMyCtCYtqcD+qNOhwMlfARQUdJ2tUX+MNJqOwIciWalZsmEjt07tfa8ma4cji9sqz+Q9hWfmMoKEbIHPOQORbhQRHIsrTYlnVTNvcq1imqmmPDdVDkJgRcTgB8Sb6epCQVmFZe+jGDiNJQLWnfx+drTKYjm0G8yH0ZAGMWzEJhUEQ4Maimgf/bkvo8PLVBsZl152y5S8+HRDfZIMCbYZ1WDp4yrdchOJw8k6R+/2pHmydK4NIK2PHdFPHtoLmHxRDwLFb7eB+M4zNZcB9NrAgjVyzLM7xyYSY13ykWfIEEd2n5/iYp3ZdrCf7fL+en+sIJu2W7E30MrAgZBD1rAAbZHPgeAMtKCg3NpSpYQUDWJu9bT3V7tOKv+NRiJc8JAKqqgCA/PNRBR7ChpiEulyQApMK1AyqcWnpSOmYh6yLiWkGJ2mklCSPIqN7UypWj3dGi5MvsHQ87MrB4VFgypJaFriaHivwcHIpmyi5LhNqtem4q0n8awM19Qk8BOS0EsqGscuuydYsIGsbT5GHnERUiMpKJl4ON7qjB4fEqlGN/hCky89232UQCiaeWpDYCJINXjT6xl4Gc7DxRCtgV0i1ma4RgWLsNtnEBRQFqZggCLiuyEydmFd7WlogpkCw5G1x4ft2psm3KAREwVwr1Gzl6RT7FDAqpVal34ewVm3VH4qn5mjGj+bYL1NgfLNeXDwtmYSpwzbruDKpTjOdgiIHDVQSb5/zBgSMbHLkxWWgghIh9QTFSDILixVwg0Eg1puooBiHAt7DzwJ7m8i8/i+jHvKf0QDnnHVkVTIqMvIQImOrzCJwhSR7qYB5gSwL6aWL9hERHCZc4G2+JrpgHNB8eCCmcIWIQ6rSdyPCyftXkDlErUkHafHRlkOIjxGbAktz75bnh50dU7YHk+Mz7wwstg6RFZb+TZuSOx1qqP5C66c0mptQmzIC2dlpte7vZrauAMm/7RfBYkGtXWGiaWTtwvAQiq2oD4YixPLXE2khB2FRaNRDTk+9sZ6K74Ia9VntCpN4BhJGJMT4Z5c5FhSepRCRWmBXqx+whVZC4me4saDs2iNqXMuCl6iAZflH8fscC1sTsy4PHeC+XYuqMBMUun5YezKbRKmEPwuK+CLzijPEQgfhahQswBBLfg/GBgBiI4QwAqzJkkyYAWtjzSg2ILgMAgqxYfwERRo3zruBL9WOryUArSD8sQOcD7fvIODJxKFS615KFPsb68USBEPPj1orNzFY2xoTtNBVTyzBhPbhFH0PI5AtlJBl2aSgNPYzxYLw7XTDBDinmVoENwiGzmngrMo8OmnRP0Z0i0Zrln9DDFcnmOoBZjABaQIbPOJYZGqX+RCMlDDbElcjaROLDoualmUIQ88Kekk3iM4OQrADcxi3rJguS4MOIBIgKgXrjd1WkbCdqxJk/4efRIFsavZA7KvvJQqp3Iid5Z0NFc5aiMRzGN3vrpBzaMy4JYde3wr96PjN90AYOIbyp6T4zj8LoE66OGcX1Ef4Z3KoWLAUF4BTg7ug/AbkG5UNQXAMkQezujSHeir2uTThgd3gpyzDrbnEdDRH2W7U6PeRvBX1ZFMP5RM+Zu6UUZZD8hDPHldVWntTCNk7To8IeOW9yn2wx0gmurwqC60AOde4r3ETi5pVMSDK8wxhoGAoEX9NLWHIR33VbrbMveii2jAJlrxwytTHbWNu8Y4N8vCCyZjAX/pcsfwXbLze2+D+u33OGBoJyAAL3jn3RuEcdp5If8O+a4NKWvxOTyDltG0IWoHhwVGe7dKkCWFT++tm+haBCikRUUMrMhYKZJKYoVuv/bsJzO8DwfVIInQq3g3BYypiz8baogH3r3GwqCwFtZnz4xMjAVOYnyOi5HWbFA8n0qz1OjSpHWFzpQOpvkNETZBGpxN8ybhtqV/DMUxd9uFZmBfKXMCn/SqkWJyKPnT6lq+4zBZni6fYRByJn6OK+OgPBGRAJluwGSk4wxjOOzyce/PKODwRlsgrVkdcsEiYrqYdXo0Er2GXi2GQZd0tNJT6c9pK1EEJG1zgDJBoTVuCXGAU8BKTvCO/cEQ1Wjk3Zzuy90JX4m3O5IlxVFhYkSUwuQB2up7jhvkm+bddRQu5F9s0XftGEJ9JSuSk+ZachCbdU45fEqbugzTIUokwoAKvpUQF/CvLbWW5BNQFqFkJg2f30E/48StNe5QwBg8zz3YAJ82FZoXBxXSv4QDooDo79NixyglO9AembuBcx5Re3CwOKTHebOPhkmFC7wNaWtoBhFuV4AkEuJ0J+1pT0tLkvFVZaNzfhs/Kd3+A9YsImlO4XK4vpCo/elHQi/9gkFg07xxnuXLt21unCIpDV+bbRxb7FC6nWYTsMFF8+1LUg4JFjVt3vqbuhHmDKbgQ4e+RGizRiO8ky05LQGMdL2IKLSNar0kNG7lHJMaXr5mLdG3nykgj6vB/KVijd1ARWkFEf3yiUw1v/WaQivVUpIDdSNrrKbjO5NPnxz6qTTGgYg03HgPhDrCFyYZTi3XQw3HXCva39mpLNFtz8AiEhxAJHpWX13gCTAwgm9YTvMeiqetdNQv6IU0hH0G+ZManTqDLPjyrOse7WiiwOJCG+J0pZYULhN8NILulmYYvmVcV2MjAfA39sGKqGdjpiPo86fecg65UPyXDIAOyOkCx5NQsLeD4gGVjTVDwOHWkbbBW0GeNjDkcSOn2Nq4cEssP54t9D749A7M1AIOBl0Fi0sSO5v3P7LCBrM6ZwFY6kp2FX6AcbGUdybnfChHPyu6WlRZ2Fwv9YM0RMI7kISRgR8HpQSJJOyTfXj/6gQKuihPtiUtlCQVPohUgzfezTg8o1b3n9pNZeco1QucaoXe40Fa5JYhqdTspFmxGtW9h5ezLFZs3j/N46f+S2rjYNC2JySXrnSAFhvAkz9a5L3pza8eYKHNoPrvBRESpxYPJdKVUxBE39nJ1chrAFpy4MMkf0qKgYALctGg1DQI1kIymyeS2AJNT4X240d3IFQb/0jQbaHJ2YRK8A+ls6WMhWmpCXYG5jqapGs5/eOJErxi2/2KWVHiPellTgh/fNl/2KYPKb7DUcAg+mCOPQFCiU9Mq/WLcU1xxC8aLePFZZlE+PCLzf7ey46INWRw2kcXySR9FDgByXzfxiNKwDFbUSMMhALPFSedyjEVM5442GZ4hTrsAEvZxIieSHGSgkwFh/nFNdrrFD4tBH4Il7fW6ur4J8Xaz7RW9jgtuPEXQsYk7gcMs2neu3zJwTyUerHKSh1iTBkj2YJh1SSOZL5pLuQbFFAvyO4k1Hxg2h99MTC6cTUkbONQIAnEfGsGkNFWRbuRyyaEZInM5pij73EA9rPIUfU4XoqQpHT9THZkW+oKFLvpyvTBMM69tN1Ydwv1LIEhHsC+ueVG+w+kyCPsvV3erRikcscHjZCkccx6VrBkBRusTDDd8847GA7p2Ucy0y0HdSRN6YIBciYa4vuXcAZbQAuSEmzw+H/AuOx+aH+tBL88H57D0MsqyiZxhOEQkF/8DR1d2hSPMj/sNOa5rxcUnBgH8ictv2J+cb4BA4v3MCShdZ2vtK30vAwkobnEWh7rsSyhmos3WC93Gn9C4nnAd/PjMMtQfyDNZsOPd6XcAsnBE/mRHtHEyJMzJfZFLE9OvQa0i9kUmToJ0ZxknTgdl/XPV8xoh0K7wNHHsnBdvFH3sv52lU7UFteseLG/VanIvcwycVA7+BE1Ulyb20BvwUWZcMTKhaCcmY3ROpvonVMV4N7yBXTL7IDtHzQ4CCcqF66LjF3xUqgErKzolLyCG6Kb7irP/MVTCCwGRxfrPGpMMGvPLgJ881PHMNMIO09T5ig7AzZTX/5PLlwnJLDAPfuHynSGhV4tPqR3gJ4kg4c06c/F1AcjGytKm2Yb5jwMotF7vro4YDLWlnMIpmPg36NgAZsGA0W1spfLSue4xxat0Gdwd0lqDBOgIaMANykwwDKejt5YaNtJYIkrSgu0KjIg0pznY0SCd1qlC6R19g97UrWDoYJGlrvCE05J/5wkjpkre727p5PTRX5FGrSBIfJqhJE/IS876PaHFkx9pGTH3oaY3jJRvLX9Iy3Edoar7cFvJqyUlOhAEiOSAyYgVEGkzHdug+oRHIEOXAExMiTSKU9A6nmRC8mp8iYhwWdP2U/5EkFAdPrZw03YA3gSyNUtMZeh7dDCu8pF5x0VORCTgKp07ehy7NZqKTpIC4UJJ89lnboyAfy5OyXzXtuDRbtAFjZRSyGFTpFrXwkpjSLIQIG3N0Vj4BtzK3wdlkBJrO18MNsgseR4BysJilI0wI6ZahLhBFA0XBmV8d4LUzEcNVb0xbLjLTETYN8OEVqNxkt10W614dd1FlFFVTIgB7/BQQp1sWlNolpIu4ekxUTBV7NmxOFKEBmmN+nA7pvF78/RII5ZHA09OAiE/66MF6HQ+qVEJCHxwymukkNvzqHEh52dULPbVasfQMgTDyBZzx4007YiKdBuUauQOt27Gmy8ISclPmEUCIcuLbkb1mzQSqIa3iE0PJh7UMYQbkpe+hXjTJKdldyt2mVPwywoODGJtBV1lJTgMsuSQBlDMwhEKIfrvsxGQjHPCEfNfMAY2oxvyKcKPUbQySkKG6tj9AQyEW3Q5rpaDJ5Sns9ScLKeizPRbvWYAw4bXkrZdmB7CQopCH8NAmqbuciZChHN8lVGaDbCnmddnqO1PQ4ieMYfcSiBE5zzMz+JV/4eyzrzTEShvqSGzgWimkNxLvUj86iAwcZuIkqdB0VaIB7wncLRmzHkiUQpPBIXbDDLHBlq7vp9xwuC9AiNkIptAYlG7Biyuk8ILdynuUM1cHWJgeB+K3wBP/ineogxkvBNNQ4AkW0hvpBOQGFfeptF2YTR75MexYDUy7Q/9uocGsx41O4IZhViw/2FvAEuGO5g2kyXBUijAggWM08bRhXg5ijgMwDJy40QeY/cQpUDZiIzmvskQpO5G1zyGZA8WByjIQU4jRoFJt56behxtHUUE/om7Rj2psYXGmq3llVOCgGYKNMo4pzwntITtapDqjvQtqpjaJwjHmDzSVGLxMt12gEXAdLi/caHSM3FPRGRf7dB7YC+cD2ho6oL2zGDCkjlf/DFoQVl8GS/56wur3rdV6ggtzZW60MRB3g+U1W8o8cvqIpMkctiGVMzXUFI7FacFLrgtdz4mTEr4aRAaQ2AFQaNeG7GX0yOJgMRYFziXdJf24kg/gBQIZMG/YcPEllRTVNoDYR6oSJ8wQNLuihfw81UpiKPm714bZX1KYjcXJdfclCUOOpvTxr9AAJevTY4HK/G7F3mUc3GOAKqh60zM0v34v+ELyhJZqhkaMA8UMMOU90f8RKEJFj7EqepBVwsRiLbwMo1J2zrE2UYJnsgIAscDmjPjnzI8a719Wxp757wqmSJBjXowhc46QN4RwKIxqEE6E5218OeK7RfcpGjWG1jD7qND+/GTk6M56Ig4yMsU6LUW1EWE+fIYycVV1thldSlbP6ltdC01y3KUfkobkt2q01YYMmxpKRvh1Z48uNKzP/IoRIZ/F6buOymSnW8gICitpJjKWBscSb9JJKaWkvEkqinAJ2kowKoqkqZftRqfRQlLtKoqvTRDi2vg/RrPD/d3a09J8JhGZlEkOM6znTsoMCsuvTmywxTCDhw5dd0GJOHCMPbsj3QLkTE3MInsZsimDQ3HkvthT7U9VA4s6G07sID0FW4SHJmRGwCl+Mu4xf0ezqeXD2PtPDnwMPo86sbwDV+9PWcgFcARUVYm3hrFQrHcgMElFGbSM2A1zUYA3baWfheJp2AINmTJLuoyYD/OwA4a6V0ChBN97E8YtDBerUECv0u0TlxR5yhJCXvJxgyM73Bb6pyq0jTFJDZ4p1Am1SA6sh8nADd1hAcGBMfq4d/UfwnmBqe0Jun1n1LzrgKuZMAnxA3NtCN7Klf4BH+14B7ibBmgt0TGUafVzI4uKlpF7v8NmgNjg90D6QE3tbx8AjSAC+OA1YJvclyPKgT27QpIEgVYpbPYGBsnyCNrGz9XUsCHkW1QAHgL2STZk12QGqmvAB0NFteERkvBIH7INDsNW9KKaAYyDMdBEMzJiWaJHZALqDxQDWRntumSDPcplyFiI1oDpT8wbwe01AHhW6+vAUUBoGhY3CT2tgwehdPqU/4Q7ZLYvhRl/ogOvR9O2+wkkPKW5vCTjD2fHRYXONCoIl4Jh1bZY0ZE1O94mMGn/dFSWBWzQ/VYk+Gezi46RgiDv3EshoTmMSlioUK6MQEN8qeyK6FRninyX8ZPeUWjjbMJChn0n/yJvrq5bh5UcCAcBYSafTFg7p0jDgrXo2QWLb3WpSOET/Hh4oSadBTvyDo10IufLzxiMLAnbZ1vcUmj3w7BQuIXjEZXifwukVxrGa9j+DXfpi12m1RbzYLg9J2wFergEwOxFyD0/JstNK06ZN2XdZSGWxcJODpQHOq4iKqjqkJUmPu1VczL5xTGUfCgLEYyNBCCbMBFT/cUP6pE/mujnHsSDeWxMbhrNilS5MyYR0nJyzanWXBeVcEQrRIhQeJA6Xt4f2eQESNeLwmC10WJVHqwx8SSyrtAAjpGjidcj1E2FYN0LObUcFQhafUKTiGmHWRHGsFCB+HEXgrzJEB5bp0QiF8ZHh11nFX8AboTD0PS4O1LqF8XBks2MpjsQnwKHF6HgaKCVLJtcr0XjqFMRGfKv8tmmykhLRzu+vqQ02+KpJBjaLt9ye1Ab+BbEBhy4EVdIJDrL2naV0o4wU8YZ2Lq04FG1mWCKC+UwkXOoAjneU/xHplMQo2cXUlrVNqJYczgYlaOEczVCs/OCgkyvLmTmdaBJc1iBLuKwmr6qtRnhowngsDxhzKFAi02tf8bmET8BO27ovJKF1plJwm3b0JpMh38+xsrXXg7U74QUM8ZCIMOpXujHntKdaRtsgyEZl5MClMVMMMZkZLNxH9+b8fH6+b8Lev30A9TuEVj9CqAdmwAAHBPbfOBFEATAPZ2CS0OH1Pj/0Q7PFUcC8hDrxESWdfgFRm+7vvWbkEppHB4T/1ApWnlTIqQwjcPl0VgS1yHSmD0OdsCVST8CQVwuiew1Y+g3QGFjNMzwRB2DSsAk26cmA8lp2wIU4p93AUBiUHFGOxOajAqD7Gm6NezNDjYzwLOaSXRBYcWipTSONHjUDXCY4mMI8XoVCR/Rrs/JLKXgEx+qkmeDlFOD1/yTQNDClRuiUyKYCllfMiQiyFkmuTz2vLsBNyRW+xz+5FElFxWB28VjYIGZ0Yd+5wIjkcoMaggxswbT0pCmckRAErbRlIlcOGdBo4djTNO8FAgQ+lT6vPS60BwTRSUAM3ddkEAZiwtEyArrkiDRnS7LJ+2hwbzd2YDQagSgACpsovmjil5wfPuXq3GuH0CyE7FK3M4FgRaFoIkaodORrPx1+JpI9psyNYIFuJogZa0/1AhOWdlHQxdAgbwacsHqPZo8u/ngAH2GmaTdhYnBfSDbBfh8CHq6Bx5bttP2+RdM+MAaYaZ0Y/ADkbNCZuAyAVQa2OcXOeICmDn9Q/eFkDeFQg5MgHEDXq/tVjj+jtd26nhaaolWxs1ixSUgOBwrDhRIGOLyOVk2/Bc0UxvseQCO2pQ2i+Krfhu/WeBovNb5dJxQtJRUDv2mCwYVpNl2efQM9xQHnK0JwLYt/U0Wf+phiA4uw8G91slC832pmOTCAoZXohg1fewCZqLBhkOUBofBWpMPsqg7XEXgPfAlDo2U5WXjtFdS87PIqClCK5nW6adCeXPkUiTGx0emOIDQqw1yFYGHEVx20xKjJVYe0O8iLmnQr3FA9nSIQilUKtJ4ZAdcTm7+ExseJauyqo30hs+1qSW211A1SFAOUgDlCGq7eTIcMAeyZkV1SQJ4j/e1Smbq4HcjqgFbLAGLyKxlMDMgZavK5NAYH19Olz3la/QCTiVelFnU6O/GCvykqS/wZJDhKN9gBtSOp/1SP5VRgJcoVj+kmf2wBgv4gjrgARBWiURYx8xENV3bEVUAAWWD3dYDKAIWk5opaCFCMR5ZjJExiCAw7gYiSZ2rkyTce4eNMY3lfGn+8p6+vBckGlKEXnA6Eota69OxDO9oOsJoy28BXOR0UoXNRaJD5ceKdlWMJlOFzDdZNpc05tkMGQtqeNF2lttZqNco1VtwXgRstLSQ6tSPChgqtGV5h2DcDReIQadaNRR6AsAYKL5gSFsCJMgfsaZ7DpKh8mg8Wz8V7H+gDnLuMxaWEIUPevIbClgap4dqmVWSrPgVYCzAoZHIa5z2Ocx1D/GvDOEqMOKLrMefWIbSWHZ6jbgA8qVBhYNHpx0P+jAgN5TB3haSifDcApp6yymEi6Ij/GsEpDYUgcHATJUYDUAmC1SCkJ4cuZXSAP2DEpQsGUjQmKJfJOvlC2x/pChkOyLW7KEoMYc5FDC4v2FGqSoRWiLsbPCiyg1U5yiHZVm1XLkHMMZL11/yxyw0UnGig3MFdZklN5FI/qiT65T+jOXOdO7XbgWurOAZR6Cv9uu1cm5LjkXX4xi6mWn5r5NjBS0gTliHhMZI2WNqSiSphEtiCAwnafS11JhseDGHYQ5+bqWiAYiAv6Jsf79/VUs4cIl+n6+WOjcgB/2l5TreoAV2717JzZbQIR0W1cl/dEqCy5kJ3ZSIHuU0vBoHooEpiHeQWVkkkOqRX27eD1FWw4BfO9CJDdKoSogQi3hAAwsPRFrN5RbX7bqLdBJ9JYMohWrgJKHSjVl1sy2xAG0E3sNyO0oCbSGOxCNBRRXTXenYKuwAoDLfnDcQaCwehUOIDiHAu5m5hMpKeKM4sIo3vxACakIxKoH2YWF2QM84e6F5C5hJU4g8uxuFOlAYnqtwxmHyNEawLW/PhoawJDrGAP0JYWHgAVUByo/bGdiv2T2EMg8gsS14/rAdzlOYazFE7w4OzxeKiWdm3nSOnQRRKXSlVo8HEAbBfyJMKqoq+SCcTSx5NDtbFwNlh8VhjGGDu7JG5/TAGAvniQSSUog0pNzTim8Owc6QTuSKSTXlQqwV3eiEnklS3LeSXYPXGK2VgeZBqNcHG6tZHvA3vTINhV0ELuQdp3t1y9+ogD8Kk/W7QoRN1UWPqM4+xdygkFDPLoTaumKReKiLWoPHOfY54m3qPx4c+4pgY3MRKKbljG8w4wvz8pxk3AqKsy4GMAkAtmRjRMsCxbb4Q2Ds0Ia9ci8cMT6DmsJG00XaHCIS+o3F8YVVeikw13w+OEDaCYYhC0ZE54kA4jpjruBr5STWeqQG6M74HHL6TZ3lXrd99ZX++7LhNatQaZosuxEf5yRA15S9gPeHskBIq3Gcw81AGb9/O53DYi/5CsQ51EmEh8Rkg4vOciClpy4d04eYsfr6fyQkBmtD+P8sNh6e+XYHJXT/lkXxT4KXU5F2sGxYyzfniMMQkb9OjDN2C8tRRgTyL7GwozH14PrEUZc6oz05Emne3Ts5EG7WolDmU8OB1LDG3VrpQxp+pT0KYV5dGtknU64JhabdqcVQbGZiAxQAnvN1u70y1AnmvOSPgLI6uB4AuDGhmAu3ATkJSw7OtS/2ToPjqkaq62/7WFG8advGlRRqxB9diP07JrXowKR9tpRa+jGJ91zxNTT1h8I2PcSfoUPtd7NejVoH03EUcqSBuFZPkMZhegHyo2ZAITovmm3zAIdGFWxoNNORiMRShgwdYwFzkPw5PA4a5MIIQpmq+nsp3YMuXt/GkXxLx/P6+ZJS0lFyz4MunC3eWSGE8xlCQrKvhKUPXr0hjpAN9ZK4PfEDrPMfMbGNWcHDzjA7ngMxTPnT7GMHar+gMQQ3NwHCv4zH4BIMYvzsdiERi6gebRmerTsVwZJTRsL8dkZgxgRxmpbgRcud+YlCIRpPwHShlUSwuipZnx9QCsEWziVazdDeKSYU5CF7UVPAhLer3CgJOQXl/zh575R5rsrmRnKAzq4POFdgbYBuEviM4+LVC15ssLNFghbTtHWerS1hDt5s4qkLUha/qpZXhWh1C6lTQAqCNQnaDjS7UGFBC6wTu8yFnKJnExCnAs3Ok9yj5KpfZESQ4lTy5pTGTnkAUpxI+yjEldJfSo4y0QhG4i4IwkRFGcjWY8+EzgYYJUK7BXQksLxAww/YYWBMhJILB9e8ePEJ4OP7z+4/wOQDl64iOYDp26DaONPxpKtBxq/aTzRGarm3VkPYTLJKx6Z/Mw2YbBGseJhPMwhhNswrIkyvV2BYzrvZbxLpKwcWJhYmFtVZ+lPEq91FzVp1HlQY1bZVLqeNR9SAUn6n0E28k/UuGkNpP1DBI5ch/EehZfjUQ9aE41NhETExoPT2gGQz0IhWJbEOvTQ4wgcXCHHFBhewYUiFHuhRSAUVmEHeCRQHQkXGFwkAgyzREJCVN7TRnTon36Zw3tPhx4EALwNdwDv+J41YSP4B2CQqz0EFgARZ4ESgBHQgROwAVn9GTI+HYexTUevLUeta4/DqKrbMVS+Yqb8hUwYCrlgKtmAq1YCrFgKrd4qpXiqZcKn1oqdWipjYKpWwVPVYqW6xUpVipKqFR3QKjagVEtAqHpxUMTitsnFaJOKx2cVhswq35RVpyiq9lFVNIKnOQVMkgqtYxVNxiqQjFS7GKlSIVIsQqPIhUWwioigFQ++KkN8VHr49HDw9Ebo9EDo9DTo9Crg9BDg9/Wx7gWx7YWwlobYrOGxWPNisAaAHEyALpkAVDIAeWAArsABVXACYuAD5cAF6wAKFQAQqgAbVAAsoAAlQAUaYAfkwAvogBWQACOgAD9AAHSAAKT4GUdMiOvFngBTwCn2AZ7Dv6B6k/90B8+yRnkV144AIBoAMTQATGgAjNAA4YABgwABZgB/mQCwyAVlwCguASlwCEuAQFwB4uAMlwBYuAJlQAUVAAhUD2KgdpUDaJgaRMDFJgX5MC1JgWJEAokQCWRAHxEAWkQBMRADpEAMkQAYROAEecC484DRpwBDTnwNOdw05tjTmiNOYwtswhYFwLA7BYG4LA2BYGOLAwRYFuLAsxYFQJAohIEyJAMwkAwiQC0JAJgkAeiQBkJAFokAPCQA0JABwcD4Dgc4cDdDgaYcDIDgYgUC6CgWgUClCgUYUAVBQBOFAEYMALgwAgDA9QYAdIn8AZzeBB2L5EcWrenUT1KXienEsuJJ7x5U8XlTjc1NVzUyXFTGb1LlpUtWlTDIjqwE4LsagowoCi2gJLKAkpoBgJQNpAIhNqaEoneI6kiiqQ6Go/n6j0cS+a2gEU8gIHJ+BwfgZX4GL+Bd/gW34FZ+BS/gUH4FN6BTegTvoEv6BJegRnYEF2A79gOvYDl2BdEjCkqkGtwXp0LNToIskOTXzh/F062yJ7AAAAEDAWAAABWhJ+KPEIJgBFxMVP7w2QJBGHASQnOBKXKFIdUK4igKA9IEaYJg);src:url(data:application/vnd.ms-fontobject;base64,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) format('embedded-opentype'),url(data:application/font-woff;base64,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) format('woff'),url(data:application/x-font-truetype;base64,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) format('truetype'),url(data:image/svg+xml;base64,<?xml version="1.0" standalone="no"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd" >
<svg xmlns="http://www.w3.org/2000/svg">
<metadata></metadata>
<defs>
<font id="glyphicons_halflingsregular" horiz-adv-x="1200" >
<font-face units-per-em="1200" ascent="960" descent="-240" />
<missing-glyph horiz-adv-x="500" />
<glyph horiz-adv-x="0" />
<glyph horiz-adv-x="400" />
<glyph unicode=" " />
<glyph unicode="*" d="M600 1100q15 0 34 -1.5t30 -3.5l11 -1q10 -2 17.5 -10.5t7.5 -18.5v-224l158 158q7 7 18 8t19 -6l106 -106q7 -8 6 -19t-8 -18l-158 -158h224q10 0 18.5 -7.5t10.5 -17.5q6 -41 6 -75q0 -15 -1.5 -34t-3.5 -30l-1 -11q-2 -10 -10.5 -17.5t-18.5 -7.5h-224l158 -158 q7 -7 8 -18t-6 -19l-106 -106q-8 -7 -19 -6t-18 8l-158 158v-224q0 -10 -7.5 -18.5t-17.5 -10.5q-41 -6 -75 -6q-15 0 -34 1.5t-30 3.5l-11 1q-10 2 -17.5 10.5t-7.5 18.5v224l-158 -158q-7 -7 -18 -8t-19 6l-106 106q-7 8 -6 19t8 18l158 158h-224q-10 0 -18.5 7.5 t-10.5 17.5q-6 41 -6 75q0 15 1.5 34t3.5 30l1 11q2 10 10.5 17.5t18.5 7.5h224l-158 158q-7 7 -8 18t6 19l106 106q8 7 19 6t18 -8l158 -158v224q0 10 7.5 18.5t17.5 10.5q41 6 75 6z" />
<glyph unicode="+" d="M450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-350h350q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-350v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v350h-350q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5 h350v350q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xa0;" />
<glyph unicode="&#xa5;" d="M825 1100h250q10 0 12.5 -5t-5.5 -13l-364 -364q-6 -6 -11 -18h268q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-100h275q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-174q0 -11 -7.5 -18.5t-18.5 -7.5h-148q-11 0 -18.5 7.5t-7.5 18.5v174 h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h125v100h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h118q-5 12 -11 18l-364 364q-8 8 -5.5 13t12.5 5h250q25 0 43 -18l164 -164q8 -8 18 -8t18 8l164 164q18 18 43 18z" />
<glyph unicode="&#x2000;" horiz-adv-x="650" />
<glyph unicode="&#x2001;" horiz-adv-x="1300" />
<glyph unicode="&#x2002;" horiz-adv-x="650" />
<glyph unicode="&#x2003;" horiz-adv-x="1300" />
<glyph unicode="&#x2004;" horiz-adv-x="433" />
<glyph unicode="&#x2005;" horiz-adv-x="325" />
<glyph unicode="&#x2006;" horiz-adv-x="216" />
<glyph unicode="&#x2007;" horiz-adv-x="216" />
<glyph unicode="&#x2008;" horiz-adv-x="162" />
<glyph unicode="&#x2009;" horiz-adv-x="260" />
<glyph unicode="&#x200a;" horiz-adv-x="72" />
<glyph unicode="&#x202f;" horiz-adv-x="260" />
<glyph unicode="&#x205f;" horiz-adv-x="325" />
<glyph unicode="&#x20ac;" d="M744 1198q242 0 354 -189q60 -104 66 -209h-181q0 45 -17.5 82.5t-43.5 61.5t-58 40.5t-60.5 24t-51.5 7.5q-19 0 -40.5 -5.5t-49.5 -20.5t-53 -38t-49 -62.5t-39 -89.5h379l-100 -100h-300q-6 -50 -6 -100h406l-100 -100h-300q9 -74 33 -132t52.5 -91t61.5 -54.5t59 -29 t47 -7.5q22 0 50.5 7.5t60.5 24.5t58 41t43.5 61t17.5 80h174q-30 -171 -128 -278q-107 -117 -274 -117q-206 0 -324 158q-36 48 -69 133t-45 204h-217l100 100h112q1 47 6 100h-218l100 100h134q20 87 51 153.5t62 103.5q117 141 297 141z" />
<glyph unicode="&#x20bd;" d="M428 1200h350q67 0 120 -13t86 -31t57 -49.5t35 -56.5t17 -64.5t6.5 -60.5t0.5 -57v-16.5v-16.5q0 -36 -0.5 -57t-6.5 -61t-17 -65t-35 -57t-57 -50.5t-86 -31.5t-120 -13h-178l-2 -100h288q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-138v-175q0 -11 -5.5 -18 t-15.5 -7h-149q-10 0 -17.5 7.5t-7.5 17.5v175h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v100h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v475q0 10 7.5 17.5t17.5 7.5zM600 1000v-300h203q64 0 86.5 33t22.5 119q0 84 -22.5 116t-86.5 32h-203z" />
<glyph unicode="&#x2212;" d="M250 700h800q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#x231b;" d="M1000 1200v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-50v-100q0 -91 -49.5 -165.5t-130.5 -109.5q81 -35 130.5 -109.5t49.5 -165.5v-150h50q21 0 35.5 -14.5t14.5 -35.5v-150h-800v150q0 21 14.5 35.5t35.5 14.5h50v150q0 91 49.5 165.5t130.5 109.5q-81 35 -130.5 109.5 t-49.5 165.5v100h-50q-21 0 -35.5 14.5t-14.5 35.5v150h800zM400 1000v-100q0 -60 32.5 -109.5t87.5 -73.5q28 -12 44 -37t16 -55t-16 -55t-44 -37q-55 -24 -87.5 -73.5t-32.5 -109.5v-150h400v150q0 60 -32.5 109.5t-87.5 73.5q-28 12 -44 37t-16 55t16 55t44 37 q55 24 87.5 73.5t32.5 109.5v100h-400z" />
<glyph unicode="&#x25fc;" horiz-adv-x="500" d="M0 0z" />
<glyph unicode="&#x2601;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -206.5q0 -121 -85 -207.5t-205 -86.5h-750q-79 0 -135.5 57t-56.5 137q0 69 42.5 122.5t108.5 67.5q-2 12 -2 37q0 153 108 260.5t260 107.5z" />
<glyph unicode="&#x26fa;" d="M774 1193.5q16 -9.5 20.5 -27t-5.5 -33.5l-136 -187l467 -746h30q20 0 35 -18.5t15 -39.5v-42h-1200v42q0 21 15 39.5t35 18.5h30l468 746l-135 183q-10 16 -5.5 34t20.5 28t34 5.5t28 -20.5l111 -148l112 150q9 16 27 20.5t34 -5zM600 200h377l-182 112l-195 534v-646z " />
<glyph unicode="&#x2709;" d="M25 1100h1150q10 0 12.5 -5t-5.5 -13l-564 -567q-8 -8 -18 -8t-18 8l-564 567q-8 8 -5.5 13t12.5 5zM18 882l264 -264q8 -8 8 -18t-8 -18l-264 -264q-8 -8 -13 -5.5t-5 12.5v550q0 10 5 12.5t13 -5.5zM918 618l264 264q8 8 13 5.5t5 -12.5v-550q0 -10 -5 -12.5t-13 5.5 l-264 264q-8 8 -8 18t8 18zM818 482l364 -364q8 -8 5.5 -13t-12.5 -5h-1150q-10 0 -12.5 5t5.5 13l364 364q8 8 18 8t18 -8l164 -164q8 -8 18 -8t18 8l164 164q8 8 18 8t18 -8z" />
<glyph unicode="&#x270f;" d="M1011 1210q19 0 33 -13l153 -153q13 -14 13 -33t-13 -33l-99 -92l-214 214l95 96q13 14 32 14zM1013 800l-615 -614l-214 214l614 614zM317 96l-333 -112l110 335z" />
<glyph unicode="&#xe001;" d="M700 650v-550h250q21 0 35.5 -14.5t14.5 -35.5v-50h-800v50q0 21 14.5 35.5t35.5 14.5h250v550l-500 550h1200z" />
<glyph unicode="&#xe002;" d="M368 1017l645 163q39 15 63 0t24 -49v-831q0 -55 -41.5 -95.5t-111.5 -63.5q-79 -25 -147 -4.5t-86 75t25.5 111.5t122.5 82q72 24 138 8v521l-600 -155v-606q0 -42 -44 -90t-109 -69q-79 -26 -147 -5.5t-86 75.5t25.5 111.5t122.5 82.5q72 24 138 7v639q0 38 14.5 59 t53.5 34z" />
<glyph unicode="&#xe003;" d="M500 1191q100 0 191 -39t156.5 -104.5t104.5 -156.5t39 -191l-1 -2l1 -5q0 -141 -78 -262l275 -274q23 -26 22.5 -44.5t-22.5 -42.5l-59 -58q-26 -20 -46.5 -20t-39.5 20l-275 274q-119 -77 -261 -77l-5 1l-2 -1q-100 0 -191 39t-156.5 104.5t-104.5 156.5t-39 191 t39 191t104.5 156.5t156.5 104.5t191 39zM500 1022q-88 0 -162 -43t-117 -117t-43 -162t43 -162t117 -117t162 -43t162 43t117 117t43 162t-43 162t-117 117t-162 43z" />
<glyph unicode="&#xe005;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104z" />
<glyph unicode="&#xe006;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429z" />
<glyph unicode="&#xe007;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429zM477 700h-240l197 -142l-74 -226 l193 139l195 -140l-74 229l192 140h-234l-78 211z" />
<glyph unicode="&#xe008;" d="M600 1200q124 0 212 -88t88 -212v-250q0 -46 -31 -98t-69 -52v-75q0 -10 6 -21.5t15 -17.5l358 -230q9 -5 15 -16.5t6 -21.5v-93q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v93q0 10 6 21.5t15 16.5l358 230q9 6 15 17.5t6 21.5v75q-38 0 -69 52 t-31 98v250q0 124 88 212t212 88z" />
<glyph unicode="&#xe009;" d="M25 1100h1150q10 0 17.5 -7.5t7.5 -17.5v-1050q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v1050q0 10 7.5 17.5t17.5 7.5zM100 1000v-100h100v100h-100zM875 1000h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5t17.5 -7.5h550 q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM1000 1000v-100h100v100h-100zM100 800v-100h100v100h-100zM1000 800v-100h100v100h-100zM100 600v-100h100v100h-100zM1000 600v-100h100v100h-100zM875 500h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5 t17.5 -7.5h550q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM100 400v-100h100v100h-100zM1000 400v-100h100v100h-100zM100 200v-100h100v100h-100zM1000 200v-100h100v100h-100z" />
<glyph unicode="&#xe010;" d="M50 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM50 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe011;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM850 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 700h200q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h200 q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5 t35.5 14.5z" />
<glyph unicode="&#xe012;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h700q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe013;" d="M465 477l571 571q8 8 18 8t17 -8l177 -177q8 -7 8 -17t-8 -18l-783 -784q-7 -8 -17.5 -8t-17.5 8l-384 384q-8 8 -8 18t8 17l177 177q7 8 17 8t18 -8l171 -171q7 -7 18 -7t18 7z" />
<glyph unicode="&#xe014;" d="M904 1083l178 -179q8 -8 8 -18.5t-8 -17.5l-267 -268l267 -268q8 -7 8 -17.5t-8 -18.5l-178 -178q-8 -8 -18.5 -8t-17.5 8l-268 267l-268 -267q-7 -8 -17.5 -8t-18.5 8l-178 178q-8 8 -8 18.5t8 17.5l267 268l-267 268q-8 7 -8 17.5t8 18.5l178 178q8 8 18.5 8t17.5 -8 l268 -267l268 268q7 7 17.5 7t18.5 -7z" />
<glyph unicode="&#xe015;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM425 900h150q10 0 17.5 -7.5t7.5 -17.5v-75h75q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5 t-17.5 -7.5h-75v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-75q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v75q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe016;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM325 800h350q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-350q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe017;" d="M550 1200h100q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM800 975v166q167 -62 272 -209.5t105 -331.5q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5 t-184.5 123t-123 184.5t-45.5 224q0 184 105 331.5t272 209.5v-166q-103 -55 -165 -155t-62 -220q0 -116 57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5q0 120 -62 220t-165 155z" />
<glyph unicode="&#xe018;" d="M1025 1200h150q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM725 800h150q10 0 17.5 -7.5t7.5 -17.5v-750q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v750 q0 10 7.5 17.5t17.5 7.5zM425 500h150q10 0 17.5 -7.5t7.5 -17.5v-450q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v450q0 10 7.5 17.5t17.5 7.5zM125 300h150q10 0 17.5 -7.5t7.5 -17.5v-250q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5 v250q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe019;" d="M600 1174q33 0 74 -5l38 -152l5 -1q49 -14 94 -39l5 -2l134 80q61 -48 104 -105l-80 -134l3 -5q25 -44 39 -93l1 -6l152 -38q5 -43 5 -73q0 -34 -5 -74l-152 -38l-1 -6q-15 -49 -39 -93l-3 -5l80 -134q-48 -61 -104 -105l-134 81l-5 -3q-44 -25 -94 -39l-5 -2l-38 -151 q-43 -5 -74 -5q-33 0 -74 5l-38 151l-5 2q-49 14 -94 39l-5 3l-134 -81q-60 48 -104 105l80 134l-3 5q-25 45 -38 93l-2 6l-151 38q-6 42 -6 74q0 33 6 73l151 38l2 6q13 48 38 93l3 5l-80 134q47 61 105 105l133 -80l5 2q45 25 94 39l5 1l38 152q43 5 74 5zM600 815 q-89 0 -152 -63t-63 -151.5t63 -151.5t152 -63t152 63t63 151.5t-63 151.5t-152 63z" />
<glyph unicode="&#xe020;" d="M500 1300h300q41 0 70.5 -29.5t29.5 -70.5v-100h275q10 0 17.5 -7.5t7.5 -17.5v-75h-1100v75q0 10 7.5 17.5t17.5 7.5h275v100q0 41 29.5 70.5t70.5 29.5zM500 1200v-100h300v100h-300zM1100 900v-800q0 -41 -29.5 -70.5t-70.5 -29.5h-700q-41 0 -70.5 29.5t-29.5 70.5 v800h900zM300 800v-700h100v700h-100zM500 800v-700h100v700h-100zM700 800v-700h100v700h-100zM900 800v-700h100v700h-100z" />
<glyph unicode="&#xe021;" d="M18 618l620 608q8 7 18.5 7t17.5 -7l608 -608q8 -8 5.5 -13t-12.5 -5h-175v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v375h-300v-375q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v575h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe022;" d="M600 1200v-400q0 -41 29.5 -70.5t70.5 -29.5h300v-650q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5h450zM1000 800h-250q-21 0 -35.5 14.5t-14.5 35.5v250z" />
<glyph unicode="&#xe023;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h50q10 0 17.5 -7.5t7.5 -17.5v-275h175q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe024;" d="M1300 0h-538l-41 400h-242l-41 -400h-538l431 1200h209l-21 -300h162l-20 300h208zM515 800l-27 -300h224l-27 300h-170z" />
<glyph unicode="&#xe025;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-450h191q20 0 25.5 -11.5t-7.5 -27.5l-327 -400q-13 -16 -32 -16t-32 16l-327 400q-13 16 -7.5 27.5t25.5 11.5h191v450q0 21 14.5 35.5t35.5 14.5zM1125 400h50q10 0 17.5 -7.5t7.5 -17.5v-350q0 -10 -7.5 -17.5t-17.5 -7.5 h-1050q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h50q10 0 17.5 -7.5t7.5 -17.5v-175h900v175q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe026;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -275q-13 -16 -32 -16t-32 16l-223 275q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z " />
<glyph unicode="&#xe027;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM632 914l223 -275q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5l223 275q13 16 32 16 t32 -16z" />
<glyph unicode="&#xe028;" d="M225 1200h750q10 0 19.5 -7t12.5 -17l186 -652q7 -24 7 -49v-425q0 -12 -4 -27t-9 -17q-12 -6 -37 -6h-1100q-12 0 -27 4t-17 8q-6 13 -6 38l1 425q0 25 7 49l185 652q3 10 12.5 17t19.5 7zM878 1000h-556q-10 0 -19 -7t-11 -18l-87 -450q-2 -11 4 -18t16 -7h150 q10 0 19.5 -7t11.5 -17l38 -152q2 -10 11.5 -17t19.5 -7h250q10 0 19.5 7t11.5 17l38 152q2 10 11.5 17t19.5 7h150q10 0 16 7t4 18l-87 450q-2 11 -11 18t-19 7z" />
<glyph unicode="&#xe029;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM540 820l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe030;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-362q0 -10 -7.5 -17.5t-17.5 -7.5h-362q-11 0 -13 5.5t5 12.5l133 133q-109 76 -238 76q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5h150q0 -117 -45.5 -224 t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117z" />
<glyph unicode="&#xe031;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-361q0 -11 -7.5 -18.5t-18.5 -7.5h-361q-11 0 -13 5.5t5 12.5l134 134q-110 75 -239 75q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5h-150q0 117 45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117zM1027 600h150 q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5q-192 0 -348 118l-134 -134q-7 -8 -12.5 -5.5t-5.5 12.5v360q0 11 7.5 18.5t18.5 7.5h360q10 0 12.5 -5.5t-5.5 -12.5l-133 -133q110 -76 240 -76q116 0 214.5 57t155.5 155.5t57 214.5z" />
<glyph unicode="&#xe032;" d="M125 1200h1050q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-1050q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM1075 1000h-850q-10 0 -17.5 -7.5t-7.5 -17.5v-850q0 -10 7.5 -17.5t17.5 -7.5h850q10 0 17.5 7.5t7.5 17.5v850 q0 10 -7.5 17.5t-17.5 7.5zM325 900h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 900h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 700h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 700h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 500h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 500h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 300h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 300h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe033;" d="M900 800v200q0 83 -58.5 141.5t-141.5 58.5h-300q-82 0 -141 -59t-59 -141v-200h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h900q41 0 70.5 29.5t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5h-100zM400 800v150q0 21 15 35.5t35 14.5h200 q20 0 35 -14.5t15 -35.5v-150h-300z" />
<glyph unicode="&#xe034;" d="M125 1100h50q10 0 17.5 -7.5t7.5 -17.5v-1075h-100v1075q0 10 7.5 17.5t17.5 7.5zM1075 1052q4 0 9 -2q16 -6 16 -23v-421q0 -6 -3 -12q-33 -59 -66.5 -99t-65.5 -58t-56.5 -24.5t-52.5 -6.5q-26 0 -57.5 6.5t-52.5 13.5t-60 21q-41 15 -63 22.5t-57.5 15t-65.5 7.5 q-85 0 -160 -57q-7 -5 -15 -5q-6 0 -11 3q-14 7 -14 22v438q22 55 82 98.5t119 46.5q23 2 43 0.5t43 -7t32.5 -8.5t38 -13t32.5 -11q41 -14 63.5 -21t57 -14t63.5 -7q103 0 183 87q7 8 18 8z" />
<glyph unicode="&#xe035;" d="M600 1175q116 0 227 -49.5t192.5 -131t131 -192.5t49.5 -227v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v300q0 127 -70.5 231.5t-184.5 161.5t-245 57t-245 -57t-184.5 -161.5t-70.5 -231.5v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50 q-10 0 -17.5 7.5t-7.5 17.5v300q0 116 49.5 227t131 192.5t192.5 131t227 49.5zM220 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460q0 8 6 14t14 6zM820 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460 q0 8 6 14t14 6z" />
<glyph unicode="&#xe036;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM900 668l120 120q7 7 17 7t17 -7l34 -34q7 -7 7 -17t-7 -17l-120 -120l120 -120q7 -7 7 -17 t-7 -17l-34 -34q-7 -7 -17 -7t-17 7l-120 119l-120 -119q-7 -7 -17 -7t-17 7l-34 34q-7 7 -7 17t7 17l119 120l-119 120q-7 7 -7 17t7 17l34 34q7 8 17 8t17 -8z" />
<glyph unicode="&#xe037;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6 l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238q-6 8 -4.5 18t9.5 17l29 22q7 5 15 5z" />
<glyph unicode="&#xe038;" d="M967 1004h3q11 -1 17 -10q135 -179 135 -396q0 -105 -34 -206.5t-98 -185.5q-7 -9 -17 -10h-3q-9 0 -16 6l-42 34q-8 6 -9 16t5 18q111 150 111 328q0 90 -29.5 176t-84.5 157q-6 9 -5 19t10 16l42 33q7 5 15 5zM321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5 t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238 q-6 8 -4.5 18.5t9.5 16.5l29 22q7 5 15 5z" />
<glyph unicode="&#xe039;" d="M500 900h100v-100h-100v-100h-400v-100h-100v600h500v-300zM1200 700h-200v-100h200v-200h-300v300h-200v300h-100v200h600v-500zM100 1100v-300h300v300h-300zM800 1100v-300h300v300h-300zM300 900h-100v100h100v-100zM1000 900h-100v100h100v-100zM300 500h200v-500 h-500v500h200v100h100v-100zM800 300h200v-100h-100v-100h-200v100h-100v100h100v200h-200v100h300v-300zM100 400v-300h300v300h-300zM300 200h-100v100h100v-100zM1200 200h-100v100h100v-100zM700 0h-100v100h100v-100zM1200 0h-300v100h300v-100z" />
<glyph unicode="&#xe040;" d="M100 200h-100v1000h100v-1000zM300 200h-100v1000h100v-1000zM700 200h-200v1000h200v-1000zM900 200h-100v1000h100v-1000zM1200 200h-200v1000h200v-1000zM400 0h-300v100h300v-100zM600 0h-100v91h100v-91zM800 0h-100v91h100v-91zM1100 0h-200v91h200v-91z" />
<glyph unicode="&#xe041;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe042;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM800 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-56 56l424 426l-700 700h150zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5 t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe043;" d="M300 1200h825q75 0 75 -75v-900q0 -25 -18 -43l-64 -64q-8 -8 -13 -5.5t-5 12.5v950q0 10 -7.5 17.5t-17.5 7.5h-700q-25 0 -43 -18l-64 -64q-8 -8 -5.5 -13t12.5 -5h700q10 0 17.5 -7.5t7.5 -17.5v-950q0 -10 -7.5 -17.5t-17.5 -7.5h-850q-10 0 -17.5 7.5t-7.5 17.5v975 q0 25 18 43l139 139q18 18 43 18z" />
<glyph unicode="&#xe044;" d="M250 1200h800q21 0 35.5 -14.5t14.5 -35.5v-1150l-450 444l-450 -445v1151q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe045;" d="M822 1200h-444q-11 0 -19 -7.5t-9 -17.5l-78 -301q-7 -24 7 -45l57 -108q6 -9 17.5 -15t21.5 -6h450q10 0 21.5 6t17.5 15l62 108q14 21 7 45l-83 301q-1 10 -9 17.5t-19 7.5zM1175 800h-150q-10 0 -21 -6.5t-15 -15.5l-78 -156q-4 -9 -15 -15.5t-21 -6.5h-550 q-10 0 -21 6.5t-15 15.5l-78 156q-4 9 -15 15.5t-21 6.5h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-650q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h750q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5 t7.5 17.5v650q0 10 -7.5 17.5t-17.5 7.5zM850 200h-500q-10 0 -19.5 -7t-11.5 -17l-38 -152q-2 -10 3.5 -17t15.5 -7h600q10 0 15.5 7t3.5 17l-38 152q-2 10 -11.5 17t-19.5 7z" />
<glyph unicode="&#xe046;" d="M500 1100h200q56 0 102.5 -20.5t72.5 -50t44 -59t25 -50.5l6 -20h150q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5h150q2 8 6.5 21.5t24 48t45 61t72 48t102.5 21.5zM900 800v-100 h100v100h-100zM600 730q-95 0 -162.5 -67.5t-67.5 -162.5t67.5 -162.5t162.5 -67.5t162.5 67.5t67.5 162.5t-67.5 162.5t-162.5 67.5zM600 603q43 0 73 -30t30 -73t-30 -73t-73 -30t-73 30t-30 73t30 73t73 30z" />
<glyph unicode="&#xe047;" d="M681 1199l385 -998q20 -50 60 -92q18 -19 36.5 -29.5t27.5 -11.5l10 -2v-66h-417v66q53 0 75 43.5t5 88.5l-82 222h-391q-58 -145 -92 -234q-11 -34 -6.5 -57t25.5 -37t46 -20t55 -6v-66h-365v66q56 24 84 52q12 12 25 30.5t20 31.5l7 13l399 1006h93zM416 521h340 l-162 457z" />
<glyph unicode="&#xe048;" d="M753 641q5 -1 14.5 -4.5t36 -15.5t50.5 -26.5t53.5 -40t50.5 -54.5t35.5 -70t14.5 -87q0 -67 -27.5 -125.5t-71.5 -97.5t-98.5 -66.5t-108.5 -40.5t-102 -13h-500v89q41 7 70.5 32.5t29.5 65.5v827q0 24 -0.5 34t-3.5 24t-8.5 19.5t-17 13.5t-28 12.5t-42.5 11.5v71 l471 -1q57 0 115.5 -20.5t108 -57t80.5 -94t31 -124.5q0 -51 -15.5 -96.5t-38 -74.5t-45 -50.5t-38.5 -30.5zM400 700h139q78 0 130.5 48.5t52.5 122.5q0 41 -8.5 70.5t-29.5 55.5t-62.5 39.5t-103.5 13.5h-118v-350zM400 200h216q80 0 121 50.5t41 130.5q0 90 -62.5 154.5 t-156.5 64.5h-159v-400z" />
<glyph unicode="&#xe049;" d="M877 1200l2 -57q-83 -19 -116 -45.5t-40 -66.5l-132 -839q-9 -49 13 -69t96 -26v-97h-500v97q186 16 200 98l173 832q3 17 3 30t-1.5 22.5t-9 17.5t-13.5 12.5t-21.5 10t-26 8.5t-33.5 10q-13 3 -19 5v57h425z" />
<glyph unicode="&#xe050;" d="M1300 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM175 1000h-75v-800h75l-125 -167l-125 167h75v800h-75l125 167z" />
<glyph unicode="&#xe051;" d="M1100 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-650q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v650h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM1167 50l-167 -125v75h-800v-75l-167 125l167 125v-75h800v75z" />
<glyph unicode="&#xe052;" d="M50 1100h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe053;" d="M250 1100h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM250 500h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe054;" d="M500 950v100q0 21 14.5 35.5t35.5 14.5h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5zM100 650v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000 q-21 0 -35.5 14.5t-14.5 35.5zM300 350v100q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5zM0 50v100q0 21 14.5 35.5t35.5 14.5h1100q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5z" />
<glyph unicode="&#xe055;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe056;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 1100h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 800h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 500h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 500h800q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 200h800 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe057;" d="M400 0h-100v1100h100v-1100zM550 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM267 550l-167 -125v75h-200v100h200v75zM550 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe058;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM900 0h-100v1100h100v-1100zM50 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM1100 600h200v-100h-200v-75l-167 125l167 125v-75zM50 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe059;" d="M75 1000h750q31 0 53 -22t22 -53v-650q0 -31 -22 -53t-53 -22h-750q-31 0 -53 22t-22 53v650q0 31 22 53t53 22zM1200 300l-300 300l300 300v-600z" />
<glyph unicode="&#xe060;" d="M44 1100h1112q18 0 31 -13t13 -31v-1012q0 -18 -13 -31t-31 -13h-1112q-18 0 -31 13t-13 31v1012q0 18 13 31t31 13zM100 1000v-737l247 182l298 -131l-74 156l293 318l236 -288v500h-1000zM342 884q56 0 95 -39t39 -94.5t-39 -95t-95 -39.5t-95 39.5t-39 95t39 94.5 t95 39z" />
<glyph unicode="&#xe062;" d="M648 1169q117 0 216 -60t156.5 -161t57.5 -218q0 -115 -70 -258q-69 -109 -158 -225.5t-143 -179.5l-54 -62q-9 8 -25.5 24.5t-63.5 67.5t-91 103t-98.5 128t-95.5 148q-60 132 -60 249q0 88 34 169.5t91.5 142t137 96.5t166.5 36zM652.5 974q-91.5 0 -156.5 -65 t-65 -157t65 -156.5t156.5 -64.5t156.5 64.5t65 156.5t-65 157t-156.5 65z" />
<glyph unicode="&#xe063;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 173v854q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57z" />
<glyph unicode="&#xe064;" d="M554 1295q21 -72 57.5 -143.5t76 -130t83 -118t82.5 -117t70 -116t49.5 -126t18.5 -136.5q0 -71 -25.5 -135t-68.5 -111t-99 -82t-118.5 -54t-125.5 -23q-84 5 -161.5 34t-139.5 78.5t-99 125t-37 164.5q0 69 18 136.5t49.5 126.5t69.5 116.5t81.5 117.5t83.5 119 t76.5 131t58.5 143zM344 710q-23 -33 -43.5 -70.5t-40.5 -102.5t-17 -123q1 -37 14.5 -69.5t30 -52t41 -37t38.5 -24.5t33 -15q21 -7 32 -1t13 22l6 34q2 10 -2.5 22t-13.5 19q-5 4 -14 12t-29.5 40.5t-32.5 73.5q-26 89 6 271q2 11 -6 11q-8 1 -15 -10z" />
<glyph unicode="&#xe065;" d="M1000 1013l108 115q2 1 5 2t13 2t20.5 -1t25 -9.5t28.5 -21.5q22 -22 27 -43t0 -32l-6 -10l-108 -115zM350 1100h400q50 0 105 -13l-187 -187h-368q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v182l200 200v-332 q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM1009 803l-362 -362l-161 -50l55 170l355 355z" />
<glyph unicode="&#xe066;" d="M350 1100h361q-164 -146 -216 -200h-195q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5l200 153v-103q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M824 1073l339 -301q8 -7 8 -17.5t-8 -17.5l-340 -306q-7 -6 -12.5 -4t-6.5 11v203q-26 1 -54.5 0t-78.5 -7.5t-92 -17.5t-86 -35t-70 -57q10 59 33 108t51.5 81.5t65 58.5t68.5 40.5t67 24.5t56 13.5t40 4.5v210q1 10 6.5 12.5t13.5 -4.5z" />
<glyph unicode="&#xe067;" d="M350 1100h350q60 0 127 -23l-178 -177h-349q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v69l200 200v-219q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M643 639l395 395q7 7 17.5 7t17.5 -7l101 -101q7 -7 7 -17.5t-7 -17.5l-531 -532q-7 -7 -17.5 -7t-17.5 7l-248 248q-7 7 -7 17.5t7 17.5l101 101q7 7 17.5 7t17.5 -7l111 -111q8 -7 18 -7t18 7z" />
<glyph unicode="&#xe068;" d="M318 918l264 264q8 8 18 8t18 -8l260 -264q7 -8 4.5 -13t-12.5 -5h-170v-200h200v173q0 10 5 12t13 -5l264 -260q8 -7 8 -17.5t-8 -17.5l-264 -265q-8 -7 -13 -5t-5 12v173h-200v-200h170q10 0 12.5 -5t-4.5 -13l-260 -264q-8 -8 -18 -8t-18 8l-264 264q-8 8 -5.5 13 t12.5 5h175v200h-200v-173q0 -10 -5 -12t-13 5l-264 265q-8 7 -8 17.5t8 17.5l264 260q8 7 13 5t5 -12v-173h200v200h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe069;" d="M250 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe070;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5 t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe071;" d="M1200 1050v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-492 480q-15 14 -15 35t15 35l492 480q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25z" />
<glyph unicode="&#xe072;" d="M243 1074l814 -498q18 -11 18 -26t-18 -26l-814 -498q-18 -11 -30.5 -4t-12.5 28v1000q0 21 12.5 28t30.5 -4z" />
<glyph unicode="&#xe073;" d="M250 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM650 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe074;" d="M1100 950v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe075;" d="M500 612v438q0 21 10.5 25t25.5 -10l492 -480q15 -14 15 -35t-15 -35l-492 -480q-15 -14 -25.5 -10t-10.5 25v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10z" />
<glyph unicode="&#xe076;" d="M1048 1102l100 1q20 0 35 -14.5t15 -35.5l5 -1000q0 -21 -14.5 -35.5t-35.5 -14.5l-100 -1q-21 0 -35.5 14.5t-14.5 35.5l-2 437l-463 -454q-14 -15 -24.5 -10.5t-10.5 25.5l-2 437l-462 -455q-15 -14 -25.5 -9.5t-10.5 24.5l-5 1000q0 21 10.5 25.5t25.5 -10.5l466 -450 l-2 438q0 20 10.5 24.5t25.5 -9.5l466 -451l-2 438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe077;" d="M850 1100h100q21 0 35.5 -14.5t14.5 -35.5v-1000q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10l464 -453v438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe078;" d="M686 1081l501 -540q15 -15 10.5 -26t-26.5 -11h-1042q-22 0 -26.5 11t10.5 26l501 540q15 15 36 15t36 -15zM150 400h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe079;" d="M885 900l-352 -353l352 -353l-197 -198l-552 552l552 550z" />
<glyph unicode="&#xe080;" d="M1064 547l-551 -551l-198 198l353 353l-353 353l198 198z" />
<glyph unicode="&#xe081;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM650 900h-100q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-150 q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5h150v-150q0 -21 14.5 -35.5t35.5 -14.5h100q21 0 35.5 14.5t14.5 35.5v150h150q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-150v150q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe082;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM850 700h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5 t35.5 -14.5h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe083;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM741.5 913q-12.5 0 -21.5 -9l-120 -120l-120 120q-9 9 -21.5 9 t-21.5 -9l-141 -141q-9 -9 -9 -21.5t9 -21.5l120 -120l-120 -120q-9 -9 -9 -21.5t9 -21.5l141 -141q9 -9 21.5 -9t21.5 9l120 120l120 -120q9 -9 21.5 -9t21.5 9l141 141q9 9 9 21.5t-9 21.5l-120 120l120 120q9 9 9 21.5t-9 21.5l-141 141q-9 9 -21.5 9z" />
<glyph unicode="&#xe084;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM546 623l-84 85q-7 7 -17.5 7t-18.5 -7l-139 -139q-7 -8 -7 -18t7 -18 l242 -241q7 -8 17.5 -8t17.5 8l375 375q7 7 7 17.5t-7 18.5l-139 139q-7 7 -17.5 7t-17.5 -7z" />
<glyph unicode="&#xe085;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM588 941q-29 0 -59 -5.5t-63 -20.5t-58 -38.5t-41.5 -63t-16.5 -89.5 q0 -25 20 -25h131q30 -5 35 11q6 20 20.5 28t45.5 8q20 0 31.5 -10.5t11.5 -28.5q0 -23 -7 -34t-26 -18q-1 0 -13.5 -4t-19.5 -7.5t-20 -10.5t-22 -17t-18.5 -24t-15.5 -35t-8 -46q-1 -8 5.5 -16.5t20.5 -8.5h173q7 0 22 8t35 28t37.5 48t29.5 74t12 100q0 47 -17 83 t-42.5 57t-59.5 34.5t-64 18t-59 4.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe086;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM675 1000h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5 t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5zM675 700h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h75v-200h-75q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h350q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5 t-17.5 7.5h-75v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe087;" d="M525 1200h150q10 0 17.5 -7.5t7.5 -17.5v-194q103 -27 178.5 -102.5t102.5 -178.5h194q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-194q-27 -103 -102.5 -178.5t-178.5 -102.5v-194q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v194 q-103 27 -178.5 102.5t-102.5 178.5h-194q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h194q27 103 102.5 178.5t178.5 102.5v194q0 10 7.5 17.5t17.5 7.5zM700 893v-168q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v168q-68 -23 -119 -74 t-74 -119h168q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-168q23 -68 74 -119t119 -74v168q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-168q68 23 119 74t74 119h-168q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h168 q-23 68 -74 119t-119 74z" />
<glyph unicode="&#xe088;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM759 823l64 -64q7 -7 7 -17.5t-7 -17.5l-124 -124l124 -124q7 -7 7 -17.5t-7 -17.5l-64 -64q-7 -7 -17.5 -7t-17.5 7l-124 124l-124 -124q-7 -7 -17.5 -7t-17.5 7l-64 64 q-7 7 -7 17.5t7 17.5l124 124l-124 124q-7 7 -7 17.5t7 17.5l64 64q7 7 17.5 7t17.5 -7l124 -124l124 124q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe089;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM782 788l106 -106q7 -7 7 -17.5t-7 -17.5l-320 -321q-8 -7 -18 -7t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l197 197q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe090;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5q0 -120 65 -225 l587 587q-105 65 -225 65zM965 819l-584 -584q104 -62 219 -62q116 0 214.5 57t155.5 155.5t57 214.5q0 115 -62 219z" />
<glyph unicode="&#xe091;" d="M39 582l522 427q16 13 27.5 8t11.5 -26v-291h550q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-550v-291q0 -21 -11.5 -26t-27.5 8l-522 427q-16 13 -16 32t16 32z" />
<glyph unicode="&#xe092;" d="M639 1009l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291h-550q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h550v291q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe093;" d="M682 1161l427 -522q13 -16 8 -27.5t-26 -11.5h-291v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v550h-291q-21 0 -26 11.5t8 27.5l427 522q13 16 32 16t32 -16z" />
<glyph unicode="&#xe094;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-550h291q21 0 26 -11.5t-8 -27.5l-427 -522q-13 -16 -32 -16t-32 16l-427 522q-13 16 -8 27.5t26 11.5h291v550q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe095;" d="M639 1109l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291q-94 -2 -182 -20t-170.5 -52t-147 -92.5t-100.5 -135.5q5 105 27 193.5t67.5 167t113 135t167 91.5t225.5 42v262q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe096;" d="M850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5zM350 0h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249 q8 7 18 7t18 -7l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5z" />
<glyph unicode="&#xe097;" d="M1014 1120l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249q8 7 18 7t18 -7zM250 600h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5z" />
<glyph unicode="&#xe101;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM704 900h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5 t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe102;" d="M260 1200q9 0 19 -2t15 -4l5 -2q22 -10 44 -23l196 -118q21 -13 36 -24q29 -21 37 -12q11 13 49 35l196 118q22 13 45 23q17 7 38 7q23 0 47 -16.5t37 -33.5l13 -16q14 -21 18 -45l25 -123l8 -44q1 -9 8.5 -14.5t17.5 -5.5h61q10 0 17.5 -7.5t7.5 -17.5v-50 q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 -7.5t-7.5 -17.5v-175h-400v300h-200v-300h-400v175q0 10 -7.5 17.5t-17.5 7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5h61q11 0 18 3t7 8q0 4 9 52l25 128q5 25 19 45q2 3 5 7t13.5 15t21.5 19.5t26.5 15.5 t29.5 7zM915 1079l-166 -162q-7 -7 -5 -12t12 -5h219q10 0 15 7t2 17l-51 149q-3 10 -11 12t-15 -6zM463 917l-177 157q-8 7 -16 5t-11 -12l-51 -143q-3 -10 2 -17t15 -7h231q11 0 12.5 5t-5.5 12zM500 0h-375q-10 0 -17.5 7.5t-7.5 17.5v375h400v-400zM1100 400v-375 q0 -10 -7.5 -17.5t-17.5 -7.5h-375v400h400z" />
<glyph unicode="&#xe103;" d="M1165 1190q8 3 21 -6.5t13 -17.5q-2 -178 -24.5 -323.5t-55.5 -245.5t-87 -174.5t-102.5 -118.5t-118 -68.5t-118.5 -33t-120 -4.5t-105 9.5t-90 16.5q-61 12 -78 11q-4 1 -12.5 0t-34 -14.5t-52.5 -40.5l-153 -153q-26 -24 -37 -14.5t-11 43.5q0 64 42 102q8 8 50.5 45 t66.5 58q19 17 35 47t13 61q-9 55 -10 102.5t7 111t37 130t78 129.5q39 51 80 88t89.5 63.5t94.5 45t113.5 36t129 31t157.5 37t182 47.5zM1116 1098q-8 9 -22.5 -3t-45.5 -50q-38 -47 -119 -103.5t-142 -89.5l-62 -33q-56 -30 -102 -57t-104 -68t-102.5 -80.5t-85.5 -91 t-64 -104.5q-24 -56 -31 -86t2 -32t31.5 17.5t55.5 59.5q25 30 94 75.5t125.5 77.5t147.5 81q70 37 118.5 69t102 79.5t99 111t86.5 148.5q22 50 24 60t-6 19z" />
<glyph unicode="&#xe104;" d="M653 1231q-39 -67 -54.5 -131t-10.5 -114.5t24.5 -96.5t47.5 -80t63.5 -62.5t68.5 -46.5t65 -30q-4 7 -17.5 35t-18.5 39.5t-17 39.5t-17 43t-13 42t-9.5 44.5t-2 42t4 43t13.5 39t23 38.5q96 -42 165 -107.5t105 -138t52 -156t13 -159t-19 -149.5q-13 -55 -44 -106.5 t-68 -87t-78.5 -64.5t-72.5 -45t-53 -22q-72 -22 -127 -11q-31 6 -13 19q6 3 17 7q13 5 32.5 21t41 44t38.5 63.5t21.5 81.5t-6.5 94.5t-50 107t-104 115.5q10 -104 -0.5 -189t-37 -140.5t-65 -93t-84 -52t-93.5 -11t-95 24.5q-80 36 -131.5 114t-53.5 171q-2 23 0 49.5 t4.5 52.5t13.5 56t27.5 60t46 64.5t69.5 68.5q-8 -53 -5 -102.5t17.5 -90t34 -68.5t44.5 -39t49 -2q31 13 38.5 36t-4.5 55t-29 64.5t-36 75t-26 75.5q-15 85 2 161.5t53.5 128.5t85.5 92.5t93.5 61t81.5 25.5z" />
<glyph unicode="&#xe105;" d="M600 1094q82 0 160.5 -22.5t140 -59t116.5 -82.5t94.5 -95t68 -95t42.5 -82.5t14 -57.5t-14 -57.5t-43 -82.5t-68.5 -95t-94.5 -95t-116.5 -82.5t-140 -59t-159.5 -22.5t-159.5 22.5t-140 59t-116.5 82.5t-94.5 95t-68.5 95t-43 82.5t-14 57.5t14 57.5t42.5 82.5t68 95 t94.5 95t116.5 82.5t140 59t160.5 22.5zM888 829q-15 15 -18 12t5 -22q25 -57 25 -119q0 -124 -88 -212t-212 -88t-212 88t-88 212q0 59 23 114q8 19 4.5 22t-17.5 -12q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q22 -36 47 -71t70 -82t92.5 -81t113 -58.5t133.5 -24.5 t133.5 24t113 58.5t92.5 81.5t70 81.5t47 70.5q11 18 9 42.5t-14 41.5q-90 117 -163 189zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l35 34q14 15 12.5 33.5t-16.5 33.5q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe106;" d="M592 0h-148l31 120q-91 20 -175.5 68.5t-143.5 106.5t-103.5 119t-66.5 110t-22 76q0 21 14 57.5t42.5 82.5t68 95t94.5 95t116.5 82.5t140 59t160.5 22.5q61 0 126 -15l32 121h148zM944 770l47 181q108 -85 176.5 -192t68.5 -159q0 -26 -19.5 -71t-59.5 -102t-93 -112 t-129 -104.5t-158 -75.5l46 173q77 49 136 117t97 131q11 18 9 42.5t-14 41.5q-54 70 -107 130zM310 824q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q18 -30 39 -60t57 -70.5t74 -73t90 -61t105 -41.5l41 154q-107 18 -178.5 101.5t-71.5 193.5q0 59 23 114q8 19 4.5 22 t-17.5 -12zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l12 11l22 86l-3 4q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe107;" d="M-90 100l642 1066q20 31 48 28.5t48 -35.5l642 -1056q21 -32 7.5 -67.5t-50.5 -35.5h-1294q-37 0 -50.5 34t7.5 66zM155 200h345v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h345l-445 723zM496 700h208q20 0 32 -14.5t8 -34.5l-58 -252 q-4 -20 -21.5 -34.5t-37.5 -14.5h-54q-20 0 -37.5 14.5t-21.5 34.5l-58 252q-4 20 8 34.5t32 14.5z" />
<glyph unicode="&#xe108;" d="M650 1200q62 0 106 -44t44 -106v-339l363 -325q15 -14 26 -38.5t11 -44.5v-41q0 -20 -12 -26.5t-29 5.5l-359 249v-263q100 -93 100 -113v-64q0 -21 -13 -29t-32 1l-205 128l-205 -128q-19 -9 -32 -1t-13 29v64q0 20 100 113v263l-359 -249q-17 -12 -29 -5.5t-12 26.5v41 q0 20 11 44.5t26 38.5l363 325v339q0 62 44 106t106 44z" />
<glyph unicode="&#xe109;" d="M850 1200h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-150h-1100v150q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5h100q21 0 35.5 -14.5t14.5 -35.5v-50h500v50q0 21 14.5 35.5t35.5 14.5zM1100 800v-750q0 -21 -14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v750h1100zM100 600v-100h100v100h-100zM300 600v-100h100v100h-100zM500 600v-100h100v100h-100zM700 600v-100h100v100h-100zM900 600v-100h100v100h-100zM100 400v-100h100v100h-100zM300 400v-100h100v100h-100zM500 400 v-100h100v100h-100zM700 400v-100h100v100h-100zM900 400v-100h100v100h-100zM100 200v-100h100v100h-100zM300 200v-100h100v100h-100zM500 200v-100h100v100h-100zM700 200v-100h100v100h-100zM900 200v-100h100v100h-100z" />
<glyph unicode="&#xe110;" d="M1135 1165l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-159l-600 -600h-291q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h209l600 600h241v150q0 21 10.5 25t24.5 -10zM522 819l-141 -141l-122 122h-209q-21 0 -35.5 14.5 t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h291zM1135 565l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-241l-181 181l141 141l122 -122h159v150q0 21 10.5 25t24.5 -10z" />
<glyph unicode="&#xe111;" d="M100 1100h1000q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-596l-304 -300v300h-100q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5z" />
<glyph unicode="&#xe112;" d="M150 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM850 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM1100 800v-300q0 -41 -3 -77.5t-15 -89.5t-32 -96t-58 -89t-89 -77t-129 -51t-174 -20t-174 20 t-129 51t-89 77t-58 89t-32 96t-15 89.5t-3 77.5v300h300v-250v-27v-42.5t1.5 -41t5 -38t10 -35t16.5 -30t25.5 -24.5t35 -19t46.5 -12t60 -4t60 4.5t46.5 12.5t35 19.5t25 25.5t17 30.5t10 35t5 38t2 40.5t-0.5 42v25v250h300z" />
<glyph unicode="&#xe113;" d="M1100 411l-198 -199l-353 353l-353 -353l-197 199l551 551z" />
<glyph unicode="&#xe114;" d="M1101 789l-550 -551l-551 551l198 199l353 -353l353 353z" />
<glyph unicode="&#xe115;" d="M404 1000h746q21 0 35.5 -14.5t14.5 -35.5v-551h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v401h-381zM135 984l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-400h385l215 -200h-750q-21 0 -35.5 14.5 t-14.5 35.5v550h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe116;" d="M56 1200h94q17 0 31 -11t18 -27l38 -162h896q24 0 39 -18.5t10 -42.5l-100 -475q-5 -21 -27 -42.5t-55 -21.5h-633l48 -200h535q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-50q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-300v-50 q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-31q-18 0 -32.5 10t-20.5 19l-5 10l-201 961h-54q-20 0 -35 14.5t-15 35.5t15 35.5t35 14.5z" />
<glyph unicode="&#xe117;" d="M1200 1000v-100h-1200v100h200q0 41 29.5 70.5t70.5 29.5h300q41 0 70.5 -29.5t29.5 -70.5h500zM0 800h1200v-800h-1200v800z" />
<glyph unicode="&#xe118;" d="M200 800l-200 -400v600h200q0 41 29.5 70.5t70.5 29.5h300q42 0 71 -29.5t29 -70.5h500v-200h-1000zM1500 700l-300 -700h-1200l300 700h1200z" />
<glyph unicode="&#xe119;" d="M635 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-601h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v601h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe120;" d="M936 864l249 -229q14 -15 14 -35.5t-14 -35.5l-249 -229q-15 -15 -25.5 -10.5t-10.5 24.5v151h-600v-151q0 -20 -10.5 -24.5t-25.5 10.5l-249 229q-14 15 -14 35.5t14 35.5l249 229q15 15 25.5 10.5t10.5 -25.5v-149h600v149q0 21 10.5 25.5t25.5 -10.5z" />
<glyph unicode="&#xe121;" d="M1169 400l-172 732q-5 23 -23 45.5t-38 22.5h-672q-20 0 -38 -20t-23 -41l-172 -739h1138zM1100 300h-1000q-41 0 -70.5 -29.5t-29.5 -70.5v-100q0 -41 29.5 -70.5t70.5 -29.5h1000q41 0 70.5 29.5t29.5 70.5v100q0 41 -29.5 70.5t-70.5 29.5zM800 100v100h100v-100h-100 zM1000 100v100h100v-100h-100z" />
<glyph unicode="&#xe122;" d="M1150 1100q21 0 35.5 -14.5t14.5 -35.5v-850q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v850q0 21 14.5 35.5t35.5 14.5zM1000 200l-675 200h-38l47 -276q3 -16 -5.5 -20t-29.5 -4h-7h-84q-20 0 -34.5 14t-18.5 35q-55 337 -55 351v250v6q0 16 1 23.5t6.5 14 t17.5 6.5h200l675 250v-850zM0 750v-250q-4 0 -11 0.5t-24 6t-30 15t-24 30t-11 48.5v50q0 26 10.5 46t25 30t29 16t25.5 7z" />
<glyph unicode="&#xe123;" d="M553 1200h94q20 0 29 -10.5t3 -29.5l-18 -37q83 -19 144 -82.5t76 -140.5l63 -327l118 -173h17q19 0 33 -14.5t14 -35t-13 -40.5t-31 -27q-8 -4 -23 -9.5t-65 -19.5t-103 -25t-132.5 -20t-158.5 -9q-57 0 -115 5t-104 12t-88.5 15.5t-73.5 17.5t-54.5 16t-35.5 12l-11 4 q-18 8 -31 28t-13 40.5t14 35t33 14.5h17l118 173l63 327q15 77 76 140t144 83l-18 32q-6 19 3.5 32t28.5 13zM498 110q50 -6 102 -6q53 0 102 6q-12 -49 -39.5 -79.5t-62.5 -30.5t-63 30.5t-39 79.5z" />
<glyph unicode="&#xe124;" d="M800 946l224 78l-78 -224l234 -45l-180 -155l180 -155l-234 -45l78 -224l-224 78l-45 -234l-155 180l-155 -180l-45 234l-224 -78l78 224l-234 45l180 155l-180 155l234 45l-78 224l224 -78l45 234l155 -180l155 180z" />
<glyph unicode="&#xe125;" d="M650 1200h50q40 0 70 -40.5t30 -84.5v-150l-28 -125h328q40 0 70 -40.5t30 -84.5v-100q0 -45 -29 -74l-238 -344q-16 -24 -38 -40.5t-45 -16.5h-250q-7 0 -42 25t-66 50l-31 25h-61q-45 0 -72.5 18t-27.5 57v400q0 36 20 63l145 196l96 198q13 28 37.5 48t51.5 20z M650 1100l-100 -212l-150 -213v-375h100l136 -100h214l250 375v125h-450l50 225v175h-50zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe126;" d="M600 1100h250q23 0 45 -16.5t38 -40.5l238 -344q29 -29 29 -74v-100q0 -44 -30 -84.5t-70 -40.5h-328q28 -118 28 -125v-150q0 -44 -30 -84.5t-70 -40.5h-50q-27 0 -51.5 20t-37.5 48l-96 198l-145 196q-20 27 -20 63v400q0 39 27.5 57t72.5 18h61q124 100 139 100z M50 1000h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM636 1000l-136 -100h-100v-375l150 -213l100 -212h50v175l-50 225h450v125l-250 375h-214z" />
<glyph unicode="&#xe127;" d="M356 873l363 230q31 16 53 -6l110 -112q13 -13 13.5 -32t-11.5 -34l-84 -121h302q84 0 138 -38t54 -110t-55 -111t-139 -39h-106l-131 -339q-6 -21 -19.5 -41t-28.5 -20h-342q-7 0 -90 81t-83 94v525q0 17 14 35.5t28 28.5zM400 792v-503l100 -89h293l131 339 q6 21 19.5 41t28.5 20h203q21 0 30.5 25t0.5 50t-31 25h-456h-7h-6h-5.5t-6 0.5t-5 1.5t-5 2t-4 2.5t-4 4t-2.5 4.5q-12 25 5 47l146 183l-86 83zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe128;" d="M475 1103l366 -230q2 -1 6 -3.5t14 -10.5t18 -16.5t14.5 -20t6.5 -22.5v-525q0 -13 -86 -94t-93 -81h-342q-15 0 -28.5 20t-19.5 41l-131 339h-106q-85 0 -139.5 39t-54.5 111t54 110t138 38h302l-85 121q-11 15 -10.5 34t13.5 32l110 112q22 22 53 6zM370 945l146 -183 q17 -22 5 -47q-2 -2 -3.5 -4.5t-4 -4t-4 -2.5t-5 -2t-5 -1.5t-6 -0.5h-6h-6.5h-6h-475v-100h221q15 0 29 -20t20 -41l130 -339h294l106 89v503l-342 236zM1050 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5 v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe129;" d="M550 1294q72 0 111 -55t39 -139v-106l339 -131q21 -6 41 -19.5t20 -28.5v-342q0 -7 -81 -90t-94 -83h-525q-17 0 -35.5 14t-28.5 28l-9 14l-230 363q-16 31 6 53l112 110q13 13 32 13.5t34 -11.5l121 -84v302q0 84 38 138t110 54zM600 972v203q0 21 -25 30.5t-50 0.5 t-25 -31v-456v-7v-6v-5.5t-0.5 -6t-1.5 -5t-2 -5t-2.5 -4t-4 -4t-4.5 -2.5q-25 -12 -47 5l-183 146l-83 -86l236 -339h503l89 100v293l-339 131q-21 6 -41 19.5t-20 28.5zM450 200h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe130;" d="M350 1100h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5zM600 306v-106q0 -84 -39 -139t-111 -55t-110 54t-38 138v302l-121 -84q-15 -12 -34 -11.5t-32 13.5l-112 110 q-22 22 -6 53l230 363q1 2 3.5 6t10.5 13.5t16.5 17t20 13.5t22.5 6h525q13 0 94 -83t81 -90v-342q0 -15 -20 -28.5t-41 -19.5zM308 900l-236 -339l83 -86l183 146q22 17 47 5q2 -1 4.5 -2.5t4 -4t2.5 -4t2 -5t1.5 -5t0.5 -6v-5.5v-6v-7v-456q0 -22 25 -31t50 0.5t25 30.5 v203q0 15 20 28.5t41 19.5l339 131v293l-89 100h-503z" />
<glyph unicode="&#xe131;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM914 632l-275 223q-16 13 -27.5 8t-11.5 -26v-137h-275 q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h275v-137q0 -21 11.5 -26t27.5 8l275 223q16 13 16 32t-16 32z" />
<glyph unicode="&#xe132;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM561 855l-275 -223q-16 -13 -16 -32t16 -32l275 -223q16 -13 27.5 -8 t11.5 26v137h275q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5h-275v137q0 21 -11.5 26t-27.5 -8z" />
<glyph unicode="&#xe133;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM855 639l-223 275q-13 16 -32 16t-32 -16l-223 -275q-13 -16 -8 -27.5 t26 -11.5h137v-275q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v275h137q21 0 26 11.5t-8 27.5z" />
<glyph unicode="&#xe134;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM675 900h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-275h-137q-21 0 -26 -11.5 t8 -27.5l223 -275q13 -16 32 -16t32 16l223 275q13 16 8 27.5t-26 11.5h-137v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe135;" d="M600 1176q116 0 222.5 -46t184 -123.5t123.5 -184t46 -222.5t-46 -222.5t-123.5 -184t-184 -123.5t-222.5 -46t-222.5 46t-184 123.5t-123.5 184t-46 222.5t46 222.5t123.5 184t184 123.5t222.5 46zM627 1101q-15 -12 -36.5 -20.5t-35.5 -12t-43 -8t-39 -6.5 q-15 -3 -45.5 0t-45.5 -2q-20 -7 -51.5 -26.5t-34.5 -34.5q-3 -11 6.5 -22.5t8.5 -18.5q-3 -34 -27.5 -91t-29.5 -79q-9 -34 5 -93t8 -87q0 -9 17 -44.5t16 -59.5q12 0 23 -5t23.5 -15t19.5 -14q16 -8 33 -15t40.5 -15t34.5 -12q21 -9 52.5 -32t60 -38t57.5 -11 q7 -15 -3 -34t-22.5 -40t-9.5 -38q13 -21 23 -34.5t27.5 -27.5t36.5 -18q0 -7 -3.5 -16t-3.5 -14t5 -17q104 -2 221 112q30 29 46.5 47t34.5 49t21 63q-13 8 -37 8.5t-36 7.5q-15 7 -49.5 15t-51.5 19q-18 0 -41 -0.5t-43 -1.5t-42 -6.5t-38 -16.5q-51 -35 -66 -12 q-4 1 -3.5 25.5t0.5 25.5q-6 13 -26.5 17.5t-24.5 6.5q1 15 -0.5 30.5t-7 28t-18.5 11.5t-31 -21q-23 -25 -42 4q-19 28 -8 58q6 16 22 22q6 -1 26 -1.5t33.5 -4t19.5 -13.5q7 -12 18 -24t21.5 -20.5t20 -15t15.5 -10.5l5 -3q2 12 7.5 30.5t8 34.5t-0.5 32q-3 18 3.5 29 t18 22.5t15.5 24.5q6 14 10.5 35t8 31t15.5 22.5t34 22.5q-6 18 10 36q8 0 24 -1.5t24.5 -1.5t20 4.5t20.5 15.5q-10 23 -31 42.5t-37.5 29.5t-49 27t-43.5 23q0 1 2 8t3 11.5t1.5 10.5t-1 9.5t-4.5 4.5q31 -13 58.5 -14.5t38.5 2.5l12 5q5 28 -9.5 46t-36.5 24t-50 15 t-41 20q-18 -4 -37 0zM613 994q0 -17 8 -42t17 -45t9 -23q-8 1 -39.5 5.5t-52.5 10t-37 16.5q3 11 16 29.5t16 25.5q10 -10 19 -10t14 6t13.5 14.5t16.5 12.5z" />
<glyph unicode="&#xe136;" d="M756 1157q164 92 306 -9l-259 -138l145 -232l251 126q6 -89 -34 -156.5t-117 -110.5q-60 -34 -127 -39.5t-126 16.5l-596 -596q-15 -16 -36.5 -16t-36.5 16l-111 110q-15 15 -15 36.5t15 37.5l600 599q-34 101 5.5 201.5t135.5 154.5z" />
<glyph unicode="&#xe137;" horiz-adv-x="1220" d="M100 1196h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 1096h-200v-100h200v100zM100 796h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 696h-500v-100h500v100zM100 396h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 296h-300v-100h300v100z " />
<glyph unicode="&#xe138;" d="M150 1200h900q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM700 500v-300l-200 -200v500l-350 500h900z" />
<glyph unicode="&#xe139;" d="M500 1200h200q41 0 70.5 -29.5t29.5 -70.5v-100h300q41 0 70.5 -29.5t29.5 -70.5v-400h-500v100h-200v-100h-500v400q0 41 29.5 70.5t70.5 29.5h300v100q0 41 29.5 70.5t70.5 29.5zM500 1100v-100h200v100h-200zM1200 400v-200q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v200h1200z" />
<glyph unicode="&#xe140;" d="M50 1200h300q21 0 25 -10.5t-10 -24.5l-94 -94l199 -199q7 -8 7 -18t-7 -18l-106 -106q-8 -7 -18 -7t-18 7l-199 199l-94 -94q-14 -14 -24.5 -10t-10.5 25v300q0 21 14.5 35.5t35.5 14.5zM850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-199 -199q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l199 199l-94 94q-14 14 -10 24.5t25 10.5zM364 470l106 -106q7 -8 7 -18t-7 -18l-199 -199l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l199 199 q8 7 18 7t18 -7zM1071 271l94 94q14 14 24.5 10t10.5 -25v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -25 10.5t10 24.5l94 94l-199 199q-7 8 -7 18t7 18l106 106q8 7 18 7t18 -7z" />
<glyph unicode="&#xe141;" d="M596 1192q121 0 231.5 -47.5t190 -127t127 -190t47.5 -231.5t-47.5 -231.5t-127 -190.5t-190 -127t-231.5 -47t-231.5 47t-190.5 127t-127 190.5t-47 231.5t47 231.5t127 190t190.5 127t231.5 47.5zM596 1010q-112 0 -207.5 -55.5t-151 -151t-55.5 -207.5t55.5 -207.5 t151 -151t207.5 -55.5t207.5 55.5t151 151t55.5 207.5t-55.5 207.5t-151 151t-207.5 55.5zM454.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38.5 -16.5t-38.5 16.5t-16 39t16 38.5t38.5 16zM754.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38 -16.5q-14 0 -29 10l-55 -145 q17 -23 17 -51q0 -36 -25.5 -61.5t-61.5 -25.5t-61.5 25.5t-25.5 61.5q0 32 20.5 56.5t51.5 29.5l122 126l1 1q-9 14 -9 28q0 23 16 39t38.5 16zM345.5 709q22.5 0 38.5 -16t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16zM854.5 709q22.5 0 38.5 -16 t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16z" />
<glyph unicode="&#xe142;" d="M546 173l469 470q91 91 99 192q7 98 -52 175.5t-154 94.5q-22 4 -47 4q-34 0 -66.5 -10t-56.5 -23t-55.5 -38t-48 -41.5t-48.5 -47.5q-376 -375 -391 -390q-30 -27 -45 -41.5t-37.5 -41t-32 -46.5t-16 -47.5t-1.5 -56.5q9 -62 53.5 -95t99.5 -33q74 0 125 51l548 548 q36 36 20 75q-7 16 -21.5 26t-32.5 10q-26 0 -50 -23q-13 -12 -39 -38l-341 -338q-15 -15 -35.5 -15.5t-34.5 13.5t-14 34.5t14 34.5q327 333 361 367q35 35 67.5 51.5t78.5 16.5q14 0 29 -1q44 -8 74.5 -35.5t43.5 -68.5q14 -47 2 -96.5t-47 -84.5q-12 -11 -32 -32 t-79.5 -81t-114.5 -115t-124.5 -123.5t-123 -119.5t-96.5 -89t-57 -45q-56 -27 -120 -27q-70 0 -129 32t-93 89q-48 78 -35 173t81 163l511 511q71 72 111 96q91 55 198 55q80 0 152 -33q78 -36 129.5 -103t66.5 -154q17 -93 -11 -183.5t-94 -156.5l-482 -476 q-15 -15 -36 -16t-37 14t-17.5 34t14.5 35z" />
<glyph unicode="&#xe143;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104zM896 972q-33 0 -64.5 -19t-56.5 -46t-47.5 -53.5t-43.5 -45.5t-37.5 -19t-36 19t-40 45.5t-43 53.5t-54 46t-65.5 19q-67 0 -122.5 -55.5t-55.5 -132.5q0 -23 13.5 -51t46 -65t57.5 -63t76 -75l22 -22q15 -14 44 -44t50.5 -51t46 -44t41 -35t23 -12 t23.5 12t42.5 36t46 44t52.5 52t44 43q4 4 12 13q43 41 63.5 62t52 55t46 55t26 46t11.5 44q0 79 -53 133.5t-120 54.5z" />
<glyph unicode="&#xe144;" d="M776.5 1214q93.5 0 159.5 -66l141 -141q66 -66 66 -160q0 -42 -28 -95.5t-62 -87.5l-29 -29q-31 53 -77 99l-18 18l95 95l-247 248l-389 -389l212 -212l-105 -106l-19 18l-141 141q-66 66 -66 159t66 159l283 283q65 66 158.5 66zM600 706l105 105q10 -8 19 -17l141 -141 q66 -66 66 -159t-66 -159l-283 -283q-66 -66 -159 -66t-159 66l-141 141q-66 66 -66 159.5t66 159.5l55 55q29 -55 75 -102l18 -17l-95 -95l247 -248l389 389z" />
<glyph unicode="&#xe145;" d="M603 1200q85 0 162 -15t127 -38t79 -48t29 -46v-953q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-41 0 -70.5 29.5t-29.5 70.5v953q0 21 30 46.5t81 48t129 37.5t163 15zM300 1000v-700h600v700h-600zM600 254q-43 0 -73.5 -30.5t-30.5 -73.5t30.5 -73.5t73.5 -30.5t73.5 30.5 t30.5 73.5t-30.5 73.5t-73.5 30.5z" />
<glyph unicode="&#xe146;" d="M902 1185l283 -282q15 -15 15 -36t-14.5 -35.5t-35.5 -14.5t-35 15l-36 35l-279 -267v-300l-212 210l-308 -307l-280 -203l203 280l307 308l-210 212h300l267 279l-35 36q-15 14 -15 35t14.5 35.5t35.5 14.5t35 -15z" />
<glyph unicode="&#xe148;" d="M700 1248v-78q38 -5 72.5 -14.5t75.5 -31.5t71 -53.5t52 -84t24 -118.5h-159q-4 36 -10.5 59t-21 45t-40 35.5t-64.5 20.5v-307l64 -13q34 -7 64 -16.5t70 -32t67.5 -52.5t47.5 -80t20 -112q0 -139 -89 -224t-244 -97v-77h-100v79q-150 16 -237 103q-40 40 -52.5 93.5 t-15.5 139.5h139q5 -77 48.5 -126t117.5 -65v335l-27 8q-46 14 -79 26.5t-72 36t-63 52t-40 72.5t-16 98q0 70 25 126t67.5 92t94.5 57t110 27v77h100zM600 754v274q-29 -4 -50 -11t-42 -21.5t-31.5 -41.5t-10.5 -65q0 -29 7 -50.5t16.5 -34t28.5 -22.5t31.5 -14t37.5 -10 q9 -3 13 -4zM700 547v-310q22 2 42.5 6.5t45 15.5t41.5 27t29 42t12 59.5t-12.5 59.5t-38 44.5t-53 31t-66.5 24.5z" />
<glyph unicode="&#xe149;" d="M561 1197q84 0 160.5 -40t123.5 -109.5t47 -147.5h-153q0 40 -19.5 71.5t-49.5 48.5t-59.5 26t-55.5 9q-37 0 -79 -14.5t-62 -35.5q-41 -44 -41 -101q0 -26 13.5 -63t26.5 -61t37 -66q6 -9 9 -14h241v-100h-197q8 -50 -2.5 -115t-31.5 -95q-45 -62 -99 -112 q34 10 83 17.5t71 7.5q32 1 102 -16t104 -17q83 0 136 30l50 -147q-31 -19 -58 -30.5t-55 -15.5t-42 -4.5t-46 -0.5q-23 0 -76 17t-111 32.5t-96 11.5q-39 -3 -82 -16t-67 -25l-23 -11l-55 145q4 3 16 11t15.5 10.5t13 9t15.5 12t14.5 14t17.5 18.5q48 55 54 126.5 t-30 142.5h-221v100h166q-23 47 -44 104q-7 20 -12 41.5t-6 55.5t6 66.5t29.5 70.5t58.5 71q97 88 263 88z" />
<glyph unicode="&#xe150;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM935 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-900h-200v900h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe151;" d="M1000 700h-100v100h-100v-100h-100v500h300v-500zM400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM801 1100v-200h100v200h-100zM1000 350l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150z " />
<glyph unicode="&#xe152;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 1050l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150zM1000 0h-100v100h-100v-100h-100v500h300v-500zM801 400v-200h100v200h-100z " />
<glyph unicode="&#xe153;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 700h-100v400h-100v100h200v-500zM1100 0h-100v100h-200v400h300v-500zM901 400v-200h100v200h-100z" />
<glyph unicode="&#xe154;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1100 700h-100v100h-200v400h300v-500zM901 1100v-200h100v200h-100zM1000 0h-100v400h-100v100h200v-500z" />
<glyph unicode="&#xe155;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM900 1000h-200v200h200v-200zM1000 700h-300v200h300v-200zM1100 400h-400v200h400v-200zM1200 100h-500v200h500v-200z" />
<glyph unicode="&#xe156;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1200 1000h-500v200h500v-200zM1100 700h-400v200h400v-200zM1000 400h-300v200h300v-200zM900 100h-200v200h200v-200z" />
<glyph unicode="&#xe157;" d="M350 1100h400q162 0 256 -93.5t94 -256.5v-400q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5z" />
<glyph unicode="&#xe158;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-163 0 -256.5 92.5t-93.5 257.5v400q0 163 94 256.5t256 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM440 770l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe159;" d="M350 1100h400q163 0 256.5 -94t93.5 -256v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 163 92.5 256.5t257.5 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM350 700h400q21 0 26.5 -12t-6.5 -28l-190 -253q-12 -17 -30 -17t-30 17l-190 253q-12 16 -6.5 28t26.5 12z" />
<glyph unicode="&#xe160;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -163 -92.5 -256.5t-257.5 -93.5h-400q-163 0 -256.5 94t-93.5 256v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM580 693l190 -253q12 -16 6.5 -28t-26.5 -12h-400q-21 0 -26.5 12t6.5 28l190 253q12 17 30 17t30 -17z" />
<glyph unicode="&#xe161;" d="M550 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h450q41 0 70.5 29.5t29.5 70.5v500q0 41 -29.5 70.5t-70.5 29.5h-450q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM338 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe162;" d="M793 1182l9 -9q8 -10 5 -27q-3 -11 -79 -225.5t-78 -221.5l300 1q24 0 32.5 -17.5t-5.5 -35.5q-1 0 -133.5 -155t-267 -312.5t-138.5 -162.5q-12 -15 -26 -15h-9l-9 8q-9 11 -4 32q2 9 42 123.5t79 224.5l39 110h-302q-23 0 -31 19q-10 21 6 41q75 86 209.5 237.5 t228 257t98.5 111.5q9 16 25 16h9z" />
<glyph unicode="&#xe163;" d="M350 1100h400q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-450q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h450q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400 q0 165 92.5 257.5t257.5 92.5zM938 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe164;" d="M750 1200h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -10.5 -25t-24.5 10l-109 109l-312 -312q-15 -15 -35.5 -15t-35.5 15l-141 141q-15 15 -15 35.5t15 35.5l312 312l-109 109q-14 14 -10 24.5t25 10.5zM456 900h-156q-41 0 -70.5 -29.5t-29.5 -70.5v-500 q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v148l200 200v-298q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5h300z" />
<glyph unicode="&#xe165;" d="M600 1186q119 0 227.5 -46.5t187 -125t125 -187t46.5 -227.5t-46.5 -227.5t-125 -187t-187 -125t-227.5 -46.5t-227.5 46.5t-187 125t-125 187t-46.5 227.5t46.5 227.5t125 187t187 125t227.5 46.5zM600 1022q-115 0 -212 -56.5t-153.5 -153.5t-56.5 -212t56.5 -212 t153.5 -153.5t212 -56.5t212 56.5t153.5 153.5t56.5 212t-56.5 212t-153.5 153.5t-212 56.5zM600 794q80 0 137 -57t57 -137t-57 -137t-137 -57t-137 57t-57 137t57 137t137 57z" />
<glyph unicode="&#xe166;" d="M450 1200h200q21 0 35.5 -14.5t14.5 -35.5v-350h245q20 0 25 -11t-9 -26l-383 -426q-14 -15 -33.5 -15t-32.5 15l-379 426q-13 15 -8.5 26t25.5 11h250v350q0 21 14.5 35.5t35.5 14.5zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe167;" d="M583 1182l378 -435q14 -15 9 -31t-26 -16h-244v-250q0 -20 -17 -35t-39 -15h-200q-20 0 -32 14.5t-12 35.5v250h-250q-20 0 -25.5 16.5t8.5 31.5l383 431q14 16 33.5 17t33.5 -14zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe168;" d="M396 723l369 369q7 7 17.5 7t17.5 -7l139 -139q7 -8 7 -18.5t-7 -17.5l-525 -525q-7 -8 -17.5 -8t-17.5 8l-292 291q-7 8 -7 18t7 18l139 139q8 7 18.5 7t17.5 -7zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50 h-100z" />
<glyph unicode="&#xe169;" d="M135 1023l142 142q14 14 35 14t35 -14l77 -77l-212 -212l-77 76q-14 15 -14 36t14 35zM655 855l210 210q14 14 24.5 10t10.5 -25l-2 -599q-1 -20 -15.5 -35t-35.5 -15l-597 -1q-21 0 -25 10.5t10 24.5l208 208l-154 155l212 212zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5 v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe170;" d="M350 1200l599 -2q20 -1 35 -15.5t15 -35.5l1 -597q0 -21 -10.5 -25t-24.5 10l-208 208l-155 -154l-212 212l155 154l-210 210q-14 14 -10 24.5t25 10.5zM524 512l-76 -77q-15 -14 -36 -14t-35 14l-142 142q-14 14 -14 35t14 35l77 77zM50 300h1000q21 0 35.5 -14.5 t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe171;" d="M1200 103l-483 276l-314 -399v423h-399l1196 796v-1096zM483 424v-230l683 953z" />
<glyph unicode="&#xe172;" d="M1100 1000v-850q0 -21 -14.5 -35.5t-35.5 -14.5h-150v400h-700v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200z" />
<glyph unicode="&#xe173;" d="M1100 1000l-2 -149l-299 -299l-95 95q-9 9 -21.5 9t-21.5 -9l-149 -147h-312v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1132 638l106 -106q7 -7 7 -17.5t-7 -17.5l-420 -421q-8 -7 -18 -7 t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l297 297q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe174;" d="M1100 1000v-269l-103 -103l-134 134q-15 15 -33.5 16.5t-34.5 -12.5l-266 -266h-329v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1202 572l70 -70q15 -15 15 -35.5t-15 -35.5l-131 -131 l131 -131q15 -15 15 -35.5t-15 -35.5l-70 -70q-15 -15 -35.5 -15t-35.5 15l-131 131l-131 -131q-15 -15 -35.5 -15t-35.5 15l-70 70q-15 15 -15 35.5t15 35.5l131 131l-131 131q-15 15 -15 35.5t15 35.5l70 70q15 15 35.5 15t35.5 -15l131 -131l131 131q15 15 35.5 15 t35.5 -15z" />
<glyph unicode="&#xe175;" d="M1100 1000v-300h-350q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-500v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM850 600h100q21 0 35.5 -14.5t14.5 -35.5v-250h150q21 0 25 -10.5t-10 -24.5 l-230 -230q-14 -14 -35 -14t-35 14l-230 230q-14 14 -10 24.5t25 10.5h150v250q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe176;" d="M1100 1000v-400l-165 165q-14 15 -35 15t-35 -15l-263 -265h-402v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM935 565l230 -229q14 -15 10 -25.5t-25 -10.5h-150v-250q0 -20 -14.5 -35 t-35.5 -15h-100q-21 0 -35.5 15t-14.5 35v250h-150q-21 0 -25 10.5t10 25.5l230 229q14 15 35 15t35 -15z" />
<glyph unicode="&#xe177;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-150h-1200v150q0 21 14.5 35.5t35.5 14.5zM1200 800v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v550h1200zM100 500v-200h400v200h-400z" />
<glyph unicode="&#xe178;" d="M935 1165l248 -230q14 -14 14 -35t-14 -35l-248 -230q-14 -14 -24.5 -10t-10.5 25v150h-400v200h400v150q0 21 10.5 25t24.5 -10zM200 800h-50q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v-200zM400 800h-100v200h100v-200zM18 435l247 230 q14 14 24.5 10t10.5 -25v-150h400v-200h-400v-150q0 -21 -10.5 -25t-24.5 10l-247 230q-15 14 -15 35t15 35zM900 300h-100v200h100v-200zM1000 500h51q20 0 34.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-34.5 -14.5h-51v200z" />
<glyph unicode="&#xe179;" d="M862 1073l276 116q25 18 43.5 8t18.5 -41v-1106q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v397q-4 1 -11 5t-24 17.5t-30 29t-24 42t-11 56.5v359q0 31 18.5 65t43.5 52zM550 1200q22 0 34.5 -12.5t14.5 -24.5l1 -13v-450q0 -28 -10.5 -59.5 t-25 -56t-29 -45t-25.5 -31.5l-10 -11v-447q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v447q-4 4 -11 11.5t-24 30.5t-30 46t-24 55t-11 60v450q0 2 0.5 5.5t4 12t8.5 15t14.5 12t22.5 5.5q20 0 32.5 -12.5t14.5 -24.5l3 -13v-350h100v350v5.5t2.5 12 t7 15t15 12t25.5 5.5q23 0 35.5 -12.5t13.5 -24.5l1 -13v-350h100v350q0 2 0.5 5.5t3 12t7 15t15 12t24.5 5.5z" />
<glyph unicode="&#xe180;" d="M1200 1100v-56q-4 0 -11 -0.5t-24 -3t-30 -7.5t-24 -15t-11 -24v-888q0 -22 25 -34.5t50 -13.5l25 -2v-56h-400v56q75 0 87.5 6.5t12.5 43.5v394h-500v-394q0 -37 12.5 -43.5t87.5 -6.5v-56h-400v56q4 0 11 0.5t24 3t30 7.5t24 15t11 24v888q0 22 -25 34.5t-50 13.5 l-25 2v56h400v-56q-75 0 -87.5 -6.5t-12.5 -43.5v-394h500v394q0 37 -12.5 43.5t-87.5 6.5v56h400z" />
<glyph unicode="&#xe181;" d="M675 1000h375q21 0 35.5 -14.5t14.5 -35.5v-150h-105l-295 -98v98l-200 200h-400l100 100h375zM100 900h300q41 0 70.5 -29.5t29.5 -70.5v-500q0 -41 -29.5 -70.5t-70.5 -29.5h-300q-41 0 -70.5 29.5t-29.5 70.5v500q0 41 29.5 70.5t70.5 29.5zM100 800v-200h300v200 h-300zM1100 535l-400 -133v163l400 133v-163zM100 500v-200h300v200h-300zM1100 398v-248q0 -21 -14.5 -35.5t-35.5 -14.5h-375l-100 -100h-375l-100 100h400l200 200h105z" />
<glyph unicode="&#xe182;" d="M17 1007l162 162q17 17 40 14t37 -22l139 -194q14 -20 11 -44.5t-20 -41.5l-119 -118q102 -142 228 -268t267 -227l119 118q17 17 42.5 19t44.5 -12l192 -136q19 -14 22.5 -37.5t-13.5 -40.5l-163 -162q-3 -1 -9.5 -1t-29.5 2t-47.5 6t-62.5 14.5t-77.5 26.5t-90 42.5 t-101.5 60t-111 83t-119 108.5q-74 74 -133.5 150.5t-94.5 138.5t-60 119.5t-34.5 100t-15 74.5t-4.5 48z" />
<glyph unicode="&#xe183;" d="M600 1100q92 0 175 -10.5t141.5 -27t108.5 -36.5t81.5 -40t53.5 -37t31 -27l9 -10v-200q0 -21 -14.5 -33t-34.5 -9l-202 34q-20 3 -34.5 20t-14.5 38v146q-141 24 -300 24t-300 -24v-146q0 -21 -14.5 -38t-34.5 -20l-202 -34q-20 -3 -34.5 9t-14.5 33v200q3 4 9.5 10.5 t31 26t54 37.5t80.5 39.5t109 37.5t141 26.5t175 10.5zM600 795q56 0 97 -9.5t60 -23.5t30 -28t12 -24l1 -10v-50l365 -303q14 -15 24.5 -40t10.5 -45v-212q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v212q0 20 10.5 45t24.5 40l365 303v50 q0 4 1 10.5t12 23t30 29t60 22.5t97 10z" />
<glyph unicode="&#xe184;" d="M1100 700l-200 -200h-600l-200 200v500h200v-200h200v200h200v-200h200v200h200v-500zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5 t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe185;" d="M700 1100h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-1000h300v1000q0 41 -29.5 70.5t-70.5 29.5zM1100 800h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-700h300v700q0 41 -29.5 70.5t-70.5 29.5zM400 0h-300v400q0 41 29.5 70.5t70.5 29.5h100q41 0 70.5 -29.5t29.5 -70.5v-400z " />
<glyph unicode="&#xe186;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe187;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 300h-100v200h-100v-200h-100v500h100v-200h100v200h100v-500zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe188;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-300h200v-100h-300v500h300v-100zM900 700h-200v-300h200v-100h-300v500h300v-100z" />
<glyph unicode="&#xe189;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 400l-300 150l300 150v-300zM900 550l-300 -150v300z" />
<glyph unicode="&#xe190;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM900 300h-700v500h700v-500zM800 700h-130q-38 0 -66.5 -43t-28.5 -108t27 -107t68 -42h130v300zM300 700v-300 h130q41 0 68 42t27 107t-28.5 108t-66.5 43h-130z" />
<glyph unicode="&#xe191;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 300h-100v400h-100v100h200v-500z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe192;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM300 700h200v-400h-300v500h100v-100zM900 300h-100v400h-100v100h200v-500zM300 600v-200h100v200h-100z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe193;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 500l-199 -200h-100v50l199 200v150h-200v100h300v-300zM900 300h-100v400h-100v100h200v-500zM701 300h-100 v100h100v-100z" />
<glyph unicode="&#xe194;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700h-300v-200h300v-100h-300l-100 100v200l100 100h300v-100z" />
<glyph unicode="&#xe195;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700v-100l-50 -50l100 -100v-50h-100l-100 100h-150v-100h-100v400h300zM500 700v-100h200v100h-200z" />
<glyph unicode="&#xe197;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -207t-85 -207t-205 -86.5h-128v250q0 21 -14.5 35.5t-35.5 14.5h-300q-21 0 -35.5 -14.5t-14.5 -35.5v-250h-222q-80 0 -136 57.5t-56 136.5q0 69 43 122.5t108 67.5q-2 19 -2 37q0 100 49 185 t134 134t185 49zM525 500h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -244q-13 -16 -32 -16t-32 16l-223 244q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe198;" d="M502 1089q110 0 201 -59.5t135 -156.5q43 15 89 15q121 0 206 -86.5t86 -206.5q0 -99 -60 -181t-150 -110l-378 360q-13 16 -31.5 16t-31.5 -16l-381 -365h-9q-79 0 -135.5 57.5t-56.5 136.5q0 69 43 122.5t108 67.5q-2 19 -2 38q0 100 49 184.5t133.5 134t184.5 49.5z M632 467l223 -228q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5q199 204 223 228q19 19 31.5 19t32.5 -19z" />
<glyph unicode="&#xe199;" d="M700 100v100h400l-270 300h170l-270 300h170l-300 333l-300 -333h170l-270 -300h170l-270 -300h400v-100h-50q-21 0 -35.5 -14.5t-14.5 -35.5v-50h400v50q0 21 -14.5 35.5t-35.5 14.5h-50z" />
<glyph unicode="&#xe200;" d="M600 1179q94 0 167.5 -56.5t99.5 -145.5q89 -6 150.5 -71.5t61.5 -155.5q0 -61 -29.5 -112.5t-79.5 -82.5q9 -29 9 -55q0 -74 -52.5 -126.5t-126.5 -52.5q-55 0 -100 30v-251q21 0 35.5 -14.5t14.5 -35.5v-50h-300v50q0 21 14.5 35.5t35.5 14.5v251q-45 -30 -100 -30 q-74 0 -126.5 52.5t-52.5 126.5q0 18 4 38q-47 21 -75.5 65t-28.5 97q0 74 52.5 126.5t126.5 52.5q5 0 23 -2q0 2 -1 10t-1 13q0 116 81.5 197.5t197.5 81.5z" />
<glyph unicode="&#xe201;" d="M1010 1010q111 -111 150.5 -260.5t0 -299t-150.5 -260.5q-83 -83 -191.5 -126.5t-218.5 -43.5t-218.5 43.5t-191.5 126.5q-111 111 -150.5 260.5t0 299t150.5 260.5q83 83 191.5 126.5t218.5 43.5t218.5 -43.5t191.5 -126.5zM476 1065q-4 0 -8 -1q-121 -34 -209.5 -122.5 t-122.5 -209.5q-4 -12 2.5 -23t18.5 -14l36 -9q3 -1 7 -1q23 0 29 22q27 96 98 166q70 71 166 98q11 3 17.5 13.5t3.5 22.5l-9 35q-3 13 -14 19q-7 4 -15 4zM512 920q-4 0 -9 -2q-80 -24 -138.5 -82.5t-82.5 -138.5q-4 -13 2 -24t19 -14l34 -9q4 -1 8 -1q22 0 28 21 q18 58 58.5 98.5t97.5 58.5q12 3 18 13.5t3 21.5l-9 35q-3 12 -14 19q-7 4 -15 4zM719.5 719.5q-49.5 49.5 -119.5 49.5t-119.5 -49.5t-49.5 -119.5t49.5 -119.5t119.5 -49.5t119.5 49.5t49.5 119.5t-49.5 119.5zM855 551q-22 0 -28 -21q-18 -58 -58.5 -98.5t-98.5 -57.5 q-11 -4 -17 -14.5t-3 -21.5l9 -35q3 -12 14 -19q7 -4 15 -4q4 0 9 2q80 24 138.5 82.5t82.5 138.5q4 13 -2.5 24t-18.5 14l-34 9q-4 1 -8 1zM1000 515q-23 0 -29 -22q-27 -96 -98 -166q-70 -71 -166 -98q-11 -3 -17.5 -13.5t-3.5 -22.5l9 -35q3 -13 14 -19q7 -4 15 -4 q4 0 8 1q121 34 209.5 122.5t122.5 209.5q4 12 -2.5 23t-18.5 14l-36 9q-3 1 -7 1z" />
<glyph unicode="&#xe202;" d="M700 800h300v-380h-180v200h-340v-200h-380v755q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM700 300h162l-212 -212l-212 212h162v200h100v-200zM520 0h-395q-10 0 -17.5 7.5t-7.5 17.5v395zM1000 220v-195q0 -10 -7.5 -17.5t-17.5 -7.5h-195z" />
<glyph unicode="&#xe203;" d="M700 800h300v-520l-350 350l-550 -550v1095q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM862 200h-162v-200h-100v200h-162l212 212zM480 0h-355q-10 0 -17.5 7.5t-7.5 17.5v55h380v-80zM1000 80v-55q0 -10 -7.5 -17.5t-17.5 -7.5h-155v80h180z" />
<glyph unicode="&#xe204;" d="M1162 800h-162v-200h100l100 -100h-300v300h-162l212 212zM200 800h200q27 0 40 -2t29.5 -10.5t23.5 -30t7 -57.5h300v-100h-600l-200 -350v450h100q0 36 7 57.5t23.5 30t29.5 10.5t40 2zM800 400h240l-240 -400h-800l300 500h500v-100z" />
<glyph unicode="&#xe205;" d="M650 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM1000 850v150q41 0 70.5 -29.5t29.5 -70.5v-800 q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-1 0 -20 4l246 246l-326 326v324q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM412 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe206;" d="M450 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM800 850v150q41 0 70.5 -29.5t29.5 -70.5v-500 h-200v-300h200q0 -36 -7 -57.5t-23.5 -30t-29.5 -10.5t-40 -2h-600q-41 0 -70.5 29.5t-29.5 70.5v800q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM1212 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe209;" d="M658 1197l637 -1104q23 -38 7 -65.5t-60 -27.5h-1276q-44 0 -60 27.5t7 65.5l637 1104q22 39 54 39t54 -39zM704 800h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM500 300v-100h200 v100h-200z" />
<glyph unicode="&#xe210;" d="M425 1100h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM825 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM25 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5zM425 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5 v150q0 10 7.5 17.5t17.5 7.5zM25 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe211;" d="M700 1200h100v-200h-100v-100h350q62 0 86.5 -39.5t-3.5 -94.5l-66 -132q-41 -83 -81 -134h-772q-40 51 -81 134l-66 132q-28 55 -3.5 94.5t86.5 39.5h350v100h-100v200h100v100h200v-100zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100 h-950l138 100h-13q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe212;" d="M600 1300q40 0 68.5 -29.5t28.5 -70.5h-194q0 41 28.5 70.5t68.5 29.5zM443 1100h314q18 -37 18 -75q0 -8 -3 -25h328q41 0 44.5 -16.5t-30.5 -38.5l-175 -145h-678l-178 145q-34 22 -29 38.5t46 16.5h328q-3 17 -3 25q0 38 18 75zM250 700h700q21 0 35.5 -14.5 t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-150v-200l275 -200h-950l275 200v200h-150q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe213;" d="M600 1181q75 0 128 -53t53 -128t-53 -128t-128 -53t-128 53t-53 128t53 128t128 53zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13 l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe214;" d="M600 1300q47 0 92.5 -53.5t71 -123t25.5 -123.5q0 -78 -55.5 -133.5t-133.5 -55.5t-133.5 55.5t-55.5 133.5q0 62 34 143l144 -143l111 111l-163 163q34 26 63 26zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45 zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe215;" d="M600 1200l300 -161v-139h-300q0 -57 18.5 -108t50 -91.5t63 -72t70 -67.5t57.5 -61h-530q-60 83 -90.5 177.5t-30.5 178.5t33 164.5t87.5 139.5t126 96.5t145.5 41.5v-98zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100 h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe216;" d="M600 1300q41 0 70.5 -29.5t29.5 -70.5v-78q46 -26 73 -72t27 -100v-50h-400v50q0 54 27 100t73 72v78q0 41 29.5 70.5t70.5 29.5zM400 800h400q54 0 100 -27t72 -73h-172v-100h200v-100h-200v-100h200v-100h-200v-100h200q0 -83 -58.5 -141.5t-141.5 -58.5h-400 q-83 0 -141.5 58.5t-58.5 141.5v400q0 83 58.5 141.5t141.5 58.5z" />
<glyph unicode="&#xe218;" d="M150 1100h900q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM125 400h950q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-283l224 -224q13 -13 13 -31.5t-13 -32 t-31.5 -13.5t-31.5 13l-88 88h-524l-87 -88q-13 -13 -32 -13t-32 13.5t-13 32t13 31.5l224 224h-289q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM541 300l-100 -100h324l-100 100h-124z" />
<glyph unicode="&#xe219;" d="M200 1100h800q83 0 141.5 -58.5t58.5 -141.5v-200h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100v200q0 83 58.5 141.5t141.5 58.5zM100 600h1000q41 0 70.5 -29.5 t29.5 -70.5v-300h-1200v300q0 41 29.5 70.5t70.5 29.5zM300 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200zM1100 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200z" />
<glyph unicode="&#xe221;" d="M480 1165l682 -683q31 -31 31 -75.5t-31 -75.5l-131 -131h-481l-517 518q-32 31 -32 75.5t32 75.5l295 296q31 31 75.5 31t76.5 -31zM108 794l342 -342l303 304l-341 341zM250 100h800q21 0 35.5 -14.5t14.5 -35.5v-50h-900v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe223;" d="M1057 647l-189 506q-8 19 -27.5 33t-40.5 14h-400q-21 0 -40.5 -14t-27.5 -33l-189 -506q-8 -19 1.5 -33t30.5 -14h625v-150q0 -21 14.5 -35.5t35.5 -14.5t35.5 14.5t14.5 35.5v150h125q21 0 30.5 14t1.5 33zM897 0h-595v50q0 21 14.5 35.5t35.5 14.5h50v50 q0 21 14.5 35.5t35.5 14.5h48v300h200v-300h47q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-50z" />
<glyph unicode="&#xe224;" d="M900 800h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-375v591l-300 300v84q0 10 7.5 17.5t17.5 7.5h375v-400zM1200 900h-200v200zM400 600h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-650q-10 0 -17.5 7.5t-7.5 17.5v950q0 10 7.5 17.5t17.5 7.5h375v-400zM700 700h-200v200z " />
<glyph unicode="&#xe225;" d="M484 1095h195q75 0 146 -32.5t124 -86t89.5 -122.5t48.5 -142q18 -14 35 -20q31 -10 64.5 6.5t43.5 48.5q10 34 -15 71q-19 27 -9 43q5 8 12.5 11t19 -1t23.5 -16q41 -44 39 -105q-3 -63 -46 -106.5t-104 -43.5h-62q-7 -55 -35 -117t-56 -100l-39 -234q-3 -20 -20 -34.5 t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l12 70q-49 -14 -91 -14h-195q-24 0 -65 8l-11 -64q-3 -20 -20 -34.5t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l26 157q-84 74 -128 175l-159 53q-19 7 -33 26t-14 40v50q0 21 14.5 35.5t35.5 14.5h124q11 87 56 166l-111 95 q-16 14 -12.5 23.5t24.5 9.5h203q116 101 250 101zM675 1000h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h250q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe226;" d="M641 900l423 247q19 8 42 2.5t37 -21.5l32 -38q14 -15 12.5 -36t-17.5 -34l-139 -120h-390zM50 1100h106q67 0 103 -17t66 -71l102 -212h823q21 0 35.5 -14.5t14.5 -35.5v-50q0 -21 -14 -40t-33 -26l-737 -132q-23 -4 -40 6t-26 25q-42 67 -100 67h-300q-62 0 -106 44 t-44 106v200q0 62 44 106t106 44zM173 928h-80q-19 0 -28 -14t-9 -35v-56q0 -51 42 -51h134q16 0 21.5 8t5.5 24q0 11 -16 45t-27 51q-18 28 -43 28zM550 727q-32 0 -54.5 -22.5t-22.5 -54.5t22.5 -54.5t54.5 -22.5t54.5 22.5t22.5 54.5t-22.5 54.5t-54.5 22.5zM130 389 l152 130q18 19 34 24t31 -3.5t24.5 -17.5t25.5 -28q28 -35 50.5 -51t48.5 -13l63 5l48 -179q13 -61 -3.5 -97.5t-67.5 -79.5l-80 -69q-47 -40 -109 -35.5t-103 51.5l-130 151q-40 47 -35.5 109.5t51.5 102.5zM380 377l-102 -88q-31 -27 2 -65l37 -43q13 -15 27.5 -19.5 t31.5 6.5l61 53q19 16 14 49q-2 20 -12 56t-17 45q-11 12 -19 14t-23 -8z" />
<glyph unicode="&#xe227;" d="M625 1200h150q10 0 17.5 -7.5t7.5 -17.5v-109q79 -33 131 -87.5t53 -128.5q1 -46 -15 -84.5t-39 -61t-46 -38t-39 -21.5l-17 -6q6 0 15 -1.5t35 -9t50 -17.5t53 -30t50 -45t35.5 -64t14.5 -84q0 -59 -11.5 -105.5t-28.5 -76.5t-44 -51t-49.5 -31.5t-54.5 -16t-49.5 -6.5 t-43.5 -1v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-100v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-175q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v600h-75q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5h175v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h100v75q0 10 7.5 17.5t17.5 7.5zM400 900v-200h263q28 0 48.5 10.5t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-263zM400 500v-200h363q28 0 48.5 10.5 t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-363z" />
<glyph unicode="&#xe230;" d="M212 1198h780q86 0 147 -61t61 -147v-416q0 -51 -18 -142.5t-36 -157.5l-18 -66q-29 -87 -93.5 -146.5t-146.5 -59.5h-572q-82 0 -147 59t-93 147q-8 28 -20 73t-32 143.5t-20 149.5v416q0 86 61 147t147 61zM600 1045q-70 0 -132.5 -11.5t-105.5 -30.5t-78.5 -41.5 t-57 -45t-36 -41t-20.5 -30.5l-6 -12l156 -243h560l156 243q-2 5 -6 12.5t-20 29.5t-36.5 42t-57 44.5t-79 42t-105 29.5t-132.5 12zM762 703h-157l195 261z" />
<glyph unicode="&#xe231;" d="M475 1300h150q103 0 189 -86t86 -189v-500q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe232;" d="M475 1300h96q0 -150 89.5 -239.5t239.5 -89.5v-446q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe233;" d="M1294 767l-638 -283l-378 170l-78 -60v-224l100 -150v-199l-150 148l-150 -149v200l100 150v250q0 4 -0.5 10.5t0 9.5t1 8t3 8t6.5 6l47 40l-147 65l642 283zM1000 380l-350 -166l-350 166v147l350 -165l350 165v-147z" />
<glyph unicode="&#xe234;" d="M250 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM650 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM1050 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe235;" d="M550 1100q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 700q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 300q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe236;" d="M125 1100h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM125 700h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM125 300h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe237;" d="M350 1200h500q162 0 256 -93.5t94 -256.5v-500q0 -165 -93.5 -257.5t-256.5 -92.5h-500q-165 0 -257.5 92.5t-92.5 257.5v500q0 165 92.5 257.5t257.5 92.5zM900 1000h-600q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h600q41 0 70.5 29.5 t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5zM350 900h500q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-500q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 14.5 35.5t35.5 14.5zM400 800v-200h400v200h-400z" />
<glyph unicode="&#xe238;" d="M150 1100h1000q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe239;" d="M650 1187q87 -67 118.5 -156t0 -178t-118.5 -155q-87 66 -118.5 155t0 178t118.5 156zM300 800q124 0 212 -88t88 -212q-124 0 -212 88t-88 212zM1000 800q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM300 500q124 0 212 -88t88 -212q-124 0 -212 88t-88 212z M1000 500q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM700 199v-144q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v142q40 -4 43 -4q17 0 57 6z" />
<glyph unicode="&#xe240;" d="M745 878l69 19q25 6 45 -12l298 -295q11 -11 15 -26.5t-2 -30.5q-5 -14 -18 -23.5t-28 -9.5h-8q1 0 1 -13q0 -29 -2 -56t-8.5 -62t-20 -63t-33 -53t-51 -39t-72.5 -14h-146q-184 0 -184 288q0 24 10 47q-20 4 -62 4t-63 -4q11 -24 11 -47q0 -288 -184 -288h-142 q-48 0 -84.5 21t-56 51t-32 71.5t-16 75t-3.5 68.5q0 13 2 13h-7q-15 0 -27.5 9.5t-18.5 23.5q-6 15 -2 30.5t15 25.5l298 296q20 18 46 11l76 -19q20 -5 30.5 -22.5t5.5 -37.5t-22.5 -31t-37.5 -5l-51 12l-182 -193h891l-182 193l-44 -12q-20 -5 -37.5 6t-22.5 31t6 37.5 t31 22.5z" />
<glyph unicode="&#xe241;" d="M1200 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM500 450h-25q0 15 -4 24.5t-9 14.5t-17 7.5t-20 3t-25 0.5h-100v-425q0 -11 12.5 -17.5t25.5 -7.5h12v-50h-200v50q50 0 50 25v425h-100q-17 0 -25 -0.5t-20 -3t-17 -7.5t-9 -14.5t-4 -24.5h-25v150h500v-150z" />
<glyph unicode="&#xe242;" d="M1000 300v50q-25 0 -55 32q-14 14 -25 31t-16 27l-4 11l-289 747h-69l-300 -754q-18 -35 -39 -56q-9 -9 -24.5 -18.5t-26.5 -14.5l-11 -5v-50h273v50q-49 0 -78.5 21.5t-11.5 67.5l69 176h293l61 -166q13 -34 -3.5 -66.5t-55.5 -32.5v-50h312zM412 691l134 342l121 -342 h-255zM1100 150v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe243;" d="M50 1200h1100q21 0 35.5 -14.5t14.5 -35.5v-1100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5zM611 1118h-70q-13 0 -18 -12l-299 -753q-17 -32 -35 -51q-18 -18 -56 -34q-12 -5 -12 -18v-50q0 -8 5.5 -14t14.5 -6 h273q8 0 14 6t6 14v50q0 8 -6 14t-14 6q-55 0 -71 23q-10 14 0 39l63 163h266l57 -153q11 -31 -6 -55q-12 -17 -36 -17q-8 0 -14 -6t-6 -14v-50q0 -8 6 -14t14 -6h313q8 0 14 6t6 14v50q0 7 -5.5 13t-13.5 7q-17 0 -42 25q-25 27 -40 63h-1l-288 748q-5 12 -19 12zM639 611 h-197l103 264z" />
<glyph unicode="&#xe244;" d="M1200 1100h-1200v100h1200v-100zM50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 1000h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM700 900v-300h300v300h-300z" />
<glyph unicode="&#xe245;" d="M50 1200h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 700h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM700 600v-300h300v300h-300zM1200 0h-1200v100h1200v-100z" />
<glyph unicode="&#xe246;" d="M50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-350h100v150q0 21 14.5 35.5t35.5 14.5h400q21 0 35.5 -14.5t14.5 -35.5v-150h100v-100h-100v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v150h-100v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM700 700v-300h300v300h-300z" />
<glyph unicode="&#xe247;" d="M100 0h-100v1200h100v-1200zM250 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM300 1000v-300h300v300h-300zM250 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe248;" d="M600 1100h150q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-100h450q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h350v100h-150q-21 0 -35.5 14.5 t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h150v100h100v-100zM400 1000v-300h300v300h-300z" />
<glyph unicode="&#xe249;" d="M1200 0h-100v1200h100v-1200zM550 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM600 1000v-300h300v300h-300zM50 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe250;" d="M865 565l-494 -494q-23 -23 -41 -23q-14 0 -22 13.5t-8 38.5v1000q0 25 8 38.5t22 13.5q18 0 41 -23l494 -494q14 -14 14 -35t-14 -35z" />
<glyph unicode="&#xe251;" d="M335 635l494 494q29 29 50 20.5t21 -49.5v-1000q0 -41 -21 -49.5t-50 20.5l-494 494q-14 14 -14 35t14 35z" />
<glyph unicode="&#xe252;" d="M100 900h1000q41 0 49.5 -21t-20.5 -50l-494 -494q-14 -14 -35 -14t-35 14l-494 494q-29 29 -20.5 50t49.5 21z" />
<glyph unicode="&#xe253;" d="M635 865l494 -494q29 -29 20.5 -50t-49.5 -21h-1000q-41 0 -49.5 21t20.5 50l494 494q14 14 35 14t35 -14z" />
<glyph unicode="&#xe254;" d="M700 741v-182l-692 -323v221l413 193l-413 193v221zM1200 0h-800v200h800v-200z" />
<glyph unicode="&#xe255;" d="M1200 900h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300zM0 700h50q0 21 4 37t9.5 26.5t18 17.5t22 11t28.5 5.5t31 2t37 0.5h100v-550q0 -22 -25 -34.5t-50 -13.5l-25 -2v-100h400v100q-4 0 -11 0.5t-24 3t-30 7t-24 15t-11 24.5v550h100q25 0 37 -0.5t31 -2 t28.5 -5.5t22 -11t18 -17.5t9.5 -26.5t4 -37h50v300h-800v-300z" />
<glyph unicode="&#xe256;" d="M800 700h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-100v-550q0 -22 25 -34.5t50 -14.5l25 -1v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v550h-100q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h800v-300zM1100 200h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300z" />
<glyph unicode="&#xe257;" d="M701 1098h160q16 0 21 -11t-7 -23l-464 -464l464 -464q12 -12 7 -23t-21 -11h-160q-13 0 -23 9l-471 471q-7 8 -7 18t7 18l471 471q10 9 23 9z" />
<glyph unicode="&#xe258;" d="M339 1098h160q13 0 23 -9l471 -471q7 -8 7 -18t-7 -18l-471 -471q-10 -9 -23 -9h-160q-16 0 -21 11t7 23l464 464l-464 464q-12 12 -7 23t21 11z" />
<glyph unicode="&#xe259;" d="M1087 882q11 -5 11 -21v-160q0 -13 -9 -23l-471 -471q-8 -7 -18 -7t-18 7l-471 471q-9 10 -9 23v160q0 16 11 21t23 -7l464 -464l464 464q12 12 23 7z" />
<glyph unicode="&#xe260;" d="M618 993l471 -471q9 -10 9 -23v-160q0 -16 -11 -21t-23 7l-464 464l-464 -464q-12 -12 -23 -7t-11 21v160q0 13 9 23l471 471q8 7 18 7t18 -7z" />
<glyph unicode="&#xf8ff;" d="M1000 1200q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM450 1000h100q21 0 40 -14t26 -33l79 -194q5 1 16 3q34 6 54 9.5t60 7t65.5 1t61 -10t56.5 -23t42.5 -42t29 -64t5 -92t-19.5 -121.5q-1 -7 -3 -19.5t-11 -50t-20.5 -73t-32.5 -81.5t-46.5 -83t-64 -70 t-82.5 -50q-13 -5 -42 -5t-65.5 2.5t-47.5 2.5q-14 0 -49.5 -3.5t-63 -3.5t-43.5 7q-57 25 -104.5 78.5t-75 111.5t-46.5 112t-26 90l-7 35q-15 63 -18 115t4.5 88.5t26 64t39.5 43.5t52 25.5t58.5 13t62.5 2t59.5 -4.5t55.5 -8l-147 192q-12 18 -5.5 30t27.5 12z" />
<glyph unicode="&#x1f511;" d="M250 1200h600q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-500l-255 -178q-19 -9 -32 -1t-13 29v650h-150q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM400 1100v-100h300v100h-300z" />
<glyph unicode="&#x1f6aa;" d="M250 1200h750q39 0 69.5 -40.5t30.5 -84.5v-933l-700 -117v950l600 125h-700v-1000h-100v1025q0 23 15.5 49t34.5 26zM500 525v-100l100 20v100z" />
</font>
</defs></svg> ) format('svg')}.glyphicon{position:relative;top:1px;display:inline-block;font-family:'Glyphicons Halflings';font-style:normal;font-weight:400;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.glyphicon-asterisk:before{content:"\2a"}.glyphicon-plus:before{content:"\2b"}.glyphicon-eur:before,.glyphicon-euro:before{content:"\20ac"}.glyphicon-minus:before{content:"\2212"}.glyphicon-cloud:before{content:"\2601"}.glyphicon-envelope:before{content:"\2709"}.glyphicon-pencil:before{content:"\270f"}.glyphicon-glass:before{content:"\e001"}.glyphicon-music:before{content:"\e002"}.glyphicon-search:before{content:"\e003"}.glyphicon-heart:before{content:"\e005"}.glyphicon-star:before{content:"\e006"}.glyphicon-star-empty:before{content:"\e007"}.glyphicon-user:before{content:"\e008"}.glyphicon-film:before{content:"\e009"}.glyphicon-th-large:before{content:"\e010"}.glyphicon-th:before{content:"\e011"}.glyphicon-th-list:before{content:"\e012"}.glyphicon-ok:before{content:"\e013"}.glyphicon-remove:before{content:"\e014"}.glyphicon-zoom-in:before{content:"\e015"}.glyphicon-zoom-out:before{content:"\e016"}.glyphicon-off:before{content:"\e017"}.glyphicon-signal:before{content:"\e018"}.glyphicon-cog:before{content:"\e019"}.glyphicon-trash:before{content:"\e020"}.glyphicon-home:before{content:"\e021"}.glyphicon-file:before{content:"\e022"}.glyphicon-time:before{content:"\e023"}.glyphicon-road:before{content:"\e024"}.glyphicon-download-alt:before{content:"\e025"}.glyphicon-download:before{content:"\e026"}.glyphicon-upload:before{content:"\e027"}.glyphicon-inbox:before{content:"\e028"}.glyphicon-play-circle:before{content:"\e029"}.glyphicon-repeat:before{content:"\e030"}.glyphicon-refresh:before{content:"\e031"}.glyphicon-list-alt:before{content:"\e032"}.glyphicon-lock:before{content:"\e033"}.glyphicon-flag:before{content:"\e034"}.glyphicon-headphones:before{content:"\e035"}.glyphicon-volume-off:before{content:"\e036"}.glyphicon-volume-down:before{content:"\e037"}.glyphicon-volume-up:before{content:"\e038"}.glyphicon-qrcode:before{content:"\e039"}.glyphicon-barcode:before{content:"\e040"}.glyphicon-tag:before{content:"\e041"}.glyphicon-tags:before{content:"\e042"}.glyphicon-book:before{content:"\e043"}.glyphicon-bookmark:before{content:"\e044"}.glyphicon-print:before{content:"\e045"}.glyphicon-camera:before{content:"\e046"}.glyphicon-font:before{content:"\e047"}.glyphicon-bold:before{content:"\e048"}.glyphicon-italic:before{content:"\e049"}.glyphicon-text-height:before{content:"\e050"}.glyphicon-text-width:before{content:"\e051"}.glyphicon-align-left:before{content:"\e052"}.glyphicon-align-center:before{content:"\e053"}.glyphicon-align-right:before{content:"\e054"}.glyphicon-align-justify:before{content:"\e055"}.glyphicon-list:before{content:"\e056"}.glyphicon-indent-left:before{content:"\e057"}.glyphicon-indent-right:before{content:"\e058"}.glyphicon-facetime-video:before{content:"\e059"}.glyphicon-picture:before{content:"\e060"}.glyphicon-map-marker:before{content:"\e062"}.glyphicon-adjust:before{content:"\e063"}.glyphicon-tint:before{content:"\e064"}.glyphicon-edit:before{content:"\e065"}.glyphicon-share:before{content:"\e066"}.glyphicon-check:before{content:"\e067"}.glyphicon-move:before{content:"\e068"}.glyphicon-step-backward:before{content:"\e069"}.glyphicon-fast-backward:before{content:"\e070"}.glyphicon-backward:before{content:"\e071"}.glyphicon-play:before{content:"\e072"}.glyphicon-pause:before{content:"\e073"}.glyphicon-stop:before{content:"\e074"}.glyphicon-forward:before{content:"\e075"}.glyphicon-fast-forward:before{content:"\e076"}.glyphicon-step-forward:before{content:"\e077"}.glyphicon-eject:before{content:"\e078"}.glyphicon-chevron-left:before{content:"\e079"}.glyphicon-chevron-right:before{content:"\e080"}.glyphicon-plus-sign:before{content:"\e081"}.glyphicon-minus-sign:before{content:"\e082"}.glyphicon-remove-sign:before{content:"\e083"}.glyphicon-ok-sign:before{content:"\e084"}.glyphicon-question-sign:before{content:"\e085"}.glyphicon-info-sign:before{content:"\e086"}.glyphicon-screenshot:before{content:"\e087"}.glyphicon-remove-circle:before{content:"\e088"}.glyphicon-ok-circle:before{content:"\e089"}.glyphicon-ban-circle:before{content:"\e090"}.glyphicon-arrow-left:before{content:"\e091"}.glyphicon-arrow-right:before{content:"\e092"}.glyphicon-arrow-up:before{content:"\e093"}.glyphicon-arrow-down:before{content:"\e094"}.glyphicon-share-alt:before{content:"\e095"}.glyphicon-resize-full:before{content:"\e096"}.glyphicon-resize-small:before{content:"\e097"}.glyphicon-exclamation-sign:before{content:"\e101"}.glyphicon-gift:before{content:"\e102"}.glyphicon-leaf:before{content:"\e103"}.glyphicon-fire:before{content:"\e104"}.glyphicon-eye-open:before{content:"\e105"}.glyphicon-eye-close:before{content:"\e106"}.glyphicon-warning-sign:before{content:"\e107"}.glyphicon-plane:before{content:"\e108"}.glyphicon-calendar:before{content:"\e109"}.glyphicon-random:before{content:"\e110"}.glyphicon-comment:before{content:"\e111"}.glyphicon-magnet:before{content:"\e112"}.glyphicon-chevron-up:before{content:"\e113"}.glyphicon-chevron-down:before{content:"\e114"}.glyphicon-retweet:before{content:"\e115"}.glyphicon-shopping-cart:before{content:"\e116"}.glyphicon-folder-close:before{content:"\e117"}.glyphicon-folder-open:before{content:"\e118"}.glyphicon-resize-vertical:before{content:"\e119"}.glyphicon-resize-horizontal:before{content:"\e120"}.glyphicon-hdd:before{content:"\e121"}.glyphicon-bullhorn:before{content:"\e122"}.glyphicon-bell:before{content:"\e123"}.glyphicon-certificate:before{content:"\e124"}.glyphicon-thumbs-up:before{content:"\e125"}.glyphicon-thumbs-down:before{content:"\e126"}.glyphicon-hand-right:before{content:"\e127"}.glyphicon-hand-left:before{content:"\e128"}.glyphicon-hand-up:before{content:"\e129"}.glyphicon-hand-down:before{content:"\e130"}.glyphicon-circle-arrow-right:before{content:"\e131"}.glyphicon-circle-arrow-left:before{content:"\e132"}.glyphicon-circle-arrow-up:before{content:"\e133"}.glyphicon-circle-arrow-down:before{content:"\e134"}.glyphicon-globe:before{content:"\e135"}.glyphicon-wrench:before{content:"\e136"}.glyphicon-tasks:before{content:"\e137"}.glyphicon-filter:before{content:"\e138"}.glyphicon-briefcase:before{content:"\e139"}.glyphicon-fullscreen:before{content:"\e140"}.glyphicon-dashboard:before{content:"\e141"}.glyphicon-paperclip:before{content:"\e142"}.glyphicon-heart-empty:before{content:"\e143"}.glyphicon-link:before{content:"\e144"}.glyphicon-phone:before{content:"\e145"}.glyphicon-pushpin:before{content:"\e146"}.glyphicon-usd:before{content:"\e148"}.glyphicon-gbp:before{content:"\e149"}.glyphicon-sort:before{content:"\e150"}.glyphicon-sort-by-alphabet:before{content:"\e151"}.glyphicon-sort-by-alphabet-alt:before{content:"\e152"}.glyphicon-sort-by-order:before{content:"\e153"}.glyphicon-sort-by-order-alt:before{content:"\e154"}.glyphicon-sort-by-attributes:before{content:"\e155"}.glyphicon-sort-by-attributes-alt:before{content:"\e156"}.glyphicon-unchecked:before{content:"\e157"}.glyphicon-expand:before{content:"\e158"}.glyphicon-collapse-down:before{content:"\e159"}.glyphicon-collapse-up:before{content:"\e160"}.glyphicon-log-in:before{content:"\e161"}.glyphicon-flash:before{content:"\e162"}.glyphicon-log-out:before{content:"\e163"}.glyphicon-new-window:before{content:"\e164"}.glyphicon-record:before{content:"\e165"}.glyphicon-save:before{content:"\e166"}.glyphicon-open:before{content:"\e167"}.glyphicon-saved:before{content:"\e168"}.glyphicon-import:before{content:"\e169"}.glyphicon-export:before{content:"\e170"}.glyphicon-send:before{content:"\e171"}.glyphicon-floppy-disk:before{content:"\e172"}.glyphicon-floppy-saved:before{content:"\e173"}.glyphicon-floppy-remove:before{content:"\e174"}.glyphicon-floppy-save:before{content:"\e175"}.glyphicon-floppy-open:before{content:"\e176"}.glyphicon-credit-card:before{content:"\e177"}.glyphicon-transfer:before{content:"\e178"}.glyphicon-cutlery:before{content:"\e179"}.glyphicon-header:before{content:"\e180"}.glyphicon-compressed:before{content:"\e181"}.glyphicon-earphone:before{content:"\e182"}.glyphicon-phone-alt:before{content:"\e183"}.glyphicon-tower:before{content:"\e184"}.glyphicon-stats:before{content:"\e185"}.glyphicon-sd-video:before{content:"\e186"}.glyphicon-hd-video:before{content:"\e187"}.glyphicon-subtitles:before{content:"\e188"}.glyphicon-sound-stereo:before{content:"\e189"}.glyphicon-sound-dolby:before{content:"\e190"}.glyphicon-sound-5-1:before{content:"\e191"}.glyphicon-sound-6-1:before{content:"\e192"}.glyphicon-sound-7-1:before{content:"\e193"}.glyphicon-copyright-mark:before{content:"\e194"}.glyphicon-registration-mark:before{content:"\e195"}.glyphicon-cloud-download:before{content:"\e197"}.glyphicon-cloud-upload:before{content:"\e198"}.glyphicon-tree-conifer:before{content:"\e199"}.glyphicon-tree-deciduous:before{content:"\e200"}.glyphicon-cd:before{content:"\e201"}.glyphicon-save-file:before{content:"\e202"}.glyphicon-open-file:before{content:"\e203"}.glyphicon-level-up:before{content:"\e204"}.glyphicon-copy:before{content:"\e205"}.glyphicon-paste:before{content:"\e206"}.glyphicon-alert:before{content:"\e209"}.glyphicon-equalizer:before{content:"\e210"}.glyphicon-king:before{content:"\e211"}.glyphicon-queen:before{content:"\e212"}.glyphicon-pawn:before{content:"\e213"}.glyphicon-bishop:before{content:"\e214"}.glyphicon-knight:before{content:"\e215"}.glyphicon-baby-formula:before{content:"\e216"}.glyphicon-tent:before{content:"\26fa"}.glyphicon-blackboard:before{content:"\e218"}.glyphicon-bed:before{content:"\e219"}.glyphicon-apple:before{content:"\f8ff"}.glyphicon-erase:before{content:"\e221"}.glyphicon-hourglass:before{content:"\231b"}.glyphicon-lamp:before{content:"\e223"}.glyphicon-duplicate:before{content:"\e224"}.glyphicon-piggy-bank:before{content:"\e225"}.glyphicon-scissors:before{content:"\e226"}.glyphicon-bitcoin:before{content:"\e227"}.glyphicon-btc:before{content:"\e227"}.glyphicon-xbt:before{content:"\e227"}.glyphicon-yen:before{content:"\00a5"}.glyphicon-jpy:before{content:"\00a5"}.glyphicon-ruble:before{content:"\20bd"}.glyphicon-rub:before{content:"\20bd"}.glyphicon-scale:before{content:"\e230"}.glyphicon-ice-lolly:before{content:"\e231"}.glyphicon-ice-lolly-tasted:before{content:"\e232"}.glyphicon-education:before{content:"\e233"}.glyphicon-option-horizontal:before{content:"\e234"}.glyphicon-option-vertical:before{content:"\e235"}.glyphicon-menu-hamburger:before{content:"\e236"}.glyphicon-modal-window:before{content:"\e237"}.glyphicon-oil:before{content:"\e238"}.glyphicon-grain:before{content:"\e239"}.glyphicon-sunglasses:before{content:"\e240"}.glyphicon-text-size:before{content:"\e241"}.glyphicon-text-color:before{content:"\e242"}.glyphicon-text-background:before{content:"\e243"}.glyphicon-object-align-top:before{content:"\e244"}.glyphicon-object-align-bottom:before{content:"\e245"}.glyphicon-object-align-horizontal:before{content:"\e246"}.glyphicon-object-align-left:before{content:"\e247"}.glyphicon-object-align-vertical:before{content:"\e248"}.glyphicon-object-align-right:before{content:"\e249"}.glyphicon-triangle-right:before{content:"\e250"}.glyphicon-triangle-left:before{content:"\e251"}.glyphicon-triangle-bottom:before{content:"\e252"}.glyphicon-triangle-top:before{content:"\e253"}.glyphicon-console:before{content:"\e254"}.glyphicon-superscript:before{content:"\e255"}.glyphicon-subscript:before{content:"\e256"}.glyphicon-menu-left:before{content:"\e257"}.glyphicon-menu-right:before{content:"\e258"}.glyphicon-menu-down:before{content:"\e259"}.glyphicon-menu-up:before{content:"\e260"}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:rgba(0,0,0,0)}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}button,input,select,textarea{font-family:inherit;font-size:inherit;line-height:inherit}a{color:#337ab7;text-decoration:none}a:focus,a:hover{color:#23527c;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}figure{margin:0}img{vertical-align:middle}.carousel-inner>.item>a>img,.carousel-inner>.item>img,.img-responsive,.thumbnail a>img,.thumbnail>img{display:block;max-width:100%;height:auto}.img-rounded{border-radius:6px}.img-thumbnail{display:inline-block;max-width:100%;height:auto;padding:4px;line-height:1.42857143;background-color:#fff;border:1px solid #ddd;border-radius:4px;-webkit-transition:all .2s ease-in-out;-o-transition:all .2s ease-in-out;transition:all .2s ease-in-out}.img-circle{border-radius:50%}hr{margin-top:20px;margin-bottom:20px;border:0;border-top:1px solid #eee}.sr-only{position:absolute;width:1px;height:1px;padding:0;margin:-1px;overflow:hidden;clip:rect(0,0,0,0);border:0}.sr-only-focusable:active,.sr-only-focusable:focus{position:static;width:auto;height:auto;margin:0;overflow:visible;clip:auto}[role=button]{cursor:pointer}.h1,.h2,.h3,.h4,.h5,.h6,h1,h2,h3,h4,h5,h6{font-family:inherit;font-weight:500;line-height:1.1;color:inherit}.h1 .small,.h1 small,.h2 .small,.h2 small,.h3 .small,.h3 small,.h4 .small,.h4 small,.h5 .small,.h5 small,.h6 .small,.h6 small,h1 .small,h1 small,h2 .small,h2 small,h3 .small,h3 small,h4 .small,h4 small,h5 .small,h5 small,h6 .small,h6 small{font-weight:400;line-height:1;color:#777}.h1,.h2,.h3,h1,h2,h3{margin-top:20px;margin-bottom:10px}.h1 .small,.h1 small,.h2 .small,.h2 small,.h3 .small,.h3 small,h1 .small,h1 small,h2 .small,h2 small,h3 .small,h3 small{font-size:65%}.h4,.h5,.h6,h4,h5,h6{margin-top:10px;margin-bottom:10px}.h4 .small,.h4 small,.h5 .small,.h5 small,.h6 .small,.h6 small,h4 .small,h4 small,h5 .small,h5 small,h6 .small,h6 small{font-size:75%}.h1,h1{font-size:36px}.h2,h2{font-size:30px}.h3,h3{font-size:24px}.h4,h4{font-size:18px}.h5,h5{font-size:14px}.h6,h6{font-size:12px}p{margin:0 0 10px}.lead{margin-bottom:20px;font-size:16px;font-weight:300;line-height:1.4}@media (min-width:768px){.lead{font-size:21px}}.small,small{font-size:85%}.mark,mark{padding:.2em;background-color:#fcf8e3}.text-left{text-align:left}.text-right{text-align:right}.text-center{text-align:center}.text-justify{text-align:justify}.text-nowrap{white-space:nowrap}.text-lowercase{text-transform:lowercase}.text-uppercase{text-transform:uppercase}.text-capitalize{text-transform:capitalize}.text-muted{color:#777}.text-primary{color:#337ab7}a.text-primary:focus,a.text-primary:hover{color:#286090}.text-success{color:#3c763d}a.text-success:focus,a.text-success:hover{color:#2b542c}.text-info{color:#31708f}a.text-info:focus,a.text-info:hover{color:#245269}.text-warning{color:#8a6d3b}a.text-warning:focus,a.text-warning:hover{color:#66512c}.text-danger{color:#a94442}a.text-danger:focus,a.text-danger:hover{color:#843534}.bg-primary{color:#fff;background-color:#337ab7}a.bg-primary:focus,a.bg-primary:hover{background-color:#286090}.bg-success{background-color:#dff0d8}a.bg-success:focus,a.bg-success:hover{background-color:#c1e2b3}.bg-info{background-color:#d9edf7}a.bg-info:focus,a.bg-info:hover{background-color:#afd9ee}.bg-warning{background-color:#fcf8e3}a.bg-warning:focus,a.bg-warning:hover{background-color:#f7ecb5}.bg-danger{background-color:#f2dede}a.bg-danger:focus,a.bg-danger:hover{background-color:#e4b9b9}.page-header{padding-bottom:9px;margin:40px 0 20px;border-bottom:1px solid #eee}ol,ul{margin-top:0;margin-bottom:10px}ol ol,ol ul,ul ol,ul ul{margin-bottom:0}.list-unstyled{padding-left:0;list-style:none}.list-inline{padding-left:0;margin-left:-5px;list-style:none}.list-inline>li{display:inline-block;padding-right:5px;padding-left:5px}dl{margin-top:0;margin-bottom:20px}dd,dt{line-height:1.42857143}dt{font-weight:700}dd{margin-left:0}@media (min-width:768px){.dl-horizontal dt{float:left;width:160px;overflow:hidden;clear:left;text-align:right;text-overflow:ellipsis;white-space:nowrap}.dl-horizontal dd{margin-left:180px}}abbr[data-original-title],abbr[title]{cursor:help;border-bottom:1px dotted #777}.initialism{font-size:90%;text-transform:uppercase}blockquote{padding:10px 20px;margin:0 0 20px;font-size:17.5px;border-left:5px solid #eee}blockquote ol:last-child,blockquote p:last-child,blockquote ul:last-child{margin-bottom:0}blockquote .small,blockquote footer,blockquote small{display:block;font-size:80%;line-height:1.42857143;color:#777}blockquote .small:before,blockquote footer:before,blockquote small:before{content:'\2014 \00A0'}.blockquote-reverse,blockquote.pull-right{padding-right:15px;padding-left:0;text-align:right;border-right:5px solid #eee;border-left:0}.blockquote-reverse .small:before,.blockquote-reverse footer:before,.blockquote-reverse small:before,blockquote.pull-right .small:before,blockquote.pull-right footer:before,blockquote.pull-right small:before{content:''}.blockquote-reverse .small:after,.blockquote-reverse footer:after,.blockquote-reverse small:after,blockquote.pull-right .small:after,blockquote.pull-right footer:after,blockquote.pull-right small:after{content:'\00A0 \2014'}address{margin-bottom:20px;font-style:normal;line-height:1.42857143}code,kbd,pre,samp{font-family:monospace}code{padding:2px 4px;font-size:90%;color:#c7254e;background-color:#f9f2f4;border-radius:4px}kbd{padding:2px 4px;font-size:90%;color:#fff;background-color:#333;border-radius:3px;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,.25);box-shadow:inset 0 -1px 0 rgba(0,0,0,.25)}kbd kbd{padding:0;font-size:100%;font-weight:700;-webkit-box-shadow:none;box-shadow:none}pre{display:block;padding:9.5px;margin:0 0 10px;font-size:13px;line-height:1.42857143;color:#333;word-break:break-all;word-wrap:break-word;background-color:#f5f5f5;border:1px solid #ccc;border-radius:4px}pre code{padding:0;font-size:inherit;color:inherit;white-space:pre-wrap;background-color:transparent;border-radius:0}.pre-scrollable{max-height:340px;overflow-y:scroll}.container{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}.row{margin-right:-15px;margin-left:-15px}.col-lg-1,.col-lg-10,.col-lg-11,.col-lg-12,.col-lg-2,.col-lg-3,.col-lg-4,.col-lg-5,.col-lg-6,.col-lg-7,.col-lg-8,.col-lg-9,.col-md-1,.col-md-10,.col-md-11,.col-md-12,.col-md-2,.col-md-3,.col-md-4,.col-md-5,.col-md-6,.col-md-7,.col-md-8,.col-md-9,.col-sm-1,.col-sm-10,.col-sm-11,.col-sm-12,.col-sm-2,.col-sm-3,.col-sm-4,.col-sm-5,.col-sm-6,.col-sm-7,.col-sm-8,.col-sm-9,.col-xs-1,.col-xs-10,.col-xs-11,.col-xs-12,.col-xs-2,.col-xs-3,.col-xs-4,.col-xs-5,.col-xs-6,.col-xs-7,.col-xs-8,.col-xs-9{position:relative;min-height:1px;padding-right:15px;padding-left:15px}.col-xs-1,.col-xs-10,.col-xs-11,.col-xs-12,.col-xs-2,.col-xs-3,.col-xs-4,.col-xs-5,.col-xs-6,.col-xs-7,.col-xs-8,.col-xs-9{float:left}.col-xs-12{width:100%}.col-xs-11{width:91.66666667%}.col-xs-10{width:83.33333333%}.col-xs-9{width:75%}.col-xs-8{width:66.66666667%}.col-xs-7{width:58.33333333%}.col-xs-6{width:50%}.col-xs-5{width:41.66666667%}.col-xs-4{width:33.33333333%}.col-xs-3{width:25%}.col-xs-2{width:16.66666667%}.col-xs-1{width:8.33333333%}.col-xs-pull-12{right:100%}.col-xs-pull-11{right:91.66666667%}.col-xs-pull-10{right:83.33333333%}.col-xs-pull-9{right:75%}.col-xs-pull-8{right:66.66666667%}.col-xs-pull-7{right:58.33333333%}.col-xs-pull-6{right:50%}.col-xs-pull-5{right:41.66666667%}.col-xs-pull-4{right:33.33333333%}.col-xs-pull-3{right:25%}.col-xs-pull-2{right:16.66666667%}.col-xs-pull-1{right:8.33333333%}.col-xs-pull-0{right:auto}.col-xs-push-12{left:100%}.col-xs-push-11{left:91.66666667%}.col-xs-push-10{left:83.33333333%}.col-xs-push-9{left:75%}.col-xs-push-8{left:66.66666667%}.col-xs-push-7{left:58.33333333%}.col-xs-push-6{left:50%}.col-xs-push-5{left:41.66666667%}.col-xs-push-4{left:33.33333333%}.col-xs-push-3{left:25%}.col-xs-push-2{left:16.66666667%}.col-xs-push-1{left:8.33333333%}.col-xs-push-0{left:auto}.col-xs-offset-12{margin-left:100%}.col-xs-offset-11{margin-left:91.66666667%}.col-xs-offset-10{margin-left:83.33333333%}.col-xs-offset-9{margin-left:75%}.col-xs-offset-8{margin-left:66.66666667%}.col-xs-offset-7{margin-left:58.33333333%}.col-xs-offset-6{margin-left:50%}.col-xs-offset-5{margin-left:41.66666667%}.col-xs-offset-4{margin-left:33.33333333%}.col-xs-offset-3{margin-left:25%}.col-xs-offset-2{margin-left:16.66666667%}.col-xs-offset-1{margin-left:8.33333333%}.col-xs-offset-0{margin-left:0}@media (min-width:768px){.col-sm-1,.col-sm-10,.col-sm-11,.col-sm-12,.col-sm-2,.col-sm-3,.col-sm-4,.col-sm-5,.col-sm-6,.col-sm-7,.col-sm-8,.col-sm-9{float:left}.col-sm-12{width:100%}.col-sm-11{width:91.66666667%}.col-sm-10{width:83.33333333%}.col-sm-9{width:75%}.col-sm-8{width:66.66666667%}.col-sm-7{width:58.33333333%}.col-sm-6{width:50%}.col-sm-5{width:41.66666667%}.col-sm-4{width:33.33333333%}.col-sm-3{width:25%}.col-sm-2{width:16.66666667%}.col-sm-1{width:8.33333333%}.col-sm-pull-12{right:100%}.col-sm-pull-11{right:91.66666667%}.col-sm-pull-10{right:83.33333333%}.col-sm-pull-9{right:75%}.col-sm-pull-8{right:66.66666667%}.col-sm-pull-7{right:58.33333333%}.col-sm-pull-6{right:50%}.col-sm-pull-5{right:41.66666667%}.col-sm-pull-4{right:33.33333333%}.col-sm-pull-3{right:25%}.col-sm-pull-2{right:16.66666667%}.col-sm-pull-1{right:8.33333333%}.col-sm-pull-0{right:auto}.col-sm-push-12{left:100%}.col-sm-push-11{left:91.66666667%}.col-sm-push-10{left:83.33333333%}.col-sm-push-9{left:75%}.col-sm-push-8{left:66.66666667%}.col-sm-push-7{left:58.33333333%}.col-sm-push-6{left:50%}.col-sm-push-5{left:41.66666667%}.col-sm-push-4{left:33.33333333%}.col-sm-push-3{left:25%}.col-sm-push-2{left:16.66666667%}.col-sm-push-1{left:8.33333333%}.col-sm-push-0{left:auto}.col-sm-offset-12{margin-left:100%}.col-sm-offset-11{margin-left:91.66666667%}.col-sm-offset-10{margin-left:83.33333333%}.col-sm-offset-9{margin-left:75%}.col-sm-offset-8{margin-left:66.66666667%}.col-sm-offset-7{margin-left:58.33333333%}.col-sm-offset-6{margin-left:50%}.col-sm-offset-5{margin-left:41.66666667%}.col-sm-offset-4{margin-left:33.33333333%}.col-sm-offset-3{margin-left:25%}.col-sm-offset-2{margin-left:16.66666667%}.col-sm-offset-1{margin-left:8.33333333%}.col-sm-offset-0{margin-left:0}}@media (min-width:992px){.col-md-1,.col-md-10,.col-md-11,.col-md-12,.col-md-2,.col-md-3,.col-md-4,.col-md-5,.col-md-6,.col-md-7,.col-md-8,.col-md-9{float:left}.col-md-12{width:100%}.col-md-11{width:91.66666667%}.col-md-10{width:83.33333333%}.col-md-9{width:75%}.col-md-8{width:66.66666667%}.col-md-7{width:58.33333333%}.col-md-6{width:50%}.col-md-5{width:41.66666667%}.col-md-4{width:33.33333333%}.col-md-3{width:25%}.col-md-2{width:16.66666667%}.col-md-1{width:8.33333333%}.col-md-pull-12{right:100%}.col-md-pull-11{right:91.66666667%}.col-md-pull-10{right:83.33333333%}.col-md-pull-9{right:75%}.col-md-pull-8{right:66.66666667%}.col-md-pull-7{right:58.33333333%}.col-md-pull-6{right:50%}.col-md-pull-5{right:41.66666667%}.col-md-pull-4{right:33.33333333%}.col-md-pull-3{right:25%}.col-md-pull-2{right:16.66666667%}.col-md-pull-1{right:8.33333333%}.col-md-pull-0{right:auto}.col-md-push-12{left:100%}.col-md-push-11{left:91.66666667%}.col-md-push-10{left:83.33333333%}.col-md-push-9{left:75%}.col-md-push-8{left:66.66666667%}.col-md-push-7{left:58.33333333%}.col-md-push-6{left:50%}.col-md-push-5{left:41.66666667%}.col-md-push-4{left:33.33333333%}.col-md-push-3{left:25%}.col-md-push-2{left:16.66666667%}.col-md-push-1{left:8.33333333%}.col-md-push-0{left:auto}.col-md-offset-12{margin-left:100%}.col-md-offset-11{margin-left:91.66666667%}.col-md-offset-10{margin-left:83.33333333%}.col-md-offset-9{margin-left:75%}.col-md-offset-8{margin-left:66.66666667%}.col-md-offset-7{margin-left:58.33333333%}.col-md-offset-6{margin-left:50%}.col-md-offset-5{margin-left:41.66666667%}.col-md-offset-4{margin-left:33.33333333%}.col-md-offset-3{margin-left:25%}.col-md-offset-2{margin-left:16.66666667%}.col-md-offset-1{margin-left:8.33333333%}.col-md-offset-0{margin-left:0}}@media (min-width:1200px){.col-lg-1,.col-lg-10,.col-lg-11,.col-lg-12,.col-lg-2,.col-lg-3,.col-lg-4,.col-lg-5,.col-lg-6,.col-lg-7,.col-lg-8,.col-lg-9{float:left}.col-lg-12{width:100%}.col-lg-11{width:91.66666667%}.col-lg-10{width:83.33333333%}.col-lg-9{width:75%}.col-lg-8{width:66.66666667%}.col-lg-7{width:58.33333333%}.col-lg-6{width:50%}.col-lg-5{width:41.66666667%}.col-lg-4{width:33.33333333%}.col-lg-3{width:25%}.col-lg-2{width:16.66666667%}.col-lg-1{width:8.33333333%}.col-lg-pull-12{right:100%}.col-lg-pull-11{right:91.66666667%}.col-lg-pull-10{right:83.33333333%}.col-lg-pull-9{right:75%}.col-lg-pull-8{right:66.66666667%}.col-lg-pull-7{right:58.33333333%}.col-lg-pull-6{right:50%}.col-lg-pull-5{right:41.66666667%}.col-lg-pull-4{right:33.33333333%}.col-lg-pull-3{right:25%}.col-lg-pull-2{right:16.66666667%}.col-lg-pull-1{right:8.33333333%}.col-lg-pull-0{right:auto}.col-lg-push-12{left:100%}.col-lg-push-11{left:91.66666667%}.col-lg-push-10{left:83.33333333%}.col-lg-push-9{left:75%}.col-lg-push-8{left:66.66666667%}.col-lg-push-7{left:58.33333333%}.col-lg-push-6{left:50%}.col-lg-push-5{left:41.66666667%}.col-lg-push-4{left:33.33333333%}.col-lg-push-3{left:25%}.col-lg-push-2{left:16.66666667%}.col-lg-push-1{left:8.33333333%}.col-lg-push-0{left:auto}.col-lg-offset-12{margin-left:100%}.col-lg-offset-11{margin-left:91.66666667%}.col-lg-offset-10{margin-left:83.33333333%}.col-lg-offset-9{margin-left:75%}.col-lg-offset-8{margin-left:66.66666667%}.col-lg-offset-7{margin-left:58.33333333%}.col-lg-offset-6{margin-left:50%}.col-lg-offset-5{margin-left:41.66666667%}.col-lg-offset-4{margin-left:33.33333333%}.col-lg-offset-3{margin-left:25%}.col-lg-offset-2{margin-left:16.66666667%}.col-lg-offset-1{margin-left:8.33333333%}.col-lg-offset-0{margin-left:0}}table{background-color:transparent}caption{padding-top:8px;padding-bottom:8px;color:#777;text-align:left}th{}.table{width:100%;max-width:100%;margin-bottom:20px}.table>tbody>tr>td,.table>tbody>tr>th,.table>tfoot>tr>td,.table>tfoot>tr>th,.table>thead>tr>td,.table>thead>tr>th{padding:8px;line-height:1.42857143;vertical-align:top;border-top:1px solid #ddd}.table>thead>tr>th{vertical-align:bottom;border-bottom:2px solid #ddd}.table>caption+thead>tr:first-child>td,.table>caption+thead>tr:first-child>th,.table>colgroup+thead>tr:first-child>td,.table>colgroup+thead>tr:first-child>th,.table>thead:first-child>tr:first-child>td,.table>thead:first-child>tr:first-child>th{border-top:0}.table>tbody+tbody{border-top:2px solid #ddd}.table .table{background-color:#fff}.table-condensed>tbody>tr>td,.table-condensed>tbody>tr>th,.table-condensed>tfoot>tr>td,.table-condensed>tfoot>tr>th,.table-condensed>thead>tr>td,.table-condensed>thead>tr>th{padding:5px}.table-bordered{border:1px solid #ddd}.table-bordered>tbody>tr>td,.table-bordered>tbody>tr>th,.table-bordered>tfoot>tr>td,.table-bordered>tfoot>tr>th,.table-bordered>thead>tr>td,.table-bordered>thead>tr>th{border:1px solid #ddd}.table-bordered>thead>tr>td,.table-bordered>thead>tr>th{border-bottom-width:2px}.table-striped>tbody>tr:nth-of-type(odd){background-color:#f9f9f9}.table-hover>tbody>tr:hover{background-color:#f5f5f5}table col[class*=col-]{position:static;display:table-column;float:none}table td[class*=col-],table th[class*=col-]{position:static;display:table-cell;float:none}.table>tbody>tr.active>td,.table>tbody>tr.active>th,.table>tbody>tr>td.active,.table>tbody>tr>th.active,.table>tfoot>tr.active>td,.table>tfoot>tr.active>th,.table>tfoot>tr>td.active,.table>tfoot>tr>th.active,.table>thead>tr.active>td,.table>thead>tr.active>th,.table>thead>tr>td.active,.table>thead>tr>th.active{background-color:#f5f5f5}.table-hover>tbody>tr.active:hover>td,.table-hover>tbody>tr.active:hover>th,.table-hover>tbody>tr:hover>.active,.table-hover>tbody>tr>td.active:hover,.table-hover>tbody>tr>th.active:hover{background-color:#e8e8e8}.table>tbody>tr.success>td,.table>tbody>tr.success>th,.table>tbody>tr>td.success,.table>tbody>tr>th.success,.table>tfoot>tr.success>td,.table>tfoot>tr.success>th,.table>tfoot>tr>td.success,.table>tfoot>tr>th.success,.table>thead>tr.success>td,.table>thead>tr.success>th,.table>thead>tr>td.success,.table>thead>tr>th.success{background-color:#dff0d8}.table-hover>tbody>tr.success:hover>td,.table-hover>tbody>tr.success:hover>th,.table-hover>tbody>tr:hover>.success,.table-hover>tbody>tr>td.success:hover,.table-hover>tbody>tr>th.success:hover{background-color:#d0e9c6}.table>tbody>tr.info>td,.table>tbody>tr.info>th,.table>tbody>tr>td.info,.table>tbody>tr>th.info,.table>tfoot>tr.info>td,.table>tfoot>tr.info>th,.table>tfoot>tr>td.info,.table>tfoot>tr>th.info,.table>thead>tr.info>td,.table>thead>tr.info>th,.table>thead>tr>td.info,.table>thead>tr>th.info{background-color:#d9edf7}.table-hover>tbody>tr.info:hover>td,.table-hover>tbody>tr.info:hover>th,.table-hover>tbody>tr:hover>.info,.table-hover>tbody>tr>td.info:hover,.table-hover>tbody>tr>th.info:hover{background-color:#c4e3f3}.table>tbody>tr.warning>td,.table>tbody>tr.warning>th,.table>tbody>tr>td.warning,.table>tbody>tr>th.warning,.table>tfoot>tr.warning>td,.table>tfoot>tr.warning>th,.table>tfoot>tr>td.warning,.table>tfoot>tr>th.warning,.table>thead>tr.warning>td,.table>thead>tr.warning>th,.table>thead>tr>td.warning,.table>thead>tr>th.warning{background-color:#fcf8e3}.table-hover>tbody>tr.warning:hover>td,.table-hover>tbody>tr.warning:hover>th,.table-hover>tbody>tr:hover>.warning,.table-hover>tbody>tr>td.warning:hover,.table-hover>tbody>tr>th.warning:hover{background-color:#faf2cc}.table>tbody>tr.danger>td,.table>tbody>tr.danger>th,.table>tbody>tr>td.danger,.table>tbody>tr>th.danger,.table>tfoot>tr.danger>td,.table>tfoot>tr.danger>th,.table>tfoot>tr>td.danger,.table>tfoot>tr>th.danger,.table>thead>tr.danger>td,.table>thead>tr.danger>th,.table>thead>tr>td.danger,.table>thead>tr>th.danger{background-color:#f2dede}.table-hover>tbody>tr.danger:hover>td,.table-hover>tbody>tr.danger:hover>th,.table-hover>tbody>tr:hover>.danger,.table-hover>tbody>tr>td.danger:hover,.table-hover>tbody>tr>th.danger:hover{background-color:#ebcccc}.table-responsive{min-height:.01%;overflow-x:auto}@media screen and (max-width:767px){.table-responsive{width:100%;margin-bottom:15px;overflow-y:hidden;-ms-overflow-style:-ms-autohiding-scrollbar;border:1px solid #ddd}.table-responsive>.table{margin-bottom:0}.table-responsive>.table>tbody>tr>td,.table-responsive>.table>tbody>tr>th,.table-responsive>.table>tfoot>tr>td,.table-responsive>.table>tfoot>tr>th,.table-responsive>.table>thead>tr>td,.table-responsive>.table>thead>tr>th{white-space:nowrap}.table-responsive>.table-bordered{border:0}.table-responsive>.table-bordered>tbody>tr>td:first-child,.table-responsive>.table-bordered>tbody>tr>th:first-child,.table-responsive>.table-bordered>tfoot>tr>td:first-child,.table-responsive>.table-bordered>tfoot>tr>th:first-child,.table-responsive>.table-bordered>thead>tr>td:first-child,.table-responsive>.table-bordered>thead>tr>th:first-child{border-left:0}.table-responsive>.table-bordered>tbody>tr>td:last-child,.table-responsive>.table-bordered>tbody>tr>th:last-child,.table-responsive>.table-bordered>tfoot>tr>td:last-child,.table-responsive>.table-bordered>tfoot>tr>th:last-child,.table-responsive>.table-bordered>thead>tr>td:last-child,.table-responsive>.table-bordered>thead>tr>th:last-child{border-right:0}.table-responsive>.table-bordered>tbody>tr:last-child>td,.table-responsive>.table-bordered>tbody>tr:last-child>th,.table-responsive>.table-bordered>tfoot>tr:last-child>td,.table-responsive>.table-bordered>tfoot>tr:last-child>th{border-bottom:0}}fieldset{min-width:0;padding:0;margin:0;border:0}legend{display:block;width:100%;padding:0;margin-bottom:20px;font-size:21px;line-height:inherit;color:#333;border:0;border-bottom:1px solid #e5e5e5}label{display:inline-block;max-width:100%;margin-bottom:5px;font-weight:700}input[type=search]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}input[type=checkbox],input[type=radio]{margin:4px 0 0;margin-top:1px\9;line-height:normal}input[type=file]{display:block}input[type=range]{display:block;width:100%}select[multiple],select[size]{height:auto}input[type=file]:focus,input[type=checkbox]:focus,input[type=radio]:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}output{display:block;padding-top:7px;font-size:14px;line-height:1.42857143;color:#555}.form-control{display:block;width:100%;height:34px;padding:6px 12px;font-size:14px;line-height:1.42857143;color:#555;background-color:#fff;background-image:none;border:1px solid #ccc;border-radius:4px;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075);-webkit-transition:border-color ease-in-out .15s,-webkit-box-shadow ease-in-out .15s;-o-transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s;transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s}.form-control:focus{border-color:#66afe9;outline:0;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 8px rgba(102,175,233,.6);box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 8px rgba(102,175,233,.6)}.form-control::-moz-placeholder{color:#999;opacity:1}.form-control:-ms-input-placeholder{color:#999}.form-control::-webkit-input-placeholder{color:#999}.form-control[disabled],.form-control[readonly],fieldset[disabled] .form-control{background-color:#eee;opacity:1}.form-control[disabled],fieldset[disabled] .form-control{cursor:not-allowed}textarea.form-control{height:auto}input[type=search]{-webkit-appearance:none}@media screen and (-webkit-min-device-pixel-ratio:0){input[type=date].form-control,input[type=time].form-control,input[type=datetime-local].form-control,input[type=month].form-control{line-height:34px}.input-group-sm input[type=date],.input-group-sm input[type=time],.input-group-sm input[type=datetime-local],.input-group-sm input[type=month],input[type=date].input-sm,input[type=time].input-sm,input[type=datetime-local].input-sm,input[type=month].input-sm{line-height:30px}.input-group-lg input[type=date],.input-group-lg input[type=time],.input-group-lg input[type=datetime-local],.input-group-lg input[type=month],input[type=date].input-lg,input[type=time].input-lg,input[type=datetime-local].input-lg,input[type=month].input-lg{line-height:46px}}.form-group{margin-bottom:15px}.checkbox,.radio{position:relative;display:block;margin-top:10px;margin-bottom:10px}.checkbox label,.radio label{min-height:20px;padding-left:20px;margin-bottom:0;font-weight:400;cursor:pointer}.checkbox input[type=checkbox],.checkbox-inline input[type=checkbox],.radio input[type=radio],.radio-inline input[type=radio]{position:absolute;margin-top:4px\9;margin-left:-20px}.checkbox+.checkbox,.radio+.radio{margin-top:-5px}.checkbox-inline,.radio-inline{position:relative;display:inline-block;padding-left:20px;margin-bottom:0;font-weight:400;vertical-align:middle;cursor:pointer}.checkbox-inline+.checkbox-inline,.radio-inline+.radio-inline{margin-top:0;margin-left:10px}fieldset[disabled] input[type=checkbox],fieldset[disabled] input[type=radio],input[type=checkbox].disabled,input[type=checkbox][disabled],input[type=radio].disabled,input[type=radio][disabled]{cursor:not-allowed}.checkbox-inline.disabled,.radio-inline.disabled,fieldset[disabled] .checkbox-inline,fieldset[disabled] .radio-inline{cursor:not-allowed}.checkbox.disabled label,.radio.disabled label,fieldset[disabled] .checkbox label,fieldset[disabled] .radio label{cursor:not-allowed}.form-control-static{min-height:34px;padding-top:7px;padding-bottom:7px;margin-bottom:0}.form-control-static.input-lg,.form-control-static.input-sm{padding-right:0;padding-left:0}.input-sm{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}select.input-sm{height:30px;line-height:30px}select[multiple].input-sm,textarea.input-sm{height:auto}.form-group-sm .form-control{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}.form-group-sm select.form-control{height:30px;line-height:30px}.form-group-sm select[multiple].form-control,.form-group-sm textarea.form-control{height:auto}.form-group-sm .form-control-static{height:30px;min-height:32px;padding:6px 10px;font-size:12px;line-height:1.5}.input-lg{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}select.input-lg{height:46px;line-height:46px}select[multiple].input-lg,textarea.input-lg{height:auto}.form-group-lg .form-control{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}.form-group-lg select.form-control{height:46px;line-height:46px}.form-group-lg select[multiple].form-control,.form-group-lg textarea.form-control{height:auto}.form-group-lg .form-control-static{height:46px;min-height:38px;padding:11px 16px;font-size:18px;line-height:1.3333333}.has-feedback{position:relative}.has-feedback .form-control{padding-right:42.5px}.form-control-feedback{position:absolute;top:0;right:0;z-index:2;display:block;width:34px;height:34px;line-height:34px;text-align:center;pointer-events:none}.form-group-lg .form-control+.form-control-feedback,.input-group-lg+.form-control-feedback,.input-lg+.form-control-feedback{width:46px;height:46px;line-height:46px}.form-group-sm .form-control+.form-control-feedback,.input-group-sm+.form-control-feedback,.input-sm+.form-control-feedback{width:30px;height:30px;line-height:30px}.has-success .checkbox,.has-success .checkbox-inline,.has-success .control-label,.has-success .help-block,.has-success .radio,.has-success .radio-inline,.has-success.checkbox label,.has-success.checkbox-inline label,.has-success.radio label,.has-success.radio-inline label{color:#3c763d}.has-success .form-control{border-color:#3c763d;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-success .form-control:focus{border-color:#2b542c;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #67b168;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #67b168}.has-success .input-group-addon{color:#3c763d;background-color:#dff0d8;border-color:#3c763d}.has-success .form-control-feedback{color:#3c763d}.has-warning .checkbox,.has-warning .checkbox-inline,.has-warning .control-label,.has-warning .help-block,.has-warning .radio,.has-warning .radio-inline,.has-warning.checkbox label,.has-warning.checkbox-inline label,.has-warning.radio label,.has-warning.radio-inline label{color:#8a6d3b}.has-warning .form-control{border-color:#8a6d3b;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-warning .form-control:focus{border-color:#66512c;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #c0a16b;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #c0a16b}.has-warning .input-group-addon{color:#8a6d3b;background-color:#fcf8e3;border-color:#8a6d3b}.has-warning .form-control-feedback{color:#8a6d3b}.has-error .checkbox,.has-error .checkbox-inline,.has-error .control-label,.has-error .help-block,.has-error .radio,.has-error .radio-inline,.has-error.checkbox label,.has-error.checkbox-inline label,.has-error.radio label,.has-error.radio-inline label{color:#a94442}.has-error .form-control{border-color:#a94442;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-error .form-control:focus{border-color:#843534;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #ce8483;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #ce8483}.has-error .input-group-addon{color:#a94442;background-color:#f2dede;border-color:#a94442}.has-error .form-control-feedback{color:#a94442}.has-feedback label~.form-control-feedback{top:25px}.has-feedback label.sr-only~.form-control-feedback{top:0}.help-block{display:block;margin-top:5px;margin-bottom:10px;color:#737373}@media (min-width:768px){.form-inline .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.form-inline .form-control{display:inline-block;width:auto;vertical-align:middle}.form-inline .form-control-static{display:inline-block}.form-inline .input-group{display:inline-table;vertical-align:middle}.form-inline .input-group .form-control,.form-inline .input-group .input-group-addon,.form-inline .input-group .input-group-btn{width:auto}.form-inline .input-group>.form-control{width:100%}.form-inline .control-label{margin-bottom:0;vertical-align:middle}.form-inline .checkbox,.form-inline .radio{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.form-inline .checkbox label,.form-inline .radio label{padding-left:0}.form-inline .checkbox input[type=checkbox],.form-inline .radio input[type=radio]{position:relative;margin-left:0}.form-inline .has-feedback .form-control-feedback{top:0}}.form-horizontal .checkbox,.form-horizontal .checkbox-inline,.form-horizontal .radio,.form-horizontal .radio-inline{padding-top:7px;margin-top:0;margin-bottom:0}.form-horizontal .checkbox,.form-horizontal .radio{min-height:27px}.form-horizontal .form-group{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.form-horizontal .control-label{padding-top:7px;margin-bottom:0;text-align:right}}.form-horizontal .has-feedback .form-control-feedback{right:15px}@media (min-width:768px){.form-horizontal .form-group-lg .control-label{padding-top:14.33px;font-size:18px}}@media (min-width:768px){.form-horizontal .form-group-sm .control-label{padding-top:6px;font-size:12px}}.btn{display:inline-block;padding:6px 12px;margin-bottom:0;font-size:14px;font-weight:400;line-height:1.42857143;text-align:center;white-space:nowrap;vertical-align:middle;-ms-touch-action:manipulation;touch-action:manipulation;cursor:pointer;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;background-image:none;border:1px solid transparent;border-radius:4px}.btn.active.focus,.btn.active:focus,.btn.focus,.btn:active.focus,.btn:active:focus,.btn:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}.btn.focus,.btn:focus,.btn:hover{color:#333;text-decoration:none}.btn.active,.btn:active{background-image:none;outline:0;-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,.125);box-shadow:inset 0 3px 5px rgba(0,0,0,.125)}.btn.disabled,.btn[disabled],fieldset[disabled] .btn{cursor:not-allowed;filter:alpha(opacity=65);-webkit-box-shadow:none;box-shadow:none;opacity:.65}a.btn.disabled,fieldset[disabled] a.btn{pointer-events:none}.btn-default{color:#333;background-color:#fff;border-color:#ccc}.btn-default.focus,.btn-default:focus{color:#333;background-color:#e6e6e6;border-color:#8c8c8c}.btn-default:hover{color:#333;background-color:#e6e6e6;border-color:#adadad}.btn-default.active,.btn-default:active,.open>.dropdown-toggle.btn-default{color:#333;background-color:#e6e6e6;border-color:#adadad}.btn-default.active.focus,.btn-default.active:focus,.btn-default.active:hover,.btn-default:active.focus,.btn-default:active:focus,.btn-default:active:hover,.open>.dropdown-toggle.btn-default.focus,.open>.dropdown-toggle.btn-default:focus,.open>.dropdown-toggle.btn-default:hover{color:#333;background-color:#d4d4d4;border-color:#8c8c8c}.btn-default.active,.btn-default:active,.open>.dropdown-toggle.btn-default{background-image:none}.btn-default.disabled,.btn-default.disabled.active,.btn-default.disabled.focus,.btn-default.disabled:active,.btn-default.disabled:focus,.btn-default.disabled:hover,.btn-default[disabled],.btn-default[disabled].active,.btn-default[disabled].focus,.btn-default[disabled]:active,.btn-default[disabled]:focus,.btn-default[disabled]:hover,fieldset[disabled] .btn-default,fieldset[disabled] .btn-default.active,fieldset[disabled] .btn-default.focus,fieldset[disabled] .btn-default:active,fieldset[disabled] .btn-default:focus,fieldset[disabled] .btn-default:hover{background-color:#fff;border-color:#ccc}.btn-default .badge{color:#fff;background-color:#333}.btn-primary{color:#fff;background-color:#337ab7;border-color:#2e6da4}.btn-primary.focus,.btn-primary:focus{color:#fff;background-color:#286090;border-color:#122b40}.btn-primary:hover{color:#fff;background-color:#286090;border-color:#204d74}.btn-primary.active,.btn-primary:active,.open>.dropdown-toggle.btn-primary{color:#fff;background-color:#286090;border-color:#204d74}.btn-primary.active.focus,.btn-primary.active:focus,.btn-primary.active:hover,.btn-primary:active.focus,.btn-primary:active:focus,.btn-primary:active:hover,.open>.dropdown-toggle.btn-primary.focus,.open>.dropdown-toggle.btn-primary:focus,.open>.dropdown-toggle.btn-primary:hover{color:#fff;background-color:#204d74;border-color:#122b40}.btn-primary.active,.btn-primary:active,.open>.dropdown-toggle.btn-primary{background-image:none}.btn-primary.disabled,.btn-primary.disabled.active,.btn-primary.disabled.focus,.btn-primary.disabled:active,.btn-primary.disabled:focus,.btn-primary.disabled:hover,.btn-primary[disabled],.btn-primary[disabled].active,.btn-primary[disabled].focus,.btn-primary[disabled]:active,.btn-primary[disabled]:focus,.btn-primary[disabled]:hover,fieldset[disabled] .btn-primary,fieldset[disabled] .btn-primary.active,fieldset[disabled] .btn-primary.focus,fieldset[disabled] .btn-primary:active,fieldset[disabled] .btn-primary:focus,fieldset[disabled] .btn-primary:hover{background-color:#337ab7;border-color:#2e6da4}.btn-primary .badge{color:#337ab7;background-color:#fff}.btn-success{color:#fff;background-color:#5cb85c;border-color:#4cae4c}.btn-success.focus,.btn-success:focus{color:#fff;background-color:#449d44;border-color:#255625}.btn-success:hover{color:#fff;background-color:#449d44;border-color:#398439}.btn-success.active,.btn-success:active,.open>.dropdown-toggle.btn-success{color:#fff;background-color:#449d44;border-color:#398439}.btn-success.active.focus,.btn-success.active:focus,.btn-success.active:hover,.btn-success:active.focus,.btn-success:active:focus,.btn-success:active:hover,.open>.dropdown-toggle.btn-success.focus,.open>.dropdown-toggle.btn-success:focus,.open>.dropdown-toggle.btn-success:hover{color:#fff;background-color:#398439;border-color:#255625}.btn-success.active,.btn-success:active,.open>.dropdown-toggle.btn-success{background-image:none}.btn-success.disabled,.btn-success.disabled.active,.btn-success.disabled.focus,.btn-success.disabled:active,.btn-success.disabled:focus,.btn-success.disabled:hover,.btn-success[disabled],.btn-success[disabled].active,.btn-success[disabled].focus,.btn-success[disabled]:active,.btn-success[disabled]:focus,.btn-success[disabled]:hover,fieldset[disabled] .btn-success,fieldset[disabled] .btn-success.active,fieldset[disabled] .btn-success.focus,fieldset[disabled] .btn-success:active,fieldset[disabled] .btn-success:focus,fieldset[disabled] .btn-success:hover{background-color:#5cb85c;border-color:#4cae4c}.btn-success .badge{color:#5cb85c;background-color:#fff}.btn-info{color:#fff;background-color:#5bc0de;border-color:#46b8da}.btn-info.focus,.btn-info:focus{color:#fff;background-color:#31b0d5;border-color:#1b6d85}.btn-info:hover{color:#fff;background-color:#31b0d5;border-color:#269abc}.btn-info.active,.btn-info:active,.open>.dropdown-toggle.btn-info{color:#fff;background-color:#31b0d5;border-color:#269abc}.btn-info.active.focus,.btn-info.active:focus,.btn-info.active:hover,.btn-info:active.focus,.btn-info:active:focus,.btn-info:active:hover,.open>.dropdown-toggle.btn-info.focus,.open>.dropdown-toggle.btn-info:focus,.open>.dropdown-toggle.btn-info:hover{color:#fff;background-color:#269abc;border-color:#1b6d85}.btn-info.active,.btn-info:active,.open>.dropdown-toggle.btn-info{background-image:none}.btn-info.disabled,.btn-info.disabled.active,.btn-info.disabled.focus,.btn-info.disabled:active,.btn-info.disabled:focus,.btn-info.disabled:hover,.btn-info[disabled],.btn-info[disabled].active,.btn-info[disabled].focus,.btn-info[disabled]:active,.btn-info[disabled]:focus,.btn-info[disabled]:hover,fieldset[disabled] .btn-info,fieldset[disabled] .btn-info.active,fieldset[disabled] .btn-info.focus,fieldset[disabled] .btn-info:active,fieldset[disabled] .btn-info:focus,fieldset[disabled] .btn-info:hover{background-color:#5bc0de;border-color:#46b8da}.btn-info .badge{color:#5bc0de;background-color:#fff}.btn-warning{color:#fff;background-color:#f0ad4e;border-color:#eea236}.btn-warning.focus,.btn-warning:focus{color:#fff;background-color:#ec971f;border-color:#985f0d}.btn-warning:hover{color:#fff;background-color:#ec971f;border-color:#d58512}.btn-warning.active,.btn-warning:active,.open>.dropdown-toggle.btn-warning{color:#fff;background-color:#ec971f;border-color:#d58512}.btn-warning.active.focus,.btn-warning.active:focus,.btn-warning.active:hover,.btn-warning:active.focus,.btn-warning:active:focus,.btn-warning:active:hover,.open>.dropdown-toggle.btn-warning.focus,.open>.dropdown-toggle.btn-warning:focus,.open>.dropdown-toggle.btn-warning:hover{color:#fff;background-color:#d58512;border-color:#985f0d}.btn-warning.active,.btn-warning:active,.open>.dropdown-toggle.btn-warning{background-image:none}.btn-warning.disabled,.btn-warning.disabled.active,.btn-warning.disabled.focus,.btn-warning.disabled:active,.btn-warning.disabled:focus,.btn-warning.disabled:hover,.btn-warning[disabled],.btn-warning[disabled].active,.btn-warning[disabled].focus,.btn-warning[disabled]:active,.btn-warning[disabled]:focus,.btn-warning[disabled]:hover,fieldset[disabled] .btn-warning,fieldset[disabled] .btn-warning.active,fieldset[disabled] .btn-warning.focus,fieldset[disabled] .btn-warning:active,fieldset[disabled] .btn-warning:focus,fieldset[disabled] .btn-warning:hover{background-color:#f0ad4e;border-color:#eea236}.btn-warning .badge{color:#f0ad4e;background-color:#fff}.btn-danger{color:#fff;background-color:#d9534f;border-color:#d43f3a}.btn-danger.focus,.btn-danger:focus{color:#fff;background-color:#c9302c;border-color:#761c19}.btn-danger:hover{color:#fff;background-color:#c9302c;border-color:#ac2925}.btn-danger.active,.btn-danger:active,.open>.dropdown-toggle.btn-danger{color:#fff;background-color:#c9302c;border-color:#ac2925}.btn-danger.active.focus,.btn-danger.active:focus,.btn-danger.active:hover,.btn-danger:active.focus,.btn-danger:active:focus,.btn-danger:active:hover,.open>.dropdown-toggle.btn-danger.focus,.open>.dropdown-toggle.btn-danger:focus,.open>.dropdown-toggle.btn-danger:hover{color:#fff;background-color:#ac2925;border-color:#761c19}.btn-danger.active,.btn-danger:active,.open>.dropdown-toggle.btn-danger{background-image:none}.btn-danger.disabled,.btn-danger.disabled.active,.btn-danger.disabled.focus,.btn-danger.disabled:active,.btn-danger.disabled:focus,.btn-danger.disabled:hover,.btn-danger[disabled],.btn-danger[disabled].active,.btn-danger[disabled].focus,.btn-danger[disabled]:active,.btn-danger[disabled]:focus,.btn-danger[disabled]:hover,fieldset[disabled] .btn-danger,fieldset[disabled] .btn-danger.active,fieldset[disabled] .btn-danger.focus,fieldset[disabled] .btn-danger:active,fieldset[disabled] .btn-danger:focus,fieldset[disabled] .btn-danger:hover{background-color:#d9534f;border-color:#d43f3a}.btn-danger .badge{color:#d9534f;background-color:#fff}.btn-link{font-weight:400;color:#337ab7;border-radius:0}.btn-link,.btn-link.active,.btn-link:active,.btn-link[disabled],fieldset[disabled] .btn-link{background-color:transparent;-webkit-box-shadow:none;box-shadow:none}.btn-link,.btn-link:active,.btn-link:focus,.btn-link:hover{border-color:transparent}.btn-link:focus,.btn-link:hover{color:#23527c;text-decoration:underline;background-color:transparent}.btn-link[disabled]:focus,.btn-link[disabled]:hover,fieldset[disabled] .btn-link:focus,fieldset[disabled] .btn-link:hover{color:#777;text-decoration:none}.btn-group-lg>.btn,.btn-lg{padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}.btn-group-sm>.btn,.btn-sm{padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}.btn-group-xs>.btn,.btn-xs{padding:1px 5px;font-size:12px;line-height:1.5;border-radius:3px}.btn-block{display:block;width:100%}.btn-block+.btn-block{margin-top:5px}input[type=button].btn-block,input[type=reset].btn-block,input[type=submit].btn-block{width:100%}.fade{opacity:0;-webkit-transition:opacity .15s linear;-o-transition:opacity .15s linear;transition:opacity .15s linear}.fade.in{opacity:1}.collapse{display:none}.collapse.in{display:block}tr.collapse.in{display:table-row}tbody.collapse.in{display:table-row-group}.collapsing{position:relative;height:0;overflow:hidden;-webkit-transition-timing-function:ease;-o-transition-timing-function:ease;transition-timing-function:ease;-webkit-transition-duration:.35s;-o-transition-duration:.35s;transition-duration:.35s;-webkit-transition-property:height,visibility;-o-transition-property:height,visibility;transition-property:height,visibility}.caret{display:inline-block;width:0;height:0;margin-left:2px;vertical-align:middle;border-top:4px dashed;border-top:4px solid\9;border-right:4px solid transparent;border-left:4px solid transparent}.dropdown,.dropup{position:relative}.dropdown-toggle:focus{outline:0}.dropdown-menu{position:absolute;top:100%;left:0;z-index:1000;display:none;float:left;min-width:160px;padding:5px 0;margin:2px 0 0;font-size:14px;text-align:left;list-style:none;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #ccc;border:1px solid rgba(0,0,0,.15);border-radius:4px;-webkit-box-shadow:0 6px 12px rgba(0,0,0,.175);box-shadow:0 6px 12px rgba(0,0,0,.175)}.dropdown-menu.pull-right{right:0;left:auto}.dropdown-menu .divider{height:1px;margin:9px 0;overflow:hidden;background-color:#e5e5e5}.dropdown-menu>li>a{display:block;padding:3px 20px;clear:both;font-weight:400;line-height:1.42857143;color:#333;white-space:nowrap}.dropdown-menu>li>a:focus,.dropdown-menu>li>a:hover{color:#262626;text-decoration:none;background-color:#f5f5f5}.dropdown-menu>.active>a,.dropdown-menu>.active>a:focus,.dropdown-menu>.active>a:hover{color:#fff;text-decoration:none;background-color:#337ab7;outline:0}.dropdown-menu>.disabled>a,.dropdown-menu>.disabled>a:focus,.dropdown-menu>.disabled>a:hover{color:#777}.dropdown-menu>.disabled>a:focus,.dropdown-menu>.disabled>a:hover{text-decoration:none;cursor:not-allowed;background-color:transparent;background-image:none;filter:progid:DXImageTransform.Microsoft.gradient(enabled=false)}.open>.dropdown-menu{display:block}.open>a{outline:0}.dropdown-menu-right{right:0;left:auto}.dropdown-menu-left{right:auto;left:0}.dropdown-header{display:block;padding:3px 20px;font-size:12px;line-height:1.42857143;color:#777;white-space:nowrap}.dropdown-backdrop{position:fixed;top:0;right:0;bottom:0;left:0;z-index:990}.pull-right>.dropdown-menu{right:0;left:auto}.dropup .caret,.navbar-fixed-bottom .dropdown .caret{content:"";border-top:0;border-bottom:4px dashed;border-bottom:4px solid\9}.dropup .dropdown-menu,.navbar-fixed-bottom .dropdown .dropdown-menu{top:auto;bottom:100%;margin-bottom:2px}@media (min-width:768px){.navbar-right .dropdown-menu{right:0;left:auto}.navbar-right .dropdown-menu-left{right:auto;left:0}}.btn-group,.btn-group-vertical{position:relative;display:inline-block;vertical-align:middle}.btn-group-vertical>.btn,.btn-group>.btn{position:relative;float:left}.btn-group-vertical>.btn.active,.btn-group-vertical>.btn:active,.btn-group-vertical>.btn:focus,.btn-group-vertical>.btn:hover,.btn-group>.btn.active,.btn-group>.btn:active,.btn-group>.btn:focus,.btn-group>.btn:hover{z-index:2}.btn-group .btn+.btn,.btn-group .btn+.btn-group,.btn-group .btn-group+.btn,.btn-group .btn-group+.btn-group{margin-left:-1px}.btn-toolbar{margin-left:-5px}.btn-toolbar .btn,.btn-toolbar .btn-group,.btn-toolbar .input-group{float:left}.btn-toolbar>.btn,.btn-toolbar>.btn-group,.btn-toolbar>.input-group{margin-left:5px}.btn-group>.btn:not(:first-child):not(:last-child):not(.dropdown-toggle){border-radius:0}.btn-group>.btn:first-child{margin-left:0}.btn-group>.btn:first-child:not(:last-child):not(.dropdown-toggle){border-top-right-radius:0;border-bottom-right-radius:0}.btn-group>.btn:last-child:not(:first-child),.btn-group>.dropdown-toggle:not(:first-child){border-top-left-radius:0;border-bottom-left-radius:0}.btn-group>.btn-group{float:left}.btn-group>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-top-right-radius:0;border-bottom-right-radius:0}.btn-group>.btn-group:last-child:not(:first-child)>.btn:first-child{border-top-left-radius:0;border-bottom-left-radius:0}.btn-group .dropdown-toggle:active,.btn-group.open .dropdown-toggle{outline:0}.btn-group>.btn+.dropdown-toggle{padding-right:8px;padding-left:8px}.btn-group>.btn-lg+.dropdown-toggle{padding-right:12px;padding-left:12px}.btn-group.open .dropdown-toggle{-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,.125);box-shadow:inset 0 3px 5px rgba(0,0,0,.125)}.btn-group.open .dropdown-toggle.btn-link{-webkit-box-shadow:none;box-shadow:none}.btn .caret{margin-left:0}.btn-lg .caret{border-width:5px 5px 0;border-bottom-width:0}.dropup .btn-lg .caret{border-width:0 5px 5px}.btn-group-vertical>.btn,.btn-group-vertical>.btn-group,.btn-group-vertical>.btn-group>.btn{display:block;float:none;width:100%;max-width:100%}.btn-group-vertical>.btn-group>.btn{float:none}.btn-group-vertical>.btn+.btn,.btn-group-vertical>.btn+.btn-group,.btn-group-vertical>.btn-group+.btn,.btn-group-vertical>.btn-group+.btn-group{margin-top:-1px;margin-left:0}.btn-group-vertical>.btn:not(:first-child):not(:last-child){border-radius:0}.btn-group-vertical>.btn:first-child:not(:last-child){border-top-right-radius:4px;border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn:last-child:not(:first-child){border-top-left-radius:0;border-top-right-radius:0;border-bottom-left-radius:4px}.btn-group-vertical>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group-vertical>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group-vertical>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn-group:last-child:not(:first-child)>.btn:first-child{border-top-left-radius:0;border-top-right-radius:0}.btn-group-justified{display:table;width:100%;table-layout:fixed;border-collapse:separate}.btn-group-justified>.btn,.btn-group-justified>.btn-group{display:table-cell;float:none;width:1%}.btn-group-justified>.btn-group .btn{width:100%}.btn-group-justified>.btn-group .dropdown-menu{left:auto}[data-toggle=buttons]>.btn input[type=checkbox],[data-toggle=buttons]>.btn input[type=radio],[data-toggle=buttons]>.btn-group>.btn input[type=checkbox],[data-toggle=buttons]>.btn-group>.btn input[type=radio]{position:absolute;clip:rect(0,0,0,0);pointer-events:none}.input-group{position:relative;display:table;border-collapse:separate}.input-group[class*=col-]{float:none;padding-right:0;padding-left:0}.input-group .form-control{position:relative;z-index:2;float:left;width:100%;margin-bottom:0}.input-group-lg>.form-control,.input-group-lg>.input-group-addon,.input-group-lg>.input-group-btn>.btn{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}select.input-group-lg>.form-control,select.input-group-lg>.input-group-addon,select.input-group-lg>.input-group-btn>.btn{height:46px;line-height:46px}select[multiple].input-group-lg>.form-control,select[multiple].input-group-lg>.input-group-addon,select[multiple].input-group-lg>.input-group-btn>.btn,textarea.input-group-lg>.form-control,textarea.input-group-lg>.input-group-addon,textarea.input-group-lg>.input-group-btn>.btn{height:auto}.input-group-sm>.form-control,.input-group-sm>.input-group-addon,.input-group-sm>.input-group-btn>.btn{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}select.input-group-sm>.form-control,select.input-group-sm>.input-group-addon,select.input-group-sm>.input-group-btn>.btn{height:30px;line-height:30px}select[multiple].input-group-sm>.form-control,select[multiple].input-group-sm>.input-group-addon,select[multiple].input-group-sm>.input-group-btn>.btn,textarea.input-group-sm>.form-control,textarea.input-group-sm>.input-group-addon,textarea.input-group-sm>.input-group-btn>.btn{height:auto}.input-group .form-control,.input-group-addon,.input-group-btn{display:table-cell}.input-group .form-control:not(:first-child):not(:last-child),.input-group-addon:not(:first-child):not(:last-child),.input-group-btn:not(:first-child):not(:last-child){border-radius:0}.input-group-addon,.input-group-btn{width:1%;white-space:nowrap;vertical-align:middle}.input-group-addon{padding:6px 12px;font-size:14px;font-weight:400;line-height:1;color:#555;text-align:center;background-color:#eee;border:1px solid #ccc;border-radius:4px}.input-group-addon.input-sm{padding:5px 10px;font-size:12px;border-radius:3px}.input-group-addon.input-lg{padding:10px 16px;font-size:18px;border-radius:6px}.input-group-addon input[type=checkbox],.input-group-addon input[type=radio]{margin-top:0}.input-group .form-control:first-child,.input-group-addon:first-child,.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group>.btn,.input-group-btn:first-child>.dropdown-toggle,.input-group-btn:last-child>.btn-group:not(:last-child)>.btn,.input-group-btn:last-child>.btn:not(:last-child):not(.dropdown-toggle){border-top-right-radius:0;border-bottom-right-radius:0}.input-group-addon:first-child{border-right:0}.input-group .form-control:last-child,.input-group-addon:last-child,.input-group-btn:first-child>.btn-group:not(:first-child)>.btn,.input-group-btn:first-child>.btn:not(:first-child),.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group>.btn,.input-group-btn:last-child>.dropdown-toggle{border-top-left-radius:0;border-bottom-left-radius:0}.input-group-addon:last-child{border-left:0}.input-group-btn{position:relative;font-size:0;white-space:nowrap}.input-group-btn>.btn{position:relative}.input-group-btn>.btn+.btn{margin-left:-1px}.input-group-btn>.btn:active,.input-group-btn>.btn:focus,.input-group-btn>.btn:hover{z-index:2}.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group{margin-right:-1px}.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group{z-index:2;margin-left:-1px}.nav{padding-left:0;margin-bottom:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.nav>li.disabled>a{color:#777}.nav>li.disabled>a:focus,.nav>li.disabled>a:hover{color:#777;text-decoration:none;cursor:not-allowed;background-color:transparent}.nav .open>a,.nav .open>a:focus,.nav .open>a:hover{background-color:#eee;border-color:#337ab7}.nav .nav-divider{height:1px;margin:9px 0;overflow:hidden;background-color:#e5e5e5}.nav>li>a>img{max-width:none}.nav-tabs{border-bottom:1px solid #ddd}.nav-tabs>li{float:left;margin-bottom:-1px}.nav-tabs>li>a{margin-right:2px;line-height:1.42857143;border:1px solid transparent;border-radius:4px 4px 0 0}.nav-tabs>li>a:hover{border-color:#eee #eee #ddd}.nav-tabs>li.active>a,.nav-tabs>li.active>a:focus,.nav-tabs>li.active>a:hover{color:#555;cursor:default;background-color:#fff;border:1px solid #ddd;border-bottom-color:transparent}.nav-tabs.nav-justified{width:100%;border-bottom:0}.nav-tabs.nav-justified>li{float:none}.nav-tabs.nav-justified>li>a{margin-bottom:5px;text-align:center}.nav-tabs.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-tabs.nav-justified>li{display:table-cell;width:1%}.nav-tabs.nav-justified>li>a{margin-bottom:0}}.nav-tabs.nav-justified>li>a{margin-right:0;border-radius:4px}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:focus,.nav-tabs.nav-justified>.active>a:hover{border:1px solid #ddd}@media (min-width:768px){.nav-tabs.nav-justified>li>a{border-bottom:1px solid #ddd;border-radius:4px 4px 0 0}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:focus,.nav-tabs.nav-justified>.active>a:hover{border-bottom-color:#fff}}.nav-pills>li{float:left}.nav-pills>li>a{border-radius:4px}.nav-pills>li+li{margin-left:2px}.nav-pills>li.active>a,.nav-pills>li.active>a:focus,.nav-pills>li.active>a:hover{color:#fff;background-color:#337ab7}.nav-stacked>li{float:none}.nav-stacked>li+li{margin-top:2px;margin-left:0}.nav-justified{width:100%}.nav-justified>li{float:none}.nav-justified>li>a{margin-bottom:5px;text-align:center}.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-justified>li{display:table-cell;width:1%}.nav-justified>li>a{margin-bottom:0}}.nav-tabs-justified{border-bottom:0}.nav-tabs-justified>li>a{margin-right:0;border-radius:4px}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:focus,.nav-tabs-justified>.active>a:hover{border:1px solid #ddd}@media (min-width:768px){.nav-tabs-justified>li>a{border-bottom:1px solid #ddd;border-radius:4px 4px 0 0}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:focus,.nav-tabs-justified>.active>a:hover{border-bottom-color:#fff}}.tab-content>.tab-pane{display:none}.tab-content>.active{display:block}.nav-tabs .dropdown-menu{margin-top:-1px;border-top-left-radius:0;border-top-right-radius:0}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.navbar-collapse{padding-right:15px;padding-left:15px;overflow-x:visible;-webkit-overflow-scrolling:touch;border-top:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,.1);box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}.navbar-collapse.in{overflow-y:auto}@media (min-width:768px){.navbar-collapse{width:auto;border-top:0;-webkit-box-shadow:none;box-shadow:none}.navbar-collapse.collapse{display:block!important;height:auto!important;padding-bottom:0;overflow:visible!important}.navbar-collapse.in{overflow-y:visible}.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse,.navbar-static-top .navbar-collapse{padding-right:0;padding-left:0}}.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse{max-height:340px}@media (max-device-width:480px) and (orientation:landscape){.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse{max-height:200px}}.container-fluid>.navbar-collapse,.container-fluid>.navbar-header,.container>.navbar-collapse,.container>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container-fluid>.navbar-collapse,.container-fluid>.navbar-header,.container>.navbar-collapse,.container>.navbar-header{margin-right:0;margin-left:0}}.navbar-static-top{z-index:1000;border-width:0 0 1px}@media (min-width:768px){.navbar-static-top{border-radius:0}}.navbar-fixed-bottom,.navbar-fixed-top{position:fixed;right:0;left:0;z-index:1030}@media (min-width:768px){.navbar-fixed-bottom,.navbar-fixed-top{border-radius:0}}.navbar-fixed-top{top:0;border-width:0 0 1px}.navbar-fixed-bottom{bottom:0;margin-bottom:0;border-width:1px 0 0}.navbar-brand{float:left;height:50px;padding:15px 15px;font-size:18px;line-height:20px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}.navbar-brand>img{display:block}@media (min-width:768px){.navbar>.container .navbar-brand,.navbar>.container-fluid .navbar-brand{margin-left:-15px}}.navbar-toggle{position:relative;float:right;padding:9px 10px;margin-top:8px;margin-right:15px;margin-bottom:8px;background-color:transparent;background-image:none;border:1px solid transparent;border-radius:4px}.navbar-toggle:focus{outline:0}.navbar-toggle .icon-bar{display:block;width:22px;height:2px;border-radius:1px}.navbar-toggle .icon-bar+.icon-bar{margin-top:4px}@media (min-width:768px){.navbar-toggle{display:none}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (max-width:767px){.navbar-nav .open .dropdown-menu{position:static;float:none;width:auto;margin-top:0;background-color:transparent;border:0;-webkit-box-shadow:none;box-shadow:none}.navbar-nav .open .dropdown-menu .dropdown-header,.navbar-nav .open .dropdown-menu>li>a{padding:5px 15px 5px 25px}.navbar-nav .open .dropdown-menu>li>a{line-height:20px}.navbar-nav .open .dropdown-menu>li>a:focus,.navbar-nav .open .dropdown-menu>li>a:hover{background-image:none}}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}}.navbar-form{padding:10px 15px;margin-top:8px;margin-right:-15px;margin-bottom:8px;margin-left:-15px;border-top:1px solid transparent;border-bottom:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,.1),0 1px 0 rgba(255,255,255,.1);box-shadow:inset 0 1px 0 rgba(255,255,255,.1),0 1px 0 rgba(255,255,255,.1)}@media (min-width:768px){.navbar-form .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.navbar-form .form-control{display:inline-block;width:auto;vertical-align:middle}.navbar-form .form-control-static{display:inline-block}.navbar-form .input-group{display:inline-table;vertical-align:middle}.navbar-form .input-group .form-control,.navbar-form .input-group .input-group-addon,.navbar-form .input-group .input-group-btn{width:auto}.navbar-form .input-group>.form-control{width:100%}.navbar-form .control-label{margin-bottom:0;vertical-align:middle}.navbar-form .checkbox,.navbar-form .radio{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.navbar-form .checkbox label,.navbar-form .radio label{padding-left:0}.navbar-form .checkbox input[type=checkbox],.navbar-form .radio input[type=radio]{position:relative;margin-left:0}.navbar-form .has-feedback .form-control-feedback{top:0}}@media (max-width:767px){.navbar-form .form-group{margin-bottom:5px}.navbar-form .form-group:last-child{margin-bottom:0}}@media (min-width:768px){.navbar-form{width:auto;padding-top:0;padding-bottom:0;margin-right:0;margin-left:0;border:0;-webkit-box-shadow:none;box-shadow:none}}.navbar-nav>li>.dropdown-menu{margin-top:0;border-top-left-radius:0;border-top-right-radius:0}.navbar-fixed-bottom .navbar-nav>li>.dropdown-menu{margin-bottom:0;border-top-left-radius:4px;border-top-right-radius:4px;border-bottom-right-radius:0;border-bottom-left-radius:0}.navbar-btn{margin-top:8px;margin-bottom:8px}.navbar-btn.btn-sm{margin-top:10px;margin-bottom:10px}.navbar-btn.btn-xs{margin-top:14px;margin-bottom:14px}.navbar-text{margin-top:15px;margin-bottom:15px}@media (min-width:768px){.navbar-text{float:left;margin-right:15px;margin-left:15px}}@media (min-width:768px){.navbar-left{float:left!important}.navbar-right{float:right!important;margin-right:-15px}.navbar-right~.navbar-right{margin-right:0}}.navbar-default{background-color:#f8f8f8;border-color:#e7e7e7}.navbar-default .navbar-brand{color:#777}.navbar-default .navbar-brand:focus,.navbar-default .navbar-brand:hover{color:#5e5e5e;background-color:transparent}.navbar-default .navbar-text{color:#777}.navbar-default .navbar-nav>li>a{color:#777}.navbar-default .navbar-nav>li>a:focus,.navbar-default .navbar-nav>li>a:hover{color:#333;background-color:transparent}.navbar-default .navbar-nav>.active>a,.navbar-default .navbar-nav>.active>a:focus,.navbar-default .navbar-nav>.active>a:hover{color:#555;background-color:#e7e7e7}.navbar-default .navbar-nav>.disabled>a,.navbar-default .navbar-nav>.disabled>a:focus,.navbar-default .navbar-nav>.disabled>a:hover{color:#ccc;background-color:transparent}.navbar-default .navbar-toggle{border-color:#ddd}.navbar-default .navbar-toggle:focus,.navbar-default .navbar-toggle:hover{background-color:#ddd}.navbar-default .navbar-toggle .icon-bar{background-color:#888}.navbar-default .navbar-collapse,.navbar-default .navbar-form{border-color:#e7e7e7}.navbar-default .navbar-nav>.open>a,.navbar-default .navbar-nav>.open>a:focus,.navbar-default .navbar-nav>.open>a:hover{color:#555;background-color:#e7e7e7}@media (max-width:767px){.navbar-default .navbar-nav .open .dropdown-menu>li>a{color:#777}.navbar-default .navbar-nav .open .dropdown-menu>li>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>li>a:hover{color:#333;background-color:transparent}.navbar-default .navbar-nav .open .dropdown-menu>.active>a,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:hover{color:#555;background-color:#e7e7e7}.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:hover{color:#ccc;background-color:transparent}}.navbar-default .navbar-link{color:#777}.navbar-default .navbar-link:hover{color:#333}.navbar-default .btn-link{color:#777}.navbar-default .btn-link:focus,.navbar-default .btn-link:hover{color:#333}.navbar-default .btn-link[disabled]:focus,.navbar-default .btn-link[disabled]:hover,fieldset[disabled] .navbar-default .btn-link:focus,fieldset[disabled] .navbar-default .btn-link:hover{color:#ccc}.navbar-inverse{background-color:#222;border-color:#080808}.navbar-inverse .navbar-brand{color:#9d9d9d}.navbar-inverse .navbar-brand:focus,.navbar-inverse .navbar-brand:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-text{color:#9d9d9d}.navbar-inverse .navbar-nav>li>a{color:#9d9d9d}.navbar-inverse .navbar-nav>li>a:focus,.navbar-inverse .navbar-nav>li>a:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-nav>.active>a,.navbar-inverse .navbar-nav>.active>a:focus,.navbar-inverse .navbar-nav>.active>a:hover{color:#fff;background-color:#080808}.navbar-inverse .navbar-nav>.disabled>a,.navbar-inverse .navbar-nav>.disabled>a:focus,.navbar-inverse .navbar-nav>.disabled>a:hover{color:#444;background-color:transparent}.navbar-inverse .navbar-toggle{border-color:#333}.navbar-inverse .navbar-toggle:focus,.navbar-inverse .navbar-toggle:hover{background-color:#333}.navbar-inverse .navbar-toggle .icon-bar{background-color:#fff}.navbar-inverse .navbar-collapse,.navbar-inverse .navbar-form{border-color:#101010}.navbar-inverse .navbar-nav>.open>a,.navbar-inverse .navbar-nav>.open>a:focus,.navbar-inverse .navbar-nav>.open>a:hover{color:#fff;background-color:#080808}@media (max-width:767px){.navbar-inverse .navbar-nav .open .dropdown-menu>.dropdown-header{border-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu .divider{background-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a{color:#9d9d9d}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:hover{color:#fff;background-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:hover{color:#444;background-color:transparent}}.navbar-inverse .navbar-link{color:#9d9d9d}.navbar-inverse .navbar-link:hover{color:#fff}.navbar-inverse .btn-link{color:#9d9d9d}.navbar-inverse .btn-link:focus,.navbar-inverse .btn-link:hover{color:#fff}.navbar-inverse .btn-link[disabled]:focus,.navbar-inverse .btn-link[disabled]:hover,fieldset[disabled] .navbar-inverse .btn-link:focus,fieldset[disabled] .navbar-inverse .btn-link:hover{color:#444}.breadcrumb{padding:8px 15px;margin-bottom:20px;list-style:none;background-color:#f5f5f5;border-radius:4px}.breadcrumb>li{display:inline-block}.breadcrumb>li+li:before{padding:0 5px;color:#ccc;content:"/\00a0"}.breadcrumb>.active{color:#777}.pagination{display:inline-block;padding-left:0;margin:20px 0;border-radius:4px}.pagination>li{display:inline}.pagination>li>a,.pagination>li>span{position:relative;float:left;padding:6px 12px;margin-left:-1px;line-height:1.42857143;color:#337ab7;text-decoration:none;background-color:#fff;border:1px solid #ddd}.pagination>li:first-child>a,.pagination>li:first-child>span{margin-left:0;border-top-left-radius:4px;border-bottom-left-radius:4px}.pagination>li:last-child>a,.pagination>li:last-child>span{border-top-right-radius:4px;border-bottom-right-radius:4px}.pagination>li>a:focus,.pagination>li>a:hover,.pagination>li>span:focus,.pagination>li>span:hover{z-index:3;color:#23527c;background-color:#eee;border-color:#ddd}.pagination>.active>a,.pagination>.active>a:focus,.pagination>.active>a:hover,.pagination>.active>span,.pagination>.active>span:focus,.pagination>.active>span:hover{z-index:2;color:#fff;cursor:default;background-color:#337ab7;border-color:#337ab7}.pagination>.disabled>a,.pagination>.disabled>a:focus,.pagination>.disabled>a:hover,.pagination>.disabled>span,.pagination>.disabled>span:focus,.pagination>.disabled>span:hover{color:#777;cursor:not-allowed;background-color:#fff;border-color:#ddd}.pagination-lg>li>a,.pagination-lg>li>span{padding:10px 16px;font-size:18px;line-height:1.3333333}.pagination-lg>li:first-child>a,.pagination-lg>li:first-child>span{border-top-left-radius:6px;border-bottom-left-radius:6px}.pagination-lg>li:last-child>a,.pagination-lg>li:last-child>span{border-top-right-radius:6px;border-bottom-right-radius:6px}.pagination-sm>li>a,.pagination-sm>li>span{padding:5px 10px;font-size:12px;line-height:1.5}.pagination-sm>li:first-child>a,.pagination-sm>li:first-child>span{border-top-left-radius:3px;border-bottom-left-radius:3px}.pagination-sm>li:last-child>a,.pagination-sm>li:last-child>span{border-top-right-radius:3px;border-bottom-right-radius:3px}.pager{padding-left:0;margin:20px 0;text-align:center;list-style:none}.pager li{display:inline}.pager li>a,.pager li>span{display:inline-block;padding:5px 14px;background-color:#fff;border:1px solid #ddd;border-radius:15px}.pager li>a:focus,.pager li>a:hover{text-decoration:none;background-color:#eee}.pager .next>a,.pager .next>span{float:right}.pager .previous>a,.pager .previous>span{float:left}.pager .disabled>a,.pager .disabled>a:focus,.pager .disabled>a:hover,.pager .disabled>span{color:#777;cursor:not-allowed;background-color:#fff}.label{display:inline;padding:.2em .6em .3em;font-size:75%;font-weight:700;line-height:1;color:#fff;text-align:center;white-space:nowrap;vertical-align:baseline;border-radius:.25em}a.label:focus,a.label:hover{color:#fff;text-decoration:none;cursor:pointer}.label:empty{display:none}.btn .label{position:relative;top:-1px}.label-default{background-color:#777}.label-default[href]:focus,.label-default[href]:hover{background-color:#5e5e5e}.label-primary{background-color:#337ab7}.label-primary[href]:focus,.label-primary[href]:hover{background-color:#286090}.label-success{background-color:#5cb85c}.label-success[href]:focus,.label-success[href]:hover{background-color:#449d44}.label-info{background-color:#5bc0de}.label-info[href]:focus,.label-info[href]:hover{background-color:#31b0d5}.label-warning{background-color:#f0ad4e}.label-warning[href]:focus,.label-warning[href]:hover{background-color:#ec971f}.label-danger{background-color:#d9534f}.label-danger[href]:focus,.label-danger[href]:hover{background-color:#c9302c}.badge{display:inline-block;min-width:10px;padding:3px 7px;font-size:12px;font-weight:700;line-height:1;color:#fff;text-align:center;white-space:nowrap;vertical-align:middle;background-color:#777;border-radius:10px}.badge:empty{display:none}.btn .badge{position:relative;top:-1px}.btn-group-xs>.btn .badge,.btn-xs .badge{top:0;padding:1px 5px}a.badge:focus,a.badge:hover{color:#fff;text-decoration:none;cursor:pointer}.list-group-item.active>.badge,.nav-pills>.active>a>.badge{color:#337ab7;background-color:#fff}.list-group-item>.badge{float:right}.list-group-item>.badge+.badge{margin-right:5px}.nav-pills>li>a>.badge{margin-left:3px}.jumbotron{padding-top:30px;padding-bottom:30px;margin-bottom:30px;color:inherit;background-color:#eee}.jumbotron .h1,.jumbotron h1{color:inherit}.jumbotron p{margin-bottom:15px;font-size:21px;font-weight:200}.jumbotron>hr{border-top-color:#d5d5d5}.container .jumbotron,.container-fluid .jumbotron{border-radius:6px}.jumbotron .container{max-width:100%}@media screen and (min-width:768px){.jumbotron{padding-top:48px;padding-bottom:48px}.container .jumbotron,.container-fluid .jumbotron{padding-right:60px;padding-left:60px}.jumbotron .h1,.jumbotron h1{font-size:63px}}.thumbnail{display:block;padding:4px;margin-bottom:20px;line-height:1.42857143;background-color:#fff;border:1px solid #ddd;border-radius:4px;-webkit-transition:border .2s ease-in-out;-o-transition:border .2s ease-in-out;transition:border .2s ease-in-out}.thumbnail a>img,.thumbnail>img{margin-right:auto;margin-left:auto}a.thumbnail.active,a.thumbnail:focus,a.thumbnail:hover{border-color:#337ab7}.thumbnail .caption{padding:9px;color:#333}.alert{padding:15px;margin-bottom:20px;border:1px solid transparent;border-radius:4px}.alert h4{margin-top:0;color:inherit}.alert .alert-link{font-weight:700}.alert>p,.alert>ul{margin-bottom:0}.alert>p+p{margin-top:5px}.alert-dismissable,.alert-dismissible{padding-right:35px}.alert-dismissable .close,.alert-dismissible .close{position:relative;top:-2px;right:-21px;color:inherit}.alert-success{color:#3c763d;background-color:#dff0d8;border-color:#d6e9c6}.alert-success hr{border-top-color:#c9e2b3}.alert-success .alert-link{color:#2b542c}.alert-info{color:#31708f;background-color:#d9edf7;border-color:#bce8f1}.alert-info hr{border-top-color:#a6e1ec}.alert-info .alert-link{color:#245269}.alert-warning{color:#8a6d3b;background-color:#fcf8e3;border-color:#faebcc}.alert-warning hr{border-top-color:#f7e1b5}.alert-warning .alert-link{color:#66512c}.alert-danger{color:#a94442;background-color:#f2dede;border-color:#ebccd1}.alert-danger hr{border-top-color:#e4b9c0}.alert-danger .alert-link{color:#843534}@-webkit-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@-o-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}.progress{height:20px;margin-bottom:20px;overflow:hidden;background-color:#f5f5f5;border-radius:4px;-webkit-box-shadow:inset 0 1px 2px rgba(0,0,0,.1);box-shadow:inset 0 1px 2px rgba(0,0,0,.1)}.progress-bar{float:left;width:0;height:100%;font-size:12px;line-height:20px;color:#fff;text-align:center;background-color:#337ab7;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,.15);box-shadow:inset 0 -1px 0 rgba(0,0,0,.15);-webkit-transition:width .6s ease;-o-transition:width .6s ease;transition:width .6s ease}.progress-bar-striped,.progress-striped .progress-bar{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);-webkit-background-size:40px 40px;background-size:40px 40px}.progress-bar.active,.progress.active .progress-bar{-webkit-animation:progress-bar-stripes 2s linear infinite;-o-animation:progress-bar-stripes 2s linear infinite;animation:progress-bar-stripes 2s linear infinite}.progress-bar-success{background-color:#5cb85c}.progress-striped .progress-bar-success{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-info{background-color:#5bc0de}.progress-striped .progress-bar-info{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-warning{background-color:#f0ad4e}.progress-striped .progress-bar-warning{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-danger{background-color:#d9534f}.progress-striped .progress-bar-danger{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.media{margin-top:15px}.media:first-child{margin-top:0}.media,.media-body{overflow:hidden;zoom:1}.media-body{width:10000px}.media-object{display:block}.media-object.img-thumbnail{max-width:none}.media-right,.media>.pull-right{padding-left:10px}.media-left,.media>.pull-left{padding-right:10px}.media-body,.media-left,.media-right{display:table-cell;vertical-align:top}.media-middle{vertical-align:middle}.media-bottom{vertical-align:bottom}.media-heading{margin-top:0;margin-bottom:5px}.media-list{padding-left:0;list-style:none}.list-group{padding-left:0;margin-bottom:20px}.list-group-item{position:relative;display:block;padding:10px 15px;margin-bottom:-1px;background-color:#fff;border:1px solid #ddd}.list-group-item:first-child{border-top-left-radius:4px;border-top-right-radius:4px}.list-group-item:last-child{margin-bottom:0;border-bottom-right-radius:4px;border-bottom-left-radius:4px}a.list-group-item,button.list-group-item{color:#555}a.list-group-item .list-group-item-heading,button.list-group-item .list-group-item-heading{color:#333}a.list-group-item:focus,a.list-group-item:hover,button.list-group-item:focus,button.list-group-item:hover{color:#555;text-decoration:none;background-color:#f5f5f5}button.list-group-item{width:100%;text-align:left}.list-group-item.disabled,.list-group-item.disabled:focus,.list-group-item.disabled:hover{color:#777;cursor:not-allowed;background-color:#eee}.list-group-item.disabled .list-group-item-heading,.list-group-item.disabled:focus .list-group-item-heading,.list-group-item.disabled:hover .list-group-item-heading{color:inherit}.list-group-item.disabled .list-group-item-text,.list-group-item.disabled:focus .list-group-item-text,.list-group-item.disabled:hover .list-group-item-text{color:#777}.list-group-item.active,.list-group-item.active:focus,.list-group-item.active:hover{z-index:2;color:#fff;background-color:#337ab7;border-color:#337ab7}.list-group-item.active .list-group-item-heading,.list-group-item.active .list-group-item-heading>.small,.list-group-item.active .list-group-item-heading>small,.list-group-item.active:focus .list-group-item-heading,.list-group-item.active:focus .list-group-item-heading>.small,.list-group-item.active:focus .list-group-item-heading>small,.list-group-item.active:hover .list-group-item-heading,.list-group-item.active:hover .list-group-item-heading>.small,.list-group-item.active:hover .list-group-item-heading>small{color:inherit}.list-group-item.active .list-group-item-text,.list-group-item.active:focus .list-group-item-text,.list-group-item.active:hover .list-group-item-text{color:#c7ddef}.list-group-item-success{color:#3c763d;background-color:#dff0d8}a.list-group-item-success,button.list-group-item-success{color:#3c763d}a.list-group-item-success .list-group-item-heading,button.list-group-item-success .list-group-item-heading{color:inherit}a.list-group-item-success:focus,a.list-group-item-success:hover,button.list-group-item-success:focus,button.list-group-item-success:hover{color:#3c763d;background-color:#d0e9c6}a.list-group-item-success.active,a.list-group-item-success.active:focus,a.list-group-item-success.active:hover,button.list-group-item-success.active,button.list-group-item-success.active:focus,button.list-group-item-success.active:hover{color:#fff;background-color:#3c763d;border-color:#3c763d}.list-group-item-info{color:#31708f;background-color:#d9edf7}a.list-group-item-info,button.list-group-item-info{color:#31708f}a.list-group-item-info .list-group-item-heading,button.list-group-item-info .list-group-item-heading{color:inherit}a.list-group-item-info:focus,a.list-group-item-info:hover,button.list-group-item-info:focus,button.list-group-item-info:hover{color:#31708f;background-color:#c4e3f3}a.list-group-item-info.active,a.list-group-item-info.active:focus,a.list-group-item-info.active:hover,button.list-group-item-info.active,button.list-group-item-info.active:focus,button.list-group-item-info.active:hover{color:#fff;background-color:#31708f;border-color:#31708f}.list-group-item-warning{color:#8a6d3b;background-color:#fcf8e3}a.list-group-item-warning,button.list-group-item-warning{color:#8a6d3b}a.list-group-item-warning .list-group-item-heading,button.list-group-item-warning .list-group-item-heading{color:inherit}a.list-group-item-warning:focus,a.list-group-item-warning:hover,button.list-group-item-warning:focus,button.list-group-item-warning:hover{color:#8a6d3b;background-color:#faf2cc}a.list-group-item-warning.active,a.list-group-item-warning.active:focus,a.list-group-item-warning.active:hover,button.list-group-item-warning.active,button.list-group-item-warning.active:focus,button.list-group-item-warning.active:hover{color:#fff;background-color:#8a6d3b;border-color:#8a6d3b}.list-group-item-danger{color:#a94442;background-color:#f2dede}a.list-group-item-danger,button.list-group-item-danger{color:#a94442}a.list-group-item-danger .list-group-item-heading,button.list-group-item-danger .list-group-item-heading{color:inherit}a.list-group-item-danger:focus,a.list-group-item-danger:hover,button.list-group-item-danger:focus,button.list-group-item-danger:hover{color:#a94442;background-color:#ebcccc}a.list-group-item-danger.active,a.list-group-item-danger.active:focus,a.list-group-item-danger.active:hover,button.list-group-item-danger.active,button.list-group-item-danger.active:focus,button.list-group-item-danger.active:hover{color:#fff;background-color:#a94442;border-color:#a94442}.list-group-item-heading{margin-top:0;margin-bottom:5px}.list-group-item-text{margin-bottom:0;line-height:1.3}.panel{margin-bottom:20px;background-color:#fff;border:1px solid transparent;border-radius:4px;-webkit-box-shadow:0 1px 1px rgba(0,0,0,.05);box-shadow:0 1px 1px rgba(0,0,0,.05)}.panel-body{padding:15px}.panel-heading{padding:10px 15px;border-bottom:1px solid transparent;border-top-left-radius:3px;border-top-right-radius:3px}.panel-heading>.dropdown .dropdown-toggle{color:inherit}.panel-title{margin-top:0;margin-bottom:0;font-size:16px;color:inherit}.panel-title>.small,.panel-title>.small>a,.panel-title>a,.panel-title>small,.panel-title>small>a{color:inherit}.panel-footer{padding:10px 15px;background-color:#f5f5f5;border-top:1px solid #ddd;border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.list-group,.panel>.panel-collapse>.list-group{margin-bottom:0}.panel>.list-group .list-group-item,.panel>.panel-collapse>.list-group .list-group-item{border-width:1px 0;border-radius:0}.panel>.list-group:first-child .list-group-item:first-child,.panel>.panel-collapse>.list-group:first-child .list-group-item:first-child{border-top:0;border-top-left-radius:3px;border-top-right-radius:3px}.panel>.list-group:last-child .list-group-item:last-child,.panel>.panel-collapse>.list-group:last-child .list-group-item:last-child{border-bottom:0;border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.panel-heading+.panel-collapse>.list-group .list-group-item:first-child{border-top-left-radius:0;border-top-right-radius:0}.panel-heading+.list-group .list-group-item:first-child{border-top-width:0}.list-group+.panel-footer{border-top-width:0}.panel>.panel-collapse>.table,.panel>.table,.panel>.table-responsive>.table{margin-bottom:0}.panel>.panel-collapse>.table caption,.panel>.table caption,.panel>.table-responsive>.table caption{padding-right:15px;padding-left:15px}.panel>.table-responsive:first-child>.table:first-child,.panel>.table:first-child{border-top-left-radius:3px;border-top-right-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child,.panel>.table:first-child>thead:first-child>tr:first-child{border-top-left-radius:3px;border-top-right-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:first-child,.panel>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table:first-child>thead:first-child>tr:first-child th:first-child{border-top-left-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:last-child,.panel>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table:first-child>thead:first-child>tr:first-child th:last-child{border-top-right-radius:3px}.panel>.table-responsive:last-child>.table:last-child,.panel>.table:last-child{border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child{border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:first-child,.panel>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:first-child{border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:last-child{border-bottom-right-radius:3px}.panel>.panel-body+.table,.panel>.panel-body+.table-responsive,.panel>.table+.panel-body,.panel>.table-responsive+.panel-body{border-top:1px solid #ddd}.panel>.table>tbody:first-child>tr:first-child td,.panel>.table>tbody:first-child>tr:first-child th{border-top:0}.panel>.table-bordered,.panel>.table-responsive>.table-bordered{border:0}.panel>.table-bordered>tbody>tr>td:first-child,.panel>.table-bordered>tbody>tr>th:first-child,.panel>.table-bordered>tfoot>tr>td:first-child,.panel>.table-bordered>tfoot>tr>th:first-child,.panel>.table-bordered>thead>tr>td:first-child,.panel>.table-bordered>thead>tr>th:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:first-child,.panel>.table-responsive>.table-bordered>thead>tr>td:first-child,.panel>.table-responsive>.table-bordered>thead>tr>th:first-child{border-left:0}.panel>.table-bordered>tbody>tr>td:last-child,.panel>.table-bordered>tbody>tr>th:last-child,.panel>.table-bordered>tfoot>tr>td:last-child,.panel>.table-bordered>tfoot>tr>th:last-child,.panel>.table-bordered>thead>tr>td:last-child,.panel>.table-bordered>thead>tr>th:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:last-child,.panel>.table-responsive>.table-bordered>thead>tr>td:last-child,.panel>.table-responsive>.table-bordered>thead>tr>th:last-child{border-right:0}.panel>.table-bordered>tbody>tr:first-child>td,.panel>.table-bordered>tbody>tr:first-child>th,.panel>.table-bordered>thead>tr:first-child>td,.panel>.table-bordered>thead>tr:first-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>th,.panel>.table-responsive>.table-bordered>thead>tr:first-child>td,.panel>.table-responsive>.table-bordered>thead>tr:first-child>th{border-bottom:0}.panel>.table-bordered>tbody>tr:last-child>td,.panel>.table-bordered>tbody>tr:last-child>th,.panel>.table-bordered>tfoot>tr:last-child>td,.panel>.table-bordered>tfoot>tr:last-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>th,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>td,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>th{border-bottom:0}.panel>.table-responsive{margin-bottom:0;border:0}.panel-group{margin-bottom:20px}.panel-group .panel{margin-bottom:0;border-radius:4px}.panel-group .panel+.panel{margin-top:5px}.panel-group .panel-heading{border-bottom:0}.panel-group .panel-heading+.panel-collapse>.list-group,.panel-group .panel-heading+.panel-collapse>.panel-body{border-top:1px solid #ddd}.panel-group .panel-footer{border-top:0}.panel-group .panel-footer+.panel-collapse .panel-body{border-bottom:1px solid #ddd}.panel-default{border-color:#ddd}.panel-default>.panel-heading{color:#333;background-color:#f5f5f5;border-color:#ddd}.panel-default>.panel-heading+.panel-collapse>.panel-body{border-top-color:#ddd}.panel-default>.panel-heading .badge{color:#f5f5f5;background-color:#333}.panel-default>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#ddd}.panel-primary{border-color:#337ab7}.panel-primary>.panel-heading{color:#fff;background-color:#337ab7;border-color:#337ab7}.panel-primary>.panel-heading+.panel-collapse>.panel-body{border-top-color:#337ab7}.panel-primary>.panel-heading .badge{color:#337ab7;background-color:#fff}.panel-primary>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#337ab7}.panel-success{border-color:#d6e9c6}.panel-success>.panel-heading{color:#3c763d;background-color:#dff0d8;border-color:#d6e9c6}.panel-success>.panel-heading+.panel-collapse>.panel-body{border-top-color:#d6e9c6}.panel-success>.panel-heading .badge{color:#dff0d8;background-color:#3c763d}.panel-success>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#d6e9c6}.panel-info{border-color:#bce8f1}.panel-info>.panel-heading{color:#31708f;background-color:#d9edf7;border-color:#bce8f1}.panel-info>.panel-heading+.panel-collapse>.panel-body{border-top-color:#bce8f1}.panel-info>.panel-heading .badge{color:#d9edf7;background-color:#31708f}.panel-info>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#bce8f1}.panel-warning{border-color:#faebcc}.panel-warning>.panel-heading{color:#8a6d3b;background-color:#fcf8e3;border-color:#faebcc}.panel-warning>.panel-heading+.panel-collapse>.panel-body{border-top-color:#faebcc}.panel-warning>.panel-heading .badge{color:#fcf8e3;background-color:#8a6d3b}.panel-warning>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#faebcc}.panel-danger{border-color:#ebccd1}.panel-danger>.panel-heading{color:#a94442;background-color:#f2dede;border-color:#ebccd1}.panel-danger>.panel-heading+.panel-collapse>.panel-body{border-top-color:#ebccd1}.panel-danger>.panel-heading .badge{color:#f2dede;background-color:#a94442}.panel-danger>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#ebccd1}.embed-responsive{position:relative;display:block;height:0;padding:0;overflow:hidden}.embed-responsive .embed-responsive-item,.embed-responsive embed,.embed-responsive iframe,.embed-responsive object,.embed-responsive video{position:absolute;top:0;bottom:0;left:0;width:100%;height:100%;border:0}.embed-responsive-16by9{padding-bottom:56.25%}.embed-responsive-4by3{padding-bottom:75%}.well{min-height:20px;padding:19px;margin-bottom:20px;background-color:#f5f5f5;border:1px solid #e3e3e3;border-radius:4px;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.05);box-shadow:inset 0 1px 1px rgba(0,0,0,.05)}.well blockquote{border-color:#ddd;border-color:rgba(0,0,0,.15)}.well-lg{padding:24px;border-radius:6px}.well-sm{padding:9px;border-radius:3px}.close{float:right;font-size:21px;font-weight:700;line-height:1;color:#000;text-shadow:0 1px 0 #fff;filter:alpha(opacity=20);opacity:.2}.close:focus,.close:hover{color:#000;text-decoration:none;cursor:pointer;filter:alpha(opacity=50);opacity:.5}button.close{-webkit-appearance:none;padding:0;cursor:pointer;background:0 0;border:0}.modal-open{overflow:hidden}.modal{position:fixed;top:0;right:0;bottom:0;left:0;z-index:1050;display:none;overflow:hidden;-webkit-overflow-scrolling:touch;outline:0}.modal.fade .modal-dialog{-webkit-transition:-webkit-transform .3s ease-out;-o-transition:-o-transform .3s ease-out;transition:transform .3s ease-out;-webkit-transform:translate(0,-25%);-ms-transform:translate(0,-25%);-o-transform:translate(0,-25%);transform:translate(0,-25%)}.modal.in .modal-dialog{-webkit-transform:translate(0,0);-ms-transform:translate(0,0);-o-transform:translate(0,0);transform:translate(0,0)}.modal-open .modal{overflow-x:hidden;overflow-y:auto}.modal-dialog{position:relative;width:auto;margin:10px}.modal-content{position:relative;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #999;border:1px solid rgba(0,0,0,.2);border-radius:6px;outline:0;-webkit-box-shadow:0 3px 9px rgba(0,0,0,.5);box-shadow:0 3px 9px rgba(0,0,0,.5)}.modal-backdrop{position:fixed;top:0;right:0;bottom:0;left:0;z-index:1040;background-color:#000}.modal-backdrop.fade{filter:alpha(opacity=0);opacity:0}.modal-backdrop.in{filter:alpha(opacity=50);opacity:.5}.modal-header{min-height:16.43px;padding:15px;border-bottom:1px solid #e5e5e5}.modal-header .close{margin-top:-2px}.modal-title{margin:0;line-height:1.42857143}.modal-body{position:relative;padding:15px}.modal-footer{padding:15px;text-align:right;border-top:1px solid #e5e5e5}.modal-footer .btn+.btn{margin-bottom:0;margin-left:5px}.modal-footer .btn-group .btn+.btn{margin-left:-1px}.modal-footer .btn-block+.btn-block{margin-left:0}.modal-scrollbar-measure{position:absolute;top:-9999px;width:50px;height:50px;overflow:scroll}@media (min-width:768px){.modal-dialog{width:600px;margin:30px auto}.modal-content{-webkit-box-shadow:0 5px 15px rgba(0,0,0,.5);box-shadow:0 5px 15px rgba(0,0,0,.5)}.modal-sm{width:300px}}@media (min-width:992px){.modal-lg{width:900px}}.tooltip{position:absolute;z-index:1070;display:block;font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:12px;font-style:normal;font-weight:400;line-height:1.42857143;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;letter-spacing:normal;word-break:normal;word-spacing:normal;word-wrap:normal;white-space:normal;filter:alpha(opacity=0);opacity:0;line-break:auto}.tooltip.in{filter:alpha(opacity=90);opacity:.9}.tooltip.top{padding:5px 0;margin-top:-3px}.tooltip.right{padding:0 5px;margin-left:3px}.tooltip.bottom{padding:5px 0;margin-top:3px}.tooltip.left{padding:0 5px;margin-left:-3px}.tooltip-inner{max-width:200px;padding:3px 8px;color:#fff;text-align:center;background-color:#000;border-radius:4px}.tooltip-arrow{position:absolute;width:0;height:0;border-color:transparent;border-style:solid}.tooltip.top .tooltip-arrow{bottom:0;left:50%;margin-left:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.top-left .tooltip-arrow{right:5px;bottom:0;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.top-right .tooltip-arrow{bottom:0;left:5px;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.right .tooltip-arrow{top:50%;left:0;margin-top:-5px;border-width:5px 5px 5px 0;border-right-color:#000}.tooltip.left .tooltip-arrow{top:50%;right:0;margin-top:-5px;border-width:5px 0 5px 5px;border-left-color:#000}.tooltip.bottom .tooltip-arrow{top:0;left:50%;margin-left:-5px;border-width:0 5px 5px;border-bottom-color:#000}.tooltip.bottom-left .tooltip-arrow{top:0;right:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#000}.tooltip.bottom-right .tooltip-arrow{top:0;left:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#000}.popover{position:absolute;top:0;left:0;z-index:1060;display:none;max-width:276px;padding:1px;font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;font-style:normal;font-weight:400;line-height:1.42857143;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;letter-spacing:normal;word-break:normal;word-spacing:normal;word-wrap:normal;white-space:normal;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #ccc;border:1px solid rgba(0,0,0,.2);border-radius:6px;-webkit-box-shadow:0 5px 10px rgba(0,0,0,.2);box-shadow:0 5px 10px rgba(0,0,0,.2);line-break:auto}.popover.top{margin-top:-10px}.popover.right{margin-left:10px}.popover.bottom{margin-top:10px}.popover.left{margin-left:-10px}.popover-title{padding:8px 14px;margin:0;font-size:14px;background-color:#f7f7f7;border-bottom:1px solid #ebebeb;border-radius:5px 5px 0 0}.popover-content{padding:9px 14px}.popover>.arrow,.popover>.arrow:after{position:absolute;display:block;width:0;height:0;border-color:transparent;border-style:solid}.popover>.arrow{border-width:11px}.popover>.arrow:after{content:"";border-width:10px}.popover.top>.arrow{bottom:-11px;left:50%;margin-left:-11px;border-top-color:#999;border-top-color:rgba(0,0,0,.25);border-bottom-width:0}.popover.top>.arrow:after{bottom:1px;margin-left:-10px;content:" ";border-top-color:#fff;border-bottom-width:0}.popover.right>.arrow{top:50%;left:-11px;margin-top:-11px;border-right-color:#999;border-right-color:rgba(0,0,0,.25);border-left-width:0}.popover.right>.arrow:after{bottom:-10px;left:1px;content:" ";border-right-color:#fff;border-left-width:0}.popover.bottom>.arrow{top:-11px;left:50%;margin-left:-11px;border-top-width:0;border-bottom-color:#999;border-bottom-color:rgba(0,0,0,.25)}.popover.bottom>.arrow:after{top:1px;margin-left:-10px;content:" ";border-top-width:0;border-bottom-color:#fff}.popover.left>.arrow{top:50%;right:-11px;margin-top:-11px;border-right-width:0;border-left-color:#999;border-left-color:rgba(0,0,0,.25)}.popover.left>.arrow:after{right:1px;bottom:-10px;content:" ";border-right-width:0;border-left-color:#fff}.carousel{position:relative}.carousel-inner{position:relative;width:100%;overflow:hidden}.carousel-inner>.item{position:relative;display:none;-webkit-transition:.6s ease-in-out left;-o-transition:.6s ease-in-out left;transition:.6s ease-in-out left}.carousel-inner>.item>a>img,.carousel-inner>.item>img{line-height:1}@media all and (transform-3d),(-webkit-transform-3d){.carousel-inner>.item{-webkit-transition:-webkit-transform .6s ease-in-out;-o-transition:-o-transform .6s ease-in-out;transition:transform .6s ease-in-out;-webkit-backface-visibility:hidden;backface-visibility:hidden;-webkit-perspective:1000px;perspective:1000px}.carousel-inner>.item.active.right,.carousel-inner>.item.next{left:0;-webkit-transform:translate3d(100%,0,0);transform:translate3d(100%,0,0)}.carousel-inner>.item.active.left,.carousel-inner>.item.prev{left:0;-webkit-transform:translate3d(-100%,0,0);transform:translate3d(-100%,0,0)}.carousel-inner>.item.active,.carousel-inner>.item.next.left,.carousel-inner>.item.prev.right{left:0;-webkit-transform:translate3d(0,0,0);transform:translate3d(0,0,0)}}.carousel-inner>.active,.carousel-inner>.next,.carousel-inner>.prev{display:block}.carousel-inner>.active{left:0}.carousel-inner>.next,.carousel-inner>.prev{position:absolute;top:0;width:100%}.carousel-inner>.next{left:100%}.carousel-inner>.prev{left:-100%}.carousel-inner>.next.left,.carousel-inner>.prev.right{left:0}.carousel-inner>.active.left{left:-100%}.carousel-inner>.active.right{left:100%}.carousel-control{position:absolute;top:0;bottom:0;left:0;width:15%;font-size:20px;color:#fff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,.6);filter:alpha(opacity=50);opacity:.5}.carousel-control.left{background-image:-webkit-linear-gradient(left,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);background-image:-o-linear-gradient(left,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);background-image:-webkit-gradient(linear,left top,right top,from(rgba(0,0,0,.5)),to(rgba(0,0,0,.0001)));background-image:linear-gradient(to right,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#80000000', endColorstr='#00000000', GradientType=1);background-repeat:repeat-x}.carousel-control.right{right:0;left:auto;background-image:-webkit-linear-gradient(left,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);background-image:-o-linear-gradient(left,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);background-image:-webkit-gradient(linear,left top,right top,from(rgba(0,0,0,.0001)),to(rgba(0,0,0,.5)));background-image:linear-gradient(to right,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#00000000', endColorstr='#80000000', GradientType=1);background-repeat:repeat-x}.carousel-control:focus,.carousel-control:hover{color:#fff;text-decoration:none;filter:alpha(opacity=90);outline:0;opacity:.9}.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next,.carousel-control .icon-prev{position:absolute;top:50%;z-index:5;display:inline-block;margin-top:-10px}.carousel-control .glyphicon-chevron-left,.carousel-control .icon-prev{left:50%;margin-left:-10px}.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next{right:50%;margin-right:-10px}.carousel-control .icon-next,.carousel-control .icon-prev{width:20px;height:20px;font-family:serif;line-height:1}.carousel-control .icon-prev:before{content:'\2039'}.carousel-control .icon-next:before{content:'\203a'}.carousel-indicators{position:absolute;bottom:10px;left:50%;z-index:15;width:60%;padding-left:0;margin-left:-30%;text-align:center;list-style:none}.carousel-indicators li{display:inline-block;width:10px;height:10px;margin:1px;text-indent:-999px;cursor:pointer;background-color:#000\9;background-color:rgba(0,0,0,0);border:1px solid #fff;border-radius:10px}.carousel-indicators .active{width:12px;height:12px;margin:0;background-color:#fff}.carousel-caption{position:absolute;right:15%;bottom:20px;left:15%;z-index:10;padding-top:20px;padding-bottom:20px;color:#fff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,.6)}.carousel-caption .btn{text-shadow:none}@media screen and (min-width:768px){.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next,.carousel-control .icon-prev{width:30px;height:30px;margin-top:-15px;font-size:30px}.carousel-control .glyphicon-chevron-left,.carousel-control .icon-prev{margin-left:-15px}.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next{margin-right:-15px}.carousel-caption{right:20%;left:20%;padding-bottom:30px}.carousel-indicators{bottom:20px}}.btn-group-vertical>.btn-group:after,.btn-group-vertical>.btn-group:before,.btn-toolbar:after,.btn-toolbar:before,.clearfix:after,.clearfix:before,.container-fluid:after,.container-fluid:before,.container:after,.container:before,.dl-horizontal dd:after,.dl-horizontal dd:before,.form-horizontal .form-group:after,.form-horizontal .form-group:before,.modal-footer:after,.modal-footer:before,.nav:after,.nav:before,.navbar-collapse:after,.navbar-collapse:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.pager:after,.pager:before,.panel-body:after,.panel-body:before,.row:after,.row:before{display:table;content:" "}.btn-group-vertical>.btn-group:after,.btn-toolbar:after,.clearfix:after,.container-fluid:after,.container:after,.dl-horizontal dd:after,.form-horizontal .form-group:after,.modal-footer:after,.nav:after,.navbar-collapse:after,.navbar-header:after,.navbar:after,.pager:after,.panel-body:after,.row:after{clear:both}.center-block{display:block;margin-right:auto;margin-left:auto}.pull-right{float:right!important}.pull-left{float:left!important}.hide{display:none!important}.show{display:block!important}.invisible{visibility:hidden}.text-hide{font:0/0 a;color:transparent;text-shadow:none;background-color:transparent;border:0}.hidden{display:none!important}.affix{position:fixed}@-ms-viewport{width:device-width}.visible-lg,.visible-md,.visible-sm,.visible-xs{display:none!important}.visible-lg-block,.visible-lg-inline,.visible-lg-inline-block,.visible-md-block,.visible-md-inline,.visible-md-inline-block,.visible-sm-block,.visible-sm-inline,.visible-sm-inline-block,.visible-xs-block,.visible-xs-inline,.visible-xs-inline-block{display:none!important}@media (max-width:767px){.visible-xs{display:block!important}table.visible-xs{display:table!important}tr.visible-xs{display:table-row!important}td.visible-xs,th.visible-xs{display:table-cell!important}}@media (max-width:767px){.visible-xs-block{display:block!important}}@media (max-width:767px){.visible-xs-inline{display:inline!important}}@media (max-width:767px){.visible-xs-inline-block{display:inline-block!important}}@media (min-width:768px) and (max-width:991px){.visible-sm{display:block!important}table.visible-sm{display:table!important}tr.visible-sm{display:table-row!important}td.visible-sm,th.visible-sm{display:table-cell!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-block{display:block!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline{display:inline!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline-block{display:inline-block!important}}@media (min-width:992px) and (max-width:1199px){.visible-md{display:block!important}table.visible-md{display:table!important}tr.visible-md{display:table-row!important}td.visible-md,th.visible-md{display:table-cell!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-block{display:block!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline{display:inline!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline-block{display:inline-block!important}}@media (min-width:1200px){.visible-lg{display:block!important}table.visible-lg{display:table!important}tr.visible-lg{display:table-row!important}td.visible-lg,th.visible-lg{display:table-cell!important}}@media (min-width:1200px){.visible-lg-block{display:block!important}}@media (min-width:1200px){.visible-lg-inline{display:inline!important}}@media (min-width:1200px){.visible-lg-inline-block{display:inline-block!important}}@media (max-width:767px){.hidden-xs{display:none!important}}@media (min-width:768px) and (max-width:991px){.hidden-sm{display:none!important}}@media (min-width:992px) and (max-width:1199px){.hidden-md{display:none!important}}@media (min-width:1200px){.hidden-lg{display:none!important}}.visible-print{display:none!important}@media print{.visible-print{display:block!important}table.visible-print{display:table!important}tr.visible-print{display:table-row!important}td.visible-print,th.visible-print{display:table-cell!important}}.visible-print-block{display:none!important}@media print{.visible-print-block{display:block!important}}.visible-print-inline{display:none!important}@media print{.visible-print-inline{display:inline!important}}.visible-print-inline-block{display:none!important}@media print{.visible-print-inline-block{display:inline-block!important}}@media print{.hidden-print{display:none!important}}
</style>
<script>/*!
 * Bootstrap v3.3.5 (http://getbootstrap.com)
 * Copyright 2011-2015 Twitter, Inc.
 * Licensed under the MIT license
 */
if("undefined"==typeof jQuery)throw new Error("Bootstrap's JavaScript requires jQuery");+function(a){"use strict";var b=a.fn.jquery.split(" ")[0].split(".");if(b[0]<2&&b[1]<9||1==b[0]&&9==b[1]&&b[2]<1)throw new Error("Bootstrap's JavaScript requires jQuery version 1.9.1 or higher")}(jQuery),+function(a){"use strict";function b(){var a=document.createElement("bootstrap"),b={WebkitTransition:"webkitTransitionEnd",MozTransition:"transitionend",OTransition:"oTransitionEnd otransitionend",transition:"transitionend"};for(var c in b)if(void 0!==a.style[c])return{end:b[c]};return!1}a.fn.emulateTransitionEnd=function(b){var c=!1,d=this;a(this).one("bsTransitionEnd",function(){c=!0});var e=function(){c||a(d).trigger(a.support.transition.end)};return setTimeout(e,b),this},a(function(){a.support.transition=b(),a.support.transition&&(a.event.special.bsTransitionEnd={bindType:a.support.transition.end,delegateType:a.support.transition.end,handle:function(b){return a(b.target).is(this)?b.handleObj.handler.apply(this,arguments):void 0}})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var c=a(this),e=c.data("bs.alert");e||c.data("bs.alert",e=new d(this)),"string"==typeof b&&e[b].call(c)})}var c='[data-dismiss="alert"]',d=function(b){a(b).on("click",c,this.close)};d.VERSION="3.3.5",d.TRANSITION_DURATION=150,d.prototype.close=function(b){function c(){g.detach().trigger("closed.bs.alert").remove()}var e=a(this),f=e.attr("data-target");f||(f=e.attr("href"),f=f&&f.replace(/.*(?=#[^\s]*$)/,""));var g=a(f);b&&b.preventDefault(),g.length||(g=e.closest(".alert")),g.trigger(b=a.Event("close.bs.alert")),b.isDefaultPrevented()||(g.removeClass("in"),a.support.transition&&g.hasClass("fade")?g.one("bsTransitionEnd",c).emulateTransitionEnd(d.TRANSITION_DURATION):c())};var e=a.fn.alert;a.fn.alert=b,a.fn.alert.Constructor=d,a.fn.alert.noConflict=function(){return a.fn.alert=e,this},a(document).on("click.bs.alert.data-api",c,d.prototype.close)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.button"),f="object"==typeof b&&b;e||d.data("bs.button",e=new c(this,f)),"toggle"==b?e.toggle():b&&e.setState(b)})}var c=function(b,d){this.$element=a(b),this.options=a.extend({},c.DEFAULTS,d),this.isLoading=!1};c.VERSION="3.3.5",c.DEFAULTS={loadingText:"loading..."},c.prototype.setState=function(b){var c="disabled",d=this.$element,e=d.is("input")?"val":"html",f=d.data();b+="Text",null==f.resetText&&d.data("resetText",d[e]()),setTimeout(a.proxy(function(){d[e](null==f[b]?this.options[b]:f[b]),"loadingText"==b?(this.isLoading=!0,d.addClass(c).attr(c,c)):this.isLoading&&(this.isLoading=!1,d.removeClass(c).removeAttr(c))},this),0)},c.prototype.toggle=function(){var a=!0,b=this.$element.closest('[data-toggle="buttons"]');if(b.length){var c=this.$element.find("input");"radio"==c.prop("type")?(c.prop("checked")&&(a=!1),b.find(".active").removeClass("active"),this.$element.addClass("active")):"checkbox"==c.prop("type")&&(c.prop("checked")!==this.$element.hasClass("active")&&(a=!1),this.$element.toggleClass("active")),c.prop("checked",this.$element.hasClass("active")),a&&c.trigger("change")}else this.$element.attr("aria-pressed",!this.$element.hasClass("active")),this.$element.toggleClass("active")};var d=a.fn.button;a.fn.button=b,a.fn.button.Constructor=c,a.fn.button.noConflict=function(){return a.fn.button=d,this},a(document).on("click.bs.button.data-api",'[data-toggle^="button"]',function(c){var d=a(c.target);d.hasClass("btn")||(d=d.closest(".btn")),b.call(d,"toggle"),a(c.target).is('input[type="radio"]')||a(c.target).is('input[type="checkbox"]')||c.preventDefault()}).on("focus.bs.button.data-api blur.bs.button.data-api",'[data-toggle^="button"]',function(b){a(b.target).closest(".btn").toggleClass("focus",/^focus(in)?$/.test(b.type))})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.carousel"),f=a.extend({},c.DEFAULTS,d.data(),"object"==typeof b&&b),g="string"==typeof b?b:f.slide;e||d.data("bs.carousel",e=new c(this,f)),"number"==typeof b?e.to(b):g?e[g]():f.interval&&e.pause().cycle()})}var c=function(b,c){this.$element=a(b),this.$indicators=this.$element.find(".carousel-indicators"),this.options=c,this.paused=null,this.sliding=null,this.interval=null,this.$active=null,this.$items=null,this.options.keyboard&&this.$element.on("keydown.bs.carousel",a.proxy(this.keydown,this)),"hover"==this.options.pause&&!("ontouchstart"in document.documentElement)&&this.$element.on("mouseenter.bs.carousel",a.proxy(this.pause,this)).on("mouseleave.bs.carousel",a.proxy(this.cycle,this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=600,c.DEFAULTS={interval:5e3,pause:"hover",wrap:!0,keyboard:!0},c.prototype.keydown=function(a){if(!/input|textarea/i.test(a.target.tagName)){switch(a.which){case 37:this.prev();break;case 39:this.next();break;default:return}a.preventDefault()}},c.prototype.cycle=function(b){return b||(this.paused=!1),this.interval&&clearInterval(this.interval),this.options.interval&&!this.paused&&(this.interval=setInterval(a.proxy(this.next,this),this.options.interval)),this},c.prototype.getItemIndex=function(a){return this.$items=a.parent().children(".item"),this.$items.index(a||this.$active)},c.prototype.getItemForDirection=function(a,b){var c=this.getItemIndex(b),d="prev"==a&&0===c||"next"==a&&c==this.$items.length-1;if(d&&!this.options.wrap)return b;var e="prev"==a?-1:1,f=(c+e)%this.$items.length;return this.$items.eq(f)},c.prototype.to=function(a){var b=this,c=this.getItemIndex(this.$active=this.$element.find(".item.active"));return a>this.$items.length-1||0>a?void 0:this.sliding?this.$element.one("slid.bs.carousel",function(){b.to(a)}):c==a?this.pause().cycle():this.slide(a>c?"next":"prev",this.$items.eq(a))},c.prototype.pause=function(b){return b||(this.paused=!0),this.$element.find(".next, .prev").length&&a.support.transition&&(this.$element.trigger(a.support.transition.end),this.cycle(!0)),this.interval=clearInterval(this.interval),this},c.prototype.next=function(){return this.sliding?void 0:this.slide("next")},c.prototype.prev=function(){return this.sliding?void 0:this.slide("prev")},c.prototype.slide=function(b,d){var e=this.$element.find(".item.active"),f=d||this.getItemForDirection(b,e),g=this.interval,h="next"==b?"left":"right",i=this;if(f.hasClass("active"))return this.sliding=!1;var j=f[0],k=a.Event("slide.bs.carousel",{relatedTarget:j,direction:h});if(this.$element.trigger(k),!k.isDefaultPrevented()){if(this.sliding=!0,g&&this.pause(),this.$indicators.length){this.$indicators.find(".active").removeClass("active");var l=a(this.$indicators.children()[this.getItemIndex(f)]);l&&l.addClass("active")}var m=a.Event("slid.bs.carousel",{relatedTarget:j,direction:h});return a.support.transition&&this.$element.hasClass("slide")?(f.addClass(b),f[0].offsetWidth,e.addClass(h),f.addClass(h),e.one("bsTransitionEnd",function(){f.removeClass([b,h].join(" ")).addClass("active"),e.removeClass(["active",h].join(" ")),i.sliding=!1,setTimeout(function(){i.$element.trigger(m)},0)}).emulateTransitionEnd(c.TRANSITION_DURATION)):(e.removeClass("active"),f.addClass("active"),this.sliding=!1,this.$element.trigger(m)),g&&this.cycle(),this}};var d=a.fn.carousel;a.fn.carousel=b,a.fn.carousel.Constructor=c,a.fn.carousel.noConflict=function(){return a.fn.carousel=d,this};var e=function(c){var d,e=a(this),f=a(e.attr("data-target")||(d=e.attr("href"))&&d.replace(/.*(?=#[^\s]+$)/,""));if(f.hasClass("carousel")){var g=a.extend({},f.data(),e.data()),h=e.attr("data-slide-to");h&&(g.interval=!1),b.call(f,g),h&&f.data("bs.carousel").to(h),c.preventDefault()}};a(document).on("click.bs.carousel.data-api","[data-slide]",e).on("click.bs.carousel.data-api","[data-slide-to]",e),a(window).on("load",function(){a('[data-ride="carousel"]').each(function(){var c=a(this);b.call(c,c.data())})})}(jQuery),+function(a){"use strict";function b(b){var c,d=b.attr("data-target")||(c=b.attr("href"))&&c.replace(/.*(?=#[^\s]+$)/,"");return a(d)}function c(b){return this.each(function(){var c=a(this),e=c.data("bs.collapse"),f=a.extend({},d.DEFAULTS,c.data(),"object"==typeof b&&b);!e&&f.toggle&&/show|hide/.test(b)&&(f.toggle=!1),e||c.data("bs.collapse",e=new d(this,f)),"string"==typeof b&&e[b]()})}var d=function(b,c){this.$element=a(b),this.options=a.extend({},d.DEFAULTS,c),this.$trigger=a('[data-toggle="collapse"][href="#'+b.id+'"],[data-toggle="collapse"][data-target="#'+b.id+'"]'),this.transitioning=null,this.options.parent?this.$parent=this.getParent():this.addAriaAndCollapsedClass(this.$element,this.$trigger),this.options.toggle&&this.toggle()};d.VERSION="3.3.5",d.TRANSITION_DURATION=350,d.DEFAULTS={toggle:!0},d.prototype.dimension=function(){var a=this.$element.hasClass("width");return a?"width":"height"},d.prototype.show=function(){if(!this.transitioning&&!this.$element.hasClass("in")){var b,e=this.$parent&&this.$parent.children(".panel").children(".in, .collapsing");if(!(e&&e.length&&(b=e.data("bs.collapse"),b&&b.transitioning))){var f=a.Event("show.bs.collapse");if(this.$element.trigger(f),!f.isDefaultPrevented()){e&&e.length&&(c.call(e,"hide"),b||e.data("bs.collapse",null));var g=this.dimension();this.$element.removeClass("collapse").addClass("collapsing")[g](0).attr("aria-expanded",!0),this.$trigger.removeClass("collapsed").attr("aria-expanded",!0),this.transitioning=1;var h=function(){this.$element.removeClass("collapsing").addClass("collapse in")[g](""),this.transitioning=0,this.$element.trigger("shown.bs.collapse")};if(!a.support.transition)return h.call(this);var i=a.camelCase(["scroll",g].join("-"));this.$element.one("bsTransitionEnd",a.proxy(h,this)).emulateTransitionEnd(d.TRANSITION_DURATION)[g](this.$element[0][i])}}}},d.prototype.hide=function(){if(!this.transitioning&&this.$element.hasClass("in")){var b=a.Event("hide.bs.collapse");if(this.$element.trigger(b),!b.isDefaultPrevented()){var c=this.dimension();this.$element[c](this.$element[c]())[0].offsetHeight,this.$element.addClass("collapsing").removeClass("collapse in").attr("aria-expanded",!1),this.$trigger.addClass("collapsed").attr("aria-expanded",!1),this.transitioning=1;var e=function(){this.transitioning=0,this.$element.removeClass("collapsing").addClass("collapse").trigger("hidden.bs.collapse")};return a.support.transition?void this.$element[c](0).one("bsTransitionEnd",a.proxy(e,this)).emulateTransitionEnd(d.TRANSITION_DURATION):e.call(this)}}},d.prototype.toggle=function(){this[this.$element.hasClass("in")?"hide":"show"]()},d.prototype.getParent=function(){return a(this.options.parent).find('[data-toggle="collapse"][data-parent="'+this.options.parent+'"]').each(a.proxy(function(c,d){var e=a(d);this.addAriaAndCollapsedClass(b(e),e)},this)).end()},d.prototype.addAriaAndCollapsedClass=function(a,b){var c=a.hasClass("in");a.attr("aria-expanded",c),b.toggleClass("collapsed",!c).attr("aria-expanded",c)};var e=a.fn.collapse;a.fn.collapse=c,a.fn.collapse.Constructor=d,a.fn.collapse.noConflict=function(){return a.fn.collapse=e,this},a(document).on("click.bs.collapse.data-api",'[data-toggle="collapse"]',function(d){var e=a(this);e.attr("data-target")||d.preventDefault();var f=b(e),g=f.data("bs.collapse"),h=g?"toggle":e.data();c.call(f,h)})}(jQuery),+function(a){"use strict";function b(b){var c=b.attr("data-target");c||(c=b.attr("href"),c=c&&/#[A-Za-z]/.test(c)&&c.replace(/.*(?=#[^\s]*$)/,""));var d=c&&a(c);return d&&d.length?d:b.parent()}function c(c){c&&3===c.which||(a(e).remove(),a(f).each(function(){var d=a(this),e=b(d),f={relatedTarget:this};e.hasClass("open")&&(c&&"click"==c.type&&/input|textarea/i.test(c.target.tagName)&&a.contains(e[0],c.target)||(e.trigger(c=a.Event("hide.bs.dropdown",f)),c.isDefaultPrevented()||(d.attr("aria-expanded","false"),e.removeClass("open").trigger("hidden.bs.dropdown",f))))}))}function d(b){return this.each(function(){var c=a(this),d=c.data("bs.dropdown");d||c.data("bs.dropdown",d=new g(this)),"string"==typeof b&&d[b].call(c)})}var e=".dropdown-backdrop",f='[data-toggle="dropdown"]',g=function(b){a(b).on("click.bs.dropdown",this.toggle)};g.VERSION="3.3.5",g.prototype.toggle=function(d){var e=a(this);if(!e.is(".disabled, :disabled")){var f=b(e),g=f.hasClass("open");if(c(),!g){"ontouchstart"in document.documentElement&&!f.closest(".navbar-nav").length&&a(document.createElement("div")).addClass("dropdown-backdrop").insertAfter(a(this)).on("click",c);var h={relatedTarget:this};if(f.trigger(d=a.Event("show.bs.dropdown",h)),d.isDefaultPrevented())return;e.trigger("focus").attr("aria-expanded","true"),f.toggleClass("open").trigger("shown.bs.dropdown",h)}return!1}},g.prototype.keydown=function(c){if(/(38|40|27|32)/.test(c.which)&&!/input|textarea/i.test(c.target.tagName)){var d=a(this);if(c.preventDefault(),c.stopPropagation(),!d.is(".disabled, :disabled")){var e=b(d),g=e.hasClass("open");if(!g&&27!=c.which||g&&27==c.which)return 27==c.which&&e.find(f).trigger("focus"),d.trigger("click");var h=" li:not(.disabled):visible a",i=e.find(".dropdown-menu"+h);if(i.length){var j=i.index(c.target);38==c.which&&j>0&&j--,40==c.which&&j<i.length-1&&j++,~j||(j=0),i.eq(j).trigger("focus")}}}};var h=a.fn.dropdown;a.fn.dropdown=d,a.fn.dropdown.Constructor=g,a.fn.dropdown.noConflict=function(){return a.fn.dropdown=h,this},a(document).on("click.bs.dropdown.data-api",c).on("click.bs.dropdown.data-api",".dropdown form",function(a){a.stopPropagation()}).on("click.bs.dropdown.data-api",f,g.prototype.toggle).on("keydown.bs.dropdown.data-api",f,g.prototype.keydown).on("keydown.bs.dropdown.data-api",".dropdown-menu",g.prototype.keydown)}(jQuery),+function(a){"use strict";function b(b,d){return this.each(function(){var e=a(this),f=e.data("bs.modal"),g=a.extend({},c.DEFAULTS,e.data(),"object"==typeof b&&b);f||e.data("bs.modal",f=new c(this,g)),"string"==typeof b?f[b](d):g.show&&f.show(d)})}var c=function(b,c){this.options=c,this.$body=a(document.body),this.$element=a(b),this.$dialog=this.$element.find(".modal-dialog"),this.$backdrop=null,this.isShown=null,this.originalBodyPad=null,this.scrollbarWidth=0,this.ignoreBackdropClick=!1,this.options.remote&&this.$element.find(".modal-content").load(this.options.remote,a.proxy(function(){this.$element.trigger("loaded.bs.modal")},this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=300,c.BACKDROP_TRANSITION_DURATION=150,c.DEFAULTS={backdrop:!0,keyboard:!0,show:!0},c.prototype.toggle=function(a){return this.isShown?this.hide():this.show(a)},c.prototype.show=function(b){var d=this,e=a.Event("show.bs.modal",{relatedTarget:b});this.$element.trigger(e),this.isShown||e.isDefaultPrevented()||(this.isShown=!0,this.checkScrollbar(),this.setScrollbar(),this.$body.addClass("modal-open"),this.escape(),this.resize(),this.$element.on("click.dismiss.bs.modal",'[data-dismiss="modal"]',a.proxy(this.hide,this)),this.$dialog.on("mousedown.dismiss.bs.modal",function(){d.$element.one("mouseup.dismiss.bs.modal",function(b){a(b.target).is(d.$element)&&(d.ignoreBackdropClick=!0)})}),this.backdrop(function(){var e=a.support.transition&&d.$element.hasClass("fade");d.$element.parent().length||d.$element.appendTo(d.$body),d.$element.show().scrollTop(0),d.adjustDialog(),e&&d.$element[0].offsetWidth,d.$element.addClass("in"),d.enforceFocus();var f=a.Event("shown.bs.modal",{relatedTarget:b});e?d.$dialog.one("bsTransitionEnd",function(){d.$element.trigger("focus").trigger(f)}).emulateTransitionEnd(c.TRANSITION_DURATION):d.$element.trigger("focus").trigger(f)}))},c.prototype.hide=function(b){b&&b.preventDefault(),b=a.Event("hide.bs.modal"),this.$element.trigger(b),this.isShown&&!b.isDefaultPrevented()&&(this.isShown=!1,this.escape(),this.resize(),a(document).off("focusin.bs.modal"),this.$element.removeClass("in").off("click.dismiss.bs.modal").off("mouseup.dismiss.bs.modal"),this.$dialog.off("mousedown.dismiss.bs.modal"),a.support.transition&&this.$element.hasClass("fade")?this.$element.one("bsTransitionEnd",a.proxy(this.hideModal,this)).emulateTransitionEnd(c.TRANSITION_DURATION):this.hideModal())},c.prototype.enforceFocus=function(){a(document).off("focusin.bs.modal").on("focusin.bs.modal",a.proxy(function(a){this.$element[0]===a.target||this.$element.has(a.target).length||this.$element.trigger("focus")},this))},c.prototype.escape=function(){this.isShown&&this.options.keyboard?this.$element.on("keydown.dismiss.bs.modal",a.proxy(function(a){27==a.which&&this.hide()},this)):this.isShown||this.$element.off("keydown.dismiss.bs.modal")},c.prototype.resize=function(){this.isShown?a(window).on("resize.bs.modal",a.proxy(this.handleUpdate,this)):a(window).off("resize.bs.modal")},c.prototype.hideModal=function(){var a=this;this.$element.hide(),this.backdrop(function(){a.$body.removeClass("modal-open"),a.resetAdjustments(),a.resetScrollbar(),a.$element.trigger("hidden.bs.modal")})},c.prototype.removeBackdrop=function(){this.$backdrop&&this.$backdrop.remove(),this.$backdrop=null},c.prototype.backdrop=function(b){var d=this,e=this.$element.hasClass("fade")?"fade":"";if(this.isShown&&this.options.backdrop){var f=a.support.transition&&e;if(this.$backdrop=a(document.createElement("div")).addClass("modal-backdrop "+e).appendTo(this.$body),this.$element.on("click.dismiss.bs.modal",a.proxy(function(a){return this.ignoreBackdropClick?void(this.ignoreBackdropClick=!1):void(a.target===a.currentTarget&&("static"==this.options.backdrop?this.$element[0].focus():this.hide()))},this)),f&&this.$backdrop[0].offsetWidth,this.$backdrop.addClass("in"),!b)return;f?this.$backdrop.one("bsTransitionEnd",b).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):b()}else if(!this.isShown&&this.$backdrop){this.$backdrop.removeClass("in");var g=function(){d.removeBackdrop(),b&&b()};a.support.transition&&this.$element.hasClass("fade")?this.$backdrop.one("bsTransitionEnd",g).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):g()}else b&&b()},c.prototype.handleUpdate=function(){this.adjustDialog()},c.prototype.adjustDialog=function(){var a=this.$element[0].scrollHeight>document.documentElement.clientHeight;this.$element.css({paddingLeft:!this.bodyIsOverflowing&&a?this.scrollbarWidth:"",paddingRight:this.bodyIsOverflowing&&!a?this.scrollbarWidth:""})},c.prototype.resetAdjustments=function(){this.$element.css({paddingLeft:"",paddingRight:""})},c.prototype.checkScrollbar=function(){var a=window.innerWidth;if(!a){var b=document.documentElement.getBoundingClientRect();a=b.right-Math.abs(b.left)}this.bodyIsOverflowing=document.body.clientWidth<a,this.scrollbarWidth=this.measureScrollbar()},c.prototype.setScrollbar=function(){var a=parseInt(this.$body.css("padding-right")||0,10);this.originalBodyPad=document.body.style.paddingRight||"",this.bodyIsOverflowing&&this.$body.css("padding-right",a+this.scrollbarWidth)},c.prototype.resetScrollbar=function(){this.$body.css("padding-right",this.originalBodyPad)},c.prototype.measureScrollbar=function(){var a=document.createElement("div");a.className="modal-scrollbar-measure",this.$body.append(a);var b=a.offsetWidth-a.clientWidth;return this.$body[0].removeChild(a),b};var d=a.fn.modal;a.fn.modal=b,a.fn.modal.Constructor=c,a.fn.modal.noConflict=function(){return a.fn.modal=d,this},a(document).on("click.bs.modal.data-api",'[data-toggle="modal"]',function(c){var d=a(this),e=d.attr("href"),f=a(d.attr("data-target")||e&&e.replace(/.*(?=#[^\s]+$)/,"")),g=f.data("bs.modal")?"toggle":a.extend({remote:!/#/.test(e)&&e},f.data(),d.data());d.is("a")&&c.preventDefault(),f.one("show.bs.modal",function(a){a.isDefaultPrevented()||f.one("hidden.bs.modal",function(){d.is(":visible")&&d.trigger("focus")})}),b.call(f,g,this)})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tooltip"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.tooltip",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.type=null,this.options=null,this.enabled=null,this.timeout=null,this.hoverState=null,this.$element=null,this.inState=null,this.init("tooltip",a,b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.DEFAULTS={animation:!0,placement:"top",selector:!1,template:'<div class="tooltip" role="tooltip"><div class="tooltip-arrow"></div><div class="tooltip-inner"></div></div>',trigger:"hover focus",title:"",delay:0,html:!1,container:!1,viewport:{selector:"body",padding:0}},c.prototype.init=function(b,c,d){if(this.enabled=!0,this.type=b,this.$element=a(c),this.options=this.getOptions(d),this.$viewport=this.options.viewport&&a(a.isFunction(this.options.viewport)?this.options.viewport.call(this,this.$element):this.options.viewport.selector||this.options.viewport),this.inState={click:!1,hover:!1,focus:!1},this.$element[0]instanceof document.constructor&&!this.options.selector)throw new Error("`selector` option must be specified when initializing "+this.type+" on the window.document object!");for(var e=this.options.trigger.split(" "),f=e.length;f--;){var g=e[f];if("click"==g)this.$element.on("click."+this.type,this.options.selector,a.proxy(this.toggle,this));else if("manual"!=g){var h="hover"==g?"mouseenter":"focusin",i="hover"==g?"mouseleave":"focusout";this.$element.on(h+"."+this.type,this.options.selector,a.proxy(this.enter,this)),this.$element.on(i+"."+this.type,this.options.selector,a.proxy(this.leave,this))}}this.options.selector?this._options=a.extend({},this.options,{trigger:"manual",selector:""}):this.fixTitle()},c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.getOptions=function(b){return b=a.extend({},this.getDefaults(),this.$element.data(),b),b.delay&&"number"==typeof b.delay&&(b.delay={show:b.delay,hide:b.delay}),b},c.prototype.getDelegateOptions=function(){var b={},c=this.getDefaults();return this._options&&a.each(this._options,function(a,d){c[a]!=d&&(b[a]=d)}),b},c.prototype.enter=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusin"==b.type?"focus":"hover"]=!0),c.tip().hasClass("in")||"in"==c.hoverState?void(c.hoverState="in"):(clearTimeout(c.timeout),c.hoverState="in",c.options.delay&&c.options.delay.show?void(c.timeout=setTimeout(function(){"in"==c.hoverState&&c.show()},c.options.delay.show)):c.show())},c.prototype.isInStateTrue=function(){for(var a in this.inState)if(this.inState[a])return!0;return!1},c.prototype.leave=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusout"==b.type?"focus":"hover"]=!1),c.isInStateTrue()?void 0:(clearTimeout(c.timeout),c.hoverState="out",c.options.delay&&c.options.delay.hide?void(c.timeout=setTimeout(function(){"out"==c.hoverState&&c.hide()},c.options.delay.hide)):c.hide())},c.prototype.show=function(){var b=a.Event("show.bs."+this.type);if(this.hasContent()&&this.enabled){this.$element.trigger(b);var d=a.contains(this.$element[0].ownerDocument.documentElement,this.$element[0]);if(b.isDefaultPrevented()||!d)return;var e=this,f=this.tip(),g=this.getUID(this.type);this.setContent(),f.attr("id",g),this.$element.attr("aria-describedby",g),this.options.animation&&f.addClass("fade");var h="function"==typeof this.options.placement?this.options.placement.call(this,f[0],this.$element[0]):this.options.placement,i=/\s?auto?\s?/i,j=i.test(h);j&&(h=h.replace(i,"")||"top"),f.detach().css({top:0,left:0,display:"block"}).addClass(h).data("bs."+this.type,this),this.options.container?f.appendTo(this.options.container):f.insertAfter(this.$element),this.$element.trigger("inserted.bs."+this.type);var k=this.getPosition(),l=f[0].offsetWidth,m=f[0].offsetHeight;if(j){var n=h,o=this.getPosition(this.$viewport);h="bottom"==h&&k.bottom+m>o.bottom?"top":"top"==h&&k.top-m<o.top?"bottom":"right"==h&&k.right+l>o.width?"left":"left"==h&&k.left-l<o.left?"right":h,f.removeClass(n).addClass(h)}var p=this.getCalculatedOffset(h,k,l,m);this.applyPlacement(p,h);var q=function(){var a=e.hoverState;e.$element.trigger("shown.bs."+e.type),e.hoverState=null,"out"==a&&e.leave(e)};a.support.transition&&this.$tip.hasClass("fade")?f.one("bsTransitionEnd",q).emulateTransitionEnd(c.TRANSITION_DURATION):q()}},c.prototype.applyPlacement=function(b,c){var d=this.tip(),e=d[0].offsetWidth,f=d[0].offsetHeight,g=parseInt(d.css("margin-top"),10),h=parseInt(d.css("margin-left"),10);isNaN(g)&&(g=0),isNaN(h)&&(h=0),b.top+=g,b.left+=h,a.offset.setOffset(d[0],a.extend({using:function(a){d.css({top:Math.round(a.top),left:Math.round(a.left)})}},b),0),d.addClass("in");var i=d[0].offsetWidth,j=d[0].offsetHeight;"top"==c&&j!=f&&(b.top=b.top+f-j);var k=this.getViewportAdjustedDelta(c,b,i,j);k.left?b.left+=k.left:b.top+=k.top;var l=/top|bottom/.test(c),m=l?2*k.left-e+i:2*k.top-f+j,n=l?"offsetWidth":"offsetHeight";d.offset(b),this.replaceArrow(m,d[0][n],l)},c.prototype.replaceArrow=function(a,b,c){this.arrow().css(c?"left":"top",50*(1-a/b)+"%").css(c?"top":"left","")},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle();a.find(".tooltip-inner")[this.options.html?"html":"text"](b),a.removeClass("fade in top bottom left right")},c.prototype.hide=function(b){function d(){"in"!=e.hoverState&&f.detach(),e.$element.removeAttr("aria-describedby").trigger("hidden.bs."+e.type),b&&b()}var e=this,f=a(this.$tip),g=a.Event("hide.bs."+this.type);return this.$element.trigger(g),g.isDefaultPrevented()?void 0:(f.removeClass("in"),a.support.transition&&f.hasClass("fade")?f.one("bsTransitionEnd",d).emulateTransitionEnd(c.TRANSITION_DURATION):d(),this.hoverState=null,this)},c.prototype.fixTitle=function(){var a=this.$element;(a.attr("title")||"string"!=typeof a.attr("data-original-title"))&&a.attr("data-original-title",a.attr("title")||"").attr("title","")},c.prototype.hasContent=function(){return this.getTitle()},c.prototype.getPosition=function(b){b=b||this.$element;var c=b[0],d="BODY"==c.tagName,e=c.getBoundingClientRect();null==e.width&&(e=a.extend({},e,{width:e.right-e.left,height:e.bottom-e.top}));var f=d?{top:0,left:0}:b.offset(),g={scroll:d?document.documentElement.scrollTop||document.body.scrollTop:b.scrollTop()},h=d?{width:a(window).width(),height:a(window).height()}:null;return a.extend({},e,g,h,f)},c.prototype.getCalculatedOffset=function(a,b,c,d){return"bottom"==a?{top:b.top+b.height,left:b.left+b.width/2-c/2}:"top"==a?{top:b.top-d,left:b.left+b.width/2-c/2}:"left"==a?{top:b.top+b.height/2-d/2,left:b.left-c}:{top:b.top+b.height/2-d/2,left:b.left+b.width}},c.prototype.getViewportAdjustedDelta=function(a,b,c,d){var e={top:0,left:0};if(!this.$viewport)return e;var f=this.options.viewport&&this.options.viewport.padding||0,g=this.getPosition(this.$viewport);if(/right|left/.test(a)){var h=b.top-f-g.scroll,i=b.top+f-g.scroll+d;h<g.top?e.top=g.top-h:i>g.top+g.height&&(e.top=g.top+g.height-i)}else{var j=b.left-f,k=b.left+f+c;j<g.left?e.left=g.left-j:k>g.right&&(e.left=g.left+g.width-k)}return e},c.prototype.getTitle=function(){var a,b=this.$element,c=this.options;return a=b.attr("data-original-title")||("function"==typeof c.title?c.title.call(b[0]):c.title)},c.prototype.getUID=function(a){do a+=~~(1e6*Math.random());while(document.getElementById(a));return a},c.prototype.tip=function(){if(!this.$tip&&(this.$tip=a(this.options.template),1!=this.$tip.length))throw new Error(this.type+" `template` option must consist of exactly 1 top-level element!");return this.$tip},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".tooltip-arrow")},c.prototype.enable=function(){this.enabled=!0},c.prototype.disable=function(){this.enabled=!1},c.prototype.toggleEnabled=function(){this.enabled=!this.enabled},c.prototype.toggle=function(b){var c=this;b&&(c=a(b.currentTarget).data("bs."+this.type),c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c))),b?(c.inState.click=!c.inState.click,c.isInStateTrue()?c.enter(c):c.leave(c)):c.tip().hasClass("in")?c.leave(c):c.enter(c)},c.prototype.destroy=function(){var a=this;clearTimeout(this.timeout),this.hide(function(){a.$element.off("."+a.type).removeData("bs."+a.type),a.$tip&&a.$tip.detach(),a.$tip=null,a.$arrow=null,a.$viewport=null})};var d=a.fn.tooltip;a.fn.tooltip=b,a.fn.tooltip.Constructor=c,a.fn.tooltip.noConflict=function(){return a.fn.tooltip=d,this}}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.popover"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.popover",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.init("popover",a,b)};if(!a.fn.tooltip)throw new Error("Popover requires tooltip.js");c.VERSION="3.3.5",c.DEFAULTS=a.extend({},a.fn.tooltip.Constructor.DEFAULTS,{placement:"right",trigger:"click",content:"",template:'<div class="popover" role="tooltip"><div class="arrow"></div><h3 class="popover-title"></h3><div class="popover-content"></div></div>'}),c.prototype=a.extend({},a.fn.tooltip.Constructor.prototype),c.prototype.constructor=c,c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle(),c=this.getContent();a.find(".popover-title")[this.options.html?"html":"text"](b),a.find(".popover-content").children().detach().end()[this.options.html?"string"==typeof c?"html":"append":"text"](c),a.removeClass("fade top bottom left right in"),a.find(".popover-title").html()||a.find(".popover-title").hide()},c.prototype.hasContent=function(){return this.getTitle()||this.getContent()},c.prototype.getContent=function(){var a=this.$element,b=this.options;return a.attr("data-content")||("function"==typeof b.content?b.content.call(a[0]):b.content)},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".arrow")};var d=a.fn.popover;a.fn.popover=b,a.fn.popover.Constructor=c,a.fn.popover.noConflict=function(){return a.fn.popover=d,this}}(jQuery),+function(a){"use strict";function b(c,d){this.$body=a(document.body),this.$scrollElement=a(a(c).is(document.body)?window:c),this.options=a.extend({},b.DEFAULTS,d),this.selector=(this.options.target||"")+" .nav li > a",this.offsets=[],this.targets=[],this.activeTarget=null,this.scrollHeight=0,this.$scrollElement.on("scroll.bs.scrollspy",a.proxy(this.process,this)),this.refresh(),this.process()}function c(c){return this.each(function(){var d=a(this),e=d.data("bs.scrollspy"),f="object"==typeof c&&c;e||d.data("bs.scrollspy",e=new b(this,f)),"string"==typeof c&&e[c]()})}b.VERSION="3.3.5",b.DEFAULTS={offset:10},b.prototype.getScrollHeight=function(){return this.$scrollElement[0].scrollHeight||Math.max(this.$body[0].scrollHeight,document.documentElement.scrollHeight)},b.prototype.refresh=function(){var b=this,c="offset",d=0;this.offsets=[],this.targets=[],this.scrollHeight=this.getScrollHeight(),a.isWindow(this.$scrollElement[0])||(c="position",d=this.$scrollElement.scrollTop()),this.$body.find(this.selector).map(function(){var b=a(this),e=b.data("target")||b.attr("href"),f=/^#./.test(e)&&a(e);return f&&f.length&&f.is(":visible")&&[[f[c]().top+d,e]]||null}).sort(function(a,b){return a[0]-b[0]}).each(function(){b.offsets.push(this[0]),b.targets.push(this[1])})},b.prototype.process=function(){var a,b=this.$scrollElement.scrollTop()+this.options.offset,c=this.getScrollHeight(),d=this.options.offset+c-this.$scrollElement.height(),e=this.offsets,f=this.targets,g=this.activeTarget;if(this.scrollHeight!=c&&this.refresh(),b>=d)return g!=(a=f[f.length-1])&&this.activate(a);if(g&&b<e[0])return this.activeTarget=null,this.clear();for(a=e.length;a--;)g!=f[a]&&b>=e[a]&&(void 0===e[a+1]||b<e[a+1])&&this.activate(f[a])},b.prototype.activate=function(b){this.activeTarget=b,this.clear();var c=this.selector+'[data-target="'+b+'"],'+this.selector+'[href="'+b+'"]',d=a(c).parents("li").addClass("active");d.parent(".dropdown-menu").length&&(d=d.closest("li.dropdown").addClass("active")),
d.trigger("activate.bs.scrollspy")},b.prototype.clear=function(){a(this.selector).parentsUntil(this.options.target,".active").removeClass("active")};var d=a.fn.scrollspy;a.fn.scrollspy=c,a.fn.scrollspy.Constructor=b,a.fn.scrollspy.noConflict=function(){return a.fn.scrollspy=d,this},a(window).on("load.bs.scrollspy.data-api",function(){a('[data-spy="scroll"]').each(function(){var b=a(this);c.call(b,b.data())})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tab");e||d.data("bs.tab",e=new c(this)),"string"==typeof b&&e[b]()})}var c=function(b){this.element=a(b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.prototype.show=function(){var b=this.element,c=b.closest("ul:not(.dropdown-menu)"),d=b.data("target");if(d||(d=b.attr("href"),d=d&&d.replace(/.*(?=#[^\s]*$)/,"")),!b.parent("li").hasClass("active")){var e=c.find(".active:last a"),f=a.Event("hide.bs.tab",{relatedTarget:b[0]}),g=a.Event("show.bs.tab",{relatedTarget:e[0]});if(e.trigger(f),b.trigger(g),!g.isDefaultPrevented()&&!f.isDefaultPrevented()){var h=a(d);this.activate(b.closest("li"),c),this.activate(h,h.parent(),function(){e.trigger({type:"hidden.bs.tab",relatedTarget:b[0]}),b.trigger({type:"shown.bs.tab",relatedTarget:e[0]})})}}},c.prototype.activate=function(b,d,e){function f(){g.removeClass("active").find("> .dropdown-menu > .active").removeClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!1),b.addClass("active").find('[data-toggle="tab"]').attr("aria-expanded",!0),h?(b[0].offsetWidth,b.addClass("in")):b.removeClass("fade"),b.parent(".dropdown-menu").length&&b.closest("li.dropdown").addClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!0),e&&e()}var g=d.find("> .active"),h=e&&a.support.transition&&(g.length&&g.hasClass("fade")||!!d.find("> .fade").length);g.length&&h?g.one("bsTransitionEnd",f).emulateTransitionEnd(c.TRANSITION_DURATION):f(),g.removeClass("in")};var d=a.fn.tab;a.fn.tab=b,a.fn.tab.Constructor=c,a.fn.tab.noConflict=function(){return a.fn.tab=d,this};var e=function(c){c.preventDefault(),b.call(a(this),"show")};a(document).on("click.bs.tab.data-api",'[data-toggle="tab"]',e).on("click.bs.tab.data-api",'[data-toggle="pill"]',e)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.affix"),f="object"==typeof b&&b;e||d.data("bs.affix",e=new c(this,f)),"string"==typeof b&&e[b]()})}var c=function(b,d){this.options=a.extend({},c.DEFAULTS,d),this.$target=a(this.options.target).on("scroll.bs.affix.data-api",a.proxy(this.checkPosition,this)).on("click.bs.affix.data-api",a.proxy(this.checkPositionWithEventLoop,this)),this.$element=a(b),this.affixed=null,this.unpin=null,this.pinnedOffset=null,this.checkPosition()};c.VERSION="3.3.5",c.RESET="affix affix-top affix-bottom",c.DEFAULTS={offset:0,target:window},c.prototype.getState=function(a,b,c,d){var e=this.$target.scrollTop(),f=this.$element.offset(),g=this.$target.height();if(null!=c&&"top"==this.affixed)return c>e?"top":!1;if("bottom"==this.affixed)return null!=c?e+this.unpin<=f.top?!1:"bottom":a-d>=e+g?!1:"bottom";var h=null==this.affixed,i=h?e:f.top,j=h?g:b;return null!=c&&c>=e?"top":null!=d&&i+j>=a-d?"bottom":!1},c.prototype.getPinnedOffset=function(){if(this.pinnedOffset)return this.pinnedOffset;this.$element.removeClass(c.RESET).addClass("affix");var a=this.$target.scrollTop(),b=this.$element.offset();return this.pinnedOffset=b.top-a},c.prototype.checkPositionWithEventLoop=function(){setTimeout(a.proxy(this.checkPosition,this),1)},c.prototype.checkPosition=function(){if(this.$element.is(":visible")){var b=this.$element.height(),d=this.options.offset,e=d.top,f=d.bottom,g=Math.max(a(document).height(),a(document.body).height());"object"!=typeof d&&(f=e=d),"function"==typeof e&&(e=d.top(this.$element)),"function"==typeof f&&(f=d.bottom(this.$element));var h=this.getState(g,b,e,f);if(this.affixed!=h){null!=this.unpin&&this.$element.css("top","");var i="affix"+(h?"-"+h:""),j=a.Event(i+".bs.affix");if(this.$element.trigger(j),j.isDefaultPrevented())return;this.affixed=h,this.unpin="bottom"==h?this.getPinnedOffset():null,this.$element.removeClass(c.RESET).addClass(i).trigger(i.replace("affix","affixed")+".bs.affix")}"bottom"==h&&this.$element.offset({top:g-b-f})}};var d=a.fn.affix;a.fn.affix=b,a.fn.affix.Constructor=c,a.fn.affix.noConflict=function(){return a.fn.affix=d,this},a(window).on("load",function(){a('[data-spy="affix"]').each(function(){var c=a(this),d=c.data();d.offset=d.offset||{},null!=d.offsetBottom&&(d.offset.bottom=d.offsetBottom),null!=d.offsetTop&&(d.offset.top=d.offsetTop),b.call(c,d)})})}(jQuery);</script>
<script>/**
* @preserve HTML5 Shiv 3.7.2 | @afarkas @jdalton @jon_neal @rem | MIT/GPL2 Licensed
*/
// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a,b){function c(a,b){var c=a.createElement("p"),d=a.getElementsByTagName("head")[0]||a.documentElement;return c.innerHTML="x<style>"+b+"</style>",d.insertBefore(c.lastChild,d.firstChild)}function d(){var a=t.elements;return"string"==typeof a?a.split(" "):a}function e(a,b){var c=t.elements;"string"!=typeof c&&(c=c.join(" ")),"string"!=typeof a&&(a=a.join(" ")),t.elements=c+" "+a,j(b)}function f(a){var b=s[a[q]];return b||(b={},r++,a[q]=r,s[r]=b),b}function g(a,c,d){if(c||(c=b),l)return c.createElement(a);d||(d=f(c));var e;return e=d.cache[a]?d.cache[a].cloneNode():p.test(a)?(d.cache[a]=d.createElem(a)).cloneNode():d.createElem(a),!e.canHaveChildren||o.test(a)||e.tagUrn?e:d.frag.appendChild(e)}function h(a,c){if(a||(a=b),l)return a.createDocumentFragment();c=c||f(a);for(var e=c.frag.cloneNode(),g=0,h=d(),i=h.length;i>g;g++)e.createElement(h[g]);return e}function i(a,b){b.cache||(b.cache={},b.createElem=a.createElement,b.createFrag=a.createDocumentFragment,b.frag=b.createFrag()),a.createElement=function(c){return t.shivMethods?g(c,a,b):b.createElem(c)},a.createDocumentFragment=Function("h,f","return function(){var n=f.cloneNode(),c=n.createElement;h.shivMethods&&("+d().join().replace(/[\w\-:]+/g,function(a){return b.createElem(a),b.frag.createElement(a),'c("'+a+'")'})+");return n}")(t,b.frag)}function j(a){a||(a=b);var d=f(a);return!t.shivCSS||k||d.hasCSS||(d.hasCSS=!!c(a,"article,aside,dialog,figcaption,figure,footer,header,hgroup,main,nav,section{display:block}mark{background:#FF0;color:#000}template{display:none}")),l||i(a,d),a}var k,l,m="3.7.2",n=a.html5||{},o=/^<|^(?:button|map|select|textarea|object|iframe|option|optgroup)$/i,p=/^(?:a|b|code|div|fieldset|h1|h2|h3|h4|h5|h6|i|label|li|ol|p|q|span|strong|style|table|tbody|td|th|tr|ul)$/i,q="_html5shiv",r=0,s={};!function(){try{var a=b.createElement("a");a.innerHTML="<xyz></xyz>",k="hidden"in a,l=1==a.childNodes.length||function(){b.createElement("a");var a=b.createDocumentFragment();return"undefined"==typeof a.cloneNode||"undefined"==typeof a.createDocumentFragment||"undefined"==typeof a.createElement}()}catch(c){k=!0,l=!0}}();var t={elements:n.elements||"abbr article aside audio bdi canvas data datalist details dialog figcaption figure footer header hgroup main mark meter nav output picture progress section summary template time video",version:m,shivCSS:n.shivCSS!==!1,supportsUnknownElements:l,shivMethods:n.shivMethods!==!1,type:"default",shivDocument:j,createElement:g,createDocumentFragment:h,addElements:e};a.html5=t,j(b)}(this,document);
};
</script>
<script>/*! Respond.js v1.4.2: min/max-width media query polyfill * Copyright 2013 Scott Jehl
 * Licensed under https://github.com/scottjehl/Respond/blob/master/LICENSE-MIT
 *  */

// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a){"use strict";a.matchMedia=a.matchMedia||function(a){var b,c=a.documentElement,d=c.firstElementChild||c.firstChild,e=a.createElement("body"),f=a.createElement("div");return f.id="mq-test-1",f.style.cssText="position:absolute;top:-100em",e.style.background="none",e.appendChild(f),function(a){return f.innerHTML='&shy;<style media="'+a+'"> #mq-test-1 { width: 42px; }</style>',c.insertBefore(e,d),b=42===f.offsetWidth,c.removeChild(e),{matches:b,media:a}}}(a.document)}(this),function(a){"use strict";function b(){u(!0)}var c={};a.respond=c,c.update=function(){};var d=[],e=function(){var b=!1;try{b=new a.XMLHttpRequest}catch(c){b=new a.ActiveXObject("Microsoft.XMLHTTP")}return function(){return b}}(),f=function(a,b){var c=e();c&&(c.open("GET",a,!0),c.onreadystatechange=function(){4!==c.readyState||200!==c.status&&304!==c.status||b(c.responseText)},4!==c.readyState&&c.send(null))};if(c.ajax=f,c.queue=d,c.regex={media:/@media[^\{]+\{([^\{\}]*\{[^\}\{]*\})+/gi,keyframes:/@(?:\-(?:o|moz|webkit)\-)?keyframes[^\{]+\{(?:[^\{\}]*\{[^\}\{]*\})+[^\}]*\}/gi,urls:/(url\()['"]?([^\/\)'"][^:\)'"]+)['"]?(\))/g,findStyles:/@media *([^\{]+)\{([\S\s]+?)$/,only:/(only\s+)?([a-zA-Z]+)\s?/,minw:/\([\s]*min\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/,maxw:/\([\s]*max\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/},c.mediaQueriesSupported=a.matchMedia&&null!==a.matchMedia("only all")&&a.matchMedia("only all").matches,!c.mediaQueriesSupported){var g,h,i,j=a.document,k=j.documentElement,l=[],m=[],n=[],o={},p=30,q=j.getElementsByTagName("head")[0]||k,r=j.getElementsByTagName("base")[0],s=q.getElementsByTagName("link"),t=function(){var a,b=j.createElement("div"),c=j.body,d=k.style.fontSize,e=c&&c.style.fontSize,f=!1;return b.style.cssText="position:absolute;font-size:1em;width:1em",c||(c=f=j.createElement("body"),c.style.background="none"),k.style.fontSize="100%",c.style.fontSize="100%",c.appendChild(b),f&&k.insertBefore(c,k.firstChild),a=b.offsetWidth,f?k.removeChild(c):c.removeChild(b),k.style.fontSize=d,e&&(c.style.fontSize=e),a=i=parseFloat(a)},u=function(b){var c="clientWidth",d=k[c],e="CSS1Compat"===j.compatMode&&d||j.body[c]||d,f={},o=s[s.length-1],r=(new Date).getTime();if(b&&g&&p>r-g)return a.clearTimeout(h),h=a.setTimeout(u,p),void 0;g=r;for(var v in l)if(l.hasOwnProperty(v)){var w=l[v],x=w.minw,y=w.maxw,z=null===x,A=null===y,B="em";x&&(x=parseFloat(x)*(x.indexOf(B)>-1?i||t():1)),y&&(y=parseFloat(y)*(y.indexOf(B)>-1?i||t():1)),w.hasquery&&(z&&A||!(z||e>=x)||!(A||y>=e))||(f[w.media]||(f[w.media]=[]),f[w.media].push(m[w.rules]))}for(var C in n)n.hasOwnProperty(C)&&n[C]&&n[C].parentNode===q&&q.removeChild(n[C]);n.length=0;for(var D in f)if(f.hasOwnProperty(D)){var E=j.createElement("style"),F=f[D].join("\n");E.type="text/css",E.media=D,q.insertBefore(E,o.nextSibling),E.styleSheet?E.styleSheet.cssText=F:E.appendChild(j.createTextNode(F)),n.push(E)}},v=function(a,b,d){var e=a.replace(c.regex.keyframes,"").match(c.regex.media),f=e&&e.length||0;b=b.substring(0,b.lastIndexOf("/"));var g=function(a){return a.replace(c.regex.urls,"$1"+b+"$2$3")},h=!f&&d;b.length&&(b+="/"),h&&(f=1);for(var i=0;f>i;i++){var j,k,n,o;h?(j=d,m.push(g(a))):(j=e[i].match(c.regex.findStyles)&&RegExp.$1,m.push(RegExp.$2&&g(RegExp.$2))),n=j.split(","),o=n.length;for(var p=0;o>p;p++)k=n[p],l.push({media:k.split("(")[0].match(c.regex.only)&&RegExp.$2||"all",rules:m.length-1,hasquery:k.indexOf("(")>-1,minw:k.match(c.regex.minw)&&parseFloat(RegExp.$1)+(RegExp.$2||""),maxw:k.match(c.regex.maxw)&&parseFloat(RegExp.$1)+(RegExp.$2||"")})}u()},w=function(){if(d.length){var b=d.shift();f(b.href,function(c){v(c,b.href,b.media),o[b.href]=!0,a.setTimeout(function(){w()},0)})}},x=function(){for(var b=0;b<s.length;b++){var c=s[b],e=c.href,f=c.media,g=c.rel&&"stylesheet"===c.rel.toLowerCase();e&&g&&!o[e]&&(c.styleSheet&&c.styleSheet.rawCssText?(v(c.styleSheet.rawCssText,e,f),o[e]=!0):(!/^([a-zA-Z:]*\/\/)/.test(e)&&!r||e.replace(RegExp.$1,"").split("/")[0]===a.location.host)&&("//"===e.substring(0,2)&&(e=a.location.protocol+e),d.push({href:e,media:f})))}w()};x(),c.update=x,c.getEmValue=t,a.addEventListener?a.addEventListener("resize",b,!1):a.attachEvent&&a.attachEvent("onresize",b)}}(this);
};
</script>
<style type="text/css">.pagedtable {
overflow: auto;
padding-left: 8px;
padding-right: 8px;
}
.pagedtable-wrapper {
border: 1px solid #ccc;
border-radius: 4px;
margin-bottom: 10px;
}
.pagedtable table {
width: 100%;
max-width: 100%;
margin: 0;
}
.pagedtable th {
padding: 0 5px 0 5px;
border: none;
border-bottom: 2px solid #dddddd;
min-width: 45px;
}
.pagedtable-empty th {
display: none;
}
.pagedtable td {
padding: 0 4px 0 4px;
}
.pagedtable .even {
background-color: rgba(140, 140, 140, 0.1);
}
.pagedtable-padding-col {
display: none;
}
.pagedtable a {
-webkit-touch-callout: none;
-webkit-user-select: none;
-khtml-user-select: none;
-moz-user-select: none;
-ms-user-select: none;
user-select: none;
}
.pagedtable-index-nav {
cursor: pointer;
padding: 0 5px 0 5px;
float: right;
border: 0;
}
.pagedtable-index-nav-disabled {
cursor: default;
text-decoration: none;
color: #999;
}
a.pagedtable-index-nav-disabled:hover {
text-decoration: none;
color: #999;
}
.pagedtable-indexes {
cursor: pointer;
float: right;
border: 0;
}
.pagedtable-index-current {
cursor: default;
text-decoration: none;
font-weight: bold;
color: #333;
border: 0;
}
a.pagedtable-index-current:hover {
text-decoration: none;
font-weight: bold;
color: #333;
}
.pagedtable-index {
width: 30px;
display: inline-block;
text-align: center;
border: 0;
}
.pagedtable-index-separator-left {
display: inline-block;
color: #333;
font-size: 9px;
padding: 0 0 0 0;
cursor: default;
}
.pagedtable-index-separator-right {
display: inline-block;
color: #333;
font-size: 9px;
padding: 0 4px 0 0;
cursor: default;
}
.pagedtable-footer {
padding-top: 4px;
padding-bottom: 5px;
}
.pagedtable-not-empty .pagedtable-footer {
border-top: 2px solid #dddddd;
}
.pagedtable-info {
overflow: hidden;
color: #999;
white-space: nowrap;
text-overflow: ellipsis;
}
.pagedtable-header-name {
overflow: hidden;
text-overflow: ellipsis;
}
.pagedtable-header-type {
color: #999;
font-weight: 400;
}
.pagedtable-na-cell {
font-style: italic;
opacity: 0.3;
}
</style>
<script>// Production steps of ECMA-262, Edition 5, 15.4.4.18
// Reference: http://es5.github.io/#x15.4.4.18
if (!Array.prototype.forEach) {

  Array.prototype.forEach = function(callback, thisArg) {

    var T, k;

    if (this === null) {
      throw new TypeError(' this is null or not defined');
    }

    // 1. Let O be the result of calling toObject() passing the
    // |this| value as the argument.
    var O = Object(this);

    // 2. Let lenValue be the result of calling the Get() internal
    // method of O with the argument "length".
    // 3. Let len be toUint32(lenValue).
    var len = O.length >>> 0;

    // 4. If isCallable(callback) is false, throw a TypeError exception.
    // See: http://es5.github.com/#x9.11
    if (typeof callback !== "function") {
      throw new TypeError(callback + ' is not a function');
    }

    // 5. If thisArg was supplied, let T be thisArg; else let
    // T be undefined.
    if (arguments.length > 1) {
      T = thisArg;
    }

    // 6. Let k be 0
    k = 0;

    // 7. Repeat, while k < len
    while (k < len) {

      var kValue;

      // a. Let Pk be ToString(k).
      //    This is implicit for LHS operands of the in operator
      // b. Let kPresent be the result of calling the HasProperty
      //    internal method of O with argument Pk.
      //    This step can be combined with c
      // c. If kPresent is true, then
      if (k in O) {

        // i. Let kValue be the result of calling the Get internal
        // method of O with argument Pk.
        kValue = O[k];

        // ii. Call the Call internal method of callback with T as
        // the this value and argument list containing kValue, k, and O.
        callback.call(T, kValue, k, O);
      }
      // d. Increase k by 1.
      k++;
    }
    // 8. return undefined
  };
}

// Production steps of ECMA-262, Edition 5, 15.4.4.19
// Reference: http://es5.github.io/#x15.4.4.19
if (!Array.prototype.map) {

  Array.prototype.map = function(callback, thisArg) {

    var T, A, k;

    if (this == null) {
      throw new TypeError(' this is null or not defined');
    }

    // 1. Let O be the result of calling ToObject passing the |this|
    //    value as the argument.
    var O = Object(this);

    // 2. Let lenValue be the result of calling the Get internal
    //    method of O with the argument "length".
    // 3. Let len be ToUint32(lenValue).
    var len = O.length >>> 0;

    // 4. If IsCallable(callback) is false, throw a TypeError exception.
    // See: http://es5.github.com/#x9.11
    if (typeof callback !== 'function') {
      throw new TypeError(callback + ' is not a function');
    }

    // 5. If thisArg was supplied, let T be thisArg; else let T be undefined.
    if (arguments.length > 1) {
      T = thisArg;
    }

    // 6. Let A be a new array created as if by the expression new Array(len)
    //    where Array is the standard built-in constructor with that name and
    //    len is the value of len.
    A = new Array(len);

    // 7. Let k be 0
    k = 0;

    // 8. Repeat, while k < len
    while (k < len) {

      var kValue, mappedValue;

      // a. Let Pk be ToString(k).
      //   This is implicit for LHS operands of the in operator
      // b. Let kPresent be the result of calling the HasProperty internal
      //    method of O with argument Pk.
      //   This step can be combined with c
      // c. If kPresent is true, then
      if (k in O) {

        // i. Let kValue be the result of calling the Get internal
        //    method of O with argument Pk.
        kValue = O[k];

        // ii. Let mappedValue be the result of calling the Call internal
        //     method of callback with T as the this value and argument
        //     list containing kValue, k, and O.
        mappedValue = callback.call(T, kValue, k, O);

        // iii. Call the DefineOwnProperty internal method of A with arguments
        // Pk, Property Descriptor
        // { Value: mappedValue,
        //   Writable: true,
        //   Enumerable: true,
        //   Configurable: true },
        // and false.

        // In browsers that support Object.defineProperty, use the following:
        // Object.defineProperty(A, k, {
        //   value: mappedValue,
        //   writable: true,
        //   enumerable: true,
        //   configurable: true
        // });

        // For best browser support, use the following:
        A[k] = mappedValue;
      }
      // d. Increase k by 1.
      k++;
    }

    // 9. return A
    return A;
  };
}

var PagedTable = function (pagedTable) {
  var me = this;

  var source = function(pagedTable) {
    var sourceElems = [].slice.call(pagedTable.children).filter(function(e) {
      return e.hasAttribute("data-pagedtable-source");
    });

    if (sourceElems === null || sourceElems.length !== 1) {
      throw("A single data-pagedtable-source was not found");
    }

    return JSON.parse(sourceElems[0].innerHTML);
  }(pagedTable);

  var options = function(source) {
    var options = typeof(source.options) !== "undefined" &&
      source.options !== null ? source.options : {};

    var columns = typeof(options.columns) !== "undefined" ? options.columns : {};
    var rows = typeof(options.rows) !== "undefined" ? options.rows : {};

    var positiveIntOrNull = function(value) {
      return parseInt(value) >= 0 ? parseInt(value) : null;
    };

    return {
      pages: positiveIntOrNull(options.pages),
      rows: {
        min: positiveIntOrNull(rows.min),
        max: positiveIntOrNull(rows.max),
        total: positiveIntOrNull(rows.total)
      },
      columns: {
        min: positiveIntOrNull(columns.min),
        max: positiveIntOrNull(columns.max),
        total: positiveIntOrNull(columns.total)
      }
    };
  }(source);

  var Measurer = function() {

    // set some default initial values that will get adjusted in runtime
    me.measures = {
      padding: 12,
      character: 8,
      height: 15,
      defaults: true
    };

    me.calculate = function(measuresCell) {
      if (!me.measures.defaults)
        return;

      var measuresCellStyle = window.getComputedStyle(measuresCell, null);

      var newPadding = parsePadding(measuresCellStyle.paddingLeft) +
            parsePadding(measuresCellStyle.paddingRight);

      var sampleString = "ABCDEFGHIJ0123456789";
      var newCharacter = Math.ceil(measuresCell.clientWidth / sampleString.length);

      if (newPadding <= 0 || newCharacter <= 0)
        return;

      me.measures.padding = newPadding;
      me.measures.character = newCharacter;
      me.measures.height = measuresCell.clientHeight;
      me.measures.defaults = false;
    };

    return me;
  };

  var Page = function(data, options) {
    var me = this;

    var defaults = {
      max: 7,
      rows: 10
    };

    var totalPages = function() {
      return Math.ceil(data.length / me.rows);
    };

    me.number = 0;
    me.max = options.pages !== null ? options.pages : defaults.max;
    me.visible = me.max;
    me.rows = options.rows.min !== null ? options.rows.min : defaults.rows;
    me.total = totalPages();

    me.setRows = function(newRows) {
      me.rows = newRows;
      me.total = totalPages();
    };

    me.setPageNumber = function(newPageNumber) {
      if (newPageNumber < 0) newPageNumber = 0;
      if (newPageNumber >= me.total) newPageNumber = me.total - 1;

      me.number = newPageNumber;
    };

    me.setVisiblePages = function(visiblePages) {
      me.visible = Math.min(me.max, visiblePages);
      me.setPageNumber(me.number);
    };

    me.getVisiblePageRange = function() {
      var start = me.number - Math.max(Math.floor((me.visible - 1) / 2), 0);
      var end = me.number + Math.floor(me.visible / 2) + 1;
      var pageCount = me.total;

      if (start < 0) {
        var diffToStart = 0 - start;
        start += diffToStart;
        end += diffToStart;
      }

      if (end > pageCount) {
        var diffToEnd = end - pageCount;
        start -= diffToEnd;
        end -= diffToEnd;
      }

      start = start < 0 ? 0 : start;
      end = end >= pageCount ? pageCount : end;

      var first = false;
      var last = false;

      if (start > 0 && me.visible > 1) {
        start = start + 1;
        first = true;
      }

      if (end < pageCount && me.visible > 2) {
        end = end - 1;
        last = true;
      }

      return {
        first: first,
        start: start,
        end: end,
        last: last
      };
    };

    me.getRowStart = function() {
      var rowStart = page.number * page.rows;
      if (rowStart < 0)
        rowStart = 0;

      return rowStart;
    };

    me.getRowEnd = function() {
      var rowStart = me.getRowStart();
      return Math.min(rowStart + me.rows, data.length);
    };

    me.getPaddingRows = function() {
      var rowStart = me.getRowStart();
      var rowEnd = me.getRowEnd();
      return data.length > me.rows ? me.rows - (rowEnd - rowStart) : 0;
    };
  };

  var Columns = function(data, columns, options) {
    var me = this;

    me.defaults = {
      min: 5
    };

    me.number = 0;
    me.visible = 0;
    me.total = columns.length;
    me.subset = [];
    me.padding = 0;
    me.min = options.columns.min !== null ? options.columns.min : me.defaults.min;
    me.max = options.columns.max !== null ? options.columns.max : null;
    me.widths = {};

    var widthsLookAhead = Math.max(100, options.rows.min);
    var paddingColChars = 10;

    me.emptyNames = function() {
      columns.forEach(function(column) {
        if (columns.label !== null && columns.label !== "")
          return false;
      });

      return true;
    };

    var parsePadding = function(value) {
      return parseInt(value) >= 0 ? parseInt(value) : 0;
    };

    me.calculateWidths = function(measures) {
      columns.forEach(function(column) {
        var maxChars = Math.max(
          column.label.toString().length,
          column.type.toString().length
        );

        for (var idxRow = 0; idxRow < Math.min(widthsLookAhead, data.length); idxRow++) {
          maxChars = Math.max(maxChars, data[idxRow][column.name.toString()].length);
        }

        me.widths[column.name] = {
          // width in characters
          chars: maxChars,
          // width for the inner html columns
          inner: maxChars * measures.character,
          // width adding outer styles like padding
          outer: maxChars * measures.character + measures.padding
        };
      });
    };

    me.getWidth = function() {
      var widthOuter = 0;
      for (var idxCol = 0; idxCol < me.subset.length; idxCol++) {
        var columnName = me.subset[idxCol].name;
        widthOuter = widthOuter + me.widths[columnName].outer;
      }

      widthOuter = widthOuter + me.padding * paddingColChars * measurer.measures.character;

      if (me.hasMoreLeftColumns()) {
        widthOuter = widthOuter + columnNavigationWidthPX + measurer.measures.padding;
      }

      if (me.hasMoreRightColumns()) {
        widthOuter = widthOuter + columnNavigationWidthPX + measurer.measures.padding;
      }

      return widthOuter;
    };

    me.updateSlice = function() {
      if (me.number + me.visible >= me.total)
        me.number = me.total - me.visible;

      if (me.number < 0) me.number = 0;

      me.subset = columns.slice(me.number, Math.min(me.number + me.visible, me.total));

      me.subset = me.subset.map(function(column) {
        Object.keys(column).forEach(function(colKey) {
          column[colKey] = column[colKey] === null ? "" : column[colKey].toString();
        });

        column.width = null;
        return column;
      });
    };

    me.setVisibleColumns = function(columnNumber, newVisibleColumns, paddingCount) {
      me.number = columnNumber;
      me.visible = newVisibleColumns;
      me.padding = paddingCount;

      me.updateSlice();
    };

    me.incColumnNumber = function(increment) {
      me.number = me.number + increment;
    };

    me.setColumnNumber = function(newNumber) {
      me.number = newNumber;
    };

    me.setPaddingCount = function(newPadding) {
      me.padding = newPadding;
    };

    me.getPaddingCount = function() {
      return me.padding;
    };

    me.hasMoreLeftColumns = function() {
      return me.number > 0;
    };

    me.hasMoreRightColumns = function() {
      return me.number + me.visible < me.total;
    };

    me.updateSlice(0);
    return me;
  };

  var data = source.data;
  var page = new Page(data, options);
  var measurer = new Measurer(data, options);
  var columns = new Columns(data, source.columns, options);

  var table = null;
  var tableDiv = null;
  var header = null;
  var footer = null;
  var tbody = null;

  // Caches pagedTable.clientWidth, specially for webkit
  var cachedPagedTableClientWidth = null;

  var onChangeCallbacks = [];

  var clearSelection = function() {
    if(document.selection && document.selection.empty) {
      document.selection.empty();
    } else if(window.getSelection) {
      var sel = window.getSelection();
      sel.removeAllRanges();
    }
  };

  var columnNavigationWidthPX = 5;

  var renderColumnNavigation = function(increment, backwards) {
    var arrow = document.createElement("div");
    arrow.setAttribute("style",
      "border-top: " + columnNavigationWidthPX + "px solid transparent;" +
      "border-bottom: " + columnNavigationWidthPX + "px solid transparent;" +
      "border-" + (backwards ? "right" : "left") + ": " + columnNavigationWidthPX + "px solid;");

    var header = document.createElement("th");
    header.appendChild(arrow);
    header.setAttribute("style",
      "cursor: pointer;" +
      "vertical-align: middle;" +
      "min-width: " + columnNavigationWidthPX + "px;" +
      "width: " + columnNavigationWidthPX + "px;");

    header.onclick = function() {
      columns.incColumnNumber(backwards ? -1 : increment);

      me.animateColumns(backwards);
      renderFooter();

      clearSelection();
      triggerOnChange();
    };

    return header;
  };

  var maxColumnWidth = function(width) {
    var padding = 80;
    var columnMax = Math.max(cachedPagedTableClientWidth - padding, 0);

    return parseInt(width) > 0 ?
      Math.min(columnMax, parseInt(width)) + "px" :
      columnMax + "px";
  };

  var clearHeader = function() {
    var thead = pagedTable.querySelectorAll("thead")[0];
    thead.innerHTML = "";
  };

  var renderHeader = function(clear) {
    cachedPagedTableClientWidth = pagedTable.clientWidth;

    var fragment = document.createDocumentFragment();

    header = document.createElement("tr");
    fragment.appendChild(header);

    if (columns.number > 0)
      header.appendChild(renderColumnNavigation(-columns.visible, true));

    columns.subset = columns.subset.map(function(columnData) {
      var column = document.createElement("th");
      column.setAttribute("align", columnData.align);
      column.style.textAlign = columnData.align;

      column.style.maxWidth = maxColumnWidth(null);
      if (columnData.width) {
        column.style.minWidth =
          column.style.maxWidth = maxColumnWidth(columnData.width);
      }

      var columnName = document.createElement("div");
      columnName.setAttribute("class", "pagedtable-header-name");
      if (columnData.label === "") {
        columnName.innerHTML = "&nbsp;";
      }
      else {
        columnName.appendChild(document.createTextNode(columnData.label));
      }
      column.appendChild(columnName);

      var columnType = document.createElement("div");
      columnType.setAttribute("class", "pagedtable-header-type");
      if (columnData.type === "") {
        columnType.innerHTML = "&nbsp;";
      }
      else {
        columnType.appendChild(document.createTextNode("<" + columnData.type + ">"));
      }
      column.appendChild(columnType);

      header.appendChild(column);

      columnData.element = column;

      return columnData;
    });

    for (var idx = 0; idx < columns.getPaddingCount(); idx++) {
      var paddingCol = document.createElement("th");
      paddingCol.setAttribute("class", "pagedtable-padding-col");
      header.appendChild(paddingCol);
    }

    if (columns.number + columns.visible < columns.total)
      header.appendChild(renderColumnNavigation(columns.visible, false));

    if (typeof(clear) == "undefined" || clear) clearHeader();
    var thead = pagedTable.querySelectorAll("thead")[0];
    thead.appendChild(fragment);
  };

  me.animateColumns = function(backwards) {
    var thead = pagedTable.querySelectorAll("thead")[0];

    var headerOld = thead.querySelectorAll("tr")[0];
    var tbodyOld = table.querySelectorAll("tbody")[0];

    me.fitColumns(backwards);

    renderHeader(false);

    header.style.opacity = "0";
    header.style.transform = backwards ? "translateX(-30px)" : "translateX(30px)";
    header.style.transition = "transform 200ms linear, opacity 200ms";
    header.style.transitionDelay = "0";

    renderBody(false);

    if (headerOld) {
      headerOld.style.position = "absolute";
      headerOld.style.transform = "translateX(0px)";
      headerOld.style.opacity = "1";
      headerOld.style.transition = "transform 100ms linear, opacity 100ms";
      headerOld.setAttribute("class", "pagedtable-remove-head");
      if (headerOld.style.transitionEnd) {
        headerOld.addEventListener("transitionend", function() {
          var headerOldByClass = thead.querySelector(".pagedtable-remove-head");
          if (headerOldByClass) thead.removeChild(headerOldByClass);
        });
      }
      else {
        thead.removeChild(headerOld);
      }
    }

    if (tbodyOld) table.removeChild(tbodyOld);

    tbody.style.opacity = "0";
    tbody.style.transition = "transform 200ms linear, opacity 200ms";
    tbody.style.transitionDelay = "0ms";

    // force relayout
    window.getComputedStyle(header).opacity;
    window.getComputedStyle(tbody).opacity;

    if (headerOld) {
      headerOld.style.transform = backwards ? "translateX(20px)" : "translateX(-30px)";
      headerOld.style.opacity = "0";
    }

    header.style.transform = "translateX(0px)";
    header.style.opacity = "1";

    tbody.style.opacity = "1";
  }

  me.onChange = function(callback) {
    onChangeCallbacks.push(callback);
  };

  var triggerOnChange = function() {
    onChangeCallbacks.forEach(function(onChange) {
      onChange();
    });
  };

  var clearBody = function() {
    if (tbody) {
      table.removeChild(tbody);
      tbody = null;
    }
  };

  var renderBody = function(clear) {
    cachedPagedTableClientWidth = pagedTable.clientWidth

    var fragment = document.createDocumentFragment();

    var pageData = data.slice(page.getRowStart(), page.getRowEnd());

    pageData.forEach(function(dataRow, idxRow) {
      var htmlRow = document.createElement("tr");
      htmlRow.setAttribute("class", (idxRow % 2 !==0) ? "even" : "odd");

      if (columns.hasMoreLeftColumns())
        htmlRow.appendChild(document.createElement("td"));

      columns.subset.forEach(function(columnData) {
        var cellName = columnData.name;
        var dataCell = dataRow[cellName];
        var htmlCell = document.createElement("td");

        if (dataCell === "NA") htmlCell.setAttribute("class", "pagedtable-na-cell");
        if (dataCell === "__NA__") dataCell = "NA";

        var cellText = document.createTextNode(dataCell);
        htmlCell.appendChild(cellText);
        if (dataCell.length > 50) {
          htmlCell.setAttribute("title", dataCell);
        }
        htmlCell.setAttribute("align", columnData.align);
        htmlCell.style.textAlign = columnData.align;
        htmlCell.style.maxWidth = maxColumnWidth(null);
        if (columnData.width) {
          htmlCell.style.minWidth = htmlCell.style.maxWidth = maxColumnWidth(columnData.width);
        }
        htmlRow.appendChild(htmlCell);
      });

      for (var idx = 0; idx < columns.getPaddingCount(); idx++) {
        var paddingCol = document.createElement("td");
        paddingCol.setAttribute("class", "pagedtable-padding-col");
        htmlRow.appendChild(paddingCol);
      }

      if (columns.hasMoreRightColumns())
        htmlRow.appendChild(document.createElement("td"));

      fragment.appendChild(htmlRow);
    });

    for (var idxPadding = 0; idxPadding < page.getPaddingRows(); idxPadding++) {
      var paddingRow = document.createElement("tr");

      var paddingCellRow = document.createElement("td");
      paddingCellRow.innerHTML = "&nbsp;";
      paddingCellRow.setAttribute("colspan", "100%");
      paddingRow.appendChild(paddingCellRow);

      fragment.appendChild(paddingRow);
    }

    if (typeof(clear) == "undefined" || clear) clearBody();
    tbody = document.createElement("tbody");
    tbody.appendChild(fragment);

    table.appendChild(tbody);
  };

  var getLabelInfo = function() {
    var pageStart = page.getRowStart();
    var pageEnd = page.getRowEnd();
    var totalRows = data.length;

    var totalRowsLabel = options.rows.total ? options.rows.total : totalRows;
    var totalRowsLabelFormat = totalRowsLabel.toString().replace(/(\d)(?=(\d\d\d)+(?!\d))/g, '$1,');

    var infoText = (pageStart + 1) + "-" + pageEnd + " of " + totalRowsLabelFormat + " rows";
    if (totalRows < page.rows) {
      infoText = totalRowsLabel + " row" + (totalRows != 1 ? "s" : "");
    }
    if (columns.total > columns.visible) {
      var totalColumnsLabel = options.columns.total ? options.columns.total : columns.total;

      infoText = infoText + " | " + (columns.number + 1) + "-" +
        (Math.min(columns.number + columns.visible, columns.total)) +
        " of " + totalColumnsLabel + " columns";
    }

    return infoText;
  };

  var clearFooter = function() {
    footer = pagedTable.querySelectorAll("div.pagedtable-footer")[0];
    footer.innerHTML = "";

    return footer;
  };

  var createPageLink = function(idxPage) {
    var pageLink = document.createElement("a");
    pageLinkClass = idxPage === page.number ? "pagedtable-index pagedtable-index-current" : "pagedtable-index";
    pageLink.setAttribute("class", pageLinkClass);
    pageLink.setAttribute("data-page-index", idxPage);
    pageLink.onclick = function() {
      page.setPageNumber(parseInt(this.getAttribute("data-page-index")));
      renderBody();
      renderFooter();

      triggerOnChange();
    };

    pageLink.appendChild(document.createTextNode(idxPage + 1));

    return pageLink;
  }

  var renderFooter = function() {
    footer = clearFooter();

    var next = document.createElement("a");
    next.appendChild(document.createTextNode("Next"));
    next.onclick = function() {
      page.setPageNumber(page.number + 1);
      renderBody();
      renderFooter();

      triggerOnChange();
    };
    if (data.length > page.rows) footer.appendChild(next);

    var pageNumbers = document.createElement("div");
    pageNumbers.setAttribute("class", "pagedtable-indexes");

    var pageRange = page.getVisiblePageRange();

    if (pageRange.first) {
      var pageLink = createPageLink(0);
      pageNumbers.appendChild(pageLink);

      var pageSeparator = document.createElement("div");
      pageSeparator.setAttribute("class", "pagedtable-index-separator-left");
      pageSeparator.appendChild(document.createTextNode("..."))
      pageNumbers.appendChild(pageSeparator);
    }

    for (var idxPage = pageRange.start; idxPage < pageRange.end; idxPage++) {
      var pageLink = createPageLink(idxPage);

      pageNumbers.appendChild(pageLink);
    }

    if (pageRange.last) {
      var pageSeparator = document.createElement("div");
      pageSeparator.setAttribute("class", "pagedtable-index-separator-right");
      pageSeparator.appendChild(document.createTextNode("..."))
      pageNumbers.appendChild(pageSeparator);

      var pageLink = createPageLink(page.total - 1);
      pageNumbers.appendChild(pageLink);
    }

    if (data.length > page.rows) footer.appendChild(pageNumbers);

    var previous = document.createElement("a");
    previous.appendChild(document.createTextNode("Previous"));
    previous.onclick = function() {
      page.setPageNumber(page.number - 1);
      renderBody();
      renderFooter();

      triggerOnChange();
    };
    if (data.length > page.rows) footer.appendChild(previous);

    var infoLabel = document.createElement("div");
    infoLabel.setAttribute("class", "pagedtable-info");
    infoLabel.setAttribute("title", getLabelInfo());
    infoLabel.appendChild(document.createTextNode(getLabelInfo()));
    footer.appendChild(infoLabel);

    var enabledClass = "pagedtable-index-nav";
    var disabledClass = "pagedtable-index-nav pagedtable-index-nav-disabled";
    previous.setAttribute("class", page.number <= 0 ? disabledClass : enabledClass);
    next.setAttribute("class", (page.number + 1) * page.rows >= data.length ? disabledClass : enabledClass);
  };

  var measuresCell = null;

  var renderMeasures = function() {
    var measuresTable = document.createElement("table");
    measuresTable.style.visibility = "hidden";
    measuresTable.style.position = "absolute";
    measuresTable.style.whiteSpace = "nowrap";
    measuresTable.style.height = "auto";
    measuresTable.style.width = "auto";

    var measuresRow = document.createElement("tr");
    measuresTable.appendChild(measuresRow);

    measuresCell = document.createElement("td");
    var sampleString = "ABCDEFGHIJ0123456789";
    measuresCell.appendChild(document.createTextNode(sampleString));

    measuresRow.appendChild(measuresCell);

    tableDiv.appendChild(measuresTable);
  }

  me.init = function() {
    tableDiv = document.createElement("div");
    pagedTable.appendChild(tableDiv);
    var pagedTableClass = data.length > 0 ?
      "pagedtable pagedtable-not-empty" :
      "pagedtable pagedtable-empty";

    if (columns.total == 0 || (columns.emptyNames() && data.length == 0)) {
      pagedTableClass = pagedTableClass + " pagedtable-empty-columns";
    }

    tableDiv.setAttribute("class", pagedTableClass);

    renderMeasures();
    measurer.calculate(measuresCell);
    columns.calculateWidths(measurer.measures);

    table = document.createElement("table");
    table.setAttribute("cellspacing", "0");
    table.setAttribute("class", "table table-condensed");
    tableDiv.appendChild(table);

    table.appendChild(document.createElement("thead"));

    var footerDiv = document.createElement("div");
    footerDiv.setAttribute("class", "pagedtable-footer");
    tableDiv.appendChild(footerDiv);

    // if the host has not yet provided horizontal space, render hidden
    if (tableDiv.clientWidth <= 0) {
      tableDiv.style.opacity = "0";
    }

    me.render();

    // retry seizing columns later if the host has not provided space
    function retryFit() {
      if (tableDiv.clientWidth <= 0) {
        setTimeout(retryFit, 100);
      } else {
        me.render();
        triggerOnChange();
      }
    }
    if (tableDiv.clientWidth <= 0) {
      retryFit();
    }
  };

  var registerWidths = function() {
    columns.subset = columns.subset.map(function(column) {
      column.width = columns.widths[column.name].inner;
      return column;
    });
  };

  var parsePadding = function(value) {
    return parseInt(value) >= 0 ? parseInt(value) : 0;
  };

  me.fixedHeight = function() {
    return options.rows.max != null;
  }

  me.fitRows = function() {
    if (me.fixedHeight())
      return;

    measurer.calculate(measuresCell);

    var rows = options.rows.min !== null ? options.rows.min : 0;
    var headerHeight = header !== null && header.offsetHeight > 0 ? header.offsetHeight : 0;
    var footerHeight = footer !== null && footer.offsetHeight > 0 ? footer.offsetHeight : 0;

    if (pagedTable.offsetHeight > 0) {
      var availableHeight = pagedTable.offsetHeight - headerHeight - footerHeight;
      rows = Math.floor((availableHeight) / measurer.measures.height);
    }

    rows = options.rows.min !== null ? Math.max(options.rows.min, rows) : rows;

    page.setRows(rows);
  }

  // The goal of this function is to add as many columns as possible
  // starting from left-to-right, when the right most limit is reached
  // it tries to add columns from the left as well.
  //
  // When startBackwards is true columns are added from right-to-left
  me.fitColumns = function(startBackwards) {
    measurer.calculate(measuresCell);
    columns.calculateWidths(measurer.measures);

    if (tableDiv.clientWidth > 0) {
      tableDiv.style.opacity = 1;
    }

    var visibleColumns = tableDiv.clientWidth <= 0 ? Math.max(columns.min, 1) : 1;
    var columnNumber = columns.number;
    var paddingCount = 0;

    // track a list of added columns as we build the visible ones to allow us
    // to remove columns when they don't fit anymore.
    var columnHistory = [];

    var lastTableHeight = 0;
    var backwards = startBackwards;

    var tableDivStyle = window.getComputedStyle(tableDiv, null);
    var tableDivPadding = parsePadding(tableDivStyle.paddingLeft) +
      parsePadding(tableDivStyle.paddingRight);

    var addPaddingCol = false;
    var currentWidth = 0;

    while (true) {
      columns.setVisibleColumns(columnNumber, visibleColumns, paddingCount);
      currentWidth = columns.getWidth();

      if (tableDiv.clientWidth - tableDivPadding < currentWidth) {
        break;
      }

      columnHistory.push({
        columnNumber: columnNumber,
        visibleColumns: visibleColumns,
        paddingCount: paddingCount
      });

      if (columnHistory.length > 100) {
        console.error("More than 100 tries to fit columns, aborting");
        break;
      }

      if (columns.max !== null &&
        columns.visible + columns.getPaddingCount() >= columns.max) {
        break;
      }

      // if we run out of right-columns
      if (!backwards && columnNumber + columns.visible >= columns.total) {
        // if we started adding right-columns, try adding left-columns
        if (!startBackwards && columnNumber > 0) {
          backwards = true;
        }
        else if (columns.min === null || visibleColumns + columns.getPaddingCount() >= columns.min) {
          break;
        }
        else {
          paddingCount = paddingCount + 1;
        }
      }

      // if we run out of left-columns
      if (backwards && columnNumber == 0) {
        // if we started adding left-columns, try adding right-columns
        if (startBackwards && columnNumber + columns.visible < columns.total) {
          backwards = false;
        }
        else if (columns.min === null || visibleColumns + columns.getPaddingCount() >= columns.min) {
          break;
        }
        else {
          paddingCount = paddingCount + 1;
        }
      }

      // when moving backwards try fitting left columns first
      if (backwards && columnNumber > 0) {
        columnNumber = columnNumber - 1;
      }

      if (columnNumber + visibleColumns < columns.total) {
        visibleColumns = visibleColumns + 1;
      }
    }

    var lastRenderableColumn = {
        columnNumber: columnNumber,
        visibleColumns: visibleColumns,
        paddingCount: paddingCount
    };

    if (columnHistory.length > 0) {
      lastRenderableColumn = columnHistory[columnHistory.length - 1];
    }

    columns.setVisibleColumns(
      lastRenderableColumn.columnNumber,
      lastRenderableColumn.visibleColumns,
      lastRenderableColumn.paddingCount);

    if (pagedTable.offsetWidth > 0) {
      page.setVisiblePages(Math.max(Math.ceil(1.0 * (pagedTable.offsetWidth - 250) / 40), 2));
    }

    registerWidths();
  };

  me.fit = function(startBackwards) {
    me.fitRows();
    me.fitColumns(startBackwards);
  }

  me.render = function() {
    me.fitColumns(false);

    // render header/footer to measure height accurately
    renderHeader();
    renderFooter();

    me.fitRows();
    renderBody();

    // re-render footer to match new rows
    renderFooter();
  }

  var resizeLastWidth = -1;
  var resizeLastHeight = -1;
  var resizeNewWidth = -1;
  var resizeNewHeight = -1;
  var resizePending = false;

  me.resize = function(newWidth, newHeight) {

    function resizeDelayed() {
      resizePending = false;

      if (
        (resizeNewWidth !== resizeLastWidth) ||
        (!me.fixedHeight() && resizeNewHeight !== resizeLastHeight)
      ) {
        resizeLastWidth = resizeNewWidth;
        resizeLastHeight = resizeNewHeight;

        setTimeout(resizeDelayed, 200);
        resizePending = true;
      } else {
        me.render();
        triggerOnChange();

        resizeLastWidth = -1;
        resizeLastHeight = -1;
      }
    }

    resizeNewWidth = newWidth;
    resizeNewHeight = newHeight;

    if (!resizePending) resizeDelayed();
  };
};

var PagedTableDoc;
(function (PagedTableDoc) {
  var allPagedTables = [];

  PagedTableDoc.initAll = function() {
    allPagedTables = [];

    var pagedTables = [].slice.call(document.querySelectorAll('[data-pagedtable="false"],[data-pagedtable=""]'));
    pagedTables.forEach(function(pagedTable, idx) {
      pagedTable.setAttribute("data-pagedtable", "true");
      pagedTable.setAttribute("pagedtable-page", 0);
      pagedTable.setAttribute("class", "pagedtable-wrapper");

      var pagedTableInstance = new PagedTable(pagedTable);
      pagedTableInstance.init();

      allPagedTables.push(pagedTableInstance);
    });
  };

  PagedTableDoc.resizeAll = function() {
    allPagedTables.forEach(function(pagedTable) {
      pagedTable.render();
    });
  };

  window.addEventListener("resize", PagedTableDoc.resizeAll);

  return PagedTableDoc;
})(PagedTableDoc || (PagedTableDoc = {}));

window.onload = function() {
  PagedTableDoc.initAll();
};
</script>
<script>/*! jQuery UI - v1.11.4 - 2016-01-05
* http://jqueryui.com
* Includes: core.js, widget.js, mouse.js, position.js, draggable.js, droppable.js, resizable.js, selectable.js, sortable.js, accordion.js, autocomplete.js, button.js, dialog.js, menu.js, progressbar.js, selectmenu.js, slider.js, spinner.js, tabs.js, tooltip.js, effect.js, effect-blind.js, effect-bounce.js, effect-clip.js, effect-drop.js, effect-explode.js, effect-fade.js, effect-fold.js, effect-highlight.js, effect-puff.js, effect-pulsate.js, effect-scale.js, effect-shake.js, effect-size.js, effect-slide.js, effect-transfer.js
* Copyright jQuery Foundation and other contributors; Licensed MIT */

(function(e){"function"==typeof define&&define.amd?define(["jquery"],e):e(jQuery)})(function(e){function t(t,s){var n,a,o,r=t.nodeName.toLowerCase();return"area"===r?(n=t.parentNode,a=n.name,t.href&&a&&"map"===n.nodeName.toLowerCase()?(o=e("img[usemap='#"+a+"']")[0],!!o&&i(o)):!1):(/^(input|select|textarea|button|object)$/.test(r)?!t.disabled:"a"===r?t.href||s:s)&&i(t)}function i(t){return e.expr.filters.visible(t)&&!e(t).parents().addBack().filter(function(){return"hidden"===e.css(this,"visibility")}).length}function s(e){return function(){var t=this.element.val();e.apply(this,arguments),this._refresh(),t!==this.element.val()&&this._trigger("change")}}e.ui=e.ui||{},e.extend(e.ui,{version:"1.11.4",keyCode:{BACKSPACE:8,COMMA:188,DELETE:46,DOWN:40,END:35,ENTER:13,ESCAPE:27,HOME:36,LEFT:37,PAGE_DOWN:34,PAGE_UP:33,PERIOD:190,RIGHT:39,SPACE:32,TAB:9,UP:38}}),e.fn.extend({scrollParent:function(t){var i=this.css("position"),s="absolute"===i,n=t?/(auto|scroll|hidden)/:/(auto|scroll)/,a=this.parents().filter(function(){var t=e(this);return s&&"static"===t.css("position")?!1:n.test(t.css("overflow")+t.css("overflow-y")+t.css("overflow-x"))}).eq(0);return"fixed"!==i&&a.length?a:e(this[0].ownerDocument||document)},uniqueId:function(){var e=0;return function(){return this.each(function(){this.id||(this.id="ui-id-"+ ++e)})}}(),removeUniqueId:function(){return this.each(function(){/^ui-id-\d+$/.test(this.id)&&e(this).removeAttr("id")})}}),e.extend(e.expr[":"],{data:e.expr.createPseudo?e.expr.createPseudo(function(t){return function(i){return!!e.data(i,t)}}):function(t,i,s){return!!e.data(t,s[3])},focusable:function(i){return t(i,!isNaN(e.attr(i,"tabindex")))},tabbable:function(i){var s=e.attr(i,"tabindex"),n=isNaN(s);return(n||s>=0)&&t(i,!n)}}),e("<a>").outerWidth(1).jquery||e.each(["Width","Height"],function(t,i){function s(t,i,s,a){return e.each(n,function(){i-=parseFloat(e.css(t,"padding"+this))||0,s&&(i-=parseFloat(e.css(t,"border"+this+"Width"))||0),a&&(i-=parseFloat(e.css(t,"margin"+this))||0)}),i}var n="Width"===i?["Left","Right"]:["Top","Bottom"],a=i.toLowerCase(),o={innerWidth:e.fn.innerWidth,innerHeight:e.fn.innerHeight,outerWidth:e.fn.outerWidth,outerHeight:e.fn.outerHeight};e.fn["inner"+i]=function(t){return void 0===t?o["inner"+i].call(this):this.each(function(){e(this).css(a,s(this,t)+"px")})},e.fn["outer"+i]=function(t,n){return"number"!=typeof t?o["outer"+i].call(this,t):this.each(function(){e(this).css(a,s(this,t,!0,n)+"px")})}}),e.fn.addBack||(e.fn.addBack=function(e){return this.add(null==e?this.prevObject:this.prevObject.filter(e))}),e("<a>").data("a-b","a").removeData("a-b").data("a-b")&&(e.fn.removeData=function(t){return function(i){return arguments.length?t.call(this,e.camelCase(i)):t.call(this)}}(e.fn.removeData)),e.ui.ie=!!/msie [\w.]+/.exec(navigator.userAgent.toLowerCase()),e.fn.extend({focus:function(t){return function(i,s){return"number"==typeof i?this.each(function(){var t=this;setTimeout(function(){e(t).focus(),s&&s.call(t)},i)}):t.apply(this,arguments)}}(e.fn.focus),disableSelection:function(){var e="onselectstart"in document.createElement("div")?"selectstart":"mousedown";return function(){return this.bind(e+".ui-disableSelection",function(e){e.preventDefault()})}}(),enableSelection:function(){return this.unbind(".ui-disableSelection")},zIndex:function(t){if(void 0!==t)return this.css("zIndex",t);if(this.length)for(var i,s,n=e(this[0]);n.length&&n[0]!==document;){if(i=n.css("position"),("absolute"===i||"relative"===i||"fixed"===i)&&(s=parseInt(n.css("zIndex"),10),!isNaN(s)&&0!==s))return s;n=n.parent()}return 0}}),e.ui.plugin={add:function(t,i,s){var n,a=e.ui[t].prototype;for(n in s)a.plugins[n]=a.plugins[n]||[],a.plugins[n].push([i,s[n]])},call:function(e,t,i,s){var n,a=e.plugins[t];if(a&&(s||e.element[0].parentNode&&11!==e.element[0].parentNode.nodeType))for(n=0;a.length>n;n++)e.options[a[n][0]]&&a[n][1].apply(e.element,i)}};var n=0,a=Array.prototype.slice;e.cleanData=function(t){return function(i){var s,n,a;for(a=0;null!=(n=i[a]);a++)try{s=e._data(n,"events"),s&&s.remove&&e(n).triggerHandler("remove")}catch(o){}t(i)}}(e.cleanData),e.widget=function(t,i,s){var n,a,o,r,h={},l=t.split(".")[0];return t=t.split(".")[1],n=l+"-"+t,s||(s=i,i=e.Widget),e.expr[":"][n.toLowerCase()]=function(t){return!!e.data(t,n)},e[l]=e[l]||{},a=e[l][t],o=e[l][t]=function(e,t){return this._createWidget?(arguments.length&&this._createWidget(e,t),void 0):new o(e,t)},e.extend(o,a,{version:s.version,_proto:e.extend({},s),_childConstructors:[]}),r=new i,r.options=e.widget.extend({},r.options),e.each(s,function(t,s){return e.isFunction(s)?(h[t]=function(){var e=function(){return i.prototype[t].apply(this,arguments)},n=function(e){return i.prototype[t].apply(this,e)};return function(){var t,i=this._super,a=this._superApply;return this._super=e,this._superApply=n,t=s.apply(this,arguments),this._super=i,this._superApply=a,t}}(),void 0):(h[t]=s,void 0)}),o.prototype=e.widget.extend(r,{widgetEventPrefix:a?r.widgetEventPrefix||t:t},h,{constructor:o,namespace:l,widgetName:t,widgetFullName:n}),a?(e.each(a._childConstructors,function(t,i){var s=i.prototype;e.widget(s.namespace+"."+s.widgetName,o,i._proto)}),delete a._childConstructors):i._childConstructors.push(o),e.widget.bridge(t,o),o},e.widget.extend=function(t){for(var i,s,n=a.call(arguments,1),o=0,r=n.length;r>o;o++)for(i in n[o])s=n[o][i],n[o].hasOwnProperty(i)&&void 0!==s&&(t[i]=e.isPlainObject(s)?e.isPlainObject(t[i])?e.widget.extend({},t[i],s):e.widget.extend({},s):s);return t},e.widget.bridge=function(t,i){var s=i.prototype.widgetFullName||t;e.fn[t]=function(n){var o="string"==typeof n,r=a.call(arguments,1),h=this;return o?this.each(function(){var i,a=e.data(this,s);return"instance"===n?(h=a,!1):a?e.isFunction(a[n])&&"_"!==n.charAt(0)?(i=a[n].apply(a,r),i!==a&&void 0!==i?(h=i&&i.jquery?h.pushStack(i.get()):i,!1):void 0):e.error("no such method '"+n+"' for "+t+" widget instance"):e.error("cannot call methods on "+t+" prior to initialization; "+"attempted to call method '"+n+"'")}):(r.length&&(n=e.widget.extend.apply(null,[n].concat(r))),this.each(function(){var t=e.data(this,s);t?(t.option(n||{}),t._init&&t._init()):e.data(this,s,new i(n,this))})),h}},e.Widget=function(){},e.Widget._childConstructors=[],e.Widget.prototype={widgetName:"widget",widgetEventPrefix:"",defaultElement:"<div>",options:{disabled:!1,create:null},_createWidget:function(t,i){i=e(i||this.defaultElement||this)[0],this.element=e(i),this.uuid=n++,this.eventNamespace="."+this.widgetName+this.uuid,this.bindings=e(),this.hoverable=e(),this.focusable=e(),i!==this&&(e.data(i,this.widgetFullName,this),this._on(!0,this.element,{remove:function(e){e.target===i&&this.destroy()}}),this.document=e(i.style?i.ownerDocument:i.document||i),this.window=e(this.document[0].defaultView||this.document[0].parentWindow)),this.options=e.widget.extend({},this.options,this._getCreateOptions(),t),this._create(),this._trigger("create",null,this._getCreateEventData()),this._init()},_getCreateOptions:e.noop,_getCreateEventData:e.noop,_create:e.noop,_init:e.noop,destroy:function(){this._destroy(),this.element.unbind(this.eventNamespace).removeData(this.widgetFullName).removeData(e.camelCase(this.widgetFullName)),this.widget().unbind(this.eventNamespace).removeAttr("aria-disabled").removeClass(this.widgetFullName+"-disabled "+"ui-state-disabled"),this.bindings.unbind(this.eventNamespace),this.hoverable.removeClass("ui-state-hover"),this.focusable.removeClass("ui-state-focus")},_destroy:e.noop,widget:function(){return this.element},option:function(t,i){var s,n,a,o=t;if(0===arguments.length)return e.widget.extend({},this.options);if("string"==typeof t)if(o={},s=t.split("."),t=s.shift(),s.length){for(n=o[t]=e.widget.extend({},this.options[t]),a=0;s.length-1>a;a++)n[s[a]]=n[s[a]]||{},n=n[s[a]];if(t=s.pop(),1===arguments.length)return void 0===n[t]?null:n[t];n[t]=i}else{if(1===arguments.length)return void 0===this.options[t]?null:this.options[t];o[t]=i}return this._setOptions(o),this},_setOptions:function(e){var t;for(t in e)this._setOption(t,e[t]);return this},_setOption:function(e,t){return this.options[e]=t,"disabled"===e&&(this.widget().toggleClass(this.widgetFullName+"-disabled",!!t),t&&(this.hoverable.removeClass("ui-state-hover"),this.focusable.removeClass("ui-state-focus"))),this},enable:function(){return this._setOptions({disabled:!1})},disable:function(){return this._setOptions({disabled:!0})},_on:function(t,i,s){var n,a=this;"boolean"!=typeof t&&(s=i,i=t,t=!1),s?(i=n=e(i),this.bindings=this.bindings.add(i)):(s=i,i=this.element,n=this.widget()),e.each(s,function(s,o){function r(){return t||a.options.disabled!==!0&&!e(this).hasClass("ui-state-disabled")?("string"==typeof o?a[o]:o).apply(a,arguments):void 0}"string"!=typeof o&&(r.guid=o.guid=o.guid||r.guid||e.guid++);var h=s.match(/^([\w:-]*)\s*(.*)$/),l=h[1]+a.eventNamespace,u=h[2];u?n.delegate(u,l,r):i.bind(l,r)})},_off:function(t,i){i=(i||"").split(" ").join(this.eventNamespace+" ")+this.eventNamespace,t.unbind(i).undelegate(i),this.bindings=e(this.bindings.not(t).get()),this.focusable=e(this.focusable.not(t).get()),this.hoverable=e(this.hoverable.not(t).get())},_delay:function(e,t){function i(){return("string"==typeof e?s[e]:e).apply(s,arguments)}var s=this;return setTimeout(i,t||0)},_hoverable:function(t){this.hoverable=this.hoverable.add(t),this._on(t,{mouseenter:function(t){e(t.currentTarget).addClass("ui-state-hover")},mouseleave:function(t){e(t.currentTarget).removeClass("ui-state-hover")}})},_focusable:function(t){this.focusable=this.focusable.add(t),this._on(t,{focusin:function(t){e(t.currentTarget).addClass("ui-state-focus")},focusout:function(t){e(t.currentTarget).removeClass("ui-state-focus")}})},_trigger:function(t,i,s){var n,a,o=this.options[t];if(s=s||{},i=e.Event(i),i.type=(t===this.widgetEventPrefix?t:this.widgetEventPrefix+t).toLowerCase(),i.target=this.element[0],a=i.originalEvent)for(n in a)n in i||(i[n]=a[n]);return this.element.trigger(i,s),!(e.isFunction(o)&&o.apply(this.element[0],[i].concat(s))===!1||i.isDefaultPrevented())}},e.each({show:"fadeIn",hide:"fadeOut"},function(t,i){e.Widget.prototype["_"+t]=function(s,n,a){"string"==typeof n&&(n={effect:n});var o,r=n?n===!0||"number"==typeof n?i:n.effect||i:t;n=n||{},"number"==typeof n&&(n={duration:n}),o=!e.isEmptyObject(n),n.complete=a,n.delay&&s.delay(n.delay),o&&e.effects&&e.effects.effect[r]?s[t](n):r!==t&&s[r]?s[r](n.duration,n.easing,a):s.queue(function(i){e(this)[t](),a&&a.call(s[0]),i()})}}),e.widget;var o=!1;e(document).mouseup(function(){o=!1}),e.widget("ui.mouse",{version:"1.11.4",options:{cancel:"input,textarea,button,select,option",distance:1,delay:0},_mouseInit:function(){var t=this;this.element.bind("mousedown."+this.widgetName,function(e){return t._mouseDown(e)}).bind("click."+this.widgetName,function(i){return!0===e.data(i.target,t.widgetName+".preventClickEvent")?(e.removeData(i.target,t.widgetName+".preventClickEvent"),i.stopImmediatePropagation(),!1):void 0}),this.started=!1},_mouseDestroy:function(){this.element.unbind("."+this.widgetName),this._mouseMoveDelegate&&this.document.unbind("mousemove."+this.widgetName,this._mouseMoveDelegate).unbind("mouseup."+this.widgetName,this._mouseUpDelegate)},_mouseDown:function(t){if(!o){this._mouseMoved=!1,this._mouseStarted&&this._mouseUp(t),this._mouseDownEvent=t;var i=this,s=1===t.which,n="string"==typeof this.options.cancel&&t.target.nodeName?e(t.target).closest(this.options.cancel).length:!1;return s&&!n&&this._mouseCapture(t)?(this.mouseDelayMet=!this.options.delay,this.mouseDelayMet||(this._mouseDelayTimer=setTimeout(function(){i.mouseDelayMet=!0},this.options.delay)),this._mouseDistanceMet(t)&&this._mouseDelayMet(t)&&(this._mouseStarted=this._mouseStart(t)!==!1,!this._mouseStarted)?(t.preventDefault(),!0):(!0===e.data(t.target,this.widgetName+".preventClickEvent")&&e.removeData(t.target,this.widgetName+".preventClickEvent"),this._mouseMoveDelegate=function(e){return i._mouseMove(e)},this._mouseUpDelegate=function(e){return i._mouseUp(e)},this.document.bind("mousemove."+this.widgetName,this._mouseMoveDelegate).bind("mouseup."+this.widgetName,this._mouseUpDelegate),t.preventDefault(),o=!0,!0)):!0}},_mouseMove:function(t){if(this._mouseMoved){if(e.ui.ie&&(!document.documentMode||9>document.documentMode)&&!t.button)return this._mouseUp(t);if(!t.which)return this._mouseUp(t)}return(t.which||t.button)&&(this._mouseMoved=!0),this._mouseStarted?(this._mouseDrag(t),t.preventDefault()):(this._mouseDistanceMet(t)&&this._mouseDelayMet(t)&&(this._mouseStarted=this._mouseStart(this._mouseDownEvent,t)!==!1,this._mouseStarted?this._mouseDrag(t):this._mouseUp(t)),!this._mouseStarted)},_mouseUp:function(t){return this.document.unbind("mousemove."+this.widgetName,this._mouseMoveDelegate).unbind("mouseup."+this.widgetName,this._mouseUpDelegate),this._mouseStarted&&(this._mouseStarted=!1,t.target===this._mouseDownEvent.target&&e.data(t.target,this.widgetName+".preventClickEvent",!0),this._mouseStop(t)),o=!1,!1},_mouseDistanceMet:function(e){return Math.max(Math.abs(this._mouseDownEvent.pageX-e.pageX),Math.abs(this._mouseDownEvent.pageY-e.pageY))>=this.options.distance},_mouseDelayMet:function(){return this.mouseDelayMet},_mouseStart:function(){},_mouseDrag:function(){},_mouseStop:function(){},_mouseCapture:function(){return!0}}),function(){function t(e,t,i){return[parseFloat(e[0])*(p.test(e[0])?t/100:1),parseFloat(e[1])*(p.test(e[1])?i/100:1)]}function i(t,i){return parseInt(e.css(t,i),10)||0}function s(t){var i=t[0];return 9===i.nodeType?{width:t.width(),height:t.height(),offset:{top:0,left:0}}:e.isWindow(i)?{width:t.width(),height:t.height(),offset:{top:t.scrollTop(),left:t.scrollLeft()}}:i.preventDefault?{width:0,height:0,offset:{top:i.pageY,left:i.pageX}}:{width:t.outerWidth(),height:t.outerHeight(),offset:t.offset()}}e.ui=e.ui||{};var n,a,o=Math.max,r=Math.abs,h=Math.round,l=/left|center|right/,u=/top|center|bottom/,d=/[\+\-]\d+(\.[\d]+)?%?/,c=/^\w+/,p=/%$/,f=e.fn.position;e.position={scrollbarWidth:function(){if(void 0!==n)return n;var t,i,s=e("<div style='display:block;position:absolute;width:50px;height:50px;overflow:hidden;'><div style='height:100px;width:auto;'></div></div>"),a=s.children()[0];return e("body").append(s),t=a.offsetWidth,s.css("overflow","scroll"),i=a.offsetWidth,t===i&&(i=s[0].clientWidth),s.remove(),n=t-i},getScrollInfo:function(t){var i=t.isWindow||t.isDocument?"":t.element.css("overflow-x"),s=t.isWindow||t.isDocument?"":t.element.css("overflow-y"),n="scroll"===i||"auto"===i&&t.width<t.element[0].scrollWidth,a="scroll"===s||"auto"===s&&t.height<t.element[0].scrollHeight;return{width:a?e.position.scrollbarWidth():0,height:n?e.position.scrollbarWidth():0}},getWithinInfo:function(t){var i=e(t||window),s=e.isWindow(i[0]),n=!!i[0]&&9===i[0].nodeType;return{element:i,isWindow:s,isDocument:n,offset:i.offset()||{left:0,top:0},scrollLeft:i.scrollLeft(),scrollTop:i.scrollTop(),width:s||n?i.width():i.outerWidth(),height:s||n?i.height():i.outerHeight()}}},e.fn.position=function(n){if(!n||!n.of)return f.apply(this,arguments);n=e.extend({},n);var p,m,g,v,y,b,_=e(n.of),x=e.position.getWithinInfo(n.within),w=e.position.getScrollInfo(x),k=(n.collision||"flip").split(" "),T={};return b=s(_),_[0].preventDefault&&(n.at="left top"),m=b.width,g=b.height,v=b.offset,y=e.extend({},v),e.each(["my","at"],function(){var e,t,i=(n[this]||"").split(" ");1===i.length&&(i=l.test(i[0])?i.concat(["center"]):u.test(i[0])?["center"].concat(i):["center","center"]),i[0]=l.test(i[0])?i[0]:"center",i[1]=u.test(i[1])?i[1]:"center",e=d.exec(i[0]),t=d.exec(i[1]),T[this]=[e?e[0]:0,t?t[0]:0],n[this]=[c.exec(i[0])[0],c.exec(i[1])[0]]}),1===k.length&&(k[1]=k[0]),"right"===n.at[0]?y.left+=m:"center"===n.at[0]&&(y.left+=m/2),"bottom"===n.at[1]?y.top+=g:"center"===n.at[1]&&(y.top+=g/2),p=t(T.at,m,g),y.left+=p[0],y.top+=p[1],this.each(function(){var s,l,u=e(this),d=u.outerWidth(),c=u.outerHeight(),f=i(this,"marginLeft"),b=i(this,"marginTop"),D=d+f+i(this,"marginRight")+w.width,S=c+b+i(this,"marginBottom")+w.height,N=e.extend({},y),M=t(T.my,u.outerWidth(),u.outerHeight());"right"===n.my[0]?N.left-=d:"center"===n.my[0]&&(N.left-=d/2),"bottom"===n.my[1]?N.top-=c:"center"===n.my[1]&&(N.top-=c/2),N.left+=M[0],N.top+=M[1],a||(N.left=h(N.left),N.top=h(N.top)),s={marginLeft:f,marginTop:b},e.each(["left","top"],function(t,i){e.ui.position[k[t]]&&e.ui.position[k[t]][i](N,{targetWidth:m,targetHeight:g,elemWidth:d,elemHeight:c,collisionPosition:s,collisionWidth:D,collisionHeight:S,offset:[p[0]+M[0],p[1]+M[1]],my:n.my,at:n.at,within:x,elem:u})}),n.using&&(l=function(e){var t=v.left-N.left,i=t+m-d,s=v.top-N.top,a=s+g-c,h={target:{element:_,left:v.left,top:v.top,width:m,height:g},element:{element:u,left:N.left,top:N.top,width:d,height:c},horizontal:0>i?"left":t>0?"right":"center",vertical:0>a?"top":s>0?"bottom":"middle"};d>m&&m>r(t+i)&&(h.horizontal="center"),c>g&&g>r(s+a)&&(h.vertical="middle"),h.important=o(r(t),r(i))>o(r(s),r(a))?"horizontal":"vertical",n.using.call(this,e,h)}),u.offset(e.extend(N,{using:l}))})},e.ui.position={fit:{left:function(e,t){var i,s=t.within,n=s.isWindow?s.scrollLeft:s.offset.left,a=s.width,r=e.left-t.collisionPosition.marginLeft,h=n-r,l=r+t.collisionWidth-a-n;t.collisionWidth>a?h>0&&0>=l?(i=e.left+h+t.collisionWidth-a-n,e.left+=h-i):e.left=l>0&&0>=h?n:h>l?n+a-t.collisionWidth:n:h>0?e.left+=h:l>0?e.left-=l:e.left=o(e.left-r,e.left)},top:function(e,t){var i,s=t.within,n=s.isWindow?s.scrollTop:s.offset.top,a=t.within.height,r=e.top-t.collisionPosition.marginTop,h=n-r,l=r+t.collisionHeight-a-n;t.collisionHeight>a?h>0&&0>=l?(i=e.top+h+t.collisionHeight-a-n,e.top+=h-i):e.top=l>0&&0>=h?n:h>l?n+a-t.collisionHeight:n:h>0?e.top+=h:l>0?e.top-=l:e.top=o(e.top-r,e.top)}},flip:{left:function(e,t){var i,s,n=t.within,a=n.offset.left+n.scrollLeft,o=n.width,h=n.isWindow?n.scrollLeft:n.offset.left,l=e.left-t.collisionPosition.marginLeft,u=l-h,d=l+t.collisionWidth-o-h,c="left"===t.my[0]?-t.elemWidth:"right"===t.my[0]?t.elemWidth:0,p="left"===t.at[0]?t.targetWidth:"right"===t.at[0]?-t.targetWidth:0,f=-2*t.offset[0];0>u?(i=e.left+c+p+f+t.collisionWidth-o-a,(0>i||r(u)>i)&&(e.left+=c+p+f)):d>0&&(s=e.left-t.collisionPosition.marginLeft+c+p+f-h,(s>0||d>r(s))&&(e.left+=c+p+f))},top:function(e,t){var i,s,n=t.within,a=n.offset.top+n.scrollTop,o=n.height,h=n.isWindow?n.scrollTop:n.offset.top,l=e.top-t.collisionPosition.marginTop,u=l-h,d=l+t.collisionHeight-o-h,c="top"===t.my[1],p=c?-t.elemHeight:"bottom"===t.my[1]?t.elemHeight:0,f="top"===t.at[1]?t.targetHeight:"bottom"===t.at[1]?-t.targetHeight:0,m=-2*t.offset[1];0>u?(s=e.top+p+f+m+t.collisionHeight-o-a,(0>s||r(u)>s)&&(e.top+=p+f+m)):d>0&&(i=e.top-t.collisionPosition.marginTop+p+f+m-h,(i>0||d>r(i))&&(e.top+=p+f+m))}},flipfit:{left:function(){e.ui.position.flip.left.apply(this,arguments),e.ui.position.fit.left.apply(this,arguments)},top:function(){e.ui.position.flip.top.apply(this,arguments),e.ui.position.fit.top.apply(this,arguments)}}},function(){var t,i,s,n,o,r=document.getElementsByTagName("body")[0],h=document.createElement("div");t=document.createElement(r?"div":"body"),s={visibility:"hidden",width:0,height:0,border:0,margin:0,background:"none"},r&&e.extend(s,{position:"absolute",left:"-1000px",top:"-1000px"});for(o in s)t.style[o]=s[o];t.appendChild(h),i=r||document.documentElement,i.insertBefore(t,i.firstChild),h.style.cssText="position: absolute; left: 10.7432222px;",n=e(h).offset().left,a=n>10&&11>n,t.innerHTML="",i.removeChild(t)}()}(),e.ui.position,e.widget("ui.draggable",e.ui.mouse,{version:"1.11.4",widgetEventPrefix:"drag",options:{addClasses:!0,appendTo:"parent",axis:!1,connectToSortable:!1,containment:!1,cursor:"auto",cursorAt:!1,grid:!1,handle:!1,helper:"original",iframeFix:!1,opacity:!1,refreshPositions:!1,revert:!1,revertDuration:500,scope:"default",scroll:!0,scrollSensitivity:20,scrollSpeed:20,snap:!1,snapMode:"both",snapTolerance:20,stack:!1,zIndex:!1,drag:null,start:null,stop:null},_create:function(){"original"===this.options.helper&&this._setPositionRelative(),this.options.addClasses&&this.element.addClass("ui-draggable"),this.options.disabled&&this.element.addClass("ui-draggable-disabled"),this._setHandleClassName(),this._mouseInit()},_setOption:function(e,t){this._super(e,t),"handle"===e&&(this._removeHandleClassName(),this._setHandleClassName())},_destroy:function(){return(this.helper||this.element).is(".ui-draggable-dragging")?(this.destroyOnClear=!0,void 0):(this.element.removeClass("ui-draggable ui-draggable-dragging ui-draggable-disabled"),this._removeHandleClassName(),this._mouseDestroy(),void 0)},_mouseCapture:function(t){var i=this.options;return this._blurActiveElement(t),this.helper||i.disabled||e(t.target).closest(".ui-resizable-handle").length>0?!1:(this.handle=this._getHandle(t),this.handle?(this._blockFrames(i.iframeFix===!0?"iframe":i.iframeFix),!0):!1)},_blockFrames:function(t){this.iframeBlocks=this.document.find(t).map(function(){var t=e(this);return e("<div>").css("position","absolute").appendTo(t.parent()).outerWidth(t.outerWidth()).outerHeight(t.outerHeight()).offset(t.offset())[0]})},_unblockFrames:function(){this.iframeBlocks&&(this.iframeBlocks.remove(),delete this.iframeBlocks)},_blurActiveElement:function(t){var i=this.document[0];if(this.handleElement.is(t.target))try{i.activeElement&&"body"!==i.activeElement.nodeName.toLowerCase()&&e(i.activeElement).blur()}catch(s){}},_mouseStart:function(t){var i=this.options;return this.helper=this._createHelper(t),this.helper.addClass("ui-draggable-dragging"),this._cacheHelperProportions(),e.ui.ddmanager&&(e.ui.ddmanager.current=this),this._cacheMargins(),this.cssPosition=this.helper.css("position"),this.scrollParent=this.helper.scrollParent(!0),this.offsetParent=this.helper.offsetParent(),this.hasFixedAncestor=this.helper.parents().filter(function(){return"fixed"===e(this).css("position")}).length>0,this.positionAbs=this.element.offset(),this._refreshOffsets(t),this.originalPosition=this.position=this._generatePosition(t,!1),this.originalPageX=t.pageX,this.originalPageY=t.pageY,i.cursorAt&&this._adjustOffsetFromHelper(i.cursorAt),this._setContainment(),this._trigger("start",t)===!1?(this._clear(),!1):(this._cacheHelperProportions(),e.ui.ddmanager&&!i.dropBehaviour&&e.ui.ddmanager.prepareOffsets(this,t),this._normalizeRightBottom(),this._mouseDrag(t,!0),e.ui.ddmanager&&e.ui.ddmanager.dragStart(this,t),!0)},_refreshOffsets:function(e){this.offset={top:this.positionAbs.top-this.margins.top,left:this.positionAbs.left-this.margins.left,scroll:!1,parent:this._getParentOffset(),relative:this._getRelativeOffset()},this.offset.click={left:e.pageX-this.offset.left,top:e.pageY-this.offset.top}},_mouseDrag:function(t,i){if(this.hasFixedAncestor&&(this.offset.parent=this._getParentOffset()),this.position=this._generatePosition(t,!0),this.positionAbs=this._convertPositionTo("absolute"),!i){var s=this._uiHash();if(this._trigger("drag",t,s)===!1)return this._mouseUp({}),!1;this.position=s.position}return this.helper[0].style.left=this.position.left+"px",this.helper[0].style.top=this.position.top+"px",e.ui.ddmanager&&e.ui.ddmanager.drag(this,t),!1},_mouseStop:function(t){var i=this,s=!1;return e.ui.ddmanager&&!this.options.dropBehaviour&&(s=e.ui.ddmanager.drop(this,t)),this.dropped&&(s=this.dropped,this.dropped=!1),"invalid"===this.options.revert&&!s||"valid"===this.options.revert&&s||this.options.revert===!0||e.isFunction(this.options.revert)&&this.options.revert.call(this.element,s)?e(this.helper).animate(this.originalPosition,parseInt(this.options.revertDuration,10),function(){i._trigger("stop",t)!==!1&&i._clear()}):this._trigger("stop",t)!==!1&&this._clear(),!1},_mouseUp:function(t){return this._unblockFrames(),e.ui.ddmanager&&e.ui.ddmanager.dragStop(this,t),this.handleElement.is(t.target)&&this.element.focus(),e.ui.mouse.prototype._mouseUp.call(this,t)},cancel:function(){return this.helper.is(".ui-draggable-dragging")?this._mouseUp({}):this._clear(),this},_getHandle:function(t){return this.options.handle?!!e(t.target).closest(this.element.find(this.options.handle)).length:!0},_setHandleClassName:function(){this.handleElement=this.options.handle?this.element.find(this.options.handle):this.element,this.handleElement.addClass("ui-draggable-handle")},_removeHandleClassName:function(){this.handleElement.removeClass("ui-draggable-handle")},_createHelper:function(t){var i=this.options,s=e.isFunction(i.helper),n=s?e(i.helper.apply(this.element[0],[t])):"clone"===i.helper?this.element.clone().removeAttr("id"):this.element;return n.parents("body").length||n.appendTo("parent"===i.appendTo?this.element[0].parentNode:i.appendTo),s&&n[0]===this.element[0]&&this._setPositionRelative(),n[0]===this.element[0]||/(fixed|absolute)/.test(n.css("position"))||n.css("position","absolute"),n},_setPositionRelative:function(){/^(?:r|a|f)/.test(this.element.css("position"))||(this.element[0].style.position="relative")},_adjustOffsetFromHelper:function(t){"string"==typeof t&&(t=t.split(" ")),e.isArray(t)&&(t={left:+t[0],top:+t[1]||0}),"left"in t&&(this.offset.click.left=t.left+this.margins.left),"right"in t&&(this.offset.click.left=this.helperProportions.width-t.right+this.margins.left),"top"in t&&(this.offset.click.top=t.top+this.margins.top),"bottom"in t&&(this.offset.click.top=this.helperProportions.height-t.bottom+this.margins.top)},_isRootNode:function(e){return/(html|body)/i.test(e.tagName)||e===this.document[0]},_getParentOffset:function(){var t=this.offsetParent.offset(),i=this.document[0];return"absolute"===this.cssPosition&&this.scrollParent[0]!==i&&e.contains(this.scrollParent[0],this.offsetParent[0])&&(t.left+=this.scrollParent.scrollLeft(),t.top+=this.scrollParent.scrollTop()),this._isRootNode(this.offsetParent[0])&&(t={top:0,left:0}),{top:t.top+(parseInt(this.offsetParent.css("borderTopWidth"),10)||0),left:t.left+(parseInt(this.offsetParent.css("borderLeftWidth"),10)||0)}},_getRelativeOffset:function(){if("relative"!==this.cssPosition)return{top:0,left:0};var e=this.element.position(),t=this._isRootNode(this.scrollParent[0]);return{top:e.top-(parseInt(this.helper.css("top"),10)||0)+(t?0:this.scrollParent.scrollTop()),left:e.left-(parseInt(this.helper.css("left"),10)||0)+(t?0:this.scrollParent.scrollLeft())}},_cacheMargins:function(){this.margins={left:parseInt(this.element.css("marginLeft"),10)||0,top:parseInt(this.element.css("marginTop"),10)||0,right:parseInt(this.element.css("marginRight"),10)||0,bottom:parseInt(this.element.css("marginBottom"),10)||0}},_cacheHelperProportions:function(){this.helperProportions={width:this.helper.outerWidth(),height:this.helper.outerHeight()}},_setContainment:function(){var t,i,s,n=this.options,a=this.document[0];return this.relativeContainer=null,n.containment?"window"===n.containment?(this.containment=[e(window).scrollLeft()-this.offset.relative.left-this.offset.parent.left,e(window).scrollTop()-this.offset.relative.top-this.offset.parent.top,e(window).scrollLeft()+e(window).width()-this.helperProportions.width-this.margins.left,e(window).scrollTop()+(e(window).height()||a.body.parentNode.scrollHeight)-this.helperProportions.height-this.margins.top],void 0):"document"===n.containment?(this.containment=[0,0,e(a).width()-this.helperProportions.width-this.margins.left,(e(a).height()||a.body.parentNode.scrollHeight)-this.helperProportions.height-this.margins.top],void 0):n.containment.constructor===Array?(this.containment=n.containment,void 0):("parent"===n.containment&&(n.containment=this.helper[0].parentNode),i=e(n.containment),s=i[0],s&&(t=/(scroll|auto)/.test(i.css("overflow")),this.containment=[(parseInt(i.css("borderLeftWidth"),10)||0)+(parseInt(i.css("paddingLeft"),10)||0),(parseInt(i.css("borderTopWidth"),10)||0)+(parseInt(i.css("paddingTop"),10)||0),(t?Math.max(s.scrollWidth,s.offsetWidth):s.offsetWidth)-(parseInt(i.css("borderRightWidth"),10)||0)-(parseInt(i.css("paddingRight"),10)||0)-this.helperProportions.width-this.margins.left-this.margins.right,(t?Math.max(s.scrollHeight,s.offsetHeight):s.offsetHeight)-(parseInt(i.css("borderBottomWidth"),10)||0)-(parseInt(i.css("paddingBottom"),10)||0)-this.helperProportions.height-this.margins.top-this.margins.bottom],this.relativeContainer=i),void 0):(this.containment=null,void 0)},_convertPositionTo:function(e,t){t||(t=this.position);var i="absolute"===e?1:-1,s=this._isRootNode(this.scrollParent[0]);return{top:t.top+this.offset.relative.top*i+this.offset.parent.top*i-("fixed"===this.cssPosition?-this.offset.scroll.top:s?0:this.offset.scroll.top)*i,left:t.left+this.offset.relative.left*i+this.offset.parent.left*i-("fixed"===this.cssPosition?-this.offset.scroll.left:s?0:this.offset.scroll.left)*i}},_generatePosition:function(e,t){var i,s,n,a,o=this.options,r=this._isRootNode(this.scrollParent[0]),h=e.pageX,l=e.pageY;return r&&this.offset.scroll||(this.offset.scroll={top:this.scrollParent.scrollTop(),left:this.scrollParent.scrollLeft()}),t&&(this.containment&&(this.relativeContainer?(s=this.relativeContainer.offset(),i=[this.containment[0]+s.left,this.containment[1]+s.top,this.containment[2]+s.left,this.containment[3]+s.top]):i=this.containment,e.pageX-this.offset.click.left<i[0]&&(h=i[0]+this.offset.click.left),e.pageY-this.offset.click.top<i[1]&&(l=i[1]+this.offset.click.top),e.pageX-this.offset.click.left>i[2]&&(h=i[2]+this.offset.click.left),e.pageY-this.offset.click.top>i[3]&&(l=i[3]+this.offset.click.top)),o.grid&&(n=o.grid[1]?this.originalPageY+Math.round((l-this.originalPageY)/o.grid[1])*o.grid[1]:this.originalPageY,l=i?n-this.offset.click.top>=i[1]||n-this.offset.click.top>i[3]?n:n-this.offset.click.top>=i[1]?n-o.grid[1]:n+o.grid[1]:n,a=o.grid[0]?this.originalPageX+Math.round((h-this.originalPageX)/o.grid[0])*o.grid[0]:this.originalPageX,h=i?a-this.offset.click.left>=i[0]||a-this.offset.click.left>i[2]?a:a-this.offset.click.left>=i[0]?a-o.grid[0]:a+o.grid[0]:a),"y"===o.axis&&(h=this.originalPageX),"x"===o.axis&&(l=this.originalPageY)),{top:l-this.offset.click.top-this.offset.relative.top-this.offset.parent.top+("fixed"===this.cssPosition?-this.offset.scroll.top:r?0:this.offset.scroll.top),left:h-this.offset.click.left-this.offset.relative.left-this.offset.parent.left+("fixed"===this.cssPosition?-this.offset.scroll.left:r?0:this.offset.scroll.left)}},_clear:function(){this.helper.removeClass("ui-draggable-dragging"),this.helper[0]===this.element[0]||this.cancelHelperRemoval||this.helper.remove(),this.helper=null,this.cancelHelperRemoval=!1,this.destroyOnClear&&this.destroy()},_normalizeRightBottom:function(){"y"!==this.options.axis&&"auto"!==this.helper.css("right")&&(this.helper.width(this.helper.width()),this.helper.css("right","auto")),"x"!==this.options.axis&&"auto"!==this.helper.css("bottom")&&(this.helper.height(this.helper.height()),this.helper.css("bottom","auto"))},_trigger:function(t,i,s){return s=s||this._uiHash(),e.ui.plugin.call(this,t,[i,s,this],!0),/^(drag|start|stop)/.test(t)&&(this.positionAbs=this._convertPositionTo("absolute"),s.offset=this.positionAbs),e.Widget.prototype._trigger.call(this,t,i,s)},plugins:{},_uiHash:function(){return{helper:this.helper,position:this.position,originalPosition:this.originalPosition,offset:this.positionAbs}}}),e.ui.plugin.add("draggable","connectToSortable",{start:function(t,i,s){var n=e.extend({},i,{item:s.element});s.sortables=[],e(s.options.connectToSortable).each(function(){var i=e(this).sortable("instance");i&&!i.options.disabled&&(s.sortables.push(i),i.refreshPositions(),i._trigger("activate",t,n))})},stop:function(t,i,s){var n=e.extend({},i,{item:s.element});s.cancelHelperRemoval=!1,e.each(s.sortables,function(){var e=this;e.isOver?(e.isOver=0,s.cancelHelperRemoval=!0,e.cancelHelperRemoval=!1,e._storedCSS={position:e.placeholder.css("position"),top:e.placeholder.css("top"),left:e.placeholder.css("left")},e._mouseStop(t),e.options.helper=e.options._helper):(e.cancelHelperRemoval=!0,e._trigger("deactivate",t,n))})},drag:function(t,i,s){e.each(s.sortables,function(){var n=!1,a=this;a.positionAbs=s.positionAbs,a.helperProportions=s.helperProportions,a.offset.click=s.offset.click,a._intersectsWith(a.containerCache)&&(n=!0,e.each(s.sortables,function(){return this.positionAbs=s.positionAbs,this.helperProportions=s.helperProportions,this.offset.click=s.offset.click,this!==a&&this._intersectsWith(this.containerCache)&&e.contains(a.element[0],this.element[0])&&(n=!1),n
})),n?(a.isOver||(a.isOver=1,s._parent=i.helper.parent(),a.currentItem=i.helper.appendTo(a.element).data("ui-sortable-item",!0),a.options._helper=a.options.helper,a.options.helper=function(){return i.helper[0]},t.target=a.currentItem[0],a._mouseCapture(t,!0),a._mouseStart(t,!0,!0),a.offset.click.top=s.offset.click.top,a.offset.click.left=s.offset.click.left,a.offset.parent.left-=s.offset.parent.left-a.offset.parent.left,a.offset.parent.top-=s.offset.parent.top-a.offset.parent.top,s._trigger("toSortable",t),s.dropped=a.element,e.each(s.sortables,function(){this.refreshPositions()}),s.currentItem=s.element,a.fromOutside=s),a.currentItem&&(a._mouseDrag(t),i.position=a.position)):a.isOver&&(a.isOver=0,a.cancelHelperRemoval=!0,a.options._revert=a.options.revert,a.options.revert=!1,a._trigger("out",t,a._uiHash(a)),a._mouseStop(t,!0),a.options.revert=a.options._revert,a.options.helper=a.options._helper,a.placeholder&&a.placeholder.remove(),i.helper.appendTo(s._parent),s._refreshOffsets(t),i.position=s._generatePosition(t,!0),s._trigger("fromSortable",t),s.dropped=!1,e.each(s.sortables,function(){this.refreshPositions()}))})}}),e.ui.plugin.add("draggable","cursor",{start:function(t,i,s){var n=e("body"),a=s.options;n.css("cursor")&&(a._cursor=n.css("cursor")),n.css("cursor",a.cursor)},stop:function(t,i,s){var n=s.options;n._cursor&&e("body").css("cursor",n._cursor)}}),e.ui.plugin.add("draggable","opacity",{start:function(t,i,s){var n=e(i.helper),a=s.options;n.css("opacity")&&(a._opacity=n.css("opacity")),n.css("opacity",a.opacity)},stop:function(t,i,s){var n=s.options;n._opacity&&e(i.helper).css("opacity",n._opacity)}}),e.ui.plugin.add("draggable","scroll",{start:function(e,t,i){i.scrollParentNotHidden||(i.scrollParentNotHidden=i.helper.scrollParent(!1)),i.scrollParentNotHidden[0]!==i.document[0]&&"HTML"!==i.scrollParentNotHidden[0].tagName&&(i.overflowOffset=i.scrollParentNotHidden.offset())},drag:function(t,i,s){var n=s.options,a=!1,o=s.scrollParentNotHidden[0],r=s.document[0];o!==r&&"HTML"!==o.tagName?(n.axis&&"x"===n.axis||(s.overflowOffset.top+o.offsetHeight-t.pageY<n.scrollSensitivity?o.scrollTop=a=o.scrollTop+n.scrollSpeed:t.pageY-s.overflowOffset.top<n.scrollSensitivity&&(o.scrollTop=a=o.scrollTop-n.scrollSpeed)),n.axis&&"y"===n.axis||(s.overflowOffset.left+o.offsetWidth-t.pageX<n.scrollSensitivity?o.scrollLeft=a=o.scrollLeft+n.scrollSpeed:t.pageX-s.overflowOffset.left<n.scrollSensitivity&&(o.scrollLeft=a=o.scrollLeft-n.scrollSpeed))):(n.axis&&"x"===n.axis||(t.pageY-e(r).scrollTop()<n.scrollSensitivity?a=e(r).scrollTop(e(r).scrollTop()-n.scrollSpeed):e(window).height()-(t.pageY-e(r).scrollTop())<n.scrollSensitivity&&(a=e(r).scrollTop(e(r).scrollTop()+n.scrollSpeed))),n.axis&&"y"===n.axis||(t.pageX-e(r).scrollLeft()<n.scrollSensitivity?a=e(r).scrollLeft(e(r).scrollLeft()-n.scrollSpeed):e(window).width()-(t.pageX-e(r).scrollLeft())<n.scrollSensitivity&&(a=e(r).scrollLeft(e(r).scrollLeft()+n.scrollSpeed)))),a!==!1&&e.ui.ddmanager&&!n.dropBehaviour&&e.ui.ddmanager.prepareOffsets(s,t)}}),e.ui.plugin.add("draggable","snap",{start:function(t,i,s){var n=s.options;s.snapElements=[],e(n.snap.constructor!==String?n.snap.items||":data(ui-draggable)":n.snap).each(function(){var t=e(this),i=t.offset();this!==s.element[0]&&s.snapElements.push({item:this,width:t.outerWidth(),height:t.outerHeight(),top:i.top,left:i.left})})},drag:function(t,i,s){var n,a,o,r,h,l,u,d,c,p,f=s.options,m=f.snapTolerance,g=i.offset.left,v=g+s.helperProportions.width,y=i.offset.top,b=y+s.helperProportions.height;for(c=s.snapElements.length-1;c>=0;c--)h=s.snapElements[c].left-s.margins.left,l=h+s.snapElements[c].width,u=s.snapElements[c].top-s.margins.top,d=u+s.snapElements[c].height,h-m>v||g>l+m||u-m>b||y>d+m||!e.contains(s.snapElements[c].item.ownerDocument,s.snapElements[c].item)?(s.snapElements[c].snapping&&s.options.snap.release&&s.options.snap.release.call(s.element,t,e.extend(s._uiHash(),{snapItem:s.snapElements[c].item})),s.snapElements[c].snapping=!1):("inner"!==f.snapMode&&(n=m>=Math.abs(u-b),a=m>=Math.abs(d-y),o=m>=Math.abs(h-v),r=m>=Math.abs(l-g),n&&(i.position.top=s._convertPositionTo("relative",{top:u-s.helperProportions.height,left:0}).top),a&&(i.position.top=s._convertPositionTo("relative",{top:d,left:0}).top),o&&(i.position.left=s._convertPositionTo("relative",{top:0,left:h-s.helperProportions.width}).left),r&&(i.position.left=s._convertPositionTo("relative",{top:0,left:l}).left)),p=n||a||o||r,"outer"!==f.snapMode&&(n=m>=Math.abs(u-y),a=m>=Math.abs(d-b),o=m>=Math.abs(h-g),r=m>=Math.abs(l-v),n&&(i.position.top=s._convertPositionTo("relative",{top:u,left:0}).top),a&&(i.position.top=s._convertPositionTo("relative",{top:d-s.helperProportions.height,left:0}).top),o&&(i.position.left=s._convertPositionTo("relative",{top:0,left:h}).left),r&&(i.position.left=s._convertPositionTo("relative",{top:0,left:l-s.helperProportions.width}).left)),!s.snapElements[c].snapping&&(n||a||o||r||p)&&s.options.snap.snap&&s.options.snap.snap.call(s.element,t,e.extend(s._uiHash(),{snapItem:s.snapElements[c].item})),s.snapElements[c].snapping=n||a||o||r||p)}}),e.ui.plugin.add("draggable","stack",{start:function(t,i,s){var n,a=s.options,o=e.makeArray(e(a.stack)).sort(function(t,i){return(parseInt(e(t).css("zIndex"),10)||0)-(parseInt(e(i).css("zIndex"),10)||0)});o.length&&(n=parseInt(e(o[0]).css("zIndex"),10)||0,e(o).each(function(t){e(this).css("zIndex",n+t)}),this.css("zIndex",n+o.length))}}),e.ui.plugin.add("draggable","zIndex",{start:function(t,i,s){var n=e(i.helper),a=s.options;n.css("zIndex")&&(a._zIndex=n.css("zIndex")),n.css("zIndex",a.zIndex)},stop:function(t,i,s){var n=s.options;n._zIndex&&e(i.helper).css("zIndex",n._zIndex)}}),e.ui.draggable,e.widget("ui.droppable",{version:"1.11.4",widgetEventPrefix:"drop",options:{accept:"*",activeClass:!1,addClasses:!0,greedy:!1,hoverClass:!1,scope:"default",tolerance:"intersect",activate:null,deactivate:null,drop:null,out:null,over:null},_create:function(){var t,i=this.options,s=i.accept;this.isover=!1,this.isout=!0,this.accept=e.isFunction(s)?s:function(e){return e.is(s)},this.proportions=function(){return arguments.length?(t=arguments[0],void 0):t?t:t={width:this.element[0].offsetWidth,height:this.element[0].offsetHeight}},this._addToManager(i.scope),i.addClasses&&this.element.addClass("ui-droppable")},_addToManager:function(t){e.ui.ddmanager.droppables[t]=e.ui.ddmanager.droppables[t]||[],e.ui.ddmanager.droppables[t].push(this)},_splice:function(e){for(var t=0;e.length>t;t++)e[t]===this&&e.splice(t,1)},_destroy:function(){var t=e.ui.ddmanager.droppables[this.options.scope];this._splice(t),this.element.removeClass("ui-droppable ui-droppable-disabled")},_setOption:function(t,i){if("accept"===t)this.accept=e.isFunction(i)?i:function(e){return e.is(i)};else if("scope"===t){var s=e.ui.ddmanager.droppables[this.options.scope];this._splice(s),this._addToManager(i)}this._super(t,i)},_activate:function(t){var i=e.ui.ddmanager.current;this.options.activeClass&&this.element.addClass(this.options.activeClass),i&&this._trigger("activate",t,this.ui(i))},_deactivate:function(t){var i=e.ui.ddmanager.current;this.options.activeClass&&this.element.removeClass(this.options.activeClass),i&&this._trigger("deactivate",t,this.ui(i))},_over:function(t){var i=e.ui.ddmanager.current;i&&(i.currentItem||i.element)[0]!==this.element[0]&&this.accept.call(this.element[0],i.currentItem||i.element)&&(this.options.hoverClass&&this.element.addClass(this.options.hoverClass),this._trigger("over",t,this.ui(i)))},_out:function(t){var i=e.ui.ddmanager.current;i&&(i.currentItem||i.element)[0]!==this.element[0]&&this.accept.call(this.element[0],i.currentItem||i.element)&&(this.options.hoverClass&&this.element.removeClass(this.options.hoverClass),this._trigger("out",t,this.ui(i)))},_drop:function(t,i){var s=i||e.ui.ddmanager.current,n=!1;return s&&(s.currentItem||s.element)[0]!==this.element[0]?(this.element.find(":data(ui-droppable)").not(".ui-draggable-dragging").each(function(){var i=e(this).droppable("instance");return i.options.greedy&&!i.options.disabled&&i.options.scope===s.options.scope&&i.accept.call(i.element[0],s.currentItem||s.element)&&e.ui.intersect(s,e.extend(i,{offset:i.element.offset()}),i.options.tolerance,t)?(n=!0,!1):void 0}),n?!1:this.accept.call(this.element[0],s.currentItem||s.element)?(this.options.activeClass&&this.element.removeClass(this.options.activeClass),this.options.hoverClass&&this.element.removeClass(this.options.hoverClass),this._trigger("drop",t,this.ui(s)),this.element):!1):!1},ui:function(e){return{draggable:e.currentItem||e.element,helper:e.helper,position:e.position,offset:e.positionAbs}}}),e.ui.intersect=function(){function e(e,t,i){return e>=t&&t+i>e}return function(t,i,s,n){if(!i.offset)return!1;var a=(t.positionAbs||t.position.absolute).left+t.margins.left,o=(t.positionAbs||t.position.absolute).top+t.margins.top,r=a+t.helperProportions.width,h=o+t.helperProportions.height,l=i.offset.left,u=i.offset.top,d=l+i.proportions().width,c=u+i.proportions().height;switch(s){case"fit":return a>=l&&d>=r&&o>=u&&c>=h;case"intersect":return a+t.helperProportions.width/2>l&&d>r-t.helperProportions.width/2&&o+t.helperProportions.height/2>u&&c>h-t.helperProportions.height/2;case"pointer":return e(n.pageY,u,i.proportions().height)&&e(n.pageX,l,i.proportions().width);case"touch":return(o>=u&&c>=o||h>=u&&c>=h||u>o&&h>c)&&(a>=l&&d>=a||r>=l&&d>=r||l>a&&r>d);default:return!1}}}(),e.ui.ddmanager={current:null,droppables:{"default":[]},prepareOffsets:function(t,i){var s,n,a=e.ui.ddmanager.droppables[t.options.scope]||[],o=i?i.type:null,r=(t.currentItem||t.element).find(":data(ui-droppable)").addBack();e:for(s=0;a.length>s;s++)if(!(a[s].options.disabled||t&&!a[s].accept.call(a[s].element[0],t.currentItem||t.element))){for(n=0;r.length>n;n++)if(r[n]===a[s].element[0]){a[s].proportions().height=0;continue e}a[s].visible="none"!==a[s].element.css("display"),a[s].visible&&("mousedown"===o&&a[s]._activate.call(a[s],i),a[s].offset=a[s].element.offset(),a[s].proportions({width:a[s].element[0].offsetWidth,height:a[s].element[0].offsetHeight}))}},drop:function(t,i){var s=!1;return e.each((e.ui.ddmanager.droppables[t.options.scope]||[]).slice(),function(){this.options&&(!this.options.disabled&&this.visible&&e.ui.intersect(t,this,this.options.tolerance,i)&&(s=this._drop.call(this,i)||s),!this.options.disabled&&this.visible&&this.accept.call(this.element[0],t.currentItem||t.element)&&(this.isout=!0,this.isover=!1,this._deactivate.call(this,i)))}),s},dragStart:function(t,i){t.element.parentsUntil("body").bind("scroll.droppable",function(){t.options.refreshPositions||e.ui.ddmanager.prepareOffsets(t,i)})},drag:function(t,i){t.options.refreshPositions&&e.ui.ddmanager.prepareOffsets(t,i),e.each(e.ui.ddmanager.droppables[t.options.scope]||[],function(){if(!this.options.disabled&&!this.greedyChild&&this.visible){var s,n,a,o=e.ui.intersect(t,this,this.options.tolerance,i),r=!o&&this.isover?"isout":o&&!this.isover?"isover":null;r&&(this.options.greedy&&(n=this.options.scope,a=this.element.parents(":data(ui-droppable)").filter(function(){return e(this).droppable("instance").options.scope===n}),a.length&&(s=e(a[0]).droppable("instance"),s.greedyChild="isover"===r)),s&&"isover"===r&&(s.isover=!1,s.isout=!0,s._out.call(s,i)),this[r]=!0,this["isout"===r?"isover":"isout"]=!1,this["isover"===r?"_over":"_out"].call(this,i),s&&"isout"===r&&(s.isout=!1,s.isover=!0,s._over.call(s,i)))}})},dragStop:function(t,i){t.element.parentsUntil("body").unbind("scroll.droppable"),t.options.refreshPositions||e.ui.ddmanager.prepareOffsets(t,i)}},e.ui.droppable,e.widget("ui.resizable",e.ui.mouse,{version:"1.11.4",widgetEventPrefix:"resize",options:{alsoResize:!1,animate:!1,animateDuration:"slow",animateEasing:"swing",aspectRatio:!1,autoHide:!1,containment:!1,ghost:!1,grid:!1,handles:"e,s,se",helper:!1,maxHeight:null,maxWidth:null,minHeight:10,minWidth:10,zIndex:90,resize:null,start:null,stop:null},_num:function(e){return parseInt(e,10)||0},_isNumber:function(e){return!isNaN(parseInt(e,10))},_hasScroll:function(t,i){if("hidden"===e(t).css("overflow"))return!1;var s=i&&"left"===i?"scrollLeft":"scrollTop",n=!1;return t[s]>0?!0:(t[s]=1,n=t[s]>0,t[s]=0,n)},_create:function(){var t,i,s,n,a,o=this,r=this.options;if(this.element.addClass("ui-resizable"),e.extend(this,{_aspectRatio:!!r.aspectRatio,aspectRatio:r.aspectRatio,originalElement:this.element,_proportionallyResizeElements:[],_helper:r.helper||r.ghost||r.animate?r.helper||"ui-resizable-helper":null}),this.element[0].nodeName.match(/^(canvas|textarea|input|select|button|img)$/i)&&(this.element.wrap(e("<div class='ui-wrapper' style='overflow: hidden;'></div>").css({position:this.element.css("position"),width:this.element.outerWidth(),height:this.element.outerHeight(),top:this.element.css("top"),left:this.element.css("left")})),this.element=this.element.parent().data("ui-resizable",this.element.resizable("instance")),this.elementIsWrapper=!0,this.element.css({marginLeft:this.originalElement.css("marginLeft"),marginTop:this.originalElement.css("marginTop"),marginRight:this.originalElement.css("marginRight"),marginBottom:this.originalElement.css("marginBottom")}),this.originalElement.css({marginLeft:0,marginTop:0,marginRight:0,marginBottom:0}),this.originalResizeStyle=this.originalElement.css("resize"),this.originalElement.css("resize","none"),this._proportionallyResizeElements.push(this.originalElement.css({position:"static",zoom:1,display:"block"})),this.originalElement.css({margin:this.originalElement.css("margin")}),this._proportionallyResize()),this.handles=r.handles||(e(".ui-resizable-handle",this.element).length?{n:".ui-resizable-n",e:".ui-resizable-e",s:".ui-resizable-s",w:".ui-resizable-w",se:".ui-resizable-se",sw:".ui-resizable-sw",ne:".ui-resizable-ne",nw:".ui-resizable-nw"}:"e,s,se"),this._handles=e(),this.handles.constructor===String)for("all"===this.handles&&(this.handles="n,e,s,w,se,sw,ne,nw"),t=this.handles.split(","),this.handles={},i=0;t.length>i;i++)s=e.trim(t[i]),a="ui-resizable-"+s,n=e("<div class='ui-resizable-handle "+a+"'></div>"),n.css({zIndex:r.zIndex}),"se"===s&&n.addClass("ui-icon ui-icon-gripsmall-diagonal-se"),this.handles[s]=".ui-resizable-"+s,this.element.append(n);this._renderAxis=function(t){var i,s,n,a;t=t||this.element;for(i in this.handles)this.handles[i].constructor===String?this.handles[i]=this.element.children(this.handles[i]).first().show():(this.handles[i].jquery||this.handles[i].nodeType)&&(this.handles[i]=e(this.handles[i]),this._on(this.handles[i],{mousedown:o._mouseDown})),this.elementIsWrapper&&this.originalElement[0].nodeName.match(/^(textarea|input|select|button)$/i)&&(s=e(this.handles[i],this.element),a=/sw|ne|nw|se|n|s/.test(i)?s.outerHeight():s.outerWidth(),n=["padding",/ne|nw|n/.test(i)?"Top":/se|sw|s/.test(i)?"Bottom":/^e$/.test(i)?"Right":"Left"].join(""),t.css(n,a),this._proportionallyResize()),this._handles=this._handles.add(this.handles[i])},this._renderAxis(this.element),this._handles=this._handles.add(this.element.find(".ui-resizable-handle")),this._handles.disableSelection(),this._handles.mouseover(function(){o.resizing||(this.className&&(n=this.className.match(/ui-resizable-(se|sw|ne|nw|n|e|s|w)/i)),o.axis=n&&n[1]?n[1]:"se")}),r.autoHide&&(this._handles.hide(),e(this.element).addClass("ui-resizable-autohide").mouseenter(function(){r.disabled||(e(this).removeClass("ui-resizable-autohide"),o._handles.show())}).mouseleave(function(){r.disabled||o.resizing||(e(this).addClass("ui-resizable-autohide"),o._handles.hide())})),this._mouseInit()},_destroy:function(){this._mouseDestroy();var t,i=function(t){e(t).removeClass("ui-resizable ui-resizable-disabled ui-resizable-resizing").removeData("resizable").removeData("ui-resizable").unbind(".resizable").find(".ui-resizable-handle").remove()};return this.elementIsWrapper&&(i(this.element),t=this.element,this.originalElement.css({position:t.css("position"),width:t.outerWidth(),height:t.outerHeight(),top:t.css("top"),left:t.css("left")}).insertAfter(t),t.remove()),this.originalElement.css("resize",this.originalResizeStyle),i(this.originalElement),this},_mouseCapture:function(t){var i,s,n=!1;for(i in this.handles)s=e(this.handles[i])[0],(s===t.target||e.contains(s,t.target))&&(n=!0);return!this.options.disabled&&n},_mouseStart:function(t){var i,s,n,a=this.options,o=this.element;return this.resizing=!0,this._renderProxy(),i=this._num(this.helper.css("left")),s=this._num(this.helper.css("top")),a.containment&&(i+=e(a.containment).scrollLeft()||0,s+=e(a.containment).scrollTop()||0),this.offset=this.helper.offset(),this.position={left:i,top:s},this.size=this._helper?{width:this.helper.width(),height:this.helper.height()}:{width:o.width(),height:o.height()},this.originalSize=this._helper?{width:o.outerWidth(),height:o.outerHeight()}:{width:o.width(),height:o.height()},this.sizeDiff={width:o.outerWidth()-o.width(),height:o.outerHeight()-o.height()},this.originalPosition={left:i,top:s},this.originalMousePosition={left:t.pageX,top:t.pageY},this.aspectRatio="number"==typeof a.aspectRatio?a.aspectRatio:this.originalSize.width/this.originalSize.height||1,n=e(".ui-resizable-"+this.axis).css("cursor"),e("body").css("cursor","auto"===n?this.axis+"-resize":n),o.addClass("ui-resizable-resizing"),this._propagate("start",t),!0},_mouseDrag:function(t){var i,s,n=this.originalMousePosition,a=this.axis,o=t.pageX-n.left||0,r=t.pageY-n.top||0,h=this._change[a];return this._updatePrevProperties(),h?(i=h.apply(this,[t,o,r]),this._updateVirtualBoundaries(t.shiftKey),(this._aspectRatio||t.shiftKey)&&(i=this._updateRatio(i,t)),i=this._respectSize(i,t),this._updateCache(i),this._propagate("resize",t),s=this._applyChanges(),!this._helper&&this._proportionallyResizeElements.length&&this._proportionallyResize(),e.isEmptyObject(s)||(this._updatePrevProperties(),this._trigger("resize",t,this.ui()),this._applyChanges()),!1):!1},_mouseStop:function(t){this.resizing=!1;var i,s,n,a,o,r,h,l=this.options,u=this;return this._helper&&(i=this._proportionallyResizeElements,s=i.length&&/textarea/i.test(i[0].nodeName),n=s&&this._hasScroll(i[0],"left")?0:u.sizeDiff.height,a=s?0:u.sizeDiff.width,o={width:u.helper.width()-a,height:u.helper.height()-n},r=parseInt(u.element.css("left"),10)+(u.position.left-u.originalPosition.left)||null,h=parseInt(u.element.css("top"),10)+(u.position.top-u.originalPosition.top)||null,l.animate||this.element.css(e.extend(o,{top:h,left:r})),u.helper.height(u.size.height),u.helper.width(u.size.width),this._helper&&!l.animate&&this._proportionallyResize()),e("body").css("cursor","auto"),this.element.removeClass("ui-resizable-resizing"),this._propagate("stop",t),this._helper&&this.helper.remove(),!1},_updatePrevProperties:function(){this.prevPosition={top:this.position.top,left:this.position.left},this.prevSize={width:this.size.width,height:this.size.height}},_applyChanges:function(){var e={};return this.position.top!==this.prevPosition.top&&(e.top=this.position.top+"px"),this.position.left!==this.prevPosition.left&&(e.left=this.position.left+"px"),this.size.width!==this.prevSize.width&&(e.width=this.size.width+"px"),this.size.height!==this.prevSize.height&&(e.height=this.size.height+"px"),this.helper.css(e),e},_updateVirtualBoundaries:function(e){var t,i,s,n,a,o=this.options;a={minWidth:this._isNumber(o.minWidth)?o.minWidth:0,maxWidth:this._isNumber(o.maxWidth)?o.maxWidth:1/0,minHeight:this._isNumber(o.minHeight)?o.minHeight:0,maxHeight:this._isNumber(o.maxHeight)?o.maxHeight:1/0},(this._aspectRatio||e)&&(t=a.minHeight*this.aspectRatio,s=a.minWidth/this.aspectRatio,i=a.maxHeight*this.aspectRatio,n=a.maxWidth/this.aspectRatio,t>a.minWidth&&(a.minWidth=t),s>a.minHeight&&(a.minHeight=s),a.maxWidth>i&&(a.maxWidth=i),a.maxHeight>n&&(a.maxHeight=n)),this._vBoundaries=a},_updateCache:function(e){this.offset=this.helper.offset(),this._isNumber(e.left)&&(this.position.left=e.left),this._isNumber(e.top)&&(this.position.top=e.top),this._isNumber(e.height)&&(this.size.height=e.height),this._isNumber(e.width)&&(this.size.width=e.width)},_updateRatio:function(e){var t=this.position,i=this.size,s=this.axis;return this._isNumber(e.height)?e.width=e.height*this.aspectRatio:this._isNumber(e.width)&&(e.height=e.width/this.aspectRatio),"sw"===s&&(e.left=t.left+(i.width-e.width),e.top=null),"nw"===s&&(e.top=t.top+(i.height-e.height),e.left=t.left+(i.width-e.width)),e},_respectSize:function(e){var t=this._vBoundaries,i=this.axis,s=this._isNumber(e.width)&&t.maxWidth&&t.maxWidth<e.width,n=this._isNumber(e.height)&&t.maxHeight&&t.maxHeight<e.height,a=this._isNumber(e.width)&&t.minWidth&&t.minWidth>e.width,o=this._isNumber(e.height)&&t.minHeight&&t.minHeight>e.height,r=this.originalPosition.left+this.originalSize.width,h=this.position.top+this.size.height,l=/sw|nw|w/.test(i),u=/nw|ne|n/.test(i);return a&&(e.width=t.minWidth),o&&(e.height=t.minHeight),s&&(e.width=t.maxWidth),n&&(e.height=t.maxHeight),a&&l&&(e.left=r-t.minWidth),s&&l&&(e.left=r-t.maxWidth),o&&u&&(e.top=h-t.minHeight),n&&u&&(e.top=h-t.maxHeight),e.width||e.height||e.left||!e.top?e.width||e.height||e.top||!e.left||(e.left=null):e.top=null,e},_getPaddingPlusBorderDimensions:function(e){for(var t=0,i=[],s=[e.css("borderTopWidth"),e.css("borderRightWidth"),e.css("borderBottomWidth"),e.css("borderLeftWidth")],n=[e.css("paddingTop"),e.css("paddingRight"),e.css("paddingBottom"),e.css("paddingLeft")];4>t;t++)i[t]=parseInt(s[t],10)||0,i[t]+=parseInt(n[t],10)||0;return{height:i[0]+i[2],width:i[1]+i[3]}},_proportionallyResize:function(){if(this._proportionallyResizeElements.length)for(var e,t=0,i=this.helper||this.element;this._proportionallyResizeElements.length>t;t++)e=this._proportionallyResizeElements[t],this.outerDimensions||(this.outerDimensions=this._getPaddingPlusBorderDimensions(e)),e.css({height:i.height()-this.outerDimensions.height||0,width:i.width()-this.outerDimensions.width||0})},_renderProxy:function(){var t=this.element,i=this.options;this.elementOffset=t.offset(),this._helper?(this.helper=this.helper||e("<div style='overflow:hidden;'></div>"),this.helper.addClass(this._helper).css({width:this.element.outerWidth()-1,height:this.element.outerHeight()-1,position:"absolute",left:this.elementOffset.left+"px",top:this.elementOffset.top+"px",zIndex:++i.zIndex}),this.helper.appendTo("body").disableSelection()):this.helper=this.element},_change:{e:function(e,t){return{width:this.originalSize.width+t}},w:function(e,t){var i=this.originalSize,s=this.originalPosition;return{left:s.left+t,width:i.width-t}},n:function(e,t,i){var s=this.originalSize,n=this.originalPosition;return{top:n.top+i,height:s.height-i}},s:function(e,t,i){return{height:this.originalSize.height+i}},se:function(t,i,s){return e.extend(this._change.s.apply(this,arguments),this._change.e.apply(this,[t,i,s]))},sw:function(t,i,s){return e.extend(this._change.s.apply(this,arguments),this._change.w.apply(this,[t,i,s]))},ne:function(t,i,s){return e.extend(this._change.n.apply(this,arguments),this._change.e.apply(this,[t,i,s]))},nw:function(t,i,s){return e.extend(this._change.n.apply(this,arguments),this._change.w.apply(this,[t,i,s]))}},_propagate:function(t,i){e.ui.plugin.call(this,t,[i,this.ui()]),"resize"!==t&&this._trigger(t,i,this.ui())},plugins:{},ui:function(){return{originalElement:this.originalElement,element:this.element,helper:this.helper,position:this.position,size:this.size,originalSize:this.originalSize,originalPosition:this.originalPosition}}}),e.ui.plugin.add("resizable","animate",{stop:function(t){var i=e(this).resizable("instance"),s=i.options,n=i._proportionallyResizeElements,a=n.length&&/textarea/i.test(n[0].nodeName),o=a&&i._hasScroll(n[0],"left")?0:i.sizeDiff.height,r=a?0:i.sizeDiff.width,h={width:i.size.width-r,height:i.size.height-o},l=parseInt(i.element.css("left"),10)+(i.position.left-i.originalPosition.left)||null,u=parseInt(i.element.css("top"),10)+(i.position.top-i.originalPosition.top)||null;i.element.animate(e.extend(h,u&&l?{top:u,left:l}:{}),{duration:s.animateDuration,easing:s.animateEasing,step:function(){var s={width:parseInt(i.element.css("width"),10),height:parseInt(i.element.css("height"),10),top:parseInt(i.element.css("top"),10),left:parseInt(i.element.css("left"),10)};n&&n.length&&e(n[0]).css({width:s.width,height:s.height}),i._updateCache(s),i._propagate("resize",t)}})}}),e.ui.plugin.add("resizable","containment",{start:function(){var t,i,s,n,a,o,r,h=e(this).resizable("instance"),l=h.options,u=h.element,d=l.containment,c=d instanceof e?d.get(0):/parent/.test(d)?u.parent().get(0):d;c&&(h.containerElement=e(c),/document/.test(d)||d===document?(h.containerOffset={left:0,top:0},h.containerPosition={left:0,top:0},h.parentData={element:e(document),left:0,top:0,width:e(document).width(),height:e(document).height()||document.body.parentNode.scrollHeight}):(t=e(c),i=[],e(["Top","Right","Left","Bottom"]).each(function(e,s){i[e]=h._num(t.css("padding"+s))}),h.containerOffset=t.offset(),h.containerPosition=t.position(),h.containerSize={height:t.innerHeight()-i[3],width:t.innerWidth()-i[1]},s=h.containerOffset,n=h.containerSize.height,a=h.containerSize.width,o=h._hasScroll(c,"left")?c.scrollWidth:a,r=h._hasScroll(c)?c.scrollHeight:n,h.parentData={element:c,left:s.left,top:s.top,width:o,height:r}))},resize:function(t){var i,s,n,a,o=e(this).resizable("instance"),r=o.options,h=o.containerOffset,l=o.position,u=o._aspectRatio||t.shiftKey,d={top:0,left:0},c=o.containerElement,p=!0;c[0]!==document&&/static/.test(c.css("position"))&&(d=h),l.left<(o._helper?h.left:0)&&(o.size.width=o.size.width+(o._helper?o.position.left-h.left:o.position.left-d.left),u&&(o.size.height=o.size.width/o.aspectRatio,p=!1),o.position.left=r.helper?h.left:0),l.top<(o._helper?h.top:0)&&(o.size.height=o.size.height+(o._helper?o.position.top-h.top:o.position.top),u&&(o.size.width=o.size.height*o.aspectRatio,p=!1),o.position.top=o._helper?h.top:0),n=o.containerElement.get(0)===o.element.parent().get(0),a=/relative|absolute/.test(o.containerElement.css("position")),n&&a?(o.offset.left=o.parentData.left+o.position.left,o.offset.top=o.parentData.top+o.position.top):(o.offset.left=o.element.offset().left,o.offset.top=o.element.offset().top),i=Math.abs(o.sizeDiff.width+(o._helper?o.offset.left-d.left:o.offset.left-h.left)),s=Math.abs(o.sizeDiff.height+(o._helper?o.offset.top-d.top:o.offset.top-h.top)),i+o.size.width>=o.parentData.width&&(o.size.width=o.parentData.width-i,u&&(o.size.height=o.size.width/o.aspectRatio,p=!1)),s+o.size.height>=o.parentData.height&&(o.size.height=o.parentData.height-s,u&&(o.size.width=o.size.height*o.aspectRatio,p=!1)),p||(o.position.left=o.prevPosition.left,o.position.top=o.prevPosition.top,o.size.width=o.prevSize.width,o.size.height=o.prevSize.height)},stop:function(){var t=e(this).resizable("instance"),i=t.options,s=t.containerOffset,n=t.containerPosition,a=t.containerElement,o=e(t.helper),r=o.offset(),h=o.outerWidth()-t.sizeDiff.width,l=o.outerHeight()-t.sizeDiff.height;t._helper&&!i.animate&&/relative/.test(a.css("position"))&&e(this).css({left:r.left-n.left-s.left,width:h,height:l}),t._helper&&!i.animate&&/static/.test(a.css("position"))&&e(this).css({left:r.left-n.left-s.left,width:h,height:l})}}),e.ui.plugin.add("resizable","alsoResize",{start:function(){var t=e(this).resizable("instance"),i=t.options;e(i.alsoResize).each(function(){var t=e(this);t.data("ui-resizable-alsoresize",{width:parseInt(t.width(),10),height:parseInt(t.height(),10),left:parseInt(t.css("left"),10),top:parseInt(t.css("top"),10)})})},resize:function(t,i){var s=e(this).resizable("instance"),n=s.options,a=s.originalSize,o=s.originalPosition,r={height:s.size.height-a.height||0,width:s.size.width-a.width||0,top:s.position.top-o.top||0,left:s.position.left-o.left||0};e(n.alsoResize).each(function(){var t=e(this),s=e(this).data("ui-resizable-alsoresize"),n={},a=t.parents(i.originalElement[0]).length?["width","height"]:["width","height","top","left"];e.each(a,function(e,t){var i=(s[t]||0)+(r[t]||0);i&&i>=0&&(n[t]=i||null)}),t.css(n)})},stop:function(){e(this).removeData("resizable-alsoresize")}}),e.ui.plugin.add("resizable","ghost",{start:function(){var t=e(this).resizable("instance"),i=t.options,s=t.size;t.ghost=t.originalElement.clone(),t.ghost.css({opacity:.25,display:"block",position:"relative",height:s.height,width:s.width,margin:0,left:0,top:0}).addClass("ui-resizable-ghost").addClass("string"==typeof i.ghost?i.ghost:""),t.ghost.appendTo(t.helper)},resize:function(){var t=e(this).resizable("instance");t.ghost&&t.ghost.css({position:"relative",height:t.size.height,width:t.size.width})},stop:function(){var t=e(this).resizable("instance");t.ghost&&t.helper&&t.helper.get(0).removeChild(t.ghost.get(0))}}),e.ui.plugin.add("resizable","grid",{resize:function(){var t,i=e(this).resizable("instance"),s=i.options,n=i.size,a=i.originalSize,o=i.originalPosition,r=i.axis,h="number"==typeof s.grid?[s.grid,s.grid]:s.grid,l=h[0]||1,u=h[1]||1,d=Math.round((n.width-a.width)/l)*l,c=Math.round((n.height-a.height)/u)*u,p=a.width+d,f=a.height+c,m=s.maxWidth&&p>s.maxWidth,g=s.maxHeight&&f>s.maxHeight,v=s.minWidth&&s.minWidth>p,y=s.minHeight&&s.minHeight>f;s.grid=h,v&&(p+=l),y&&(f+=u),m&&(p-=l),g&&(f-=u),/^(se|s|e)$/.test(r)?(i.size.width=p,i.size.height=f):/^(ne)$/.test(r)?(i.size.width=p,i.size.height=f,i.position.top=o.top-c):/^(sw)$/.test(r)?(i.size.width=p,i.size.height=f,i.position.left=o.left-d):((0>=f-u||0>=p-l)&&(t=i._getPaddingPlusBorderDimensions(this)),f-u>0?(i.size.height=f,i.position.top=o.top-c):(f=u-t.height,i.size.height=f,i.position.top=o.top+a.height-f),p-l>0?(i.size.width=p,i.position.left=o.left-d):(p=l-t.width,i.size.width=p,i.position.left=o.left+a.width-p))}}),e.ui.resizable,e.widget("ui.selectable",e.ui.mouse,{version:"1.11.4",options:{appendTo:"body",autoRefresh:!0,distance:0,filter:"*",tolerance:"touch",selected:null,selecting:null,start:null,stop:null,unselected:null,unselecting:null},_create:function(){var t,i=this;this.element.addClass("ui-selectable"),this.dragged=!1,this.refresh=function(){t=e(i.options.filter,i.element[0]),t.addClass("ui-selectee"),t.each(function(){var t=e(this),i=t.offset();e.data(this,"selectable-item",{element:this,$element:t,left:i.left,top:i.top,right:i.left+t.outerWidth(),bottom:i.top+t.outerHeight(),startselected:!1,selected:t.hasClass("ui-selected"),selecting:t.hasClass("ui-selecting"),unselecting:t.hasClass("ui-unselecting")})})},this.refresh(),this.selectees=t.addClass("ui-selectee"),this._mouseInit(),this.helper=e("<div class='ui-selectable-helper'></div>")},_destroy:function(){this.selectees.removeClass("ui-selectee").removeData("selectable-item"),this.element.removeClass("ui-selectable ui-selectable-disabled"),this._mouseDestroy()},_mouseStart:function(t){var i=this,s=this.options;this.opos=[t.pageX,t.pageY],this.options.disabled||(this.selectees=e(s.filter,this.element[0]),this._trigger("start",t),e(s.appendTo).append(this.helper),this.helper.css({left:t.pageX,top:t.pageY,width:0,height:0}),s.autoRefresh&&this.refresh(),this.selectees.filter(".ui-selected").each(function(){var s=e.data(this,"selectable-item");s.startselected=!0,t.metaKey||t.ctrlKey||(s.$element.removeClass("ui-selected"),s.selected=!1,s.$element.addClass("ui-unselecting"),s.unselecting=!0,i._trigger("unselecting",t,{unselecting:s.element}))}),e(t.target).parents().addBack().each(function(){var s,n=e.data(this,"selectable-item");return n?(s=!t.metaKey&&!t.ctrlKey||!n.$element.hasClass("ui-selected"),n.$element.removeClass(s?"ui-unselecting":"ui-selected").addClass(s?"ui-selecting":"ui-unselecting"),n.unselecting=!s,n.selecting=s,n.selected=s,s?i._trigger("selecting",t,{selecting:n.element}):i._trigger("unselecting",t,{unselecting:n.element}),!1):void 0}))},_mouseDrag:function(t){if(this.dragged=!0,!this.options.disabled){var i,s=this,n=this.options,a=this.opos[0],o=this.opos[1],r=t.pageX,h=t.pageY;return a>r&&(i=r,r=a,a=i),o>h&&(i=h,h=o,o=i),this.helper.css({left:a,top:o,width:r-a,height:h-o}),this.selectees.each(function(){var i=e.data(this,"selectable-item"),l=!1;
i&&i.element!==s.element[0]&&("touch"===n.tolerance?l=!(i.left>r||a>i.right||i.top>h||o>i.bottom):"fit"===n.tolerance&&(l=i.left>a&&r>i.right&&i.top>o&&h>i.bottom),l?(i.selected&&(i.$element.removeClass("ui-selected"),i.selected=!1),i.unselecting&&(i.$element.removeClass("ui-unselecting"),i.unselecting=!1),i.selecting||(i.$element.addClass("ui-selecting"),i.selecting=!0,s._trigger("selecting",t,{selecting:i.element}))):(i.selecting&&((t.metaKey||t.ctrlKey)&&i.startselected?(i.$element.removeClass("ui-selecting"),i.selecting=!1,i.$element.addClass("ui-selected"),i.selected=!0):(i.$element.removeClass("ui-selecting"),i.selecting=!1,i.startselected&&(i.$element.addClass("ui-unselecting"),i.unselecting=!0),s._trigger("unselecting",t,{unselecting:i.element}))),i.selected&&(t.metaKey||t.ctrlKey||i.startselected||(i.$element.removeClass("ui-selected"),i.selected=!1,i.$element.addClass("ui-unselecting"),i.unselecting=!0,s._trigger("unselecting",t,{unselecting:i.element})))))}),!1}},_mouseStop:function(t){var i=this;return this.dragged=!1,e(".ui-unselecting",this.element[0]).each(function(){var s=e.data(this,"selectable-item");s.$element.removeClass("ui-unselecting"),s.unselecting=!1,s.startselected=!1,i._trigger("unselected",t,{unselected:s.element})}),e(".ui-selecting",this.element[0]).each(function(){var s=e.data(this,"selectable-item");s.$element.removeClass("ui-selecting").addClass("ui-selected"),s.selecting=!1,s.selected=!0,s.startselected=!0,i._trigger("selected",t,{selected:s.element})}),this._trigger("stop",t),this.helper.remove(),!1}}),e.widget("ui.sortable",e.ui.mouse,{version:"1.11.4",widgetEventPrefix:"sort",ready:!1,options:{appendTo:"parent",axis:!1,connectWith:!1,containment:!1,cursor:"auto",cursorAt:!1,dropOnEmpty:!0,forcePlaceholderSize:!1,forceHelperSize:!1,grid:!1,handle:!1,helper:"original",items:"> *",opacity:!1,placeholder:!1,revert:!1,scroll:!0,scrollSensitivity:20,scrollSpeed:20,scope:"default",tolerance:"intersect",zIndex:1e3,activate:null,beforeStop:null,change:null,deactivate:null,out:null,over:null,receive:null,remove:null,sort:null,start:null,stop:null,update:null},_isOverAxis:function(e,t,i){return e>=t&&t+i>e},_isFloating:function(e){return/left|right/.test(e.css("float"))||/inline|table-cell/.test(e.css("display"))},_create:function(){this.containerCache={},this.element.addClass("ui-sortable"),this.refresh(),this.offset=this.element.offset(),this._mouseInit(),this._setHandleClassName(),this.ready=!0},_setOption:function(e,t){this._super(e,t),"handle"===e&&this._setHandleClassName()},_setHandleClassName:function(){this.element.find(".ui-sortable-handle").removeClass("ui-sortable-handle"),e.each(this.items,function(){(this.instance.options.handle?this.item.find(this.instance.options.handle):this.item).addClass("ui-sortable-handle")})},_destroy:function(){this.element.removeClass("ui-sortable ui-sortable-disabled").find(".ui-sortable-handle").removeClass("ui-sortable-handle"),this._mouseDestroy();for(var e=this.items.length-1;e>=0;e--)this.items[e].item.removeData(this.widgetName+"-item");return this},_mouseCapture:function(t,i){var s=null,n=!1,a=this;return this.reverting?!1:this.options.disabled||"static"===this.options.type?!1:(this._refreshItems(t),e(t.target).parents().each(function(){return e.data(this,a.widgetName+"-item")===a?(s=e(this),!1):void 0}),e.data(t.target,a.widgetName+"-item")===a&&(s=e(t.target)),s?!this.options.handle||i||(e(this.options.handle,s).find("*").addBack().each(function(){this===t.target&&(n=!0)}),n)?(this.currentItem=s,this._removeCurrentsFromItems(),!0):!1:!1)},_mouseStart:function(t,i,s){var n,a,o=this.options;if(this.currentContainer=this,this.refreshPositions(),this.helper=this._createHelper(t),this._cacheHelperProportions(),this._cacheMargins(),this.scrollParent=this.helper.scrollParent(),this.offset=this.currentItem.offset(),this.offset={top:this.offset.top-this.margins.top,left:this.offset.left-this.margins.left},e.extend(this.offset,{click:{left:t.pageX-this.offset.left,top:t.pageY-this.offset.top},parent:this._getParentOffset(),relative:this._getRelativeOffset()}),this.helper.css("position","absolute"),this.cssPosition=this.helper.css("position"),this.originalPosition=this._generatePosition(t),this.originalPageX=t.pageX,this.originalPageY=t.pageY,o.cursorAt&&this._adjustOffsetFromHelper(o.cursorAt),this.domPosition={prev:this.currentItem.prev()[0],parent:this.currentItem.parent()[0]},this.helper[0]!==this.currentItem[0]&&this.currentItem.hide(),this._createPlaceholder(),o.containment&&this._setContainment(),o.cursor&&"auto"!==o.cursor&&(a=this.document.find("body"),this.storedCursor=a.css("cursor"),a.css("cursor",o.cursor),this.storedStylesheet=e("<style>*{ cursor: "+o.cursor+" !important; }</style>").appendTo(a)),o.opacity&&(this.helper.css("opacity")&&(this._storedOpacity=this.helper.css("opacity")),this.helper.css("opacity",o.opacity)),o.zIndex&&(this.helper.css("zIndex")&&(this._storedZIndex=this.helper.css("zIndex")),this.helper.css("zIndex",o.zIndex)),this.scrollParent[0]!==this.document[0]&&"HTML"!==this.scrollParent[0].tagName&&(this.overflowOffset=this.scrollParent.offset()),this._trigger("start",t,this._uiHash()),this._preserveHelperProportions||this._cacheHelperProportions(),!s)for(n=this.containers.length-1;n>=0;n--)this.containers[n]._trigger("activate",t,this._uiHash(this));return e.ui.ddmanager&&(e.ui.ddmanager.current=this),e.ui.ddmanager&&!o.dropBehaviour&&e.ui.ddmanager.prepareOffsets(this,t),this.dragging=!0,this.helper.addClass("ui-sortable-helper"),this._mouseDrag(t),!0},_mouseDrag:function(t){var i,s,n,a,o=this.options,r=!1;for(this.position=this._generatePosition(t),this.positionAbs=this._convertPositionTo("absolute"),this.lastPositionAbs||(this.lastPositionAbs=this.positionAbs),this.options.scroll&&(this.scrollParent[0]!==this.document[0]&&"HTML"!==this.scrollParent[0].tagName?(this.overflowOffset.top+this.scrollParent[0].offsetHeight-t.pageY<o.scrollSensitivity?this.scrollParent[0].scrollTop=r=this.scrollParent[0].scrollTop+o.scrollSpeed:t.pageY-this.overflowOffset.top<o.scrollSensitivity&&(this.scrollParent[0].scrollTop=r=this.scrollParent[0].scrollTop-o.scrollSpeed),this.overflowOffset.left+this.scrollParent[0].offsetWidth-t.pageX<o.scrollSensitivity?this.scrollParent[0].scrollLeft=r=this.scrollParent[0].scrollLeft+o.scrollSpeed:t.pageX-this.overflowOffset.left<o.scrollSensitivity&&(this.scrollParent[0].scrollLeft=r=this.scrollParent[0].scrollLeft-o.scrollSpeed)):(t.pageY-this.document.scrollTop()<o.scrollSensitivity?r=this.document.scrollTop(this.document.scrollTop()-o.scrollSpeed):this.window.height()-(t.pageY-this.document.scrollTop())<o.scrollSensitivity&&(r=this.document.scrollTop(this.document.scrollTop()+o.scrollSpeed)),t.pageX-this.document.scrollLeft()<o.scrollSensitivity?r=this.document.scrollLeft(this.document.scrollLeft()-o.scrollSpeed):this.window.width()-(t.pageX-this.document.scrollLeft())<o.scrollSensitivity&&(r=this.document.scrollLeft(this.document.scrollLeft()+o.scrollSpeed))),r!==!1&&e.ui.ddmanager&&!o.dropBehaviour&&e.ui.ddmanager.prepareOffsets(this,t)),this.positionAbs=this._convertPositionTo("absolute"),this.options.axis&&"y"===this.options.axis||(this.helper[0].style.left=this.position.left+"px"),this.options.axis&&"x"===this.options.axis||(this.helper[0].style.top=this.position.top+"px"),i=this.items.length-1;i>=0;i--)if(s=this.items[i],n=s.item[0],a=this._intersectsWithPointer(s),a&&s.instance===this.currentContainer&&n!==this.currentItem[0]&&this.placeholder[1===a?"next":"prev"]()[0]!==n&&!e.contains(this.placeholder[0],n)&&("semi-dynamic"===this.options.type?!e.contains(this.element[0],n):!0)){if(this.direction=1===a?"down":"up","pointer"!==this.options.tolerance&&!this._intersectsWithSides(s))break;this._rearrange(t,s),this._trigger("change",t,this._uiHash());break}return this._contactContainers(t),e.ui.ddmanager&&e.ui.ddmanager.drag(this,t),this._trigger("sort",t,this._uiHash()),this.lastPositionAbs=this.positionAbs,!1},_mouseStop:function(t,i){if(t){if(e.ui.ddmanager&&!this.options.dropBehaviour&&e.ui.ddmanager.drop(this,t),this.options.revert){var s=this,n=this.placeholder.offset(),a=this.options.axis,o={};a&&"x"!==a||(o.left=n.left-this.offset.parent.left-this.margins.left+(this.offsetParent[0]===this.document[0].body?0:this.offsetParent[0].scrollLeft)),a&&"y"!==a||(o.top=n.top-this.offset.parent.top-this.margins.top+(this.offsetParent[0]===this.document[0].body?0:this.offsetParent[0].scrollTop)),this.reverting=!0,e(this.helper).animate(o,parseInt(this.options.revert,10)||500,function(){s._clear(t)})}else this._clear(t,i);return!1}},cancel:function(){if(this.dragging){this._mouseUp({target:null}),"original"===this.options.helper?this.currentItem.css(this._storedCSS).removeClass("ui-sortable-helper"):this.currentItem.show();for(var t=this.containers.length-1;t>=0;t--)this.containers[t]._trigger("deactivate",null,this._uiHash(this)),this.containers[t].containerCache.over&&(this.containers[t]._trigger("out",null,this._uiHash(this)),this.containers[t].containerCache.over=0)}return this.placeholder&&(this.placeholder[0].parentNode&&this.placeholder[0].parentNode.removeChild(this.placeholder[0]),"original"!==this.options.helper&&this.helper&&this.helper[0].parentNode&&this.helper.remove(),e.extend(this,{helper:null,dragging:!1,reverting:!1,_noFinalSort:null}),this.domPosition.prev?e(this.domPosition.prev).after(this.currentItem):e(this.domPosition.parent).prepend(this.currentItem)),this},serialize:function(t){var i=this._getItemsAsjQuery(t&&t.connected),s=[];return t=t||{},e(i).each(function(){var i=(e(t.item||this).attr(t.attribute||"id")||"").match(t.expression||/(.+)[\-=_](.+)/);i&&s.push((t.key||i[1]+"[]")+"="+(t.key&&t.expression?i[1]:i[2]))}),!s.length&&t.key&&s.push(t.key+"="),s.join("&")},toArray:function(t){var i=this._getItemsAsjQuery(t&&t.connected),s=[];return t=t||{},i.each(function(){s.push(e(t.item||this).attr(t.attribute||"id")||"")}),s},_intersectsWith:function(e){var t=this.positionAbs.left,i=t+this.helperProportions.width,s=this.positionAbs.top,n=s+this.helperProportions.height,a=e.left,o=a+e.width,r=e.top,h=r+e.height,l=this.offset.click.top,u=this.offset.click.left,d="x"===this.options.axis||s+l>r&&h>s+l,c="y"===this.options.axis||t+u>a&&o>t+u,p=d&&c;return"pointer"===this.options.tolerance||this.options.forcePointerForContainers||"pointer"!==this.options.tolerance&&this.helperProportions[this.floating?"width":"height"]>e[this.floating?"width":"height"]?p:t+this.helperProportions.width/2>a&&o>i-this.helperProportions.width/2&&s+this.helperProportions.height/2>r&&h>n-this.helperProportions.height/2},_intersectsWithPointer:function(e){var t="x"===this.options.axis||this._isOverAxis(this.positionAbs.top+this.offset.click.top,e.top,e.height),i="y"===this.options.axis||this._isOverAxis(this.positionAbs.left+this.offset.click.left,e.left,e.width),s=t&&i,n=this._getDragVerticalDirection(),a=this._getDragHorizontalDirection();return s?this.floating?a&&"right"===a||"down"===n?2:1:n&&("down"===n?2:1):!1},_intersectsWithSides:function(e){var t=this._isOverAxis(this.positionAbs.top+this.offset.click.top,e.top+e.height/2,e.height),i=this._isOverAxis(this.positionAbs.left+this.offset.click.left,e.left+e.width/2,e.width),s=this._getDragVerticalDirection(),n=this._getDragHorizontalDirection();return this.floating&&n?"right"===n&&i||"left"===n&&!i:s&&("down"===s&&t||"up"===s&&!t)},_getDragVerticalDirection:function(){var e=this.positionAbs.top-this.lastPositionAbs.top;return 0!==e&&(e>0?"down":"up")},_getDragHorizontalDirection:function(){var e=this.positionAbs.left-this.lastPositionAbs.left;return 0!==e&&(e>0?"right":"left")},refresh:function(e){return this._refreshItems(e),this._setHandleClassName(),this.refreshPositions(),this},_connectWith:function(){var e=this.options;return e.connectWith.constructor===String?[e.connectWith]:e.connectWith},_getItemsAsjQuery:function(t){function i(){r.push(this)}var s,n,a,o,r=[],h=[],l=this._connectWith();if(l&&t)for(s=l.length-1;s>=0;s--)for(a=e(l[s],this.document[0]),n=a.length-1;n>=0;n--)o=e.data(a[n],this.widgetFullName),o&&o!==this&&!o.options.disabled&&h.push([e.isFunction(o.options.items)?o.options.items.call(o.element):e(o.options.items,o.element).not(".ui-sortable-helper").not(".ui-sortable-placeholder"),o]);for(h.push([e.isFunction(this.options.items)?this.options.items.call(this.element,null,{options:this.options,item:this.currentItem}):e(this.options.items,this.element).not(".ui-sortable-helper").not(".ui-sortable-placeholder"),this]),s=h.length-1;s>=0;s--)h[s][0].each(i);return e(r)},_removeCurrentsFromItems:function(){var t=this.currentItem.find(":data("+this.widgetName+"-item)");this.items=e.grep(this.items,function(e){for(var i=0;t.length>i;i++)if(t[i]===e.item[0])return!1;return!0})},_refreshItems:function(t){this.items=[],this.containers=[this];var i,s,n,a,o,r,h,l,u=this.items,d=[[e.isFunction(this.options.items)?this.options.items.call(this.element[0],t,{item:this.currentItem}):e(this.options.items,this.element),this]],c=this._connectWith();if(c&&this.ready)for(i=c.length-1;i>=0;i--)for(n=e(c[i],this.document[0]),s=n.length-1;s>=0;s--)a=e.data(n[s],this.widgetFullName),a&&a!==this&&!a.options.disabled&&(d.push([e.isFunction(a.options.items)?a.options.items.call(a.element[0],t,{item:this.currentItem}):e(a.options.items,a.element),a]),this.containers.push(a));for(i=d.length-1;i>=0;i--)for(o=d[i][1],r=d[i][0],s=0,l=r.length;l>s;s++)h=e(r[s]),h.data(this.widgetName+"-item",o),u.push({item:h,instance:o,width:0,height:0,left:0,top:0})},refreshPositions:function(t){this.floating=this.items.length?"x"===this.options.axis||this._isFloating(this.items[0].item):!1,this.offsetParent&&this.helper&&(this.offset.parent=this._getParentOffset());var i,s,n,a;for(i=this.items.length-1;i>=0;i--)s=this.items[i],s.instance!==this.currentContainer&&this.currentContainer&&s.item[0]!==this.currentItem[0]||(n=this.options.toleranceElement?e(this.options.toleranceElement,s.item):s.item,t||(s.width=n.outerWidth(),s.height=n.outerHeight()),a=n.offset(),s.left=a.left,s.top=a.top);if(this.options.custom&&this.options.custom.refreshContainers)this.options.custom.refreshContainers.call(this);else for(i=this.containers.length-1;i>=0;i--)a=this.containers[i].element.offset(),this.containers[i].containerCache.left=a.left,this.containers[i].containerCache.top=a.top,this.containers[i].containerCache.width=this.containers[i].element.outerWidth(),this.containers[i].containerCache.height=this.containers[i].element.outerHeight();return this},_createPlaceholder:function(t){t=t||this;var i,s=t.options;s.placeholder&&s.placeholder.constructor!==String||(i=s.placeholder,s.placeholder={element:function(){var s=t.currentItem[0].nodeName.toLowerCase(),n=e("<"+s+">",t.document[0]).addClass(i||t.currentItem[0].className+" ui-sortable-placeholder").removeClass("ui-sortable-helper");return"tbody"===s?t._createTrPlaceholder(t.currentItem.find("tr").eq(0),e("<tr>",t.document[0]).appendTo(n)):"tr"===s?t._createTrPlaceholder(t.currentItem,n):"img"===s&&n.attr("src",t.currentItem.attr("src")),i||n.css("visibility","hidden"),n},update:function(e,n){(!i||s.forcePlaceholderSize)&&(n.height()||n.height(t.currentItem.innerHeight()-parseInt(t.currentItem.css("paddingTop")||0,10)-parseInt(t.currentItem.css("paddingBottom")||0,10)),n.width()||n.width(t.currentItem.innerWidth()-parseInt(t.currentItem.css("paddingLeft")||0,10)-parseInt(t.currentItem.css("paddingRight")||0,10)))}}),t.placeholder=e(s.placeholder.element.call(t.element,t.currentItem)),t.currentItem.after(t.placeholder),s.placeholder.update(t,t.placeholder)},_createTrPlaceholder:function(t,i){var s=this;t.children().each(function(){e("<td>&#160;</td>",s.document[0]).attr("colspan",e(this).attr("colspan")||1).appendTo(i)})},_contactContainers:function(t){var i,s,n,a,o,r,h,l,u,d,c=null,p=null;for(i=this.containers.length-1;i>=0;i--)if(!e.contains(this.currentItem[0],this.containers[i].element[0]))if(this._intersectsWith(this.containers[i].containerCache)){if(c&&e.contains(this.containers[i].element[0],c.element[0]))continue;c=this.containers[i],p=i}else this.containers[i].containerCache.over&&(this.containers[i]._trigger("out",t,this._uiHash(this)),this.containers[i].containerCache.over=0);if(c)if(1===this.containers.length)this.containers[p].containerCache.over||(this.containers[p]._trigger("over",t,this._uiHash(this)),this.containers[p].containerCache.over=1);else{for(n=1e4,a=null,u=c.floating||this._isFloating(this.currentItem),o=u?"left":"top",r=u?"width":"height",d=u?"clientX":"clientY",s=this.items.length-1;s>=0;s--)e.contains(this.containers[p].element[0],this.items[s].item[0])&&this.items[s].item[0]!==this.currentItem[0]&&(h=this.items[s].item.offset()[o],l=!1,t[d]-h>this.items[s][r]/2&&(l=!0),n>Math.abs(t[d]-h)&&(n=Math.abs(t[d]-h),a=this.items[s],this.direction=l?"up":"down"));if(!a&&!this.options.dropOnEmpty)return;if(this.currentContainer===this.containers[p])return this.currentContainer.containerCache.over||(this.containers[p]._trigger("over",t,this._uiHash()),this.currentContainer.containerCache.over=1),void 0;a?this._rearrange(t,a,null,!0):this._rearrange(t,null,this.containers[p].element,!0),this._trigger("change",t,this._uiHash()),this.containers[p]._trigger("change",t,this._uiHash(this)),this.currentContainer=this.containers[p],this.options.placeholder.update(this.currentContainer,this.placeholder),this.containers[p]._trigger("over",t,this._uiHash(this)),this.containers[p].containerCache.over=1}},_createHelper:function(t){var i=this.options,s=e.isFunction(i.helper)?e(i.helper.apply(this.element[0],[t,this.currentItem])):"clone"===i.helper?this.currentItem.clone():this.currentItem;return s.parents("body").length||e("parent"!==i.appendTo?i.appendTo:this.currentItem[0].parentNode)[0].appendChild(s[0]),s[0]===this.currentItem[0]&&(this._storedCSS={width:this.currentItem[0].style.width,height:this.currentItem[0].style.height,position:this.currentItem.css("position"),top:this.currentItem.css("top"),left:this.currentItem.css("left")}),(!s[0].style.width||i.forceHelperSize)&&s.width(this.currentItem.width()),(!s[0].style.height||i.forceHelperSize)&&s.height(this.currentItem.height()),s},_adjustOffsetFromHelper:function(t){"string"==typeof t&&(t=t.split(" ")),e.isArray(t)&&(t={left:+t[0],top:+t[1]||0}),"left"in t&&(this.offset.click.left=t.left+this.margins.left),"right"in t&&(this.offset.click.left=this.helperProportions.width-t.right+this.margins.left),"top"in t&&(this.offset.click.top=t.top+this.margins.top),"bottom"in t&&(this.offset.click.top=this.helperProportions.height-t.bottom+this.margins.top)},_getParentOffset:function(){this.offsetParent=this.helper.offsetParent();var t=this.offsetParent.offset();return"absolute"===this.cssPosition&&this.scrollParent[0]!==this.document[0]&&e.contains(this.scrollParent[0],this.offsetParent[0])&&(t.left+=this.scrollParent.scrollLeft(),t.top+=this.scrollParent.scrollTop()),(this.offsetParent[0]===this.document[0].body||this.offsetParent[0].tagName&&"html"===this.offsetParent[0].tagName.toLowerCase()&&e.ui.ie)&&(t={top:0,left:0}),{top:t.top+(parseInt(this.offsetParent.css("borderTopWidth"),10)||0),left:t.left+(parseInt(this.offsetParent.css("borderLeftWidth"),10)||0)}},_getRelativeOffset:function(){if("relative"===this.cssPosition){var e=this.currentItem.position();return{top:e.top-(parseInt(this.helper.css("top"),10)||0)+this.scrollParent.scrollTop(),left:e.left-(parseInt(this.helper.css("left"),10)||0)+this.scrollParent.scrollLeft()}}return{top:0,left:0}},_cacheMargins:function(){this.margins={left:parseInt(this.currentItem.css("marginLeft"),10)||0,top:parseInt(this.currentItem.css("marginTop"),10)||0}},_cacheHelperProportions:function(){this.helperProportions={width:this.helper.outerWidth(),height:this.helper.outerHeight()}},_setContainment:function(){var t,i,s,n=this.options;"parent"===n.containment&&(n.containment=this.helper[0].parentNode),("document"===n.containment||"window"===n.containment)&&(this.containment=[0-this.offset.relative.left-this.offset.parent.left,0-this.offset.relative.top-this.offset.parent.top,"document"===n.containment?this.document.width():this.window.width()-this.helperProportions.width-this.margins.left,("document"===n.containment?this.document.width():this.window.height()||this.document[0].body.parentNode.scrollHeight)-this.helperProportions.height-this.margins.top]),/^(document|window|parent)$/.test(n.containment)||(t=e(n.containment)[0],i=e(n.containment).offset(),s="hidden"!==e(t).css("overflow"),this.containment=[i.left+(parseInt(e(t).css("borderLeftWidth"),10)||0)+(parseInt(e(t).css("paddingLeft"),10)||0)-this.margins.left,i.top+(parseInt(e(t).css("borderTopWidth"),10)||0)+(parseInt(e(t).css("paddingTop"),10)||0)-this.margins.top,i.left+(s?Math.max(t.scrollWidth,t.offsetWidth):t.offsetWidth)-(parseInt(e(t).css("borderLeftWidth"),10)||0)-(parseInt(e(t).css("paddingRight"),10)||0)-this.helperProportions.width-this.margins.left,i.top+(s?Math.max(t.scrollHeight,t.offsetHeight):t.offsetHeight)-(parseInt(e(t).css("borderTopWidth"),10)||0)-(parseInt(e(t).css("paddingBottom"),10)||0)-this.helperProportions.height-this.margins.top])},_convertPositionTo:function(t,i){i||(i=this.position);var s="absolute"===t?1:-1,n="absolute"!==this.cssPosition||this.scrollParent[0]!==this.document[0]&&e.contains(this.scrollParent[0],this.offsetParent[0])?this.scrollParent:this.offsetParent,a=/(html|body)/i.test(n[0].tagName);return{top:i.top+this.offset.relative.top*s+this.offset.parent.top*s-("fixed"===this.cssPosition?-this.scrollParent.scrollTop():a?0:n.scrollTop())*s,left:i.left+this.offset.relative.left*s+this.offset.parent.left*s-("fixed"===this.cssPosition?-this.scrollParent.scrollLeft():a?0:n.scrollLeft())*s}},_generatePosition:function(t){var i,s,n=this.options,a=t.pageX,o=t.pageY,r="absolute"!==this.cssPosition||this.scrollParent[0]!==this.document[0]&&e.contains(this.scrollParent[0],this.offsetParent[0])?this.scrollParent:this.offsetParent,h=/(html|body)/i.test(r[0].tagName);return"relative"!==this.cssPosition||this.scrollParent[0]!==this.document[0]&&this.scrollParent[0]!==this.offsetParent[0]||(this.offset.relative=this._getRelativeOffset()),this.originalPosition&&(this.containment&&(t.pageX-this.offset.click.left<this.containment[0]&&(a=this.containment[0]+this.offset.click.left),t.pageY-this.offset.click.top<this.containment[1]&&(o=this.containment[1]+this.offset.click.top),t.pageX-this.offset.click.left>this.containment[2]&&(a=this.containment[2]+this.offset.click.left),t.pageY-this.offset.click.top>this.containment[3]&&(o=this.containment[3]+this.offset.click.top)),n.grid&&(i=this.originalPageY+Math.round((o-this.originalPageY)/n.grid[1])*n.grid[1],o=this.containment?i-this.offset.click.top>=this.containment[1]&&i-this.offset.click.top<=this.containment[3]?i:i-this.offset.click.top>=this.containment[1]?i-n.grid[1]:i+n.grid[1]:i,s=this.originalPageX+Math.round((a-this.originalPageX)/n.grid[0])*n.grid[0],a=this.containment?s-this.offset.click.left>=this.containment[0]&&s-this.offset.click.left<=this.containment[2]?s:s-this.offset.click.left>=this.containment[0]?s-n.grid[0]:s+n.grid[0]:s)),{top:o-this.offset.click.top-this.offset.relative.top-this.offset.parent.top+("fixed"===this.cssPosition?-this.scrollParent.scrollTop():h?0:r.scrollTop()),left:a-this.offset.click.left-this.offset.relative.left-this.offset.parent.left+("fixed"===this.cssPosition?-this.scrollParent.scrollLeft():h?0:r.scrollLeft())}},_rearrange:function(e,t,i,s){i?i[0].appendChild(this.placeholder[0]):t.item[0].parentNode.insertBefore(this.placeholder[0],"down"===this.direction?t.item[0]:t.item[0].nextSibling),this.counter=this.counter?++this.counter:1;var n=this.counter;this._delay(function(){n===this.counter&&this.refreshPositions(!s)})},_clear:function(e,t){function i(e,t,i){return function(s){i._trigger(e,s,t._uiHash(t))}}this.reverting=!1;var s,n=[];if(!this._noFinalSort&&this.currentItem.parent().length&&this.placeholder.before(this.currentItem),this._noFinalSort=null,this.helper[0]===this.currentItem[0]){for(s in this._storedCSS)("auto"===this._storedCSS[s]||"static"===this._storedCSS[s])&&(this._storedCSS[s]="");this.currentItem.css(this._storedCSS).removeClass("ui-sortable-helper")}else this.currentItem.show();for(this.fromOutside&&!t&&n.push(function(e){this._trigger("receive",e,this._uiHash(this.fromOutside))}),!this.fromOutside&&this.domPosition.prev===this.currentItem.prev().not(".ui-sortable-helper")[0]&&this.domPosition.parent===this.currentItem.parent()[0]||t||n.push(function(e){this._trigger("update",e,this._uiHash())}),this!==this.currentContainer&&(t||(n.push(function(e){this._trigger("remove",e,this._uiHash())}),n.push(function(e){return function(t){e._trigger("receive",t,this._uiHash(this))}}.call(this,this.currentContainer)),n.push(function(e){return function(t){e._trigger("update",t,this._uiHash(this))}}.call(this,this.currentContainer)))),s=this.containers.length-1;s>=0;s--)t||n.push(i("deactivate",this,this.containers[s])),this.containers[s].containerCache.over&&(n.push(i("out",this,this.containers[s])),this.containers[s].containerCache.over=0);if(this.storedCursor&&(this.document.find("body").css("cursor",this.storedCursor),this.storedStylesheet.remove()),this._storedOpacity&&this.helper.css("opacity",this._storedOpacity),this._storedZIndex&&this.helper.css("zIndex","auto"===this._storedZIndex?"":this._storedZIndex),this.dragging=!1,t||this._trigger("beforeStop",e,this._uiHash()),this.placeholder[0].parentNode.removeChild(this.placeholder[0]),this.cancelHelperRemoval||(this.helper[0]!==this.currentItem[0]&&this.helper.remove(),this.helper=null),!t){for(s=0;n.length>s;s++)n[s].call(this,e);this._trigger("stop",e,this._uiHash())}return this.fromOutside=!1,!this.cancelHelperRemoval},_trigger:function(){e.Widget.prototype._trigger.apply(this,arguments)===!1&&this.cancel()},_uiHash:function(t){var i=t||this;return{helper:i.helper,placeholder:i.placeholder||e([]),position:i.position,originalPosition:i.originalPosition,offset:i.positionAbs,item:i.currentItem,sender:t?t.element:null}}}),e.widget("ui.accordion",{version:"1.11.4",options:{active:0,animate:{},collapsible:!1,event:"click",header:"> li > :first-child,> :not(li):even",heightStyle:"auto",icons:{activeHeader:"ui-icon-triangle-1-s",header:"ui-icon-triangle-1-e"},activate:null,beforeActivate:null},hideProps:{borderTopWidth:"hide",borderBottomWidth:"hide",paddingTop:"hide",paddingBottom:"hide",height:"hide"},showProps:{borderTopWidth:"show",borderBottomWidth:"show",paddingTop:"show",paddingBottom:"show",height:"show"},_create:function(){var t=this.options;this.prevShow=this.prevHide=e(),this.element.addClass("ui-accordion ui-widget ui-helper-reset").attr("role","tablist"),t.collapsible||t.active!==!1&&null!=t.active||(t.active=0),this._processPanels(),0>t.active&&(t.active+=this.headers.length),this._refresh()},_getCreateEventData:function(){return{header:this.active,panel:this.active.length?this.active.next():e()}},_createIcons:function(){var t=this.options.icons;t&&(e("<span>").addClass("ui-accordion-header-icon ui-icon "+t.header).prependTo(this.headers),this.active.children(".ui-accordion-header-icon").removeClass(t.header).addClass(t.activeHeader),this.headers.addClass("ui-accordion-icons"))},_destroyIcons:function(){this.headers.removeClass("ui-accordion-icons").children(".ui-accordion-header-icon").remove()},_destroy:function(){var e;this.element.removeClass("ui-accordion ui-widget ui-helper-reset").removeAttr("role"),this.headers.removeClass("ui-accordion-header ui-accordion-header-active ui-state-default ui-corner-all ui-state-active ui-state-disabled ui-corner-top").removeAttr("role").removeAttr("aria-expanded").removeAttr("aria-selected").removeAttr("aria-controls").removeAttr("tabIndex").removeUniqueId(),this._destroyIcons(),e=this.headers.next().removeClass("ui-helper-reset ui-widget-content ui-corner-bottom ui-accordion-content ui-accordion-content-active ui-state-disabled").css("display","").removeAttr("role").removeAttr("aria-hidden").removeAttr("aria-labelledby").removeUniqueId(),"content"!==this.options.heightStyle&&e.css("height","")},_setOption:function(e,t){return"active"===e?(this._activate(t),void 0):("event"===e&&(this.options.event&&this._off(this.headers,this.options.event),this._setupEvents(t)),this._super(e,t),"collapsible"!==e||t||this.options.active!==!1||this._activate(0),"icons"===e&&(this._destroyIcons(),t&&this._createIcons()),"disabled"===e&&(this.element.toggleClass("ui-state-disabled",!!t).attr("aria-disabled",t),this.headers.add(this.headers.next()).toggleClass("ui-state-disabled",!!t)),void 0)},_keydown:function(t){if(!t.altKey&&!t.ctrlKey){var i=e.ui.keyCode,s=this.headers.length,n=this.headers.index(t.target),a=!1;switch(t.keyCode){case i.RIGHT:case i.DOWN:a=this.headers[(n+1)%s];break;case i.LEFT:case i.UP:a=this.headers[(n-1+s)%s];break;case i.SPACE:case i.ENTER:this._eventHandler(t);break;case i.HOME:a=this.headers[0];break;case i.END:a=this.headers[s-1]}a&&(e(t.target).attr("tabIndex",-1),e(a).attr("tabIndex",0),a.focus(),t.preventDefault())}},_panelKeyDown:function(t){t.keyCode===e.ui.keyCode.UP&&t.ctrlKey&&e(t.currentTarget).prev().focus()},refresh:function(){var t=this.options;this._processPanels(),t.active===!1&&t.collapsible===!0||!this.headers.length?(t.active=!1,this.active=e()):t.active===!1?this._activate(0):this.active.length&&!e.contains(this.element[0],this.active[0])?this.headers.length===this.headers.find(".ui-state-disabled").length?(t.active=!1,this.active=e()):this._activate(Math.max(0,t.active-1)):t.active=this.headers.index(this.active),this._destroyIcons(),this._refresh()},_processPanels:function(){var e=this.headers,t=this.panels;this.headers=this.element.find(this.options.header).addClass("ui-accordion-header ui-state-default ui-corner-all"),this.panels=this.headers.next().addClass("ui-accordion-content ui-helper-reset ui-widget-content ui-corner-bottom").filter(":not(.ui-accordion-content-active)").hide(),t&&(this._off(e.not(this.headers)),this._off(t.not(this.panels)))},_refresh:function(){var t,i=this.options,s=i.heightStyle,n=this.element.parent();this.active=this._findActive(i.active).addClass("ui-accordion-header-active ui-state-active ui-corner-top").removeClass("ui-corner-all"),this.active.next().addClass("ui-accordion-content-active").show(),this.headers.attr("role","tab").each(function(){var t=e(this),i=t.uniqueId().attr("id"),s=t.next(),n=s.uniqueId().attr("id");t.attr("aria-controls",n),s.attr("aria-labelledby",i)}).next().attr("role","tabpanel"),this.headers.not(this.active).attr({"aria-selected":"false","aria-expanded":"false",tabIndex:-1}).next().attr({"aria-hidden":"true"}).hide(),this.active.length?this.active.attr({"aria-selected":"true","aria-expanded":"true",tabIndex:0}).next().attr({"aria-hidden":"false"}):this.headers.eq(0).attr("tabIndex",0),this._createIcons(),this._setupEvents(i.event),"fill"===s?(t=n.height(),this.element.siblings(":visible").each(function(){var i=e(this),s=i.css("position");"absolute"!==s&&"fixed"!==s&&(t-=i.outerHeight(!0))}),this.headers.each(function(){t-=e(this).outerHeight(!0)}),this.headers.next().each(function(){e(this).height(Math.max(0,t-e(this).innerHeight()+e(this).height()))}).css("overflow","auto")):"auto"===s&&(t=0,this.headers.next().each(function(){t=Math.max(t,e(this).css("height","").height())}).height(t))},_activate:function(t){var i=this._findActive(t)[0];i!==this.active[0]&&(i=i||this.active[0],this._eventHandler({target:i,currentTarget:i,preventDefault:e.noop}))},_findActive:function(t){return"number"==typeof t?this.headers.eq(t):e()},_setupEvents:function(t){var i={keydown:"_keydown"};t&&e.each(t.split(" "),function(e,t){i[t]="_eventHandler"}),this._off(this.headers.add(this.headers.next())),this._on(this.headers,i),this._on(this.headers.next(),{keydown:"_panelKeyDown"}),this._hoverable(this.headers),this._focusable(this.headers)},_eventHandler:function(t){var i=this.options,s=this.active,n=e(t.currentTarget),a=n[0]===s[0],o=a&&i.collapsible,r=o?e():n.next(),h=s.next(),l={oldHeader:s,oldPanel:h,newHeader:o?e():n,newPanel:r};
t.preventDefault(),a&&!i.collapsible||this._trigger("beforeActivate",t,l)===!1||(i.active=o?!1:this.headers.index(n),this.active=a?e():n,this._toggle(l),s.removeClass("ui-accordion-header-active ui-state-active"),i.icons&&s.children(".ui-accordion-header-icon").removeClass(i.icons.activeHeader).addClass(i.icons.header),a||(n.removeClass("ui-corner-all").addClass("ui-accordion-header-active ui-state-active ui-corner-top"),i.icons&&n.children(".ui-accordion-header-icon").removeClass(i.icons.header).addClass(i.icons.activeHeader),n.next().addClass("ui-accordion-content-active")))},_toggle:function(t){var i=t.newPanel,s=this.prevShow.length?this.prevShow:t.oldPanel;this.prevShow.add(this.prevHide).stop(!0,!0),this.prevShow=i,this.prevHide=s,this.options.animate?this._animate(i,s,t):(s.hide(),i.show(),this._toggleComplete(t)),s.attr({"aria-hidden":"true"}),s.prev().attr({"aria-selected":"false","aria-expanded":"false"}),i.length&&s.length?s.prev().attr({tabIndex:-1,"aria-expanded":"false"}):i.length&&this.headers.filter(function(){return 0===parseInt(e(this).attr("tabIndex"),10)}).attr("tabIndex",-1),i.attr("aria-hidden","false").prev().attr({"aria-selected":"true","aria-expanded":"true",tabIndex:0})},_animate:function(e,t,i){var s,n,a,o=this,r=0,h=e.css("box-sizing"),l=e.length&&(!t.length||e.index()<t.index()),u=this.options.animate||{},d=l&&u.down||u,c=function(){o._toggleComplete(i)};return"number"==typeof d&&(a=d),"string"==typeof d&&(n=d),n=n||d.easing||u.easing,a=a||d.duration||u.duration,t.length?e.length?(s=e.show().outerHeight(),t.animate(this.hideProps,{duration:a,easing:n,step:function(e,t){t.now=Math.round(e)}}),e.hide().animate(this.showProps,{duration:a,easing:n,complete:c,step:function(e,i){i.now=Math.round(e),"height"!==i.prop?"content-box"===h&&(r+=i.now):"content"!==o.options.heightStyle&&(i.now=Math.round(s-t.outerHeight()-r),r=0)}}),void 0):t.animate(this.hideProps,a,n,c):e.animate(this.showProps,a,n,c)},_toggleComplete:function(e){var t=e.oldPanel;t.removeClass("ui-accordion-content-active").prev().removeClass("ui-corner-top").addClass("ui-corner-all"),t.length&&(t.parent()[0].className=t.parent()[0].className),this._trigger("activate",null,e)}}),e.widget("ui.menu",{version:"1.11.4",defaultElement:"<ul>",delay:300,options:{icons:{submenu:"ui-icon-carat-1-e"},items:"> *",menus:"ul",position:{my:"left-1 top",at:"right top"},role:"menu",blur:null,focus:null,select:null},_create:function(){this.activeMenu=this.element,this.mouseHandled=!1,this.element.uniqueId().addClass("ui-menu ui-widget ui-widget-content").toggleClass("ui-menu-icons",!!this.element.find(".ui-icon").length).attr({role:this.options.role,tabIndex:0}),this.options.disabled&&this.element.addClass("ui-state-disabled").attr("aria-disabled","true"),this._on({"mousedown .ui-menu-item":function(e){e.preventDefault()},"click .ui-menu-item":function(t){var i=e(t.target);!this.mouseHandled&&i.not(".ui-state-disabled").length&&(this.select(t),t.isPropagationStopped()||(this.mouseHandled=!0),i.has(".ui-menu").length?this.expand(t):!this.element.is(":focus")&&e(this.document[0].activeElement).closest(".ui-menu").length&&(this.element.trigger("focus",[!0]),this.active&&1===this.active.parents(".ui-menu").length&&clearTimeout(this.timer)))},"mouseenter .ui-menu-item":function(t){if(!this.previousFilter){var i=e(t.currentTarget);i.siblings(".ui-state-active").removeClass("ui-state-active"),this.focus(t,i)}},mouseleave:"collapseAll","mouseleave .ui-menu":"collapseAll",focus:function(e,t){var i=this.active||this.element.find(this.options.items).eq(0);t||this.focus(e,i)},blur:function(t){this._delay(function(){e.contains(this.element[0],this.document[0].activeElement)||this.collapseAll(t)})},keydown:"_keydown"}),this.refresh(),this._on(this.document,{click:function(e){this._closeOnDocumentClick(e)&&this.collapseAll(e),this.mouseHandled=!1}})},_destroy:function(){this.element.removeAttr("aria-activedescendant").find(".ui-menu").addBack().removeClass("ui-menu ui-widget ui-widget-content ui-menu-icons ui-front").removeAttr("role").removeAttr("tabIndex").removeAttr("aria-labelledby").removeAttr("aria-expanded").removeAttr("aria-hidden").removeAttr("aria-disabled").removeUniqueId().show(),this.element.find(".ui-menu-item").removeClass("ui-menu-item").removeAttr("role").removeAttr("aria-disabled").removeUniqueId().removeClass("ui-state-hover").removeAttr("tabIndex").removeAttr("role").removeAttr("aria-haspopup").children().each(function(){var t=e(this);t.data("ui-menu-submenu-carat")&&t.remove()}),this.element.find(".ui-menu-divider").removeClass("ui-menu-divider ui-widget-content")},_keydown:function(t){var i,s,n,a,o=!0;switch(t.keyCode){case e.ui.keyCode.PAGE_UP:this.previousPage(t);break;case e.ui.keyCode.PAGE_DOWN:this.nextPage(t);break;case e.ui.keyCode.HOME:this._move("first","first",t);break;case e.ui.keyCode.END:this._move("last","last",t);break;case e.ui.keyCode.UP:this.previous(t);break;case e.ui.keyCode.DOWN:this.next(t);break;case e.ui.keyCode.LEFT:this.collapse(t);break;case e.ui.keyCode.RIGHT:this.active&&!this.active.is(".ui-state-disabled")&&this.expand(t);break;case e.ui.keyCode.ENTER:case e.ui.keyCode.SPACE:this._activate(t);break;case e.ui.keyCode.ESCAPE:this.collapse(t);break;default:o=!1,s=this.previousFilter||"",n=String.fromCharCode(t.keyCode),a=!1,clearTimeout(this.filterTimer),n===s?a=!0:n=s+n,i=this._filterMenuItems(n),i=a&&-1!==i.index(this.active.next())?this.active.nextAll(".ui-menu-item"):i,i.length||(n=String.fromCharCode(t.keyCode),i=this._filterMenuItems(n)),i.length?(this.focus(t,i),this.previousFilter=n,this.filterTimer=this._delay(function(){delete this.previousFilter},1e3)):delete this.previousFilter}o&&t.preventDefault()},_activate:function(e){this.active.is(".ui-state-disabled")||(this.active.is("[aria-haspopup='true']")?this.expand(e):this.select(e))},refresh:function(){var t,i,s=this,n=this.options.icons.submenu,a=this.element.find(this.options.menus);this.element.toggleClass("ui-menu-icons",!!this.element.find(".ui-icon").length),a.filter(":not(.ui-menu)").addClass("ui-menu ui-widget ui-widget-content ui-front").hide().attr({role:this.options.role,"aria-hidden":"true","aria-expanded":"false"}).each(function(){var t=e(this),i=t.parent(),s=e("<span>").addClass("ui-menu-icon ui-icon "+n).data("ui-menu-submenu-carat",!0);i.attr("aria-haspopup","true").prepend(s),t.attr("aria-labelledby",i.attr("id"))}),t=a.add(this.element),i=t.find(this.options.items),i.not(".ui-menu-item").each(function(){var t=e(this);s._isDivider(t)&&t.addClass("ui-widget-content ui-menu-divider")}),i.not(".ui-menu-item, .ui-menu-divider").addClass("ui-menu-item").uniqueId().attr({tabIndex:-1,role:this._itemRole()}),i.filter(".ui-state-disabled").attr("aria-disabled","true"),this.active&&!e.contains(this.element[0],this.active[0])&&this.blur()},_itemRole:function(){return{menu:"menuitem",listbox:"option"}[this.options.role]},_setOption:function(e,t){"icons"===e&&this.element.find(".ui-menu-icon").removeClass(this.options.icons.submenu).addClass(t.submenu),"disabled"===e&&this.element.toggleClass("ui-state-disabled",!!t).attr("aria-disabled",t),this._super(e,t)},focus:function(e,t){var i,s;this.blur(e,e&&"focus"===e.type),this._scrollIntoView(t),this.active=t.first(),s=this.active.addClass("ui-state-focus").removeClass("ui-state-active"),this.options.role&&this.element.attr("aria-activedescendant",s.attr("id")),this.active.parent().closest(".ui-menu-item").addClass("ui-state-active"),e&&"keydown"===e.type?this._close():this.timer=this._delay(function(){this._close()},this.delay),i=t.children(".ui-menu"),i.length&&e&&/^mouse/.test(e.type)&&this._startOpening(i),this.activeMenu=t.parent(),this._trigger("focus",e,{item:t})},_scrollIntoView:function(t){var i,s,n,a,o,r;this._hasScroll()&&(i=parseFloat(e.css(this.activeMenu[0],"borderTopWidth"))||0,s=parseFloat(e.css(this.activeMenu[0],"paddingTop"))||0,n=t.offset().top-this.activeMenu.offset().top-i-s,a=this.activeMenu.scrollTop(),o=this.activeMenu.height(),r=t.outerHeight(),0>n?this.activeMenu.scrollTop(a+n):n+r>o&&this.activeMenu.scrollTop(a+n-o+r))},blur:function(e,t){t||clearTimeout(this.timer),this.active&&(this.active.removeClass("ui-state-focus"),this.active=null,this._trigger("blur",e,{item:this.active}))},_startOpening:function(e){clearTimeout(this.timer),"true"===e.attr("aria-hidden")&&(this.timer=this._delay(function(){this._close(),this._open(e)},this.delay))},_open:function(t){var i=e.extend({of:this.active},this.options.position);clearTimeout(this.timer),this.element.find(".ui-menu").not(t.parents(".ui-menu")).hide().attr("aria-hidden","true"),t.show().removeAttr("aria-hidden").attr("aria-expanded","true").position(i)},collapseAll:function(t,i){clearTimeout(this.timer),this.timer=this._delay(function(){var s=i?this.element:e(t&&t.target).closest(this.element.find(".ui-menu"));s.length||(s=this.element),this._close(s),this.blur(t),this.activeMenu=s},this.delay)},_close:function(e){e||(e=this.active?this.active.parent():this.element),e.find(".ui-menu").hide().attr("aria-hidden","true").attr("aria-expanded","false").end().find(".ui-state-active").not(".ui-state-focus").removeClass("ui-state-active")},_closeOnDocumentClick:function(t){return!e(t.target).closest(".ui-menu").length},_isDivider:function(e){return!/[^\-\u2014\u2013\s]/.test(e.text())},collapse:function(e){var t=this.active&&this.active.parent().closest(".ui-menu-item",this.element);t&&t.length&&(this._close(),this.focus(e,t))},expand:function(e){var t=this.active&&this.active.children(".ui-menu ").find(this.options.items).first();t&&t.length&&(this._open(t.parent()),this._delay(function(){this.focus(e,t)}))},next:function(e){this._move("next","first",e)},previous:function(e){this._move("prev","last",e)},isFirstItem:function(){return this.active&&!this.active.prevAll(".ui-menu-item").length},isLastItem:function(){return this.active&&!this.active.nextAll(".ui-menu-item").length},_move:function(e,t,i){var s;this.active&&(s="first"===e||"last"===e?this.active["first"===e?"prevAll":"nextAll"](".ui-menu-item").eq(-1):this.active[e+"All"](".ui-menu-item").eq(0)),s&&s.length&&this.active||(s=this.activeMenu.find(this.options.items)[t]()),this.focus(i,s)},nextPage:function(t){var i,s,n;return this.active?(this.isLastItem()||(this._hasScroll()?(s=this.active.offset().top,n=this.element.height(),this.active.nextAll(".ui-menu-item").each(function(){return i=e(this),0>i.offset().top-s-n}),this.focus(t,i)):this.focus(t,this.activeMenu.find(this.options.items)[this.active?"last":"first"]())),void 0):(this.next(t),void 0)},previousPage:function(t){var i,s,n;return this.active?(this.isFirstItem()||(this._hasScroll()?(s=this.active.offset().top,n=this.element.height(),this.active.prevAll(".ui-menu-item").each(function(){return i=e(this),i.offset().top-s+n>0}),this.focus(t,i)):this.focus(t,this.activeMenu.find(this.options.items).first())),void 0):(this.next(t),void 0)},_hasScroll:function(){return this.element.outerHeight()<this.element.prop("scrollHeight")},select:function(t){this.active=this.active||e(t.target).closest(".ui-menu-item");var i={item:this.active};this.active.has(".ui-menu").length||this.collapseAll(t,!0),this._trigger("select",t,i)},_filterMenuItems:function(t){var i=t.replace(/[\-\[\]{}()*+?.,\\\^$|#\s]/g,"\\$&"),s=RegExp("^"+i,"i");return this.activeMenu.find(this.options.items).filter(".ui-menu-item").filter(function(){return s.test(e.trim(e(this).text()))})}}),e.widget("ui.autocomplete",{version:"1.11.4",defaultElement:"<input>",options:{appendTo:null,autoFocus:!1,delay:300,minLength:1,position:{my:"left top",at:"left bottom",collision:"none"},source:null,change:null,close:null,focus:null,open:null,response:null,search:null,select:null},requestIndex:0,pending:0,_create:function(){var t,i,s,n=this.element[0].nodeName.toLowerCase(),a="textarea"===n,o="input"===n;this.isMultiLine=a?!0:o?!1:this.element.prop("isContentEditable"),this.valueMethod=this.element[a||o?"val":"text"],this.isNewMenu=!0,this.element.addClass("ui-autocomplete-input").attr("autocomplete","off"),this._on(this.element,{keydown:function(n){if(this.element.prop("readOnly"))return t=!0,s=!0,i=!0,void 0;t=!1,s=!1,i=!1;var a=e.ui.keyCode;switch(n.keyCode){case a.PAGE_UP:t=!0,this._move("previousPage",n);break;case a.PAGE_DOWN:t=!0,this._move("nextPage",n);break;case a.UP:t=!0,this._keyEvent("previous",n);break;case a.DOWN:t=!0,this._keyEvent("next",n);break;case a.ENTER:this.menu.active&&(t=!0,n.preventDefault(),this.menu.select(n));break;case a.TAB:this.menu.active&&this.menu.select(n);break;case a.ESCAPE:this.menu.element.is(":visible")&&(this.isMultiLine||this._value(this.term),this.close(n),n.preventDefault());break;default:i=!0,this._searchTimeout(n)}},keypress:function(s){if(t)return t=!1,(!this.isMultiLine||this.menu.element.is(":visible"))&&s.preventDefault(),void 0;if(!i){var n=e.ui.keyCode;switch(s.keyCode){case n.PAGE_UP:this._move("previousPage",s);break;case n.PAGE_DOWN:this._move("nextPage",s);break;case n.UP:this._keyEvent("previous",s);break;case n.DOWN:this._keyEvent("next",s)}}},input:function(e){return s?(s=!1,e.preventDefault(),void 0):(this._searchTimeout(e),void 0)},focus:function(){this.selectedItem=null,this.previous=this._value()},blur:function(e){return this.cancelBlur?(delete this.cancelBlur,void 0):(clearTimeout(this.searching),this.close(e),this._change(e),void 0)}}),this._initSource(),this.menu=e("<ul>").addClass("ui-autocomplete ui-front").appendTo(this._appendTo()).menu({role:null}).hide().menu("instance"),this._on(this.menu.element,{mousedown:function(t){t.preventDefault(),this.cancelBlur=!0,this._delay(function(){delete this.cancelBlur});var i=this.menu.element[0];e(t.target).closest(".ui-menu-item").length||this._delay(function(){var t=this;this.document.one("mousedown",function(s){s.target===t.element[0]||s.target===i||e.contains(i,s.target)||t.close()})})},menufocus:function(t,i){var s,n;return this.isNewMenu&&(this.isNewMenu=!1,t.originalEvent&&/^mouse/.test(t.originalEvent.type))?(this.menu.blur(),this.document.one("mousemove",function(){e(t.target).trigger(t.originalEvent)}),void 0):(n=i.item.data("ui-autocomplete-item"),!1!==this._trigger("focus",t,{item:n})&&t.originalEvent&&/^key/.test(t.originalEvent.type)&&this._value(n.value),s=i.item.attr("aria-label")||n.value,s&&e.trim(s).length&&(this.liveRegion.children().hide(),e("<div>").text(s).appendTo(this.liveRegion)),void 0)},menuselect:function(e,t){var i=t.item.data("ui-autocomplete-item"),s=this.previous;this.element[0]!==this.document[0].activeElement&&(this.element.focus(),this.previous=s,this._delay(function(){this.previous=s,this.selectedItem=i})),!1!==this._trigger("select",e,{item:i})&&this._value(i.value),this.term=this._value(),this.close(e),this.selectedItem=i}}),this.liveRegion=e("<span>",{role:"status","aria-live":"assertive","aria-relevant":"additions"}).addClass("ui-helper-hidden-accessible").appendTo(this.document[0].body),this._on(this.window,{beforeunload:function(){this.element.removeAttr("autocomplete")}})},_destroy:function(){clearTimeout(this.searching),this.element.removeClass("ui-autocomplete-input").removeAttr("autocomplete"),this.menu.element.remove(),this.liveRegion.remove()},_setOption:function(e,t){this._super(e,t),"source"===e&&this._initSource(),"appendTo"===e&&this.menu.element.appendTo(this._appendTo()),"disabled"===e&&t&&this.xhr&&this.xhr.abort()},_appendTo:function(){var t=this.options.appendTo;return t&&(t=t.jquery||t.nodeType?e(t):this.document.find(t).eq(0)),t&&t[0]||(t=this.element.closest(".ui-front")),t.length||(t=this.document[0].body),t},_initSource:function(){var t,i,s=this;e.isArray(this.options.source)?(t=this.options.source,this.source=function(i,s){s(e.ui.autocomplete.filter(t,i.term))}):"string"==typeof this.options.source?(i=this.options.source,this.source=function(t,n){s.xhr&&s.xhr.abort(),s.xhr=e.ajax({url:i,data:t,dataType:"json",success:function(e){n(e)},error:function(){n([])}})}):this.source=this.options.source},_searchTimeout:function(e){clearTimeout(this.searching),this.searching=this._delay(function(){var t=this.term===this._value(),i=this.menu.element.is(":visible"),s=e.altKey||e.ctrlKey||e.metaKey||e.shiftKey;(!t||t&&!i&&!s)&&(this.selectedItem=null,this.search(null,e))},this.options.delay)},search:function(e,t){return e=null!=e?e:this._value(),this.term=this._value(),e.length<this.options.minLength?this.close(t):this._trigger("search",t)!==!1?this._search(e):void 0},_search:function(e){this.pending++,this.element.addClass("ui-autocomplete-loading"),this.cancelSearch=!1,this.source({term:e},this._response())},_response:function(){var t=++this.requestIndex;return e.proxy(function(e){t===this.requestIndex&&this.__response(e),this.pending--,this.pending||this.element.removeClass("ui-autocomplete-loading")},this)},__response:function(e){e&&(e=this._normalize(e)),this._trigger("response",null,{content:e}),!this.options.disabled&&e&&e.length&&!this.cancelSearch?(this._suggest(e),this._trigger("open")):this._close()},close:function(e){this.cancelSearch=!0,this._close(e)},_close:function(e){this.menu.element.is(":visible")&&(this.menu.element.hide(),this.menu.blur(),this.isNewMenu=!0,this._trigger("close",e))},_change:function(e){this.previous!==this._value()&&this._trigger("change",e,{item:this.selectedItem})},_normalize:function(t){return t.length&&t[0].label&&t[0].value?t:e.map(t,function(t){return"string"==typeof t?{label:t,value:t}:e.extend({},t,{label:t.label||t.value,value:t.value||t.label})})},_suggest:function(t){var i=this.menu.element.empty();this._renderMenu(i,t),this.isNewMenu=!0,this.menu.refresh(),i.show(),this._resizeMenu(),i.position(e.extend({of:this.element},this.options.position)),this.options.autoFocus&&this.menu.next()},_resizeMenu:function(){var e=this.menu.element;e.outerWidth(Math.max(e.width("").outerWidth()+1,this.element.outerWidth()))},_renderMenu:function(t,i){var s=this;e.each(i,function(e,i){s._renderItemData(t,i)})},_renderItemData:function(e,t){return this._renderItem(e,t).data("ui-autocomplete-item",t)},_renderItem:function(t,i){return e("<li>").text(i.label).appendTo(t)},_move:function(e,t){return this.menu.element.is(":visible")?this.menu.isFirstItem()&&/^previous/.test(e)||this.menu.isLastItem()&&/^next/.test(e)?(this.isMultiLine||this._value(this.term),this.menu.blur(),void 0):(this.menu[e](t),void 0):(this.search(null,t),void 0)},widget:function(){return this.menu.element},_value:function(){return this.valueMethod.apply(this.element,arguments)},_keyEvent:function(e,t){(!this.isMultiLine||this.menu.element.is(":visible"))&&(this._move(e,t),t.preventDefault())}}),e.extend(e.ui.autocomplete,{escapeRegex:function(e){return e.replace(/[\-\[\]{}()*+?.,\\\^$|#\s]/g,"\\$&")},filter:function(t,i){var s=RegExp(e.ui.autocomplete.escapeRegex(i),"i");return e.grep(t,function(e){return s.test(e.label||e.value||e)})}}),e.widget("ui.autocomplete",e.ui.autocomplete,{options:{messages:{noResults:"No search results.",results:function(e){return e+(e>1?" results are":" result is")+" available, use up and down arrow keys to navigate."}}},__response:function(t){var i;this._superApply(arguments),this.options.disabled||this.cancelSearch||(i=t&&t.length?this.options.messages.results(t.length):this.options.messages.noResults,this.liveRegion.children().hide(),e("<div>").text(i).appendTo(this.liveRegion))}}),e.ui.autocomplete;var r,h="ui-button ui-widget ui-state-default ui-corner-all",l="ui-button-icons-only ui-button-icon-only ui-button-text-icons ui-button-text-icon-primary ui-button-text-icon-secondary ui-button-text-only",u=function(){var t=e(this);setTimeout(function(){t.find(":ui-button").button("refresh")},1)},d=function(t){var i=t.name,s=t.form,n=e([]);return i&&(i=i.replace(/'/g,"\\'"),n=s?e(s).find("[name='"+i+"'][type=radio]"):e("[name='"+i+"'][type=radio]",t.ownerDocument).filter(function(){return!this.form})),n};e.widget("ui.button",{version:"1.11.4",defaultElement:"<button>",options:{disabled:null,text:!0,label:null,icons:{primary:null,secondary:null}},_create:function(){this.element.closest("form").unbind("reset"+this.eventNamespace).bind("reset"+this.eventNamespace,u),"boolean"!=typeof this.options.disabled?this.options.disabled=!!this.element.prop("disabled"):this.element.prop("disabled",this.options.disabled),this._determineButtonType(),this.hasTitle=!!this.buttonElement.attr("title");var t=this,i=this.options,s="checkbox"===this.type||"radio"===this.type,n=s?"":"ui-state-active";null===i.label&&(i.label="input"===this.type?this.buttonElement.val():this.buttonElement.html()),this._hoverable(this.buttonElement),this.buttonElement.addClass(h).attr("role","button").bind("mouseenter"+this.eventNamespace,function(){i.disabled||this===r&&e(this).addClass("ui-state-active")}).bind("mouseleave"+this.eventNamespace,function(){i.disabled||e(this).removeClass(n)}).bind("click"+this.eventNamespace,function(e){i.disabled&&(e.preventDefault(),e.stopImmediatePropagation())}),this._on({focus:function(){this.buttonElement.addClass("ui-state-focus")},blur:function(){this.buttonElement.removeClass("ui-state-focus")}}),s&&this.element.bind("change"+this.eventNamespace,function(){t.refresh()}),"checkbox"===this.type?this.buttonElement.bind("click"+this.eventNamespace,function(){return i.disabled?!1:void 0}):"radio"===this.type?this.buttonElement.bind("click"+this.eventNamespace,function(){if(i.disabled)return!1;e(this).addClass("ui-state-active"),t.buttonElement.attr("aria-pressed","true");var s=t.element[0];d(s).not(s).map(function(){return e(this).button("widget")[0]}).removeClass("ui-state-active").attr("aria-pressed","false")}):(this.buttonElement.bind("mousedown"+this.eventNamespace,function(){return i.disabled?!1:(e(this).addClass("ui-state-active"),r=this,t.document.one("mouseup",function(){r=null}),void 0)}).bind("mouseup"+this.eventNamespace,function(){return i.disabled?!1:(e(this).removeClass("ui-state-active"),void 0)}).bind("keydown"+this.eventNamespace,function(t){return i.disabled?!1:((t.keyCode===e.ui.keyCode.SPACE||t.keyCode===e.ui.keyCode.ENTER)&&e(this).addClass("ui-state-active"),void 0)}).bind("keyup"+this.eventNamespace+" blur"+this.eventNamespace,function(){e(this).removeClass("ui-state-active")}),this.buttonElement.is("a")&&this.buttonElement.keyup(function(t){t.keyCode===e.ui.keyCode.SPACE&&e(this).click()})),this._setOption("disabled",i.disabled),this._resetButton()},_determineButtonType:function(){var e,t,i;this.type=this.element.is("[type=checkbox]")?"checkbox":this.element.is("[type=radio]")?"radio":this.element.is("input")?"input":"button","checkbox"===this.type||"radio"===this.type?(e=this.element.parents().last(),t="label[for='"+this.element.attr("id")+"']",this.buttonElement=e.find(t),this.buttonElement.length||(e=e.length?e.siblings():this.element.siblings(),this.buttonElement=e.filter(t),this.buttonElement.length||(this.buttonElement=e.find(t))),this.element.addClass("ui-helper-hidden-accessible"),i=this.element.is(":checked"),i&&this.buttonElement.addClass("ui-state-active"),this.buttonElement.prop("aria-pressed",i)):this.buttonElement=this.element},widget:function(){return this.buttonElement},_destroy:function(){this.element.removeClass("ui-helper-hidden-accessible"),this.buttonElement.removeClass(h+" ui-state-active "+l).removeAttr("role").removeAttr("aria-pressed").html(this.buttonElement.find(".ui-button-text").html()),this.hasTitle||this.buttonElement.removeAttr("title")},_setOption:function(e,t){return this._super(e,t),"disabled"===e?(this.widget().toggleClass("ui-state-disabled",!!t),this.element.prop("disabled",!!t),t&&("checkbox"===this.type||"radio"===this.type?this.buttonElement.removeClass("ui-state-focus"):this.buttonElement.removeClass("ui-state-focus ui-state-active")),void 0):(this._resetButton(),void 0)},refresh:function(){var t=this.element.is("input, button")?this.element.is(":disabled"):this.element.hasClass("ui-button-disabled");t!==this.options.disabled&&this._setOption("disabled",t),"radio"===this.type?d(this.element[0]).each(function(){e(this).is(":checked")?e(this).button("widget").addClass("ui-state-active").attr("aria-pressed","true"):e(this).button("widget").removeClass("ui-state-active").attr("aria-pressed","false")}):"checkbox"===this.type&&(this.element.is(":checked")?this.buttonElement.addClass("ui-state-active").attr("aria-pressed","true"):this.buttonElement.removeClass("ui-state-active").attr("aria-pressed","false"))},_resetButton:function(){if("input"===this.type)return this.options.label&&this.element.val(this.options.label),void 0;var t=this.buttonElement.removeClass(l),i=e("<span></span>",this.document[0]).addClass("ui-button-text").html(this.options.label).appendTo(t.empty()).text(),s=this.options.icons,n=s.primary&&s.secondary,a=[];s.primary||s.secondary?(this.options.text&&a.push("ui-button-text-icon"+(n?"s":s.primary?"-primary":"-secondary")),s.primary&&t.prepend("<span class='ui-button-icon-primary ui-icon "+s.primary+"'></span>"),s.secondary&&t.append("<span class='ui-button-icon-secondary ui-icon "+s.secondary+"'></span>"),this.options.text||(a.push(n?"ui-button-icons-only":"ui-button-icon-only"),this.hasTitle||t.attr("title",e.trim(i)))):a.push("ui-button-text-only"),t.addClass(a.join(" "))}}),e.widget("ui.buttonset",{version:"1.11.4",options:{items:"button, input[type=button], input[type=submit], input[type=reset], input[type=checkbox], input[type=radio], a, :data(ui-button)"},_create:function(){this.element.addClass("ui-buttonset")},_init:function(){this.refresh()},_setOption:function(e,t){"disabled"===e&&this.buttons.button("option",e,t),this._super(e,t)},refresh:function(){var t="rtl"===this.element.css("direction"),i=this.element.find(this.options.items),s=i.filter(":ui-button");i.not(":ui-button").button(),s.button("refresh"),this.buttons=i.map(function(){return e(this).button("widget")[0]}).removeClass("ui-corner-all ui-corner-left ui-corner-right").filter(":first").addClass(t?"ui-corner-right":"ui-corner-left").end().filter(":last").addClass(t?"ui-corner-left":"ui-corner-right").end().end()},_destroy:function(){this.element.removeClass("ui-buttonset"),this.buttons.map(function(){return e(this).button("widget")[0]}).removeClass("ui-corner-left ui-corner-right").end().button("destroy")}}),e.ui.button,e.widget("ui.dialog",{version:"1.11.4",options:{appendTo:"body",autoOpen:!0,buttons:[],closeOnEscape:!0,closeText:"Close",dialogClass:"",draggable:!0,hide:null,height:"auto",maxHeight:null,maxWidth:null,minHeight:150,minWidth:150,modal:!1,position:{my:"center",at:"center",of:window,collision:"fit",using:function(t){var i=e(this).css(t).offset().top;0>i&&e(this).css("top",t.top-i)}},resizable:!0,show:null,title:null,width:300,beforeClose:null,close:null,drag:null,dragStart:null,dragStop:null,focus:null,open:null,resize:null,resizeStart:null,resizeStop:null},sizeRelatedOptions:{buttons:!0,height:!0,maxHeight:!0,maxWidth:!0,minHeight:!0,minWidth:!0,width:!0},resizableRelatedOptions:{maxHeight:!0,maxWidth:!0,minHeight:!0,minWidth:!0},_create:function(){this.originalCss={display:this.element[0].style.display,width:this.element[0].style.width,minHeight:this.element[0].style.minHeight,maxHeight:this.element[0].style.maxHeight,height:this.element[0].style.height},this.originalPosition={parent:this.element.parent(),index:this.element.parent().children().index(this.element)},this.originalTitle=this.element.attr("title"),this.options.title=this.options.title||this.originalTitle,this._createWrapper(),this.element.show().removeAttr("title").addClass("ui-dialog-content ui-widget-content").appendTo(this.uiDialog),this._createTitlebar(),this._createButtonPane(),this.options.draggable&&e.fn.draggable&&this._makeDraggable(),this.options.resizable&&e.fn.resizable&&this._makeResizable(),this._isOpen=!1,this._trackFocus()},_init:function(){this.options.autoOpen&&this.open()},_appendTo:function(){var t=this.options.appendTo;return t&&(t.jquery||t.nodeType)?e(t):this.document.find(t||"body").eq(0)},_destroy:function(){var e,t=this.originalPosition;this._untrackInstance(),this._destroyOverlay(),this.element.removeUniqueId().removeClass("ui-dialog-content ui-widget-content").css(this.originalCss).detach(),this.uiDialog.stop(!0,!0).remove(),this.originalTitle&&this.element.attr("title",this.originalTitle),e=t.parent.children().eq(t.index),e.length&&e[0]!==this.element[0]?e.before(this.element):t.parent.append(this.element)},widget:function(){return this.uiDialog},disable:e.noop,enable:e.noop,close:function(t){var i,s=this;if(this._isOpen&&this._trigger("beforeClose",t)!==!1){if(this._isOpen=!1,this._focusedElement=null,this._destroyOverlay(),this._untrackInstance(),!this.opener.filter(":focusable").focus().length)try{i=this.document[0].activeElement,i&&"body"!==i.nodeName.toLowerCase()&&e(i).blur()}catch(n){}this._hide(this.uiDialog,this.options.hide,function(){s._trigger("close",t)})}},isOpen:function(){return this._isOpen},moveToTop:function(){this._moveToTop()},_moveToTop:function(t,i){var s=!1,n=this.uiDialog.siblings(".ui-front:visible").map(function(){return+e(this).css("z-index")}).get(),a=Math.max.apply(null,n);return a>=+this.uiDialog.css("z-index")&&(this.uiDialog.css("z-index",a+1),s=!0),s&&!i&&this._trigger("focus",t),s},open:function(){var t=this;return this._isOpen?(this._moveToTop()&&this._focusTabbable(),void 0):(this._isOpen=!0,this.opener=e(this.document[0].activeElement),this._size(),this._position(),this._createOverlay(),this._moveToTop(null,!0),this.overlay&&this.overlay.css("z-index",this.uiDialog.css("z-index")-1),this._show(this.uiDialog,this.options.show,function(){t._focusTabbable(),t._trigger("focus")}),this._makeFocusTarget(),this._trigger("open"),void 0)},_focusTabbable:function(){var e=this._focusedElement;e||(e=this.element.find("[autofocus]")),e.length||(e=this.element.find(":tabbable")),e.length||(e=this.uiDialogButtonPane.find(":tabbable")),e.length||(e=this.uiDialogTitlebarClose.filter(":tabbable")),e.length||(e=this.uiDialog),e.eq(0).focus()},_keepFocus:function(t){function i(){var t=this.document[0].activeElement,i=this.uiDialog[0]===t||e.contains(this.uiDialog[0],t);i||this._focusTabbable()}t.preventDefault(),i.call(this),this._delay(i)},_createWrapper:function(){this.uiDialog=e("<div>").addClass("ui-dialog ui-widget ui-widget-content ui-corner-all ui-front "+this.options.dialogClass).hide().attr({tabIndex:-1,role:"dialog"}).appendTo(this._appendTo()),this._on(this.uiDialog,{keydown:function(t){if(this.options.closeOnEscape&&!t.isDefaultPrevented()&&t.keyCode&&t.keyCode===e.ui.keyCode.ESCAPE)return t.preventDefault(),this.close(t),void 0;if(t.keyCode===e.ui.keyCode.TAB&&!t.isDefaultPrevented()){var i=this.uiDialog.find(":tabbable"),s=i.filter(":first"),n=i.filter(":last");t.target!==n[0]&&t.target!==this.uiDialog[0]||t.shiftKey?t.target!==s[0]&&t.target!==this.uiDialog[0]||!t.shiftKey||(this._delay(function(){n.focus()}),t.preventDefault()):(this._delay(function(){s.focus()}),t.preventDefault())}},mousedown:function(e){this._moveToTop(e)&&this._focusTabbable()}}),this.element.find("[aria-describedby]").length||this.uiDialog.attr({"aria-describedby":this.element.uniqueId().attr("id")})},_createTitlebar:function(){var t;this.uiDialogTitlebar=e("<div>").addClass("ui-dialog-titlebar ui-widget-header ui-corner-all ui-helper-clearfix").prependTo(this.uiDialog),this._on(this.uiDialogTitlebar,{mousedown:function(t){e(t.target).closest(".ui-dialog-titlebar-close")||this.uiDialog.focus()}}),this.uiDialogTitlebarClose=e("<button type='button'></button>").button({label:this.options.closeText,icons:{primary:"ui-icon-closethick"},text:!1}).addClass("ui-dialog-titlebar-close").appendTo(this.uiDialogTitlebar),this._on(this.uiDialogTitlebarClose,{click:function(e){e.preventDefault(),this.close(e)}}),t=e("<span>").uniqueId().addClass("ui-dialog-title").prependTo(this.uiDialogTitlebar),this._title(t),this.uiDialog.attr({"aria-labelledby":t.attr("id")})},_title:function(e){this.options.title||e.html("&#160;"),e.text(this.options.title)
},_createButtonPane:function(){this.uiDialogButtonPane=e("<div>").addClass("ui-dialog-buttonpane ui-widget-content ui-helper-clearfix"),this.uiButtonSet=e("<div>").addClass("ui-dialog-buttonset").appendTo(this.uiDialogButtonPane),this._createButtons()},_createButtons:function(){var t=this,i=this.options.buttons;return this.uiDialogButtonPane.remove(),this.uiButtonSet.empty(),e.isEmptyObject(i)||e.isArray(i)&&!i.length?(this.uiDialog.removeClass("ui-dialog-buttons"),void 0):(e.each(i,function(i,s){var n,a;s=e.isFunction(s)?{click:s,text:i}:s,s=e.extend({type:"button"},s),n=s.click,s.click=function(){n.apply(t.element[0],arguments)},a={icons:s.icons,text:s.showText},delete s.icons,delete s.showText,e("<button></button>",s).button(a).appendTo(t.uiButtonSet)}),this.uiDialog.addClass("ui-dialog-buttons"),this.uiDialogButtonPane.appendTo(this.uiDialog),void 0)},_makeDraggable:function(){function t(e){return{position:e.position,offset:e.offset}}var i=this,s=this.options;this.uiDialog.draggable({cancel:".ui-dialog-content, .ui-dialog-titlebar-close",handle:".ui-dialog-titlebar",containment:"document",start:function(s,n){e(this).addClass("ui-dialog-dragging"),i._blockFrames(),i._trigger("dragStart",s,t(n))},drag:function(e,s){i._trigger("drag",e,t(s))},stop:function(n,a){var o=a.offset.left-i.document.scrollLeft(),r=a.offset.top-i.document.scrollTop();s.position={my:"left top",at:"left"+(o>=0?"+":"")+o+" "+"top"+(r>=0?"+":"")+r,of:i.window},e(this).removeClass("ui-dialog-dragging"),i._unblockFrames(),i._trigger("dragStop",n,t(a))}})},_makeResizable:function(){function t(e){return{originalPosition:e.originalPosition,originalSize:e.originalSize,position:e.position,size:e.size}}var i=this,s=this.options,n=s.resizable,a=this.uiDialog.css("position"),o="string"==typeof n?n:"n,e,s,w,se,sw,ne,nw";this.uiDialog.resizable({cancel:".ui-dialog-content",containment:"document",alsoResize:this.element,maxWidth:s.maxWidth,maxHeight:s.maxHeight,minWidth:s.minWidth,minHeight:this._minHeight(),handles:o,start:function(s,n){e(this).addClass("ui-dialog-resizing"),i._blockFrames(),i._trigger("resizeStart",s,t(n))},resize:function(e,s){i._trigger("resize",e,t(s))},stop:function(n,a){var o=i.uiDialog.offset(),r=o.left-i.document.scrollLeft(),h=o.top-i.document.scrollTop();s.height=i.uiDialog.height(),s.width=i.uiDialog.width(),s.position={my:"left top",at:"left"+(r>=0?"+":"")+r+" "+"top"+(h>=0?"+":"")+h,of:i.window},e(this).removeClass("ui-dialog-resizing"),i._unblockFrames(),i._trigger("resizeStop",n,t(a))}}).css("position",a)},_trackFocus:function(){this._on(this.widget(),{focusin:function(t){this._makeFocusTarget(),this._focusedElement=e(t.target)}})},_makeFocusTarget:function(){this._untrackInstance(),this._trackingInstances().unshift(this)},_untrackInstance:function(){var t=this._trackingInstances(),i=e.inArray(this,t);-1!==i&&t.splice(i,1)},_trackingInstances:function(){var e=this.document.data("ui-dialog-instances");return e||(e=[],this.document.data("ui-dialog-instances",e)),e},_minHeight:function(){var e=this.options;return"auto"===e.height?e.minHeight:Math.min(e.minHeight,e.height)},_position:function(){var e=this.uiDialog.is(":visible");e||this.uiDialog.show(),this.uiDialog.position(this.options.position),e||this.uiDialog.hide()},_setOptions:function(t){var i=this,s=!1,n={};e.each(t,function(e,t){i._setOption(e,t),e in i.sizeRelatedOptions&&(s=!0),e in i.resizableRelatedOptions&&(n[e]=t)}),s&&(this._size(),this._position()),this.uiDialog.is(":data(ui-resizable)")&&this.uiDialog.resizable("option",n)},_setOption:function(e,t){var i,s,n=this.uiDialog;"dialogClass"===e&&n.removeClass(this.options.dialogClass).addClass(t),"disabled"!==e&&(this._super(e,t),"appendTo"===e&&this.uiDialog.appendTo(this._appendTo()),"buttons"===e&&this._createButtons(),"closeText"===e&&this.uiDialogTitlebarClose.button({label:""+t}),"draggable"===e&&(i=n.is(":data(ui-draggable)"),i&&!t&&n.draggable("destroy"),!i&&t&&this._makeDraggable()),"position"===e&&this._position(),"resizable"===e&&(s=n.is(":data(ui-resizable)"),s&&!t&&n.resizable("destroy"),s&&"string"==typeof t&&n.resizable("option","handles",t),s||t===!1||this._makeResizable()),"title"===e&&this._title(this.uiDialogTitlebar.find(".ui-dialog-title")))},_size:function(){var e,t,i,s=this.options;this.element.show().css({width:"auto",minHeight:0,maxHeight:"none",height:0}),s.minWidth>s.width&&(s.width=s.minWidth),e=this.uiDialog.css({height:"auto",width:s.width}).outerHeight(),t=Math.max(0,s.minHeight-e),i="number"==typeof s.maxHeight?Math.max(0,s.maxHeight-e):"none","auto"===s.height?this.element.css({minHeight:t,maxHeight:i,height:"auto"}):this.element.height(Math.max(0,s.height-e)),this.uiDialog.is(":data(ui-resizable)")&&this.uiDialog.resizable("option","minHeight",this._minHeight())},_blockFrames:function(){this.iframeBlocks=this.document.find("iframe").map(function(){var t=e(this);return e("<div>").css({position:"absolute",width:t.outerWidth(),height:t.outerHeight()}).appendTo(t.parent()).offset(t.offset())[0]})},_unblockFrames:function(){this.iframeBlocks&&(this.iframeBlocks.remove(),delete this.iframeBlocks)},_allowInteraction:function(t){return e(t.target).closest(".ui-dialog").length?!0:!!e(t.target).closest(".ui-datepicker").length},_createOverlay:function(){if(this.options.modal){var t=!0;this._delay(function(){t=!1}),this.document.data("ui-dialog-overlays")||this._on(this.document,{focusin:function(e){t||this._allowInteraction(e)||(e.preventDefault(),this._trackingInstances()[0]._focusTabbable())}}),this.overlay=e("<div>").addClass("ui-widget-overlay ui-front").appendTo(this._appendTo()),this._on(this.overlay,{mousedown:"_keepFocus"}),this.document.data("ui-dialog-overlays",(this.document.data("ui-dialog-overlays")||0)+1)}},_destroyOverlay:function(){if(this.options.modal&&this.overlay){var e=this.document.data("ui-dialog-overlays")-1;e?this.document.data("ui-dialog-overlays",e):this.document.unbind("focusin").removeData("ui-dialog-overlays"),this.overlay.remove(),this.overlay=null}}}),e.widget("ui.progressbar",{version:"1.11.4",options:{max:100,value:0,change:null,complete:null},min:0,_create:function(){this.oldValue=this.options.value=this._constrainedValue(),this.element.addClass("ui-progressbar ui-widget ui-widget-content ui-corner-all").attr({role:"progressbar","aria-valuemin":this.min}),this.valueDiv=e("<div class='ui-progressbar-value ui-widget-header ui-corner-left'></div>").appendTo(this.element),this._refreshValue()},_destroy:function(){this.element.removeClass("ui-progressbar ui-widget ui-widget-content ui-corner-all").removeAttr("role").removeAttr("aria-valuemin").removeAttr("aria-valuemax").removeAttr("aria-valuenow"),this.valueDiv.remove()},value:function(e){return void 0===e?this.options.value:(this.options.value=this._constrainedValue(e),this._refreshValue(),void 0)},_constrainedValue:function(e){return void 0===e&&(e=this.options.value),this.indeterminate=e===!1,"number"!=typeof e&&(e=0),this.indeterminate?!1:Math.min(this.options.max,Math.max(this.min,e))},_setOptions:function(e){var t=e.value;delete e.value,this._super(e),this.options.value=this._constrainedValue(t),this._refreshValue()},_setOption:function(e,t){"max"===e&&(t=Math.max(this.min,t)),"disabled"===e&&this.element.toggleClass("ui-state-disabled",!!t).attr("aria-disabled",t),this._super(e,t)},_percentage:function(){return this.indeterminate?100:100*(this.options.value-this.min)/(this.options.max-this.min)},_refreshValue:function(){var t=this.options.value,i=this._percentage();this.valueDiv.toggle(this.indeterminate||t>this.min).toggleClass("ui-corner-right",t===this.options.max).width(i.toFixed(0)+"%"),this.element.toggleClass("ui-progressbar-indeterminate",this.indeterminate),this.indeterminate?(this.element.removeAttr("aria-valuenow"),this.overlayDiv||(this.overlayDiv=e("<div class='ui-progressbar-overlay'></div>").appendTo(this.valueDiv))):(this.element.attr({"aria-valuemax":this.options.max,"aria-valuenow":t}),this.overlayDiv&&(this.overlayDiv.remove(),this.overlayDiv=null)),this.oldValue!==t&&(this.oldValue=t,this._trigger("change")),t===this.options.max&&this._trigger("complete")}}),e.widget("ui.selectmenu",{version:"1.11.4",defaultElement:"<select>",options:{appendTo:null,disabled:null,icons:{button:"ui-icon-triangle-1-s"},position:{my:"left top",at:"left bottom",collision:"none"},width:null,change:null,close:null,focus:null,open:null,select:null},_create:function(){var e=this.element.uniqueId().attr("id");this.ids={element:e,button:e+"-button",menu:e+"-menu"},this._drawButton(),this._drawMenu(),this.options.disabled&&this.disable()},_drawButton:function(){var t=this;this.label=e("label[for='"+this.ids.element+"']").attr("for",this.ids.button),this._on(this.label,{click:function(e){this.button.focus(),e.preventDefault()}}),this.element.hide(),this.button=e("<span>",{"class":"ui-selectmenu-button ui-widget ui-state-default ui-corner-all",tabindex:this.options.disabled?-1:0,id:this.ids.button,role:"combobox","aria-expanded":"false","aria-autocomplete":"list","aria-owns":this.ids.menu,"aria-haspopup":"true"}).insertAfter(this.element),e("<span>",{"class":"ui-icon "+this.options.icons.button}).prependTo(this.button),this.buttonText=e("<span>",{"class":"ui-selectmenu-text"}).appendTo(this.button),this._setText(this.buttonText,this.element.find("option:selected").text()),this._resizeButton(),this._on(this.button,this._buttonEvents),this.button.one("focusin",function(){t.menuItems||t._refreshMenu()}),this._hoverable(this.button),this._focusable(this.button)},_drawMenu:function(){var t=this;this.menu=e("<ul>",{"aria-hidden":"true","aria-labelledby":this.ids.button,id:this.ids.menu}),this.menuWrap=e("<div>",{"class":"ui-selectmenu-menu ui-front"}).append(this.menu).appendTo(this._appendTo()),this.menuInstance=this.menu.menu({role:"listbox",select:function(e,i){e.preventDefault(),t._setSelection(),t._select(i.item.data("ui-selectmenu-item"),e)},focus:function(e,i){var s=i.item.data("ui-selectmenu-item");null!=t.focusIndex&&s.index!==t.focusIndex&&(t._trigger("focus",e,{item:s}),t.isOpen||t._select(s,e)),t.focusIndex=s.index,t.button.attr("aria-activedescendant",t.menuItems.eq(s.index).attr("id"))}}).menu("instance"),this.menu.addClass("ui-corner-bottom").removeClass("ui-corner-all"),this.menuInstance._off(this.menu,"mouseleave"),this.menuInstance._closeOnDocumentClick=function(){return!1},this.menuInstance._isDivider=function(){return!1}},refresh:function(){this._refreshMenu(),this._setText(this.buttonText,this._getSelectedItem().text()),this.options.width||this._resizeButton()},_refreshMenu:function(){this.menu.empty();var e,t=this.element.find("option");t.length&&(this._parseOptions(t),this._renderMenu(this.menu,this.items),this.menuInstance.refresh(),this.menuItems=this.menu.find("li").not(".ui-selectmenu-optgroup"),e=this._getSelectedItem(),this.menuInstance.focus(null,e),this._setAria(e.data("ui-selectmenu-item")),this._setOption("disabled",this.element.prop("disabled")))},open:function(e){this.options.disabled||(this.menuItems?(this.menu.find(".ui-state-focus").removeClass("ui-state-focus"),this.menuInstance.focus(null,this._getSelectedItem())):this._refreshMenu(),this.isOpen=!0,this._toggleAttr(),this._resizeMenu(),this._position(),this._on(this.document,this._documentClick),this._trigger("open",e))},_position:function(){this.menuWrap.position(e.extend({of:this.button},this.options.position))},close:function(e){this.isOpen&&(this.isOpen=!1,this._toggleAttr(),this.range=null,this._off(this.document),this._trigger("close",e))},widget:function(){return this.button},menuWidget:function(){return this.menu},_renderMenu:function(t,i){var s=this,n="";e.each(i,function(i,a){a.optgroup!==n&&(e("<li>",{"class":"ui-selectmenu-optgroup ui-menu-divider"+(a.element.parent("optgroup").prop("disabled")?" ui-state-disabled":""),text:a.optgroup}).appendTo(t),n=a.optgroup),s._renderItemData(t,a)})},_renderItemData:function(e,t){return this._renderItem(e,t).data("ui-selectmenu-item",t)},_renderItem:function(t,i){var s=e("<li>");return i.disabled&&s.addClass("ui-state-disabled"),this._setText(s,i.label),s.appendTo(t)},_setText:function(e,t){t?e.text(t):e.html("&#160;")},_move:function(e,t){var i,s,n=".ui-menu-item";this.isOpen?i=this.menuItems.eq(this.focusIndex):(i=this.menuItems.eq(this.element[0].selectedIndex),n+=":not(.ui-state-disabled)"),s="first"===e||"last"===e?i["first"===e?"prevAll":"nextAll"](n).eq(-1):i[e+"All"](n).eq(0),s.length&&this.menuInstance.focus(t,s)},_getSelectedItem:function(){return this.menuItems.eq(this.element[0].selectedIndex)},_toggle:function(e){this[this.isOpen?"close":"open"](e)},_setSelection:function(){var e;this.range&&(window.getSelection?(e=window.getSelection(),e.removeAllRanges(),e.addRange(this.range)):this.range.select(),this.button.focus())},_documentClick:{mousedown:function(t){this.isOpen&&(e(t.target).closest(".ui-selectmenu-menu, #"+this.ids.button).length||this.close(t))}},_buttonEvents:{mousedown:function(){var e;window.getSelection?(e=window.getSelection(),e.rangeCount&&(this.range=e.getRangeAt(0))):this.range=document.selection.createRange()},click:function(e){this._setSelection(),this._toggle(e)},keydown:function(t){var i=!0;switch(t.keyCode){case e.ui.keyCode.TAB:case e.ui.keyCode.ESCAPE:this.close(t),i=!1;break;case e.ui.keyCode.ENTER:this.isOpen&&this._selectFocusedItem(t);break;case e.ui.keyCode.UP:t.altKey?this._toggle(t):this._move("prev",t);break;case e.ui.keyCode.DOWN:t.altKey?this._toggle(t):this._move("next",t);break;case e.ui.keyCode.SPACE:this.isOpen?this._selectFocusedItem(t):this._toggle(t);break;case e.ui.keyCode.LEFT:this._move("prev",t);break;case e.ui.keyCode.RIGHT:this._move("next",t);break;case e.ui.keyCode.HOME:case e.ui.keyCode.PAGE_UP:this._move("first",t);break;case e.ui.keyCode.END:case e.ui.keyCode.PAGE_DOWN:this._move("last",t);break;default:this.menu.trigger(t),i=!1}i&&t.preventDefault()}},_selectFocusedItem:function(e){var t=this.menuItems.eq(this.focusIndex);t.hasClass("ui-state-disabled")||this._select(t.data("ui-selectmenu-item"),e)},_select:function(e,t){var i=this.element[0].selectedIndex;this.element[0].selectedIndex=e.index,this._setText(this.buttonText,e.label),this._setAria(e),this._trigger("select",t,{item:e}),e.index!==i&&this._trigger("change",t,{item:e}),this.close(t)},_setAria:function(e){var t=this.menuItems.eq(e.index).attr("id");this.button.attr({"aria-labelledby":t,"aria-activedescendant":t}),this.menu.attr("aria-activedescendant",t)},_setOption:function(e,t){"icons"===e&&this.button.find("span.ui-icon").removeClass(this.options.icons.button).addClass(t.button),this._super(e,t),"appendTo"===e&&this.menuWrap.appendTo(this._appendTo()),"disabled"===e&&(this.menuInstance.option("disabled",t),this.button.toggleClass("ui-state-disabled",t).attr("aria-disabled",t),this.element.prop("disabled",t),t?(this.button.attr("tabindex",-1),this.close()):this.button.attr("tabindex",0)),"width"===e&&this._resizeButton()},_appendTo:function(){var t=this.options.appendTo;return t&&(t=t.jquery||t.nodeType?e(t):this.document.find(t).eq(0)),t&&t[0]||(t=this.element.closest(".ui-front")),t.length||(t=this.document[0].body),t},_toggleAttr:function(){this.button.toggleClass("ui-corner-top",this.isOpen).toggleClass("ui-corner-all",!this.isOpen).attr("aria-expanded",this.isOpen),this.menuWrap.toggleClass("ui-selectmenu-open",this.isOpen),this.menu.attr("aria-hidden",!this.isOpen)},_resizeButton:function(){var e=this.options.width;e||(e=this.element.show().outerWidth(),this.element.hide()),this.button.outerWidth(e)},_resizeMenu:function(){this.menu.outerWidth(Math.max(this.button.outerWidth(),this.menu.width("").outerWidth()+1))},_getCreateOptions:function(){return{disabled:this.element.prop("disabled")}},_parseOptions:function(t){var i=[];t.each(function(t,s){var n=e(s),a=n.parent("optgroup");i.push({element:n,index:t,value:n.val(),label:n.text(),optgroup:a.attr("label")||"",disabled:a.prop("disabled")||n.prop("disabled")})}),this.items=i},_destroy:function(){this.menuWrap.remove(),this.button.remove(),this.element.show(),this.element.removeUniqueId(),this.label.attr("for",this.ids.element)}}),e.widget("ui.slider",e.ui.mouse,{version:"1.11.4",widgetEventPrefix:"slide",options:{animate:!1,distance:0,max:100,min:0,orientation:"horizontal",range:!1,step:1,value:0,values:null,change:null,slide:null,start:null,stop:null},numPages:5,_create:function(){this._keySliding=!1,this._mouseSliding=!1,this._animateOff=!0,this._handleIndex=null,this._detectOrientation(),this._mouseInit(),this._calculateNewMax(),this.element.addClass("ui-slider ui-slider-"+this.orientation+" ui-widget"+" ui-widget-content"+" ui-corner-all"),this._refresh(),this._setOption("disabled",this.options.disabled),this._animateOff=!1},_refresh:function(){this._createRange(),this._createHandles(),this._setupEvents(),this._refreshValue()},_createHandles:function(){var t,i,s=this.options,n=this.element.find(".ui-slider-handle").addClass("ui-state-default ui-corner-all"),a="<span class='ui-slider-handle ui-state-default ui-corner-all' tabindex='0'></span>",o=[];for(i=s.values&&s.values.length||1,n.length>i&&(n.slice(i).remove(),n=n.slice(0,i)),t=n.length;i>t;t++)o.push(a);this.handles=n.add(e(o.join("")).appendTo(this.element)),this.handle=this.handles.eq(0),this.handles.each(function(t){e(this).data("ui-slider-handle-index",t)})},_createRange:function(){var t=this.options,i="";t.range?(t.range===!0&&(t.values?t.values.length&&2!==t.values.length?t.values=[t.values[0],t.values[0]]:e.isArray(t.values)&&(t.values=t.values.slice(0)):t.values=[this._valueMin(),this._valueMin()]),this.range&&this.range.length?this.range.removeClass("ui-slider-range-min ui-slider-range-max").css({left:"",bottom:""}):(this.range=e("<div></div>").appendTo(this.element),i="ui-slider-range ui-widget-header ui-corner-all"),this.range.addClass(i+("min"===t.range||"max"===t.range?" ui-slider-range-"+t.range:""))):(this.range&&this.range.remove(),this.range=null)},_setupEvents:function(){this._off(this.handles),this._on(this.handles,this._handleEvents),this._hoverable(this.handles),this._focusable(this.handles)},_destroy:function(){this.handles.remove(),this.range&&this.range.remove(),this.element.removeClass("ui-slider ui-slider-horizontal ui-slider-vertical ui-widget ui-widget-content ui-corner-all"),this._mouseDestroy()},_mouseCapture:function(t){var i,s,n,a,o,r,h,l,u=this,d=this.options;return d.disabled?!1:(this.elementSize={width:this.element.outerWidth(),height:this.element.outerHeight()},this.elementOffset=this.element.offset(),i={x:t.pageX,y:t.pageY},s=this._normValueFromMouse(i),n=this._valueMax()-this._valueMin()+1,this.handles.each(function(t){var i=Math.abs(s-u.values(t));(n>i||n===i&&(t===u._lastChangedValue||u.values(t)===d.min))&&(n=i,a=e(this),o=t)}),r=this._start(t,o),r===!1?!1:(this._mouseSliding=!0,this._handleIndex=o,a.addClass("ui-state-active").focus(),h=a.offset(),l=!e(t.target).parents().addBack().is(".ui-slider-handle"),this._clickOffset=l?{left:0,top:0}:{left:t.pageX-h.left-a.width()/2,top:t.pageY-h.top-a.height()/2-(parseInt(a.css("borderTopWidth"),10)||0)-(parseInt(a.css("borderBottomWidth"),10)||0)+(parseInt(a.css("marginTop"),10)||0)},this.handles.hasClass("ui-state-hover")||this._slide(t,o,s),this._animateOff=!0,!0))},_mouseStart:function(){return!0},_mouseDrag:function(e){var t={x:e.pageX,y:e.pageY},i=this._normValueFromMouse(t);return this._slide(e,this._handleIndex,i),!1},_mouseStop:function(e){return this.handles.removeClass("ui-state-active"),this._mouseSliding=!1,this._stop(e,this._handleIndex),this._change(e,this._handleIndex),this._handleIndex=null,this._clickOffset=null,this._animateOff=!1,!1},_detectOrientation:function(){this.orientation="vertical"===this.options.orientation?"vertical":"horizontal"},_normValueFromMouse:function(e){var t,i,s,n,a;return"horizontal"===this.orientation?(t=this.elementSize.width,i=e.x-this.elementOffset.left-(this._clickOffset?this._clickOffset.left:0)):(t=this.elementSize.height,i=e.y-this.elementOffset.top-(this._clickOffset?this._clickOffset.top:0)),s=i/t,s>1&&(s=1),0>s&&(s=0),"vertical"===this.orientation&&(s=1-s),n=this._valueMax()-this._valueMin(),a=this._valueMin()+s*n,this._trimAlignValue(a)},_start:function(e,t){var i={handle:this.handles[t],value:this.value()};return this.options.values&&this.options.values.length&&(i.value=this.values(t),i.values=this.values()),this._trigger("start",e,i)},_slide:function(e,t,i){var s,n,a;this.options.values&&this.options.values.length?(s=this.values(t?0:1),2===this.options.values.length&&this.options.range===!0&&(0===t&&i>s||1===t&&s>i)&&(i=s),i!==this.values(t)&&(n=this.values(),n[t]=i,a=this._trigger("slide",e,{handle:this.handles[t],value:i,values:n}),s=this.values(t?0:1),a!==!1&&this.values(t,i))):i!==this.value()&&(a=this._trigger("slide",e,{handle:this.handles[t],value:i}),a!==!1&&this.value(i))},_stop:function(e,t){var i={handle:this.handles[t],value:this.value()};this.options.values&&this.options.values.length&&(i.value=this.values(t),i.values=this.values()),this._trigger("stop",e,i)},_change:function(e,t){if(!this._keySliding&&!this._mouseSliding){var i={handle:this.handles[t],value:this.value()};this.options.values&&this.options.values.length&&(i.value=this.values(t),i.values=this.values()),this._lastChangedValue=t,this._trigger("change",e,i)}},value:function(e){return arguments.length?(this.options.value=this._trimAlignValue(e),this._refreshValue(),this._change(null,0),void 0):this._value()},values:function(t,i){var s,n,a;if(arguments.length>1)return this.options.values[t]=this._trimAlignValue(i),this._refreshValue(),this._change(null,t),void 0;if(!arguments.length)return this._values();if(!e.isArray(arguments[0]))return this.options.values&&this.options.values.length?this._values(t):this.value();for(s=this.options.values,n=arguments[0],a=0;s.length>a;a+=1)s[a]=this._trimAlignValue(n[a]),this._change(null,a);this._refreshValue()},_setOption:function(t,i){var s,n=0;switch("range"===t&&this.options.range===!0&&("min"===i?(this.options.value=this._values(0),this.options.values=null):"max"===i&&(this.options.value=this._values(this.options.values.length-1),this.options.values=null)),e.isArray(this.options.values)&&(n=this.options.values.length),"disabled"===t&&this.element.toggleClass("ui-state-disabled",!!i),this._super(t,i),t){case"orientation":this._detectOrientation(),this.element.removeClass("ui-slider-horizontal ui-slider-vertical").addClass("ui-slider-"+this.orientation),this._refreshValue(),this.handles.css("horizontal"===i?"bottom":"left","");break;case"value":this._animateOff=!0,this._refreshValue(),this._change(null,0),this._animateOff=!1;break;case"values":for(this._animateOff=!0,this._refreshValue(),s=0;n>s;s+=1)this._change(null,s);this._animateOff=!1;break;case"step":case"min":case"max":this._animateOff=!0,this._calculateNewMax(),this._refreshValue(),this._animateOff=!1;break;case"range":this._animateOff=!0,this._refresh(),this._animateOff=!1}},_value:function(){var e=this.options.value;return e=this._trimAlignValue(e)},_values:function(e){var t,i,s;if(arguments.length)return t=this.options.values[e],t=this._trimAlignValue(t);if(this.options.values&&this.options.values.length){for(i=this.options.values.slice(),s=0;i.length>s;s+=1)i[s]=this._trimAlignValue(i[s]);return i}return[]},_trimAlignValue:function(e){if(this._valueMin()>=e)return this._valueMin();if(e>=this._valueMax())return this._valueMax();var t=this.options.step>0?this.options.step:1,i=(e-this._valueMin())%t,s=e-i;return 2*Math.abs(i)>=t&&(s+=i>0?t:-t),parseFloat(s.toFixed(5))},_calculateNewMax:function(){var e=this.options.max,t=this._valueMin(),i=this.options.step,s=Math.floor(+(e-t).toFixed(this._precision())/i)*i;e=s+t,this.max=parseFloat(e.toFixed(this._precision()))},_precision:function(){var e=this._precisionOf(this.options.step);return null!==this.options.min&&(e=Math.max(e,this._precisionOf(this.options.min))),e},_precisionOf:function(e){var t=""+e,i=t.indexOf(".");return-1===i?0:t.length-i-1},_valueMin:function(){return this.options.min},_valueMax:function(){return this.max},_refreshValue:function(){var t,i,s,n,a,o=this.options.range,r=this.options,h=this,l=this._animateOff?!1:r.animate,u={};this.options.values&&this.options.values.length?this.handles.each(function(s){i=100*((h.values(s)-h._valueMin())/(h._valueMax()-h._valueMin())),u["horizontal"===h.orientation?"left":"bottom"]=i+"%",e(this).stop(1,1)[l?"animate":"css"](u,r.animate),h.options.range===!0&&("horizontal"===h.orientation?(0===s&&h.range.stop(1,1)[l?"animate":"css"]({left:i+"%"},r.animate),1===s&&h.range[l?"animate":"css"]({width:i-t+"%"},{queue:!1,duration:r.animate})):(0===s&&h.range.stop(1,1)[l?"animate":"css"]({bottom:i+"%"},r.animate),1===s&&h.range[l?"animate":"css"]({height:i-t+"%"},{queue:!1,duration:r.animate}))),t=i}):(s=this.value(),n=this._valueMin(),a=this._valueMax(),i=a!==n?100*((s-n)/(a-n)):0,u["horizontal"===this.orientation?"left":"bottom"]=i+"%",this.handle.stop(1,1)[l?"animate":"css"](u,r.animate),"min"===o&&"horizontal"===this.orientation&&this.range.stop(1,1)[l?"animate":"css"]({width:i+"%"},r.animate),"max"===o&&"horizontal"===this.orientation&&this.range[l?"animate":"css"]({width:100-i+"%"},{queue:!1,duration:r.animate}),"min"===o&&"vertical"===this.orientation&&this.range.stop(1,1)[l?"animate":"css"]({height:i+"%"},r.animate),"max"===o&&"vertical"===this.orientation&&this.range[l?"animate":"css"]({height:100-i+"%"},{queue:!1,duration:r.animate}))},_handleEvents:{keydown:function(t){var i,s,n,a,o=e(t.target).data("ui-slider-handle-index");switch(t.keyCode){case e.ui.keyCode.HOME:case e.ui.keyCode.END:case e.ui.keyCode.PAGE_UP:case e.ui.keyCode.PAGE_DOWN:case e.ui.keyCode.UP:case e.ui.keyCode.RIGHT:case e.ui.keyCode.DOWN:case e.ui.keyCode.LEFT:if(t.preventDefault(),!this._keySliding&&(this._keySliding=!0,e(t.target).addClass("ui-state-active"),i=this._start(t,o),i===!1))return}switch(a=this.options.step,s=n=this.options.values&&this.options.values.length?this.values(o):this.value(),t.keyCode){case e.ui.keyCode.HOME:n=this._valueMin();break;case e.ui.keyCode.END:n=this._valueMax();break;case e.ui.keyCode.PAGE_UP:n=this._trimAlignValue(s+(this._valueMax()-this._valueMin())/this.numPages);break;case e.ui.keyCode.PAGE_DOWN:n=this._trimAlignValue(s-(this._valueMax()-this._valueMin())/this.numPages);break;case e.ui.keyCode.UP:case e.ui.keyCode.RIGHT:if(s===this._valueMax())return;n=this._trimAlignValue(s+a);break;case e.ui.keyCode.DOWN:case e.ui.keyCode.LEFT:if(s===this._valueMin())return;n=this._trimAlignValue(s-a)}this._slide(t,o,n)},keyup:function(t){var i=e(t.target).data("ui-slider-handle-index");this._keySliding&&(this._keySliding=!1,this._stop(t,i),this._change(t,i),e(t.target).removeClass("ui-state-active"))}}}),e.widget("ui.spinner",{version:"1.11.4",defaultElement:"<input>",widgetEventPrefix:"spin",options:{culture:null,icons:{down:"ui-icon-triangle-1-s",up:"ui-icon-triangle-1-n"},incremental:!0,max:null,min:null,numberFormat:null,page:10,step:1,change:null,spin:null,start:null,stop:null},_create:function(){this._setOption("max",this.options.max),this._setOption("min",this.options.min),this._setOption("step",this.options.step),""!==this.value()&&this._value(this.element.val(),!0),this._draw(),this._on(this._events),this._refresh(),this._on(this.window,{beforeunload:function(){this.element.removeAttr("autocomplete")}})},_getCreateOptions:function(){var t={},i=this.element;return e.each(["min","max","step"],function(e,s){var n=i.attr(s);void 0!==n&&n.length&&(t[s]=n)}),t},_events:{keydown:function(e){this._start(e)&&this._keydown(e)&&e.preventDefault()},keyup:"_stop",focus:function(){this.previous=this.element.val()},blur:function(e){return this.cancelBlur?(delete this.cancelBlur,void 0):(this._stop(),this._refresh(),this.previous!==this.element.val()&&this._trigger("change",e),void 0)},mousewheel:function(e,t){if(t){if(!this.spinning&&!this._start(e))return!1;this._spin((t>0?1:-1)*this.options.step,e),clearTimeout(this.mousewheelTimer),this.mousewheelTimer=this._delay(function(){this.spinning&&this._stop(e)},100),e.preventDefault()}},"mousedown .ui-spinner-button":function(t){function i(){var e=this.element[0]===this.document[0].activeElement;e||(this.element.focus(),this.previous=s,this._delay(function(){this.previous=s}))}var s;s=this.element[0]===this.document[0].activeElement?this.previous:this.element.val(),t.preventDefault(),i.call(this),this.cancelBlur=!0,this._delay(function(){delete this.cancelBlur,i.call(this)}),this._start(t)!==!1&&this._repeat(null,e(t.currentTarget).hasClass("ui-spinner-up")?1:-1,t)},"mouseup .ui-spinner-button":"_stop","mouseenter .ui-spinner-button":function(t){return e(t.currentTarget).hasClass("ui-state-active")?this._start(t)===!1?!1:(this._repeat(null,e(t.currentTarget).hasClass("ui-spinner-up")?1:-1,t),void 0):void 0},"mouseleave .ui-spinner-button":"_stop"},_draw:function(){var e=this.uiSpinner=this.element.addClass("ui-spinner-input").attr("autocomplete","off").wrap(this._uiSpinnerHtml()).parent().append(this._buttonHtml());this.element.attr("role","spinbutton"),this.buttons=e.find(".ui-spinner-button").attr("tabIndex",-1).button().removeClass("ui-corner-all"),this.buttons.height()>Math.ceil(.5*e.height())&&e.height()>0&&e.height(e.height()),this.options.disabled&&this.disable()},_keydown:function(t){var i=this.options,s=e.ui.keyCode;switch(t.keyCode){case s.UP:return this._repeat(null,1,t),!0;case s.DOWN:return this._repeat(null,-1,t),!0;case s.PAGE_UP:return this._repeat(null,i.page,t),!0;case s.PAGE_DOWN:return this._repeat(null,-i.page,t),!0}return!1},_uiSpinnerHtml:function(){return"<span class='ui-spinner ui-widget ui-widget-content ui-corner-all'></span>"},_buttonHtml:function(){return"<a class='ui-spinner-button ui-spinner-up ui-corner-tr'><span class='ui-icon "+this.options.icons.up+"'>&#9650;</span>"+"</a>"+"<a class='ui-spinner-button ui-spinner-down ui-corner-br'>"+"<span class='ui-icon "+this.options.icons.down+"'>&#9660;</span>"+"</a>"},_start:function(e){return this.spinning||this._trigger("start",e)!==!1?(this.counter||(this.counter=1),this.spinning=!0,!0):!1},_repeat:function(e,t,i){e=e||500,clearTimeout(this.timer),this.timer=this._delay(function(){this._repeat(40,t,i)},e),this._spin(t*this.options.step,i)},_spin:function(e,t){var i=this.value()||0;this.counter||(this.counter=1),i=this._adjustValue(i+e*this._increment(this.counter)),this.spinning&&this._trigger("spin",t,{value:i})===!1||(this._value(i),this.counter++)},_increment:function(t){var i=this.options.incremental;return i?e.isFunction(i)?i(t):Math.floor(t*t*t/5e4-t*t/500+17*t/200+1):1},_precision:function(){var e=this._precisionOf(this.options.step);return null!==this.options.min&&(e=Math.max(e,this._precisionOf(this.options.min))),e},_precisionOf:function(e){var t=""+e,i=t.indexOf(".");return-1===i?0:t.length-i-1},_adjustValue:function(e){var t,i,s=this.options;return t=null!==s.min?s.min:0,i=e-t,i=Math.round(i/s.step)*s.step,e=t+i,e=parseFloat(e.toFixed(this._precision())),null!==s.max&&e>s.max?s.max:null!==s.min&&s.min>e?s.min:e},_stop:function(e){this.spinning&&(clearTimeout(this.timer),clearTimeout(this.mousewheelTimer),this.counter=0,this.spinning=!1,this._trigger("stop",e))},_setOption:function(e,t){if("culture"===e||"numberFormat"===e){var i=this._parse(this.element.val());return this.options[e]=t,this.element.val(this._format(i)),void 0}("max"===e||"min"===e||"step"===e)&&"string"==typeof t&&(t=this._parse(t)),"icons"===e&&(this.buttons.first().find(".ui-icon").removeClass(this.options.icons.up).addClass(t.up),this.buttons.last().find(".ui-icon").removeClass(this.options.icons.down).addClass(t.down)),this._super(e,t),"disabled"===e&&(this.widget().toggleClass("ui-state-disabled",!!t),this.element.prop("disabled",!!t),this.buttons.button(t?"disable":"enable"))},_setOptions:s(function(e){this._super(e)}),_parse:function(e){return"string"==typeof e&&""!==e&&(e=window.Globalize&&this.options.numberFormat?Globalize.parseFloat(e,10,this.options.culture):+e),""===e||isNaN(e)?null:e
},_format:function(e){return""===e?"":window.Globalize&&this.options.numberFormat?Globalize.format(e,this.options.numberFormat,this.options.culture):e},_refresh:function(){this.element.attr({"aria-valuemin":this.options.min,"aria-valuemax":this.options.max,"aria-valuenow":this._parse(this.element.val())})},isValid:function(){var e=this.value();return null===e?!1:e===this._adjustValue(e)},_value:function(e,t){var i;""!==e&&(i=this._parse(e),null!==i&&(t||(i=this._adjustValue(i)),e=this._format(i))),this.element.val(e),this._refresh()},_destroy:function(){this.element.removeClass("ui-spinner-input").prop("disabled",!1).removeAttr("autocomplete").removeAttr("role").removeAttr("aria-valuemin").removeAttr("aria-valuemax").removeAttr("aria-valuenow"),this.uiSpinner.replaceWith(this.element)},stepUp:s(function(e){this._stepUp(e)}),_stepUp:function(e){this._start()&&(this._spin((e||1)*this.options.step),this._stop())},stepDown:s(function(e){this._stepDown(e)}),_stepDown:function(e){this._start()&&(this._spin((e||1)*-this.options.step),this._stop())},pageUp:s(function(e){this._stepUp((e||1)*this.options.page)}),pageDown:s(function(e){this._stepDown((e||1)*this.options.page)}),value:function(e){return arguments.length?(s(this._value).call(this,e),void 0):this._parse(this.element.val())},widget:function(){return this.uiSpinner}}),e.widget("ui.tabs",{version:"1.11.4",delay:300,options:{active:null,collapsible:!1,event:"click",heightStyle:"content",hide:null,show:null,activate:null,beforeActivate:null,beforeLoad:null,load:null},_isLocal:function(){var e=/#.*$/;return function(t){var i,s;t=t.cloneNode(!1),i=t.href.replace(e,""),s=location.href.replace(e,"");try{i=decodeURIComponent(i)}catch(n){}try{s=decodeURIComponent(s)}catch(n){}return t.hash.length>1&&i===s}}(),_create:function(){var t=this,i=this.options;this.running=!1,this.element.addClass("ui-tabs ui-widget ui-widget-content ui-corner-all").toggleClass("ui-tabs-collapsible",i.collapsible),this._processTabs(),i.active=this._initialActive(),e.isArray(i.disabled)&&(i.disabled=e.unique(i.disabled.concat(e.map(this.tabs.filter(".ui-state-disabled"),function(e){return t.tabs.index(e)}))).sort()),this.active=this.options.active!==!1&&this.anchors.length?this._findActive(i.active):e(),this._refresh(),this.active.length&&this.load(i.active)},_initialActive:function(){var t=this.options.active,i=this.options.collapsible,s=location.hash.substring(1);return null===t&&(s&&this.tabs.each(function(i,n){return e(n).attr("aria-controls")===s?(t=i,!1):void 0}),null===t&&(t=this.tabs.index(this.tabs.filter(".ui-tabs-active"))),(null===t||-1===t)&&(t=this.tabs.length?0:!1)),t!==!1&&(t=this.tabs.index(this.tabs.eq(t)),-1===t&&(t=i?!1:0)),!i&&t===!1&&this.anchors.length&&(t=0),t},_getCreateEventData:function(){return{tab:this.active,panel:this.active.length?this._getPanelForTab(this.active):e()}},_tabKeydown:function(t){var i=e(this.document[0].activeElement).closest("li"),s=this.tabs.index(i),n=!0;if(!this._handlePageNav(t)){switch(t.keyCode){case e.ui.keyCode.RIGHT:case e.ui.keyCode.DOWN:s++;break;case e.ui.keyCode.UP:case e.ui.keyCode.LEFT:n=!1,s--;break;case e.ui.keyCode.END:s=this.anchors.length-1;break;case e.ui.keyCode.HOME:s=0;break;case e.ui.keyCode.SPACE:return t.preventDefault(),clearTimeout(this.activating),this._activate(s),void 0;case e.ui.keyCode.ENTER:return t.preventDefault(),clearTimeout(this.activating),this._activate(s===this.options.active?!1:s),void 0;default:return}t.preventDefault(),clearTimeout(this.activating),s=this._focusNextTab(s,n),t.ctrlKey||t.metaKey||(i.attr("aria-selected","false"),this.tabs.eq(s).attr("aria-selected","true"),this.activating=this._delay(function(){this.option("active",s)},this.delay))}},_panelKeydown:function(t){this._handlePageNav(t)||t.ctrlKey&&t.keyCode===e.ui.keyCode.UP&&(t.preventDefault(),this.active.focus())},_handlePageNav:function(t){return t.altKey&&t.keyCode===e.ui.keyCode.PAGE_UP?(this._activate(this._focusNextTab(this.options.active-1,!1)),!0):t.altKey&&t.keyCode===e.ui.keyCode.PAGE_DOWN?(this._activate(this._focusNextTab(this.options.active+1,!0)),!0):void 0},_findNextTab:function(t,i){function s(){return t>n&&(t=0),0>t&&(t=n),t}for(var n=this.tabs.length-1;-1!==e.inArray(s(),this.options.disabled);)t=i?t+1:t-1;return t},_focusNextTab:function(e,t){return e=this._findNextTab(e,t),this.tabs.eq(e).focus(),e},_setOption:function(e,t){return"active"===e?(this._activate(t),void 0):"disabled"===e?(this._setupDisabled(t),void 0):(this._super(e,t),"collapsible"===e&&(this.element.toggleClass("ui-tabs-collapsible",t),t||this.options.active!==!1||this._activate(0)),"event"===e&&this._setupEvents(t),"heightStyle"===e&&this._setupHeightStyle(t),void 0)},_sanitizeSelector:function(e){return e?e.replace(/[!"$%&'()*+,.\/:;<=>?@\[\]\^`{|}~]/g,"\\$&"):""},refresh:function(){var t=this.options,i=this.tablist.children(":has(a[href])");t.disabled=e.map(i.filter(".ui-state-disabled"),function(e){return i.index(e)}),this._processTabs(),t.active!==!1&&this.anchors.length?this.active.length&&!e.contains(this.tablist[0],this.active[0])?this.tabs.length===t.disabled.length?(t.active=!1,this.active=e()):this._activate(this._findNextTab(Math.max(0,t.active-1),!1)):t.active=this.tabs.index(this.active):(t.active=!1,this.active=e()),this._refresh()},_refresh:function(){this._setupDisabled(this.options.disabled),this._setupEvents(this.options.event),this._setupHeightStyle(this.options.heightStyle),this.tabs.not(this.active).attr({"aria-selected":"false","aria-expanded":"false",tabIndex:-1}),this.panels.not(this._getPanelForTab(this.active)).hide().attr({"aria-hidden":"true"}),this.active.length?(this.active.addClass("ui-tabs-active ui-state-active").attr({"aria-selected":"true","aria-expanded":"true",tabIndex:0}),this._getPanelForTab(this.active).show().attr({"aria-hidden":"false"})):this.tabs.eq(0).attr("tabIndex",0)},_processTabs:function(){var t=this,i=this.tabs,s=this.anchors,n=this.panels;this.tablist=this._getList().addClass("ui-tabs-nav ui-helper-reset ui-helper-clearfix ui-widget-header ui-corner-all").attr("role","tablist").delegate("> li","mousedown"+this.eventNamespace,function(t){e(this).is(".ui-state-disabled")&&t.preventDefault()}).delegate(".ui-tabs-anchor","focus"+this.eventNamespace,function(){e(this).closest("li").is(".ui-state-disabled")&&this.blur()}),this.tabs=this.tablist.find("> li:has(a[href])").addClass("ui-state-default ui-corner-top").attr({role:"tab",tabIndex:-1}),this.anchors=this.tabs.map(function(){return e("a",this)[0]}).addClass("ui-tabs-anchor").attr({role:"presentation",tabIndex:-1}),this.panels=e(),this.anchors.each(function(i,s){var n,a,o,r=e(s).uniqueId().attr("id"),h=e(s).closest("li"),l=h.attr("aria-controls");t._isLocal(s)?(n=s.hash,o=n.substring(1),a=t.element.find(t._sanitizeSelector(n))):(o=h.attr("aria-controls")||e({}).uniqueId()[0].id,n="#"+o,a=t.element.find(n),a.length||(a=t._createPanel(o),a.insertAfter(t.panels[i-1]||t.tablist)),a.attr("aria-live","polite")),a.length&&(t.panels=t.panels.add(a)),l&&h.data("ui-tabs-aria-controls",l),h.attr({"aria-controls":o,"aria-labelledby":r}),a.attr("aria-labelledby",r)}),this.panels.addClass("ui-tabs-panel ui-widget-content ui-corner-bottom").attr("role","tabpanel"),i&&(this._off(i.not(this.tabs)),this._off(s.not(this.anchors)),this._off(n.not(this.panels)))},_getList:function(){return this.tablist||this.element.find("ol,ul").eq(0)},_createPanel:function(t){return e("<div>").attr("id",t).addClass("ui-tabs-panel ui-widget-content ui-corner-bottom").data("ui-tabs-destroy",!0)},_setupDisabled:function(t){e.isArray(t)&&(t.length?t.length===this.anchors.length&&(t=!0):t=!1);for(var i,s=0;i=this.tabs[s];s++)t===!0||-1!==e.inArray(s,t)?e(i).addClass("ui-state-disabled").attr("aria-disabled","true"):e(i).removeClass("ui-state-disabled").removeAttr("aria-disabled");this.options.disabled=t},_setupEvents:function(t){var i={};t&&e.each(t.split(" "),function(e,t){i[t]="_eventHandler"}),this._off(this.anchors.add(this.tabs).add(this.panels)),this._on(!0,this.anchors,{click:function(e){e.preventDefault()}}),this._on(this.anchors,i),this._on(this.tabs,{keydown:"_tabKeydown"}),this._on(this.panels,{keydown:"_panelKeydown"}),this._focusable(this.tabs),this._hoverable(this.tabs)},_setupHeightStyle:function(t){var i,s=this.element.parent();"fill"===t?(i=s.height(),i-=this.element.outerHeight()-this.element.height(),this.element.siblings(":visible").each(function(){var t=e(this),s=t.css("position");"absolute"!==s&&"fixed"!==s&&(i-=t.outerHeight(!0))}),this.element.children().not(this.panels).each(function(){i-=e(this).outerHeight(!0)}),this.panels.each(function(){e(this).height(Math.max(0,i-e(this).innerHeight()+e(this).height()))}).css("overflow","auto")):"auto"===t&&(i=0,this.panels.each(function(){i=Math.max(i,e(this).height("").height())}).height(i))},_eventHandler:function(t){var i=this.options,s=this.active,n=e(t.currentTarget),a=n.closest("li"),o=a[0]===s[0],r=o&&i.collapsible,h=r?e():this._getPanelForTab(a),l=s.length?this._getPanelForTab(s):e(),u={oldTab:s,oldPanel:l,newTab:r?e():a,newPanel:h};t.preventDefault(),a.hasClass("ui-state-disabled")||a.hasClass("ui-tabs-loading")||this.running||o&&!i.collapsible||this._trigger("beforeActivate",t,u)===!1||(i.active=r?!1:this.tabs.index(a),this.active=o?e():a,this.xhr&&this.xhr.abort(),l.length||h.length||e.error("jQuery UI Tabs: Mismatching fragment identifier."),h.length&&this.load(this.tabs.index(a),t),this._toggle(t,u))},_toggle:function(t,i){function s(){a.running=!1,a._trigger("activate",t,i)}function n(){i.newTab.closest("li").addClass("ui-tabs-active ui-state-active"),o.length&&a.options.show?a._show(o,a.options.show,s):(o.show(),s())}var a=this,o=i.newPanel,r=i.oldPanel;this.running=!0,r.length&&this.options.hide?this._hide(r,this.options.hide,function(){i.oldTab.closest("li").removeClass("ui-tabs-active ui-state-active"),n()}):(i.oldTab.closest("li").removeClass("ui-tabs-active ui-state-active"),r.hide(),n()),r.attr("aria-hidden","true"),i.oldTab.attr({"aria-selected":"false","aria-expanded":"false"}),o.length&&r.length?i.oldTab.attr("tabIndex",-1):o.length&&this.tabs.filter(function(){return 0===e(this).attr("tabIndex")}).attr("tabIndex",-1),o.attr("aria-hidden","false"),i.newTab.attr({"aria-selected":"true","aria-expanded":"true",tabIndex:0})},_activate:function(t){var i,s=this._findActive(t);s[0]!==this.active[0]&&(s.length||(s=this.active),i=s.find(".ui-tabs-anchor")[0],this._eventHandler({target:i,currentTarget:i,preventDefault:e.noop}))},_findActive:function(t){return t===!1?e():this.tabs.eq(t)},_getIndex:function(e){return"string"==typeof e&&(e=this.anchors.index(this.anchors.filter("[href$='"+e+"']"))),e},_destroy:function(){this.xhr&&this.xhr.abort(),this.element.removeClass("ui-tabs ui-widget ui-widget-content ui-corner-all ui-tabs-collapsible"),this.tablist.removeClass("ui-tabs-nav ui-helper-reset ui-helper-clearfix ui-widget-header ui-corner-all").removeAttr("role"),this.anchors.removeClass("ui-tabs-anchor").removeAttr("role").removeAttr("tabIndex").removeUniqueId(),this.tablist.unbind(this.eventNamespace),this.tabs.add(this.panels).each(function(){e.data(this,"ui-tabs-destroy")?e(this).remove():e(this).removeClass("ui-state-default ui-state-active ui-state-disabled ui-corner-top ui-corner-bottom ui-widget-content ui-tabs-active ui-tabs-panel").removeAttr("tabIndex").removeAttr("aria-live").removeAttr("aria-busy").removeAttr("aria-selected").removeAttr("aria-labelledby").removeAttr("aria-hidden").removeAttr("aria-expanded").removeAttr("role")}),this.tabs.each(function(){var t=e(this),i=t.data("ui-tabs-aria-controls");i?t.attr("aria-controls",i).removeData("ui-tabs-aria-controls"):t.removeAttr("aria-controls")}),this.panels.show(),"content"!==this.options.heightStyle&&this.panels.css("height","")},enable:function(t){var i=this.options.disabled;i!==!1&&(void 0===t?i=!1:(t=this._getIndex(t),i=e.isArray(i)?e.map(i,function(e){return e!==t?e:null}):e.map(this.tabs,function(e,i){return i!==t?i:null})),this._setupDisabled(i))},disable:function(t){var i=this.options.disabled;if(i!==!0){if(void 0===t)i=!0;else{if(t=this._getIndex(t),-1!==e.inArray(t,i))return;i=e.isArray(i)?e.merge([t],i).sort():[t]}this._setupDisabled(i)}},load:function(t,i){t=this._getIndex(t);var s=this,n=this.tabs.eq(t),a=n.find(".ui-tabs-anchor"),o=this._getPanelForTab(n),r={tab:n,panel:o},h=function(e,t){"abort"===t&&s.panels.stop(!1,!0),n.removeClass("ui-tabs-loading"),o.removeAttr("aria-busy"),e===s.xhr&&delete s.xhr};this._isLocal(a[0])||(this.xhr=e.ajax(this._ajaxSettings(a,i,r)),this.xhr&&"canceled"!==this.xhr.statusText&&(n.addClass("ui-tabs-loading"),o.attr("aria-busy","true"),this.xhr.done(function(e,t,n){setTimeout(function(){o.html(e),s._trigger("load",i,r),h(n,t)},1)}).fail(function(e,t){setTimeout(function(){h(e,t)},1)})))},_ajaxSettings:function(t,i,s){var n=this;return{url:t.attr("href"),beforeSend:function(t,a){return n._trigger("beforeLoad",i,e.extend({jqXHR:t,ajaxSettings:a},s))}}},_getPanelForTab:function(t){var i=e(t).attr("aria-controls");return this.element.find(this._sanitizeSelector("#"+i))}}),e.widget("ui.tooltip",{version:"1.11.4",options:{content:function(){var t=e(this).attr("title")||"";return e("<a>").text(t).html()},hide:!0,items:"[title]:not([disabled])",position:{my:"left top+15",at:"left bottom",collision:"flipfit flip"},show:!0,tooltipClass:null,track:!1,close:null,open:null},_addDescribedBy:function(t,i){var s=(t.attr("aria-describedby")||"").split(/\s+/);s.push(i),t.data("ui-tooltip-id",i).attr("aria-describedby",e.trim(s.join(" ")))},_removeDescribedBy:function(t){var i=t.data("ui-tooltip-id"),s=(t.attr("aria-describedby")||"").split(/\s+/),n=e.inArray(i,s);-1!==n&&s.splice(n,1),t.removeData("ui-tooltip-id"),s=e.trim(s.join(" ")),s?t.attr("aria-describedby",s):t.removeAttr("aria-describedby")},_create:function(){this._on({mouseover:"open",focusin:"open"}),this.tooltips={},this.parents={},this.options.disabled&&this._disable(),this.liveRegion=e("<div>").attr({role:"log","aria-live":"assertive","aria-relevant":"additions"}).addClass("ui-helper-hidden-accessible").appendTo(this.document[0].body)},_setOption:function(t,i){var s=this;return"disabled"===t?(this[i?"_disable":"_enable"](),this.options[t]=i,void 0):(this._super(t,i),"content"===t&&e.each(this.tooltips,function(e,t){s._updateContent(t.element)}),void 0)},_disable:function(){var t=this;e.each(this.tooltips,function(i,s){var n=e.Event("blur");n.target=n.currentTarget=s.element[0],t.close(n,!0)}),this.element.find(this.options.items).addBack().each(function(){var t=e(this);t.is("[title]")&&t.data("ui-tooltip-title",t.attr("title")).removeAttr("title")})},_enable:function(){this.element.find(this.options.items).addBack().each(function(){var t=e(this);t.data("ui-tooltip-title")&&t.attr("title",t.data("ui-tooltip-title"))})},open:function(t){var i=this,s=e(t?t.target:this.element).closest(this.options.items);s.length&&!s.data("ui-tooltip-id")&&(s.attr("title")&&s.data("ui-tooltip-title",s.attr("title")),s.data("ui-tooltip-open",!0),t&&"mouseover"===t.type&&s.parents().each(function(){var t,s=e(this);s.data("ui-tooltip-open")&&(t=e.Event("blur"),t.target=t.currentTarget=this,i.close(t,!0)),s.attr("title")&&(s.uniqueId(),i.parents[this.id]={element:this,title:s.attr("title")},s.attr("title",""))}),this._registerCloseHandlers(t,s),this._updateContent(s,t))},_updateContent:function(e,t){var i,s=this.options.content,n=this,a=t?t.type:null;return"string"==typeof s?this._open(t,e,s):(i=s.call(e[0],function(i){n._delay(function(){e.data("ui-tooltip-open")&&(t&&(t.type=a),this._open(t,e,i))})}),i&&this._open(t,e,i),void 0)},_open:function(t,i,s){function n(e){l.of=e,o.is(":hidden")||o.position(l)}var a,o,r,h,l=e.extend({},this.options.position);if(s){if(a=this._find(i))return a.tooltip.find(".ui-tooltip-content").html(s),void 0;i.is("[title]")&&(t&&"mouseover"===t.type?i.attr("title",""):i.removeAttr("title")),a=this._tooltip(i),o=a.tooltip,this._addDescribedBy(i,o.attr("id")),o.find(".ui-tooltip-content").html(s),this.liveRegion.children().hide(),s.clone?(h=s.clone(),h.removeAttr("id").find("[id]").removeAttr("id")):h=s,e("<div>").html(h).appendTo(this.liveRegion),this.options.track&&t&&/^mouse/.test(t.type)?(this._on(this.document,{mousemove:n}),n(t)):o.position(e.extend({of:i},this.options.position)),o.hide(),this._show(o,this.options.show),this.options.show&&this.options.show.delay&&(r=this.delayedShow=setInterval(function(){o.is(":visible")&&(n(l.of),clearInterval(r))},e.fx.interval)),this._trigger("open",t,{tooltip:o})}},_registerCloseHandlers:function(t,i){var s={keyup:function(t){if(t.keyCode===e.ui.keyCode.ESCAPE){var s=e.Event(t);s.currentTarget=i[0],this.close(s,!0)}}};i[0]!==this.element[0]&&(s.remove=function(){this._removeTooltip(this._find(i).tooltip)}),t&&"mouseover"!==t.type||(s.mouseleave="close"),t&&"focusin"!==t.type||(s.focusout="close"),this._on(!0,i,s)},close:function(t){var i,s=this,n=e(t?t.currentTarget:this.element),a=this._find(n);return a?(i=a.tooltip,a.closing||(clearInterval(this.delayedShow),n.data("ui-tooltip-title")&&!n.attr("title")&&n.attr("title",n.data("ui-tooltip-title")),this._removeDescribedBy(n),a.hiding=!0,i.stop(!0),this._hide(i,this.options.hide,function(){s._removeTooltip(e(this))}),n.removeData("ui-tooltip-open"),this._off(n,"mouseleave focusout keyup"),n[0]!==this.element[0]&&this._off(n,"remove"),this._off(this.document,"mousemove"),t&&"mouseleave"===t.type&&e.each(this.parents,function(t,i){e(i.element).attr("title",i.title),delete s.parents[t]}),a.closing=!0,this._trigger("close",t,{tooltip:i}),a.hiding||(a.closing=!1)),void 0):(n.removeData("ui-tooltip-open"),void 0)},_tooltip:function(t){var i=e("<div>").attr("role","tooltip").addClass("ui-tooltip ui-widget ui-corner-all ui-widget-content "+(this.options.tooltipClass||"")),s=i.uniqueId().attr("id");return e("<div>").addClass("ui-tooltip-content").appendTo(i),i.appendTo(this.document[0].body),this.tooltips[s]={element:t,tooltip:i}},_find:function(e){var t=e.data("ui-tooltip-id");return t?this.tooltips[t]:null},_removeTooltip:function(e){e.remove(),delete this.tooltips[e.attr("id")]},_destroy:function(){var t=this;e.each(this.tooltips,function(i,s){var n=e.Event("blur"),a=s.element;n.target=n.currentTarget=a[0],t.close(n,!0),e("#"+i).remove(),a.data("ui-tooltip-title")&&(a.attr("title")||a.attr("title",a.data("ui-tooltip-title")),a.removeData("ui-tooltip-title"))}),this.liveRegion.remove()}});var c="ui-effects-",p=e;e.effects={effect:{}},function(e,t){function i(e,t,i){var s=d[t.type]||{};return null==e?i||!t.def?null:t.def:(e=s.floor?~~e:parseFloat(e),isNaN(e)?t.def:s.mod?(e+s.mod)%s.mod:0>e?0:e>s.max?s.max:e)}function s(i){var s=l(),n=s._rgba=[];return i=i.toLowerCase(),f(h,function(e,a){var o,r=a.re.exec(i),h=r&&a.parse(r),l=a.space||"rgba";return h?(o=s[l](h),s[u[l].cache]=o[u[l].cache],n=s._rgba=o._rgba,!1):t}),n.length?("0,0,0,0"===n.join()&&e.extend(n,a.transparent),s):a[i]}function n(e,t,i){return i=(i+1)%1,1>6*i?e+6*(t-e)*i:1>2*i?t:2>3*i?e+6*(t-e)*(2/3-i):e}var a,o="backgroundColor borderBottomColor borderLeftColor borderRightColor borderTopColor color columnRuleColor outlineColor textDecorationColor textEmphasisColor",r=/^([\-+])=\s*(\d+\.?\d*)/,h=[{re:/rgba?\(\s*(\d{1,3})\s*,\s*(\d{1,3})\s*,\s*(\d{1,3})\s*(?:,\s*(\d?(?:\.\d+)?)\s*)?\)/,parse:function(e){return[e[1],e[2],e[3],e[4]]}},{re:/rgba?\(\s*(\d+(?:\.\d+)?)\%\s*,\s*(\d+(?:\.\d+)?)\%\s*,\s*(\d+(?:\.\d+)?)\%\s*(?:,\s*(\d?(?:\.\d+)?)\s*)?\)/,parse:function(e){return[2.55*e[1],2.55*e[2],2.55*e[3],e[4]]}},{re:/#([a-f0-9]{2})([a-f0-9]{2})([a-f0-9]{2})/,parse:function(e){return[parseInt(e[1],16),parseInt(e[2],16),parseInt(e[3],16)]}},{re:/#([a-f0-9])([a-f0-9])([a-f0-9])/,parse:function(e){return[parseInt(e[1]+e[1],16),parseInt(e[2]+e[2],16),parseInt(e[3]+e[3],16)]}},{re:/hsla?\(\s*(\d+(?:\.\d+)?)\s*,\s*(\d+(?:\.\d+)?)\%\s*,\s*(\d+(?:\.\d+)?)\%\s*(?:,\s*(\d?(?:\.\d+)?)\s*)?\)/,space:"hsla",parse:function(e){return[e[1],e[2]/100,e[3]/100,e[4]]}}],l=e.Color=function(t,i,s,n){return new e.Color.fn.parse(t,i,s,n)},u={rgba:{props:{red:{idx:0,type:"byte"},green:{idx:1,type:"byte"},blue:{idx:2,type:"byte"}}},hsla:{props:{hue:{idx:0,type:"degrees"},saturation:{idx:1,type:"percent"},lightness:{idx:2,type:"percent"}}}},d={"byte":{floor:!0,max:255},percent:{max:1},degrees:{mod:360,floor:!0}},c=l.support={},p=e("<p>")[0],f=e.each;p.style.cssText="background-color:rgba(1,1,1,.5)",c.rgba=p.style.backgroundColor.indexOf("rgba")>-1,f(u,function(e,t){t.cache="_"+e,t.props.alpha={idx:3,type:"percent",def:1}}),l.fn=e.extend(l.prototype,{parse:function(n,o,r,h){if(n===t)return this._rgba=[null,null,null,null],this;(n.jquery||n.nodeType)&&(n=e(n).css(o),o=t);var d=this,c=e.type(n),p=this._rgba=[];return o!==t&&(n=[n,o,r,h],c="array"),"string"===c?this.parse(s(n)||a._default):"array"===c?(f(u.rgba.props,function(e,t){p[t.idx]=i(n[t.idx],t)}),this):"object"===c?(n instanceof l?f(u,function(e,t){n[t.cache]&&(d[t.cache]=n[t.cache].slice())}):f(u,function(t,s){var a=s.cache;f(s.props,function(e,t){if(!d[a]&&s.to){if("alpha"===e||null==n[e])return;d[a]=s.to(d._rgba)}d[a][t.idx]=i(n[e],t,!0)}),d[a]&&0>e.inArray(null,d[a].slice(0,3))&&(d[a][3]=1,s.from&&(d._rgba=s.from(d[a])))}),this):t},is:function(e){var i=l(e),s=!0,n=this;return f(u,function(e,a){var o,r=i[a.cache];return r&&(o=n[a.cache]||a.to&&a.to(n._rgba)||[],f(a.props,function(e,i){return null!=r[i.idx]?s=r[i.idx]===o[i.idx]:t})),s}),s},_space:function(){var e=[],t=this;return f(u,function(i,s){t[s.cache]&&e.push(i)}),e.pop()},transition:function(e,t){var s=l(e),n=s._space(),a=u[n],o=0===this.alpha()?l("transparent"):this,r=o[a.cache]||a.to(o._rgba),h=r.slice();return s=s[a.cache],f(a.props,function(e,n){var a=n.idx,o=r[a],l=s[a],u=d[n.type]||{};null!==l&&(null===o?h[a]=l:(u.mod&&(l-o>u.mod/2?o+=u.mod:o-l>u.mod/2&&(o-=u.mod)),h[a]=i((l-o)*t+o,n)))}),this[n](h)},blend:function(t){if(1===this._rgba[3])return this;var i=this._rgba.slice(),s=i.pop(),n=l(t)._rgba;return l(e.map(i,function(e,t){return(1-s)*n[t]+s*e}))},toRgbaString:function(){var t="rgba(",i=e.map(this._rgba,function(e,t){return null==e?t>2?1:0:e});return 1===i[3]&&(i.pop(),t="rgb("),t+i.join()+")"},toHslaString:function(){var t="hsla(",i=e.map(this.hsla(),function(e,t){return null==e&&(e=t>2?1:0),t&&3>t&&(e=Math.round(100*e)+"%"),e});return 1===i[3]&&(i.pop(),t="hsl("),t+i.join()+")"},toHexString:function(t){var i=this._rgba.slice(),s=i.pop();return t&&i.push(~~(255*s)),"#"+e.map(i,function(e){return e=(e||0).toString(16),1===e.length?"0"+e:e}).join("")},toString:function(){return 0===this._rgba[3]?"transparent":this.toRgbaString()}}),l.fn.parse.prototype=l.fn,u.hsla.to=function(e){if(null==e[0]||null==e[1]||null==e[2])return[null,null,null,e[3]];var t,i,s=e[0]/255,n=e[1]/255,a=e[2]/255,o=e[3],r=Math.max(s,n,a),h=Math.min(s,n,a),l=r-h,u=r+h,d=.5*u;return t=h===r?0:s===r?60*(n-a)/l+360:n===r?60*(a-s)/l+120:60*(s-n)/l+240,i=0===l?0:.5>=d?l/u:l/(2-u),[Math.round(t)%360,i,d,null==o?1:o]},u.hsla.from=function(e){if(null==e[0]||null==e[1]||null==e[2])return[null,null,null,e[3]];var t=e[0]/360,i=e[1],s=e[2],a=e[3],o=.5>=s?s*(1+i):s+i-s*i,r=2*s-o;return[Math.round(255*n(r,o,t+1/3)),Math.round(255*n(r,o,t)),Math.round(255*n(r,o,t-1/3)),a]},f(u,function(s,n){var a=n.props,o=n.cache,h=n.to,u=n.from;l.fn[s]=function(s){if(h&&!this[o]&&(this[o]=h(this._rgba)),s===t)return this[o].slice();var n,r=e.type(s),d="array"===r||"object"===r?s:arguments,c=this[o].slice();return f(a,function(e,t){var s=d["object"===r?e:t.idx];null==s&&(s=c[t.idx]),c[t.idx]=i(s,t)}),u?(n=l(u(c)),n[o]=c,n):l(c)},f(a,function(t,i){l.fn[t]||(l.fn[t]=function(n){var a,o=e.type(n),h="alpha"===t?this._hsla?"hsla":"rgba":s,l=this[h](),u=l[i.idx];return"undefined"===o?u:("function"===o&&(n=n.call(this,u),o=e.type(n)),null==n&&i.empty?this:("string"===o&&(a=r.exec(n),a&&(n=u+parseFloat(a[2])*("+"===a[1]?1:-1))),l[i.idx]=n,this[h](l)))})})}),l.hook=function(t){var i=t.split(" ");f(i,function(t,i){e.cssHooks[i]={set:function(t,n){var a,o,r="";if("transparent"!==n&&("string"!==e.type(n)||(a=s(n)))){if(n=l(a||n),!c.rgba&&1!==n._rgba[3]){for(o="backgroundColor"===i?t.parentNode:t;(""===r||"transparent"===r)&&o&&o.style;)try{r=e.css(o,"backgroundColor"),o=o.parentNode}catch(h){}n=n.blend(r&&"transparent"!==r?r:"_default")}n=n.toRgbaString()}try{t.style[i]=n}catch(h){}}},e.fx.step[i]=function(t){t.colorInit||(t.start=l(t.elem,i),t.end=l(t.end),t.colorInit=!0),e.cssHooks[i].set(t.elem,t.start.transition(t.end,t.pos))}})},l.hook(o),e.cssHooks.borderColor={expand:function(e){var t={};return f(["Top","Right","Bottom","Left"],function(i,s){t["border"+s+"Color"]=e}),t}},a=e.Color.names={aqua:"#00ffff",black:"#000000",blue:"#0000ff",fuchsia:"#ff00ff",gray:"#808080",green:"#008000",lime:"#00ff00",maroon:"#800000",navy:"#000080",olive:"#808000",purple:"#800080",red:"#ff0000",silver:"#c0c0c0",teal:"#008080",white:"#ffffff",yellow:"#ffff00",transparent:[null,null,null,0],_default:"#ffffff"}}(p),function(){function t(t){var i,s,n=t.ownerDocument.defaultView?t.ownerDocument.defaultView.getComputedStyle(t,null):t.currentStyle,a={};if(n&&n.length&&n[0]&&n[n[0]])for(s=n.length;s--;)i=n[s],"string"==typeof n[i]&&(a[e.camelCase(i)]=n[i]);else for(i in n)"string"==typeof n[i]&&(a[i]=n[i]);return a}function i(t,i){var s,a,o={};for(s in i)a=i[s],t[s]!==a&&(n[s]||(e.fx.step[s]||!isNaN(parseFloat(a)))&&(o[s]=a));return o}var s=["add","remove","toggle"],n={border:1,borderBottom:1,borderColor:1,borderLeft:1,borderRight:1,borderTop:1,borderWidth:1,margin:1,padding:1};e.each(["borderLeftStyle","borderRightStyle","borderBottomStyle","borderTopStyle"],function(t,i){e.fx.step[i]=function(e){("none"!==e.end&&!e.setAttr||1===e.pos&&!e.setAttr)&&(p.style(e.elem,i,e.end),e.setAttr=!0)}}),e.fn.addBack||(e.fn.addBack=function(e){return this.add(null==e?this.prevObject:this.prevObject.filter(e))}),e.effects.animateClass=function(n,a,o,r){var h=e.speed(a,o,r);return this.queue(function(){var a,o=e(this),r=o.attr("class")||"",l=h.children?o.find("*").addBack():o;l=l.map(function(){var i=e(this);return{el:i,start:t(this)}}),a=function(){e.each(s,function(e,t){n[t]&&o[t+"Class"](n[t])})},a(),l=l.map(function(){return this.end=t(this.el[0]),this.diff=i(this.start,this.end),this}),o.attr("class",r),l=l.map(function(){var t=this,i=e.Deferred(),s=e.extend({},h,{queue:!1,complete:function(){i.resolve(t)}});return this.el.animate(this.diff,s),i.promise()}),e.when.apply(e,l.get()).done(function(){a(),e.each(arguments,function(){var t=this.el;e.each(this.diff,function(e){t.css(e,"")})}),h.complete.call(o[0])})})},e.fn.extend({addClass:function(t){return function(i,s,n,a){return s?e.effects.animateClass.call(this,{add:i},s,n,a):t.apply(this,arguments)}}(e.fn.addClass),removeClass:function(t){return function(i,s,n,a){return arguments.length>1?e.effects.animateClass.call(this,{remove:i},s,n,a):t.apply(this,arguments)}}(e.fn.removeClass),toggleClass:function(t){return function(i,s,n,a,o){return"boolean"==typeof s||void 0===s?n?e.effects.animateClass.call(this,s?{add:i}:{remove:i},n,a,o):t.apply(this,arguments):e.effects.animateClass.call(this,{toggle:i},s,n,a)}}(e.fn.toggleClass),switchClass:function(t,i,s,n,a){return e.effects.animateClass.call(this,{add:i,remove:t},s,n,a)}})}(),function(){function t(t,i,s,n){return e.isPlainObject(t)&&(i=t,t=t.effect),t={effect:t},null==i&&(i={}),e.isFunction(i)&&(n=i,s=null,i={}),("number"==typeof i||e.fx.speeds[i])&&(n=s,s=i,i={}),e.isFunction(s)&&(n=s,s=null),i&&e.extend(t,i),s=s||i.duration,t.duration=e.fx.off?0:"number"==typeof s?s:s in e.fx.speeds?e.fx.speeds[s]:e.fx.speeds._default,t.complete=n||i.complete,t}function i(t){return!t||"number"==typeof t||e.fx.speeds[t]?!0:"string"!=typeof t||e.effects.effect[t]?e.isFunction(t)?!0:"object"!=typeof t||t.effect?!1:!0:!0}e.extend(e.effects,{version:"1.11.4",save:function(e,t){for(var i=0;t.length>i;i++)null!==t[i]&&e.data(c+t[i],e[0].style[t[i]])},restore:function(e,t){var i,s;for(s=0;t.length>s;s++)null!==t[s]&&(i=e.data(c+t[s]),void 0===i&&(i=""),e.css(t[s],i))},setMode:function(e,t){return"toggle"===t&&(t=e.is(":hidden")?"show":"hide"),t},getBaseline:function(e,t){var i,s;switch(e[0]){case"top":i=0;break;case"middle":i=.5;break;case"bottom":i=1;break;default:i=e[0]/t.height}switch(e[1]){case"left":s=0;break;case"center":s=.5;break;case"right":s=1;break;default:s=e[1]/t.width}return{x:s,y:i}},createWrapper:function(t){if(t.parent().is(".ui-effects-wrapper"))return t.parent();var i={width:t.outerWidth(!0),height:t.outerHeight(!0),"float":t.css("float")},s=e("<div></div>").addClass("ui-effects-wrapper").css({fontSize:"100%",background:"transparent",border:"none",margin:0,padding:0}),n={width:t.width(),height:t.height()},a=document.activeElement;try{a.id}catch(o){a=document.body}return t.wrap(s),(t[0]===a||e.contains(t[0],a))&&e(a).focus(),s=t.parent(),"static"===t.css("position")?(s.css({position:"relative"}),t.css({position:"relative"})):(e.extend(i,{position:t.css("position"),zIndex:t.css("z-index")}),e.each(["top","left","bottom","right"],function(e,s){i[s]=t.css(s),isNaN(parseInt(i[s],10))&&(i[s]="auto")}),t.css({position:"relative",top:0,left:0,right:"auto",bottom:"auto"})),t.css(n),s.css(i).show()},removeWrapper:function(t){var i=document.activeElement;return t.parent().is(".ui-effects-wrapper")&&(t.parent().replaceWith(t),(t[0]===i||e.contains(t[0],i))&&e(i).focus()),t},setTransition:function(t,i,s,n){return n=n||{},e.each(i,function(e,i){var a=t.cssUnit(i);a[0]>0&&(n[i]=a[0]*s+a[1])}),n}}),e.fn.extend({effect:function(){function i(t){function i(){e.isFunction(a)&&a.call(n[0]),e.isFunction(t)&&t()}var n=e(this),a=s.complete,r=s.mode;(n.is(":hidden")?"hide"===r:"show"===r)?(n[r](),i()):o.call(n[0],s,i)}var s=t.apply(this,arguments),n=s.mode,a=s.queue,o=e.effects.effect[s.effect];return e.fx.off||!o?n?this[n](s.duration,s.complete):this.each(function(){s.complete&&s.complete.call(this)}):a===!1?this.each(i):this.queue(a||"fx",i)},show:function(e){return function(s){if(i(s))return e.apply(this,arguments);var n=t.apply(this,arguments);return n.mode="show",this.effect.call(this,n)}}(e.fn.show),hide:function(e){return function(s){if(i(s))return e.apply(this,arguments);var n=t.apply(this,arguments);return n.mode="hide",this.effect.call(this,n)}}(e.fn.hide),toggle:function(e){return function(s){if(i(s)||"boolean"==typeof s)return e.apply(this,arguments);var n=t.apply(this,arguments);return n.mode="toggle",this.effect.call(this,n)}}(e.fn.toggle),cssUnit:function(t){var i=this.css(t),s=[];return e.each(["em","px","%","pt"],function(e,t){i.indexOf(t)>0&&(s=[parseFloat(i),t])}),s}})}(),function(){var t={};e.each(["Quad","Cubic","Quart","Quint","Expo"],function(e,i){t[i]=function(t){return Math.pow(t,e+2)}}),e.extend(t,{Sine:function(e){return 1-Math.cos(e*Math.PI/2)},Circ:function(e){return 1-Math.sqrt(1-e*e)},Elastic:function(e){return 0===e||1===e?e:-Math.pow(2,8*(e-1))*Math.sin((80*(e-1)-7.5)*Math.PI/15)},Back:function(e){return e*e*(3*e-2)},Bounce:function(e){for(var t,i=4;((t=Math.pow(2,--i))-1)/11>e;);return 1/Math.pow(4,3-i)-7.5625*Math.pow((3*t-2)/22-e,2)}}),e.each(t,function(t,i){e.easing["easeIn"+t]=i,e.easing["easeOut"+t]=function(e){return 1-i(1-e)},e.easing["easeInOut"+t]=function(e){return.5>e?i(2*e)/2:1-i(-2*e+2)/2}})}(),e.effects,e.effects.effect.blind=function(t,i){var s,n,a,o=e(this),r=/up|down|vertical/,h=/up|left|vertical|horizontal/,l=["position","top","bottom","left","right","height","width"],u=e.effects.setMode(o,t.mode||"hide"),d=t.direction||"up",c=r.test(d),p=c?"height":"width",f=c?"top":"left",m=h.test(d),g={},v="show"===u;o.parent().is(".ui-effects-wrapper")?e.effects.save(o.parent(),l):e.effects.save(o,l),o.show(),s=e.effects.createWrapper(o).css({overflow:"hidden"}),n=s[p](),a=parseFloat(s.css(f))||0,g[p]=v?n:0,m||(o.css(c?"bottom":"right",0).css(c?"top":"left","auto").css({position:"absolute"}),g[f]=v?a:n+a),v&&(s.css(p,0),m||s.css(f,a+n)),s.animate(g,{duration:t.duration,easing:t.easing,queue:!1,complete:function(){"hide"===u&&o.hide(),e.effects.restore(o,l),e.effects.removeWrapper(o),i()
}})},e.effects.effect.bounce=function(t,i){var s,n,a,o=e(this),r=["position","top","bottom","left","right","height","width"],h=e.effects.setMode(o,t.mode||"effect"),l="hide"===h,u="show"===h,d=t.direction||"up",c=t.distance,p=t.times||5,f=2*p+(u||l?1:0),m=t.duration/f,g=t.easing,v="up"===d||"down"===d?"top":"left",y="up"===d||"left"===d,b=o.queue(),_=b.length;for((u||l)&&r.push("opacity"),e.effects.save(o,r),o.show(),e.effects.createWrapper(o),c||(c=o["top"===v?"outerHeight":"outerWidth"]()/3),u&&(a={opacity:1},a[v]=0,o.css("opacity",0).css(v,y?2*-c:2*c).animate(a,m,g)),l&&(c/=Math.pow(2,p-1)),a={},a[v]=0,s=0;p>s;s++)n={},n[v]=(y?"-=":"+=")+c,o.animate(n,m,g).animate(a,m,g),c=l?2*c:c/2;l&&(n={opacity:0},n[v]=(y?"-=":"+=")+c,o.animate(n,m,g)),o.queue(function(){l&&o.hide(),e.effects.restore(o,r),e.effects.removeWrapper(o),i()}),_>1&&b.splice.apply(b,[1,0].concat(b.splice(_,f+1))),o.dequeue()},e.effects.effect.clip=function(t,i){var s,n,a,o=e(this),r=["position","top","bottom","left","right","height","width"],h=e.effects.setMode(o,t.mode||"hide"),l="show"===h,u=t.direction||"vertical",d="vertical"===u,c=d?"height":"width",p=d?"top":"left",f={};e.effects.save(o,r),o.show(),s=e.effects.createWrapper(o).css({overflow:"hidden"}),n="IMG"===o[0].tagName?s:o,a=n[c](),l&&(n.css(c,0),n.css(p,a/2)),f[c]=l?a:0,f[p]=l?0:a/2,n.animate(f,{queue:!1,duration:t.duration,easing:t.easing,complete:function(){l||o.hide(),e.effects.restore(o,r),e.effects.removeWrapper(o),i()}})},e.effects.effect.drop=function(t,i){var s,n=e(this),a=["position","top","bottom","left","right","opacity","height","width"],o=e.effects.setMode(n,t.mode||"hide"),r="show"===o,h=t.direction||"left",l="up"===h||"down"===h?"top":"left",u="up"===h||"left"===h?"pos":"neg",d={opacity:r?1:0};e.effects.save(n,a),n.show(),e.effects.createWrapper(n),s=t.distance||n["top"===l?"outerHeight":"outerWidth"](!0)/2,r&&n.css("opacity",0).css(l,"pos"===u?-s:s),d[l]=(r?"pos"===u?"+=":"-=":"pos"===u?"-=":"+=")+s,n.animate(d,{queue:!1,duration:t.duration,easing:t.easing,complete:function(){"hide"===o&&n.hide(),e.effects.restore(n,a),e.effects.removeWrapper(n),i()}})},e.effects.effect.explode=function(t,i){function s(){b.push(this),b.length===d*c&&n()}function n(){p.css({visibility:"visible"}),e(b).remove(),m||p.hide(),i()}var a,o,r,h,l,u,d=t.pieces?Math.round(Math.sqrt(t.pieces)):3,c=d,p=e(this),f=e.effects.setMode(p,t.mode||"hide"),m="show"===f,g=p.show().css("visibility","hidden").offset(),v=Math.ceil(p.outerWidth()/c),y=Math.ceil(p.outerHeight()/d),b=[];for(a=0;d>a;a++)for(h=g.top+a*y,u=a-(d-1)/2,o=0;c>o;o++)r=g.left+o*v,l=o-(c-1)/2,p.clone().appendTo("body").wrap("<div></div>").css({position:"absolute",visibility:"visible",left:-o*v,top:-a*y}).parent().addClass("ui-effects-explode").css({position:"absolute",overflow:"hidden",width:v,height:y,left:r+(m?l*v:0),top:h+(m?u*y:0),opacity:m?0:1}).animate({left:r+(m?0:l*v),top:h+(m?0:u*y),opacity:m?1:0},t.duration||500,t.easing,s)},e.effects.effect.fade=function(t,i){var s=e(this),n=e.effects.setMode(s,t.mode||"toggle");s.animate({opacity:n},{queue:!1,duration:t.duration,easing:t.easing,complete:i})},e.effects.effect.fold=function(t,i){var s,n,a=e(this),o=["position","top","bottom","left","right","height","width"],r=e.effects.setMode(a,t.mode||"hide"),h="show"===r,l="hide"===r,u=t.size||15,d=/([0-9]+)%/.exec(u),c=!!t.horizFirst,p=h!==c,f=p?["width","height"]:["height","width"],m=t.duration/2,g={},v={};e.effects.save(a,o),a.show(),s=e.effects.createWrapper(a).css({overflow:"hidden"}),n=p?[s.width(),s.height()]:[s.height(),s.width()],d&&(u=parseInt(d[1],10)/100*n[l?0:1]),h&&s.css(c?{height:0,width:u}:{height:u,width:0}),g[f[0]]=h?n[0]:u,v[f[1]]=h?n[1]:0,s.animate(g,m,t.easing).animate(v,m,t.easing,function(){l&&a.hide(),e.effects.restore(a,o),e.effects.removeWrapper(a),i()})},e.effects.effect.highlight=function(t,i){var s=e(this),n=["backgroundImage","backgroundColor","opacity"],a=e.effects.setMode(s,t.mode||"show"),o={backgroundColor:s.css("backgroundColor")};"hide"===a&&(o.opacity=0),e.effects.save(s,n),s.show().css({backgroundImage:"none",backgroundColor:t.color||"#ffff99"}).animate(o,{queue:!1,duration:t.duration,easing:t.easing,complete:function(){"hide"===a&&s.hide(),e.effects.restore(s,n),i()}})},e.effects.effect.size=function(t,i){var s,n,a,o=e(this),r=["position","top","bottom","left","right","width","height","overflow","opacity"],h=["position","top","bottom","left","right","overflow","opacity"],l=["width","height","overflow"],u=["fontSize"],d=["borderTopWidth","borderBottomWidth","paddingTop","paddingBottom"],c=["borderLeftWidth","borderRightWidth","paddingLeft","paddingRight"],p=e.effects.setMode(o,t.mode||"effect"),f=t.restore||"effect"!==p,m=t.scale||"both",g=t.origin||["middle","center"],v=o.css("position"),y=f?r:h,b={height:0,width:0,outerHeight:0,outerWidth:0};"show"===p&&o.show(),s={height:o.height(),width:o.width(),outerHeight:o.outerHeight(),outerWidth:o.outerWidth()},"toggle"===t.mode&&"show"===p?(o.from=t.to||b,o.to=t.from||s):(o.from=t.from||("show"===p?b:s),o.to=t.to||("hide"===p?b:s)),a={from:{y:o.from.height/s.height,x:o.from.width/s.width},to:{y:o.to.height/s.height,x:o.to.width/s.width}},("box"===m||"both"===m)&&(a.from.y!==a.to.y&&(y=y.concat(d),o.from=e.effects.setTransition(o,d,a.from.y,o.from),o.to=e.effects.setTransition(o,d,a.to.y,o.to)),a.from.x!==a.to.x&&(y=y.concat(c),o.from=e.effects.setTransition(o,c,a.from.x,o.from),o.to=e.effects.setTransition(o,c,a.to.x,o.to))),("content"===m||"both"===m)&&a.from.y!==a.to.y&&(y=y.concat(u).concat(l),o.from=e.effects.setTransition(o,u,a.from.y,o.from),o.to=e.effects.setTransition(o,u,a.to.y,o.to)),e.effects.save(o,y),o.show(),e.effects.createWrapper(o),o.css("overflow","hidden").css(o.from),g&&(n=e.effects.getBaseline(g,s),o.from.top=(s.outerHeight-o.outerHeight())*n.y,o.from.left=(s.outerWidth-o.outerWidth())*n.x,o.to.top=(s.outerHeight-o.to.outerHeight)*n.y,o.to.left=(s.outerWidth-o.to.outerWidth)*n.x),o.css(o.from),("content"===m||"both"===m)&&(d=d.concat(["marginTop","marginBottom"]).concat(u),c=c.concat(["marginLeft","marginRight"]),l=r.concat(d).concat(c),o.find("*[width]").each(function(){var i=e(this),s={height:i.height(),width:i.width(),outerHeight:i.outerHeight(),outerWidth:i.outerWidth()};f&&e.effects.save(i,l),i.from={height:s.height*a.from.y,width:s.width*a.from.x,outerHeight:s.outerHeight*a.from.y,outerWidth:s.outerWidth*a.from.x},i.to={height:s.height*a.to.y,width:s.width*a.to.x,outerHeight:s.height*a.to.y,outerWidth:s.width*a.to.x},a.from.y!==a.to.y&&(i.from=e.effects.setTransition(i,d,a.from.y,i.from),i.to=e.effects.setTransition(i,d,a.to.y,i.to)),a.from.x!==a.to.x&&(i.from=e.effects.setTransition(i,c,a.from.x,i.from),i.to=e.effects.setTransition(i,c,a.to.x,i.to)),i.css(i.from),i.animate(i.to,t.duration,t.easing,function(){f&&e.effects.restore(i,l)})})),o.animate(o.to,{queue:!1,duration:t.duration,easing:t.easing,complete:function(){0===o.to.opacity&&o.css("opacity",o.from.opacity),"hide"===p&&o.hide(),e.effects.restore(o,y),f||("static"===v?o.css({position:"relative",top:o.to.top,left:o.to.left}):e.each(["top","left"],function(e,t){o.css(t,function(t,i){var s=parseInt(i,10),n=e?o.to.left:o.to.top;return"auto"===i?n+"px":s+n+"px"})})),e.effects.removeWrapper(o),i()}})},e.effects.effect.scale=function(t,i){var s=e(this),n=e.extend(!0,{},t),a=e.effects.setMode(s,t.mode||"effect"),o=parseInt(t.percent,10)||(0===parseInt(t.percent,10)?0:"hide"===a?0:100),r=t.direction||"both",h=t.origin,l={height:s.height(),width:s.width(),outerHeight:s.outerHeight(),outerWidth:s.outerWidth()},u={y:"horizontal"!==r?o/100:1,x:"vertical"!==r?o/100:1};n.effect="size",n.queue=!1,n.complete=i,"effect"!==a&&(n.origin=h||["middle","center"],n.restore=!0),n.from=t.from||("show"===a?{height:0,width:0,outerHeight:0,outerWidth:0}:l),n.to={height:l.height*u.y,width:l.width*u.x,outerHeight:l.outerHeight*u.y,outerWidth:l.outerWidth*u.x},n.fade&&("show"===a&&(n.from.opacity=0,n.to.opacity=1),"hide"===a&&(n.from.opacity=1,n.to.opacity=0)),s.effect(n)},e.effects.effect.puff=function(t,i){var s=e(this),n=e.effects.setMode(s,t.mode||"hide"),a="hide"===n,o=parseInt(t.percent,10)||150,r=o/100,h={height:s.height(),width:s.width(),outerHeight:s.outerHeight(),outerWidth:s.outerWidth()};e.extend(t,{effect:"scale",queue:!1,fade:!0,mode:n,complete:i,percent:a?o:100,from:a?h:{height:h.height*r,width:h.width*r,outerHeight:h.outerHeight*r,outerWidth:h.outerWidth*r}}),s.effect(t)},e.effects.effect.pulsate=function(t,i){var s,n=e(this),a=e.effects.setMode(n,t.mode||"show"),o="show"===a,r="hide"===a,h=o||"hide"===a,l=2*(t.times||5)+(h?1:0),u=t.duration/l,d=0,c=n.queue(),p=c.length;for((o||!n.is(":visible"))&&(n.css("opacity",0).show(),d=1),s=1;l>s;s++)n.animate({opacity:d},u,t.easing),d=1-d;n.animate({opacity:d},u,t.easing),n.queue(function(){r&&n.hide(),i()}),p>1&&c.splice.apply(c,[1,0].concat(c.splice(p,l+1))),n.dequeue()},e.effects.effect.shake=function(t,i){var s,n=e(this),a=["position","top","bottom","left","right","height","width"],o=e.effects.setMode(n,t.mode||"effect"),r=t.direction||"left",h=t.distance||20,l=t.times||3,u=2*l+1,d=Math.round(t.duration/u),c="up"===r||"down"===r?"top":"left",p="up"===r||"left"===r,f={},m={},g={},v=n.queue(),y=v.length;for(e.effects.save(n,a),n.show(),e.effects.createWrapper(n),f[c]=(p?"-=":"+=")+h,m[c]=(p?"+=":"-=")+2*h,g[c]=(p?"-=":"+=")+2*h,n.animate(f,d,t.easing),s=1;l>s;s++)n.animate(m,d,t.easing).animate(g,d,t.easing);n.animate(m,d,t.easing).animate(f,d/2,t.easing).queue(function(){"hide"===o&&n.hide(),e.effects.restore(n,a),e.effects.removeWrapper(n),i()}),y>1&&v.splice.apply(v,[1,0].concat(v.splice(y,u+1))),n.dequeue()},e.effects.effect.slide=function(t,i){var s,n=e(this),a=["position","top","bottom","left","right","width","height"],o=e.effects.setMode(n,t.mode||"show"),r="show"===o,h=t.direction||"left",l="up"===h||"down"===h?"top":"left",u="up"===h||"left"===h,d={};e.effects.save(n,a),n.show(),s=t.distance||n["top"===l?"outerHeight":"outerWidth"](!0),e.effects.createWrapper(n).css({overflow:"hidden"}),r&&n.css(l,u?isNaN(s)?"-"+s:-s:s),d[l]=(r?u?"+=":"-=":u?"-=":"+=")+s,n.animate(d,{queue:!1,duration:t.duration,easing:t.easing,complete:function(){"hide"===o&&n.hide(),e.effects.restore(n,a),e.effects.removeWrapper(n),i()}})},e.effects.effect.transfer=function(t,i){var s=e(this),n=e(t.to),a="fixed"===n.css("position"),o=e("body"),r=a?o.scrollTop():0,h=a?o.scrollLeft():0,l=n.offset(),u={top:l.top-r,left:l.left-h,height:n.innerHeight(),width:n.innerWidth()},d=s.offset(),c=e("<div class='ui-effects-transfer'></div>").appendTo(document.body).addClass(t.className).css({top:d.top-r,left:d.left-h,height:s.innerHeight(),width:s.innerWidth(),position:a?"fixed":"absolute"}).animate(u,t.duration,t.easing,function(){c.remove(),i()})}});</script>
<style type="text/css">

.tocify {
width: 20%;
max-height: 90%;
overflow: auto;
margin-left: 2%;
position: fixed;
border: 1px solid #ccc;
webkit-border-radius: 6px;
moz-border-radius: 6px;
border-radius: 6px;
}

.tocify ul, .tocify li {
list-style: none;
margin: 0;
padding: 0;
border: none;
line-height: 30px;
}

.tocify-header {
text-indent: 10px;
}

.tocify-subheader {
text-indent: 20px;
display: none;
}

.tocify-subheader li {
font-size: 12px;
}

.tocify-subheader .tocify-subheader {
text-indent: 30px;
}

.tocify-subheader .tocify-subheader .tocify-subheader {
text-indent: 40px;
}

.tocify .tocify-item > a, .tocify .nav-list .nav-header {
margin: 0px;
}

.tocify .tocify-item a, .tocify .list-group-item {
padding: 5px;
}
.tocify .nav-pills > li {
float: none;
}


</style>
<script>/* jquery Tocify - v1.9.1 - 2013-10-22
 * http://www.gregfranko.com/jquery.tocify.js/
 * Copyright (c) 2013 Greg Franko; Licensed MIT */

// Immediately-Invoked Function Expression (IIFE) [Ben Alman Blog Post](http://benalman.com/news/2010/11/immediately-invoked-function-expression/) that calls another IIFE that contains all of the plugin logic.  I used this pattern so that anyone viewing this code would not have to scroll to the bottom of the page to view the local parameters that were passed to the main IIFE.
(function(tocify) {

    // ECMAScript 5 Strict Mode: [John Resig Blog Post](http://ejohn.org/blog/ecmascript-5-strict-mode-json-and-more/)
    "use strict";

    // Calls the second IIFE and locally passes in the global jQuery, window, and document objects
    tocify(window.jQuery, window, document);

  }

  // Locally passes in `jQuery`, the `window` object, the `document` object, and an `undefined` variable.  The `jQuery`, `window` and `document` objects are passed in locally, to improve performance, since javascript first searches for a variable match within the local variables set before searching the global variables set.  All of the global variables are also passed in locally to be minifier friendly. `undefined` can be passed in locally, because it is not a reserved word in JavaScript.
  (function($, window, document, undefined) {

    // ECMAScript 5 Strict Mode: [John Resig Blog Post](http://ejohn.org/blog/ecmascript-5-strict-mode-json-and-more/)
    "use strict";

    var tocClassName = "tocify",
      tocClass = "." + tocClassName,
      tocFocusClassName = "tocify-focus",
      tocHoverClassName = "tocify-hover",
      hideTocClassName = "tocify-hide",
      hideTocClass = "." + hideTocClassName,
      headerClassName = "tocify-header",
      headerClass = "." + headerClassName,
      subheaderClassName = "tocify-subheader",
      subheaderClass = "." + subheaderClassName,
      itemClassName = "tocify-item",
      itemClass = "." + itemClassName,
      extendPageClassName = "tocify-extend-page",
      extendPageClass = "." + extendPageClassName;

    // Calling the jQueryUI Widget Factory Method
    $.widget("toc.tocify", {

      //Plugin version
      version: "1.9.1",

      // These options will be used as defaults
      options: {

        // **context**: Accepts String: Any jQuery selector
        // The container element that holds all of the elements used to generate the table of contents
        context: "body",

        // **ignoreSelector**: Accepts String: Any jQuery selector
        // A selector to any element that would be matched by selectors that you wish to be ignored
        ignoreSelector: null,

        // **selectors**: Accepts an Array of Strings: Any jQuery selectors
        // The element's used to generate the table of contents.  The order is very important since it will determine the table of content's nesting structure
        selectors: "h1, h2, h3",

        // **showAndHide**: Accepts a boolean: true or false
        // Used to determine if elements should be shown and hidden
        showAndHide: true,

        // **showEffect**: Accepts String: "none", "fadeIn", "show", or "slideDown"
        // Used to display any of the table of contents nested items
        showEffect: "slideDown",

        // **showEffectSpeed**: Accepts Number (milliseconds) or String: "slow", "medium", or "fast"
        // The time duration of the show animation
        showEffectSpeed: "medium",

        // **hideEffect**: Accepts String: "none", "fadeOut", "hide", or "slideUp"
        // Used to hide any of the table of contents nested items
        hideEffect: "slideUp",

        // **hideEffectSpeed**: Accepts Number (milliseconds) or String: "slow", "medium", or "fast"
        // The time duration of the hide animation
        hideEffectSpeed: "medium",

        // **smoothScroll**: Accepts a boolean: true or false
        // Determines if a jQuery animation should be used to scroll to specific table of contents items on the page
        smoothScroll: true,

        // **smoothScrollSpeed**: Accepts Number (milliseconds) or String: "slow", "medium", or "fast"
        // The time duration of the smoothScroll animation
        smoothScrollSpeed: "medium",

        // **scrollTo**: Accepts Number (pixels)
        // The amount of space between the top of page and the selected table of contents item after the page has been scrolled
        scrollTo: 0,

        // **showAndHideOnScroll**: Accepts a boolean: true or false
        // Determines if table of contents nested items should be shown and hidden while scrolling
        showAndHideOnScroll: true,

        // **highlightOnScroll**: Accepts a boolean: true or false
        // Determines if table of contents nested items should be highlighted (set to a different color) while scrolling
        highlightOnScroll: true,

        // **highlightOffset**: Accepts a number
        // The offset distance in pixels to trigger the next active table of contents item
        highlightOffset: 40,

        // **theme**: Accepts a string: "bootstrap", "jqueryui", or "none"
        // Determines if Twitter Bootstrap, jQueryUI, or Tocify classes should be added to the table of contents
        theme: "bootstrap",

        // **extendPage**: Accepts a boolean: true or false
        // If a user scrolls to the bottom of the page and the page is not tall enough to scroll to the last table of contents item, then the page height is increased
        extendPage: true,

        // **extendPageOffset**: Accepts a number: pixels
        // How close to the bottom of the page a user must scroll before the page is extended
        extendPageOffset: 100,

        // **history**: Accepts a boolean: true or false
        // Adds a hash to the page url to maintain history
        history: true,

        // **scrollHistory**: Accepts a boolean: true or false
        // Adds a hash to the page url, to maintain history, when scrolling to a TOC item
        scrollHistory: false,

        // **hashGenerator**: How the hash value (the anchor segment of the URL, following the
        // # character) will be generated.
        //
        // "compact" (default) - #CompressesEverythingTogether
        // "pretty" - #looks-like-a-nice-url-and-is-easily-readable
        // function(text, element){} - Your own hash generation function that accepts the text as an
        // argument, and returns the hash value.
        hashGenerator: "compact",

        // **highlightDefault**: Accepts a boolean: true or false
        // Set's the first TOC item as active if no other TOC item is active.
        highlightDefault: true

      },

      // _Create
      // -------
      //      Constructs the plugin.  Only called once.
      _create: function() {

        var self = this;

        self.extendPageScroll = true;

        // Internal array that keeps track of all TOC items (Helps to recognize if there are duplicate TOC item strings)
        self.items = [];

        // Generates the HTML for the dynamic table of contents
        self._generateToc();

        // Adds CSS classes to the newly generated table of contents HTML
        self._addCSSClasses();

        self.webkit = (function() {

          for (var prop in window) {

            if (prop) {

              if (prop.toLowerCase().indexOf("webkit") !== -1) {

                return true;

              }

            }

          }

          return false;

        }());

        // Adds jQuery event handlers to the newly generated table of contents
        self._setEventHandlers();

        // Binding to the Window load event to make sure the correct scrollTop is calculated
        $(window).load(function() {

          // Sets the active TOC item
          self._setActiveElement(true);

          // Once all animations on the page are complete, this callback function will be called
          $("html, body").promise().done(function() {

            setTimeout(function() {

              self.extendPageScroll = false;

            }, 0);

          });

        });

      },

      // _generateToc
      // ------------
      //      Generates the HTML for the dynamic table of contents
      _generateToc: function() {

        // _Local variables_

        // Stores the plugin context in the self variable
        var self = this,

          // All of the HTML tags found within the context provided (i.e. body) that match the top level jQuery selector above
          firstElem,

          // Instantiated variable that will store the top level newly created unordered list DOM element
          ul,
          ignoreSelector = self.options.ignoreSelector;


        // Determine the element to start the toc with
        // get all the top level selectors
        firstElem = [];
        var selectors = this.options.selectors.replace(/ /g, "").split(",");
        // find the first set that have at least one non-ignored element
        for(var i = 0; i < selectors.length; i++) {
          var foundSelectors = $(this.options.context).find(selectors[i]);
          for (var s = 0; s < foundSelectors.length; s++) {
            if (!$(foundSelectors[s]).is(ignoreSelector)) {
              firstElem = foundSelectors;
              break;
            }
          }
          if (firstElem.length> 0)
            break;
        }

        if (!firstElem.length) {

          self.element.addClass(hideTocClassName);

          return;

        }

        self.element.addClass(tocClassName);

        // Loops through each top level selector
        firstElem.each(function(index) {

          //If the element matches the ignoreSelector then we skip it
          if ($(this).is(ignoreSelector)) {
            return;
          }

          // Creates an unordered list HTML element and adds a dynamic ID and standard class name
          ul = $("<ul/>", {
            "id": headerClassName + index,
            "class": headerClassName
          }).

          // Appends a top level list item HTML element to the previously created HTML header
          append(self._nestElements($(this), index));

          // Add the created unordered list element to the HTML element calling the plugin
          self.element.append(ul);

          // Finds all of the HTML tags between the header and subheader elements
          $(this).nextUntil(this.nodeName.toLowerCase()).each(function() {

            // If there are no nested subheader elemements
            if ($(this).find(self.options.selectors).length === 0) {

              // Loops through all of the subheader elements
              $(this).filter(self.options.selectors).each(function() {

                //If the element matches the ignoreSelector then we skip it
                if ($(this).is(ignoreSelector)) {
                  return;
                }

                self._appendSubheaders.call(this, self, ul);

              });

            }

            // If there are nested subheader elements
            else {

              // Loops through all of the subheader elements
              $(this).find(self.options.selectors).each(function() {

                //If the element matches the ignoreSelector then we skip it
                if ($(this).is(ignoreSelector)) {
                  return;
                }

                self._appendSubheaders.call(this, self, ul);

              });

            }

          });

        });

      },

      _setActiveElement: function(pageload) {

        var self = this,

          hash = window.location.hash.substring(1),

          elem = self.element.find('li[data-unique="' + hash + '"]');

        if (hash.length) {

          // Removes highlighting from all of the list item's
          self.element.find("." + self.focusClass).removeClass(self.focusClass);

          // Highlights the current list item that was clicked
          elem.addClass(self.focusClass);

          // Triggers the click event on the currently focused TOC item
          elem.click();

        } else {

          // Removes highlighting from all of the list item's
          self.element.find("." + self.focusClass).removeClass(self.focusClass);

          if (!hash.length && pageload && self.options.highlightDefault) {

            // Highlights the first TOC item if no other items are highlighted
            self.element.find(itemClass).first().addClass(self.focusClass);

          }

        }

        return self;

      },

      // _nestElements
      // -------------
      //      Helps create the table of contents list by appending nested list items
      _nestElements: function(self, index) {

        var arr, item, hashValue;

        arr = $.grep(this.items, function(item) {

          return item === self.text();

        });

        // If there is already a duplicate TOC item
        if (arr.length) {

          // Adds the current TOC item text and index (for slight randomization) to the internal array
          this.items.push(self.text() + index);

        }

        // If there not a duplicate TOC item
        else {

          // Adds the current TOC item text to the internal array
          this.items.push(self.text());

        }

        hashValue = this._generateHashValue(arr, self, index);

        // Appends a list item HTML element to the last unordered list HTML element found within the HTML element calling the plugin
        item = $("<li/>", {

          // Sets a common class name to the list item
          "class": itemClassName,

          "data-unique": hashValue

        });

        if (this.options.theme !== "bootstrap3") {

          item.append($("<a/>", {

            "text": self.text()

          }));

        } else {

          item.text(self.text());

        }

        // Adds an HTML anchor tag before the currently traversed HTML element
        self.before($("<div/>", {

          // Sets a name attribute on the anchor tag to the text of the currently traversed HTML element (also making sure that all whitespace is replaced with an underscore)
          "name": hashValue,

          "data-unique": hashValue

        }));

        return item;

      },

      // _generateHashValue
      // ------------------
      //      Generates the hash value that will be used to refer to each item.
      _generateHashValue: function(arr, self, index) {

        var hashValue = "",
          hashGeneratorOption = this.options.hashGenerator;

        if (hashGeneratorOption === "pretty") {

          // prettify the text
          hashValue = self.text().toLowerCase().replace(/\s/g, "-");

          // fix double hyphens
          while (hashValue.indexOf("--") > -1) {
            hashValue = hashValue.replace(/--/g, "-");
          }

          // fix colon-space instances
          while (hashValue.indexOf(":-") > -1) {
            hashValue = hashValue.replace(/:-/g, "-");
          }

        } else if (typeof hashGeneratorOption === "function") {

          // call the function
          hashValue = hashGeneratorOption(self.text(), self);

        } else {

          // compact - the default
          hashValue = self.text().replace(/\s/g, "");

        }

        // add the index if we need to
        if (arr.length) {
          hashValue += "" + index;
        }

        // return the value
        return hashValue;

      },

      // _appendElements
      // ---------------
      //      Helps create the table of contents list by appending subheader elements

      _appendSubheaders: function(self, ul) {

        // The current element index
        var index = $(this).index(self.options.selectors),

          // Finds the previous header DOM element
          previousHeader = $(self.options.selectors).eq(index - 1),

          currentTagName = +$(this).prop("tagName").charAt(1),

          previousTagName = +previousHeader.prop("tagName").charAt(1),

          lastSubheader;

        // If the current header DOM element is smaller than the previous header DOM element or the first subheader
        if (currentTagName < previousTagName) {

          // Selects the last unordered list HTML found within the HTML element calling the plugin
          self.element.find(subheaderClass + "[data-tag=" + currentTagName + "]").last().append(self._nestElements($(this), index));

        }

        // If the current header DOM element is the same type of header(eg. h4) as the previous header DOM element
        else if (currentTagName === previousTagName) {

          ul.find(itemClass).last().after(self._nestElements($(this), index));

        } else {

          // Selects the last unordered list HTML found within the HTML element calling the plugin
          ul.find(itemClass).last().

          // Appends an unorderedList HTML element to the dynamic `unorderedList` variable and sets a common class name
          after($("<ul/>", {

            "class": subheaderClassName,

            "data-tag": currentTagName

          })).next(subheaderClass).

          // Appends a list item HTML element to the last unordered list HTML element found within the HTML element calling the plugin
          append(self._nestElements($(this), index));
        }

      },

      // _setEventHandlers
      // ----------------
      //      Adds jQuery event handlers to the newly generated table of contents
      _setEventHandlers: function() {

        // _Local variables_

        // Stores the plugin context in the self variable
        var self = this,

          // Instantiates a new variable that will be used to hold a specific element's context
          $self,

          // Instantiates a new variable that will be used to determine the smoothScroll animation time duration
          duration;

        // Event delegation that looks for any clicks on list item elements inside of the HTML element calling the plugin
        this.element.on("click.tocify", "li", function(event) {

          if (self.options.history) {

            window.location.hash = $(this).attr("data-unique");

          }

          // Removes highlighting from all of the list item's
          self.element.find("." + self.focusClass).removeClass(self.focusClass);

          // Highlights the current list item that was clicked
          $(this).addClass(self.focusClass);

          // If the showAndHide option is true
          if (self.options.showAndHide) {

            var elem = $('li[data-unique="' + $(this).attr("data-unique") + '"]');

            self._triggerShow(elem);

          }

          self._scrollTo($(this));

        });

        // Mouseenter and Mouseleave event handlers for the list item's within the HTML element calling the plugin
        this.element.find("li").on({

          // Mouseenter event handler
          "mouseenter.tocify": function() {

            // Adds a hover CSS class to the current list item
            $(this).addClass(self.hoverClass);

            // Makes sure the cursor is set to the pointer icon
            $(this).css("cursor", "pointer");

          },

          // Mouseleave event handler
          "mouseleave.tocify": function() {

            if (self.options.theme !== "bootstrap") {

              // Removes the hover CSS class from the current list item
              $(this).removeClass(self.hoverClass);

            }

          }
        });

        // only attach handler if needed (expensive in IE)
        if (self.options.extendPage || self.options.highlightOnScroll || self.options.scrollHistory || self.options.showAndHideOnScroll) {
          // Window scroll event handler
          $(window).on("scroll.tocify", function() {

            // Once all animations on the page are complete, this callback function will be called
            $("html, body").promise().done(function() {

              // Local variables

              // Stores how far the user has scrolled
              var winScrollTop = $(window).scrollTop(),

                // Stores the height of the window
                winHeight = $(window).height(),

                // Stores the height of the document
                docHeight = $(document).height(),

                scrollHeight = $("body")[0].scrollHeight,

                // Instantiates a variable that will be used to hold a selected HTML element
                elem,

                lastElem,

                lastElemOffset,

                currentElem;

              if (self.options.extendPage) {

                // If the user has scrolled to the bottom of the page and the last toc item is not focused
                if ((self.webkit && winScrollTop >= scrollHeight - winHeight - self.options.extendPageOffset) || (!self.webkit && winHeight + winScrollTop > docHeight - self.options.extendPageOffset)) {

                  if (!$(extendPageClass).length) {

                    lastElem = $('div[data-unique="' + $(itemClass).last().attr("data-unique") + '"]');

                    if (!lastElem.length) return;

                    // Gets the top offset of the page header that is linked to the last toc item
                    lastElemOffset = lastElem.offset().top;

                    // Appends a div to the bottom of the page and sets the height to the difference of the window scrollTop and the last element's position top offset
                    $(self.options.context).append($("<div/>", {

                      "class": extendPageClassName,

                      "height": Math.abs(lastElemOffset - winScrollTop) + "px",

                      "data-unique": extendPageClassName

                    }));

                    if (self.extendPageScroll) {

                      currentElem = self.element.find('li.' + self.focusClass);

                      self._scrollTo($('div[data-unique="' + currentElem.attr("data-unique") + '"]'));

                    }

                  }

                }

              }

              // The zero timeout ensures the following code is run after the scroll events
              setTimeout(function() {

                // _Local variables_

                // Stores the distance to the closest anchor
                var closestAnchorDistance = null,

                  // Stores the index of the closest anchor
                  closestAnchorIdx = null,

                  // Keeps a reference to all anchors
                  anchors = $(self.options.context).find("div[data-unique]"),

                  anchorText;

                // Determines the index of the closest anchor
                anchors.each(function(idx) {
                  var distance = Math.abs(($(this).next().length ? $(this).next() : $(this)).offset().top - winScrollTop - self.options.highlightOffset);
                  if (closestAnchorDistance == null || distance < closestAnchorDistance) {
                    closestAnchorDistance = distance;
                    closestAnchorIdx = idx;
                  } else {
                    return false;
                  }
                });

                anchorText = $(anchors[closestAnchorIdx]).attr("data-unique");

                // Stores the list item HTML element that corresponds to the currently traversed anchor tag
                elem = $('li[data-unique="' + anchorText + '"]');

                // If the `highlightOnScroll` option is true and a next element is found
                if (self.options.highlightOnScroll && elem.length) {

                  // Removes highlighting from all of the list item's
                  self.element.find("." + self.focusClass).removeClass(self.focusClass);

                  // Highlights the corresponding list item
                  elem.addClass(self.focusClass);

                }

                if (self.options.scrollHistory) {

                  if (window.location.hash !== "#" + anchorText) {

                    window.location.replace("#" + anchorText);

                  }
                }

                // If the `showAndHideOnScroll` option is true
                if (self.options.showAndHideOnScroll && self.options.showAndHide) {

                  self._triggerShow(elem, true);

                }

              }, 0);

            });

          });
        }

      },

      // Show
      // ----
      //      Opens the current sub-header
      show: function(elem, scroll) {

        // Stores the plugin context in the `self` variable
        var self = this,
          element = elem;

        // If the sub-header is not already visible
        if (!elem.is(":visible")) {

          // If the current element does not have any nested subheaders, is not a header, and its parent is not visible
          if (!elem.find(subheaderClass).length && !elem.parent().is(headerClass) && !elem.parent().is(":visible")) {

            // Sets the current element to all of the subheaders within the current header
            elem = elem.parents(subheaderClass).add(elem);

          }

          // If the current element does not have any nested subheaders and is not a header
          else if (!elem.children(subheaderClass).length && !elem.parent().is(headerClass)) {

            // Sets the current element to the closest subheader
            elem = elem.closest(subheaderClass);

          }

          //Determines what jQuery effect to use
          switch (self.options.showEffect) {

            //Uses `no effect`
            case "none":

              elem.show();

              break;

              //Uses the jQuery `show` special effect
            case "show":

              elem.show(self.options.showEffectSpeed);

              break;

              //Uses the jQuery `slideDown` special effect
            case "slideDown":

              elem.slideDown(self.options.showEffectSpeed);

              break;

              //Uses the jQuery `fadeIn` special effect
            case "fadeIn":

              elem.fadeIn(self.options.showEffectSpeed);

              break;

              //If none of the above options were passed, then a `jQueryUI show effect` is expected
            default:

              elem.show();

              break;

          }

        }

        // If the current subheader parent element is a header
        if (elem.parent().is(headerClass)) {

          // Hides all non-active sub-headers
          self.hide($(subheaderClass).not(elem));

        }

        // If the current subheader parent element is not a header
        else {

          // Hides all non-active sub-headers
          self.hide($(subheaderClass).not(elem.closest(headerClass).find(subheaderClass).not(elem.siblings())));

        }

        // Maintains chainablity
        return self;

      },

      // Hide
      // ----
      //      Closes the current sub-header
      hide: function(elem) {

        // Stores the plugin context in the `self` variable
        var self = this;

        //Determines what jQuery effect to use
        switch (self.options.hideEffect) {

          // Uses `no effect`
          case "none":

            elem.hide();

            break;

            // Uses the jQuery `hide` special effect
          case "hide":

            elem.hide(self.options.hideEffectSpeed);

            break;

            // Uses the jQuery `slideUp` special effect
          case "slideUp":

            elem.slideUp(self.options.hideEffectSpeed);

            break;

            // Uses the jQuery `fadeOut` special effect
          case "fadeOut":

            elem.fadeOut(self.options.hideEffectSpeed);

            break;

            // If none of the above options were passed, then a `jqueryUI hide effect` is expected
          default:

            elem.hide();

            break;

        }

        // Maintains chainablity
        return self;
      },

      // _triggerShow
      // ------------
      //      Determines what elements get shown on scroll and click
      _triggerShow: function(elem, scroll) {

        var self = this;

        // If the current element's parent is a header element or the next element is a nested subheader element
        if (elem.parent().is(headerClass) || elem.next().is(subheaderClass)) {

          // Shows the next sub-header element
          self.show(elem.next(subheaderClass), scroll);

        }

        // If the current element's parent is a subheader element
        else if (elem.parent().is(subheaderClass)) {

          // Shows the parent sub-header element
          self.show(elem.parent(), scroll);

        }

        // Maintains chainability
        return self;

      },

      // _addCSSClasses
      // --------------
      //      Adds CSS classes to the newly generated table of contents HTML
      _addCSSClasses: function() {

        // If the user wants a jqueryUI theme
        if (this.options.theme === "jqueryui") {

          this.focusClass = "ui-state-default";

          this.hoverClass = "ui-state-hover";

          //Adds the default styling to the dropdown list
          this.element.addClass("ui-widget").find(".toc-title").addClass("ui-widget-header").end().find("li").addClass("ui-widget-content");

        }

        // If the user wants a twitterBootstrap theme
        else if (this.options.theme === "bootstrap") {

          this.element.find(headerClass + "," + subheaderClass).addClass("nav nav-list");

          this.focusClass = "active";

        }

        // If the user wants a twitterBootstrap theme
        else if (this.options.theme === "bootstrap3") {

          this.element.find(headerClass + "," + subheaderClass).addClass("list-group");

          this.element.find(itemClass).addClass("list-group-item");

          this.focusClass = "active";

        }

        // If a user does not want a prebuilt theme
        else {

          // Adds more neutral classes (instead of jqueryui)

          this.focusClass = tocFocusClassName;

          this.hoverClass = tocHoverClassName;

        }

        //Maintains chainability
        return this;

      },

      // setOption
      // ---------
      //      Sets a single Tocify option after the plugin is invoked
      setOption: function() {

        // Calls the jQueryUI Widget Factory setOption method
        $.Widget.prototype._setOption.apply(this, arguments);

      },

      // setOptions
      // ----------
      //      Sets a single or multiple Tocify options after the plugin is invoked
      setOptions: function() {

        // Calls the jQueryUI Widget Factory setOptions method
        $.Widget.prototype._setOptions.apply(this, arguments);

      },

      // _scrollTo
      // ---------
      //      Scrolls to a specific element
      _scrollTo: function(elem) {

        var self = this,
          duration = self.options.smoothScroll || 0,
          scrollTo = self.options.scrollTo,
          currentDiv = $('div[data-unique="' + elem.attr("data-unique") + '"]');

        if (!currentDiv.length) {

          return self;

        }

        // Once all animations on the page are complete, this callback function will be called
        $("html, body").promise().done(function() {

          // Animates the html and body element scrolltops
          $("html, body").animate({

            // Sets the jQuery `scrollTop` to the top offset of the HTML div tag that matches the current list item's `data-unique` tag
            "scrollTop": currentDiv.offset().top - ($.isFunction(scrollTo) ? scrollTo.call() : scrollTo) + "px"

          }, {

            // Sets the smoothScroll animation time duration to the smoothScrollSpeed option
            "duration": duration

          });

        });

        // Maintains chainability
        return self;

      }

    });

  })); //end of plugin
</script>
<script>

/**
 * jQuery Plugin: Sticky Tabs
 *
 * @author Aidan Lister <aidan@php.net>
 * adapted by Ruben Arslan to activate parent tabs too
 * http://www.aidanlister.com/2014/03/persisting-the-tab-state-in-bootstrap/
 */
(function($) {
  "use strict";
  $.fn.rmarkdownStickyTabs = function() {
    var context = this;
    // Show the tab corresponding with the hash in the URL, or the first tab
    var showStuffFromHash = function() {
      var hash = window.location.hash;
      var selector = hash ? 'a[href="' + hash + '"]' : 'li.active > a';
      var $selector = $(selector, context);
      if($selector.data('toggle') === "tab") {
        $selector.tab('show');
        // walk up the ancestors of this element, show any hidden tabs
        $selector.parents('.section.tabset').each(function(i, elm) {
          var link = $('a[href="#' + $(elm).attr('id') + '"]');
          if(link.data('toggle') === "tab") {
            link.tab("show");
          }
        });
      }
    };


    // Set the correct tab when the page loads
    showStuffFromHash(context);

    // Set the correct tab when a user uses their back/forward button
    $(window).on('hashchange', function() {
      showStuffFromHash(context);
    });

    // Change the URL when tabs are clicked
    $('a', context).on('click', function(e) {
      history.pushState(null, null, this.href);
      showStuffFromHash(context);
    });

    return this;
  };
}(jQuery));

window.buildTabsets = function(tocID) {

  // build a tabset from a section div with the .tabset class
  function buildTabset(tabset) {

    // check for fade and pills options
    var fade = tabset.hasClass("tabset-fade");
    var pills = tabset.hasClass("tabset-pills");
    var navClass = pills ? "nav-pills" : "nav-tabs";

    // determine the heading level of the tabset and tabs
    var match = tabset.attr('class').match(/level(\d) /);
    if (match === null)
      return;
    var tabsetLevel = Number(match[1]);
    var tabLevel = tabsetLevel + 1;

    // find all subheadings immediately below
    var tabs = tabset.find("div.section.level" + tabLevel);
    if (!tabs.length)
      return;

    // create tablist and tab-content elements
    var tabList = $('<ul class="nav ' + navClass + '" role="tablist"></ul>');
    $(tabs[0]).before(tabList);
    var tabContent = $('<div class="tab-content"></div>');
    $(tabs[0]).before(tabContent);

    // build the tabset
    var activeTab = 0;
    tabs.each(function(i) {

      // get the tab div
      var tab = $(tabs[i]);

      // get the id then sanitize it for use with bootstrap tabs
      var id = tab.attr('id');

      // see if this is marked as the active tab
      if (tab.hasClass('active'))
        activeTab = i;

      // remove any table of contents entries associated with
      // this ID (since we'll be removing the heading element)
      $("div#" + tocID + " li a[href='#" + id + "']").parent().remove();

      // sanitize the id for use with bootstrap tabs
      id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
      tab.attr('id', id);

      // get the heading element within it, grab it's text, then remove it
      var heading = tab.find('h' + tabLevel + ':first');
      var headingText = heading.html();
      heading.remove();

      // build and append the tab list item
      var a = $('<a role="tab" data-toggle="tab">' + headingText + '</a>');
      a.attr('href', '#' + id);
      a.attr('aria-controls', id);
      var li = $('<li role="presentation"></li>');
      li.append(a);
      tabList.append(li);

      // set it's attributes
      tab.attr('role', 'tabpanel');
      tab.addClass('tab-pane');
      tab.addClass('tabbed-pane');
      if (fade)
        tab.addClass('fade');

      // move it into the tab content div
      tab.detach().appendTo(tabContent);
    });

    // set active tab
    $(tabList.children('li')[activeTab]).addClass('active');
    var active = $(tabContent.children('div.section')[activeTab]);
    active.addClass('active');
    if (fade)
      active.addClass('in');

    if (tabset.hasClass("tabset-sticky"))
      tabset.rmarkdownStickyTabs();
  }

  // convert section divs with the .tabset class to tabsets
  var tabsets = $("div.section.tabset");
  tabsets.each(function(i) {
    buildTabset($(tabsets[i]));
  });
};

</script>
<script>
window.initializeCodeFolding = function(show) {

  // handlers for show-all and hide all
  $("#rmd-show-all-code").click(function() {
    $('div.r-code-collapse').each(function() {
      $(this).collapse('show');
    });
  });
  $("#rmd-hide-all-code").click(function() {
    $('div.r-code-collapse').each(function() {
      $(this).collapse('hide');
    });
  });

  // index for unique code element ids
  var currentIndex = 1;

  // select all R code blocks
  var rCodeBlocks = $('pre.r, pre.python, pre.bash, pre.sql, pre.cpp, pre.stan, pre.julia');
  rCodeBlocks.each(function() {

    // create a collapsable div to wrap the code in
    var div = $('<div class="collapse r-code-collapse"></div>');
    if (show)
      div.addClass('in');
    var id = 'rcode-643E0F36' + currentIndex++;
    div.attr('id', id);
    $(this).before(div);
    $(this).detach().appendTo(div);

    // add a show code button right above
    var showCodeText = $('<span>' + (show ? 'Hide' : 'Code') + '</span>');
    var showCodeButton = $('<button type="button" class="btn btn-default btn-xs code-folding-btn pull-right"></button>');
    showCodeButton.append(showCodeText);
    showCodeButton
        .attr('data-toggle', 'collapse')
        .attr('data-target', '#' + id)
        .attr('aria-expanded', show)
        .attr('aria-controls', id);

    var buttonRow = $('<div class="row"></div>');
    var buttonCol = $('<div class="col-md-12"></div>');

    buttonCol.append(showCodeButton);
    buttonRow.append(buttonCol);

    div.before(buttonRow);

    // update state of button on show/hide
    div.on('hidden.bs.collapse', function () {
      showCodeText.text('Code');
    });
    div.on('show.bs.collapse', function () {
      showCodeText.text('Hide');
    });
  });

}
</script>
<script>
window.initializeSourceEmbed = function(filename) {
  $("#rmd-download-source").click(function() {
    var src = $("#rmd-source-code").html();
    var a = document.createElement('a');
    a.href = "data:text/x-r-markdown;base64," + src;
    a.download = filename;
    document.body.appendChild(a);
    a.click();
    document.body.removeChild(a);
  });
};
</script>
<style type="text/css">.hljs-literal {
color: rgb(88, 72, 246);
}
.hljs-number {
color: rgb(0, 0, 205);
}
.hljs-comment {
color: rgb(76, 136, 107);
}
.hljs-keyword {
color: rgb(0, 0, 255);
}
.hljs-string {
color: rgb(3, 106, 7);
}
</style>
<script src="data:application/javascript;base64,/*! highlight.js v9.12.0 | BSD3 License | git.io/hljslicense */
!function(e){var n="object"==typeof window&&window||"object"==typeof self&&self;"undefined"!=typeof exports?e(exports):n&&(n.hljs=e({}),"function"==typeof define&&define.amd&&define([],function(){return n.hljs}))}(function(e){function n(e){return e.replace(/&/g,"&amp;").replace(/</g,"&lt;").replace(/>/g,"&gt;")}function t(e){return e.nodeName.toLowerCase()}function r(e,n){var t=e&&e.exec(n);return t&&0===t.index}function a(e){return k.test(e)}function i(e){var n,t,r,i,o=e.className+" ";if(o+=e.parentNode?e.parentNode.className:"",t=B.exec(o))return w(t[1])?t[1]:"no-highlight";for(o=o.split(/\s+/),n=0,r=o.length;r>n;n++)if(i=o[n],a(i)||w(i))return i}function o(e){var n,t={},r=Array.prototype.slice.call(arguments,1);for(n in e)t[n]=e[n];return r.forEach(function(e){for(n in e)t[n]=e[n]}),t}function u(e){var n=[];return function r(e,a){for(var i=e.firstChild;i;i=i.nextSibling)3===i.nodeType?a+=i.nodeValue.length:1===i.nodeType&&(n.push({event:"start",offset:a,node:i}),a=r(i,a),t(i).match(/br|hr|img|input/)||n.push({event:"stop",offset:a,node:i}));return a}(e,0),n}function c(e,r,a){function i(){return e.length&&r.length?e[0].offset!==r[0].offset?e[0].offset<r[0].offset?e:r:"start"===r[0].event?e:r:e.length?e:r}function o(e){function r(e){return" "+e.nodeName+'="'+n(e.value).replace('"',"&quot;")+'"'}s+="<"+t(e)+E.map.call(e.attributes,r).join("")+">"}function u(e){s+="</"+t(e)+">"}function c(e){("start"===e.event?o:u)(e.node)}for(var l=0,s="",f=[];e.length||r.length;){var g=i();if(s+=n(a.substring(l,g[0].offset)),l=g[0].offset,g===e){f.reverse().forEach(u);do c(g.splice(0,1)[0]),g=i();while(g===e&&g.length&&g[0].offset===l);f.reverse().forEach(o)}else"start"===g[0].event?f.push(g[0].node):f.pop(),c(g.splice(0,1)[0])}return s+n(a.substr(l))}function l(e){return e.v&&!e.cached_variants&&(e.cached_variants=e.v.map(function(n){return o(e,{v:null},n)})),e.cached_variants||e.eW&&[o(e)]||[e]}function s(e){function n(e){return e&&e.source||e}function t(t,r){return new RegExp(n(t),"m"+(e.cI?"i":"")+(r?"g":""))}function r(a,i){if(!a.compiled){if(a.compiled=!0,a.k=a.k||a.bK,a.k){var o={},u=function(n,t){e.cI&&(t=t.toLowerCase()),t.split(" ").forEach(function(e){var t=e.split("|");o[t[0]]=[n,t[1]?Number(t[1]):1]})};"string"==typeof a.k?u("keyword",a.k):x(a.k).forEach(function(e){u(e,a.k[e])}),a.k=o}a.lR=t(a.l||/\w+/,!0),i&&(a.bK&&(a.b="\\b("+a.bK.split(" ").join("|")+")\\b"),a.b||(a.b=/\B|\b/),a.bR=t(a.b),a.e||a.eW||(a.e=/\B|\b/),a.e&&(a.eR=t(a.e)),a.tE=n(a.e)||"",a.eW&&i.tE&&(a.tE+=(a.e?"|":"")+i.tE)),a.i&&(a.iR=t(a.i)),null==a.r&&(a.r=1),a.c||(a.c=[]),a.c=Array.prototype.concat.apply([],a.c.map(function(e){return l("self"===e?a:e)})),a.c.forEach(function(e){r(e,a)}),a.starts&&r(a.starts,i);var c=a.c.map(function(e){return e.bK?"\\.?("+e.b+")\\.?":e.b}).concat([a.tE,a.i]).map(n).filter(Boolean);a.t=c.length?t(c.join("|"),!0):{exec:function(){return null}}}}r(e)}function f(e,t,a,i){function o(e,n){var t,a;for(t=0,a=n.c.length;a>t;t++)if(r(n.c[t].bR,e))return n.c[t]}function u(e,n){if(r(e.eR,n)){for(;e.endsParent&&e.parent;)e=e.parent;return e}return e.eW?u(e.parent,n):void 0}function c(e,n){return!a&&r(n.iR,e)}function l(e,n){var t=N.cI?n[0].toLowerCase():n[0];return e.k.hasOwnProperty(t)&&e.k[t]}function p(e,n,t,r){var a=r?"":I.classPrefix,i='<span class="'+a,o=t?"":C;return i+=e+'">',i+n+o}function h(){var e,t,r,a;if(!E.k)return n(k);for(a="",t=0,E.lR.lastIndex=0,r=E.lR.exec(k);r;)a+=n(k.substring(t,r.index)),e=l(E,r),e?(B+=e[1],a+=p(e[0],n(r[0]))):a+=n(r[0]),t=E.lR.lastIndex,r=E.lR.exec(k);return a+n(k.substr(t))}function d(){var e="string"==typeof E.sL;if(e&&!y[E.sL])return n(k);var t=e?f(E.sL,k,!0,x[E.sL]):g(k,E.sL.length?E.sL:void 0);return E.r>0&&(B+=t.r),e&&(x[E.sL]=t.top),p(t.language,t.value,!1,!0)}function b(){L+=null!=E.sL?d():h(),k=""}function v(e){L+=e.cN?p(e.cN,"",!0):"",E=Object.create(e,{parent:{value:E}})}function m(e,n){if(k+=e,null==n)return b(),0;var t=o(n,E);if(t)return t.skip?k+=n:(t.eB&&(k+=n),b(),t.rB||t.eB||(k=n)),v(t,n),t.rB?0:n.length;var r=u(E,n);if(r){var a=E;a.skip?k+=n:(a.rE||a.eE||(k+=n),b(),a.eE&&(k=n));do E.cN&&(L+=C),E.skip||(B+=E.r),E=E.parent;while(E!==r.parent);return r.starts&&v(r.starts,""),a.rE?0:n.length}if(c(n,E))throw new Error('Illegal lexeme "'+n+'" for mode "'+(E.cN||"<unnamed>")+'"');return k+=n,n.length||1}var N=w(e);if(!N)throw new Error('Unknown language: "'+e+'"');s(N);var R,E=i||N,x={},L="";for(R=E;R!==N;R=R.parent)R.cN&&(L=p(R.cN,"",!0)+L);var k="",B=0;try{for(var M,j,O=0;;){if(E.t.lastIndex=O,M=E.t.exec(t),!M)break;j=m(t.substring(O,M.index),M[0]),O=M.index+j}for(m(t.substr(O)),R=E;R.parent;R=R.parent)R.cN&&(L+=C);return{r:B,value:L,language:e,top:E}}catch(T){if(T.message&&-1!==T.message.indexOf("Illegal"))return{r:0,value:n(t)};throw T}}function g(e,t){t=t||I.languages||x(y);var r={r:0,value:n(e)},a=r;return t.filter(w).forEach(function(n){var t=f(n,e,!1);t.language=n,t.r>a.r&&(a=t),t.r>r.r&&(a=r,r=t)}),a.language&&(r.second_best=a),r}function p(e){return I.tabReplace||I.useBR?e.replace(M,function(e,n){return I.useBR&&"\n"===e?"<br>":I.tabReplace?n.replace(/\t/g,I.tabReplace):""}):e}function h(e,n,t){var r=n?L[n]:t,a=[e.trim()];return e.match(/\bhljs\b/)||a.push("hljs"),-1===e.indexOf(r)&&a.push(r),a.join(" ").trim()}function d(e){var n,t,r,o,l,s=i(e);a(s)||(I.useBR?(n=document.createElementNS("http://www.w3.org/1999/xhtml","div"),n.innerHTML=e.innerHTML.replace(/\n/g,"").replace(/<br[ \/]*>/g,"\n")):n=e,l=n.textContent,r=s?f(s,l,!0):g(l),t=u(n),t.length&&(o=document.createElementNS("http://www.w3.org/1999/xhtml","div"),o.innerHTML=r.value,r.value=c(t,u(o),l)),r.value=p(r.value),e.innerHTML=r.value,e.className=h(e.className,s,r.language),e.result={language:r.language,re:r.r},r.second_best&&(e.second_best={language:r.second_best.language,re:r.second_best.r}))}function b(e){I=o(I,e)}function v(){if(!v.called){v.called=!0;var e=document.querySelectorAll("pre code");E.forEach.call(e,d)}}function m(){addEventListener("DOMContentLoaded",v,!1),addEventListener("load",v,!1)}function N(n,t){var r=y[n]=t(e);r.aliases&&r.aliases.forEach(function(e){L[e]=n})}function R(){return x(y)}function w(e){return e=(e||"").toLowerCase(),y[e]||y[L[e]]}var E=[],x=Object.keys,y={},L={},k=/^(no-?highlight|plain|text)$/i,B=/\blang(?:uage)?-([\w-]+)\b/i,M=/((^(<[^>]+>|\t|)+|(?:\n)))/gm,C="</span>",I={classPrefix:"hljs-",tabReplace:null,useBR:!1,languages:void 0};return e.highlight=f,e.highlightAuto=g,e.fixMarkup=p,e.highlightBlock=d,e.configure=b,e.initHighlighting=v,e.initHighlightingOnLoad=m,e.registerLanguage=N,e.listLanguages=R,e.getLanguage=w,e.inherit=o,e.IR="[a-zA-Z]\\w*",e.UIR="[a-zA-Z_]\\w*",e.NR="\\b\\d+(\\.\\d+)?",e.CNR="(-?)(\\b0[xX][a-fA-F0-9]+|(\\b\\d+(\\.\\d*)?|\\.\\d+)([eE][-+]?\\d+)?)",e.BNR="\\b(0b[01]+)",e.RSR="!|!=|!==|%|%=|&|&&|&=|\\*|\\*=|\\+|\\+=|,|-|-=|/=|/|:|;|<<|<<=|<=|<|===|==|=|>>>=|>>=|>=|>>>|>>|>|\\?|\\[|\\{|\\(|\\^|\\^=|\\||\\|=|\\|\\||~",e.BE={b:"\\\\[\\s\\S]",r:0},e.ASM={cN:"string",b:"'",e:"'",i:"\\n",c:[e.BE]},e.QSM={cN:"string",b:'"',e:'"',i:"\\n",c:[e.BE]},e.PWM={b:/\b(a|an|the|are|I'm|isn't|don't|doesn't|won't|but|just|should|pretty|simply|enough|gonna|going|wtf|so|such|will|you|your|they|like|more)\b/},e.C=function(n,t,r){var a=e.inherit({cN:"comment",b:n,e:t,c:[]},r||{});return a.c.push(e.PWM),a.c.push({cN:"doctag",b:"(?:TODO|FIXME|NOTE|BUG|XXX):",r:0}),a},e.CLCM=e.C("//","$"),e.CBCM=e.C("/\\*","\\*/"),e.HCM=e.C("#","$"),e.NM={cN:"number",b:e.NR,r:0},e.CNM={cN:"number",b:e.CNR,r:0},e.BNM={cN:"number",b:e.BNR,r:0},e.CSSNM={cN:"number",b:e.NR+"(%|em|ex|ch|rem|vw|vh|vmin|vmax|cm|mm|in|pt|pc|px|deg|grad|rad|turn|s|ms|Hz|kHz|dpi|dpcm|dppx)?",r:0},e.RM={cN:"regexp",b:/\//,e:/\/[gimuy]*/,i:/\n/,c:[e.BE,{b:/\[/,e:/\]/,r:0,c:[e.BE]}]},e.TM={cN:"title",b:e.IR,r:0},e.UTM={cN:"title",b:e.UIR,r:0},e.METHOD_GUARD={b:"\\.\\s*"+e.UIR,r:0},e});hljs.registerLanguage("sql",function(e){var t=e.C("--","$");return{cI:!0,i:/[<>{}*#]/,c:[{bK:"begin end start commit rollback savepoint lock alter create drop rename call delete do handler insert load replace select truncate update set show pragma grant merge describe use explain help declare prepare execute deallocate release unlock purge reset change stop analyze cache flush optimize repair kill install uninstall checksum restore check backup revoke comment",e:/;/,eW:!0,l:/[\w\.]+/,k:{keyword:"abort abs absolute acc acce accep accept access accessed accessible account acos action activate add addtime admin administer advanced advise aes_decrypt aes_encrypt after agent aggregate ali alia alias allocate allow alter always analyze ancillary and any anydata anydataset anyschema anytype apply archive archived archivelog are as asc ascii asin assembly assertion associate asynchronous at atan atn2 attr attri attrib attribu attribut attribute attributes audit authenticated authentication authid authors auto autoallocate autodblink autoextend automatic availability avg backup badfile basicfile before begin beginning benchmark between bfile bfile_base big bigfile bin binary_double binary_float binlog bit_and bit_count bit_length bit_or bit_xor bitmap blob_base block blocksize body both bound buffer_cache buffer_pool build bulk by byte byteordermark bytes cache caching call calling cancel capacity cascade cascaded case cast catalog category ceil ceiling chain change changed char_base char_length character_length characters characterset charindex charset charsetform charsetid check checksum checksum_agg child choose chr chunk class cleanup clear client clob clob_base clone close cluster_id cluster_probability cluster_set clustering coalesce coercibility col collate collation collect colu colum column column_value columns columns_updated comment commit compact compatibility compiled complete composite_limit compound compress compute concat concat_ws concurrent confirm conn connec connect connect_by_iscycle connect_by_isleaf connect_by_root connect_time connection consider consistent constant constraint constraints constructor container content contents context contributors controlfile conv convert convert_tz corr corr_k corr_s corresponding corruption cos cost count count_big counted covar_pop covar_samp cpu_per_call cpu_per_session crc32 create creation critical cross cube cume_dist curdate current current_date current_time current_timestamp current_user cursor curtime customdatum cycle data database databases datafile datafiles datalength date_add date_cache date_format date_sub dateadd datediff datefromparts datename datepart datetime2fromparts day day_to_second dayname dayofmonth dayofweek dayofyear days db_role_change dbtimezone ddl deallocate declare decode decompose decrement decrypt deduplicate def defa defau defaul default defaults deferred defi defin define degrees delayed delegate delete delete_all delimited demand dense_rank depth dequeue des_decrypt des_encrypt des_key_file desc descr descri describ describe descriptor deterministic diagnostics difference dimension direct_load directory disable disable_all disallow disassociate discardfile disconnect diskgroup distinct distinctrow distribute distributed div do document domain dotnet double downgrade drop dumpfile duplicate duration each edition editionable editions element ellipsis else elsif elt empty enable enable_all enclosed encode encoding encrypt end end-exec endian enforced engine engines enqueue enterprise entityescaping eomonth error errors escaped evalname evaluate event eventdata events except exception exceptions exchange exclude excluding execu execut execute exempt exists exit exp expire explain export export_set extended extent external external_1 external_2 externally extract failed failed_login_attempts failover failure far fast feature_set feature_value fetch field fields file file_name_convert filesystem_like_logging final finish first first_value fixed flash_cache flashback floor flush following follows for forall force form forma format found found_rows freelist freelists freepools fresh from from_base64 from_days ftp full function general generated get get_format get_lock getdate getutcdate global global_name globally go goto grant grants greatest group group_concat group_id grouping grouping_id groups gtid_subtract guarantee guard handler hash hashkeys having hea head headi headin heading heap help hex hierarchy high high_priority hosts hour http id ident_current ident_incr ident_seed identified identity idle_time if ifnull ignore iif ilike ilm immediate import in include including increment index indexes indexing indextype indicator indices inet6_aton inet6_ntoa inet_aton inet_ntoa infile initial initialized initially initrans inmemory inner innodb input insert install instance instantiable instr interface interleaved intersect into invalidate invisible is is_free_lock is_ipv4 is_ipv4_compat is_not is_not_null is_used_lock isdate isnull isolation iterate java join json json_exists keep keep_duplicates key keys kill language large last last_day last_insert_id last_value lax lcase lead leading least leaves left len lenght length less level levels library like like2 like4 likec limit lines link list listagg little ln load load_file lob lobs local localtime localtimestamp locate locator lock locked log log10 log2 logfile logfiles logging logical logical_reads_per_call logoff logon logs long loop low low_priority lower lpad lrtrim ltrim main make_set makedate maketime managed management manual map mapping mask master master_pos_wait match matched materialized max maxextents maximize maxinstances maxlen maxlogfiles maxloghistory maxlogmembers maxsize maxtrans md5 measures median medium member memcompress memory merge microsecond mid migration min minextents minimum mining minus minute minvalue missing mod mode model modification modify module monitoring month months mount move movement multiset mutex name name_const names nan national native natural nav nchar nclob nested never new newline next nextval no no_write_to_binlog noarchivelog noaudit nobadfile nocheck nocompress nocopy nocycle nodelay nodiscardfile noentityescaping noguarantee nokeep nologfile nomapping nomaxvalue nominimize nominvalue nomonitoring none noneditionable nonschema noorder nopr nopro noprom nopromp noprompt norely noresetlogs noreverse normal norowdependencies noschemacheck noswitch not nothing notice notrim novalidate now nowait nth_value nullif nulls num numb numbe nvarchar nvarchar2 object ocicoll ocidate ocidatetime ociduration ociinterval ociloblocator ocinumber ociref ocirefcursor ocirowid ocistring ocitype oct octet_length of off offline offset oid oidindex old on online only opaque open operations operator optimal optimize option optionally or oracle oracle_date oradata ord ordaudio orddicom orddoc order ordimage ordinality ordvideo organization orlany orlvary out outer outfile outline output over overflow overriding package pad parallel parallel_enable parameters parent parse partial partition partitions pascal passing password password_grace_time password_lock_time password_reuse_max password_reuse_time password_verify_function patch path patindex pctincrease pctthreshold pctused pctversion percent percent_rank percentile_cont percentile_disc performance period period_add period_diff permanent physical pi pipe pipelined pivot pluggable plugin policy position post_transaction pow power pragma prebuilt precedes preceding precision prediction prediction_cost prediction_details prediction_probability prediction_set prepare present preserve prior priority private private_sga privileges procedural procedure procedure_analyze processlist profiles project prompt protection public publishingservername purge quarter query quick quiesce quota quotename radians raise rand range rank raw read reads readsize rebuild record records recover recovery recursive recycle redo reduced ref reference referenced references referencing refresh regexp_like register regr_avgx regr_avgy regr_count regr_intercept regr_r2 regr_slope regr_sxx regr_sxy reject rekey relational relative relaylog release release_lock relies_on relocate rely rem remainder rename repair repeat replace replicate replication required reset resetlogs resize resource respect restore restricted result result_cache resumable resume retention return returning returns reuse reverse revoke right rlike role roles rollback rolling rollup round row row_count rowdependencies rowid rownum rows rtrim rules safe salt sample save savepoint sb1 sb2 sb4 scan schema schemacheck scn scope scroll sdo_georaster sdo_topo_geometry search sec_to_time second section securefile security seed segment select self sequence sequential serializable server servererror session session_user sessions_per_user set sets settings sha sha1 sha2 share shared shared_pool short show shrink shutdown si_averagecolor si_colorhistogram si_featurelist si_positionalcolor si_stillimage si_texture siblings sid sign sin size size_t sizes skip slave sleep smalldatetimefromparts smallfile snapshot some soname sort soundex source space sparse spfile split sql sql_big_result sql_buffer_result sql_cache sql_calc_found_rows sql_small_result sql_variant_property sqlcode sqldata sqlerror sqlname sqlstate sqrt square standalone standby start starting startup statement static statistics stats_binomial_test stats_crosstab stats_ks_test stats_mode stats_mw_test stats_one_way_anova stats_t_test_ stats_t_test_indep stats_t_test_one stats_t_test_paired stats_wsr_test status std stddev stddev_pop stddev_samp stdev stop storage store stored str str_to_date straight_join strcmp strict string struct stuff style subdate subpartition subpartitions substitutable substr substring subtime subtring_index subtype success sum suspend switch switchoffset switchover sync synchronous synonym sys sys_xmlagg sysasm sysaux sysdate sysdatetimeoffset sysdba sysoper system system_user sysutcdatetime table tables tablespace tan tdo template temporary terminated tertiary_weights test than then thread through tier ties time time_format time_zone timediff timefromparts timeout timestamp timestampadd timestampdiff timezone_abbr timezone_minute timezone_region to to_base64 to_date to_days to_seconds todatetimeoffset trace tracking transaction transactional translate translation treat trigger trigger_nestlevel triggers trim truncate try_cast try_convert try_parse type ub1 ub2 ub4 ucase unarchived unbounded uncompress under undo unhex unicode uniform uninstall union unique unix_timestamp unknown unlimited unlock unpivot unrecoverable unsafe unsigned until untrusted unusable unused update updated upgrade upped upper upsert url urowid usable usage use use_stored_outlines user user_data user_resources users using utc_date utc_timestamp uuid uuid_short validate validate_password_strength validation valist value values var var_samp varcharc vari varia variab variabl variable variables variance varp varraw varrawc varray verify version versions view virtual visible void wait wallet warning warnings week weekday weekofyear wellformed when whene whenev wheneve whenever where while whitespace with within without work wrapped xdb xml xmlagg xmlattributes xmlcast xmlcolattval xmlelement xmlexists xmlforest xmlindex xmlnamespaces xmlpi xmlquery xmlroot xmlschema xmlserialize xmltable xmltype xor year year_to_month years yearweek",literal:"true false null",built_in:"array bigint binary bit blob boolean char character date dec decimal float int int8 integer interval number numeric real record serial serial8 smallint text varchar varying void"},c:[{cN:"string",b:"'",e:"'",c:[e.BE,{b:"''"}]},{cN:"string",b:'"',e:'"',c:[e.BE,{b:'""'}]},{cN:"string",b:"`",e:"`",c:[e.BE]},e.CNM,e.CBCM,t]},e.CBCM,t]}});hljs.registerLanguage("r",function(e){var r="([a-zA-Z]|\\.[a-zA-Z.])[a-zA-Z0-9._]*";return{c:[e.HCM,{b:r,l:r,k:{keyword:"function if in break next repeat else for return switch while try tryCatch stop warning require library attach detach source setMethod setGeneric setGroupGeneric setClass ...",literal:"NULL NA TRUE FALSE T F Inf NaN NA_integer_|10 NA_real_|10 NA_character_|10 NA_complex_|10"},r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"\\d+(?:[eE][+\\-]?\\d*)?L\\b",r:0},{cN:"number",b:"\\d+\\.(?!\\d)(?:i\\b)?",r:0},{cN:"number",b:"\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{b:"`",e:"`",r:0},{cN:"string",c:[e.BE],v:[{b:'"',e:'"'},{b:"'",e:"'"}]}]}});hljs.registerLanguage("perl",function(e){var t="getpwent getservent quotemeta msgrcv scalar kill dbmclose undef lc ma syswrite tr send umask sysopen shmwrite vec qx utime local oct semctl localtime readpipe do return format read sprintf dbmopen pop getpgrp not getpwnam rewinddir qqfileno qw endprotoent wait sethostent bless s|0 opendir continue each sleep endgrent shutdown dump chomp connect getsockname die socketpair close flock exists index shmgetsub for endpwent redo lstat msgctl setpgrp abs exit select print ref gethostbyaddr unshift fcntl syscall goto getnetbyaddr join gmtime symlink semget splice x|0 getpeername recv log setsockopt cos last reverse gethostbyname getgrnam study formline endhostent times chop length gethostent getnetent pack getprotoent getservbyname rand mkdir pos chmod y|0 substr endnetent printf next open msgsnd readdir use unlink getsockopt getpriority rindex wantarray hex system getservbyport endservent int chr untie rmdir prototype tell listen fork shmread ucfirst setprotoent else sysseek link getgrgid shmctl waitpid unpack getnetbyname reset chdir grep split require caller lcfirst until warn while values shift telldir getpwuid my getprotobynumber delete and sort uc defined srand accept package seekdir getprotobyname semop our rename seek if q|0 chroot sysread setpwent no crypt getc chown sqrt write setnetent setpriority foreach tie sin msgget map stat getlogin unless elsif truncate exec keys glob tied closedirioctl socket readlink eval xor readline binmode setservent eof ord bind alarm pipe atan2 getgrent exp time push setgrent gt lt or ne m|0 break given say state when",r={cN:"subst",b:"[$@]\\{",e:"\\}",k:t},s={b:"->{",e:"}"},n={v:[{b:/\$\d/},{b:/[\$%@](\^\w\b|#\w+(::\w+)*|{\w+}|\w+(::\w*)*)/},{b:/[\$%@][^\s\w{]/,r:0}]},i=[e.BE,r,n],o=[n,e.HCM,e.C("^\\=\\w","\\=cut",{eW:!0}),s,{cN:"string",c:i,v:[{b:"q[qwxr]?\\s*\\(",e:"\\)",r:5},{b:"q[qwxr]?\\s*\\[",e:"\\]",r:5},{b:"q[qwxr]?\\s*\\{",e:"\\}",r:5},{b:"q[qwxr]?\\s*\\|",e:"\\|",r:5},{b:"q[qwxr]?\\s*\\<",e:"\\>",r:5},{b:"qw\\s+q",e:"q",r:5},{b:"'",e:"'",c:[e.BE]},{b:'"',e:'"'},{b:"`",e:"`",c:[e.BE]},{b:"{\\w+}",c:[],r:0},{b:"-?\\w+\\s*\\=\\>",c:[],r:0}]},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{b:"(\\/\\/|"+e.RSR+"|\\b(split|return|print|reverse|grep)\\b)\\s*",k:"split return print reverse grep",r:0,c:[e.HCM,{cN:"regexp",b:"(s|tr|y)/(\\\\.|[^/])*/(\\\\.|[^/])*/[a-z]*",r:10},{cN:"regexp",b:"(m|qr)?/",e:"/[a-z]*",c:[e.BE],r:0}]},{cN:"function",bK:"sub",e:"(\\s*\\(.*?\\))?[;{]",eE:!0,r:5,c:[e.TM]},{b:"-\\w\\b",r:0},{b:"^__DATA__$",e:"^__END__$",sL:"mojolicious",c:[{b:"^@@.*",e:"$",cN:"comment"}]}];return r.c=o,s.c=o,{aliases:["pl","pm"],l:/[\w\.]+/,k:t,c:o}});hljs.registerLanguage("ini",function(e){var b={cN:"string",c:[e.BE],v:[{b:"'''",e:"'''",r:10},{b:'"""',e:'"""',r:10},{b:'"',e:'"'},{b:"'",e:"'"}]};return{aliases:["toml"],cI:!0,i:/\S/,c:[e.C(";","$"),e.HCM,{cN:"section",b:/^\s*\[+/,e:/\]+/},{b:/^[a-z0-9\[\]_-]+\s*=\s*/,e:"$",rB:!0,c:[{cN:"attr",b:/[a-z0-9\[\]_-]+/},{b:/=/,eW:!0,r:0,c:[{cN:"literal",b:/\bon|off|true|false|yes|no\b/},{cN:"variable",v:[{b:/\$[\w\d"][\w\d_]*/},{b:/\$\{(.*?)}/}]},b,{cN:"number",b:/([\+\-]+)?[\d]+_[\d_]+/},e.NM]}]}]}});hljs.registerLanguage("diff",function(e){return{aliases:["patch"],c:[{cN:"meta",r:10,v:[{b:/^@@ +\-\d+,\d+ +\+\d+,\d+ +@@$/},{b:/^\*\*\* +\d+,\d+ +\*\*\*\*$/},{b:/^\-\-\- +\d+,\d+ +\-\-\-\-$/}]},{cN:"comment",v:[{b:/Index: /,e:/$/},{b:/={3,}/,e:/$/},{b:/^\-{3}/,e:/$/},{b:/^\*{3} /,e:/$/},{b:/^\+{3}/,e:/$/},{b:/\*{5}/,e:/\*{5}$/}]},{cN:"addition",b:"^\\+",e:"$"},{cN:"deletion",b:"^\\-",e:"$"},{cN:"addition",b:"^\\!",e:"$"}]}});hljs.registerLanguage("go",function(e){var t={keyword:"break default func interface select case map struct chan else goto package switch const fallthrough if range type continue for import return var go defer bool byte complex64 complex128 float32 float64 int8 int16 int32 int64 string uint8 uint16 uint32 uint64 int uint uintptr rune",literal:"true false iota nil",built_in:"append cap close complex copy imag len make new panic print println real recover delete"};return{aliases:["golang"],k:t,i:"</",c:[e.CLCM,e.CBCM,{cN:"string",v:[e.QSM,{b:"'",e:"[^\\\\]'"},{b:"`",e:"`"}]},{cN:"number",v:[{b:e.CNR+"[dflsi]",r:1},e.CNM]},{b:/:=/},{cN:"function",bK:"func",e:/\s*\{/,eE:!0,c:[e.TM,{cN:"params",b:/\(/,e:/\)/,k:t,i:/["']/}]}]}});hljs.registerLanguage("bash",function(e){var t={cN:"variable",v:[{b:/\$[\w\d#@][\w\d_]*/},{b:/\$\{(.*?)}/}]},s={cN:"string",b:/"/,e:/"/,c:[e.BE,t,{cN:"variable",b:/\$\(/,e:/\)/,c:[e.BE]}]},a={cN:"string",b:/'/,e:/'/};return{aliases:["sh","zsh"],l:/\b-?[a-z\._]+\b/,k:{keyword:"if then else elif fi for while in do done case esac function",literal:"true false",built_in:"break cd continue eval exec exit export getopts hash pwd readonly return shift test times trap umask unset alias bind builtin caller command declare echo enable help let local logout mapfile printf read readarray source type typeset ulimit unalias set shopt autoload bg bindkey bye cap chdir clone comparguments compcall compctl compdescribe compfiles compgroups compquote comptags comptry compvalues dirs disable disown echotc echoti emulate fc fg float functions getcap getln history integer jobs kill limit log noglob popd print pushd pushln rehash sched setcap setopt stat suspend ttyctl unfunction unhash unlimit unsetopt vared wait whence where which zcompile zformat zftp zle zmodload zparseopts zprof zpty zregexparse zsocket zstyle ztcp",_:"-ne -eq -lt -gt -f -d -e -s -l -a"},c:[{cN:"meta",b:/^#![^\n]+sh\s*$/,r:10},{cN:"function",b:/\w[\w\d_]*\s*\(\s*\)\s*\{/,rB:!0,c:[e.inherit(e.TM,{b:/\w[\w\d_]*/})],r:0},e.HCM,s,a,t]}});hljs.registerLanguage("python",function(e){var r={keyword:"and elif is global as in if from raise for except finally print import pass return exec else break not with class assert yield try while continue del or def lambda async await nonlocal|10 None True False",built_in:"Ellipsis NotImplemented"},b={cN:"meta",b:/^(>>>|\.\.\.) /},c={cN:"subst",b:/\{/,e:/\}/,k:r,i:/#/},a={cN:"string",c:[e.BE],v:[{b:/(u|b)?r?'''/,e:/'''/,c:[b],r:10},{b:/(u|b)?r?"""/,e:/"""/,c:[b],r:10},{b:/(fr|rf|f)'''/,e:/'''/,c:[b,c]},{b:/(fr|rf|f)"""/,e:/"""/,c:[b,c]},{b:/(u|r|ur)'/,e:/'/,r:10},{b:/(u|r|ur)"/,e:/"/,r:10},{b:/(b|br)'/,e:/'/},{b:/(b|br)"/,e:/"/},{b:/(fr|rf|f)'/,e:/'/,c:[c]},{b:/(fr|rf|f)"/,e:/"/,c:[c]},e.ASM,e.QSM]},s={cN:"number",r:0,v:[{b:e.BNR+"[lLjJ]?"},{b:"\\b(0o[0-7]+)[lLjJ]?"},{b:e.CNR+"[lLjJ]?"}]},i={cN:"params",b:/\(/,e:/\)/,c:["self",b,s,a]};return c.c=[a,s,b],{aliases:["py","gyp"],k:r,i:/(<\/|->|\?)|=>/,c:[b,s,a,e.HCM,{v:[{cN:"function",bK:"def"},{cN:"class",bK:"class"}],e:/:/,i:/[${=;\n,]/,c:[e.UTM,i,{b:/->/,eW:!0,k:"None"}]},{cN:"meta",b:/^[\t ]*@/,e:/$/},{b:/\b(print|exec)\(/}]}});hljs.registerLanguage("julia",function(e){var r={keyword:"in isa where baremodule begin break catch ccall const continue do else elseif end export false finally for function global if import importall let local macro module quote return true try using while type immutable abstract bitstype typealias ",literal:"true false ARGS C_NULL DevNull ENDIAN_BOM ENV I Inf Inf16 Inf32 Inf64 InsertionSort JULIA_HOME LOAD_PATH MergeSort NaN NaN16 NaN32 NaN64 PROGRAM_FILE QuickSort RoundDown RoundFromZero RoundNearest RoundNearestTiesAway RoundNearestTiesUp RoundToZero RoundUp STDERR STDIN STDOUT VERSION catalan e|0 eu|0 eulergamma golden im nothing pi γ π φ ",built_in:"ANY AbstractArray AbstractChannel AbstractFloat AbstractMatrix AbstractRNG AbstractSerializer AbstractSet AbstractSparseArray AbstractSparseMatrix AbstractSparseVector AbstractString AbstractUnitRange AbstractVecOrMat AbstractVector Any ArgumentError Array AssertionError Associative Base64DecodePipe Base64EncodePipe Bidiagonal BigFloat BigInt BitArray BitMatrix BitVector Bool BoundsError BufferStream CachingPool CapturedException CartesianIndex CartesianRange Cchar Cdouble Cfloat Channel Char Cint Cintmax_t Clong Clonglong ClusterManager Cmd CodeInfo Colon Complex Complex128 Complex32 Complex64 CompositeException Condition ConjArray ConjMatrix ConjVector Cptrdiff_t Cshort Csize_t Cssize_t Cstring Cuchar Cuint Cuintmax_t Culong Culonglong Cushort Cwchar_t Cwstring DataType Date DateFormat DateTime DenseArray DenseMatrix DenseVecOrMat DenseVector Diagonal Dict DimensionMismatch Dims DirectIndexString Display DivideError DomainError EOFError EachLine Enum Enumerate ErrorException Exception ExponentialBackOff Expr Factorization FileMonitor Float16 Float32 Float64 Function Future GlobalRef GotoNode HTML Hermitian IO IOBuffer IOContext IOStream IPAddr IPv4 IPv6 IndexCartesian IndexLinear IndexStyle InexactError InitError Int Int128 Int16 Int32 Int64 Int8 IntSet Integer InterruptException InvalidStateException Irrational KeyError LabelNode LinSpace LineNumberNode LoadError LowerTriangular MIME Matrix MersenneTwister Method MethodError MethodTable Module NTuple NewvarNode NullException Nullable Number ObjectIdDict OrdinalRange OutOfMemoryError OverflowError Pair ParseError PartialQuickSort PermutedDimsArray Pipe PollingFileWatcher ProcessExitedException Ptr QuoteNode RandomDevice Range RangeIndex Rational RawFD ReadOnlyMemoryError Real ReentrantLock Ref Regex RegexMatch RemoteChannel RemoteException RevString RoundingMode RowVector SSAValue SegmentationFault SerializationState Set SharedArray SharedMatrix SharedVector Signed SimpleVector Slot SlotNumber SparseMatrixCSC SparseVector StackFrame StackOverflowError StackTrace StepRange StepRangeLen StridedArray StridedMatrix StridedVecOrMat StridedVector String SubArray SubString SymTridiagonal Symbol Symmetric SystemError TCPSocket Task Text TextDisplay Timer Tridiagonal Tuple Type TypeError TypeMapEntry TypeMapLevel TypeName TypeVar TypedSlot UDPSocket UInt UInt128 UInt16 UInt32 UInt64 UInt8 UndefRefError UndefVarError UnicodeError UniformScaling Union UnionAll UnitRange Unsigned UpperTriangular Val Vararg VecElement VecOrMat Vector VersionNumber Void WeakKeyDict WeakRef WorkerConfig WorkerPool "},t="[A-Za-z_\\u00A1-\\uFFFF][A-Za-z_0-9\\u00A1-\\uFFFF]*",a={l:t,k:r,i:/<\//},n={cN:"number",b:/(\b0x[\d_]*(\.[\d_]*)?|0x\.\d[\d_]*)p[-+]?\d+|\b0[box][a-fA-F0-9][a-fA-F0-9_]*|(\b\d[\d_]*(\.[\d_]*)?|\.\d[\d_]*)([eEfF][-+]?\d+)?/,r:0},o={cN:"string",b:/'(.|\\[xXuU][a-zA-Z0-9]+)'/},i={cN:"subst",b:/\$\(/,e:/\)/,k:r},l={cN:"variable",b:"\\$"+t},c={cN:"string",c:[e.BE,i,l],v:[{b:/\w*"""/,e:/"""\w*/,r:10},{b:/\w*"/,e:/"\w*/}]},s={cN:"string",c:[e.BE,i,l],b:"`",e:"`"},d={cN:"meta",b:"@"+t},u={cN:"comment",v:[{b:"#=",e:"=#",r:10},{b:"#",e:"$"}]};return a.c=[n,o,c,s,d,u,e.HCM,{cN:"keyword",b:"\\b(((abstract|primitive)\\s+)type|(mutable\\s+)?struct)\\b"},{b:/<:/}],i.c=a.c,a});hljs.registerLanguage("coffeescript",function(e){var c={keyword:"in if for while finally new do return else break catch instanceof throw try this switch continue typeof delete debugger super yield import export from as default await then unless until loop of by when and or is isnt not",literal:"true false null undefined yes no on off",built_in:"npm require console print module global window document"},n="[A-Za-z$_][0-9A-Za-z$_]*",r={cN:"subst",b:/#\{/,e:/}/,k:c},i=[e.BNM,e.inherit(e.CNM,{starts:{e:"(\\s*/)?",r:0}}),{cN:"string",v:[{b:/'''/,e:/'''/,c:[e.BE]},{b:/'/,e:/'/,c:[e.BE]},{b:/"""/,e:/"""/,c:[e.BE,r]},{b:/"/,e:/"/,c:[e.BE,r]}]},{cN:"regexp",v:[{b:"///",e:"///",c:[r,e.HCM]},{b:"//[gim]*",r:0},{b:/\/(?![ *])(\\\/|.)*?\/[gim]*(?=\W|$)/}]},{b:"@"+n},{sL:"javascript",eB:!0,eE:!0,v:[{b:"```",e:"```"},{b:"`",e:"`"}]}];r.c=i;var s=e.inherit(e.TM,{b:n}),t="(\\(.*\\))?\\s*\\B[-=]>",o={cN:"params",b:"\\([^\\(]",rB:!0,c:[{b:/\(/,e:/\)/,k:c,c:["self"].concat(i)}]};return{aliases:["coffee","cson","iced"],k:c,i:/\/\*/,c:i.concat([e.C("###","###"),e.HCM,{cN:"function",b:"^\\s*"+n+"\\s*=\\s*"+t,e:"[-=]>",rB:!0,c:[s,o]},{b:/[:\(,=]\s*/,r:0,c:[{cN:"function",b:t,e:"[-=]>",rB:!0,c:[o]}]},{cN:"class",bK:"class",e:"$",i:/[:="\[\]]/,c:[{bK:"extends",eW:!0,i:/[:="\[\]]/,c:[s]},s]},{b:n+":",e:":",rB:!0,rE:!0,r:0}])}});hljs.registerLanguage("cpp",function(t){var e={cN:"keyword",b:"\\b[a-z\\d_]*_t\\b"},r={cN:"string",v:[{b:'(u8?|U)?L?"',e:'"',i:"\\n",c:[t.BE]},{b:'(u8?|U)?R"',e:'"',c:[t.BE]},{b:"'\\\\?.",e:"'",i:"."}]},s={cN:"number",v:[{b:"\\b(0b[01']+)"},{b:"(-?)\\b([\\d']+(\\.[\\d']*)?|\\.[\\d']+)(u|U|l|L|ul|UL|f|F|b|B)"},{b:"(-?)(\\b0[xX][a-fA-F0-9']+|(\\b[\\d']+(\\.[\\d']*)?|\\.[\\d']+)([eE][-+]?[\\d']+)?)"}],r:0},i={cN:"meta",b:/#\s*[a-z]+\b/,e:/$/,k:{"meta-keyword":"if else elif endif define undef warning error line pragma ifdef ifndef include"},c:[{b:/\\\n/,r:0},t.inherit(r,{cN:"meta-string"}),{cN:"meta-string",b:/<[^\n>]*>/,e:/$/,i:"\\n"},t.CLCM,t.CBCM]},a=t.IR+"\\s*\\(",c={keyword:"int float while private char catch import module export virtual operator sizeof dynamic_cast|10 typedef const_cast|10 const for static_cast|10 union namespace unsigned long volatile static protected bool template mutable if public friend do goto auto void enum else break extern using asm case typeid short reinterpret_cast|10 default double register explicit signed typename try this switch continue inline delete alignof constexpr decltype noexcept static_assert thread_local restrict _Bool complex _Complex _Imaginary atomic_bool atomic_char atomic_schar atomic_uchar atomic_short atomic_ushort atomic_int atomic_uint atomic_long atomic_ulong atomic_llong atomic_ullong new throw return and or not",built_in:"std string cin cout cerr clog stdin stdout stderr stringstream istringstream ostringstream auto_ptr deque list queue stack vector map set bitset multiset multimap unordered_set unordered_map unordered_multiset unordered_multimap array shared_ptr abort abs acos asin atan2 atan calloc ceil cosh cos exit exp fabs floor fmod fprintf fputs free frexp fscanf isalnum isalpha iscntrl isdigit isgraph islower isprint ispunct isspace isupper isxdigit tolower toupper labs ldexp log10 log malloc realloc memchr memcmp memcpy memset modf pow printf putchar puts scanf sinh sin snprintf sprintf sqrt sscanf strcat strchr strcmp strcpy strcspn strlen strncat strncmp strncpy strpbrk strrchr strspn strstr tanh tan vfprintf vprintf vsprintf endl initializer_list unique_ptr",literal:"true false nullptr NULL"},n=[e,t.CLCM,t.CBCM,s,r];return{aliases:["c","cc","h","c++","h++","hpp"],k:c,i:"</",c:n.concat([i,{b:"\\b(deque|list|queue|stack|vector|map|set|bitset|multiset|multimap|unordered_map|unordered_set|unordered_multiset|unordered_multimap|array)\\s*<",e:">",k:c,c:["self",e]},{b:t.IR+"::",k:c},{v:[{b:/=/,e:/;/},{b:/\(/,e:/\)/},{bK:"new throw return else",e:/;/}],k:c,c:n.concat([{b:/\(/,e:/\)/,k:c,c:n.concat(["self"]),r:0}]),r:0},{cN:"function",b:"("+t.IR+"[\\*&\\s]+)+"+a,rB:!0,e:/[{;=]/,eE:!0,k:c,i:/[^\w\s\*&]/,c:[{b:a,rB:!0,c:[t.TM],r:0},{cN:"params",b:/\(/,e:/\)/,k:c,r:0,c:[t.CLCM,t.CBCM,r,s,e]},t.CLCM,t.CBCM,i]},{cN:"class",bK:"class struct",e:/[{;:]/,c:[{b:/</,e:/>/,c:["self"]},t.TM]}]),exports:{preprocessor:i,strings:r,k:c}}});hljs.registerLanguage("ruby",function(e){var b="[a-zA-Z_]\\w*[!?=]?|[-+~]\\@|<<|>>|=~|===?|<=>|[<>]=?|\\*\\*|[-/+%^&*~`|]|\\[\\]=?",r={keyword:"and then defined module in return redo if BEGIN retry end for self when next until do begin unless END rescue else break undef not super class case require yield alias while ensure elsif or include attr_reader attr_writer attr_accessor",literal:"true false nil"},c={cN:"doctag",b:"@[A-Za-z]+"},a={b:"#<",e:">"},s=[e.C("#","$",{c:[c]}),e.C("^\\=begin","^\\=end",{c:[c],r:10}),e.C("^__END__","\\n$")],n={cN:"subst",b:"#\\{",e:"}",k:r},t={cN:"string",c:[e.BE,n],v:[{b:/'/,e:/'/},{b:/"/,e:/"/},{b:/`/,e:/`/},{b:"%[qQwWx]?\\(",e:"\\)"},{b:"%[qQwWx]?\\[",e:"\\]"},{b:"%[qQwWx]?{",e:"}"},{b:"%[qQwWx]?<",e:">"},{b:"%[qQwWx]?/",e:"/"},{b:"%[qQwWx]?%",e:"%"},{b:"%[qQwWx]?-",e:"-"},{b:"%[qQwWx]?\\|",e:"\\|"},{b:/\B\?(\\\d{1,3}|\\x[A-Fa-f0-9]{1,2}|\\u[A-Fa-f0-9]{4}|\\?\S)\b/},{b:/<<(-?)\w+$/,e:/^\s*\w+$/}]},i={cN:"params",b:"\\(",e:"\\)",endsParent:!0,k:r},d=[t,a,{cN:"class",bK:"class module",e:"$|;",i:/=/,c:[e.inherit(e.TM,{b:"[A-Za-z_]\\w*(::\\w+)*(\\?|\\!)?"}),{b:"<\\s*",c:[{b:"("+e.IR+"::)?"+e.IR}]}].concat(s)},{cN:"function",bK:"def",e:"$|;",c:[e.inherit(e.TM,{b:b}),i].concat(s)},{b:e.IR+"::"},{cN:"symbol",b:e.UIR+"(\\!|\\?)?:",r:0},{cN:"symbol",b:":(?!\\s)",c:[t,{b:b}],r:0},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{b:"(\\$\\W)|((\\$|\\@\\@?)(\\w+))"},{cN:"params",b:/\|/,e:/\|/,k:r},{b:"("+e.RSR+"|unless)\\s*",k:"unless",c:[a,{cN:"regexp",c:[e.BE,n],i:/\n/,v:[{b:"/",e:"/[a-z]*"},{b:"%r{",e:"}[a-z]*"},{b:"%r\\(",e:"\\)[a-z]*"},{b:"%r!",e:"![a-z]*"},{b:"%r\\[",e:"\\][a-z]*"}]}].concat(s),r:0}].concat(s);n.c=d,i.c=d;var l="[>?]>",o="[\\w#]+\\(\\w+\\):\\d+:\\d+>",u="(\\w+-)?\\d+\\.\\d+\\.\\d(p\\d+)?[^>]+>",w=[{b:/^\s*=>/,starts:{e:"$",c:d}},{cN:"meta",b:"^("+l+"|"+o+"|"+u+")",starts:{e:"$",c:d}}];return{aliases:["rb","gemspec","podspec","thor","irb"],k:r,i:/\/\*/,c:s.concat(w).concat(d)}});hljs.registerLanguage("yaml",function(e){var b="true false yes no null",a="^[ \\-]*",r="[a-zA-Z_][\\w\\-]*",t={cN:"attr",v:[{b:a+r+":"},{b:a+'"'+r+'":'},{b:a+"'"+r+"':"}]},c={cN:"template-variable",v:[{b:"{{",e:"}}"},{b:"%{",e:"}"}]},l={cN:"string",r:0,v:[{b:/'/,e:/'/},{b:/"/,e:/"/},{b:/\S+/}],c:[e.BE,c]};return{cI:!0,aliases:["yml","YAML","yaml"],c:[t,{cN:"meta",b:"^---s*$",r:10},{cN:"string",b:"[\\|>] *$",rE:!0,c:l.c,e:t.v[0].b},{b:"<%[%=-]?",e:"[%-]?%>",sL:"ruby",eB:!0,eE:!0,r:0},{cN:"type",b:"!!"+e.UIR},{cN:"meta",b:"&"+e.UIR+"$"},{cN:"meta",b:"\\*"+e.UIR+"$"},{cN:"bullet",b:"^ *-",r:0},e.HCM,{bK:b,k:{literal:b}},e.CNM,l]}});hljs.registerLanguage("css",function(e){var c="[a-zA-Z-][a-zA-Z0-9_-]*",t={b:/[A-Z\_\.\-]+\s*:/,rB:!0,e:";",eW:!0,c:[{cN:"attribute",b:/\S/,e:":",eE:!0,starts:{eW:!0,eE:!0,c:[{b:/[\w-]+\(/,rB:!0,c:[{cN:"built_in",b:/[\w-]+/},{b:/\(/,e:/\)/,c:[e.ASM,e.QSM]}]},e.CSSNM,e.QSM,e.ASM,e.CBCM,{cN:"number",b:"#[0-9A-Fa-f]+"},{cN:"meta",b:"!important"}]}}]};return{cI:!0,i:/[=\/|'\$]/,c:[e.CBCM,{cN:"selector-id",b:/#[A-Za-z0-9_-]+/},{cN:"selector-class",b:/\.[A-Za-z0-9_-]+/},{cN:"selector-attr",b:/\[/,e:/\]/,i:"$"},{cN:"selector-pseudo",b:/:(:)?[a-zA-Z0-9\_\-\+\(\)"'.]+/},{b:"@(font-face|page)",l:"[a-z-]+",k:"font-face page"},{b:"@",e:"[{;]",i:/:/,c:[{cN:"keyword",b:/\w+/},{b:/\s/,eW:!0,eE:!0,r:0,c:[e.ASM,e.QSM,e.CSSNM]}]},{cN:"selector-tag",b:c,r:0},{b:"{",e:"}",i:/\S/,c:[e.CBCM,t]}]}});hljs.registerLanguage("fortran",function(e){var t={cN:"params",b:"\\(",e:"\\)"},n={literal:".False. .True.",keyword:"kind do while private call intrinsic where elsewhere type endtype endmodule endselect endinterface end enddo endif if forall endforall only contains default return stop then public subroutine|10 function program .and. .or. .not. .le. .eq. .ge. .gt. .lt. goto save else use module select case access blank direct exist file fmt form formatted iostat name named nextrec number opened rec recl sequential status unformatted unit continue format pause cycle exit c_null_char c_alert c_backspace c_form_feed flush wait decimal round iomsg synchronous nopass non_overridable pass protected volatile abstract extends import non_intrinsic value deferred generic final enumerator class associate bind enum c_int c_short c_long c_long_long c_signed_char c_size_t c_int8_t c_int16_t c_int32_t c_int64_t c_int_least8_t c_int_least16_t c_int_least32_t c_int_least64_t c_int_fast8_t c_int_fast16_t c_int_fast32_t c_int_fast64_t c_intmax_t C_intptr_t c_float c_double c_long_double c_float_complex c_double_complex c_long_double_complex c_bool c_char c_null_ptr c_null_funptr c_new_line c_carriage_return c_horizontal_tab c_vertical_tab iso_c_binding c_loc c_funloc c_associated  c_f_pointer c_ptr c_funptr iso_fortran_env character_storage_size error_unit file_storage_size input_unit iostat_end iostat_eor numeric_storage_size output_unit c_f_procpointer ieee_arithmetic ieee_support_underflow_control ieee_get_underflow_mode ieee_set_underflow_mode newunit contiguous recursive pad position action delim readwrite eor advance nml interface procedure namelist include sequence elemental pure integer real character complex logical dimension allocatable|10 parameter external implicit|10 none double precision assign intent optional pointer target in out common equivalence data",built_in:"alog alog10 amax0 amax1 amin0 amin1 amod cabs ccos cexp clog csin csqrt dabs dacos dasin datan datan2 dcos dcosh ddim dexp dint dlog dlog10 dmax1 dmin1 dmod dnint dsign dsin dsinh dsqrt dtan dtanh float iabs idim idint idnint ifix isign max0 max1 min0 min1 sngl algama cdabs cdcos cdexp cdlog cdsin cdsqrt cqabs cqcos cqexp cqlog cqsin cqsqrt dcmplx dconjg derf derfc dfloat dgamma dimag dlgama iqint qabs qacos qasin qatan qatan2 qcmplx qconjg qcos qcosh qdim qerf qerfc qexp qgamma qimag qlgama qlog qlog10 qmax1 qmin1 qmod qnint qsign qsin qsinh qsqrt qtan qtanh abs acos aimag aint anint asin atan atan2 char cmplx conjg cos cosh exp ichar index int log log10 max min nint sign sin sinh sqrt tan tanh print write dim lge lgt lle llt mod nullify allocate deallocate adjustl adjustr all allocated any associated bit_size btest ceiling count cshift date_and_time digits dot_product eoshift epsilon exponent floor fraction huge iand ibclr ibits ibset ieor ior ishft ishftc lbound len_trim matmul maxexponent maxloc maxval merge minexponent minloc minval modulo mvbits nearest pack present product radix random_number random_seed range repeat reshape rrspacing scale scan selected_int_kind selected_real_kind set_exponent shape size spacing spread sum system_clock tiny transpose trim ubound unpack verify achar iachar transfer dble entry dprod cpu_time command_argument_count get_command get_command_argument get_environment_variable is_iostat_end ieee_arithmetic ieee_support_underflow_control ieee_get_underflow_mode ieee_set_underflow_mode is_iostat_eor move_alloc new_line selected_char_kind same_type_as extends_type_ofacosh asinh atanh bessel_j0 bessel_j1 bessel_jn bessel_y0 bessel_y1 bessel_yn erf erfc erfc_scaled gamma log_gamma hypot norm2 atomic_define atomic_ref execute_command_line leadz trailz storage_size merge_bits bge bgt ble blt dshiftl dshiftr findloc iall iany iparity image_index lcobound ucobound maskl maskr num_images parity popcnt poppar shifta shiftl shiftr this_image"};return{cI:!0,aliases:["f90","f95"],k:n,i:/\/\*/,c:[e.inherit(e.ASM,{cN:"string",r:0}),e.inherit(e.QSM,{cN:"string",r:0}),{cN:"function",bK:"subroutine function program",i:"[${=\\n]",c:[e.UTM,t]},e.C("!","$",{r:0}),{cN:"number",b:"(?=\\b|\\+|\\-|\\.)(?=\\.\\d|\\d)(?:\\d+)?(?:\\.?\\d*)(?:[de][+-]?\\d+)?\\b\\.?",r:0}]}});hljs.registerLanguage("awk",function(e){var r={cN:"variable",v:[{b:/\$[\w\d#@][\w\d_]*/},{b:/\$\{(.*?)}/}]},b="BEGIN END if else while do for in break continue delete next nextfile function func exit|10",n={cN:"string",c:[e.BE],v:[{b:/(u|b)?r?'''/,e:/'''/,r:10},{b:/(u|b)?r?"""/,e:/"""/,r:10},{b:/(u|r|ur)'/,e:/'/,r:10},{b:/(u|r|ur)"/,e:/"/,r:10},{b:/(b|br)'/,e:/'/},{b:/(b|br)"/,e:/"/},e.ASM,e.QSM]};return{k:{keyword:b},c:[r,n,e.RM,e.HCM,e.NM]}});hljs.registerLanguage("makefile",function(e){var i={cN:"variable",v:[{b:"\\$\\("+e.UIR+"\\)",c:[e.BE]},{b:/\$[@%<?\^\+\*]/}]},r={cN:"string",b:/"/,e:/"/,c:[e.BE,i]},a={cN:"variable",b:/\$\([\w-]+\s/,e:/\)/,k:{built_in:"subst patsubst strip findstring filter filter-out sort word wordlist firstword lastword dir notdir suffix basename addsuffix addprefix join wildcard realpath abspath error warning shell origin flavor foreach if or and call eval file value"},c:[i]},n={b:"^"+e.UIR+"\\s*[:+?]?=",i:"\\n",rB:!0,c:[{b:"^"+e.UIR,e:"[:+?]?=",eE:!0}]},t={cN:"meta",b:/^\.PHONY:/,e:/$/,k:{"meta-keyword":".PHONY"},l:/[\.\w]+/},l={cN:"section",b:/^[^\s]+:/,e:/$/,c:[i]};return{aliases:["mk","mak"],k:"define endef undefine ifdef ifndef ifeq ifneq else endif include -include sinclude override export unexport private vpath",l:/[\w-]+/,c:[e.HCM,i,r,a,n,t,l]}});hljs.registerLanguage("java",function(e){var a="[À-ʸa-zA-Z_$][À-ʸa-zA-Z_$0-9]*",t=a+"(<"+a+"(\\s*,\\s*"+a+")*>)?",r="false synchronized int abstract float private char boolean static null if const for true while long strictfp finally protected import native final void enum else break transient catch instanceof byte super volatile case assert short package default double public try this switch continue throws protected public private module requires exports do",s="\\b(0[bB]([01]+[01_]+[01]+|[01]+)|0[xX]([a-fA-F0-9]+[a-fA-F0-9_]+[a-fA-F0-9]+|[a-fA-F0-9]+)|(([\\d]+[\\d_]+[\\d]+|[\\d]+)(\\.([\\d]+[\\d_]+[\\d]+|[\\d]+))?|\\.([\\d]+[\\d_]+[\\d]+|[\\d]+))([eE][-+]?\\d+)?)[lLfF]?",c={cN:"number",b:s,r:0};return{aliases:["jsp"],k:r,i:/<\/|#/,c:[e.C("/\\*\\*","\\*/",{r:0,c:[{b:/\w+@/,r:0},{cN:"doctag",b:"@[A-Za-z]+"}]}),e.CLCM,e.CBCM,e.ASM,e.QSM,{cN:"class",bK:"class interface",e:/[{;=]/,eE:!0,k:"class interface",i:/[:"\[\]]/,c:[{bK:"extends implements"},e.UTM]},{bK:"new throw return else",r:0},{cN:"function",b:"("+t+"\\s+)+"+e.UIR+"\\s*\\(",rB:!0,e:/[{;=]/,eE:!0,k:r,c:[{b:e.UIR+"\\s*\\(",rB:!0,r:0,c:[e.UTM]},{cN:"params",b:/\(/,e:/\)/,k:r,r:0,c:[e.ASM,e.QSM,e.CNM,e.CBCM]},e.CLCM,e.CBCM]},c,{cN:"meta",b:"@[A-Za-z]+"}]}});hljs.registerLanguage("stan",function(e){return{c:[e.HCM,e.CLCM,e.CBCM,{b:e.UIR,l:e.UIR,k:{name:"for in while repeat until if then else",symbol:"bernoulli bernoulli_logit binomial binomial_logit beta_binomial hypergeometric categorical categorical_logit ordered_logistic neg_binomial neg_binomial_2 neg_binomial_2_log poisson poisson_log multinomial normal exp_mod_normal skew_normal student_t cauchy double_exponential logistic gumbel lognormal chi_square inv_chi_square scaled_inv_chi_square exponential inv_gamma weibull frechet rayleigh wiener pareto pareto_type_2 von_mises uniform multi_normal multi_normal_prec multi_normal_cholesky multi_gp multi_gp_cholesky multi_student_t gaussian_dlm_obs dirichlet lkj_corr lkj_corr_cholesky wishart inv_wishart","selector-tag":"int real vector simplex unit_vector ordered positive_ordered row_vector matrix cholesky_factor_corr cholesky_factor_cov corr_matrix cov_matrix",title:"functions model data parameters quantities transformed generated",literal:"true false"},r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"\\d+(?:[eE][+\\-]?\\d*)?L\\b",r:0},{cN:"number",b:"\\d+\\.(?!\\d)(?:i\\b)?",r:0},{cN:"number",b:"\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",r:0}]}});hljs.registerLanguage("javascript",function(e){var r="[A-Za-z$_][0-9A-Za-z$_]*",t={keyword:"in of if for while finally var new function do return void else break catch instanceof with throw case default try this switch continue typeof delete let yield const export super debugger as async await static import from as",literal:"true false null undefined NaN Infinity",built_in:"eval isFinite isNaN parseFloat parseInt decodeURI decodeURIComponent encodeURI encodeURIComponent escape unescape Object Function Boolean Error EvalError InternalError RangeError ReferenceError StopIteration SyntaxError TypeError URIError Number Math Date String RegExp Array Float32Array Float64Array Int16Array Int32Array Int8Array Uint16Array Uint32Array Uint8Array Uint8ClampedArray ArrayBuffer DataView JSON Intl arguments require module console window document Symbol Set Map WeakSet WeakMap Proxy Reflect Promise"},a={cN:"number",v:[{b:"\\b(0[bB][01]+)"},{b:"\\b(0[oO][0-7]+)"},{b:e.CNR}],r:0},n={cN:"subst",b:"\\$\\{",e:"\\}",k:t,c:[]},c={cN:"string",b:"`",e:"`",c:[e.BE,n]};n.c=[e.ASM,e.QSM,c,a,e.RM];var s=n.c.concat([e.CBCM,e.CLCM]);return{aliases:["js","jsx"],k:t,c:[{cN:"meta",r:10,b:/^\s*['"]use (strict|asm)['"]/},{cN:"meta",b:/^#!/,e:/$/},e.ASM,e.QSM,c,e.CLCM,e.CBCM,a,{b:/[{,]\s*/,r:0,c:[{b:r+"\\s*:",rB:!0,r:0,c:[{cN:"attr",b:r,r:0}]}]},{b:"("+e.RSR+"|\\b(case|return|throw)\\b)\\s*",k:"return throw case",c:[e.CLCM,e.CBCM,e.RM,{cN:"function",b:"(\\(.*?\\)|"+r+")\\s*=>",rB:!0,e:"\\s*=>",c:[{cN:"params",v:[{b:r},{b:/\(\s*\)/},{b:/\(/,e:/\)/,eB:!0,eE:!0,k:t,c:s}]}]},{b:/</,e:/(\/\w+|\w+\/)>/,sL:"xml",c:[{b:/<\w+\s*\/>/,skip:!0},{b:/<\w+/,e:/(\/\w+|\w+\/)>/,skip:!0,c:[{b:/<\w+\s*\/>/,skip:!0},"self"]}]}],r:0},{cN:"function",bK:"function",e:/\{/,eE:!0,c:[e.inherit(e.TM,{b:r}),{cN:"params",b:/\(/,e:/\)/,eB:!0,eE:!0,c:s}],i:/\[|%/},{b:/\$[(.]/},e.METHOD_GUARD,{cN:"class",bK:"class",e:/[{;=]/,eE:!0,i:/[:"\[\]]/,c:[{bK:"extends"},e.UTM]},{bK:"constructor",e:/\{/,eE:!0}],i:/#(?!!)/}});hljs.registerLanguage("tex",function(c){var e={cN:"tag",b:/\\/,r:0,c:[{cN:"name",v:[{b:/[a-zA-Zа-яА-я]+[*]?/},{b:/[^a-zA-Zа-яА-я0-9]/}],starts:{eW:!0,r:0,c:[{cN:"string",v:[{b:/\[/,e:/\]/},{b:/\{/,e:/\}/}]},{b:/\s*=\s*/,eW:!0,r:0,c:[{cN:"number",b:/-?\d*\.?\d+(pt|pc|mm|cm|in|dd|cc|ex|em)?/}]}]}}]};return{c:[e,{cN:"formula",c:[e],r:0,v:[{b:/\$\$/,e:/\$\$/},{b:/\$/,e:/\$/}]},c.C("%","$",{r:0})]}});hljs.registerLanguage("xml",function(s){var e="[A-Za-z0-9\\._:-]+",t={eW:!0,i:/</,r:0,c:[{cN:"attr",b:e,r:0},{b:/=\s*/,r:0,c:[{cN:"string",endsParent:!0,v:[{b:/"/,e:/"/},{b:/'/,e:/'/},{b:/[^\s"'=<>`]+/}]}]}]};return{aliases:["html","xhtml","rss","atom","xjb","xsd","xsl","plist"],cI:!0,c:[{cN:"meta",b:"<!DOCTYPE",e:">",r:10,c:[{b:"\\[",e:"\\]"}]},s.C("<!--","-->",{r:10}),{b:"<\\!\\[CDATA\\[",e:"\\]\\]>",r:10},{b:/<\?(php)?/,e:/\?>/,sL:"php",c:[{b:"/\\*",e:"\\*/",skip:!0}]},{cN:"tag",b:"<style(?=\\s|>|$)",e:">",k:{name:"style"},c:[t],starts:{e:"</style>",rE:!0,sL:["css","xml"]}},{cN:"tag",b:"<script(?=\\s|>|$)",e:">",k:{name:"script"},c:[t],starts:{e:"</script>",rE:!0,sL:["actionscript","javascript","handlebars","xml"]}},{cN:"meta",v:[{b:/<\?xml/,e:/\?>/,r:10},{b:/<\?\w+/,e:/\?>/}]},{cN:"tag",b:"</?",e:"/?>",c:[{cN:"name",b:/[^\/><\s]+/,r:0},t]}]}});hljs.registerLanguage("markdown",function(e){return{aliases:["md","mkdown","mkd"],c:[{cN:"section",v:[{b:"^#{1,6}",e:"$"},{b:"^.+?\\n[=-]{2,}$"}]},{b:"<",e:">",sL:"xml",r:0},{cN:"bullet",b:"^([*+-]|(\\d+\\.))\\s+"},{cN:"strong",b:"[*_]{2}.+?[*_]{2}"},{cN:"emphasis",v:[{b:"\\*.+?\\*"},{b:"_.+?_",r:0}]},{cN:"quote",b:"^>\\s+",e:"$"},{cN:"code",v:[{b:"^```w*s*$",e:"^```s*$"},{b:"`.+?`"},{b:"^( {4}|	)",e:"$",r:0}]},{b:"^[-\\*]{3,}",e:"$"},{b:"\\[.+?\\][\\(\\[].*?[\\)\\]]",rB:!0,c:[{cN:"string",b:"\\[",e:"\\]",eB:!0,rE:!0,r:0},{cN:"link",b:"\\]\\(",e:"\\)",eB:!0,eE:!0},{cN:"symbol",b:"\\]\\[",e:"\\]",eB:!0,eE:!0}],r:10},{b:/^\[[^\n]+\]:/,rB:!0,c:[{cN:"symbol",b:/\[/,e:/\]/,eB:!0,eE:!0},{cN:"link",b:/:\s*/,e:/$/,eB:!0}]}]}});hljs.registerLanguage("json",function(e){var i={literal:"true false null"},n=[e.QSM,e.CNM],r={e:",",eW:!0,eE:!0,c:n,k:i},t={b:"{",e:"}",c:[{cN:"attr",b:/"/,e:/"/,c:[e.BE],i:"\\n"},e.inherit(r,{b:/:/})],i:"\\S"},c={b:"\\[",e:"\\]",c:[e.inherit(r)],i:"\\S"};return n.splice(n.length,0,t,c),{c:n,k:i,i:"\\S"}});"></script>

<style type="text/css">code{white-space: pre;}</style>
<style type="text/css">
  pre:not([class]) {
    background-color: white;
  }
</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>



<style type="text/css">
h1 {
  font-size: 34px;
}
h1.title {
  font-size: 38px;
}
h2 {
  font-size: 30px;
}
h3 {
  font-size: 24px;
}
h4 {
  font-size: 18px;
}
h5 {
  font-size: 16px;
}
h6 {
  font-size: 12px;
}
.table th:not([align]) {
  text-align: left;
}
#rmd-source-code {
  display: none;
}
</style>




<style type="text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
code {
  color: inherit;
  background-color: rgba(0, 0, 0, 0.04);
}
img {
  max-width:100%;
  height: auto;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
</style>

<style type="text/css">
.kable-table {
  border: 1px solid #ccc;
  border-radius: 4px;
  overflow: auto;
  padding-left: 8px;
  padding-right: 8px;
  margin-bottom: 20px;
  max-height: 350px;
}

.kable-table table {
  margin-bottom: 0px;
}

.kable-table table>thead>tr>th {
  border: none;
  border-bottom: 2px solid #dddddd;
}

.kable-table table>thead {
  background-color: #fff;
}
</style>


<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  background: white;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "";
  border: none;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open')
  });
});
</script>

<!-- code folding -->
<style type="text/css">
.code-folding-btn { margin-bottom: 4px; }
</style>
<script>
$(document).ready(function () {
  window.initializeSourceEmbed("batch_correct_combat.Rmd");
  window.initializeCodeFolding("show" === "show");
});
</script>



<script>
$(document).ready(function ()  {

    // move toc-ignore selectors from section div to header
    $('div.section.toc-ignore')
        .removeClass('toc-ignore')
        .children('h1,h2,h3,h4,h5').addClass('toc-ignore');

    // establish options
    var options = {
      selectors: "h1,h2,h3",
      theme: "bootstrap3",
      context: '.toc-content',
      hashGenerator: function (text) {
        return text.replace(/[.\\/?&!#<>]/g, '').replace(/\s/g, '_').toLowerCase();
      },
      ignoreSelector: ".toc-ignore",
      scrollTo: 0
    };
    options.showAndHide = true;
    options.smoothScroll = true;

    // tocify
    var toc = $("#TOC").tocify(options).data("toc-tocify");
});
</script>

<style type="text/css">

#TOC {
  margin: 25px 0px 20px 0px;
}
@media (max-width: 768px) {
#TOC {
  position: relative;
  width: 100%;
}
}


.toc-content {
  padding-left: 30px;
  padding-right: 40px;
}

div.main-container {
  max-width: 1200px;
}

div.tocify {
  width: 20%;
  max-width: 260px;
  max-height: 85%;
}

@media (min-width: 768px) and (max-width: 991px) {
  div.tocify {
    width: 25%;
  }
}

@media (max-width: 767px) {
  div.tocify {
    width: 100%;
    max-width: none;
  }
}

.tocify ul, .tocify li {
  line-height: 20px;
}

.tocify-subheader .tocify-item {
  font-size: 0.90em;
  padding-left: 25px;
  text-indent: 0;
}

.tocify .list-group-item {
  border-radius: 0px;
}


</style>



</head>

<body>


<div class="container-fluid main-container">


<!-- setup 3col/9col grid for toc_float and main content  -->
<div class="row-fluid">
<div class="col-xs-12 col-sm-4 col-md-3">
<div id="TOC" class="tocify">
</div>
</div>

<div class="toc-content col-xs-12 col-sm-8 col-md-9">




<div class="fluid-row" id="header">

<div class="btn-group pull-right">
<button type="button" class="btn btn-default btn-xs dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"><span>Code</span> <span class="caret"></span></button>
<ul class="dropdown-menu" style="min-width: 50px;">
<li><a id="rmd-show-all-code" href="#">Show All Code</a></li>
<li><a id="rmd-hide-all-code" href="#">Hide All Code</a></li>
<li role="separator" class="divider"></li>
<li><a id="rmd-download-source" href="#">Download Rmd</a></li>
</ul>
</div>



<h1 class="title toc-ignore">Batch Correction</h1>
<h4 class="author">ALSF CCDL - Candace Savonen</h4>

</div>


<!-- rnb-text-begin -->
<p><em>Purpose</em>: This notebook illustrates how to assess batch effects and how to use ComBat to correct for them.</p>
<p>This method is based on: Johnson, WE, Rabinovic, A, and Li, C (2007). Adjusting batch effects in microarray expression data using Empirical Bayes methods. Biostatistics 8(1):118-127.</p>
<div id="set-up-libraries" class="section level2">
<h2>1) Set up libraries</h2>
<p>Install <code>sva</code> if you havent done so before.</p>
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjpbInNvdXJjZShcImh0dHBzOi8vYmlvY29uZHVjdG9yLm9yZy9iaW9jTGl0ZS5SXCIpIiwiYmlvY0xpdGUoXCJzdmFcIiwgc3VwcHJlc3NVcGRhdGVzID0gVFJVRSkiXX0= -->
<pre class="r"><code>source(&quot;https://bioconductor.org/biocLite.R&quot;)
biocLite(&quot;sva&quot;, suppressUpdates = TRUE)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuIyBNYWdyaXR0ciBwaXBlXG5gJT4lYCA8LSBkcGx5cjo6YCU+JWBcbiMgTG9hZCBnZ3Bsb3QyIGZvciBncmFwaGluZ1xubGlicmFyeShnZ3Bsb3QyKVxuYGBgIn0= -->
<pre class="r"><code># Magrittr pipe
`%&gt;%` &lt;- dplyr::`%&gt;%`
# Load ggplot2 for graphing
library(ggplot2)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
</div>
<div id="import-and-set-up-data" class="section level2">
<h2>2) Import and set up data</h2>
<p>Data downloaded from refine.bio include a metadata tab separated values (tsv) file and a data tsv file. These files were obtained from <a href="https://www.refine.bio/">refine.bio</a> by entering the search term HEK 293 and then aggregating by <code>species</code>.</p>
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuIyBQdXQgbmFtZSBvZiBkYXRhIGZpbGVcbmRhdGEuZmlsZW5hbWUgPC0gZmlsZS5wYXRoKFwiLi5cIiwgXCJkYXRhXCIsIFwiSE9NT19TQVBJRU5TLnRzdlwiKVxuIyBVbnppcCB0aGUgZmlsZSBhbmQgZGlyZWN0IGl0IHRvIHRoZSBkYXRhIGZvbGRlclxudW56aXAocGFzdGUwKGRhdGEuZmlsZW5hbWUsIFwiLnppcFwiKSwgZXhkaXIgPSBmaWxlLnBhdGgoXCIuLlwiLCBcImRhdGFcIikpXG4jIFJlYWQgaW4gZGF0YSB0c3YgZmlsZVxuZGYgPC0gcmVhZHI6OnJlYWRfdHN2KGRhdGEuZmlsZW5hbWUpICU+JSBcbiAgdGliYmxlOjpjb2x1bW5fdG9fcm93bmFtZXMoJ1gxJykgXG5gYGAifQ== -->
<pre class="r"><code># Put name of data file
data.filename &lt;- file.path(&quot;..&quot;, &quot;data&quot;, &quot;HOMO_SAPIENS.tsv&quot;)
# Unzip the file and direct it to the data folder
unzip(paste0(data.filename, &quot;.zip&quot;), exdir = file.path(&quot;..&quot;, &quot;data&quot;))
# Read in data tsv file
df &lt;- readr::read_tsv(data.filename) %&gt;% 
  tibble::column_to_rownames(&#39;X1&#39;) </code></pre>
<!-- rnb-source-end -->
<!-- rnb-output-begin eyJkYXRhIjoiTWlzc2luZyBjb2x1bW4gbmFtZXMgZmlsbGVkIGluOiAnWDEnIFsxXVBhcnNlZCB3aXRoIGNvbHVtbiBzcGVjaWZpY2F0aW9uOlxuY29scyhcbiAgLmRlZmF1bHQgPSBjb2xfZG91YmxlKCksXG4gIFgxID0gXHUwMDFiWzMxbWNvbF9jaGFyYWN0ZXIoKVx1MDAxYlszOW1cbilcblNlZSBzcGVjKC4uLikgZm9yIGZ1bGwgY29sdW1uIHNwZWNpZmljYXRpb25zLlxuIn0= -->
<pre><code>Missing column names filled in: &#39;X1&#39; [1]Parsed with column specification:
cols(
  .default = col_double(),
  X1 = [31mcol_character()[39m
)
See spec(...) for full column specifications.</code></pre>
<!-- rnb-output-end -->
<!-- rnb-output-begin {"data":"\n|==============                                                                        |  17%   29 MB\n|===============                                                                       |  17%   29 MB\n|===============                                                                       |  17%   29 MB\n|===============                                                                       |  17%   29 MB\n|===============                                                                       |  17%   29 MB\n|===============                                                                       |  17%   30 MB\n|===============                                                                       |  17%   30 MB\n|===============                                                                       |  17%   30 MB\n|===============                                                                       |  18%   30 MB\n|===============                                                                       |  18%   30 MB\n|===============                                                                       |  18%   31 MB\n|================                                                                      |  18%   31 MB\n|================                                                                      |  18%   31 MB\n|================                                                                      |  18%   31 MB\n|================                                                                      |  18%   31 MB\n|================                                                                      |  18%   31 MB\n|================                                                                      |  18%   32 MB\n|================                                                                      |  19%   32 MB\n|================                                                                      |  19%   32 MB\n|================                                                                      |  19%   32 MB\n|================                                                                      |  19%   32 MB\n|================                                                                      |  19%   33 MB\n|=================                                                                     |  19%   33 MB\n|=================                                                                     |  19%   33 MB\n|=================                                                                     |  19%   33 MB\n|=================                                                                     |  19%   33 MB\n|=================                                                                     |  20%   33 MB\n|=================                                                                     |  20%   34 MB\n|=================                                                                     |  20%   34 MB\n|=================                                                                     |  20%   34 MB\n|=================                                                                     |  20%   34 MB\n|=================                                                                     |  20%   34 MB\n|=================                                                                     |  20%   35 MB\n|==================                                                                    |  20%   35 MB\n|==================                                                                    |  20%   35 MB\n|==================                                                                    |  20%   35 MB\n|==================                                                                    |  21%   35 MB\n|==================                                                                    |  21%   35 MB\n|==================                                                                    |  21%   36 MB\n|==================                                                                    |  21%   36 MB\n|==================                                                                    |  21%   36 MB\n|==================                                                                    |  21%   36 MB\n|==================                                                                    |  21%   36 MB\n|===================                                                                   |  21%   37 MB\n|===================                                                                   |  21%   37 MB\n|===================                                                                   |  22%   37 MB\n|===================                                                                   |  22%   37 MB\n|===================                                                                   |  22%   37 MB\n|===================                                                                   |  22%   37 MB\n|===================                                                                   |  22%   38 MB\n|===================                                                                   |  22%   38 MB\n|===================                                                                   |  22%   38 MB\n|===================                                                                   |  22%   38 MB\n|===================                                                                   |  22%   38 MB\n|====================                                                                  |  23%   39 MB\n|====================                                                                  |  23%   39 MB\n|====================                                                                  |  23%   39 MB\n|====================                                                                  |  23%   39 MB\n|====================                                                                  |  23%   39 MB\n|====================                                                                  |  23%   40 MB\n|====================                                                                  |  23%   40 MB\n|====================                                                                  |  23%   40 MB\n|====================                                                                  |  23%   40 MB\n|====================                                                                  |  24%   40 MB\n|====================                                                                  |  24%   40 MB\n|=====================                                                                 |  24%   41 MB\n|=====================                                                                 |  24%   41 MB\n|=====================                                                                 |  24%   41 MB\n|=====================                                                                 |  24%   41 MB\n|=====================                                                                 |  24%   41 MB\n|=====================                                                                 |  24%   42 MB\n|=====================                                                                 |  24%   42 MB\n|=====================                                                                 |  24%   42 MB\n|=====================                                                                 |  25%   42 MB\n|=====================                                                                 |  25%   42 MB\n|======================                                                                |  25%   42 MB\n|======================                                                                |  25%   43 MB\n|======================                                                                |  25%   43 MB\n|======================                                                                |  25%   43 MB\n|======================                                                                |  25%   43 MB\n|======================                                                                |  25%   43 MB\n|======================                                                                |  25%   44 MB\n|======================                                                                |  26%   44 MB\n|======================                                                                |  26%   44 MB\n|======================                                                                |  26%   44 MB\n|======================                                                                |  26%   44 MB\n|=======================                                                               |  26%   44 MB\n|=======================                                                               |  26%   45 MB\n|=======================                                                               |  26%   45 MB\n|=======================                                                               |  26%   45 MB\n|=======================                                                               |  26%   45 MB\n|=======================                                                               |  27%   45 MB\n|=======================                                                               |  27%   46 MB\n|=======================                                                               |  27%   46 MB\n|=======================                                                               |  27%   46 MB\n|=======================                                                               |  27%   46 MB\n|=======================                                                               |  27%   46 MB\n|========================                                                              |  27%   46 MB\n|========================                                                              |  27%   47 MB\n|========================                                                              |  27%   47 MB\n|========================                                                              |  28%   47 MB\n|========================                                                              |  28%   47 MB\n|========================                                                              |  28%   47 MB\n|========================                                                              |  28%   48 MB\n|========================                                                              |  28%   48 MB\n|========================                                                              |  28%   48 MB\n|========================                                                              |  28%   48 MB\n|=========================                                                             |  28%   48 MB\n|=========================                                                             |  28%   48 MB\n|=========================                                                             |  28%   49 MB\n|=========================                                                             |  29%   49 MB\n|=========================                                                             |  29%   49 MB\n|=========================                                                             |  29%   49 MB\n|=========================                                                             |  29%   49 MB\n|=========================                                                             |  29%   50 MB\n|=========================                                                             |  29%   50 MB\n|=========================                                                             |  29%   50 MB\n|=========================                                                             |  29%   50 MB\n|==========================                                                            |  29%   50 MB\n|==========================                                                            |  30%   50 MB\n|==========================                                                            |  30%   51 MB\n|==========================                                                            |  30%   51 MB\n|==========================                                                            |  30%   51 MB\n|==========================                                                            |  30%   51 MB\n|==========================                                                            |  30%   51 MB\n|==========================                                                            |  30%   52 MB\n|==========================                                                            |  30%   52 MB\n|==========================                                                            |  30%   52 MB\n|==========================                                                            |  31%   52 MB\n|===========================                                                           |  31%   52 MB\n|===========================                                                           |  31%   52 MB\n|===========================                                                           |  31%   53 MB\n|===========================                                                           |  31%   53 MB\n|===========================                                                           |  31%   53 MB\n|===========================                                                           |  31%   53 MB\n|===========================                                                           |  31%   53 MB\n|===========================                                                           |  31%   54 MB\n|===========================                                                           |  31%   54 MB\n|===========================                                                           |  32%   54 MB\n|============================                                                          |  32%   54 MB\n|============================                                                          |  32%   54 MB\n|============================                                                          |  32%   54 MB\n|============================                                                          |  32%   55 MB\n|============================                                                          |  32%   55 MB\n|============================                                                          |  32%   55 MB\n|============================                                                          |  32%   55 MB\n|============================                                                          |  32%   55 MB\n|============================                                                          |  33%   56 MB\n|============================                                                          |  33%   56 MB\n|============================                                                          |  33%   56 MB\n|=============================                                                         |  33%   56 MB\n|=============================                                                         |  33%   56 MB\n|=============================                                                         |  33%   56 MB\n|=============================                                                         |  33%   57 MB\n|=============================                                                         |  33%   57 MB\n|=============================                                                         |  33%   57 MB\n|=============================                                                         |  34%   57 MB\n|=============================                                                         |  34%   57 MB\n|=============================                                                         |  34%   58 MB\n|=============================                                                         |  34%   58 MB\n|=============================                                                         |  34%   58 MB\n|==============================                                                        |  34%   58 MB\n|==============================                                                        |  34%   58 MB\n|==============================                                                        |  34%   58 MB\n|==============================                                                        |  34%   59 MB\n|==============================                                                        |  34%   59 MB\n|==============================                                                        |  35%   59 MB\n|==============================                                                        |  35%   59 MB\n|==============================                                                        |  35%   59 MB\n|==============================                                                        |  35%   60 MB\n|==============================                                                        |  35%   60 MB\n|==============================                                                        |  35%   60 MB\n|===============================                                                       |  35%   60 MB\n|===============================                                                       |  35%   60 MB\n|===============================                                                       |  35%   60 MB\n|===============================                                                       |  36%   61 MB\n|===============================                                                       |  36%   61 MB\n|===============================                                                       |  36%   61 MB\n|===============================                                                       |  36%   61 MB\n|===============================                                                       |  36%   61 MB\n|===============================                                                       |  36%   62 MB\n|===============================                                                       |  36%   62 MB\n|================================                                                      |  36%   62 MB\n|================================                                                      |  36%   62 MB\n|================================                                                      |  37%   62 MB\n|================================                                                      |  37%   62 MB\n|================================                                                      |  37%   63 MB\n|================================                                                      |  37%   63 MB\n|================================                                                      |  37%   63 MB\n|================================                                                      |  37%   63 MB\n|================================                                                      |  37%   63 MB\n|================================                                                      |  37%   64 MB\n|================================                                                      |  37%   64 MB\n|=================================                                                     |  38%   64 MB\n|=================================                                                     |  38%   64 MB\n|=================================                                                     |  38%   64 MB\n|=================================                                                     |  38%   65 MB\n|=================================                                                     |  38%   65 MB\n|=================================                                                     |  38%   65 MB\n|=================================                                                     |  38%   65 MB\n|=================================                                                     |  38%   65 MB\n|=================================                                                     |  38%   65 MB\n|=================================                                                     |  38%   66 MB\n|=================================                                                     |  39%   66 MB\n|==================================                                                    |  39%   66 MB\n|==================================                                                    |  39%   66 MB\n|==================================                                                    |  39%   66 MB\n|==================================                                                    |  39%   67 MB\n|==================================                                                    |  39%   67 MB\n|==================================                                                    |  39%   67 MB\n|==================================                                                    |  39%   67 MB\n|==================================                                                    |  39%   67 MB\n|==================================                                                    |  40%   67 MB\n|==================================                                                    |  40%   68 MB\n|===================================                                                   |  40%   68 MB\n|===================================                                                   |  40%   68 MB\n|===================================                                                   |  40%   68 MB\n|===================================                                                   |  40%   68 MB\n|===================================                                                   |  40%   69 MB\n|===================================                                                   |  40%   69 MB\n|===================================                                                   |  40%   69 MB\n|===================================                                                   |  41%   69 MB\n|===================================                                                   |  41%   69 MB\n|===================================                                                   |  41%   69 MB\n|===================================                                                   |  41%   70 MB\n|====================================                                                  |  41%   70 MB\n|====================================                                                  |  41%   70 MB\n|====================================                                                  |  41%   70 MB\n|====================================                                                  |  41%   70 MB\n|====================================                                                  |  41%   71 MB\n|====================================                                                  |  42%   71 MB\n|====================================                                                  |  42%   71 MB\n|====================================                                                  |  42%   71 MB\n|====================================                                                  |  42%   71 MB\n|====================================                                                  |  42%   72 MB\n|=====================================                                                 |  42%   72 MB\n|=====================================                                                 |  42%   72 MB\n|=====================================                                                 |  42%   72 MB\n|=====================================                                                 |  42%   72 MB\n|=====================================                                                 |  42%   72 MB\n|=====================================                                                 |  43%   73 MB\n|=====================================                                                 |  43%   73 MB\n|=====================================                                                 |  43%   73 MB\n|=====================================                                                 |  43%   73 MB\n|=====================================                                                 |  43%   73 MB\n|=====================================                                                 |  43%   74 MB\n|======================================                                                |  43%   74 MB\n|======================================                                                |  43%   74 MB\n|======================================                                                |  43%   74 MB\n|======================================                                                |  44%   74 MB\n|======================================                                                |  44%   74 MB\n|======================================                                                |  44%   75 MB\n|======================================                                                |  44%   75 MB\n|======================================                                                |  44%   75 MB\n|======================================                                                |  44%   75 MB\n|======================================                                                |  44%   75 MB\n|======================================                                                |  44%   76 MB\n|=======================================                                               |  44%   76 MB\n|=======================================                                               |  45%   76 MB\n|=======================================                                               |  45%   76 MB\n|=======================================                                               |  45%   76 MB\n|=======================================                                               |  45%   76 MB\n|=======================================                                               |  45%   77 MB\n|=======================================                                               |  45%   77 MB\n|=======================================                                               |  45%   77 MB\n|=======================================                                               |  45%   77 MB\n|=======================================                                               |  45%   77 MB\n|========================================                                              |  46%   78 MB\n|========================================                                              |  46%   78 MB\n|========================================                                              |  46%   78 MB\n|========================================                                              |  46%   78 MB\n|========================================                                              |  46%   78 MB\n|========================================                                              |  46%   78 MB\n|========================================                                              |  46%   79 MB\n|========================================                                              |  46%   79 MB\n|========================================                                              |  46%   79 MB\n|========================================                                              |  46%   79 MB\n|========================================                                              |  47%   79 MB\n|=========================================                                             |  47%   80 MB\n|=========================================                                             |  47%   80 MB\n|=========================================                                             |  47%   80 MB\n|=========================================                                             |  47%   80 MB\n|=========================================                                             |  47%   80 MB\n|=========================================                                             |  47%   80 MB\n|=========================================                                             |  47%   81 MB\n|=========================================                                             |  47%   81 MB\n|=========================================                                             |  48%   81 MB\n|=========================================                                             |  48%   81 MB\n|=========================================                                             |  48%   81 MB\n|==========================================                                            |  48%   82 MB\n|==========================================                                            |  48%   82 MB\n|==========================================                                            |  48%   82 MB\n|==========================================                                            |  48%   82 MB\n|==========================================                                            |  48%   82 MB\n|==========================================                                            |  48%   83 MB\n|==========================================                                            |  49%   83 MB\n|==========================================                                            |  49%   83 MB\n|==========================================                                            |  49%   83 MB\n|==========================================                                            |  49%   83 MB\n|===========================================                                           |  49%   83 MB\n|===========================================                                           |  49%   84 MB\n|===========================================                                           |  49%   84 MB\n|===========================================                                           |  49%   84 MB\n|===========================================                                           |  49%   84 MB\n|===========================================                                           |  50%   84 MB\n|===========================================                                           |  50%   85 MB\n|===========================================                                           |  50%   85 MB\n|===========================================                                           |  50%   85 MB\n|===========================================                                           |  50%   85 MB\n|===========================================                                           |  50%   85 MB\n|============================================                                          |  50%   85 MB\n|============================================                                          |  50%   86 MB\n|============================================                                          |  50%   86 MB\n|============================================                                          |  50%   86 MB\n|============================================                                          |  51%   86 MB\n|============================================                                          |  51%   86 MB\n|============================================                                          |  51%   87 MB\n|============================================                                          |  51%   87 MB\n|============================================                                          |  51%   87 MB\n|============================================                                          |  51%   87 MB\n|============================================                                          |  51%   87 MB\n|=============================================                                         |  51%   87 MB\n|=============================================                                         |  51%   88 MB\n|=============================================                                         |  52%   88 MB\n|=============================================                                         |  52%   88 MB\n|=============================================                                         |  52%   88 MB\n|=============================================                                         |  52%   88 MB\n|=============================================                                         |  52%   89 MB\n|=============================================                                         |  52%   89 MB\n|=============================================                                         |  52%   89 MB\n|=============================================                                         |  52%   89 MB\n|==============================================                                        |  52%   89 MB\n|==============================================                                        |  53%   89 MB\n|==============================================                                        |  53%   90 MB\n|==============================================                                        |  53%   90 MB\n|==============================================                                        |  53%   90 MB\n|==============================================                                        |  53%   90 MB\n|==============================================                                        |  53%   90 MB\n|==============================================                                        |  53%   91 MB\n|==============================================                                        |  53%   91 MB\n|==============================================                                        |  53%   91 MB\n|==============================================                                        |  53%   91 MB\n|===============================================                                       |  54%   91 MB\n|===============================================                                       |  54%   91 MB\n|===============================================                                       |  54%   92 MB\n|===============================================                                       |  54%   92 MB\n|===============================================                                       |  54%   92 MB\n|===============================================                                       |  54%   92 MB\n|===============================================                                       |  54%   92 MB\n|===============================================                                       |  54%   93 MB\n|===============================================                                       |  54%   93 MB\n|===============================================                                       |  55%   93 MB\n|================================================                                      |  55%   93 MB\n|================================================                                      |  55%   93 MB\n|================================================                                      |  55%   93 MB\n|================================================                                      |  55%   94 MB\n|================================================                                      |  55%   94 MB\n|================================================                                      |  55%   94 MB\n|================================================                                      |  55%   94 MB\n|================================================                                      |  55%   94 MB\n|================================================                                      |  56%   95 MB\n|================================================                                      |  56%   95 MB\n|================================================                                      |  56%   95 MB\n|=================================================                                     |  56%   95 MB\n|=================================================                                     |  56%   95 MB\n|=================================================                                     |  56%   95 MB\n|=================================================                                     |  56%   96 MB\n|=================================================                                     |  56%   96 MB\n|=================================================                                     |  56%   96 MB\n|=================================================                                     |  57%   96 MB\n|=================================================                                     |  57%   96 MB\n|=================================================                                     |  57%   97 MB\n|=================================================                                     |  57%   97 MB\n|=================================================                                     |  57%   97 MB\n|==================================================                                    |  57%   97 MB\n|==================================================                                    |  57%   97 MB\n|==================================================                                    |  57%   97 MB\n|==================================================                                    |  57%   98 MB\n|==================================================                                    |  57%   98 MB\n|==================================================                                    |  58%   98 MB\n|==================================================                                    |  58%   98 MB\n|==================================================                                    |  58%   98 MB\n|==================================================                                    |  58%   99 MB\n|==================================================                                    |  58%   99 MB\n|==================================================                                    |  58%   99 MB\n|===================================================                                   |  58%   99 MB\n|===================================================                                   |  58%   99 MB\n|===================================================                                   |  58%   99 MB\n|===================================================                                   |  59%  100 MB\n|===================================================                                   |  59%  100 MB\n|===================================================                                   |  59%  100 MB\n|===================================================                                   |  59%  100 MB\n|===================================================                                   |  59%  100 MB\n|===================================================                                   |  59%  101 MB\n|===================================================                                   |  59%  101 MB\n|====================================================                                  |  59%  101 MB\n|====================================================                                  |  59%  101 MB\n|====================================================                                  |  60%  101 MB\n|====================================================                                  |  60%  102 MB\n|====================================================                                  |  60%  102 MB\n|====================================================                                  |  60%  102 MB\n|====================================================                                  |  60%  102 MB\n|====================================================                                  |  60%  102 MB\n|====================================================                                  |  60%  102 MB\n|====================================================                                  |  60%  103 MB\n|====================================================                                  |  60%  103 MB\n|=====================================================                                 |  60%  103 MB\n|=====================================================                                 |  61%  103 MB\n|=====================================================                                 |  61%  103 MB\n|=====================================================                                 |  61%  104 MB\n|=====================================================                                 |  61%  104 MB\n|=====================================================                                 |  61%  104 MB\n|=====================================================                                 |  61%  104 MB\n|=====================================================                                 |  61%  104 MB\n|=====================================================                                 |  61%  104 MB\n|=====================================================                                 |  61%  105 MB\n|======================================================                                |  62%  105 MB\n|======================================================                                |  62%  105 MB\n|======================================================                                |  62%  105 MB\n|======================================================                                |  62%  105 MB\n|======================================================                                |  62%  106 MB\n|======================================================                                |  62%  106 MB\n|======================================================                                |  62%  106 MB\n|======================================================                                |  62%  106 MB\n|======================================================                                |  62%  106 MB\n|======================================================                                |  63%  106 MB\n|======================================================                                |  63%  107 MB\n|=======================================================                               |  63%  107 MB\n|=======================================================                               |  63%  107 MB\n|=======================================================                               |  63%  107 MB\n|=======================================================                               |  63%  107 MB\n|=======================================================                               |  63%  108 MB\n|=======================================================                               |  63%  108 MB\n|=======================================================                               |  63%  108 MB\n|=======================================================                               |  64%  108 MB\n|=======================================================                               |  64%  108 MB\n|=======================================================                               |  64%  108 MB\n|=======================================================                               |  64%  109 MB\n|========================================================                              |  64%  109 MB\n|========================================================                              |  64%  109 MB\n|========================================================                              |  64%  109 MB\n|========================================================                              |  64%  109 MB\n|========================================================                              |  64%  110 MB\n|========================================================                              |  64%  110 MB\n|========================================================                              |  65%  110 MB\n|========================================================                              |  65%  110 MB\n|========================================================                              |  65%  110 MB\n|========================================================                              |  65%  111 MB\n|=========================================================                             |  65%  111 MB\n|=========================================================                             |  65%  111 MB\n|=========================================================                             |  65%  111 MB\n|=========================================================                             |  65%  111 MB\n|=========================================================                             |  65%  111 MB\n|=========================================================                             |  66%  112 MB\n|=========================================================                             |  66%  112 MB\n|=========================================================                             |  66%  112 MB\n|=========================================================                             |  66%  112 MB\n|=========================================================                             |  66%  112 MB\n|=========================================================                             |  66%  113 MB\n|==========================================================                            |  66%  113 MB\n|==========================================================                            |  66%  113 MB\n|==========================================================                            |  66%  113 MB\n|==========================================================                            |  67%  113 MB\n|==========================================================                            |  67%  113 MB\n|==========================================================                            |  67%  114 MB\n|==========================================================                            |  67%  114 MB\n|==========================================================                            |  67%  114 MB\n|==========================================================                            |  67%  114 MB\n|==========================================================                            |  67%  114 MB\n|==========================================================                            |  67%  115 MB\n|===========================================================                           |  67%  115 MB\n|===========================================================                           |  68%  115 MB\n|===========================================================                           |  68%  115 MB\n|===========================================================                           |  68%  115 MB\n|===========================================================                           |  68%  115 MB\n|===========================================================                           |  68%  116 MB\n|===========================================================                           |  68%  116 MB\n|===========================================================                           |  68%  116 MB\n|===========================================================                           |  68%  116 MB\n|===========================================================                           |  68%  116 MB\n|============================================================                          |  68%  117 MB\n|============================================================                          |  69%  117 MB\n|============================================================                          |  69%  117 MB\n|============================================================                          |  69%  117 MB\n|============================================================                          |  69%  117 MB\n|============================================================                          |  69%  117 MB\n|============================================================                          |  69%  118 MB\n|============================================================                          |  69%  118 MB\n|============================================================                          |  69%  118 MB\n|============================================================                          |  69%  118 MB\n|============================================================                          |  70%  118 MB\n|=============================================================                         |  70%  119 MB\n|=============================================================                         |  70%  119 MB\n|=============================================================                         |  70%  119 MB\n|=============================================================                         |  70%  119 MB\n|=============================================================                         |  70%  119 MB\n|=============================================================                         |  70%  120 MB\n|=============================================================                         |  70%  120 MB\n|=============================================================                         |  70%  120 MB\n|=============================================================                         |  71%  120 MB\n|=============================================================                         |  71%  120 MB\n|==============================================================                        |  71%  120 MB\n|==============================================================                        |  71%  121 MB\n|==============================================================                        |  71%  121 MB\n|==============================================================                        |  71%  121 MB\n|==============================================================                        |  71%  121 MB\n|==============================================================                        |  71%  121 MB\n|==============================================================                        |  71%  122 MB\n|==============================================================                        |  72%  122 MB\n|==============================================================                        |  72%  122 MB\n|==============================================================                        |  72%  122 MB\n|==============================================================                        |  72%  122 MB\n|===============================================================                       |  72%  122 MB\n|===============================================================                       |  72%  123 MB\n|===============================================================                       |  72%  123 MB\n|===============================================================                       |  72%  123 MB\n|===============================================================                       |  72%  123 MB\n|===============================================================                       |  73%  123 MB\n|===============================================================                       |  73%  124 MB\n|===============================================================                       |  73%  124 MB\n|===============================================================                       |  73%  124 MB\n|===============================================================                       |  73%  124 MB\n|===============================================================                       |  73%  124 MB\n|================================================================                      |  73%  124 MB\n|================================================================                      |  73%  125 MB\n|================================================================                      |  73%  125 MB\n|================================================================                      |  73%  125 MB\n|================================================================                      |  74%  125 MB\n|================================================================                      |  74%  125 MB\n|================================================================                      |  74%  126 MB\n|================================================================                      |  74%  126 MB\n|================================================================                      |  74%  126 MB\n|================================================================                      |  74%  126 MB\n|=================================================================                     |  74%  126 MB\n|=================================================================                     |  74%  126 MB\n|=================================================================                     |  74%  127 MB\n|=================================================================                     |  75%  127 MB\n|=================================================================                     |  75%  127 MB\n|=================================================================                     |  75%  127 MB\n|=================================================================                     |  75%  127 MB\n|=================================================================                     |  75%  128 MB\n|=================================================================                     |  75%  128 MB\n|=================================================================                     |  75%  128 MB\n|=================================================================                     |  75%  128 MB\n|==================================================================                    |  75%  128 MB\n|==================================================================                    |  76%  129 MB\n|==================================================================                    |  76%  129 MB\n|==================================================================                    |  76%  129 MB\n|==================================================================                    |  76%  129 MB\n|==================================================================                    |  76%  129 MB\n|==================================================================                    |  76%  129 MB\n|==================================================================                    |  76%  130 MB\n|==================================================================                    |  76%  130 MB\n|==================================================================                    |  76%  130 MB\n|===================================================================                   |  77%  130 MB\n|===================================================================                   |  77%  130 MB\n|===================================================================                   |  77%  131 MB\n|===================================================================                   |  77%  131 MB\n|===================================================================                   |  77%  131 MB\n|===================================================================                   |  77%  131 MB\n|===================================================================                   |  77%  131 MB\n|===================================================================                   |  77%  131 MB\n|===================================================================                   |  77%  132 MB\n|===================================================================                   |  77%  132 MB\n|===================================================================                   |  78%  132 MB\n|====================================================================                  |  78%  132 MB\n|====================================================================                  |  78%  132 MB\n|====================================================================                  |  78%  133 MB\n|====================================================================                  |  78%  133 MB\n|====================================================================                  |  78%  133 MB\n|====================================================================                  |  78%  133 MB\n|====================================================================                  |  78%  133 MB\n|====================================================================                  |  78%  133 MB\n|====================================================================                  |  79%  134 MB\n|====================================================================                  |  79%  134 MB\n|====================================================================                  |  79%  134 MB\n|=====================================================================                 |  79%  134 MB\n|=====================================================================                 |  79%  134 MB\n|=====================================================================                 |  79%  135 MB\n|=====================================================================                 |  79%  135 MB\n|=====================================================================                 |  79%  135 MB\n|=====================================================================                 |  79%  135 MB\n|=====================================================================                 |  80%  135 MB\n|=====================================================================                 |  80%  135 MB\n|=====================================================================                 |  80%  136 MB\n|=====================================================================                 |  80%  136 MB\n|======================================================================                |  80%  136 MB\n|======================================================================                |  80%  136 MB\n|======================================================================                |  80%  136 MB\n|======================================================================                |  80%  137 MB\n|======================================================================                |  80%  137 MB\n|======================================================================                |  81%  137 MB\n|======================================================================                |  81%  137 MB\n|======================================================================                |  81%  137 MB\n|======================================================================                |  81%  138 MB\n|======================================================================                |  81%  138 MB\n|======================================================================                |  81%  138 MB\n|=======================================================================               |  81%  138 MB\n|=======================================================================               |  81%  138 MB\n|=======================================================================               |  81%  138 MB\n|=======================================================================               |  82%  139 MB\n|=======================================================================               |  82%  139 MB\n|=======================================================================               |  82%  139 MB\n|=======================================================================               |  82%  139 MB\n|=======================================================================               |  82%  139 MB\n|=======================================================================               |  82%  140 MB\n|=======================================================================               |  82%  140 MB\n|========================================================================              |  82%  140 MB\n|========================================================================              |  82%  140 MB\n|========================================================================              |  82%  140 MB\n|========================================================================              |  83%  140 MB\n|========================================================================              |  83%  141 MB\n|========================================================================              |  83%  141 MB\n|========================================================================              |  83%  141 MB\n|========================================================================              |  83%  141 MB\n|========================================================================              |  83%  141 MB\n|========================================================================              |  83%  142 MB\n|========================================================================              |  83%  142 MB\n|=========================================================================             |  83%  142 MB\n|=========================================================================             |  84%  142 MB\n|=========================================================================             |  84%  142 MB\n|=========================================================================             |  84%  142 MB\n|=========================================================================             |  84%  143 MB\n|=========================================================================             |  84%  143 MB\n|=========================================================================             |  84%  143 MB\n|=========================================================================             |  84%  143 MB\n|=========================================================================             |  84%  143 MB\n|=========================================================================             |  84%  144 MB\n|=========================================================================             |  85%  144 MB\n|==========================================================================            |  85%  144 MB\n|==========================================================================            |  85%  144 MB\n|==========================================================================            |  85%  144 MB\n|==========================================================================            |  85%  144 MB\n|==========================================================================            |  85%  145 MB\n|==========================================================================            |  85%  145 MB\n|==========================================================================            |  85%  145 MB\n|==========================================================================            |  85%  145 MB\n|==========================================================================            |  85%  145 MB\n|==========================================================================            |  86%  146 MB\n|===========================================================================           |  86%  146 MB\n|===========================================================================           |  86%  146 MB\n|===========================================================================           |  86%  146 MB\n|===========================================================================           |  86%  146 MB\n|===========================================================================           |  86%  147 MB\n|===========================================================================           |  86%  147 MB\n|===========================================================================           |  86%  147 MB\n|===========================================================================           |  86%  147 MB\n|===========================================================================           |  87%  147 MB\n|===========================================================================           |  87%  147 MB\n|===========================================================================           |  87%  148 MB\n|============================================================================          |  87%  148 MB\n|============================================================================          |  87%  148 MB\n|============================================================================          |  87%  148 MB\n|============================================================================          |  87%  148 MB\n|============================================================================          |  87%  149 MB\n|============================================================================          |  87%  149 MB\n|============================================================================          |  88%  149 MB\n|============================================================================          |  88%  149 MB\n|============================================================================          |  88%  149 MB\n|============================================================================          |  88%  149 MB\n|============================================================================          |  88%  150 MB\n|=============================================================================         |  88%  150 MB\n|=============================================================================         |  88%  150 MB\n|=============================================================================         |  88%  150 MB\n|=============================================================================         |  88%  150 MB\n|=============================================================================         |  89%  151 MB\n|=============================================================================         |  89%  151 MB\n|=============================================================================         |  89%  151 MB\n|=============================================================================         |  89%  151 MB\n|=============================================================================         |  89%  151 MB\n|=============================================================================         |  89%  151 MB\n|==============================================================================        |  89%  152 MB\n|==============================================================================        |  89%  152 MB\n|==============================================================================        |  89%  152 MB\n|==============================================================================        |  90%  152 MB\n|==============================================================================        |  90%  152 MB\n|==============================================================================        |  90%  153 MB\n|==============================================================================        |  90%  153 MB\n|==============================================================================        |  90%  153 MB\n|==============================================================================        |  90%  153 MB\n|==============================================================================        |  90%  153 MB\n|==============================================================================        |  90%  154 MB\n|===============================================================================       |  90%  154 MB\n|===============================================================================       |  90%  154 MB\n|===============================================================================       |  91%  154 MB\n|===============================================================================       |  91%  154 MB\n|===============================================================================       |  91%  154 MB\n|===============================================================================       |  91%  155 MB\n|===============================================================================       |  91%  155 MB\n|===============================================================================       |  91%  155 MB\n|===============================================================================       |  91%  155 MB\n|===============================================================================       |  91%  155 MB\n|================================================================================      |  91%  156 MB\n|================================================================================      |  92%  156 MB\n|================================================================================      |  92%  156 MB\n|================================================================================      |  92%  156 MB\n|================================================================================      |  92%  156 MB\n|================================================================================      |  92%  156 MB\n|================================================================================      |  92%  157 MB\n|================================================================================      |  92%  157 MB\n|================================================================================      |  92%  157 MB\n|================================================================================      |  92%  157 MB\n|================================================================================      |  93%  157 MB\n|=================================================================================     |  93%  158 MB\n|=================================================================================     |  93%  158 MB\n|=================================================================================     |  93%  158 MB\n|=================================================================================     |  93%  158 MB\n|=================================================================================     |  93%  158 MB\n|=================================================================================     |  93%  158 MB\n|=================================================================================     |  93%  159 MB\n|=================================================================================     |  93%  159 MB\n|=================================================================================     |  94%  159 MB\n|=================================================================================     |  94%  159 MB\n|==================================================================================    |  94%  159 MB\n|==================================================================================    |  94%  160 MB\n|==================================================================================    |  94%  160 MB\n|==================================================================================    |  94%  160 MB\n|==================================================================================    |  94%  160 MB\n|==================================================================================    |  94%  160 MB\n|==================================================================================    |  94%  161 MB\n|==================================================================================    |  95%  161 MB\n|==================================================================================    |  95%  161 MB\n|==================================================================================    |  95%  161 MB\n|==================================================================================    |  95%  161 MB\n|===================================================================================   |  95%  161 MB\n|===================================================================================   |  95%  162 MB\n|===================================================================================   |  95%  162 MB\n|===================================================================================   |  95%  162 MB\n|===================================================================================   |  95%  162 MB\n|===================================================================================   |  95%  162 MB\n|===================================================================================   |  96%  163 MB\n|===================================================================================   |  96%  163 MB\n|===================================================================================   |  96%  163 MB\n|===================================================================================   |  96%  163 MB\n|===================================================================================   |  96%  163 MB\n|====================================================================================  |  96%  163 MB\n|====================================================================================  |  96%  164 MB\n|====================================================================================  |  96%  164 MB\n|====================================================================================  |  96%  164 MB\n|====================================================================================  |  97%  164 MB\n|====================================================================================  |  97%  164 MB\n|====================================================================================  |  97%  165 MB\n|====================================================================================  |  97%  165 MB\n|====================================================================================  |  97%  165 MB\n|====================================================================================  |  97%  165 MB\n|===================================================================================== |  97%  165 MB\n|===================================================================================== |  97%  165 MB\n|===================================================================================== |  97%  166 MB\n|===================================================================================== |  98%  166 MB\n|===================================================================================== |  98%  166 MB\n|===================================================================================== |  98%  166 MB\n|===================================================================================== |  98%  166 MB\n|===================================================================================== |  98%  167 MB\n|===================================================================================== |  98%  167 MB\n|===================================================================================== |  98%  167 MB\n|===================================================================================== |  98%  167 MB\n|======================================================================================|  98%  167 MB\n|======================================================================================|  99%  168 MB\n|======================================================================================|  99%  168 MB\n|======================================================================================|  99%  168 MB\n|======================================================================================|  99%  168 MB\n|======================================================================================|  99%  168 MB\n|======================================================================================|  99%  168 MB\n|======================================================================================|  99%  169 MB\n|======================================================================================|  99%  169 MB\n|======================================================================================|  99%  169 MB\n|=======================================================================================| 100%  169 MB\n"} -->
<pre><code>
|==============                                                                        |  17%   29 MB
|===============                                                                       |  17%   29 MB
|===============                                                                       |  17%   29 MB
|===============                                                                       |  17%   29 MB
|===============                                                                       |  17%   29 MB
|===============                                                                       |  17%   30 MB
|===============                                                                       |  17%   30 MB
|===============                                                                       |  17%   30 MB
|===============                                                                       |  18%   30 MB
|===============                                                                       |  18%   30 MB
|===============                                                                       |  18%   31 MB
|================                                                                      |  18%   31 MB
|================                                                                      |  18%   31 MB
|================                                                                      |  18%   31 MB
|================                                                                      |  18%   31 MB
|================                                                                      |  18%   31 MB
|================                                                                      |  18%   32 MB
|================                                                                      |  19%   32 MB
|================                                                                      |  19%   32 MB
|================                                                                      |  19%   32 MB
|================                                                                      |  19%   32 MB
|================                                                                      |  19%   33 MB
|=================                                                                     |  19%   33 MB
|=================                                                                     |  19%   33 MB
|=================                                                                     |  19%   33 MB
|=================                                                                     |  19%   33 MB
|=================                                                                     |  20%   33 MB
|=================                                                                     |  20%   34 MB
|=================                                                                     |  20%   34 MB
|=================                                                                     |  20%   34 MB
|=================                                                                     |  20%   34 MB
|=================                                                                     |  20%   34 MB
|=================                                                                     |  20%   35 MB
|==================                                                                    |  20%   35 MB
|==================                                                                    |  20%   35 MB
|==================                                                                    |  20%   35 MB
|==================                                                                    |  21%   35 MB
|==================                                                                    |  21%   35 MB
|==================                                                                    |  21%   36 MB
|==================                                                                    |  21%   36 MB
|==================                                                                    |  21%   36 MB
|==================                                                                    |  21%   36 MB
|==================                                                                    |  21%   36 MB
|===================                                                                   |  21%   37 MB
|===================                                                                   |  21%   37 MB
|===================                                                                   |  22%   37 MB
|===================                                                                   |  22%   37 MB
|===================                                                                   |  22%   37 MB
|===================                                                                   |  22%   37 MB
|===================                                                                   |  22%   38 MB
|===================                                                                   |  22%   38 MB
|===================                                                                   |  22%   38 MB
|===================                                                                   |  22%   38 MB
|===================                                                                   |  22%   38 MB
|====================                                                                  |  23%   39 MB
|====================                                                                  |  23%   39 MB
|====================                                                                  |  23%   39 MB
|====================                                                                  |  23%   39 MB
|====================                                                                  |  23%   39 MB
|====================                                                                  |  23%   40 MB
|====================                                                                  |  23%   40 MB
|====================                                                                  |  23%   40 MB
|====================                                                                  |  23%   40 MB
|====================                                                                  |  24%   40 MB
|====================                                                                  |  24%   40 MB
|=====================                                                                 |  24%   41 MB
|=====================                                                                 |  24%   41 MB
|=====================                                                                 |  24%   41 MB
|=====================                                                                 |  24%   41 MB
|=====================                                                                 |  24%   41 MB
|=====================                                                                 |  24%   42 MB
|=====================                                                                 |  24%   42 MB
|=====================                                                                 |  24%   42 MB
|=====================                                                                 |  25%   42 MB
|=====================                                                                 |  25%   42 MB
|======================                                                                |  25%   42 MB
|======================                                                                |  25%   43 MB
|======================                                                                |  25%   43 MB
|======================                                                                |  25%   43 MB
|======================                                                                |  25%   43 MB
|======================                                                                |  25%   43 MB
|======================                                                                |  25%   44 MB
|======================                                                                |  26%   44 MB
|======================                                                                |  26%   44 MB
|======================                                                                |  26%   44 MB
|======================                                                                |  26%   44 MB
|=======================                                                               |  26%   44 MB
|=======================                                                               |  26%   45 MB
|=======================                                                               |  26%   45 MB
|=======================                                                               |  26%   45 MB
|=======================                                                               |  26%   45 MB
|=======================                                                               |  27%   45 MB
|=======================                                                               |  27%   46 MB
|=======================                                                               |  27%   46 MB
|=======================                                                               |  27%   46 MB
|=======================                                                               |  27%   46 MB
|=======================                                                               |  27%   46 MB
|========================                                                              |  27%   46 MB
|========================                                                              |  27%   47 MB
|========================                                                              |  27%   47 MB
|========================                                                              |  28%   47 MB
|========================                                                              |  28%   47 MB
|========================                                                              |  28%   47 MB
|========================                                                              |  28%   48 MB
|========================                                                              |  28%   48 MB
|========================                                                              |  28%   48 MB
|========================                                                              |  28%   48 MB
|=========================                                                             |  28%   48 MB
|=========================                                                             |  28%   48 MB
|=========================                                                             |  28%   49 MB
|=========================                                                             |  29%   49 MB
|=========================                                                             |  29%   49 MB
|=========================                                                             |  29%   49 MB
|=========================                                                             |  29%   49 MB
|=========================                                                             |  29%   50 MB
|=========================                                                             |  29%   50 MB
|=========================                                                             |  29%   50 MB
|=========================                                                             |  29%   50 MB
|==========================                                                            |  29%   50 MB
|==========================                                                            |  30%   50 MB
|==========================                                                            |  30%   51 MB
|==========================                                                            |  30%   51 MB
|==========================                                                            |  30%   51 MB
|==========================                                                            |  30%   51 MB
|==========================                                                            |  30%   51 MB
|==========================                                                            |  30%   52 MB
|==========================                                                            |  30%   52 MB
|==========================                                                            |  30%   52 MB
|==========================                                                            |  31%   52 MB
|===========================                                                           |  31%   52 MB
|===========================                                                           |  31%   52 MB
|===========================                                                           |  31%   53 MB
|===========================                                                           |  31%   53 MB
|===========================                                                           |  31%   53 MB
|===========================                                                           |  31%   53 MB
|===========================                                                           |  31%   53 MB
|===========================                                                           |  31%   54 MB
|===========================                                                           |  31%   54 MB
|===========================                                                           |  32%   54 MB
|============================                                                          |  32%   54 MB
|============================                                                          |  32%   54 MB
|============================                                                          |  32%   54 MB
|============================                                                          |  32%   55 MB
|============================                                                          |  32%   55 MB
|============================                                                          |  32%   55 MB
|============================                                                          |  32%   55 MB
|============================                                                          |  32%   55 MB
|============================                                                          |  33%   56 MB
|============================                                                          |  33%   56 MB
|============================                                                          |  33%   56 MB
|=============================                                                         |  33%   56 MB
|=============================                                                         |  33%   56 MB
|=============================                                                         |  33%   56 MB
|=============================                                                         |  33%   57 MB
|=============================                                                         |  33%   57 MB
|=============================                                                         |  33%   57 MB
|=============================                                                         |  34%   57 MB
|=============================                                                         |  34%   57 MB
|=============================                                                         |  34%   58 MB
|=============================                                                         |  34%   58 MB
|=============================                                                         |  34%   58 MB
|==============================                                                        |  34%   58 MB
|==============================                                                        |  34%   58 MB
|==============================                                                        |  34%   58 MB
|==============================                                                        |  34%   59 MB
|==============================                                                        |  34%   59 MB
|==============================                                                        |  35%   59 MB
|==============================                                                        |  35%   59 MB
|==============================                                                        |  35%   59 MB
|==============================                                                        |  35%   60 MB
|==============================                                                        |  35%   60 MB
|==============================                                                        |  35%   60 MB
|===============================                                                       |  35%   60 MB
|===============================                                                       |  35%   60 MB
|===============================                                                       |  35%   60 MB
|===============================                                                       |  36%   61 MB
|===============================                                                       |  36%   61 MB
|===============================                                                       |  36%   61 MB
|===============================                                                       |  36%   61 MB
|===============================                                                       |  36%   61 MB
|===============================                                                       |  36%   62 MB
|===============================                                                       |  36%   62 MB
|================================                                                      |  36%   62 MB
|================================                                                      |  36%   62 MB
|================================                                                      |  37%   62 MB
|================================                                                      |  37%   62 MB
|================================                                                      |  37%   63 MB
|================================                                                      |  37%   63 MB
|================================                                                      |  37%   63 MB
|================================                                                      |  37%   63 MB
|================================                                                      |  37%   63 MB
|================================                                                      |  37%   64 MB
|================================                                                      |  37%   64 MB
|=================================                                                     |  38%   64 MB
|=================================                                                     |  38%   64 MB
|=================================                                                     |  38%   64 MB
|=================================                                                     |  38%   65 MB
|=================================                                                     |  38%   65 MB
|=================================                                                     |  38%   65 MB
|=================================                                                     |  38%   65 MB
|=================================                                                     |  38%   65 MB
|=================================                                                     |  38%   65 MB
|=================================                                                     |  38%   66 MB
|=================================                                                     |  39%   66 MB
|==================================                                                    |  39%   66 MB
|==================================                                                    |  39%   66 MB
|==================================                                                    |  39%   66 MB
|==================================                                                    |  39%   67 MB
|==================================                                                    |  39%   67 MB
|==================================                                                    |  39%   67 MB
|==================================                                                    |  39%   67 MB
|==================================                                                    |  39%   67 MB
|==================================                                                    |  40%   67 MB
|==================================                                                    |  40%   68 MB
|===================================                                                   |  40%   68 MB
|===================================                                                   |  40%   68 MB
|===================================                                                   |  40%   68 MB
|===================================                                                   |  40%   68 MB
|===================================                                                   |  40%   69 MB
|===================================                                                   |  40%   69 MB
|===================================                                                   |  40%   69 MB
|===================================                                                   |  41%   69 MB
|===================================                                                   |  41%   69 MB
|===================================                                                   |  41%   69 MB
|===================================                                                   |  41%   70 MB
|====================================                                                  |  41%   70 MB
|====================================                                                  |  41%   70 MB
|====================================                                                  |  41%   70 MB
|====================================                                                  |  41%   70 MB
|====================================                                                  |  41%   71 MB
|====================================                                                  |  42%   71 MB
|====================================                                                  |  42%   71 MB
|====================================                                                  |  42%   71 MB
|====================================                                                  |  42%   71 MB
|====================================                                                  |  42%   72 MB
|=====================================                                                 |  42%   72 MB
|=====================================                                                 |  42%   72 MB
|=====================================                                                 |  42%   72 MB
|=====================================                                                 |  42%   72 MB
|=====================================                                                 |  42%   72 MB
|=====================================                                                 |  43%   73 MB
|=====================================                                                 |  43%   73 MB
|=====================================                                                 |  43%   73 MB
|=====================================                                                 |  43%   73 MB
|=====================================                                                 |  43%   73 MB
|=====================================                                                 |  43%   74 MB
|======================================                                                |  43%   74 MB
|======================================                                                |  43%   74 MB
|======================================                                                |  43%   74 MB
|======================================                                                |  44%   74 MB
|======================================                                                |  44%   74 MB
|======================================                                                |  44%   75 MB
|======================================                                                |  44%   75 MB
|======================================                                                |  44%   75 MB
|======================================                                                |  44%   75 MB
|======================================                                                |  44%   75 MB
|======================================                                                |  44%   76 MB
|=======================================                                               |  44%   76 MB
|=======================================                                               |  45%   76 MB
|=======================================                                               |  45%   76 MB
|=======================================                                               |  45%   76 MB
|=======================================                                               |  45%   76 MB
|=======================================                                               |  45%   77 MB
|=======================================                                               |  45%   77 MB
|=======================================                                               |  45%   77 MB
|=======================================                                               |  45%   77 MB
|=======================================                                               |  45%   77 MB
|========================================                                              |  46%   78 MB
|========================================                                              |  46%   78 MB
|========================================                                              |  46%   78 MB
|========================================                                              |  46%   78 MB
|========================================                                              |  46%   78 MB
|========================================                                              |  46%   78 MB
|========================================                                              |  46%   79 MB
|========================================                                              |  46%   79 MB
|========================================                                              |  46%   79 MB
|========================================                                              |  46%   79 MB
|========================================                                              |  47%   79 MB
|=========================================                                             |  47%   80 MB
|=========================================                                             |  47%   80 MB
|=========================================                                             |  47%   80 MB
|=========================================                                             |  47%   80 MB
|=========================================                                             |  47%   80 MB
|=========================================                                             |  47%   80 MB
|=========================================                                             |  47%   81 MB
|=========================================                                             |  47%   81 MB
|=========================================                                             |  48%   81 MB
|=========================================                                             |  48%   81 MB
|=========================================                                             |  48%   81 MB
|==========================================                                            |  48%   82 MB
|==========================================                                            |  48%   82 MB
|==========================================                                            |  48%   82 MB
|==========================================                                            |  48%   82 MB
|==========================================                                            |  48%   82 MB
|==========================================                                            |  48%   83 MB
|==========================================                                            |  49%   83 MB
|==========================================                                            |  49%   83 MB
|==========================================                                            |  49%   83 MB
|==========================================                                            |  49%   83 MB
|===========================================                                           |  49%   83 MB
|===========================================                                           |  49%   84 MB
|===========================================                                           |  49%   84 MB
|===========================================                                           |  49%   84 MB
|===========================================                                           |  49%   84 MB
|===========================================                                           |  50%   84 MB
|===========================================                                           |  50%   85 MB
|===========================================                                           |  50%   85 MB
|===========================================                                           |  50%   85 MB
|===========================================                                           |  50%   85 MB
|===========================================                                           |  50%   85 MB
|============================================                                          |  50%   85 MB
|============================================                                          |  50%   86 MB
|============================================                                          |  50%   86 MB
|============================================                                          |  50%   86 MB
|============================================                                          |  51%   86 MB
|============================================                                          |  51%   86 MB
|============================================                                          |  51%   87 MB
|============================================                                          |  51%   87 MB
|============================================                                          |  51%   87 MB
|============================================                                          |  51%   87 MB
|============================================                                          |  51%   87 MB
|=============================================                                         |  51%   87 MB
|=============================================                                         |  51%   88 MB
|=============================================                                         |  52%   88 MB
|=============================================                                         |  52%   88 MB
|=============================================                                         |  52%   88 MB
|=============================================                                         |  52%   88 MB
|=============================================                                         |  52%   89 MB
|=============================================                                         |  52%   89 MB
|=============================================                                         |  52%   89 MB
|=============================================                                         |  52%   89 MB
|==============================================                                        |  52%   89 MB
|==============================================                                        |  53%   89 MB
|==============================================                                        |  53%   90 MB
|==============================================                                        |  53%   90 MB
|==============================================                                        |  53%   90 MB
|==============================================                                        |  53%   90 MB
|==============================================                                        |  53%   90 MB
|==============================================                                        |  53%   91 MB
|==============================================                                        |  53%   91 MB
|==============================================                                        |  53%   91 MB
|==============================================                                        |  53%   91 MB
|===============================================                                       |  54%   91 MB
|===============================================                                       |  54%   91 MB
|===============================================                                       |  54%   92 MB
|===============================================                                       |  54%   92 MB
|===============================================                                       |  54%   92 MB
|===============================================                                       |  54%   92 MB
|===============================================                                       |  54%   92 MB
|===============================================                                       |  54%   93 MB
|===============================================                                       |  54%   93 MB
|===============================================                                       |  55%   93 MB
|================================================                                      |  55%   93 MB
|================================================                                      |  55%   93 MB
|================================================                                      |  55%   93 MB
|================================================                                      |  55%   94 MB
|================================================                                      |  55%   94 MB
|================================================                                      |  55%   94 MB
|================================================                                      |  55%   94 MB
|================================================                                      |  55%   94 MB
|================================================                                      |  56%   95 MB
|================================================                                      |  56%   95 MB
|================================================                                      |  56%   95 MB
|=================================================                                     |  56%   95 MB
|=================================================                                     |  56%   95 MB
|=================================================                                     |  56%   95 MB
|=================================================                                     |  56%   96 MB
|=================================================                                     |  56%   96 MB
|=================================================                                     |  56%   96 MB
|=================================================                                     |  57%   96 MB
|=================================================                                     |  57%   96 MB
|=================================================                                     |  57%   97 MB
|=================================================                                     |  57%   97 MB
|=================================================                                     |  57%   97 MB
|==================================================                                    |  57%   97 MB
|==================================================                                    |  57%   97 MB
|==================================================                                    |  57%   97 MB
|==================================================                                    |  57%   98 MB
|==================================================                                    |  57%   98 MB
|==================================================                                    |  58%   98 MB
|==================================================                                    |  58%   98 MB
|==================================================                                    |  58%   98 MB
|==================================================                                    |  58%   99 MB
|==================================================                                    |  58%   99 MB
|==================================================                                    |  58%   99 MB
|===================================================                                   |  58%   99 MB
|===================================================                                   |  58%   99 MB
|===================================================                                   |  58%   99 MB
|===================================================                                   |  59%  100 MB
|===================================================                                   |  59%  100 MB
|===================================================                                   |  59%  100 MB
|===================================================                                   |  59%  100 MB
|===================================================                                   |  59%  100 MB
|===================================================                                   |  59%  101 MB
|===================================================                                   |  59%  101 MB
|====================================================                                  |  59%  101 MB
|====================================================                                  |  59%  101 MB
|====================================================                                  |  60%  101 MB
|====================================================                                  |  60%  102 MB
|====================================================                                  |  60%  102 MB
|====================================================                                  |  60%  102 MB
|====================================================                                  |  60%  102 MB
|====================================================                                  |  60%  102 MB
|====================================================                                  |  60%  102 MB
|====================================================                                  |  60%  103 MB
|====================================================                                  |  60%  103 MB
|=====================================================                                 |  60%  103 MB
|=====================================================                                 |  61%  103 MB
|=====================================================                                 |  61%  103 MB
|=====================================================                                 |  61%  104 MB
|=====================================================                                 |  61%  104 MB
|=====================================================                                 |  61%  104 MB
|=====================================================                                 |  61%  104 MB
|=====================================================                                 |  61%  104 MB
|=====================================================                                 |  61%  104 MB
|=====================================================                                 |  61%  105 MB
|======================================================                                |  62%  105 MB
|======================================================                                |  62%  105 MB
|======================================================                                |  62%  105 MB
|======================================================                                |  62%  105 MB
|======================================================                                |  62%  106 MB
|======================================================                                |  62%  106 MB
|======================================================                                |  62%  106 MB
|======================================================                                |  62%  106 MB
|======================================================                                |  62%  106 MB
|======================================================                                |  63%  106 MB
|======================================================                                |  63%  107 MB
|=======================================================                               |  63%  107 MB
|=======================================================                               |  63%  107 MB
|=======================================================                               |  63%  107 MB
|=======================================================                               |  63%  107 MB
|=======================================================                               |  63%  108 MB
|=======================================================                               |  63%  108 MB
|=======================================================                               |  63%  108 MB
|=======================================================                               |  64%  108 MB
|=======================================================                               |  64%  108 MB
|=======================================================                               |  64%  108 MB
|=======================================================                               |  64%  109 MB
|========================================================                              |  64%  109 MB
|========================================================                              |  64%  109 MB
|========================================================                              |  64%  109 MB
|========================================================                              |  64%  109 MB
|========================================================                              |  64%  110 MB
|========================================================                              |  64%  110 MB
|========================================================                              |  65%  110 MB
|========================================================                              |  65%  110 MB
|========================================================                              |  65%  110 MB
|========================================================                              |  65%  111 MB
|=========================================================                             |  65%  111 MB
|=========================================================                             |  65%  111 MB
|=========================================================                             |  65%  111 MB
|=========================================================                             |  65%  111 MB
|=========================================================                             |  65%  111 MB
|=========================================================                             |  66%  112 MB
|=========================================================                             |  66%  112 MB
|=========================================================                             |  66%  112 MB
|=========================================================                             |  66%  112 MB
|=========================================================                             |  66%  112 MB
|=========================================================                             |  66%  113 MB
|==========================================================                            |  66%  113 MB
|==========================================================                            |  66%  113 MB
|==========================================================                            |  66%  113 MB
|==========================================================                            |  67%  113 MB
|==========================================================                            |  67%  113 MB
|==========================================================                            |  67%  114 MB
|==========================================================                            |  67%  114 MB
|==========================================================                            |  67%  114 MB
|==========================================================                            |  67%  114 MB
|==========================================================                            |  67%  114 MB
|==========================================================                            |  67%  115 MB
|===========================================================                           |  67%  115 MB
|===========================================================                           |  68%  115 MB
|===========================================================                           |  68%  115 MB
|===========================================================                           |  68%  115 MB
|===========================================================                           |  68%  115 MB
|===========================================================                           |  68%  116 MB
|===========================================================                           |  68%  116 MB
|===========================================================                           |  68%  116 MB
|===========================================================                           |  68%  116 MB
|===========================================================                           |  68%  116 MB
|============================================================                          |  68%  117 MB
|============================================================                          |  69%  117 MB
|============================================================                          |  69%  117 MB
|============================================================                          |  69%  117 MB
|============================================================                          |  69%  117 MB
|============================================================                          |  69%  117 MB
|============================================================                          |  69%  118 MB
|============================================================                          |  69%  118 MB
|============================================================                          |  69%  118 MB
|============================================================                          |  69%  118 MB
|============================================================                          |  70%  118 MB
|=============================================================                         |  70%  119 MB
|=============================================================                         |  70%  119 MB
|=============================================================                         |  70%  119 MB
|=============================================================                         |  70%  119 MB
|=============================================================                         |  70%  119 MB
|=============================================================                         |  70%  120 MB
|=============================================================                         |  70%  120 MB
|=============================================================                         |  70%  120 MB
|=============================================================                         |  71%  120 MB
|=============================================================                         |  71%  120 MB
|==============================================================                        |  71%  120 MB
|==============================================================                        |  71%  121 MB
|==============================================================                        |  71%  121 MB
|==============================================================                        |  71%  121 MB
|==============================================================                        |  71%  121 MB
|==============================================================                        |  71%  121 MB
|==============================================================                        |  71%  122 MB
|==============================================================                        |  72%  122 MB
|==============================================================                        |  72%  122 MB
|==============================================================                        |  72%  122 MB
|==============================================================                        |  72%  122 MB
|===============================================================                       |  72%  122 MB
|===============================================================                       |  72%  123 MB
|===============================================================                       |  72%  123 MB
|===============================================================                       |  72%  123 MB
|===============================================================                       |  72%  123 MB
|===============================================================                       |  73%  123 MB
|===============================================================                       |  73%  124 MB
|===============================================================                       |  73%  124 MB
|===============================================================                       |  73%  124 MB
|===============================================================                       |  73%  124 MB
|===============================================================                       |  73%  124 MB
|================================================================                      |  73%  124 MB
|================================================================                      |  73%  125 MB
|================================================================                      |  73%  125 MB
|================================================================                      |  73%  125 MB
|================================================================                      |  74%  125 MB
|================================================================                      |  74%  125 MB
|================================================================                      |  74%  126 MB
|================================================================                      |  74%  126 MB
|================================================================                      |  74%  126 MB
|================================================================                      |  74%  126 MB
|=================================================================                     |  74%  126 MB
|=================================================================                     |  74%  126 MB
|=================================================================                     |  74%  127 MB
|=================================================================                     |  75%  127 MB
|=================================================================                     |  75%  127 MB
|=================================================================                     |  75%  127 MB
|=================================================================                     |  75%  127 MB
|=================================================================                     |  75%  128 MB
|=================================================================                     |  75%  128 MB
|=================================================================                     |  75%  128 MB
|=================================================================                     |  75%  128 MB
|==================================================================                    |  75%  128 MB
|==================================================================                    |  76%  129 MB
|==================================================================                    |  76%  129 MB
|==================================================================                    |  76%  129 MB
|==================================================================                    |  76%  129 MB
|==================================================================                    |  76%  129 MB
|==================================================================                    |  76%  129 MB
|==================================================================                    |  76%  130 MB
|==================================================================                    |  76%  130 MB
|==================================================================                    |  76%  130 MB
|===================================================================                   |  77%  130 MB
|===================================================================                   |  77%  130 MB
|===================================================================                   |  77%  131 MB
|===================================================================                   |  77%  131 MB
|===================================================================                   |  77%  131 MB
|===================================================================                   |  77%  131 MB
|===================================================================                   |  77%  131 MB
|===================================================================                   |  77%  131 MB
|===================================================================                   |  77%  132 MB
|===================================================================                   |  77%  132 MB
|===================================================================                   |  78%  132 MB
|====================================================================                  |  78%  132 MB
|====================================================================                  |  78%  132 MB
|====================================================================                  |  78%  133 MB
|====================================================================                  |  78%  133 MB
|====================================================================                  |  78%  133 MB
|====================================================================                  |  78%  133 MB
|====================================================================                  |  78%  133 MB
|====================================================================                  |  78%  133 MB
|====================================================================                  |  79%  134 MB
|====================================================================                  |  79%  134 MB
|====================================================================                  |  79%  134 MB
|=====================================================================                 |  79%  134 MB
|=====================================================================                 |  79%  134 MB
|=====================================================================                 |  79%  135 MB
|=====================================================================                 |  79%  135 MB
|=====================================================================                 |  79%  135 MB
|=====================================================================                 |  79%  135 MB
|=====================================================================                 |  80%  135 MB
|=====================================================================                 |  80%  135 MB
|=====================================================================                 |  80%  136 MB
|=====================================================================                 |  80%  136 MB
|======================================================================                |  80%  136 MB
|======================================================================                |  80%  136 MB
|======================================================================                |  80%  136 MB
|======================================================================                |  80%  137 MB
|======================================================================                |  80%  137 MB
|======================================================================                |  81%  137 MB
|======================================================================                |  81%  137 MB
|======================================================================                |  81%  137 MB
|======================================================================                |  81%  138 MB
|======================================================================                |  81%  138 MB
|======================================================================                |  81%  138 MB
|=======================================================================               |  81%  138 MB
|=======================================================================               |  81%  138 MB
|=======================================================================               |  81%  138 MB
|=======================================================================               |  82%  139 MB
|=======================================================================               |  82%  139 MB
|=======================================================================               |  82%  139 MB
|=======================================================================               |  82%  139 MB
|=======================================================================               |  82%  139 MB
|=======================================================================               |  82%  140 MB
|=======================================================================               |  82%  140 MB
|========================================================================              |  82%  140 MB
|========================================================================              |  82%  140 MB
|========================================================================              |  82%  140 MB
|========================================================================              |  83%  140 MB
|========================================================================              |  83%  141 MB
|========================================================================              |  83%  141 MB
|========================================================================              |  83%  141 MB
|========================================================================              |  83%  141 MB
|========================================================================              |  83%  141 MB
|========================================================================              |  83%  142 MB
|========================================================================              |  83%  142 MB
|=========================================================================             |  83%  142 MB
|=========================================================================             |  84%  142 MB
|=========================================================================             |  84%  142 MB
|=========================================================================             |  84%  142 MB
|=========================================================================             |  84%  143 MB
|=========================================================================             |  84%  143 MB
|=========================================================================             |  84%  143 MB
|=========================================================================             |  84%  143 MB
|=========================================================================             |  84%  143 MB
|=========================================================================             |  84%  144 MB
|=========================================================================             |  85%  144 MB
|==========================================================================            |  85%  144 MB
|==========================================================================            |  85%  144 MB
|==========================================================================            |  85%  144 MB
|==========================================================================            |  85%  144 MB
|==========================================================================            |  85%  145 MB
|==========================================================================            |  85%  145 MB
|==========================================================================            |  85%  145 MB
|==========================================================================            |  85%  145 MB
|==========================================================================            |  85%  145 MB
|==========================================================================            |  86%  146 MB
|===========================================================================           |  86%  146 MB
|===========================================================================           |  86%  146 MB
|===========================================================================           |  86%  146 MB
|===========================================================================           |  86%  146 MB
|===========================================================================           |  86%  147 MB
|===========================================================================           |  86%  147 MB
|===========================================================================           |  86%  147 MB
|===========================================================================           |  86%  147 MB
|===========================================================================           |  87%  147 MB
|===========================================================================           |  87%  147 MB
|===========================================================================           |  87%  148 MB
|============================================================================          |  87%  148 MB
|============================================================================          |  87%  148 MB
|============================================================================          |  87%  148 MB
|============================================================================          |  87%  148 MB
|============================================================================          |  87%  149 MB
|============================================================================          |  87%  149 MB
|============================================================================          |  88%  149 MB
|============================================================================          |  88%  149 MB
|============================================================================          |  88%  149 MB
|============================================================================          |  88%  149 MB
|============================================================================          |  88%  150 MB
|=============================================================================         |  88%  150 MB
|=============================================================================         |  88%  150 MB
|=============================================================================         |  88%  150 MB
|=============================================================================         |  88%  150 MB
|=============================================================================         |  89%  151 MB
|=============================================================================         |  89%  151 MB
|=============================================================================         |  89%  151 MB
|=============================================================================         |  89%  151 MB
|=============================================================================         |  89%  151 MB
|=============================================================================         |  89%  151 MB
|==============================================================================        |  89%  152 MB
|==============================================================================        |  89%  152 MB
|==============================================================================        |  89%  152 MB
|==============================================================================        |  90%  152 MB
|==============================================================================        |  90%  152 MB
|==============================================================================        |  90%  153 MB
|==============================================================================        |  90%  153 MB
|==============================================================================        |  90%  153 MB
|==============================================================================        |  90%  153 MB
|==============================================================================        |  90%  153 MB
|==============================================================================        |  90%  154 MB
|===============================================================================       |  90%  154 MB
|===============================================================================       |  90%  154 MB
|===============================================================================       |  91%  154 MB
|===============================================================================       |  91%  154 MB
|===============================================================================       |  91%  154 MB
|===============================================================================       |  91%  155 MB
|===============================================================================       |  91%  155 MB
|===============================================================================       |  91%  155 MB
|===============================================================================       |  91%  155 MB
|===============================================================================       |  91%  155 MB
|================================================================================      |  91%  156 MB
|================================================================================      |  92%  156 MB
|================================================================================      |  92%  156 MB
|================================================================================      |  92%  156 MB
|================================================================================      |  92%  156 MB
|================================================================================      |  92%  156 MB
|================================================================================      |  92%  157 MB
|================================================================================      |  92%  157 MB
|================================================================================      |  92%  157 MB
|================================================================================      |  92%  157 MB
|================================================================================      |  93%  157 MB
|=================================================================================     |  93%  158 MB
|=================================================================================     |  93%  158 MB
|=================================================================================     |  93%  158 MB
|=================================================================================     |  93%  158 MB
|=================================================================================     |  93%  158 MB
|=================================================================================     |  93%  158 MB
|=================================================================================     |  93%  159 MB
|=================================================================================     |  93%  159 MB
|=================================================================================     |  94%  159 MB
|=================================================================================     |  94%  159 MB
|==================================================================================    |  94%  159 MB
|==================================================================================    |  94%  160 MB
|==================================================================================    |  94%  160 MB
|==================================================================================    |  94%  160 MB
|==================================================================================    |  94%  160 MB
|==================================================================================    |  94%  160 MB
|==================================================================================    |  94%  161 MB
|==================================================================================    |  95%  161 MB
|==================================================================================    |  95%  161 MB
|==================================================================================    |  95%  161 MB
|==================================================================================    |  95%  161 MB
|===================================================================================   |  95%  161 MB
|===================================================================================   |  95%  162 MB
|===================================================================================   |  95%  162 MB
|===================================================================================   |  95%  162 MB
|===================================================================================   |  95%  162 MB
|===================================================================================   |  95%  162 MB
|===================================================================================   |  96%  163 MB
|===================================================================================   |  96%  163 MB
|===================================================================================   |  96%  163 MB
|===================================================================================   |  96%  163 MB
|===================================================================================   |  96%  163 MB
|====================================================================================  |  96%  163 MB
|====================================================================================  |  96%  164 MB
|====================================================================================  |  96%  164 MB
|====================================================================================  |  96%  164 MB
|====================================================================================  |  97%  164 MB
|====================================================================================  |  97%  164 MB
|====================================================================================  |  97%  165 MB
|====================================================================================  |  97%  165 MB
|====================================================================================  |  97%  165 MB
|====================================================================================  |  97%  165 MB
|===================================================================================== |  97%  165 MB
|===================================================================================== |  97%  165 MB
|===================================================================================== |  97%  166 MB
|===================================================================================== |  98%  166 MB
|===================================================================================== |  98%  166 MB
|===================================================================================== |  98%  166 MB
|===================================================================================== |  98%  166 MB
|===================================================================================== |  98%  167 MB
|===================================================================================== |  98%  167 MB
|===================================================================================== |  98%  167 MB
|===================================================================================== |  98%  167 MB
|======================================================================================|  98%  167 MB
|======================================================================================|  99%  168 MB
|======================================================================================|  99%  168 MB
|======================================================================================|  99%  168 MB
|======================================================================================|  99%  168 MB
|======================================================================================|  99%  168 MB
|======================================================================================|  99%  168 MB
|======================================================================================|  99%  169 MB
|======================================================================================|  99%  169 MB
|======================================================================================|  99%  169 MB
|=======================================================================================| 100%  169 MB</code></pre>
<!-- rnb-output-end -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuIyBNYWtlIHRoZSBnZW5lIGNvbHVtbiB0aGUgcm93bmFtZXMgc28gdGhlIGdlbmUgbmFtZXMgYXJlIG91dCBvZiB0aGUgd2F5IGZvciBjYWxjdWxhdGlvbnNcbmBgYCJ9 -->
<pre class="r"><code># Make the gene column the rownames so the gene names are out of the way for calculations</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<p>Prep metadata to be in proper format for batch info to be used by ComBat</p>
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuIyBNZXRhZGF0YSBmaWxlIG5hbWVcbm1ldGFkYXRhLmZpbGVuYW1lIDwtIGZpbGUucGF0aChcIi4uXCIsIFwiZGF0YVwiLCBcIm1ldGFkYXRhX0hPTU9fU0FQSUVOUy50c3ZcIilcbiMgUmVhZCBpbiBkYXRhIHRzdiBmaWxlXG5tZXRhZGF0YSA8LSByZWFkcjo6cmVhZF90c3YobWV0YWRhdGEuZmlsZW5hbWUpXG5gYGAifQ== -->
<pre class="r"><code># Metadata file name
metadata.filename &lt;- file.path(&quot;..&quot;, &quot;data&quot;, &quot;metadata_HOMO_SAPIENS.tsv&quot;)
# Read in data tsv file
metadata &lt;- readr::read_tsv(metadata.filename)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-output-begin 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 -->
<pre><code>Parsed with column specification:
cols(
  .default = col_character(),
  refinebio_age = [33mcol_logical()[39m,
  refinebio_compound = [33mcol_logical()[39m,
  refinebio_disease_stage = [33mcol_logical()[39m,
  refinebio_genetic_information = [33mcol_logical()[39m,
  refinebio_race = [33mcol_logical()[39m,
  refinebio_sex = [33mcol_logical()[39m,
  refinebio_source_archive_url = [33mcol_logical()[39m,
  refinebio_subject = [33mcol_logical()[39m,
  `amount to core` = [32mcol_double()[39m,
  `cdna processing date` = [34mcol_date(format = &quot;&quot;)[39m,
  channel_count = [32mcol_double()[39m,
  `chip nr` = [32mcol_double()[39m,
  `chip#` = [32mcol_double()[39m,
  data_row_count = [32mcol_double()[39m,
  `date of rna extraction` = [34mcol_date(format = &quot;&quot;)[39m,
  detection_percentage = [32mcol_double()[39m,
  `dose (um)` = [32mcol_double()[39m,
  `exposure date` = [34mcol_date(format = &quot;&quot;)[39m,
  `harvest time point` = [32mcol_double()[39m,
  `hybridisation batch` = [32mcol_double()[39m
  # ... with 11 more columns
)
See spec(...) for full column specifications.</code></pre>
<!-- rnb-output-end -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuIyBkYXRhc2V0IDwtIGFzLmZhY3RvcihzdHJpbmdyOjp3b3JkKGNvbG5hbWVzKGRmKSwgc2VwID0gXCI6XCIsIDEpKVxuZGYgPC0gZGZbLCBtZXRhZGF0YSRyZWZpbmViaW9fYWNjZXNzaW9uX2NvZGVdXG4jIENoZWNrIGlmIHRoZSBzYW1wbGVzIGFyZSBpbiB0aGUgc2FtZSBvcmRlclxuYWxsLmVxdWFsKG1ldGFkYXRhJHJlZmluZWJpb19hY2Nlc3Npb25fY29kZSwgY29sbmFtZXMoZGYpKVxuYGBgIn0= -->
<pre class="r"><code># dataset &lt;- as.factor(stringr::word(colnames(df), sep = &quot;:&quot;, 1))
df &lt;- df[, metadata$refinebio_accession_code]
# Check if the samples are in the same order
all.equal(metadata$refinebio_accession_code, colnames(df))</code></pre>
<!-- rnb-source-end -->
<!-- rnb-output-begin eyJkYXRhIjoiWzFdIFRSVUVcbiJ9 -->
<pre><code>[1] TRUE</code></pre>
<!-- rnb-output-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<p>The refine.bio search gave us some cells that arent HEK293 so we will need to do some filtering. Because the metadata obtained from combining multiple datasets are not always able to be harmonized, we are going to have to search for HEK 293 cells in a couple different columns.</p>
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuIyBLZWVwIG9ubHkgdGhpbmdzIHRoYXQgaGF2ZSBldmlkZW5jZSB0aGF0IHRoZXkgYXJlIEhFSyBjZWxsc1xuaGVrMjkzIDwtIGdyZXAoXCJoZWt8MjkzfGhlayAyOTN8aGVrLTI5M1wiLCBcbiAgICAgICAgICAgICAgIHBhc3RlMChtZXRhZGF0YSRyZWZpbmViaW9fY2VsbF9saW5lLCBtZXRhZGF0YSRgY2VsbCBsaW5lYCwgbWV0YWRhdGEkdGl0bGUpLCBcbiAgICAgICAgICAgICAgIGlnbm9yZS5jYXNlID0gVFJVRSlcbiMgT25seSBrZWVwIHRoZXNlIGluIHRoZSBkYXRhIGFuZCBtZXRhZGF0YVxubWV0YWRhdGEgPC0gbWV0YWRhdGFbaGVrMjkzLCBdICU+JSBcbiAgcmVhZHI6OndyaXRlX3RzdihcImZpbHRlcmVkX21ldGFkYXRhX0hPTU9fU0FQSUVOUy50c3ZcIilcbiMgT25seSBrZWVwIHRoZXNlIGluIHRoZSBkYXRhIGFuZCBtZXRhZGF0YVxuZGYgPC0gZGZbLCBoZWsyOTNdICU+JSBcbiAgcmVhZHI6OndyaXRlX3RzdihcImZpbHRlcmVkX0hPTU9fU0FQSUVOUy50c3ZcIilcbiMgVGFrZSBhIGxvb2sgYXQgdGhlIGluZm9ybWF0aW9uIHdlIGhhdmUgZm9yIHRoZXNlIGRhdGFcbm1ldGFkYXRhXG5gYGAifQ== -->
<pre class="r"><code># Keep only things that have evidence that they are HEK cells
hek293 &lt;- grep(&quot;hek|293|hek 293|hek-293&quot;, 
               paste0(metadata$refinebio_cell_line, metadata$`cell line`, metadata$title), 
               ignore.case = TRUE)
# Only keep these in the data and metadata
metadata &lt;- metadata[hek293, ] %&gt;% 
  readr::write_tsv(&quot;filtered_metadata_HOMO_SAPIENS.tsv&quot;)
# Only keep these in the data and metadata
df &lt;- df[, hek293] %&gt;% 
  readr::write_tsv(&quot;filtered_HOMO_SAPIENS.tsv&quot;)
# Take a look at the information we have for these data
metadata</code></pre>
<!-- rnb-source-end -->
<!-- rnb-frame-begin {"metadata":{"classes":["tbl_df","tbl","data.frame"],"ncol":126,"nrow":622},"rdf":"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"} -->
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":["refinebio_accession_code"],"name":[1],"type":["chr"],"align":["left"]},{"label":["refinebio_age"],"name":[2],"type":["lgl"],"align":["right"]},{"label":["refinebio_cell_line"],"name":[3],"type":["chr"],"align":["left"]},{"label":["refinebio_compound"],"name":[4],"type":["lgl"],"align":["right"]},{"label":["refinebio_disease"],"name":[5],"type":["chr"],"align":["left"]},{"label":["refinebio_disease_stage"],"name":[6],"type":["lgl"],"align":["right"]},{"label":["refinebio_genetic_information"],"name":[7],"type":["lgl"],"align":["right"]},{"label":["refinebio_organism"],"name":[8],"type":["chr"],"align":["left"]},{"label":["refinebio_platform"],"name":[9],"type":["chr"],"align":["left"]},{"label":["refinebio_race"],"name":[10],"type":["lgl"],"align":["right"]},{"label":["refinebio_sex"],"name":[11],"type":["lgl"],"align":["right"]},{"label":["refinebio_source_archive_url"],"name":[12],"type":["lgl"],"align":["right"]},{"label":["refinebio_source_database"],"name":[13],"type":["chr"],"align":["left"]},{"label":["refinebio_specimen_part"],"name":[14],"type":["chr"],"align":["left"]},{"label":["refinebio_subject"],"name":[15],"type":["lgl"],"align":["right"]},{"label":["refinebio_time"],"name":[16],"type":["chr"],"align":["left"]},{"label":["refinebio_title"],"name":[17],"type":["chr"],"align":["left"]},{"label":["refinebio_treatment"],"name":[18],"type":["chr"],"align":["left"]},{"label":["agent"],"name":[19],"type":["chr"],"align":["left"]},{"label":["amount to core"],"name":[20],"type":["dbl"],"align":["right"]},{"label":["antibiotics (yes or no?)"],"name":[21],"type":["chr"],"align":["left"]},{"label":["array type"],"name":[22],"type":["chr"],"align":["left"]},{"label":["atcc number"],"name":[23],"type":["chr"],"align":["left"]},{"label":["background cell line"],"name":[24],"type":["chr"],"align":["left"]},{"label":["bioanalyzer results"],"name":[25],"type":["chr"],"align":["left"]},{"label":["biomaterial_provider_ch1"],"name":[26],"type":["chr"],"align":["left"]},{"label":["cd44 transfected"],"name":[27],"type":["chr"],"align":["left"]},{"label":["cdna processing date"],"name":[28],"type":["chr"],"align":["left"]},{"label":["cdna processing technician"],"name":[29],"type":["chr"],"align":["left"]},{"label":["cell line"],"name":[30],"type":["chr"],"align":["left"]},{"label":["cell population"],"name":[31],"type":["chr"],"align":["left"]},{"label":["cell type"],"name":[32],"type":["chr"],"align":["left"]},{"label":["channel_count"],"name":[33],"type":["dbl"],"align":["right"]},{"label":["chip nr"],"name":[34],"type":["dbl"],"align":["right"]},{"label":["chip#"],"name":[35],"type":["dbl"],"align":["right"]},{"label":["concentration"],"name":[36],"type":["chr"],"align":["left"]},{"label":["contact_address"],"name":[37],"type":["chr"],"align":["left"]},{"label":["contact_city"],"name":[38],"type":["chr"],"align":["left"]},{"label":["contact_country"],"name":[39],"type":["chr"],"align":["left"]},{"label":["contact_department"],"name":[40],"type":["chr"],"align":["left"]},{"label":["contact_email"],"name":[41],"type":["chr"],"align":["left"]},{"label":["contact_fax"],"name":[42],"type":["chr"],"align":["left"]},{"label":["contact_institute"],"name":[43],"type":["chr"],"align":["left"]},{"label":["contact_laboratory"],"name":[44],"type":["chr"],"align":["left"]},{"label":["contact_name"],"name":[45],"type":["chr"],"align":["left"]},{"label":["contact_phone"],"name":[46],"type":["chr"],"align":["left"]},{"label":["contact_state"],"name":[47],"type":["chr"],"align":["left"]},{"label":["contact_web_link"],"name":[48],"type":["chr"],"align":["left"]},{"label":["contact_zip/postal_code"],"name":[49],"type":["chr"],"align":["left"]},{"label":["data_processing"],"name":[50],"type":["chr"],"align":["left"]},{"label":["data_row_count"],"name":[51],"type":["dbl"],"align":["right"]},{"label":["date of rna extraction"],"name":[52],"type":["chr"],"align":["left"]},{"label":["description"],"name":[53],"type":["chr"],"align":["left"]},{"label":["detected_platform"],"name":[54],"type":["chr"],"align":["left"]},{"label":["detection_percentage"],"name":[55],"type":["dbl"],"align":["right"]},{"label":["dilution"],"name":[56],"type":["chr"],"align":["left"]},{"label":["dose (um)"],"name":[57],"type":["dbl"],"align":["right"]},{"label":["exposure date"],"name":[58],"type":["chr"],"align":["left"]},{"label":["expression vector"],"name":[59],"type":["chr"],"align":["left"]},{"label":["extract_protocol_ch1"],"name":[60],"type":["chr"],"align":["left"]},{"label":["genetic modifications"],"name":[61],"type":["chr"],"align":["left"]},{"label":["genotype"],"name":[62],"type":["chr"],"align":["left"]},{"label":["genotype/variation"],"name":[63],"type":["chr"],"align":["left"]},{"label":["geo_accession"],"name":[64],"type":["chr"],"align":["left"]},{"label":["glucose concentration"],"name":[65],"type":["chr"],"align":["left"]},{"label":["gnrhr"],"name":[66],"type":["chr"],"align":["left"]},{"label":["growth"],"name":[67],"type":["chr"],"align":["left"]},{"label":["growth condition"],"name":[68],"type":["chr"],"align":["left"]},{"label":["growth_protocol_ch1"],"name":[69],"type":["chr"],"align":["left"]},{"label":["harvest date"],"name":[70],"type":["chr"],"align":["left"]},{"label":["harvest time point"],"name":[71],"type":["dbl"],"align":["right"]},{"label":["hyb_protocol"],"name":[72],"type":["chr"],"align":["left"]},{"label":["hybridisation batch"],"name":[73],"type":["dbl"],"align":["right"]},{"label":["hybridization date"],"name":[74],"type":["chr"],"align":["left"]},{"label":["hybridization technician"],"name":[75],"type":["chr"],"align":["left"]},{"label":["immortalization method"],"name":[76],"type":["chr"],"align":["left"]},{"label":["label_ch1"],"name":[77],"type":["chr"],"align":["left"]},{"label":["label_protocol_ch1"],"name":[78],"type":["chr"],"align":["left"]},{"label":["labelling batch"],"name":[79],"type":["dbl"],"align":["right"]},{"label":["last_update_date"],"name":[80],"type":["chr"],"align":["left"]},{"label":["mapped_percentage"],"name":[81],"type":["dbl"],"align":["right"]},{"label":["molecule_ch1"],"name":[82],"type":["chr"],"align":["left"]},{"label":["number of cells seeded"],"name":[83],"type":["chr"],"align":["left"]},{"label":["organism_ch1"],"name":[84],"type":["chr"],"align":["left"]},{"label":["platform_id"],"name":[85],"type":["chr"],"align":["left"]},{"label":["protocol"],"name":[86],"type":["chr"],"align":["left"]},{"label":["ratio"],"name":[87],"type":["dbl"],"align":["right"]},{"label":["relation"],"name":[88],"type":["chr"],"align":["left"]},{"label":["replicate"],"name":[89],"type":["dbl"],"align":["right"]},{"label":["rna extraction method"],"name":[90],"type":["chr"],"align":["left"]},{"label":["rna extraction technician"],"name":[91],"type":["chr"],"align":["left"]},{"label":["rna integrity number"],"name":[92],"type":["dbl"],"align":["right"]},{"label":["sample preservation"],"name":[93],"type":["chr"],"align":["left"]},{"label":["sample type"],"name":[94],"type":["chr"],"align":["left"]},{"label":["scan date"],"name":[95],"type":["chr"],"align":["left"]},{"label":["scan_protocol"],"name":[96],"type":["chr"],"align":["left"]},{"label":["separation type"],"name":[97],"type":["chr"],"align":["left"]},{"label":["series_id"],"name":[98],"type":["chr"],"align":["left"]},{"label":["shRNA"],"name":[99],"type":["chr"],"align":["left"]},{"label":["sirna"],"name":[100],"type":["chr"],"align":["left"]},{"label":["sirna transfection"],"name":[101],"type":["chr"],"align":["left"]},{"label":["source_name_ch1"],"name":[102],"type":["chr"],"align":["left"]},{"label":["status"],"name":[103],"type":["chr"],"align":["left"]},{"label":["stimulation"],"name":[104],"type":["chr"],"align":["left"]},{"label":["stress"],"name":[105],"type":["chr"],"align":["left"]},{"label":["submission_date"],"name":[106],"type":["chr"],"align":["left"]},{"label":["supplementary_file"],"name":[107],"type":["chr"],"align":["left"]},{"label":["taxid_ch1"],"name":[108],"type":["dbl"],"align":["right"]},{"label":["time"],"name":[109],"type":["chr"],"align":["left"]},{"label":["time after transfection"],"name":[110],"type":["chr"],"align":["left"]},{"label":["time after transfection (hr)"],"name":[111],"type":["dbl"],"align":["right"]},{"label":["time point"],"name":[112],"type":["chr"],"align":["left"]},{"label":["time point (h)"],"name":[113],"type":["dbl"],"align":["right"]},{"label":["timepoint (h)"],"name":[114],"type":["dbl"],"align":["right"]},{"label":["tissue"],"name":[115],"type":["chr"],"align":["left"]},{"label":["title"],"name":[116],"type":["chr"],"align":["left"]},{"label":["transfected rna"],"name":[117],"type":["chr"],"align":["left"]},{"label":["transfected with"],"name":[118],"type":["chr"],"align":["left"]},{"label":["transfection"],"name":[119],"type":["chr"],"align":["left"]},{"label":["transgene"],"name":[120],"type":["chr"],"align":["left"]},{"label":["treatment"],"name":[121],"type":["chr"],"align":["left"]},{"label":["treatment_protocol_ch1"],"name":[122],"type":["chr"],"align":["left"]},{"label":["type"],"name":[123],"type":["chr"],"align":["left"]},{"label":["units of amount"],"name":[124],"type":["chr"],"align":["left"]},{"label":["units of harvest time point"],"name":[125],"type":["chr"],"align":["left"]},{"label":["vector"],"name":[126],"type":["chr"],"align":["left"]}],"data":[{"1":"GSM1254227","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293-CT.R3","18":"control","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"data were normalized with RMA, analysed with LPE with three FDR methods; the zreal value is indicated in the matrix","51":"28869","52":"NA","53":"Gene expression data","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the RNeasy Mini Kit (Qiagen), from three biological replicates, according to was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1254227","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown at 37C, in a humidified 10% CO2 incubator, in Dulbecco's modified Eagle's medium with GlutaMAX (Gibco) supplied with 10%FBS (Gibco) and 200 ug/ml Hygromycin B (10687-010-Invitrogen).","70":"NA","71":"NA","72":"Labeled cDNA was hybridized wiht GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) as described by the manufacturer.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RNA was amplified with GeneChip WT cDNA Synthesis and Amplification Kit (Affymetrix) and biotin labeld with GeneChip WT Terminal Labeling Kit (Affymetrix) according to the manufacturer's","79":"NA","80":"Jan 20 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Microarrays was scanned with the Affymetrix GeneChip Scanner 7G and the FS450_0007 protocol , as recommended in the GeneChip Hybridization, Wash, and Stain Kit (Affymetrix)","97":"NA","98":"['GSE51863', 'GSE51868']","99":"NA","100":"NA","101":"NA","102":"HEK293-CT cells","103":"Public on Dec 11 2015","104":"NA","105":"NA","106":"Oct 29 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1254nnn/GSM1254227/suppl/GSM1254227_HEK293-CT.R3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293-CT.R3","117":"NA","118":"NA","119":"NA","120":"NA","121":"control","122":"HEK-BAHD1 were generated by integration of a single copy of the BAHD1 cDNA under the control of the human cytomegalovirus (CMV) immediate-early enhancer/promoter in the HEK293 genome. In the isogenic control line (HEK293-CT), the -galactosidase DNA sequence was inserted in place of BAHD1, albeit out-of-frame to avoid translation into protein.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1039981","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,transfected,biological rep 5","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"GFP_5","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1039981","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 22 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE59666","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"['GSE20615', 'GSE59666']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,transfected,biological rep 5_24h","103":"Public on Nov 21 2012","104":"NA","105":"NA","106":"Nov 21 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1039nnn/GSM1039981/suppl/GSM1039981_AnP_Hu13302_062910_04_P27.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,transfected,biological rep 5","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546585","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"t469ns_3","18":"no treatment","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"t469ns_3:42ug.","61":"NA","62":"mutant hek_t469","63":"NA","64":"GSM546585","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C, 5% C02","70":"23-12-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"t469ns_3","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546585/suppl/GSM546585_t469ns_3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"t469ns_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"no treatment","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2129124","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"shCTL_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293t","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Chungang Univ., Heukseok-dong, Dongjak-gu, Seoul, Republic of Korea","38":"Seoul","39":"South Korea","40":"Department of Life Science","41":"NA","42":"NA","43":"Chung-Ang university","44":"Functional Genomics Laboratory","45":"Oh-Seok,,Jeong","46":"NA","47":"N/A","48":"NA","49":"ASI|KR|KS013|SEOUL","50":"Array data export processing and analysis was performed using Illumina GenomeStudio v2011.1 (Gene Expression Module v1.9.0)","51":"47321","52":"NA","53":"['3999350127_A_Grn', 'SAMPLE 1']","54":"illuminaHumanv4","55":"98.36614","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from shCTL, shlinc00598#2, and shlinc00598#3 cells using RNAiso Plus (TaKaRa).","61":"NA","62":"NA","63":"control","64":"GSM2129124","65":"NA","66":"NA","67":"NA","68":"NA","69":"linc00598 knockdown stable and control shRNA HEK293t cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% heat-inactivated fetal bovine serum and 0.05% penicillin-streptomycin at 37 C in a 5% CO2 atmosphere.","70":"NA","71":"NA","72":"Following fragmentation, 0.75 ug of cRNA were hybridized to the Illumina Expression Beadchip according to the protocols provided by the manufacturer","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared from 0.55 ug total RNA using the Illumina TotalPrep RNA Amplification Kit (Ambion, Austin,TX)","79":"NA","80":"Apr 22 2016","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using the Illumina Bead Array Reader Confocal Scanner","97":"NA","98":"GSE80514","99":"shCTL","100":"NA","101":"NA","102":"HEK293t, shCTL","103":"Public on Apr 22 2016","104":"NA","105":"NA","106":"Apr 21 2016","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"shCTL_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881015","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 1","17":"Producer culture - fermentation 1- time point 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"2","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 13","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"recombinant protein producer","64":"GSM881015","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Producer culture - fermentation 1- time point 1","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 1","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Producer culture - fermentation 1- time point 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM569353","2":"NA","3":"embryonic kidney cell line hek","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Mutatn in the absence of tetracycline, rep3","18":"NA","19":"untreated","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Embryonic kidney cell line HEK","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1 Oryong-dong Buk-gu","38":"Gwangju","39":"South Korea","40":"Life science","41":"lbc0523@gist.ac.kr","42":"82629702540","43":"Gwangju Institutue Science and Technology","44":"NA","45":"Byoung-Cheol,,Lee","46":"82629702566","47":"NA","48":"NA","49":"500712","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from HEK cells non-expressing mutant TRPM7 channel', 'Mutant no3']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"mutant channel","64":"GSM569353","65":"NA","66":"NA","67":"NA","68":"NA","69":"Stabel cell-lines were grown in in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum and an antibiotic, 5 ug/mL blasticidin (Invitrogen). Cells were cultured in a humidified atmosphere of 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Fragmented cRNA was hybridized to the Human Genome UI133 Plus 2.0 Array (Affymetrix) at 45C for 16 h according to the Affymetrix standard protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"5 ug of total RNA from each cell-lines was used for labeling. Probe synthesis from total RNA samples, hybridization, detection, and scanning were performed according to standard protocols from Affymetrix, Inc..","79":"NA","80":"Jul 23 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"After hybridization, the arrays were washed in a GeneChip Fluidics Station 450 with a non-stringent wash buffer at 25C followed by a stringent wash buffer at 50C. After washing, the arrays were stained with a streptavidin-phycoerythrin complex. After staining, intensities were determined with a GeneChip scanner 3000 (Affymetrix), controlled by GCOS Affymetrix software.","97":"NA","98":"GSE23102","99":"NA","100":"NA","101":"NA","102":"HEK cell lines non-expressing mutant channel","103":"Public on Jul 23 2011","104":"NA","105":"NA","106":"Jul 23 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM569nnn/GSM569353/suppl/GSM569353.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Mutatn in the absence of tetracycline, rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 ug of tetracycline was treated to stabel cell-lines which overexressing WT and mutant TRPM7 channel for 72 hours","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM569345","2":"NA","3":"embryonic kidney cell line hek","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"WT in the absence of tetracycline, rep1","18":"NA","19":"untreated","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Embryonic kidney cell line HEK","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1 Oryong-dong Buk-gu","38":"Gwangju","39":"South Korea","40":"Life science","41":"lbc0523@gist.ac.kr","42":"82629702540","43":"Gwangju Institutue Science and Technology","44":"NA","45":"Byoung-Cheol,,Lee","46":"82629702566","47":"NA","48":"NA","49":"500712","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from HEK cells non-expressing WT TRPM7 channel', 'WT no1']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"WT channel","64":"GSM569345","65":"NA","66":"NA","67":"NA","68":"NA","69":"Stabel cell-lines were grown in in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum and an antibiotic, 5 ug/mL blasticidin (Invitrogen). Cells were cultured in a humidified atmosphere of 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Fragmented cRNA was hybridized to the Human Genome UI133 Plus 2.0 Array (Affymetrix) at 45C for 16 h according to the Affymetrix standard protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"5 ug of total RNA from each cell-lines was used for labeling. Probe synthesis from total RNA samples, hybridization, detection, and scanning were performed according to standard protocols from Affymetrix, Inc..","79":"NA","80":"Jul 23 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"After hybridization, the arrays were washed in a GeneChip Fluidics Station 450 with a non-stringent wash buffer at 25C followed by a stringent wash buffer at 50C. After washing, the arrays were stained with a streptavidin-phycoerythrin complex. After staining, intensities were determined with a GeneChip scanner 3000 (Affymetrix), controlled by GCOS Affymetrix software.","97":"NA","98":"GSE23102","99":"NA","100":"NA","101":"NA","102":"HEK cell lines non-expressing WT channel","103":"Public on Jul 23 2011","104":"NA","105":"NA","106":"Jul 23 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM569nnn/GSM569345/suppl/GSM569345.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"WT in the absence of tetracycline, rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 ug of tetracycline was treated to stabel cell-lines which overexressing WT and mutant TRPM7 channel for 72 hours","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442100","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,8h,transfected,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"8 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442100","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, transfected_8h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442100/suppl/GSM1442100_8hGFPP_REP2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,8h,transfected,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2089908","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U219 Array (hgu219)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T_siRNA(dharmacon)BRD1_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Bartholins All 6","38":"Aarhus","39":"Denmark","40":"Biomedicine","41":"tue@biomed.au.dk","42":"NA","43":"Aarhus University","44":"Prof Anders Borglum's lab","45":"Tue,,Fryland","46":"NA","47":"Aarhus","48":"NA","49":"8000","50":"rma","51":"49386","52":"NA","53":"siRNA treatment targeted against the BRD1 mRNA transcript (Dharmacon) rep1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Qiagen Rneasy + Qiagen shredder columns (performed according to the supplied protocol)","61":"NA","62":"NA","63":"NA","64":"GSM2089908","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells (controls and stable BRD1-S-V5 and BRD1-L-V5 cell lines) were grown in DMEM medium (Invitrogen, San Diego, CA, USA) supplemented with 5% fetal calf serum (FCS), 175 mg/L glutamine, 36 mg/L penicillin and 60 mg/L streptomycine at 37 oC in 5% CO2","70":"NA","71":"NA","72":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","79":"NA","80":"Mar 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL13667","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"standard Affymetrix protocol","97":"NA","98":"GSE79255","99":"NA","100":"NA","101":"NA","102":"Cell line culture, siRNA agianst BRD1 method 2","103":"Public on Mar 16 2016","104":"NA","105":"NA","106":"Mar 15 2016","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2089nnn/GSM2089908/suppl/GSM2089908_A897-03.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_siRNA(dharmacon)BRD1_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693950","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"72h","17":"HEK293T_mock-transfection_72h_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_m_2_72', 'MOCK_m_2_0ng_72h_293T.CEL', 'Gene expression data from HEK 293T cells 72h after mock transfection without siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"control","64":"GSM693950","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"mock (without siRNA)","102":"HEK 293T cells, mock transfection, 72h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693950/suppl/GSM693950.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693950/suppl/GSM693950.EXP.gz']","108":"9606","109":"72h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_mock-transfection_72h_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1399567","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"78h after transfection","17":"shLSD1, bio. replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"615 N. Wolfe St.","38":"Baltimore","39":"USA","40":"NA","41":"NA","42":"NA","43":"Johns Hopkins University","44":"NA","45":"Jiou,,Wang","46":"NA","47":"MD","48":"NA","49":"21205","50":"[\"Affymetrix CEL files were extracted and their data normalized with the Partek GS 6.6 platform.  Partek's Extended Meta-Probeset set was used with RMA normalization to create quantile-normalized log2 transcript signal values, which were used in subsequent ANOVA analyses.\", 'probe group file: HuGene-1_0-st-v1.r4.pgf', 'meta-probeset file: HuGene-1_0-st-v1.na32.hg19.transcript.csv']","51":"33297","52":"NA","53":"SAMPLE 3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Cells were lysed using RNAeasy mini kit (Qiagen), according to manufacturer's instructions. Genomic DNA was first removed by DNAse treatment on the column, and then, additionally, after total RNA was isolated, using DNase Turbo kit (Ambion), followed by additional round of cleaning through RNAeasy columns.","61":"NA","62":"NA","63":"NA","64":"GSM1399567","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells grown in DMEM, 10%FBS, 37C, 5% CO2","70":"NA","71":"NA","72":"17hrs at 45 C with rotation (60rpm) as described by Affymetrix in their GeneChip Expression Analysis Technical Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The Ambion Expression WT kit was used as described in the manufacturer's manual.","79":"NA","80":"Feb 09 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Using Affymetrix GeneChip Scanner 3000 7G and default parameters described by the manufacturer in their GeneChip Expression Analysis Technical Manual","97":"NA","98":"GSE58026","99":"NA","100":"NA","101":"NA","102":"HEK293_shLSD1","103":"Public on Feb 09 2017","104":"NA","105":"NA","106":"May 28 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1399nnn/GSM1399567/suppl/GSM1399567_GPer-SOD-A3_L-1a-HuGene_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"78h after transfection","113":"NA","114":"NA","115":"NA","116":"shLSD1, bio. replicate 1","117":"NA","118":"shRNAs against LSD1","119":"NA","120":"NA","121":"NA","122":"Cells were transfected in 60mm dishes using 4g DNA, 10l Lipofectamine 2000, in total 4.5ml  Optimem-MEM1. Origene's pRS-RFP-C plasmids encoding shRNAs against UBE4B and LSD1, or non-targeting control (CTRL) were used for knockdown. Cells were knocked down for 78h before lysis.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861624","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Mutant, no leptin, biological replicate 2","18":"untreated","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"PO Box 800741","38":"Charlottesville","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Virginia","44":"NA","45":"Stephen,,Turner","46":"NA","47":"VA","48":"NA","49":"22908","50":"Data extraction, QC, and GCRMA normalization were performed with BioConductor software.  Differential expression was assessed with moderated ANOVA, using the BioConductor limma package; false discovery rate (FDR) estimates were calculated using the Benjamini-Hochberg method.","51":"54675","52":"NA","53":"Mutant, no leptin, biological replicate 2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was prepared using RNeasy Mini kit (QIAGEN) and its quality was verified in an Agilent Bioanalyzer.","61":"NA","62":"NA","63":"NA","64":"GSM861624","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T/17 cells were maintained in a humidified incubator at 37 C with 5% CO2. HEK293T/17 cells were cultured in DMEM/F12 (Gibco) with non-essential amino acids, sodium pyruvate and 10% heat inactivated FBS.  Jurkat T-cells were cultured in RPMI supplemented with 10% heat inactivated FBS.  Caco-2 cells were cultured in EMEM (Gibco) supplemented with non-essential amino acids, sodium pyruvate and 20% heat inactivated FBS.  Cells were discarded after passage 25 and new cultures were started from frozen stocks. HEK293T117 cells were transiently transfected using lipofectamine 2000 per the product instructions (Invitrogen, Carlsbad, CA). The plasmids mLEPRb/pCDNA3 (47), mLEPRbR223/pCDNA3 (35) and LEPRbDelta65/pCDNA3 (47) were obtained from Martin Myers and have been described previously as referenced. pCDNA3 was used as a vector control. The plasmid mLEPRb/pCDNA3 was used as a template for site-directed mutagenesis to construct mLEPRb985L/pCDNA3, LEPRb1077L/pCDNA3 and mLEPRb1138L/pCDNA3.  Site-directed mutagenesis was done using the quikchange kit (Stragene/Agilent, Santa Clara, CA).    The presence of the desired mutations and the absence of other mutations were confirmed by DNA sequencing.","70":"NA","71":"NA","72":"Three biological replicates of each sample were hybridized to Human Genome U133 Plus 2.0 gene chips (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA was amplified and converted to cDNA using the 3' IVT Express Kit (Affymetrix).","79":"NA","80":"Jan 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned using the GeneChip Scanner 3000 7G (AffyMetrix).","97":"NA","98":"GSE35068","99":"NA","100":"NA","101":"NA","102":"Mutant, no leptin","103":"Public on Jan 01 2015","104":"NA","105":"NA","106":"Jan 12 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861624/suppl/GSM861624_MUT+2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Mutant, no leptin, biological replicate 2","117":"NA","118":"NA","119":"Y1138L (STAT3-mutant) leptin receptor","120":"NA","121":"untreated","122":"HEK293 cells were transfected with WT LepR or Y1138L (STAT3-mutant) leptin receptor.  48 hours post-transfection cells were made quiescent by incubation in optimum plus 0.5% BSA for 3 hours.  Cells were then stimulated with 100ng of leptin or maintained in optimum plus 0.5% BSA for an additional 3 hours. Leptin was purchased from Dr. A.F. Parlow, National Hormone and Peptide Program (Torrance, CA). The STAT3 inhibitor, Stattic, the PI3K inhibitor, LY294002 and the MEK inhibitor PD98059 were purchased from EMD chemicals (Gibbstown, NJ).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874637","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T2h_DMSO+2h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874637","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 2h and subsequent DMSO 2h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874637/suppl/GSM1874637_RG_38_4OHT_DMSO_2h_2h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T2h_DMSO+2h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693947","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"72h","17":"HEK293T_BACH1-siRNA2_72h_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_s_2_72', 'BACH1_s_2_300ng_72h_293T.CEL', 'Gene expression data from HEK 293T cells 72h after knockdown of BACH1 with Stealth siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693947","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"siRNA2 HSS100910 (s)","102":"HEK 293T cells, BACH1 knockdown, 72h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693947/suppl/GSM693947.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693947/suppl/GSM693947.EXP.gz']","108":"9606","109":"72h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-siRNA2_72h_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546581","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"t466nsbis_2","18":"no treatment","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"t466ns_2:62ug.","61":"NA","62":"mutant hek293_t466","63":"NA","64":"GSM546581","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C, 5% C02","70":"20-10-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"t466nsbis_2","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546581/suppl/GSM546581_t466nsbis_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"t466nsbis_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"no treatment","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1039977","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,control,biological rep 4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"CTR_4","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1039977","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Nov 21 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE20615","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,control,biological rep 4","103":"Public on Nov 21 2012","104":"NA","105":"NA","106":"Nov 21 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1039nnn/GSM1039977/suppl/GSM1039977_AnP_Hu13302_062910_03_CTR26.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,control,biological rep 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733385","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071128 CEES exposure 1.0 uM_1h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-22","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-30","53":"Gene expression data from NHEK_071128 CEES exposure 1.0 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"1.0","58":"2007-11-28","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733385","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-08","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-10","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071128 CEES exposure 1.0 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733385/suppl/GSM733385_071128_CEES_1h_1.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_071128 CEES exposure 1.0 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560879","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 h","17":"MOCK_6h_MDP_biological replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"control mock","63":"NA","64":"GSM560879","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560879/suppl/GSM560879.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"6 h","113":"NA","114":"NA","115":"NA","116":"MOCK_6h_MDP_biological replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM648456","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"empty vector control, biological rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"3-1-1 Maidashi, Higashi-ku","38":"Fukuoka","39":"Japan","40":"Reseach Center for Genetic Information","41":"yiwasita@gen.kyushu-u.ac.jp","42":"+81-92-632-2375","43":"Kyushu University, Medical Institute of Bioregulation","44":"Division of Genome Analysis","45":"Yuji,,Iwashita","46":"+81-92-642-6170","47":"Fukuoka","48":"http://www.gen.kyushu-u.ac.jp/~genome/","49":"812-8582","50":"['Cel files were summarized and normalized with Robust Multi-array Average (RMA) method in Expression Console software version 1.1.1 (Affymetrix). Logarithmic signal intensities were antilog-transformed to linear scale using Expression Console.', 'probe group file: HuGene-1_0-st-v1.r3.pgf', 'meta-probeset file: HuGene-1_0-st-v1.r3.mps']","51":"33297","52":"NA","53":"neo-3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from triplicated transfectants for each plasmid using RNeasy plus mini kit (74134, Qiagen, Hilden, Germany). RNA quality was checked using 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA), and RNA Integrity Number (RIN) was confirmed to be 9.4 or greater for all samples. Total RNA at 200 ng was amplified and reverse-transcribed using GeneChip WT Sense Target Labeling and Control Reagents (900652, Affymetrix).","61":"NA","62":"NA","63":"NA","64":"GSM648456","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were obtained from Clontech (Mountain View, MO) and maintained in Dulbeccos modified Eagles medium (D5796, Sigma-Aldrich, St. Louis, CA), supplemented with 10% fetal bovine serum, 100 units/ml penicillin and 100 g/ml streptomycin (15140-122, Invitrogen, Carlsbad, CA), in 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Samples were hybridized using Affymetrix hybridization kit materials. The cocktails were heated at 99C for 5 minutes, then 45C for 5 minutes and centrifuged at max speed for 1 minute. The 80 l of hyb solution was transfered to each array, then seal the holes with sticker. They were hybridized for 18 hours in 45C hybridization oven at 60 rpm. Fluidics Script Protocol was FS450_0007","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Samples were enzymatically fragmented and biotinylated using the WT Terminal Labeling Kit (Affymetrix)","79":"NA","80":"Jan 31 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix GeneChiP Scanner 3000 7G","97":"NA","98":"GSE26420","99":"NA","100":"NA","101":"NA","102":"HEK293 cell clone stably transformed with pCI-neo (empty vector). Clone No.3","103":"Public on Jan 31 2012","104":"NA","105":"NA","106":"Jan 04 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM648nnn/GSM648456/suppl/GSM648456.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"empty vector control, biological rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293 cells were transfected with pCI-neo (empty vector control) or pCI-neo-FLAG-HA-MIBP1 linearized with AclI and selected at 400 g/ml G418 (345812, Calbiochem, San Diego, CA) for 2 weeks. Selected cells were cloned using cloning rings and maintained in the presence of G418. Genomic integration and protein expression of MIBP1 were confirmed by genomic PCR and immunoblotting using anti-FLAG M2 antibody (Sigma-Aldrich).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM360323","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Human embryonic kidney cells (HEK293) at 0hr, replicate 4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"50 South Drive, Bldg.50, Rm.2347","38":"Bethesda","39":"USA","40":"NA","41":"changah@nhlbi.nih.gov","42":"NA","43":"NIH\\\\NHLBI","44":"Laboratory of Biochemistry","45":"Allen,HK,Chang","46":"NA","47":"MD","48":"NA","49":"20892","50":"The data were first processed with GCOS1.4 using Affymetrix default analysis settings. The trimmed mean target intensity of each array was arbitrarily set to 1000. Intensities obtained in CHP file generated by GCOS were normalized using an adaptive variance-stabilizing quantile normalization (Munson, P.J., GeneLogic Workshop of Low Level Analysis of Affymetrix GeneChip Data, 2001, software available at http://abs.cit.nih.gov/geneexpression.html).","51":"54675","52":"NA","53":"gene expression data from human embryonic kidney cells (cell culture)","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 cells using Qiagen RNeasy Mini Kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM360323","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells are maintained in DMEM supplemented with 10% fetal bovine serum in 3% oxygen, 5% carbon dioxide, 37 degrees Celsius humidified incubator.","70":"NA","71":"NA","72":"Fragmented RNA was hybridized to Affymetrix HG-U133 plus 2.0 chips for 16 hours, washed, stained on an Affymetrix fluidics station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol using Affymetrixs IVT labeling kit following the manufacturers directions.","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Hybridized chips were scanned using Affymetrix genechip scanner 3000","97":"NA","98":"GSE14429","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) at 0hr","103":"Public on Jan 15 2009","104":"NA","105":"NA","106":"Jan 14 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM360nnn/GSM360323/suppl/GSM360323.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Human embryonic kidney cells (HEK293) at 0hr, replicate 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 uM epoxomicin is added to HEK293 cells and incubated for 1 and 6 hours before RNA extraction. RNA was extracted from cells without treatment at zero time point as control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1254228","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK-BAHD1.R1","18":"over-expressing the bahd1 gene","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"data were normalized with RMA, analysed with LPE with three FDR methods; the zreal value is indicated in the matrix","51":"28869","52":"NA","53":"Gene expression data","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the RNeasy Mini Kit (Qiagen), from three biological replicates, according to was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1254228","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown at 37C, in a humidified 10% CO2 incubator, in Dulbecco's modified Eagle's medium with GlutaMAX (Gibco) supplied with 10%FBS (Gibco) and 200 ug/ml Hygromycin B (10687-010-Invitrogen).","70":"NA","71":"NA","72":"Labeled cDNA was hybridized wiht GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) as described by the manufacturer.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RNA was amplified with GeneChip WT cDNA Synthesis and Amplification Kit (Affymetrix) and biotin labeld with GeneChip WT Terminal Labeling Kit (Affymetrix) according to the manufacturer's","79":"NA","80":"Jan 20 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Microarrays was scanned with the Affymetrix GeneChip Scanner 7G and the FS450_0007 protocol , as recommended in the GeneChip Hybridization, Wash, and Stain Kit (Affymetrix)","97":"NA","98":"['GSE51863', 'GSE51868']","99":"NA","100":"NA","101":"NA","102":"HEK-BAHD1 cells","103":"Public on Dec 11 2015","104":"NA","105":"NA","106":"Oct 29 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1254nnn/GSM1254228/suppl/GSM1254228_HEK-BAHD1.R1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK-BAHD1.R1","117":"NA","118":"NA","119":"NA","120":"NA","121":"over-expressing the BAHD1 gene","122":"HEK-BAHD1 were generated by integration of a single copy of the BAHD1 cDNA under the control of the human cytomegalovirus (CMV) immediate-early enhancer/promoter in the HEK293 genome. In the isogenic control line (HEK293-CT), the -galactosidase DNA sequence was inserted in place of BAHD1, albeit out-of-frame to avoid translation into protein.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM678680","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Control_0_h_Replicate 1","18":"NA","19":"Control","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"5","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 2","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678680","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"2","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"1","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"0","114":"NA","115":"NA","116":"HEK293_Control_0_h_Replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1399576","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"78h after transfection","17":"shUBE4B+shLSD1, bio. replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"615 N. Wolfe St.","38":"Baltimore","39":"USA","40":"NA","41":"NA","42":"NA","43":"Johns Hopkins University","44":"NA","45":"Jiou,,Wang","46":"NA","47":"MD","48":"NA","49":"21205","50":"[\"Affymetrix CEL files were extracted and their data normalized with the Partek GS 6.6 platform.  Partek's Extended Meta-Probeset set was used with RMA normalization to create quantile-normalized log2 transcript signal values, which were used in subsequent ANOVA analyses.\", 'probe group file: HuGene-1_0-st-v1.r4.pgf', 'meta-probeset file: HuGene-1_0-st-v1.na32.hg19.transcript.csv']","51":"33297","52":"NA","53":"SAMPLE 12","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Cells were lysed using RNAeasy mini kit (Qiagen), according to manufacturer's instructions. Genomic DNA was first removed by DNAse treatment on the column, and then, additionally, after total RNA was isolated, using DNase Turbo kit (Ambion), followed by additional round of cleaning through RNAeasy columns.","61":"NA","62":"NA","63":"NA","64":"GSM1399576","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells grown in DMEM, 10%FBS, 37C, 5% CO2","70":"NA","71":"NA","72":"17hrs at 45 C with rotation (60rpm) as described by Affymetrix in their GeneChip Expression Analysis Technical Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The Ambion Expression WT kit was used as described in the manufacturer's manual.","79":"NA","80":"Feb 09 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Using Affymetrix GeneChip Scanner 3000 7G and default parameters described by the manufacturer in their GeneChip Expression Analysis Technical Manual","97":"NA","98":"GSE58026","99":"NA","100":"NA","101":"NA","102":"HEK293_shUBE4B+shLSD1","103":"Public on Feb 09 2017","104":"NA","105":"NA","106":"May 28 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1399nnn/GSM1399576/suppl/GSM1399576_GPer-SOD-C4_UL-1a-HuGene_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"78h after transfection","113":"NA","114":"NA","115":"NA","116":"shUBE4B+shLSD1, bio. replicate 3","117":"NA","118":"shRNAs against UBE4B and LSD1","119":"NA","120":"NA","121":"NA","122":"Cells were transfected in 60mm dishes using 4g DNA, 10l Lipofectamine 2000, in total 4.5ml  Optimem-MEM1. Origene's pRS-RFP-C plasmids encoding shRNAs against UBE4B and LSD1, or non-targeting control (CTRL) were used for knockdown. Cells were knocked down for 78h before lysis.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1754835","2":"NA","3":"hek-293t (human kidney epithelial cell line)","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK-293T_194","18":"transfected with mir-194 mimics for 48 hrs","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293T (human kidney epithelial cell line)","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Shanghai Medical College, Fudan University 1207 Rm., 2# Bldg., 270 Dong An Rd.","38":"Shanghai","39":"China","40":"Fudan University Shanghai Cancer Center","41":"cybao.cpu@163.com","42":"NA","43":"Fudan University","44":"NA","45":"Chunyang,,Bao","46":"86-21-34777580","47":"Shanghai","48":"NA","49":"200032","50":"Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0  (Agilent technologies, Santa Clara, CA, US).","51":"54675","52":"NA","53":"Gene expression data from HEK-293T cells transfected with miR-194 mimics","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1754835","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK-293T cells were cultured in Dulbeccos modified Eagles medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics at 37C and 5% CO2.","70":"NA","71":"NA","72":"Array hybridization and wash was performed using GeneChip  Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturers instructions.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol, using the GeneChip 3IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US).","79":"NA","80":"Jul 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Slides were scanned by GeneChip Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US) and Command Console Software 3.1 (Affymetrix, Santa Clara, CA, US) with default settings.","97":"NA","98":"GSE70434","99":"NA","100":"NA","101":"NA","102":"HEK-293T cells transfected with miR-194 mimics","103":"Public on Jul 01 2015","104":"NA","105":"NA","106":"Jul 01 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1754nnn/GSM1754835/suppl/GSM1754835_HEK-293T_194.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK-293T_194","117":"NA","118":"NA","119":"NA","120":"NA","121":"transfected with mir-194 mimics for 48 hrs","122":"We used lipofectamine 2000 reagent (Invitrogen) to transfect cells with in vitro synthesized miRNA mimic (Genepharma) at a final concentration of 50 nM.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM569349","2":"NA","3":"embryonic kidney cell line hek","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"WT in the presence of tetracycline, rep2","18":"NA","19":"tetracycline","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Embryonic kidney cell line HEK","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1 Oryong-dong Buk-gu","38":"Gwangju","39":"South Korea","40":"Life science","41":"lbc0523@gist.ac.kr","42":"82629702540","43":"Gwangju Institutue Science and Technology","44":"NA","45":"Byoung-Cheol,,Lee","46":"82629702566","47":"NA","48":"NA","49":"500712","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from HEK cells expressing WT TRPM7 channel', 'WT tet2']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"WT channel","64":"GSM569349","65":"NA","66":"NA","67":"NA","68":"NA","69":"Stabel cell-lines were grown in in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum and an antibiotic, 5 ug/mL blasticidin (Invitrogen). Cells were cultured in a humidified atmosphere of 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Fragmented cRNA was hybridized to the Human Genome UI133 Plus 2.0 Array (Affymetrix) at 45C for 16 h according to the Affymetrix standard protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"5 ug of total RNA from each cell-lines was used for labeling. Probe synthesis from total RNA samples, hybridization, detection, and scanning were performed according to standard protocols from Affymetrix, Inc..","79":"NA","80":"Jul 23 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"After hybridization, the arrays were washed in a GeneChip Fluidics Station 450 with a non-stringent wash buffer at 25C followed by a stringent wash buffer at 50C. After washing, the arrays were stained with a streptavidin-phycoerythrin complex. After staining, intensities were determined with a GeneChip scanner 3000 (Affymetrix), controlled by GCOS Affymetrix software.","97":"NA","98":"GSE23102","99":"NA","100":"NA","101":"NA","102":"HEK cell lines expressing WT channel","103":"Public on Jul 23 2011","104":"NA","105":"NA","106":"Jul 23 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM569nnn/GSM569349/suppl/GSM569349.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"WT in the presence of tetracycline, rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 ug of tetracycline was treated to stabel cell-lines which overexressing WT and mutant TRPM7 channel for 72 hours","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693934","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24h","17":"HEK293T_BACH1-siRNA2_24h_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_s_2_24', 'BACH1_s_2_300ng_24h_293T.CEL', 'Gene expression data from HEK 293T cells 24h after knockdown of BACH1 with Stealth siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693934","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"siRNA2 HSS100910 (s)","102":"HEK 293T cells, BACH1 knockdown, 24h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693934/suppl/GSM693934.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693934/suppl/GSM693934.EXP.gz']","108":"9606","109":"24h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-siRNA2_24h_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2716910","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human emborynic kidney 293 cells","15":"NA","16":"NA","17":"overexpression of the empty lentiviral vector_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"156 Xierhuan Road","38":"Fuzhou","39":"China","40":"NA","41":"xmuywj@163.com","42":"NA","43":"Fuzhou General Hospital","44":"NA","45":"Yang,,wenjing","46":"+8615959229926","47":"NA","48":"NA","49":"350025","50":"The data were analyzed using Affymetrix GeneChip Command Console Software.","51":"54675","52":"NA","53":"overexpression of the empty lentiviral vector in HEK293T cells","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM2716910","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell lines were grown at 37C with 5% CO2","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 23 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using GeneChip Scanner 3000.","97":"NA","98":"GSE101830","99":"NA","100":"NA","101":"NA","102":"overexpression of the empty lentiviral vector in HEK293T cells","103":"Public on Jul 26 2017","104":"NA","105":"NA","106":"Jul 25 2017","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2716nnn/GSM2716910/suppl/GSM2716910_161020-160682B_A_HG-U133_Plus_2_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"human emborynic kidney 293 cells","116":"overexpression of the empty lentiviral vector_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"DMEM medium with 10% FBS and 1% penicillin/streptomycin","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693942","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"72h","17":"HEK293T_BACH1-esiRNA_72h_rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_e_3_72', 'BACH1_e_3_200ng_72h_293T.CEL', 'Gene expression data from HEK 293T cells 72h after knockdown of BACH1 with esiRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693942","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"esiRNA (e)","102":"HEK 293T cells, BACH1 knockdown, 72h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693942/suppl/GSM693942.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693942/suppl/GSM693942.EXP.gz']","108":"9606","109":"72h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-esiRNA_72h_rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733277","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070926 NM exposure 25 uM_24h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-08","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-05","53":"Gene expression data from NHEK_070926 NM exposure 25 uM_24h timepoint","54":"NA","55":"NA","56":"NA","57":"25.0","58":"2007-09-26","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733277","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-24","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-08-07","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070926 NM exposure 25 uM_24h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733277/suppl/GSM733277_070926_NM_24h_25.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"24","115":"NA","116":"NHEK_070926 NM exposure 25 uM_24h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1049715","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek cell clones","15":"NA","16":"NA","17":"Cultured GRK2-K220R-expressing HEK cell clone-rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK cell clones","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"['HEK-K220R-2', 'Cultured GRK2-K220R-expressing HEK cell clone', 'Gene expression data of cultured GRK2-K220R-expressing HEK cell clone']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from HEK cell clones with the RNeasy Mini kit according to the manufacturer`s instructions (Qiagen).","61":"NA","62":"NA","63":"GRK2-K220R","64":"GSM1049715","65":"NA","66":"NA","67":"NA","68":"NA","69":"The study was performed with HEK cell clones stably expressing GRK2 or the kinase-deficient GRK2-K220R mutant. HEK cell clones were either expanded for 4 weeks in vivo in immunodeficient NOD.Scid mice (3 months of age), cultured in vitro, or re-cultured in vitro after expansion in NOD.Scid mice","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Affymetrix Human genome U133 Plus 2.0 Array) in 200 l of the hybrization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual).","79":"NA","80":"Dec 06 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"cultured in vitro","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE42771","99":"NA","100":"NA","101":"NA","102":"Cultured HEK cell clone with GRK2-K220R expression","103":"Public on Dec 06 2012","104":"NA","105":"NA","106":"Dec 06 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049715/suppl/GSM1049715_HEK-K220R-2.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049715/suppl/GSM1049715_HEK-K220R-2.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Cultured GRK2-K220R-expressing HEK cell clone-rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For the microarray study, cell pellets were isolated from three study groups: (i) NOD.Scid mouse-expanded HEK clones expressing either GRK2 or kinase-deficient GRK2-K220R (Scid), (ii) in vitro cultured HEK cell clones expressing GRK2 or GRK2-K220R (HEK), and (iii) in vitro re-cultured HEK cell clones after NOD.Scid mouse expansion (Ex-Scid).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM897028","2":"NA","3":"hek293 cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T-REx293-NPAP1-induced-2","18":"induced","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293 cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with RMA default setting in Partek GS","51":"33297","52":"NA","53":"Gene expression data from cell line T-REx293-NPAP1, 24 h after induced expression of the integrated NPAP1 gene, technical replicate 2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using the RNeasy mini kit (QIAGEN), treated with DNase I, followed by cleaning-up on spin columns (RNeasy mini kit. Qiagen)","61":"NA","62":"NA","63":"NA","64":"GSM897028","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were cultured in DMEM medium supplemented with 10% FCS, 1% penstrep and appropriate concentration of selective antibiotics","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Human Gene 1.0 ST. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix Hybridization, Wash and Stain Kit..","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Amplified cDNA was prepared according to the Ambion WT Expression Kit protocol starting from 200 ng total RNA. Amplified cDNA was fragmented with UDG and APE1 and finally labelled using the Affymetrix WT terminal labelling kit","79":"NA","80":"Jun 18 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned in the Affymetrix GeneChip Scanner 3000 wit G7 update","97":"NA","98":"GSE36575","99":"NA","100":"NA","101":"NA","102":"Flp-In T-REx 293","103":"Public on Jun 18 2012","104":"NA","105":"NA","106":"Mar 16 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM897nnn/GSM897028/suppl/GSM897028_TRex3_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T-REx293-NPAP1-induced-2","117":"NA","118":"NA","119":"NA","120":"NPAP1/C15orf2","121":"induced","122":"1 g/ml doxycycline was used to induce expression of the integrated NPAP1 copy.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1058029","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293  treated OO-A(15) 48hr biological replicate 2","18":"oo-a(15)","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Department of Mathematics and Computer Science, Faculty of Science, Chulalongkorn University","38":"Bangkok","39":"Thailand","40":"NA","41":"NA","42":"NA","43":"Chulalongkorn University","44":"NA","45":"Chatchawit,,Aporntewan","46":"NA","47":"NA","48":"NA","49":"10330","50":"['The scanned images were inspected for hybridization efficiency and CEL files generated from GCOS (GeneChip Operating Software) were imported into Expression Console (EC) 1.2 software for array QC. The matrix was created by Affymetrix Power Tools (APT) -- Release 1.14.3 on Windows 7. The command was apt-probeset-summarize -a rma -d HuGene-1_0-st-v1.r3.cdf -o out --cel-files cel_list.txt.', 'HuGene-1_0-st-v1.r4.pgf', 'HuGene-1_0-st-v1.r4.mps', 'RMA normalization was performed on the samples to generate the quality control (QC) metrics to determine data quality. These include, perfect match mean (PM_Mean), Background mean (Bgd_Mean), positive and negative probes (POS vs NEG AUC), bacterials spike controls, and polyA controls.']","51":"33252","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"All samples were RNA extracted according to the manufacturers protocol using Trizol (Invitrogen). Total RNA was reverse transcribed processed according to the Affymetrix and NuGEN recommended protocols, to produce cDNA/mRNA hybrid molecule, which was subsequently used as a template to create double stranded cDNA with a unique DNA/RNA heteroduplex on one end.","61":"NA","62":"NA","63":"NA","64":"GSM1058029","65":"NA","66":"NA","67":"adherent and monolayer","68":"NA","69":"HEK 293 cells were grown according to the manufacturers protocol in DMEM (Gibco-BRL) supplemented with 2 mM L-glutamine and 10% heat-inactivated fetal calf serum (FCS), and 10 mg/ml antibiotic antimycotic (Invitrogen) as before and after transfection. Cell harvest was performed at 48 hr post-transfection.","70":"NA","71":"NA","72":"The cDNAs were hybridized using Affymetrix Human Gene 1.0 ST arrays for 18 hours at 45oC with rotation at 60 rpm. Arrays were then washed and stained using the FS450_0007 fluidics protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"DNA/RNA heteroduplex was amplified via SPIA (Single Primer Isothermal Amplification), which produces single stranded anti-sense DNA. Post SPIA Modification generates sense target cDNA that was fragmented, biotin labeled according to Origen Labs Encore Biotin Module.","79":"NA","80":"Sep 03 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix Gene ChIP Scanner 3000 7G","97":"NA","98":"GSE43185","99":"NA","100":"NA","101":"NA","102":"Human Embryonic Kidney 293 cells, treated OO-A(15), 48hr","103":"Public on Sep 03 2013","104":"NA","105":"NA","106":"Dec 28 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1058nnn/GSM1058029/suppl/GSM1058029_AFGE1224-3_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293  treated OO-A(15) 48hr biological replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"OO-A(15)","122":"HEK293 cells were transfected with  50 nM of OO-A(15) and scramble OO-PNA oligo (OO-acgttcgcgcaacga).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1049718","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek cell clones","15":"NA","16":"NA","17":"Re-cultured GRK2-K220R-expressing HEK cell clone after NOD.Scid mouse expansion-rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK cell clones","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"['Ex-Scid-K220R-1', 'Re-cultured GRK2-K220R-expressing HEK cell clone after expansion in NOD.Scid mice', 'Gene expression data of re-cultured NOD.Scid-mouse-expanded GRK2-K220R-expressing HEK cell clone']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from HEK cell clones with the RNeasy Mini kit according to the manufacturer`s instructions (Qiagen).","61":"NA","62":"NA","63":"GRK2-K220R","64":"GSM1049718","65":"NA","66":"NA","67":"NA","68":"NA","69":"The study was performed with HEK cell clones stably expressing GRK2 or the kinase-deficient GRK2-K220R mutant. HEK cell clones were either expanded for 4 weeks in vivo in immunodeficient NOD.Scid mice (3 months of age), cultured in vitro, or re-cultured in vitro after expansion in NOD.Scid mice","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Affymetrix Human genome U133 Plus 2.0 Array) in 200 l of the hybrization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual).","79":"NA","80":"Dec 06 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"re-cultured in vitro after expansion in NOD.Scid mice","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE42771","99":"NA","100":"NA","101":"NA","102":"Re-cultured GRK2-K220R-expressing HEK cell clone after NOD.Scid mouse expansion","103":"Public on Dec 06 2012","104":"NA","105":"NA","106":"Dec 06 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049718/suppl/GSM1049718_Ex-Scid-K220R-1.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049718/suppl/GSM1049718_Ex-Scid-K220R-1.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Re-cultured GRK2-K220R-expressing HEK cell clone after NOD.Scid mouse expansion-rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For the microarray study, cell pellets were isolated from three study groups: (i) NOD.Scid mouse-expanded HEK clones expressing either GRK2 or kinase-deficient GRK2-K220R (Scid), (ii) in vitro cultured HEK cell clones expressing GRK2 or GRK2-K220R (HEK), and (iii) in vitro re-cultured HEK cell clones after NOD.Scid mouse expansion (Ex-Scid).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733167","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070912 NM exposure 400 uM_4h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-17","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-24","53":"Gene expression data from NHEK_070912 NM exposure 400 uM_4h timepoint","54":"NA","55":"NA","56":"NA","57":"400.0","58":"2007-09-12","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733167","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-22","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-24","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070912 NM exposure 400 uM_4h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733167/suppl/GSM733167_070912_NM_4h_400.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"4","115":"NA","116":"NHEK_070912 NM exposure 400 uM_4h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1049712","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek cell clones","15":"NA","16":"NA","17":"Cultured GRK2-expressing HEK cell clone-rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK cell clones","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"['HEK-GRK-1', 'Cultured GRK2-expressing HEK cell clone', 'Gene expression data of cultured GRK2-expressing HEK cell clone']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from HEK cell clones with the RNeasy Mini kit according to the manufacturer`s instructions (Qiagen).","61":"NA","62":"NA","63":"GRK2","64":"GSM1049712","65":"NA","66":"NA","67":"NA","68":"NA","69":"The study was performed with HEK cell clones stably expressing GRK2 or the kinase-deficient GRK2-K220R mutant. HEK cell clones were either expanded for 4 weeks in vivo in immunodeficient NOD.Scid mice (3 months of age), cultured in vitro, or re-cultured in vitro after expansion in NOD.Scid mice","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Affymetrix Human genome U133 Plus 2.0 Array) in 200 l of the hybrization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual).","79":"NA","80":"Dec 06 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"cultured in vitro","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE42771","99":"NA","100":"NA","101":"NA","102":"Cultured HEK cell clone with GRK2 expression","103":"Public on Dec 06 2012","104":"NA","105":"NA","106":"Dec 06 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049712/suppl/GSM1049712_HEK-GRK-1.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049712/suppl/GSM1049712_HEK-GRK-1.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Cultured GRK2-expressing HEK cell clone-rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For the microarray study, cell pellets were isolated from three study groups: (i) NOD.Scid mouse-expanded HEK clones expressing either GRK2 or kinase-deficient GRK2-K220R (Scid), (ii) in vitro cultured HEK cell clones expressing GRK2 or GRK2-K220R (HEK), and (iii) in vitro re-cultured HEK cell clones after NOD.Scid mouse expansion (Ex-Scid).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874646","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"EGF_2h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874646","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER EGF 2h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874646/suppl/GSM1874646_NB_55_EGF_2h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"EGF_2h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM675226","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek293 cells","15":"NA","16":"NA","17":"HEK293_MosIR plasmid_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK293 cells","33":"1","34":"NA","35":"NA","36":"NA","37":"Videnska 1083","38":"Prague 4","39":"Czech Republic","40":"NA","41":"NA","42":"NA","43":"Institute of Molecular Genetics","44":"NA","45":"Matyas,,Flemr","46":"NA","47":"NA","48":"NA","49":"14220","50":"All arrays were normalized using the GCRMA algorithm with quantile normalization composed of 100 bins using Genedata's Refiner application. Per chip normalization was performed by scaling the median of the genes called present (detection P-value < 0.04) to a value of 500.","51":"54675","52":"NA","53":"['04-Hek-500ng-2', 'Gene expression data from cultured HEK293 cells 24 hours after transfection with MosIR plasmid']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 or HeLa cells in a confluent 6-well dish 24 hours post-transfection using Absolutely RNA Miniprep Kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM675226","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 and HeLa cells were maintained in Dulbeccos Modified Eagle Medium (DMEM, Invitrogen) supplemented with 10 % FCS (Invitrogen), penicillin (100 U/mL, Invitrogen), and streptomycin (100 g/mL, Invitrogen) at 37 C and 5 % CO2 atmosphere.","70":"NA","71":"NA","72":"Biotinylated cRNA (20 g) was fragmented by heating with magnesium (as per Affymetrix's instructions) and 15 g of fragmented cRNA was hybridized to Human U133 plus 2.0 GeneChips.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA (5 g) from each replicate was reverse transcribed with the Affymetrix cDNA synthesis kit and cRNA was produced by in vitro transcription (IVT) by T7 RNA polymerase using the Affymetrix IVT kit as per manufacturer's instructions.","79":"NA","80":"Oct 11 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Affymetrix procedures","97":"NA","98":"GSE27316","99":"NA","100":"NA","101":"NA","102":"HEK293 cells transfected with MosIR plasmid","103":"Public on Oct 11 2011","104":"NA","105":"NA","106":"Feb 15 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM675nnn/GSM675226/suppl/GSM675226.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293_MosIR plasmid_rep2","117":"NA","118":"NA","119":"MosIR plasmid","120":"NA","121":"NA","122":"HEK293 and HeLa cells grown in a 6-well plate were transfected with 500ng control parental MosIR plasmid expressing EGFP or with 500ng MosIR plasmid expressing EGFP with 3'UTR containing long inverted repeat derived from mouse c-Mos coding sequence.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1288897","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"SilX-CT.R3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"Data were normalized with RMA","51":"33297","52":"NA","53":"Gene expression data","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the RNeasy Mini Kit (Qiagen), from three biological replicates, according to the manufacturer's instructions.  RNA was treated with DNase I to remove residual DNA and then cleaned with DNase Inactivation Reagent (Ambion Inc.) RNA was quality checked an then store at -80C.","61":"NA","62":"NA","63":"control","64":"GSM1288897","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown at 37C, in a humidified 10% CO2 incubator, in Dulbecco's modified Eagle's medium with GlutaMAX (Gibco) supplied with 10%FBS (Gibco) and 70 ug/ml Hygromycin B (10687-010-Invitrogen).","70":"NA","71":"NA","72":"Labeled cDNA was hybridized wiht GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) as described by the manufacturer.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RNA was amplified with GeneChip WT cDNA Synthesis and Amplification Kit (Affymetrix) and biotin labeld with GeneChip WT Terminal Labeling Kit (Affymetrix) according to the manufacturer's","79":"NA","80":"Jan 20 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix Human Gene 1.0 ST Array was scanned with the Affymetrix GeneChip Scanner 7G and the FS450_0007 protocol , as recommended in the GeneChip Hybridization, Wash, and Stain Kit (Affymetrix)","97":"NA","98":"['GSE51868', 'GSE53284']","99":"NA","100":"NA","101":"NA","102":"SilX-CT cells","103":"Public on Dec 11 2015","104":"NA","105":"NA","106":"Dec 13 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1288nnn/GSM1288897/suppl/GSM1288897_SilX-CT-R3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"SilX-CT.R3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"We established a BAHD1 gene-specific knockdown cell line using the SilenciX siRNA delivery system (Tebu-bio). This technology is based on EBV-replication, and ensures chromosome-like replication of an episome stably expressing either a shRNA against BAHD1 (silXBAHD1) or a control shRNA (silX-CT).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1269604","2":"NA","3":"hek 293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"293 transfected with Aire replicate #3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"513 Parnassus Avenue, HSW Room  1102, Box 0540","38":"San Francisco","39":"USA","40":"Diabetes Center","41":"manderson@diabetes.ucsf.edu","42":"NA","43":"UCSF","44":"Anderson Lab","45":"Mark,Stuart,Anderson","46":"NA","47":"CA","48":"NA","49":"94143","50":"AGCC 3.2.2 Microarrays were normalized for array-specific effects using Affymetrix's Robust Multi-Array (RMA) normalization","51":"28829","52":"NA","53":"293 cells transfected with Aire only biologic replicate #3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Qiagen RNAeasy mini kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1269604","65":"NA","66":"NA","67":"NA","68":"NA","69":"Transfected HEK 293 cells were grown for 72hrs in complete DMEM prior to RNA extraction.","70":"NA","71":"NA","72":"See manufacturer protocol","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"NuGEN Ovation Pico WTA V2 and NuGEN Encore Biotin Module","79":"NA","80":"Nov 21 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCS3000","97":"NA","98":"['GSE52546', 'GSE52548']","99":"NA","100":"NA","101":"NA","102":"293 transfected with Aire","103":"Public on Nov 21 2013","104":"NA","105":"NA","106":"Nov 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1269nnn/GSM1269604/suppl/GSM1269604_06.Aire-3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"293 transfected with Aire replicate #3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK 293 cells were transfected using Mirus 293 transfection reagent following manufacturers protocol.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM402138","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Wild-type control 197_3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"3333 Burnet Ave","38":"Cincinnati","39":"USA","40":"NA","41":"yan.xu@cchmc.org","42":"NA","43":"Cincinnati Children's Hospital Medical Center","44":"NA","45":"Yan,,Xu","46":"513-6368921","47":"OH","48":"NA","49":"45229","50":"MAS5 normalization, ANOVA","51":"54675","52":"NA","53":"transitently transfected with wild-type surfactant protein C","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"accroding to manufacture's protocol (Affymetrix)","61":"NA","62":"NA","63":"NA","64":"GSM402138","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"accroding to manufacture's protocol (Affymetrix)","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"accroding to manufacture's protocol (Affymetrix)","79":"NA","80":"May 13 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"accroding to manufacture's protocol (Affymetrix)","97":"NA","98":"GSE16054","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line","103":"Public on May 14 2009","104":"NA","105":"NA","106":"May 11 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM402nnn/GSM402138/suppl/GSM402138.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Wild-type control 197_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693933","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24h","17":"HEK293T_BACH1-siRNA2_24h_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_s_1_24', 'BACH1_s_1_300ng_24h_293T.CEL', 'Gene expression data from HEK 293T cells 24h after knockdown of BACH1 with Stealth siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693933","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"siRNA2 HSS100910 (s)","102":"HEK 293T cells, BACH1 knockdown, 24h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693933/suppl/GSM693933.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693933/suppl/GSM693933.EXP.gz']","108":"9606","109":"24h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-siRNA2_24h_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM711419","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"HEK293Tcells_si76_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"1000 E 50th St","38":"Kansas City","39":"USA","40":"Genomics","41":"seidel@phageT4.org","42":"NA","43":"Stowers Institute","44":"Seidel","45":"Chris,W,Seidel","46":"816 926 9054","47":"MO","48":"NA","49":"64110","50":"Array intensities were processed using the RMA algorithm in R/bioconductor. Bioconductor 2.6 and affy package affy_1.24.2","51":"54675","52":"NA","53":"Gene expression from HEK293T cells after transfection with siRNA s18076 targeting Med26, replicate 1.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the standard Qiagen RNeasy cleanup protocol.","61":"NA","62":"NA","63":"NA","64":"GSM711419","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in 6 well tissue culture plates or 10 cm dishes for 48 hours after transfection.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 plus 2.0 Arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the Ambion MessageAmp III protocol from 300 ng total RNA (MessageAmp III Amplification kit Manual, 2007, Ambion).","79":"NA","80":"Sep 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 and processed with AGCC v3.0 software.","97":"NA","98":"GSE28715","99":"NA","100":"Med26 targeting s18076","101":"NA","102":"HEK293T cells","103":"Public on Sep 01 2011","104":"NA","105":"NA","106":"Apr 19 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM711nnn/GSM711419/suppl/GSM711419_si-76-1_HG-U133_Plus_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293Tcells_si76_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293T cells in 6 well tissue culture plates (~1x105 cells/well) or 10 cm dishes (~2 x106 cells/dish) were transfected with 25 nM siRNAs targeting human Med26 (Ambion/Applied Biosystems, #4, s18074; #5, s18075; #6, s18076) or 25 nM siCONTROL NON-TARGETING siRNA #2 (Dharmacon D-001210-01) using X-tremeGENE siRNA Transfection Reagent (Roche) and grown for 48 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM897029","2":"NA","3":"hek293 cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T-REx293-NPAP1-induced-3","18":"induced","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293 cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with RMA default setting in Partek GS","51":"33297","52":"NA","53":"Gene expression data from cell line T-REx293-NPAP1, 24 h after induced expression of the integrated NPAP1 gene, technical replicate 3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using the RNeasy mini kit (QIAGEN), treated with DNase I, followed by cleaning-up on spin columns (RNeasy mini kit. Qiagen)","61":"NA","62":"NA","63":"NA","64":"GSM897029","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were cultured in DMEM medium supplemented with 10% FCS, 1% penstrep and appropriate concentration of selective antibiotics","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Human Gene 1.0 ST. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix Hybridization, Wash and Stain Kit..","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Amplified cDNA was prepared according to the Ambion WT Expression Kit protocol starting from 200 ng total RNA. Amplified cDNA was fragmented with UDG and APE1 and finally labelled using the Affymetrix WT terminal labelling kit","79":"NA","80":"Jun 18 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned in the Affymetrix GeneChip Scanner 3000 wit G7 update","97":"NA","98":"GSE36575","99":"NA","100":"NA","101":"NA","102":"Flp-In T-REx 293","103":"Public on Jun 18 2012","104":"NA","105":"NA","106":"Mar 16 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM897nnn/GSM897029/suppl/GSM897029_TRex3_3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T-REx293-NPAP1-induced-3","117":"NA","118":"NA","119":"NA","120":"NPAP1/C15orf2","121":"induced","122":"1 g/ml doxycycline was used to induce expression of the integrated NPAP1 copy.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733400","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071128 CEES exposure 2.0 uM_4h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-28","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-04","53":"Gene expression data from NHEK_071128 CEES exposure 2.0 uM_4h timepoint","54":"NA","55":"NA","56":"NA","57":"2.0","58":"2007-11-28","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733400","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-09","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-11","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071128 CEES exposure 2.0 uM_4h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733400/suppl/GSM733400_071128_CEES_4h_2.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"4","115":"NA","116":"NHEK_071128 CEES exposure 2.0 uM_4h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM853612","2":"NA","3":"hek293 cells wtx inducible clone f5","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 F5_doxycycline untreated","18":"NA","19":"control","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293 cells WTX inducible clone F5","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"149 13th St","38":"Charlestown","39":"USA","40":"Cancer Center","41":"NA","42":"NA","43":"Massachusetts General Hospital","44":"NA","45":"Woo,Jae,Kim","46":"NA","47":"Ma","48":"NA","49":"02129","50":"['Affymetrix GCOS', 'Target scaling = 150']","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Qiagen RNeasy Kit","61":"NA","62":"NA","63":"NA","64":"GSM853612","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Affymetrix standard protocol for 3'-IVT expression microarrays","73":"NA","74":"NA","75":"NA","76":"NA","77":"ENZO 3'-labeling kit","78":"ENZO 3'-labeling kit manufacturer's instruction","79":"NA","80":"Jan 01 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix scanner G7","97":"NA","98":"GSE34715","99":"NA","100":"NA","101":"NA","102":"HEK293 F5 WTX inducible","103":"Public on Jan 01 2012","104":"NA","105":"NA","106":"Dec 23 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM853nnn/GSM853612/suppl/GSM853612_HABE_1906.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM853nnn/GSM853612/suppl/GSM853612_HABE_1906.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 F5_doxycycline untreated","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"untreated","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1049708","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek cell clones","15":"NA","16":"NA","17":"NOD.Scid mouse-expanded GRK2-expressing HEK clone-rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK cell clones","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"['Scid-GRK-1', 'GRK2-expressing HEK clone expanded for 4 weeks in immunodeficient NOD.Scid mice', 'Gene expression data of NOD.Scid mouse-expanded GRK2-expressing HEK clone']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from HEK cell clones with the RNeasy Mini kit according to the manufacturer`s instructions (Qiagen).","61":"NA","62":"NA","63":"GRK2","64":"GSM1049708","65":"NA","66":"NA","67":"NA","68":"NA","69":"The study was performed with HEK cell clones stably expressing GRK2 or the kinase-deficient GRK2-K220R mutant. HEK cell clones were either expanded for 4 weeks in vivo in immunodeficient NOD.Scid mice (3 months of age), cultured in vitro, or re-cultured in vitro after expansion in NOD.Scid mice","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Affymetrix Human genome U133 Plus 2.0 Array) in 200 l of the hybrization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual).","79":"NA","80":"Dec 06 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"expanded for 4 weeks in NOD.Scid mice","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE42771","99":"NA","100":"NA","101":"NA","102":"NOD.Scid mouse-expanded HEK clone with GRK2 expression","103":"Public on Dec 06 2012","104":"NA","105":"NA","106":"Dec 06 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049708/suppl/GSM1049708_Scid-GRK-1.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049708/suppl/GSM1049708_Scid-GRK-1.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"NOD.Scid mouse-expanded GRK2-expressing HEK clone-rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For the microarray study, cell pellets were isolated from three study groups: (i) NOD.Scid mouse-expanded HEK clones expressing either GRK2 or kinase-deficient GRK2-K220R (Scid), (ii) in vitro cultured HEK cell clones expressing GRK2 or GRK2-K220R (HEK), and (iii) in vitro re-cultured HEK cell clones after NOD.Scid mouse expansion (Ex-Scid).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM463020","2":"NA","3":"hek293e","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293E cells, TDP-43 siRNA, replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293E","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Calwer Str. 7","38":"Tuebingen","39":"Germany","40":"Department of Medical Genetics","41":"michael.walter@agilent.com","42":"NA","43":"University of Tuebingen","44":"The Microarray Facility Tbingen","45":"Michael,H.,Walter","46":"NA","47":"NA","48":"NA","49":"72076","50":"The data were analysed using GC-RMA for background correction, normalization and probe summarization using the Bioconductor package gcrma with default values.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA  was extracted by using RNeasy Mini Kit (Qiagen) following manufacturers instructions for animal cells.","61":"NA","62":"NA","63":"NA","64":"GSM463020","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293E cells were grown in Dulbeccos modified Eagle medium (DMEM) (Biochrom) supplemented with 10% fetal bovine serum (PAA) at 37C under humidified 5% CO2/air","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 Plus 2.0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Oct 19 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GCS3000 gene chip scanner.","97":"NA","98":"GSE18632","99":"NA","100":"NA","101":"NA","102":"HEK cells transfected with TDP-43 siRNA, 24h after transfection","103":"Public on Oct 20 2009","104":"NA","105":"NA","106":"Oct 19 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463020/suppl/GSM463020.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293E cells, TDP-43 siRNA, replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were transiently transfected three consecutive days using HiPerfect with 5nmol scrambled (both Qiagen) or TDP-specific  siRNAs (5-CAATAGCAATAGACAGTTA-3) and cultivated for 24h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2089910","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U219 Array (hgu219)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T_siRNA(dharmacon)BRD1_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Bartholins All 6","38":"Aarhus","39":"Denmark","40":"Biomedicine","41":"tue@biomed.au.dk","42":"NA","43":"Aarhus University","44":"Prof Anders Borglum's lab","45":"Tue,,Fryland","46":"NA","47":"Aarhus","48":"NA","49":"8000","50":"rma","51":"49386","52":"NA","53":"siRNA treatment targeted against the BRD1 mRNA transcript (Dharmacon) rep2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Qiagen Rneasy + Qiagen shredder columns (performed according to the supplied protocol)","61":"NA","62":"NA","63":"NA","64":"GSM2089910","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells (controls and stable BRD1-S-V5 and BRD1-L-V5 cell lines) were grown in DMEM medium (Invitrogen, San Diego, CA, USA) supplemented with 5% fetal calf serum (FCS), 175 mg/L glutamine, 36 mg/L penicillin and 60 mg/L streptomycine at 37 oC in 5% CO2","70":"NA","71":"NA","72":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","79":"NA","80":"Mar 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL13667","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"standard Affymetrix protocol","97":"NA","98":"GSE79255","99":"NA","100":"NA","101":"NA","102":"Cell line culture, siRNA agianst BRD1 method 2","103":"Public on Mar 16 2016","104":"NA","105":"NA","106":"Mar 15 2016","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2089nnn/GSM2089910/suppl/GSM2089910_A897-05.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_siRNA(dharmacon)BRD1_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM926168","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina humanRef-8 v1.0 expression beadchip (Illumina_HumanRef-8_v1.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK-293 anti-miR-107 Experimental Replicate 1 1897008128_D","18":"anti-mir-107","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ring Road","38":"Callaghan","39":"Australia","40":"NA","41":"NA","42":"NA","43":"University of Newcastle","44":"NA","45":"Adam,,Carroll","46":"NA","47":"NSW","48":"NA","49":"2308","50":"Illumina Beadstudio software computed average signal intensities and detection p-values.","51":"22184","52":"NA","53":"Experimental Replicate 1","54":"illuminaHumanv2","55":"44.83337","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted with Trizol reagent, followed by clean-up with DNase I treatment and the RNeasy MinElute cleanup kit (Qiagen) in accordance with manufacturer's instructions. Quality control was performed with an Experion (BioRad) bioanalyser.","61":"NA","62":"NA","63":"NA","64":"GSM926168","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cell models were grown as confluent monolayers in standard tissue culture conditions.","70":"NA","71":"NA","72":"Standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA was prepared using the TotalPrep RNA amplification kit (Ambion) for Illumina arrays.","79":"NA","80":"Nov 01 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6104","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol.","97":"NA","98":"GSE37729","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Nov 01 2012","104":"NA","105":"NA","106":"May 02 2012","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK-293 anti-miR-107 Experimental Replicate 1 1897008128_D","117":"NA","118":"NA","119":"NA","120":"NA","121":"anti-miR-107","122":"Cells were transfected with either synthetic miRNA or anti-miR inhibitor oligonucleotides. Control refers to untransfected cell models; siEGFP control refers to transfection with an siRNA to EGFP as a transfection control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820002","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hrs","17":"HEK293T FMR4siRNA 6hr 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"FMR4 knockdown","64":"GSM1820002","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, FMR4 knockdown, 6 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820002/suppl/GSM1820002_Zane_6hr_FMR4si_1_A1_102011.CEL.gz","108":"9606","109":"6 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T FMR4siRNA 6hr 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM648460","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"MIBP1 overexpression, biological rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"3-1-1 Maidashi, Higashi-ku","38":"Fukuoka","39":"Japan","40":"Reseach Center for Genetic Information","41":"yiwasita@gen.kyushu-u.ac.jp","42":"+81-92-632-2375","43":"Kyushu University, Medical Institute of Bioregulation","44":"Division of Genome Analysis","45":"Yuji,,Iwashita","46":"+81-92-642-6170","47":"Fukuoka","48":"http://www.gen.kyushu-u.ac.jp/~genome/","49":"812-8582","50":"['Cel files were summarized and normalized with Robust Multi-array Average (RMA) method in Expression Console software version 1.1.1 (Affymetrix). Logarithmic signal intensities were antilog-transformed to linear scale using Expression Console.', 'probe group file: HuGene-1_0-st-v1.r3.pgf', 'meta-probeset file: HuGene-1_0-st-v1.r3.mps']","51":"33297","52":"NA","53":"FHM-49","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from triplicated transfectants for each plasmid using RNeasy plus mini kit (74134, Qiagen, Hilden, Germany). RNA quality was checked using 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA), and RNA Integrity Number (RIN) was confirmed to be 9.4 or greater for all samples. Total RNA at 200 ng was amplified and reverse-transcribed using GeneChip WT Sense Target Labeling and Control Reagents (900652, Affymetrix).","61":"NA","62":"NA","63":"NA","64":"GSM648460","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were obtained from Clontech (Mountain View, MO) and maintained in Dulbeccos modified Eagles medium (D5796, Sigma-Aldrich, St. Louis, CA), supplemented with 10% fetal bovine serum, 100 units/ml penicillin and 100 g/ml streptomycin (15140-122, Invitrogen, Carlsbad, CA), in 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Samples were hybridized using Affymetrix hybridization kit materials. The cocktails were heated at 99C for 5 minutes, then 45C for 5 minutes and centrifuged at max speed for 1 minute. The 80 l of hyb solution was transfered to each array, then seal the holes with sticker. They were hybridized for 18 hours in 45C hybridization oven at 60 rpm. Fluidics Script Protocol was FS450_0007","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Samples were enzymatically fragmented and biotinylated using the WT Terminal Labeling Kit (Affymetrix)","79":"NA","80":"Jan 31 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix GeneChiP Scanner 3000 7G","97":"NA","98":"GSE26420","99":"NA","100":"NA","101":"NA","102":"HEK293 cell clone stably overexpressing MIBP1. Clone No.49","103":"Public on Jan 31 2012","104":"NA","105":"NA","106":"Jan 04 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM648nnn/GSM648460/suppl/GSM648460.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"MIBP1 overexpression, biological rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293 cells were transfected with pCI-neo (empty vector control) or pCI-neo-FLAG-HA-MIBP1 linearized with AclI and selected at 400 g/ml G418 (345812, Calbiochem, San Diego, CA) for 2 weeks. Selected cells were cloned using cloning rings and maintained in the presence of G418. Genomic integration and protein expression of MIBP1 were confirmed by genomic PCR and immunoblotting using anti-FLAG M2 antibody (Sigma-Aldrich).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM569356","2":"NA","3":"embryonic kidney cell line hek","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Mutant in the presence of tetracycline, rep3","18":"NA","19":"tetracycline","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Embryonic kidney cell line HEK","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1 Oryong-dong Buk-gu","38":"Gwangju","39":"South Korea","40":"Life science","41":"lbc0523@gist.ac.kr","42":"82629702540","43":"Gwangju Institutue Science and Technology","44":"NA","45":"Byoung-Cheol,,Lee","46":"82629702566","47":"NA","48":"NA","49":"500712","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from HEK cells expressing mutant TRPM7 channel', 'Mutant tet3']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"mutant channel","64":"GSM569356","65":"NA","66":"NA","67":"NA","68":"NA","69":"Stabel cell-lines were grown in in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum and an antibiotic, 5 ug/mL blasticidin (Invitrogen). Cells were cultured in a humidified atmosphere of 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Fragmented cRNA was hybridized to the Human Genome UI133 Plus 2.0 Array (Affymetrix) at 45C for 16 h according to the Affymetrix standard protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"5 ug of total RNA from each cell-lines was used for labeling. Probe synthesis from total RNA samples, hybridization, detection, and scanning were performed according to standard protocols from Affymetrix, Inc..","79":"NA","80":"Jul 23 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"After hybridization, the arrays were washed in a GeneChip Fluidics Station 450 with a non-stringent wash buffer at 25C followed by a stringent wash buffer at 50C. After washing, the arrays were stained with a streptavidin-phycoerythrin complex. After staining, intensities were determined with a GeneChip scanner 3000 (Affymetrix), controlled by GCOS Affymetrix software.","97":"NA","98":"GSE23102","99":"NA","100":"NA","101":"NA","102":"HEK cell lines expressing mutant channel","103":"Public on Jul 23 2011","104":"NA","105":"NA","106":"Jul 23 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM569nnn/GSM569356/suppl/GSM569356.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Mutant in the presence of tetracycline, rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 ug of tetracycline was treated to stabel cell-lines which overexressing WT and mutant TRPM7 channel for 72 hours","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM853611","2":"NA","3":"hek293 cells wtx inducible clone f5","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 F5_doxycycline treated","18":"NA","19":"doxycycline","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293 cells WTX inducible clone F5","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"149 13th St","38":"Charlestown","39":"USA","40":"Cancer Center","41":"NA","42":"NA","43":"Massachusetts General Hospital","44":"NA","45":"Woo,Jae,Kim","46":"NA","47":"Ma","48":"NA","49":"02129","50":"['Affymetrix GCOS', 'Target scaling = 150']","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Qiagen RNeasy Kit","61":"NA","62":"NA","63":"NA","64":"GSM853611","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Affymetrix standard protocol for 3'-IVT expression microarrays","73":"NA","74":"NA","75":"NA","76":"NA","77":"ENZO 3'-labeling kit","78":"ENZO 3'-labeling kit manufacturer's instruction","79":"NA","80":"Jan 01 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix scanner G7","97":"NA","98":"GSE34715","99":"NA","100":"NA","101":"NA","102":"HEK293 F5 WTX inducible","103":"Public on Jan 01 2012","104":"NA","105":"NA","106":"Dec 23 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM853nnn/GSM853611/suppl/GSM853611_HABE_1905.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM853nnn/GSM853611/suppl/GSM853611_HABE_1905.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 F5_doxycycline treated","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 g/ml doxycycline for 12 hr treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874634","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T2h_U0126+1h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874634","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 2h and subsequent U0126 1h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874634/suppl/GSM1874634_RG_35_4OHT_U0126_2h_1h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T2h_U0126+1h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1399572","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"78h after transfection","17":"shUBE4B+shLSD1, bio. replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"615 N. Wolfe St.","38":"Baltimore","39":"USA","40":"NA","41":"NA","42":"NA","43":"Johns Hopkins University","44":"NA","45":"Jiou,,Wang","46":"NA","47":"MD","48":"NA","49":"21205","50":"[\"Affymetrix CEL files were extracted and their data normalized with the Partek GS 6.6 platform.  Partek's Extended Meta-Probeset set was used with RMA normalization to create quantile-normalized log2 transcript signal values, which were used in subsequent ANOVA analyses.\", 'probe group file: HuGene-1_0-st-v1.r4.pgf', 'meta-probeset file: HuGene-1_0-st-v1.na32.hg19.transcript.csv']","51":"33297","52":"NA","53":"SAMPLE 8","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Cells were lysed using RNAeasy mini kit (Qiagen), according to manufacturer's instructions. Genomic DNA was first removed by DNAse treatment on the column, and then, additionally, after total RNA was isolated, using DNase Turbo kit (Ambion), followed by additional round of cleaning through RNAeasy columns.","61":"NA","62":"NA","63":"NA","64":"GSM1399572","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells grown in DMEM, 10%FBS, 37C, 5% CO2","70":"NA","71":"NA","72":"17hrs at 45 C with rotation (60rpm) as described by Affymetrix in their GeneChip Expression Analysis Technical Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The Ambion Expression WT kit was used as described in the manufacturer's manual.","79":"NA","80":"Feb 09 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Using Affymetrix GeneChip Scanner 3000 7G and default parameters described by the manufacturer in their GeneChip Expression Analysis Technical Manual","97":"NA","98":"GSE58026","99":"NA","100":"NA","101":"NA","102":"HEK293_shUBE4B+shLSD1","103":"Public on Feb 09 2017","104":"NA","105":"NA","106":"May 28 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1399nnn/GSM1399572/suppl/GSM1399572_GPer-SOD-B4_UL-1a-HuGene_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"78h after transfection","113":"NA","114":"NA","115":"NA","116":"shUBE4B+shLSD1, bio. replicate 2","117":"NA","118":"shRNAs against UBE4B and LSD1","119":"NA","120":"NA","121":"NA","122":"Cells were transfected in 60mm dishes using 4g DNA, 10l Lipofectamine 2000, in total 4.5ml  Optimem-MEM1. Origene's pRS-RFP-C plasmids encoding shRNAs against UBE4B and LSD1, or non-targeting control (CTRL) were used for knockdown. Cells were knocked down for 78h before lysis.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733465","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080116 CEES exposure 3.5 uM_24h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-05-06","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-08","53":"Gene expression data from NHEK_080116 CEES exposure 3.5 uM_24h timepoint","54":"NA","55":"NA","56":"NA","57":"3.5","58":"2008-01-16","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733465","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-15","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-07-17","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080116 CEES exposure 3.5 uM_24h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733465/suppl/GSM733465_080116_CEES_24h_3.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"24","115":"NA","116":"NHEK_080116 CEES exposure 3.5 uM_24h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM432931","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Empty vector replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"401 Terry Avenue North","38":"Seattle","39":"USA","40":"NA","41":"cplaisier@systemsbiology.org","42":"NA","43":"Institute for Systems Biology","44":"Nitin Baliga","45":"Christopher,L,Plaisier","46":"2067322139","47":"Washington","48":"NA","49":"98109","50":"A rigorous quality control pipeline was developed to prepare the gene expression microarray data for analysis. First, the CEL files were imported into R 2.8.0 using the justRMA function of the Affymetrix library from Bioconductor, which applies background subtraction and quantile normalization. An alternate CDF file (U133Plus2msk.cdf.gz) was used to exclude mis-targeted and nonspecific probes from the microarrays (Zhang et al. 2005), and probesets with less than 7 remaining probes were also excluded. Probesets with more than 50% absent calls were excluded, as calculated using the panp package from Bioconductor. Finally, the ComBat library in R was used to correct for batch effect (Johnson et al. 2007).","51":"16569","52":"NA","53":"n/a","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was collected using the RNeasy Plus Mini Kit (Cat No. 74134) 48 hours after transient transfection of HEK293T cells.","61":"NA","62":"NA","63":"NA","64":"GSM432931","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"The cRNA probes were then hybridized using standard Affymetrix protocols described in the GeneChip Expression Analysis Technical Manual (Affymetrix P/N 702232).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Samples were then converted to cRNA probes using standard Affymetrix protocols described in the GeneChip Expression Analysis Technical Manual (Affymetrix P/N 702232).","79":"NA","80":"Sep 12 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The chips were scanned using the GeneArray scanner (Affymetrix) to produce CEL files.","97":"NA","98":"GSE17300","99":"NA","100":"NA","101":"NA","102":"HEK293T cell line","103":"Public on Sep 14 2009","104":"NA","105":"NA","106":"Jul 24 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM432nnn/GSM432931/suppl/GSM432931.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Empty vector replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442120","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,16h,untransfected,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"16 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442120","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_16h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442120/suppl/GSM1442120_16hGFPM_REP2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,16h,untransfected,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM618029","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney","15":"NA","16":"NA","17":"HEK-TLR2 24h-LPS rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"human embryonic kidney (HEK) cells stably transfected with Toll-like receptor 2 (TLR2)","33":"1","34":"NA","35":"NA","36":"NA","37":"St. James's Hospital","38":"Dublin 8","39":"Ireland","40":"NA","41":"NA","42":"NA","43":"Trinity College Dublin","44":"Trinity Centre for Health Sciences","45":"Sinead,Marian,Smith","46":"NA","47":"NA","48":"NA","49":"D8","50":"Scanned images, obtained using Affymetrix Software (MAS5), were normalized using robust multichip average (RMA) analysis with RMAExpress version 0.4.1.","51":"54675","52":"NA","53":"gene expression in untreated HEK-TLR2 cells at 24h","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"At time points of 2, 4, 8, 24 and 48 h post-stimulation, cells were harvested and RNA isolated using the Nucleospin RNAII kit (Machery Nagel) according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM618029","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK-TLR2 cells were routinely maintained in MEM alpha medium (Gibco) supplemented with 10% foetal calf serum (Gibco), 2 mM L-glutamine (Sigma), 100 U/ml penicillin (Sigma), 100 g/ml streptomycin and 500 g/ml G418 (Sigma). The day before treatment, cells were seeded in 6-well plates at 1x106 cells/well.","70":"NA","71":"NA","72":"Following fragmentation, cRNA was hybridized for 16 hr at 45C on Affymetrix U133 plus 2.0 genechips. GeneChips were washed and stained in the Automated fluidics 450 station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 g total RNA (Expression Analysis Technical Manual, 2001, Affymetrix) using the Affymetrix IVT labeling kit.","79":"NA","80":"Jan 13 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips were scanned using the GeneChip 3000 7G scanner","97":"NA","98":"['GSE25148', 'GSE25155']","99":"NA","100":"NA","101":"NA","102":"HEK-TLR2 cells untreated for 24h rep 1","103":"Public on Jan 12 2011","104":"NA","105":"NA","106":"Nov 04 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM618nnn/GSM618029/suppl/GSM618029.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"embryonic kidney","116":"HEK-TLR2 24h-LPS rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"The morning of treatment, the cell culture medium was replaced with either fresh medium (untreated) or medium containing 10 g/ml H. pylori lipopolysaccharide","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1288900","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"SilX-BAHD1.R3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"Data were normalized with RMA","51":"33297","52":"NA","53":"Gene expression data","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the RNeasy Mini Kit (Qiagen), from three biological replicates, according to the manufacturer's instructions.  RNA was treated with DNase I to remove residual DNA and then cleaned with DNase Inactivation Reagent (Ambion Inc.) RNA was quality checked an then store at -80C.","61":"NA","62":"NA","63":"BAHD1 knockdown","64":"GSM1288900","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown at 37C, in a humidified 10% CO2 incubator, in Dulbecco's modified Eagle's medium with GlutaMAX (Gibco) supplied with 10%FBS (Gibco) and 70 ug/ml Hygromycin B (10687-010-Invitrogen).","70":"NA","71":"NA","72":"Labeled cDNA was hybridized wiht GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) as described by the manufacturer.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RNA was amplified with GeneChip WT cDNA Synthesis and Amplification Kit (Affymetrix) and biotin labeld with GeneChip WT Terminal Labeling Kit (Affymetrix) according to the manufacturer's","79":"NA","80":"Jan 20 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix Human Gene 1.0 ST Array was scanned with the Affymetrix GeneChip Scanner 7G and the FS450_0007 protocol , as recommended in the GeneChip Hybridization, Wash, and Stain Kit (Affymetrix)","97":"NA","98":"['GSE51868', 'GSE53284']","99":"NA","100":"NA","101":"NA","102":"SilX-BAHD1 cells","103":"Public on Dec 11 2015","104":"NA","105":"NA","106":"Dec 13 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1288nnn/GSM1288900/suppl/GSM1288900_SilX-BAHD1.R3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"SilX-BAHD1.R3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"We established a BAHD1 gene-specific knockdown cell line using the SilenciX siRNA delivery system (Tebu-bio). This technology is based on EBV-replication, and ensures chromosome-like replication of an episome stably expressing either a shRNA against BAHD1 (silXBAHD1) or a control shRNA (silX-CT).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610829","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0hr","17":"HEK293T_miR-neg_FSK0hr_rep1","18":"NA","19":"untreated","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610829","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610829/suppl/GSM610829.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610829/suppl/GSM610829.chp.gz']","108":"9606","109":"0hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-neg_FSK0hr_rep1","117":"negative control","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM205755","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 cell line #4 with noninduced HNF4a2 wild type","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 1000.","51":"54675","52":"NA","53":"Analysis of gene expression in human embryonic kidney cells (HEK293) overexpressing the transcription factor HNF4a2 or mutant forms HNF4a2 C106R or R154X, which were introduced by FRT/FLP recombination. The analysis were performed 24 hours following 1 g/ml doxycyclin treatment to induce the expression of the trans-genes. Results identify HNF4 regulated genes in kidney cells being several of these genes deregulated in renal cell carcinoma.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Rneasy mini extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM205755","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133_Plus_2.0 arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual v2, Affymetrix).","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000.","97":"NA","98":"GSE8289","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line #4 with noninduced HNF4a2 wild type","103":"Public on Jun 20 2008","104":"NA","105":"NA","106":"Jun 26 2007","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205755/suppl/GSM205755.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205755/suppl/GSM205755.CHP.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205755/suppl/GSM205755.EXP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cell line #4 with noninduced HNF4a2 wild type","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were treated for 24 h with 1 g/ml doxycyclin or solvent.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861634","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Wild Type, leptin-stimulated, biological replicate 3","18":"100ng leptin","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"PO Box 800741","38":"Charlottesville","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Virginia","44":"NA","45":"Stephen,,Turner","46":"NA","47":"VA","48":"NA","49":"22908","50":"Data extraction, QC, and GCRMA normalization were performed with BioConductor software.  Differential expression was assessed with moderated ANOVA, using the BioConductor limma package; false discovery rate (FDR) estimates were calculated using the Benjamini-Hochberg method.","51":"54675","52":"NA","53":"Wild Type, leptin-stimulated, biological replicate 3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was prepared using RNeasy Mini kit (QIAGEN) and its quality was verified in an Agilent Bioanalyzer.","61":"NA","62":"NA","63":"NA","64":"GSM861634","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T/17 cells were maintained in a humidified incubator at 37 C with 5% CO2. HEK293T/17 cells were cultured in DMEM/F12 (Gibco) with non-essential amino acids, sodium pyruvate and 10% heat inactivated FBS.  Jurkat T-cells were cultured in RPMI supplemented with 10% heat inactivated FBS.  Caco-2 cells were cultured in EMEM (Gibco) supplemented with non-essential amino acids, sodium pyruvate and 20% heat inactivated FBS.  Cells were discarded after passage 25 and new cultures were started from frozen stocks. HEK293T117 cells were transiently transfected using lipofectamine 2000 per the product instructions (Invitrogen, Carlsbad, CA). The plasmids mLEPRb/pCDNA3 (47), mLEPRbR223/pCDNA3 (35) and LEPRbDelta65/pCDNA3 (47) were obtained from Martin Myers and have been described previously as referenced. pCDNA3 was used as a vector control. The plasmid mLEPRb/pCDNA3 was used as a template for site-directed mutagenesis to construct mLEPRb985L/pCDNA3, LEPRb1077L/pCDNA3 and mLEPRb1138L/pCDNA3.  Site-directed mutagenesis was done using the quikchange kit (Stragene/Agilent, Santa Clara, CA).    The presence of the desired mutations and the absence of other mutations were confirmed by DNA sequencing.","70":"NA","71":"NA","72":"Three biological replicates of each sample were hybridized to Human Genome U133 Plus 2.0 gene chips (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA was amplified and converted to cDNA using the 3' IVT Express Kit (Affymetrix).","79":"NA","80":"Jan 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned using the GeneChip Scanner 3000 7G (AffyMetrix).","97":"NA","98":"GSE35068","99":"NA","100":"NA","101":"NA","102":"Wild Type, leptin-stimulated","103":"Public on Jan 01 2015","104":"NA","105":"NA","106":"Jan 12 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861634/suppl/GSM861634_WT-3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Wild Type, leptin-stimulated, biological replicate 3","117":"NA","118":"NA","119":"Wild-type leptin receptor","120":"NA","121":"100ng leptin","122":"HEK293 cells were transfected with WT LepR or Y1138L (STAT3-mutant) leptin receptor.  48 hours post-transfection cells were made quiescent by incubation in optimum plus 0.5% BSA for 3 hours.  Cells were then stimulated with 100ng of leptin or maintained in optimum plus 0.5% BSA for an additional 3 hours. Leptin was purchased from Dr. A.F. Parlow, National Hormone and Peptide Program (Torrance, CA). The STAT3 inhibitor, Stattic, the PI3K inhibitor, LY294002 and the MEK inhibitor PD98059 were purchased from EMD chemicals (Gibbstown, NJ).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM569352","2":"NA","3":"embryonic kidney cell line hek","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Mutant in the absence of tetracycline, rep2","18":"NA","19":"untreated","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Embryonic kidney cell line HEK","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1 Oryong-dong Buk-gu","38":"Gwangju","39":"South Korea","40":"Life science","41":"lbc0523@gist.ac.kr","42":"82629702540","43":"Gwangju Institutue Science and Technology","44":"NA","45":"Byoung-Cheol,,Lee","46":"82629702566","47":"NA","48":"NA","49":"500712","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from HEK cells non-expressing mutant TRPM7 channel', 'Mutant no2']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"mutant channel","64":"GSM569352","65":"NA","66":"NA","67":"NA","68":"NA","69":"Stabel cell-lines were grown in in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum and an antibiotic, 5 ug/mL blasticidin (Invitrogen). Cells were cultured in a humidified atmosphere of 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Fragmented cRNA was hybridized to the Human Genome UI133 Plus 2.0 Array (Affymetrix) at 45C for 16 h according to the Affymetrix standard protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"5 ug of total RNA from each cell-lines was used for labeling. Probe synthesis from total RNA samples, hybridization, detection, and scanning were performed according to standard protocols from Affymetrix, Inc..","79":"NA","80":"Jul 23 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"After hybridization, the arrays were washed in a GeneChip Fluidics Station 450 with a non-stringent wash buffer at 25C followed by a stringent wash buffer at 50C. After washing, the arrays were stained with a streptavidin-phycoerythrin complex. After staining, intensities were determined with a GeneChip scanner 3000 (Affymetrix), controlled by GCOS Affymetrix software.","97":"NA","98":"GSE23102","99":"NA","100":"NA","101":"NA","102":"HEK cell lines non-expressing mutant channel","103":"Public on Jul 23 2011","104":"NA","105":"NA","106":"Jul 23 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM569nnn/GSM569352/suppl/GSM569352.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Mutant in the absence of tetracycline, rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 ug of tetracycline was treated to stabel cell-lines which overexressing WT and mutant TRPM7 channel for 72 hours","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM389758","2":"NA","3":"hek 293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 in low glucose #1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"Gene expression data from cells cultivated in low glucose","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated with the RNeasy Mini kit according to the manufacturer`s instructions (Qiagen).","61":"NA","62":"NA","63":"NA","64":"GSM389758","65":"low glucose (100 mg/dl)","66":"NA","67":"NA","68":"NA","69":"Human embryonic kidney (HEK293) cells were grown for 7 days in DMEM (supplemented with 10 % FCS) containing 450 mg/dl glucose (high glucose) or 100 mg/dl glucose (low glucose).","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Human Genome U133 Plus 2.0 Array) in 200 l of the hybrization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual; Rev. 5).","79":"NA","80":"Apr 19 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE15575","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) cultivated for 7 days in DMEM containing low (100 mg/dl) glucose.","103":"Public on Apr 08 2009","104":"NA","105":"NA","106":"Apr 06 2009","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM389nnn/GSM389758/suppl/GSM389758.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM389nnn/GSM389758/suppl/GSM389758.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 in low glucose #1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1174942","2":"NA","3":"isogenic human embryonal kidney (hek293) cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 h","17":"wtGR_dex_6h_rep2","18":"100 nm of dexamethasone","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Isogenic Human Embryonal Kidney (HEK293) Cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Yliopistonranta 1E","38":"Kuopio","39":"Finland","40":"School of Medicine","41":"villepaakinaho@gmail.com","42":"NA","43":"University of Eastern Finland","44":"Biomedicine","45":"Ville,,Paakinaho","46":"NA","47":"NA","48":"NA","49":"70210","50":"Obtained data was normalized using VST transformation and RSN normalization  used as standard approach for Illumina arrays with the R/lumi package","51":"47323","52":"NA","53":"['stably expressing wtGR', 'GR_5']","54":"illuminaHumanv4","55":"98.37030","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using TriPure (Roche Diagnostics GmbH, Mannheim, Germany) according to manufacture's instructions","61":"NA","62":"NA","63":"NA","64":"GSM1174942","65":"NA","66":"NA","67":"NA","68":"NA","69":"Isogenic HEK293 cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 g/ml streptomycin, and 100 g hygromycin-B,  and kept at 37 C in a humidified 95% air/ 5% CO2","70":"NA","71":"NA","72":"Standart Illumina hybridization protocol","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared with the Ambion MessageAmk kit for Illumina arrays","79":"NA","80":"Nov 05 2013","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standart Illumina scanning protocol","97":"NA","98":"['GSE48328', 'GSE48379']","99":"NA","100":"NA","101":"NA","102":"Isogenic HEK293 Cells, dex treated, 6 h","103":"Public on Nov 05 2013","104":"NA","105":"NA","106":"Jun 26 2013","107":"NONE","108":"9606","109":"6 h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"wtGR_dex_6h_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"100 nM of dexamethasone","122":"3x105x of Isogenic HEK293 cells were seeded at 6-well plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 36 h and the cells were subsequently treated with 100 nM of dexamethasone for 6 h prior extraction of RNA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874651","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"IGF_1h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874651","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER IGF 1h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874651/suppl/GSM1874651_NB_60_IGF_1h_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"IGF_1h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546587","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hours","17":"t469fsh_1","18":"fsh - hormone treatment - fsh stimulation","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"3nM","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"t469fsh_1:24ug.","61":"NA","62":"mutant hek_t469","63":"NA","64":"GSM546587","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C, 5% C02","70":"23-12-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"t469fsh_1","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546587/suppl/GSM546587_t469fsh_1.CEL.gz","108":"9606","109":"6 hours","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"t469fsh_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"FSH - hormone treatment - fsh stimulation","122":"Name:FSH - hormone treatment - fsh stimulation,follicle stimulating hormone (fsh):quantity 3nM time 6hour . 3nM","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442099","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,8h,transfected,biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"8 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442099","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, transfected_8h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442099/suppl/GSM1442099_8hGFPP_REP1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,8h,transfected,biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM678676","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Treated_24_h_Replicate 1","18":"NA","19":"Triptorelin","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"5","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 1","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678676","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"2","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"3","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"24","114":"NA","115":"NA","116":"HEK293_Treated_24_h_Replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733545","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080813 SM exposure 600 uM_2h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-08-20","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-08-14","53":"Gene expression data from NHEK_080813 SM exposure 600 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"600.0","58":"2008-08-13","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733545","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-08-25","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-08-27","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080813 SM exposure 600 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733545/suppl/GSM733545_080813_HD_2h_600.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_080813 SM exposure 600 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM711414","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"HEK293Tcells_si74_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"1000 E 50th St","38":"Kansas City","39":"USA","40":"Genomics","41":"seidel@phageT4.org","42":"NA","43":"Stowers Institute","44":"Seidel","45":"Chris,W,Seidel","46":"816 926 9054","47":"MO","48":"NA","49":"64110","50":"Array intensities were processed using the RMA algorithm in R/bioconductor. Bioconductor 2.6 and affy package affy_1.24.2","51":"54675","52":"NA","53":"Gene expression from HEK293T cells after transfection with siRNA s18074 targeting Med26, replicate 2.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the standard Qiagen RNeasy cleanup protocol.","61":"NA","62":"NA","63":"NA","64":"GSM711414","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in 6 well tissue culture plates or 10 cm dishes for 48 hours after transfection.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 plus 2.0 Arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the Ambion MessageAmp III protocol from 300 ng total RNA (MessageAmp III Amplification kit Manual, 2007, Ambion).","79":"NA","80":"Sep 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 and processed with AGCC v3.0 software.","97":"NA","98":"GSE28715","99":"NA","100":"Med26 targeting s18074","101":"NA","102":"HEK293T cells","103":"Public on Sep 01 2011","104":"NA","105":"NA","106":"Apr 19 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM711nnn/GSM711414/suppl/GSM711414_si-74-2_HG-U133_Plus_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293Tcells_si74_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293T cells in 6 well tissue culture plates (~1x105 cells/well) or 10 cm dishes (~2 x106 cells/dish) were transfected with 25 nM siRNAs targeting human Med26 (Ambion/Applied Biosystems, #4, s18074; #5, s18075; #6, s18076) or 25 nM siCONTROL NON-TARGETING siRNA #2 (Dharmacon D-001210-01) using X-tremeGENE siRNA Transfection Reagent (Roche) and grown for 48 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693927","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24h","17":"HEK293T_BACH1-esiRNA_24h_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_e_1_24', 'BACH1_e_1_200ng_24h_293T.CEL', 'Gene expression data from HEK 293T cells 24h after knockdown of BACH1 with esiRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693927","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"esiRNA (e)","102":"HEK 293T cells, BACH1 knockdown, 24h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693927/suppl/GSM693927.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693927/suppl/GSM693927.EXP.gz']","108":"9606","109":"24h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-esiRNA_24h_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM926166","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina humanRef-8 v1.0 expression beadchip (Illumina_HumanRef-8_v1.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK-293 anti-miR-181b Experimental Replicate 1 1897008128_C","18":"anti-mir-181b","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ring Road","38":"Callaghan","39":"Australia","40":"NA","41":"NA","42":"NA","43":"University of Newcastle","44":"NA","45":"Adam,,Carroll","46":"NA","47":"NSW","48":"NA","49":"2308","50":"Illumina Beadstudio software computed average signal intensities and detection p-values.","51":"22184","52":"NA","53":"Experimental Replicate 1","54":"illuminaHumanv2","55":"44.83337","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted with Trizol reagent, followed by clean-up with DNase I treatment and the RNeasy MinElute cleanup kit (Qiagen) in accordance with manufacturer's instructions. Quality control was performed with an Experion (BioRad) bioanalyser.","61":"NA","62":"NA","63":"NA","64":"GSM926166","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cell models were grown as confluent monolayers in standard tissue culture conditions.","70":"NA","71":"NA","72":"Standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA was prepared using the TotalPrep RNA amplification kit (Ambion) for Illumina arrays.","79":"NA","80":"Nov 01 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6104","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol.","97":"NA","98":"GSE37729","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Nov 01 2012","104":"NA","105":"NA","106":"May 02 2012","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK-293 anti-miR-181b Experimental Replicate 1 1897008128_C","117":"NA","118":"NA","119":"NA","120":"NA","121":"anti-miR-181b","122":"Cells were transfected with either synthetic miRNA or anti-miR inhibitor oligonucleotides. Control refers to untransfected cell models; siEGFP control refers to transfection with an siRNA to EGFP as a transfection control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1558598","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK_Native_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"no","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Nonnenwald 2","38":"Penzberg","39":"Germany","40":"Pharmaceutical Sciences","41":"fabian.birzele@roche.com","42":"NA","43":"Roche Diagnostics GmbH","44":"NA","45":"Fabian,,Birzele","46":"NA","47":"NA","48":"NA","49":"82377","50":"Partek Genomics suite was used to process CEL files, perform normalization and QC as well as to identify differentially regulated genes between native and CD44 transfected HEK293 cells using ANOVA.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"HEK293-CD44s Clone 4, expressing an average level of HA, was picked for profiling gene expression using Affymetrix Human Genome U133plus 2.0 arrays. Total RNA was prepared using the RNeasy Mini Kit (Qiagen, Germany), Microarray RNA Target Synthesis Kit T7 and RNeasy Mini-Spin Columns (Roche, Germany) and a hybridization mix was created consisting of 30 l of fragmented cRNA solution mixed with control oligonucleotide, staggered control cRNAs, herring sperm DNA, acetylated BSA and hybridization buffer in a total volume of 300 l. All kit procedures were performed according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1558598","65":"NA","66":"NA","67":"NA","68":"NA","69":"For cloning and expression of human CD44 (EMBL accession number M24915) the sequence was codon optimized (Geneart, Germany) and CD44s was expressed using a pcDNA3.1(-) vector (Invitrogen, Germany). PCR was performed with a denaturation step at 94C for 2 min, followed by 30 cycles of denaturation at 94C for 30 sec, annealing at 58C for 30 sec, and extension at 68C for 45 sec, with a final extension of 7 minutes at 68C (Expand High Fidelity PCR Kit, Roche). The PCR product and the vector were digested with EcoRI/HindIII restriction endonucleases, and DNA fragments were resolved by 1% agarose gel electrophoresis,purified from gels (GFX PCR DNA and Gel Band Purification Kit) and ligated (Rapid DNA Ligation Kit, Roche). Vectors were transferred into XL-10 Gold super-competent cells (Stratagene, The Netherlands) by heat shock and transformed cells were isolated form agar plates containing 100g/ml Ampicilin. Vector DNA from transfected cells was isolated using the High Pure Plasmid Isolation Kit (Roche, Germany).","70":"NA","71":"NA","72":"The hybridization mix was loaded onto the arrays and incubated in a roller device for 16 hrs. Hybridization solution was removed, arrays were washed, stained","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"standard Affymtrix protocol","79":"NA","80":"Dec 05 2014","81":"NA","82":"polyA RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned with an Affymetrix GeneChip Scanner 3000 (7G)","97":"NA","98":"GSE63862","99":"NA","100":"NA","101":"NA","102":"cell culture, native HEK293 cells","103":"Public on Dec 05 2014","104":"NA","105":"NA","106":"Dec 04 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1558nnn/GSM1558598/suppl/GSM1558598_KLP_RW13_101125_CD44_PZ.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK_Native_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236708","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"RHOXF1 48h_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_19']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236708","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, RHOXF1 transfected, 48h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236708/suppl/GSM2236708_Human_Gene_1_0_ST_20150205_19.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236708/suppl/GSM2236708_Human_Gene_1_0_ST_20150205_19.chp.gz']","108":"9606","109":"NA","110":"48h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"RHOXF1 48h_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"RHOXF1 expression vector"},{"1":"GSM733424","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071128 CEES exposure 1.0 uM_24h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-05-01","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-04","53":"Gene expression data from NHEK_071128 CEES exposure 1.0 uM_24h timepoint","54":"NA","55":"NA","56":"NA","57":"1.0","58":"2007-11-28","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733424","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-14","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-16","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071128 CEES exposure 1.0 uM_24h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733424/suppl/GSM733424_071128_CEES_24h_1.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"24","115":"NA","116":"NHEK_071128 CEES exposure 1.0 uM_24h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733338","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071107 CEES exposure 1.5 uM_2h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-14","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-30","53":"Gene expression data from NHEK_071107 CEES exposure 1.5 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"1.5","58":"2007-11-07","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733338","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-25","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-08-08","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071107 CEES exposure 1.5 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733338/suppl/GSM733338_071107_CEES_2h_1.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_071107 CEES exposure 1.5 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM517902","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,control,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"CTR_2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM517902","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Nov 21 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE20615","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,control,biological rep 2","103":"Public on Oct 05 2011","104":"NA","105":"NA","106":"Mar 03 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM517nnn/GSM517902/suppl/GSM517902.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,control,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2545286","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek-293t","15":"NA","16":"48 h after transfection","17":"293T-DME rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK-293T","33":"1","34":"NA","35":"NA","36":"NA","37":"Gwanak-gu","38":"Seoul","39":"South Korea","40":"Dept Plant Science","41":"huhjh@snu.ac.kr","42":"NA","43":"Seoul National University","44":"NA","45":"Jin Hoe,,Huh","46":"NA","47":"NA","48":"NA","49":"151-921","50":"The Micorarray Suite version 5 (MAS5) algorithm implemented in Affymetrix Expression Console software (version1.3.1) was used to normalize the raw data. Highly expressed genes that showed over 2-fold difference between the signal values of control and test samples were selected for further study.","51":"54675","52":"NA","53":"['DME-2', 'Gene expression data from 293T-DME']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted and purified using Qiagen RNeasy Kit according to standard instructions","61":"NA","62":"NA","63":"NA","64":"GSM2545286","65":"NA","66":"NA","67":"NA","68":"NA","69":"GFP and DME were transfected in HEK-293T cells and the cells harvested 48 h after transfection. HEK-293T cells were grown in Dulbeccos modified Eagles medium (DMEM) supplemented with 10% fetal bovine serum and a 1% antibiotic/antimycotic solution at 37C in 5% CO2 humidity chamber.","70":"NA","71":"NA","72":"Following fragmentation, fragmented cDNA were hybridized for 16 hr at 45C on Affymetrix GeneChip Human Genome U133 Plus 2.0 ST Array. The GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cDNA were prepared according to the standard Affymetrix protocol from 300  ng total RNA (GeneChip WT Terminal Labeling and Controls Kit P/N 901525 1, Affymetrix).","79":"NA","80":"Sep 20 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G","97":"NA","98":"['GSE96863', 'GSE96866']","99":"NA","100":"NA","101":"NA","102":"293T-DME","103":"Public on Sep 20 2017","104":"NA","105":"NA","106":"Mar 21 2017","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2545nnn/GSM2545286/suppl/GSM2545286_DME-2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"48 h after transfection","113":"NA","114":"NA","115":"NA","116":"293T-DME rep2","117":"NA","118":"plant-derived DNA demethylase DME","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560871","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"2 h","17":"MOCK_2h_MDP_biological replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"control mock","63":"NA","64":"GSM560871","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560871/suppl/GSM560871.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"2 h","113":"NA","114":"NA","115":"NA","116":"MOCK_2h_MDP_biological replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM258530","2":"NA","3":"hek293 human embryonic kidney cell line","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina human-6 v2.0 expression beadchip (Illumina_Human-6_V2.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_MIF siRNA 2#_24h_Illumina","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293 human embryonic kidney cell line","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Handan Road 220#","38":"Shanghai","39":"China","40":"Life Science","41":"liulingfeng1111@gmail.com","42":"NA","43":"Fudan University","44":"the State Key Laboratory of Genetic Engineering","45":"Lingfeng,,Liu","46":"+86-21-65643262","47":"NA","48":"NA","49":"200433","50":"Cubic spline normalization using Illumina BeadStudio Version \"BSGX Version3.2.3\"","51":"48702","52":"NA","53":"MIF siRNA(50pmol/ml)-mediated MIF knockdown in HEK293 cells","54":"illuminaHumanv2","55":"98.42364","56":"NA","57":"NA","58":"NA","59":"NA","60":"Illumina TotalPrep RNA amplification kit (Ambion Catalog#IL1791)","61":"NA","62":"NA","63":"NA","64":"GSM258530","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Refer to the Illumina Gene Expression System Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"Streptavidin Cy3","78":"As described in the illumina Human-6 chip processing protocol. Briefly, generation of biotin labelled cRNA from the product of RT cDNA synthesis and 2nd strand cDNA synthesis.","79":"NA","80":"Mar 29 2010","81":"99.99795","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6102","86":"MIF depletion, siRNA-mediated","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Refer to the Illumina Gene Expression System Manual","97":"NA","98":"GSE10241","99":"NA","100":"NA","101":"NA","102":"HEK293 cell, MIF Knockdown","103":"Public on Nov 03 2009","104":"NA","105":"NA","106":"Jan 23 2008","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM258nnn/GSM258530/suppl/GSM258530.txt.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293_MIF siRNA 2#_24h_Illumina","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1269602","2":"NA","3":"hek 293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"293 transfected with Aire replicate #1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"513 Parnassus Avenue, HSW Room  1102, Box 0540","38":"San Francisco","39":"USA","40":"Diabetes Center","41":"manderson@diabetes.ucsf.edu","42":"NA","43":"UCSF","44":"Anderson Lab","45":"Mark,Stuart,Anderson","46":"NA","47":"CA","48":"NA","49":"94143","50":"AGCC 3.2.2 Microarrays were normalized for array-specific effects using Affymetrix's Robust Multi-Array (RMA) normalization","51":"28829","52":"NA","53":"293 cells transfected with Aire only biologic replicate #1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Qiagen RNAeasy mini kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1269602","65":"NA","66":"NA","67":"NA","68":"NA","69":"Transfected HEK 293 cells were grown for 72hrs in complete DMEM prior to RNA extraction.","70":"NA","71":"NA","72":"See manufacturer protocol","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"NuGEN Ovation Pico WTA V2 and NuGEN Encore Biotin Module","79":"NA","80":"Nov 21 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCS3000","97":"NA","98":"['GSE52546', 'GSE52548']","99":"NA","100":"NA","101":"NA","102":"293 transfected with Aire","103":"Public on Nov 21 2013","104":"NA","105":"NA","106":"Nov 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1269nnn/GSM1269602/suppl/GSM1269602_04.Aire-1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"293 transfected with Aire replicate #1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK 293 cells were transfected using Mirus 293 transfection reagent following manufacturers protocol.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820020","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24 hrs","17":"HEK293T FMR4pcDNA 24hr 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"FMR4 overexpression","64":"GSM1820020","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, FMR4 overexpression, 24 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820020/suppl/GSM1820020_Zane_24hr_FMR4OX_1_B7_102011.CEL.gz","108":"9606","109":"24 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T FMR4pcDNA 24hr 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM569355","2":"NA","3":"embryonic kidney cell line hek","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Mutant in the presence of tetracycline, rep2","18":"NA","19":"tetracycline","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Embryonic kidney cell line HEK","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1 Oryong-dong Buk-gu","38":"Gwangju","39":"South Korea","40":"Life science","41":"lbc0523@gist.ac.kr","42":"82629702540","43":"Gwangju Institutue Science and Technology","44":"NA","45":"Byoung-Cheol,,Lee","46":"82629702566","47":"NA","48":"NA","49":"500712","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from HEK cells expressing mutant TRPM7 channel', 'Mutant tet2']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"mutant channel","64":"GSM569355","65":"NA","66":"NA","67":"NA","68":"NA","69":"Stabel cell-lines were grown in in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum and an antibiotic, 5 ug/mL blasticidin (Invitrogen). Cells were cultured in a humidified atmosphere of 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Fragmented cRNA was hybridized to the Human Genome UI133 Plus 2.0 Array (Affymetrix) at 45C for 16 h according to the Affymetrix standard protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"5 ug of total RNA from each cell-lines was used for labeling. Probe synthesis from total RNA samples, hybridization, detection, and scanning were performed according to standard protocols from Affymetrix, Inc..","79":"NA","80":"Jul 23 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"After hybridization, the arrays were washed in a GeneChip Fluidics Station 450 with a non-stringent wash buffer at 25C followed by a stringent wash buffer at 50C. After washing, the arrays were stained with a streptavidin-phycoerythrin complex. After staining, intensities were determined with a GeneChip scanner 3000 (Affymetrix), controlled by GCOS Affymetrix software.","97":"NA","98":"GSE23102","99":"NA","100":"NA","101":"NA","102":"HEK cell lines expressing mutant channel","103":"Public on Jul 23 2011","104":"NA","105":"NA","106":"Jul 23 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM569nnn/GSM569355/suppl/GSM569355.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Mutant in the presence of tetracycline, rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 ug of tetracycline was treated to stabel cell-lines which overexressing WT and mutant TRPM7 channel for 72 hours","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM517903","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,control,biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"CTR_3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM517903","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Nov 21 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE20615","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,control,biological rep 3","103":"Public on Oct 05 2011","104":"NA","105":"NA","106":"Mar 03 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM517nnn/GSM517903/suppl/GSM517903.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,control,biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM205753","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 cell line #1 with noninduced HNF4a2 wild type","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 1000.","51":"54675","52":"NA","53":"Analysis of gene expression in human embryonic kidney cells (HEK293) overexpressing the transcription factor HNF4a2 or mutant forms HNF4a2 C106R or R154X, which were introduced by FRT/FLP recombination. The analysis were performed 24 hours following 1 g/ml doxycyclin treatment to induce the expression of the trans-genes. Results identify HNF4 regulated genes in kidney cells being several of these genes deregulated in renal cell carcinoma.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Rneasy mini extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM205753","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133_Plus_2.0 arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual v2, Affymetrix).","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000.","97":"NA","98":"GSE8289","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line #1 with noninduced HNF4a2 wild type","103":"Public on Jun 20 2008","104":"NA","105":"NA","106":"Jun 26 2007","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205753/suppl/GSM205753.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205753/suppl/GSM205753.CHP.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205753/suppl/GSM205753.EXP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cell line #1 with noninduced HNF4a2 wild type","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were treated for 24 h with 1 g/ml doxycyclin or solvent.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881014","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 3","17":"Non-producer culture - fermentation 3- time point 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"1","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 12","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"non-producing parent","64":"GSM881014","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Non-producer culture - fermentation 3- time point 3","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 3","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Non-producer culture - fermentation 3- time point 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2545288","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek-293t","15":"NA","16":"48 h after transfection","17":"293T-GFP rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK-293T","33":"1","34":"NA","35":"NA","36":"NA","37":"Gwanak-gu","38":"Seoul","39":"South Korea","40":"Dept Plant Science","41":"huhjh@snu.ac.kr","42":"NA","43":"Seoul National University","44":"NA","45":"Jin Hoe,,Huh","46":"NA","47":"NA","48":"NA","49":"151-921","50":"The Micorarray Suite version 5 (MAS5) algorithm implemented in Affymetrix Expression Console software (version1.3.1) was used to normalize the raw data. Highly expressed genes that showed over 2-fold difference between the signal values of control and test samples were selected for further study.","51":"54675","52":"NA","53":"['GFP-1', 'Gene expression data from 293T-GFP']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted and purified using Qiagen RNeasy Kit according to standard instructions","61":"NA","62":"NA","63":"NA","64":"GSM2545288","65":"NA","66":"NA","67":"NA","68":"NA","69":"GFP and DME were transfected in HEK-293T cells and the cells harvested 48 h after transfection. HEK-293T cells were grown in Dulbeccos modified Eagles medium (DMEM) supplemented with 10% fetal bovine serum and a 1% antibiotic/antimycotic solution at 37C in 5% CO2 humidity chamber.","70":"NA","71":"NA","72":"Following fragmentation, fragmented cDNA were hybridized for 16 hr at 45C on Affymetrix GeneChip Human Genome U133 Plus 2.0 ST Array. The GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cDNA were prepared according to the standard Affymetrix protocol from 300  ng total RNA (GeneChip WT Terminal Labeling and Controls Kit P/N 901525 1, Affymetrix).","79":"NA","80":"Sep 20 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G","97":"NA","98":"['GSE96863', 'GSE96866']","99":"NA","100":"NA","101":"NA","102":"293T-GFP","103":"Public on Sep 20 2017","104":"NA","105":"NA","106":"Mar 21 2017","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2545nnn/GSM2545288/suppl/GSM2545288_GFP-1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"48 h after transfection","113":"NA","114":"NA","115":"NA","116":"293T-GFP rep1","117":"NA","118":"GFP","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693928","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24h","17":"HEK293T_BACH1-esiRNA_24h_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_e_2_24', 'BACH1_e_2_200ng_24h_293T.CEL', 'Gene expression data from HEK 293T cells 24h after knockdown of BACH1 with esiRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693928","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"esiRNA (e)","102":"HEK 293T cells, BACH1 knockdown, 24h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693928/suppl/GSM693928.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693928/suppl/GSM693928.EXP.gz']","108":"9606","109":"24h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-esiRNA_24h_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM373105","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"transformed hek cells","15":"NA","16":"NA","17":"Hek-HT Ras^G12V Replicate-4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"transformed Hek cells","33":"1","34":"NA","35":"NA","36":"NA","37":"6431 Fannin St","38":"Houston","39":"USA","40":"NA","41":"jeffrey.t.chang@uth.tmc.edu","42":"NA","43":"UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON","44":"NA","45":"Jeffrey,,Chang","46":"NA","47":"TX","48":"NA","49":"77030","50":"MAS5.0","51":"22277","52":"NA","53":"1462_2979_14865_12V-4_HG-U133A+2.CEL","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"We extracted total RNA using Qiagen Rneasy mini kits.","61":"NA","62":"NA","63":"NA","64":"GSM373105","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"The cRNA is fragmented before hybridization and a hybridization cocktail is prepared that contains the fragmented cRNA, probe array controls, BSA and herring sperm DNA.  The cRNA is hybridized to the oligonucleotide probes on the array for 16 hours at 45C.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"We performed an in vitro transcription reaction to produce a biotin-labeled cRNA from the cDNA.","79":"NA","80":"Feb 20 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Immediately following hybridization, the hybridized probe arrays undergo an automated washing and staining protocol on the fluidic station and are then scanned on the GeneChip Scanner 3000 7G.","97":"NA","98":"GSE14934","99":"NA","100":"NA","101":"NA","102":"12V-4","103":"Public on Feb 21 2009","104":"NA","105":"NA","106":"Feb 20 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM373nnn/GSM373105/suppl/GSM373105.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Hek-HT Ras^G12V Replicate-4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2089909","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U219 Array (hgu219)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T_mock(dharmacon)BRD1_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Bartholins All 6","38":"Aarhus","39":"Denmark","40":"Biomedicine","41":"tue@biomed.au.dk","42":"NA","43":"Aarhus University","44":"Prof Anders Borglum's lab","45":"Tue,,Fryland","46":"NA","47":"Aarhus","48":"NA","49":"8000","50":"rma","51":"49386","52":"NA","53":"Mock treatment targeted against the BRD1 mRNA transcript (Dharmacon) rep1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Qiagen Rneasy + Qiagen shredder columns (performed according to the supplied protocol)","61":"NA","62":"NA","63":"NA","64":"GSM2089909","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells (controls and stable BRD1-S-V5 and BRD1-L-V5 cell lines) were grown in DMEM medium (Invitrogen, San Diego, CA, USA) supplemented with 5% fetal calf serum (FCS), 175 mg/L glutamine, 36 mg/L penicillin and 60 mg/L streptomycine at 37 oC in 5% CO2","70":"NA","71":"NA","72":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","79":"NA","80":"Mar 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL13667","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"standard Affymetrix protocol","97":"NA","98":"GSE79255","99":"NA","100":"NA","101":"NA","102":"Cell line culture, mock method 2","103":"Public on Mar 16 2016","104":"NA","105":"NA","106":"Mar 15 2016","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2089nnn/GSM2089909/suppl/GSM2089909_A897-04.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_mock(dharmacon)BRD1_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM678652","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Control_1_h_Replicate 2","18":"NA","19":"Control","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"3","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 28","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678652","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"1","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"1","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"1","114":"NA","115":"NA","116":"HEK293_Control_1_h_Replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1039983","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,untransfected,biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"GFPMINUS_1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1039983","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 22 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE59666","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"['GSE20615', 'GSE59666']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,untransfected,biological rep 1_24h","103":"Public on Nov 21 2012","104":"NA","105":"NA","106":"Nov 21 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1039nnn/GSM1039983/suppl/GSM1039983_AnP_Hu13302_062910_02_M26.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,untransfected,biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1305856","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"EA07047_56010_H133+_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"5635 Fishers Lane, Suite 510","38":"Rockville","39":"USA","40":"NA","41":"raducojo@gmail.com","42":"NA","43":"Elsevier","44":"NA","45":"Radu,,Cojocaru","46":"NA","47":"MD","48":"NA","49":"20852","50":"Data was analyzed using GeneSpring software including QC analysis.","51":"41751","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted from control and myocilin expressing cells after induction with selected concentrations of doxycycline using a Trizol reagent. The extracted RNA was used for each microarray study.","61":"NA","62":"NA","63":"NA","64":"GSM1305856","65":"NA","66":"NA","67":"NA","68":"NA","69":"Tet-on stably transfected cells were maintained in Dulbecco modified Eagle medium (DMEM) supplemented with 10% Tet system proved fetal bovine serum, penicillin (100 U/ml), streptomycin (100 g/ml), hygromycin B (200 g/ml) and G418 (100 g/ml) at 37 C in a humidified atmosphere of 5% CO2.","70":"NA","71":"NA","72":"Not provided.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Not provided.","79":"NA","80":"May 21 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Not provided.","97":"NA","98":"GSE53985","99":"NA","100":"NA","101":"NA","102":"Stable Cell line transfected with control vector","103":"Public on May 21 2014","104":"NA","105":"NA","106":"Jan 13 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1305nnn/GSM1305856/suppl/GSM1305856_EA07047_56010_H133+_1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"EA07047_56010_H133+_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Tet-on stably transfected cells were treated with 0.2 or 1 g/ ml of doxycycline for 48 hr to induce myocilin expression.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2089913","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U219 Array (hgu219)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T_stableexpression_BRD1-L (NM_001304808.1 refseq)","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Bartholins All 6","38":"Aarhus","39":"Denmark","40":"Biomedicine","41":"tue@biomed.au.dk","42":"NA","43":"Aarhus University","44":"Prof Anders Borglum's lab","45":"Tue,,Fryland","46":"NA","47":"Aarhus","48":"NA","49":"8000","50":"rma","51":"49386","52":"NA","53":"Stable/episomal expression of His6/V5 tagged BRD1-L (refseq NM_001304808.1  )","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Qiagen Rneasy + Qiagen shredder columns (performed according to the supplied protocol)","61":"NA","62":"NA","63":"NA","64":"GSM2089913","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells (controls and stable BRD1-S-V5 and BRD1-L-V5 cell lines) were grown in DMEM medium (Invitrogen, San Diego, CA, USA) supplemented with 5% fetal calf serum (FCS), 175 mg/L glutamine, 36 mg/L penicillin and 60 mg/L streptomycine at 37 oC in 5% CO2","70":"NA","71":"NA","72":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","79":"NA","80":"Mar 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL13667","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"standard Affymetrix protocol","97":"NA","98":"GSE79255","99":"NA","100":"NA","101":"NA","102":"Cell line culture, stable/episomal expression BRD1-L","103":"Public on Mar 16 2016","104":"NA","105":"NA","106":"Mar 15 2016","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2089nnn/GSM2089913/suppl/GSM2089913_A897-08.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_stableexpression_BRD1-L (NM_001304808.1 refseq)","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442118","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,8h,transfected,biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"8 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442118","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, transfected_8h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442118/suppl/GSM1442118_8hGFPP_REP3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,8h,transfected,biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2698670","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 2.0 ST Array (hugene20st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"mimic-1825 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Einstein-Allee 11","38":"Ulm","39":"Germany","40":"Neurology","41":"axel.freischmidt@uni-ulm.de","42":"NA","43":"Ulm University","44":"NA","45":"Axel,,Freischmidt","46":"+4973150063051","47":"NA","48":"NA","49":"89081","50":"Affymetrix Expression Console Software 1.4.1.46 for feature extraction and normalization, BRB Array Tools for statistical analysis","51":"53617","52":"NA","53":"['transcriptome of HEK293 cells after transfection of miR-1825-mimic', 'm2_mimic-2']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Isolation of total RNA was performed with the RNeasy Plus Mini Kit (Qiagen) as specified by the manufacturer.","61":"NA","62":"NA","63":"NA","64":"GSM2698670","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were grown under standard conditions (37 C; 5% CO2) in DMEM (Thermo Fisher Scientifc #41965039) supplemented with 10% fetal bovine serum.","70":"NA","71":"NA","72":"according to Affymetrix Whole Transcript (WT) Sense Target Labeling Assay","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Whole Transcript (WT) Sense Target Labeling Assay","79":"NA","80":"Jul 30 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL16686","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"according to Affymetrix protocols using a GeneChip 3000 Scanner","97":"NA","98":"GSE101046","99":"NA","100":"NA","101":"NA","102":"mimic-1825","103":"Public on Jul 30 2018","104":"NA","105":"NA","106":"Jul 10 2017","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2698nnn/GSM2698670/suppl/GSM2698670_m2_mimic-2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"mimic-1825 2","117":"NA","118":"NA","119":"miR-1825-mimic","120":"NA","121":"NA","122":"For transfections of AllStars Negative Control siRNA (Qiagen #1027280) or Syn-hsa-miR-1825 (Qiagen #MSY0006765) in a concentration of 5 nM we used the HiPerfect transfection reagent (Qiagen). 24 h post-transfection, the cells were washed twice with PBS followed by RNA extraction.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820001","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hrs","17":"HEK293T CTLsiRNA 6hr 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"knockdown control","64":"GSM1820001","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, knockdown control, 6 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820001/suppl/GSM1820001_Zane_6hr_CTLsi_3_A6_102011.CEL.gz","108":"9606","109":"6 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T CTLsiRNA 6hr 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861812","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293-Vc-rep2","18":"none","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"10 Amistad Street","38":"New Haven","39":"USA","40":"NA","41":"dianqing.wu@yale.edu","42":"NA","43":"Yale University","44":"NA","45":"Dan,,Wu","46":"NA","47":"NA","48":"NA","49":"06510","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"Gene expression data from HEK293 cells","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM861812","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were incubated in DMEM with 10% FBS","70":"NA","71":"NA","72":"After labeling the samples are prepared for hybridization and then rotate in oven at 45 degrees for 16 hours. GeneChips were washed and stained on GeneChip Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Fragment and label the single-stranded cDNA were prepared according to  the standard Affymetrix protocol (GeneChip WT Terminal Lableing and Hybridization User Manual).","79":"NA","80":"Jan 14 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 7G.","97":"NA","98":"GSE35084","99":"NA","100":"NA","101":"NA","102":"HEK293","103":"Public on Jan 14 2012","104":"NA","105":"NA","106":"Jan 13 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861812/suppl/GSM861812_HEK293-Vc-2.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861812/suppl/GSM861812_HEK293-Vc-2.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293-Vc-rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"none","122":"The cells were incubated with serum-free medium for overnight and then stimulated with LPA (1uM) for 2 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874624","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T0.5h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874624","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 0.5h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874624/suppl/GSM1874624_RG_24_4OHT_0.5h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T0.5h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733433","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080116 CEES exposure 1.5 uM_1h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-05-05","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-06","53":"Gene expression data from NHEK_080116 CEES exposure 1.5 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"1.5","58":"2008-01-16","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733433","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-14","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-16","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080116 CEES exposure 1.5 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733433/suppl/GSM733433_080116_CEES_1h_1.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_080116 CEES exposure 1.5 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM463018","2":"NA","3":"hek293e","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293E cells, scrambled siRNA, replicate 4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293E","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Calwer Str. 7","38":"Tuebingen","39":"Germany","40":"Department of Medical Genetics","41":"michael.walter@agilent.com","42":"NA","43":"University of Tuebingen","44":"The Microarray Facility Tbingen","45":"Michael,H.,Walter","46":"NA","47":"NA","48":"NA","49":"72076","50":"The data were analysed using GC-RMA for background correction, normalization and probe summarization using the Bioconductor package gcrma with default values.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA  was extracted by using RNeasy Mini Kit (Qiagen) following manufacturers instructions for animal cells.","61":"NA","62":"NA","63":"NA","64":"GSM463018","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293E cells were grown in Dulbeccos modified Eagle medium (DMEM) (Biochrom) supplemented with 10% fetal bovine serum (PAA) at 37C under humidified 5% CO2/air","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 Plus 2.0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Oct 19 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GCS3000 gene chip scanner.","97":"NA","98":"GSE18632","99":"NA","100":"NA","101":"NA","102":"HEK cells transfected with scrambled siRNA, 24h after transfection","103":"Public on Oct 20 2009","104":"NA","105":"NA","106":"Oct 19 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463018/suppl/GSM463018.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293E cells, scrambled siRNA, replicate 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were transiently transfected three consecutive days using HiPerfect with 5nmol scrambled (both Qiagen) or TDP-specific  siRNAs (5-CAATAGCAATAGACAGTTA-3) and cultivated for 24h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881026","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 4","17":"Non-producer culture - fermentation 3- time point 4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"2","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 24","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"non-producing parent","64":"GSM881026","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Non-producer culture - fermentation 3- time point 4","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 4","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Non-producer culture - fermentation 3- time point 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733387","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071128 CEES exposure 2.0 uM_1h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-22","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-30","53":"Gene expression data from NHEK_071128 CEES exposure 2.0 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"2.0","58":"2007-11-28","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733387","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-08","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-10","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071128 CEES exposure 2.0 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733387/suppl/GSM733387_071128_CEES_1h_2.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_071128 CEES exposure 2.0 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610837","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"4hr","17":"HEK293T_miR-381_FSK4hr_rep1","18":"NA","19":"FSK","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610837","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610837/suppl/GSM610837.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610837/suppl/GSM610837.chp.gz']","108":"9606","109":"4hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-381_FSK4hr_rep1","117":"miR-381","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733256","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070926 NM exposure 1000 uM_2h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-02","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-28","53":"Gene expression data from NHEK_070926 NM exposure 1000 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"1000.0","58":"2007-09-26","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733256","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-23","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-07-25","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070926 NM exposure 1000 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733256/suppl/GSM733256_070926_NM_2h_1000.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_070926 NM exposure 1000 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM205758","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 cell line #1 with induced HNF4a2 mutant C106R","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 1000.","51":"54675","52":"NA","53":"Analysis of gene expression in human embryonic kidney cells (HEK293) overexpressing the transcription factor HNF4a2 or mutant forms HNF4a2 C106R or R154X, which were introduced by FRT/FLP recombination. The analysis were performed 24 hours following 1 g/ml doxycyclin treatment to induce the expression of the trans-genes. Results identify HNF4 regulated genes in kidney cells being several of these genes deregulated in renal cell carcinoma.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Rneasy mini extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM205758","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133_Plus_2.0 arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual v2, Affymetrix).","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000.","97":"NA","98":"GSE8289","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line #1 with induced HNF4a2 mutant C106R","103":"Public on Jun 20 2008","104":"NA","105":"NA","106":"Jun 26 2007","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205758/suppl/GSM205758.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205758/suppl/GSM205758.CHP.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205758/suppl/GSM205758.EXP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cell line #1 with induced HNF4a2 mutant C106R","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were treated for 24 h with 1 g/ml doxycyclin or solvent.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1171539","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"R749H-amr RD40a","18":"r749h-amr","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"2 Hertzl st.","38":"Rehovot","39":"Israel","40":"NA","41":"rivka.dikstein@weizmann.ac.il","42":"NA","43":"The Weizmann Institute of Science","44":"NA","45":"Rivka,,Dikstein","46":"NA","47":"NA","48":"NA","49":"76100","50":"RMA was carried out using Partek Genomic Suite 6.5 (Inc. St. Charles, MO; www.partek.com)","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Tri-reagent (MRC inc.) according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1171539","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T were maintained in Dulbeccos modified Eagles medium (DMEM) supplemented with 10 % fetal calf serum.","70":"NA","71":"NA","72":"cDNA in 80 ul were hybridized to a Human Gene 1.0 ST array using Affymetrix hybridization kit materials and hybridized for 17 hours at 45 at 60rpm. Post-hyb washes were done with Affymetrix wash solutions on the FS450 station using FS450_0007 protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"200ng TotalRNA were used. cDNA samples were generated and labeled using Affymetrix WT-cDNA synthesis and labeling kit","79":"NA","80":"Jul 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned on the Affymetrix GeneChip Scanner 3000 7G","97":"NA","98":"GSE48163","99":"NA","100":"NA","101":"NA","102":"4 slow","103":"Public on Jul 01 2013","104":"NA","105":"NA","106":"Jun 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1171nnn/GSM1171539/suppl/GSM1171539_RD40a_HuST.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"R749H-amr RD40a","117":"NA","118":"NA","119":"NA","120":"NA","121":"R749H-amr","122":"Cells were transfected with plasmids directing the expression of -amanitin-resistant variants of Pol II (Rpb1-amr and R749H-amr). -amanitin was added and RNA was prepared 24 and 48 h later, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM678673","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Treated_24_h_Replicate 2","18":"NA","19":"Triptorelin","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"4","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 21","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678673","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"2","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"1","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"24","114":"NA","115":"NA","116":"HEK293_Treated_24_h_Replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236703","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"RHOXF2 24h_3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_8']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236703","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, RHOXF2 transfected, 24h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236703/suppl/GSM2236703_Human_Gene_1_0_ST_20150205_8.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236703/suppl/GSM2236703_Human_Gene_1_0_ST_20150205_8.chp.gz']","108":"9606","109":"NA","110":"24h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"RHOXF2 24h_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"RHOXF2 expression vector"},{"1":"GSM2716908","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human emborynic kidney 293 cells","15":"NA","16":"NA","17":"overexpression of the truncated FMRP_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"156 Xierhuan Road","38":"Fuzhou","39":"China","40":"NA","41":"xmuywj@163.com","42":"NA","43":"Fuzhou General Hospital","44":"NA","45":"Yang,,wenjing","46":"+8615959229926","47":"NA","48":"NA","49":"350025","50":"The data were analyzed using Affymetrix GeneChip Command Console Software.","51":"54675","52":"NA","53":"overexpression of the truncated FMRP in HEK293T cells","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM2716908","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell lines were grown at 37C with 5% CO2","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 23 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using GeneChip Scanner 3000.","97":"NA","98":"GSE101830","99":"NA","100":"NA","101":"NA","102":"overexpression of the new truncated FMRP in HEK293T cells","103":"Public on Jul 26 2017","104":"NA","105":"NA","106":"Jul 25 2017","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2716nnn/GSM2716908/suppl/GSM2716908_161020-160682B_B_HG-U133_Plus_2_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"human emborynic kidney 293 cells","116":"overexpression of the truncated FMRP_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"DMEM medium with 10% FBS and 1% penicillin/streptomycin","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560878","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 h","17":"NOD2-L1007fsinsC_6h_MDP_biological replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 L1007fsinsC","63":"NA","64":"GSM560878","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560878/suppl/GSM560878.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"6 h","113":"NA","114":"NA","115":"NA","116":"NOD2-L1007fsinsC_6h_MDP_biological replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693945","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"72h","17":"HEK293T_BACH1-siRNA1_72h_rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_q_3_72', 'BACH1_q_3_300ng_72h_293T.CEL', 'Gene expression data from HEK 293T cells 72h after knockdown of BACH1 with Qiagen siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693945","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"siRNA1 SI00309876 (q)","102":"HEK 293T cells, BACH1 knockdown, 72h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693945/suppl/GSM693945.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693945/suppl/GSM693945.EXP.gz']","108":"9606","109":"72h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-siRNA1_72h_rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693939","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24h","17":"HEK293T_mock-transfection_24h_rep4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_m_4_24', 'MOCK_m_4_0ng_24h_293T.CEL', 'Gene expression data from HEK 293T cells 24h after mock transfection without siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"control","64":"GSM693939","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"mock (without siRNA)","102":"HEK 293T cells, mock transfection, 24h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693939/suppl/GSM693939.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693939/suppl/GSM693939.EXP.gz']","108":"9606","109":"24h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_mock-transfection_24h_rep4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM897032","2":"NA","3":"hek293 cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T-REx293-NPAP1-uninduced-3","18":"uninduced","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293 cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with RMA default setting in Partek GS","51":"33297","52":"NA","53":"Gene expression data from cell line T-REx293-NPAP1, not induced, technical replicate 3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using the RNeasy mini kit (QIAGEN), treated with DNase I, followed by cleaning-up on spin columns (RNeasy mini kit. Qiagen)","61":"NA","62":"NA","63":"NA","64":"GSM897032","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were cultured in DMEM medium supplemented with 10% FCS, 1% penstrep and appropriate concentration of selective antibiotics","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Human Gene 1.0 ST. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix Hybridization, Wash and Stain Kit..","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Amplified cDNA was prepared according to the Ambion WT Expression Kit protocol starting from 200 ng total RNA. Amplified cDNA was fragmented with UDG and APE1 and finally labelled using the Affymetrix WT terminal labelling kit","79":"NA","80":"Jun 18 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned in the Affymetrix GeneChip Scanner 3000 wit G7 update","97":"NA","98":"GSE36575","99":"NA","100":"NA","101":"NA","102":"Flp-In T-REx 293","103":"Public on Jun 18 2012","104":"NA","105":"NA","106":"Mar 16 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM897nnn/GSM897032/suppl/GSM897032_TRex3_6.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T-REx293-NPAP1-uninduced-3","117":"NA","118":"NA","119":"NA","120":"NPAP1/C15orf2","121":"uninduced","122":"Cells were mock treated (H2O)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM360326","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 1hr, replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"50 South Drive, Bldg.50, Rm.2347","38":"Bethesda","39":"USA","40":"NA","41":"changah@nhlbi.nih.gov","42":"NA","43":"NIH\\\\NHLBI","44":"Laboratory of Biochemistry","45":"Allen,HK,Chang","46":"NA","47":"MD","48":"NA","49":"20892","50":"The data were first processed with GCOS1.4 using Affymetrix default analysis settings. The trimmed mean target intensity of each array was arbitrarily set to 1000. Intensities obtained in CHP file generated by GCOS were normalized using an adaptive variance-stabilizing quantile normalization (Munson, P.J., GeneLogic Workshop of Low Level Analysis of Affymetrix GeneChip Data, 2001, software available at http://abs.cit.nih.gov/geneexpression.html).","51":"54675","52":"NA","53":"gene expression data from human embryonic kidney cells (cell culture) treated with epoxomicin for 1hr","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 cells using Qiagen RNeasy Mini Kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM360326","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells are maintained in DMEM supplemented with 10% fetal bovine serum in 3% oxygen, 5% carbon dioxide, 37 degrees Celsius humidified incubator.","70":"NA","71":"NA","72":"Fragmented RNA was hybridized to Affymetrix HG-U133 plus 2.0 chips for 16 hours, washed, stained on an Affymetrix fluidics station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol using Affymetrixs IVT labeling kit following the manufacturers directions.","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Hybridized chips were scanned using Affymetrix genechip scanner 3000","97":"NA","98":"GSE14429","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 1hr","103":"Public on Jan 15 2009","104":"NA","105":"NA","106":"Jan 14 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM360nnn/GSM360326/suppl/GSM360326.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 1hr, replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 uM epoxomicin is added to HEK293 cells and incubated for 1 and 6 hours before RNA extraction. RNA was extracted from cells without treatment at zero time point as control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1174939","2":"NA","3":"isogenic human embryonal kidney (hek293) cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 h","17":"wtGR_vehicle_6h_rep2","18":"vehicle","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Isogenic Human Embryonal Kidney (HEK293) Cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Yliopistonranta 1E","38":"Kuopio","39":"Finland","40":"School of Medicine","41":"villepaakinaho@gmail.com","42":"NA","43":"University of Eastern Finland","44":"Biomedicine","45":"Ville,,Paakinaho","46":"NA","47":"NA","48":"NA","49":"70210","50":"Obtained data was normalized using VST transformation and RSN normalization  used as standard approach for Illumina arrays with the R/lumi package","51":"47323","52":"NA","53":"['stably expressing wtGR', 'GR_2']","54":"illuminaHumanv4","55":"98.37030","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using TriPure (Roche Diagnostics GmbH, Mannheim, Germany) according to manufacture's instructions","61":"NA","62":"NA","63":"NA","64":"GSM1174939","65":"NA","66":"NA","67":"NA","68":"NA","69":"Isogenic HEK293 cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 g/ml streptomycin, and 100 g hygromycin-B,  and kept at 37 C in a humidified 95% air/ 5% CO2","70":"NA","71":"NA","72":"Standart Illumina hybridization protocol","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared with the Ambion MessageAmk kit for Illumina arrays","79":"NA","80":"Nov 05 2013","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standart Illumina scanning protocol","97":"NA","98":"['GSE48328', 'GSE48379']","99":"NA","100":"NA","101":"NA","102":"Isogenic HEK293 Cells, vehicle treated, 6 h","103":"Public on Nov 05 2013","104":"NA","105":"NA","106":"Jun 26 2013","107":"NONE","108":"9606","109":"6 h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"wtGR_vehicle_6h_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"vehicle","122":"3x105x of Isogenic HEK293 cells were seeded at 6-well plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 36 h and the cells were subsequently treated with 100 nM of dexamethasone for 6 h prior extraction of RNA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1049711","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek cell clones","15":"NA","16":"NA","17":"NOD.Scid mouse-expanded GRK2-K220R-expressing HEK clone-rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK cell clones","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"['Scid-K220R-2', 'GRK2-K220R-expressing HEK clone expanded for 4 weeks in immunodeficient NOD.Scid mice', 'Gene expression data of NOD.Scid mouse-expanded GRK2-K220R-expressing HEK clone']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from HEK cell clones with the RNeasy Mini kit according to the manufacturer`s instructions (Qiagen).","61":"NA","62":"NA","63":"GRK2-K220R","64":"GSM1049711","65":"NA","66":"NA","67":"NA","68":"NA","69":"The study was performed with HEK cell clones stably expressing GRK2 or the kinase-deficient GRK2-K220R mutant. HEK cell clones were either expanded for 4 weeks in vivo in immunodeficient NOD.Scid mice (3 months of age), cultured in vitro, or re-cultured in vitro after expansion in NOD.Scid mice","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Affymetrix Human genome U133 Plus 2.0 Array) in 200 l of the hybrization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual).","79":"NA","80":"Dec 06 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"expanded for 4 weeks in NOD.Scid mice","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE42771","99":"NA","100":"NA","101":"NA","102":"NOD.Scid mouse-expanded HEK clone with GRK2-K220R expression","103":"Public on Dec 06 2012","104":"NA","105":"NA","106":"Dec 06 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049711/suppl/GSM1049711_Scid-K220R-2.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049711/suppl/GSM1049711_Scid-K220R-2.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"NOD.Scid mouse-expanded GRK2-K220R-expressing HEK clone-rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For the microarray study, cell pellets were isolated from three study groups: (i) NOD.Scid mouse-expanded HEK clones expressing either GRK2 or kinase-deficient GRK2-K220R (Scid), (ii) in vitro cultured HEK cell clones expressing GRK2 or GRK2-K220R (HEK), and (iii) in vitro re-cultured HEK cell clones after NOD.Scid mouse expansion (Ex-Scid).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236700","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"RHOXF2 24h_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_5']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236700","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, RHOXF2 transfected, 24h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236700/suppl/GSM2236700_Human_Gene_1_0_ST_20150205_5.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236700/suppl/GSM2236700_Human_Gene_1_0_ST_20150205_5.chp.gz']","108":"9606","109":"NA","110":"24h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"RHOXF2 24h_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"RHOXF2 expression vector"},{"1":"GSM1820008","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hrs","17":"HEK293T FMR4pcDNA 6hr 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"FMR4 overexpression","64":"GSM1820008","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, FMR4 overexpression, 6 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820008/suppl/GSM1820008_Zane_6hr_FMR4OX_1_B1_102011.CEL.gz","108":"9606","109":"6 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T FMR4pcDNA 6hr 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236704","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"control 24h_3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_9']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236704","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, control vector, 24h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236704/suppl/GSM2236704_Human_Gene_1_0_ST_20150205_9.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236704/suppl/GSM2236704_Human_Gene_1_0_ST_20150205_9.chp.gz']","108":"9606","109":"NA","110":"24h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"control 24h_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"empty control vector"},{"1":"GSM625868","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney cells","15":"NA","16":"NA","17":"ZAPS","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney cells","33":"1","34":"NA","35":"NA","36":"NA","37":"Kita15, Nishi8, Kitat-ku","38":"Sapporo","39":"Japan","40":"NA","41":"NA","42":"NA","43":"Hokkaido University","44":"NA","45":"Akinori,,Takaoka","46":"NA","47":"NA","48":"NA","49":"060-0815","50":"MAS5.0 data analysis was performed with GeneChip Operating Software (Affymetrix).","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"ZAPS","60":"Total RNA was extracted with ISOGEN (Nippon gene) according to the manufacturer's instruction.","61":"NA","62":"NA","63":"NA","64":"GSM625868","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Standard Affymetrix procedures.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Cy3","78":"Standard Affymetrix procedures.","79":"NA","80":"Dec 22 2010","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChip Scanner 3000 7G.","97":"NA","98":"GSE25471","99":"NA","100":"NA","101":"NA","102":"HEK293T, ZAPS","103":"Public on Dec 22 2010","104":"NA","105":"NA","106":"Nov 18 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM625nnn/GSM625868/suppl/GSM625868.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM625nnn/GSM625868/suppl/GSM625868.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"ZAPS","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293T cells were transfected with ZAPS expression vector or control for 48 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM402829","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 cells siRNA BAHD1 biological rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"CEL files were generated using GCOS software and preprocessed using GC-RMA method","51":"54675","52":"NA","53":"Gene expression data from HEK293 cells transfected with BAHD1  siRNA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA from cells  was extracted and purified by using the RNeasy kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM402829","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells(ATCC #CRL 1573) were grown in DMEM supplemented with Glutamax (Gibco) and 10% FCS","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133Plus2.0  Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RT on 5 g of total RNA using oligo(dT) primers and  in vitro  transcription of the cDNA in presence of biotin were performed by using a GeneChip Amplification One-Cycle Target Labeling kit according to Affymetrix (Santa Clara, CA) standard protocols  Labeling kit according to Affymetrix (Santa Clara, CA) standard protocols.","79":"NA","80":"Jul 16 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix Scanner 3000 7G.","97":"NA","98":"GSE16097","99":"NA","100":"NA","101":"NA","102":"HEK293 cells + BAHD1 siRNA 72h","103":"Public on Jul 16 2009","104":"NA","105":"NA","106":"May 13 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM402nnn/GSM402829/suppl/GSM402829.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cells siRNA BAHD1 biological rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293 cells were  transfected 72h with siRNA BAHD1 or siRNA control (Ambion) using lipofectamine RNAi max (Invitrogen)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1288898","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"SilX-BAHD1.R1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"Data were normalized with RMA","51":"33297","52":"NA","53":"Gene expression data","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the RNeasy Mini Kit (Qiagen), from three biological replicates, according to the manufacturer's instructions.  RNA was treated with DNase I to remove residual DNA and then cleaned with DNase Inactivation Reagent (Ambion Inc.) RNA was quality checked an then store at -80C.","61":"NA","62":"NA","63":"BAHD1 knockdown","64":"GSM1288898","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown at 37C, in a humidified 10% CO2 incubator, in Dulbecco's modified Eagle's medium with GlutaMAX (Gibco) supplied with 10%FBS (Gibco) and 70 ug/ml Hygromycin B (10687-010-Invitrogen).","70":"NA","71":"NA","72":"Labeled cDNA was hybridized wiht GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) as described by the manufacturer.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RNA was amplified with GeneChip WT cDNA Synthesis and Amplification Kit (Affymetrix) and biotin labeld with GeneChip WT Terminal Labeling Kit (Affymetrix) according to the manufacturer's","79":"NA","80":"Jan 20 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix Human Gene 1.0 ST Array was scanned with the Affymetrix GeneChip Scanner 7G and the FS450_0007 protocol , as recommended in the GeneChip Hybridization, Wash, and Stain Kit (Affymetrix)","97":"NA","98":"['GSE51868', 'GSE53284']","99":"NA","100":"NA","101":"NA","102":"SilX-BAHD1 cells","103":"Public on Dec 11 2015","104":"NA","105":"NA","106":"Dec 13 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1288nnn/GSM1288898/suppl/GSM1288898_SilX-BAHD1.R1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"SilX-BAHD1.R1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"We established a BAHD1 gene-specific knockdown cell line using the SilenciX siRNA delivery system (Tebu-bio). This technology is based on EBV-replication, and ensures chromosome-like replication of an episome stably expressing either a shRNA against BAHD1 (silXBAHD1) or a control shRNA (silX-CT).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733133","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070829 SM exposure 50 uM_16h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-02-26","29":"Phillips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-14","53":"Gene expression data from NHEK_070829 SM exposure 50 uM_16h timepoint","54":"NA","55":"NA","56":"NA","57":"50.0","58":"2007-08-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733133","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-11","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-07-25","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070829 SM exposure 50 uM_16h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733133/suppl/GSM733133_070829_HD_16h_50.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"16","115":"NA","116":"NHEK_070829 SM exposure 50 uM_16h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1171536","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Rpb1-amr  RD37a","18":"rpb1-amr","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"2 Hertzl st.","38":"Rehovot","39":"Israel","40":"NA","41":"rivka.dikstein@weizmann.ac.il","42":"NA","43":"The Weizmann Institute of Science","44":"NA","45":"Rivka,,Dikstein","46":"NA","47":"NA","48":"NA","49":"76100","50":"RMA was carried out using Partek Genomic Suite 6.5 (Inc. St. Charles, MO; www.partek.com)","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Tri-reagent (MRC inc.) according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1171536","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T were maintained in Dulbeccos modified Eagles medium (DMEM) supplemented with 10 % fetal calf serum.","70":"NA","71":"NA","72":"cDNA in 80 ul were hybridized to a Human Gene 1.0 ST array using Affymetrix hybridization kit materials and hybridized for 17 hours at 45 at 60rpm. Post-hyb washes were done with Affymetrix wash solutions on the FS450 station using FS450_0007 protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"200ng TotalRNA were used. cDNA samples were generated and labeled using Affymetrix WT-cDNA synthesis and labeling kit","79":"NA","80":"Jul 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned on the Affymetrix GeneChip Scanner 3000 7G","97":"NA","98":"GSE48163","99":"NA","100":"NA","101":"NA","102":"3 wt","103":"Public on Jul 01 2013","104":"NA","105":"NA","106":"Jun 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1171nnn/GSM1171536/suppl/GSM1171536_RD37a_HuST.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Rpb1-amr  RD37a","117":"NA","118":"NA","119":"NA","120":"NA","121":"Rpb1-amr","122":"Cells were transfected with plasmids directing the expression of -amanitin-resistant variants of Pol II (Rpb1-amr and R749H-amr). -amanitin was added and RNA was prepared 24 and 48 h later, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM432930","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Empty vector replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"401 Terry Avenue North","38":"Seattle","39":"USA","40":"NA","41":"cplaisier@systemsbiology.org","42":"NA","43":"Institute for Systems Biology","44":"Nitin Baliga","45":"Christopher,L,Plaisier","46":"2067322139","47":"Washington","48":"NA","49":"98109","50":"A rigorous quality control pipeline was developed to prepare the gene expression microarray data for analysis. First, the CEL files were imported into R 2.8.0 using the justRMA function of the Affymetrix library from Bioconductor, which applies background subtraction and quantile normalization. An alternate CDF file (U133Plus2msk.cdf.gz) was used to exclude mis-targeted and nonspecific probes from the microarrays (Zhang et al. 2005), and probesets with less than 7 remaining probes were also excluded. Probesets with more than 50% absent calls were excluded, as calculated using the panp package from Bioconductor. Finally, the ComBat library in R was used to correct for batch effect (Johnson et al. 2007).","51":"16569","52":"NA","53":"n/a","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was collected using the RNeasy Plus Mini Kit (Cat No. 74134) 48 hours after transient transfection of HEK293T cells.","61":"NA","62":"NA","63":"NA","64":"GSM432930","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"The cRNA probes were then hybridized using standard Affymetrix protocols described in the GeneChip Expression Analysis Technical Manual (Affymetrix P/N 702232).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Samples were then converted to cRNA probes using standard Affymetrix protocols described in the GeneChip Expression Analysis Technical Manual (Affymetrix P/N 702232).","79":"NA","80":"Sep 12 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The chips were scanned using the GeneArray scanner (Affymetrix) to produce CEL files.","97":"NA","98":"GSE17300","99":"NA","100":"NA","101":"NA","102":"HEK293T cell line","103":"Public on Sep 14 2009","104":"NA","105":"NA","106":"Jul 24 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM432nnn/GSM432930/suppl/GSM432930.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Empty vector replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM648461","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"MIBP1 overexpression, biological rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"3-1-1 Maidashi, Higashi-ku","38":"Fukuoka","39":"Japan","40":"Reseach Center for Genetic Information","41":"yiwasita@gen.kyushu-u.ac.jp","42":"+81-92-632-2375","43":"Kyushu University, Medical Institute of Bioregulation","44":"Division of Genome Analysis","45":"Yuji,,Iwashita","46":"+81-92-642-6170","47":"Fukuoka","48":"http://www.gen.kyushu-u.ac.jp/~genome/","49":"812-8582","50":"['Cel files were summarized and normalized with Robust Multi-array Average (RMA) method in Expression Console software version 1.1.1 (Affymetrix). Logarithmic signal intensities were antilog-transformed to linear scale using Expression Console.', 'probe group file: HuGene-1_0-st-v1.r3.pgf', 'meta-probeset file: HuGene-1_0-st-v1.r3.mps']","51":"33297","52":"NA","53":"FHM-76","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from triplicated transfectants for each plasmid using RNeasy plus mini kit (74134, Qiagen, Hilden, Germany). RNA quality was checked using 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA), and RNA Integrity Number (RIN) was confirmed to be 9.4 or greater for all samples. Total RNA at 200 ng was amplified and reverse-transcribed using GeneChip WT Sense Target Labeling and Control Reagents (900652, Affymetrix).","61":"NA","62":"NA","63":"NA","64":"GSM648461","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were obtained from Clontech (Mountain View, MO) and maintained in Dulbeccos modified Eagles medium (D5796, Sigma-Aldrich, St. Louis, CA), supplemented with 10% fetal bovine serum, 100 units/ml penicillin and 100 g/ml streptomycin (15140-122, Invitrogen, Carlsbad, CA), in 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Samples were hybridized using Affymetrix hybridization kit materials. The cocktails were heated at 99C for 5 minutes, then 45C for 5 minutes and centrifuged at max speed for 1 minute. The 80 l of hyb solution was transfered to each array, then seal the holes with sticker. They were hybridized for 18 hours in 45C hybridization oven at 60 rpm. Fluidics Script Protocol was FS450_0007","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Samples were enzymatically fragmented and biotinylated using the WT Terminal Labeling Kit (Affymetrix)","79":"NA","80":"Jan 31 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix GeneChiP Scanner 3000 7G","97":"NA","98":"GSE26420","99":"NA","100":"NA","101":"NA","102":"HEK293 cell clone stably overexpressing MIBP1. Clone No.76","103":"Public on Jan 31 2012","104":"NA","105":"NA","106":"Jan 04 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM648nnn/GSM648461/suppl/GSM648461.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"MIBP1 overexpression, biological rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293 cells were transfected with pCI-neo (empty vector control) or pCI-neo-FLAG-HA-MIBP1 linearized with AclI and selected at 400 g/ml G418 (345812, Calbiochem, San Diego, CA) for 2 weeks. Selected cells were cloned using cloning rings and maintained in the presence of G418. Genomic integration and protein expression of MIBP1 were confirmed by genomic PCR and immunoblotting using anti-FLAG M2 antibody (Sigma-Aldrich).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM897031","2":"NA","3":"hek293 cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T-REx293-NPAP1-uninduced-2","18":"uninduced","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293 cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with RMA default setting in Partek GS","51":"33297","52":"NA","53":"Gene expression data from cell line T-REx293-NPAP1, not induced, technical replicate 2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using the RNeasy mini kit (QIAGEN), treated with DNase I, followed by cleaning-up on spin columns (RNeasy mini kit. Qiagen)","61":"NA","62":"NA","63":"NA","64":"GSM897031","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were cultured in DMEM medium supplemented with 10% FCS, 1% penstrep and appropriate concentration of selective antibiotics","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Human Gene 1.0 ST. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix Hybridization, Wash and Stain Kit..","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Amplified cDNA was prepared according to the Ambion WT Expression Kit protocol starting from 200 ng total RNA. Amplified cDNA was fragmented with UDG and APE1 and finally labelled using the Affymetrix WT terminal labelling kit","79":"NA","80":"Jun 18 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned in the Affymetrix GeneChip Scanner 3000 wit G7 update","97":"NA","98":"GSE36575","99":"NA","100":"NA","101":"NA","102":"Flp-In T-REx 293","103":"Public on Jun 18 2012","104":"NA","105":"NA","106":"Mar 16 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM897nnn/GSM897031/suppl/GSM897031_TRex3_5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T-REx293-NPAP1-uninduced-2","117":"NA","118":"NA","119":"NA","120":"NPAP1/C15orf2","121":"uninduced","122":"Cells were mock treated (H2O)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733151","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070912 NM exposure 1000 uM_1h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-12","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-24","53":"Gene expression data from NHEK_070912 NM exposure 1000 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"1000.0","58":"2007-09-12","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733151","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-22","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-24","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070912 NM exposure 1000 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733151/suppl/GSM733151_070912_NM_1h_1000.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_070912 NM exposure 1000 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560864","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"2 h","17":"NOD2wt_2h_MDP_biological replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 wt","63":"NA","64":"GSM560864","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560864/suppl/GSM560864.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"2 h","113":"NA","114":"NA","115":"NA","116":"NOD2wt_2h_MDP_biological replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1060464","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina MouseWG-6 v2.0 expression beadchip (Illumina_MouseWG-6_v2.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"ING1b_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ackermannweg 4","38":"Mainz","39":"Germany","40":"NA","41":"e.karaulanov@imb-mainz.de","42":"NA","43":"Institute of Molecular Biology","44":"NA","45":"Emil,,Karaulanov","46":"NA","47":"NA","48":"NA","49":"55128","50":"Raw array data were imported and preprocessed in GenomeStudio V2011.1 software (Illumina) using background subtraction and cubic spline normalization. Subsequent differential expression analysis of the grouped replicate samples was performed within GenomeStudio on the probe level utilizing the Illumina custom error model with FDR multiple-testing correction.","51":"47323","52":"NA","53":"SAMPLE 6","54":"illuminaHumanv4","55":"98.37030","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated using the RNeasy mini kit with on-column DNase digest (Qiagen) following the supplied protocol, quantified with a Thermo NanoDrop and quality tested on Agilent Bioanalyzer.","61":"NA","62":"NA","63":"human ING1b protein overexpression","64":"GSM1060464","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were cultured at 37C with 10% CO2 in Dulbeccos Modified Eagles Medium (DMEM), 10% fetal calf serum, 2 mM L-Glutamine, 100 U/ml penicillin and 100 ug/ml streptomycin.","70":"NA","71":"NA","72":"Microarrays were hybridized following Illumina's standard hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared with the Ambion TotalPrep kit for Illumina arrays.","79":"NA","80":"Feb 14 2013","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Processed arrays were scanned on Illumina iScan System array reader according to the manufacturer's instructions.","97":"NA","98":"['GSE43317', 'GSE43319']","99":"NA","100":"NA","101":"NA","102":"HEK293T cells transfected with ING1b expression construct","103":"Public on Feb 04 2013","104":"NA","105":"NA","106":"Jan 07 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1060nnn/GSM1060464/suppl/GSM1060464.idat.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"ING1b_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Plasmid DNA constructs were transfected using X-tremeGENE 9 (Roche) according to the manufacturer's protocol 48 h before cell harvesting.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881022","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 1","17":"Non-producer culture - fermentation 2- time point 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"2","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 20","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"non-producing parent","64":"GSM881022","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Non-producer culture - fermentation 2- time point 1","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 1","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Non-producer culture - fermentation 2- time point 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442102","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,16h,untransfected,biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"16 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442102","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_16h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442102/suppl/GSM1442102_16hGFPM_REP1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,16h,untransfected,biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861628","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Mutant, leptin-stimulated, biological replicate 3","18":"100ng leptin","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"PO Box 800741","38":"Charlottesville","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Virginia","44":"NA","45":"Stephen,,Turner","46":"NA","47":"VA","48":"NA","49":"22908","50":"Data extraction, QC, and GCRMA normalization were performed with BioConductor software.  Differential expression was assessed with moderated ANOVA, using the BioConductor limma package; false discovery rate (FDR) estimates were calculated using the Benjamini-Hochberg method.","51":"54675","52":"NA","53":"Mutant, leptin-stimulated, biological replicate 3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was prepared using RNeasy Mini kit (QIAGEN) and its quality was verified in an Agilent Bioanalyzer.","61":"NA","62":"NA","63":"NA","64":"GSM861628","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T/17 cells were maintained in a humidified incubator at 37 C with 5% CO2. HEK293T/17 cells were cultured in DMEM/F12 (Gibco) with non-essential amino acids, sodium pyruvate and 10% heat inactivated FBS.  Jurkat T-cells were cultured in RPMI supplemented with 10% heat inactivated FBS.  Caco-2 cells were cultured in EMEM (Gibco) supplemented with non-essential amino acids, sodium pyruvate and 20% heat inactivated FBS.  Cells were discarded after passage 25 and new cultures were started from frozen stocks. HEK293T117 cells were transiently transfected using lipofectamine 2000 per the product instructions (Invitrogen, Carlsbad, CA). The plasmids mLEPRb/pCDNA3 (47), mLEPRbR223/pCDNA3 (35) and LEPRbDelta65/pCDNA3 (47) were obtained from Martin Myers and have been described previously as referenced. pCDNA3 was used as a vector control. The plasmid mLEPRb/pCDNA3 was used as a template for site-directed mutagenesis to construct mLEPRb985L/pCDNA3, LEPRb1077L/pCDNA3 and mLEPRb1138L/pCDNA3.  Site-directed mutagenesis was done using the quikchange kit (Stragene/Agilent, Santa Clara, CA).    The presence of the desired mutations and the absence of other mutations were confirmed by DNA sequencing.","70":"NA","71":"NA","72":"Three biological replicates of each sample were hybridized to Human Genome U133 Plus 2.0 gene chips (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA was amplified and converted to cDNA using the 3' IVT Express Kit (Affymetrix).","79":"NA","80":"Jan 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned using the GeneChip Scanner 3000 7G (AffyMetrix).","97":"NA","98":"GSE35068","99":"NA","100":"NA","101":"NA","102":"Mutant, leptin-stimulated","103":"Public on Jan 01 2015","104":"NA","105":"NA","106":"Jan 12 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861628/suppl/GSM861628_MUT-3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Mutant, leptin-stimulated, biological replicate 3","117":"NA","118":"NA","119":"Y1138L (STAT3-mutant) leptin receptor","120":"NA","121":"100ng leptin","122":"HEK293 cells were transfected with WT LepR or Y1138L (STAT3-mutant) leptin receptor.  48 hours post-transfection cells were made quiescent by incubation in optimum plus 0.5% BSA for 3 hours.  Cells were then stimulated with 100ng of leptin or maintained in optimum plus 0.5% BSA for an additional 3 hours. Leptin was purchased from Dr. A.F. Parlow, National Hormone and Peptide Program (Torrance, CA). The STAT3 inhibitor, Stattic, the PI3K inhibitor, LY294002 and the MEK inhibitor PD98059 were purchased from EMD chemicals (Gibbstown, NJ).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM625518","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney cells","15":"NA","16":"NA","17":"Control","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney cells","33":"1","34":"NA","35":"NA","36":"NA","37":"Kita15, Nishi8, Kitat-ku","38":"Sapporo","39":"Japan","40":"NA","41":"NA","42":"NA","43":"Hokkaido University","44":"NA","45":"Akinori,,Takaoka","46":"NA","47":"NA","48":"NA","49":"060-0815","50":"MAS5.0 data analysis was performed with GeneChip Operating Software (Affymetrix).","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"control","60":"Total RNA was extracted with ISOGEN (Nippon gene) according to the manufacturer's instruction.","61":"NA","62":"NA","63":"NA","64":"GSM625518","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Standard Affymetrix procedures.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Cy3","78":"Standard Affymetrix procedures.","79":"NA","80":"Dec 22 2010","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChip Scanner 3000 7G.","97":"NA","98":"GSE25471","99":"NA","100":"NA","101":"NA","102":"HEK293T, control","103":"Public on Dec 22 2010","104":"NA","105":"NA","106":"Nov 18 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM625nnn/GSM625518/suppl/GSM625518.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM625nnn/GSM625518/suppl/GSM625518.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Control","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293T cells were transfected with ZAPS expression vector or control for 48 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1954210","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"pcDNA3.1-GFP","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with MAS5 using Affymetrix default analysis settings and global scaling to a target intensity of 1000 as normalization method.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted by using the RNeasy Mini Kit (Qiagen). Total-RNA concentration and purity of total-RNA samples was measured with the NanoDrop 1000 spectrophotometer (NanoDrop Technologies/Thermo Scientific).","61":"NA","62":"NA","63":"NA","64":"GSM1954210","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemeted with 10 % (v/v) FCS , 2 mM L-Glutamine and 1 % (v/v) Pen Strep at 37C and 5 % CO2","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133Plus_2. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix Hybridization, Wash and Stain Kit..","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA were prepared according to the Affymetrix ExpressKit protocol starting from 200 ng total RNA.","79":"NA","80":"Nov 14 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned in a GeneChip 3000 scanner with G7 update.","97":"NA","98":"GSE75376","99":"NA","100":"NA","101":"NA","102":"HEK293T + pcDNA3.1-GFP","103":"Public on Nov 14 2016","104":"NA","105":"NA","106":"Nov 24 2015","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1954nnn/GSM1954210/suppl/GSM1954210_pCDNA3.1-GFP_HG-U133_Plus_2_.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1954nnn/GSM1954210/suppl/GSM1954210_pCDNA3.1-GFP_HG-U133_Plus_2_.mas5.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"pcDNA3.1-GFP","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were transfected with polyethylenimine and harvest 48 hous after the transient expression of the pcDNA3.1-IRX1::GFP / pcDNA3.1-GFP vectors. GFP positive cells were sorted by FACS.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM402155","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"L188Q mutant LQ_3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"3333 Burnet Ave","38":"Cincinnati","39":"USA","40":"NA","41":"yan.xu@cchmc.org","42":"NA","43":"Cincinnati Children's Hospital Medical Center","44":"NA","45":"Yan,,Xu","46":"513-6368921","47":"OH","48":"NA","49":"45229","50":"MAS5 normalization, ANOVA","51":"54675","52":"NA","53":"transitently transfected with L 188Q mutant of surfactant protein C","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"accroding to manufacture's protocol (Affymetrix)","61":"NA","62":"NA","63":"NA","64":"GSM402155","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"accroding to manufacture's protocol (Affymetrix)","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"accroding to manufacture's protocol (Affymetrix)","79":"NA","80":"May 13 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"accroding to manufacture's protocol (Affymetrix)","97":"NA","98":"GSE16054","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line","103":"Public on May 14 2009","104":"NA","105":"NA","106":"May 11 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM402nnn/GSM402155/suppl/GSM402155.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"L188Q mutant LQ_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1049717","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek cell clones","15":"NA","16":"NA","17":"Re-cultured GRK2-expressing HEK cell clone after NOD.Scid mouse expansion-rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK cell clones","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"['Ex-Scid-GRK-2', 'Re-cultured GRK2-expressing HEK cell clone after expansion in NOD.Scid mice', 'Gene expression data of re-cultured NOD.Scid-mouse-expanded GRK2-expressing HEK cell clone']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from HEK cell clones with the RNeasy Mini kit according to the manufacturer`s instructions (Qiagen).","61":"NA","62":"NA","63":"GRK2","64":"GSM1049717","65":"NA","66":"NA","67":"NA","68":"NA","69":"The study was performed with HEK cell clones stably expressing GRK2 or the kinase-deficient GRK2-K220R mutant. HEK cell clones were either expanded for 4 weeks in vivo in immunodeficient NOD.Scid mice (3 months of age), cultured in vitro, or re-cultured in vitro after expansion in NOD.Scid mice","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Affymetrix Human genome U133 Plus 2.0 Array) in 200 l of the hybrization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual).","79":"NA","80":"Dec 06 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"re-cultured in vitro after expansion in NOD.Scid mice","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE42771","99":"NA","100":"NA","101":"NA","102":"Re-cultured GRK2-expressing HEK cell clone after NOD.Scid mouse expansion","103":"Public on Dec 06 2012","104":"NA","105":"NA","106":"Dec 06 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049717/suppl/GSM1049717_Ex-Scid-GRK-2.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049717/suppl/GSM1049717_Ex-Scid-GRK-2.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Re-cultured GRK2-expressing HEK cell clone after NOD.Scid mouse expansion-rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For the microarray study, cell pellets were isolated from three study groups: (i) NOD.Scid mouse-expanded HEK clones expressing either GRK2 or kinase-deficient GRK2-K220R (Scid), (ii) in vitro cultured HEK cell clones expressing GRK2 or GRK2-K220R (HEK), and (iii) in vitro re-cultured HEK cell clones after NOD.Scid mouse expansion (Ex-Scid).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1288899","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"SilX-BAHD1.R2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"Data were normalized with RMA","51":"33297","52":"NA","53":"Gene expression data","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the RNeasy Mini Kit (Qiagen), from three biological replicates, according to the manufacturer's instructions.  RNA was treated with DNase I to remove residual DNA and then cleaned with DNase Inactivation Reagent (Ambion Inc.) RNA was quality checked an then store at -80C.","61":"NA","62":"NA","63":"BAHD1 knockdown","64":"GSM1288899","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown at 37C, in a humidified 10% CO2 incubator, in Dulbecco's modified Eagle's medium with GlutaMAX (Gibco) supplied with 10%FBS (Gibco) and 70 ug/ml Hygromycin B (10687-010-Invitrogen).","70":"NA","71":"NA","72":"Labeled cDNA was hybridized wiht GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) as described by the manufacturer.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RNA was amplified with GeneChip WT cDNA Synthesis and Amplification Kit (Affymetrix) and biotin labeld with GeneChip WT Terminal Labeling Kit (Affymetrix) according to the manufacturer's","79":"NA","80":"Jan 20 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix Human Gene 1.0 ST Array was scanned with the Affymetrix GeneChip Scanner 7G and the FS450_0007 protocol , as recommended in the GeneChip Hybridization, Wash, and Stain Kit (Affymetrix)","97":"NA","98":"['GSE51868', 'GSE53284']","99":"NA","100":"NA","101":"NA","102":"SilX-BAHD1 cells","103":"Public on Dec 11 2015","104":"NA","105":"NA","106":"Dec 13 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1288nnn/GSM1288899/suppl/GSM1288899_SilX-BAHD1.R2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"SilX-BAHD1.R2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"We established a BAHD1 gene-specific knockdown cell line using the SilenciX siRNA delivery system (Tebu-bio). This technology is based on EBV-replication, and ensures chromosome-like replication of an episome stably expressing either a shRNA against BAHD1 (silXBAHD1) or a control shRNA (silX-CT).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733318","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071003 SM exposure 100 uM_16h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-04","29":"Phillips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-22","53":"Gene expression data from NHEK_071003 SM exposure 100 uM_16h timepoint","54":"NA","55":"NA","56":"NA","57":"100.0","58":"2007-10-03","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733318","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-02","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-06-04","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071003 SM exposure 100 uM_16h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733318/suppl/GSM733318_071003_HD_16h_100.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"16","115":"NA","116":"NHEK_071003 SM exposure 100 uM_16h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874657","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"ActD_8","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874657","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Actinomycin D 8h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874657/suppl/GSM1874657_RG_47_ActD_8h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"ActD_8","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM941943","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture, untransfected, biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"untransfected","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"24 h gene profile of untransfected (GFP negative) HEK293T cells.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM941943","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm.","97":"NA","98":"['GSE38422', 'GSE59665']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_24h","103":"Public on Jun 03 2012","104":"NA","105":"NA","106":"Jun 02 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM941nnn/GSM941943/suppl/GSM941943_AnP_Hu13302_081910_08_M39.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture, untransfected, biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic PEI polymer mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18 h after seeding and flow separated after another 24 h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560859","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0 h","17":"NOD2-L1007fsinsC_0h_MDP_biological replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 L1007fsinsC","63":"NA","64":"GSM560859","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560859/suppl/GSM560859.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"0 h","113":"NA","114":"NA","115":"NA","116":"NOD2-L1007fsinsC_0h_MDP_biological replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733200","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070919 NM exposure 600 uM_1h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-24","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-28","53":"Gene expression data from NHEK_070919 NM exposure 600 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"600.0","58":"2007-09-19","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733200","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-22","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-07-24","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070919 NM exposure 600 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733200/suppl/GSM733200_070919_NM_1h_600.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_070919 NM exposure 600 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546593","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"t469ns_2","18":"no treatment","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"t469ns_2:72ug.","61":"NA","62":"mutant hek_t469","63":"NA","64":"GSM546593","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C, 5% C02","70":"23-12-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"t469ns_2","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546593/suppl/GSM546593_t469ns_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"t469ns_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"no treatment","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM678629","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Control_24_h_Replicate 4","18":"NA","19":"Control","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"1","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 76","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678629","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"1","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"2","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"24","114":"NA","115":"NA","116":"HEK293_Control_24_h_Replicate 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560862","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0 h","17":"MOCK_0h_MDP_biological replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"control mock","63":"NA","64":"GSM560862","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560862/suppl/GSM560862.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"0 h","113":"NA","114":"NA","115":"NA","116":"MOCK_0h_MDP_biological replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560870","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"2 h","17":"MOCK_2h_MDP_biological replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"control mock","63":"NA","64":"GSM560870","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560870/suppl/GSM560870.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"2 h","113":"NA","114":"NA","115":"NA","116":"MOCK_2h_MDP_biological replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1754834","2":"NA","3":"hek-293t (human kidney epithelial cell line)","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK-293T_NC","18":"transfected with negative control mimics for 48 hrs","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293T (human kidney epithelial cell line)","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Shanghai Medical College, Fudan University 1207 Rm., 2# Bldg., 270 Dong An Rd.","38":"Shanghai","39":"China","40":"Fudan University Shanghai Cancer Center","41":"cybao.cpu@163.com","42":"NA","43":"Fudan University","44":"NA","45":"Chunyang,,Bao","46":"86-21-34777580","47":"Shanghai","48":"NA","49":"200032","50":"Raw data were normalized by MAS 5.0 algorithm, Gene Spring Software 11.0  (Agilent technologies, Santa Clara, CA, US).","51":"54675","52":"NA","53":"Gene expression data from HEK-293T cells transfected with negative control mimics","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1754834","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK-293T cells were cultured in Dulbeccos modified Eagles medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics at 37C and 5% CO2.","70":"NA","71":"NA","72":"Array hybridization and wash was performed using GeneChip  Hybridization, Wash and Stain Kit (Cat#900720, Affymetrix, Santa Clara, CA, US)in Hybridization Oven 645 (Cat#00-0331-220V, Affymetrix, Santa Clara, CA, US)and Fluidics Station 450 (Cat#00-0079, Affymetrix, Santa Clara, CA, US) followed the manufacturers instructions.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol, using the GeneChip 3IVT Express Kit (Cat#901229, Affymetrix, Santa Clara, CA, US).","79":"NA","80":"Jul 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Slides were scanned by GeneChip Scanner 3000 (Cat#00-00212, Affymetrix, Santa Clara, CA, US) and Command Console Software 3.1 (Affymetrix, Santa Clara, CA, US) with default settings.","97":"NA","98":"GSE70434","99":"NA","100":"NA","101":"NA","102":"HEK-293T cells transfected with negative control mimics","103":"Public on Jul 01 2015","104":"NA","105":"NA","106":"Jul 01 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1754nnn/GSM1754834/suppl/GSM1754834_HEK-293T_NC.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK-293T_NC","117":"NA","118":"NA","119":"NA","120":"NA","121":"transfected with negative control mimics for 48 hrs","122":"We used lipofectamine 2000 reagent (Invitrogen) to transfect cells with in vitro synthesized miRNA mimic (Genepharma) at a final concentration of 50 nM.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733540","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080730 NM exposure 200 uM_2h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-08-06","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-08-04","53":"Gene expression data from NHEK_080730 NM exposure 200 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"200.0","58":"2008-07-30","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733540","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-08-11","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-08-13","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080730 NM exposure 200 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733540/suppl/GSM733540_080730_NM_2h_200.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_080730 NM exposure 200 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820021","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24 hrs","17":"HEK293T FMR4pcDNA 24hr 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"FMR4 overexpression","64":"GSM1820021","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, FMR4 overexpression, 24 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820021/suppl/GSM1820021_Zane_24hr_FMR4OX_2_B8_102011.CEL.gz","108":"9606","109":"24 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T FMR4pcDNA 24hr 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM925900","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"parental HEK293 Flp-In rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Maulbeerstrasse 66","38":"Basel","39":"Switzerland","40":"Functional Genomics","41":"tim.roloff@fmi.ch","42":"NA","43":"FMI","44":"NA","45":"Tim,,Roloff","46":"NA","47":"NA","48":"NA","49":"4058","50":"Arrays were normalized and probeset-level log2 expression values were calculated using the rma function from the R/Bioconductor (v2.14) package affy.","51":"32321","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and further cleaned up using RNeasy Columns.","61":"NA","62":"NA","63":"wild-type","64":"GSM925900","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were grown in DMEM supplemented with 2 mM glutamine and 10% FCS. 50 ug/ml hygromycin B was added to the culture medium for the maintance of FHA-TRIM71 expressing cell lines.","70":"NA","71":"NA","72":"Affymetrix Gene Chip Arrays were hybridized following the GeneChip Whole Transcript (WT) Sense Target Labeling Assay Manual (Affymetrix) with a hybridization time of 16h. The Affymetrix Fluidiscs protocol FS450_0007 was used for washing.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"100ng of extracted total RNA was amplified using the Ambion WT Expression kit (Ambion) and the resulting sense-strand cDNA was fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling kit (Affymetrix).","79":"NA","80":"Jan 23 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed with Affzmetrix GCC Scan Control v. 3.0.0.1214 on a GeneChip Scanner 3000 with autoloader.","97":"NA","98":"['GSE37713', 'GSE37714']","99":"NA","100":"NA","101":"NA","102":"wild-type HEK293 Flp-In","103":"Public on Jan 22 2013","104":"NA","105":"NA","106":"May 02 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM925nnn/GSM925900/suppl/GSM925900_wf20110324hg10_01_wtI_503_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"parental HEK293 Flp-In rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546582","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hours","17":"t469fsh_3","18":"fsh - hormone treatment - fsh stimulation","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"3nM","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"t469fsh_3:23.6ug.","61":"NA","62":"mutant hek_t469","63":"NA","64":"GSM546582","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C, 5% C02","70":"23-12-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"t469fsh_3","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546582/suppl/GSM546582_t469fsh_3.CEL.gz","108":"9606","109":"6 hours","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"t469fsh_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"FSH - hormone treatment - fsh stimulation","122":"Name:FSH - hormone treatment - fsh stimulation,follicle stimulating hormone (fsh):quantity 3nM time 6hour . 3nM","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733241","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070926 NM exposure 50 uM_1h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-01","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-28","53":"Gene expression data from NHEK_070926 NM exposure 50 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"50.0","58":"2007-09-26","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733241","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-24","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-08-07","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070926 NM exposure 50 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733241/suppl/GSM733241_070926_NM_1h_50.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_070926 NM exposure 50 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2129128","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"shlinc00598#2_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293t","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Chungang Univ., Heukseok-dong, Dongjak-gu, Seoul, Republic of Korea","38":"Seoul","39":"South Korea","40":"Department of Life Science","41":"NA","42":"NA","43":"Chung-Ang university","44":"Functional Genomics Laboratory","45":"Oh-Seok,,Jeong","46":"NA","47":"N/A","48":"NA","49":"ASI|KR|KS013|SEOUL","50":"Array data export processing and analysis was performed using Illumina GenomeStudio v2011.1 (Gene Expression Module v1.9.0)","51":"47321","52":"NA","53":"['3999350127_E_Grn', 'SAMPLE 5']","54":"illuminaHumanv4","55":"98.36614","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from shCTL, shlinc00598#2, and shlinc00598#3 cells using RNAiso Plus (TaKaRa).","61":"NA","62":"NA","63":"linc00598 knockdown","64":"GSM2129128","65":"NA","66":"NA","67":"NA","68":"NA","69":"linc00598 knockdown stable and control shRNA HEK293t cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% heat-inactivated fetal bovine serum and 0.05% penicillin-streptomycin at 37 C in a 5% CO2 atmosphere.","70":"NA","71":"NA","72":"Following fragmentation, 0.75 ug of cRNA were hybridized to the Illumina Expression Beadchip according to the protocols provided by the manufacturer","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared from 0.55 ug total RNA using the Illumina TotalPrep RNA Amplification Kit (Ambion, Austin,TX)","79":"NA","80":"Apr 22 2016","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using the Illumina Bead Array Reader Confocal Scanner","97":"NA","98":"GSE80514","99":"shlinc00598#2","100":"NA","101":"NA","102":"HEK293t, shlinc00598#2","103":"Public on Apr 22 2016","104":"NA","105":"NA","106":"Apr 21 2016","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"shlinc00598#2_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733393","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071128 CEES exposure 3.0 uM_2h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-28","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-30","53":"Gene expression data from NHEK_071128 CEES exposure 3.0 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"3.0","58":"2007-11-28","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733393","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-09","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-11","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071128 CEES exposure 3.0 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733393/suppl/GSM733393_071128_CEES_2h_3.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_071128 CEES exposure 3.0 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874638","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T2h_DMSO+4h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874638","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 2h and subsequent DMSO 4h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874638/suppl/GSM1874638_RG_39_4OHT_DMSO_2h_4h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T2h_DMSO+4h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM402826","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 cells siRNA control, biological rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"CEL files were generated using GCOS software and preprocessed using GC-RMA method","51":"54675","52":"NA","53":"Gene expression data from HEK293 cells transfected with control  siRNA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA from cells  was extracted and purified by using the RNeasy kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM402826","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells(ATCC #CRL 1573) were grown in DMEM supplemented with Glutamax (Gibco) and 10% FCS","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133Plus2.0  Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RT on 5 g of total RNA using oligo(dT) primers and  in vitro  transcription of the cDNA in presence of biotin were performed by using a GeneChip Amplification One-Cycle Target Labeling kit according to Affymetrix (Santa Clara, CA) standard protocols  Labeling kit according to Affymetrix (Santa Clara, CA) standard protocols.","79":"NA","80":"Jul 16 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix Scanner 3000 7G.","97":"NA","98":"GSE16097","99":"NA","100":"NA","101":"NA","102":"HEK293 cells + control siRNA 72h","103":"Public on Jul 16 2009","104":"NA","105":"NA","106":"May 13 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM402nnn/GSM402826/suppl/GSM402826.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cells siRNA control, biological rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293 cells were  transfected 72h with siRNA BAHD1 or siRNA control (Ambion) using lipofectamine RNAi max (Invitrogen)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1039979","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,control,biological rep 6","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"CTR_6","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1039979","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Nov 21 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE20615","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,control,biological rep 6","103":"Public on Nov 21 2012","104":"NA","105":"NA","106":"Nov 21 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1039nnn/GSM1039979/suppl/GSM1039979_AnP_Hu13302_062910_09_CTR29.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,control,biological rep 6","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM941942","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture, untransfected, biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"untransfected","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"24 h gene profile of untransfected (GFP negative) HEK293T cells.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM941942","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm.","97":"NA","98":"['GSE38422', 'GSE59665']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_24h","103":"Public on Jun 03 2012","104":"NA","105":"NA","106":"Jun 02 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM941nnn/GSM941942/suppl/GSM941942_AnP_Hu13302_081910_05_M38.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture, untransfected, biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic PEI polymer mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18 h after seeding and flow separated after another 24 h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733514","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080730 CEES exposure 1.0 uM_2h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-08-05","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-08-04","53":"Gene expression data from NHEK_080730 CEES exposure 1.0 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"1.0","58":"2008-07-30","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733514","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-08-06","75":"Phillips","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-08-08","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080730 CEES exposure 1.0 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733514/suppl/GSM733514_080730_CEES_2h_1.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_080730 CEES exposure 1.0 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236707","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"control 48h_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_18']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236707","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, control vector, 48h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236707/suppl/GSM2236707_Human_Gene_1_0_ST_20150205_18.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236707/suppl/GSM2236707_Human_Gene_1_0_ST_20150205_18.chp.gz']","108":"9606","109":"NA","110":"48h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"control 48h_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"empty control vector"},{"1":"GSM1045512","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293, stable PRL-1 transfectant, biological replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"723 West Michigan St., Room SL306","38":"Indianapolis","39":"USA","40":"Biology","41":"cdumaual@gmail.com","42":"NA","43":"Indiana University-Purdue University Indianapolis","44":"Lab of Stephen K. Randall","45":"Carmen,M.,Dumaual","46":"NA","47":"IN","48":"NA","49":"46285","50":"The data were processed with R-project software version 2.13.1 through the Rstudio interface version 0.94.92.  Intensity values were read using the affy library of the Bioconductor package  version 2.8.  Normalizaton and calls were made using the mas5 procedure under default parameters.","51":"54675","52":"NA","53":"PRL-1 Overexpressing","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the TRIzol reagent (Life Technologies) and further purified with a Qiagen Rneasy Mini Kit, following the manufacturers' instructions for both.","61":"NA","62":"NA","63":"NA","64":"GSM1045512","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells stably overexpressing PRL-1 or transfected with empty pcDNA4 vector were grown in 100mm plates in DMEM supplemented with 10% (v/v) fetal bovine serum, 50 units/ml penicillin, and 50ug/ml streptomycin.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C to Affymetrix HG U133 Plus 2.0 arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Affymetrix Genechip Expression Analysis Technical Manual, 2002, Affymetrix).","79":"NA","80":"Jul 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G.","97":"NA","98":"['GSE42586', 'GSE42588']","99":"NA","100":"NA","101":"NA","102":"HEK293 cells stably transfected with pcDNA4-PRL-1","103":"Public on Jul 30 2013","104":"NA","105":"NA","106":"Nov 28 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1045nnn/GSM1045512/suppl/GSM1045512_PRL1_OvrxSt2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293, stable PRL-1 transfectant, biological replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874643","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"UT_2_n","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874643","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER New untreated replicate 2","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874643/suppl/GSM1874643_NB_52_UT_2hW_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"UT_2_n","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1558595","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK_CD44s-Transfected_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"yes","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Nonnenwald 2","38":"Penzberg","39":"Germany","40":"Pharmaceutical Sciences","41":"fabian.birzele@roche.com","42":"NA","43":"Roche Diagnostics GmbH","44":"NA","45":"Fabian,,Birzele","46":"NA","47":"NA","48":"NA","49":"82377","50":"Partek Genomics suite was used to process CEL files, perform normalization and QC as well as to identify differentially regulated genes between native and CD44 transfected HEK293 cells using ANOVA.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"HEK293-CD44s Clone 4, expressing an average level of HA, was picked for profiling gene expression using Affymetrix Human Genome U133plus 2.0 arrays. Total RNA was prepared using the RNeasy Mini Kit (Qiagen, Germany), Microarray RNA Target Synthesis Kit T7 and RNeasy Mini-Spin Columns (Roche, Germany) and a hybridization mix was created consisting of 30 l of fragmented cRNA solution mixed with control oligonucleotide, staggered control cRNAs, herring sperm DNA, acetylated BSA and hybridization buffer in a total volume of 300 l. All kit procedures were performed according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1558595","65":"NA","66":"NA","67":"NA","68":"NA","69":"For cloning and expression of human CD44 (EMBL accession number M24915) the sequence was codon optimized (Geneart, Germany) and CD44s was expressed using a pcDNA3.1(-) vector (Invitrogen, Germany). PCR was performed with a denaturation step at 94C for 2 min, followed by 30 cycles of denaturation at 94C for 30 sec, annealing at 58C for 30 sec, and extension at 68C for 45 sec, with a final extension of 7 minutes at 68C (Expand High Fidelity PCR Kit, Roche). The PCR product and the vector were digested with EcoRI/HindIII restriction endonucleases, and DNA fragments were resolved by 1% agarose gel electrophoresis,purified from gels (GFX PCR DNA and Gel Band Purification Kit) and ligated (Rapid DNA Ligation Kit, Roche). Vectors were transferred into XL-10 Gold super-competent cells (Stratagene, The Netherlands) by heat shock and transformed cells were isolated form agar plates containing 100g/ml Ampicilin. Vector DNA from transfected cells was isolated using the High Pure Plasmid Isolation Kit (Roche, Germany).","70":"NA","71":"NA","72":"The hybridization mix was loaded onto the arrays and incubated in a roller device for 16 hrs. Hybridization solution was removed, arrays were washed, stained","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"standard Affymtrix protocol","79":"NA","80":"Dec 05 2014","81":"NA","82":"polyA RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned with an Affymetrix GeneChip Scanner 3000 (7G)","97":"NA","98":"GSE63862","99":"NA","100":"NA","101":"NA","102":"cell culture, HEK transfected with CD44s","103":"Public on Dec 05 2014","104":"NA","105":"NA","106":"Dec 04 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1558nnn/GSM1558595/suppl/GSM1558595_KLP_RW1_101125_CD44_PZ.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK_CD44s-Transfected_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1049713","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek cell clones","15":"NA","16":"NA","17":"Cultured GRK2-expressing HEK cell clone-rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK cell clones","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"['HEK-GRK-2', 'Cultured GRK2-expressing HEK cell clone', 'Gene expression data of cultured GRK2-expressing HEK cell clone']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from HEK cell clones with the RNeasy Mini kit according to the manufacturer`s instructions (Qiagen).","61":"NA","62":"NA","63":"GRK2","64":"GSM1049713","65":"NA","66":"NA","67":"NA","68":"NA","69":"The study was performed with HEK cell clones stably expressing GRK2 or the kinase-deficient GRK2-K220R mutant. HEK cell clones were either expanded for 4 weeks in vivo in immunodeficient NOD.Scid mice (3 months of age), cultured in vitro, or re-cultured in vitro after expansion in NOD.Scid mice","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Affymetrix Human genome U133 Plus 2.0 Array) in 200 l of the hybrization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual).","79":"NA","80":"Dec 06 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"cultured in vitro","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE42771","99":"NA","100":"NA","101":"NA","102":"Cultured HEK cell clone with GRK2 expression","103":"Public on Dec 06 2012","104":"NA","105":"NA","106":"Dec 06 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049713/suppl/GSM1049713_HEK-GRK-2.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049713/suppl/GSM1049713_HEK-GRK-2.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Cultured GRK2-expressing HEK cell clone-rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For the microarray study, cell pellets were isolated from three study groups: (i) NOD.Scid mouse-expanded HEK clones expressing either GRK2 or kinase-deficient GRK2-K220R (Scid), (ii) in vitro cultured HEK cell clones expressing GRK2 or GRK2-K220R (HEK), and (iii) in vitro re-cultured HEK cell clones after NOD.Scid mouse expansion (Ex-Scid).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693940","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"72h","17":"HEK293T_BACH1-esiRNA_72h_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_e_1_72', 'BACH1_e_1_200ng_72h_293T.CEL', 'Gene expression data from HEK 293T cells 72h after knockdown of BACH1 with esiRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693940","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"esiRNA (e)","102":"HEK 293T cells, BACH1 knockdown, 72h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693940/suppl/GSM693940.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693940/suppl/GSM693940.EXP.gz']","108":"9606","109":"72h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-esiRNA_72h_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM711413","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"HEK293Tcells_si74_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"1000 E 50th St","38":"Kansas City","39":"USA","40":"Genomics","41":"seidel@phageT4.org","42":"NA","43":"Stowers Institute","44":"Seidel","45":"Chris,W,Seidel","46":"816 926 9054","47":"MO","48":"NA","49":"64110","50":"Array intensities were processed using the RMA algorithm in R/bioconductor. Bioconductor 2.6 and affy package affy_1.24.2","51":"54675","52":"NA","53":"Gene expression from HEK293T cells after transfection with siRNA s18074 targeting Med26, replicate 1.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the standard Qiagen RNeasy cleanup protocol.","61":"NA","62":"NA","63":"NA","64":"GSM711413","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in 6 well tissue culture plates or 10 cm dishes for 48 hours after transfection.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 plus 2.0 Arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the Ambion MessageAmp III protocol from 300 ng total RNA (MessageAmp III Amplification kit Manual, 2007, Ambion).","79":"NA","80":"Sep 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 and processed with AGCC v3.0 software.","97":"NA","98":"GSE28715","99":"NA","100":"Med26 targeting s18074","101":"NA","102":"HEK293T cells","103":"Public on Sep 01 2011","104":"NA","105":"NA","106":"Apr 19 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM711nnn/GSM711413/suppl/GSM711413_si-74-1_HG-U133_Plus_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293Tcells_si74_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293T cells in 6 well tissue culture plates (~1x105 cells/well) or 10 cm dishes (~2 x106 cells/dish) were transfected with 25 nM siRNAs targeting human Med26 (Ambion/Applied Biosystems, #4, s18074; #5, s18075; #6, s18076) or 25 nM siCONTROL NON-TARGETING siRNA #2 (Dharmacon D-001210-01) using X-tremeGENE siRNA Transfection Reagent (Roche) and grown for 48 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1645160","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"4_GFPscr","18":"control","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Hufelandstrasse 55","38":"Essen","39":"Germany","40":"Universitaetsklinikum Essen","41":"bernhard.horsthemke@uni-due.de","42":"NA","43":"Institut fuer Humangenetik","44":"NA","45":"Bernhard,,Horsthemke","46":"NA","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with MAS5 using Affymetrix default analysis settings and global scaling to a target intensity of 1000 as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from GFP#1 clone, 96 h after treatment with non-targeting control siRNAs', 'total RNA (>200 nt)']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using the AllPrep DNA/RNA/Protein Mini kit (Qiagen) and treated with the RNase-Free DNase Set (Qiagen)","61":"NA","62":"NA","63":"NA","64":"GSM1645160","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were cultured in DMEM supplemented with 10% FCS, 1% Pen/Strep and appropriate concentrations of selective antibiotics.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133Plus_2. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix Hybridization, Wash and Stain Kit..","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA were prepared according to the Affymetrix ExpressKit protocol starting from 200 ng total RNA.","79":"NA","80":"Jul 17 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned in a GeneArray Scanner (Agilent).","97":"NA","98":"['GSE67348', 'GSE67351']","99":"NA","100":"NA","101":"NA","102":"Flp-In T-REx 293","103":"Public on Jul 16 2015","104":"NA","105":"NA","106":"Mar 27 2015","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1645nnn/GSM1645160/suppl/GSM1645160_4_GFPscr.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1645nnn/GSM1645160/suppl/GSM1645160_4_GFPscr.mas5.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"4_GFPscr","117":"NA","118":"NA","119":"NA","120":"GFP","121":"control","122":"Cells were treated either with siRNA against TET1, TET2 and TET3 or a non-targeting pool. All cells carried an inducible, stable GFP transgene whose expression was not induced.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2089907","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U219 Array (hgu219)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T_mock(Qiagen kit)BRD1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Bartholins All 6","38":"Aarhus","39":"Denmark","40":"Biomedicine","41":"tue@biomed.au.dk","42":"NA","43":"Aarhus University","44":"Prof Anders Borglum's lab","45":"Tue,,Fryland","46":"NA","47":"Aarhus","48":"NA","49":"8000","50":"rma","51":"49386","52":"NA","53":"Mock treatment targeted against the BRD1 mRNA transcript (Qiagen kit)","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Qiagen Rneasy + Qiagen shredder columns (performed according to the supplied protocol)","61":"NA","62":"NA","63":"NA","64":"GSM2089907","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells (controls and stable BRD1-S-V5 and BRD1-L-V5 cell lines) were grown in DMEM medium (Invitrogen, San Diego, CA, USA) supplemented with 5% fetal calf serum (FCS), 175 mg/L glutamine, 36 mg/L penicillin and 60 mg/L streptomycine at 37 oC in 5% CO2","70":"NA","71":"NA","72":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","79":"NA","80":"Mar 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL13667","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"standard Affymetrix protocol","97":"NA","98":"GSE79255","99":"NA","100":"NA","101":"NA","102":"Cell line culture, mock method 1","103":"Public on Mar 16 2016","104":"NA","105":"NA","106":"Mar 15 2016","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2089nnn/GSM2089907/suppl/GSM2089907_A897-02.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_mock(Qiagen kit)BRD1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881009","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 2","17":"Non Producer culture - fermentation 1- time point 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"1","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 7","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"non-producing parent","64":"GSM881009","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Non Producer culture - fermentation 1- time point 2","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 2","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Non Producer culture - fermentation 1- time point 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861626","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Mutant, leptin-stimulated, biological replicate 1","18":"100ng leptin","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"PO Box 800741","38":"Charlottesville","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Virginia","44":"NA","45":"Stephen,,Turner","46":"NA","47":"VA","48":"NA","49":"22908","50":"Data extraction, QC, and GCRMA normalization were performed with BioConductor software.  Differential expression was assessed with moderated ANOVA, using the BioConductor limma package; false discovery rate (FDR) estimates were calculated using the Benjamini-Hochberg method.","51":"54675","52":"NA","53":"Mutant, leptin-stimulated, biological replicate 1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was prepared using RNeasy Mini kit (QIAGEN) and its quality was verified in an Agilent Bioanalyzer.","61":"NA","62":"NA","63":"NA","64":"GSM861626","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T/17 cells were maintained in a humidified incubator at 37 C with 5% CO2. HEK293T/17 cells were cultured in DMEM/F12 (Gibco) with non-essential amino acids, sodium pyruvate and 10% heat inactivated FBS.  Jurkat T-cells were cultured in RPMI supplemented with 10% heat inactivated FBS.  Caco-2 cells were cultured in EMEM (Gibco) supplemented with non-essential amino acids, sodium pyruvate and 20% heat inactivated FBS.  Cells were discarded after passage 25 and new cultures were started from frozen stocks. HEK293T117 cells were transiently transfected using lipofectamine 2000 per the product instructions (Invitrogen, Carlsbad, CA). The plasmids mLEPRb/pCDNA3 (47), mLEPRbR223/pCDNA3 (35) and LEPRbDelta65/pCDNA3 (47) were obtained from Martin Myers and have been described previously as referenced. pCDNA3 was used as a vector control. The plasmid mLEPRb/pCDNA3 was used as a template for site-directed mutagenesis to construct mLEPRb985L/pCDNA3, LEPRb1077L/pCDNA3 and mLEPRb1138L/pCDNA3.  Site-directed mutagenesis was done using the quikchange kit (Stragene/Agilent, Santa Clara, CA).    The presence of the desired mutations and the absence of other mutations were confirmed by DNA sequencing.","70":"NA","71":"NA","72":"Three biological replicates of each sample were hybridized to Human Genome U133 Plus 2.0 gene chips (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA was amplified and converted to cDNA using the 3' IVT Express Kit (Affymetrix).","79":"NA","80":"Jan 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned using the GeneChip Scanner 3000 7G (AffyMetrix).","97":"NA","98":"GSE35068","99":"NA","100":"NA","101":"NA","102":"Mutant, leptin-stimulated","103":"Public on Jan 01 2015","104":"NA","105":"NA","106":"Jan 12 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861626/suppl/GSM861626_MUT-1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Mutant, leptin-stimulated, biological replicate 1","117":"NA","118":"NA","119":"Y1138L (STAT3-mutant) leptin receptor","120":"NA","121":"100ng leptin","122":"HEK293 cells were transfected with WT LepR or Y1138L (STAT3-mutant) leptin receptor.  48 hours post-transfection cells were made quiescent by incubation in optimum plus 0.5% BSA for 3 hours.  Cells were then stimulated with 100ng of leptin or maintained in optimum plus 0.5% BSA for an additional 3 hours. Leptin was purchased from Dr. A.F. Parlow, National Hormone and Peptide Program (Torrance, CA). The STAT3 inhibitor, Stattic, the PI3K inhibitor, LY294002 and the MEK inhibitor PD98059 were purchased from EMD chemicals (Gibbstown, NJ).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2129125","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"shlinc00598#2_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293t","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Chungang Univ., Heukseok-dong, Dongjak-gu, Seoul, Republic of Korea","38":"Seoul","39":"South Korea","40":"Department of Life Science","41":"NA","42":"NA","43":"Chung-Ang university","44":"Functional Genomics Laboratory","45":"Oh-Seok,,Jeong","46":"NA","47":"N/A","48":"NA","49":"ASI|KR|KS013|SEOUL","50":"Array data export processing and analysis was performed using Illumina GenomeStudio v2011.1 (Gene Expression Module v1.9.0)","51":"47321","52":"NA","53":"['3999350127_B_Grn', 'SAMPLE 2']","54":"illuminaHumanv4","55":"98.36614","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from shCTL, shlinc00598#2, and shlinc00598#3 cells using RNAiso Plus (TaKaRa).","61":"NA","62":"NA","63":"linc00598 knockdown","64":"GSM2129125","65":"NA","66":"NA","67":"NA","68":"NA","69":"linc00598 knockdown stable and control shRNA HEK293t cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% heat-inactivated fetal bovine serum and 0.05% penicillin-streptomycin at 37 C in a 5% CO2 atmosphere.","70":"NA","71":"NA","72":"Following fragmentation, 0.75 ug of cRNA were hybridized to the Illumina Expression Beadchip according to the protocols provided by the manufacturer","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared from 0.55 ug total RNA using the Illumina TotalPrep RNA Amplification Kit (Ambion, Austin,TX)","79":"NA","80":"Apr 22 2016","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using the Illumina Bead Array Reader Confocal Scanner","97":"NA","98":"GSE80514","99":"shlinc00598#2","100":"NA","101":"NA","102":"HEK293t, shlinc00598#2","103":"Public on Apr 22 2016","104":"NA","105":"NA","106":"Apr 21 2016","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"shlinc00598#2_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733479","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080129 SM exposure 200 uM_2h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-06","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-06","53":"Gene expression data from NHEK_080129 SM exposure 200 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"200.0","58":"2008-01-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733479","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-16","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-07-30","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080129 SM exposure 200 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733479/suppl/GSM733479_080129_HD_2h_200.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_080129 SM exposure 200 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1171538","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Rpb1-amr  RD39a","18":"rpb1-amr","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"2 Hertzl st.","38":"Rehovot","39":"Israel","40":"NA","41":"rivka.dikstein@weizmann.ac.il","42":"NA","43":"The Weizmann Institute of Science","44":"NA","45":"Rivka,,Dikstein","46":"NA","47":"NA","48":"NA","49":"76100","50":"RMA was carried out using Partek Genomic Suite 6.5 (Inc. St. Charles, MO; www.partek.com)","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Tri-reagent (MRC inc.) according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1171538","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T were maintained in Dulbeccos modified Eagles medium (DMEM) supplemented with 10 % fetal calf serum.","70":"NA","71":"NA","72":"cDNA in 80 ul were hybridized to a Human Gene 1.0 ST array using Affymetrix hybridization kit materials and hybridized for 17 hours at 45 at 60rpm. Post-hyb washes were done with Affymetrix wash solutions on the FS450 station using FS450_0007 protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"200ng TotalRNA were used. cDNA samples were generated and labeled using Affymetrix WT-cDNA synthesis and labeling kit","79":"NA","80":"Jul 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned on the Affymetrix GeneChip Scanner 3000 7G","97":"NA","98":"GSE48163","99":"NA","100":"NA","101":"NA","102":"4 wt","103":"Public on Jul 01 2013","104":"NA","105":"NA","106":"Jun 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1171nnn/GSM1171538/suppl/GSM1171538_RD39a_HuST.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Rpb1-amr  RD39a","117":"NA","118":"NA","119":"NA","120":"NA","121":"Rpb1-amr","122":"Cells were transfected with plasmids directing the expression of -amanitin-resistant variants of Pol II (Rpb1-amr and R749H-amr). -amanitin was added and RNA was prepared 24 and 48 h later, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM648458","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"empty vector control, biological rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"3-1-1 Maidashi, Higashi-ku","38":"Fukuoka","39":"Japan","40":"Reseach Center for Genetic Information","41":"yiwasita@gen.kyushu-u.ac.jp","42":"+81-92-632-2375","43":"Kyushu University, Medical Institute of Bioregulation","44":"Division of Genome Analysis","45":"Yuji,,Iwashita","46":"+81-92-642-6170","47":"Fukuoka","48":"http://www.gen.kyushu-u.ac.jp/~genome/","49":"812-8582","50":"['Cel files were summarized and normalized with Robust Multi-array Average (RMA) method in Expression Console software version 1.1.1 (Affymetrix). Logarithmic signal intensities were antilog-transformed to linear scale using Expression Console.', 'probe group file: HuGene-1_0-st-v1.r3.pgf', 'meta-probeset file: HuGene-1_0-st-v1.r3.mps']","51":"33297","52":"NA","53":"neo-11","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from triplicated transfectants for each plasmid using RNeasy plus mini kit (74134, Qiagen, Hilden, Germany). RNA quality was checked using 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA), and RNA Integrity Number (RIN) was confirmed to be 9.4 or greater for all samples. Total RNA at 200 ng was amplified and reverse-transcribed using GeneChip WT Sense Target Labeling and Control Reagents (900652, Affymetrix).","61":"NA","62":"NA","63":"NA","64":"GSM648458","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were obtained from Clontech (Mountain View, MO) and maintained in Dulbeccos modified Eagles medium (D5796, Sigma-Aldrich, St. Louis, CA), supplemented with 10% fetal bovine serum, 100 units/ml penicillin and 100 g/ml streptomycin (15140-122, Invitrogen, Carlsbad, CA), in 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Samples were hybridized using Affymetrix hybridization kit materials. The cocktails were heated at 99C for 5 minutes, then 45C for 5 minutes and centrifuged at max speed for 1 minute. The 80 l of hyb solution was transfered to each array, then seal the holes with sticker. They were hybridized for 18 hours in 45C hybridization oven at 60 rpm. Fluidics Script Protocol was FS450_0007","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Samples were enzymatically fragmented and biotinylated using the WT Terminal Labeling Kit (Affymetrix)","79":"NA","80":"Jan 31 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix GeneChiP Scanner 3000 7G","97":"NA","98":"GSE26420","99":"NA","100":"NA","101":"NA","102":"HEK293 cell clone stably transformed with pCI-neo (empty vector). Clone No.11","103":"Public on Jan 31 2012","104":"NA","105":"NA","106":"Jan 04 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM648nnn/GSM648458/suppl/GSM648458.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"empty vector control, biological rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293 cells were transfected with pCI-neo (empty vector control) or pCI-neo-FLAG-HA-MIBP1 linearized with AclI and selected at 400 g/ml G418 (345812, Calbiochem, San Diego, CA) for 2 weeks. Selected cells were cloned using cloning rings and maintained in the presence of G418. Genomic integration and protein expression of MIBP1 were confirmed by genomic PCR and immunoblotting using anti-FLAG M2 antibody (Sigma-Aldrich).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM853613","2":"NA","3":"hek293 cells wtx inducible clone f18","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 F18_doxycycline treated","18":"NA","19":"doxycycline","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293 cells WTX inducible clone F18","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"149 13th St","38":"Charlestown","39":"USA","40":"Cancer Center","41":"NA","42":"NA","43":"Massachusetts General Hospital","44":"NA","45":"Woo,Jae,Kim","46":"NA","47":"Ma","48":"NA","49":"02129","50":"['Affymetrix GCOS', 'Target scaling = 150']","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Qiagen RNeasy Kit","61":"NA","62":"NA","63":"NA","64":"GSM853613","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Affymetrix standard protocol for 3'-IVT expression microarrays","73":"NA","74":"NA","75":"NA","76":"NA","77":"ENZO 3'-labeling kit","78":"ENZO 3'-labeling kit manufacturer's instruction","79":"NA","80":"Jan 01 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix scanner G7","97":"NA","98":"GSE34715","99":"NA","100":"NA","101":"NA","102":"HEK293 F18 WTX inducible","103":"Public on Jan 01 2012","104":"NA","105":"NA","106":"Dec 23 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM853nnn/GSM853613/suppl/GSM853613_HABE_1907.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM853nnn/GSM853613/suppl/GSM853613_HABE_1907.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 F18_doxycycline treated","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 g/ml doxycycline for 12 hr treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610836","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"4hr","17":"HEK293T_miR-132_FSK4hr_rep1","18":"NA","19":"FSK","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610836","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610836/suppl/GSM610836.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610836/suppl/GSM610836.chp.gz']","108":"9606","109":"4hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-132_FSK4hr_rep1","117":"miR-132","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861625","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Mutant, no leptin, biological replicate 3","18":"untreated","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"PO Box 800741","38":"Charlottesville","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Virginia","44":"NA","45":"Stephen,,Turner","46":"NA","47":"VA","48":"NA","49":"22908","50":"Data extraction, QC, and GCRMA normalization were performed with BioConductor software.  Differential expression was assessed with moderated ANOVA, using the BioConductor limma package; false discovery rate (FDR) estimates were calculated using the Benjamini-Hochberg method.","51":"54675","52":"NA","53":"Mutant, no leptin, biological replicate 3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was prepared using RNeasy Mini kit (QIAGEN) and its quality was verified in an Agilent Bioanalyzer.","61":"NA","62":"NA","63":"NA","64":"GSM861625","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T/17 cells were maintained in a humidified incubator at 37 C with 5% CO2. HEK293T/17 cells were cultured in DMEM/F12 (Gibco) with non-essential amino acids, sodium pyruvate and 10% heat inactivated FBS.  Jurkat T-cells were cultured in RPMI supplemented with 10% heat inactivated FBS.  Caco-2 cells were cultured in EMEM (Gibco) supplemented with non-essential amino acids, sodium pyruvate and 20% heat inactivated FBS.  Cells were discarded after passage 25 and new cultures were started from frozen stocks. HEK293T117 cells were transiently transfected using lipofectamine 2000 per the product instructions (Invitrogen, Carlsbad, CA). The plasmids mLEPRb/pCDNA3 (47), mLEPRbR223/pCDNA3 (35) and LEPRbDelta65/pCDNA3 (47) were obtained from Martin Myers and have been described previously as referenced. pCDNA3 was used as a vector control. The plasmid mLEPRb/pCDNA3 was used as a template for site-directed mutagenesis to construct mLEPRb985L/pCDNA3, LEPRb1077L/pCDNA3 and mLEPRb1138L/pCDNA3.  Site-directed mutagenesis was done using the quikchange kit (Stragene/Agilent, Santa Clara, CA).    The presence of the desired mutations and the absence of other mutations were confirmed by DNA sequencing.","70":"NA","71":"NA","72":"Three biological replicates of each sample were hybridized to Human Genome U133 Plus 2.0 gene chips (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA was amplified and converted to cDNA using the 3' IVT Express Kit (Affymetrix).","79":"NA","80":"Jan 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned using the GeneChip Scanner 3000 7G (AffyMetrix).","97":"NA","98":"GSE35068","99":"NA","100":"NA","101":"NA","102":"Mutant, no leptin","103":"Public on Jan 01 2015","104":"NA","105":"NA","106":"Jan 12 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861625/suppl/GSM861625_MUT+3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Mutant, no leptin, biological replicate 3","117":"NA","118":"NA","119":"Y1138L (STAT3-mutant) leptin receptor","120":"NA","121":"untreated","122":"HEK293 cells were transfected with WT LepR or Y1138L (STAT3-mutant) leptin receptor.  48 hours post-transfection cells were made quiescent by incubation in optimum plus 0.5% BSA for 3 hours.  Cells were then stimulated with 100ng of leptin or maintained in optimum plus 0.5% BSA for an additional 3 hours. Leptin was purchased from Dr. A.F. Parlow, National Hormone and Peptide Program (Torrance, CA). The STAT3 inhibitor, Stattic, the PI3K inhibitor, LY294002 and the MEK inhibitor PD98059 were purchased from EMD chemicals (Gibbstown, NJ).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1558596","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK_CD44s-Transfected_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"yes","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Nonnenwald 2","38":"Penzberg","39":"Germany","40":"Pharmaceutical Sciences","41":"fabian.birzele@roche.com","42":"NA","43":"Roche Diagnostics GmbH","44":"NA","45":"Fabian,,Birzele","46":"NA","47":"NA","48":"NA","49":"82377","50":"Partek Genomics suite was used to process CEL files, perform normalization and QC as well as to identify differentially regulated genes between native and CD44 transfected HEK293 cells using ANOVA.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"HEK293-CD44s Clone 4, expressing an average level of HA, was picked for profiling gene expression using Affymetrix Human Genome U133plus 2.0 arrays. Total RNA was prepared using the RNeasy Mini Kit (Qiagen, Germany), Microarray RNA Target Synthesis Kit T7 and RNeasy Mini-Spin Columns (Roche, Germany) and a hybridization mix was created consisting of 30 l of fragmented cRNA solution mixed with control oligonucleotide, staggered control cRNAs, herring sperm DNA, acetylated BSA and hybridization buffer in a total volume of 300 l. All kit procedures were performed according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1558596","65":"NA","66":"NA","67":"NA","68":"NA","69":"For cloning and expression of human CD44 (EMBL accession number M24915) the sequence was codon optimized (Geneart, Germany) and CD44s was expressed using a pcDNA3.1(-) vector (Invitrogen, Germany). PCR was performed with a denaturation step at 94C for 2 min, followed by 30 cycles of denaturation at 94C for 30 sec, annealing at 58C for 30 sec, and extension at 68C for 45 sec, with a final extension of 7 minutes at 68C (Expand High Fidelity PCR Kit, Roche). The PCR product and the vector were digested with EcoRI/HindIII restriction endonucleases, and DNA fragments were resolved by 1% agarose gel electrophoresis,purified from gels (GFX PCR DNA and Gel Band Purification Kit) and ligated (Rapid DNA Ligation Kit, Roche). Vectors were transferred into XL-10 Gold super-competent cells (Stratagene, The Netherlands) by heat shock and transformed cells were isolated form agar plates containing 100g/ml Ampicilin. Vector DNA from transfected cells was isolated using the High Pure Plasmid Isolation Kit (Roche, Germany).","70":"NA","71":"NA","72":"The hybridization mix was loaded onto the arrays and incubated in a roller device for 16 hrs. Hybridization solution was removed, arrays were washed, stained","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"standard Affymtrix protocol","79":"NA","80":"Dec 05 2014","81":"NA","82":"polyA RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned with an Affymetrix GeneChip Scanner 3000 (7G)","97":"NA","98":"GSE63862","99":"NA","100":"NA","101":"NA","102":"cell culture, HEK transfected with CD44s","103":"Public on Dec 05 2014","104":"NA","105":"NA","106":"Dec 04 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1558nnn/GSM1558596/suppl/GSM1558596_KLP_RW2_101125_CD44_PZ.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK_CD44s-Transfected_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874632","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T8h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874632","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 8h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874632/suppl/GSM1874632_RG_32_4OHT_8h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T8h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM360321","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Human embryonic kidney cells (HEK293) at 0hr, replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"50 South Drive, Bldg.50, Rm.2347","38":"Bethesda","39":"USA","40":"NA","41":"changah@nhlbi.nih.gov","42":"NA","43":"NIH\\\\NHLBI","44":"Laboratory of Biochemistry","45":"Allen,HK,Chang","46":"NA","47":"MD","48":"NA","49":"20892","50":"The data were first processed with GCOS1.4 using Affymetrix default analysis settings. The trimmed mean target intensity of each array was arbitrarily set to 1000. Intensities obtained in CHP file generated by GCOS were normalized using an adaptive variance-stabilizing quantile normalization (Munson, P.J., GeneLogic Workshop of Low Level Analysis of Affymetrix GeneChip Data, 2001, software available at http://abs.cit.nih.gov/geneexpression.html).","51":"54675","52":"NA","53":"gene expression data from human embryonic kidney cells (cell culture)","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 cells using Qiagen RNeasy Mini Kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM360321","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells are maintained in DMEM supplemented with 10% fetal bovine serum in 3% oxygen, 5% carbon dioxide, 37 degrees Celsius humidified incubator.","70":"NA","71":"NA","72":"Fragmented RNA was hybridized to Affymetrix HG-U133 plus 2.0 chips for 16 hours, washed, stained on an Affymetrix fluidics station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol using Affymetrixs IVT labeling kit following the manufacturers directions.","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Hybridized chips were scanned using Affymetrix genechip scanner 3000","97":"NA","98":"GSE14429","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) at 0hr","103":"Public on Jan 15 2009","104":"NA","105":"NA","106":"Jan 14 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM360nnn/GSM360321/suppl/GSM360321.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Human embryonic kidney cells (HEK293) at 0hr, replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 uM epoxomicin is added to HEK293 cells and incubated for 1 and 6 hours before RNA extraction. RNA was extracted from cells without treatment at zero time point as control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1269607","2":"NA","3":"hek 293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"293 transfected with MBDVP16 replicate #3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"513 Parnassus Avenue, HSW Room  1102, Box 0540","38":"San Francisco","39":"USA","40":"Diabetes Center","41":"manderson@diabetes.ucsf.edu","42":"NA","43":"UCSF","44":"Anderson Lab","45":"Mark,Stuart,Anderson","46":"NA","47":"CA","48":"NA","49":"94143","50":"AGCC 3.2.2 Microarrays were normalized for array-specific effects using Affymetrix's Robust Multi-Array (RMA) normalization","51":"28829","52":"NA","53":"293 cells transfected with MBDVP16 only biologic replicate #3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Qiagen RNAeasy mini kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1269607","65":"NA","66":"NA","67":"NA","68":"NA","69":"Transfected HEK 293 cells were grown for 72hrs in complete DMEM prior to RNA extraction.","70":"NA","71":"NA","72":"See manufacturer protocol","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"NuGEN Ovation Pico WTA V2 and NuGEN Encore Biotin Module","79":"NA","80":"Nov 21 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCS3000","97":"NA","98":"['GSE52546', 'GSE52548']","99":"NA","100":"NA","101":"NA","102":"293 transfected with MBDVP16","103":"Public on Nov 21 2013","104":"NA","105":"NA","106":"Nov 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1269nnn/GSM1269607/suppl/GSM1269607_09.MBDVP16-3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"293 transfected with MBDVP16 replicate #3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK 293 cells were transfected using Mirus 293 transfection reagent following manufacturers protocol.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM360324","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 1hr, replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"50 South Drive, Bldg.50, Rm.2347","38":"Bethesda","39":"USA","40":"NA","41":"changah@nhlbi.nih.gov","42":"NA","43":"NIH\\\\NHLBI","44":"Laboratory of Biochemistry","45":"Allen,HK,Chang","46":"NA","47":"MD","48":"NA","49":"20892","50":"The data were first processed with GCOS1.4 using Affymetrix default analysis settings. The trimmed mean target intensity of each array was arbitrarily set to 1000. Intensities obtained in CHP file generated by GCOS were normalized using an adaptive variance-stabilizing quantile normalization (Munson, P.J., GeneLogic Workshop of Low Level Analysis of Affymetrix GeneChip Data, 2001, software available at http://abs.cit.nih.gov/geneexpression.html).","51":"54675","52":"NA","53":"gene expression data from human embryonic kidney cells (cell culture) treated with epoxomicin for 1hr","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 cells using Qiagen RNeasy Mini Kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM360324","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells are maintained in DMEM supplemented with 10% fetal bovine serum in 3% oxygen, 5% carbon dioxide, 37 degrees Celsius humidified incubator.","70":"NA","71":"NA","72":"Fragmented RNA was hybridized to Affymetrix HG-U133 plus 2.0 chips for 16 hours, washed, stained on an Affymetrix fluidics station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol using Affymetrixs IVT labeling kit following the manufacturers directions.","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Hybridized chips were scanned using Affymetrix genechip scanner 3000","97":"NA","98":"GSE14429","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 1hr","103":"Public on Jan 15 2009","104":"NA","105":"NA","106":"Jan 14 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM360nnn/GSM360324/suppl/GSM360324.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 1hr, replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 uM epoxomicin is added to HEK293 cells and incubated for 1 and 6 hours before RNA extraction. RNA was extracted from cells without treatment at zero time point as control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM618026","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney","15":"NA","16":"NA","17":"HEK-TLR2 8h-LPS rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"human embryonic kidney (HEK) cells stably transfected with Toll-like receptor 2 (TLR2)","33":"1","34":"NA","35":"NA","36":"NA","37":"St. James's Hospital","38":"Dublin 8","39":"Ireland","40":"NA","41":"NA","42":"NA","43":"Trinity College Dublin","44":"Trinity Centre for Health Sciences","45":"Sinead,Marian,Smith","46":"NA","47":"NA","48":"NA","49":"D8","50":"Scanned images, obtained using Affymetrix Software (MAS5), were normalized using robust multichip average (RMA) analysis with RMAExpress version 0.4.1.","51":"54675","52":"NA","53":"gene expression in untreated HEK-TLR2 cells at 8h","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"At time points of 2, 4, 8, 24 and 48 h post-stimulation, cells were harvested and RNA isolated using the Nucleospin RNAII kit (Machery Nagel) according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM618026","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK-TLR2 cells were routinely maintained in MEM alpha medium (Gibco) supplemented with 10% foetal calf serum (Gibco), 2 mM L-glutamine (Sigma), 100 U/ml penicillin (Sigma), 100 g/ml streptomycin and 500 g/ml G418 (Sigma). The day before treatment, cells were seeded in 6-well plates at 1x106 cells/well.","70":"NA","71":"NA","72":"Following fragmentation, cRNA was hybridized for 16 hr at 45C on Affymetrix U133 plus 2.0 genechips. GeneChips were washed and stained in the Automated fluidics 450 station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 g total RNA (Expression Analysis Technical Manual, 2001, Affymetrix) using the Affymetrix IVT labeling kit.","79":"NA","80":"Jan 13 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips were scanned using the GeneChip 3000 7G scanner","97":"NA","98":"['GSE25148', 'GSE25155']","99":"NA","100":"NA","101":"NA","102":"HEK-TLR2 cells untreated for 8h rep 2","103":"Public on Jan 12 2011","104":"NA","105":"NA","106":"Nov 04 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM618nnn/GSM618026/suppl/GSM618026.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"embryonic kidney","116":"HEK-TLR2 8h-LPS rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"The morning of treatment, the cell culture medium was replaced with either fresh medium (untreated) or medium containing 10 g/ml H. pylori lipopolysaccharide","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733391","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071128 CEES exposure 1.5 uM_2h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-23","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-30","53":"Gene expression data from NHEK_071128 CEES exposure 1.5 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"1.5","58":"2007-11-28","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733391","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-09","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-11","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071128 CEES exposure 1.5 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733391/suppl/GSM733391_071128_CEES_2h_1.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_071128 CEES exposure 1.5 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1039978","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,control,biological rep 5","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"CTR_5","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1039978","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Nov 21 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE20615","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,control,biological rep 5","103":"Public on Nov 21 2012","104":"NA","105":"NA","106":"Nov 21 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1039nnn/GSM1039978/suppl/GSM1039978_AnP_Hu13302_062910_06_CTR27.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,control,biological rep 5","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2129126","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"shlinc00598#3_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293t","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Chungang Univ., Heukseok-dong, Dongjak-gu, Seoul, Republic of Korea","38":"Seoul","39":"South Korea","40":"Department of Life Science","41":"NA","42":"NA","43":"Chung-Ang university","44":"Functional Genomics Laboratory","45":"Oh-Seok,,Jeong","46":"NA","47":"N/A","48":"NA","49":"ASI|KR|KS013|SEOUL","50":"Array data export processing and analysis was performed using Illumina GenomeStudio v2011.1 (Gene Expression Module v1.9.0)","51":"47321","52":"NA","53":"['3999350127_C_Grn', 'SAMPLE 3']","54":"illuminaHumanv4","55":"98.36614","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from shCTL, shlinc00598#2, and shlinc00598#3 cells using RNAiso Plus (TaKaRa).","61":"NA","62":"NA","63":"linc00598 knockdown","64":"GSM2129126","65":"NA","66":"NA","67":"NA","68":"NA","69":"linc00598 knockdown stable and control shRNA HEK293t cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% heat-inactivated fetal bovine serum and 0.05% penicillin-streptomycin at 37 C in a 5% CO2 atmosphere.","70":"NA","71":"NA","72":"Following fragmentation, 0.75 ug of cRNA were hybridized to the Illumina Expression Beadchip according to the protocols provided by the manufacturer","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared from 0.55 ug total RNA using the Illumina TotalPrep RNA Amplification Kit (Ambion, Austin,TX)","79":"NA","80":"Apr 22 2016","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using the Illumina Bead Array Reader Confocal Scanner","97":"NA","98":"GSE80514","99":"shlinc00598#3","100":"NA","101":"NA","102":"HEK293t, shlinc00598#3","103":"Public on Apr 22 2016","104":"NA","105":"NA","106":"Apr 21 2016","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"shlinc00598#3_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733524","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080730 CEES exposure 2.0 uM_4h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-08-05","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-08-04","53":"Gene expression data from NHEK_080730 CEES exposure 2.0 uM_4h timepoint","54":"NA","55":"NA","56":"NA","57":"2.0","58":"2008-07-30","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733524","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-08-06","75":"Phillips","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-08-08","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080730 CEES exposure 2.0 uM_4h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733524/suppl/GSM733524_080730_CEES_4h_2.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"4","115":"NA","116":"NHEK_080730 CEES exposure 2.0 uM_4h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM373110","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"transformed hek cells","15":"NA","16":"NA","17":"Hek-HT Ras^G12V Replicate-5","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"transformed Hek cells","33":"1","34":"NA","35":"NA","36":"NA","37":"6431 Fannin St","38":"Houston","39":"USA","40":"NA","41":"jeffrey.t.chang@uth.tmc.edu","42":"NA","43":"UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON","44":"NA","45":"Jeffrey,,Chang","46":"NA","47":"TX","48":"NA","49":"77030","50":"MAS5.0","51":"22277","52":"NA","53":"1462_2979_14870_12V-5_HG-U133A+2.CEL","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"We extracted total RNA using Qiagen Rneasy mini kits.","61":"NA","62":"NA","63":"NA","64":"GSM373110","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"The cRNA is fragmented before hybridization and a hybridization cocktail is prepared that contains the fragmented cRNA, probe array controls, BSA and herring sperm DNA.  The cRNA is hybridized to the oligonucleotide probes on the array for 16 hours at 45C.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"We performed an in vitro transcription reaction to produce a biotin-labeled cRNA from the cDNA.","79":"NA","80":"Feb 20 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Immediately following hybridization, the hybridized probe arrays undergo an automated washing and staining protocol on the fluidic station and are then scanned on the GeneChip Scanner 3000 7G.","97":"NA","98":"GSE14934","99":"NA","100":"NA","101":"NA","102":"12V-5","103":"Public on Feb 21 2009","104":"NA","105":"NA","106":"Feb 20 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM373nnn/GSM373110/suppl/GSM373110.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Hek-HT Ras^G12V Replicate-5","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820016","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24 hrs","17":"HEK293T FMR4siRNA 24hr 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"FMR4 knockdown","64":"GSM1820016","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, FMR4 knockdown, 24 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820016/suppl/GSM1820016_Zane_24hr_FMR4si_3_A9_102011.CEL.gz","108":"9606","109":"24 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T FMR4siRNA 24hr 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1058031","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293  treated  scramble OO-PNA oligo 48hr biological replicate 2","18":"scramble oo-pna oligo","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Department of Mathematics and Computer Science, Faculty of Science, Chulalongkorn University","38":"Bangkok","39":"Thailand","40":"NA","41":"NA","42":"NA","43":"Chulalongkorn University","44":"NA","45":"Chatchawit,,Aporntewan","46":"NA","47":"NA","48":"NA","49":"10330","50":"['The scanned images were inspected for hybridization efficiency and CEL files generated from GCOS (GeneChip Operating Software) were imported into Expression Console (EC) 1.2 software for array QC. The matrix was created by Affymetrix Power Tools (APT) -- Release 1.14.3 on Windows 7. The command was apt-probeset-summarize -a rma -d HuGene-1_0-st-v1.r3.cdf -o out --cel-files cel_list.txt.', 'HuGene-1_0-st-v1.r4.pgf', 'HuGene-1_0-st-v1.r4.mps', 'RMA normalization was performed on the samples to generate the quality control (QC) metrics to determine data quality. These include, perfect match mean (PM_Mean), Background mean (Bgd_Mean), positive and negative probes (POS vs NEG AUC), bacterials spike controls, and polyA controls.']","51":"33252","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"All samples were RNA extracted according to the manufacturers protocol using Trizol (Invitrogen). Total RNA was reverse transcribed processed according to the Affymetrix and NuGEN recommended protocols, to produce cDNA/mRNA hybrid molecule, which was subsequently used as a template to create double stranded cDNA with a unique DNA/RNA heteroduplex on one end.","61":"NA","62":"NA","63":"NA","64":"GSM1058031","65":"NA","66":"NA","67":"adherent and monolayer","68":"NA","69":"HEK 293 cells were grown according to the manufacturers protocol in DMEM (Gibco-BRL) supplemented with 2 mM L-glutamine and 10% heat-inactivated fetal calf serum (FCS), and 10 mg/ml antibiotic antimycotic (Invitrogen) as before and after transfection. Cell harvest was performed at 48 hr post-transfection.","70":"NA","71":"NA","72":"The cDNAs were hybridized using Affymetrix Human Gene 1.0 ST arrays for 18 hours at 45oC with rotation at 60 rpm. Arrays were then washed and stained using the FS450_0007 fluidics protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"DNA/RNA heteroduplex was amplified via SPIA (Single Primer Isothermal Amplification), which produces single stranded anti-sense DNA. Post SPIA Modification generates sense target cDNA that was fragmented, biotin labeled according to Origen Labs Encore Biotin Module.","79":"NA","80":"Sep 03 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix Gene ChIP Scanner 3000 7G","97":"NA","98":"GSE43185","99":"NA","100":"NA","101":"NA","102":"Human Embryonic Kidney 293 cells, treated  scramble OO-PNA oligo, 48hr","103":"Public on Sep 03 2013","104":"NA","105":"NA","106":"Dec 28 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1058nnn/GSM1058031/suppl/GSM1058031_AFGE1224-5_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293  treated  scramble OO-PNA oligo 48hr biological replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"scramble OO-PNA oligo","122":"HEK293 cells were transfected with  50 nM of OO-A(15) and scramble OO-PNA oligo (OO-acgttcgcgcaacga).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610833","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"1hr","17":"HEK293T_miR-132_FSK1hr_rep1","18":"NA","19":"FSK","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610833","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610833/suppl/GSM610833.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610833/suppl/GSM610833.chp.gz']","108":"9606","109":"1hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-132_FSK1hr_rep1","117":"miR-132","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733112","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070829 SM exposure 25 uM_4h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-02-25","29":"Phillips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-14","53":"Gene expression data from NHEK_070829 SM exposure 25 uM_4h timepoint","54":"NA","55":"NA","56":"NA","57":"25.0","58":"2007-08-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733112","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-05-13","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-05-15","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070829 SM exposure 25 uM_4h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733112/suppl/GSM733112_070829_HD_4h_25.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"4","115":"NA","116":"NHEK_070829 SM exposure 25 uM_4h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560856","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0 h","17":"NOD2wt_0h_MDP_biological replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 wt","63":"NA","64":"GSM560856","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560856/suppl/GSM560856.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"0 h","113":"NA","114":"NA","115":"NA","116":"NOD2wt_0h_MDP_biological replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM360322","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Human embryonic kidney cells (HEK293) at 0hr, replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"50 South Drive, Bldg.50, Rm.2347","38":"Bethesda","39":"USA","40":"NA","41":"changah@nhlbi.nih.gov","42":"NA","43":"NIH\\\\NHLBI","44":"Laboratory of Biochemistry","45":"Allen,HK,Chang","46":"NA","47":"MD","48":"NA","49":"20892","50":"The data were first processed with GCOS1.4 using Affymetrix default analysis settings. The trimmed mean target intensity of each array was arbitrarily set to 1000. Intensities obtained in CHP file generated by GCOS were normalized using an adaptive variance-stabilizing quantile normalization (Munson, P.J., GeneLogic Workshop of Low Level Analysis of Affymetrix GeneChip Data, 2001, software available at http://abs.cit.nih.gov/geneexpression.html).","51":"54675","52":"NA","53":"gene expression data from human embryonic kidney cells (cell culture)","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 cells using Qiagen RNeasy Mini Kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM360322","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells are maintained in DMEM supplemented with 10% fetal bovine serum in 3% oxygen, 5% carbon dioxide, 37 degrees Celsius humidified incubator.","70":"NA","71":"NA","72":"Fragmented RNA was hybridized to Affymetrix HG-U133 plus 2.0 chips for 16 hours, washed, stained on an Affymetrix fluidics station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol using Affymetrixs IVT labeling kit following the manufacturers directions.","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Hybridized chips were scanned using Affymetrix genechip scanner 3000","97":"NA","98":"GSE14429","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) at 0hr","103":"Public on Jan 15 2009","104":"NA","105":"NA","106":"Jan 14 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM360nnn/GSM360322/suppl/GSM360322.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Human embryonic kidney cells (HEK293) at 0hr, replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 uM epoxomicin is added to HEK293 cells and incubated for 1 and 6 hours before RNA extraction. RNA was extracted from cells without treatment at zero time point as control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1288895","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"SilX-CT.R1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"Data were normalized with RMA","51":"33297","52":"NA","53":"Gene expression data","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the RNeasy Mini Kit (Qiagen), from three biological replicates, according to the manufacturer's instructions.  RNA was treated with DNase I to remove residual DNA and then cleaned with DNase Inactivation Reagent (Ambion Inc.) RNA was quality checked an then store at -80C.","61":"NA","62":"NA","63":"control","64":"GSM1288895","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown at 37C, in a humidified 10% CO2 incubator, in Dulbecco's modified Eagle's medium with GlutaMAX (Gibco) supplied with 10%FBS (Gibco) and 70 ug/ml Hygromycin B (10687-010-Invitrogen).","70":"NA","71":"NA","72":"Labeled cDNA was hybridized wiht GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) as described by the manufacturer.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RNA was amplified with GeneChip WT cDNA Synthesis and Amplification Kit (Affymetrix) and biotin labeld with GeneChip WT Terminal Labeling Kit (Affymetrix) according to the manufacturer's","79":"NA","80":"Jan 20 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix Human Gene 1.0 ST Array was scanned with the Affymetrix GeneChip Scanner 7G and the FS450_0007 protocol , as recommended in the GeneChip Hybridization, Wash, and Stain Kit (Affymetrix)","97":"NA","98":"['GSE51868', 'GSE53284']","99":"NA","100":"NA","101":"NA","102":"SilX-CT cells","103":"Public on Dec 11 2015","104":"NA","105":"NA","106":"Dec 13 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1288nnn/GSM1288895/suppl/GSM1288895_SilX-CT.R1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"SilX-CT.R1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"We established a BAHD1 gene-specific knockdown cell line using the SilenciX siRNA delivery system (Tebu-bio). This technology is based on EBV-replication, and ensures chromosome-like replication of an episome stably expressing either a shRNA against BAHD1 (silXBAHD1) or a control shRNA (silX-CT).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442117","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,8h,transfected,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"8 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442117","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, transfected_8h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442117/suppl/GSM1442117_8hGFPP_REP2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,8h,transfected,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442109","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,2h,untreated,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"2 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442109","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untreated_2h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442109/suppl/GSM1442109_2hCONTROL_REP2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,2h,untreated,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1087804","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"LIN28B_induced_rep2 [Affymetrix]","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1230 York Ave Box 186","38":"New York","39":"USA","40":"NA","41":"miguel.a.brown@gmail.com","42":"NA","43":"The Rockefeller University","44":"NA","45":"Miguel,,Brown","46":"NA","47":"New York","48":"NA","49":"10065","50":"We imported the CEL files into the R software (http://www.R-project.org) using the BioConductor affy package (Gentleman et al., 2004). The transcript probe set intensities were background-corrected, adjusted for non-specific binding and quantile normalized with the GCRMA algorithm (Wu, 2006). Probe sets with more than 6 of the 11 probes mapping ambiguously to the genome were discarded, as were probe sets that mapped to multiple genes. We then collected all probe sets matching a given gene, and we selected for further analysis the RefSeq transcript with median 3'UTR length corresponding to that gene. In total 16,063 transcripts were identified. The log-intensity of probe sets mapping to the gene were then averaged to obtain the expression level per RefSeq transcript. The changes of transcript abundances were computed as the logarithm of the ratio of transcript expression in the cocktails of siRNA treated samples and mock-transfected cells. Detailed analysis procedure can be found in the Supplement to Hafner et al. Cell, 2010,141(1),129-141 Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP","51":"13008","52":"NA","53":"Gene expression data from HEK293 cells inducibly expressing FLAG/HA tagged LIN28B; FH/LIN28B  induced","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1087804","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 T-REx Flp-In cells (Invitrogen) were grown in D-MEM high glucose with 10% (v/v) fetal bovine serum, 1% (v/v) 2 mM L-glutamine, 1% (v/v) 10,000 U/ml penicillin/10,000 g/ml streptomycin, 100 g/ml zeocin and 15 g/ml blasticidin. Cell lines stably expressing FLAG/HA-tagged proteins were generated by co-transfection of pFRT/TO/FLAG/HA or pFRT/FLAG/HA constructs with pOG44 (Invitrogen). Cells were selected by exchanging zeocin with 100 g/ml hygromycin. Expression of FLAG/HA-LIN28B was induced by addition of 250 ng/ml doxycycline 15 to 20 h before crosslinking.  Detailed experimental procedure can be found in the Methods section of Hafner et al., RNA, in press, Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition","70":"NA","71":"NA","72":"3 g cRNA hybridized to HGU133 Plus 2.0 Arrays for 16 h at 45C","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"2 g of purified total RNA was used in the One-Cycle Eukaryotic Target Labeling Assay (Affymetrix) according to manufacturer's protocol. Biotinylated cRNA targets were cleaned up, fragmented, and hybridized to Human Genome U133 Plus 2.0 Array (Affymetrix).","79":"NA","80":"Feb 26 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips scanned on Affymetrix Genechip 300 7G scanner","97":"NA","98":"['GSE44613', 'GSE44616']","99":"NA","100":"NA","101":"NA","102":"HEK 293 cells expressing FLAG/HA tagged LIN28B; transgene expression induced; mock transfected; replicate 2","103":"Public on Feb 26 2013","104":"NA","105":"NA","106":"Feb 25 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1087nnn/GSM1087804/suppl/GSM1087804_LIN28B_induced_rep2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"LIN28B_induced_rep2 [Affymetrix]","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"siRNA transfections of HEK293 T-REx Flp-In cells were performed in 6-well format using Lipofectamine RNAiMAX (Invitrogen) as described by the manufacturer. Detailed experimental procedure can be found in the Methods section of Hafner et al., RNA, in press Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM925901","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"parental HEK293 Flp-In rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Maulbeerstrasse 66","38":"Basel","39":"Switzerland","40":"Functional Genomics","41":"tim.roloff@fmi.ch","42":"NA","43":"FMI","44":"NA","45":"Tim,,Roloff","46":"NA","47":"NA","48":"NA","49":"4058","50":"Arrays were normalized and probeset-level log2 expression values were calculated using the rma function from the R/Bioconductor (v2.14) package affy.","51":"32321","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and further cleaned up using RNeasy Columns.","61":"NA","62":"NA","63":"wild-type","64":"GSM925901","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were grown in DMEM supplemented with 2 mM glutamine and 10% FCS. 50 ug/ml hygromycin B was added to the culture medium for the maintance of FHA-TRIM71 expressing cell lines.","70":"NA","71":"NA","72":"Affymetrix Gene Chip Arrays were hybridized following the GeneChip Whole Transcript (WT) Sense Target Labeling Assay Manual (Affymetrix) with a hybridization time of 16h. The Affymetrix Fluidiscs protocol FS450_0007 was used for washing.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"100ng of extracted total RNA was amplified using the Ambion WT Expression kit (Ambion) and the resulting sense-strand cDNA was fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling kit (Affymetrix).","79":"NA","80":"Jan 23 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed with Affzmetrix GCC Scan Control v. 3.0.0.1214 on a GeneChip Scanner 3000 with autoloader.","97":"NA","98":"['GSE37713', 'GSE37714']","99":"NA","100":"NA","101":"NA","102":"wild-type HEK293 Flp-In","103":"Public on Jan 22 2013","104":"NA","105":"NA","106":"May 02 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM925nnn/GSM925901/suppl/GSM925901_wf20110324hg10_02_wtII_503_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"parental HEK293 Flp-In rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733476","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080129 SM exposure 25 uM_2h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-06","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-06","53":"Gene expression data from NHEK_080129 SM exposure 25 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"25.0","58":"2008-01-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733476","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-02","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-06-04","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080129 SM exposure 25 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733476/suppl/GSM733476_080129_HD_2h_25.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_080129 SM exposure 25 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM897030","2":"NA","3":"hek293 cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T-REx293-NPAP1-uninduced-1","18":"uninduced","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293 cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with RMA default setting in Partek GS","51":"33297","52":"NA","53":"Gene expression data from cell line T-REx293-NPAP1, not induced, technical replicate 1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using the RNeasy mini kit (QIAGEN), treated with DNase I, followed by cleaning-up on spin columns (RNeasy mini kit. Qiagen)","61":"NA","62":"NA","63":"NA","64":"GSM897030","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were cultured in DMEM medium supplemented with 10% FCS, 1% penstrep and appropriate concentration of selective antibiotics","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Human Gene 1.0 ST. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix Hybridization, Wash and Stain Kit..","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Amplified cDNA was prepared according to the Ambion WT Expression Kit protocol starting from 200 ng total RNA. Amplified cDNA was fragmented with UDG and APE1 and finally labelled using the Affymetrix WT terminal labelling kit","79":"NA","80":"Jun 18 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned in the Affymetrix GeneChip Scanner 3000 wit G7 update","97":"NA","98":"GSE36575","99":"NA","100":"NA","101":"NA","102":"Flp-In T-REx 293","103":"Public on Jun 18 2012","104":"NA","105":"NA","106":"Mar 16 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM897nnn/GSM897030/suppl/GSM897030_TRex3_4.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T-REx293-NPAP1-uninduced-1","117":"NA","118":"NA","119":"NA","120":"NPAP1/C15orf2","121":"uninduced","122":"Cells were mock treated (H2O)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733390","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071128 CEES exposure 1.0 uM_2h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-23","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-30","53":"Gene expression data from NHEK_071128 CEES exposure 1.0 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"1.0","58":"2007-11-28","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733390","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-09","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-11","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071128 CEES exposure 1.0 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733390/suppl/GSM733390_071128_CEES_2h_1.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_071128 CEES exposure 1.0 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236711","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"RHOXF1 48h_3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_22']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236711","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, RHOXF1 transfected, 48h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236711/suppl/GSM2236711_Human_Gene_1_0_ST_20150205_22.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236711/suppl/GSM2236711_Human_Gene_1_0_ST_20150205_22.chp.gz']","108":"9606","109":"NA","110":"48h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"RHOXF1 48h_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"RHOXF1 expression vector"},{"1":"GSM693935","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24h","17":"HEK293T_BACH1-siRNA2_24h_rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_s_3_24', 'BACH1_s_3_300ng_24h_293T.CEL', 'Gene expression data from HEK 293T cells 24h after knockdown of BACH1 with Stealth siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693935","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"siRNA2 HSS100910 (s)","102":"HEK 293T cells, BACH1 knockdown, 24h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693935/suppl/GSM693935.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693935/suppl/GSM693935.EXP.gz']","108":"9606","109":"24h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-siRNA2_24h_rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733407","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071128 CEES exposure 1.5 uM_8h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-29","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-04","53":"Gene expression data from NHEK_071128 CEES exposure 1.5 uM_8h timepoint","54":"NA","55":"NA","56":"NA","57":"1.5","58":"2007-11-28","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733407","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-09","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-11","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071128 CEES exposure 1.5 uM_8h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733407/suppl/GSM733407_071128_CEES_8h_1.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"8","115":"NA","116":"NHEK_071128 CEES exposure 1.5 uM_8h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1254226","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293-CT.R2","18":"control","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"data were normalized with RMA, analysed with LPE with three FDR methods; the zreal value is indicated in the matrix","51":"28869","52":"NA","53":"Gene expression data","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the RNeasy Mini Kit (Qiagen), from three biological replicates, according to was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1254226","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown at 37C, in a humidified 10% CO2 incubator, in Dulbecco's modified Eagle's medium with GlutaMAX (Gibco) supplied with 10%FBS (Gibco) and 200 ug/ml Hygromycin B (10687-010-Invitrogen).","70":"NA","71":"NA","72":"Labeled cDNA was hybridized wiht GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) as described by the manufacturer.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RNA was amplified with GeneChip WT cDNA Synthesis and Amplification Kit (Affymetrix) and biotin labeld with GeneChip WT Terminal Labeling Kit (Affymetrix) according to the manufacturer's","79":"NA","80":"Jan 20 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Microarrays was scanned with the Affymetrix GeneChip Scanner 7G and the FS450_0007 protocol , as recommended in the GeneChip Hybridization, Wash, and Stain Kit (Affymetrix)","97":"NA","98":"['GSE51863', 'GSE51868']","99":"NA","100":"NA","101":"NA","102":"HEK293-CT cells","103":"Public on Dec 11 2015","104":"NA","105":"NA","106":"Oct 29 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1254nnn/GSM1254226/suppl/GSM1254226_HEK293-CT.R2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293-CT.R2","117":"NA","118":"NA","119":"NA","120":"NA","121":"control","122":"HEK-BAHD1 were generated by integration of a single copy of the BAHD1 cDNA under the control of the human cytomegalovirus (CMV) immediate-early enhancer/promoter in the HEK293 genome. In the isogenic control line (HEK293-CT), the -galactosidase DNA sequence was inserted in place of BAHD1, albeit out-of-frame to avoid translation into protein.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442095","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,2h,treated,biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"2 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442095","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, treated_2h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442095/suppl/GSM1442095_2hGFP_REP3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,2h,treated,biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442107","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,16h,transfected,biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"16 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442107","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, transfected","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442107/suppl/GSM1442107_16hGFPP_REP3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,16h,transfected,biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733470","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080129 SM exposure 100 uM_1h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-06","29":"Philips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-06","53":"Gene expression data from NHEK_080129 SM exposure 100 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"100.0","58":"2008-01-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733470","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-02","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-06-04","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080129 SM exposure 100 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733470/suppl/GSM733470_080129_HD_1h_100.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_080129 SM exposure 100 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733349","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071107 CEES exposure 2.0 uM_4h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-15","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-30","53":"Gene expression data from NHEK_071107 CEES exposure 2.0 uM_4h timepoint","54":"NA","55":"NA","56":"NA","57":"2.0","58":"2007-11-07","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733349","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-30","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-08-13","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071107 CEES exposure 2.0 uM_4h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733349/suppl/GSM733349_071107_CEES_4h_2.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"4","115":"NA","116":"NHEK_071107 CEES exposure 2.0 uM_4h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM648459","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"MIBP1 overexpression, biological rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"3-1-1 Maidashi, Higashi-ku","38":"Fukuoka","39":"Japan","40":"Reseach Center for Genetic Information","41":"yiwasita@gen.kyushu-u.ac.jp","42":"+81-92-632-2375","43":"Kyushu University, Medical Institute of Bioregulation","44":"Division of Genome Analysis","45":"Yuji,,Iwashita","46":"+81-92-642-6170","47":"Fukuoka","48":"http://www.gen.kyushu-u.ac.jp/~genome/","49":"812-8582","50":"['Cel files were summarized and normalized with Robust Multi-array Average (RMA) method in Expression Console software version 1.1.1 (Affymetrix). Logarithmic signal intensities were antilog-transformed to linear scale using Expression Console.', 'probe group file: HuGene-1_0-st-v1.r3.pgf', 'meta-probeset file: HuGene-1_0-st-v1.r3.mps']","51":"33297","52":"NA","53":"FHM-31","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from triplicated transfectants for each plasmid using RNeasy plus mini kit (74134, Qiagen, Hilden, Germany). RNA quality was checked using 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA), and RNA Integrity Number (RIN) was confirmed to be 9.4 or greater for all samples. Total RNA at 200 ng was amplified and reverse-transcribed using GeneChip WT Sense Target Labeling and Control Reagents (900652, Affymetrix).","61":"NA","62":"NA","63":"NA","64":"GSM648459","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were obtained from Clontech (Mountain View, MO) and maintained in Dulbeccos modified Eagles medium (D5796, Sigma-Aldrich, St. Louis, CA), supplemented with 10% fetal bovine serum, 100 units/ml penicillin and 100 g/ml streptomycin (15140-122, Invitrogen, Carlsbad, CA), in 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Samples were hybridized using Affymetrix hybridization kit materials. The cocktails were heated at 99C for 5 minutes, then 45C for 5 minutes and centrifuged at max speed for 1 minute. The 80 l of hyb solution was transfered to each array, then seal the holes with sticker. They were hybridized for 18 hours in 45C hybridization oven at 60 rpm. Fluidics Script Protocol was FS450_0007","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Samples were enzymatically fragmented and biotinylated using the WT Terminal Labeling Kit (Affymetrix)","79":"NA","80":"Jan 31 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix GeneChiP Scanner 3000 7G","97":"NA","98":"GSE26420","99":"NA","100":"NA","101":"NA","102":"HEK293 cell clone stably overexpressing MIBP1. Clone No.31","103":"Public on Jan 31 2012","104":"NA","105":"NA","106":"Jan 04 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM648nnn/GSM648459/suppl/GSM648459.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"MIBP1 overexpression, biological rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293 cells were transfected with pCI-neo (empty vector control) or pCI-neo-FLAG-HA-MIBP1 linearized with AclI and selected at 400 g/ml G418 (345812, Calbiochem, San Diego, CA) for 2 weeks. Selected cells were cloned using cloning rings and maintained in the presence of G418. Genomic integration and protein expression of MIBP1 were confirmed by genomic PCR and immunoblotting using anti-FLAG M2 antibody (Sigma-Aldrich).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733420","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071128 CEES exposure 3.5 uM_16h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-05-01","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-04","53":"Gene expression data from NHEK_071128 CEES exposure 3.5 uM_16h timepoint","54":"NA","55":"NA","56":"NA","57":"3.5","58":"2007-11-28","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733420","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-14","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-16","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071128 CEES exposure 3.5 uM_16h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733420/suppl/GSM733420_071128_CEES_16h_3.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"16","115":"NA","116":"NHEK_071128 CEES exposure 3.5 uM_16h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861629","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Wild Type, no leptin, biological replicate 1","18":"untreated","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"PO Box 800741","38":"Charlottesville","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Virginia","44":"NA","45":"Stephen,,Turner","46":"NA","47":"VA","48":"NA","49":"22908","50":"Data extraction, QC, and GCRMA normalization were performed with BioConductor software.  Differential expression was assessed with moderated ANOVA, using the BioConductor limma package; false discovery rate (FDR) estimates were calculated using the Benjamini-Hochberg method.","51":"54675","52":"NA","53":"Wild Type, no leptin, biological replicate 1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was prepared using RNeasy Mini kit (QIAGEN) and its quality was verified in an Agilent Bioanalyzer.","61":"NA","62":"NA","63":"NA","64":"GSM861629","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T/17 cells were maintained in a humidified incubator at 37 C with 5% CO2. HEK293T/17 cells were cultured in DMEM/F12 (Gibco) with non-essential amino acids, sodium pyruvate and 10% heat inactivated FBS.  Jurkat T-cells were cultured in RPMI supplemented with 10% heat inactivated FBS.  Caco-2 cells were cultured in EMEM (Gibco) supplemented with non-essential amino acids, sodium pyruvate and 20% heat inactivated FBS.  Cells were discarded after passage 25 and new cultures were started from frozen stocks. HEK293T117 cells were transiently transfected using lipofectamine 2000 per the product instructions (Invitrogen, Carlsbad, CA). The plasmids mLEPRb/pCDNA3 (47), mLEPRbR223/pCDNA3 (35) and LEPRbDelta65/pCDNA3 (47) were obtained from Martin Myers and have been described previously as referenced. pCDNA3 was used as a vector control. The plasmid mLEPRb/pCDNA3 was used as a template for site-directed mutagenesis to construct mLEPRb985L/pCDNA3, LEPRb1077L/pCDNA3 and mLEPRb1138L/pCDNA3.  Site-directed mutagenesis was done using the quikchange kit (Stragene/Agilent, Santa Clara, CA).    The presence of the desired mutations and the absence of other mutations were confirmed by DNA sequencing.","70":"NA","71":"NA","72":"Three biological replicates of each sample were hybridized to Human Genome U133 Plus 2.0 gene chips (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA was amplified and converted to cDNA using the 3' IVT Express Kit (Affymetrix).","79":"NA","80":"Jan 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned using the GeneChip Scanner 3000 7G (AffyMetrix).","97":"NA","98":"GSE35068","99":"NA","100":"NA","101":"NA","102":"Wild Type, no leptin","103":"Public on Jan 01 2015","104":"NA","105":"NA","106":"Jan 12 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861629/suppl/GSM861629_WT+1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Wild Type, no leptin, biological replicate 1","117":"NA","118":"NA","119":"Wild-type leptin receptor","120":"NA","121":"untreated","122":"HEK293 cells were transfected with WT LepR or Y1138L (STAT3-mutant) leptin receptor.  48 hours post-transfection cells were made quiescent by incubation in optimum plus 0.5% BSA for 3 hours.  Cells were then stimulated with 100ng of leptin or maintained in optimum plus 0.5% BSA for an additional 3 hours. Leptin was purchased from Dr. A.F. Parlow, National Hormone and Peptide Program (Torrance, CA). The STAT3 inhibitor, Stattic, the PI3K inhibitor, LY294002 and the MEK inhibitor PD98059 were purchased from EMD chemicals (Gibbstown, NJ).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733475","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080129 SM exposure 12.5 uM_2h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-06","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-06","53":"Gene expression data from NHEK_080129 SM exposure 12.5 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"12.5","58":"2008-01-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733475","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-02","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-06-04","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080129 SM exposure 12.5 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733475/suppl/GSM733475_080129_HD_2h_12.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_080129 SM exposure 12.5 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM925902","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"parental HEK293 Flp-In rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Maulbeerstrasse 66","38":"Basel","39":"Switzerland","40":"Functional Genomics","41":"tim.roloff@fmi.ch","42":"NA","43":"FMI","44":"NA","45":"Tim,,Roloff","46":"NA","47":"NA","48":"NA","49":"4058","50":"Arrays were normalized and probeset-level log2 expression values were calculated using the rma function from the R/Bioconductor (v2.14) package affy.","51":"32321","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and further cleaned up using RNeasy Columns.","61":"NA","62":"NA","63":"wild-type","64":"GSM925902","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were grown in DMEM supplemented with 2 mM glutamine and 10% FCS. 50 ug/ml hygromycin B was added to the culture medium for the maintance of FHA-TRIM71 expressing cell lines.","70":"NA","71":"NA","72":"Affymetrix Gene Chip Arrays were hybridized following the GeneChip Whole Transcript (WT) Sense Target Labeling Assay Manual (Affymetrix) with a hybridization time of 16h. The Affymetrix Fluidiscs protocol FS450_0007 was used for washing.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"100ng of extracted total RNA was amplified using the Ambion WT Expression kit (Ambion) and the resulting sense-strand cDNA was fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling kit (Affymetrix).","79":"NA","80":"Jan 23 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed with Affzmetrix GCC Scan Control v. 3.0.0.1214 on a GeneChip Scanner 3000 with autoloader.","97":"NA","98":"['GSE37713', 'GSE37714']","99":"NA","100":"NA","101":"NA","102":"wild-type HEK293 Flp-In","103":"Public on Jan 22 2013","104":"NA","105":"NA","106":"May 02 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM925nnn/GSM925902/suppl/GSM925902_wf20110324hg10_03_wtIII_503_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"parental HEK293 Flp-In rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874636","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T2h_U0126+4h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874636","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 2h and subsequent U0126 4h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874636/suppl/GSM1874636_RG_37_4OHT_U0126_2h_4h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T2h_U0126+4h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236705","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"RHOXF1 48h_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_16']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236705","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, RHOXF1 transfected, 48h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236705/suppl/GSM2236705_Human_Gene_1_0_ST_20150205_16.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236705/suppl/GSM2236705_Human_Gene_1_0_ST_20150205_16.chp.gz']","108":"9606","109":"NA","110":"48h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"RHOXF1 48h_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"RHOXF1 expression vector"},{"1":"GSM733173","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070912 NM exposure 25 uM_8h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-18","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-24","53":"Gene expression data from NHEK_070912 NM exposure 25 uM_8h timepoint","54":"NA","55":"NA","56":"NA","57":"25.0","58":"2007-09-12","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733173","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-17","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-31","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070912 NM exposure 25 uM_8h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733173/suppl/GSM733173_070912_NM_8h_25.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"8","115":"NA","116":"NHEK_070912 NM exposure 25 uM_8h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM618020","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney","15":"NA","16":"NA","17":"HEK-TLR2 2h+LPS rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"human embryonic kidney (HEK) cells stably transfected with Toll-like receptor 2 (TLR2)","33":"1","34":"NA","35":"NA","36":"NA","37":"St. James's Hospital","38":"Dublin 8","39":"Ireland","40":"NA","41":"NA","42":"NA","43":"Trinity College Dublin","44":"Trinity Centre for Health Sciences","45":"Sinead,Marian,Smith","46":"NA","47":"NA","48":"NA","49":"D8","50":"Scanned images, obtained using Affymetrix Software (MAS5), were normalized using robust multichip average (RMA) analysis with RMAExpress version 0.4.1.","51":"54675","52":"NA","53":"gene expression in treated HEK-TLR2 cells at 2h","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"At time points of 2, 4, 8, 24 and 48 h post-stimulation, cells were harvested and RNA isolated using the Nucleospin RNAII kit (Machery Nagel) according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM618020","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK-TLR2 cells were routinely maintained in MEM alpha medium (Gibco) supplemented with 10% foetal calf serum (Gibco), 2 mM L-glutamine (Sigma), 100 U/ml penicillin (Sigma), 100 g/ml streptomycin and 500 g/ml G418 (Sigma). The day before treatment, cells were seeded in 6-well plates at 1x106 cells/well.","70":"NA","71":"NA","72":"Following fragmentation, cRNA was hybridized for 16 hr at 45C on Affymetrix U133 plus 2.0 genechips. GeneChips were washed and stained in the Automated fluidics 450 station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 g total RNA (Expression Analysis Technical Manual, 2001, Affymetrix) using the Affymetrix IVT labeling kit.","79":"NA","80":"Jan 13 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips were scanned using the GeneChip 3000 7G scanner","97":"NA","98":"['GSE25148', 'GSE25155']","99":"NA","100":"NA","101":"NA","102":"HEK-TLR2 cells treated with 10 g/ml H. pylori LPS for 2h rep 2","103":"Public on Jan 12 2011","104":"NA","105":"NA","106":"Nov 04 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM618nnn/GSM618020/suppl/GSM618020.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"embryonic kidney","116":"HEK-TLR2 2h+LPS rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"The morning of treatment, the cell culture medium was replaced with either fresh medium (untreated) or medium containing 10 g/ml H. pylori lipopolysaccharide","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874639","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T1h_CYHX_1h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874639","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen and CYHX 1h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874639/suppl/GSM1874639_RG_48_4OHT_CYHX_1h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T1h_CYHX_1h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733237","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070919 NM exposure 100 uM_24h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-01","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-24","53":"Gene expression data from NHEK_070919 NM exposure 100 uM_24h timepoint","54":"NA","55":"NA","56":"NA","57":"100.0","58":"2007-09-19","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733237","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-23","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-08-06","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070919 NM exposure 100 uM_24h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733237/suppl/GSM733237_070919_NM_24h_100.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"24","115":"NA","116":"NHEK_070919 NM exposure 100 uM_24h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693930","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24h","17":"HEK293T_BACH1-siRNA1_24h_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_q_1_24', 'BACH1_q_1_300ng_24h_293T.CEL', 'Gene expression data from HEK 293T cells 24h after knockdown of BACH1 with Qiagen siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693930","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"siRNA1 SI00309876 (q)","102":"HEK 293T cells, BACH1 knockdown, 24h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693930/suppl/GSM693930.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693930/suppl/GSM693930.EXP.gz']","108":"9606","109":"24h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-siRNA1_24h_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM463021","2":"NA","3":"hek293e","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293E cells, TDP-43 siRNA, replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293E","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Calwer Str. 7","38":"Tuebingen","39":"Germany","40":"Department of Medical Genetics","41":"michael.walter@agilent.com","42":"NA","43":"University of Tuebingen","44":"The Microarray Facility Tbingen","45":"Michael,H.,Walter","46":"NA","47":"NA","48":"NA","49":"72076","50":"The data were analysed using GC-RMA for background correction, normalization and probe summarization using the Bioconductor package gcrma with default values.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA  was extracted by using RNeasy Mini Kit (Qiagen) following manufacturers instructions for animal cells.","61":"NA","62":"NA","63":"NA","64":"GSM463021","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293E cells were grown in Dulbeccos modified Eagle medium (DMEM) (Biochrom) supplemented with 10% fetal bovine serum (PAA) at 37C under humidified 5% CO2/air","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 Plus 2.0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Oct 19 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GCS3000 gene chip scanner.","97":"NA","98":"GSE18632","99":"NA","100":"NA","101":"NA","102":"HEK cells transfected with TDP-43 siRNA, 24h after transfection","103":"Public on Oct 20 2009","104":"NA","105":"NA","106":"Oct 19 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463021/suppl/GSM463021.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293E cells, TDP-43 siRNA, replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were transiently transfected three consecutive days using HiPerfect with 5nmol scrambled (both Qiagen) or TDP-specific  siRNAs (5-CAATAGCAATAGACAGTTA-3) and cultivated for 24h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881024","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 4","17":"Non-producer culture - fermentation 1- time point 4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"2","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 22","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"non-producing parent","64":"GSM881024","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Non-producer culture - fermentation 1- time point 4","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 4","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Non-producer culture - fermentation 1- time point 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733232","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070919 NM exposure 50 uM_16h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-31","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-24","53":"Gene expression data from NHEK_070919 NM exposure 50 uM_16h timepoint","54":"NA","55":"NA","56":"NA","57":"50.0","58":"2007-09-19","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733232","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-23","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-08-06","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070919 NM exposure 50 uM_16h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733232/suppl/GSM733232_070919_NM_16h_50.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"16","115":"NA","116":"NHEK_070919 NM exposure 50 uM_16h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693944","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"72h","17":"HEK293T_BACH1-siRNA1_72h_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_q_2_72', 'BACH1_q_2_300ng_72h_293T.CEL', 'Gene expression data from HEK 293T cells 72h after knockdown of BACH1 with Qiagen siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693944","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"siRNA1 SI00309876 (q)","102":"HEK 293T cells, BACH1 knockdown, 72h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693944/suppl/GSM693944.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693944/suppl/GSM693944.EXP.gz']","108":"9606","109":"72h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-siRNA1_72h_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM463017","2":"NA","3":"hek293e","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293E cells, scrambled siRNA, replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293E","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Calwer Str. 7","38":"Tuebingen","39":"Germany","40":"Department of Medical Genetics","41":"michael.walter@agilent.com","42":"NA","43":"University of Tuebingen","44":"The Microarray Facility Tbingen","45":"Michael,H.,Walter","46":"NA","47":"NA","48":"NA","49":"72076","50":"The data were analysed using GC-RMA for background correction, normalization and probe summarization using the Bioconductor package gcrma with default values.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA  was extracted by using RNeasy Mini Kit (Qiagen) following manufacturers instructions for animal cells.","61":"NA","62":"NA","63":"NA","64":"GSM463017","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293E cells were grown in Dulbeccos modified Eagle medium (DMEM) (Biochrom) supplemented with 10% fetal bovine serum (PAA) at 37C under humidified 5% CO2/air","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 Plus 2.0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Oct 19 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GCS3000 gene chip scanner.","97":"NA","98":"GSE18632","99":"NA","100":"NA","101":"NA","102":"HEK cells transfected with scrambled siRNA, 24h after transfection","103":"Public on Oct 20 2009","104":"NA","105":"NA","106":"Oct 19 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463017/suppl/GSM463017.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293E cells, scrambled siRNA, replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were transiently transfected three consecutive days using HiPerfect with 5nmol scrambled (both Qiagen) or TDP-specific  siRNAs (5-CAATAGCAATAGACAGTTA-3) and cultivated for 24h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM258517","2":"NA","3":"hek293 human embryonic kidney cell line","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina human-6 v2.0 expression beadchip (Illumina_Human-6_V2.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Control RNA_24h_Illumina","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293 human embryonic kidney cell line","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Handan Road 220#","38":"Shanghai","39":"China","40":"Life Science","41":"liulingfeng1111@gmail.com","42":"NA","43":"Fudan University","44":"the State Key Laboratory of Genetic Engineering","45":"Lingfeng,,Liu","46":"+86-21-65643262","47":"NA","48":"NA","49":"200433","50":"Cubic spline normalization using Illumina BeadStudio Version \"BSGX Version3.2.3\"","51":"48702","52":"NA","53":"The HEK293 cells treated with control RNA for 24h","54":"illuminaHumanv2","55":"98.42364","56":"NA","57":"NA","58":"NA","59":"NA","60":"Illumina TotalPrep RNA amplification kit (Ambion Catalog#IL1791)","61":"NA","62":"NA","63":"NA","64":"GSM258517","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"['Refer to the Illumina Gene Expression System Manual', '']","73":"NA","74":"NA","75":"NA","76":"NA","77":"Streptavidin Cy3","78":"As described in the illumina Human-6 chip processing protocol. Briefly, generation of biotin labelled cRNA from the product of RT cDNA synthesis and 2nd strand cDNA synthesis.","79":"NA","80":"Mar 29 2010","81":"99.99795","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6102","86":"control (control RNA)","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"['Refer to the Illumina Gene Expression System Manual', '']","97":"NA","98":"GSE10241","99":"NA","100":"NA","101":"NA","102":"HEK293, Control RNA treatment","103":"Public on Nov 03 2009","104":"NA","105":"NA","106":"Jan 23 2008","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM258nnn/GSM258517/suppl/GSM258517.txt.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293_Control RNA_24h_Illumina","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM678639","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Control_1_h_Replicate 3","18":"NA","19":"Control","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"1","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 51","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678639","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"1","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"2","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"1","114":"NA","115":"NA","116":"HEK293_Control_1_h_Replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236696","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"RHOXF1 24h_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_1']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236696","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, RHOXF1 transfected, 24h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236696/suppl/GSM2236696_Human_Gene_1_0_ST_20150205_1.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236696/suppl/GSM2236696_Human_Gene_1_0_ST_20150205_1.chp.gz']","108":"9606","109":"NA","110":"24h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"RHOXF1 24h_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"RHOXF1 expression vector"},{"1":"GSM1305857","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"EA07047_56011_H133+_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"5635 Fishers Lane, Suite 510","38":"Rockville","39":"USA","40":"NA","41":"raducojo@gmail.com","42":"NA","43":"Elsevier","44":"NA","45":"Radu,,Cojocaru","46":"NA","47":"MD","48":"NA","49":"20852","50":"Data was analyzed using GeneSpring software including QC analysis.","51":"41751","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted from control and myocilin expressing cells after induction with selected concentrations of doxycycline using a Trizol reagent. The extracted RNA was used for each microarray study.","61":"NA","62":"NA","63":"NA","64":"GSM1305857","65":"NA","66":"NA","67":"NA","68":"NA","69":"Tet-on stably transfected cells were maintained in Dulbecco modified Eagle medium (DMEM) supplemented with 10% Tet system proved fetal bovine serum, penicillin (100 U/ml), streptomycin (100 g/ml), hygromycin B (200 g/ml) and G418 (100 g/ml) at 37 C in a humidified atmosphere of 5% CO2.","70":"NA","71":"NA","72":"Not provided.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Not provided.","79":"NA","80":"May 21 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Not provided.","97":"NA","98":"GSE53985","99":"NA","100":"NA","101":"NA","102":"Stable Cell line transfected with control vector","103":"Public on May 21 2014","104":"NA","105":"NA","106":"Jan 13 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1305nnn/GSM1305857/suppl/GSM1305857_EA07047_56011_H133+_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"EA07047_56011_H133+_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Tet-on stably transfected cells were treated with 0.2 or 1 g/ ml of doxycycline for 48 hr to induce myocilin expression.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1269603","2":"NA","3":"hek 293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"293 transfected with Aire replicate #2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"513 Parnassus Avenue, HSW Room  1102, Box 0540","38":"San Francisco","39":"USA","40":"Diabetes Center","41":"manderson@diabetes.ucsf.edu","42":"NA","43":"UCSF","44":"Anderson Lab","45":"Mark,Stuart,Anderson","46":"NA","47":"CA","48":"NA","49":"94143","50":"AGCC 3.2.2 Microarrays were normalized for array-specific effects using Affymetrix's Robust Multi-Array (RMA) normalization","51":"28829","52":"NA","53":"293 cells transfected with Aire only biologic replicate #2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Qiagen RNAeasy mini kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1269603","65":"NA","66":"NA","67":"NA","68":"NA","69":"Transfected HEK 293 cells were grown for 72hrs in complete DMEM prior to RNA extraction.","70":"NA","71":"NA","72":"See manufacturer protocol","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"NuGEN Ovation Pico WTA V2 and NuGEN Encore Biotin Module","79":"NA","80":"Nov 21 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCS3000","97":"NA","98":"['GSE52546', 'GSE52548']","99":"NA","100":"NA","101":"NA","102":"293 transfected with Aire","103":"Public on Nov 21 2013","104":"NA","105":"NA","106":"Nov 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1269nnn/GSM1269603/suppl/GSM1269603_05.Aire-2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"293 transfected with Aire replicate #2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK 293 cells were transfected using Mirus 293 transfection reagent following manufacturers protocol.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM465435","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney cells","15":"NA","16":"NA","17":"HEK293 cells in vitro, rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"embryonic kidney cells","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"Gene expression data from in vitro cultivated HEK293 cells.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated with the RNeasy Mini kit according to the manufacturer's instructions (Qiagen).","61":"NA","62":"NA","63":"NA","64":"GSM465435","65":"NA","66":"NA","67":"in vitro cell cultivation","68":"NA","69":"Human embryonic kidney (HEK293) cells were grown in DMEM (glucose concentration 450 mg/dl), either injected in NOD.Scid mice and expanded for three weeks in vivo, or cultivated in vitro.","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Human Genome U133 Plus 2.0 Array) in 200 l of the hybridization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual; Rev. 5).","79":"NA","80":"Oct 26 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE18739","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) in vitro cultivated in DMEM (450 mg/dl glucose)","103":"Public on Oct 27 2009","104":"NA","105":"NA","106":"Oct 26 2009","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM465nnn/GSM465435/suppl/GSM465435.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM465nnn/GSM465435/suppl/GSM465435.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cells in vitro, rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874653","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"IGF_4h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874653","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER IGF 4h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874653/suppl/GSM1874653_NB_62_IGF_4h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"IGF_4h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1645159","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"3_GFPsiRNA","18":"simultaneous knockdown of tet1, tet2 and tet3","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Hufelandstrasse 55","38":"Essen","39":"Germany","40":"Universitaetsklinikum Essen","41":"bernhard.horsthemke@uni-due.de","42":"NA","43":"Institut fuer Humangenetik","44":"NA","45":"Bernhard,,Horsthemke","46":"NA","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with MAS5 using Affymetrix default analysis settings and global scaling to a target intensity of 1000 as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from GFP#3 clone, 96 h after simultaneous siRNA-mediated knockdown of TET1, TET2, TET3', 'total RNA (>200 nt)']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using the AllPrep DNA/RNA/Protein Mini kit (Qiagen) and treated with the RNase-Free DNase Set (Qiagen)","61":"NA","62":"NA","63":"NA","64":"GSM1645159","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were cultured in DMEM supplemented with 10% FCS, 1% Pen/Strep and appropriate concentrations of selective antibiotics.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133Plus_2. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix Hybridization, Wash and Stain Kit..","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA were prepared according to the Affymetrix ExpressKit protocol starting from 200 ng total RNA.","79":"NA","80":"Jul 17 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned in a GeneArray Scanner (Agilent).","97":"NA","98":"['GSE67348', 'GSE67351']","99":"NA","100":"NA","101":"NA","102":"Flp-In T-REx 293","103":"Public on Jul 16 2015","104":"NA","105":"NA","106":"Mar 27 2015","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1645nnn/GSM1645159/suppl/GSM1645159_3_GFPsiRNA.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1645nnn/GSM1645159/suppl/GSM1645159_3_GFPsiRNA.mas5.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"3_GFPsiRNA","117":"NA","118":"NA","119":"NA","120":"GFP","121":"simultaneous knockdown of TET1, TET2 and TET3","122":"Cells were treated either with siRNA against TET1, TET2 and TET3 or a non-targeting pool. All cells carried an inducible, stable GFP transgene whose expression was not induced.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM925904","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 Flp-In TRIM71 rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Maulbeerstrasse 66","38":"Basel","39":"Switzerland","40":"Functional Genomics","41":"tim.roloff@fmi.ch","42":"NA","43":"FMI","44":"NA","45":"Tim,,Roloff","46":"NA","47":"NA","48":"NA","49":"4058","50":"Arrays were normalized and probeset-level log2 expression values were calculated using the rma function from the R/Bioconductor (v2.14) package affy.","51":"32321","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and further cleaned up using RNeasy Columns.","61":"NA","62":"NA","63":"FHA-TRIM71 overexpression","64":"GSM925904","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were grown in DMEM supplemented with 2 mM glutamine and 10% FCS. 50 ug/ml hygromycin B was added to the culture medium for the maintance of FHA-TRIM71 expressing cell lines.","70":"NA","71":"NA","72":"Affymetrix Gene Chip Arrays were hybridized following the GeneChip Whole Transcript (WT) Sense Target Labeling Assay Manual (Affymetrix) with a hybridization time of 16h. The Affymetrix Fluidiscs protocol FS450_0007 was used for washing.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"100ng of extracted total RNA was amplified using the Ambion WT Expression kit (Ambion) and the resulting sense-strand cDNA was fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling kit (Affymetrix).","79":"NA","80":"Jan 23 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed with Affzmetrix GCC Scan Control v. 3.0.0.1214 on a GeneChip Scanner 3000 with autoloader.","97":"NA","98":"['GSE37713', 'GSE37714']","99":"NA","100":"NA","101":"NA","102":"FHA-TRIM71 HEK293","103":"Public on Jan 22 2013","104":"NA","105":"NA","106":"May 02 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM925nnn/GSM925904/suppl/GSM925904_wf20110324hg10_05_FHA-TR71II_503_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 Flp-In TRIM71 rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874635","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T2h_U0126+2h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874635","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 2h and subsequent U0126 2h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874635/suppl/GSM1874635_RG_36_4OHT_U0126_2h_2h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T2h_U0126+2h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM711410","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"HEK293Tcells_wt_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"1000 E 50th St","38":"Kansas City","39":"USA","40":"Genomics","41":"seidel@phageT4.org","42":"NA","43":"Stowers Institute","44":"Seidel","45":"Chris,W,Seidel","46":"816 926 9054","47":"MO","48":"NA","49":"64110","50":"Array intensities were processed using the RMA algorithm in R/bioconductor. Bioconductor 2.6 and affy package affy_1.24.2","51":"54675","52":"NA","53":"Gene expression from HEK293T cells after transfection with non-targeting siRNA, replicate 1.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the standard Qiagen RNeasy cleanup protocol.","61":"NA","62":"NA","63":"NA","64":"GSM711410","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in 6 well tissue culture plates or 10 cm dishes for 48 hours after transfection.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 plus 2.0 Arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the Ambion MessageAmp III protocol from 300 ng total RNA (MessageAmp III Amplification kit Manual, 2007, Ambion).","79":"NA","80":"Sep 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 and processed with AGCC v3.0 software.","97":"NA","98":"GSE28715","99":"NA","100":"Dharmacon non-targeting #2","101":"NA","102":"HEK293T cells","103":"Public on Sep 01 2011","104":"NA","105":"NA","106":"Apr 19 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM711nnn/GSM711410/suppl/GSM711410_cont-1_HG-U133_Plus_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293Tcells_wt_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293T cells in 6 well tissue culture plates (~1x105 cells/well) or 10 cm dishes (~2 x106 cells/dish) were transfected with 25 nM siRNAs targeting human Med26 (Ambion/Applied Biosystems, #4, s18074; #5, s18075; #6, s18076) or 25 nM siCONTROL NON-TARGETING siRNA #2 (Dharmacon D-001210-01) using X-tremeGENE siRNA Transfection Reagent (Roche) and grown for 48 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM569350","2":"NA","3":"embryonic kidney cell line hek","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"WT in the presence of tetracycline, rep3","18":"NA","19":"tetracycline","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Embryonic kidney cell line HEK","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1 Oryong-dong Buk-gu","38":"Gwangju","39":"South Korea","40":"Life science","41":"lbc0523@gist.ac.kr","42":"82629702540","43":"Gwangju Institutue Science and Technology","44":"NA","45":"Byoung-Cheol,,Lee","46":"82629702566","47":"NA","48":"NA","49":"500712","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from HEK cells expressing WT TRPM7 channel', 'WT tet3']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"WT channel","64":"GSM569350","65":"NA","66":"NA","67":"NA","68":"NA","69":"Stabel cell-lines were grown in in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum and an antibiotic, 5 ug/mL blasticidin (Invitrogen). Cells were cultured in a humidified atmosphere of 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Fragmented cRNA was hybridized to the Human Genome UI133 Plus 2.0 Array (Affymetrix) at 45C for 16 h according to the Affymetrix standard protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"5 ug of total RNA from each cell-lines was used for labeling. Probe synthesis from total RNA samples, hybridization, detection, and scanning were performed according to standard protocols from Affymetrix, Inc..","79":"NA","80":"Jul 23 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"After hybridization, the arrays were washed in a GeneChip Fluidics Station 450 with a non-stringent wash buffer at 25C followed by a stringent wash buffer at 50C. After washing, the arrays were stained with a streptavidin-phycoerythrin complex. After staining, intensities were determined with a GeneChip scanner 3000 (Affymetrix), controlled by GCOS Affymetrix software.","97":"NA","98":"GSE23102","99":"NA","100":"NA","101":"NA","102":"HEK cell lines expressing WT channel","103":"Public on Jul 23 2011","104":"NA","105":"NA","106":"Jul 23 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM569nnn/GSM569350/suppl/GSM569350.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"WT in the presence of tetracycline, rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 ug of tetracycline was treated to stabel cell-lines which overexressing WT and mutant TRPM7 channel for 72 hours","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM360327","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 1hr, replicate 4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"50 South Drive, Bldg.50, Rm.2347","38":"Bethesda","39":"USA","40":"NA","41":"changah@nhlbi.nih.gov","42":"NA","43":"NIH\\\\NHLBI","44":"Laboratory of Biochemistry","45":"Allen,HK,Chang","46":"NA","47":"MD","48":"NA","49":"20892","50":"The data were first processed with GCOS1.4 using Affymetrix default analysis settings. The trimmed mean target intensity of each array was arbitrarily set to 1000. Intensities obtained in CHP file generated by GCOS were normalized using an adaptive variance-stabilizing quantile normalization (Munson, P.J., GeneLogic Workshop of Low Level Analysis of Affymetrix GeneChip Data, 2001, software available at http://abs.cit.nih.gov/geneexpression.html).","51":"54675","52":"NA","53":"gene expression data from human embryonic kidney cells (cell culture) treated with epoxomicin for 1hr","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 cells using Qiagen RNeasy Mini Kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM360327","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells are maintained in DMEM supplemented with 10% fetal bovine serum in 3% oxygen, 5% carbon dioxide, 37 degrees Celsius humidified incubator.","70":"NA","71":"NA","72":"Fragmented RNA was hybridized to Affymetrix HG-U133 plus 2.0 chips for 16 hours, washed, stained on an Affymetrix fluidics station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol using Affymetrixs IVT labeling kit following the manufacturers directions.","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Hybridized chips were scanned using Affymetrix genechip scanner 3000","97":"NA","98":"GSE14429","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 1hr","103":"Public on Jan 15 2009","104":"NA","105":"NA","106":"Jan 14 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM360nnn/GSM360327/suppl/GSM360327.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 1hr, replicate 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 uM epoxomicin is added to HEK293 cells and incubated for 1 and 6 hours before RNA extraction. RNA was extracted from cells without treatment at zero time point as control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442094","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,2h,treated,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"2 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442094","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, treated_2h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442094/suppl/GSM1442094_2hGFP_REP2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,2h,treated,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881020","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 4","17":"Producer culture - fermentation 3- time point 4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"2","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 18","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"recombinant protein producer","64":"GSM881020","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Producer culture - fermentation 3- time point 4","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 4","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Producer culture - fermentation 3- time point 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM569348","2":"NA","3":"embryonic kidney cell line hek","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"WT in the presence of tetracycline, rep1","18":"NA","19":"tetracycline","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Embryonic kidney cell line HEK","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1 Oryong-dong Buk-gu","38":"Gwangju","39":"South Korea","40":"Life science","41":"lbc0523@gist.ac.kr","42":"82629702540","43":"Gwangju Institutue Science and Technology","44":"NA","45":"Byoung-Cheol,,Lee","46":"82629702566","47":"NA","48":"NA","49":"500712","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from HEK cells expressing WT TRPM7 channel', 'WT tet1']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"WT channel","64":"GSM569348","65":"NA","66":"NA","67":"NA","68":"NA","69":"Stabel cell-lines were grown in in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum and an antibiotic, 5 ug/mL blasticidin (Invitrogen). Cells were cultured in a humidified atmosphere of 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Fragmented cRNA was hybridized to the Human Genome UI133 Plus 2.0 Array (Affymetrix) at 45C for 16 h according to the Affymetrix standard protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"5 ug of total RNA from each cell-lines was used for labeling. Probe synthesis from total RNA samples, hybridization, detection, and scanning were performed according to standard protocols from Affymetrix, Inc..","79":"NA","80":"Jul 23 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"After hybridization, the arrays were washed in a GeneChip Fluidics Station 450 with a non-stringent wash buffer at 25C followed by a stringent wash buffer at 50C. After washing, the arrays were stained with a streptavidin-phycoerythrin complex. After staining, intensities were determined with a GeneChip scanner 3000 (Affymetrix), controlled by GCOS Affymetrix software.","97":"NA","98":"GSE23102","99":"NA","100":"NA","101":"NA","102":"HEK cell lines expressing WT channel","103":"Public on Jul 23 2011","104":"NA","105":"NA","106":"Jul 23 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM569nnn/GSM569348/suppl/GSM569348.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"WT in the presence of tetracycline, rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 ug of tetracycline was treated to stabel cell-lines which overexressing WT and mutant TRPM7 channel for 72 hours","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1058028","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293  treated OO-A(15) 48hr biological replicate 1","18":"oo-a(15)","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Department of Mathematics and Computer Science, Faculty of Science, Chulalongkorn University","38":"Bangkok","39":"Thailand","40":"NA","41":"NA","42":"NA","43":"Chulalongkorn University","44":"NA","45":"Chatchawit,,Aporntewan","46":"NA","47":"NA","48":"NA","49":"10330","50":"['The scanned images were inspected for hybridization efficiency and CEL files generated from GCOS (GeneChip Operating Software) were imported into Expression Console (EC) 1.2 software for array QC. The matrix was created by Affymetrix Power Tools (APT) -- Release 1.14.3 on Windows 7. The command was apt-probeset-summarize -a rma -d HuGene-1_0-st-v1.r3.cdf -o out --cel-files cel_list.txt.', 'HuGene-1_0-st-v1.r4.pgf', 'HuGene-1_0-st-v1.r4.mps', 'RMA normalization was performed on the samples to generate the quality control (QC) metrics to determine data quality. These include, perfect match mean (PM_Mean), Background mean (Bgd_Mean), positive and negative probes (POS vs NEG AUC), bacterials spike controls, and polyA controls.']","51":"33252","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"All samples were RNA extracted according to the manufacturers protocol using Trizol (Invitrogen). Total RNA was reverse transcribed processed according to the Affymetrix and NuGEN recommended protocols, to produce cDNA/mRNA hybrid molecule, which was subsequently used as a template to create double stranded cDNA with a unique DNA/RNA heteroduplex on one end.","61":"NA","62":"NA","63":"NA","64":"GSM1058028","65":"NA","66":"NA","67":"adherent and monolayer","68":"NA","69":"HEK 293 cells were grown according to the manufacturers protocol in DMEM (Gibco-BRL) supplemented with 2 mM L-glutamine and 10% heat-inactivated fetal calf serum (FCS), and 10 mg/ml antibiotic antimycotic (Invitrogen) as before and after transfection. Cell harvest was performed at 48 hr post-transfection.","70":"NA","71":"NA","72":"The cDNAs were hybridized using Affymetrix Human Gene 1.0 ST arrays for 18 hours at 45oC with rotation at 60 rpm. Arrays were then washed and stained using the FS450_0007 fluidics protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"DNA/RNA heteroduplex was amplified via SPIA (Single Primer Isothermal Amplification), which produces single stranded anti-sense DNA. Post SPIA Modification generates sense target cDNA that was fragmented, biotin labeled according to Origen Labs Encore Biotin Module.","79":"NA","80":"Sep 03 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix Gene ChIP Scanner 3000 7G","97":"NA","98":"GSE43185","99":"NA","100":"NA","101":"NA","102":"Human Embryonic Kidney 293 cells, treated OO-A(15), 48hr","103":"Public on Sep 03 2013","104":"NA","105":"NA","106":"Dec 28 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1058nnn/GSM1058028/suppl/GSM1058028_AFGE1224-1_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293  treated OO-A(15) 48hr biological replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"OO-A(15)","122":"HEK293 cells were transfected with  50 nM of OO-A(15) and scramble OO-PNA oligo (OO-acgttcgcgcaacga).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861810","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293-Vc-rep1","18":"none","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"10 Amistad Street","38":"New Haven","39":"USA","40":"NA","41":"dianqing.wu@yale.edu","42":"NA","43":"Yale University","44":"NA","45":"Dan,,Wu","46":"NA","47":"NA","48":"NA","49":"06510","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"Gene expression data from HEK293 cells","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM861810","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were incubated in DMEM with 10% FBS","70":"NA","71":"NA","72":"After labeling the samples are prepared for hybridization and then rotate in oven at 45 degrees for 16 hours. GeneChips were washed and stained on GeneChip Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Fragment and label the single-stranded cDNA were prepared according to  the standard Affymetrix protocol (GeneChip WT Terminal Lableing and Hybridization User Manual).","79":"NA","80":"Jan 14 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 7G.","97":"NA","98":"GSE35084","99":"NA","100":"NA","101":"NA","102":"HEK293","103":"Public on Jan 14 2012","104":"NA","105":"NA","106":"Jan 13 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861810/suppl/GSM861810_HEK293-Vc-1.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861810/suppl/GSM861810_HEK293-Vc-1.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293-Vc-rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"none","122":"The cells were incubated with serum-free medium for overnight and then stimulated with LPA (1uM) for 2 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442103","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,16h,untransfected,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"16 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442103","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_16h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442103/suppl/GSM1442103_16hGFPM_REP2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,16h,untransfected,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733500","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080129 SM exposure 800 uM_8h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-10","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-06","53":"Gene expression data from NHEK_080129 SM exposure 800 uM_8h timepoint","54":"NA","55":"NA","56":"NA","57":"800.0","58":"2008-01-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733500","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-22","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-07-24","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080129 SM exposure 800 uM_8h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733500/suppl/GSM733500_080129_HD_8h_800.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"8","115":"NA","116":"NHEK_080129 SM exposure 800 uM_8h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560868","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"2 h","17":"NOD2-L1007fsinsC_2h_MDP_biological replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 L1007fsinsC","63":"NA","64":"GSM560868","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560868/suppl/GSM560868.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"2 h","113":"NA","114":"NA","115":"NA","116":"NOD2-L1007fsinsC_2h_MDP_biological replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733481","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080129 SM exposure 600 uM_2h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-06","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-06","53":"Gene expression data from NHEK_080129 SM exposure 600 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"600.0","58":"2008-01-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733481","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-22","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-07-24","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080129 SM exposure 600 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733481/suppl/GSM733481_080129_HD_2h_600.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_080129 SM exposure 600 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610831","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0hr","17":"HEK293T_miR-381_FSK0hr_rep1","18":"NA","19":"untreated","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610831","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610831/suppl/GSM610831.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610831/suppl/GSM610831.chp.gz']","108":"9606","109":"0hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-381_FSK0hr_rep1","117":"miR-381","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861811","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293-LPA-rep1","18":"lpa","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"10 Amistad Street","38":"New Haven","39":"USA","40":"NA","41":"dianqing.wu@yale.edu","42":"NA","43":"Yale University","44":"NA","45":"Dan,,Wu","46":"NA","47":"NA","48":"NA","49":"06510","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"Gene expression data from HEK293 cells treatment with LPA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM861811","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were incubated in DMEM with 10% FBS","70":"NA","71":"NA","72":"After labeling the samples are prepared for hybridization and then rotate in oven at 45 degrees for 16 hours. GeneChips were washed and stained on GeneChip Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Fragment and label the single-stranded cDNA were prepared according to  the standard Affymetrix protocol (GeneChip WT Terminal Lableing and Hybridization User Manual).","79":"NA","80":"Jan 14 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 7G.","97":"NA","98":"GSE35084","99":"NA","100":"NA","101":"NA","102":"HEK293","103":"Public on Jan 14 2012","104":"NA","105":"NA","106":"Jan 13 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861811/suppl/GSM861811_HEK293-LPA-1.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861811/suppl/GSM861811_HEK293-LPA-1.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293-LPA-rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"LPA","122":"The cells were incubated with serum-free medium for overnight and then stimulated with LPA (1uM) for 2 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733312","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071003 SM exposure 600 uM_8h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-04","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-22","53":"Gene expression data from NHEK_071003 SM exposure 600 uM_8h timepoint","54":"NA","55":"NA","56":"NA","57":"600.0","58":"2007-10-03","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733312","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-21","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-07-23","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071003 SM exposure 600 uM_8h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733312/suppl/GSM733312_071003_HD_8h_600.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"8","115":"NA","116":"NHEK_071003 SM exposure 600 uM_8h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881018","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 4","17":"Producer culture - fermentation 1- time point 4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"2","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 16","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"recombinant protein producer","64":"GSM881018","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Producer culture - fermentation 1- time point 4","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 4","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Producer culture - fermentation 1- time point 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610834","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"1hr","17":"HEK293T_miR-381_FSK1hr_rep1","18":"NA","19":"FSK","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610834","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610834/suppl/GSM610834.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610834/suppl/GSM610834.chp.gz']","108":"9606","109":"1hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-381_FSK1hr_rep1","117":"miR-381","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1399571","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"78h after transfection","17":"shLSD1, bio. replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"615 N. Wolfe St.","38":"Baltimore","39":"USA","40":"NA","41":"NA","42":"NA","43":"Johns Hopkins University","44":"NA","45":"Jiou,,Wang","46":"NA","47":"MD","48":"NA","49":"21205","50":"[\"Affymetrix CEL files were extracted and their data normalized with the Partek GS 6.6 platform.  Partek's Extended Meta-Probeset set was used with RMA normalization to create quantile-normalized log2 transcript signal values, which were used in subsequent ANOVA analyses.\", 'probe group file: HuGene-1_0-st-v1.r4.pgf', 'meta-probeset file: HuGene-1_0-st-v1.na32.hg19.transcript.csv']","51":"33297","52":"NA","53":"SAMPLE 7","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Cells were lysed using RNAeasy mini kit (Qiagen), according to manufacturer's instructions. Genomic DNA was first removed by DNAse treatment on the column, and then, additionally, after total RNA was isolated, using DNase Turbo kit (Ambion), followed by additional round of cleaning through RNAeasy columns.","61":"NA","62":"NA","63":"NA","64":"GSM1399571","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells grown in DMEM, 10%FBS, 37C, 5% CO2","70":"NA","71":"NA","72":"17hrs at 45 C with rotation (60rpm) as described by Affymetrix in their GeneChip Expression Analysis Technical Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The Ambion Expression WT kit was used as described in the manufacturer's manual.","79":"NA","80":"Feb 09 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Using Affymetrix GeneChip Scanner 3000 7G and default parameters described by the manufacturer in their GeneChip Expression Analysis Technical Manual","97":"NA","98":"GSE58026","99":"NA","100":"NA","101":"NA","102":"HEK293_shLSD1","103":"Public on Feb 09 2017","104":"NA","105":"NA","106":"May 28 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1399nnn/GSM1399571/suppl/GSM1399571_GPer-SOD-B3_L-1a-HuGene_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"78h after transfection","113":"NA","114":"NA","115":"NA","116":"shLSD1, bio. replicate 2","117":"NA","118":"shRNAs against LSD1","119":"NA","120":"NA","121":"NA","122":"Cells were transfected in 60mm dishes using 4g DNA, 10l Lipofectamine 2000, in total 4.5ml  Optimem-MEM1. Origene's pRS-RFP-C plasmids encoding shRNAs against UBE4B and LSD1, or non-targeting control (CTRL) were used for knockdown. Cells were knocked down for 78h before lysis.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733239","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070926 NM exposure 12.5 uM_1h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-01","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-28","53":"Gene expression data from NHEK_070926 NM exposure 12.5 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"12.5","58":"2007-09-26","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733239","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-24","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-08-07","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070926 NM exposure 12.5 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733239/suppl/GSM733239_070926_NM_1h_12.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_070926 NM exposure 12.5 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874623","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"UT_3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874623","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Untreated replicate 3","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874623/suppl/GSM1874623_RG_23_ut_3_10h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"UT_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM618031","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney","15":"NA","16":"NA","17":"HEK-TLR2 24h+LPS rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"human embryonic kidney (HEK) cells stably transfected with Toll-like receptor 2 (TLR2)","33":"1","34":"NA","35":"NA","36":"NA","37":"St. James's Hospital","38":"Dublin 8","39":"Ireland","40":"NA","41":"NA","42":"NA","43":"Trinity College Dublin","44":"Trinity Centre for Health Sciences","45":"Sinead,Marian,Smith","46":"NA","47":"NA","48":"NA","49":"D8","50":"Scanned images, obtained using Affymetrix Software (MAS5), were normalized using robust multichip average (RMA) analysis with RMAExpress version 0.4.1.","51":"54675","52":"NA","53":"gene expression in treated HEK-TLR2 cells at 24h","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"At time points of 2, 4, 8, 24 and 48 h post-stimulation, cells were harvested and RNA isolated using the Nucleospin RNAII kit (Machery Nagel) according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM618031","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK-TLR2 cells were routinely maintained in MEM alpha medium (Gibco) supplemented with 10% foetal calf serum (Gibco), 2 mM L-glutamine (Sigma), 100 U/ml penicillin (Sigma), 100 g/ml streptomycin and 500 g/ml G418 (Sigma). The day before treatment, cells were seeded in 6-well plates at 1x106 cells/well.","70":"NA","71":"NA","72":"Following fragmentation, cRNA was hybridized for 16 hr at 45C on Affymetrix U133 plus 2.0 genechips. GeneChips were washed and stained in the Automated fluidics 450 station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 g total RNA (Expression Analysis Technical Manual, 2001, Affymetrix) using the Affymetrix IVT labeling kit.","79":"NA","80":"Jan 13 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips were scanned using the GeneChip 3000 7G scanner","97":"NA","98":"['GSE25148', 'GSE25155']","99":"NA","100":"NA","101":"NA","102":"HEK-TLR2 cells treated with 10 g/ml H. pylori LPS for 24h rep 1","103":"Public on Jan 12 2011","104":"NA","105":"NA","106":"Nov 04 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM618nnn/GSM618031/suppl/GSM618031.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"embryonic kidney","116":"HEK-TLR2 24h+LPS rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"The morning of treatment, the cell culture medium was replaced with either fresh medium (untreated) or medium containing 10 g/ml H. pylori lipopolysaccharide","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874661","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"ActD_4OHT_8","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874661","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 2h and subsequent actinomycin D 8h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874661/suppl/GSM1874661_RG_43_4OHT_ActD_2h_8h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"ActD_4OHT_8","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM675223","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek293 cells","15":"NA","16":"NA","17":"HEK293_control plasmid_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK293 cells","33":"1","34":"NA","35":"NA","36":"NA","37":"Videnska 1083","38":"Prague 4","39":"Czech Republic","40":"NA","41":"NA","42":"NA","43":"Institute of Molecular Genetics","44":"NA","45":"Matyas,,Flemr","46":"NA","47":"NA","48":"NA","49":"14220","50":"All arrays were normalized using the GCRMA algorithm with quantile normalization composed of 100 bins using Genedata's Refiner application. Per chip normalization was performed by scaling the median of the genes called present (detection P-value < 0.04) to a value of 500.","51":"54675","52":"NA","53":"['01-Hek-0ng-1', 'Gene expression data from cultured HEK293 cells 24 hours after transfection with control plasmid']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 or HeLa cells in a confluent 6-well dish 24 hours post-transfection using Absolutely RNA Miniprep Kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM675223","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 and HeLa cells were maintained in Dulbeccos Modified Eagle Medium (DMEM, Invitrogen) supplemented with 10 % FCS (Invitrogen), penicillin (100 U/mL, Invitrogen), and streptomycin (100 g/mL, Invitrogen) at 37 C and 5 % CO2 atmosphere.","70":"NA","71":"NA","72":"Biotinylated cRNA (20 g) was fragmented by heating with magnesium (as per Affymetrix's instructions) and 15 g of fragmented cRNA was hybridized to Human U133 plus 2.0 GeneChips.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA (5 g) from each replicate was reverse transcribed with the Affymetrix cDNA synthesis kit and cRNA was produced by in vitro transcription (IVT) by T7 RNA polymerase using the Affymetrix IVT kit as per manufacturer's instructions.","79":"NA","80":"Oct 11 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Affymetrix procedures","97":"NA","98":"GSE27316","99":"NA","100":"NA","101":"NA","102":"HEK293 cells transfected with control plasmid","103":"Public on Oct 11 2011","104":"NA","105":"NA","106":"Feb 15 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM675nnn/GSM675223/suppl/GSM675223.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293_control plasmid_rep1","117":"NA","118":"NA","119":"control plasmid","120":"NA","121":"NA","122":"HEK293 and HeLa cells grown in a 6-well plate were transfected with 500ng control parental MosIR plasmid expressing EGFP or with 500ng MosIR plasmid expressing EGFP with 3'UTR containing long inverted repeat derived from mouse c-Mos coding sequence.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM432929","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Empty vector replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"401 Terry Avenue North","38":"Seattle","39":"USA","40":"NA","41":"cplaisier@systemsbiology.org","42":"NA","43":"Institute for Systems Biology","44":"Nitin Baliga","45":"Christopher,L,Plaisier","46":"2067322139","47":"Washington","48":"NA","49":"98109","50":"A rigorous quality control pipeline was developed to prepare the gene expression microarray data for analysis. First, the CEL files were imported into R 2.8.0 using the justRMA function of the Affymetrix library from Bioconductor, which applies background subtraction and quantile normalization. An alternate CDF file (U133Plus2msk.cdf.gz) was used to exclude mis-targeted and nonspecific probes from the microarrays (Zhang et al. 2005), and probesets with less than 7 remaining probes were also excluded. Probesets with more than 50% absent calls were excluded, as calculated using the panp package from Bioconductor. Finally, the ComBat library in R was used to correct for batch effect (Johnson et al. 2007).","51":"16569","52":"NA","53":"n/a","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was collected using the RNeasy Plus Mini Kit (Cat No. 74134) 48 hours after transient transfection of HEK293T cells.","61":"NA","62":"NA","63":"NA","64":"GSM432929","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"The cRNA probes were then hybridized using standard Affymetrix protocols described in the GeneChip Expression Analysis Technical Manual (Affymetrix P/N 702232).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Samples were then converted to cRNA probes using standard Affymetrix protocols described in the GeneChip Expression Analysis Technical Manual (Affymetrix P/N 702232).","79":"NA","80":"Sep 12 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The chips were scanned using the GeneArray scanner (Affymetrix) to produce CEL files.","97":"NA","98":"GSE17300","99":"NA","100":"NA","101":"NA","102":"HEK293T cell line","103":"Public on Sep 14 2009","104":"NA","105":"NA","106":"Jul 24 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM432nnn/GSM432929/suppl/GSM432929.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Empty vector replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546592","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hours","17":"wtfsh_2","18":"fsh - hormone treatment - fsh stimulation","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"3nM","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"wtfsh_2:44ug.","61":"NA","62":"wild type","63":"NA","64":"GSM546592","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C; 5% C02","70":"20-10-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"wtfsh_2","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546592/suppl/GSM546592_wtfsh_2.CEL.gz","108":"9606","109":"6 hours","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"wtfsh_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"FSH - hormone treatment - fsh stimulation","122":"Name:FSH - hormone treatment - fsh stimulation,follicle stimulating hormone (fsh):quantity 3nM time 6hour . 3nM","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733360","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071107 CEES exposure 2.5 uM_8h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-23","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-04","53":"Gene expression data from NHEK_071107 CEES exposure 2.5 uM_8h timepoint","54":"NA","55":"NA","56":"NA","57":"2.5","58":"2007-11-07","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733360","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-30","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-08-13","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071107 CEES exposure 2.5 uM_8h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733360/suppl/GSM733360_071107_CEES_8h_2.5_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"8","115":"NA","116":"NHEK_071107 CEES exposure 2.5 uM_8h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM569346","2":"NA","3":"embryonic kidney cell line hek","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"WT in the absence of tetracycline, rep2","18":"NA","19":"untreated","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Embryonic kidney cell line HEK","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1 Oryong-dong Buk-gu","38":"Gwangju","39":"South Korea","40":"Life science","41":"lbc0523@gist.ac.kr","42":"82629702540","43":"Gwangju Institutue Science and Technology","44":"NA","45":"Byoung-Cheol,,Lee","46":"82629702566","47":"NA","48":"NA","49":"500712","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from HEK cells non-expressing WT TRPM7 channel', 'WT no2']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"WT channel","64":"GSM569346","65":"NA","66":"NA","67":"NA","68":"NA","69":"Stabel cell-lines were grown in in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum and an antibiotic, 5 ug/mL blasticidin (Invitrogen). Cells were cultured in a humidified atmosphere of 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Fragmented cRNA was hybridized to the Human Genome UI133 Plus 2.0 Array (Affymetrix) at 45C for 16 h according to the Affymetrix standard protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"5 ug of total RNA from each cell-lines was used for labeling. Probe synthesis from total RNA samples, hybridization, detection, and scanning were performed according to standard protocols from Affymetrix, Inc..","79":"NA","80":"Jul 23 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"After hybridization, the arrays were washed in a GeneChip Fluidics Station 450 with a non-stringent wash buffer at 25C followed by a stringent wash buffer at 50C. After washing, the arrays were stained with a streptavidin-phycoerythrin complex. After staining, intensities were determined with a GeneChip scanner 3000 (Affymetrix), controlled by GCOS Affymetrix software.","97":"NA","98":"GSE23102","99":"NA","100":"NA","101":"NA","102":"HEK cell lines non-expressing WT channel","103":"Public on Jul 23 2011","104":"NA","105":"NA","106":"Jul 23 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM569nnn/GSM569346/suppl/GSM569346.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"WT in the absence of tetracycline, rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 ug of tetracycline was treated to stabel cell-lines which overexressing WT and mutant TRPM7 channel for 72 hours","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560869","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"2 h","17":"NOD2-L1007fsinsC_2h_MDP_biological replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 L1007fsinsC","63":"NA","64":"GSM560869","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560869/suppl/GSM560869.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"2 h","113":"NA","114":"NA","115":"NA","116":"NOD2-L1007fsinsC_2h_MDP_biological replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693949","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"72h","17":"HEK293T_mock-transfection_72h_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_m_1_72', 'MOCK_m_1_0ng_72h_293T.CEL', 'Gene expression data from HEK 293T cells 72h after mock transfection without siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"control","64":"GSM693949","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"mock (without siRNA)","102":"HEK 293T cells, mock transfection, 72h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693949/suppl/GSM693949.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693949/suppl/GSM693949.EXP.gz']","108":"9606","109":"72h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_mock-transfection_72h_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610843","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"1hr","17":"HEK293T_miR-132_FSK1hr_rep2","18":"NA","19":"FSK","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610843","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610843/suppl/GSM610843.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610843/suppl/GSM610843.chp.gz']","108":"9606","109":"1hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-132_FSK1hr_rep2","117":"miR-132","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM675224","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek293 cells","15":"NA","16":"NA","17":"HEK293_control plasmid_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK293 cells","33":"1","34":"NA","35":"NA","36":"NA","37":"Videnska 1083","38":"Prague 4","39":"Czech Republic","40":"NA","41":"NA","42":"NA","43":"Institute of Molecular Genetics","44":"NA","45":"Matyas,,Flemr","46":"NA","47":"NA","48":"NA","49":"14220","50":"All arrays were normalized using the GCRMA algorithm with quantile normalization composed of 100 bins using Genedata's Refiner application. Per chip normalization was performed by scaling the median of the genes called present (detection P-value < 0.04) to a value of 500.","51":"54675","52":"NA","53":"['02-Hek-0ng-2', 'Gene expression data from cultured HEK293 cells 24 hours after transfection with control plasmid']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 or HeLa cells in a confluent 6-well dish 24 hours post-transfection using Absolutely RNA Miniprep Kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM675224","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 and HeLa cells were maintained in Dulbeccos Modified Eagle Medium (DMEM, Invitrogen) supplemented with 10 % FCS (Invitrogen), penicillin (100 U/mL, Invitrogen), and streptomycin (100 g/mL, Invitrogen) at 37 C and 5 % CO2 atmosphere.","70":"NA","71":"NA","72":"Biotinylated cRNA (20 g) was fragmented by heating with magnesium (as per Affymetrix's instructions) and 15 g of fragmented cRNA was hybridized to Human U133 plus 2.0 GeneChips.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA (5 g) from each replicate was reverse transcribed with the Affymetrix cDNA synthesis kit and cRNA was produced by in vitro transcription (IVT) by T7 RNA polymerase using the Affymetrix IVT kit as per manufacturer's instructions.","79":"NA","80":"Oct 11 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Affymetrix procedures","97":"NA","98":"GSE27316","99":"NA","100":"NA","101":"NA","102":"HEK293 cells transfected with control plasmid","103":"Public on Oct 11 2011","104":"NA","105":"NA","106":"Feb 15 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM675nnn/GSM675224/suppl/GSM675224.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293_control plasmid_rep2","117":"NA","118":"NA","119":"control plasmid","120":"NA","121":"NA","122":"HEK293 and HeLa cells grown in a 6-well plate were transfected with 500ng control parental MosIR plasmid expressing EGFP or with 500ng MosIR plasmid expressing EGFP with 3'UTR containing long inverted repeat derived from mouse c-Mos coding sequence.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874647","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"EGF_4h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874647","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER EGF 4h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874647/suppl/GSM1874647_NB_56_EGF_4h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"EGF_4h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM678661","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Control_0_h_Replicate 3","18":"NA","19":"Control","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"3","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 50","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678661","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"1","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"2","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"0","114":"NA","115":"NA","116":"HEK293_Control_0_h_Replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM711412","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"HEK293Tcells_wt_rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"1000 E 50th St","38":"Kansas City","39":"USA","40":"Genomics","41":"seidel@phageT4.org","42":"NA","43":"Stowers Institute","44":"Seidel","45":"Chris,W,Seidel","46":"816 926 9054","47":"MO","48":"NA","49":"64110","50":"Array intensities were processed using the RMA algorithm in R/bioconductor. Bioconductor 2.6 and affy package affy_1.24.2","51":"54675","52":"NA","53":"Gene expression from HEK293T cells after transfection with non-targeting siRNA, replicate 3.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the standard Qiagen RNeasy cleanup protocol.","61":"NA","62":"NA","63":"NA","64":"GSM711412","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in 6 well tissue culture plates or 10 cm dishes for 48 hours after transfection.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 plus 2.0 Arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the Ambion MessageAmp III protocol from 300 ng total RNA (MessageAmp III Amplification kit Manual, 2007, Ambion).","79":"NA","80":"Sep 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 and processed with AGCC v3.0 software.","97":"NA","98":"GSE28715","99":"NA","100":"Dharmacon non-targeting #4","101":"NA","102":"HEK293T cells","103":"Public on Sep 01 2011","104":"NA","105":"NA","106":"Apr 19 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM711nnn/GSM711412/suppl/GSM711412_cont-3_HG-U133_Plus_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293Tcells_wt_rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293T cells in 6 well tissue culture plates (~1x105 cells/well) or 10 cm dishes (~2 x106 cells/dish) were transfected with 25 nM siRNAs targeting human Med26 (Ambion/Applied Biosystems, #4, s18074; #5, s18075; #6, s18076) or 25 nM siCONTROL NON-TARGETING siRNA #2 (Dharmacon D-001210-01) using X-tremeGENE siRNA Transfection Reagent (Roche) and grown for 48 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733507","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080129 SM exposure 50 uM_24h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-11","29":"Phillips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-07","53":"Gene expression data from NHEK_080129 SM exposure 50 uM_24h timepoint","54":"NA","55":"NA","56":"NA","57":"50.0","58":"2008-01-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733507","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-16","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-07-30","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080129 SM exposure 50 uM_24h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733507/suppl/GSM733507_080129_HD_24h_50.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"24","115":"NA","116":"NHEK_080129 SM exposure 50 uM_24h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM517906","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,transfected,biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"GFP_3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM517906","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 22 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE59666","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"['GSE20615', 'GSE59666']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,transfected,biological rep 3_24h","103":"Public on Oct 05 2011","104":"NA","105":"NA","106":"Mar 03 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM517nnn/GSM517906/suppl/GSM517906.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,transfected,biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442106","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,16h,transfected,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"16 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442106","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, transfected","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442106/suppl/GSM1442106_16hGFPP_REP2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,16h,transfected,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1058030","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293  treated  scramble OO-PNA oligo 48hr biological replicate 1","18":"scramble oo-pna oligo","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Department of Mathematics and Computer Science, Faculty of Science, Chulalongkorn University","38":"Bangkok","39":"Thailand","40":"NA","41":"NA","42":"NA","43":"Chulalongkorn University","44":"NA","45":"Chatchawit,,Aporntewan","46":"NA","47":"NA","48":"NA","49":"10330","50":"['The scanned images were inspected for hybridization efficiency and CEL files generated from GCOS (GeneChip Operating Software) were imported into Expression Console (EC) 1.2 software for array QC. The matrix was created by Affymetrix Power Tools (APT) -- Release 1.14.3 on Windows 7. The command was apt-probeset-summarize -a rma -d HuGene-1_0-st-v1.r3.cdf -o out --cel-files cel_list.txt.', 'HuGene-1_0-st-v1.r4.pgf', 'HuGene-1_0-st-v1.r4.mps', 'RMA normalization was performed on the samples to generate the quality control (QC) metrics to determine data quality. These include, perfect match mean (PM_Mean), Background mean (Bgd_Mean), positive and negative probes (POS vs NEG AUC), bacterials spike controls, and polyA controls.']","51":"33252","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"All samples were RNA extracted according to the manufacturers protocol using Trizol (Invitrogen). Total RNA was reverse transcribed processed according to the Affymetrix and NuGEN recommended protocols, to produce cDNA/mRNA hybrid molecule, which was subsequently used as a template to create double stranded cDNA with a unique DNA/RNA heteroduplex on one end.","61":"NA","62":"NA","63":"NA","64":"GSM1058030","65":"NA","66":"NA","67":"adherent and monolayer","68":"NA","69":"HEK 293 cells were grown according to the manufacturers protocol in DMEM (Gibco-BRL) supplemented with 2 mM L-glutamine and 10% heat-inactivated fetal calf serum (FCS), and 10 mg/ml antibiotic antimycotic (Invitrogen) as before and after transfection. Cell harvest was performed at 48 hr post-transfection.","70":"NA","71":"NA","72":"The cDNAs were hybridized using Affymetrix Human Gene 1.0 ST arrays for 18 hours at 45oC with rotation at 60 rpm. Arrays were then washed and stained using the FS450_0007 fluidics protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"DNA/RNA heteroduplex was amplified via SPIA (Single Primer Isothermal Amplification), which produces single stranded anti-sense DNA. Post SPIA Modification generates sense target cDNA that was fragmented, biotin labeled according to Origen Labs Encore Biotin Module.","79":"NA","80":"Sep 03 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix Gene ChIP Scanner 3000 7G","97":"NA","98":"GSE43185","99":"NA","100":"NA","101":"NA","102":"Human Embryonic Kidney 293 cells, treated  scramble OO-PNA oligo, 48hr","103":"Public on Sep 03 2013","104":"NA","105":"NA","106":"Dec 28 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1058nnn/GSM1058030/suppl/GSM1058030_AFGE1224-4_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293  treated  scramble OO-PNA oligo 48hr biological replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"scramble OO-PNA oligo","122":"HEK293 cells were transfected with  50 nM of OO-A(15) and scramble OO-PNA oligo (OO-acgttcgcgcaacga).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM926185","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina humanRef-8 v1.0 expression beadchip (Illumina_HumanRef-8_v1.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK-293 control miR-107 Experimental Replicate 2 1895213040_F","18":"mir-107","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ring Road","38":"Callaghan","39":"Australia","40":"NA","41":"NA","42":"NA","43":"University of Newcastle","44":"NA","45":"Adam,,Carroll","46":"NA","47":"NSW","48":"NA","49":"2308","50":"Illumina Beadstudio software computed average signal intensities and detection p-values.","51":"22184","52":"NA","53":"Experimental Replicate 2","54":"illuminaHumanv2","55":"44.83337","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted with Trizol reagent, followed by clean-up with DNase I treatment and the RNeasy MinElute cleanup kit (Qiagen) in accordance with manufacturer's instructions. Quality control was performed with an Experion (BioRad) bioanalyser.","61":"NA","62":"NA","63":"NA","64":"GSM926185","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cell models were grown as confluent monolayers in standard tissue culture conditions.","70":"NA","71":"NA","72":"Standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA was prepared using the TotalPrep RNA amplification kit (Ambion) for Illumina arrays.","79":"NA","80":"Nov 01 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6104","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol.","97":"NA","98":"GSE37729","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Nov 01 2012","104":"NA","105":"NA","106":"May 02 2012","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK-293 control miR-107 Experimental Replicate 2 1895213040_F","117":"NA","118":"NA","119":"NA","120":"NA","121":"miR-107","122":"Cells were transfected with either synthetic miRNA or anti-miR inhibitor oligonucleotides. Control refers to untransfected cell models; siEGFP control refers to transfection with an siRNA to EGFP as a transfection control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1305858","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"EA07047_56012_H133+_3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"5635 Fishers Lane, Suite 510","38":"Rockville","39":"USA","40":"NA","41":"raducojo@gmail.com","42":"NA","43":"Elsevier","44":"NA","45":"Radu,,Cojocaru","46":"NA","47":"MD","48":"NA","49":"20852","50":"Data was analyzed using GeneSpring software including QC analysis.","51":"41751","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted from control and myocilin expressing cells after induction with selected concentrations of doxycycline using a Trizol reagent. The extracted RNA was used for each microarray study.","61":"NA","62":"NA","63":"NA","64":"GSM1305858","65":"NA","66":"NA","67":"NA","68":"NA","69":"Tet-on stably transfected cells were maintained in Dulbecco modified Eagle medium (DMEM) supplemented with 10% Tet system proved fetal bovine serum, penicillin (100 U/ml), streptomycin (100 g/ml), hygromycin B (200 g/ml) and G418 (100 g/ml) at 37 C in a humidified atmosphere of 5% CO2.","70":"NA","71":"NA","72":"Not provided.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Not provided.","79":"NA","80":"May 21 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Not provided.","97":"NA","98":"GSE53985","99":"NA","100":"NA","101":"NA","102":"Stable Cell line transfected with control vector","103":"Public on May 21 2014","104":"NA","105":"NA","106":"Jan 13 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1305nnn/GSM1305858/suppl/GSM1305858_EA07047_56012_H133+_3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"EA07047_56012_H133+_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Tet-on stably transfected cells were treated with 0.2 or 1 g/ ml of doxycycline for 48 hr to induce myocilin expression.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881017","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 1","17":"Producer culture - fermentation 3- time point 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"2","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 15","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"recombinant protein producer","64":"GSM881017","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Producer culture - fermentation 3- time point 1","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 1","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Producer culture - fermentation 3- time point 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1049719","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek cell clones","15":"NA","16":"NA","17":"Re-cultured GRK2-K220R-expressing HEK cell clone after NOD.Scid mouse expansion-rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK cell clones","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"['Ex-Scid-K220R-2', 'Re-cultured GRK2-K220R-expressing HEK cell clone after expansion in NOD.Scid mice', 'Gene expression data of re-cultured NOD.Scid-mouse-expanded GRK2-K220R-expressing HEK cell clone']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from HEK cell clones with the RNeasy Mini kit according to the manufacturer`s instructions (Qiagen).","61":"NA","62":"NA","63":"GRK2-K220R","64":"GSM1049719","65":"NA","66":"NA","67":"NA","68":"NA","69":"The study was performed with HEK cell clones stably expressing GRK2 or the kinase-deficient GRK2-K220R mutant. HEK cell clones were either expanded for 4 weeks in vivo in immunodeficient NOD.Scid mice (3 months of age), cultured in vitro, or re-cultured in vitro after expansion in NOD.Scid mice","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Affymetrix Human genome U133 Plus 2.0 Array) in 200 l of the hybrization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual).","79":"NA","80":"Dec 06 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"re-cultured in vitro after expansion in NOD.Scid mice","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE42771","99":"NA","100":"NA","101":"NA","102":"Re-cultured GRK2-K220R-expressing HEK cell clone after NOD.Scid mouse expansion","103":"Public on Dec 06 2012","104":"NA","105":"NA","106":"Dec 06 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049719/suppl/GSM1049719_Ex-Scid-K220R-2.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049719/suppl/GSM1049719_Ex-Scid-K220R-2.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Re-cultured GRK2-K220R-expressing HEK cell clone after NOD.Scid mouse expansion-rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For the microarray study, cell pellets were isolated from three study groups: (i) NOD.Scid mouse-expanded HEK clones expressing either GRK2 or kinase-deficient GRK2-K220R (Scid), (ii) in vitro cultured HEK cell clones expressing GRK2 or GRK2-K220R (HEK), and (iii) in vitro re-cultured HEK cell clones after NOD.Scid mouse expansion (Ex-Scid).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM527383","2":"NA","3":"hek-293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"kidney","15":"NA","16":"NA","17":"kidney_R06173_HG-U133_Plus_2_HSF1","18":"NA","19":"NA","20":"17.0","21":"NA","22":"HG-U133_Plus_2","23":"CRL-11268","24":"NA","25":"excellent","26":"R. Thomas, The Hamner Institutes for Health Sciences, 6 Davis Dr, RTP, NC, 27709, R. Thomas, rthomas@thehamner.org, 919 558 1311, 919 558 1300","27":"NA","28":"NA","29":"NA","30":"HEK-293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"6 Davis Drive","38":"Research Triangle Park","39":"USA","40":"NA","41":"rthomas@thehamner.org","42":"919-558-1300","43":"The Hamner Institutes for Health Sciences","44":"NA","45":"Russell,Scott,Thomas","46":"919-558-1311","47":"NC","48":"NA","49":"27709","50":"Affymetrix GCOS 1.0","51":"54675","52":"NA","53":"R06173_HG-U133_Plus_2_HSF1 regulation: Assay human embryonic kidney cells (HEK293T) for expression of cDNAs before designing siRNAs","54":"NA","55":"NA","56":"1/10","57":"NA","58":"NA","59":"NA","60":"Extraction Method: RNeasy","61":"temperature sensitive gene for SV40 T-antigen was inserted","62":"NA","63":"NA","64":"GSM527383","65":"NA","66":"NA","67":"NA","68":"NA","69":"Growth Media: DMEM, Amount of Media: 3, Units of Media: ml, Growth Conditions: DMEM, 10%FBS(HI), Pen/Strep/GlutaMax","70":"NA","71":"24","72":"standard Affymetrix procedures","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"standard Affymetrix protocol","79":"NA","80":"Mar 30 2010","81":"NA","82":"total RNA","83":"1 Mio/6 well dish","84":"Homo sapiens","85":"GPL570","86":"NA","87":"1.84","88":"NA","89":"NA","90":"NA","91":"NA","92":"9.5","93":"N/A","94":"NA","95":"NA","96":"standard Affymetrix procedures","97":"Scrape in Lysis buffer","98":"GSE21092","99":"NA","100":"NA","101":"NA","102":"total RNA from human embryonic kidney TC cells","103":"Public on Mar 31 2010","104":"NA","105":"NA","106":"Mar 26 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM527nnn/GSM527383/suppl/GSM527383.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM527nnn/GSM527383/suppl/GSM527383.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"kidney","116":"kidney_R06173_HG-U133_Plus_2_HSF1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"ug","125":"h past seeding","126":"NA"},{"1":"GSM733242","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070926 NM exposure 100 uM_1h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-01","29":"Phillips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-28","53":"Gene expression data from NHEK_070926 NM exposure 100 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"100.0","58":"2007-09-26","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733242","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-24","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-08-07","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070926 NM exposure 100 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733242/suppl/GSM733242_070926_NM_1h_100.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_070926 NM exposure 100 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1269599","2":"NA","3":"hek 293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"293 transfected with PCMV replicate #1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"513 Parnassus Avenue, HSW Room  1102, Box 0540","38":"San Francisco","39":"USA","40":"Diabetes Center","41":"manderson@diabetes.ucsf.edu","42":"NA","43":"UCSF","44":"Anderson Lab","45":"Mark,Stuart,Anderson","46":"NA","47":"CA","48":"NA","49":"94143","50":"AGCC 3.2.2 Microarrays were normalized for array-specific effects using Affymetrix's Robust Multi-Array (RMA) normalization","51":"28829","52":"NA","53":"293 cells transfected with vector only biologic replicate #1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Qiagen RNAeasy mini kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1269599","65":"NA","66":"NA","67":"NA","68":"NA","69":"Transfected HEK 293 cells were grown for 72hrs in complete DMEM prior to RNA extraction.","70":"NA","71":"NA","72":"See manufacturer protocol","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"NuGEN Ovation Pico WTA V2 and NuGEN Encore Biotin Module","79":"NA","80":"Nov 21 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCS3000","97":"NA","98":"['GSE52546', 'GSE52548']","99":"NA","100":"NA","101":"NA","102":"293 transfected with PCMV","103":"Public on Nov 21 2013","104":"NA","105":"NA","106":"Nov 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1269nnn/GSM1269599/suppl/GSM1269599_01.PCMV-1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"293 transfected with PCMV replicate #1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK 293 cells were transfected using Mirus 293 transfection reagent following manufacturers protocol.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM373101","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"transformed hek cells","15":"NA","16":"NA","17":"Hek-HT Ras^G12V,T35S Replicate-3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"transformed Hek cells","33":"1","34":"NA","35":"NA","36":"NA","37":"6431 Fannin St","38":"Houston","39":"USA","40":"NA","41":"jeffrey.t.chang@uth.tmc.edu","42":"NA","43":"UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON","44":"NA","45":"Jeffrey,,Chang","46":"NA","47":"TX","48":"NA","49":"77030","50":"MAS5.0","51":"22277","52":"NA","53":"1462_2979_14861_35S-3_HG-U133A+2.CEL","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"We extracted total RNA using Qiagen Rneasy mini kits.","61":"NA","62":"NA","63":"NA","64":"GSM373101","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"The cRNA is fragmented before hybridization and a hybridization cocktail is prepared that contains the fragmented cRNA, probe array controls, BSA and herring sperm DNA.  The cRNA is hybridized to the oligonucleotide probes on the array for 16 hours at 45C.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"We performed an in vitro transcription reaction to produce a biotin-labeled cRNA from the cDNA.","79":"NA","80":"Feb 20 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Immediately following hybridization, the hybridized probe arrays undergo an automated washing and staining protocol on the fluidic station and are then scanned on the GeneChip Scanner 3000 7G.","97":"NA","98":"GSE14934","99":"NA","100":"NA","101":"NA","102":"35S-3","103":"Public on Feb 21 2009","104":"NA","105":"NA","106":"Feb 20 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM373nnn/GSM373101/suppl/GSM373101.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Hek-HT Ras^G12V,T35S Replicate-3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820017","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24 hrs","17":"HEK293T CTRLpcDNA 24hr 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"overexpression control","64":"GSM1820017","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, overexpression control, 24 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820017/suppl/GSM1820017_Zane_24hr_pcDNA_1_B10_102011.CEL.gz","108":"9606","109":"24 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T CTRLpcDNA 24hr 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874652","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"IGF_2h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874652","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER IGF 2h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874652/suppl/GSM1874652_NB_61_IGF_2h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"IGF_2h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1171537","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"R749H-amr RD38a","18":"r749h-amr","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"2 Hertzl st.","38":"Rehovot","39":"Israel","40":"NA","41":"rivka.dikstein@weizmann.ac.il","42":"NA","43":"The Weizmann Institute of Science","44":"NA","45":"Rivka,,Dikstein","46":"NA","47":"NA","48":"NA","49":"76100","50":"RMA was carried out using Partek Genomic Suite 6.5 (Inc. St. Charles, MO; www.partek.com)","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Tri-reagent (MRC inc.) according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1171537","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T were maintained in Dulbeccos modified Eagles medium (DMEM) supplemented with 10 % fetal calf serum.","70":"NA","71":"NA","72":"cDNA in 80 ul were hybridized to a Human Gene 1.0 ST array using Affymetrix hybridization kit materials and hybridized for 17 hours at 45 at 60rpm. Post-hyb washes were done with Affymetrix wash solutions on the FS450 station using FS450_0007 protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"200ng TotalRNA were used. cDNA samples were generated and labeled using Affymetrix WT-cDNA synthesis and labeling kit","79":"NA","80":"Jul 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned on the Affymetrix GeneChip Scanner 3000 7G","97":"NA","98":"GSE48163","99":"NA","100":"NA","101":"NA","102":"3 slow","103":"Public on Jul 01 2013","104":"NA","105":"NA","106":"Jun 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1171nnn/GSM1171537/suppl/GSM1171537_RD38a_HuST.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"R749H-amr RD38a","117":"NA","118":"NA","119":"NA","120":"NA","121":"R749H-amr","122":"Cells were transfected with plasmids directing the expression of -amanitin-resistant variants of Pol II (Rpb1-amr and R749H-amr). -amanitin was added and RNA was prepared 24 and 48 h later, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM205756","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 cell line #4 with induced HNF4a2 wild type","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 1000.","51":"54675","52":"NA","53":"Analysis of gene expression in human embryonic kidney cells (HEK293) overexpressing the transcription factor HNF4a2 or mutant forms HNF4a2 C106R or R154X, which were introduced by FRT/FLP recombination. The analysis were performed 24 hours following 1 g/ml doxycyclin treatment to induce the expression of the trans-genes. Results identify HNF4 regulated genes in kidney cells being several of these genes deregulated in renal cell carcinoma.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Rneasy mini extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM205756","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133_Plus_2.0 arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual v2, Affymetrix).","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000.","97":"NA","98":"GSE8289","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line #4 with induced HNF4a2 wild type","103":"Public on Jun 20 2008","104":"NA","105":"NA","106":"Jun 26 2007","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205756/suppl/GSM205756.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205756/suppl/GSM205756.CHP.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205756/suppl/GSM205756.EXP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cell line #4 with induced HNF4a2 wild type","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were treated for 24 h with 1 g/ml doxycyclin or solvent.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1645157","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"1_GFPsiRNA","18":"simultaneous knockdown of tet1, tet2 and tet3","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Hufelandstrasse 55","38":"Essen","39":"Germany","40":"Universitaetsklinikum Essen","41":"bernhard.horsthemke@uni-due.de","42":"NA","43":"Institut fuer Humangenetik","44":"NA","45":"Bernhard,,Horsthemke","46":"NA","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with MAS5 using Affymetrix default analysis settings and global scaling to a target intensity of 1000 as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from GFP#1 clone, 96 h after simultaneous siRNA-mediated knockdown of TET1, TET2, TET3', 'total RNA (>200 nt)']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using the AllPrep DNA/RNA/Protein Mini kit (Qiagen) and treated with the RNase-Free DNase Set (Qiagen)","61":"NA","62":"NA","63":"NA","64":"GSM1645157","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were cultured in DMEM supplemented with 10% FCS, 1% Pen/Strep and appropriate concentrations of selective antibiotics.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133Plus_2. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix Hybridization, Wash and Stain Kit..","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA were prepared according to the Affymetrix ExpressKit protocol starting from 200 ng total RNA.","79":"NA","80":"Jul 17 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned in a GeneArray Scanner (Agilent).","97":"NA","98":"['GSE67348', 'GSE67351']","99":"NA","100":"NA","101":"NA","102":"Flp-In T-REx 293","103":"Public on Jul 16 2015","104":"NA","105":"NA","106":"Mar 27 2015","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1645nnn/GSM1645157/suppl/GSM1645157_1_GFPsiRNA.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1645nnn/GSM1645157/suppl/GSM1645157_1_GFPsiRNA.mas5.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"1_GFPsiRNA","117":"NA","118":"NA","119":"NA","120":"GFP","121":"simultaneous knockdown of TET1, TET2 and TET3","122":"Cells were treated either with siRNA against TET1, TET2 and TET3 or a non-targeting pool. All cells carried an inducible, stable GFP transgene whose expression was not induced.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM711415","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"HEK293Tcells_si74_rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"1000 E 50th St","38":"Kansas City","39":"USA","40":"Genomics","41":"seidel@phageT4.org","42":"NA","43":"Stowers Institute","44":"Seidel","45":"Chris,W,Seidel","46":"816 926 9054","47":"MO","48":"NA","49":"64110","50":"Array intensities were processed using the RMA algorithm in R/bioconductor. Bioconductor 2.6 and affy package affy_1.24.2","51":"54675","52":"NA","53":"Gene expression from HEK293T cells after transfection with siRNA s18074 targeting Med26, replicate 3.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the standard Qiagen RNeasy cleanup protocol.","61":"NA","62":"NA","63":"NA","64":"GSM711415","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in 6 well tissue culture plates or 10 cm dishes for 48 hours after transfection.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 plus 2.0 Arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the Ambion MessageAmp III protocol from 300 ng total RNA (MessageAmp III Amplification kit Manual, 2007, Ambion).","79":"NA","80":"Sep 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 and processed with AGCC v3.0 software.","97":"NA","98":"GSE28715","99":"NA","100":"Med26 targeting s18074","101":"NA","102":"HEK293T cells","103":"Public on Sep 01 2011","104":"NA","105":"NA","106":"Apr 19 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM711nnn/GSM711415/suppl/GSM711415_si-74-3_HG-U133_Plus_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293Tcells_si74_rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293T cells in 6 well tissue culture plates (~1x105 cells/well) or 10 cm dishes (~2 x106 cells/dish) were transfected with 25 nM siRNAs targeting human Med26 (Ambion/Applied Biosystems, #4, s18074; #5, s18075; #6, s18076) or 25 nM siCONTROL NON-TARGETING siRNA #2 (Dharmacon D-001210-01) using X-tremeGENE siRNA Transfection Reagent (Roche) and grown for 48 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1087806","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"LIN28B_knockdown_rep2 [Affymetrix]","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1230 York Ave Box 186","38":"New York","39":"USA","40":"NA","41":"miguel.a.brown@gmail.com","42":"NA","43":"The Rockefeller University","44":"NA","45":"Miguel,,Brown","46":"NA","47":"New York","48":"NA","49":"10065","50":"We imported the CEL files into the R software (http://www.R-project.org) using the BioConductor affy package (Gentleman et al., 2004). The transcript probe set intensities were background-corrected, adjusted for non-specific binding and quantile normalized with the GCRMA algorithm (Wu, 2006). Probe sets with more than 6 of the 11 probes mapping ambiguously to the genome were discarded, as were probe sets that mapped to multiple genes. We then collected all probe sets matching a given gene, and we selected for further analysis the RefSeq transcript with median 3'UTR length corresponding to that gene. In total 16,063 transcripts were identified. The log-intensity of probe sets mapping to the gene were then averaged to obtain the expression level per RefSeq transcript. The changes of transcript abundances were computed as the logarithm of the ratio of transcript expression in the cocktails of siRNA treated samples and mock-transfected cells. Detailed analysis procedure can be found in the Supplement to Hafner et al. Cell, 2010,141(1),129-141 Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP","51":"13008","52":"NA","53":"Gene expression data from HEK293 cells inducibly expressing FLAG/HA tagged LIN28B after knockdown with siRNA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1087806","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 T-REx Flp-In cells (Invitrogen) were grown in D-MEM high glucose with 10% (v/v) fetal bovine serum, 1% (v/v) 2 mM L-glutamine, 1% (v/v) 10,000 U/ml penicillin/10,000 g/ml streptomycin, 100 g/ml zeocin and 15 g/ml blasticidin. Cell lines stably expressing FLAG/HA-tagged proteins were generated by co-transfection of pFRT/TO/FLAG/HA or pFRT/FLAG/HA constructs with pOG44 (Invitrogen). Cells were selected by exchanging zeocin with 100 g/ml hygromycin. Expression of FLAG/HA-LIN28B was induced by addition of 250 ng/ml doxycycline 15 to 20 h before crosslinking.  Detailed experimental procedure can be found in the Methods section of Hafner et al., RNA, in press, Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition","70":"NA","71":"NA","72":"3 g cRNA hybridized to HGU133 Plus 2.0 Arrays for 16 h at 45C","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"2 g of purified total RNA was used in the One-Cycle Eukaryotic Target Labeling Assay (Affymetrix) according to manufacturer's protocol. Biotinylated cRNA targets were cleaned up, fragmented, and hybridized to Human Genome U133 Plus 2.0 Array (Affymetrix).","79":"NA","80":"Feb 26 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips scanned on Affymetrix Genechip 300 7G scanner","97":"NA","98":"['GSE44613', 'GSE44616']","99":"NA","100":"NA","101":"NA","102":"HEK 293 cells inducibly expressing FLAG/HA tagged LIN28B; transgene not induced; siRNA transfected; replicate 2","103":"Public on Feb 26 2013","104":"NA","105":"NA","106":"Feb 25 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1087nnn/GSM1087806/suppl/GSM1087806_LIN28B_knockdown_rep2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"LIN28B_knockdown_rep2 [Affymetrix]","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"siRNA transfections of HEK293 T-REx Flp-In cells were performed in 6-well format using Lipofectamine RNAiMAX (Invitrogen) as described by the manufacturer. Detailed experimental procedure can be found in the Methods section of Hafner et al., RNA, in press Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733288","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071003 SM exposure 800 uM_1h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-02-27","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-17","53":"Gene expression data from NHEK_071003 SM exposure 800 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"800.0","58":"2007-10-03","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733288","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-21","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-23","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071003 SM exposure 800 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733288/suppl/GSM733288_071003_HD_1h_800.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_071003 SM exposure 800 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM402154","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"L188Q mutant LQ_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"3333 Burnet Ave","38":"Cincinnati","39":"USA","40":"NA","41":"yan.xu@cchmc.org","42":"NA","43":"Cincinnati Children's Hospital Medical Center","44":"NA","45":"Yan,,Xu","46":"513-6368921","47":"OH","48":"NA","49":"45229","50":"MAS5 normalization, ANOVA","51":"54675","52":"NA","53":"transitently transfected with L 188Q mutant of surfactant protein C","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"accroding to manufacture's protocol (Affymetrix)","61":"NA","62":"NA","63":"NA","64":"GSM402154","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"accroding to manufacture's protocol (Affymetrix)","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"accroding to manufacture's protocol (Affymetrix)","79":"NA","80":"May 13 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"accroding to manufacture's protocol (Affymetrix)","97":"NA","98":"GSE16054","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line","103":"Public on May 14 2009","104":"NA","105":"NA","106":"May 11 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM402nnn/GSM402154/suppl/GSM402154.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"L188Q mutant LQ_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM925903","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 Flp-In TRIM71 rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Maulbeerstrasse 66","38":"Basel","39":"Switzerland","40":"Functional Genomics","41":"tim.roloff@fmi.ch","42":"NA","43":"FMI","44":"NA","45":"Tim,,Roloff","46":"NA","47":"NA","48":"NA","49":"4058","50":"Arrays were normalized and probeset-level log2 expression values were calculated using the rma function from the R/Bioconductor (v2.14) package affy.","51":"32321","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and further cleaned up using RNeasy Columns.","61":"NA","62":"NA","63":"FHA-TRIM71 overexpression","64":"GSM925903","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were grown in DMEM supplemented with 2 mM glutamine and 10% FCS. 50 ug/ml hygromycin B was added to the culture medium for the maintance of FHA-TRIM71 expressing cell lines.","70":"NA","71":"NA","72":"Affymetrix Gene Chip Arrays were hybridized following the GeneChip Whole Transcript (WT) Sense Target Labeling Assay Manual (Affymetrix) with a hybridization time of 16h. The Affymetrix Fluidiscs protocol FS450_0007 was used for washing.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"100ng of extracted total RNA was amplified using the Ambion WT Expression kit (Ambion) and the resulting sense-strand cDNA was fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling kit (Affymetrix).","79":"NA","80":"Jan 23 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed with Affzmetrix GCC Scan Control v. 3.0.0.1214 on a GeneChip Scanner 3000 with autoloader.","97":"NA","98":"['GSE37713', 'GSE37714']","99":"NA","100":"NA","101":"NA","102":"FHA-TRIM71 HEK293","103":"Public on Jan 22 2013","104":"NA","105":"NA","106":"May 02 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM925nnn/GSM925903/suppl/GSM925903_wf20110324hg10_04_FHA-TR71I_503_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 Flp-In TRIM71 rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2129127","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"shCTL_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293t","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Chungang Univ., Heukseok-dong, Dongjak-gu, Seoul, Republic of Korea","38":"Seoul","39":"South Korea","40":"Department of Life Science","41":"NA","42":"NA","43":"Chung-Ang university","44":"Functional Genomics Laboratory","45":"Oh-Seok,,Jeong","46":"NA","47":"N/A","48":"NA","49":"ASI|KR|KS013|SEOUL","50":"Array data export processing and analysis was performed using Illumina GenomeStudio v2011.1 (Gene Expression Module v1.9.0)","51":"47321","52":"NA","53":"['3999350127_D_Grn', 'SAMPLE 4']","54":"illuminaHumanv4","55":"98.36614","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from shCTL, shlinc00598#2, and shlinc00598#3 cells using RNAiso Plus (TaKaRa).","61":"NA","62":"NA","63":"control","64":"GSM2129127","65":"NA","66":"NA","67":"NA","68":"NA","69":"linc00598 knockdown stable and control shRNA HEK293t cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% heat-inactivated fetal bovine serum and 0.05% penicillin-streptomycin at 37 C in a 5% CO2 atmosphere.","70":"NA","71":"NA","72":"Following fragmentation, 0.75 ug of cRNA were hybridized to the Illumina Expression Beadchip according to the protocols provided by the manufacturer","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared from 0.55 ug total RNA using the Illumina TotalPrep RNA Amplification Kit (Ambion, Austin,TX)","79":"NA","80":"Apr 22 2016","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using the Illumina Bead Array Reader Confocal Scanner","97":"NA","98":"GSE80514","99":"shCTL","100":"NA","101":"NA","102":"HEK293t, shCTL","103":"Public on Apr 22 2016","104":"NA","105":"NA","106":"Apr 21 2016","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"shCTL_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2089914","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U219 Array (hgu219)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T_untreated","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Bartholins All 6","38":"Aarhus","39":"Denmark","40":"Biomedicine","41":"tue@biomed.au.dk","42":"NA","43":"Aarhus University","44":"Prof Anders Borglum's lab","45":"Tue,,Fryland","46":"NA","47":"Aarhus","48":"NA","49":"8000","50":"rma","51":"49386","52":"NA","53":"Untreated cells","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Qiagen Rneasy + Qiagen shredder columns (performed according to the supplied protocol)","61":"NA","62":"NA","63":"NA","64":"GSM2089914","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells (controls and stable BRD1-S-V5 and BRD1-L-V5 cell lines) were grown in DMEM medium (Invitrogen, San Diego, CA, USA) supplemented with 5% fetal calf serum (FCS), 175 mg/L glutamine, 36 mg/L penicillin and 60 mg/L streptomycine at 37 oC in 5% CO2","70":"NA","71":"NA","72":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","79":"NA","80":"Mar 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL13667","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"standard Affymetrix protocol","97":"NA","98":"GSE79255","99":"NA","100":"NA","101":"NA","102":"Cell line culture, Untreated","103":"Public on Mar 16 2016","104":"NA","105":"NA","106":"Mar 15 2016","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2089nnn/GSM2089914/suppl/GSM2089914_A897-09.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_untreated","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693937","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24h","17":"HEK293T_mock-transfection_24h_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_m_2_24', 'MOCK_m_2_0ng_24h_293T.CEL', 'Gene expression data from HEK 293T cells 24h after mock transfection without siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"control","64":"GSM693937","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"mock (without siRNA)","102":"HEK 293T cells, mock transfection, 24h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693937/suppl/GSM693937.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693937/suppl/GSM693937.EXP.gz']","108":"9606","109":"24h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_mock-transfection_24h_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236702","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"RHOXF1 24h_3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_7']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236702","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, RHOXF1 transfected, 24h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236702/suppl/GSM2236702_Human_Gene_1_0_ST_20150205_7.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236702/suppl/GSM2236702_Human_Gene_1_0_ST_20150205_7.chp.gz']","108":"9606","109":"NA","110":"24h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"RHOXF1 24h_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"RHOXF1 expression vector"},{"1":"GSM1254229","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK-BAHD1.R2","18":"over-expressing the bahd1 gene","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"data were normalized with RMA, analysed with LPE with three FDR methods; the zreal value is indicated in the matrix","51":"28869","52":"NA","53":"Gene expression data","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the RNeasy Mini Kit (Qiagen), from three biological replicates, according to was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1254229","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown at 37C, in a humidified 10% CO2 incubator, in Dulbecco's modified Eagle's medium with GlutaMAX (Gibco) supplied with 10%FBS (Gibco) and 200 ug/ml Hygromycin B (10687-010-Invitrogen).","70":"NA","71":"NA","72":"Labeled cDNA was hybridized wiht GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) as described by the manufacturer.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RNA was amplified with GeneChip WT cDNA Synthesis and Amplification Kit (Affymetrix) and biotin labeld with GeneChip WT Terminal Labeling Kit (Affymetrix) according to the manufacturer's","79":"NA","80":"Jan 20 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Microarrays was scanned with the Affymetrix GeneChip Scanner 7G and the FS450_0007 protocol , as recommended in the GeneChip Hybridization, Wash, and Stain Kit (Affymetrix)","97":"NA","98":"['GSE51863', 'GSE51868']","99":"NA","100":"NA","101":"NA","102":"HEK-BAHD1 cells","103":"Public on Dec 11 2015","104":"NA","105":"NA","106":"Oct 29 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1254nnn/GSM1254229/suppl/GSM1254229_HEK-BAHD1.R2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK-BAHD1.R2","117":"NA","118":"NA","119":"NA","120":"NA","121":"over-expressing the BAHD1 gene","122":"HEK-BAHD1 were generated by integration of a single copy of the BAHD1 cDNA under the control of the human cytomegalovirus (CMV) immediate-early enhancer/promoter in the HEK293 genome. In the isogenic control line (HEK293-CT), the -galactosidase DNA sequence was inserted in place of BAHD1, albeit out-of-frame to avoid translation into protein.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733276","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070926 NM exposure 12.5 uM_24h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-08","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-05","53":"Gene expression data from NHEK_070926 NM exposure 12.5 uM_24h timepoint","54":"NA","55":"NA","56":"NA","57":"12.5","58":"2007-09-26","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733276","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-24","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-08-07","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070926 NM exposure 12.5 uM_24h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733276/suppl/GSM733276_070926_NM_24h_12.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"24","115":"NA","116":"NHEK_070926 NM exposure 12.5 uM_24h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861627","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Mutant, leptin-stimulated, biological replicate 2","18":"100ng leptin","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"PO Box 800741","38":"Charlottesville","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Virginia","44":"NA","45":"Stephen,,Turner","46":"NA","47":"VA","48":"NA","49":"22908","50":"Data extraction, QC, and GCRMA normalization were performed with BioConductor software.  Differential expression was assessed with moderated ANOVA, using the BioConductor limma package; false discovery rate (FDR) estimates were calculated using the Benjamini-Hochberg method.","51":"54675","52":"NA","53":"Mutant, leptin-stimulated, biological replicate 2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was prepared using RNeasy Mini kit (QIAGEN) and its quality was verified in an Agilent Bioanalyzer.","61":"NA","62":"NA","63":"NA","64":"GSM861627","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T/17 cells were maintained in a humidified incubator at 37 C with 5% CO2. HEK293T/17 cells were cultured in DMEM/F12 (Gibco) with non-essential amino acids, sodium pyruvate and 10% heat inactivated FBS.  Jurkat T-cells were cultured in RPMI supplemented with 10% heat inactivated FBS.  Caco-2 cells were cultured in EMEM (Gibco) supplemented with non-essential amino acids, sodium pyruvate and 20% heat inactivated FBS.  Cells were discarded after passage 25 and new cultures were started from frozen stocks. HEK293T117 cells were transiently transfected using lipofectamine 2000 per the product instructions (Invitrogen, Carlsbad, CA). The plasmids mLEPRb/pCDNA3 (47), mLEPRbR223/pCDNA3 (35) and LEPRbDelta65/pCDNA3 (47) were obtained from Martin Myers and have been described previously as referenced. pCDNA3 was used as a vector control. The plasmid mLEPRb/pCDNA3 was used as a template for site-directed mutagenesis to construct mLEPRb985L/pCDNA3, LEPRb1077L/pCDNA3 and mLEPRb1138L/pCDNA3.  Site-directed mutagenesis was done using the quikchange kit (Stragene/Agilent, Santa Clara, CA).    The presence of the desired mutations and the absence of other mutations were confirmed by DNA sequencing.","70":"NA","71":"NA","72":"Three biological replicates of each sample were hybridized to Human Genome U133 Plus 2.0 gene chips (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA was amplified and converted to cDNA using the 3' IVT Express Kit (Affymetrix).","79":"NA","80":"Jan 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned using the GeneChip Scanner 3000 7G (AffyMetrix).","97":"NA","98":"GSE35068","99":"NA","100":"NA","101":"NA","102":"Mutant, leptin-stimulated","103":"Public on Jan 01 2015","104":"NA","105":"NA","106":"Jan 12 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861627/suppl/GSM861627_MUT-2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Mutant, leptin-stimulated, biological replicate 2","117":"NA","118":"NA","119":"Y1138L (STAT3-mutant) leptin receptor","120":"NA","121":"100ng leptin","122":"HEK293 cells were transfected with WT LepR or Y1138L (STAT3-mutant) leptin receptor.  48 hours post-transfection cells were made quiescent by incubation in optimum plus 0.5% BSA for 3 hours.  Cells were then stimulated with 100ng of leptin or maintained in optimum plus 0.5% BSA for an additional 3 hours. Leptin was purchased from Dr. A.F. Parlow, National Hormone and Peptide Program (Torrance, CA). The STAT3 inhibitor, Stattic, the PI3K inhibitor, LY294002 and the MEK inhibitor PD98059 were purchased from EMD chemicals (Gibbstown, NJ).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820006","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hrs","17":"HEK293T CTRLpcDNA 6hr 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"overexpression control","64":"GSM1820006","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, overexpression control, 6 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820006/suppl/GSM1820006_Zane_6hr_pcDNA_2_B5_102011.CEL.gz","108":"9606","109":"6 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T CTRLpcDNA 6hr 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1221012","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HSP70K71E HEK293 sample3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"37 convent drive, Bldg 37,  Rm 1042","38":"Bethesda","39":"USA","40":"NA","41":"byunjs@mail.nih.gov","42":"NA","43":"NCI/NIH","44":"Genetics Branch","45":"Jung,S,Byun","46":"3014352890","47":"MD","48":"NA","49":"20892","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"H3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was harvested (RNAeasy kit(Qiagen)/ standard protocol as manufacture recommended) and measured the concentration for mRNA analysis","61":"NA","62":"NA","63":"expressing  HSP70K71E","64":"GSM1221012","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells and the cells expressing  HSP70K71E were proliferated with RPMI1640, 10% FBS, 25 mM HEPES, 1X PS","70":"NA","71":"NA","72":"Following fragmentation, 20 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human U133 plus 2 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Ambion MessageAmp II Biotin-enhanced protocol from 1 ug total RNA (Message Amp II Biotin-Enhanced Technical Manual, 2006, Ambion).","79":"NA","80":"Sep 24 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix 3000 Laser Scanner.","97":"NA","98":"['GSE50547', 'GSE51118']","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line, expressing  HSP70K71E","103":"Public on Sep 24 2013","104":"NA","105":"NA","106":"Sep 03 2013","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1221nnn/GSM1221012/suppl/GSM1221012_H3_HG-U133_Plus_2_.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1221nnn/GSM1221012/suppl/GSM1221012_H3_HG-U133_Plus_2_.mas5.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HSP70K71E HEK293 sample3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1399565","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"78h after transfection","17":"shCTRL, bio. replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"615 N. Wolfe St.","38":"Baltimore","39":"USA","40":"NA","41":"NA","42":"NA","43":"Johns Hopkins University","44":"NA","45":"Jiou,,Wang","46":"NA","47":"MD","48":"NA","49":"21205","50":"[\"Affymetrix CEL files were extracted and their data normalized with the Partek GS 6.6 platform.  Partek's Extended Meta-Probeset set was used with RMA normalization to create quantile-normalized log2 transcript signal values, which were used in subsequent ANOVA analyses.\", 'probe group file: HuGene-1_0-st-v1.r4.pgf', 'meta-probeset file: HuGene-1_0-st-v1.na32.hg19.transcript.csv']","51":"33297","52":"NA","53":"SAMPLE 1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Cells were lysed using RNAeasy mini kit (Qiagen), according to manufacturer's instructions. Genomic DNA was first removed by DNAse treatment on the column, and then, additionally, after total RNA was isolated, using DNase Turbo kit (Ambion), followed by additional round of cleaning through RNAeasy columns.","61":"NA","62":"NA","63":"NA","64":"GSM1399565","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells grown in DMEM, 10%FBS, 37C, 5% CO2","70":"NA","71":"NA","72":"17hrs at 45 C with rotation (60rpm) as described by Affymetrix in their GeneChip Expression Analysis Technical Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The Ambion Expression WT kit was used as described in the manufacturer's manual.","79":"NA","80":"Feb 09 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Using Affymetrix GeneChip Scanner 3000 7G and default parameters described by the manufacturer in their GeneChip Expression Analysis Technical Manual","97":"NA","98":"GSE58026","99":"NA","100":"NA","101":"NA","102":"HEK293_shCTRL","103":"Public on Feb 09 2017","104":"NA","105":"NA","106":"May 28 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1399nnn/GSM1399565/suppl/GSM1399565_GPer-SOD-A1_ctrl-1a-HuGene_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"78h after transfection","113":"NA","114":"NA","115":"NA","116":"shCTRL, bio. replicate 1","117":"NA","118":"non-targeting shRNA (control)","119":"NA","120":"NA","121":"NA","122":"Cells were transfected in 60mm dishes using 4g DNA, 10l Lipofectamine 2000, in total 4.5ml  Optimem-MEM1. Origene's pRS-RFP-C plasmids encoding shRNAs against UBE4B and LSD1, or non-targeting control (CTRL) were used for knockdown. Cells were knocked down for 78h before lysis.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM618032","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney","15":"NA","16":"NA","17":"HEK-TLR2 24h+LPS rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"human embryonic kidney (HEK) cells stably transfected with Toll-like receptor 2 (TLR2)","33":"1","34":"NA","35":"NA","36":"NA","37":"St. James's Hospital","38":"Dublin 8","39":"Ireland","40":"NA","41":"NA","42":"NA","43":"Trinity College Dublin","44":"Trinity Centre for Health Sciences","45":"Sinead,Marian,Smith","46":"NA","47":"NA","48":"NA","49":"D8","50":"Scanned images, obtained using Affymetrix Software (MAS5), were normalized using robust multichip average (RMA) analysis with RMAExpress version 0.4.1.","51":"54675","52":"NA","53":"gene expression in treated HEK-TLR2 cells at 24h","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"At time points of 2, 4, 8, 24 and 48 h post-stimulation, cells were harvested and RNA isolated using the Nucleospin RNAII kit (Machery Nagel) according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM618032","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK-TLR2 cells were routinely maintained in MEM alpha medium (Gibco) supplemented with 10% foetal calf serum (Gibco), 2 mM L-glutamine (Sigma), 100 U/ml penicillin (Sigma), 100 g/ml streptomycin and 500 g/ml G418 (Sigma). The day before treatment, cells were seeded in 6-well plates at 1x106 cells/well.","70":"NA","71":"NA","72":"Following fragmentation, cRNA was hybridized for 16 hr at 45C on Affymetrix U133 plus 2.0 genechips. GeneChips were washed and stained in the Automated fluidics 450 station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 g total RNA (Expression Analysis Technical Manual, 2001, Affymetrix) using the Affymetrix IVT labeling kit.","79":"NA","80":"Jan 13 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips were scanned using the GeneChip 3000 7G scanner","97":"NA","98":"['GSE25148', 'GSE25155']","99":"NA","100":"NA","101":"NA","102":"HEK-TLR2 cells treated with 10 g/ml H. pylori LPS for 24h rep 2","103":"Public on Jan 12 2011","104":"NA","105":"NA","106":"Nov 04 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM618nnn/GSM618032/suppl/GSM618032.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"embryonic kidney","116":"HEK-TLR2 24h+LPS rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"The morning of treatment, the cell culture medium was replaced with either fresh medium (untreated) or medium containing 10 g/ml H. pylori lipopolysaccharide","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1645162","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"6_GFPscr","18":"control","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Hufelandstrasse 55","38":"Essen","39":"Germany","40":"Universitaetsklinikum Essen","41":"bernhard.horsthemke@uni-due.de","42":"NA","43":"Institut fuer Humangenetik","44":"NA","45":"Bernhard,,Horsthemke","46":"NA","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with MAS5 using Affymetrix default analysis settings and global scaling to a target intensity of 1000 as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from GFP#3 clone, 96 h after treatment with non-targeting control siRNAs', 'total RNA (>200 nt)']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using the AllPrep DNA/RNA/Protein Mini kit (Qiagen) and treated with the RNase-Free DNase Set (Qiagen)","61":"NA","62":"NA","63":"NA","64":"GSM1645162","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were cultured in DMEM supplemented with 10% FCS, 1% Pen/Strep and appropriate concentrations of selective antibiotics.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133Plus_2. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix Hybridization, Wash and Stain Kit..","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA were prepared according to the Affymetrix ExpressKit protocol starting from 200 ng total RNA.","79":"NA","80":"Jul 17 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned in a GeneArray Scanner (Agilent).","97":"NA","98":"['GSE67348', 'GSE67351']","99":"NA","100":"NA","101":"NA","102":"Flp-In T-REx 293","103":"Public on Jul 16 2015","104":"NA","105":"NA","106":"Mar 27 2015","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1645nnn/GSM1645162/suppl/GSM1645162_6_GFPscr.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1645nnn/GSM1645162/suppl/GSM1645162_6_GFPscr.mas5.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"6_GFPscr","117":"NA","118":"NA","119":"NA","120":"GFP","121":"control","122":"Cells were treated either with siRNA against TET1, TET2 and TET3 or a non-targeting pool. All cells carried an inducible, stable GFP transgene whose expression was not induced.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820000","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hrs","17":"HEK293T CTLsiRNA 6hr 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"knockdown control","64":"GSM1820000","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, knockdown control, 6 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820000/suppl/GSM1820000_Zane_6hr_CTLsi_2_A5_102011.CEL.gz","108":"9606","109":"6 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T CTLsiRNA 6hr 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM205759","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 cell line #6 with noninduced HNF4a2 mutant R154X","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 1000.","51":"54675","52":"NA","53":"Analysis of gene expression in human embryonic kidney cells (HEK293) overexpressing the transcription factor HNF4a2 or mutant forms HNF4a2 C106R or R154X, which were introduced by FRT/FLP recombination. The analysis were performed 24 hours following 1 g/ml doxycyclin treatment to induce the expression of the trans-genes. Results identify HNF4 regulated genes in kidney cells being several of these genes deregulated in renal cell carcinoma.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Rneasy mini extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM205759","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133_Plus_2.0 arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual v2, Affymetrix).","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000.","97":"NA","98":"GSE8289","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line #6 with noninduced HNF4a2 mutant R154X","103":"Public on Jun 20 2008","104":"NA","105":"NA","106":"Jun 26 2007","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205759/suppl/GSM205759.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205759/suppl/GSM205759.CHP.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205759/suppl/GSM205759.EXP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cell line #6 with noninduced HNF4a2 mutant R154X","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were treated for 24 h with 1 g/ml doxycyclin or solvent.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820007","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hrs","17":"HEK293T CTRLpcDNA 6hr 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"overexpression control","64":"GSM1820007","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, overexpression control, 6 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820007/suppl/GSM1820007_Zane_6hr_pcDNA_3_B6_102011.CEL.gz","108":"9606","109":"6 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T CTRLpcDNA 6hr 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1954211","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"pcDNA3.1-IRX1::GFP","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with MAS5 using Affymetrix default analysis settings and global scaling to a target intensity of 1000 as normalization method.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted by using the RNeasy Mini Kit (Qiagen). Total-RNA concentration and purity of total-RNA samples was measured with the NanoDrop 1000 spectrophotometer (NanoDrop Technologies/Thermo Scientific).","61":"NA","62":"NA","63":"NA","64":"GSM1954211","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemeted with 10 % (v/v) FCS , 2 mM L-Glutamine and 1 % (v/v) Pen Strep at 37C and 5 % CO2","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133Plus_2. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix Hybridization, Wash and Stain Kit..","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA were prepared according to the Affymetrix ExpressKit protocol starting from 200 ng total RNA.","79":"NA","80":"Nov 14 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned in a GeneChip 3000 scanner with G7 update.","97":"NA","98":"GSE75376","99":"NA","100":"NA","101":"NA","102":"HEK293T + pcDNA3.1-IRX1::GFP","103":"Public on Nov 14 2016","104":"NA","105":"NA","106":"Nov 24 2015","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1954nnn/GSM1954211/suppl/GSM1954211_IRX1-GFP_HG-U133_Plus_2_.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1954nnn/GSM1954211/suppl/GSM1954211_IRX1-GFP_HG-U133_Plus_2_.mas5.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"pcDNA3.1-IRX1::GFP","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were transfected with polyethylenimine and harvest 48 hous after the transient expression of the pcDNA3.1-IRX1::GFP / pcDNA3.1-GFP vectors. GFP positive cells were sorted by FACS.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1678757","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T_pLEX-MCS_Truncated FMRP","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Xihuanbei Road","38":"Fuzhou","39":"China","40":"Department of Clinical Genetics and Experimental Medicine","41":"xgfu2010@163.com","42":"NA","43":"Fuzhou General Hospital","44":"NA","45":"Xianguo,,Fu","46":"NA","47":"NA","48":"NA","49":"350025","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and RMA as normalization method.","51":"54675","52":"NA","53":"stable over-expression of truncated FMRP","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA were isolated from stably transfected HEK293T cells with TRIzol (Invitrogen, Carlsbad, CA), and then followed by a DNase I treatment.","61":"NA","62":"NA","63":"NA","64":"GSM1678757","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK 293T cells were maintained in DMEM/F12 (1:1) medium containing 10% fetal bovine serum. All cells were cultured at 37 C in an incubator containing 5% CO2.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 with constant rotation at the speed of 60 rpm. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 100ng total RNA (Cat. AM1792, Ambion).","79":"NA","80":"May 08 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","97":"NA","98":"GSE68668","99":"NA","100":"NA","101":"NA","102":"stably transfected HEK 293T cells of  the over-expression of truncated FMRP","103":"Public on May 08 2015","104":"NA","105":"NA","106":"May 07 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1678nnn/GSM1678757/suppl/GSM1678757_Truncated_FMRP.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_pLEX-MCS_Truncated FMRP","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Two transfections of pLEX-MCS lentiviral empty vector and pLEX-MCS lentiviral vector with the truncated FMRP were constructed. Transfections were performed with Polyethylenimine for the lentiviral pLEX-MCS vector transfection. For stable transfection, at 24h post transfection, the transiently transfected cells were cultured in DMEM/F12 (1:1) medium containing puromycin for about 2 weeks. Two stable transfectants of empty vector ( pLEX-MCS), pLEX-MCS containing truncated FMR1 (pLEX-MCS-FMR1) were generated and maintained in culture for further studies.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733337","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071107 CEES exposure 1.0 uM_2h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-14","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-30","53":"Gene expression data from NHEK_071107 CEES exposure 1.0 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"1.0","58":"2007-11-07","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733337","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-25","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-08-08","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071107 CEES exposure 1.0 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733337/suppl/GSM733337_071107_CEES_2h_1.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_071107 CEES exposure 1.0 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM463015","2":"NA","3":"hek293e","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293E cells, scrambled siRNA, replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293E","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Calwer Str. 7","38":"Tuebingen","39":"Germany","40":"Department of Medical Genetics","41":"michael.walter@agilent.com","42":"NA","43":"University of Tuebingen","44":"The Microarray Facility Tbingen","45":"Michael,H.,Walter","46":"NA","47":"NA","48":"NA","49":"72076","50":"The data were analysed using GC-RMA for background correction, normalization and probe summarization using the Bioconductor package gcrma with default values.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA  was extracted by using RNeasy Mini Kit (Qiagen) following manufacturers instructions for animal cells.","61":"NA","62":"NA","63":"NA","64":"GSM463015","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293E cells were grown in Dulbeccos modified Eagle medium (DMEM) (Biochrom) supplemented with 10% fetal bovine serum (PAA) at 37C under humidified 5% CO2/air","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 Plus 2.0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Oct 19 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GCS3000 gene chip scanner.","97":"NA","98":"GSE18632","99":"NA","100":"NA","101":"NA","102":"HEK cells transfected with scrambled siRNA, 24h after transfection","103":"Public on Oct 20 2009","104":"NA","105":"NA","106":"Oct 19 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463015/suppl/GSM463015.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293E cells, scrambled siRNA, replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were transiently transfected three consecutive days using HiPerfect with 5nmol scrambled (both Qiagen) or TDP-specific  siRNAs (5-CAATAGCAATAGACAGTTA-3) and cultivated for 24h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560873","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 h","17":"NOD2wt_6h_MDP_biological replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 wt","63":"NA","64":"GSM560873","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560873/suppl/GSM560873.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"6 h","113":"NA","114":"NA","115":"NA","116":"NOD2wt_6h_MDP_biological replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560876","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 h","17":"NOD2-L1007fsinsC_6h_MDP_biological replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 L1007fsinsC","63":"NA","64":"GSM560876","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560876/suppl/GSM560876.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"6 h","113":"NA","114":"NA","115":"NA","116":"NOD2-L1007fsinsC_6h_MDP_biological replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236698","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"control 24h_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_3']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236698","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, control vector, 24h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236698/suppl/GSM2236698_Human_Gene_1_0_ST_20150205_3.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236698/suppl/GSM2236698_Human_Gene_1_0_ST_20150205_3.chp.gz']","108":"9606","109":"NA","110":"24h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"control 24h_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"empty control vector"},{"1":"GSM527384","2":"NA","3":"hek-293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"kidney","15":"NA","16":"NA","17":"kidney_R06283_HG-U133_Plus_2_HSF1","18":"NA","19":"NA","20":"26.4","21":"NA","22":"HG-U133_Plus_2","23":"CRL-11268","24":"NA","25":"excellent","26":"R. Thomas, The Hamner Institutes for Health Sciences, 6 Davis Dr, RTP, NC, 27709, R. Thomas, rthomas@thehamner.org, 919 558 1311, 919 558 1300","27":"NA","28":"NA","29":"NA","30":"HEK-293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"6 Davis Drive","38":"Research Triangle Park","39":"USA","40":"NA","41":"rthomas@thehamner.org","42":"919-558-1300","43":"The Hamner Institutes for Health Sciences","44":"NA","45":"Russell,Scott,Thomas","46":"919-558-1311","47":"NC","48":"NA","49":"27709","50":"Affymetrix GCOS 1.0","51":"54675","52":"NA","53":"R06283_HG-U133_Plus_2_HSF1 regulation: Assay human embryonic kidney cells (HEK293T) for expression of cDNAs before designing siRNAs","54":"NA","55":"NA","56":"1/10","57":"NA","58":"NA","59":"NA","60":"Extraction Method: RNeasy","61":"temperature sensitive gene for SV40 T-antigen was inserted","62":"NA","63":"NA","64":"GSM527384","65":"NA","66":"NA","67":"NA","68":"NA","69":"Growth Media: DMEM, Amount of Media: 3, Units of Media: ml, Growth Conditions: DMEM, 10%FBS(HI), Pen/Strep/GlutaMax","70":"NA","71":"48","72":"standard Affymetrix procedures","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"standard Affymetrix protocol","79":"NA","80":"Mar 30 2010","81":"NA","82":"total RNA","83":"750K /6 well dish","84":"Homo sapiens","85":"GPL570","86":"NA","87":"1.87","88":"NA","89":"NA","90":"NA","91":"NA","92":"10.0","93":"N/A","94":"NA","95":"NA","96":"standard Affymetrix procedures","97":"Scrape in Lysis buffer","98":"GSE21092","99":"NA","100":"NA","101":"NA","102":"total RNA from human embryonic kidney TC cells","103":"Public on Mar 31 2010","104":"NA","105":"NA","106":"Mar 26 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM527nnn/GSM527384/suppl/GSM527384.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM527nnn/GSM527384/suppl/GSM527384.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"kidney","116":"kidney_R06283_HG-U133_Plus_2_HSF1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"ug","125":"h past seeding","126":"NA"},{"1":"GSM1442104","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,16h,untransfected,biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"16 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442104","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_16h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442104/suppl/GSM1442104_16hGFPM_REP3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,16h,untransfected,biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM465438","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney cells","15":"NA","16":"NA","17":"HEK293 in NOD.Scid, rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"embryonic kidney cells","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"Gene expression data from in vivo expanded HEK293 cells.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated with the RNeasy Mini kit according to the manufacturer's instructions (Qiagen).","61":"NA","62":"NA","63":"NA","64":"GSM465438","65":"NA","66":"NA","67":"in vivo cell expansion","68":"NA","69":"Human embryonic kidney (HEK293) cells were grown in DMEM (glucose concentration 450 mg/dl), either injected in NOD.Scid mice and expanded for three weeks in vivo, or cultivated in vitro.","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Human Genome U133 Plus 2.0 Array) in 200 l of the hybridization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual; Rev. 5).","79":"NA","80":"Oct 26 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE18739","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) expanded for three weeks in immunodeficient NOD.Scid mice","103":"Public on Oct 27 2009","104":"NA","105":"NA","106":"Oct 26 2009","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM465nnn/GSM465438/suppl/GSM465438.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM465nnn/GSM465438/suppl/GSM465438.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 in NOD.Scid, rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874628","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T2h_3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874628","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 2h replicate 3","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874628/suppl/GSM1874628_RG_28_4OHT_2h_3_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T2h_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820014","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24 hrs","17":"HEK293T FMR4siRNA 24hr 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"FMR4 knockdown","64":"GSM1820014","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, FMR4 knockdown, 24 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820014/suppl/GSM1820014_Zane_24hr_FMR4si_1_A7_102011.CEL.gz","108":"9606","109":"24 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T FMR4siRNA 24hr 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM678636","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Treated_1_h_Replicate 3","18":"NA","19":"Triptorelin","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"1","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 48","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678636","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"1","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"2","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"1","114":"NA","115":"NA","116":"HEK293_Treated_1_h_Replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM360328","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 6hr, replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"50 South Drive, Bldg.50, Rm.2347","38":"Bethesda","39":"USA","40":"NA","41":"changah@nhlbi.nih.gov","42":"NA","43":"NIH\\\\NHLBI","44":"Laboratory of Biochemistry","45":"Allen,HK,Chang","46":"NA","47":"MD","48":"NA","49":"20892","50":"The data were first processed with GCOS1.4 using Affymetrix default analysis settings. The trimmed mean target intensity of each array was arbitrarily set to 1000. Intensities obtained in CHP file generated by GCOS were normalized using an adaptive variance-stabilizing quantile normalization (Munson, P.J., GeneLogic Workshop of Low Level Analysis of Affymetrix GeneChip Data, 2001, software available at http://abs.cit.nih.gov/geneexpression.html).","51":"54675","52":"NA","53":"gene expression data from human embryonic kidney cells (cell culture) treated with epoxomicin for 6hr","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 cells using Qiagen RNeasy Mini Kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM360328","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells are maintained in DMEM supplemented with 10% fetal bovine serum in 3% oxygen, 5% carbon dioxide, 37 degrees Celsius humidified incubator.","70":"NA","71":"NA","72":"Fragmented RNA was hybridized to Affymetrix HG-U133 plus 2.0 chips for 16 hours, washed, stained on an Affymetrix fluidics station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol using Affymetrixs IVT labeling kit following the manufacturers directions.","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Hybridized chips were scanned using Affymetrix genechip scanner 3000","97":"NA","98":"GSE14429","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 6hr","103":"Public on Jan 15 2009","104":"NA","105":"NA","106":"Jan 14 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM360nnn/GSM360328/suppl/GSM360328.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 6hr, replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 uM epoxomicin is added to HEK293 cells and incubated for 1 and 6 hours before RNA extraction. RNA was extracted from cells without treatment at zero time point as control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546591","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hours","17":"t466fsh_2","18":"fsh - hormone treatment - fsh stimulation","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"3nM","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"t466fsh_2:45.7ug.","61":"NA","62":"mutant hek293_t466","63":"NA","64":"GSM546591","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C, 5% C02","70":"20-10-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"t466fsh_2","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546591/suppl/GSM546591_t466fsh_2.CEL.gz","108":"9606","109":"6 hours","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"t466fsh_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"FSH - hormone treatment - fsh stimulation","122":"Name:FSH - hormone treatment - fsh stimulation,follicle stimulating hormone (fsh):quantity 3nM time 6hour . 3nM","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733095","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070829 SM exposure 200 uM_1h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-02-20","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-14","53":"Gene expression data from NHEK_070829 SM exposure 200 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"200.0","58":"2007-08-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733095","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-05-13","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-05-15","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070829 SM exposure 200 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733095/suppl/GSM733095_070829_HD_1h_200.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_070829 SM exposure 200 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM402828","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 cells siRNA BAHD1 biological rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"CEL files were generated using GCOS software and preprocessed using GC-RMA method","51":"54675","52":"NA","53":"Gene expression data from HEK293 cells transfected with BAHD1  siRNA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA from cells  was extracted and purified by using the RNeasy kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM402828","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells(ATCC #CRL 1573) were grown in DMEM supplemented with Glutamax (Gibco) and 10% FCS","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133Plus2.0  Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RT on 5 g of total RNA using oligo(dT) primers and  in vitro  transcription of the cDNA in presence of biotin were performed by using a GeneChip Amplification One-Cycle Target Labeling kit according to Affymetrix (Santa Clara, CA) standard protocols  Labeling kit according to Affymetrix (Santa Clara, CA) standard protocols.","79":"NA","80":"Jul 16 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix Scanner 3000 7G.","97":"NA","98":"GSE16097","99":"NA","100":"NA","101":"NA","102":"HEK293 cells + BAHD1 siRNA 72h","103":"Public on Jul 16 2009","104":"NA","105":"NA","106":"May 13 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM402nnn/GSM402828/suppl/GSM402828.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cells siRNA BAHD1 biological rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293 cells were  transfected 72h with siRNA BAHD1 or siRNA control (Ambion) using lipofectamine RNAi max (Invitrogen)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874621","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"UT_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874621","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Untreated replicate 1","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874621/suppl/GSM1874621_RG_21_ut_1_10h_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"UT_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1221013","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Control HEK293 sample1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"37 convent drive, Bldg 37,  Rm 1042","38":"Bethesda","39":"USA","40":"NA","41":"byunjs@mail.nih.gov","42":"NA","43":"NCI/NIH","44":"Genetics Branch","45":"Jung,S,Byun","46":"3014352890","47":"MD","48":"NA","49":"20892","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"P1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was harvested (RNAeasy kit(Qiagen)/ standard protocol as manufacture recommended) and measured the concentration for mRNA analysis","61":"NA","62":"NA","63":"control","64":"GSM1221013","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells and the cells expressing  HSP70K71E were proliferated with RPMI1640, 10% FBS, 25 mM HEPES, 1X PS","70":"NA","71":"NA","72":"Following fragmentation, 20 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human U133 plus 2 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Ambion MessageAmp II Biotin-enhanced protocol from 1 ug total RNA (Message Amp II Biotin-Enhanced Technical Manual, 2006, Ambion).","79":"NA","80":"Sep 24 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix 3000 Laser Scanner.","97":"NA","98":"['GSE50547', 'GSE51118']","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line, control","103":"Public on Sep 24 2013","104":"NA","105":"NA","106":"Sep 03 2013","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1221nnn/GSM1221013/suppl/GSM1221013_P1_HG-U133_Plus_2_.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1221nnn/GSM1221013/suppl/GSM1221013_P1_HG-U133_Plus_2_.mas5.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Control HEK293 sample1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2698663","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 2.0 ST Array (hugene20st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"control 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Einstein-Allee 11","38":"Ulm","39":"Germany","40":"Neurology","41":"axel.freischmidt@uni-ulm.de","42":"NA","43":"Ulm University","44":"NA","45":"Axel,,Freischmidt","46":"+4973150063051","47":"NA","48":"NA","49":"89081","50":"Affymetrix Expression Console Software 1.4.1.46 for feature extraction and normalization, BRB Array Tools for statistical analysis","51":"53617","52":"NA","53":"['transcriptome of HEK293 cells after transfection of a control RNA', 'a1_allstar-1']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Isolation of total RNA was performed with the RNeasy Plus Mini Kit (Qiagen) as specified by the manufacturer.","61":"NA","62":"NA","63":"NA","64":"GSM2698663","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were grown under standard conditions (37 C; 5% CO2) in DMEM (Thermo Fisher Scientifc #41965039) supplemented with 10% fetal bovine serum.","70":"NA","71":"NA","72":"according to Affymetrix Whole Transcript (WT) Sense Target Labeling Assay","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Whole Transcript (WT) Sense Target Labeling Assay","79":"NA","80":"Jul 30 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL16686","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"according to Affymetrix protocols using a GeneChip 3000 Scanner","97":"NA","98":"GSE101046","99":"NA","100":"NA","101":"NA","102":"control","103":"Public on Jul 30 2018","104":"NA","105":"NA","106":"Jul 10 2017","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2698nnn/GSM2698663/suppl/GSM2698663_a1_allstar-1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"control 1","117":"NA","118":"NA","119":"control RNA","120":"NA","121":"NA","122":"For transfections of AllStars Negative Control siRNA (Qiagen #1027280) or Syn-hsa-miR-1825 (Qiagen #MSY0006765) in a concentration of 5 nM we used the HiPerfect transfection reagent (Qiagen). 24 h post-transfection, the cells were washed twice with PBS followed by RNA extraction.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820013","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24 hrs","17":"HEK293T CTLsiRNA 24hr 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"knockdown control","64":"GSM1820013","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, knockdown control, 24 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820013/suppl/GSM1820013_Zane_24hr_CTLsi_3_A12_102011.CEL.gz","108":"9606","109":"24 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T CTLsiRNA 24hr 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM897027","2":"NA","3":"hek293 cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T-REx293-NPAP1-induced-1","18":"induced","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293 cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with RMA default setting in Partek GS","51":"33297","52":"NA","53":"Gene expression data from cell line T-REx293-NPAP1, 24 h after induced expression of the integrated NPAP1 gene, technical replicate 1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using the RNeasy mini kit (QIAGEN), treated with DNase I, followed by cleaning-up on spin columns (RNeasy mini kit. Qiagen)","61":"NA","62":"NA","63":"NA","64":"GSM897027","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were cultured in DMEM medium supplemented with 10% FCS, 1% penstrep and appropriate concentration of selective antibiotics","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on Human Gene 1.0 ST. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix Hybridization, Wash and Stain Kit..","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Amplified cDNA was prepared according to the Ambion WT Expression Kit protocol starting from 200 ng total RNA. Amplified cDNA was fragmented with UDG and APE1 and finally labelled using the Affymetrix WT terminal labelling kit","79":"NA","80":"Jun 18 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned in the Affymetrix GeneChip Scanner 3000 wit G7 update","97":"NA","98":"GSE36575","99":"NA","100":"NA","101":"NA","102":"Flp-In T-REx 293","103":"Public on Jun 18 2012","104":"NA","105":"NA","106":"Mar 16 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM897nnn/GSM897027/suppl/GSM897027_TRex3_1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T-REx293-NPAP1-induced-1","117":"NA","118":"NA","119":"NA","120":"NPAP1/C15orf2","121":"induced","122":"1 g/ml doxycycline or mock (H2O) was used to induce expression of the integrated NPAP1 copy.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1087801","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"LIN28B_not_induced_rep1 [Affymetrix]","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1230 York Ave Box 186","38":"New York","39":"USA","40":"NA","41":"miguel.a.brown@gmail.com","42":"NA","43":"The Rockefeller University","44":"NA","45":"Miguel,,Brown","46":"NA","47":"New York","48":"NA","49":"10065","50":"We imported the CEL files into the R software (http://www.R-project.org) using the BioConductor affy package (Gentleman et al., 2004). The transcript probe set intensities were background-corrected, adjusted for non-specific binding and quantile normalized with the GCRMA algorithm (Wu, 2006). Probe sets with more than 6 of the 11 probes mapping ambiguously to the genome were discarded, as were probe sets that mapped to multiple genes. We then collected all probe sets matching a given gene, and we selected for further analysis the RefSeq transcript with median 3'UTR length corresponding to that gene. In total 16,063 transcripts were identified. The log-intensity of probe sets mapping to the gene were then averaged to obtain the expression level per RefSeq transcript. The changes of transcript abundances were computed as the logarithm of the ratio of transcript expression in the cocktails of siRNA treated samples and mock-transfected cells. Detailed analysis procedure can be found in the Supplement to Hafner et al. Cell, 2010,141(1),129-141 Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP","51":"13008","52":"NA","53":"Gene expression data from HEK293 cells inducibly expressing FLAG/HA tagged LIN28B; FH/LIN28B not induced","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1087801","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 T-REx Flp-In cells (Invitrogen) were grown in D-MEM high glucose with 10% (v/v) fetal bovine serum, 1% (v/v) 2 mM L-glutamine, 1% (v/v) 10,000 U/ml penicillin/10,000 g/ml streptomycin, 100 g/ml zeocin and 15 g/ml blasticidin. Cell lines stably expressing FLAG/HA-tagged proteins were generated by co-transfection of pFRT/TO/FLAG/HA or pFRT/FLAG/HA constructs with pOG44 (Invitrogen). Cells were selected by exchanging zeocin with 100 g/ml hygromycin. Expression of FLAG/HA-LIN28B was induced by addition of 250 ng/ml doxycycline 15 to 20 h before crosslinking.  Detailed experimental procedure can be found in the Methods section of Hafner et al., RNA, in press, Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition","70":"NA","71":"NA","72":"3 g cRNA hybridized to HGU133 Plus 2.0 Arrays for 16 h at 45C","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"2 g of purified total RNA was used in the One-Cycle Eukaryotic Target Labeling Assay (Affymetrix) according to manufacturer's protocol. Biotinylated cRNA targets were cleaned up, fragmented, and hybridized to Human Genome U133 Plus 2.0 Array (Affymetrix).","79":"NA","80":"Feb 26 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips scanned on Affymetrix Genechip 300 7G scanner","97":"NA","98":"['GSE44613', 'GSE44616']","99":"NA","100":"NA","101":"NA","102":"HEK 293 cells inducibly expressing FLAG/HA tagged LIN28B; transgene expression not induced; mock transfected; replicate 1","103":"Public on Feb 26 2013","104":"NA","105":"NA","106":"Feb 25 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1087nnn/GSM1087801/suppl/GSM1087801_LIN28B_not_induced_rep1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"LIN28B_not_induced_rep1 [Affymetrix]","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"siRNA transfections of HEK293 T-REx Flp-In cells were performed in 6-well format using Lipofectamine RNAiMAX (Invitrogen) as described by the manufacturer. Detailed experimental procedure can be found in the Methods section of Hafner et al., RNA, in press Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1039985","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,untransfected,biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"GFPMINUS_3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1039985","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 22 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE59666","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"['GSE20615', 'GSE59666']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,untransfected,biological rep 3_24h","103":"Public on Nov 21 2012","104":"NA","105":"NA","106":"Nov 21 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1039nnn/GSM1039985/suppl/GSM1039985_AnP_Hu13302_062910_08_M29.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,untransfected,biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560872","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"2 h","17":"MOCK_2h_MDP_biological replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"control mock","63":"NA","64":"GSM560872","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560872/suppl/GSM560872.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"2 h","113":"NA","114":"NA","115":"NA","116":"MOCK_2h_MDP_biological replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM465436","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney cells","15":"NA","16":"NA","17":"HEK293 cells in vitro, rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"embryonic kidney cells","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"Gene expression data from in vitro cultivated HEK293 cells.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated with the RNeasy Mini kit according to the manufacturer's instructions (Qiagen).","61":"NA","62":"NA","63":"NA","64":"GSM465436","65":"NA","66":"NA","67":"in vitro cell cultivation","68":"NA","69":"Human embryonic kidney (HEK293) cells were grown in DMEM (glucose concentration 450 mg/dl), either injected in NOD.Scid mice and expanded for three weeks in vivo, or cultivated in vitro.","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Human Genome U133 Plus 2.0 Array) in 200 l of the hybridization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual; Rev. 5).","79":"NA","80":"Oct 26 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE18739","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) in vitro cultivated in DMEM (450 mg/dl glucose)","103":"Public on Oct 27 2009","104":"NA","105":"NA","106":"Oct 26 2009","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM465nnn/GSM465436/suppl/GSM465436.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM465nnn/GSM465436/suppl/GSM465436.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cells in vitro, rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820010","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hrs","17":"HEK293T FMR4pcDNA 6hr 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"FMR4 overexpression","64":"GSM1820010","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, FMR4 overexpression, 6 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820010/suppl/GSM1820010_Zane_6hr_FMR4OX_3_B3_102011.CEL.gz","108":"9606","109":"6 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T FMR4pcDNA 6hr 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733482","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080129 SM exposure 800 uM_2h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-06","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-06","53":"Gene expression data from NHEK_080129 SM exposure 800 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"800.0","58":"2008-01-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733482","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-22","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-07-24","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080129 SM exposure 800 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733482/suppl/GSM733482_080129_HD_2h_800.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_080129 SM exposure 800 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1087805","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"LIN28B_knockdown_rep1 [Affymetrix]","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1230 York Ave Box 186","38":"New York","39":"USA","40":"NA","41":"miguel.a.brown@gmail.com","42":"NA","43":"The Rockefeller University","44":"NA","45":"Miguel,,Brown","46":"NA","47":"New York","48":"NA","49":"10065","50":"We imported the CEL files into the R software (http://www.R-project.org) using the BioConductor affy package (Gentleman et al., 2004). The transcript probe set intensities were background-corrected, adjusted for non-specific binding and quantile normalized with the GCRMA algorithm (Wu, 2006). Probe sets with more than 6 of the 11 probes mapping ambiguously to the genome were discarded, as were probe sets that mapped to multiple genes. We then collected all probe sets matching a given gene, and we selected for further analysis the RefSeq transcript with median 3'UTR length corresponding to that gene. In total 16,063 transcripts were identified. The log-intensity of probe sets mapping to the gene were then averaged to obtain the expression level per RefSeq transcript. The changes of transcript abundances were computed as the logarithm of the ratio of transcript expression in the cocktails of siRNA treated samples and mock-transfected cells. Detailed analysis procedure can be found in the Supplement to Hafner et al. Cell, 2010,141(1),129-141 Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP","51":"13008","52":"NA","53":"Gene expression data from HEK293 cells inducibly expressing FLAG/HA tagged LIN28B after knockdown with siRNA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1087805","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 T-REx Flp-In cells (Invitrogen) were grown in D-MEM high glucose with 10% (v/v) fetal bovine serum, 1% (v/v) 2 mM L-glutamine, 1% (v/v) 10,000 U/ml penicillin/10,000 g/ml streptomycin, 100 g/ml zeocin and 15 g/ml blasticidin. Cell lines stably expressing FLAG/HA-tagged proteins were generated by co-transfection of pFRT/TO/FLAG/HA or pFRT/FLAG/HA constructs with pOG44 (Invitrogen). Cells were selected by exchanging zeocin with 100 g/ml hygromycin. Expression of FLAG/HA-LIN28B was induced by addition of 250 ng/ml doxycycline 15 to 20 h before crosslinking.  Detailed experimental procedure can be found in the Methods section of Hafner et al., RNA, in press, Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition","70":"NA","71":"NA","72":"3 g cRNA hybridized to HGU133 Plus 2.0 Arrays for 16 h at 45C","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"2 g of purified total RNA was used in the One-Cycle Eukaryotic Target Labeling Assay (Affymetrix) according to manufacturer's protocol. Biotinylated cRNA targets were cleaned up, fragmented, and hybridized to Human Genome U133 Plus 2.0 Array (Affymetrix).","79":"NA","80":"Feb 26 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips scanned on Affymetrix Genechip 300 7G scanner","97":"NA","98":"['GSE44613', 'GSE44616']","99":"NA","100":"NA","101":"NA","102":"HEK 293 cells inducibly expressing FLAG/HA tagged LIN28B; transgene not induced; siRNA transfected; replicate 1","103":"Public on Feb 26 2013","104":"NA","105":"NA","106":"Feb 25 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1087nnn/GSM1087805/suppl/GSM1087805_LIN28B_knockdown_rep1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"LIN28B_knockdown_rep1 [Affymetrix]","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"siRNA transfections of HEK293 T-REx Flp-In cells were performed in 6-well format using Lipofectamine RNAiMAX (Invitrogen) as described by the manufacturer. Detailed experimental procedure can be found in the Methods section of Hafner et al., RNA, in press Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546596","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"t466nsbis_3","18":"no treatment","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"t466ns_3:53.5ug.","61":"NA","62":"mutant hek293_t466","63":"NA","64":"GSM546596","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C, 5% C02","70":"20-10-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"t466nsbis_3","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546596/suppl/GSM546596_t466nsbis_3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"t466nsbis_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"no treatment","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733381","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071107 CEES exposure 4.0 uM_24h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-22","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-04","53":"Gene expression data from NHEK_071107 CEES exposure 4.0 uM_24h timepoint","54":"NA","55":"NA","56":"NA","57":"4.0","58":"2007-11-07","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733381","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-08","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-07-10","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071107 CEES exposure 4.0 uM_24h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733381/suppl/GSM733381_071107_CEES_24h_4.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"24","115":"NA","116":"NHEK_071107 CEES exposure 4.0 uM_24h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1269605","2":"NA","3":"hek 293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"293 transfected with MBDVP16 replicate #1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"513 Parnassus Avenue, HSW Room  1102, Box 0540","38":"San Francisco","39":"USA","40":"Diabetes Center","41":"manderson@diabetes.ucsf.edu","42":"NA","43":"UCSF","44":"Anderson Lab","45":"Mark,Stuart,Anderson","46":"NA","47":"CA","48":"NA","49":"94143","50":"AGCC 3.2.2 Microarrays were normalized for array-specific effects using Affymetrix's Robust Multi-Array (RMA) normalization","51":"28829","52":"NA","53":"293 cells transfected with MBDVP16 only biologic replicate #1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Qiagen RNAeasy mini kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1269605","65":"NA","66":"NA","67":"NA","68":"NA","69":"Transfected HEK 293 cells were grown for 72hrs in complete DMEM prior to RNA extraction.","70":"NA","71":"NA","72":"See manufacturer protocol","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"NuGEN Ovation Pico WTA V2 and NuGEN Encore Biotin Module","79":"NA","80":"Nov 21 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCS3000","97":"NA","98":"['GSE52546', 'GSE52548']","99":"NA","100":"NA","101":"NA","102":"293 transfected with MBDVP16","103":"Public on Nov 21 2013","104":"NA","105":"NA","106":"Nov 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1269nnn/GSM1269605/suppl/GSM1269605_07.MBDVP16-1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"293 transfected with MBDVP16 replicate #1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK 293 cells were transfected using Mirus 293 transfection reagent following manufacturers protocol.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236713","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"control 48h_3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_24']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236713","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, control vector, 48h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236713/suppl/GSM2236713_Human_Gene_1_0_ST_20150205_24.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236713/suppl/GSM2236713_Human_Gene_1_0_ST_20150205_24.chp.gz']","108":"9606","109":"NA","110":"48h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"control 48h_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"empty control vector"},{"1":"GSM678672","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Control_24_h_Replicate 1","18":"NA","19":"Control","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"4","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 16","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678672","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"2","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"1","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"24","114":"NA","115":"NA","116":"HEK293_Control_24_h_Replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881007","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 3","17":"Producer culture - fermentation 2- time point 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"1","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 5","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"recombinant protein producer","64":"GSM881007","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Producer culture - fermentation 2- time point 3","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 3","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Producer culture - fermentation 2- time point 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693948","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"72h","17":"HEK293T_BACH1-siRNA2_72h_rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_s_3_72', 'BACH1_s_3_300ng_72h_293T.CEL', 'Gene expression data from HEK 293T cells 72h after knockdown of BACH1 with Stealth siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693948","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"siRNA2 HSS100910 (s)","102":"HEK 293T cells, BACH1 knockdown, 72h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693948/suppl/GSM693948.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693948/suppl/GSM693948.EXP.gz']","108":"9606","109":"72h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-siRNA2_72h_rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874656","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"ActD_4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874656","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Actinomycin D 4h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874656/suppl/GSM1874656_RG_46_ActD_4h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"ActD_4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881006","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 3","17":"Producer culture - fermentation 1- time point 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"1","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 4","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"recombinant protein producer","64":"GSM881006","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Producer culture - fermentation 1- time point 3","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 3","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Producer culture - fermentation 1- time point 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2433276","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 2.0 ST Array (hugene20st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"embryonic kidney cells - c - negative control","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Bldg 8, Room 1A11, NIDDK/NIH","38":"Bethesda","39":"USA","40":"GCL","41":"weipingChen@niddk.nih.gov","42":"NA","43":"NIDDK/NIH","44":"Genomics Core Lab","45":"WeiPing,,Chen","46":"301-496-0175","47":"MD","48":"NA","49":"20892","50":"The data were normalized by RMA with Parteck Genomic Suit 6.6","51":"53617","52":"NA","53":"NIH-Inwood-HuGene2.0-5-NC-c","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM2433276","65":"NA","66":"NA","67":"NA","68":"NA","69":"Standard human embryonic kidney cells growth protocal","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Dec 17 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL16686","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","97":"NA","98":"GSE92599","99":"NA","100":"NA","101":"NA","102":"human embryonic kidney cells","103":"Public on Dec 17 2017","104":"NA","105":"NA","106":"Dec 19 2016","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2433nnn/GSM2433276/suppl/GSM2433276_NIH-Inwood-HuGene2.0-5-NC-c.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"embryonic kidney cells - c - negative control","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"mRNA is obtained by Co-Ip with FLAG tagged PAB-1 expressed in seam cells and VPCs converted to cDNA and amplified using NuGEN pico amplification kit","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874629","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T3h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874629","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 3h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874629/suppl/GSM1874629_RG_29_4OHT_3h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T3h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881013","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 3","17":"Non-producer culture - fermentation 2- time point 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"1","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 11","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"non-producing parent","64":"GSM881013","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Non-producer culture - fermentation 2- time point 3","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 3","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Non-producer culture - fermentation 2- time point 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693951","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"72h","17":"HEK293T_mock-transfection_72h_rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_m_3_72', 'MOCK_m_3_0ng_72h_293T.CEL', 'Gene expression data from HEK 293T cells 72h after mock transfection without siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"control","64":"GSM693951","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"mock (without siRNA)","102":"HEK 293T cells, mock transfection, 72h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693951/suppl/GSM693951.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693951/suppl/GSM693951.EXP.gz']","108":"9606","109":"72h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_mock-transfection_72h_rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442108","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,2h,untreated,biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"2 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442108","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untreated_2h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442108/suppl/GSM1442108_2hCONTROL_REP1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,2h,untreated,biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820012","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24 hrs","17":"HEK293T CTLsiRNA 24hr 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"knockdown control","64":"GSM1820012","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, knockdown control, 24 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820012/suppl/GSM1820012_Zane_24hr_CTLsi_2_A11_102011.CEL.gz","108":"9606","109":"24 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T CTLsiRNA 24hr 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442110","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,2h,treated,biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"2 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442110","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, treated_2h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442110/suppl/GSM1442110_2hGFP_REP1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,2h,treated,biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881008","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 3","17":"Producer culture - fermentation 3- time point 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"1","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 6","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"recombinant protein producer","64":"GSM881008","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Producer culture - fermentation 3- time point 3","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 3","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Producer culture - fermentation 3- time point 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442119","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,16h,untransfected,biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"16 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442119","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_16h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442119/suppl/GSM1442119_16hGFPM_REP1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,16h,untransfected,biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874622","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"UT_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874622","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Untreated replicate 2","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874622/suppl/GSM1874622_RG_22_ut_2_10h_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"UT_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610841","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"1hr","17":"HEK293T_miR-neg_FSK1hr_rep2","18":"NA","19":"FSK","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610841","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610841/suppl/GSM610841.CEL.gz","108":"9606","109":"1hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-neg_FSK1hr_rep2","117":"negative control","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2716909","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human emborynic kidney 293 cells","15":"NA","16":"NA","17":"overexpression of the truncated FMRP_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"156 Xierhuan Road","38":"Fuzhou","39":"China","40":"NA","41":"xmuywj@163.com","42":"NA","43":"Fuzhou General Hospital","44":"NA","45":"Yang,,wenjing","46":"+8615959229926","47":"NA","48":"NA","49":"350025","50":"The data were analyzed using Affymetrix GeneChip Command Console Software.","51":"54675","52":"NA","53":"overexpression of the truncated FMRP in HEK293T cells","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM2716909","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell lines were grown at 37C with 5% CO2","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 23 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using GeneChip Scanner 3000.","97":"NA","98":"GSE101830","99":"NA","100":"NA","101":"NA","102":"overexpression of the new truncated FMRP in HEK293T cells","103":"Public on Jul 26 2017","104":"NA","105":"NA","106":"Jul 25 2017","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2716nnn/GSM2716909/suppl/GSM2716909_161020-160682B_I_HG-U133_Plus_2_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"human emborynic kidney 293 cells","116":"overexpression of the truncated FMRP_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"DMEM medium with 10% FBS and 1% penicillin/streptomycin","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM941941","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture, untransfected, biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"untransfected","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"24 h gene profile of untransfected (GFP negative) HEK293T cells.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM941941","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm.","97":"NA","98":"['GSE38422', 'GSE59665']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_24h","103":"Public on Jun 03 2012","104":"NA","105":"NA","106":"Jun 02 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM941nnn/GSM941941/suppl/GSM941941_AnP_Hu13302_081910_02_M36.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture, untransfected, biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic PEI polymer mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18 h after seeding and flow separated after another 24 h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874625","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T1h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874625","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 1h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874625/suppl/GSM1874625_RG_25_4OHT_1h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T1h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861630","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Wild Type, no leptin, biological replicate 2","18":"untreated","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"PO Box 800741","38":"Charlottesville","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Virginia","44":"NA","45":"Stephen,,Turner","46":"NA","47":"VA","48":"NA","49":"22908","50":"Data extraction, QC, and GCRMA normalization were performed with BioConductor software.  Differential expression was assessed with moderated ANOVA, using the BioConductor limma package; false discovery rate (FDR) estimates were calculated using the Benjamini-Hochberg method.","51":"54675","52":"NA","53":"Wild Type, no leptin, biological replicate 2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was prepared using RNeasy Mini kit (QIAGEN) and its quality was verified in an Agilent Bioanalyzer.","61":"NA","62":"NA","63":"NA","64":"GSM861630","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T/17 cells were maintained in a humidified incubator at 37 C with 5% CO2. HEK293T/17 cells were cultured in DMEM/F12 (Gibco) with non-essential amino acids, sodium pyruvate and 10% heat inactivated FBS.  Jurkat T-cells were cultured in RPMI supplemented with 10% heat inactivated FBS.  Caco-2 cells were cultured in EMEM (Gibco) supplemented with non-essential amino acids, sodium pyruvate and 20% heat inactivated FBS.  Cells were discarded after passage 25 and new cultures were started from frozen stocks. HEK293T117 cells were transiently transfected using lipofectamine 2000 per the product instructions (Invitrogen, Carlsbad, CA). The plasmids mLEPRb/pCDNA3 (47), mLEPRbR223/pCDNA3 (35) and LEPRbDelta65/pCDNA3 (47) were obtained from Martin Myers and have been described previously as referenced. pCDNA3 was used as a vector control. The plasmid mLEPRb/pCDNA3 was used as a template for site-directed mutagenesis to construct mLEPRb985L/pCDNA3, LEPRb1077L/pCDNA3 and mLEPRb1138L/pCDNA3.  Site-directed mutagenesis was done using the quikchange kit (Stragene/Agilent, Santa Clara, CA).    The presence of the desired mutations and the absence of other mutations were confirmed by DNA sequencing.","70":"NA","71":"NA","72":"Three biological replicates of each sample were hybridized to Human Genome U133 Plus 2.0 gene chips (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA was amplified and converted to cDNA using the 3' IVT Express Kit (Affymetrix).","79":"NA","80":"Jan 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned using the GeneChip Scanner 3000 7G (AffyMetrix).","97":"NA","98":"GSE35068","99":"NA","100":"NA","101":"NA","102":"Wild Type, no leptin","103":"Public on Jan 01 2015","104":"NA","105":"NA","106":"Jan 12 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861630/suppl/GSM861630_WT+2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Wild Type, no leptin, biological replicate 2","117":"NA","118":"NA","119":"Wild-type leptin receptor","120":"NA","121":"untreated","122":"HEK293 cells were transfected with WT LepR or Y1138L (STAT3-mutant) leptin receptor.  48 hours post-transfection cells were made quiescent by incubation in optimum plus 0.5% BSA for 3 hours.  Cells were then stimulated with 100ng of leptin or maintained in optimum plus 0.5% BSA for an additional 3 hours. Leptin was purchased from Dr. A.F. Parlow, National Hormone and Peptide Program (Torrance, CA). The STAT3 inhibitor, Stattic, the PI3K inhibitor, LY294002 and the MEK inhibitor PD98059 were purchased from EMD chemicals (Gibbstown, NJ).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442092","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,2h,untreated,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"2 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442092","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untreated_2h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442092/suppl/GSM1442092_2hCONTROL_REP2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,2h,untreated,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733266","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070926 NM exposure 12.5 uM_8h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-02","29":"Phillips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-28","53":"Gene expression data from NHEK_070926 NM exposure 12.5 uM_8h timepoint","54":"NA","55":"NA","56":"NA","57":"12.5","58":"2007-09-26","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733266","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-24","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-08-07","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070926 NM exposure 12.5 uM_8h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733266/suppl/GSM733266_070926_NM_8h_12.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"8","115":"NA","116":"NHEK_070926 NM exposure 12.5 uM_8h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM606063","2":"NA","3":"293tetluc","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney cell","15":"NA","16":"NA","17":"Control, 293TetLuc, doxcycline 48 h, rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"293TetLuc","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"No 35, Keyan Road, Zhunan Town","38":"Miaoli Conunty","39":"Taiwan","40":"NA","41":"sflin1@gmail.com","42":"NA","43":"National Health Research Institutes, Taiwan","44":"NA","45":"Su-Fang,,Lin","46":"NA","47":"NA","48":"NA","49":"35053","50":"The data were analyzed using Affymetrix Expression Console Software (version 1.1) default analysis settings and RMA (Robust Multi-Array) summarization and normalization options.","51":"33297","52":"NA","53":"Cell densitiy was maintained at 200,000 / ml before induction.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using a RNeasy Mini kit (Qiagene), according to the manufacturers instructions. A 2-round amplification was performed with the ExpressArt TRinucleotide mRNA Amplification Kit (AmpTec) according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM606063","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown to log-phase in DMEM supplemented with 10% tetracycline-free fetal bovine serum before induction.","70":"NA","71":"NA","72":"Samples were hybridized with GeneChip Human Gene 1.0 ST Arrays (Affymetrix) and scanned at the NHRI Microarray Core Facility (Miaoli County, Taiwan).","73":"NA","74":"NA","75":"NA","76":"transformed with sheared Ad5 DNA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Mar 31 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Array scanning was performed according to the manufacturer's instruction (Affymetrix).","97":"NA","98":"['GSE24585', 'GSE24587']","99":"NA","100":"NA","101":"NA","102":"293 luciferase inducible line, doxycycline 48 h","103":"Public on Mar 31 2011","104":"NA","105":"NA","106":"Oct 07 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM606nnn/GSM606063/suppl/GSM606063.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"embryonic kidney cell","116":"Control, 293TetLuc, doxcycline 48 h, rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were treated with doxycycline (50 nanogram/ml) for 48 h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM618022","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney","15":"NA","16":"NA","17":"HEK-TLR2 4h-LPS rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"human embryonic kidney (HEK) cells stably transfected with Toll-like receptor 2 (TLR2)","33":"1","34":"NA","35":"NA","36":"NA","37":"St. James's Hospital","38":"Dublin 8","39":"Ireland","40":"NA","41":"NA","42":"NA","43":"Trinity College Dublin","44":"Trinity Centre for Health Sciences","45":"Sinead,Marian,Smith","46":"NA","47":"NA","48":"NA","49":"D8","50":"Scanned images, obtained using Affymetrix Software (MAS5), were normalized using robust multichip average (RMA) analysis with RMAExpress version 0.4.1.","51":"54675","52":"NA","53":"gene expression in untreated HEK-TLR2 cells at 4h","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"At time points of 2, 4, 8, 24 and 48 h post-stimulation, cells were harvested and RNA isolated using the Nucleospin RNAII kit (Machery Nagel) according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM618022","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK-TLR2 cells were routinely maintained in MEM alpha medium (Gibco) supplemented with 10% foetal calf serum (Gibco), 2 mM L-glutamine (Sigma), 100 U/ml penicillin (Sigma), 100 g/ml streptomycin and 500 g/ml G418 (Sigma). The day before treatment, cells were seeded in 6-well plates at 1x106 cells/well.","70":"NA","71":"NA","72":"Following fragmentation, cRNA was hybridized for 16 hr at 45C on Affymetrix U133 plus 2.0 genechips. GeneChips were washed and stained in the Automated fluidics 450 station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 g total RNA (Expression Analysis Technical Manual, 2001, Affymetrix) using the Affymetrix IVT labeling kit.","79":"NA","80":"Jan 13 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips were scanned using the GeneChip 3000 7G scanner","97":"NA","98":"['GSE25148', 'GSE25155']","99":"NA","100":"NA","101":"NA","102":"HEK-TLR2 cells untreated for 4h rep 2","103":"Public on Jan 12 2011","104":"NA","105":"NA","106":"Nov 04 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM618nnn/GSM618022/suppl/GSM618022.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"embryonic kidney","116":"HEK-TLR2 4h-LPS rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"The morning of treatment, the cell culture medium was replaced with either fresh medium (untreated) or medium containing 10 g/ml H. pylori lipopolysaccharide","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM926187","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina humanRef-8 v1.0 expression beadchip (Illumina_HumanRef-8_v1.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK-293 control miR-181b Experimental Replicate 2 1895213040_H","18":"mir-181b","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ring Road","38":"Callaghan","39":"Australia","40":"NA","41":"NA","42":"NA","43":"University of Newcastle","44":"NA","45":"Adam,,Carroll","46":"NA","47":"NSW","48":"NA","49":"2308","50":"Illumina Beadstudio software computed average signal intensities and detection p-values.","51":"22184","52":"NA","53":"Experimental Replicate 2","54":"illuminaHumanv2","55":"44.83337","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted with Trizol reagent, followed by clean-up with DNase I treatment and the RNeasy MinElute cleanup kit (Qiagen) in accordance with manufacturer's instructions. Quality control was performed with an Experion (BioRad) bioanalyser.","61":"NA","62":"NA","63":"NA","64":"GSM926187","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cell models were grown as confluent monolayers in standard tissue culture conditions.","70":"NA","71":"NA","72":"Standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA was prepared using the TotalPrep RNA amplification kit (Ambion) for Illumina arrays.","79":"NA","80":"Nov 01 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6104","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol.","97":"NA","98":"GSE37729","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Nov 01 2012","104":"NA","105":"NA","106":"May 02 2012","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK-293 control miR-181b Experimental Replicate 2 1895213040_H","117":"NA","118":"NA","119":"NA","120":"NA","121":"miR-181b","122":"Cells were transfected with either synthetic miRNA or anti-miR inhibitor oligonucleotides. Control refers to untransfected cell models; siEGFP control refers to transfection with an siRNA to EGFP as a transfection control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560858","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0 h","17":"NOD2-L1007fsinsC_0h_MDP_biological replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 L1007fsinsC","63":"NA","64":"GSM560858","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560858/suppl/GSM560858.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"0 h","113":"NA","114":"NA","115":"NA","116":"NOD2-L1007fsinsC_0h_MDP_biological replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442115","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,8h,untransfected,biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"8 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442115","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_8h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442115/suppl/GSM1442115_8hGFPM_REP3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,8h,untransfected,biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM402825","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 cells siRNA control, biological rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"CEL files were generated using GCOS software and preprocessed using GC-RMA method","51":"54675","52":"NA","53":"Gene expression data from HEK293 cells transfected with control  siRNA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA from cells  was extracted and purified by using the RNeasy kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM402825","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells(ATCC #CRL 1573) were grown in DMEM supplemented with Glutamax (Gibco) and 10% FCS","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133Plus2.0  Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RT on 5 g of total RNA using oligo(dT) primers and  in vitro  transcription of the cDNA in presence of biotin were performed by using a GeneChip Amplification One-Cycle Target Labeling kit according to Affymetrix (Santa Clara, CA) standard protocols  Labeling kit according to Affymetrix (Santa Clara, CA) standard protocols.","79":"NA","80":"Jul 16 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix Scanner 3000 7G.","97":"NA","98":"GSE16097","99":"NA","100":"NA","101":"NA","102":"HEK293 cells + control siRNA 72h","103":"Public on Jul 16 2009","104":"NA","105":"NA","106":"May 13 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM402nnn/GSM402825/suppl/GSM402825.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cells siRNA control, biological rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293 cells were  transfected 72h with siRNA BAHD1 or siRNA control (Ambion) using lipofectamine RNAi max (Invitrogen)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM373089","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"transformed hek cells","15":"NA","16":"NA","17":"Hek-HT Control Replicate-1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"transformed Hek cells","33":"1","34":"NA","35":"NA","36":"NA","37":"6431 Fannin St","38":"Houston","39":"USA","40":"NA","41":"jeffrey.t.chang@uth.tmc.edu","42":"NA","43":"UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON","44":"NA","45":"Jeffrey,,Chang","46":"NA","47":"TX","48":"NA","49":"77030","50":"MAS5.0","51":"22277","52":"NA","53":"1462_2979_14849_THX-1_HG-U133A+2.CEL","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"We extracted total RNA using Qiagen Rneasy mini kits.","61":"NA","62":"NA","63":"NA","64":"GSM373089","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"The cRNA is fragmented before hybridization and a hybridization cocktail is prepared that contains the fragmented cRNA, probe array controls, BSA and herring sperm DNA.  The cRNA is hybridized to the oligonucleotide probes on the array for 16 hours at 45C.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"We performed an in vitro transcription reaction to produce a biotin-labeled cRNA from the cDNA.","79":"NA","80":"Feb 20 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Immediately following hybridization, the hybridized probe arrays undergo an automated washing and staining protocol on the fluidic station and are then scanned on the GeneChip Scanner 3000 7G.","97":"NA","98":"GSE14934","99":"NA","100":"NA","101":"NA","102":"THX-1","103":"Public on Feb 21 2009","104":"NA","105":"NA","106":"Feb 20 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM373nnn/GSM373089/suppl/GSM373089.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Hek-HT Control Replicate-1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2698665","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 2.0 ST Array (hugene20st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"control 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Einstein-Allee 11","38":"Ulm","39":"Germany","40":"Neurology","41":"axel.freischmidt@uni-ulm.de","42":"NA","43":"Ulm University","44":"NA","45":"Axel,,Freischmidt","46":"+4973150063051","47":"NA","48":"NA","49":"89081","50":"Affymetrix Expression Console Software 1.4.1.46 for feature extraction and normalization, BRB Array Tools for statistical analysis","51":"53617","52":"NA","53":"['transcriptome of HEK293 cells after transfection of a control RNA', 'a3_allstar-3']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Isolation of total RNA was performed with the RNeasy Plus Mini Kit (Qiagen) as specified by the manufacturer.","61":"NA","62":"NA","63":"NA","64":"GSM2698665","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were grown under standard conditions (37 C; 5% CO2) in DMEM (Thermo Fisher Scientifc #41965039) supplemented with 10% fetal bovine serum.","70":"NA","71":"NA","72":"according to Affymetrix Whole Transcript (WT) Sense Target Labeling Assay","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Whole Transcript (WT) Sense Target Labeling Assay","79":"NA","80":"Jul 30 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL16686","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"according to Affymetrix protocols using a GeneChip 3000 Scanner","97":"NA","98":"GSE101046","99":"NA","100":"NA","101":"NA","102":"control","103":"Public on Jul 30 2018","104":"NA","105":"NA","106":"Jul 10 2017","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2698nnn/GSM2698665/suppl/GSM2698665_a3_allstar-3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"control 3","117":"NA","118":"NA","119":"control RNA","120":"NA","121":"NA","122":"For transfections of AllStars Negative Control siRNA (Qiagen #1027280) or Syn-hsa-miR-1825 (Qiagen #MSY0006765) in a concentration of 5 nM we used the HiPerfect transfection reagent (Qiagen). 24 h post-transfection, the cells were washed twice with PBS followed by RNA extraction.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546579","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"t469ns_1","18":"no treatment","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"t469ns_1:17.4ug.","61":"NA","62":"mutant hek_t469","63":"NA","64":"GSM546579","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C, 5% C02","70":"23-12-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"t469ns_1","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546579/suppl/GSM546579_t469ns_1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"t469ns_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"no treatment","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733411","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071128 CEES exposure 3.5 uM_8h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-30","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-04","53":"Gene expression data from NHEK_071128 CEES exposure 3.5 uM_8h timepoint","54":"NA","55":"NA","56":"NA","57":"3.5","58":"2007-11-28","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733411","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-09","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-11","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071128 CEES exposure 3.5 uM_8h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733411/suppl/GSM733411_071128_CEES_8h_3.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"8","115":"NA","116":"NHEK_071128 CEES exposure 3.5 uM_8h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM606066","2":"NA","3":"293teter","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney cell","15":"NA","16":"NA","17":"293TetER doxycycline 48 h, rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"293TetER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"No 35, Keyan Road, Zhunan Town","38":"Miaoli Conunty","39":"Taiwan","40":"NA","41":"sflin1@gmail.com","42":"NA","43":"National Health Research Institutes, Taiwan","44":"NA","45":"Su-Fang,,Lin","46":"NA","47":"NA","48":"NA","49":"35053","50":"The data were analyzed using Affymetrix Expression Console Software (version 1.1) default analysis settings and RMA (Robust Multi-Array) summarization and normalization options.","51":"33297","52":"NA","53":"Cell densitiy was maintained at 200,000 / ml before induction.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using a RNeasy Mini kit (Qiagene), according to the manufacturers instructions. A 2-round amplification was performed with the ExpressArt TRinucleotide mRNA Amplification Kit (AmpTec) according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM606066","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown to log-phase in DMEM supplemented with 10% tetracycline-free fetal bovine serum before induction.","70":"NA","71":"NA","72":"Samples were hybridized with GeneChip Human Gene 1.0 ST Arrays (Affymetrix) and scanned at the NHRI Microarray Core Facility (Miaoli County, Taiwan).","73":"NA","74":"NA","75":"NA","76":"transformed with sheared Ad5 DNA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Mar 31 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Array scanning was performed according to the manufacturer's instruction (Affymetrix).","97":"NA","98":"['GSE24585', 'GSE24587']","99":"NA","100":"NA","101":"NA","102":"293 EBV Rta inducible line, doxycycline 48 h","103":"Public on Mar 31 2011","104":"NA","105":"NA","106":"Oct 07 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM606nnn/GSM606066/suppl/GSM606066.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"embryonic kidney cell","116":"293TetER doxycycline 48 h, rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were treated with doxycycline (50 nanogram/ml) for 48 h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1045510","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293, empty pcDNA4 vector, biological replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"723 West Michigan St., Room SL306","38":"Indianapolis","39":"USA","40":"Biology","41":"cdumaual@gmail.com","42":"NA","43":"Indiana University-Purdue University Indianapolis","44":"Lab of Stephen K. Randall","45":"Carmen,M.,Dumaual","46":"NA","47":"IN","48":"NA","49":"46285","50":"The data were processed with R-project software version 2.13.1 through the Rstudio interface version 0.94.92.  Intensity values were read using the affy library of the Bioconductor package  version 2.8.  Normalizaton and calls were made using the mas5 procedure under default parameters.","51":"54675","52":"NA","53":"Control","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the TRIzol reagent (Life Technologies) and further purified with a Qiagen Rneasy Mini Kit, following the manufacturers' instructions for both.","61":"NA","62":"NA","63":"NA","64":"GSM1045510","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells stably overexpressing PRL-1 or transfected with empty pcDNA4 vector were grown in 100mm plates in DMEM supplemented with 10% (v/v) fetal bovine serum, 50 units/ml penicillin, and 50ug/ml streptomycin.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C to Affymetrix HG U133 Plus 2.0 arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Affymetrix Genechip Expression Analysis Technical Manual, 2002, Affymetrix).","79":"NA","80":"Jul 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G.","97":"NA","98":"['GSE42586', 'GSE42588']","99":"NA","100":"NA","101":"NA","102":"HEK293 cells stably transfected with empty pcDNA4 vector","103":"Public on Jul 30 2013","104":"NA","105":"NA","106":"Nov 28 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1045nnn/GSM1045510/suppl/GSM1045510_PRL1_EVSt3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293, empty pcDNA4 vector, biological replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1558597","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK_CD44s-Transfected_3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"yes","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Nonnenwald 2","38":"Penzberg","39":"Germany","40":"Pharmaceutical Sciences","41":"fabian.birzele@roche.com","42":"NA","43":"Roche Diagnostics GmbH","44":"NA","45":"Fabian,,Birzele","46":"NA","47":"NA","48":"NA","49":"82377","50":"Partek Genomics suite was used to process CEL files, perform normalization and QC as well as to identify differentially regulated genes between native and CD44 transfected HEK293 cells using ANOVA.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"HEK293-CD44s Clone 4, expressing an average level of HA, was picked for profiling gene expression using Affymetrix Human Genome U133plus 2.0 arrays. Total RNA was prepared using the RNeasy Mini Kit (Qiagen, Germany), Microarray RNA Target Synthesis Kit T7 and RNeasy Mini-Spin Columns (Roche, Germany) and a hybridization mix was created consisting of 30 l of fragmented cRNA solution mixed with control oligonucleotide, staggered control cRNAs, herring sperm DNA, acetylated BSA and hybridization buffer in a total volume of 300 l. All kit procedures were performed according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1558597","65":"NA","66":"NA","67":"NA","68":"NA","69":"For cloning and expression of human CD44 (EMBL accession number M24915) the sequence was codon optimized (Geneart, Germany) and CD44s was expressed using a pcDNA3.1(-) vector (Invitrogen, Germany). PCR was performed with a denaturation step at 94C for 2 min, followed by 30 cycles of denaturation at 94C for 30 sec, annealing at 58C for 30 sec, and extension at 68C for 45 sec, with a final extension of 7 minutes at 68C (Expand High Fidelity PCR Kit, Roche). The PCR product and the vector were digested with EcoRI/HindIII restriction endonucleases, and DNA fragments were resolved by 1% agarose gel electrophoresis,purified from gels (GFX PCR DNA and Gel Band Purification Kit) and ligated (Rapid DNA Ligation Kit, Roche). Vectors were transferred into XL-10 Gold super-competent cells (Stratagene, The Netherlands) by heat shock and transformed cells were isolated form agar plates containing 100g/ml Ampicilin. Vector DNA from transfected cells was isolated using the High Pure Plasmid Isolation Kit (Roche, Germany).","70":"NA","71":"NA","72":"The hybridization mix was loaded onto the arrays and incubated in a roller device for 16 hrs. Hybridization solution was removed, arrays were washed, stained","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"standard Affymtrix protocol","79":"NA","80":"Dec 05 2014","81":"NA","82":"polyA RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned with an Affymetrix GeneChip Scanner 3000 (7G)","97":"NA","98":"GSE63862","99":"NA","100":"NA","101":"NA","102":"cell culture, HEK transfected with CD44s","103":"Public on Dec 05 2014","104":"NA","105":"NA","106":"Dec 04 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1558nnn/GSM1558597/suppl/GSM1558597_KLP_RW3_101125_CD44_PZ.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK_CD44s-Transfected_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1678758","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T_pLEX-MCS_Empty Vector","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Xihuanbei Road","38":"Fuzhou","39":"China","40":"Department of Clinical Genetics and Experimental Medicine","41":"xgfu2010@163.com","42":"NA","43":"Fuzhou General Hospital","44":"NA","45":"Xianguo,,Fu","46":"NA","47":"NA","48":"NA","49":"350025","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and RMA as normalization method.","51":"54675","52":"NA","53":"stable expression of empty vector","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA were isolated from stably transfected HEK293T cells with TRIzol (Invitrogen, Carlsbad, CA), and then followed by a DNase I treatment.","61":"NA","62":"NA","63":"NA","64":"GSM1678758","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK 293T cells were maintained in DMEM/F12 (1:1) medium containing 10% fetal bovine serum. All cells were cultured at 37 C in an incubator containing 5% CO2.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 Plus 2.0 with constant rotation at the speed of 60 rpm. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 100ng total RNA (Cat. AM1792, Ambion).","79":"NA","80":"May 08 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","97":"NA","98":"GSE68668","99":"NA","100":"NA","101":"NA","102":"stably transfected HEK 293T cells of empty lentiviral vector (pLEX-MCS)","103":"Public on May 08 2015","104":"NA","105":"NA","106":"May 07 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1678nnn/GSM1678758/suppl/GSM1678758_Empty_Vector.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_pLEX-MCS_Empty Vector","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Two transfections of pLEX-MCS lentiviral empty vector and pLEX-MCS lentiviral vector with the truncated FMRP were constructed. Transfections were performed with Polyethylenimine for the lentiviral pLEX-MCS vector transfection. For stable transfection, at 24h post transfection, the transiently transfected cells were cultured in DMEM/F12 (1:1) medium containing puromycin for about 2 weeks. Two stable transfectants of empty vector ( pLEX-MCS), pLEX-MCS containing truncated FMR1 (pLEX-MCS-FMR1) were generated and maintained in culture for further studies.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM432927","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"USF1 replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"401 Terry Avenue North","38":"Seattle","39":"USA","40":"NA","41":"cplaisier@systemsbiology.org","42":"NA","43":"Institute for Systems Biology","44":"Nitin Baliga","45":"Christopher,L,Plaisier","46":"2067322139","47":"Washington","48":"NA","49":"98109","50":"A rigorous quality control pipeline was developed to prepare the gene expression microarray data for analysis. First, the CEL files were imported into R 2.8.0 using the justRMA function of the Affymetrix library from Bioconductor, which applies background subtraction and quantile normalization. An alternate CDF file (U133Plus2msk.cdf.gz) was used to exclude mis-targeted and nonspecific probes from the microarrays (Zhang et al. 2005), and probesets with less than 7 remaining probes were also excluded. Probesets with more than 50% absent calls were excluded, as calculated using the panp package from Bioconductor. Finally, the ComBat library in R was used to correct for batch effect (Johnson et al. 2007).","51":"16569","52":"NA","53":"n/a","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was collected using the RNeasy Plus Mini Kit (Cat No. 74134) 48 hours after transient transfection of HEK293T cells.","61":"NA","62":"NA","63":"NA","64":"GSM432927","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"The cRNA probes were then hybridized using standard Affymetrix protocols described in the GeneChip Expression Analysis Technical Manual (Affymetrix P/N 702232).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Samples were then converted to cRNA probes using standard Affymetrix protocols described in the GeneChip Expression Analysis Technical Manual (Affymetrix P/N 702232).","79":"NA","80":"Sep 12 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The chips were scanned using the GeneArray scanner (Affymetrix) to produce CEL files.","97":"NA","98":"GSE17300","99":"NA","100":"NA","101":"NA","102":"HEK293T cell line","103":"Public on Sep 14 2009","104":"NA","105":"NA","106":"Jul 24 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM432nnn/GSM432927/suppl/GSM432927.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"USF1 replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560863","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0 h","17":"MOCK_0h_MDP_biological replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"contol mock","63":"NA","64":"GSM560863","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560863/suppl/GSM560863.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"0 h","113":"NA","114":"NA","115":"NA","116":"MOCK_0h_MDP_biological replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610839","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0hr","17":"HEK293T_miR-132_FSK0hr_rep2","18":"NA","19":"untreated","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610839","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610839/suppl/GSM610839.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610839/suppl/GSM610839.chp.gz']","108":"9606","109":"0hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-132_FSK0hr_rep2","117":"miR-132","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2433277","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 2.0 ST Array (hugene20st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"embryonic kidney cells - c - treated with Mir 22-3p","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Bldg 8, Room 1A11, NIDDK/NIH","38":"Bethesda","39":"USA","40":"GCL","41":"weipingChen@niddk.nih.gov","42":"NA","43":"NIDDK/NIH","44":"Genomics Core Lab","45":"WeiPing,,Chen","46":"301-496-0175","47":"MD","48":"NA","49":"20892","50":"The data were normalized by RMA with Parteck Genomic Suit 6.6","51":"53617","52":"NA","53":"NIH-Inwood-HuGene2.0-6-13-c","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM2433277","65":"NA","66":"NA","67":"NA","68":"NA","69":"Standard human embryonic kidney cells growth protocal","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Dec 17 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL16686","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.","97":"NA","98":"GSE92599","99":"NA","100":"NA","101":"NA","102":"human embryonic kidney cells","103":"Public on Dec 17 2017","104":"NA","105":"NA","106":"Dec 19 2016","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2433nnn/GSM2433277/suppl/GSM2433277_NIH-Inwood-HuGene2.0-6-13-c.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"embryonic kidney cells - c - treated with Mir 22-3p","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"mRNA is obtained by Co-Ip with FLAG tagged PAB-1 expressed in seam cells and VPCs converted to cDNA and amplified using NuGEN pico amplification kit","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1399568","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"78h after transfection","17":"shUBE4B+shLSD1, bio. replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"615 N. Wolfe St.","38":"Baltimore","39":"USA","40":"NA","41":"NA","42":"NA","43":"Johns Hopkins University","44":"NA","45":"Jiou,,Wang","46":"NA","47":"MD","48":"NA","49":"21205","50":"[\"Affymetrix CEL files were extracted and their data normalized with the Partek GS 6.6 platform.  Partek's Extended Meta-Probeset set was used with RMA normalization to create quantile-normalized log2 transcript signal values, which were used in subsequent ANOVA analyses.\", 'probe group file: HuGene-1_0-st-v1.r4.pgf', 'meta-probeset file: HuGene-1_0-st-v1.na32.hg19.transcript.csv']","51":"33297","52":"NA","53":"SAMPLE 4","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Cells were lysed using RNAeasy mini kit (Qiagen), according to manufacturer's instructions. Genomic DNA was first removed by DNAse treatment on the column, and then, additionally, after total RNA was isolated, using DNase Turbo kit (Ambion), followed by additional round of cleaning through RNAeasy columns.","61":"NA","62":"NA","63":"NA","64":"GSM1399568","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells grown in DMEM, 10%FBS, 37C, 5% CO2","70":"NA","71":"NA","72":"17hrs at 45 C with rotation (60rpm) as described by Affymetrix in their GeneChip Expression Analysis Technical Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The Ambion Expression WT kit was used as described in the manufacturer's manual.","79":"NA","80":"Feb 09 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Using Affymetrix GeneChip Scanner 3000 7G and default parameters described by the manufacturer in their GeneChip Expression Analysis Technical Manual","97":"NA","98":"GSE58026","99":"NA","100":"NA","101":"NA","102":"HEK293_shUBE4B+shLSD1","103":"Public on Feb 09 2017","104":"NA","105":"NA","106":"May 28 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1399nnn/GSM1399568/suppl/GSM1399568_GPer-SOD-A4_UL-1a-HuGene_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"78h after transfection","113":"NA","114":"NA","115":"NA","116":"shUBE4B+shLSD1, bio. replicate 1","117":"NA","118":"shRNAs against UBE4B and LSD1","119":"NA","120":"NA","121":"NA","122":"Cells were transfected in 60mm dishes using 4g DNA, 10l Lipofectamine 2000, in total 4.5ml  Optimem-MEM1. Origene's pRS-RFP-C plasmids encoding shRNAs against UBE4B and LSD1, or non-targeting control (CTRL) were used for knockdown. Cells were knocked down for 78h before lysis.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820005","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hrs","17":"HEK293T CTRLpcDNA 6hr 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"overexpression control","64":"GSM1820005","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, overexpression control, 6 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820005/suppl/GSM1820005_Zane_6hr_pcDNA_1_B4_102011.CEL.gz","108":"9606","109":"6 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T CTRLpcDNA 6hr 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733505","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080129 SM exposure 200 uM_16h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-11","29":"Phillips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-06","53":"Gene expression data from NHEK_080129 SM exposure 200 uM_16h timepoint","54":"NA","55":"NA","56":"NA","57":"200.0","58":"2008-01-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733505","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-16","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-07-30","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080129 SM exposure 200 uM_16h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733505/suppl/GSM733505_080129_HD_16h_200.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"16","115":"NA","116":"NHEK_080129 SM exposure 200 uM_16h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874630","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T4h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874630","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 4h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874630/suppl/GSM1874630_RG_30_4OHT_4h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T4h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874655","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"ActD_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874655","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Actinomycin D 2h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874655/suppl/GSM1874655_RG_45_ActD_2h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"ActD_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881005","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 2","17":"Producer culture - fermentation 3- time point 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"1","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 3","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"recombinant protein producer","64":"GSM881005","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Producer culture - fermentation 3- time point 2","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 2","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Producer culture - fermentation 3- time point 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560865","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"2 h","17":"NOD2wt_2h_MDP_biological replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 wt","63":"NA","64":"GSM560865","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560865/suppl/GSM560865.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"2 h","113":"NA","114":"NA","115":"NA","116":"NOD2wt_2h_MDP_biological replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733118","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070829 SM exposure 800 uM_4h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-02-26","29":"Phillips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-14","53":"Gene expression data from NHEK_070829 SM exposure 800 uM_4h timepoint","54":"NA","55":"NA","56":"NA","57":"800.0","58":"2007-08-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733118","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-21","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-07-23","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070829 SM exposure 800 uM_4h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733118/suppl/GSM733118_070829_HD_4h_800.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"4","115":"NA","116":"NHEK_070829 SM exposure 800 uM_4h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1212436","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 2.0 ST Array (hugene20st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"shTET1#2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1515 Holcombe Blvd","38":"Houston","39":"USA","40":"NA","41":"jincl1980@gmail.com","42":"NA","43":"The University of Texas MD Anderson Cancer Center","44":"NA","45":"CHUNLEI,,JIN","46":"NA","47":"TX","48":"NA","49":"77030","50":"The data were analyzed using the Affymetrix Gene Expression Console (v.1.3.1) with RMA (Robust Multi-array Average) normalization algorithm.","51":"53981","52":"NA","53":"Sample 3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1212436","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were cultured in Dulbecco's Modified Eagle Medium modified with 10% fetal bovine serum and 100 g/ml streptomycin-penicillin.","70":"NA","71":"NA","72":"Affymetrix GeneChip Human Gene 2.0 ST arrays were hybridized to 5.5ug of biotin labeled cDNA, washed and stained according to Affymetrix protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"100 ng of total RNA were amplified using the Ambion WT Expression Kit and cDNA were biotin labelled using Affymetrix GeneChip WT Terminal Labeling protocol.","79":"NA","80":"Jun 04 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL16686","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using GeneChip Scanner 3000 (Affymetrix)","97":"NA","98":"['GSE44039', 'GSE50016']","99":"NA","100":"NA","101":"NA","102":"HEK293T_TET1 shRNA","103":"Public on Jun 04 2014","104":"NA","105":"NA","106":"Aug 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1212nnn/GSM1212436/suppl/GSM1212436_YC-04-03-2013-HuGene-shTET1_2_Temple.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"shTET1#2","117":"NA","118":"TET1 shRNA#2","119":"NA","120":"NA","121":"NA","122":"mTET1-CD, TET1-CD, mTET1-FL, TET1-FL expression plasmid or empty vector was transfected into HEK293T cells by using OPTI-MEM (Invitrogen) and FuGene HD transfection reagent (Roche). Three days after transfection, overexpressed cells were purified with fluorescent activated cell sortng. Lentiviral shRNA-mediated TET1 knockdown were also established in HEK293T cells, and one control and two TET1 knockdown clones were identified.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560857","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0 h","17":"NOD2wt_0h_MDP_biological replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 wt","63":"NA","64":"GSM560857","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560857/suppl/GSM560857.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"0 h","113":"NA","114":"NA","115":"NA","116":"NOD2wt_0h_MDP_biological replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM678667","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Control_1_h_Replicate 4","18":"NA","19":"Control","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"4","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 65","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678667","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"2","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"2","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"1","114":"NA","115":"NA","116":"HEK293_Control_1_h_Replicate 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442112","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,2h,treated,biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"2 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442112","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, treated_2h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442112/suppl/GSM1442112_2hGFP_REP3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,2h,treated,biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM360325","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 1hr, replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"50 South Drive, Bldg.50, Rm.2347","38":"Bethesda","39":"USA","40":"NA","41":"changah@nhlbi.nih.gov","42":"NA","43":"NIH\\\\NHLBI","44":"Laboratory of Biochemistry","45":"Allen,HK,Chang","46":"NA","47":"MD","48":"NA","49":"20892","50":"The data were first processed with GCOS1.4 using Affymetrix default analysis settings. The trimmed mean target intensity of each array was arbitrarily set to 1000. Intensities obtained in CHP file generated by GCOS were normalized using an adaptive variance-stabilizing quantile normalization (Munson, P.J., GeneLogic Workshop of Low Level Analysis of Affymetrix GeneChip Data, 2001, software available at http://abs.cit.nih.gov/geneexpression.html).","51":"54675","52":"NA","53":"gene expression data from human embryonic kidney cells (cell culture) treated with epoxomicin for 1hr","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 cells using Qiagen RNeasy Mini Kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM360325","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells are maintained in DMEM supplemented with 10% fetal bovine serum in 3% oxygen, 5% carbon dioxide, 37 degrees Celsius humidified incubator.","70":"NA","71":"NA","72":"Fragmented RNA was hybridized to Affymetrix HG-U133 plus 2.0 chips for 16 hours, washed, stained on an Affymetrix fluidics station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol using Affymetrixs IVT labeling kit following the manufacturers directions.","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Hybridized chips were scanned using Affymetrix genechip scanner 3000","97":"NA","98":"GSE14429","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 1hr","103":"Public on Jan 15 2009","104":"NA","105":"NA","106":"Jan 14 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM360nnn/GSM360325/suppl/GSM360325.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 1hr, replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 uM epoxomicin is added to HEK293 cells and incubated for 1 and 6 hours before RNA extraction. RNA was extracted from cells without treatment at zero time point as control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693943","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"72h","17":"HEK293T_BACH1-siRNA1_72h_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_q_1_72', 'BACH1_q_1_300ng_72h_293T.CEL', 'Gene expression data from HEK 293T cells 72h after knockdown of BACH1 with Qiagen siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693943","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"siRNA1 SI00309876 (q)","102":"HEK 293T cells, BACH1 knockdown, 72h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693943/suppl/GSM693943.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693943/suppl/GSM693943.EXP.gz']","108":"9606","109":"72h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-siRNA1_72h_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861623","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Mutant, no leptin, biological replicate 1","18":"untreated","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"PO Box 800741","38":"Charlottesville","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Virginia","44":"NA","45":"Stephen,,Turner","46":"NA","47":"VA","48":"NA","49":"22908","50":"Data extraction, QC, and GCRMA normalization were performed with BioConductor software.  Differential expression was assessed with moderated ANOVA, using the BioConductor limma package; false discovery rate (FDR) estimates were calculated using the Benjamini-Hochberg method.","51":"54675","52":"NA","53":"Mutant, no leptin, biological replicate 1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was prepared using RNeasy Mini kit (QIAGEN) and its quality was verified in an Agilent Bioanalyzer.","61":"NA","62":"NA","63":"NA","64":"GSM861623","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T/17 cells were maintained in a humidified incubator at 37 C with 5% CO2. HEK293T/17 cells were cultured in DMEM/F12 (Gibco) with non-essential amino acids, sodium pyruvate and 10% heat inactivated FBS.  Jurkat T-cells were cultured in RPMI supplemented with 10% heat inactivated FBS.  Caco-2 cells were cultured in EMEM (Gibco) supplemented with non-essential amino acids, sodium pyruvate and 20% heat inactivated FBS.  Cells were discarded after passage 25 and new cultures were started from frozen stocks. HEK293T117 cells were transiently transfected using lipofectamine 2000 per the product instructions (Invitrogen, Carlsbad, CA). The plasmids mLEPRb/pCDNA3 (47), mLEPRbR223/pCDNA3 (35) and LEPRbDelta65/pCDNA3 (47) were obtained from Martin Myers and have been described previously as referenced. pCDNA3 was used as a vector control. The plasmid mLEPRb/pCDNA3 was used as a template for site-directed mutagenesis to construct mLEPRb985L/pCDNA3, LEPRb1077L/pCDNA3 and mLEPRb1138L/pCDNA3.  Site-directed mutagenesis was done using the quikchange kit (Stragene/Agilent, Santa Clara, CA).    The presence of the desired mutations and the absence of other mutations were confirmed by DNA sequencing.","70":"NA","71":"NA","72":"Three biological replicates of each sample were hybridized to Human Genome U133 Plus 2.0 gene chips (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA was amplified and converted to cDNA using the 3' IVT Express Kit (Affymetrix).","79":"NA","80":"Jan 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned using the GeneChip Scanner 3000 7G (AffyMetrix).","97":"NA","98":"GSE35068","99":"NA","100":"NA","101":"NA","102":"Mutant, no leptin","103":"Public on Jan 01 2015","104":"NA","105":"NA","106":"Jan 12 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861623/suppl/GSM861623_MUT+1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Mutant, no leptin, biological replicate 1","117":"NA","118":"NA","119":"Y1138L (STAT3-mutant) leptin receptor","120":"NA","121":"untreated","122":"HEK293 cells were transfected with WT LepR or Y1138L (STAT3-mutant) leptin receptor.  48 hours post-transfection cells were made quiescent by incubation in optimum plus 0.5% BSA for 3 hours.  Cells were then stimulated with 100ng of leptin or maintained in optimum plus 0.5% BSA for an additional 3 hours. Leptin was purchased from Dr. A.F. Parlow, National Hormone and Peptide Program (Torrance, CA). The STAT3 inhibitor, Stattic, the PI3K inhibitor, LY294002 and the MEK inhibitor PD98059 were purchased from EMD chemicals (Gibbstown, NJ).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733150","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070912 NM exposure 800 uM_1h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-11","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-24","53":"Gene expression data from NHEK_070912 NM exposure 800 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"800.0","58":"2007-09-12","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733150","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-22","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-24","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070912 NM exposure 800 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733150/suppl/GSM733150_070912_NM_1h_800.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_070912 NM exposure 800 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM360329","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 6hr, replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"50 South Drive, Bldg.50, Rm.2347","38":"Bethesda","39":"USA","40":"NA","41":"changah@nhlbi.nih.gov","42":"NA","43":"NIH\\\\NHLBI","44":"Laboratory of Biochemistry","45":"Allen,HK,Chang","46":"NA","47":"MD","48":"NA","49":"20892","50":"The data were first processed with GCOS1.4 using Affymetrix default analysis settings. The trimmed mean target intensity of each array was arbitrarily set to 1000. Intensities obtained in CHP file generated by GCOS were normalized using an adaptive variance-stabilizing quantile normalization (Munson, P.J., GeneLogic Workshop of Low Level Analysis of Affymetrix GeneChip Data, 2001, software available at http://abs.cit.nih.gov/geneexpression.html).","51":"54675","52":"NA","53":"gene expression data from human embryonic kidney cells (cell culture) treated with epoxomicin for 6hr","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 cells using Qiagen RNeasy Mini Kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM360329","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells are maintained in DMEM supplemented with 10% fetal bovine serum in 3% oxygen, 5% carbon dioxide, 37 degrees Celsius humidified incubator.","70":"NA","71":"NA","72":"Fragmented RNA was hybridized to Affymetrix HG-U133 plus 2.0 chips for 16 hours, washed, stained on an Affymetrix fluidics station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol using Affymetrixs IVT labeling kit following the manufacturers directions.","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Hybridized chips were scanned using Affymetrix genechip scanner 3000","97":"NA","98":"GSE14429","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 6hr","103":"Public on Jan 15 2009","104":"NA","105":"NA","106":"Jan 14 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM360nnn/GSM360329/suppl/GSM360329.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 6hr, replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 uM epoxomicin is added to HEK293 cells and incubated for 1 and 6 hours before RNA extraction. RNA was extracted from cells without treatment at zero time point as control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733164","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070912 NM exposure 50 uM_4h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-17","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-24","53":"Gene expression data from NHEK_070912 NM exposure 50 uM_4h timepoint","54":"NA","55":"NA","56":"NA","57":"50.0","58":"2007-09-12","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733164","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-17","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-31","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070912 NM exposure 50 uM_4h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733164/suppl/GSM733164_070912_NM_4h_50.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"4","115":"NA","116":"NHEK_070912 NM exposure 50 uM_4h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM258515","2":"NA","3":"hek293 human embryonic kidney cell line","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina human-6 v2.0 expression beadchip (Illumina_Human-6_V2.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_MIF siRNA 1#_24h_Illumina","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293 human embryonic kidney cell line","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Handan Road 220#","38":"Shanghai","39":"China","40":"Life Science","41":"liulingfeng1111@gmail.com","42":"NA","43":"Fudan University","44":"the State Key Laboratory of Genetic Engineering","45":"Lingfeng,,Liu","46":"+86-21-65643262","47":"NA","48":"NA","49":"200433","50":"Cubic spline normalization using Illumina BeadStudio Version \"BSGX Version3.2.3\"","51":"48702","52":"NA","53":"MIF siRNA-mediated MIF knockdown in HEK293 cells","54":"illuminaHumanv2","55":"98.42364","56":"NA","57":"NA","58":"NA","59":"NA","60":"Illumina TotalPrep RNA amplification kit (Ambion Catalog#IL1791)","61":"NA","62":"NA","63":"NA","64":"GSM258515","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Refer to the Illumina Gene Expression System Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"Streptavidin Cy3","78":"As described in the illumina Human-6 chip processing protocol. Briefly, generation of biotin labelled cRNA from the product of RT cDNA synthesis and 2nd strand cDNA synthesis.","79":"NA","80":"Mar 29 2010","81":"99.99795","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6102","86":"MIF depletion, siRNA-mediated","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Refer to the Illumina Gene Expression System Manual","97":"NA","98":"GSE10241","99":"NA","100":"NA","101":"NA","102":"HEK293 cell, siRNA-mediated MIF knockdown","103":"Public on Nov 03 2009","104":"NA","105":"NA","106":"Jan 23 2008","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM258nnn/GSM258515/suppl/GSM258515.txt.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293_MIF siRNA 1#_24h_Illumina","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM205760","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 cell line #6 with induced HNF4a2 mutant R154X","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 1000.","51":"54675","52":"NA","53":"Analysis of gene expression in human embryonic kidney cells (HEK293) overexpressing the transcription factor HNF4a2 or mutant forms HNF4a2 C106R or R154X, which were introduced by FRT/FLP recombination. The analysis were performed 24 hours following 1 g/ml doxycyclin treatment to induce the expression of the trans-genes. Results identify HNF4 regulated genes in kidney cells being several of these genes deregulated in renal cell carcinoma.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Rneasy mini extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM205760","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133_Plus_2.0 arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual v2, Affymetrix).","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000.","97":"NA","98":"GSE8289","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line #6 with induced HNF4a2 mutant R154X","103":"Public on Jun 20 2008","104":"NA","105":"NA","106":"Jun 26 2007","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205760/suppl/GSM205760.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205760/suppl/GSM205760.CHP.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205760/suppl/GSM205760.EXP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cell line #6 with induced HNF4a2 mutant R154X","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were treated for 24 h with 1 g/ml doxycyclin or solvent.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874645","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"EGF_1h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874645","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER EGF 1h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874645/suppl/GSM1874645_NB_54_EGF_1h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"EGF_1h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733180","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070912 NM exposure 1000 uM_8h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-19","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-24","53":"Gene expression data from NHEK_070912 NM exposure 1000 uM_8h timepoint","54":"NA","55":"NA","56":"NA","57":"1000.0","58":"2007-09-12","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733180","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-22","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-24","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070912 NM exposure 1000 uM_8h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733180/suppl/GSM733180_070912_NM_8h_1000.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"8","115":"NA","116":"NHEK_070912 NM exposure 1000 uM_8h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733468","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080129 SM exposure 25 uM_1h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-06","29":"Philips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-06","53":"Gene expression data from NHEK_080129 SM exposure 25 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"25.0","58":"2008-01-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733468","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-02","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-06-04","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080129 SM exposure 25 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733468/suppl/GSM733468_080129_HD_1h_25.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_080129 SM exposure 25 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874650","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"FGF_4h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874650","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER FGF 4h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874650/suppl/GSM1874650_NB_59_FGF_4h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"FGF_4h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733452","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080116 CEES exposure 0.1 uM_16h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-05-06","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-07","53":"Gene expression data from NHEK_080116 CEES exposure 0.1 uM_16h timepoint","54":"NA","55":"NA","56":"NA","57":"0.1","58":"2008-01-16","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733452","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-15","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-17","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080116 CEES exposure 0.1 uM_16h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733452/suppl/GSM733452_080116_CEES_16h_0.1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"16","115":"NA","116":"NHEK_080116 CEES exposure 0.1 uM_16h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1049716","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek cell clones","15":"NA","16":"NA","17":"Re-cultured GRK2-expressing HEK cell clone after NOD.Scid mouse expansion-rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK cell clones","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"['Ex-Scid-GRK-1', 'Re-cultured GRK2-expressing HEK cell clone after expansion in NOD.Scid mice', 'Gene expression data of re-cultured NOD.Scid-mouse-expanded GRK2-expressing HEK cell clone']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from HEK cell clones with the RNeasy Mini kit according to the manufacturer`s instructions (Qiagen).","61":"NA","62":"NA","63":"GRK2","64":"GSM1049716","65":"NA","66":"NA","67":"NA","68":"NA","69":"The study was performed with HEK cell clones stably expressing GRK2 or the kinase-deficient GRK2-K220R mutant. HEK cell clones were either expanded for 4 weeks in vivo in immunodeficient NOD.Scid mice (3 months of age), cultured in vitro, or re-cultured in vitro after expansion in NOD.Scid mice","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Affymetrix Human genome U133 Plus 2.0 Array) in 200 l of the hybrization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual).","79":"NA","80":"Dec 06 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"re-cultured in vitro after expansion in NOD.Scid mice","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE42771","99":"NA","100":"NA","101":"NA","102":"Re-cultured GRK2-expressing HEK cell clone after NOD.Scid mouse expansion","103":"Public on Dec 06 2012","104":"NA","105":"NA","106":"Dec 06 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049716/suppl/GSM1049716_Ex-Scid-GRK-1.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049716/suppl/GSM1049716_Ex-Scid-GRK-1.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Re-cultured GRK2-expressing HEK cell clone after NOD.Scid mouse expansion-rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For the microarray study, cell pellets were isolated from three study groups: (i) NOD.Scid mouse-expanded HEK clones expressing either GRK2 or kinase-deficient GRK2-K220R (Scid), (ii) in vitro cultured HEK cell clones expressing GRK2 or GRK2-K220R (HEK), and (iii) in vitro re-cultured HEK cell clones after NOD.Scid mouse expansion (Ex-Scid).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820018","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24 hrs","17":"HEK293T CTRLpcDNA 24hr 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"overexpression control","64":"GSM1820018","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, overexpression control, 24 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820018/suppl/GSM1820018_Zane_24hr_pcDNA_2_B11_102011.CEL.gz","108":"9606","109":"24 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T CTRLpcDNA 24hr 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM941939","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture, transfected, biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"transfected","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"24 h gene profile of transfected (GFP positive) HEK293T cells.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM941939","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm.","97":"NA","98":"['GSE38422', 'GSE59665']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, transfected_24h","103":"Public on Jun 03 2012","104":"NA","105":"NA","106":"Jun 02 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM941nnn/GSM941939/suppl/GSM941939_AnP_Hu13302_081910_04_P38.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture, transfected, biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic PEI polymer mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18 h after seeding and flow separated after another 24 h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874658","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"ActD_4OHT_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874658","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 2h and subsequent actinomycin D 1h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874658/suppl/GSM1874658_RG_40_4OHT_ActD_2h_1h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"ActD_4OHT_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1212437","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina Genome Analyzer II (Illumina Genome Analyzer II)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Vector control","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1515 Holcombe Blvd","38":"Houston","39":"USA","40":"NA","41":"jincl1980@gmail.com","42":"NA","43":"The University of Texas MD Anderson Cancer Center","44":"NA","45":"CHUNLEI,,JIN","46":"NA","47":"TX","48":"NA","49":"77030","50":"The data were analyzed using the Affymetrix Gene Expression Console (v.1.3.1) with RMA (Robust Multi-array Average) normalization algorithm.","51":"53981","52":"NA","53":"Sample 4","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1212437","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were cultured in Dulbecco's Modified Eagle Medium modified with 10% fetal bovine serum and 100 g/ml streptomycin-penicillin.","70":"NA","71":"NA","72":"Affymetrix GeneChip Human Gene 2.0 ST arrays were hybridized to 5.5ug of biotin labeled cDNA, washed and stained according to Affymetrix protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"100 ng of total RNA were amplified using the Ambion WT Expression Kit and cDNA were biotin labelled using Affymetrix GeneChip WT Terminal Labeling protocol.","79":"NA","80":"Jun 04 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL16686","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using GeneChip Scanner 3000 (Affymetrix)","97":"NA","98":"['GSE44039', 'GSE50016']","99":"NA","100":"NA","101":"NA","102":"HEK293T_empty vector","103":"Public on Jun 04 2014","104":"NA","105":"NA","106":"Aug 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1212nnn/GSM1212437/suppl/GSM1212437_YC-04-03-2013-HuGene-Empty_vector_Temple.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Vector control","117":"NA","118":"empty vector","119":"NA","120":"NA","121":"NA","122":"mTET1-CD, TET1-CD, mTET1-FL, TET1-FL expression plasmid or empty vector was transfected into HEK293T cells by using OPTI-MEM (Invitrogen) and FuGene HD transfection reagent (Roche). Three days after transfection, overexpressed cells were purified with fluorescent activated cell sortng. Lentiviral shRNA-mediated TET1 knockdown were also established in HEK293T cells, and one control and two TET1 knockdown clones were identified.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733359","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071107 CEES exposure 2.0 uM_8h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-23","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-30","53":"Gene expression data from NHEK_071107 CEES exposure 2.0 uM_8h timepoint","54":"NA","55":"NA","56":"NA","57":"2.0","58":"2007-11-07","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733359","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-30","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-08-13","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071107 CEES exposure 2.0 uM_8h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733359/suppl/GSM733359_071107_CEES_8h_2.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"8","115":"NA","116":"NHEK_071107 CEES exposure 2.0 uM_8h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874648","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"FGF_1h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874648","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER FGF 1h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874648/suppl/GSM1874648_NB_57_FGF_1h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"FGF_1h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM569347","2":"NA","3":"embryonic kidney cell line hek","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"WT in the absence of tetracycline, rep3","18":"NA","19":"untreated","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Embryonic kidney cell line HEK","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1 Oryong-dong Buk-gu","38":"Gwangju","39":"South Korea","40":"Life science","41":"lbc0523@gist.ac.kr","42":"82629702540","43":"Gwangju Institutue Science and Technology","44":"NA","45":"Byoung-Cheol,,Lee","46":"82629702566","47":"NA","48":"NA","49":"500712","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from HEK cells non-expressing WT TRPM7 channel', 'WT no3']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"WT channel","64":"GSM569347","65":"NA","66":"NA","67":"NA","68":"NA","69":"Stabel cell-lines were grown in in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum and an antibiotic, 5 ug/mL blasticidin (Invitrogen). Cells were cultured in a humidified atmosphere of 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Fragmented cRNA was hybridized to the Human Genome UI133 Plus 2.0 Array (Affymetrix) at 45C for 16 h according to the Affymetrix standard protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"5 ug of total RNA from each cell-lines was used for labeling. Probe synthesis from total RNA samples, hybridization, detection, and scanning were performed according to standard protocols from Affymetrix, Inc..","79":"NA","80":"Jul 23 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"After hybridization, the arrays were washed in a GeneChip Fluidics Station 450 with a non-stringent wash buffer at 25C followed by a stringent wash buffer at 50C. After washing, the arrays were stained with a streptavidin-phycoerythrin complex. After staining, intensities were determined with a GeneChip scanner 3000 (Affymetrix), controlled by GCOS Affymetrix software.","97":"NA","98":"GSE23102","99":"NA","100":"NA","101":"NA","102":"HEK cell lines non-expressing WT channel","103":"Public on Jul 23 2011","104":"NA","105":"NA","106":"Jul 23 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM569nnn/GSM569347/suppl/GSM569347.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"WT in the absence of tetracycline, rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 ug of tetracycline was treated to stabel cell-lines which overexressing WT and mutant TRPM7 channel for 72 hours","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874660","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"ActD_4OHT_4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874660","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 2h and subsequent actinomycin D 4h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874660/suppl/GSM1874660_RG_42_4OHT_ActD_2h_4h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"ActD_4OHT_4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693938","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24h","17":"HEK293T_mock-transfection_24h_rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_m_3_24', 'MOCK_m_3_0ng_24h_293T.CEL', 'Gene expression data from HEK 293T cells 24h after mock transfection without siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"control","64":"GSM693938","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"mock (without siRNA)","102":"HEK 293T cells, mock transfection, 24h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693938/suppl/GSM693938.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693938/suppl/GSM693938.EXP.gz']","108":"9606","109":"24h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_mock-transfection_24h_rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1039982","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,transfected,biological rep 6","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"GFP_6","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1039982","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 22 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE59666","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"['GSE20615', 'GSE59666']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,transfected,biological rep 6_24h","103":"Public on Nov 21 2012","104":"NA","105":"NA","106":"Nov 21 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1039nnn/GSM1039982/suppl/GSM1039982_AnP_Hu13302_062910_07_P29.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,transfected,biological rep 6","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM402153","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"L188Q mutant LQ_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"3333 Burnet Ave","38":"Cincinnati","39":"USA","40":"NA","41":"yan.xu@cchmc.org","42":"NA","43":"Cincinnati Children's Hospital Medical Center","44":"NA","45":"Yan,,Xu","46":"513-6368921","47":"OH","48":"NA","49":"45229","50":"MAS5 normalization, ANOVA","51":"54675","52":"NA","53":"transitently transfected with L 188Q mutant of surfactant protein C","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"accroding to manufacture's protocol (Affymetrix)","61":"NA","62":"NA","63":"NA","64":"GSM402153","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"accroding to manufacture's protocol (Affymetrix)","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"accroding to manufacture's protocol (Affymetrix)","79":"NA","80":"May 13 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"accroding to manufacture's protocol (Affymetrix)","97":"NA","98":"GSE16054","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line","103":"Public on May 14 2009","104":"NA","105":"NA","106":"May 11 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM402nnn/GSM402153/suppl/GSM402153.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"L188Q mutant LQ_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733497","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080129 SM exposure 200 uM_8h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-10","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-06","53":"Gene expression data from NHEK_080129 SM exposure 200 uM_8h timepoint","54":"NA","55":"NA","56":"NA","57":"200.0","58":"2008-01-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733497","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-16","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-07-30","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080129 SM exposure 200 uM_8h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733497/suppl/GSM733497_080129_HD_8h_200.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"8","115":"NA","116":"NHEK_080129 SM exposure 200 uM_8h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2716911","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human emborynic kidney 293 cells","15":"NA","16":"NA","17":"overexpression of the empty lentiviral vector_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"156 Xierhuan Road","38":"Fuzhou","39":"China","40":"NA","41":"xmuywj@163.com","42":"NA","43":"Fuzhou General Hospital","44":"NA","45":"Yang,,wenjing","46":"+8615959229926","47":"NA","48":"NA","49":"350025","50":"The data were analyzed using Affymetrix GeneChip Command Console Software.","51":"54675","52":"NA","53":"overexpression of the empty lentiviral vector in HEK293T cells","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM2716911","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell lines were grown at 37C with 5% CO2","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 23 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using GeneChip Scanner 3000.","97":"NA","98":"GSE101830","99":"NA","100":"NA","101":"NA","102":"overexpression of the empty lentiviral vector in HEK293T cells","103":"Public on Jul 26 2017","104":"NA","105":"NA","106":"Jul 25 2017","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2716nnn/GSM2716911/suppl/GSM2716911_161020-160682B_H_HG-U133_Plus_2_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"human emborynic kidney 293 cells","116":"overexpression of the empty lentiviral vector_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"DMEM medium with 10% FBS and 1% penicillin/streptomycin","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820004","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hrs","17":"HEK293T FMR4siRNA 6hr 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"FMR4 knockdown","64":"GSM1820004","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, FMR4 knockdown, 6 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820004/suppl/GSM1820004_Zane_6hr_FMR4si_3_A3_102011.CEL.gz","108":"9606","109":"6 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T FMR4siRNA 6hr 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693932","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24h","17":"HEK293T_BACH1-siRNA1_24h_rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_q_3_24', 'BACH1_q_3_300ng_24h_293T.CEL', 'Gene expression data from HEK 293T cells 24h after knockdown of BACH1 with Qiagen siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693932","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"siRNA1 SI00309876 (q)","102":"HEK 293T cells, BACH1 knockdown, 24h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693932/suppl/GSM693932.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693932/suppl/GSM693932.EXP.gz']","108":"9606","109":"24h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-siRNA1_24h_rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442096","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,8h,untransfected,biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"8 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442096","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_8h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442096/suppl/GSM1442096_8hGFPM_REP1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,8h,untransfected,biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1174945","2":"NA","3":"isogenic human embryonal kidney (hek293) cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 h","17":"GR3KR_vehicle_6h_rep2","18":"vehicle","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Isogenic Human Embryonal Kidney (HEK293) Cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Yliopistonranta 1E","38":"Kuopio","39":"Finland","40":"School of Medicine","41":"villepaakinaho@gmail.com","42":"NA","43":"University of Eastern Finland","44":"Biomedicine","45":"Ville,,Paakinaho","46":"NA","47":"NA","48":"NA","49":"70210","50":"Obtained data was normalized using VST transformation and RSN normalization  used as standard approach for Illumina arrays with the R/lumi package","51":"47323","52":"NA","53":"['stably expressing GR3KR', '3KR_8']","54":"illuminaHumanv4","55":"98.37030","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using TriPure (Roche Diagnostics GmbH, Mannheim, Germany) according to manufacture's instructions","61":"NA","62":"NA","63":"NA","64":"GSM1174945","65":"NA","66":"NA","67":"NA","68":"NA","69":"Isogenic HEK293 cells were grown in Dulbecco's Modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 25 U/ml penicillin and 25 g/ml streptomycin, and 100 g hygromycin-B,  and kept at 37 C in a humidified 95% air/ 5% CO2","70":"NA","71":"NA","72":"Standart Illumina hybridization protocol","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared with the Ambion MessageAmk kit for Illumina arrays","79":"NA","80":"Nov 05 2013","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standart Illumina scanning protocol","97":"NA","98":"['GSE48328', 'GSE48379']","99":"NA","100":"NA","101":"NA","102":"Isogenic HEK293 Cells, vehicle treated, 6 h","103":"Public on Nov 05 2013","104":"NA","105":"NA","106":"Jun 26 2013","107":"NONE","108":"9606","109":"6 h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"GR3KR_vehicle_6h_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"vehicle","122":"3x105x of Isogenic HEK293 cells were seeded at 6-well plates and allowed to grow in steroid-depleted medium (2.5 %  charcoal stripped FBS in DMEM) 36 h and the cells were subsequently treated with 100 nM of dexamethasone for 6 h prior extraction of RNA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM432926","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"USF1 replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"401 Terry Avenue North","38":"Seattle","39":"USA","40":"NA","41":"cplaisier@systemsbiology.org","42":"NA","43":"Institute for Systems Biology","44":"Nitin Baliga","45":"Christopher,L,Plaisier","46":"2067322139","47":"Washington","48":"NA","49":"98109","50":"A rigorous quality control pipeline was developed to prepare the gene expression microarray data for analysis. First, the CEL files were imported into R 2.8.0 using the justRMA function of the Affymetrix library from Bioconductor, which applies background subtraction and quantile normalization. An alternate CDF file (U133Plus2msk.cdf.gz) was used to exclude mis-targeted and nonspecific probes from the microarrays (Zhang et al. 2005), and probesets with less than 7 remaining probes were also excluded. Probesets with more than 50% absent calls were excluded, as calculated using the panp package from Bioconductor. Finally, the ComBat library in R was used to correct for batch effect (Johnson et al. 2007).","51":"16569","52":"NA","53":"n/a","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was collected using the RNeasy Plus Mini Kit (Cat No. 74134) 48 hours after transient transfection of HEK293T cells.","61":"NA","62":"NA","63":"NA","64":"GSM432926","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"The cRNA probes were then hybridized using standard Affymetrix protocols described in the GeneChip Expression Analysis Technical Manual (Affymetrix P/N 702232).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Samples were then converted to cRNA probes using standard Affymetrix protocols described in the GeneChip Expression Analysis Technical Manual (Affymetrix P/N 702232).","79":"NA","80":"Sep 12 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The chips were scanned using the GeneArray scanner (Affymetrix) to produce CEL files.","97":"NA","98":"GSE17300","99":"NA","100":"NA","101":"NA","102":"HEK293T cell line","103":"Public on Sep 14 2009","104":"NA","105":"NA","106":"Jul 24 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM432nnn/GSM432926/suppl/GSM432926.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"USF1 replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874649","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"FGF_2h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874649","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER FGF 2h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874649/suppl/GSM1874649_NB_58_FGF_2h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"FGF_2h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM432928","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"USF1 replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"401 Terry Avenue North","38":"Seattle","39":"USA","40":"NA","41":"cplaisier@systemsbiology.org","42":"NA","43":"Institute for Systems Biology","44":"Nitin Baliga","45":"Christopher,L,Plaisier","46":"2067322139","47":"Washington","48":"NA","49":"98109","50":"A rigorous quality control pipeline was developed to prepare the gene expression microarray data for analysis. First, the CEL files were imported into R 2.8.0 using the justRMA function of the Affymetrix library from Bioconductor, which applies background subtraction and quantile normalization. An alternate CDF file (U133Plus2msk.cdf.gz) was used to exclude mis-targeted and nonspecific probes from the microarrays (Zhang et al. 2005), and probesets with less than 7 remaining probes were also excluded. Probesets with more than 50% absent calls were excluded, as calculated using the panp package from Bioconductor. Finally, the ComBat library in R was used to correct for batch effect (Johnson et al. 2007).","51":"16569","52":"NA","53":"n/a","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was collected using the RNeasy Plus Mini Kit (Cat No. 74134) 48 hours after transient transfection of HEK293T cells.","61":"NA","62":"NA","63":"NA","64":"GSM432928","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"The cRNA probes were then hybridized using standard Affymetrix protocols described in the GeneChip Expression Analysis Technical Manual (Affymetrix P/N 702232).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Samples were then converted to cRNA probes using standard Affymetrix protocols described in the GeneChip Expression Analysis Technical Manual (Affymetrix P/N 702232).","79":"NA","80":"Sep 12 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The chips were scanned using the GeneArray scanner (Affymetrix) to produce CEL files.","97":"NA","98":"GSE17300","99":"NA","100":"NA","101":"NA","102":"HEK293T cell line","103":"Public on Sep 14 2009","104":"NA","105":"NA","106":"Jul 24 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM432nnn/GSM432928/suppl/GSM432928.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"USF1 replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881019","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 4","17":"Producer culture - fermentation 2- time point 4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"2","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 17","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"recombinant protein producer","64":"GSM881019","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Producer culture - fermentation 2- time point 4","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 4","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Producer culture - fermentation 2- time point 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546584","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hours","17":"t466fsh_3","18":"fsh - hormone treatment - fsh stimulation","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"3nM","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"t466fsh_3:43ug.","61":"NA","62":"mutant hek293_t466","63":"NA","64":"GSM546584","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C, 5% C02","70":"20-10-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"t466fsh_3","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546584/suppl/GSM546584_t466fsh_3.CEL.gz","108":"9606","109":"6 hours","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"t466fsh_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"FSH - hormone treatment - fsh stimulation","122":"Name:FSH - hormone treatment - fsh stimulation,follicle stimulating hormone (fsh):quantity 3nM time 6hour . 3nM","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733478","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080129 SM exposure 100 uM_2h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-06","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-06","53":"Gene expression data from NHEK_080129 SM exposure 100 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"100.0","58":"2008-01-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733478","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-16","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-07-30","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080129 SM exposure 100 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733478/suppl/GSM733478_080129_HD_2h_100.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_080129 SM exposure 100 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610838","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0hr","17":"HEK293T_miR-neg_FSK0hr_rep2","18":"NA","19":"untreated","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610838","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610838/suppl/GSM610838.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610838/suppl/GSM610838.chp.gz']","108":"9606","109":"0hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-neg_FSK0hr_rep2","117":"negative control","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733218","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070919 NM exposure 600 uM_4h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-25","29":"Phillips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-25","53":"Gene expression data from NHEK_070919 NM exposure 600 uM_4h timepoint","54":"NA","55":"NA","56":"NA","57":"600.0","58":"2007-09-19","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733218","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-23","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-07-25","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070919 NM exposure 600 uM_4h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733218/suppl/GSM733218_070919_NM_4h_600.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"4","115":"NA","116":"NHEK_070919 NM exposure 600 uM_4h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1399574","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"78h after transfection","17":"shUBE4B-3, bio. replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"615 N. Wolfe St.","38":"Baltimore","39":"USA","40":"NA","41":"NA","42":"NA","43":"Johns Hopkins University","44":"NA","45":"Jiou,,Wang","46":"NA","47":"MD","48":"NA","49":"21205","50":"[\"Affymetrix CEL files were extracted and their data normalized with the Partek GS 6.6 platform.  Partek's Extended Meta-Probeset set was used with RMA normalization to create quantile-normalized log2 transcript signal values, which were used in subsequent ANOVA analyses.\", 'probe group file: HuGene-1_0-st-v1.r4.pgf', 'meta-probeset file: HuGene-1_0-st-v1.na32.hg19.transcript.csv']","51":"33297","52":"NA","53":"SAMPLE 10","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Cells were lysed using RNAeasy mini kit (Qiagen), according to manufacturer's instructions. Genomic DNA was first removed by DNAse treatment on the column, and then, additionally, after total RNA was isolated, using DNase Turbo kit (Ambion), followed by additional round of cleaning through RNAeasy columns.","61":"NA","62":"NA","63":"NA","64":"GSM1399574","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells grown in DMEM, 10%FBS, 37C, 5% CO2","70":"NA","71":"NA","72":"17hrs at 45 C with rotation (60rpm) as described by Affymetrix in their GeneChip Expression Analysis Technical Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The Ambion Expression WT kit was used as described in the manufacturer's manual.","79":"NA","80":"Feb 09 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Using Affymetrix GeneChip Scanner 3000 7G and default parameters described by the manufacturer in their GeneChip Expression Analysis Technical Manual","97":"NA","98":"GSE58026","99":"NA","100":"NA","101":"NA","102":"HEK293_shUBE4B","103":"Public on Feb 09 2017","104":"NA","105":"NA","106":"May 28 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1399nnn/GSM1399574/suppl/GSM1399574_GPer-SOD-C2_U-1a-HuGene_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"78h after transfection","113":"NA","114":"NA","115":"NA","116":"shUBE4B-3, bio. replicate 3","117":"NA","118":"shRNAs against UBE4B","119":"NA","120":"NA","121":"NA","122":"Cells were transfected in 60mm dishes using 4g DNA, 10l Lipofectamine 2000, in total 4.5ml  Optimem-MEM1. Origene's pRS-RFP-C plasmids encoding shRNAs against UBE4B and LSD1, or non-targeting control (CTRL) were used for knockdown. Cells were knocked down for 78h before lysis.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442098","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,8h,untransfected,biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"8 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442098","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_8h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442098/suppl/GSM1442098_8hGFPM_REP3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,8h,untransfected,biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874626","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T2h_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874626","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 2h replicate 1","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874626/suppl/GSM1874626_RG_26_4OHT_2h_1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T2h_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2089911","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U219 Array (hgu219)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T_mock(dharmacon)BRD1_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Bartholins All 6","38":"Aarhus","39":"Denmark","40":"Biomedicine","41":"tue@biomed.au.dk","42":"NA","43":"Aarhus University","44":"Prof Anders Borglum's lab","45":"Tue,,Fryland","46":"NA","47":"Aarhus","48":"NA","49":"8000","50":"rma","51":"49386","52":"NA","53":"Mock treatment targeted against the BRD1 mRNA transcript (Dharmacon) rep2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Qiagen Rneasy + Qiagen shredder columns (performed according to the supplied protocol)","61":"NA","62":"NA","63":"NA","64":"GSM2089911","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells (controls and stable BRD1-S-V5 and BRD1-L-V5 cell lines) were grown in DMEM medium (Invitrogen, San Diego, CA, USA) supplemented with 5% fetal calf serum (FCS), 175 mg/L glutamine, 36 mg/L penicillin and 60 mg/L streptomycine at 37 oC in 5% CO2","70":"NA","71":"NA","72":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","79":"NA","80":"Mar 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL13667","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"standard Affymetrix protocol","97":"NA","98":"GSE79255","99":"NA","100":"NA","101":"NA","102":"Cell line culture, mock method 2","103":"Public on Mar 16 2016","104":"NA","105":"NA","106":"Mar 15 2016","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2089nnn/GSM2089911/suppl/GSM2089911_A897-06.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_mock(dharmacon)BRD1_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546590","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hours","17":"wtfsh_3","18":"fsh - hormone treatment - fsh stimulation","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"3nM","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"wtfsh_3:85ug.","61":"NA","62":"wild type","63":"NA","64":"GSM546590","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C; 5% C02","70":"20-10-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"wtfsh_3","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546590/suppl/GSM546590_wtfsh_3.CEL.gz","108":"9606","109":"6 hours","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"wtfsh_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"FSH - hormone treatment - fsh stimulation","122":"Name:FSH - hormone treatment - fsh stimulation,follicle stimulating hormone (fsh):quantity 3nM time 6hour . 3nM","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442123","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,16h,transfected,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"16 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442123","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, transfected_16h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442123/suppl/GSM1442123_16hGFPP_REP2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,16h,transfected,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733412","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071128 CEES exposure 4.0 uM_8h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-30","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-04","53":"Gene expression data from NHEK_071128 CEES exposure 4.0 uM_8h timepoint","54":"NA","55":"NA","56":"NA","57":"4.0","58":"2007-11-28","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733412","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-09","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-11","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071128 CEES exposure 4.0 uM_8h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733412/suppl/GSM733412_071128_CEES_8h_4.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"8","115":"NA","116":"NHEK_071128 CEES exposure 4.0 uM_8h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1305859","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"EA07047_56016_H133+_7","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"5635 Fishers Lane, Suite 510","38":"Rockville","39":"USA","40":"NA","41":"raducojo@gmail.com","42":"NA","43":"Elsevier","44":"NA","45":"Radu,,Cojocaru","46":"NA","47":"MD","48":"NA","49":"20852","50":"Data was analyzed using GeneSpring software including QC analysis.","51":"41751","52":"NA","53":"Cells were treated with doxycycline to induce myocilin expression","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted from control and myocilin expressing cells after induction with selected concentrations of doxycycline using a Trizol reagent. The extracted RNA was used for each microarray study.","61":"NA","62":"NA","63":"NA","64":"GSM1305859","65":"NA","66":"NA","67":"NA","68":"NA","69":"Tet-on stably transfected cells were maintained in Dulbecco modified Eagle medium (DMEM) supplemented with 10% Tet system proved fetal bovine serum, penicillin (100 U/ml), streptomycin (100 g/ml), hygromycin B (200 g/ml) and G418 (100 g/ml) at 37 C in a humidified atmosphere of 5% CO2.","70":"NA","71":"NA","72":"Not provided.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Not provided.","79":"NA","80":"May 21 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Not provided.","97":"NA","98":"GSE53985","99":"NA","100":"NA","101":"NA","102":"Stable Cell line transfected with myocilin expressing vector","103":"Public on May 21 2014","104":"NA","105":"NA","106":"Jan 13 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1305nnn/GSM1305859/suppl/GSM1305859_EA07047_56016_H133+_7.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"EA07047_56016_H133+_7","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Tet-on stably transfected cells were treated with 0.2 or 1 g/ ml of doxycycline for 48 hr to induce myocilin expression.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874642","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"UT_1_n","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874642","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER New untreated replicate 1","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874642/suppl/GSM1874642_NB_51_UT_1_HuGene-1_0-st-v1_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"UT_1_n","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874659","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"ActD_4OHT_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874659","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 2h and subsequent actinomycin D 2h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874659/suppl/GSM1874659_RG_41_4OHT_ActD_2h_2h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"ActD_4OHT_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1399569","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"78h after transfection","17":"shCTRL, bio. replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"615 N. Wolfe St.","38":"Baltimore","39":"USA","40":"NA","41":"NA","42":"NA","43":"Johns Hopkins University","44":"NA","45":"Jiou,,Wang","46":"NA","47":"MD","48":"NA","49":"21205","50":"[\"Affymetrix CEL files were extracted and their data normalized with the Partek GS 6.6 platform.  Partek's Extended Meta-Probeset set was used with RMA normalization to create quantile-normalized log2 transcript signal values, which were used in subsequent ANOVA analyses.\", 'probe group file: HuGene-1_0-st-v1.r4.pgf', 'meta-probeset file: HuGene-1_0-st-v1.na32.hg19.transcript.csv']","51":"33297","52":"NA","53":"SAMPLE 5","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Cells were lysed using RNAeasy mini kit (Qiagen), according to manufacturer's instructions. Genomic DNA was first removed by DNAse treatment on the column, and then, additionally, after total RNA was isolated, using DNase Turbo kit (Ambion), followed by additional round of cleaning through RNAeasy columns.","61":"NA","62":"NA","63":"NA","64":"GSM1399569","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells grown in DMEM, 10%FBS, 37C, 5% CO2","70":"NA","71":"NA","72":"17hrs at 45 C with rotation (60rpm) as described by Affymetrix in their GeneChip Expression Analysis Technical Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The Ambion Expression WT kit was used as described in the manufacturer's manual.","79":"NA","80":"Feb 09 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Using Affymetrix GeneChip Scanner 3000 7G and default parameters described by the manufacturer in their GeneChip Expression Analysis Technical Manual","97":"NA","98":"GSE58026","99":"NA","100":"NA","101":"NA","102":"HEK293_shCTRL","103":"Public on Feb 09 2017","104":"NA","105":"NA","106":"May 28 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1399nnn/GSM1399569/suppl/GSM1399569_GPer-SOD-B1_ctrl-1a-HuGene_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"78h after transfection","113":"NA","114":"NA","115":"NA","116":"shCTRL, bio. replicate 2","117":"NA","118":"non-targeting shRNA (control)","119":"NA","120":"NA","121":"NA","122":"Cells were transfected in 60mm dishes using 4g DNA, 10l Lipofectamine 2000, in total 4.5ml  Optimem-MEM1. Origene's pRS-RFP-C plasmids encoding shRNAs against UBE4B and LSD1, or non-targeting control (CTRL) were used for knockdown. Cells were knocked down for 78h before lysis.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1269601","2":"NA","3":"hek 293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"293 transfected with PCMV replicate #3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"513 Parnassus Avenue, HSW Room  1102, Box 0540","38":"San Francisco","39":"USA","40":"Diabetes Center","41":"manderson@diabetes.ucsf.edu","42":"NA","43":"UCSF","44":"Anderson Lab","45":"Mark,Stuart,Anderson","46":"NA","47":"CA","48":"NA","49":"94143","50":"AGCC 3.2.2 Microarrays were normalized for array-specific effects using Affymetrix's Robust Multi-Array (RMA) normalization","51":"28829","52":"NA","53":"293 cells transfected with vector only biologic replicate #3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Qiagen RNAeasy mini kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1269601","65":"NA","66":"NA","67":"NA","68":"NA","69":"Transfected HEK 293 cells were grown for 72hrs in complete DMEM prior to RNA extraction.","70":"NA","71":"NA","72":"See manufacturer protocol","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"NuGEN Ovation Pico WTA V2 and NuGEN Encore Biotin Module","79":"NA","80":"Nov 21 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCS3000","97":"NA","98":"['GSE52546', 'GSE52548']","99":"NA","100":"NA","101":"NA","102":"293 transfected with PCMV","103":"Public on Nov 21 2013","104":"NA","105":"NA","106":"Nov 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1269nnn/GSM1269601/suppl/GSM1269601_03.PCMV-3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"293 transfected with PCMV replicate #3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK 293 cells were transfected using Mirus 293 transfection reagent following manufacturers protocol.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733498","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080129 SM exposure 400 uM_8h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-10","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-06","53":"Gene expression data from NHEK_080129 SM exposure 400 uM_8h timepoint","54":"NA","55":"NA","56":"NA","57":"400.0","58":"2008-01-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733498","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-22","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-07-24","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080129 SM exposure 400 uM_8h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733498/suppl/GSM733498_080129_HD_8h_400.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"8","115":"NA","116":"NHEK_080129 SM exposure 400 uM_8h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1171535","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"R749H-amr RD36a","18":"r749h-amr","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"2 Hertzl st.","38":"Rehovot","39":"Israel","40":"NA","41":"rivka.dikstein@weizmann.ac.il","42":"NA","43":"The Weizmann Institute of Science","44":"NA","45":"Rivka,,Dikstein","46":"NA","47":"NA","48":"NA","49":"76100","50":"RMA was carried out using Partek Genomic Suite 6.5 (Inc. St. Charles, MO; www.partek.com)","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Tri-reagent (MRC inc.) according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1171535","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T were maintained in Dulbeccos modified Eagles medium (DMEM) supplemented with 10 % fetal calf serum.","70":"NA","71":"NA","72":"cDNA in 80 ul were hybridized to a Human Gene 1.0 ST array using Affymetrix hybridization kit materials and hybridized for 17 hours at 45 at 60rpm. Post-hyb washes were done with Affymetrix wash solutions on the FS450 station using FS450_0007 protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"200ng TotalRNA were used. cDNA samples were generated and labeled using Affymetrix WT-cDNA synthesis and labeling kit","79":"NA","80":"Jul 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned on the Affymetrix GeneChip Scanner 3000 7G","97":"NA","98":"GSE48163","99":"NA","100":"NA","101":"NA","102":"1 slow","103":"Public on Jul 01 2013","104":"NA","105":"NA","106":"Jun 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1171nnn/GSM1171535/suppl/GSM1171535_RD36a_HuST.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"R749H-amr RD36a","117":"NA","118":"NA","119":"NA","120":"NA","121":"R749H-amr","122":"Cells were transfected with plasmids directing the expression of -amanitin-resistant variants of Pol II (Rpb1-amr and R749H-amr). -amanitin was added and RNA was prepared 24 and 48 h later, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM569354","2":"NA","3":"embryonic kidney cell line hek","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Mutant in the presence of tetracycline, rep1","18":"NA","19":"tetracycline","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Embryonic kidney cell line HEK","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1 Oryong-dong Buk-gu","38":"Gwangju","39":"South Korea","40":"Life science","41":"lbc0523@gist.ac.kr","42":"82629702540","43":"Gwangju Institutue Science and Technology","44":"NA","45":"Byoung-Cheol,,Lee","46":"82629702566","47":"NA","48":"NA","49":"500712","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from HEK cells expressing mutant TRPM7 channel', 'Mutant tet1']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"mutant channel","64":"GSM569354","65":"NA","66":"NA","67":"NA","68":"NA","69":"Stabel cell-lines were grown in in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum and an antibiotic, 5 ug/mL blasticidin (Invitrogen). Cells were cultured in a humidified atmosphere of 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Fragmented cRNA was hybridized to the Human Genome UI133 Plus 2.0 Array (Affymetrix) at 45C for 16 h according to the Affymetrix standard protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"5 ug of total RNA from each cell-lines was used for labeling. Probe synthesis from total RNA samples, hybridization, detection, and scanning were performed according to standard protocols from Affymetrix, Inc..","79":"NA","80":"Jul 23 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"After hybridization, the arrays were washed in a GeneChip Fluidics Station 450 with a non-stringent wash buffer at 25C followed by a stringent wash buffer at 50C. After washing, the arrays were stained with a streptavidin-phycoerythrin complex. After staining, intensities were determined with a GeneChip scanner 3000 (Affymetrix), controlled by GCOS Affymetrix software.","97":"NA","98":"GSE23102","99":"NA","100":"NA","101":"NA","102":"HEK cell lines expressing mutant channel","103":"Public on Jul 23 2011","104":"NA","105":"NA","106":"Jul 23 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM569nnn/GSM569354/suppl/GSM569354.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Mutant in the presence of tetracycline, rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 ug of tetracycline was treated to stabel cell-lines which overexressing WT and mutant TRPM7 channel for 72 hours","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881023","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 1","17":"Non-producer culture - fermentation 3- time point 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"2","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 21","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"non-producing parent","64":"GSM881023","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Non-producer culture - fermentation 3- time point 1","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 1","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Non-producer culture - fermentation 3- time point 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733341","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071107 CEES exposure 3.0 uM_2h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-14","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-30","53":"Gene expression data from NHEK_071107 CEES exposure 3.0 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"3.0","58":"2007-11-07","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733341","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-30","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-08-13","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071107 CEES exposure 3.0 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733341/suppl/GSM733341_071107_CEES_2h_3.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_071107 CEES exposure 3.0 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881010","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 2","17":"Non-producer culture - fermentation 2- time point 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"1","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 8","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"non-producing parent","64":"GSM881010","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Non-producer culture - fermentation 2- time point 2","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 2","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Non-producer culture - fermentation 2- time point 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442093","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,2h,treated,biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"2 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442093","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, treated_2h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442093/suppl/GSM1442093_2hGFP_REP1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,2h,treated,biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546595","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"wtns_3","18":"no treatment","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"wtns_3:92.3ug.","61":"NA","62":"wild type","63":"NA","64":"GSM546595","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C; 5% C02","70":"20-10-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"wtns_3","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546595/suppl/GSM546595_wtns_3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"wtns_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"no treatment","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1558600","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK_Native_3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"no","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Nonnenwald 2","38":"Penzberg","39":"Germany","40":"Pharmaceutical Sciences","41":"fabian.birzele@roche.com","42":"NA","43":"Roche Diagnostics GmbH","44":"NA","45":"Fabian,,Birzele","46":"NA","47":"NA","48":"NA","49":"82377","50":"Partek Genomics suite was used to process CEL files, perform normalization and QC as well as to identify differentially regulated genes between native and CD44 transfected HEK293 cells using ANOVA.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"HEK293-CD44s Clone 4, expressing an average level of HA, was picked for profiling gene expression using Affymetrix Human Genome U133plus 2.0 arrays. Total RNA was prepared using the RNeasy Mini Kit (Qiagen, Germany), Microarray RNA Target Synthesis Kit T7 and RNeasy Mini-Spin Columns (Roche, Germany) and a hybridization mix was created consisting of 30 l of fragmented cRNA solution mixed with control oligonucleotide, staggered control cRNAs, herring sperm DNA, acetylated BSA and hybridization buffer in a total volume of 300 l. All kit procedures were performed according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1558600","65":"NA","66":"NA","67":"NA","68":"NA","69":"For cloning and expression of human CD44 (EMBL accession number M24915) the sequence was codon optimized (Geneart, Germany) and CD44s was expressed using a pcDNA3.1(-) vector (Invitrogen, Germany). PCR was performed with a denaturation step at 94C for 2 min, followed by 30 cycles of denaturation at 94C for 30 sec, annealing at 58C for 30 sec, and extension at 68C for 45 sec, with a final extension of 7 minutes at 68C (Expand High Fidelity PCR Kit, Roche). The PCR product and the vector were digested with EcoRI/HindIII restriction endonucleases, and DNA fragments were resolved by 1% agarose gel electrophoresis,purified from gels (GFX PCR DNA and Gel Band Purification Kit) and ligated (Rapid DNA Ligation Kit, Roche). Vectors were transferred into XL-10 Gold super-competent cells (Stratagene, The Netherlands) by heat shock and transformed cells were isolated form agar plates containing 100g/ml Ampicilin. Vector DNA from transfected cells was isolated using the High Pure Plasmid Isolation Kit (Roche, Germany).","70":"NA","71":"NA","72":"The hybridization mix was loaded onto the arrays and incubated in a roller device for 16 hrs. Hybridization solution was removed, arrays were washed, stained","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"standard Affymtrix protocol","79":"NA","80":"Dec 05 2014","81":"NA","82":"polyA RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned with an Affymetrix GeneChip Scanner 3000 (7G)","97":"NA","98":"GSE63862","99":"NA","100":"NA","101":"NA","102":"cell culture, native HEK293 cells","103":"Public on Dec 05 2014","104":"NA","105":"NA","106":"Dec 04 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1558nnn/GSM1558600/suppl/GSM1558600_KLP_RW15_101125_CD44_PZ.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK_Native_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1087802","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"LIN28B_not_induced_rep2 [Affymetrix]","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1230 York Ave Box 186","38":"New York","39":"USA","40":"NA","41":"miguel.a.brown@gmail.com","42":"NA","43":"The Rockefeller University","44":"NA","45":"Miguel,,Brown","46":"NA","47":"New York","48":"NA","49":"10065","50":"We imported the CEL files into the R software (http://www.R-project.org) using the BioConductor affy package (Gentleman et al., 2004). The transcript probe set intensities were background-corrected, adjusted for non-specific binding and quantile normalized with the GCRMA algorithm (Wu, 2006). Probe sets with more than 6 of the 11 probes mapping ambiguously to the genome were discarded, as were probe sets that mapped to multiple genes. We then collected all probe sets matching a given gene, and we selected for further analysis the RefSeq transcript with median 3'UTR length corresponding to that gene. In total 16,063 transcripts were identified. The log-intensity of probe sets mapping to the gene were then averaged to obtain the expression level per RefSeq transcript. The changes of transcript abundances were computed as the logarithm of the ratio of transcript expression in the cocktails of siRNA treated samples and mock-transfected cells. Detailed analysis procedure can be found in the Supplement to Hafner et al. Cell, 2010,141(1),129-141 Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP","51":"13008","52":"NA","53":"Gene expression data from HEK293 cells inducibly expressing FLAG/HA tagged LIN28B; FH/LIN28B not induced","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1087802","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 T-REx Flp-In cells (Invitrogen) were grown in D-MEM high glucose with 10% (v/v) fetal bovine serum, 1% (v/v) 2 mM L-glutamine, 1% (v/v) 10,000 U/ml penicillin/10,000 g/ml streptomycin, 100 g/ml zeocin and 15 g/ml blasticidin. Cell lines stably expressing FLAG/HA-tagged proteins were generated by co-transfection of pFRT/TO/FLAG/HA or pFRT/FLAG/HA constructs with pOG44 (Invitrogen). Cells were selected by exchanging zeocin with 100 g/ml hygromycin. Expression of FLAG/HA-LIN28B was induced by addition of 250 ng/ml doxycycline 15 to 20 h before crosslinking.  Detailed experimental procedure can be found in the Methods section of Hafner et al., RNA, in press, Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition","70":"NA","71":"NA","72":"3 g cRNA hybridized to HGU133 Plus 2.0 Arrays for 16 h at 45C","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"2 g of purified total RNA was used in the One-Cycle Eukaryotic Target Labeling Assay (Affymetrix) according to manufacturer's protocol. Biotinylated cRNA targets were cleaned up, fragmented, and hybridized to Human Genome U133 Plus 2.0 Array (Affymetrix).","79":"NA","80":"Feb 26 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips scanned on Affymetrix Genechip 300 7G scanner","97":"NA","98":"['GSE44613', 'GSE44616']","99":"NA","100":"NA","101":"NA","102":"HEK 293 cells inducibly expressing FLAG/HA tagged LIN28B; transgene expression not induced; mock transfected; replicate 2","103":"Public on Feb 26 2013","104":"NA","105":"NA","106":"Feb 25 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1087nnn/GSM1087802/suppl/GSM1087802_LIN28B_not_induced_rep2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"LIN28B_not_induced_rep2 [Affymetrix]","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"siRNA transfections of HEK293 T-REx Flp-In cells were performed in 6-well format using Lipofectamine RNAiMAX (Invitrogen) as described by the manufacturer. Detailed experimental procedure can be found in the Methods section of Hafner et al., RNA, in press Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM941940","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture, transfected, biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"transfected","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"24 h gene profile of transfected (GFP positive) HEK293T cells.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM941940","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm.","97":"NA","98":"['GSE38422', 'GSE59665']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, transfected_24h","103":"Public on Jun 03 2012","104":"NA","105":"NA","106":"Jun 02 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM941nnn/GSM941940/suppl/GSM941940_AnP_Hu13302_081910_07_P39.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture, transfected, biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic PEI polymer mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18 h after seeding and flow separated after another 24 h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2129129","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"shlinc00598#3_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293t","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Chungang Univ., Heukseok-dong, Dongjak-gu, Seoul, Republic of Korea","38":"Seoul","39":"South Korea","40":"Department of Life Science","41":"NA","42":"NA","43":"Chung-Ang university","44":"Functional Genomics Laboratory","45":"Oh-Seok,,Jeong","46":"NA","47":"N/A","48":"NA","49":"ASI|KR|KS013|SEOUL","50":"Array data export processing and analysis was performed using Illumina GenomeStudio v2011.1 (Gene Expression Module v1.9.0)","51":"47321","52":"NA","53":"['3999350127_F_Grn', 'SAMPLE 6']","54":"illuminaHumanv4","55":"98.36614","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from shCTL, shlinc00598#2, and shlinc00598#3 cells using RNAiso Plus (TaKaRa).","61":"NA","62":"NA","63":"linc00598 knockdown","64":"GSM2129129","65":"NA","66":"NA","67":"NA","68":"NA","69":"linc00598 knockdown stable and control shRNA HEK293t cells were grown in Dulbecco's modified Eagle's medium (DMEM) containing 10% heat-inactivated fetal bovine serum and 0.05% penicillin-streptomycin at 37 C in a 5% CO2 atmosphere.","70":"NA","71":"NA","72":"Following fragmentation, 0.75 ug of cRNA were hybridized to the Illumina Expression Beadchip according to the protocols provided by the manufacturer","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared from 0.55 ug total RNA using the Illumina TotalPrep RNA Amplification Kit (Ambion, Austin,TX)","79":"NA","80":"Apr 22 2016","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using the Illumina Bead Array Reader Confocal Scanner","97":"NA","98":"GSE80514","99":"shlinc00598#3","100":"NA","101":"NA","102":"HEK293t, shlinc00598#3","103":"Public on Apr 22 2016","104":"NA","105":"NA","106":"Apr 21 2016","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"shlinc00598#3_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2545285","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek-293t","15":"NA","16":"48 h after transfection","17":"293T-DME rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK-293T","33":"1","34":"NA","35":"NA","36":"NA","37":"Gwanak-gu","38":"Seoul","39":"South Korea","40":"Dept Plant Science","41":"huhjh@snu.ac.kr","42":"NA","43":"Seoul National University","44":"NA","45":"Jin Hoe,,Huh","46":"NA","47":"NA","48":"NA","49":"151-921","50":"The Micorarray Suite version 5 (MAS5) algorithm implemented in Affymetrix Expression Console software (version1.3.1) was used to normalize the raw data. Highly expressed genes that showed over 2-fold difference between the signal values of control and test samples were selected for further study.","51":"54675","52":"NA","53":"['DME-1', 'Gene expression data from 293T-DME']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted and purified using Qiagen RNeasy Kit according to standard instructions","61":"NA","62":"NA","63":"NA","64":"GSM2545285","65":"NA","66":"NA","67":"NA","68":"NA","69":"GFP and DME were transfected in HEK-293T cells and the cells harvested 48 h after transfection. HEK-293T cells were grown in Dulbeccos modified Eagles medium (DMEM) supplemented with 10% fetal bovine serum and a 1% antibiotic/antimycotic solution at 37C in 5% CO2 humidity chamber.","70":"NA","71":"NA","72":"Following fragmentation, fragmented cDNA were hybridized for 16 hr at 45C on Affymetrix GeneChip Human Genome U133 Plus 2.0 ST Array. The GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cDNA were prepared according to the standard Affymetrix protocol from 300  ng total RNA (GeneChip WT Terminal Labeling and Controls Kit P/N 901525 1, Affymetrix).","79":"NA","80":"Sep 20 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G","97":"NA","98":"['GSE96863', 'GSE96866']","99":"NA","100":"NA","101":"NA","102":"293T-DME","103":"Public on Sep 20 2017","104":"NA","105":"NA","106":"Mar 21 2017","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2545nnn/GSM2545285/suppl/GSM2545285_DME-1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"48 h after transfection","113":"NA","114":"NA","115":"NA","116":"293T-DME rep1","117":"NA","118":"plant-derived DNA demethylase DME","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1269600","2":"NA","3":"hek 293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"293 transfected with PCMV replicate #2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"513 Parnassus Avenue, HSW Room  1102, Box 0540","38":"San Francisco","39":"USA","40":"Diabetes Center","41":"manderson@diabetes.ucsf.edu","42":"NA","43":"UCSF","44":"Anderson Lab","45":"Mark,Stuart,Anderson","46":"NA","47":"CA","48":"NA","49":"94143","50":"AGCC 3.2.2 Microarrays were normalized for array-specific effects using Affymetrix's Robust Multi-Array (RMA) normalization","51":"28829","52":"NA","53":"293 cells transfected with vector only biologic replicate #2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Qiagen RNAeasy mini kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1269600","65":"NA","66":"NA","67":"NA","68":"NA","69":"Transfected HEK 293 cells were grown for 72hrs in complete DMEM prior to RNA extraction.","70":"NA","71":"NA","72":"See manufacturer protocol","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"NuGEN Ovation Pico WTA V2 and NuGEN Encore Biotin Module","79":"NA","80":"Nov 21 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCS3000","97":"NA","98":"['GSE52546', 'GSE52548']","99":"NA","100":"NA","101":"NA","102":"293 transfected with PCMV","103":"Public on Nov 21 2013","104":"NA","105":"NA","106":"Nov 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1269nnn/GSM1269600/suppl/GSM1269600_02.PCMV-2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"293 transfected with PCMV replicate #2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK 293 cells were transfected using Mirus 293 transfection reagent following manufacturers protocol.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM941938","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture, transfected, biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"transfected","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"24 h gene profile of transfected (GFP positive) HEK293T cells.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM941938","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm.","97":"NA","98":"['GSE38422', 'GSE59665']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, transfected_24h","103":"Public on Jun 03 2012","104":"NA","105":"NA","106":"Jun 02 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM941nnn/GSM941938/suppl/GSM941938_AnP_Hu13302_081910_01_P36.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture, transfected, biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic PEI polymer mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18 h after seeding and flow separated after another 24 h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442121","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,16h,untransfected,biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"16 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442121","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_16h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442121/suppl/GSM1442121_16hGFPM_REP3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,16h,untransfected,biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1049710","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek cell clones","15":"NA","16":"NA","17":"NOD.Scid mouse-expanded GRK2-K220R-expressing HEK clone-rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK cell clones","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"['Scid-K220R-1', 'GRK2-K220R-expressing HEK clone expanded for 4 weeks in immunodeficient NOD.Scid mice', 'Gene expression data of NOD.Scid mouse-expanded GRK2-K220R-expressing HEK clone']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from HEK cell clones with the RNeasy Mini kit according to the manufacturer`s instructions (Qiagen).","61":"NA","62":"NA","63":"GRK2-K220R","64":"GSM1049710","65":"NA","66":"NA","67":"NA","68":"NA","69":"The study was performed with HEK cell clones stably expressing GRK2 or the kinase-deficient GRK2-K220R mutant. HEK cell clones were either expanded for 4 weeks in vivo in immunodeficient NOD.Scid mice (3 months of age), cultured in vitro, or re-cultured in vitro after expansion in NOD.Scid mice","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Affymetrix Human genome U133 Plus 2.0 Array) in 200 l of the hybrization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual).","79":"NA","80":"Dec 06 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"expanded for 4 weeks in NOD.Scid mice","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE42771","99":"NA","100":"NA","101":"NA","102":"NOD.Scid mouse-expanded HEK clone with GRK2-K220R expression","103":"Public on Dec 06 2012","104":"NA","105":"NA","106":"Dec 06 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049710/suppl/GSM1049710_Scid-K220R-1.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049710/suppl/GSM1049710_Scid-K220R-1.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"NOD.Scid mouse-expanded GRK2-K220R-expressing HEK clone-rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For the microarray study, cell pellets were isolated from three study groups: (i) NOD.Scid mouse-expanded HEK clones expressing either GRK2 or kinase-deficient GRK2-K220R (Scid), (ii) in vitro cultured HEK cell clones expressing GRK2 or GRK2-K220R (HEK), and (iii) in vitro re-cultured HEK cell clones after NOD.Scid mouse expansion (Ex-Scid).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881016","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 1","17":"Producer culture - fermentation 2- time point 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"2","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 14","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"recombinant protein producer","64":"GSM881016","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Producer culture - fermentation 2- time point 1","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 1","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Producer culture - fermentation 2- time point 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236699","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"RHOXF1 24h_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_4']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236699","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, RHOXF1 transfected, 24h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236699/suppl/GSM2236699_Human_Gene_1_0_ST_20150205_4.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236699/suppl/GSM2236699_Human_Gene_1_0_ST_20150205_4.chp.gz']","108":"9606","109":"NA","110":"24h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"RHOXF1 24h_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"RHOXF1 expression vector"},{"1":"GSM546594","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"wtns_2","18":"no treatment","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"wtns_2:74.5ug.","61":"NA","62":"wild type","63":"NA","64":"GSM546594","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C; 5% C02","70":"20-10-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"wtns_2","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546594/suppl/GSM546594_wtns_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"wtns_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"no treatment","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM402827","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 cells siRNA BAHD1 biological rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"CEL files were generated using GCOS software and preprocessed using GC-RMA method","51":"54675","52":"NA","53":"Gene expression data from HEK293 cells transfected with BAHD1  siRNA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA from cells  was extracted and purified by using the RNeasy kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM402827","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells(ATCC #CRL 1573) were grown in DMEM supplemented with Glutamax (Gibco) and 10% FCS","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133Plus2.0  Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RT on 5 g of total RNA using oligo(dT) primers and  in vitro  transcription of the cDNA in presence of biotin were performed by using a GeneChip Amplification One-Cycle Target Labeling kit according to Affymetrix (Santa Clara, CA) standard protocols  Labeling kit according to Affymetrix (Santa Clara, CA) standard protocols.","79":"NA","80":"Jul 16 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix Scanner 3000 7G.","97":"NA","98":"GSE16097","99":"NA","100":"NA","101":"NA","102":"HEK293 cells + BAHD1 siRNA 72h","103":"Public on Jul 16 2009","104":"NA","105":"NA","106":"May 13 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM402nnn/GSM402827/suppl/GSM402827.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cells siRNA BAHD1 biological rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293 cells were  transfected 72h with siRNA BAHD1 or siRNA control (Ambion) using lipofectamine RNAi max (Invitrogen)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM258516","2":"NA","3":"hek293 human embryonic kidney cell line","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina human-6 v2.0 expression beadchip (Illumina_Human-6_V2.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Normal_24h_Illumina","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293 human embryonic kidney cell line","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Handan Road 220#","38":"Shanghai","39":"China","40":"Life Science","41":"liulingfeng1111@gmail.com","42":"NA","43":"Fudan University","44":"the State Key Laboratory of Genetic Engineering","45":"Lingfeng,,Liu","46":"+86-21-65643262","47":"NA","48":"NA","49":"200433","50":"Cubic spline normalization using Illumina BeadStudio Version \"BSGX Version3.2.3\"","51":"48702","52":"NA","53":"The untreated HEK293 cells","54":"illuminaHumanv2","55":"98.42364","56":"NA","57":"NA","58":"NA","59":"NA","60":"Illumina TotalPrep RNA amplification kit (Ambion Catalog#IL1791)","61":"NA","62":"NA","63":"NA","64":"GSM258516","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Refer to the Illumina Gene Expression System Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"Streptavidin Cy3","78":"As described in the illumina Human-6 chip processing protocol. Briefly, generation of biotin labelled cRNA from the product of RT cDNA synthesis and 2nd strand cDNA synthesis.","79":"NA","80":"Mar 29 2010","81":"99.99795","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6102","86":"control (untreated)","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Refer to the Illumina Gene Expression System Manual","97":"NA","98":"GSE10241","99":"NA","100":"NA","101":"NA","102":"Normal HEK293 cell","103":"Public on Nov 03 2009","104":"NA","105":"NA","106":"Jan 23 2008","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM258nnn/GSM258516/suppl/GSM258516.txt.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293_Normal_24h_Illumina","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874633","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T10h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874633","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 10h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874633/suppl/GSM1874633_RG_33_4OHT_10h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T10h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1399570","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"78h after transfection","17":"shUBE4B, bio. replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"615 N. Wolfe St.","38":"Baltimore","39":"USA","40":"NA","41":"NA","42":"NA","43":"Johns Hopkins University","44":"NA","45":"Jiou,,Wang","46":"NA","47":"MD","48":"NA","49":"21205","50":"[\"Affymetrix CEL files were extracted and their data normalized with the Partek GS 6.6 platform.  Partek's Extended Meta-Probeset set was used with RMA normalization to create quantile-normalized log2 transcript signal values, which were used in subsequent ANOVA analyses.\", 'probe group file: HuGene-1_0-st-v1.r4.pgf', 'meta-probeset file: HuGene-1_0-st-v1.na32.hg19.transcript.csv']","51":"33297","52":"NA","53":"SAMPLE 6","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Cells were lysed using RNAeasy mini kit (Qiagen), according to manufacturer's instructions. Genomic DNA was first removed by DNAse treatment on the column, and then, additionally, after total RNA was isolated, using DNase Turbo kit (Ambion), followed by additional round of cleaning through RNAeasy columns.","61":"NA","62":"NA","63":"NA","64":"GSM1399570","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells grown in DMEM, 10%FBS, 37C, 5% CO2","70":"NA","71":"NA","72":"17hrs at 45 C with rotation (60rpm) as described by Affymetrix in their GeneChip Expression Analysis Technical Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The Ambion Expression WT kit was used as described in the manufacturer's manual.","79":"NA","80":"Feb 09 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Using Affymetrix GeneChip Scanner 3000 7G and default parameters described by the manufacturer in their GeneChip Expression Analysis Technical Manual","97":"NA","98":"GSE58026","99":"NA","100":"NA","101":"NA","102":"HEK293_shUBE4B","103":"Public on Feb 09 2017","104":"NA","105":"NA","106":"May 28 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1399nnn/GSM1399570/suppl/GSM1399570_GPer-SOD-B2_U-1a-HuGene_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"78h after transfection","113":"NA","114":"NA","115":"NA","116":"shUBE4B, bio. replicate 2","117":"NA","118":"shRNAs against UBE4B","119":"NA","120":"NA","121":"NA","122":"Cells were transfected in 60mm dishes using 4g DNA, 10l Lipofectamine 2000, in total 4.5ml  Optimem-MEM1. Origene's pRS-RFP-C plasmids encoding shRNAs against UBE4B and LSD1, or non-targeting control (CTRL) were used for knockdown. Cells were knocked down for 78h before lysis.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM527382","2":"NA","3":"hek-293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"kidney","15":"NA","16":"NA","17":"kidney_R06282_HG-U133_Plus_2_HSF1","18":"NA","19":"NA","20":"14.7","21":"NA","22":"HG-U133_Plus_2","23":"CRL-11268","24":"NA","25":"excellent","26":"R. Thomas, The Hamner Institutes for Health Sciences, 6 Davis Dr, RTP, NC, 27709, R. Thomas, rthomas@thehamner.org, 919 558 1311, 919 558 1300","27":"NA","28":"NA","29":"NA","30":"HEK-293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"6 Davis Drive","38":"Research Triangle Park","39":"USA","40":"NA","41":"rthomas@thehamner.org","42":"919-558-1300","43":"The Hamner Institutes for Health Sciences","44":"NA","45":"Russell,Scott,Thomas","46":"919-558-1311","47":"NC","48":"NA","49":"27709","50":"Affymetrix GCOS 1.0","51":"54675","52":"NA","53":"R06282_HG-U133_Plus_2_HSF1 regulation: Assay human embryonic kidney cells (HEK293T) for expression of cDNAs before designing siRNAs","54":"NA","55":"NA","56":"1/10","57":"NA","58":"NA","59":"NA","60":"Extraction Method: RNeasy","61":"temperature sensitive gene for SV40 T-antigen was inserted","62":"NA","63":"NA","64":"GSM527382","65":"NA","66":"NA","67":"NA","68":"NA","69":"Growth Media: DMEM, Amount of Media: 3, Units of Media: ml, Growth Conditions: DMEM, 10%FBS(HI), Pen/Strep/GlutaMax","70":"NA","71":"48","72":"standard Affymetrix procedures","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"standard Affymetrix protocol","79":"NA","80":"Mar 30 2010","81":"NA","82":"total RNA","83":"375K /6 well dish","84":"Homo sapiens","85":"GPL570","86":"NA","87":"1.87","88":"NA","89":"NA","90":"NA","91":"NA","92":"9.6","93":"N/A","94":"NA","95":"NA","96":"standard Affymetrix procedures","97":"Scrape in Lysis buffer","98":"GSE21092","99":"NA","100":"NA","101":"NA","102":"total RNA from human embryonic kidney TC cells","103":"Public on Mar 31 2010","104":"NA","105":"NA","106":"Mar 26 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM527nnn/GSM527382/suppl/GSM527382.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM527nnn/GSM527382/suppl/GSM527382.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"kidney","116":"kidney_R06282_HG-U133_Plus_2_HSF1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"ug","125":"h past seeding","126":"NA"},{"1":"GSM560867","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"2 h","17":"NOD2-L1007fsinsC_2h_MDP_biological replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 L1007fsinsC","63":"NA","64":"GSM560867","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560867/suppl/GSM560867.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"2 h","113":"NA","114":"NA","115":"NA","116":"NOD2-L1007fsinsC_2h_MDP_biological replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM205757","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 cell line #1 with noninduced HNF4a2 mutant C106R","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 1000.","51":"54675","52":"NA","53":"Analysis of gene expression in human embryonic kidney cells (HEK293) overexpressing the transcription factor HNF4a2 or mutant forms HNF4a2 C106R or R154X, which were introduced by FRT/FLP recombination. The analysis were performed 24 hours following 1 g/ml doxycyclin treatment to induce the expression of the trans-genes. Results identify HNF4 regulated genes in kidney cells being several of these genes deregulated in renal cell carcinoma.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Rneasy mini extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM205757","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133_Plus_2.0 arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual v2, Affymetrix).","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000.","97":"NA","98":"GSE8289","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line #1 with noninduced HNF4a2 mutant C106R","103":"Public on Jun 20 2008","104":"NA","105":"NA","106":"Jun 26 2007","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205757/suppl/GSM205757.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205757/suppl/GSM205757.CHP.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205757/suppl/GSM205757.EXP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cell line #1 with noninduced HNF4a2 mutant C106R","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were treated for 24 h with 1 g/ml doxycyclin or solvent.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM926169","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina humanRef-8 v1.0 expression beadchip (Illumina_HumanRef-8_v1.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK-293 anti-miR-107 Experimental Replicate 2 1895213044_C","18":"anti-mir-107","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ring Road","38":"Callaghan","39":"Australia","40":"NA","41":"NA","42":"NA","43":"University of Newcastle","44":"NA","45":"Adam,,Carroll","46":"NA","47":"NSW","48":"NA","49":"2308","50":"Illumina Beadstudio software computed average signal intensities and detection p-values.","51":"22184","52":"NA","53":"Experimental Replicate 2","54":"illuminaHumanv2","55":"44.83337","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted with Trizol reagent, followed by clean-up with DNase I treatment and the RNeasy MinElute cleanup kit (Qiagen) in accordance with manufacturer's instructions. Quality control was performed with an Experion (BioRad) bioanalyser.","61":"NA","62":"NA","63":"NA","64":"GSM926169","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cell models were grown as confluent monolayers in standard tissue culture conditions.","70":"NA","71":"NA","72":"Standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA was prepared using the TotalPrep RNA amplification kit (Ambion) for Illumina arrays.","79":"NA","80":"Nov 01 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6104","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol.","97":"NA","98":"GSE37729","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Nov 01 2012","104":"NA","105":"NA","106":"May 02 2012","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK-293 anti-miR-107 Experimental Replicate 2 1895213044_C","117":"NA","118":"NA","119":"NA","120":"NA","121":"anti-miR-107","122":"Cells were transfected with either synthetic miRNA or anti-miR inhibitor oligonucleotides. Control refers to untransfected cell models; siEGFP control refers to transfection with an siRNA to EGFP as a transfection control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236712","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"RHOXF2 48h_3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_23']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236712","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, RHOXF2 transfected, 48h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236712/suppl/GSM2236712_Human_Gene_1_0_ST_20150205_23.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236712/suppl/GSM2236712_Human_Gene_1_0_ST_20150205_23.chp.gz']","108":"9606","109":"NA","110":"48h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"RHOXF2 48h_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"RHOXF2 expression vector"},{"1":"GSM1399566","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"78h after transfection","17":"shUBE4B, bio. replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"615 N. Wolfe St.","38":"Baltimore","39":"USA","40":"NA","41":"NA","42":"NA","43":"Johns Hopkins University","44":"NA","45":"Jiou,,Wang","46":"NA","47":"MD","48":"NA","49":"21205","50":"[\"Affymetrix CEL files were extracted and their data normalized with the Partek GS 6.6 platform.  Partek's Extended Meta-Probeset set was used with RMA normalization to create quantile-normalized log2 transcript signal values, which were used in subsequent ANOVA analyses.\", 'probe group file: HuGene-1_0-st-v1.r4.pgf', 'meta-probeset file: HuGene-1_0-st-v1.na32.hg19.transcript.csv']","51":"33297","52":"NA","53":"SAMPLE 2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Cells were lysed using RNAeasy mini kit (Qiagen), according to manufacturer's instructions. Genomic DNA was first removed by DNAse treatment on the column, and then, additionally, after total RNA was isolated, using DNase Turbo kit (Ambion), followed by additional round of cleaning through RNAeasy columns.","61":"NA","62":"NA","63":"NA","64":"GSM1399566","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells grown in DMEM, 10%FBS, 37C, 5% CO2","70":"NA","71":"NA","72":"17hrs at 45 C with rotation (60rpm) as described by Affymetrix in their GeneChip Expression Analysis Technical Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The Ambion Expression WT kit was used as described in the manufacturer's manual.","79":"NA","80":"Feb 09 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Using Affymetrix GeneChip Scanner 3000 7G and default parameters described by the manufacturer in their GeneChip Expression Analysis Technical Manual","97":"NA","98":"GSE58026","99":"NA","100":"NA","101":"NA","102":"HEK293_shUBE4B","103":"Public on Feb 09 2017","104":"NA","105":"NA","106":"May 28 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1399nnn/GSM1399566/suppl/GSM1399566_GPer-SOD-A2_U-1a-HuGene_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"78h after transfection","113":"NA","114":"NA","115":"NA","116":"shUBE4B, bio. replicate 1","117":"NA","118":"shRNAs against UBE4B","119":"NA","120":"NA","121":"NA","122":"Cells were transfected in 60mm dishes using 4g DNA, 10l Lipofectamine 2000, in total 4.5ml  Optimem-MEM1. Origene's pRS-RFP-C plasmids encoding shRNAs against UBE4B and LSD1, or non-targeting control (CTRL) were used for knockdown. Cells were knocked down for 78h before lysis.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1305860","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"EA07047_56017_H133+_8","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"5635 Fishers Lane, Suite 510","38":"Rockville","39":"USA","40":"NA","41":"raducojo@gmail.com","42":"NA","43":"Elsevier","44":"NA","45":"Radu,,Cojocaru","46":"NA","47":"MD","48":"NA","49":"20852","50":"Data was analyzed using GeneSpring software including QC analysis.","51":"41751","52":"NA","53":"Cells were treated with doxycycline to induce myocilin expression","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted from control and myocilin expressing cells after induction with selected concentrations of doxycycline using a Trizol reagent. The extracted RNA was used for each microarray study.","61":"NA","62":"NA","63":"NA","64":"GSM1305860","65":"NA","66":"NA","67":"NA","68":"NA","69":"Tet-on stably transfected cells were maintained in Dulbecco modified Eagle medium (DMEM) supplemented with 10% Tet system proved fetal bovine serum, penicillin (100 U/ml), streptomycin (100 g/ml), hygromycin B (200 g/ml) and G418 (100 g/ml) at 37 C in a humidified atmosphere of 5% CO2.","70":"NA","71":"NA","72":"Not provided.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Not provided.","79":"NA","80":"May 21 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Not provided.","97":"NA","98":"GSE53985","99":"NA","100":"NA","101":"NA","102":"Stable Cell line transfected with myocilin expressing vector","103":"Public on May 21 2014","104":"NA","105":"NA","106":"Jan 13 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1305nnn/GSM1305860/suppl/GSM1305860_EA07047_56017_H133+_8.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"EA07047_56017_H133+_8","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Tet-on stably transfected cells were treated with 0.2 or 1 g/ ml of doxycycline for 48 hr to induce myocilin expression.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1045509","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293, empty pcDNA4 vector, biological replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"723 West Michigan St., Room SL306","38":"Indianapolis","39":"USA","40":"Biology","41":"cdumaual@gmail.com","42":"NA","43":"Indiana University-Purdue University Indianapolis","44":"Lab of Stephen K. Randall","45":"Carmen,M.,Dumaual","46":"NA","47":"IN","48":"NA","49":"46285","50":"The data were processed with R-project software version 2.13.1 through the Rstudio interface version 0.94.92.  Intensity values were read using the affy library of the Bioconductor package  version 2.8.  Normalizaton and calls were made using the mas5 procedure under default parameters.","51":"54675","52":"NA","53":"Control","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the TRIzol reagent (Life Technologies) and further purified with a Qiagen Rneasy Mini Kit, following the manufacturers' instructions for both.","61":"NA","62":"NA","63":"NA","64":"GSM1045509","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells stably overexpressing PRL-1 or transfected with empty pcDNA4 vector were grown in 100mm plates in DMEM supplemented with 10% (v/v) fetal bovine serum, 50 units/ml penicillin, and 50ug/ml streptomycin.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C to Affymetrix HG U133 Plus 2.0 arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Affymetrix Genechip Expression Analysis Technical Manual, 2002, Affymetrix).","79":"NA","80":"Jul 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G.","97":"NA","98":"['GSE42586', 'GSE42588']","99":"NA","100":"NA","101":"NA","102":"HEK293 cells stably transfected with empty pcDNA4 vector","103":"Public on Jul 30 2013","104":"NA","105":"NA","106":"Nov 28 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1045nnn/GSM1045509/suppl/GSM1045509_PRL1_EVSt2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293, empty pcDNA4 vector, biological replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1269606","2":"NA","3":"hek 293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"293 transfected with MBDVP16 replicate #2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"513 Parnassus Avenue, HSW Room  1102, Box 0540","38":"San Francisco","39":"USA","40":"Diabetes Center","41":"manderson@diabetes.ucsf.edu","42":"NA","43":"UCSF","44":"Anderson Lab","45":"Mark,Stuart,Anderson","46":"NA","47":"CA","48":"NA","49":"94143","50":"AGCC 3.2.2 Microarrays were normalized for array-specific effects using Affymetrix's Robust Multi-Array (RMA) normalization","51":"28829","52":"NA","53":"293 cells transfected with MBDVP16 only biologic replicate #2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Qiagen RNAeasy mini kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1269606","65":"NA","66":"NA","67":"NA","68":"NA","69":"Transfected HEK 293 cells were grown for 72hrs in complete DMEM prior to RNA extraction.","70":"NA","71":"NA","72":"See manufacturer protocol","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"NuGEN Ovation Pico WTA V2 and NuGEN Encore Biotin Module","79":"NA","80":"Nov 21 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCS3000","97":"NA","98":"['GSE52546', 'GSE52548']","99":"NA","100":"NA","101":"NA","102":"293 transfected with MBDVP16","103":"Public on Nov 21 2013","104":"NA","105":"NA","106":"Nov 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1269nnn/GSM1269606/suppl/GSM1269606_08.MBDVP16-2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"293 transfected with MBDVP16 replicate #2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK 293 cells were transfected using Mirus 293 transfection reagent following manufacturers protocol.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610847","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"4hr","17":"HEK293T_miR-381_FSK4hr_rep2","18":"NA","19":"FSK","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610847","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610847/suppl/GSM610847.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610847/suppl/GSM610847.chp.gz']","108":"9606","109":"4hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-381_FSK4hr_rep2","117":"miR-381","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733542","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080730 NM exposure 400 uM_8h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-08-06","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-08-04","53":"Gene expression data from NHEK_080730 NM exposure 400 uM_8h timepoint","54":"NA","55":"NA","56":"NA","57":"400.0","58":"2008-07-30","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733542","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-08-11","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-08-13","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080730 NM exposure 400 uM_8h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733542/suppl/GSM733542_080730_NM_8h_400.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"8","115":"NA","116":"NHEK_080730 NM exposure 400 uM_8h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM463022","2":"NA","3":"hek293e","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293E cells, TDP-43 siRNA, replicate 4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293E","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Calwer Str. 7","38":"Tuebingen","39":"Germany","40":"Department of Medical Genetics","41":"michael.walter@agilent.com","42":"NA","43":"University of Tuebingen","44":"The Microarray Facility Tbingen","45":"Michael,H.,Walter","46":"NA","47":"NA","48":"NA","49":"72076","50":"The data were analysed using GC-RMA for background correction, normalization and probe summarization using the Bioconductor package gcrma with default values.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA  was extracted by using RNeasy Mini Kit (Qiagen) following manufacturers instructions for animal cells.","61":"NA","62":"NA","63":"NA","64":"GSM463022","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293E cells were grown in Dulbeccos modified Eagle medium (DMEM) (Biochrom) supplemented with 10% fetal bovine serum (PAA) at 37C under humidified 5% CO2/air","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 Plus 2.0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Oct 19 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GCS3000 gene chip scanner.","97":"NA","98":"GSE18632","99":"NA","100":"NA","101":"NA","102":"HEK cells transfected with TDP-43 siRNA, 24h after transfection","103":"Public on Oct 20 2009","104":"NA","105":"NA","106":"Oct 19 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463022/suppl/GSM463022.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293E cells, TDP-43 siRNA, replicate 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were transiently transfected three consecutive days using HiPerfect with 5nmol scrambled (both Qiagen) or TDP-specific  siRNAs (5-CAATAGCAATAGACAGTTA-3) and cultivated for 24h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236710","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"control 48h_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_21']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236710","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, control vector, 48h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236710/suppl/GSM2236710_Human_Gene_1_0_ST_20150205_21.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236710/suppl/GSM2236710_Human_Gene_1_0_ST_20150205_21.chp.gz']","108":"9606","109":"NA","110":"48h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"control 48h_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"empty control vector"},{"1":"GSM205754","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 cell line #1 with induced HNF4a2 wild type","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Virchowstr. 173","38":"Essen","39":"Germany","40":"Universitaetsklinikum","41":"ludger.klein-hitpass@uni-essen.de","42":"NA","43":"Institut fuer Zellbiologie","44":"BioChip Lab","45":"Ludger,,Klein-Hitpass","46":"+49 201 723 85552","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method. The trimmed mean target intensity of each array was arbitrarily set to 1000.","51":"54675","52":"NA","53":"Analysis of gene expression in human embryonic kidney cells (HEK293) overexpressing the transcription factor HNF4a2 or mutant forms HNF4a2 C106R or R154X, which were introduced by FRT/FLP recombination. The analysis were performed 24 hours following 1 g/ml doxycyclin treatment to induce the expression of the trans-genes. Results identify HNF4 regulated genes in kidney cells being several of these genes deregulated in renal cell carcinoma.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Rneasy mini extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM205754","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133_Plus_2.0 arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Expression Analysis Technical Manual v2, Affymetrix).","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000.","97":"NA","98":"GSE8289","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line #1 with induced HNF4a2 wild type","103":"Public on Jun 20 2008","104":"NA","105":"NA","106":"Jun 26 2007","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205754/suppl/GSM205754.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205754/suppl/GSM205754.CHP.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM205nnn/GSM205754/suppl/GSM205754.EXP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cell line #1 with induced HNF4a2 wild type","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were treated for 24 h with 1 g/ml doxycyclin or solvent.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733538","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080730 SM exposure 50 uM_16h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-08-06","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-08-04","53":"Gene expression data from NHEK_080730 SM exposure 50 uM_16h timepoint","54":"NA","55":"NA","56":"NA","57":"50.0","58":"2008-07-30","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733538","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-08-11","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-08-13","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080730 SM exposure 50 uM_16h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733538/suppl/GSM733538_080730_HD_16h_50.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"16","115":"NA","116":"NHEK_080730 SM exposure 50 uM_16h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733274","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070926 NM exposure 100 uM_16h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-08","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-05","53":"Gene expression data from NHEK_070926 NM exposure 100 uM_16h timepoint","54":"NA","55":"NA","56":"NA","57":"100.0","58":"2007-09-26","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733274","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-24","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-08-07","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070926 NM exposure 100 uM_16h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733274/suppl/GSM733274_070926_NM_16h_100.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"16","115":"NA","116":"NHEK_070926 NM exposure 100 uM_16h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1819999","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hrs","17":"HEK293T CTLsiRNA 6hr 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"knockdown control","64":"GSM1819999","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, knockdown control, 6 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1819nnn/GSM1819999/suppl/GSM1819999_Zane_6hr_CTLsi_1_A4_102011.CEL.gz","108":"9606","109":"6 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T CTLsiRNA 6hr 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560866","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"2 h","17":"NOD2wt_2h_MDP_biological replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 wt","63":"NA","64":"GSM560866","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560866/suppl/GSM560866.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"2 h","113":"NA","114":"NA","115":"NA","116":"NOD2wt_2h_MDP_biological replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM373100","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"transformed hek cells","15":"NA","16":"NA","17":"Hek-HT Ras^G12V Replicate-3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"transformed Hek cells","33":"1","34":"NA","35":"NA","36":"NA","37":"6431 Fannin St","38":"Houston","39":"USA","40":"NA","41":"jeffrey.t.chang@uth.tmc.edu","42":"NA","43":"UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON","44":"NA","45":"Jeffrey,,Chang","46":"NA","47":"TX","48":"NA","49":"77030","50":"MAS5.0","51":"22277","52":"NA","53":"1462_2979_14860_12V-3_HG-U133A+2.CEL","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"We extracted total RNA using Qiagen Rneasy mini kits.","61":"NA","62":"NA","63":"NA","64":"GSM373100","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"The cRNA is fragmented before hybridization and a hybridization cocktail is prepared that contains the fragmented cRNA, probe array controls, BSA and herring sperm DNA.  The cRNA is hybridized to the oligonucleotide probes on the array for 16 hours at 45C.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"We performed an in vitro transcription reaction to produce a biotin-labeled cRNA from the cDNA.","79":"NA","80":"Feb 20 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Immediately following hybridization, the hybridized probe arrays undergo an automated washing and staining protocol on the fluidic station and are then scanned on the GeneChip Scanner 3000 7G.","97":"NA","98":"GSE14934","99":"NA","100":"NA","101":"NA","102":"12V-3","103":"Public on Feb 21 2009","104":"NA","105":"NA","106":"Feb 20 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM373nnn/GSM373100/suppl/GSM373100.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Hek-HT Ras^G12V Replicate-3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733395","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071128 CEES exposure 4.0 uM_2h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-28","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-30","53":"Gene expression data from NHEK_071128 CEES exposure 4.0 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"4.0","58":"2007-11-28","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733395","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-09","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-11","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071128 CEES exposure 4.0 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733395/suppl/GSM733395_071128_CEES_2h_4.0.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_071128 CEES exposure 4.0 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM401537","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Wild-type control 197_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"3333 Burnet Ave","38":"Cincinnati","39":"USA","40":"NA","41":"yan.xu@cchmc.org","42":"NA","43":"Cincinnati Children's Hospital Medical Center","44":"NA","45":"Yan,,Xu","46":"513-6368921","47":"OH","48":"NA","49":"45229","50":"MAS5 normalization, ANOVA","51":"54675","52":"NA","53":"transitently transfected with wild-type surfactant protein C","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"accroding to manufacture's protocol (Affymetrix)","61":"NA","62":"NA","63":"NA","64":"GSM401537","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"accroding to manufacture's protocol (Affymetrix)","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"accroding to manufacture's protocol (Affymetrix)","79":"NA","80":"May 13 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"accroding to manufacture's protocol (Affymetrix)","97":"NA","98":"GSE16054","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line","103":"Public on May 14 2009","104":"NA","105":"NA","106":"May 11 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM401nnn/GSM401537/suppl/GSM401537.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Wild-type control 197_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442114","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,8h,untransfected,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"8 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442114","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_8h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442114/suppl/GSM1442114_8hGFPM_REP2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,8h,untransfected,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236706","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"RHOXF2 48h_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_17']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236706","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, RHOXF2 transfected, 48h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236706/suppl/GSM2236706_Human_Gene_1_0_ST_20150205_17.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236706/suppl/GSM2236706_Human_Gene_1_0_ST_20150205_17.chp.gz']","108":"9606","109":"NA","110":"48h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"RHOXF2 48h_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"RHOXF2 expression vector"},{"1":"GSM1288896","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"SilX-CT.R2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"Data were normalized with RMA","51":"33297","52":"NA","53":"Gene expression data","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the RNeasy Mini Kit (Qiagen), from three biological replicates, according to the manufacturer's instructions.  RNA was treated with DNase I to remove residual DNA and then cleaned with DNase Inactivation Reagent (Ambion Inc.) RNA was quality checked an then store at -80C.","61":"NA","62":"NA","63":"control","64":"GSM1288896","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown at 37C, in a humidified 10% CO2 incubator, in Dulbecco's modified Eagle's medium with GlutaMAX (Gibco) supplied with 10%FBS (Gibco) and 70 ug/ml Hygromycin B (10687-010-Invitrogen).","70":"NA","71":"NA","72":"Labeled cDNA was hybridized wiht GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) as described by the manufacturer.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RNA was amplified with GeneChip WT cDNA Synthesis and Amplification Kit (Affymetrix) and biotin labeld with GeneChip WT Terminal Labeling Kit (Affymetrix) according to the manufacturer's","79":"NA","80":"Jan 20 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix Human Gene 1.0 ST Array was scanned with the Affymetrix GeneChip Scanner 7G and the FS450_0007 protocol , as recommended in the GeneChip Hybridization, Wash, and Stain Kit (Affymetrix)","97":"NA","98":"['GSE51868', 'GSE53284']","99":"NA","100":"NA","101":"NA","102":"SilX-CT cells","103":"Public on Dec 11 2015","104":"NA","105":"NA","106":"Dec 13 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1288nnn/GSM1288896/suppl/GSM1288896_SilX-CT.R2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"SilX-CT.R2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"We established a BAHD1 gene-specific knockdown cell line using the SilenciX siRNA delivery system (Tebu-bio). This technology is based on EBV-replication, and ensures chromosome-like replication of an episome stably expressing either a shRNA against BAHD1 (silXBAHD1) or a control shRNA (silX-CT).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM675225","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek293 cells","15":"NA","16":"NA","17":"HEK293_MosIR plasmid_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK293 cells","33":"1","34":"NA","35":"NA","36":"NA","37":"Videnska 1083","38":"Prague 4","39":"Czech Republic","40":"NA","41":"NA","42":"NA","43":"Institute of Molecular Genetics","44":"NA","45":"Matyas,,Flemr","46":"NA","47":"NA","48":"NA","49":"14220","50":"All arrays were normalized using the GCRMA algorithm with quantile normalization composed of 100 bins using Genedata's Refiner application. Per chip normalization was performed by scaling the median of the genes called present (detection P-value < 0.04) to a value of 500.","51":"54675","52":"NA","53":"['03-Hek-500ng-1', 'Gene expression data from cultured HEK293 cells 24 hours after transfection with MosIR plasmid']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 or HeLa cells in a confluent 6-well dish 24 hours post-transfection using Absolutely RNA Miniprep Kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM675225","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 and HeLa cells were maintained in Dulbeccos Modified Eagle Medium (DMEM, Invitrogen) supplemented with 10 % FCS (Invitrogen), penicillin (100 U/mL, Invitrogen), and streptomycin (100 g/mL, Invitrogen) at 37 C and 5 % CO2 atmosphere.","70":"NA","71":"NA","72":"Biotinylated cRNA (20 g) was fragmented by heating with magnesium (as per Affymetrix's instructions) and 15 g of fragmented cRNA was hybridized to Human U133 plus 2.0 GeneChips.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA (5 g) from each replicate was reverse transcribed with the Affymetrix cDNA synthesis kit and cRNA was produced by in vitro transcription (IVT) by T7 RNA polymerase using the Affymetrix IVT kit as per manufacturer's instructions.","79":"NA","80":"Oct 11 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Affymetrix procedures","97":"NA","98":"GSE27316","99":"NA","100":"NA","101":"NA","102":"HEK293 cells transfected with MosIR plasmid","103":"Public on Oct 11 2011","104":"NA","105":"NA","106":"Feb 15 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM675nnn/GSM675225/suppl/GSM675225.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293_MosIR plasmid_rep1","117":"NA","118":"NA","119":"MosIR plasmid","120":"NA","121":"NA","122":"HEK293 and HeLa cells grown in a 6-well plate were transfected with 500ng control parental MosIR plasmid expressing EGFP or with 500ng MosIR plasmid expressing EGFP with 3'UTR containing long inverted repeat derived from mouse c-Mos coding sequence.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881012","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 3","17":"Non-producer culture - fermentation 1- time point 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"1","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 10","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"non-producing parent","64":"GSM881012","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Non-producer culture - fermentation 1- time point 3","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 3","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Non-producer culture - fermentation 1- time point 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1212434","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 2.0 ST Array (hugene20st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"shControl","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1515 Holcombe Blvd","38":"Houston","39":"USA","40":"NA","41":"jincl1980@gmail.com","42":"NA","43":"The University of Texas MD Anderson Cancer Center","44":"NA","45":"CHUNLEI,,JIN","46":"NA","47":"TX","48":"NA","49":"77030","50":"The data were analyzed using the Affymetrix Gene Expression Console (v.1.3.1) with RMA (Robust Multi-array Average) normalization algorithm.","51":"53981","52":"NA","53":"Sample 1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1212434","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were cultured in Dulbecco's Modified Eagle Medium modified with 10% fetal bovine serum and 100 g/ml streptomycin-penicillin.","70":"NA","71":"NA","72":"Affymetrix GeneChip Human Gene 2.0 ST arrays were hybridized to 5.5ug of biotin labeled cDNA, washed and stained according to Affymetrix protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"100 ng of total RNA were amplified using the Ambion WT Expression Kit and cDNA were biotin labelled using Affymetrix GeneChip WT Terminal Labeling protocol.","79":"NA","80":"Jun 04 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL16686","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using GeneChip Scanner 3000 (Affymetrix)","97":"NA","98":"['GSE44039', 'GSE50016']","99":"NA","100":"NA","101":"NA","102":"HEK293T_control shRNA","103":"Public on Jun 04 2014","104":"NA","105":"NA","106":"Aug 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1212nnn/GSM1212434/suppl/GSM1212434_YC-04-03-2013-HuGene-shControl_Temple.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"shControl","117":"NA","118":"control shRNA","119":"NA","120":"NA","121":"NA","122":"mTET1-CD, TET1-CD, mTET1-FL, TET1-FL expression plasmid or empty vector was transfected into HEK293T cells by using OPTI-MEM (Invitrogen) and FuGene HD transfection reagent (Roche). Three days after transfection, overexpressed cells were purified with fluorescent activated cell sortng. Lentiviral shRNA-mediated TET1 knockdown were also established in HEK293T cells, and one control and two TET1 knockdown clones were identified.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM606064","2":"NA","3":"293tetluc","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney cell","15":"NA","16":"NA","17":"Control, 293TetLuc, doxcycline 48 h, rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"293TetLuc","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"No 35, Keyan Road, Zhunan Town","38":"Miaoli Conunty","39":"Taiwan","40":"NA","41":"sflin1@gmail.com","42":"NA","43":"National Health Research Institutes, Taiwan","44":"NA","45":"Su-Fang,,Lin","46":"NA","47":"NA","48":"NA","49":"35053","50":"The data were analyzed using Affymetrix Expression Console Software (version 1.1) default analysis settings and RMA (Robust Multi-Array) summarization and normalization options.","51":"33297","52":"NA","53":"Cell densitiy was maintained at 200,000 / ml before induction.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using a RNeasy Mini kit (Qiagene), according to the manufacturers instructions. A 2-round amplification was performed with the ExpressArt TRinucleotide mRNA Amplification Kit (AmpTec) according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM606064","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown to log-phase in DMEM supplemented with 10% tetracycline-free fetal bovine serum before induction.","70":"NA","71":"NA","72":"Samples were hybridized with GeneChip Human Gene 1.0 ST Arrays (Affymetrix) and scanned at the NHRI Microarray Core Facility (Miaoli County, Taiwan).","73":"NA","74":"NA","75":"NA","76":"transformed with sheared Ad5 DNA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Mar 31 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Array scanning was performed according to the manufacturer's instruction (Affymetrix).","97":"NA","98":"['GSE24585', 'GSE24587']","99":"NA","100":"NA","101":"NA","102":"293 luciferase inducible line, doxycycline 48 h","103":"Public on Mar 31 2011","104":"NA","105":"NA","106":"Oct 07 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM606nnn/GSM606064/suppl/GSM606064.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"embryonic kidney cell","116":"Control, 293TetLuc, doxcycline 48 h, rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were treated with doxycycline (50 nanogram/ml) for 48 h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560874","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 h","17":"NOD2wt_6h_MDP_biological replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 wt","63":"NA","64":"GSM560874","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560874/suppl/GSM560874.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"6 h","113":"NA","114":"NA","115":"NA","116":"NOD2wt_6h_MDP_biological replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733122","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070829 SM exposure 25 uM_8h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-02-26","29":"Phillips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-14","53":"Gene expression data from NHEK_070829 SM exposure 25 uM_8h timepoint","54":"NA","55":"NA","56":"NA","57":"25.0","58":"2007-08-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733122","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-05-13","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-05-15","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070829 SM exposure 25 uM_8h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733122/suppl/GSM733122_070829_HD_8h_25.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"8","115":"NA","116":"NHEK_070829 SM exposure 25 uM_8h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236697","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"RHOXF2 24h_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_2']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236697","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, RHOXF2 transfected, 24h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236697/suppl/GSM2236697_Human_Gene_1_0_ST_20150205_2.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236697/suppl/GSM2236697_Human_Gene_1_0_ST_20150205_2.chp.gz']","108":"9606","109":"NA","110":"24h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"RHOXF2 24h_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"RHOXF2 expression vector"},{"1":"GSM1442097","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,8h,untransfected,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"8 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442097","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_8h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442097/suppl/GSM1442097_8hGFPM_REP2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,8h,untransfected,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881011","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 2","17":"Non-producer culture - fermentation 3- time point 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"1","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 9","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"non-producing parent","64":"GSM881011","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Non-producer culture - fermentation 3- time point 2","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 2","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Non-producer culture - fermentation 3- time point 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546588","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hours","17":"t469fsh_2","18":"fsh - hormone treatment - fsh stimulation","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"3nM","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"t469fsh_2:25.7ug.","61":"NA","62":"mutant hek_t469","63":"NA","64":"GSM546588","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C, 5% C02","70":"23-12-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"t469fsh_2","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546588/suppl/GSM546588_t469fsh_2.CEL.gz","108":"9606","109":"6 hours","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"t469fsh_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"FSH - hormone treatment - fsh stimulation","122":"Name:FSH - hormone treatment - fsh stimulation,follicle stimulating hormone (fsh):quantity 3nM time 6hour . 3nM","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM402152","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Delta Exon 4 mutant Ex4_3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"3333 Burnet Ave","38":"Cincinnati","39":"USA","40":"NA","41":"yan.xu@cchmc.org","42":"NA","43":"Cincinnati Children's Hospital Medical Center","44":"NA","45":"Yan,,Xu","46":"513-6368921","47":"OH","48":"NA","49":"45229","50":"MAS5 normalization, ANOVA","51":"54675","52":"NA","53":"transitently transfected with exon 4 mutant of surfactant protein C","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"accroding to manufacture's protocol (Affymetrix)","61":"NA","62":"NA","63":"NA","64":"GSM402152","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"accroding to manufacture's protocol (Affymetrix)","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"accroding to manufacture's protocol (Affymetrix)","79":"NA","80":"May 13 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"accroding to manufacture's protocol (Affymetrix)","97":"NA","98":"GSE16054","99":"NA","100":"NA","101":"NA","102":"HEK293 cell line","103":"Public on May 14 2009","104":"NA","105":"NA","106":"May 11 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM402nnn/GSM402152/suppl/GSM402152.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Delta Exon 4 mutant Ex4_3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1039980","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,transfected,biological rep 4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"GFP_4","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1039980","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 22 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE59666","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"['GSE20615', 'GSE59666']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,transfected,biological rep 4_24h","103":"Public on Nov 21 2012","104":"NA","105":"NA","106":"Nov 21 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1039nnn/GSM1039980/suppl/GSM1039980_AnP_Hu13302_062910_01_P26.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,transfected,biological rep 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1254230","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK-BAHD1.R3","18":"over-expressing the bahd1 gene","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"data were normalized with RMA, analysed with LPE with three FDR methods; the zreal value is indicated in the matrix","51":"28869","52":"NA","53":"Gene expression data","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the RNeasy Mini Kit (Qiagen), from three biological replicates, according to was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1254230","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown at 37C, in a humidified 10% CO2 incubator, in Dulbecco's modified Eagle's medium with GlutaMAX (Gibco) supplied with 10%FBS (Gibco) and 200 ug/ml Hygromycin B (10687-010-Invitrogen).","70":"NA","71":"NA","72":"Labeled cDNA was hybridized wiht GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) as described by the manufacturer.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RNA was amplified with GeneChip WT cDNA Synthesis and Amplification Kit (Affymetrix) and biotin labeld with GeneChip WT Terminal Labeling Kit (Affymetrix) according to the manufacturer's","79":"NA","80":"Jan 20 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Microarrays was scanned with the Affymetrix GeneChip Scanner 7G and the FS450_0007 protocol , as recommended in the GeneChip Hybridization, Wash, and Stain Kit (Affymetrix)","97":"NA","98":"['GSE51863', 'GSE51868']","99":"NA","100":"NA","101":"NA","102":"HEK-BAHD1 cells","103":"Public on Dec 11 2015","104":"NA","105":"NA","106":"Oct 29 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1254nnn/GSM1254230/suppl/GSM1254230_HEK-BAHD1.R3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK-BAHD1.R3","117":"NA","118":"NA","119":"NA","120":"NA","121":"over-expressing the BAHD1 gene","122":"HEK-BAHD1 were generated by integration of a single copy of the BAHD1 cDNA under the control of the human cytomegalovirus (CMV) immediate-early enhancer/promoter in the HEK293 genome. In the isogenic control line (HEK293-CT), the -galactosidase DNA sequence was inserted in place of BAHD1, albeit out-of-frame to avoid translation into protein.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM569351","2":"NA","3":"embryonic kidney cell line hek","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Mutant in the absence of tetracycline, rep1","18":"NA","19":"untreated","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Embryonic kidney cell line HEK","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1 Oryong-dong Buk-gu","38":"Gwangju","39":"South Korea","40":"Life science","41":"lbc0523@gist.ac.kr","42":"82629702540","43":"Gwangju Institutue Science and Technology","44":"NA","45":"Byoung-Cheol,,Lee","46":"82629702566","47":"NA","48":"NA","49":"500712","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from HEK cells non-expressing mutant TRPM7 channel', 'Mutant no1']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"mutant channel","64":"GSM569351","65":"NA","66":"NA","67":"NA","68":"NA","69":"Stabel cell-lines were grown in in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum and an antibiotic, 5 ug/mL blasticidin (Invitrogen). Cells were cultured in a humidified atmosphere of 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Fragmented cRNA was hybridized to the Human Genome UI133 Plus 2.0 Array (Affymetrix) at 45C for 16 h according to the Affymetrix standard protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"5 ug of total RNA from each cell-lines was used for labeling. Probe synthesis from total RNA samples, hybridization, detection, and scanning were performed according to standard protocols from Affymetrix, Inc..","79":"NA","80":"Jul 23 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"After hybridization, the arrays were washed in a GeneChip Fluidics Station 450 with a non-stringent wash buffer at 25C followed by a stringent wash buffer at 50C. After washing, the arrays were stained with a streptavidin-phycoerythrin complex. After staining, intensities were determined with a GeneChip scanner 3000 (Affymetrix), controlled by GCOS Affymetrix software.","97":"NA","98":"GSE23102","99":"NA","100":"NA","101":"NA","102":"HEK cell lines non-expressing mutant channel","103":"Public on Jul 23 2011","104":"NA","105":"NA","106":"Jul 23 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM569nnn/GSM569351/suppl/GSM569351.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Mutant in the absence of tetracycline, rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 ug of tetracycline was treated to stabel cell-lines which overexressing WT and mutant TRPM7 channel for 72 hours","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM678683","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Control_1_h_Replicate 1","18":"NA","19":"Control","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"5","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 10","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678683","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"2","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"3","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"1","114":"NA","115":"NA","116":"HEK293_Control_1_h_Replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM853614","2":"NA","3":"hek293 cells wtx inducible clone f18","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 F18_doxycycline untreated","18":"NA","19":"control","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293 cells WTX inducible clone F18","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"149 13th St","38":"Charlestown","39":"USA","40":"Cancer Center","41":"NA","42":"NA","43":"Massachusetts General Hospital","44":"NA","45":"Woo,Jae,Kim","46":"NA","47":"Ma","48":"NA","49":"02129","50":"['Affymetrix GCOS', 'Target scaling = 150']","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Qiagen RNeasy Kit","61":"NA","62":"NA","63":"NA","64":"GSM853614","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Affymetrix standard protocol for 3'-IVT expression microarrays","73":"NA","74":"NA","75":"NA","76":"NA","77":"ENZO 3'-labeling kit","78":"ENZO 3'-labeling kit manufacturer's instruction","79":"NA","80":"Jan 01 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix scanner G7","97":"NA","98":"GSE34715","99":"NA","100":"NA","101":"NA","102":"HEK293 F18 WTX inducible","103":"Public on Jan 01 2012","104":"NA","105":"NA","106":"Dec 23 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM853nnn/GSM853614/suppl/GSM853614_HABE_1908.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM853nnn/GSM853614/suppl/GSM853614_HABE_1908.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 F18_doxycycline untreated","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"untreatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881021","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 1","17":"Non Producer culture - fermentation 1- time point 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"2","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 19","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"non-producing parent","64":"GSM881021","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Non Producer culture - fermentation 1- time point 1","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 1","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Non Producer culture - fermentation 1- time point 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1305861","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"EA07047_56018_H133+_9","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"5635 Fishers Lane, Suite 510","38":"Rockville","39":"USA","40":"NA","41":"raducojo@gmail.com","42":"NA","43":"Elsevier","44":"NA","45":"Radu,,Cojocaru","46":"NA","47":"MD","48":"NA","49":"20852","50":"Data was analyzed using GeneSpring software including QC analysis.","51":"41751","52":"NA","53":"Cells were treated with doxycycline to induce myocilin expression","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted from control and myocilin expressing cells after induction with selected concentrations of doxycycline using a Trizol reagent. The extracted RNA was used for each microarray study.","61":"NA","62":"NA","63":"NA","64":"GSM1305861","65":"NA","66":"NA","67":"NA","68":"NA","69":"Tet-on stably transfected cells were maintained in Dulbecco modified Eagle medium (DMEM) supplemented with 10% Tet system proved fetal bovine serum, penicillin (100 U/ml), streptomycin (100 g/ml), hygromycin B (200 g/ml) and G418 (100 g/ml) at 37 C in a humidified atmosphere of 5% CO2.","70":"NA","71":"NA","72":"Not provided.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Not provided.","79":"NA","80":"May 21 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Not provided.","97":"NA","98":"GSE53985","99":"NA","100":"NA","101":"NA","102":"Stable Cell line transfected with myocilin expressing vector","103":"Public on May 21 2014","104":"NA","105":"NA","106":"Jan 13 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1305nnn/GSM1305861/suppl/GSM1305861_EA07047_56018_H133+_9.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"EA07047_56018_H133+_9","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Tet-on stably transfected cells were treated with 0.2 or 1 g/ ml of doxycycline for 48 hr to induce myocilin expression.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820019","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24 hrs","17":"HEK293T CTRLpcDNA 24hr 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"overexpression control","64":"GSM1820019","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, overexpression control, 24 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820019/suppl/GSM1820019_Zane_24hr_pcDNA_3_B12_102011.CEL.gz","108":"9606","109":"24 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T CTRLpcDNA 24hr 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM463019","2":"NA","3":"hek293e","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293E cells, TDP-43 siRNA, replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293E","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Calwer Str. 7","38":"Tuebingen","39":"Germany","40":"Department of Medical Genetics","41":"michael.walter@agilent.com","42":"NA","43":"University of Tuebingen","44":"The Microarray Facility Tbingen","45":"Michael,H.,Walter","46":"NA","47":"NA","48":"NA","49":"72076","50":"The data were analysed using GC-RMA for background correction, normalization and probe summarization using the Bioconductor package gcrma with default values.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA  was extracted by using RNeasy Mini Kit (Qiagen) following manufacturers instructions for animal cells.","61":"NA","62":"NA","63":"NA","64":"GSM463019","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293E cells were grown in Dulbeccos modified Eagle medium (DMEM) (Biochrom) supplemented with 10% fetal bovine serum (PAA) at 37C under humidified 5% CO2/air","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C on GeneChip U133 Plus 2.0 Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Oct 19 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GCS3000 gene chip scanner.","97":"NA","98":"GSE18632","99":"NA","100":"NA","101":"NA","102":"HEK cells transfected with TDP-43 siRNA, 24h after transfection","103":"Public on Oct 20 2009","104":"NA","105":"NA","106":"Oct 19 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM463nnn/GSM463019/suppl/GSM463019.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293E cells, TDP-43 siRNA, replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were transiently transfected three consecutive days using HiPerfect with 5nmol scrambled (both Qiagen) or TDP-specific  siRNAs (5-CAATAGCAATAGACAGTTA-3) and cultivated for 24h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM711411","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"HEK293Tcells_wt_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"1000 E 50th St","38":"Kansas City","39":"USA","40":"Genomics","41":"seidel@phageT4.org","42":"NA","43":"Stowers Institute","44":"Seidel","45":"Chris,W,Seidel","46":"816 926 9054","47":"MO","48":"NA","49":"64110","50":"Array intensities were processed using the RMA algorithm in R/bioconductor. Bioconductor 2.6 and affy package affy_1.24.2","51":"54675","52":"NA","53":"Gene expression from HEK293T cells after transfection with non-targeting siRNA, replicate 2.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the standard Qiagen RNeasy cleanup protocol.","61":"NA","62":"NA","63":"NA","64":"GSM711411","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in 6 well tissue culture plates or 10 cm dishes for 48 hours after transfection.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 plus 2.0 Arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the Ambion MessageAmp III protocol from 300 ng total RNA (MessageAmp III Amplification kit Manual, 2007, Ambion).","79":"NA","80":"Sep 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 and processed with AGCC v3.0 software.","97":"NA","98":"GSE28715","99":"NA","100":"Dharmacon non-targeting #3","101":"NA","102":"HEK293T cells","103":"Public on Sep 01 2011","104":"NA","105":"NA","106":"Apr 19 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM711nnn/GSM711411/suppl/GSM711411_cont-2_HG-U133_Plus_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293Tcells_wt_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293T cells in 6 well tissue culture plates (~1x105 cells/well) or 10 cm dishes (~2 x106 cells/dish) were transfected with 25 nM siRNAs targeting human Med26 (Ambion/Applied Biosystems, #4, s18074; #5, s18075; #6, s18076) or 25 nM siCONTROL NON-TARGETING siRNA #2 (Dharmacon D-001210-01) using X-tremeGENE siRNA Transfection Reagent (Roche) and grown for 48 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610832","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"1hr","17":"HEK293T_miR-neg_FSK1hr_rep1","18":"NA","19":"FSK","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610832","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610832/suppl/GSM610832.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610832/suppl/GSM610832.chp.gz']","108":"9606","109":"1hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-neg_FSK1hr_rep1","117":"negative control","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610830","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0hr","17":"HEK293T_miR-132_FSK0hr_rep1","18":"NA","19":"untreated","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610830","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610830/suppl/GSM610830.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610830/suppl/GSM610830.chp.gz']","108":"9606","109":"0hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-132_FSK0hr_rep1","117":"miR-132","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861631","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Wild Type, no leptin, biological replicate 3","18":"untreated","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"PO Box 800741","38":"Charlottesville","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Virginia","44":"NA","45":"Stephen,,Turner","46":"NA","47":"VA","48":"NA","49":"22908","50":"Data extraction, QC, and GCRMA normalization were performed with BioConductor software.  Differential expression was assessed with moderated ANOVA, using the BioConductor limma package; false discovery rate (FDR) estimates were calculated using the Benjamini-Hochberg method.","51":"54675","52":"NA","53":"Wild Type, no leptin, biological replicate 3","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was prepared using RNeasy Mini kit (QIAGEN) and its quality was verified in an Agilent Bioanalyzer.","61":"NA","62":"NA","63":"NA","64":"GSM861631","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T/17 cells were maintained in a humidified incubator at 37 C with 5% CO2. HEK293T/17 cells were cultured in DMEM/F12 (Gibco) with non-essential amino acids, sodium pyruvate and 10% heat inactivated FBS.  Jurkat T-cells were cultured in RPMI supplemented with 10% heat inactivated FBS.  Caco-2 cells were cultured in EMEM (Gibco) supplemented with non-essential amino acids, sodium pyruvate and 20% heat inactivated FBS.  Cells were discarded after passage 25 and new cultures were started from frozen stocks. HEK293T117 cells were transiently transfected using lipofectamine 2000 per the product instructions (Invitrogen, Carlsbad, CA). The plasmids mLEPRb/pCDNA3 (47), mLEPRbR223/pCDNA3 (35) and LEPRbDelta65/pCDNA3 (47) were obtained from Martin Myers and have been described previously as referenced. pCDNA3 was used as a vector control. The plasmid mLEPRb/pCDNA3 was used as a template for site-directed mutagenesis to construct mLEPRb985L/pCDNA3, LEPRb1077L/pCDNA3 and mLEPRb1138L/pCDNA3.  Site-directed mutagenesis was done using the quikchange kit (Stragene/Agilent, Santa Clara, CA).    The presence of the desired mutations and the absence of other mutations were confirmed by DNA sequencing.","70":"NA","71":"NA","72":"Three biological replicates of each sample were hybridized to Human Genome U133 Plus 2.0 gene chips (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA was amplified and converted to cDNA using the 3' IVT Express Kit (Affymetrix).","79":"NA","80":"Jan 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned using the GeneChip Scanner 3000 7G (AffyMetrix).","97":"NA","98":"GSE35068","99":"NA","100":"NA","101":"NA","102":"Wild Type, no leptin","103":"Public on Jan 01 2015","104":"NA","105":"NA","106":"Jan 12 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861631/suppl/GSM861631_WT+3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Wild Type, no leptin, biological replicate 3","117":"NA","118":"NA","119":"Wild-type leptin receptor","120":"NA","121":"untreated","122":"HEK293 cells were transfected with WT LepR or Y1138L (STAT3-mutant) leptin receptor.  48 hours post-transfection cells were made quiescent by incubation in optimum plus 0.5% BSA for 3 hours.  Cells were then stimulated with 100ng of leptin or maintained in optimum plus 0.5% BSA for an additional 3 hours. Leptin was purchased from Dr. A.F. Parlow, National Hormone and Peptide Program (Torrance, CA). The STAT3 inhibitor, Stattic, the PI3K inhibitor, LY294002 and the MEK inhibitor PD98059 were purchased from EMD chemicals (Gibbstown, NJ).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM389756","2":"NA","3":"hek 293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 in high glucose #1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"Gene expression data from cells cultivated in high glucose","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated with the RNeasy Mini kit according to the manufacturer`s instructions (Qiagen).","61":"NA","62":"NA","63":"NA","64":"GSM389756","65":"high glucose (450 mg/dl)","66":"NA","67":"NA","68":"NA","69":"Human embryonic kidney (HEK293) cells were grown for 7 days in DMEM (supplemented with 10 % FCS) containing 450 mg/dl glucose (high glucose) or 100 mg/dl glucose (low glucose).","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Human Genome U133 Plus 2.0 Array) in 200 l of the hybrization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual; Rev. 5).","79":"NA","80":"Apr 19 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE15575","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) cultivated for 7 days in DMEM containing high (450 mg/dl) glucose.","103":"Public on Apr 08 2009","104":"NA","105":"NA","106":"Apr 06 2009","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM389nnn/GSM389756/suppl/GSM389756.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM389nnn/GSM389756/suppl/GSM389756.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 in high glucose #1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442116","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,8h,transfected,biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"8 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442116","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, transfected_8h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442116/suppl/GSM1442116_8hGFPP_REP1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,8h,transfected,biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM517905","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,transfected,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"GFP_2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM517905","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 22 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE59666","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"['GSE20615', 'GSE59666']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,transfected,biological rep 2_24h","103":"Public on Oct 05 2011","104":"NA","105":"NA","106":"Mar 03 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM517nnn/GSM517905/suppl/GSM517905.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,transfected,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM926186","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina humanRef-8 v1.0 expression beadchip (Illumina_HumanRef-8_v1.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK-293 control miR-181b Experimental Replicate 1 1895213040_G","18":"mir-181b","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ring Road","38":"Callaghan","39":"Australia","40":"NA","41":"NA","42":"NA","43":"University of Newcastle","44":"NA","45":"Adam,,Carroll","46":"NA","47":"NSW","48":"NA","49":"2308","50":"Illumina Beadstudio software computed average signal intensities and detection p-values.","51":"22184","52":"NA","53":"Experimental Replicate 1","54":"illuminaHumanv2","55":"44.83337","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted with Trizol reagent, followed by clean-up with DNase I treatment and the RNeasy MinElute cleanup kit (Qiagen) in accordance with manufacturer's instructions. Quality control was performed with an Experion (BioRad) bioanalyser.","61":"NA","62":"NA","63":"NA","64":"GSM926186","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cell models were grown as confluent monolayers in standard tissue culture conditions.","70":"NA","71":"NA","72":"Standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA was prepared using the TotalPrep RNA amplification kit (Ambion) for Illumina arrays.","79":"NA","80":"Nov 01 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6104","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol.","97":"NA","98":"GSE37729","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Nov 01 2012","104":"NA","105":"NA","106":"May 02 2012","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK-293 control miR-181b Experimental Replicate 1 1895213040_G","117":"NA","118":"NA","119":"NA","120":"NA","121":"miR-181b","122":"Cells were transfected with either synthetic miRNA or anti-miR inhibitor oligonucleotides. Control refers to untransfected cell models; siEGFP control refers to transfection with an siRNA to EGFP as a transfection control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1045508","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293, empty pcDNA4 vector, biological replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"723 West Michigan St., Room SL306","38":"Indianapolis","39":"USA","40":"Biology","41":"cdumaual@gmail.com","42":"NA","43":"Indiana University-Purdue University Indianapolis","44":"Lab of Stephen K. Randall","45":"Carmen,M.,Dumaual","46":"NA","47":"IN","48":"NA","49":"46285","50":"The data were processed with R-project software version 2.13.1 through the Rstudio interface version 0.94.92.  Intensity values were read using the affy library of the Bioconductor package  version 2.8.  Normalizaton and calls were made using the mas5 procedure under default parameters.","51":"54675","52":"NA","53":"Control","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the TRIzol reagent (Life Technologies) and further purified with a Qiagen Rneasy Mini Kit, following the manufacturers' instructions for both.","61":"NA","62":"NA","63":"NA","64":"GSM1045508","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells stably overexpressing PRL-1 or transfected with empty pcDNA4 vector were grown in 100mm plates in DMEM supplemented with 10% (v/v) fetal bovine serum, 50 units/ml penicillin, and 50ug/ml streptomycin.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C to Affymetrix HG U133 Plus 2.0 arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Affymetrix Genechip Expression Analysis Technical Manual, 2002, Affymetrix).","79":"NA","80":"Jul 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G.","97":"NA","98":"['GSE42586', 'GSE42588']","99":"NA","100":"NA","101":"NA","102":"HEK293 cells stably transfected with empty pcDNA4 vector","103":"Public on Jul 30 2013","104":"NA","105":"NA","106":"Nov 28 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1045nnn/GSM1045508/suppl/GSM1045508_PRL1_EVSt1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293, empty pcDNA4 vector, biological replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1212435","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 2.0 ST Array (hugene20st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"shTET1#1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1515 Holcombe Blvd","38":"Houston","39":"USA","40":"NA","41":"jincl1980@gmail.com","42":"NA","43":"The University of Texas MD Anderson Cancer Center","44":"NA","45":"CHUNLEI,,JIN","46":"NA","47":"TX","48":"NA","49":"77030","50":"The data were analyzed using the Affymetrix Gene Expression Console (v.1.3.1) with RMA (Robust Multi-array Average) normalization algorithm.","51":"53981","52":"NA","53":"Sample 2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1212435","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were cultured in Dulbecco's Modified Eagle Medium modified with 10% fetal bovine serum and 100 g/ml streptomycin-penicillin.","70":"NA","71":"NA","72":"Affymetrix GeneChip Human Gene 2.0 ST arrays were hybridized to 5.5ug of biotin labeled cDNA, washed and stained according to Affymetrix protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"100 ng of total RNA were amplified using the Ambion WT Expression Kit and cDNA were biotin labelled using Affymetrix GeneChip WT Terminal Labeling protocol.","79":"NA","80":"Jun 04 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL16686","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using GeneChip Scanner 3000 (Affymetrix)","97":"NA","98":"['GSE44039', 'GSE50016']","99":"NA","100":"NA","101":"NA","102":"HEK293T_TET1 shRNA","103":"Public on Jun 04 2014","104":"NA","105":"NA","106":"Aug 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1212nnn/GSM1212435/suppl/GSM1212435_YC-04-03-2013-HuGene-shTET1_1_Temple.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"shTET1#1","117":"NA","118":"TET1 shRNA#1","119":"NA","120":"NA","121":"NA","122":"mTET1-CD, TET1-CD, mTET1-FL, TET1-FL expression plasmid or empty vector was transfected into HEK293T cells by using OPTI-MEM (Invitrogen) and FuGene HD transfection reagent (Roche). Three days after transfection, overexpressed cells were purified with fluorescent activated cell sortng. Lentiviral shRNA-mediated TET1 knockdown were also established in HEK293T cells, and one control and two TET1 knockdown clones were identified.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM618034","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney","15":"NA","16":"NA","17":"HEK-TLR2 48h-LPS rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"human embryonic kidney (HEK) cells stably transfected with Toll-like receptor 2 (TLR2)","33":"1","34":"NA","35":"NA","36":"NA","37":"St. James's Hospital","38":"Dublin 8","39":"Ireland","40":"NA","41":"NA","42":"NA","43":"Trinity College Dublin","44":"Trinity Centre for Health Sciences","45":"Sinead,Marian,Smith","46":"NA","47":"NA","48":"NA","49":"D8","50":"Scanned images, obtained using Affymetrix Software (MAS5), were normalized using robust multichip average (RMA) analysis with RMAExpress version 0.4.1.","51":"54675","52":"NA","53":"gene expression in untreated HEK-TLR2 cells at 48h","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"At time points of 2, 4, 8, 24 and 48 h post-stimulation, cells were harvested and RNA isolated using the Nucleospin RNAII kit (Machery Nagel) according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM618034","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK-TLR2 cells were routinely maintained in MEM alpha medium (Gibco) supplemented with 10% foetal calf serum (Gibco), 2 mM L-glutamine (Sigma), 100 U/ml penicillin (Sigma), 100 g/ml streptomycin and 500 g/ml G418 (Sigma). The day before treatment, cells were seeded in 6-well plates at 1x106 cells/well.","70":"NA","71":"NA","72":"Following fragmentation, cRNA was hybridized for 16 hr at 45C on Affymetrix U133 plus 2.0 genechips. GeneChips were washed and stained in the Automated fluidics 450 station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 g total RNA (Expression Analysis Technical Manual, 2001, Affymetrix) using the Affymetrix IVT labeling kit.","79":"NA","80":"Jan 13 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips were scanned using the GeneChip 3000 7G scanner","97":"NA","98":"['GSE25148', 'GSE25155']","99":"NA","100":"NA","101":"NA","102":"HEK-TLR2 cells untreated for 48h rep 2","103":"Public on Jan 12 2011","104":"NA","105":"NA","106":"Nov 04 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM618nnn/GSM618034/suppl/GSM618034.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"embryonic kidney","116":"HEK-TLR2 48h-LPS rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"The morning of treatment, the cell culture medium was replaced with either fresh medium (untreated) or medium containing 10 g/ml H. pylori lipopolysaccharide","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1717896","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney cells","15":"NA","16":"NA","17":"HEK293T_WT_REP2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney cells","33":"1","34":"NA","35":"NA","36":"NA","37":"Universiteitsplein 1","38":"Edegem","39":"Belgium","40":"NA","41":"ken.opdebeeck@uantwerpen.be","42":"NA","43":"University Of Antwerp","44":"NA","45":"Ken,,Op de Beeck","46":"NA","47":"NA","48":"NA","49":"2650","50":"The data were quantile normalized in limma 3.24.4 for R","51":"42000","52":"NA","53":"replicate 2","54":"illuminaHumanv4","55":"87.30538","56":"NA","57":"NA","58":"NA","59":"NA","60":"An RNeasy mini kit was used for RNA extraction from transfected HEK293T cells (Qiagen, Hilden, Germany) at different time-points. For the microarray experiment, RNA was extracted 12h post-transfection.","61":"NA","62":"NA","63":"NA","64":"GSM1717896","65":"NA","66":"NA","67":"NA","68":"NA","69":"The microarray experiments in human cell lines were performed using Human Embryonic Kidney 293T cells (HEK293T). HEK293T cells were subcultured in 60 mm dishes at a density of 2  106 cells in Dulbeccos modified Eagles medium containing 4500 mg/L glucose supplemented with 10% (v/v) fetal calf serum, 100 U/ml penicillin, 100 g/ml streptomycin, and 2 mM L-glutamine.","70":"NA","71":"NA","72":"Standard Illumina hybridization protocol","73":"NA","74":"NA","75":"NA","76":"NA","77":"cy3","78":"Biotinylated cRNA were prepared with the Illumina Totalprep RNA amplification kit (Life technologies)","79":"NA","80":"Jun 24 2015","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"['GSE70167', 'GSE70169']","99":"NA","100":"NA","101":"NA","102":"HEK293T_WT","103":"Public on Jun 24 2015","104":"NA","105":"NA","106":"Jun 23 2015","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_WT_REP2","117":"NA","118":"wild type DFNA5","119":"NA","120":"NA","121":"NA","122":"Overnight cultures were transfected with either  wtDFNA5 or mutDFNA5 using lipofectamine. Six hours post transfection, cells were harvested using Triple-x reagent for RNA extraction.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693931","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24h","17":"HEK293T_BACH1-siRNA1_24h_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_q_2_24', 'BACH1_q_2_300ng_24h_293T.CEL', 'Gene expression data from HEK 293T cells 24h after knockdown of BACH1 with Qiagen siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693931","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"siRNA1 SI00309876 (q)","102":"HEK 293T cells, BACH1 knockdown, 24h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693931/suppl/GSM693931.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693931/suppl/GSM693931.EXP.gz']","108":"9606","109":"24h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-siRNA1_24h_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM618030","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney","15":"NA","16":"NA","17":"HEK-TLR2 24h-LPS rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"human embryonic kidney (HEK) cells stably transfected with Toll-like receptor 2 (TLR2)","33":"1","34":"NA","35":"NA","36":"NA","37":"St. James's Hospital","38":"Dublin 8","39":"Ireland","40":"NA","41":"NA","42":"NA","43":"Trinity College Dublin","44":"Trinity Centre for Health Sciences","45":"Sinead,Marian,Smith","46":"NA","47":"NA","48":"NA","49":"D8","50":"Scanned images, obtained using Affymetrix Software (MAS5), were normalized using robust multichip average (RMA) analysis with RMAExpress version 0.4.1.","51":"54675","52":"NA","53":"gene expression in untreated HEK-TLR2 cells at 24h","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"At time points of 2, 4, 8, 24 and 48 h post-stimulation, cells were harvested and RNA isolated using the Nucleospin RNAII kit (Machery Nagel) according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM618030","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK-TLR2 cells were routinely maintained in MEM alpha medium (Gibco) supplemented with 10% foetal calf serum (Gibco), 2 mM L-glutamine (Sigma), 100 U/ml penicillin (Sigma), 100 g/ml streptomycin and 500 g/ml G418 (Sigma). The day before treatment, cells were seeded in 6-well plates at 1x106 cells/well.","70":"NA","71":"NA","72":"Following fragmentation, cRNA was hybridized for 16 hr at 45C on Affymetrix U133 plus 2.0 genechips. GeneChips were washed and stained in the Automated fluidics 450 station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 g total RNA (Expression Analysis Technical Manual, 2001, Affymetrix) using the Affymetrix IVT labeling kit.","79":"NA","80":"Jan 13 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips were scanned using the GeneChip 3000 7G scanner","97":"NA","98":"['GSE25148', 'GSE25155']","99":"NA","100":"NA","101":"NA","102":"HEK-TLR2 cells untreated for 24h rep 2","103":"Public on Jan 12 2011","104":"NA","105":"NA","106":"Nov 04 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM618nnn/GSM618030/suppl/GSM618030.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"embryonic kidney","116":"HEK-TLR2 24h-LPS rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"The morning of treatment, the cell culture medium was replaced with either fresh medium (untreated) or medium containing 10 g/ml H. pylori lipopolysaccharide","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236709","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"RHOXF2 48h_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_20']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236709","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, RHOXF2 transfected, 48h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236709/suppl/GSM2236709_Human_Gene_1_0_ST_20150205_20.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236709/suppl/GSM2236709_Human_Gene_1_0_ST_20150205_20.chp.gz']","108":"9606","109":"NA","110":"48h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"RHOXF2 48h_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"RHOXF2 expression vector"},{"1":"GSM1049709","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek cell clones","15":"NA","16":"NA","17":"NOD.Scid mouse-expanded GRK2-expressing HEK clone-rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK cell clones","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"['Scid-GRK-2', 'GRK2-expressing HEK clone expanded for 4 weeks in immunodeficient NOD.Scid mice', 'Gene expression data of NOD.Scid mouse-expanded GRK2-expressing HEK clone']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated from HEK cell clones with the RNeasy Mini kit according to the manufacturer`s instructions (Qiagen).","61":"NA","62":"NA","63":"GRK2","64":"GSM1049709","65":"NA","66":"NA","67":"NA","68":"NA","69":"The study was performed with HEK cell clones stably expressing GRK2 or the kinase-deficient GRK2-K220R mutant. HEK cell clones were either expanded for 4 weeks in vivo in immunodeficient NOD.Scid mice (3 months of age), cultured in vitro, or re-cultured in vitro after expansion in NOD.Scid mice","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Affymetrix Human genome U133 Plus 2.0 Array) in 200 l of the hybrization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual).","79":"NA","80":"Dec 06 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"expanded for 4 weeks in NOD.Scid mice","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE42771","99":"NA","100":"NA","101":"NA","102":"NOD.Scid mouse-expanded HEK clone with GRK2 expression","103":"Public on Dec 06 2012","104":"NA","105":"NA","106":"Dec 06 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049709/suppl/GSM1049709_Scid-GRK-2.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1049nnn/GSM1049709/suppl/GSM1049709_Scid-GRK-2.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"NOD.Scid mouse-expanded GRK2-expressing HEK clone-rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For the microarray study, cell pellets were isolated from three study groups: (i) NOD.Scid mouse-expanded HEK clones expressing either GRK2 or kinase-deficient GRK2-K220R (Scid), (ii) in vitro cultured HEK cell clones expressing GRK2 or GRK2-K220R (HEK), and (iii) in vitro re-cultured HEK cell clones after NOD.Scid mouse expansion (Ex-Scid).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560875","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 h","17":"NOD2wt_6h_MDP_biological replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 wt","63":"NA","64":"GSM560875","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560875/suppl/GSM560875.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"6 h","113":"NA","114":"NA","115":"NA","116":"NOD2wt_6h_MDP_biological replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874644","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"UT_3_n","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874644","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER New untreated replicate 3","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874644/suppl/GSM1874644_NB_53_UT_3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"UT_3_n","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881003","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 2","17":"Producer culture - fermentation 1- time point 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"1","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 1","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"recombinant protein producer","64":"GSM881003","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Producer culture - fermentation 1- time point 2","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 2","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Producer culture - fermentation 1- time point 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442113","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,8h,untransfected,biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"8 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442113","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untransfected_8h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442113/suppl/GSM1442113_8hGFPM_REP1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,8h,untransfected,biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733506","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_080129 SM exposure 12.5 uM_24h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-11","29":"Phillips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-07","53":"Gene expression data from NHEK_080129 SM exposure 12.5 uM_24h timepoint","54":"NA","55":"NA","56":"NA","57":"12.5","58":"2008-01-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733506","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-16","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-07-30","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_080129 SM exposure 12.5 uM_24h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733506/suppl/GSM733506_080129_HD_24h_12.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"24","115":"NA","116":"NHEK_080129 SM exposure 12.5 uM_24h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM360330","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 6hr, replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"50 South Drive, Bldg.50, Rm.2347","38":"Bethesda","39":"USA","40":"NA","41":"changah@nhlbi.nih.gov","42":"NA","43":"NIH\\\\NHLBI","44":"Laboratory of Biochemistry","45":"Allen,HK,Chang","46":"NA","47":"MD","48":"NA","49":"20892","50":"The data were first processed with GCOS1.4 using Affymetrix default analysis settings. The trimmed mean target intensity of each array was arbitrarily set to 1000. Intensities obtained in CHP file generated by GCOS were normalized using an adaptive variance-stabilizing quantile normalization (Munson, P.J., GeneLogic Workshop of Low Level Analysis of Affymetrix GeneChip Data, 2001, software available at http://abs.cit.nih.gov/geneexpression.html).","51":"54675","52":"NA","53":"gene expression data from human embryonic kidney cells (cell culture) treated with epoxomicin for 6hr","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 cells using Qiagen RNeasy Mini Kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM360330","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells are maintained in DMEM supplemented with 10% fetal bovine serum in 3% oxygen, 5% carbon dioxide, 37 degrees Celsius humidified incubator.","70":"NA","71":"NA","72":"Fragmented RNA was hybridized to Affymetrix HG-U133 plus 2.0 chips for 16 hours, washed, stained on an Affymetrix fluidics station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol using Affymetrixs IVT labeling kit following the manufacturers directions.","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Hybridized chips were scanned using Affymetrix genechip scanner 3000","97":"NA","98":"GSE14429","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 6hr","103":"Public on Jan 15 2009","104":"NA","105":"NA","106":"Jan 14 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM360nnn/GSM360330/suppl/GSM360330.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 6hr, replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 uM epoxomicin is added to HEK293 cells and incubated for 1 and 6 hours before RNA extraction. RNA was extracted from cells without treatment at zero time point as control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861633","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Wild Type, leptin-stimulated, biological replicate 2","18":"100ng leptin","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"PO Box 800741","38":"Charlottesville","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Virginia","44":"NA","45":"Stephen,,Turner","46":"NA","47":"VA","48":"NA","49":"22908","50":"Data extraction, QC, and GCRMA normalization were performed with BioConductor software.  Differential expression was assessed with moderated ANOVA, using the BioConductor limma package; false discovery rate (FDR) estimates were calculated using the Benjamini-Hochberg method.","51":"54675","52":"NA","53":"Wild Type, leptin-stimulated, biological replicate 2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was prepared using RNeasy Mini kit (QIAGEN) and its quality was verified in an Agilent Bioanalyzer.","61":"NA","62":"NA","63":"NA","64":"GSM861633","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T/17 cells were maintained in a humidified incubator at 37 C with 5% CO2. HEK293T/17 cells were cultured in DMEM/F12 (Gibco) with non-essential amino acids, sodium pyruvate and 10% heat inactivated FBS.  Jurkat T-cells were cultured in RPMI supplemented with 10% heat inactivated FBS.  Caco-2 cells were cultured in EMEM (Gibco) supplemented with non-essential amino acids, sodium pyruvate and 20% heat inactivated FBS.  Cells were discarded after passage 25 and new cultures were started from frozen stocks. HEK293T117 cells were transiently transfected using lipofectamine 2000 per the product instructions (Invitrogen, Carlsbad, CA). The plasmids mLEPRb/pCDNA3 (47), mLEPRbR223/pCDNA3 (35) and LEPRbDelta65/pCDNA3 (47) were obtained from Martin Myers and have been described previously as referenced. pCDNA3 was used as a vector control. The plasmid mLEPRb/pCDNA3 was used as a template for site-directed mutagenesis to construct mLEPRb985L/pCDNA3, LEPRb1077L/pCDNA3 and mLEPRb1138L/pCDNA3.  Site-directed mutagenesis was done using the quikchange kit (Stragene/Agilent, Santa Clara, CA).    The presence of the desired mutations and the absence of other mutations were confirmed by DNA sequencing.","70":"NA","71":"NA","72":"Three biological replicates of each sample were hybridized to Human Genome U133 Plus 2.0 gene chips (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA was amplified and converted to cDNA using the 3' IVT Express Kit (Affymetrix).","79":"NA","80":"Jan 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned using the GeneChip Scanner 3000 7G (AffyMetrix).","97":"NA","98":"GSE35068","99":"NA","100":"NA","101":"NA","102":"Wild Type, leptin-stimulated","103":"Public on Jan 01 2015","104":"NA","105":"NA","106":"Jan 12 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861633/suppl/GSM861633_WT-2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Wild Type, leptin-stimulated, biological replicate 2","117":"NA","118":"NA","119":"Wild-type leptin receptor","120":"NA","121":"100ng leptin","122":"HEK293 cells were transfected with WT LepR or Y1138L (STAT3-mutant) leptin receptor.  48 hours post-transfection cells were made quiescent by incubation in optimum plus 0.5% BSA for 3 hours.  Cells were then stimulated with 100ng of leptin or maintained in optimum plus 0.5% BSA for an additional 3 hours. Leptin was purchased from Dr. A.F. Parlow, National Hormone and Peptide Program (Torrance, CA). The STAT3 inhibitor, Stattic, the PI3K inhibitor, LY294002 and the MEK inhibitor PD98059 were purchased from EMD chemicals (Gibbstown, NJ).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733259","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070926 NM exposure 50 uM_4h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-02","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-28","53":"Gene expression data from NHEK_070926 NM exposure 50 uM_4h timepoint","54":"NA","55":"NA","56":"NA","57":"50.0","58":"2007-09-26","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733259","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-24","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-08-07","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070926 NM exposure 50 uM_4h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733259/suppl/GSM733259_070926_NM_4h_50.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"4","115":"NA","116":"NHEK_070926 NM exposure 50 uM_4h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM360320","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Human embryonic kidney cells (HEK293) at 0hr, replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"50 South Drive, Bldg.50, Rm.2347","38":"Bethesda","39":"USA","40":"NA","41":"changah@nhlbi.nih.gov","42":"NA","43":"NIH\\\\NHLBI","44":"Laboratory of Biochemistry","45":"Allen,HK,Chang","46":"NA","47":"MD","48":"NA","49":"20892","50":"The data were first processed with GCOS1.4 using Affymetrix default analysis settings. The trimmed mean target intensity of each array was arbitrarily set to 1000. Intensities obtained in CHP file generated by GCOS were normalized using an adaptive variance-stabilizing quantile normalization (Munson, P.J., GeneLogic Workshop of Low Level Analysis of Affymetrix GeneChip Data, 2001, software available at http://abs.cit.nih.gov/geneexpression.html).","51":"54675","52":"NA","53":"gene expression data from human embryonic kidney cells (cell culture)","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 cells using Qiagen RNeasy Mini Kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM360320","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells are maintained in DMEM supplemented with 10% fetal bovine serum in 3% oxygen, 5% carbon dioxide, 37 degrees Celsius humidified incubator.","70":"NA","71":"NA","72":"Fragmented RNA was hybridized to Affymetrix HG-U133 plus 2.0 chips for 16 hours, washed, stained on an Affymetrix fluidics station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol using Affymetrixs IVT labeling kit following the manufacturers directions.","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Hybridized chips were scanned using Affymetrix genechip scanner 3000","97":"NA","98":"GSE14429","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) at 0hr","103":"Public on Jan 15 2009","104":"NA","105":"NA","106":"Jan 14 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM360nnn/GSM360320/suppl/GSM360320.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Human embryonic kidney cells (HEK293) at 0hr, replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 uM epoxomicin is added to HEK293 cells and incubated for 1 and 6 hours before RNA extraction. RNA was extracted from cells without treatment at zero time point as control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820009","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hrs","17":"HEK293T FMR4pcDNA 6hr 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"FMR4 overexpression","64":"GSM1820009","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, FMR4 overexpression, 6 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820009/suppl/GSM1820009_Zane_6hr_FMR4OX_2_B2_102011.CEL.gz","108":"9606","109":"6 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T FMR4pcDNA 6hr 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM941944","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture, untreated, biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"untreated","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"24 h gene profile of untreated HEK293T cells.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM941944","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jun 03 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm.","97":"NA","98":"GSE38422","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untreated","103":"Public on Jun 03 2012","104":"NA","105":"NA","106":"Jun 02 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM941nnn/GSM941944/suppl/GSM941944_AnP_Hu13302_081910_03_CTR36.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture, untreated, biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic PEI polymer mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18 h after seeding and flow separated after another 24 h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546583","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hours","17":"wtfsh_1","18":"fsh - hormone treatment - fsh stimulation","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"3nM","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"wtfsh_1:70.6ug.","61":"NA","62":"wild type","63":"NA","64":"GSM546583","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C; 5% C02","70":"20-10-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"wtfsh_1","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546583/suppl/GSM546583_wtfsh_1.CEL.gz","108":"9606","109":"6 hours","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"wtfsh_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"FSH - hormone treatment - fsh stimulation","122":"Name:FSH - hormone treatment - fsh stimulation,follicle stimulating hormone (fsh):quantity 3nM time 6hour . 3nM","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM402824","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 cells siRNA control, biological rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"CEL files were generated using GCOS software and preprocessed using GC-RMA method","51":"54675","52":"NA","53":"Gene expression data from HEK293 cells transfected with control  siRNA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA from cells  was extracted and purified by using the RNeasy kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM402824","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells(ATCC #CRL 1573) were grown in DMEM supplemented with Glutamax (Gibco) and 10% FCS","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133Plus2.0  Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RT on 5 g of total RNA using oligo(dT) primers and  in vitro  transcription of the cDNA in presence of biotin were performed by using a GeneChip Amplification One-Cycle Target Labeling kit according to Affymetrix (Santa Clara, CA) standard protocols  Labeling kit according to Affymetrix (Santa Clara, CA) standard protocols.","79":"NA","80":"Jul 16 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix Scanner 3000 7G.","97":"NA","98":"GSE16097","99":"NA","100":"NA","101":"NA","102":"HEK293 cells + control siRNA 72h","103":"Public on Jul 16 2009","104":"NA","105":"NA","106":"May 13 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM402nnn/GSM402824/suppl/GSM402824.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 cells siRNA control, biological rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293 cells were  transfected 72h with siRNA BAHD1 or siRNA control (Ambion) using lipofectamine RNAi max (Invitrogen)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693936","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24h","17":"HEK293T_mock-transfection_24h_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_m_1_24', 'MOCK_m_1_0ng_24h_293T.CEL', 'Gene expression data from HEK 293T cells 24h after mock transfection without siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"control","64":"GSM693936","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"mock (without siRNA)","102":"HEK 293T cells, mock transfection, 24h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693936/suppl/GSM693936.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693936/suppl/GSM693936.EXP.gz']","108":"9606","109":"24h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_mock-transfection_24h_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546586","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"wtns_1","18":"no treatment","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"wtns_1:31.4ug.","61":"NA","62":"wild type","63":"NA","64":"GSM546586","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C; 5% C02","70":"20-10-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"wtns_1","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546586/suppl/GSM546586_wtns_1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"wtns_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"no treatment","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442101","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,8h,transfected,biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"8 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442101","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, transfected_16h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442101/suppl/GSM1442101_8hGFPP_REP3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,8h,transfected,biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1045511","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293, stable PRL-1 transfectant, biological replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"723 West Michigan St., Room SL306","38":"Indianapolis","39":"USA","40":"Biology","41":"cdumaual@gmail.com","42":"NA","43":"Indiana University-Purdue University Indianapolis","44":"Lab of Stephen K. Randall","45":"Carmen,M.,Dumaual","46":"NA","47":"IN","48":"NA","49":"46285","50":"The data were processed with R-project software version 2.13.1 through the Rstudio interface version 0.94.92.  Intensity values were read using the affy library of the Bioconductor package  version 2.8.  Normalizaton and calls were made using the mas5 procedure under default parameters.","51":"54675","52":"NA","53":"PRL-1 Overexpressing","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the TRIzol reagent (Life Technologies) and further purified with a Qiagen Rneasy Mini Kit, following the manufacturers' instructions for both.","61":"NA","62":"NA","63":"NA","64":"GSM1045511","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells stably overexpressing PRL-1 or transfected with empty pcDNA4 vector were grown in 100mm plates in DMEM supplemented with 10% (v/v) fetal bovine serum, 50 units/ml penicillin, and 50ug/ml streptomycin.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C to Affymetrix HG U133 Plus 2.0 arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 ug total RNA (Affymetrix Genechip Expression Analysis Technical Manual, 2002, Affymetrix).","79":"NA","80":"Jul 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G.","97":"NA","98":"['GSE42586', 'GSE42588']","99":"NA","100":"NA","101":"NA","102":"HEK293 cells stably transfected with pcDNA4-PRL-1","103":"Public on Jul 30 2013","104":"NA","105":"NA","106":"Nov 28 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1045nnn/GSM1045511/suppl/GSM1045511_PRL1_OvrxSt1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293, stable PRL-1 transfectant, biological replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1171534","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Rpb1-amr  RD35a","18":"rpb1-amr","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"2 Hertzl st.","38":"Rehovot","39":"Israel","40":"NA","41":"rivka.dikstein@weizmann.ac.il","42":"NA","43":"The Weizmann Institute of Science","44":"NA","45":"Rivka,,Dikstein","46":"NA","47":"NA","48":"NA","49":"76100","50":"RMA was carried out using Partek Genomic Suite 6.5 (Inc. St. Charles, MO; www.partek.com)","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted with Tri-reagent (MRC inc.) according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1171534","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T were maintained in Dulbeccos modified Eagles medium (DMEM) supplemented with 10 % fetal calf serum.","70":"NA","71":"NA","72":"cDNA in 80 ul were hybridized to a Human Gene 1.0 ST array using Affymetrix hybridization kit materials and hybridized for 17 hours at 45 at 60rpm. Post-hyb washes were done with Affymetrix wash solutions on the FS450 station using FS450_0007 protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"200ng TotalRNA were used. cDNA samples were generated and labeled using Affymetrix WT-cDNA synthesis and labeling kit","79":"NA","80":"Jul 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned on the Affymetrix GeneChip Scanner 3000 7G","97":"NA","98":"GSE48163","99":"NA","100":"NA","101":"NA","102":"1 wt","103":"Public on Jul 01 2013","104":"NA","105":"NA","106":"Jun 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1171nnn/GSM1171534/suppl/GSM1171534_RD35a_HuST.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Rpb1-amr  RD35a","117":"NA","118":"NA","119":"NA","120":"NA","121":"Rpb1-amr","122":"Cells were transfected with plasmids directing the expression of -amanitin-resistant variants of Pol II (Rpb1-amr and R749H-amr). -amanitin was added and RNA was prepared 24 and 48 h later, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1645161","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"5_GFPscr","18":"control","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Hufelandstrasse 55","38":"Essen","39":"Germany","40":"Universitaetsklinikum Essen","41":"bernhard.horsthemke@uni-due.de","42":"NA","43":"Institut fuer Humangenetik","44":"NA","45":"Bernhard,,Horsthemke","46":"NA","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with MAS5 using Affymetrix default analysis settings and global scaling to a target intensity of 1000 as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from GFP#2 clone, 96 h after treatment with non-targeting control siRNAs', 'total RNA (>200 nt)']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using the AllPrep DNA/RNA/Protein Mini kit (Qiagen) and treated with the RNase-Free DNase Set (Qiagen)","61":"NA","62":"NA","63":"NA","64":"GSM1645161","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were cultured in DMEM supplemented with 10% FCS, 1% Pen/Strep and appropriate concentrations of selective antibiotics.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133Plus_2. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix Hybridization, Wash and Stain Kit..","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA were prepared according to the Affymetrix ExpressKit protocol starting from 200 ng total RNA.","79":"NA","80":"Jul 17 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned in a GeneArray Scanner (Agilent).","97":"NA","98":"['GSE67348', 'GSE67351']","99":"NA","100":"NA","101":"NA","102":"Flp-In T-REx 293","103":"Public on Jul 16 2015","104":"NA","105":"NA","106":"Mar 27 2015","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1645nnn/GSM1645161/suppl/GSM1645161_5_GFPscr.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1645nnn/GSM1645161/suppl/GSM1645161_5_GFPscr.mas5.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"5_GFPscr","117":"NA","118":"NA","119":"NA","120":"GFP","121":"control","122":"Cells were treated either with siRNA against TET1, TET2 and TET3 or a non-targeting pool. All cells carried an inducible, stable GFP transgene whose expression was not induced.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693946","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"72h","17":"HEK293T_BACH1-siRNA2_72h_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_s_1_72', 'BACH1_s_1_300ng_72h_293T.CEL', 'Gene expression data from HEK 293T cells 72h after knockdown of BACH1 with Stealth siRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693946","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"siRNA2 HSS100910 (s)","102":"HEK 293T cells, BACH1 knockdown, 72h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693946/suppl/GSM693946.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693946/suppl/GSM693946.EXP.gz']","108":"9606","109":"72h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-siRNA2_72h_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM926184","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina humanRef-8 v1.0 expression beadchip (Illumina_HumanRef-8_v1.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK-293 control miR-107 Experimental Replicate 1 1895213040_E","18":"mir-107","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ring Road","38":"Callaghan","39":"Australia","40":"NA","41":"NA","42":"NA","43":"University of Newcastle","44":"NA","45":"Adam,,Carroll","46":"NA","47":"NSW","48":"NA","49":"2308","50":"Illumina Beadstudio software computed average signal intensities and detection p-values.","51":"22184","52":"NA","53":"Experimental Replicate 1","54":"illuminaHumanv2","55":"44.83337","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted with Trizol reagent, followed by clean-up with DNase I treatment and the RNeasy MinElute cleanup kit (Qiagen) in accordance with manufacturer's instructions. Quality control was performed with an Experion (BioRad) bioanalyser.","61":"NA","62":"NA","63":"NA","64":"GSM926184","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cell models were grown as confluent monolayers in standard tissue culture conditions.","70":"NA","71":"NA","72":"Standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA was prepared using the TotalPrep RNA amplification kit (Ambion) for Illumina arrays.","79":"NA","80":"Nov 01 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6104","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol.","97":"NA","98":"GSE37729","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Nov 01 2012","104":"NA","105":"NA","106":"May 02 2012","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK-293 control miR-107 Experimental Replicate 1 1895213040_E","117":"NA","118":"NA","119":"NA","120":"NA","121":"miR-107","122":"Cells were transfected with either synthetic miRNA or anti-miR inhibitor oligonucleotides. Control refers to untransfected cell models; siEGFP control refers to transfection with an siRNA to EGFP as a transfection control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733114","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070829 SM exposure 100 uM_4h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-02-27","29":"Phillips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-14","53":"Gene expression data from NHEK_070829 SM exposure 100 uM_4h timepoint","54":"NA","55":"NA","56":"NA","57":"100.0","58":"2007-08-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733114","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-05-13","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-05-15","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070829 SM exposure 100 uM_4h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733114/suppl/GSM733114_070829_HD_4h_100.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"4","115":"NA","116":"NHEK_070829 SM exposure 100 uM_4h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM517901","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,control,biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"CTR_1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM517901","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Nov 21 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE20615","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,control,biological rep 1","103":"Public on Oct 05 2011","104":"NA","105":"NA","106":"Mar 03 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM517nnn/GSM517901/suppl/GSM517901.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,control,biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2545287","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"hek-293t","15":"NA","16":"48 h after transfection","17":"293T-DME rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"HEK-293T","33":"1","34":"NA","35":"NA","36":"NA","37":"Gwanak-gu","38":"Seoul","39":"South Korea","40":"Dept Plant Science","41":"huhjh@snu.ac.kr","42":"NA","43":"Seoul National University","44":"NA","45":"Jin Hoe,,Huh","46":"NA","47":"NA","48":"NA","49":"151-921","50":"The Micorarray Suite version 5 (MAS5) algorithm implemented in Affymetrix Expression Console software (version1.3.1) was used to normalize the raw data. Highly expressed genes that showed over 2-fold difference between the signal values of control and test samples were selected for further study.","51":"54675","52":"NA","53":"['DME-3', 'Gene expression data from 293T-DME']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted and purified using Qiagen RNeasy Kit according to standard instructions","61":"NA","62":"NA","63":"NA","64":"GSM2545287","65":"NA","66":"NA","67":"NA","68":"NA","69":"GFP and DME were transfected in HEK-293T cells and the cells harvested 48 h after transfection. HEK-293T cells were grown in Dulbeccos modified Eagles medium (DMEM) supplemented with 10% fetal bovine serum and a 1% antibiotic/antimycotic solution at 37C in 5% CO2 humidity chamber.","70":"NA","71":"NA","72":"Following fragmentation, fragmented cDNA were hybridized for 16 hr at 45C on Affymetrix GeneChip Human Genome U133 Plus 2.0 ST Array. The GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cDNA were prepared according to the standard Affymetrix protocol from 300  ng total RNA (GeneChip WT Terminal Labeling and Controls Kit P/N 901525 1, Affymetrix).","79":"NA","80":"Sep 20 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G","97":"NA","98":"['GSE96863', 'GSE96866']","99":"NA","100":"NA","101":"NA","102":"293T-DME","103":"Public on Sep 20 2017","104":"NA","105":"NA","106":"Mar 21 2017","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2545nnn/GSM2545287/suppl/GSM2545287_DME-3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"48 h after transfection","113":"NA","114":"NA","115":"NA","116":"293T-DME rep3","117":"NA","118":"plant-derived DNA demethylase DME","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442091","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"PEI_HEK293T cell culture,2h,untreated,biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"2 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442091","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59665","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untreated_2h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442091/suppl/GSM1442091_2hCONTROL_REP1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"PEI_HEK293T cell culture,2h,untreated,biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic 25kDa bPEI was mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of polyplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of polyplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with polyplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733197","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070919 NM exposure 100 uM_1h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-24","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-28","53":"Gene expression data from NHEK_070919 NM exposure 100 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"100.0","58":"2007-09-19","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733197","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-23","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Rothwell","92":"NA","93":"NA","94":"NA","95":"2008-08-06","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070919 NM exposure 100 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733197/suppl/GSM733197_070919_NM_1h_100.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_070919 NM exposure 100 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610840","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0hr","17":"HEK293T_miR-381_FSK0hr_rep2","18":"NA","19":"untreated","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610840","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610840/suppl/GSM610840.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610840/suppl/GSM610840.chp.gz']","108":"9606","109":"0hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-381_FSK0hr_rep2","117":"miR-381","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM389759","2":"NA","3":"hek 293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 in low glucose #2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"Gene expression data from cells cultivated in low glucose","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated with the RNeasy Mini kit according to the manufacturer`s instructions (Qiagen).","61":"NA","62":"NA","63":"NA","64":"GSM389759","65":"low glucose (100 mg/dl)","66":"NA","67":"NA","68":"NA","69":"Human embryonic kidney (HEK293) cells were grown for 7 days in DMEM (supplemented with 10 % FCS) containing 450 mg/dl glucose (high glucose) or 100 mg/dl glucose (low glucose).","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Human Genome U133 Plus 2.0 Array) in 200 l of the hybrization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual; Rev. 5).","79":"NA","80":"Apr 19 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE15575","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) cultivated for 7 days in DMEM containing low (100 mg/dl) glucose.","103":"Public on Apr 08 2009","104":"NA","105":"NA","106":"Apr 06 2009","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM389nnn/GSM389759/suppl/GSM389759.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM389nnn/GSM389759/suppl/GSM389759.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 in low glucose #2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM926167","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina humanRef-8 v1.0 expression beadchip (Illumina_HumanRef-8_v1.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK-293 anti-miR-181b Experimental Replicate 2 1895213044_D","18":"anti-mir-181b","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ring Road","38":"Callaghan","39":"Australia","40":"NA","41":"NA","42":"NA","43":"University of Newcastle","44":"NA","45":"Adam,,Carroll","46":"NA","47":"NSW","48":"NA","49":"2308","50":"Illumina Beadstudio software computed average signal intensities and detection p-values.","51":"22184","52":"NA","53":"Experimental Replicate 2","54":"illuminaHumanv2","55":"44.83337","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted with Trizol reagent, followed by clean-up with DNase I treatment and the RNeasy MinElute cleanup kit (Qiagen) in accordance with manufacturer's instructions. Quality control was performed with an Experion (BioRad) bioanalyser.","61":"NA","62":"NA","63":"NA","64":"GSM926167","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cell models were grown as confluent monolayers in standard tissue culture conditions.","70":"NA","71":"NA","72":"Standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA was prepared using the TotalPrep RNA amplification kit (Ambion) for Illumina arrays.","79":"NA","80":"Nov 01 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6104","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol.","97":"NA","98":"GSE37729","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Nov 01 2012","104":"NA","105":"NA","106":"May 02 2012","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK-293 anti-miR-181b Experimental Replicate 2 1895213044_D","117":"NA","118":"NA","119":"NA","120":"NA","121":"anti-miR-181b","122":"Cells were transfected with either synthetic miRNA or anti-miR inhibitor oligonucleotides. Control refers to untransfected cell models; siEGFP control refers to transfection with an siRNA to EGFP as a transfection control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM618017","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney","15":"NA","16":"NA","17":"HEK-TLR2 2h-LPS rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"human embryonic kidney (HEK) cells stably transfected with Toll-like receptor 2 (TLR2)","33":"1","34":"NA","35":"NA","36":"NA","37":"St. James's Hospital","38":"Dublin 8","39":"Ireland","40":"NA","41":"NA","42":"NA","43":"Trinity College Dublin","44":"Trinity Centre for Health Sciences","45":"Sinead,Marian,Smith","46":"NA","47":"NA","48":"NA","49":"D8","50":"Scanned images, obtained using Affymetrix Software (MAS5), were normalized using robust multichip average (RMA) analysis with RMAExpress version 0.4.1.","51":"54675","52":"NA","53":"gene expression in untreated HEK-TLR2 cells at 2h","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"At time points of 2, 4, 8, 24 and 48 h post-stimulation, cells were harvested and RNA isolated using the Nucleospin RNAII kit (Machery Nagel) according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM618017","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK-TLR2 cells were routinely maintained in MEM alpha medium (Gibco) supplemented with 10% foetal calf serum (Gibco), 2 mM L-glutamine (Sigma), 100 U/ml penicillin (Sigma), 100 g/ml streptomycin and 500 g/ml G418 (Sigma). The day before treatment, cells were seeded in 6-well plates at 1x106 cells/well.","70":"NA","71":"NA","72":"Following fragmentation, cRNA was hybridized for 16 hr at 45C on Affymetrix U133 plus 2.0 genechips. GeneChips were washed and stained in the Automated fluidics 450 station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 5 g total RNA (Expression Analysis Technical Manual, 2001, Affymetrix) using the Affymetrix IVT labeling kit.","79":"NA","80":"Jan 13 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips were scanned using the GeneChip 3000 7G scanner","97":"NA","98":"['GSE25148', 'GSE25155']","99":"NA","100":"NA","101":"NA","102":"HEK-TLR2 cells untreated for 2h rep 1","103":"Public on Jan 12 2011","104":"NA","105":"NA","106":"Nov 04 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM618nnn/GSM618017/suppl/GSM618017.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"embryonic kidney","116":"HEK-TLR2 2h-LPS rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"The morning of treatment, the cell culture medium was replaced with either fresh medium (untreated) or medium containing 10 g/ml H. pylori lipopolysaccharide","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM925905","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293 Flp-In TRIM71 rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Maulbeerstrasse 66","38":"Basel","39":"Switzerland","40":"Functional Genomics","41":"tim.roloff@fmi.ch","42":"NA","43":"FMI","44":"NA","45":"Tim,,Roloff","46":"NA","47":"NA","48":"NA","49":"4058","50":"Arrays were normalized and probeset-level log2 expression values were calculated using the rma function from the R/Bioconductor (v2.14) package affy.","51":"32321","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and further cleaned up using RNeasy Columns.","61":"NA","62":"NA","63":"FHA-TRIM71 overexpression","64":"GSM925905","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were grown in DMEM supplemented with 2 mM glutamine and 10% FCS. 50 ug/ml hygromycin B was added to the culture medium for the maintance of FHA-TRIM71 expressing cell lines.","70":"NA","71":"NA","72":"Affymetrix Gene Chip Arrays were hybridized following the GeneChip Whole Transcript (WT) Sense Target Labeling Assay Manual (Affymetrix) with a hybridization time of 16h. The Affymetrix Fluidiscs protocol FS450_0007 was used for washing.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"100ng of extracted total RNA was amplified using the Ambion WT Expression kit (Ambion) and the resulting sense-strand cDNA was fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling kit (Affymetrix).","79":"NA","80":"Jan 23 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed with Affzmetrix GCC Scan Control v. 3.0.0.1214 on a GeneChip Scanner 3000 with autoloader.","97":"NA","98":"['GSE37713', 'GSE37714']","99":"NA","100":"NA","101":"NA","102":"FHA-TRIM71 HEK293","103":"Public on Jan 22 2013","104":"NA","105":"NA","106":"May 02 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM925nnn/GSM925905/suppl/GSM925905_wf20110324hg10_06_FHA-TR71III_503_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 Flp-In TRIM71 rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610835","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"4hr","17":"HEK293T_miR-neg_FSK4hr_rep1","18":"NA","19":"FSK","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610835","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610835/suppl/GSM610835.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610835/suppl/GSM610835.chp.gz']","108":"9606","109":"4hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-neg_FSK4hr_rep1","117":"negative control","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693929","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24h","17":"HEK293T_BACH1-esiRNA_24h_rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_e_3_24', 'BACH1_e_3_200ng_24h_293T.CEL', 'Gene expression data from HEK 293T cells 24h after knockdown of BACH1 with esiRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693929","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"esiRNA (e)","102":"HEK 293T cells, BACH1 knockdown, 24h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693929/suppl/GSM693929.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693929/suppl/GSM693929.EXP.gz']","108":"9606","109":"24h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-esiRNA_24h_rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820022","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24 hrs","17":"HEK293T FMR4pcDNA 24hr 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"FMR4 overexpression","64":"GSM1820022","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, FMR4 overexpression, 24 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820022/suppl/GSM1820022_Zane_24hr_FMR4OX_3_B9_102011.CEL.gz","108":"9606","109":"24 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T FMR4pcDNA 24hr 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM678650","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Control_0_h_Replicate 2","18":"NA","19":"Control","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"2","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 27","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678650","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"1","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"1","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"0","114":"NA","115":"NA","116":"HEK293_Control_0_h_Replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546580","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"t466nsbis_1","18":"no treatment","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"t466ns_1:62.8ug.","61":"NA","62":"mutant hek293_t466","63":"NA","64":"GSM546580","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C, 5% C02","70":"20-10-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"t466nsbis_1","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546580/suppl/GSM546580_t466nsbis_1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"t466nsbis_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"no treatment","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820003","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hrs","17":"HEK293T FMR4siRNA 6hr 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"FMR4 knockdown","64":"GSM1820003","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, FMR4 knockdown, 6 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820003/suppl/GSM1820003_Zane_6hr_FMR4si_2_A2_102011.CEL.gz","108":"9606","109":"6 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T FMR4siRNA 6hr 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM517904","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,transfected,biological rep 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"GFP_1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM517904","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 22 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE59666","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"['GSE20615', 'GSE59666']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,transfected,biological rep 1_24h","103":"Public on Oct 05 2011","104":"NA","105":"NA","106":"Mar 03 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM517nnn/GSM517904/suppl/GSM517904.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,transfected,biological rep 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1558599","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK_Native_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"no","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Nonnenwald 2","38":"Penzberg","39":"Germany","40":"Pharmaceutical Sciences","41":"fabian.birzele@roche.com","42":"NA","43":"Roche Diagnostics GmbH","44":"NA","45":"Fabian,,Birzele","46":"NA","47":"NA","48":"NA","49":"82377","50":"Partek Genomics suite was used to process CEL files, perform normalization and QC as well as to identify differentially regulated genes between native and CD44 transfected HEK293 cells using ANOVA.","51":"54675","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"HEK293-CD44s Clone 4, expressing an average level of HA, was picked for profiling gene expression using Affymetrix Human Genome U133plus 2.0 arrays. Total RNA was prepared using the RNeasy Mini Kit (Qiagen, Germany), Microarray RNA Target Synthesis Kit T7 and RNeasy Mini-Spin Columns (Roche, Germany) and a hybridization mix was created consisting of 30 l of fragmented cRNA solution mixed with control oligonucleotide, staggered control cRNAs, herring sperm DNA, acetylated BSA and hybridization buffer in a total volume of 300 l. All kit procedures were performed according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1558599","65":"NA","66":"NA","67":"NA","68":"NA","69":"For cloning and expression of human CD44 (EMBL accession number M24915) the sequence was codon optimized (Geneart, Germany) and CD44s was expressed using a pcDNA3.1(-) vector (Invitrogen, Germany). PCR was performed with a denaturation step at 94C for 2 min, followed by 30 cycles of denaturation at 94C for 30 sec, annealing at 58C for 30 sec, and extension at 68C for 45 sec, with a final extension of 7 minutes at 68C (Expand High Fidelity PCR Kit, Roche). The PCR product and the vector were digested with EcoRI/HindIII restriction endonucleases, and DNA fragments were resolved by 1% agarose gel electrophoresis,purified from gels (GFX PCR DNA and Gel Band Purification Kit) and ligated (Rapid DNA Ligation Kit, Roche). Vectors were transferred into XL-10 Gold super-competent cells (Stratagene, The Netherlands) by heat shock and transformed cells were isolated form agar plates containing 100g/ml Ampicilin. Vector DNA from transfected cells was isolated using the High Pure Plasmid Isolation Kit (Roche, Germany).","70":"NA","71":"NA","72":"The hybridization mix was loaded onto the arrays and incubated in a roller device for 16 hrs. Hybridization solution was removed, arrays were washed, stained","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"standard Affymtrix protocol","79":"NA","80":"Dec 05 2014","81":"NA","82":"polyA RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned with an Affymetrix GeneChip Scanner 3000 (7G)","97":"NA","98":"GSE63862","99":"NA","100":"NA","101":"NA","102":"cell culture, native HEK293 cells","103":"Public on Dec 05 2014","104":"NA","105":"NA","106":"Dec 04 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1558nnn/GSM1558599/suppl/GSM1558599_KLP_RW14_101125_CD44_PZ.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK_Native_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"no treatment","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874627","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T2h_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874627","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 2h replicate 2","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874627/suppl/GSM1874627_RG_27_4OHT_2h_2_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T2h_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1717905","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney cells","15":"NA","16":"NA","17":"HEK293T_KO_REP6","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney cells","33":"1","34":"NA","35":"NA","36":"NA","37":"Universiteitsplein 1","38":"Edegem","39":"Belgium","40":"NA","41":"ken.opdebeeck@uantwerpen.be","42":"NA","43":"University Of Antwerp","44":"NA","45":"Ken,,Op de Beeck","46":"NA","47":"NA","48":"NA","49":"2650","50":"The data were quantile normalized in limma 3.24.4 for R","51":"42000","52":"NA","53":"replicate 6","54":"illuminaHumanv4","55":"87.30538","56":"NA","57":"NA","58":"NA","59":"NA","60":"An RNeasy mini kit was used for RNA extraction from transfected HEK293T cells (Qiagen, Hilden, Germany) at different time-points. For the microarray experiment, RNA was extracted 12h post-transfection.","61":"NA","62":"NA","63":"NA","64":"GSM1717905","65":"NA","66":"NA","67":"NA","68":"NA","69":"The microarray experiments in human cell lines were performed using Human Embryonic Kidney 293T cells (HEK293T). HEK293T cells were subcultured in 60 mm dishes at a density of 2  106 cells in Dulbeccos modified Eagles medium containing 4500 mg/L glucose supplemented with 10% (v/v) fetal calf serum, 100 U/ml penicillin, 100 g/ml streptomycin, and 2 mM L-glutamine.","70":"NA","71":"NA","72":"Standard Illumina hybridization protocol","73":"NA","74":"NA","75":"NA","76":"NA","77":"cy3","78":"Biotinylated cRNA were prepared with the Illumina Totalprep RNA amplification kit (Life technologies)","79":"NA","80":"Jun 24 2015","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"['GSE70167', 'GSE70169']","99":"NA","100":"NA","101":"NA","102":"HEK293T_KO","103":"Public on Jun 24 2015","104":"NA","105":"NA","106":"Jun 23 2015","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_KO_REP6","117":"NA","118":"mutant DFNA5","119":"NA","120":"NA","121":"NA","122":"Overnight cultures were transfected with either  wtDFNA5 or mutDFNA5 using lipofectamine. Six hours post transfection, cells were harvested using Triple-x reagent for RNA extraction.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM546589","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133A 2.0 Array (hgu133a2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 hours","17":"t466fsh_1","18":"fsh - hormone treatment - fsh stimulation","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"3nM","37":"Rue G. Morel","38":"Beaucouze","39":"France","40":"NA","41":"NA","42":"NA","43":"INRA","44":"IRHS","45":"sandrine,,balzergue","46":"NA","47":"NA","48":"NA","49":"49000","50":"The data were normalized with the gcrma algorithm (Irizarry et al., 2003), available in the Bioconductor package (Gentleman and Carey, 2002).","51":"22277","52":"NA","53":"- G protein-coupled receptors (GPCR) are centrally involved in most physiological processes and are a major drug targets. They transduce extracellular signals inside the cells through at least two different mechanisms: i) the classical coupling to heterotrimeric G proteins and ii) a newly discovered -arrestin-dependent pathway. The fundamental issue of the respective impacts that these two transduction mechanisms exert on gene regulation has not been clearly addressed to date. To tackle this question, we have developed two mutants of the follicle stimulating hormone (FSH) receptors which do not couple to G proteins upon FSH activation but continue to recruit -arrestins and signal through them.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"t466fsh_1:48ug.","61":"NA","62":"mutant hek293_t466","63":"NA","64":"GSM546589","65":"NA","66":"NA","67":"NA","68":"NA","69":"cell culture/primary cell - MEM (PAA Laboratory GmbH) + Fetal Bovin Serum 10% + Penicilin and Streptomycin 1% 37C, 5% C02","70":"20-10-09","71":"NA","72":"labelled extract quantity: 15ug","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"labelling Biotin direct, amplification=yes, cRNA 20 ug.","79":"NA","80":"Apr 30 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL571","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GCOS, Biotin:pmt voltage 570nm,650V,laser power 1","97":"NA","98":"GSE21982","99":"NA","100":"NA","101":"NA","102":"t466fsh_1","103":"Public on Nov 25 2011","104":"NA","105":"NA","106":"May 25 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM546nnn/GSM546589/suppl/GSM546589_t466fsh_1.CEL.gz","108":"9606","109":"6 hours","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"t466fsh_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"FSH - hormone treatment - fsh stimulation","122":"Name:FSH - hormone treatment - fsh stimulation,follicle stimulating hormone (fsh):quantity 3nM time 6hour . 3nM","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820011","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24 hrs","17":"HEK293T CTLsiRNA 24hr 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"knockdown control","64":"GSM1820011","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, knockdown control, 24 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820011/suppl/GSM1820011_Zane_24hr_CTLsi_1_A10_102011.CEL.gz","108":"9606","109":"24 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T CTLsiRNA 24hr 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881004","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 2","17":"Producer culture - fermentation 2- time point 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"1","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 2","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"recombinant protein producer","64":"GSM881004","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Producer culture - fermentation 2- time point 2","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 2","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Producer culture - fermentation 2- time point 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442111","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,2h,treated,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"2 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442111","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, treated_2h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442111/suppl/GSM1442111_2hGFP_REP2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,2h,treated,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733110","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070829 SM exposure control 0 uM_2h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-02-25","29":"Phillips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-10","53":"Gene expression data from NHEK_070829 SM exposure control 0 uM_2h timepoint","54":"NA","55":"NA","56":"NA","57":"0.0","58":"2007-08-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733110","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-05-13","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-05-15","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070829 SM exposure control 0 uM_2h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733110/suppl/GSM733110_070829_HD_2h_Control.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"2","115":"NA","116":"NHEK_070829 SM exposure control 0 uM_2h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1820015","2":"NA","3":"hek 293t cells","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"24 hrs","17":"HEK293T FMR4siRNA 24hr 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK 293T cells","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1501 NW 10th Ave","38":"Miami","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Miami","44":"NA","45":"Veronica,J,Peschansky","46":"NA","47":"FL","48":"NA","49":"33136","50":"Background subtraction, normalization and quality control were performed using the Affymetrix GeneChip Command Console Software and R bioconductor. Data were normalized with GC-RMA.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using Trizol and the RNeasy Mini Kit columns from Qiagen.","61":"NA","62":"NA","63":"FMR4 knockdown","64":"GSM1820015","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Final yield was hybridized onto the array, washed and stained using the Affymetrix GeneChip Hybridization, Wash, and Stain Kit (cat# 900720).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"At 6 or 24 hours post transfection, RNA was extracted and samples were submitted to the Hussman Institute for Human Genomics Center for Genome Technology for microarray analysis using Affymetrix Human Gene 1.0 ST Arrays. Total RNA samples were first prepared using the Ambion WT Expression Kit (cat# 4411974). Briefly, the kit generates sense-strand cDNA from total RNA using a reverse transcription priming method that specifically primes non-ribosomal RNA, including both poly(A) and non-poly(A) mRNA. Next, samples are fragmented and labeled using the Affymetrix GeneChip WT Terminal Labeling Kit (cat# 902280).","79":"NA","80":"Sep 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned using GeneChip Scanner 3000 7G system.","97":"NA","98":"GSE70817","99":"NA","100":"NA","101":"NA","102":"HEK 293T cells, FMR4 knockdown, 24 hrs","103":"Public on Sep 01 2015","104":"NA","105":"NA","106":"Jul 13 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1820nnn/GSM1820015/suppl/GSM1820015_Zane_24hr_FMR4si_2_A8_102011.CEL.gz","108":"9606","109":"24 hrs","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T FMR4siRNA 24hr 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"CTLsiRNA & FMR4siRNA were transfected with Lipofectamine RNAiMAX and 40nM siRNA. CTRLpcDNA & FMR4pcDNA were transfected with Lipofectamine 2000CD and 0.5ug pcDNA 3.1 vector w/ or w/o FMR4, respectively.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560861","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0 h","17":"MOCK_0h_MDP_biological replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"control mock","63":"NA","64":"GSM560861","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560861/suppl/GSM560861.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"0 h","113":"NA","114":"NA","115":"NA","116":"MOCK_0h_MDP_biological replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM678642","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Control_24_h_Replicate 3","18":"NA","19":"Control","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"2","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 54","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678642","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"1","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"2","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"24","114":"NA","115":"NA","116":"HEK293_Control_24_h_Replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1442124","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,16h,transfected,biological rep 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.11.1 with Bioconductor 2.4. Arrays were normalised via RMA. Differential expression was obtained from normalized expression data using nonparametric mean-variance smoothing method (see PMID 21611181). For 2h, differential expression is between treated samples and untreated samples. For 8h and 16h, differential expression is between GFP+ and GFP- arrays.","51":"54675","52":"NA","53":"16 h gene profile","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was Trizol extracted and further purified using Qiagen RNeasy Mini kit according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1442124","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug purified RNA (Expression Analysis Technical Manual, 2001, Affymetrix)","79":"NA","80":"Jul 23 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"GSE59666","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, transfected_16h","103":"Public on Jul 23 2014","104":"NA","105":"NA","106":"Jul 22 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1442nnn/GSM1442124/suppl/GSM1442124_16hGFPP_REP3.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,16h,transfected,biological rep 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic Lipofectamine 2000 was mixed with pEGFP-LUC to form lipoplexes. Cells were treated with lipoplexes 18h after seeding. For 2h arrays, cells were harvested 2h after delivery of lipoplexes. For 8h and 16h arrays, cells were harvested and flow separated 8h or 16h, respectively, after delivery of lipoplexes into fluorescent (GFP positive; GFPP) and non-fluorescent (GFP minus; GFPM) populations. 2h control samples were not treated with lipoplexes.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM678675","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Treated_1_h_Replicate 1","18":"NA","19":"Triptorelin","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"5","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 13","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678675","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"2","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"3","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"1","114":"NA","115":"NA","116":"HEK293_Treated_1_h_Replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874641","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T4h_CYHX_4h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874641","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen and CYHX 4h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874641/suppl/GSM1874641_RG_50_4OHT_CYHX_4h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T4h_CYHX_4h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874640","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T2h_CYHX_2h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874640","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen and CYHX 2h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874640/suppl/GSM1874640_RG_49_4OHT_CYHX_2h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T2h_CYHX_2h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM941945","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture, untreated, biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"untreated","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"32 Chase Hall","38":"Lincoln","39":"USA","40":"Biological Systems Engineering","41":"NA","42":"NA","43":"University of Nebraska-Lincoln","44":"Pannier","45":"Timothy,,Martin","46":"NA","47":"NE","48":"NA","49":"68583-0726","50":"The data was analysed using R 2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"24 h gene profile of untreated HEK293T cells.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM941945","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in T75 in DMEM supplemented with 10% FBS, 1% Pen/Strep, 1% Sodium Pyruvate.","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jun 03 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm.","97":"NA","98":"GSE38422","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture, untreated","103":"Public on Jun 03 2012","104":"NA","105":"NA","106":"Jun 02 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM941nnn/GSM941945/suppl/GSM941945_AnP_Hu13302_081910_06_CTR38.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture, untreated, biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cationic PEI polymer mixed with pEGFP-LUC to form polyplexes. Cells were treated with polyplexes 18 h after seeding and flow separated after another 24 h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560855","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0 h","17":"NOD2wt_0h_MDP_biological replicate 1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 wt","63":"NA","64":"GSM560855","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560855/suppl/GSM560855.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"0 h","113":"NA","114":"NA","115":"NA","116":"NOD2wt_0h_MDP_biological replicate 1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1645158","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"2_GFPsiRNA","18":"simultaneous knockdown of tet1, tet2 and tet3","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Hufelandstrasse 55","38":"Essen","39":"Germany","40":"Universitaetsklinikum Essen","41":"bernhard.horsthemke@uni-due.de","42":"NA","43":"Institut fuer Humangenetik","44":"NA","45":"Bernhard,,Horsthemke","46":"NA","47":"NA","48":"NA","49":"D-45122","50":"The data were analyzed with MAS5 using Affymetrix default analysis settings and global scaling to a target intensity of 1000 as normalization method.","51":"54675","52":"NA","53":"['Gene expression data from GFP#2 clone, 96 h after simultaneous siRNA-mediated knockdown of TET1, TET2, TET3', 'total RNA (>200 nt)']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was extracted using the AllPrep DNA/RNA/Protein Mini kit (Qiagen) and treated with the RNase-Free DNase Set (Qiagen)","61":"NA","62":"NA","63":"NA","64":"GSM1645158","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were cultured in DMEM supplemented with 10% FCS, 1% Pen/Strep and appropriate concentrations of selective antibiotics.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip HG-U133Plus_2. GeneChips were washed and stained in the Affymetrix Fluidics Station 450 using the Affymetrix Hybridization, Wash and Stain Kit..","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Biotinylated cRNA were prepared according to the Affymetrix ExpressKit protocol starting from 200 ng total RNA.","79":"NA","80":"Jul 17 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays were scanned in a GeneArray Scanner (Agilent).","97":"NA","98":"['GSE67348', 'GSE67351']","99":"NA","100":"NA","101":"NA","102":"Flp-In T-REx 293","103":"Public on Jul 16 2015","104":"NA","105":"NA","106":"Mar 27 2015","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1645nnn/GSM1645158/suppl/GSM1645158_2_GFPsiRNA.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1645nnn/GSM1645158/suppl/GSM1645158_2_GFPsiRNA.mas5.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"2_GFPsiRNA","117":"NA","118":"NA","119":"NA","120":"GFP","121":"simultaneous knockdown of TET1, TET2 and TET3","122":"Cells were treated either with siRNA against TET1, TET2 and TET3 or a non-targeting pool. All cells carried an inducible, stable GFP transgene whose expression was not induced.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610846","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"4hr","17":"HEK293T_miR-132_FSK4hr_rep2","18":"NA","19":"FSK","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610846","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610846/suppl/GSM610846.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610846/suppl/GSM610846.chp.gz']","108":"9606","109":"4hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-132_FSK4hr_rep2","117":"miR-132","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM711418","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"HEK293Tcells_si75_rep3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"1000 E 50th St","38":"Kansas City","39":"USA","40":"Genomics","41":"seidel@phageT4.org","42":"NA","43":"Stowers Institute","44":"Seidel","45":"Chris,W,Seidel","46":"816 926 9054","47":"MO","48":"NA","49":"64110","50":"Array intensities were processed using the RMA algorithm in R/bioconductor. Bioconductor 2.6 and affy package affy_1.24.2","51":"54675","52":"NA","53":"Gene expression from HEK293T cells after transfection with siRNA s18075 targeting Med26, replicate 3.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the standard Qiagen RNeasy cleanup protocol.","61":"NA","62":"NA","63":"NA","64":"GSM711418","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in 6 well tissue culture plates or 10 cm dishes for 48 hours after transfection.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 plus 2.0 Arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the Ambion MessageAmp III protocol from 300 ng total RNA (MessageAmp III Amplification kit Manual, 2007, Ambion).","79":"NA","80":"Sep 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 and processed with AGCC v3.0 software.","97":"NA","98":"GSE28715","99":"NA","100":"Med26 targeting s18075","101":"NA","102":"HEK293T cells","103":"Public on Sep 01 2011","104":"NA","105":"NA","106":"Apr 19 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM711nnn/GSM711418/suppl/GSM711418_si-75-3_HG-U133_Plus_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293Tcells_si75_rep3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293T cells in 6 well tissue culture plates (~1x105 cells/well) or 10 cm dishes (~2 x106 cells/dish) were transfected with 25 nM siRNAs targeting human Med26 (Ambion/Applied Biosystems, #4, s18074; #5, s18075; #6, s18076) or 25 nM siCONTROL NON-TARGETING siRNA #2 (Dharmacon D-001210-01) using X-tremeGENE siRNA Transfection Reagent (Roche) and grown for 48 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM465437","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney cells","15":"NA","16":"NA","17":"HEK293 in NOD.Scid, rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"embryonic kidney cells","33":"1","34":"NA","35":"NA","36":"NA","37":"Winterthurerstrasse 190","38":"Zurich","39":"Switzerland","40":"Molecular Pharmacology","41":"ursula.quitterer@pharma.ethz.ch","42":"NA","43":"ETH Zrich (Swiss Federal Institute of Technology)","44":"NA","45":"Ursula,,Quitterer","46":"0041446329801","47":"NA","48":"NA","49":"CH-8057","50":"The signals were processed using Affymetrix GeneChip Operating Software (GCOS; v.1.4; Affymetrix). To compare samples and experiments, the trimmed mean signal of each array was scaled to a target intensity of 200.","51":"54675","52":"NA","53":"Gene expression data from in vivo expanded HEK293 cells.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was isolated with the RNeasy Mini kit according to the manufacturer's instructions (Qiagen).","61":"NA","62":"NA","63":"NA","64":"GSM465437","65":"NA","66":"NA","67":"in vivo cell expansion","68":"NA","69":"Human embryonic kidney (HEK293) cells were grown in DMEM (glucose concentration 450 mg/dl), either injected in NOD.Scid mice and expanded for three weeks in vivo, or cultivated in vitro.","70":"NA","71":"NA","72":"For hybridization, 15 g of fragmented cRNA were incubated with the chip (Human Genome U133 Plus 2.0 Array) in 200 l of the hybridization solution in a Hybridization Oven 640 (Affymetrix) for 16 h at 45 C. GeneChips were then washed and stained using the Affymetrix Fluidics Station 450 according to the GeneChip Expression Analysis Technical Manual (Rev. 5).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA was prepared according to the protocol of the manufacturer (Affymetrix; GeneChip Expression Analysis Technical Manual; Rev. 5).","79":"NA","80":"Oct 26 2009","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 7G.","97":"NA","98":"GSE18739","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) expanded for three weeks in immunodeficient NOD.Scid mice","103":"Public on Oct 27 2009","104":"NA","105":"NA","106":"Oct 26 2009","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM465nnn/GSM465437/suppl/GSM465437.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM465nnn/GSM465437/suppl/GSM465437.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293 in NOD.Scid, rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM360331","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 6hr, replicate 4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"NA","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"50 South Drive, Bldg.50, Rm.2347","38":"Bethesda","39":"USA","40":"NA","41":"changah@nhlbi.nih.gov","42":"NA","43":"NIH\\\\NHLBI","44":"Laboratory of Biochemistry","45":"Allen,HK,Chang","46":"NA","47":"MD","48":"NA","49":"20892","50":"The data were first processed with GCOS1.4 using Affymetrix default analysis settings. The trimmed mean target intensity of each array was arbitrarily set to 1000. Intensities obtained in CHP file generated by GCOS were normalized using an adaptive variance-stabilizing quantile normalization (Munson, P.J., GeneLogic Workshop of Low Level Analysis of Affymetrix GeneChip Data, 2001, software available at http://abs.cit.nih.gov/geneexpression.html).","51":"54675","52":"NA","53":"gene expression data from human embryonic kidney cells (cell culture) treated with epoxomicin for 6hr","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from HEK293 cells using Qiagen RNeasy Mini Kit according to manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM360331","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells are maintained in DMEM supplemented with 10% fetal bovine serum in 3% oxygen, 5% carbon dioxide, 37 degrees Celsius humidified incubator.","70":"NA","71":"NA","72":"Fragmented RNA was hybridized to Affymetrix HG-U133 plus 2.0 chips for 16 hours, washed, stained on an Affymetrix fluidics station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol using Affymetrixs IVT labeling kit following the manufacturers directions.","79":"NA","80":"Aug 28 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE119087","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Hybridized chips were scanned using Affymetrix genechip scanner 3000","97":"NA","98":"GSE14429","99":"NA","100":"NA","101":"NA","102":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 6hr","103":"Public on Jan 15 2009","104":"NA","105":"NA","106":"Jan 14 2009","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM360nnn/GSM360331/suppl/GSM360331.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Human embryonic kidney cells (HEK293) treated with epoxomicin for 6hr, replicate 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"1 uM epoxomicin is added to HEK293 cells and incubated for 1 and 6 hours before RNA extraction. RNA was extracted from cells without treatment at zero time point as control.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1254225","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293-CT.R1","18":"control","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Domaine de Vilvert, bat 442, INRA Micalis","38":"Jouy-en-Josas","39":"France","40":"Micalis Institute","41":"helene.bierne@inra.fr","42":"NA","43":"INRA","44":"EPIMIC","45":"Helene,,Bierne","46":"33134652289","47":"NA","48":"NA","49":"78350","50":"data were normalized with RMA, analysed with LPE with three FDR methods; the zreal value is indicated in the matrix","51":"28869","52":"NA","53":"Gene expression data","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the RNeasy Mini Kit (Qiagen), from three biological replicates, according to was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1254225","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown at 37C, in a humidified 10% CO2 incubator, in Dulbecco's modified Eagle's medium with GlutaMAX (Gibco) supplied with 10%FBS (Gibco) and 200 ug/ml Hygromycin B (10687-010-Invitrogen).","70":"NA","71":"NA","72":"Labeled cDNA was hybridized wiht GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) as described by the manufacturer.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"RNA was amplified with GeneChip WT cDNA Synthesis and Amplification Kit (Affymetrix) and biotin labeld with GeneChip WT Terminal Labeling Kit (Affymetrix) according to the manufacturer's","79":"NA","80":"Jan 20 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Microarrays was scanned with the Affymetrix GeneChip Scanner 7G and the FS450_0007 protocol , as recommended in the GeneChip Hybridization, Wash, and Stain Kit (Affymetrix)","97":"NA","98":"['GSE51863', 'GSE51868']","99":"NA","100":"NA","101":"NA","102":"HEK293-CT cells","103":"Public on Dec 11 2015","104":"NA","105":"NA","106":"Oct 29 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1254nnn/GSM1254225/suppl/GSM1254225_HEK293-CT.R1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293-CT.R1","117":"NA","118":"NA","119":"NA","120":"NA","121":"control","122":"HEK-BAHD1 were generated by integration of a single copy of the BAHD1 cDNA under the control of the human cytomegalovirus (CMV) immediate-early enhancer/promoter in the HEK293 genome. In the isogenic control line (HEK293-CT), the -galactosidase DNA sequence was inserted in place of BAHD1, albeit out-of-frame to avoid translation into protein.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM711416","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"HEK293Tcells_si75_rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"1000 E 50th St","38":"Kansas City","39":"USA","40":"Genomics","41":"seidel@phageT4.org","42":"NA","43":"Stowers Institute","44":"Seidel","45":"Chris,W,Seidel","46":"816 926 9054","47":"MO","48":"NA","49":"64110","50":"Array intensities were processed using the RMA algorithm in R/bioconductor. Bioconductor 2.6 and affy package affy_1.24.2","51":"54675","52":"NA","53":"Gene expression from HEK293T cells after transfection with siRNA s18075 targeting Med26, replicate 1.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the standard Qiagen RNeasy cleanup protocol.","61":"NA","62":"NA","63":"NA","64":"GSM711416","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in 6 well tissue culture plates or 10 cm dishes for 48 hours after transfection.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 plus 2.0 Arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the Ambion MessageAmp III protocol from 300 ng total RNA (MessageAmp III Amplification kit Manual, 2007, Ambion).","79":"NA","80":"Sep 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 and processed with AGCC v3.0 software.","97":"NA","98":"GSE28715","99":"NA","100":"Med26 targeting s18075","101":"NA","102":"HEK293T cells","103":"Public on Sep 01 2011","104":"NA","105":"NA","106":"Apr 19 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM711nnn/GSM711416/suppl/GSM711416_si-75-1_HG-U133_Plus_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293Tcells_si75_rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293T cells in 6 well tissue culture plates (~1x105 cells/well) or 10 cm dishes (~2 x106 cells/dish) were transfected with 25 nM siRNAs targeting human Med26 (Ambion/Applied Biosystems, #4, s18074; #5, s18075; #6, s18076) or 25 nM siCONTROL NON-TARGETING siRNA #2 (Dharmacon D-001210-01) using X-tremeGENE siRNA Transfection Reagent (Roche) and grown for 48 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM606065","2":"NA","3":"293teter","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"embryonic kidney cell","15":"NA","16":"NA","17":"293TetER doxycycline 48 h, rep1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"293TetER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"No 35, Keyan Road, Zhunan Town","38":"Miaoli Conunty","39":"Taiwan","40":"NA","41":"sflin1@gmail.com","42":"NA","43":"National Health Research Institutes, Taiwan","44":"NA","45":"Su-Fang,,Lin","46":"NA","47":"NA","48":"NA","49":"35053","50":"The data were analyzed using Affymetrix Expression Console Software (version 1.1) default analysis settings and RMA (Robust Multi-Array) summarization and normalization options.","51":"33297","52":"NA","53":"Cell densitiy was maintained at 200,000 / ml before induction.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using a RNeasy Mini kit (Qiagene), according to the manufacturers instructions. A 2-round amplification was performed with the ExpressArt TRinucleotide mRNA Amplification Kit (AmpTec) according to the manufacturers instructions.","61":"NA","62":"NA","63":"NA","64":"GSM606065","65":"NA","66":"NA","67":"NA","68":"NA","69":"Cells were grown to log-phase in DMEM supplemented with 10% tetracycline-free fetal bovine serum before induction.","70":"NA","71":"NA","72":"Samples were hybridized with GeneChip Human Gene 1.0 ST Arrays (Affymetrix) and scanned at the NHRI Microarray Core Facility (Miaoli County, Taiwan).","73":"NA","74":"NA","75":"NA","76":"transformed with sheared Ad5 DNA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA with the WT cDNA Synthesis Kit (Affymetrix) and then fragmented and labeled with the WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Mar 31 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Array scanning was performed according to the manufacturer's instruction (Affymetrix).","97":"NA","98":"['GSE24585', 'GSE24587']","99":"NA","100":"NA","101":"NA","102":"293 EBV Rta inducible line, doxycycline 48 h","103":"Public on Mar 31 2011","104":"NA","105":"NA","106":"Oct 07 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM606nnn/GSM606065/suppl/GSM606065.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"embryonic kidney cell","116":"293TetER doxycycline 48 h, rep1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were treated with doxycycline (50 nanogram/ml) for 48 h.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861813","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293-LPA-rep2","18":"lpa","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"10 Amistad Street","38":"New Haven","39":"USA","40":"NA","41":"dianqing.wu@yale.edu","42":"NA","43":"Yale University","44":"NA","45":"Dan,,Wu","46":"NA","47":"NA","48":"NA","49":"06510","50":"The data were analyzed with Microarray Suite version 5.0 (MAS 5.0) using Affymetrix default analysis settings and global scaling as normalization method.","51":"54675","52":"NA","53":"Gene expression data from HEK293 cells treatment with LPA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM861813","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were incubated in DMEM with 10% FBS","70":"NA","71":"NA","72":"After labeling the samples are prepared for hybridization and then rotate in oven at 45 degrees for 16 hours. GeneChips were washed and stained on GeneChip Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Fragment and label the single-stranded cDNA were prepared according to  the standard Affymetrix protocol (GeneChip WT Terminal Lableing and Hybridization User Manual).","79":"NA","80":"Jan 14 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 7G.","97":"NA","98":"GSE35084","99":"NA","100":"NA","101":"NA","102":"HEK293","103":"Public on Jan 14 2012","104":"NA","105":"NA","106":"Jan 13 2012","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861813/suppl/GSM861813_HEK293-LPA-2.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861813/suppl/GSM861813_HEK293-LPA-2.CHP.gz']","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293-LPA-rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"LPA","122":"The cells were incubated with serum-free medium for overnight and then stimulated with LPA (1uM) for 2 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733139","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070829 SM exposure 50 uM_24h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-02-26","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-14","53":"Gene expression data from NHEK_070829 SM exposure 50 uM_24h timepoint","54":"NA","55":"NA","56":"NA","57":"50.0","58":"2007-08-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733139","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-11","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-07-25","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070829 SM exposure 50 uM_24h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733139/suppl/GSM733139_070829_HD_24h_50.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"24","115":"NA","116":"NHEK_070829 SM exposure 50 uM_24h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1399573","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"78h after transfection","17":"shCTRL, bio. replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"615 N. Wolfe St.","38":"Baltimore","39":"USA","40":"NA","41":"NA","42":"NA","43":"Johns Hopkins University","44":"NA","45":"Jiou,,Wang","46":"NA","47":"MD","48":"NA","49":"21205","50":"[\"Affymetrix CEL files were extracted and their data normalized with the Partek GS 6.6 platform.  Partek's Extended Meta-Probeset set was used with RMA normalization to create quantile-normalized log2 transcript signal values, which were used in subsequent ANOVA analyses.\", 'probe group file: HuGene-1_0-st-v1.r4.pgf', 'meta-probeset file: HuGene-1_0-st-v1.na32.hg19.transcript.csv']","51":"33297","52":"NA","53":"SAMPLE 9","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Cells were lysed using RNAeasy mini kit (Qiagen), according to manufacturer's instructions. Genomic DNA was first removed by DNAse treatment on the column, and then, additionally, after total RNA was isolated, using DNase Turbo kit (Ambion), followed by additional round of cleaning through RNAeasy columns.","61":"NA","62":"NA","63":"NA","64":"GSM1399573","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells grown in DMEM, 10%FBS, 37C, 5% CO2","70":"NA","71":"NA","72":"17hrs at 45 C with rotation (60rpm) as described by Affymetrix in their GeneChip Expression Analysis Technical Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The Ambion Expression WT kit was used as described in the manufacturer's manual.","79":"NA","80":"Feb 09 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Using Affymetrix GeneChip Scanner 3000 7G and default parameters described by the manufacturer in their GeneChip Expression Analysis Technical Manual","97":"NA","98":"GSE58026","99":"NA","100":"NA","101":"NA","102":"HEK293_shCTRL","103":"Public on Feb 09 2017","104":"NA","105":"NA","106":"May 28 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1399nnn/GSM1399573/suppl/GSM1399573_GPer-SOD-C1_ctrl-1a-HuGene_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"78h after transfection","113":"NA","114":"NA","115":"NA","116":"shCTRL, bio. replicate 3","117":"NA","118":"non-targeting shRNA (control)","119":"NA","120":"NA","121":"NA","122":"Cells were transfected in 60mm dishes using 4g DNA, 10l Lipofectamine 2000, in total 4.5ml  Optimem-MEM1. Origene's pRS-RFP-C plasmids encoding shRNAs against UBE4B and LSD1, or non-targeting control (CTRL) were used for knockdown. Cells were knocked down for 78h before lysis.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM711417","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"HEK293Tcells_si75_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"1000 E 50th St","38":"Kansas City","39":"USA","40":"Genomics","41":"seidel@phageT4.org","42":"NA","43":"Stowers Institute","44":"Seidel","45":"Chris,W,Seidel","46":"816 926 9054","47":"MO","48":"NA","49":"64110","50":"Array intensities were processed using the RMA algorithm in R/bioconductor. Bioconductor 2.6 and affy package affy_1.24.2","51":"54675","52":"NA","53":"Gene expression from HEK293T cells after transfection with siRNA s18075 targeting Med26, replicate 2.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the standard Qiagen RNeasy cleanup protocol.","61":"NA","62":"NA","63":"NA","64":"GSM711417","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in 6 well tissue culture plates or 10 cm dishes for 48 hours after transfection.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 plus 2.0 Arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the Ambion MessageAmp III protocol from 300 ng total RNA (MessageAmp III Amplification kit Manual, 2007, Ambion).","79":"NA","80":"Sep 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 and processed with AGCC v3.0 software.","97":"NA","98":"GSE28715","99":"NA","100":"Med26 targeting s18075","101":"NA","102":"HEK293T cells","103":"Public on Sep 01 2011","104":"NA","105":"NA","106":"Apr 19 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM711nnn/GSM711417/suppl/GSM711417_si-75-2_HG-U133_Plus_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293Tcells_si75_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293T cells in 6 well tissue culture plates (~1x105 cells/well) or 10 cm dishes (~2 x106 cells/dish) were transfected with 25 nM siRNAs targeting human Med26 (Ambion/Applied Biosystems, #4, s18074; #5, s18075; #6, s18076) or 25 nM siCONTROL NON-TARGETING siRNA #2 (Dharmacon D-001210-01) using X-tremeGENE siRNA Transfection Reagent (Roche) and grown for 48 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733402","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071128 CEES exposure 3.5 uM_4h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-29","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-02-04","53":"Gene expression data from NHEK_071128 CEES exposure 3.5 uM_4h timepoint","54":"NA","55":"NA","56":"NA","57":"3.5","58":"2007-11-28","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733402","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-09","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-11","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071128 CEES exposure 3.5 uM_4h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733402/suppl/GSM733402_071128_CEES_4h_3.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"4","115":"NA","116":"NHEK_071128 CEES exposure 3.5 uM_4h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2236701","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"control 24h_2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Albert-Schweitzer Campus 1, Building D11","38":"Mnster","39":"Germany","40":"Centre of Reproductive Medicine and Andrology","41":"Jennifer.Borgmann@ukmuenster.de","42":"NA","43":"University Hospital Muenster","44":"NA","45":"Jennifer,,Borgmann","46":"NA","47":"NA","48":"NA","49":"48149","50":"Normalization, quality control, and output file (CHP format) generation was performed with Affymetrix Gene Expression Console v.3.1 using the Robust Multi-Chip Analysis (RMA) algorithm. Differently expressed genes were identified with Affymetrix transcriptome analysis console (TAC) v.2.0 (Affymetrix). Data were obtained using one-way analysis of variance (ANOVA) and p-value correction according to Benjamini and Hochberg False Discovery Rate (FDR) for multiple testing.","51":"33297","52":"NA","53":"['RMA expression value derived from Expression Console software v.3.1', 'Human_Gene_1_0_ST_20150205_6']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"After 24h and 48h of transfection, cells were washed with PBS and total RNA was isolated using Total RNA Isolation Kit (Agilent). The quality of the RNA was assessed with the Bioanalyzer 2100 (Agilent) and only samples with an RNA integrity number (RIN) > 7 were included in the analysis.","61":"NA","62":"NA","63":"NA","64":"GSM2236701","65":"NA","66":"NA","67":"NA","68":"NA","69":"Human Embryonic Kidney 293 (HEK293) cells (CLS, Eppelheim, Germany) were culture in DMEM/F12 1:1 (Gibco, Carlsbad, CA, USA) containing 10% (v/v) FCS (PAA Laboratories, Pasching, Austria), 1 % penicillinstreptomycin (Gibco) and 2 mM L-Glutamine (Gibco) at 37C and 5 % CO2 (v/v).Twenty four hours prior to transfection, HEK293 cells were seeded in 24-well plates (9x10^5).","70":"NA","71":"NA","72":"Samples were hybridized with  GeneCHip Human Gene 1.0 ST Arrays (Affymetrix) using GeneChip Hybridization, Wash, and Stain Kit (Affymetrix) and GeneChip Hybridization Control Kit (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Single-stranded cDNA was generated from the amplified cRNA  using  the  Ambion  WT  Expression  Kit (Thermo Fischer Sientific)  and then fragmented and labeled with the GeneChip WT Terminal Labeling Kit (Affymetrix).","79":"NA","80":"Jul 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Arrays  were  scanned  with  an Affymetrix GCS3000 7G using the AGCC Scan Control software.","97":"NA","98":"GSE84463","99":"NA","100":"NA","101":"NA","102":"HEK293, control vector, 24h","103":"Public on Jul 16 2016","104":"NA","105":"NA","106":"Jul 15 2016","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236701/suppl/GSM2236701_Human_Gene_1_0_ST_20150205_6.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2236nnn/GSM2236701/suppl/GSM2236701_Human_Gene_1_0_ST_20150205_6.chp.gz']","108":"9606","109":"NA","110":"24h","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"control 24h_2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transient transfection, wild type (RHOXF1: RG217618, RHOXF2: RG205957, pCMV6-AC-GFP: PS100010, OriGene, Rockville, MD, USA)  were mixed with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) in a 1:2,5 ratio. Cells were covered with 475 ml serum-free medium (DMEM/F12) and 25 l of the prepared DNA-lipofectamine complex was added.","123":"RNA","124":"NA","125":"NA","126":"empty control vector"},{"1":"GSM2089906","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U219 Array (hgu219)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T_siRNA(Qiagen kit)BRD1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Bartholins All 6","38":"Aarhus","39":"Denmark","40":"Biomedicine","41":"tue@biomed.au.dk","42":"NA","43":"Aarhus University","44":"Prof Anders Borglum's lab","45":"Tue,,Fryland","46":"NA","47":"Aarhus","48":"NA","49":"8000","50":"rma","51":"49386","52":"NA","53":"siRNA treatment targeted against the BRD1 mRNA transcript (Qiagen kit)","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Qiagen Rneasy + Qiagen shredder columns (performed according to the supplied protocol)","61":"NA","62":"NA","63":"NA","64":"GSM2089906","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells (controls and stable BRD1-S-V5 and BRD1-L-V5 cell lines) were grown in DMEM medium (Invitrogen, San Diego, CA, USA) supplemented with 5% fetal calf serum (FCS), 175 mg/L glutamine, 36 mg/L penicillin and 60 mg/L streptomycine at 37 oC in 5% CO2","70":"NA","71":"NA","72":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","79":"NA","80":"Mar 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL13667","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"standard Affymetrix protocol","97":"NA","98":"GSE79255","99":"NA","100":"NA","101":"NA","102":"Cell line culture, siRNA agianst BRD1 method 1","103":"Public on Mar 16 2016","104":"NA","105":"NA","106":"Mar 15 2016","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2089nnn/GSM2089906/suppl/GSM2089906_A897-01.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_siRNA(Qiagen kit)BRD1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733111","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070829 SM exposure 12.5 uM_4h timepoint","18":"NA","19":"SM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-02-25","29":"Phillips","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-14","53":"Gene expression data from NHEK_070829 SM exposure 12.5 uM_4h timepoint","54":"NA","55":"NA","56":"NA","57":"12.5","58":"2007-08-29","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733111","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-05-13","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Qiacube","91":"Qiacube","92":"NA","93":"NA","94":"NA","95":"2008-05-15","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070829 SM exposure 12.5 uM_4h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733111/suppl/GSM733111_070829_HD_4h_12.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"4","115":"NA","116":"NHEK_070829 SM exposure 12.5 uM_4h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610845","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"4hr","17":"HEK293T_miR-neg_FSK4hr_rep2","18":"NA","19":"FSK","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610845","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610845/suppl/GSM610845.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610845/suppl/GSM610845.chp.gz']","108":"9606","109":"4hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-neg_FSK4hr_rep2","117":"negative control","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM693941","2":"NA","3":"embryonic kidney cell line hek 293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"72h","17":"HEK293T_BACH1-esiRNA_72h_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"embryonic kidney cell line HEK 293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Ihnestrasse 63-73","38":"Berlin","39":"Germany","40":"Vertebrate Genomics","41":"warnatz@molgen.mpg.de","42":"NA","43":"Max Planck Institute for Molecular Genetics","44":"Gene Expression and Regulation","45":"Hans-Jrg,,Warnatz","46":"NA","47":"NA","48":"NA","49":"14195","50":"The array probe intensities from the knock-down samples were normalized together with those from the control samples using GC-RMA from the R/Bioconductor package  to give p-values from a Students t-test. The expression ratios for each probe were calculated as average of the ratios of the treated samples divided by the average of the ratios of the control samples.","51":"54675","52":"NA","53":"['Sample name: BACH1_e_2_72', 'BACH1_e_2_200ng_72h_293T.CEL', 'Gene expression data from HEK 293T cells 72h after knockdown of BACH1 with esiRNA.']","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from cultured cells at 24h and 72h post transfection using the RNeasy Mini Kit (Qiagen) following the manufacturers instructions. All RNA samples were treated on-column with RNase-free DNase I, quantified by UV spectrophotometry and controlled for integrity by gel electrophoresis and capillary electrophoresis using the Agilent 2100 bioanalyzer.","61":"NA","62":"NA","63":"BACH1 knockdown","64":"GSM693941","65":"NA","66":"NA","67":"NA","68":"NA","69":"The human embryonic kidney cell line HEK 293T/17 (CRL-11268 from ATCC) was cultured in DMEM low glucose (Invitrogen) supplemented with 100 U/ml Penicillin/G-Streptomycin (Invitrogen) and 10% heat-inactivated FBS (Biochrom) at 37C and 5% CO2","70":"NA","71":"NA","72":"Following integrity control using an Agilent 2100 bioanalyzer, the cRNA was fragmented and hybridized to the Affymetrix GeneChip Human Genome U133 Plus 2.0 (HG-U133Plus2).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Reverse transcription reactions were performed with random hexamer primers and SuperScript II reverse transcriptase (Invitrogen). Complementary DNA for quantitative real-time PCR analysis was prepared from 1 g of total RNA of each sample in 20 l reactions and diluted to 12.5 ng/l equivalent of total RNA. For hybridizations on microarrays, 1 g of DNA-free total RNA from each sample was used to synthetize biotinylated cRNA using the GeneChip Expression 3' Amplification One-Cycle Target Labeling and Control Reagents kit from Affymetrix (P/N 900493).","79":"NA","80":"May 14 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"The arrays were washed, stained, and scanned by the German Resource Center for Genome Research (RZPD) following recommended protocols from Affymetrix.","97":"NA","98":"['GSE28050', 'GSE28053']","99":"NA","100":"NA","101":"esiRNA (e)","102":"HEK 293T cells, BACH1 knockdown, 72h","103":"Public on May 13 2011","104":"NA","105":"NA","106":"Mar 21 2011","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693941/suppl/GSM693941.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM693nnn/GSM693941/suppl/GSM693941.EXP.gz']","108":"9606","109":"72h","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_BACH1-esiRNA_72h_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"For transfection, ca. 18,000 cells/cm were seeded in 12-well plates together with esiRNA/HiPerFect complexes (200 ng esiRNA/6 l HiPerFect per well) or siRNA/HiPerFect complexes (300 ng siRNA/6 l HiPerFect per well) according to the HiPerFect fast-forward protocol (Qiagen). For the mock transfections, cells were treated with HiPerFect reagent only.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM861632","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"Wild Type, leptin-stimulated, biological replicate 1","18":"100ng leptin","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"PO Box 800741","38":"Charlottesville","39":"USA","40":"NA","41":"NA","42":"NA","43":"University of Virginia","44":"NA","45":"Stephen,,Turner","46":"NA","47":"VA","48":"NA","49":"22908","50":"Data extraction, QC, and GCRMA normalization were performed with BioConductor software.  Differential expression was assessed with moderated ANOVA, using the BioConductor limma package; false discovery rate (FDR) estimates were calculated using the Benjamini-Hochberg method.","51":"54675","52":"NA","53":"Wild Type, leptin-stimulated, biological replicate 1","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was prepared using RNeasy Mini kit (QIAGEN) and its quality was verified in an Agilent Bioanalyzer.","61":"NA","62":"NA","63":"NA","64":"GSM861632","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T/17 cells were maintained in a humidified incubator at 37 C with 5% CO2. HEK293T/17 cells were cultured in DMEM/F12 (Gibco) with non-essential amino acids, sodium pyruvate and 10% heat inactivated FBS.  Jurkat T-cells were cultured in RPMI supplemented with 10% heat inactivated FBS.  Caco-2 cells were cultured in EMEM (Gibco) supplemented with non-essential amino acids, sodium pyruvate and 20% heat inactivated FBS.  Cells were discarded after passage 25 and new cultures were started from frozen stocks. HEK293T117 cells were transiently transfected using lipofectamine 2000 per the product instructions (Invitrogen, Carlsbad, CA). The plasmids mLEPRb/pCDNA3 (47), mLEPRbR223/pCDNA3 (35) and LEPRbDelta65/pCDNA3 (47) were obtained from Martin Myers and have been described previously as referenced. pCDNA3 was used as a vector control. The plasmid mLEPRb/pCDNA3 was used as a template for site-directed mutagenesis to construct mLEPRb985L/pCDNA3, LEPRb1077L/pCDNA3 and mLEPRb1138L/pCDNA3.  Site-directed mutagenesis was done using the quikchange kit (Stragene/Agilent, Santa Clara, CA).    The presence of the desired mutations and the absence of other mutations were confirmed by DNA sequencing.","70":"NA","71":"NA","72":"Three biological replicates of each sample were hybridized to Human Genome U133 Plus 2.0 gene chips (Affymetrix).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Total RNA was amplified and converted to cDNA using the 3' IVT Express Kit (Affymetrix).","79":"NA","80":"Jan 01 2015","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanned using the GeneChip Scanner 3000 7G (AffyMetrix).","97":"NA","98":"GSE35068","99":"NA","100":"NA","101":"NA","102":"Wild Type, leptin-stimulated","103":"Public on Jan 01 2015","104":"NA","105":"NA","106":"Jan 12 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM861nnn/GSM861632/suppl/GSM861632_WT-1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Wild Type, leptin-stimulated, biological replicate 1","117":"NA","118":"NA","119":"Wild-type leptin receptor","120":"NA","121":"100ng leptin","122":"HEK293 cells were transfected with WT LepR or Y1138L (STAT3-mutant) leptin receptor.  48 hours post-transfection cells were made quiescent by incubation in optimum plus 0.5% BSA for 3 hours.  Cells were then stimulated with 100ng of leptin or maintained in optimum plus 0.5% BSA for an additional 3 hours. Leptin was purchased from Dr. A.F. Parlow, National Hormone and Peptide Program (Torrance, CA). The STAT3 inhibitor, Stattic, the PI3K inhibitor, LY294002 and the MEK inhibitor PD98059 were purchased from EMD chemicals (Gibbstown, NJ).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874631","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"T6h","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874631","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Tamoxifen 6h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874631/suppl/GSM1874631_RG_31_4OHT_6h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"T6h","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1212438","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 2.0 ST Array (hugene20st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"TET1-CD","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1515 Holcombe Blvd","38":"Houston","39":"USA","40":"NA","41":"jincl1980@gmail.com","42":"NA","43":"The University of Texas MD Anderson Cancer Center","44":"NA","45":"CHUNLEI,,JIN","46":"NA","47":"TX","48":"NA","49":"77030","50":"The data were analyzed using the Affymetrix Gene Expression Console (v.1.3.1) with RMA (Robust Multi-array Average) normalization algorithm.","51":"53981","52":"NA","53":"Sample 5","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1212438","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were cultured in Dulbecco's Modified Eagle Medium modified with 10% fetal bovine serum and 100 g/ml streptomycin-penicillin.","70":"NA","71":"NA","72":"Affymetrix GeneChip Human Gene 2.0 ST arrays were hybridized to 5.5ug of biotin labeled cDNA, washed and stained according to Affymetrix protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"100 ng of total RNA were amplified using the Ambion WT Expression Kit and cDNA were biotin labelled using Affymetrix GeneChip WT Terminal Labeling protocol.","79":"NA","80":"Jun 04 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL16686","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using GeneChip Scanner 3000 (Affymetrix)","97":"NA","98":"['GSE44039', 'GSE50016']","99":"NA","100":"NA","101":"NA","102":"HEK293T_TET1-CD expression plasmid","103":"Public on Jun 04 2014","104":"NA","105":"NA","106":"Aug 20 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1212nnn/GSM1212438/suppl/GSM1212438_YC-04-03-2013-HuGene-TET1-CD_Temple.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"TET1-CD","117":"NA","118":"TET1-CD expression plasmid","119":"NA","120":"NA","121":"NA","122":"mTET1-CD, TET1-CD, mTET1-FL, TET1-FL expression plasmid or empty vector was transfected into HEK293T cells by using OPTI-MEM (Invitrogen) and FuGene HD transfection reagent (Roche). Three days after transfection, overexpressed cells were purified with fluorescent activated cell sortng. Lentiviral shRNA-mediated TET1 knockdown were also established in HEK293T cells, and one control and two TET1 knockdown clones were identified.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560860","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"0 h","17":"NOD2-L1007fsinsC_0h_MDP_biological replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 L1007fsinsC","63":"NA","64":"GSM560860","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560860/suppl/GSM560860.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"0 h","113":"NA","114":"NA","115":"NA","116":"NOD2-L1007fsinsC_0h_MDP_biological replicate 3","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM881025","2":"NA","3":"hek293f","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V4.0 expression beadchip (Illumina_HumanHT-12_V4.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"time point 4","17":"Non-producer culture - fermentation 2- time point 4","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"Hek293F","31":"NA","32":"NA","33":"1","34":"2","35":"NA","36":"NA","37":"Bldg 75","38":"Brisbane","39":"Australia","40":"Australian Institute for Bioengineering and Nanotechnology","41":"stefanie.dietmair@googlemail.com","42":"NA","43":"The University of Queensland","44":"NA","45":"Stefanie,,Dietmair","46":"NA","47":"QLD","48":"NA","49":"4072","50":"['The data from Genome studio was imported into GeneSpring version 11.5.1 (Agilent), log2 transformed and quantile normalised without baseline transformation. See Data table below.', \"A filter was applied to remove probes which were not expressed in 12/24 samples (the lower cut-off of the detection p-value was set to > 0.99).  See 'filtered_processed_data_matrix.txt' supplementary file on Series record.\"]","51":"47218","52":"NA","53":"Sample 23","54":"illuminaHumanv4","55":"98.15204","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using an RNeasy Midi Kit (75144, Qiagen, Doncaster, Australia) according to the manufacturers instructions including on-column digestion of DNA (79254, Qiagen).","61":"NA","62":"NA","63":"non-producing parent","64":"GSM881025","65":"NA","66":"NA","67":"NA","68":"NA","69":"Producer and non-producer cells were cultivated in 1.5 L of Freestyle 293 Expression Medium in a 3 L Applikon bioreactor (Z611000220, Applikon Biotechnologies, The Netherlands). Stirrer speed was 150 rpm, temperature was maintained at 37C, pH was controlled at 7.0 and pO2 at 50% air saturation. Duplicate samples for transcriptomics (total RNA) were taken approximately 30, 43, 51 and 67 hours after inoculation of the bioreactor.","70":"NA","71":"NA","72":"Hybridisation was performed according to the standard Illumina hybridization protocol.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The RNA was amplified and labelled using the Illumina TotalPrep RNA Amplification kit (IL1791, Ambion/Applied Biosystems, Austen, USA) according to the manufacturer's instructions.","79":"NA","80":"Dec 20 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL10558","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Scanning was performed according to the standard Illumina scanning protocol.","97":"NA","98":"GSE36094","99":"NA","100":"NA","101":"NA","102":"Non-producer culture - fermentation 2- time point 4","103":"Public on Dec 20 2012","104":"NA","105":"NA","106":"Feb 27 2012","107":"NONE","108":"9606","109":"time point 4","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"Non-producer culture - fermentation 2- time point 4","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Approximately 5 x 106 cells were removed from the bioreactor and centrifuged at 200 rcf for 2 min. The supernatant was discarded and the cell pellet frozen in liquid nitrogen and stored at -80C until extraction of RNA which was performed one day after sampling.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1087803","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"LIN28B_induced_rep1 [Affymetrix]","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1230 York Ave Box 186","38":"New York","39":"USA","40":"NA","41":"miguel.a.brown@gmail.com","42":"NA","43":"The Rockefeller University","44":"NA","45":"Miguel,,Brown","46":"NA","47":"New York","48":"NA","49":"10065","50":"We imported the CEL files into the R software (http://www.R-project.org) using the BioConductor affy package (Gentleman et al., 2004). The transcript probe set intensities were background-corrected, adjusted for non-specific binding and quantile normalized with the GCRMA algorithm (Wu, 2006). Probe sets with more than 6 of the 11 probes mapping ambiguously to the genome were discarded, as were probe sets that mapped to multiple genes. We then collected all probe sets matching a given gene, and we selected for further analysis the RefSeq transcript with median 3'UTR length corresponding to that gene. In total 16,063 transcripts were identified. The log-intensity of probe sets mapping to the gene were then averaged to obtain the expression level per RefSeq transcript. The changes of transcript abundances were computed as the logarithm of the ratio of transcript expression in the cocktails of siRNA treated samples and mock-transfected cells. Detailed analysis procedure can be found in the Supplement to Hafner et al. Cell, 2010,141(1),129-141 Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP","51":"13008","52":"NA","53":"Gene expression data from HEK293 cells inducibly expressing FLAG/HA tagged LIN28B; FH/LIN28B  induced","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1087803","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 T-REx Flp-In cells (Invitrogen) were grown in D-MEM high glucose with 10% (v/v) fetal bovine serum, 1% (v/v) 2 mM L-glutamine, 1% (v/v) 10,000 U/ml penicillin/10,000 g/ml streptomycin, 100 g/ml zeocin and 15 g/ml blasticidin. Cell lines stably expressing FLAG/HA-tagged proteins were generated by co-transfection of pFRT/TO/FLAG/HA or pFRT/FLAG/HA constructs with pOG44 (Invitrogen). Cells were selected by exchanging zeocin with 100 g/ml hygromycin. Expression of FLAG/HA-LIN28B was induced by addition of 250 ng/ml doxycycline 15 to 20 h before crosslinking.  Detailed experimental procedure can be found in the Methods section of Hafner et al., RNA, in press, Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition","70":"NA","71":"NA","72":"3 g cRNA hybridized to HGU133 Plus 2.0 Arrays for 16 h at 45C","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"2 g of purified total RNA was used in the One-Cycle Eukaryotic Target Labeling Assay (Affymetrix) according to manufacturer's protocol. Biotinylated cRNA targets were cleaned up, fragmented, and hybridized to Human Genome U133 Plus 2.0 Array (Affymetrix).","79":"NA","80":"Feb 26 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Genechips scanned on Affymetrix Genechip 300 7G scanner","97":"NA","98":"['GSE44613', 'GSE44616']","99":"NA","100":"NA","101":"NA","102":"HEK 293 cells expressing FLAG/HA tagged LIN28B; transgene expression induced; mock transfected; replicate 1","103":"Public on Feb 26 2013","104":"NA","105":"NA","106":"Feb 25 2013","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1087nnn/GSM1087803/suppl/GSM1087803_LIN28B_induced_rep1.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"LIN28B_induced_rep1 [Affymetrix]","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"siRNA transfections of HEK293 T-REx Flp-In cells were performed in 6-well format using Lipofectamine RNAiMAX (Invitrogen) as described by the manufacturer. Detailed experimental procedure can be found in the Methods section of Hafner et al., RNA, in press Identification of mRNAs bound and regulated by human LIN28 proteins and molecular requirements for RNA recognition","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM711420","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"human embryonic kidney","15":"NA","16":"NA","17":"HEK293Tcells_si76_rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"human embryonic kidney","33":"1","34":"NA","35":"NA","36":"NA","37":"1000 E 50th St","38":"Kansas City","39":"USA","40":"Genomics","41":"seidel@phageT4.org","42":"NA","43":"Stowers Institute","44":"Seidel","45":"Chris,W,Seidel","46":"816 926 9054","47":"MO","48":"NA","49":"64110","50":"Array intensities were processed using the RMA algorithm in R/bioconductor. Bioconductor 2.6 and affy package affy_1.24.2","51":"54675","52":"NA","53":"Gene expression from HEK293T cells after transfection with siRNA s18076 targeting Med26, replicate 2.","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted using the standard Qiagen RNeasy cleanup protocol.","61":"NA","62":"NA","63":"NA","64":"GSM711420","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in 6 well tissue culture plates or 10 cm dishes for 48 hours after transfection.","70":"NA","71":"NA","72":"Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Human Genome U133 plus 2.0 Arrays. GeneChips were washed and stained in the Affymetrix Fluidics Station 450.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the Ambion MessageAmp III protocol from 300 ng total RNA (MessageAmp III Amplification kit Manual, 2007, Ambion).","79":"NA","80":"Sep 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the GeneChip Scanner 3000 and processed with AGCC v3.0 software.","97":"NA","98":"GSE28715","99":"NA","100":"Med26 targeting s18076","101":"NA","102":"HEK293T cells","103":"Public on Sep 01 2011","104":"NA","105":"NA","106":"Apr 19 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM711nnn/GSM711420/suppl/GSM711420_si-76-2_HG-U133_Plus_2.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293Tcells_si76_rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293T cells in 6 well tissue culture plates (~1x105 cells/well) or 10 cm dishes (~2 x106 cells/dish) were transfected with 25 nM siRNAs targeting human Med26 (Ambion/Applied Biosystems, #4, s18074; #5, s18075; #6, s18076) or 25 nM siCONTROL NON-TARGETING siRNA #2 (Dharmacon D-001210-01) using X-tremeGENE siRNA Transfection Reagent (Roche) and grown for 48 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM560877","2":"NA","3":"hek-293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"6 h","17":"NOD2-L1007fsinsC_6h_MDP_biological replicate 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK-293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Schittenhelmstrae 12","38":"Kiel","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Institute of Clinical Molecular Biology Christian-Albrechts-Universitt Kiel","44":"NA","45":"Susanne,,Billmann","46":"NA","47":"NA","48":"NA","49":"D-24105","50":"The data were analyzed with Gene Chip Operating Software 1.1. Represents the relative level of expression of a transcript. The median of the data is identified and each datum is weighted by how far it is from the median using One-step Tukey's Biweight Algorithm. A weighted mean is then calculated.","51":"54675","52":"NA","53":"RNA from cell culture with different NOD2 genotypes","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"RNA was isolated using the RNeasy Kit (Qiagen)","61":"NA","62":"NOD2 L1007fsinsC","63":"NA","64":"GSM560877","65":"NA","66":"NA","67":"NA","68":"NA","69":"NOD2wt and NOD2-L1007fsinsC expressing cells were generated with the FLP-IN system (Invitrogen, Carlsbad, CA, USA). HEK 293 cells containing the recombination site were purchased from Invitrogen. Wildtype and mutated NOD2 were inserted to the genomic recombination site by FLP-recombinase enzyme. A control cell line was generated by transfecting an empty mock vector. All stable cell lines were selected for Hygromycin B resistance and consequently cultured in MEM + 10 % FCS + 1% Penicillin/Streptomycin + 50 g/ml Hygromycin B (Invitrogen).","70":"NA","71":"NA","72":"Following fragmentation, cRNA were hybridized for 16 hr at 45C on Affymetrix Human Genome U133 Plus 2.0 Array in a Affymetrix Hybridization Oven 640. GeneChips were washed and stained in the Affymetrix Fluidics Station.","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 1 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jan 01 2013","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner  3000.","97":"NA","98":"GSE22611","99":"NA","100":"NA","101":"NA","102":"HEK-293","103":"Public on Jan 01 2013","104":"Muramyl-dipeptide (MDP) 10 g/ml","105":"NA","106":"Jun 29 2010","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM560nnn/GSM560877/suppl/GSM560877.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"6 h","113":"NA","114":"NA","115":"NA","116":"NOD2-L1007fsinsC_6h_MDP_biological replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"FLP-IN HEK 293-NOD2wt, HEK 293-NOD2L1007fsinsC and HEK 293mock cells were cultivated in medium without FCS for 7 h before stimulation with 10 g/ml MDP for 0h, 2h and 6h. Cells were harvested simultaneously.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1874654","2":"NA","3":"hek293raf-1:er","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"ActD_1","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293Raf-1:ER","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Charitplatz 1","38":"Berlin","39":"Germany","40":"NA","41":"NA","42":"NA","43":"Charit - Universittsmedizin Berlin","44":"NA","45":"Florian,,Uhlitz","46":"NA","47":"NA","48":"NA","49":"10117","50":"All samples (except ActD-treated samples) were background normalised, quantile normalised and summarised in R with RMA (BioConductor package 'oligo'). ActD-treated samples were background normalised and summarised in R with RMA, but not quantile normalised. Instead, distributions were normalised to median value of long-lived genes identified in Friedel et al. 2009 and Yang et al. 2003.","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extraced with Trizol. RNA integrity was checked by analyzing on the 2100 Bioanalyzer. (Agilent technologies, PA, USA)","61":"NA","62":"NA","63":"NA","64":"GSM1874654","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293RAF1:ER cells were cultured in DMEM complete w/o phenol red. Cells were serum starved over night before treatment.","70":"NA","71":"NA","72":"The biotinylated DNA was added to a hybridization cocktail for hybridization to the Human/Mouse/Rat Gene 1.0ST Array, also containing 50pM control oligonucleotide B2, eukaryotic hybridization controls (bioB, bioC, bioD, 1,5, 5; 25 pM respectively), accordingly to the manufacturers protocol (Hybridization Wash and Stain Kit, Affymetrix). The hybridization in the Affymetrix hybridization oven 640 at 45C and 60 rpm for 16hrs, the staining and washing, processed in the Fluidics Station 450, were carried out as recommended by Affymetrix (Affymetrix Inc., Santa Clara, CA, USA).","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"For the first cycle cDNA synthesis 100 - 300ng of total RNA was used. During the following in vitro transcription reaction cRNA was obtained and used as starting material for the second cycle cDNA synthesis. The second cycle random-primed single strand DNA synthesis resulted in a product containing incorporated deoxyuridine at predefined ratios relative to thymidine WT Expression Plus Kit (Affymetrix Inc., Santa Clara, CA, USA). Subsequently, 5.5 g of this generated single-strand DNA was fragmented with a combination of uracil DNA glucosylase (UDG) and apurinic/apyrimidinic endonuclease 1 (APE1) and then labeled using the WT terminal labeling kit (Affymetrix catalogue #900671).","79":"NA","80":"Apr 29 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChipScanner 3000 G7","97":"NA","98":"['GSE72919', 'GSE93611']","99":"NA","100":"NA","101":"NA","102":"HEK293Raf-1:ER Actinomycin D 1h","103":"Public on Apr 28 2017","104":"NA","105":"NA","106":"Sep 10 2015","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1874nnn/GSM1874654/suppl/GSM1874654_RG_44_ActD_1h.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"ActD_1","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"Treatment durations lasted between 30 minutes and 10 hours.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733384","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_071128 CEES exposure 0.5 uM_1h timepoint","18":"NA","19":"CEES","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-04-22","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-30","53":"Gene expression data from NHEK_071128 CEES exposure 0.5 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"0.5","58":"2007-11-28","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733384","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-07-08","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-10","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_071128 CEES exposure 0.5 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733384/suppl/GSM733384_071128_CEES_1h_0.5.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_071128 CEES exposure 0.5 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM733152","2":"NA","3":"NA","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"primary human epidermal keratinocytes (nhek)","15":"NA","16":"NA","17":"NHEK_070912 NM exposure control 0 uM_1h timepoint","18":"NA","19":"NM","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"2008-03-11","29":"Rothwell","30":"NA","31":"NA","32":"primary human epidermal keratinocytes (NHEK)","33":"1","34":"NA","35":"NA","36":"NA","37":"3100 Ricketts Point Rd","38":"Aberdeen Proving Ground","39":"USA","40":"Cell and Molecular Biology Branch","41":"james.f.dillman2.civ@mail.mil","42":"NA","43":"U.S. Army Medical Research Institute of Chemical Defense","44":"Molecular Toxicology Team","45":"James,F,Dillman","46":"4104361723","47":"MD","48":"NA","49":"21010-5400","50":"Raw signal intensities were imported into Partek Genomics Solutions v6.5 (Partek, St. Louis, MO) and normalized using the robust multi-array averaging (RMA) algorithm.","51":"54675","52":"2008-01-24","53":"Gene expression data from NHEK_070912 NM exposure control 0 uM_1h timepoint","54":"NA","55":"NA","56":"NA","57":"0.0","58":"2007-09-12","59":"NA","60":"Cell lysates were collected in 400uL 1% beta-mercaptoethanol in RLT lysis buffer and processed through QIAshredder columns (QIAGEN, Valencia, CA) per the manufacturer's instructions.  Total RNA was extracted and DNase I-treated using the RNeasy Mini Kit and RNase-Free DNase Set (QIAGEN) according to the manufacturers protocol.  The quantity and quality of the RNA was determined with a NanoDrop ND-1000 UV-vis spectrophotometer (Thermo Scientific, Wilmington, DE) and an Agilent bioanalyzer (Agilent Technologies, Santa Clara, CA) throughout sample processing.","61":"NA","62":"NA","63":"NA","64":"GSM733152","65":"NA","66":"NA","67":"NA","68":"NA","69":"Normal human epidermal keratinocytes (NHEK) (Lonza, Walkersville, MD) were seeded at a density of 1.2 x103 cells per cm2 in 25 cm2 flasks, and grown to approximately 80 % confluency.  Cells were fed 24 hours prior to exposure with appropriate amount of media for final exposure concentration volume.  Cells were grown at 37C with 5% CO2.","70":"NA","71":"NA","72":"Spike controls were added to 15 g fragmented cRNA before hybridization (36h) using 10 g of cRNA.  Arrays were washed and stained with streptavidin-phycoerythrin before being scanned on an Affymetrix GeneChip Scanner.","73":"NA","74":"2008-06-17","75":"Rothwell","76":"NA","77":"biotin","78":"Total RNA was processed for hybridization to GeneChip Human Genome U133 Plus 2.0 oligonucleotide arrays (Affymetrix, Inc., Santa Clara, CA) using the BioArray Single-Round RNA Amplification and Biotin Labeling System (Enzo Life Sciences, Inc., Farmingdale, NY).  In brief, 10 g of total RNA was used to generate first strand cDNA by using a T7-linked oligo(dT) primer.  After second strand synthesis, in vitro transcription was performed with biotinylated UTP and CTP for cRNA amplification.","79":"NA","80":"Jun 15 2018","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"NA","89":"NA","90":"Manual","91":"Davidson","92":"NA","93":"NA","94":"NA","95":"2008-07-31","96":"After scanning, array images were assessed by eye to confirm scanner alignment and the absence of significant bubbles or scratches on the chip surface. The 3'/5' ratios for GAPDH and B-actin were checked for quality. BioB, BioC, BioD and CreX spike controls were also examined to determine sample quality. All arrays were scaled to a target intensity of 150 using Affymetrix GeneChip Operating System (GCOS) software.","97":"NA","98":"GSE29604","99":"NA","100":"NA","101":"NA","102":"NHEK_070912 NM exposure control 0 uM_1h timepoint","103":"Public on Jun 15 2018","104":"NA","105":"NA","106":"May 27 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM733nnn/GSM733152/suppl/GSM733152_070912_NM_1h_Control.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"1","115":"NA","116":"NHEK_070912 NM exposure control 0 uM_1h timepoint","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"On the day of exposure 1M stocks of either mechlorethamine hydrochloride (nitrogen mustard;NM) or 2-chloroethyl ethyl sulfide (CEES) were reconstituted in dimethyl sulphoxide (DMSO). From these stock solutions, 4 mM solutions in KGM Media (Lonza, Walkersville, MD) were made and immediately placed on ice prior to exposure.  A frozen aliquot of neat bis-(2-chloroethyl) sulfide (sulfur mustard;SM) in KGM was thawed and vortexed for 30 sec to generate a 4 mM stock SM solution. This solution was placed on ice immediately after generation prior to exposure.  Cells were exposed to 12.5M, 25M, 50uM, 100uM, 200uM, 400uM, 600uM, 800uM, and 1000uM NM or SM.  Cells were exposed to .1mM, .5mM, 1.0mM, 1.5mM, 2.0mM, 2.5mM, 3.0mM, 3.5 and 4.0mM CEES.  Post agent exposure cells were incubated in a chemical fume hood for one hour at 37C without CO2, and placed in tissue culture incubator at 37C with 5% CO2 for the remainder of the exposure period.  Exposure periods were 1hr, 2hr, 4hr, 8hr, 16hr, and 24hr.  Time matched controls were carried out with each exposure group.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM610844","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"1hr","17":"HEK293T_miR-381_FSK1hr_rep2","18":"NA","19":"FSK","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"835 BRB II/III, 421 Curie Blvd","38":"Philadelphia","39":"USA","40":"Pharmacology","41":"olarerin@mail.med.upenn.edu","42":"215-573-9004","43":"University of Pennsylvania","44":"Hogenesch Lab","45":"Anthony,O,Olarerin-George","46":"215-573-6197","47":"PA","48":"NA","49":"19153","50":"RMA normalized expression values calculated with Affymetrix Expression console","51":"33297","52":"NA","53":"NA","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA (including small RNAs) was extracted using Trizol (Invitrogen) and the aqueous phase was purified with RNeasy Mini kit (Qiagen) according to the manufacturers protocols.","61":"NA","62":"NA","63":"NA","64":"GSM610844","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells were grown in DMEM supplemented with 10% FBS and 1X PSG.","70":"NA","71":"NA","72":"The cRNA products were fragmented to 200 nucleotides or less, heated at 99 degrees C for 5 min and hybridized for 16 h at 45 degrees C. The microarrays were then washed at low (6X SSPE) and high (100mM MES, 0.1M NaCl) stringency and stained with streptavidin-phycoerythrin. Fluorescence was amplified by adding biotinylated anti-streptavidin and an additional aliquot of streptavidin-phycoerythrin stain.","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Second-strand cDNA synthesis was followed by in vitro transcription for linear amplification of each transcript and incorporation of biotinylated CTP and UTP.","79":"NA","80":"Jul 01 2011","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"A confocal scanner was used to collect fluorescence signal at 3um resolution after excitation at 570 nm. The average signal from two sequential scans was calculated for each microarray feature.","97":"NA","98":"GSE24812","99":"NA","100":"NA","101":"NA","102":"HEK 293T Human embryonic kidney cells","103":"Public on Jul 01 2011","104":"NA","105":"NA","106":"Oct 19 2010","107":"['ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610844/suppl/GSM610844.CEL.gz', 'ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM610nnn/GSM610844/suppl/GSM610844.chp.gz']","108":"9606","109":"1hr","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_miR-381_FSK1hr_rep2","117":"miR-381","118":"NA","119":"NA","120":"NA","121":"NA","122":"Cells were reverse transfected with RNA using Lipofectamine2000 at a final concentration of 50 nM.  Approximately 72hrs post-transfection, cells were treated with 15uM forskolin for 0, 1 or 4 hrs.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1039984","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T cell culture,untransfected,biological rep 2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"1901 Vine Street","38":"Lincoln","39":"USA","40":"Beadle Center for Biotechnology","41":"jeanjack@unl.edu","42":"NA","43":"University of Nebraska-Lincoln","44":"Bioinformatics Core Research Facility","45":"Jean-Jack,M.,Riethoven","46":"NA","47":"NE","48":"NA","49":"68588-0665","50":"The data was analysed using R  2.9.0 with Bioconductor 2.4. Arrays were normalised via RMA, and all treatments were compared to the control LA via the limma package. Benjamini-Hochberg adjusted p-values were used as significance measurement.","51":"54675","52":"NA","53":"GFPMINUS_2","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Trizol extraction of total RNA was performed according to the manufacturer's (Invitrogen) instructions.","61":"NA","62":"NA","63":"NA","64":"GSM1039984","65":"NA","66":"NA","67":"NA","68":"NA","69":"NA","70":"NA","71":"NA","72":"Following fragmentation, 15 ug of cRNA were hybridized for 16 hr at 45C, refer to GeneChip Expression Analysis Technical Manual (www.affymetrix.com). GeneChips were washed and stained with streptavidin-phycoerythrin conjugate on an Affymetrix Fluidics Station 450","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Biotinylated cRNA were prepared according to the standard Affymetrix protocol (reaction at 37C for 16h) from 15 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).","79":"NA","80":"Jul 22 2014","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL570","86":"NA","87":"NA","88":"Reanalyzed by: GSE59666","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G; Pixel size: 1.56 um; Filter: 570 nm","97":"NA","98":"['GSE20615', 'GSE59666']","99":"NA","100":"NA","101":"NA","102":"HEK293T human embryonic epithelial kidney cell culture,untransfected,biological rep 2_24h","103":"Public on Nov 21 2012","104":"NA","105":"NA","106":"Nov 21 2012","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1039nnn/GSM1039984/suppl/GSM1039984_AnP_Hu13302_062910_05_M27.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T cell culture,untransfected,biological rep 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM2089912","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Genome U219 Array (hgu219)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293T_stableexpression_BRD1-S (NM_001304809.1)","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"Bartholins All 6","38":"Aarhus","39":"Denmark","40":"Biomedicine","41":"tue@biomed.au.dk","42":"NA","43":"Aarhus University","44":"Prof Anders Borglum's lab","45":"Tue,,Fryland","46":"NA","47":"Aarhus","48":"NA","49":"8000","50":"rma","51":"49386","52":"NA","53":"Stable/episomal expression of His6/V5 tagged BRD1-S (refseq NM_001304809.1 )","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Qiagen Rneasy + Qiagen shredder columns (performed according to the supplied protocol)","61":"NA","62":"NA","63":"NA","64":"GSM2089912","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293T cells (controls and stable BRD1-S-V5 and BRD1-L-V5 cell lines) were grown in DMEM medium (Invitrogen, San Diego, CA, USA) supplemented with 5% fetal calf serum (FCS), 175 mg/L glutamine, 36 mg/L penicillin and 60 mg/L streptomycine at 37 oC in 5% CO2","70":"NA","71":"NA","72":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Affymetrix GeneChip Hybridization, Wash, and Stain Kit","79":"NA","80":"Mar 16 2016","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL13667","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"standard Affymetrix protocol","97":"NA","98":"GSE79255","99":"NA","100":"NA","101":"NA","102":"Cell line culture, stable/episomal expression BRD1-S","103":"Public on Mar 16 2016","104":"NA","105":"NA","106":"Mar 15 2016","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM2089nnn/GSM2089912/suppl/GSM2089912_A897-07.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"HEK293T_stableexpression_BRD1-S (NM_001304809.1)","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"NA","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM648457","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"empty vector control, biological rep2","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"3-1-1 Maidashi, Higashi-ku","38":"Fukuoka","39":"Japan","40":"Reseach Center for Genetic Information","41":"yiwasita@gen.kyushu-u.ac.jp","42":"+81-92-632-2375","43":"Kyushu University, Medical Institute of Bioregulation","44":"Division of Genome Analysis","45":"Yuji,,Iwashita","46":"+81-92-642-6170","47":"Fukuoka","48":"http://www.gen.kyushu-u.ac.jp/~genome/","49":"812-8582","50":"['Cel files were summarized and normalized with Robust Multi-array Average (RMA) method in Expression Console software version 1.1.1 (Affymetrix). Logarithmic signal intensities were antilog-transformed to linear scale using Expression Console.', 'probe group file: HuGene-1_0-st-v1.r3.pgf', 'meta-probeset file: HuGene-1_0-st-v1.r3.mps']","51":"33297","52":"NA","53":"neo-6","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Total RNA was extracted from triplicated transfectants for each plasmid using RNeasy plus mini kit (74134, Qiagen, Hilden, Germany). RNA quality was checked using 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA), and RNA Integrity Number (RIN) was confirmed to be 9.4 or greater for all samples. Total RNA at 200 ng was amplified and reverse-transcribed using GeneChip WT Sense Target Labeling and Control Reagents (900652, Affymetrix).","61":"NA","62":"NA","63":"NA","64":"GSM648457","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells were obtained from Clontech (Mountain View, MO) and maintained in Dulbeccos modified Eagles medium (D5796, Sigma-Aldrich, St. Louis, CA), supplemented with 10% fetal bovine serum, 100 units/ml penicillin and 100 g/ml streptomycin (15140-122, Invitrogen, Carlsbad, CA), in 5% CO2 at 37 C.","70":"NA","71":"NA","72":"Samples were hybridized using Affymetrix hybridization kit materials. The cocktails were heated at 99C for 5 minutes, then 45C for 5 minutes and centrifuged at max speed for 1 minute. The 80 l of hyb solution was transfered to each array, then seal the holes with sticker. They were hybridized for 18 hours in 45C hybridization oven at 60 rpm. Fluidics Script Protocol was FS450_0007","73":"NA","74":"NA","75":"NA","76":"NA","77":"Biotin","78":"Samples were enzymatically fragmented and biotinylated using the WT Terminal Labeling Kit (Affymetrix)","79":"NA","80":"Jan 31 2012","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Affymetrix GeneChiP Scanner 3000 7G","97":"NA","98":"GSE26420","99":"NA","100":"NA","101":"NA","102":"HEK293 cell clone stably transformed with pCI-neo (empty vector). Clone No.6","103":"Public on Jan 31 2012","104":"NA","105":"NA","106":"Jan 04 2011","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM648nnn/GSM648457/suppl/GSM648457.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"NA","114":"NA","115":"NA","116":"empty vector control, biological rep2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"HEK293 cells were transfected with pCI-neo (empty vector control) or pCI-neo-FLAG-HA-MIBP1 linearized with AclI and selected at 400 g/ml G418 (345812, Calbiochem, San Diego, CA) for 2 weeks. Selected cells were cloned using cloning rings and maintained in the presence of G418. Genomic integration and protein expression of MIBP1 were confirmed by genomic PCR and immunoblotting using anti-FLAG M2 antibody (Sigma-Aldrich).","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM1399575","2":"NA","3":"hek293t","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Affymetrix Human Gene 1.0 ST Array (hugene10st)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"78h after transfection","17":"shLSD1-3, bio. replicate 3","18":"NA","19":"NA","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293T","31":"NA","32":"NA","33":"1","34":"NA","35":"NA","36":"NA","37":"615 N. Wolfe St.","38":"Baltimore","39":"USA","40":"NA","41":"NA","42":"NA","43":"Johns Hopkins University","44":"NA","45":"Jiou,,Wang","46":"NA","47":"MD","48":"NA","49":"21205","50":"[\"Affymetrix CEL files were extracted and their data normalized with the Partek GS 6.6 platform.  Partek's Extended Meta-Probeset set was used with RMA normalization to create quantile-normalized log2 transcript signal values, which were used in subsequent ANOVA analyses.\", 'probe group file: HuGene-1_0-st-v1.r4.pgf', 'meta-probeset file: HuGene-1_0-st-v1.na32.hg19.transcript.csv']","51":"33297","52":"NA","53":"SAMPLE 11","54":"NA","55":"NA","56":"NA","57":"NA","58":"NA","59":"NA","60":"Cells were lysed using RNAeasy mini kit (Qiagen), according to manufacturer's instructions. Genomic DNA was first removed by DNAse treatment on the column, and then, additionally, after total RNA was isolated, using DNase Turbo kit (Ambion), followed by additional round of cleaning through RNAeasy columns.","61":"NA","62":"NA","63":"NA","64":"GSM1399575","65":"NA","66":"NA","67":"NA","68":"NA","69":"HEK293 cells grown in DMEM, 10%FBS, 37C, 5% CO2","70":"NA","71":"NA","72":"17hrs at 45 C with rotation (60rpm) as described by Affymetrix in their GeneChip Expression Analysis Technical Manual","73":"NA","74":"NA","75":"NA","76":"NA","77":"biotin","78":"The Ambion Expression WT kit was used as described in the manufacturer's manual.","79":"NA","80":"Feb 09 2017","81":"NA","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6244","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Using Affymetrix GeneChip Scanner 3000 7G and default parameters described by the manufacturer in their GeneChip Expression Analysis Technical Manual","97":"NA","98":"GSE58026","99":"NA","100":"NA","101":"NA","102":"HEK293_shLSD1","103":"Public on Feb 09 2017","104":"NA","105":"NA","106":"May 28 2014","107":"ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM1399nnn/GSM1399575/suppl/GSM1399575_GPer-SOD-C3_L-1a-HuGene_HuGene-1_0-st-v1_.CEL.gz","108":"9606","109":"NA","110":"NA","111":"NA","112":"78h after transfection","113":"NA","114":"NA","115":"NA","116":"shLSD1-3, bio. replicate 3","117":"NA","118":"shRNAs against LSD1","119":"NA","120":"NA","121":"NA","122":"Cells were transfected in 60mm dishes using 4g DNA, 10l Lipofectamine 2000, in total 4.5ml  Optimem-MEM1. Origene's pRS-RFP-C plasmids encoding shRNAs against UBE4B and LSD1, or non-targeting control (CTRL) were used for knockdown. Cells were knocked down for 78h before lysis.","123":"RNA","124":"NA","125":"NA","126":"NA"},{"1":"GSM678656","2":"NA","3":"hek293","4":"NA","5":"NA","6":"NA","7":"NA","8":"HOMO_SAPIENS","9":"Illumina HumanHT-12 V3.0 expression beadchip (Illumina_HumanHT-12_V3.0)","10":"NA","11":"NA","12":"NA","13":"GEO","14":"NA","15":"NA","16":"NA","17":"HEK293_Treated_1_h_Replicate 2","18":"NA","19":"Triptorelin","20":"NA","21":"NA","22":"NA","23":"NA","24":"NA","25":"NA","26":"NA","27":"NA","28":"NA","29":"NA","30":"HEK293","31":"NA","32":"NA","33":"1","34":"NA","35":"3","36":"NA","37":"Systems Medicine Building","38":"Carrington Crescent","39":"United Kingdom","40":"Institute of Genetics and Molecular Medicine","41":"andrew.sims@ed.ac.uk","42":"NA","43":"University of Edinburgh","44":"Applied Bioinformatics of Cancer","45":"Andrew,H,Sims","46":"NA","47":"Edinburgh","48":"NA","49":"EH4 2XR","50":"The data were normalised using quantile normalisation in BeadArray","51":"48803","52":"NA","53":"Sample name: 26","54":"illuminaHumanv3","55":"98.44078","56":"NA","57":"NA","58":"NA","59":"NA","60":"Absolutely RNA miniprep kit (Stratagene).","61":"NA","62":"NA","63":"NA","64":"GSM678656","65":"NA","66":"Undetectable","67":"NA","68":"NA","69":"HEK293 and SCL60 cells were grown in DMEM 10% FCS + P/S. SCL60 cells were supplemented with G418 (0.5mg/ml). Tissue culture plates were coated with a diluted Matrigel solution (200ul Matrigel per 6ml media, 37C for 1-2h, remove excess before gently adding cells) to assist cell adherence.","70":"NA","71":"NA","72":"Standard Illumina hybridisation protocol","73":"1","74":"NA","75":"NA","76":"NA","77":"biotin","78":"Illumina TotalPrep RNA Amplification Kit (Ambion)","79":"1","80":"Dec 21 2012","81":"100.00000","82":"total RNA","83":"NA","84":"Homo sapiens","85":"GPL6947","86":"NA","87":"NA","88":"NA","89":"NA","90":"NA","91":"NA","92":"NA","93":"NA","94":"NA","95":"NA","96":"Standard Illumina scanning protocol","97":"NA","98":"GSE27467","99":"NA","100":"NA","101":"NA","102":"HEK293 (unresponsive parental cells)","103":"Public on Dec 21 2012","104":"NA","105":"NA","106":"Feb 23 2011","107":"NONE","108":"9606","109":"NA","110":"NA","111":"NA","112":"NA","113":"1","114":"NA","115":"NA","116":"HEK293_Treated_1_h_Replicate 2","117":"NA","118":"NA","119":"NA","120":"NA","121":"NA","122":"100nM Triptorelin (Sigma)","123":"RNA","124":"NA","125":"NA","126":"NA"}],"options":{"columns":{"min":{},"max":[10],"total":[126]},"rows":{"min":[10],"max":[10],"total":[622]},"pages":{}}}
  </script>
</div>
<!-- rnb-frame-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
</div>
<div id="perform-principal-components-analysis" class="section level2">
<h2>3) Perform Principal Components Analysis</h2>
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuIyBDYWxjdWxhdGUgUENBXG5wY2EgPC0gcHJjb21wKHQoZGYpKVxuIyBNYWtlIGludG8gZGF0YWZyYW1lIGZvciBwbG90dGluZyB3aXRoIGdncGxvdDJcbnBjYS5kZiA8LSBkYXRhLmZyYW1lKHBjYSR4WywgMToyXSwgXG4gICAgICAgICAgICAgICAgICAgICBkYXRhc2V0ID0gbWV0YWRhdGEkc2VyaWVzX2lkKVxuYGBgIn0= -->
<pre class="r"><code># Calculate PCA
pca &lt;- prcomp(t(df))
# Make into dataframe for plotting with ggplot2
pca.df &lt;- data.frame(pca$x[, 1:2], 
                     dataset = metadata$series_id)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<p>Plot these PC scores. We will likely see a difference between the datasets.</p>
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuZ2dwbG90KHBjYS5kZiwgYWVzKHggPSBQQzEsIHkgPSBQQzIsIGNvbG9yID0gZGF0YXNldCkpICtcbiAgZ2VvbV9wb2ludCgpICsgXG4gIHRoZW1lKGxlZ2VuZC5wb3NpdGlvbiA9IFwibm9uZVwiKSArXG4gIGdndGl0bGUoXCJOb24tYmF0Y2ggY29ycmVjdGVkXCIpXG5gYGAifQ== -->
<pre class="r"><code>ggplot(pca.df, aes(x = PC1, y = PC2, color = dataset)) +
  geom_point() + 
  theme(legend.position = &quot;none&quot;) +
  ggtitle(&quot;Non-batch corrected&quot;)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-plot-begin eyJjb25kaXRpb25zIjpbXSwiaGVpZ2h0Ijo0MzIuNjMyOSwic2l6ZV9iZWhhdmlvciI6MCwid2lkdGgiOjcwMH0= -->
<p><img src="data:image/png;base64,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" /></p>
<!-- rnb-plot-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
</div>
<div id="peform-combat-correction" class="section level2">
<h2>4) Peform ComBat correction</h2>
<p>To run ComBat, we need batch information, in this case we will use the dataset ids.</p>
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuY29ycmVjdGVkLmRmIDwtIHN2YTo6Q29tQmF0KGFzLm1hdHJpeChkZiksIG1ldGFkYXRhJHNlcmllc19pZClcbmBgYCJ9 -->
<pre class="r"><code>corrected.df &lt;- sva::ComBat(as.matrix(df), metadata$series_id)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-output-begin eyJkYXRhIjoiRm91bmQ2NmJhdGNoZXNcbk5vdGU6IG9uZSBiYXRjaCBoYXMgb25seSBvbmUgc2FtcGxlLCBzZXR0aW5nIG1lYW4ub25seT1UUlVFXG5BZGp1c3RpbmcgZm9yMGNvdmFyaWF0ZShzKSBvciBjb3ZhcmlhdGUgbGV2ZWwocylcbiJ9 -->
<pre><code>Found66batches
Note: one batch has only one sample, setting mean.only=TRUE
Adjusting for0covariate(s) or covariate level(s)</code></pre>
<!-- rnb-output-end -->
<!-- rnb-output-begin eyJkYXRhIjoiU3RhbmRhcmRpemluZyBEYXRhIGFjcm9zcyBnZW5lc1xuIn0= -->
<pre><code>Standardizing Data across genes</code></pre>
<!-- rnb-output-end -->
<!-- rnb-output-begin eyJkYXRhIjoiRml0dGluZyBML1MgbW9kZWwgYW5kIGZpbmRpbmcgcHJpb3JzXG5GaW5kaW5nIHBhcmFtZXRyaWMgYWRqdXN0bWVudHNcbkFkanVzdGluZyB0aGUgRGF0YVxuIn0= -->
<pre><code>Fitting L/S model and finding priors
Finding parametric adjustments
Adjusting the Data</code></pre>
<!-- rnb-output-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
</div>
<div id="re-evaluate-pca-after-batch-correction" class="section level2">
<h2>5) Re-evaluate PCA after batch correction</h2>
<p>Lets see if ComBat helped with making PC scores less divided by batches.</p>
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuIyBDYWxjdWxhdGUgUENBXG5jb3JyZWN0ZWQucGNhIDwtIHByY29tcCh0KGNvcnJlY3RlZC5kZikpXG4jIE1ha2UgaW50byBkYXRhZnJhbWUgZm9yIHBsb3R0aW5nIHdpdGggZ2dwbG90MlxuY29ycmVjdGVkLnBjYS5kZiA8LSBkYXRhLmZyYW1lKGNvcnJlY3RlZC5wY2EkeFssIDE6Ml0sIFxuICAgICAgICAgICAgICAgICAgICAgICAgICAgICAgIGRhdGFzZXQgPSBtZXRhZGF0YSRzZXJpZXNfaWQpXG5gYGAifQ== -->
<pre class="r"><code># Calculate PCA
corrected.pca &lt;- prcomp(t(corrected.df))
# Make into dataframe for plotting with ggplot2
corrected.pca.df &lt;- data.frame(corrected.pca$x[, 1:2], 
                               dataset = metadata$series_id)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<p>Plot these batch corrected data PC scores.</p>
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuZ2dwbG90KGNvcnJlY3RlZC5wY2EuZGYsIGFlcyh4ID0gUEMxLCB5ID0gUEMyLCBjb2xvciA9IGRhdGFzZXQpKSArXG4gIGdlb21fcG9pbnQoKSArIFxuICB0aGVtZShsZWdlbmQucG9zaXRpb24gPSBcIm5vbmVcIikgK1xuICBnZ3RpdGxlKFwiQmF0Y2ggY29ycmVjdGVkXCIpXG5gYGAifQ== -->
<pre class="r"><code>ggplot(corrected.pca.df, aes(x = PC1, y = PC2, color = dataset)) +
  geom_point() + 
  theme(legend.position = &quot;none&quot;) +
  ggtitle(&quot;Batch corrected&quot;)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-plot-begin eyJjb25kaXRpb25zIjpbXSwiaGVpZ2h0Ijo0MzIuNjMyOSwic2l6ZV9iZWhhdmlvciI6MCwid2lkdGgiOjcwMH0= -->
<p><img src="data:image/png;base64,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" /></p>
<!-- rnb-plot-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
</div>
<div id="save-batch-corrected-data-to-tsv-file" class="section level2">
<h2>6) Save batch corrected data to tsv file</h2>
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuY29ycmVjdGVkLmRmICU+JSBhcy5kYXRhLmZyYW1lKCkgJT4lIFxuICB0aWJibGU6OnJvd25hbWVzX3RvX2NvbHVtbihcImdlbmVcIikgJT4lXG4gIHJlYWRyOjp3cml0ZV90c3YoXCJIRUsyOTNfYmF0Y2hfY29ycmVjdGVkX2V4cHJzLnRzdlwiKVxuYGBgIn0= -->
<pre class="r"><code>corrected.df %&gt;% as.data.frame() %&gt;% 
  tibble::rownames_to_column(&quot;gene&quot;) %&gt;%
  readr::write_tsv(&quot;HEK293_batch_corrected_exprs.tsv&quot;)</code></pre>
<!-- rnb-source-end -->
<!-- rnb-chunk-end -->
<!-- rnb-text-begin -->
<p>Session info:</p>
<!-- rnb-text-end -->
<!-- rnb-chunk-begin -->
<!-- rnb-source-begin eyJkYXRhIjoiYGBgclxuIyBQcmludCBzZXNzaW9uIGluZm8gXG5zZXNzaW9uSW5mbygpXG5gYGAifQ== -->
<pre class="r"><code># Print session info 
sessionInfo()</code></pre>
<!-- rnb-source-end -->
<!-- rnb-output-begin 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 -->
<pre><code>R version 3.5.1 (2018-07-02)
Platform: x86_64-apple-darwin17.6.0 (64-bit)
Running under: macOS  10.14.3

Matrix products: default
BLAS: /System/Library/Frameworks/Accelerate.framework/Versions/A/Frameworks/vecLib.framework/Versions/A/libBLAS.dylib
LAPACK: /System/Library/Frameworks/Accelerate.framework/Versions/A/Frameworks/vecLib.framework/Versions/A/libLAPACK.dylib

locale:
[1] en_US.UTF-8/en_US.UTF-8/en_US.UTF-8/C/en_US.UTF-8/en_US.UTF-8

attached base packages:
[1] stats     graphics  grDevices utils     datasets  methods   base     

other attached packages:
 [1] bindrcpp_0.2.2       BiocInstaller_1.30.0 PLIER_0.99.0         qvalue_2.14.1       
 [5] rsvd_1.0.0           knitr_1.22           glmnet_2.0-16        foreach_1.4.4       
 [9] Matrix_1.2-17        pheatmap_1.0.12      gplots_3.0.1.1       RColorBrewer_1.1-2  
[13] ggplot2_3.1.1       

loaded via a namespace (and not attached):
 [1] nlme_3.1-138         fs_1.2.7             bitops_1.0-6         matrixStats_0.54.0  
 [5] usethis_1.5.0        devtools_2.0.1       bit64_0.9-7          rprojroot_1.3-2     
 [9] backports_1.1.3      tools_3.5.1          R6_2.4.0             KernSmooth_2.23-15  
[13] DBI_1.0.0            lazyeval_0.2.2       BiocGenerics_0.26.0  mgcv_1.8-28         
[17] colorspace_1.4-1     withr_2.1.2          tidyselect_0.2.5     prettyunits_1.0.2   
[21] processx_3.3.0       bit_1.1-14           compiler_3.5.1       cli_1.1.0           
[25] Biobase_2.40.0       desc_1.2.0           labeling_0.3         caTools_1.17.1.2    
[29] scales_1.0.0         readr_1.3.1          genefilter_1.64.0    callr_3.2.0         
[33] stringr_1.4.0        digest_0.6.18        rmarkdown_1.12       base64enc_0.1-3     
[37] pkgconfig_2.0.2      htmltools_0.3.6      sessioninfo_1.1.1    limma_3.36.5        
[41] rlang_0.3.4          rstudioapi_0.10      RSQLite_2.1.1        bindr_0.1.1         
[45] jsonlite_1.6         BiocParallel_1.16.6  gtools_3.8.1         dplyr_0.7.8         
[49] RCurl_1.95-4.12      magrittr_1.5         Rcpp_0.12.19         munsell_0.5.0       
[53] S4Vectors_0.18.3     stringi_1.4.3        yaml_2.2.0           org.Hs.eg.db_3.6.0  
[57] pkgbuild_1.0.3       plyr_1.8.4           grid_3.5.1           blob_1.1.1          
[61] parallel_3.5.1       gdata_2.18.0         crayon_1.3.4         lattice_0.20-38     
[65] splines_3.5.1        annotate_1.60.1      hms_0.4.2            ps_1.3.0            
[69] pillar_1.3.1         reshape2_1.4.3       codetools_0.2-16     stats4_3.5.1        
[73] pkgload_1.0.2        XML_3.98-1.19        glue_1.3.1           evaluate_0.13       
[77] remotes_2.0.2        data.table_1.12.2    testthat_2.0.1       gtable_0.3.0        
[81] purrr_0.3.2          assertthat_0.2.0     xfun_0.6             xtable_1.8-3        
[85] survival_2.42-6      tibble_2.1.1         iterators_1.0.10     AnnotationDbi_1.42.1
[89] memoise_1.1.0        IRanges_2.14.12      sva_3.28.0          </code></pre>
<!-- rnb-output-end -->
<!-- rnb-chunk-end -->
</div>

<div id="rmd-source-code">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</div>


</div>
</div>

</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.header').parent('thead').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});

$(document).ready(function () {
  $('.knitsql-table').addClass('kable-table');
  var container = $('.kable-table');
  container.each(function() {

    // move the caption out of the table
    var table = $(this).children('table');
    var caption = table.children('caption').detach();
    caption.insertBefore($(this)).css('display', 'inherit');
  });
});

</script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
